0001656472-20-000073.txt : 20200806 0001656472-20-000073.hdr.sgml : 20200806 20200806073704 ACCESSION NUMBER: 0001656472-20-000073 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 121 CONFORMED PERIOD OF REPORT: 20200630 FILED AS OF DATE: 20200806 DATE AS OF CHANGE: 20200806 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cronos Group Inc. CENTRAL INDEX KEY: 0001656472 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 000000000 STATE OF INCORPORATION: A6 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-38403 FILM NUMBER: 201079851 BUSINESS ADDRESS: STREET 1: 111 PETER STREET STREET 2: SUITE 300 CITY: TORONTO STATE: A6 ZIP: M5V 2G9 BUSINESS PHONE: (416) 504-0004 MAIL ADDRESS: STREET 1: 111 PETER STREET STREET 2: SUITE 300 CITY: TORONTO STATE: A6 ZIP: M5V 2G9 FORMER COMPANY: FORMER CONFORMED NAME: PharmaCan Capital Corp. DATE OF NAME CHANGE: 20151021 10-Q 1 cron-20200630.htm 10-Q cron-20200630
false2020Q20001656472--12-31.3333.3333.333300016564722020-01-012020-06-30xbrli:shares00016564722020-08-05iso4217:USD00016564722020-06-3000016564722019-12-3100016564722020-04-012020-06-3000016564722019-04-012019-06-3000016564722019-01-012019-06-30iso4217:USDxbrli:shares0001656472us-gaap:CommonStockMember2020-03-310001656472us-gaap:AdditionalPaidInCapitalMember2020-03-310001656472us-gaap:RetainedEarningsMember2020-03-310001656472us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-03-310001656472us-gaap:NoncontrollingInterestMember2020-03-3100016564722020-03-310001656472us-gaap:AdditionalPaidInCapitalMember2020-04-012020-06-300001656472us-gaap:CommonStockMember2020-04-012020-06-300001656472us-gaap:RetainedEarningsMember2020-04-012020-06-300001656472us-gaap:NoncontrollingInterestMember2020-04-012020-06-300001656472us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-04-012020-06-300001656472us-gaap:CommonStockMember2020-06-300001656472us-gaap:AdditionalPaidInCapitalMember2020-06-300001656472us-gaap:RetainedEarningsMember2020-06-300001656472us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-06-300001656472us-gaap:NoncontrollingInterestMember2020-06-300001656472us-gaap:CommonStockMember2019-03-310001656472us-gaap:AdditionalPaidInCapitalMember2019-03-310001656472us-gaap:RetainedEarningsMember2019-03-310001656472us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-03-310001656472us-gaap:NoncontrollingInterestMember2019-03-3100016564722019-03-310001656472us-gaap:CommonStockMember2019-04-012019-06-300001656472us-gaap:AdditionalPaidInCapitalMember2019-04-012019-06-300001656472us-gaap:RetainedEarningsMember2019-04-012019-06-300001656472us-gaap:NoncontrollingInterestMember2019-04-012019-06-300001656472us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-04-012019-06-300001656472us-gaap:CommonStockMember2019-06-300001656472us-gaap:AdditionalPaidInCapitalMember2019-06-300001656472us-gaap:RetainedEarningsMember2019-06-300001656472us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-06-300001656472us-gaap:NoncontrollingInterestMember2019-06-3000016564722019-06-300001656472us-gaap:CommonStockMember2019-12-310001656472us-gaap:AdditionalPaidInCapitalMember2019-12-310001656472us-gaap:RetainedEarningsMember2019-12-310001656472us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-12-310001656472us-gaap:NoncontrollingInterestMember2019-12-310001656472us-gaap:AdditionalPaidInCapitalMember2020-01-012020-06-300001656472us-gaap:CommonStockMember2020-01-012020-06-300001656472us-gaap:RetainedEarningsMember2020-01-012020-06-300001656472us-gaap:NoncontrollingInterestMember2020-01-012020-06-300001656472us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-01-012020-06-300001656472us-gaap:CommonStockMember2018-12-310001656472us-gaap:AdditionalPaidInCapitalMember2018-12-310001656472us-gaap:RetainedEarningsMember2018-12-310001656472us-gaap:AccumulatedOtherComprehensiveIncomeMember2018-12-310001656472us-gaap:NoncontrollingInterestMember2018-12-3100016564722018-12-310001656472us-gaap:CommonStockMember2019-01-012019-06-300001656472us-gaap:AdditionalPaidInCapitalMember2019-01-012019-06-300001656472us-gaap:RetainedEarningsMember2019-01-012019-06-300001656472us-gaap:NoncontrollingInterestMember2019-01-012019-06-300001656472us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-01-012019-06-30cron:continentcron:brandcron:venturexbrli:pure0001656472cron:CronosAustraliaLimitedMember2020-06-300001656472cron:CronosIsraelG.S.CultivationsLtd.Member2020-01-012020-06-300001656472cron:CronosIsraelG.S.ManufacturingLtd.Member2020-01-012020-06-300001656472cron:CronosIsraelG.S.StoreLtd.Member2020-01-012020-06-300001656472cron:CronosIsraelG.S.PharmaciesLtd.Member2020-01-012020-06-30cron:reportingUnit0001656472cron:InventoryDryCannabisMember2020-06-300001656472cron:InventoryDryCannabisMember2019-06-300001656472cron:InventoryCannabisExtractsMember2020-06-300001656472cron:InventoryCannabisExtractsMember2019-06-300001656472us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMembercron:CronosGrowingCompanyInc.Member2018-06-142018-06-140001656472us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMembercron:NatueraMember2020-01-012020-06-300001656472us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMembercron:MedMenCanadaInc.Membersrt:MinimumMember2018-03-132018-03-130001656472us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMembercron:MedMenCanadaInc.Member2018-03-132018-03-13iso4217:ILS0001656472us-gaap:VariableInterestEntityPrimaryBeneficiaryMembercron:CannasoulAnalyticsLtdMemberus-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember2020-06-300001656472us-gaap:VariableInterestEntityPrimaryBeneficiaryMembercron:CannasoulAnalyticsLtdMemberus-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember2020-01-012020-06-300001656472cron:CronosAustraliaLimitedMember2019-12-310001656472cron:CronosGrowingCompanyInc.Member2020-06-300001656472cron:CronosGrowingCompanyInc.Member2019-12-310001656472cron:MedMenCanadaInc.Member2020-06-300001656472cron:MedMenCanadaInc.Member2019-12-310001656472cron:NatueraMember2020-06-300001656472cron:NatueraMember2019-12-310001656472cron:CronosAustraliaLimitedMemberus-gaap:IPOMember2019-10-252019-10-250001656472cron:CronosAustraliaLimitedMemberus-gaap:IPOMember2019-10-250001656472us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMembercron:CronosAustraliaLimitedMember2019-11-062019-11-060001656472us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMembercron:CronosAustraliaLimitedMember2019-11-072019-11-070001656472cron:WhistlerMedicalMarijuanaCompanyMember2020-04-012020-06-300001656472cron:WhistlerMedicalMarijuanaCompanyMember2019-04-012019-06-300001656472cron:WhistlerMedicalMarijuanaCompanyMember2020-01-012020-06-300001656472cron:WhistlerMedicalMarijuanaCompanyMember2019-01-012019-06-300001656472cron:CronosAustraliaLimitedMember2020-04-012020-06-300001656472cron:CronosAustraliaLimitedMember2019-04-012019-06-300001656472cron:CronosAustraliaLimitedMember2020-01-012020-06-300001656472cron:CronosAustraliaLimitedMember2019-01-012019-06-300001656472cron:CronosGrowingCompanyInc.Member2020-04-012020-06-300001656472cron:CronosGrowingCompanyInc.Member2019-04-012019-06-300001656472cron:CronosGrowingCompanyInc.Member2020-01-012020-06-300001656472cron:CronosGrowingCompanyInc.Member2019-01-012019-06-300001656472cron:MedMenCanadaInc.Member2020-04-012020-06-300001656472cron:MedMenCanadaInc.Member2019-04-012019-06-300001656472cron:MedMenCanadaInc.Member2020-01-012020-06-300001656472cron:MedMenCanadaInc.Member2019-01-012019-06-300001656472cron:NatueraMember2020-04-012020-06-300001656472cron:NatueraMember2019-04-012019-06-300001656472cron:NatueraMember2020-01-012020-06-300001656472cron:NatueraMember2019-01-012019-06-300001656472cron:CronosAustraliaLimitedMember2019-06-300001656472cron:MedMenCanadaInc.Member2018-12-310001656472cron:CronosGrowingCompanyInc.Member2018-12-310001656472cron:CronosAustraliaLimitedMember2018-12-310001656472cron:NatueraMember2018-12-310001656472cron:MedMenCanadaInc.Member2019-01-012019-12-310001656472cron:CronosGrowingCompanyInc.Member2019-01-012019-12-310001656472cron:CronosAustraliaLimitedMember2019-01-012019-12-310001656472cron:NatueraMember2019-01-012019-12-3100016564722019-01-012019-12-31iso4217:AUD0001656472cron:AuroraCannabisInc.Memberus-gaap:EquitySecuritiesMember2020-01-012020-06-30cron:milestone0001656472cron:WhistlerMedicalMarijuanaCompanyMemberus-gaap:EquitySecuritiesMember2020-06-30utr:D0001656472cron:WhistlerMedicalMarijuanaCompanyMemberus-gaap:EquitySecuritiesMember2019-03-042019-03-040001656472cron:AuroraCannabisInc.Memberus-gaap:EquitySecuritiesMember2019-03-042019-03-040001656472cron:AuroraCannabisInc.Memberus-gaap:EquitySecuritiesMember2019-01-012019-06-300001656472cron:CanopyGrowthCorporationMemberus-gaap:EquitySecuritiesMember2019-01-012019-06-300001656472cron:AOCIAccumulatedGainLossRevaluationAndDisposalOfOtherInvestmentsParentMemberMember2020-03-310001656472cron:AOCIAccumulatedGainLossRevaluationAndDisposalOfOtherInvestmentsParentMemberMember2019-03-310001656472cron:AOCIAccumulatedGainLossRevaluationAndDisposalOfOtherInvestmentsParentMemberMember2019-12-310001656472cron:AOCIAccumulatedGainLossRevaluationAndDisposalOfOtherInvestmentsParentMemberMember2018-12-310001656472cron:AOCIAccumulatedGainLossRevaluationAndDisposalOfOtherInvestmentsParentMemberMemberus-gaap:AccountingStandardsUpdate201601Member2020-04-010001656472cron:AOCIAccumulatedGainLossRevaluationAndDisposalOfOtherInvestmentsParentMemberMemberus-gaap:AccountingStandardsUpdate201601Member2019-04-010001656472cron:AOCIAccumulatedGainLossRevaluationAndDisposalOfOtherInvestmentsParentMemberMemberus-gaap:AccountingStandardsUpdate201601Member2020-01-010001656472cron:AOCIAccumulatedGainLossRevaluationAndDisposalOfOtherInvestmentsParentMemberMemberus-gaap:AccountingStandardsUpdate201601Member2019-01-010001656472cron:AOCIAccumulatedGainLossRevaluationAndDisposalOfOtherInvestmentsParentMemberMember2020-06-300001656472cron:AOCIAccumulatedGainLossRevaluationAndDisposalOfOtherInvestmentsParentMemberMember2019-06-300001656472us-gaap:AccumulatedTranslationAdjustmentMember2020-03-310001656472us-gaap:AccumulatedTranslationAdjustmentMember2019-03-310001656472us-gaap:AccumulatedTranslationAdjustmentMember2019-12-310001656472us-gaap:AccumulatedTranslationAdjustmentMember2018-12-310001656472us-gaap:AccumulatedTranslationAdjustmentMember2020-04-012020-06-300001656472us-gaap:AccumulatedTranslationAdjustmentMember2019-04-012019-06-300001656472us-gaap:AccumulatedTranslationAdjustmentMember2020-01-012020-06-300001656472us-gaap:AccumulatedTranslationAdjustmentMember2019-01-012019-06-300001656472us-gaap:AccumulatedTranslationAdjustmentMember2020-06-300001656472us-gaap:AccumulatedTranslationAdjustmentMember2019-06-300001656472srt:MinimumMembercron:LandBuildingsAndEquipmentMember2020-06-300001656472srt:MaximumMembercron:LandBuildingsAndEquipmentMember2020-06-300001656472cron:LandBuildingsAndEquipmentMember2020-06-30cron:lease0001656472us-gaap:BuildingMember2020-01-012020-06-300001656472us-gaap:LoansReceivableMembercron:NatuEraSeriesALoanMember2020-06-300001656472us-gaap:LoansReceivableMembercron:NatuEraSeriesALoanMember2019-12-310001656472us-gaap:LoansReceivableMembercron:CronosGrowCoCreditFacilityMember2020-06-300001656472us-gaap:LoansReceivableMembercron:CronosGrowCoCreditFacilityMember2019-12-310001656472us-gaap:LoansReceivableMember2020-06-300001656472us-gaap:LoansReceivableMember2019-12-310001656472us-gaap:LoansReceivableMembercron:A2645485OntarioInc.MucciPromissoryNoteMember2020-06-300001656472us-gaap:LoansReceivableMembercron:A2645485OntarioInc.MucciPromissoryNoteMember2019-12-310001656472us-gaap:LoansReceivableMembercron:CannasoulCollaborationLoanMember2020-06-300001656472us-gaap:LoansReceivableMembercron:CannasoulCollaborationLoanMember2019-12-310001656472us-gaap:LoansReceivableMembercron:NatuEraSeriesALoanMember2019-09-270001656472us-gaap:LoansReceivableMembercron:NatuEraSeriesALoanMembercron:NatueraMember2019-09-27iso4217:CAD0001656472us-gaap:LoansReceivableMembercron:CronosGrowCoCreditFacilityMember2019-08-230001656472cron:CronosGrowingCompanyInc.Membercron:MucciMember2020-06-300001656472us-gaap:LoansReceivableMembercron:CronosGrowCoCreditFacilityMember2019-08-232020-03-310001656472us-gaap:LoansReceivableMembercron:A2645485OntarioInc.MucciPromissoryNoteMember2019-06-280001656472us-gaap:LoansReceivableMembercron:A2645485OntarioInc.MucciPromissoryNoteMember2019-06-282019-06-280001656472us-gaap:LoansReceivableMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMembercron:CannasoulAnalyticsLtdMembercron:CannasoulCollaborationLoanMemberus-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember2020-04-010001656472us-gaap:LoansReceivableMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMembercron:CannasoulAnalyticsLtdMembercron:CannasoulCollaborationLoanMemberus-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember2020-04-012020-04-010001656472us-gaap:LoansReceivableMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMembercron:CannasoulAnalyticsLtdMembercron:CannasoulCollaborationLoanMemberus-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember2020-06-300001656472cron:AltriaInvestmentMember2019-03-082019-03-08cron:warrant0001656472cron:AltriaWarrantMembercron:CronosGroupInc.Member2019-03-082019-03-080001656472cron:AltriaGroupInc.Membercron:CronosGroupInc.Member2019-03-080001656472srt:SubsidiariesMembercron:AltriaGroupInc.Member2019-03-080001656472cron:AltriaInvestmentMember2019-03-080001656472cron:AltriaInvestmentMember2020-06-30iso4217:CADxbrli:shares0001656472cron:AltriaWarrantMember2019-03-080001656472cron:PreemptiveRightsMember2019-03-080001656472cron:TopupRightsMember2019-03-082019-03-08cron:day0001656472cron:TopupRightsMember2019-03-080001656472cron:TopupRightsMember2020-01-012020-06-300001656472cron:AltriaWarrantMember2020-03-310001656472cron:AltriaWarrantMember2020-04-012020-06-300001656472cron:AltriaWarrantMember2020-06-300001656472cron:PreemptiveRightsMember2020-03-310001656472cron:PreemptiveRightsMember2020-04-012020-06-300001656472cron:PreemptiveRightsMember2020-06-300001656472cron:TopupRightsMember2020-03-310001656472cron:TopupRightsMember2020-04-012020-06-300001656472cron:TopupRightsMember2020-06-300001656472cron:AltriaWarrantMember2019-12-310001656472cron:AltriaWarrantMember2020-01-012020-06-300001656472cron:PreemptiveRightsMember2019-12-310001656472cron:PreemptiveRightsMember2020-01-012020-06-300001656472cron:TopupRightsMember2019-12-310001656472us-gaap:MeasurementInputSharePriceMembercron:AltriaWarrantMember2020-06-300001656472cron:PreemptiveRightsMemberus-gaap:MeasurementInputSharePriceMember2020-06-300001656472cron:TopupRightsMemberus-gaap:MeasurementInputSharePriceMember2020-06-300001656472us-gaap:MeasurementInputSharePriceMembercron:AltriaWarrantMember2019-12-310001656472cron:PreemptiveRightsMemberus-gaap:MeasurementInputSharePriceMember2019-12-310001656472cron:TopupRightsMemberus-gaap:MeasurementInputSharePriceMember2019-12-310001656472cron:MeasurementInputSubscriptionPriceMembercron:AltriaWarrantMember2020-06-300001656472cron:MeasurementInputSubscriptionPriceMembercron:PreemptiveRightsMember2020-06-300001656472cron:MeasurementInputSubscriptionPriceMembercron:TopupRightsMember2020-06-300001656472cron:MeasurementInputSubscriptionPriceMembercron:AltriaWarrantMember2019-12-310001656472cron:MeasurementInputSubscriptionPriceMembercron:PreemptiveRightsMember2019-12-310001656472cron:MeasurementInputSubscriptionPriceMembercron:TopupRightsMember2019-12-310001656472srt:WeightedAverageMembercron:AltriaWarrantMemberus-gaap:MeasurementInputRiskFreeInterestRateMember2020-06-300001656472srt:WeightedAverageMembercron:PreemptiveRightsMemberus-gaap:MeasurementInputRiskFreeInterestRateMember2020-06-300001656472srt:WeightedAverageMembercron:TopupRightsMemberus-gaap:MeasurementInputRiskFreeInterestRateMember2020-06-300001656472srt:WeightedAverageMembercron:AltriaWarrantMemberus-gaap:MeasurementInputRiskFreeInterestRateMember2019-12-310001656472srt:WeightedAverageMembercron:PreemptiveRightsMemberus-gaap:MeasurementInputRiskFreeInterestRateMember2019-12-310001656472srt:WeightedAverageMembercron:TopupRightsMemberus-gaap:MeasurementInputRiskFreeInterestRateMember2019-12-310001656472srt:WeightedAverageMemberus-gaap:MeasurementInputExpectedTermMembercron:AltriaWarrantMember2020-01-012020-06-300001656472srt:WeightedAverageMembercron:PreemptiveRightsMemberus-gaap:MeasurementInputExpectedTermMember2020-01-012020-06-300001656472srt:WeightedAverageMembercron:TopupRightsMemberus-gaap:MeasurementInputExpectedTermMember2020-01-012020-06-300001656472srt:WeightedAverageMemberus-gaap:MeasurementInputExpectedTermMembercron:AltriaWarrantMember2019-01-012019-12-310001656472srt:WeightedAverageMembercron:PreemptiveRightsMemberus-gaap:MeasurementInputExpectedTermMember2019-01-012019-12-310001656472srt:WeightedAverageMembercron:TopupRightsMemberus-gaap:MeasurementInputExpectedTermMember2019-01-012019-12-310001656472us-gaap:MeasurementInputPriceVolatilityMembercron:AltriaWarrantMember2020-06-300001656472cron:PreemptiveRightsMemberus-gaap:MeasurementInputPriceVolatilityMember2020-06-300001656472cron:TopupRightsMemberus-gaap:MeasurementInputPriceVolatilityMember2020-06-300001656472us-gaap:MeasurementInputPriceVolatilityMembercron:AltriaWarrantMember2019-12-310001656472cron:PreemptiveRightsMemberus-gaap:MeasurementInputPriceVolatilityMember2019-12-310001656472cron:TopupRightsMemberus-gaap:MeasurementInputPriceVolatilityMember2019-12-310001656472us-gaap:MeasurementInputExpectedDividendRateMembercron:AltriaWarrantMember2020-06-300001656472us-gaap:MeasurementInputExpectedDividendRateMembercron:PreemptiveRightsMember2020-06-300001656472us-gaap:MeasurementInputExpectedDividendRateMembercron:TopupRightsMember2020-06-300001656472us-gaap:MeasurementInputExpectedDividendRateMembercron:AltriaWarrantMember2019-12-310001656472us-gaap:MeasurementInputExpectedDividendRateMembercron:PreemptiveRightsMember2019-12-310001656472us-gaap:MeasurementInputExpectedDividendRateMembercron:TopupRightsMember2019-12-310001656472cron:PreEmptiveRightsAndTopUpRightsMembersrt:MinimumMemberus-gaap:MeasurementInputRiskFreeInterestRateMember2020-06-300001656472cron:PreEmptiveRightsAndTopUpRightsMembersrt:MaximumMemberus-gaap:MeasurementInputRiskFreeInterestRateMember2020-06-300001656472cron:PreEmptiveRightsAndTopUpRightsMembersrt:MinimumMemberus-gaap:MeasurementInputRiskFreeInterestRateMember2019-12-310001656472cron:PreEmptiveRightsAndTopUpRightsMembersrt:MaximumMemberus-gaap:MeasurementInputRiskFreeInterestRateMember2019-12-310001656472cron:PreEmptiveRightsAndTopUpRightsMembersrt:MinimumMemberus-gaap:MeasurementInputExpectedTermMember2020-01-012020-06-300001656472cron:PreEmptiveRightsAndTopUpRightsMemberus-gaap:MeasurementInputExpectedTermMembersrt:MaximumMember2020-01-012020-06-300001656472cron:PreEmptiveRightsAndTopUpRightsMembersrt:MinimumMemberus-gaap:MeasurementInputExpectedTermMember2019-01-012019-12-310001656472cron:PreEmptiveRightsAndTopUpRightsMemberus-gaap:MeasurementInputExpectedTermMembersrt:MaximumMember2019-01-012019-12-310001656472us-gaap:LandMember2020-06-300001656472us-gaap:LandMember2019-12-310001656472us-gaap:BuildingMember2020-06-300001656472us-gaap:BuildingMember2019-12-310001656472us-gaap:FurnitureAndFixturesMember2020-06-300001656472us-gaap:FurnitureAndFixturesMember2019-12-310001656472us-gaap:ComputerEquipmentMember2020-06-300001656472us-gaap:ComputerEquipmentMember2019-12-310001656472us-gaap:LeaseholdImprovementsMember2020-06-300001656472us-gaap:LeaseholdImprovementsMember2019-12-310001656472us-gaap:ConstructionInProgressMember2020-06-300001656472us-gaap:ConstructionInProgressMember2019-12-310001656472cron:UnitedStatesSegmentMember2020-04-012020-06-300001656472us-gaap:TradeNamesMember2020-04-012020-06-300001656472us-gaap:ComputerSoftwareIntangibleAssetMember2020-06-300001656472cron:EnterpriseResourcePlanningSystemMember2020-01-012020-06-300001656472cron:EnterpriseResourcePlanningSystemMember2020-06-300001656472cron:HealthCanadaLicensingAgreementsMember2020-01-012020-06-300001656472cron:HealthCanadaLicensingAgreementsMember2020-06-300001656472us-gaap:TradeNamesMember2020-06-300001656472us-gaap:TrademarksMember2020-06-300001656472cron:IsraeliCodesLicensingAgreementsMember2020-01-012020-06-300001656472cron:IsraeliCodesLicensingAgreementsMember2020-06-300001656472us-gaap:ComputerSoftwareIntangibleAssetMember2019-12-310001656472cron:HealthCanadaLicensingAgreementsMember2019-01-012019-12-310001656472cron:HealthCanadaLicensingAgreementsMember2019-12-310001656472us-gaap:TradeNamesMember2019-12-310001656472us-gaap:TrademarksMember2019-12-310001656472cron:IsraeliCodesLicensingAgreementsMember2019-01-012019-12-310001656472cron:IsraeliCodesLicensingAgreementsMember2019-12-310001656472us-gaap:ComputerSoftwareIntangibleAssetMember2020-01-012020-06-300001656472cron:OGBCReportingUnitMember2019-12-310001656472cron:OGBCReportingUnitMember2020-01-012020-06-300001656472cron:OGBCReportingUnitMember2020-06-300001656472cron:PeaceNaturalsReportingUnitMember2019-12-310001656472cron:PeaceNaturalsReportingUnitMember2020-01-012020-06-300001656472cron:PeaceNaturalsReportingUnitMember2020-06-300001656472cron:RedwoodReportingUnitMember2019-12-310001656472cron:RedwoodReportingUnitMember2020-01-012020-06-300001656472cron:RedwoodReportingUnitMember2020-06-300001656472us-gaap:WarrantMember2019-12-310001656472us-gaap:WarrantMember2020-06-300001656472us-gaap:WarrantMember2018-12-310001656472us-gaap:WarrantMember2019-01-012019-06-300001656472us-gaap:WarrantMember2019-06-300001656472us-gaap:WarrantMembercron:GrantedRange1Member2020-06-300001656472us-gaap:WarrantMembercron:GrantedRangeTwoMember2020-06-300001656472cron:A2015StockOptionPlanMemberus-gaap:EmployeeStockOptionMember2018-06-280001656472cron:A2015StockOptionPlanMember2020-06-300001656472cron:A2018StockOptionPlanMember2020-06-300001656472cron:A2020OmnibusPlanMember2020-06-300001656472us-gaap:EmployeeStockOptionMember2020-04-012020-06-300001656472us-gaap:EmployeeStockOptionMember2019-04-012019-06-300001656472us-gaap:EmployeeStockOptionMember2020-01-012020-06-300001656472us-gaap:EmployeeStockOptionMember2019-01-012019-06-3000016564722018-01-012018-12-310001656472srt:MinimumMemberus-gaap:EmployeeStockOptionMember2019-06-300001656472us-gaap:EmployeeStockOptionMembersrt:MaximumMember2019-06-300001656472srt:MinimumMemberus-gaap:EmployeeStockOptionMember2019-01-012019-06-300001656472us-gaap:EmployeeStockOptionMembersrt:MaximumMember2019-01-012019-06-300001656472cron:A2018StockOptionPlanMember2020-01-012020-06-300001656472srt:WeightedAverageMemberus-gaap:EmployeeStockOptionMember2019-06-300001656472us-gaap:RestrictedStockUnitsRSUMember2020-05-112020-05-110001656472us-gaap:RestrictedStockUnitsRSUMember2020-05-110001656472us-gaap:RestrictedStockUnitsRSUMember2020-01-012020-06-300001656472us-gaap:RestrictedStockUnitsRSUMember2019-09-052019-09-05cron:subsidiary0001656472cron:RedwoodHoldingGroupLLCMember2019-09-052019-09-050001656472us-gaap:RestrictedStockUnitsRSUMember2019-09-050001656472us-gaap:RestrictedStockUnitsRSUMemberus-gaap:SubsequentEventMember2020-07-202020-07-200001656472us-gaap:RestrictedStockUnitsRSUMember2020-04-012020-06-300001656472us-gaap:RestrictedStockUnitsRSUMember2019-04-012019-06-300001656472us-gaap:RestrictedStockUnitsRSUMember2019-01-012019-06-300001656472us-gaap:RestrictedStockUnitsRSUMember2019-12-310001656472us-gaap:RestrictedStockUnitsRSUMember2020-06-300001656472us-gaap:RestrictedStockUnitsRSUMember2019-06-300001656472cron:DeferredShareUnitsDSUsMember2019-12-310001656472cron:DeferredShareUnitsDSUsMember2020-01-012020-06-300001656472cron:DeferredShareUnitsDSUsMember2020-06-300001656472cron:DeferredShareUnitsDSUsMember2019-06-300001656472cron:DeferredShareUnitsDSUsMember2019-01-012019-06-300001656472us-gaap:WarrantMember2020-04-012020-06-300001656472us-gaap:WarrantMember2019-04-012019-06-300001656472us-gaap:WarrantMember2020-01-012020-06-300001656472cron:AltriaWarrantMember2019-04-012019-06-300001656472cron:AltriaWarrantMember2019-01-012019-06-300001656472cron:TopupRightsMember2019-04-012019-06-300001656472cron:TopupRightsMember2019-01-012019-06-300001656472cron:GinkgoEquityMilestonesMember2020-04-012020-06-300001656472cron:GinkgoEquityMilestonesMember2019-04-012019-06-300001656472cron:GinkgoEquityMilestonesMember2020-01-012020-06-300001656472cron:GinkgoEquityMilestonesMember2019-01-012019-06-300001656472cron:PreemptiveRightsMember2020-04-012020-06-300001656472cron:PreemptiveRightsMember2019-04-012019-06-300001656472cron:PreemptiveRightsMember2020-01-012020-06-300001656472cron:PreemptiveRightsMember2019-01-012019-06-300001656472cron:TopUpRightsFixedPriceMember2020-04-012020-06-300001656472cron:TopUpRightsFixedPriceMember2019-04-012019-06-300001656472cron:TopUpRightsFixedPriceMember2020-01-012020-06-300001656472cron:TopUpRightsFixedPriceMember2019-01-012019-06-300001656472cron:TopUpRightsMarketPriceMember2020-04-012020-06-300001656472cron:TopUpRightsMarketPriceMember2019-04-012019-06-300001656472cron:TopUpRightsMarketPriceMember2020-01-012020-06-300001656472cron:TopUpRightsMarketPriceMember2019-01-012019-06-300001656472cron:AltriaWarrantMember2020-04-012020-06-300001656472cron:AltriaWarrantMember2019-04-012019-06-300001656472cron:AltriaWarrantMember2020-01-012020-06-300001656472cron:AltriaWarrantMember2019-01-012019-06-300001656472us-gaap:EmployeeStockOptionMember2020-04-012020-06-300001656472us-gaap:EmployeeStockOptionMember2019-04-012019-06-300001656472us-gaap:EmployeeStockOptionMember2020-01-012020-06-300001656472us-gaap:EmployeeStockOptionMember2019-01-012019-06-300001656472us-gaap:WarrantMember2020-04-012020-06-300001656472us-gaap:WarrantMember2019-04-012019-06-300001656472us-gaap:WarrantMember2020-01-012020-06-300001656472us-gaap:WarrantMember2019-01-012019-06-300001656472us-gaap:RestrictedStockUnitsRSUMember2020-04-012020-06-300001656472us-gaap:RestrictedStockUnitsRSUMember2019-04-012019-06-300001656472us-gaap:RestrictedStockUnitsRSUMember2020-01-012020-06-300001656472us-gaap:RestrictedStockUnitsRSUMember2019-01-012019-06-300001656472srt:AffiliatedEntityMembercron:ConsultingServicesMembercron:AltriaPinnacleLLC.Member2020-04-012020-06-300001656472srt:AffiliatedEntityMembercron:ConsultingServicesMembercron:AltriaPinnacleLLC.Member2020-01-012020-06-300001656472srt:AffiliatedEntityMembercron:ConsultingServicesMembercron:AltriaPinnacleLLC.Member2020-06-300001656472srt:AffiliatedEntityMembercron:ConsultingServicesMembercron:AltriaPinnacleLLC.Member2019-12-310001656472srt:AffiliatedEntityMembercron:ConsultingServicesMembercron:AltriaPinnacleLLC.Member2019-04-012019-06-300001656472srt:AffiliatedEntityMembercron:ConsultingServicesMembercron:AltriaPinnacleLLC.Member2019-01-012019-06-300001656472srt:AffiliatedEntityMembercron:PurchaseOfMachineryAndEquipmentMembercron:AltriaPinnacleLLC.Member2019-01-012019-12-31cron:segment0001656472cron:CannabisFlowerMemberus-gaap:OperatingSegmentsMembercron:UnitedStatesSegmentMember2020-04-012020-06-300001656472cron:CannabisFlowerMemberus-gaap:OperatingSegmentsMembercron:RestOfWorldSegmentMember2020-04-012020-06-300001656472cron:CannabisFlowerMemberus-gaap:CorporateNonSegmentMember2020-04-012020-06-300001656472cron:CannabisFlowerMember2020-04-012020-06-300001656472us-gaap:OperatingSegmentsMembercron:UnitedStatesSegmentMembercron:CannabisExtractsMember2020-04-012020-06-300001656472us-gaap:OperatingSegmentsMembercron:CannabisExtractsMembercron:RestOfWorldSegmentMember2020-04-012020-06-300001656472us-gaap:CorporateNonSegmentMembercron:CannabisExtractsMember2020-04-012020-06-300001656472cron:CannabisExtractsMember2020-04-012020-06-300001656472us-gaap:OperatingSegmentsMembercron:UnitedStatesSegmentMemberus-gaap:ProductAndServiceOtherMember2020-04-012020-06-300001656472us-gaap:OperatingSegmentsMembercron:RestOfWorldSegmentMemberus-gaap:ProductAndServiceOtherMember2020-04-012020-06-300001656472us-gaap:CorporateNonSegmentMemberus-gaap:ProductAndServiceOtherMember2020-04-012020-06-300001656472us-gaap:ProductAndServiceOtherMember2020-04-012020-06-300001656472us-gaap:OperatingSegmentsMembercron:UnitedStatesSegmentMember2020-04-012020-06-300001656472us-gaap:OperatingSegmentsMembercron:RestOfWorldSegmentMember2020-04-012020-06-300001656472us-gaap:CorporateNonSegmentMember2020-04-012020-06-300001656472us-gaap:OperatingSegmentsMembercron:UnitedStatesSegmentMember2020-01-012020-06-300001656472cron:CannabisFlowerMemberus-gaap:OperatingSegmentsMembercron:UnitedStatesSegmentMember2020-01-012020-06-300001656472cron:CannabisFlowerMemberus-gaap:OperatingSegmentsMembercron:RestOfWorldSegmentMember2020-01-012020-06-300001656472cron:CannabisFlowerMemberus-gaap:CorporateNonSegmentMember2020-01-012020-06-300001656472cron:CannabisFlowerMember2020-01-012020-06-300001656472us-gaap:OperatingSegmentsMembercron:UnitedStatesSegmentMembercron:CannabisExtractsMember2020-01-012020-06-300001656472us-gaap:OperatingSegmentsMembercron:CannabisExtractsMembercron:RestOfWorldSegmentMember2020-01-012020-06-300001656472us-gaap:CorporateNonSegmentMembercron:CannabisExtractsMember2020-01-012020-06-300001656472cron:CannabisExtractsMember2020-01-012020-06-300001656472us-gaap:OperatingSegmentsMembercron:UnitedStatesSegmentMemberus-gaap:ProductAndServiceOtherMember2020-01-012020-06-300001656472us-gaap:OperatingSegmentsMembercron:RestOfWorldSegmentMemberus-gaap:ProductAndServiceOtherMember2020-01-012020-06-300001656472us-gaap:CorporateNonSegmentMemberus-gaap:ProductAndServiceOtherMember2020-01-012020-06-300001656472us-gaap:ProductAndServiceOtherMember2020-01-012020-06-300001656472us-gaap:OperatingSegmentsMembercron:RestOfWorldSegmentMember2020-01-012020-06-300001656472us-gaap:CorporateNonSegmentMember2020-01-012020-06-300001656472us-gaap:OperatingSegmentsMembercron:UnitedStatesSegmentMember2020-06-300001656472us-gaap:OperatingSegmentsMembercron:RestOfWorldSegmentMember2020-06-300001656472us-gaap:CorporateNonSegmentMember2020-06-300001656472cron:CannabisFlowerMember2019-04-012019-06-300001656472cron:CannabisFlowerMember2019-01-012019-06-300001656472cron:CannabisExtractsMember2019-04-012019-06-300001656472cron:CannabisExtractsMember2019-01-012019-06-300001656472us-gaap:ProductAndServiceOtherMember2019-04-012019-06-300001656472us-gaap:ProductAndServiceOtherMember2019-01-012019-06-300001656472country:CA2020-04-012020-06-300001656472country:CA2019-04-012019-06-300001656472country:CA2020-01-012020-06-300001656472country:CA2019-01-012019-06-300001656472country:US2020-04-012020-06-300001656472country:US2019-04-012019-06-300001656472country:US2020-01-012020-06-300001656472country:US2019-01-012019-06-300001656472cron:OtherCountriesMember2020-04-012020-06-300001656472cron:OtherCountriesMember2019-04-012019-06-300001656472cron:OtherCountriesMember2020-01-012020-06-300001656472cron:OtherCountriesMember2019-01-012019-06-300001656472country:CA2020-06-300001656472country:CA2019-12-310001656472country:US2020-06-300001656472country:US2019-12-310001656472cron:OtherCountriesMember2020-06-300001656472cron:OtherCountriesMember2019-12-310001656472cron:UnitedStatesSegmentMember2020-06-300001656472cron:UnitedStatesSegmentMember2019-12-310001656472cron:FourMajorCustomersMembercron:RestOfWorldSegmentMember2020-04-012020-06-300001656472us-gaap:RevenueFromContractWithCustomerMembercron:RestOfWorldSegmentMembercron:BCLiquorDistributionBranchMemberus-gaap:CustomerConcentrationRiskMember2020-04-012020-06-300001656472us-gaap:RevenueFromContractWithCustomerMembercron:AlbertGamingLiquorAndCannabisCommissionMembercron:RestOfWorldSegmentMemberus-gaap:CustomerConcentrationRiskMember2020-04-012020-06-300001656472us-gaap:RevenueFromContractWithCustomerMembercron:OntarioCannabisRetailCorporationMembercron:RestOfWorldSegmentMemberus-gaap:CustomerConcentrationRiskMember2020-04-012020-06-300001656472cron:SocieteQuebecoiseDuCannabisMemberus-gaap:RevenueFromContractWithCustomerMembercron:RestOfWorldSegmentMemberus-gaap:CustomerConcentrationRiskMember2020-04-012020-06-300001656472cron:OneMajorCustomerMemberus-gaap:RevenueFromContractWithCustomerMembercron:RestOfWorldSegmentMemberus-gaap:CustomerConcentrationRiskMember2019-04-012019-06-300001656472cron:OneMajorCustomerMemberus-gaap:RevenueFromContractWithCustomerMembercron:RestOfWorldSegmentMemberus-gaap:CustomerConcentrationRiskMember2020-04-012020-06-300001656472cron:FourMajorCustomersMembercron:RestOfWorldSegmentMember2020-01-012020-06-300001656472us-gaap:RevenueFromContractWithCustomerMembercron:RestOfWorldSegmentMembercron:BCLiquorDistributionBranchMemberus-gaap:CustomerConcentrationRiskMember2020-01-012020-06-300001656472us-gaap:RevenueFromContractWithCustomerMembercron:AlbertGamingLiquorAndCannabisCommissionMembercron:RestOfWorldSegmentMemberus-gaap:CustomerConcentrationRiskMember2020-01-012020-06-300001656472us-gaap:RevenueFromContractWithCustomerMembercron:OntarioCannabisRetailCorporationMembercron:RestOfWorldSegmentMemberus-gaap:CustomerConcentrationRiskMember2020-01-012020-06-300001656472cron:SocieteQuebecoiseDuCannabisMemberus-gaap:RevenueFromContractWithCustomerMembercron:RestOfWorldSegmentMemberus-gaap:CustomerConcentrationRiskMember2020-01-012020-06-300001656472us-gaap:RevenueFromContractWithCustomerMembercron:RestOfWorldSegmentMemberus-gaap:CustomerConcentrationRiskMembercron:TwoMajorCustomersMember2019-04-012019-06-300001656472us-gaap:RevenueFromContractWithCustomerMembercron:RestOfWorldSegmentMemberus-gaap:CustomerConcentrationRiskMembercron:TwoMajorCustomersMember2019-01-012019-06-300001656472cron:RestOfWorldSegmentMember2020-06-300001656472cron:RestOfWorldSegmentMember2019-12-31cron:cannabinoid0001656472cron:GinkgoBioworksInc.Memberus-gaap:ResearchAndDevelopmentArrangementMember2018-09-040001656472cron:GinkgoBioworksInc.Memberus-gaap:ResearchAndDevelopmentArrangementMember2018-09-042018-09-040001656472cron:GinkgoBioworksInc.Memberus-gaap:ResearchAndDevelopmentArrangementMember2018-07-170001656472cron:TechnionResearchAndDevelopmentFoundationMemberus-gaap:ResearchAndDevelopmentArrangementMember2018-10-152018-10-150001656472cron:AltriaVenturesInc.Membercron:ConsultingServicesArrangementMember2019-02-182019-02-180001656472us-gaap:CommonStockMemberus-gaap:PrivatePlacementMember2019-12-232019-12-230001656472us-gaap:CommonStockMemberus-gaap:PrivatePlacementMember2019-12-230001656472us-gaap:CommonStockMembercron:SaleOfStockPerformanceMilestoneOneMemberus-gaap:PrivatePlacementMember2019-12-230001656472us-gaap:CommonStockMembercron:SaleOfStockPerformanceMilestoneTwoMemberus-gaap:PrivatePlacementMember2019-12-230001656472srt:MinimumMemberus-gaap:InventoriesMember2020-01-310001656472us-gaap:InventoriesMember2020-01-012020-01-310001656472us-gaap:InventoriesMembersrt:MaximumMember2020-01-310001656472us-gaap:InventoriesMember2020-06-300001656472us-gaap:CommonStockMemberus-gaap:PrivatePlacementMemberus-gaap:ShareBasedCompensationAwardTrancheOneMember2020-01-312020-01-310001656472us-gaap:ShareBasedCompensationAwardTrancheTwoMemberus-gaap:CommonStockMembersrt:ScenarioForecastMemberus-gaap:PrivatePlacementMember2021-06-232021-06-230001656472us-gaap:CommonStockMembersrt:ScenarioForecastMemberus-gaap:ShareBasedCompensationAwardTrancheThreeMemberus-gaap:PrivatePlacementMember2022-12-232022-12-23cron:shareholder0001656472cron:USDistrictCourtOfEasternDistrictOfNewYorkVsCronosMemberus-gaap:PendingLitigationMember2020-03-112020-03-12cron:complaint0001656472us-gaap:UnfavorableRegulatoryActionMemberus-gaap:PendingLitigationMember2020-06-162020-06-160001656472cron:FourCustomersMemberus-gaap:AccountsReceivableMemberus-gaap:CreditConcentrationRiskMember2020-01-012020-06-300001656472cron:TwoCustomersMemberus-gaap:AccountsReceivableMemberus-gaap:CreditConcentrationRiskMember2019-01-012019-12-310001656472us-gaap:SupplierConcentrationRiskMemberus-gaap:AccountsPayableMembercron:OneVendorMember2020-01-012020-06-300001656472us-gaap:SupplierConcentrationRiskMembercron:ThreeVendorsMemberus-gaap:AccountsPayableMember2019-01-012019-12-310001656472us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2020-06-300001656472us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2020-06-300001656472us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2020-06-300001656472us-gaap:FairValueMeasurementsRecurringMember2020-06-300001656472us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2019-12-310001656472us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2019-12-310001656472us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2019-12-310001656472us-gaap:FairValueMeasurementsRecurringMember2019-12-31cron:transaction0001656472us-gaap:ExchangeOfProductHeldForSaleForSimilarProductMember2019-03-282019-03-280001656472us-gaap:LoansReceivableMembercron:NatuEraSeriesALoanMemberus-gaap:SubsequentEventMember2020-07-240001656472us-gaap:LoansReceivableMembercron:NatuEraSeriesALoanMembercron:NatueraMemberus-gaap:SubsequentEventMember2020-07-240001656472srt:ScenarioForecastMemberus-gaap:RestrictedStockUnitsRSUMemberus-gaap:SubsequentEventMember2020-07-012020-09-30


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
__________________
Form 10-Q
_______________
(Mark One)
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 2020
or
 TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from to .
Commission File No. 001-38403
__________________________
CRONOS GROUP INC.
(Exact name of registrant as specified in its charter)
__________________________
British Columbia, Canada
N/A
(State or other jurisdiction of(I.R.S. Employer
incorporation or organization)Identification No.)
111 Peter St. Suite 300
Toronto, Ontario
M5V 2G9
(Address of principal executive offices)(Zip Code)
416-504-0004
(Registrant’s telephone number, including area code)
____________________________
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Shares, no par valueCRONThe Nasdaq Stock Market LLC


Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or Section 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes x No o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filerxAccelerated filer
Non-accelerated fileroSmaller reporting company
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No x
As of August 5, 2020, there were 349,886,402 common shares of the registrant issued and outstanding.






1




Unless otherwise noted or the context indicates otherwise, references in this Quarterly Report on Form 10-Q (the “Quarterly Report”) to the “Company”, “Cronos Group”, “we”, “us” and “our” refer to Cronos Group Inc., its direct and indirect wholly owned subsidiaries and, if applicable, its joint ventures and investments accounted for by the equity method; the term “cannabis” means the plant of any species or subspecies of genus Cannabis and any part of that plant, including all derivatives, extracts, cannabinoids, isomers, acids, salts, and salts of isomers; and the term “U.S. hemp” has the meaning given to term “hemp” in the U.S. Agricultural Improvement Act of 2018 (the “2018 Farm Bill”), including hemp-derived cannabidiol (“CBD”).
This Quarterly Report contains references to our trademarks and trade names and to trademarks and trade names belonging to other entities. Solely for convenience, trademarks and trade names referred to in this report may appear without the ® or symbols, but such references are not intended to indicate, in any way, that their respective owners will not assert, to the fullest extent under applicable law, their rights thereto. We do not intend our use or display of other companies’ trademarks or trade names to imply a relationship with, or endorsement or sponsorship of us or our business by, any other companies.
All currency amounts in this Quarterly Report are stated in U.S. dollars, which is our reporting currency, unless otherwise noted. All references to “dollars” or “$” are to U.S. dollars; all references to “C$” are to Canadian dollars; all references to “A$” are to Australian dollars and all references to “ILS” are to Israeli New Shekels.

2


PART I
FINANCIAL INFORMATION

Item 1. Financial statements (Unaudited)

3


Cronos Group Inc.
Condensed Consolidated Balance Sheets
As of June 30, 2020 and December 31, 2019
(In thousands of U.S. dollars, except share amounts, unaudited)


As of
June 30, 2020December 31, 2019
Assets
Current assets
Cash and cash equivalents$1,109,700  $1,199,693  
Short-term investments213,614  306,347  
Accounts receivable(1)
3,477  4,638  
Other receivables9,568  7,232  
Current portion of loans receivable4,458  4,664  
Prepaids and other assets7,827  9,395  
Inventory53,216  38,043  
Total current assets1,401,860  1,570,012  
Investments in equity accounted investees933  557  
Advances to joint ventures18,598  19,437  
Loan receivable, net65,371  44,967  
Property, plant and equipment164,290  161,809  
Right-of-use assets10,100  6,546  
Intangible assets69,399  72,320  
Goodwill179,736  214,794  
Total assets$1,910,287  $2,090,442  
Liabilities
Current liabilities
Accounts payable and other liabilities$28,316  $35,301  
Current portion of lease obligation1,206  427  
Derivative liabilities205,714  297,160  
Total current liabilities235,236  332,888  
Due to non-controlling interests3,048  1,844  
Lease obligation8,958  6,680  
Total liabilities$247,242  $341,412  
Commitments and contingencies(2)
Shareholders’ equity
Share capital(3,4)
$565,211  $561,165  
Additional paid-in capital27,046  23,234  
Retained earnings1,106,709  1,137,646  
Accumulated other comprehensive income (loss)(33,970) 27,838  
Total equity attributable to shareholders of Cronos Group1,664,996  1,749,883  
Non-controlling interests(1,951) (853) 
Total shareholders’ equity1,663,045  1,749,030  
Total liabilities and shareholders’ equity$1,910,287  $2,090,442  
(1) Net of current expected credit loss allowance of $80 as of June 30, 2020 (December 31, 2019 – $136)
(2) Refer to Note 19 and Note 20 in the notes to condensed consolidated financial statements.
(3) Authorized for issuance as of June 30, 2020: unlimited (December 31, 2019 – unlimited).
(4) Shares issued as of June 30, 2020: 349,886,402 (as of December 31, 2019: 348,817,472)

See notes to condensed consolidated financial statements.
4


Cronos Group Inc.
Condensed Consolidated Statements of Net Income (Loss) and Comprehensive Income (Loss)
For the three and six months ended June 30, 2020 and 2019
(In thousands of U.S dollars, except share and per share amounts)


Three months ended June 30,Six months ended June 30,
2020201920202019
Net revenue, before excise taxes$11,432  $8,064  $20,776  $11,455  
Excise taxes(1,549) (411) (2,461) (798) 
Net revenue9,883  7,653  18,315  10,657  
Cost of sales9,774  3,560  16,720  5,009  
Inventory write-down3,062    11,024    
Gross profit (loss)(2,953) 4,093  (9,429) 5,648  
Operating expenses
Sales and marketing6,504  4,005  13,616  5,133  
Research and development (“R&D”)3,631  2,300  8,221  3,471  
General and administrative18,437  11,488  42,196  18,781  
Share-based payments2,546  2,647  4,982  4,418  
Depreciation and amortization684  408  1,371  726  
Total operating expenses31,802  20,848  70,386  32,529  
Operating loss(34,755) (16,755) (79,815) (26,881) 
Other income (expense)
Interest income, net3,734  9,442  11,485  11,528  
Share of loss from investments in equity accounted investees(794) (741) (1,966) (939) 
Gain (loss) on revaluation of derivative liabilities(35,880) 197,310  77,488  525,526  
Impairment loss on goodwill and intangible assets(40,000)   (40,000)   
Financing and transaction costs  (3,368)   (25,601) 
Other income (loss)(8)   786  16,243  
Total other income (loss)(72,948) 202,643  47,793  526,757  
Income (loss) before income taxes(107,703) 185,888  (32,022) 499,876  
Income tax expense        
Net income (loss)$(107,703) $185,888  $(32,022) $499,876  
Net income (loss) attributable to:
Cronos Group$(106,977) $185,999  $(30,937) $500,090  
Non-controlling interests(726) (111) (1,085) (214) 
$(107,703) $185,888  $(32,022) $499,876  
Other comprehensive income (loss)
Foreign exchange gain (loss) on translation$51,871  $17,947  $(61,821) $21,845  
Total other comprehensive income (loss)51,871  17,947  (61,821) 21,845  
Comprehensive income (loss)$(55,832) $203,835  $(93,843) $521,721  
Comprehensive income (loss) attributable to:
Cronos Group$(55,070) $203,947  $(92,745) $521,932  
Non-controlling interests(762) (112) (1,098) (211) 
$(55,832) $203,835  $(93,843) $521,721  
Net income (loss) per share
Basic$(0.31) $0.56  $(0.09) $1.57  
Diluted$(0.31) $0.16  $(0.09) $0.41  
Weighted average number of outstanding shares
Basic349,075,408  334,665,873  348,946,439  317,940,749  
Diluted(1)
349,075,408  374,676,595  348,946,439  364,872,093  
(1) In computing diluted earnings per share, incremental common shares are not considered in periods in which a net loss is reported, as the inclusion of the common share equivalents would be anti-dilutive.
See notes to condensed consolidated financial statements.
5


Cronos Group Inc.
Condensed Consolidated Statements of Changes in Equity (Deficit)
For the three months ended June 30, 2020 and 2019
(In thousands of U.S. dollars, except share amounts)


Number of sharesShare capitalAdditional paid-in capitalRetained earnings Accumulated other comprehensive income (loss)Non-controlling interestsTotal shareholders' equity (deficit)
Balance at March 31, 2020348,817,472  $563,165  $25,483  $1,213,686  $(85,877) $(1,189) $1,715,268  
Vesting of options—  —  1,770  —  —  —  1,770  
Options exercised1,068,930  1,329  (1,328) —  —  —  1  
Top-up rights exercised—  717  —  —  —  —  717  
Vesting of restricted share units—  —  776  —  —  —  776  
Vesting of common shares issued in connection with the use of certain publicity rights in brand development—  —  345  —  —  —  345  
Net income (loss)—  —  —  (106,977) —  (726) (107,703) 
Other comprehensive income (loss)—  —  —  —  51,907  (36) 51,871  
Balance at June 30, 2020349,886,402  $565,211  $27,046  $1,106,709  $(33,970) $(1,951) $1,663,045  
Number of sharesShare capitalAdditional paid-in capitalRetained earnings Accumulated other comprehensive income (loss)Non-controlling interestsTotal shareholders' equity (deficit)
Balance at March 31, 2019333,020,377  $421,340  $12,244  $285,736  $(5,975) $  $713,345  
Share issuance costs—  (76) —  —  —  —  (76) 
Warrants exercised3,000,000  617  (67) —  —  —  550  
Vesting of options—  —  2,647  —  —  —  2,647  
Options exercised73,228  56  (45) (425) —  —  (414) 
Top-up rights exercised50,938  1,171  —  —  —  —  1,171  
Net income (loss)—  —  —  185,999  —  (111) 185,888  
Other comprehensive loss—  —  —  —  17,948  (1) 17,947  
Balance at June 30, 2019336,144,543  $423,108  $14,779  $471,310  $11,973  $(112) $921,058  

See notes to condensed consolidated financial statements.
6


Cronos Group Inc.
Condensed Consolidated Statements of Changes in Equity (Deficit)
For the six months ended June 30, 2020 and 2019
(In thousands of U.S. dollars, except share amounts, unaudited)


Number of sharesShare capitalAdditional paid-in capitalRetained earningsAccumulated other comprehensive income (loss)Non-controlling interestsTotal shareholders’ equity (deficit)
Balance as of January 1, 2020348,817,472  $561,165  $23,234  $1,137,646  $27,838  $(853) $1,749,030  
Vesting of options—  —  3,500  —  —  —  3,500  
Options exercised1,068,930  1,329  (1,328) —  —  —  1  
Vesting of restricted share units—  —  1,482  —  —  —  1,482  
Top-up rights exercised—  717  —  —  —  —  717  
Vesting of common shares issued in connection with the use of certain publicity rights in brand development—  2,000  158  —  —  —  2,158  
Net income (loss)—  —  —  (30,937) —  (1,085) (32,022) 
Other comprehensive income (loss)—  —  —  —  (61,808) (13) (61,821) 
Balance at June 30, 2020349,886,402  $565,211  $27,046  $1,106,709  $(33,970) $(1,951) $1,663,045  
Number of sharesShare capitalAdditional paid-in capitalRetained earningsAccumulated other comprehensive income (loss)Non-controlling interestsTotal shareholders’ equity (deficit)
Balance as of January 1, 2019178,720,022  $175,001  $11,263  $(27,945) $(9,870) $100  $148,549  
Shares issued149,831,154  248,302  —  —  —  —  248,302  
Share issuance costs—  (3,718) —  —  —  —  (3,718) 
Warrants exercised7,390,961  2,034  (596) —  —  —  1,438  
Vesting of options—  —  4,418  —  —  —  4,418  
Options exercised151,468  318  (306) (835) —  —  (823) 
Top-up rights exercised50,938  1,171  —  —  —  —  1,171  
Net income (loss)—  —  —  500,090  —  (214) 499,876  
Other comprehensive income (loss)—  —  —  —  21,843  2  21,845  
Balance at June 30, 2019336,144,543  $423,108  $14,779  $471,310  $11,973  $(112) $921,058  
See notes to condensed consolidated financial statements.
7


Cronos Group Inc.
Condensed Consolidated Statements of Cash Flows
For the six months ended June 30, 2020 and 2019
(In thousands of U.S. dollars, except share amounts, unaudited)


Six months ended June 30,
20202019
Operating activities
Net (loss) income$(32,022) $499,876  
Items not affecting cash:
Inventory write-down11,024    
Share-based payments4,982  4,418  
Depreciation and amortization2,879  1,174  
Share of loss from investments in equity accounted investees1,966  939  
Gain on revaluation of derivative liabilities(77,488) (525,526) 
Gain on disposal of other investments(769) (15,498) 
Impairment loss on goodwill and intangible assets40,000    
Loss (gain) on unrealized foreign exchange(1,097) 184  
Provision for doubtful accounts1,437    
Non-cash sales and marketing2,158    
Other, net307  (745) 
Net changes in non-cash working capital(30,570) (21,591) 
Cash flows used in operating activities(77,193) (56,769) 
Investing activities
Purchase of short-term investments(124,576) (556,876) 
Proceeds from disposal of short-term investments203,678    
Investments in equity accounted investees  (1,658) 
Proceeds from sale of other investments769  19,614  
Advances to joint ventures  (15,990) 
Purchase of property, plant and equipment(13,344) (20,918) 
Payment of accrued interest on construction loan payable  (89) 
Purchase of intangible assets(2,754) (470) 
Advances on loans receivable(23,974) (12,222) 
Cash flows provided (used) in investing activities39,799  (588,609) 
Financing activities
Advance from non-controlling interests  85  
Repayment of lease obligations(1,184) (160) 
Proceeds from Altria Investment  1,809,556  
Proceeds from exercise of Top-up Rights  619  
Proceeds from exercise of warrants and options1  1,450  
Withholding taxes paid on options  (836) 
Share issuance costs  (3,718) 
Advance of loans payable  48,715  
Repayment of loans payable  (48,309) 
Transaction costs paid on construction loan payable  (15,971) 
Cash flows provided (used) in financing activities(1,183) 1,791,431  
Effect of foreign currency translation on cash and cash equivalents(51,416) 36,079  
Increase (decrease) in cash and cash equivalents(89,993) 1,182,132  
Cash and cash equivalents, beginning of period1,199,693  23,927  
Cash and cash equivalents, end of period$1,109,700  $1,206,059  
Supplemental cash flow information
Interest paid90  589  
Interest received11,575  7,871  

See notes to condensed consolidated financial statements.
8

Cronos Group Inc.
Notes to Condensed Consolidated Financial Statements
For the six months ended June 30, 2020
(In thousands of U.S. dollars, except for gram and share amounts, unaudited)
1. Background
Cronos Group Inc. (“Cronos Group” or the “Company”) was incorporated on August 21, 2012 under the Business Corporations Act (Ontario). Effective July 9, 2020, the Company’s legal existence was continued to the Province of British Columbia and under the British Columbia Business Corporations Act. The Company’s common shares are currently listed on the Toronto Stock Exchange (“TSX”) and Nasdaq Global Market (“Nasdaq”) under the ticker symbol “CRON.”
Cronos Group is an innovative global cannabinoid company, with international production and distribution across five continents. The Company is committed to building disruptive intellectual property by advancing cannabis research, technology and product development and is building an iconic brand portfolio. Cronos Group’s brand portfolio includes PEACE NATURALS, a global wellness platform; two adult-use brands, COVE and Spinach; and two U.S. hemp-derived consumer products brands, Lord Jones and PEACE+.
Cronos Group has established four strategic joint ventures in Canada, Israel, and Colombia. One of these strategic joint ventures, Cronos Israel (as defined herein) is consolidated for financial reporting purposes. The Company also holds approximately 31% of the issued capital of Cronos Australia Limited (“Cronos Australia”) and accounts for its investment in Cronos Australia under the equity method of accounting. For additional discussion regarding the joint ventures and strategic investment, see Note 6.

2. Summary of Significant Accounting Policies
(a)Basis of Presentation
The interim condensed consolidated financial statements of Cronos Group are unaudited. They have been prepared in accordance with Generally Accepted Accounting Principles in the United States (“U.S. GAAP”) for interim financial information and with applicable rules and regulations of the U.S. Securities and Exchange Commission relating to interim financial statements. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three and six months ended June 30, 2020 are not necessarily indicative of the results that may be expected for any other reporting period.
These condensed consolidated financial statements should be read in conjunction with the Company’s consolidated financial statements and related notes included in its Annual Report on Form 10-K/A for the year ended December 31, 2019 (the “Annual Financial Statements”).
(b)Basis of Consolidation
The accompanying condensed consolidated financial statements include the accounts of the Company, and all entities in which the Company has a controlling voting interest and/or is the primary beneficiary of a variable interest as of and for the period presented. The Company consolidates the financial results of the following entities, which the Company controls:
SubsidiariesJurisdiction of IncorporationIncorporation Date
Ownership Interest (ii)
Cronos Israel G.S. Cultivations Ltd. (i)
IsraelFebruary 4, 201870%
Cronos Israel G.S. Manufacturing Ltd. (i)
IsraelSeptember 4, 201890%
Cronos Israel G.S. Store Ltd. (i)
IsraelJune 28, 201890%
Cronos Israel G.S. Pharmacies Ltd. (i)
IsraelFebruary 15, 201890%
(i) These Israeli entities are collectively referred to as “Cronos Israel.”
(ii) “Ownership interest” is defined as the proportionate share of net income to which the Company is entitled; equity interest may differ from ownership interest.
In the condensed consolidated statements of net income (loss) and comprehensive income (loss), the net income (loss) and comprehensive income (loss) are attributed to the equity holders of the Company and to the non-controlling interests. Non-controlling interests in the equity of Cronos Israel are presented separately in the shareholders’ equity (deficit) section of the condensed consolidated balance sheets and condensed consolidated statements of changes in equity (deficit). All intercompany transactions and balances are eliminated upon consolidation.
9

Cronos Group Inc.
Notes to Condensed Consolidated Financial Statements
For the six months ended June 30, 2020
(In thousands of U.S. dollars, except for gram and share amounts, unaudited)
(c)  Goodwill and indefinite life intangible assets
Goodwill and indefinite life intangible assets are reviewed for impairment annually or more frequently when events or changes in circumstances indicate that fair value of the reporting unit has been reduced to less than its carrying value. The Company performs an impairment test annually in the fourth quarter, by comparing the fair value of the reporting unit with its carrying amount, including goodwill. If the fair value of the reporting unit exceeds its carrying amount, goodwill is not considered to be impaired. An impairment charge would be recognized for the amount by which the carrying amount exceeds the reporting unit’s fair value. The Company determined that it has two reporting units: the U.S. reporting unit and the Rest of World reporting unit.
During the three months ended June 30, 2020, the Company concluded that the projected impact of the COVID-19 pandemic on its sales and revenues in the near term, together with the volatility in the market conditions during the quarter represented potential indicators of impairment for the U.S. reporting unit. Accordingly, the Company performed an interim impairment analysis during the second quarter of 2020. See Note 13 for more information regarding intangibles assets and goodwill.

3. New Accounting Pronouncements
(a)Adoption of new accounting pronouncements
On January 1, 2020, the Company adopted ASU No. 2018-13, Disclosure Framework – Changes to the Disclosure Requirements for Fair Value Measurement (Topic 820) (“ASU No. 2018-13”). ASU No. 2018-13 adds, modifies, and removes certain fair value measurement disclosure requirements. The adoption of this standard was applied prospectively and did not have a material impact on the Company’s condensed consolidated financial statements.
On January 1, 2020, the Company adopted ASU No. 2018-15, Intangibles – Goodwill and Other Internal-use-software (Subtopic 350-40): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract (“ASU No. 2018-15”). ASU No. 2018-15 amends current guidance to align the accounting for costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing costs associated with developing or obtaining internal-use software. The guidance in ASU No. 2018-15 is effective for annual and interim periods beginning after December 15, 2019, with early adoption permitted. The adoption of this standard was applied prospectively and did not have a material impact on the Company’s condensed consolidated financial statements.
On January 1, 2020, the Company adopted ASU No. 2017-04, Intangibles – Goodwill and Other (Topic 350) – Simplifying the Test for Goodwill Impairment (“ASU No. 2017-04”). ASU No. 2017-04 eliminates step 2 from the goodwill impairment test and instead requires an entity to measure the impairment of goodwill assigned to a reporting unit if the carrying value of assets and liabilities assigned to the reporting unit, including goodwill, exceeds the reporting unit’s fair value. The guidance in ASU No. 2017-04 is effective for annual and interim goodwill tests completed by the Company beginning on January 1, 2020. The adoption of this standard was applied prospectively and the Company follows a one-step model for goodwill impairment.
(b)New accounting pronouncements not yet adopted
In January 2020, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2020-01, Investments-Equity Securities (Topic 321), Investments-Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815) (“ASU No. 2020-01”). ASU No. 2020-01 clarifies the interaction of accounting for the transition into and out of the equity method. The new standard also clarifies the accounting for measuring certain purchased options and forward contracts to acquire investments. The guidance in ASU No. 2020-01 is effective for annual and interim periods beginning after December 15, 2020, with early adoption permitted. The Company is currently evaluating the effect of the adoption of ASU No. 2020-01, but anticipates that the adoption will not have a material impact on its condensed consolidated financial statements.
In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes (“ASU No. 2019-12”). ASU No. 2019-12 eliminates certain exceptions and simplifies the application of U.S. GAAP-related changes in enacted tax laws or rates and employee stock option plans. ASU No. 2019-12 is effective for annual and interim periods beginning after December 15, 2020. Early adoption is permitted. The Company is currently evaluating the effect of the adoption of ASU No. 2019-12, but anticipates that the adoption will not have a material impact on its condensed consolidated financial statements.

10

Cronos Group Inc.
Notes to Condensed Consolidated Financial Statements
For the six months ended June 30, 2020
(In thousands of U.S. dollars, except for gram and share amounts, unaudited)
4. Revenues from Contracts with Customers
Cronos Group disaggregates net revenues based on product type. For further discussion, see Note 18. Receivables were $3,477 as of June 30, 2020 (December 31, 2019 – $4,638). The Company recorded a current expected credit loss allowance on receivables of $80 as of June 30, 2020 (December 31, 2019 – $136).
The Company offers discounts to customers for prompt payment and calculates cash discounts as a percentage of the list price based on historical experience and agreed-upon payment terms. The Company records an allowance for cash discounts, which is included as a contra-asset against receivables on the Company’s condensed consolidated balance sheets.
Revenue is measured net of returns. As a result, the Company is required to estimate the amount of returns based on the historical data by customer and product type, adjusted for forward-looking information. This is recorded as a provision against accounts receivable on the Company’s consolidated balance sheets. The Company estimates sales returns based principally on historical volume and return rates, as a reduction to revenues. The difference between actual sales and estimated sales returns is recorded in the period in which the actual amounts become known. These differences, if any, have not had a material impact on the Company’s condensed consolidated financial statements.
Upon return, products can be extracted from dried cannabis, resold, or destroyed depending on the nature of the product. The Company has assessed that the amount recoverable from returned products for the six months ended June 30, 2020 is not material.

5. Inventory
Inventory is comprised of the following items:
As of
June 30, 2020December 31, 2019
Raw materials$5,488  $2,469  
Work-in-progress – dry cannabis21,772  11,538  
Work-in-progress – cannabis extracts19,210  17,975  
Finished goods – dry cannabis4,505  1,798  
Finished goods – cannabis extracts1,716  2,624  
Supplies and consumables525  1,639  
Total$53,216  $38,043  
Inventory is written down for any obsolescence such as slow-moving or non-marketable products, or when the net realizable value of inventory is less than the carrying value. For the three and six months ended June 30, 2020, the Company recorded write-downs related to inventory of $3,062 and $11,024, respectively.
There were no inventory write-downs for the six months ended June 30, 2019.

11

Cronos Group Inc.
Notes to Condensed Consolidated Financial Statements
For the six months ended June 30, 2020
(In thousands of U.S. dollars, except for gram and share amounts, unaudited)
6. Investments and Advances to Joint Ventures
Variable Interest Entities
The Company holds variable interests in Cronos Growing Company Inc. (“Cronos GrowCo”), Natuera S.à.r.l (“Natuera”), MedMen Canada Inc. (“MedMen Canada”) and Cannasoul Lab Services Ltd. (“CLS”).
Cronos GrowCo is a joint venture incorporated under the Canada Business Corporations Act (“CBCA”) on June 14, 2018 with the objective of building a cannabis production greenhouse, applying for cannabis licenses under the Cannabis Act (Canada), and growing, cultivating, extracting, producing and selling cannabis in accordance with such licenses. Cronos Group holds variable interests in Cronos GrowCo through its ownership of 50% of Cronos GrowCo’s common shares and senior secured debt in Cronos GrowCo. The Company has also agreed to purchase a minimum amount of Cronos GrowCo’s cannabis product annually, subject to Cronos GrowCo’s receipt of all applicable licenses and permits. Cronos GrowCo’s economic performance is driven by the quantity and strains of cannabis grown. The joint venture partners mutually determine the quantity and strains of cannabis grown.
Natuera is a joint venture registered in Luxembourg with the objective of cultivating and commercializing medical cannabis to serve the export market. Cronos holds variable interests in Natuera through its ownership of 50% of Natuera’s common shares and other debt in the entity. Natuera’s economic performance is driven by the quantity and strains of cannabis to be grown. The joint venture partners mutually determine the quantity and strains of cannabis grown.
MedMen Canada is a joint venture incorporated under the CBCA on March 13, 2018, with the objective of the retail sale and marketing of cannabis products in Canada. MedMen Canada holds the exclusive license to the MedMen brand in Canada for a minimum term of 20 years. Cronos holds variable interests in MedMen Canada through its ownership of 50% of MedMen Canada’s common shares and other subordinated debt in the entity. MedMen Canada’s economic performance is driven by the quantity and strains of cannabis sold. Subject to applicable law, the joint venture partners mutually determine the quantity and strains of cannabis to be sold in MedMen Canada’s retail stores, if and when stores are opened.
The Company’s investments in Cronos GrowCo, Natuera and MedMen Canada are exposed to economic variability from each entity’s performance, however the Company does not consolidate the entities as it does not have the power to direct the activities that most significantly impact the joint ventures’ economic performance. Thus, Cronos Group is not considered the primary beneficiary of the entity. These investments are accounted for as equity method investments classified as “Investments in equity accounted investees” in the consolidated balance sheets.
CLS is a wholly owned subsidiary of Cannasoul Analytics Ltd., incorporated with the purpose of establishing a commercial cannabis analytical testing laboratory located on the premises of Cronos Israel (the “Cannasoul Collaboration”). Cronos Israel will advance ILS 8,297 (approximately $2,446) by a non-recourse loan to CLS over a period of two years from April 1, 2020 for the capital and operating expenditures of the laboratory. The loan will bear interest at 3.5% annually. Cronos Israel will receive 70% of the profits of the laboratory until such time as it has recovered 150% of the amounts advanced to CLS, after which time it will receive 50% of the laboratory profits. As a result, the Company is exposed to economic variability from CLS’s performance. The Company does not consolidate CLS as it does not have the power to direct the activities that most significantly impact the entity’s economic performance; thus, the Company is not considered the primary beneficiary of the entity. The carrying amount of the non-recourse loan is recorded under loans receivable and the full loan amount, ILS 8,297, represents the Company’s maximum potential exposure to losses through the Cannasoul Collaboration. See Note 10 for further information regarding loans receivable.

12

Cronos Group Inc.
Notes to Condensed Consolidated Financial Statements
For the six months ended June 30, 2020
(In thousands of U.S. dollars, except for gram and share amounts, unaudited)
(a)Net investment in equity accounted investees
A reconciliation of the carrying amount of the investments in associates and joint ventures is as follows:
Carrying Amount
Ownership %June 30, 2020December 31, 2019
Cronos Australia(i)
31%$  $(346) 
Cronos GrowCo50%933  1,501  
MedMen Canada50%    
Natuera50%  (598) 
$933  $557  
(i) On October 25, 2019, Cronos Australia issued 40 million new shares in an initial public offering at an offering price of A$0.50 per share. The Company’s ownership in Cronos Australia decreased from 50% to 31% on November 7, 2019 when Cronos Australia began trading on the Australian Securities Exchange. This resulted in a reconsideration event, which required the reassessment of the Company’s VIE conclusion. Upon reconsideration, the Company determined that the entity was no longer a VIE as of December 31, 2019 and is now reported under the equity method.
The Company’s share of net earnings (losses) from equity investments accounted for under the equity method of accounting:
For the three months ended June 30,For the six months ended June 30,
2020201920202019
Whistler Medicinal Marijuana Company (“Whistler”)$  $  $  $29  
Cronos Australia(i)
(235) (397) (235) (641) 
Cronos GrowCo(190) (38) (501) (27) 
MedMen Canada  (2)   4  
Natuera(ii)
(369) (304) (1,230) (304) 
$(794) $(741) $(1,966) $(939) 
(i) The Company’s share of accumulated net losses in excess of its equity investment and advances in Cronos Australia was $512 for the six months ended June 30, 2020 (June 30, 2019 – $nil).
(ii) The Company’s share of accumulated net losses in excess of its equity investment in Natuera has been applied as a loss allowance on the loan receivable. See Note 6(b) and Note 10.
13

Cronos Group Inc.
Notes to Condensed Consolidated Financial Statements
For the six months ended June 30, 2020
(In thousands of U.S. dollars, except for gram and share amounts, unaudited)
(b)Advances to Joint Venture
MedMen Canada(i)
Cronos GrowCo
Cronos Australia (ii)
NatueraTotal
As of January 1, 2020$471  $18,966  $  $  $19,437  
Credit loss allowance (iii)
          
Effect from foreign exchange(20) (819)     (839) 
As of June 30, 2020$451  $18,147  $  $  $18,598  
As of January 1, 2019$1,244  $2,970  $475  $  $4,689  
Advances (repayment)(852) 15,494  274  219  15,135  
Advances to joint ventures recovered from (applied to) carrying amount of investments35  22  (779) (224) (946) 
Effect from foreign exchange44  480  30  5  559  
As of December 31, 2019$471  $18,966  $  $  $19,437  
(i) Advance is unsecured, non-interest bearing, and there are no terms of repayment.
(ii) A$1,500 is governed by an unsecured loan bearing interest at a rate of 12% per annum, calculated and compounded daily, in arrears, on the amounts advanced from the date of each advance. The loan is due on January 1, 2022. If the loan is overdue, the outstanding amount bears interest at an additional 2% per annum.
(iii) For the three months ended June 30, 2020, a reversal of $917 related to the credit loss allowance for Cronos GrowCo was recorded as the Company assessed its recoverability. As of June 30, 2020, total credit losses were $nil.

7. Other Investments
Other investments consist of investments in common shares and warrants of several companies in the cannabis industry. As of June 30, 2020, the Company did not hold any other investments.
During the six months ended June 30, 2020, in connection with the achievement of a milestone related to the Whistler transaction described below, the Company received 578,101 shares of Aurora Cannabis Inc. (“Aurora”). The Company sold all of the Aurora shares on March 6, 2020 for gross proceeds of $769 recorded as an other item in other income (expenses). The Company expects to further receive Aurora common shares upon the satisfaction of one milestone remaining, which has not been recognized in these condensed consolidated financial statements. The exact number of Aurora common shares to be issued to the Company following the satisfaction of such milestone will be determined in reference to the five-day volume weighted average price of Aurora common shares immediately prior to the achievement of the applicable milestone. No transactions occurred during the three months ended June 30, 2020.
On March 4, 2019, the Company sold all 2,563 shares of Whistler, representing approximately 19.0% of Whistler’s issued and outstanding common shares, to Aurora, in connection with Aurora's acquisition of Whistler (the “Whistler Transaction”). As a result of the closing of the Whistler Transaction, the Company received 2,524,341 Aurora common shares. During the six months ended June 30, 2019, the Company sold all 2,524,341 common shares of Aurora, for gross proceeds of $19,259 recorded as an other item in other income (expenses). No transactions occurred during the three months ended June 30, 2019.
During the six months ended June 30, 2019, the Company sold all remaining 11,062 common shares of Canopy Growth Corporation (“Canopy”) for gross proceeds of $355. The gains and losses on the Canopy investment were classified as fair value through net income. No transactions occurred during the three months ended June 30, 2019.

14

Cronos Group Inc.
Notes to Condensed Consolidated Financial Statements
For the six months ended June 30, 2020
(In thousands of U.S. dollars, except for gram and share amounts, unaudited)
8. Accumulated Other Comprehensive Income (Loss)
The following are continuity schedules of accumulated other comprehensive income (loss):

Three months ended June 30,Six months ended June 30,
2020201920202019
Net unrealized gain (loss) on revaluation and disposal of other investments
Balance beginning of period5  5  5  5  
Cumulative effect from adoption of ASU 2016-01        
Balance as of June 305  5  5  5  
Net foreign exchange gain (loss) on translation
Balance beginning of period(85,882) (5,980) 27,833  (9,875) 
Net unrealized (loss) gain51,907  17,948  (61,808) 21,843  
Balance as of June 30(33,975) 11,968  (33,975) 11,968  
Total accumulated other comprehensive income (loss)$(33,970) $11,973  $(33,970) $11,973  

9. Leases
The Company has entered into leases primarily for land-use rights, office premises and equipment used in the production of cannabis and related products. The Company’s leases have terms which range from three years to six years, excluding land use rights, which generally extend to 15 years. These leases often include options to extend the term of the lease for up to 10 years. When it is reasonably certain that the option will be exercised, the impact of the option is included in the lease term for purposes of determining total future lease payments.
Operating leases greater than one year are included in right-of-use assets and operating lease liabilities. Finance leases are included in property, plant and equipment on the Company’s consolidated balance sheet.
During the six months ended June 30, 2020, the Company recognized two new operating leases for office premises which are included within the lease obligation and right-of-use lines in the condensed consolidated balance sheet.
In June 2020, the Company terminated an operating lease for office premises. The lease was removed from the lease obligation and right-of-use balances in the condensed consolidated balance sheet.
The Company’s finance leases were not material as of June 30, 2020 and December 31, 2019.

15

Cronos Group Inc.
Notes to Condensed Consolidated Financial Statements
For the six months ended June 30, 2020
(In thousands of U.S. dollars, except for gram and share amounts, unaudited)
10. Loans Receivable, net
As of
June 30, 2020December 31, 2019
Current portion
Natuera Series A loan (i)
$2,984  $4,575  
Cronos GrowCo Credit Facility (ii)
1,474    
Add: Accrued interest  89  
Total current portion of loans receivable4,458  4,664  
Long term portion
Cronos GrowCo Credit Facility (ii)
50,582  31,678  
2645485 Ontario Inc. (Mucci) Promissory Note (iii)
11,793  12,587  
Cannasoul Collaboration Loan (iv)
1,174    
Add: Accrued interest1,822  702  
Total long-term portion of loans receivable65,371  44,967  
Total loans receivable$69,829  $49,631  
(i)On September 27, 2019, the Company entered into a master loan agreement (the “Series A Loan”) for $4,575 with Natuera with effect as of August 29, 2019. The total aggregate principal amount of the Series A Loan is $9,150, of which the Company has committed to fund 50% and its joint venture partner has committed to fund the remaining 50%. Outstanding principal amounts bear interest at a fixed annual rate of 5.67% with a maturity date of August 29, 2020. As of June 30, 2020, accrued interest is recorded in other receivables. Subsequent to June 30, 2020, an amendement to the agreement was executed. Refer to Note 25.
For the six months ended June 30, 2020, a loss allowance of $1,591 was recorded against the Natuera Series A Loan related to the Company’s share of net loss from Natuera in excess of the carrying value of the equity method investment. Refer to Note 6.
(ii)On August 23, 2019, the Company entered into a credit agreement with Cronos GrowCo in respect of a C$100,000 ($73,660) secured non-revolving term loan credit facility (the “GrowCo Credit Facility”). The GrowCo Credit Facility will mature on March 31, 2031 and will bear interest at varying rates based on the Canadian prime rate as announced by the Bank of Montreal. Interest began to accrue as of the closing date of the GrowCo Credit Facility and is payable on a quarterly basis until maturity, except that any interest accrued prior to March 31, 2021 will be payable no later than December 31, 2021. Repayment of principal will be made on a quarterly basis commencing on March 31, 2021. The credit facility is secured by substantially all present and after acquired property of Cronos GrowCo and its subsidiaries. Mucci, the other 50% shareholder of Cronos GrowCo, has provided a limited recourse guarantee in favor of Cronos GrowCo, secured by Mucci’s shares in Cronos GrowCo. As of June 30, 2020, Cronos GrowCo had drawn C$72,150 ($53,145) from the Cronos GrowCo Credit Facility.
For the six months ended June 30, 2020, a current expected credit loss allowance of $1,089 was recorded against the GrowCo Facility.
(iii)On June 28, 2019, the Company entered into a promissory note receivable agreement (the “Mucci Promissory Note”) for C$16,350 ($12,043) with Mucci. The outstanding principal amount of the Mucci Promissory Note bears interest at 3.95% annually and is due within 90 days of demand. The Company does not intend to demand the loan within 12 months. Interest accrued under the Mucci Promissory Note until July 1, 2021 is payable by way of capitalization on the principal amount and interest thereafter must be paid in cash on a quarterly basis. The Mucci Promissory Note is secured by a general security agreement covering all the assets of Mucci.
For the six months ended June 30, 2020, a current expected credit loss allowance of $250 has been recorded against the Mucci loan.
(iv)On April 1, 2020, Cronos Israel entered into the Cannasoul Collaboration. Cronos Israel has agreed to advance approximately ILS 8,297 (approximately $2,446) by a non-recourse loan to CLS over a period of two years for the capital and operating expenditures of the laboratory. The outstanding principal on the loan bears interest at 3.5% annually and will be repaid through the profits generated from the Cannasoul Collaboration. As of June 30, 2020, CLS has received the first installment of ILS 4,149 (approximately $1,198).
For the six months ended June 30, 2020, a current expected credit loss allowance of $24 has been recorded against the Cannasoul Collaboration loan.

16

Cronos Group Inc.
Notes to Condensed Consolidated Financial Statements
For the six months ended June 30, 2020
(In thousands of U.S. dollars, except for gram and share amounts, unaudited)
11. Derivative Liabilities
On March 8, 2019, the Company closed the previously announced investment in the Company (the “Altria Investment”) by Altria Group, Inc. (“Altria”), pursuant to a subscription agreement dated December 7, 2018. As of the closing date of the Altria Investment, the Altria Investment consisted of 149,831,154 common shares of the Company as of the closing date, issued to a wholly owned subsidiary of Altria and one warrant of the Company (the “Altria Warrant”), refer to Note 15(a), issued to a wholly owned subsidiary of Altria. As of the closing date of the Altria Investment, Altria beneficially held an approximately 45% ownership interest in the Company (calculated on a non-diluted basis). As summarized in this note, if exercised in full on such date, the exercise of the Altria Warrant would have resulted in Altria holding a total ownership interest in the Company of approximately 55% (calculated on a non-diluted basis). Pursuant to the investor rights agreement between the Company and Altria, entered into in connection with the closing of the Altria Investment (the “Investor Rights Agreement”), the Company granted Altria certain rights, among others, summarized in this note.
The summaries below are qualified entirely by the terms and conditions fully set out in the Investor Rights Agreement and the Altria Warrant, as applicable.
a.The Altria Warrant entitles the holder, subject to certain qualifications and limitations, to subscribe for and purchase up to an additional 10% of the common shares of Cronos (approximately 77.8 million common shares at June 30, 2020) at a per share exercise price of C$19.00 which expires on March 8, 2023.
b.The Company granted to Altria, subject to certain qualifications and limitations, upon the occurrence of certain issuances of common shares of the Company executed by the Company (including issuances pursuant to the R&D partnership with Ginkgo Bioworks Inc. (“Ginkgo”) (the “Ginkgo Strategic Partnership”), which is discussed in Note 19(a)(i) below, the right to purchase up to such number of common shares of the Company in order to maintain their ownership percentage of issued and outstanding common shares of the Company immediately preceding any issuance of shares by the Company (“Pre-emptive Rights”), at the same price per common share of the Company at which the common shares are sold in the relevant issuance. The price per common share of the Company to be paid by Altria pursuant to its exercise of its Pre-emptive Rights related to the Ginkgo Strategic Partnership will be C$16.25 per common share. These rights may not be exercised if Altria’s ownership percentage of the issued and outstanding shares of the Company falls below 20%.
c.In addition to (and without duplication of) the Pre-emptive Rights, the Company granted to Altria, subject to certain qualifications and limitations, the right to subscribe for common shares of the Company issuable in connection with the exercise, conversion or exchange of convertible securities of the Company issued prior to March 8, 2019 or thereafter (excluding any convertible securities of the Company owned by Altria or any of its subsidiaries), a share incentive plan of the Company, the exercise of any right granted by the Company pro rata to all shareholders of the Company to purchase additional common shares and/or securities of the Company, bona fide bank debt, equipment financing or non-equity interim financing transactions that contemplate an equity component or bona fide acquisitions (including acquisitions of assets or rights under a license or otherwise), mergers or similar business combination transactions or joint ventures involving the Company in order to maintain their ownership percentage of issued and outstanding common shares of the Company immediately preceding any such transactions (“Top-up Rights”).
The price per common share to be paid by Altria pursuant to the exercise of its Top-up Rights will be, subject to certain limited exceptions, the 10-day volume-weighted average price of the common shares of the Company on the TSX for the ten full days preceding such exercise by Altria, provided that the price per common share of the Company to be paid by Altria pursuant to the exercise of its Top-up Rights in connection with the issuance of common shares of the Company pursuant to the exercise of options or warrants that were outstanding as of March 8, 2019 will be C$16.25 per common share without any set off, counterclaim, deduction, or withholding. These rights may not be exercised if Altria’s ownership percentage of the issued and outstanding shares of the Company falls below 20%. The Altria Warrant, Pre-emptive Rights, and fixed price Top-up Rights have been classified as derivative liabilities; related transaction costs of $22,355 were expensed as financing costs during the year ended December 31, 2019.
17

Cronos Group Inc.
Notes to Condensed Consolidated Financial Statements
For the six months ended June 30, 2020
(In thousands of U.S. dollars, except for gram and share amounts, unaudited)
A reconciliation of the carrying amounts of the derivative liability is presented below:
April 1, 2020(Gain) / Loss on revaluationExercise of RightsEffect from foreign exchangeAs of June 30, 2020
(a) Altria Warrant$132,366  $30,052  $  $3,540  $165,958  
(b) Pre-emptive Rights13,070  2,610    500  16,180  
(c) Top-up Rights20,740  3,218  (727) 1,072  23,576  
$166,176  $35,880  $(727) $5,112  $205,714  

January 1, 2020(Gain) / Loss on revaluationExercise of RightsEffect from foreign exchangeAs of June 30, 2020
(a) Altria Warrant$234,428  $(58,052) $  $(10,418) $165,958  
(b) Pre-emptive Rights12,787  3,925    (532) 16,180  
(c) Top-up Rights49,945  (23,361) (727) (2,281) 23,576  
$297,160  $(77,488) $(727) $(13,231) $205,714  
Fluctuations in the Company’s share price are a primary driver for the changes in the derivative valuations during each reporting period. As the share price decreases for each of the related derivative instruments, the liability of the instrument generally decreases. Share price is one of the significant observable inputs used in the fair value measurement of each of the Company’s derivative instruments. During the six months ended June 30, 2020, the Company’s share price decreased from December 31, 2019 resulting in a gain on revaluation of $77,488.
The fair values of the derivative liabilities were determined using the Black-Scholes pricing model as of June 30, 2020 and December 31, 2019 applying the following inputs:
As of June 30, 2020As of December 31, 2019
Altria WarrantPre-emptive RightsTop-up RightsAltria WarrantPre-emptive RightsTop-up Rights
Share price at valuation date (per share in C$)$8.18$8.18$8.18$9.97$9.97$9.97
Subscription price (per share in C$)$19.00$16.25$16.25$19.00$16.25$16.25
Weighted average risk-free interest rate (i)
0.30%0.29%0.26%1.69%1.73%1.71%
Weighted average expected life (in years) (ii)
2.682.001.113.181.251.66
Expected annualized volatility (iii)
91%91%91%82%82%82%
Expected dividend yield%%%%%%
(i) The risk-free interest rate was based on Bank of Canada government treasury bills and bonds with a remaining term equal to the expected life of the derivative liabilities. The risk-free interest rate uses a range of approximately 0.21% to 0.61% as of June 30, 2020 (December 31, 2019 – 1.66% to 1.73%) for the Pre-emptive rights and Top-up rights.
(ii) The expected life in years represents the period of time that the derivative liabilities are expected to be outstanding. The expected life of the Pre-emptive Rights and Top-up Rights is determined based on the expected term of the underlying options, warrants, and shares, to which the Pre-emptive Rights and Top-up Rights are linked. The expected life uses a range of approximately 0.25 year to 5.5 years as of June 30, 2020 (December 31, 2019 – 0.25 year to 6 years).
(iii) Volatility was based on an equally weighted blended historical volatility level of the underlying equity securities of the Company and peer companies.
18

Cronos Group Inc.
Notes to Condensed Consolidated Financial Statements
For the six months ended June 30, 2020
(In thousands of U.S. dollars, except for gram and share amounts, unaudited)
The following table quantifies each of the significant inputs described above and provides a sensitivity analysis of the impact on the reported values of the derivative liabilities. The sensitivity analysis for each significant input is performed by assuming a 10% decrease in the input while other significant inputs remain constant at management’s best estimate as of the respective dates. A decrease in the inputs noted below would cause a decrease in derivative liability and as of June 30, 2020, there would be an equal but opposite impact on net income (loss).
Decrease as of June 30, 2020Decrease as of December 31, 2019
Altria WarrantPre-emptive RightsTop-up RightsAltria WarrantPre-emptive RightsTop-up Rights
Share price$26,300  $2,779  $4,939  $36,436  $2,743  $9,577  
Weighted average expected life14,249  1,744  1,272  17,471  2,366  2,178  
Expected annualized volatility27,711  2,652  4,769  33,343  2,180  7,714  
These inputs are classified in Level 3 on the fair value hierarchy and are subject to volatility and several factors outside of the Company’s control, which could significantly affect the fair value of these derivative liabilities in future periods.

12. Property, Plant and Equipment
Property, plant and equipment, net consisted of the following:
As of
June 30, 2020December 31, 2019
Cost
Land$3,618  $3,727  
Building146,685  150,324  
Furniture and equipment11,394  10,156  
Computer equipment651  687  
Leasehold improvements3,116  2,789  
Construction in progress12,492  3,569  
Less: accumulated depreciation(13,666) (9,443) 
Total$164,290  $161,809  
Depreciation expense included in cost of sales relating to manufacturing equipment and production facilities for the six months ended June 30, 2020 was $759 (June 30, 2019 – $448). Depreciation expense included in operating expenses related to general office space and equipment for six months ended June 30, 2020 was $1,025 (June 30, 2019 – $425). The remaining depreciation is included in inventory.
For the six months ended June 30, 2020, there is $nil (June 30, 2019 – $367) of capitalized interest included in construction in progress.


19

Cronos Group Inc.
Notes to Condensed Consolidated Financial Statements
For the six months ended June 30, 2020
(In thousands of U.S. dollars, except for gram and share amounts, unaudited)
13. Intangible Assets and Goodwill
The ongoing restrictions and closures experienced by retail stores in the U.S. as a result of the COVID-19 pandemic have negatively impacted sales and demand which has resulted in slower than expected revenue growth in the U.S. reporting unit for the three months ended June 30, 2020. The Company expects the revenue growth and operating results in the U.S. reporting unit to continue to be negatively impacted as the decrease in customer demand and retail closures are expected to continue as a result of the pandemic. The Company performed an interim impairment test during the three months ended June 30, 2020 on the U.S. reporting unit, which holds the Redwood goodwill, as well as the indefinite-lived intangible asset (Lord Jones™ brand) to determine whether the carrying amount of the reporting unit and intangible asset exceeded their respective fair values. The Company reassessed its estimates and forecasts during the second quarter to determine the fair values of the reporting unit and intangible asset. The fair values were determined using a discounted cash flow method on the reporting unit and the relief-from-royalty method on the Lord Jones™ brand. Based on these valuations, the carrying value exceeded the fair value resulting in an impairment on both the reporting unit as well as the Lord Jones™ brand. The Company does not believe the declines in fair values are temporary. The Company recorded $35.0 million of impairment charges on the U.S. reporting unit and $5.0 million on the Lord Jones™ brand for the three and six months ended June 30, 2020.
No impairment loss was recorded for either goodwill or intangible assets during the three and six months ended June 30, 2019.
(a)Intangible Assets
Intangible assets are comprised of the following items:

Weighted Average Amortization Period (in years)As of June 30, 2020
CostAccumulated AmortizationImpairment chargesNet
Software (i)
N/A$612  $(298) $—  $314  
Enterprise Resource Planning (“ERP”) system (ii)
52,570    —  2,570  
Health Canada licenses 178,255  (1,167) —  7,088  
Lord Jones brand
N/A64,000  —  (5,000) 59,000  
TrademarksN/A140  —  —  140  
Israeli Codes (iii)
25297  (10) —  287  
$75,874  $(1,475) $(5,000) $69,399  
(i)Software amortizes using a double declining method.
(ii)During the six months ended June 30, 2020, the Company capitalized costs for the ERP system. As of June 30, 2020, the system is not yet available for use, resulting in no amortization being recorded against the asset.
(iii)The preliminary licenses granted to Kibbutz Gan Shmuel (the Cronos Israel joint venture partner) by the Medical Cannabis Unit of the Israeli Ministry of Health in early 2017 (the “Israeli Codes”) were transferred by non-controlling interests to Cronos Israel in exchange for their equity interests in the Cronos Israel entities specified above.
Weighted Average Amortization Period (in years)As of December 31, 2019
CostAccumulated AmortizationNet
Software (i)
N/A$541  $(202) $339  
Health Canada licenses 178,627  (976) 7,651  
Lord Jones brand
N/A64,000  —  64,000  
TrademarksN/A36  —  36  
Israeli Codes (ii)
25298  (4) 294  
$73,502  $(1,182) $72,320  
(i)Software amortizes using a double declining method.
(ii)  The Israeli Codes were transferred by non-controlling interests to Cronos Israel in exchange for their equity interests in the Cronos Israel entities specified above.
The aggregate amortization for the six months ended June 30, 2020 was $346 (June 30, 2019 – $301). Intangible asset additions in 2020 included the ERP system for $2,570. There was $37 related to disposals of software during the six months ended June 30, 2020.
The amortization expense for the next five years on intangible assets in use is estimated to be as follows: 2021 – $565; 2022 – $553; 2023: $536; 2024 – $520; 2025 – $506.
20

Cronos Group Inc.
Notes to Condensed Consolidated Financial Statements
For the six months ended June 30, 2020
(In thousands of U.S. dollars, except for gram and share amounts, unaudited)
(b)Goodwill
As of December 31, 2019AdditionsImpairment chargesEffect of foreign exchangeAs of June 30, 2020
OGBC$302  $  $  $(13) $289  
Peace Naturals1,078      (45) 1,033  
Redwood213,414    (35,000)   178,414  
$214,794  $  $(35,000) $(58) $179,736  

14. General and Administrative Expenses
General and administrative expense are comprised of the following items:
Three months ended June 30,Six months ended June 30,
2020201920202019
Salaries and wages$6,337  $3,354  $13,803  $5,348  
Professional and consulting3,263  5,051  8,849  7,254  
Office and general3,545  2,622  6,620  5,523  
Review costs related to restatement of 2019 interim financial statements (i)
3,459    7,866    
Other1,833  461  5,058  656  
Total$18,437  $11,488  $42,196  $18,781  
(i)These financial statement review costs include costs related to the restatement of the Company’s 2019 interim financial statements and costs related to the Company’s responses to request for information from various regulatory authorities relating to such restatement.

15. Share-based Payments
(a)Warrants
The following is a summary of the changes in warrants during the six months ended June 30, 2020 and 2019:
Weighted average exercise price (C$)Number of warrants
Balance as of January 1, 2020$0.26  $18,066,662  
Balance as of June 30, 2020$0.26  $18,066,662  
Balance as of January 1, 2019$0.26  $25,457,623  
Exercise of warrants0.36  (7,390,961) 
Balance as of June 30, 2019$0.22  $18,066,662  

As of June 30, 2020, the Company had outstanding warrants as follows. For a description of the Altria Warrant, see Note 11.
Grant DateExpiry dateWeighted average exercise price (C$)Number of warrants
October 8 – 28, 2015October 8 – 28, 2020$0.31  $2,976,610  
May 13 – 27, 2016May 13 – 27, 20210.25  15,090,052  
As of June 30, 2020$0.26  $18,066,662  
21

Cronos Group Inc.
Notes to Condensed Consolidated Financial Statements
For the six months ended June 30, 2020
(In thousands of U.S. dollars, except for gram and share amounts, unaudited)
(b)Stock options
(i)Stock option plans
The Company adopted an amended and restated stock option plan dated May 26, 2015 (the “2015 Stock Option Plan”) which was approved by shareholders of the Company at the annual general meeting of shareholders held on June 28, 2017. The 2015 Stock Option Plan allowed the Company’s Board of Directors (the “Board”) to award options to purchase shares to directors, officers, key employees and service providers of the Company. As of June 28, 2018, no further awards will be granted under the 2015 Stock Option Plan; however, shares may be purchased via option exercise by the holders of any outstanding options previously issued under the 2015 Stock Option Plan. As of June 30, 2020, options to purchase 10,486,569 Company common shares were outstanding under the 2015 Stock Option Plan.
On June 28, 2018, the shareholders of the Company approved a stock option plan (the “2018 Stock Option Plan”), which replaced the 2015 Stock Option Plan. As of June 25, 2020, the date on which the 2020 Omnibus Plan (as defined below) was approved by the shareholders of the Company, no further awards will be granted under the 2018 Stock Option Plan; however, shares may be purchased via option exercise by the holders of any outstanding options previously issued under the 2018 Stock Option Plan. As of June 30, 2020, options to purchase 1,727,979 Company common shares were outstanding under the 2018 Stock Option Plan.
On March 29, 2020, the Board adopted a new omnibus equity incentive plan (the “2020 Omnibus Plan”), which was approved by the shareholders of the Company at the annual and special meeting of shareholders held on June 25, 2020. The 2020 Omnibus Plan provides for grants of stock options, share appreciation rights, restricted shares, restricted share units and other share-based or cash-based awards, which are subject to terms as determined by the Compensation Committee of the Board, and awards may be granted to eligible employees, non-employee directors and consultants. As of June 30, 2020, no grants of options have been made under the 2020 Omnibus Plan.
For the three and six months ended June 30, 2020, the total stock-based compensation expense associated with the stock option plans was $1,770 (June 30, 2019 – $2,647) and $3,500 (June 30, 2019 – $4,418), respectively.
(ii) Summary of changes
The following is a summary of the changes during the six months ended June 30, 2020 and 2019:
Weighted average exercise price (C$)Number of optionsWeighted average remaining contractual term (years)
Balance as of January 1, 2020$4.84  14,149,502  2.56
Exercise of options2.05  (1,807,909) 
Cancellation, forfeiture and expiry of options15.78  (127,045) 
Balance as of June 30, 2020$5.13  12,214,548  2.05
Exercisable at June 30, 20203.42  8,688,645  1.78
Balance as of January 1, 2019$2.99  12,902,995  3.35
Issuance of options20.81  1,315,787  
Exercise of options3.76  (227,342) 
Cancellation, forfeiture and expiry of options1.63  (2,895) 
Balance as of June 30, 2019$4.66  13,988,545  3.04
Exercisable as of June 30, 20192.406,580,238  2.69
22

Cronos Group Inc.
Notes to Condensed Consolidated Financial Statements
For the six months ended June 30, 2020
(In thousands of U.S. dollars, except for gram and share amounts, unaudited)
(iii)Fair value of options issued
The fair value of the options issued was determined using the Black-Scholes option pricing model, using the following inputs:
For the six months ended June 30, 2019
Share price at grant date (per share)
C$20.65 - C$24.75
Exercise price (per option)
C$20.65 - C$24.75
Risk-free interest rate
1.51% - 1.62%
Expected life of options (in years)5
Expected annualized volatility80%
Expected dividend yield%
Weighted average Black-Scholes value at grant date (per option)
C$13.29 - C$15.91
Forfeiture rate%
No stock options were granted under the 2018 Stock Option Plan or the 2020 Omnibus Plan during the six months ended June 30, 2020. During the six months ended June 30, 2019, the weighted average fair value per share at grant date of options was C$13.35.
The expected life of the awards represents the period of time stock options are expected to be outstanding and is estimated considering vesting terms and employees’ and non-employees’ historical exercise and post-vesting employment termination behavior. Volatility was estimated by using the historical volatility of the Company, adjusted for the Company’s expectation of volatility going forward. The risk-free interest rate was based on the Bank of Canada government bonds with a remaining term equal to the expected life of the options at the grant date.
(c)Restricted share units
On May 11, 2020, the Company issued an aggregate of 279,277 restricted stock units (“RSUs”) to certain employees in connection with the 2020 Omnibus Plan. Each RSU entitles the holder to receive upon vesting one common share of the Company. The fair value of these RSUs has been determined based on the quoted market price of the applicable exchange on the date of issuance of C$7.52 per share on TSX or $5.42 per share on NASDAQ. The RSUs vest annually in equal installments over a three-year period following the grant date and have no performance requirements.
On September 5, 2019, the Company issued an aggregate of 732,972 RSUs to certain employees in connection with the acquisition of four Redwood Holding Group, LLC subsidiaries (collectively, “Redwood”) and pursuant to Employment Inducement Award Plan. Each RSU entitles the holder to receive upon vesting one common share of the Company. The fair value of these RSUs has been determined based on the quoted market price on the date of issuance of C$15.34 per share. Under the terms of the corresponding RSU agreement, the RSUs vest on the third anniversary following the grant date and have no performance requirements.
On July 20, 2020, the Company entered into separation agreements with Robert Rosenheck and another Redwood Wellness, LLC (“Redwood”) employee pursuant to which they resigned from their employment with Redwood. In connection with such separation agreements, the 732972 outstanding and unvested RSUs as of July 20, 2020 to which they were entitled were accelerated and vested as of July 20, 2020. Refer to Note 25 for further information.
For the three and six months ended June 30, 2020, the Company recorded $776 and $1,482 (June 30, 2019 – $nil) in share-based compensation expense related to these RSUs, respectively.
The following is a summary of the changes in RSUs from January 1, 2020 to June 30, 2020:
Number of RSUsShare-based reserve
Balance as of January 1, 2020732,972  $889  
Issuance of RSUs279,277  —  
Vesting of issued RSUs —  1,482  
Balance as of June 30, 20201,012,249  $2,371  
No RSUs were granted or outstanding during the six months ended June 30, 2019.
23

Cronos Group Inc.
Notes to Condensed Consolidated Financial Statements
For the six months ended June 30, 2020
(In thousands of U.S. dollars, except for gram and share amounts, unaudited)
(d)Deferred share units
On August 10, 2019, the Company established a cash-settled deferred share unit plan (“DSU Plan”) pursuant to which its non-executive directors receive deferred share units (“DSUs”). The DSU Plan is designed to promote a greater alignment of long-term interests between non-executive directors and shareholders. The number of DSUs granted under the DSU Plan (including fractional DSUs) is determined by dividing the amount of remuneration payable by the closing price as reported by the TSX on the trading day immediately preceding the day of grant. DSUs are payable at the time a non-executive director ceases to hold the office of director for any reason and are settled by a lump-sum cash payment, in accordance with the terms of the DSU Plan, based on the fair value of the DSUs at such time. The fair value of the cash payout is determined by multiplying the number of DSUs vested at the payout date by the closing price as reported by the TSX on the trading day immediately preceding the payout date. The fair value of the cash payout is determined at each reporting date based on the fair value of the Company’s common shares at the reporting date and is recorded within other liabilities.
The following is a summary of the changes in DSUs from January 1, 2020 to June 30, 2020:
Number of DSUsFinancial liability
Balance as of January 1, 202033,397  $255  
Liabilities settled(8,484) (46) 
Loss (gain) on revaluation —  (56) 
Balance as of June 30, 202024,913  $153  
No DSUs were granted or outstanding during the six months ended June 30, 2019.

16. Earnings (loss) Per Share
Basic and diluted earnings (loss) per share are calculated using the following numerators and denominators:
For the three months ended June 30,For the six months ended June 30,
2020201920202019
Basic earnings per share computation
Net income (loss) attributable to common shareholders of Cronos Group$(106,977) $185,999  $(30,937) $500,090  
Weighted average number of common shares outstanding349,075,408  334,665,873  348,946,439  317,940,749  
 Basic earnings per share $(0.31) $0.56  $(0.09) $1.57  
Diluted earnings per share computation(i)
Net income (loss) used in the computation of basic earnings per share$(106,977) $185,999  $(30,937) $500,090  
Adjustment for gain (loss) on revaluation of derivative liabilities(729) (126,032) (729) (350,758) 
Net income (loss) used in the computation of diluted income per share$(107,706) $59,967  $(31,666) $149,332  
Weighted average number of common shares outstanding used in the computation of basic earnings per share349,075,408  334,665,873  348,946,439317,940,749
Dilutive effect of warrants (i)
  19,287,262    21,239,056
Dilutive effect of stock options (i)
  10,992,464    11,291,914
Dilutive effect of restricted share units (i)
        
Dilutive effect of Altria Warrant (i)
  9,100,465    13,633,605
Dilutive effect of Top-up Rights – exercised and exercisable fixed price (i)
  630,531    766,769
Weighted average number of common shares for computation of diluted income (loss) per share349,075,408  374,676,595  348,946.439  364,872,093  
Diluted earnings per share$(0.31) $0.16  $(0.09) $0.41  
(i) In computing diluted earnings per share, incremental common shares are not considered in periods in which a net loss is reported, as the inclusion of the common share equivalents would be anti-dilutive.
24

Cronos Group Inc.
Notes to Condensed Consolidated Financial Statements
For the six months ended June 30, 2020
(In thousands of U.S. dollars, except for gram and share amounts, unaudited)
The following securities were not included in the computation of diluted shares outstanding because the effect would be anti-dilutive or because conditions for contingently issuable shares were not satisfied at the end of the reporting periods.
Three months ended June 30,Six months ended June 30,
2020201920202019
Ginkgo Equity Milestones14,674,904  14,674,904  14,674,904  14,674,904  
Pre-emptive Rights12,006,740  12,006,740  12,006,740  12,006,740  
Top-up Rights – fixed price26,686,413    26,686,413    
Top-up Rights – market price1,941,349  25,150,434  1,941,349  25,150,434  
Altria Warrant77,752,533  1,076,553  77,752,533  1,076,553  
Stock options10,495,235  51,830  10,547,256  51,830  
Warrants17,536,558    17,521,903    
Restricted share units1,012,249    1,012,249    
Total anti-dilutive securities162,091,326  52,960,461  162,158,002  52,960,461  

17. Related Party Transactions and Balances
On March 8, 2019, in connection with the Altria Investment, Altria, through certain of its wholly owned subsidiaries, purchased a 45% equity interest in the Company. During the three and six months ended June 30, 2020, the Company incurred $281 and $953 respectively, for consulting services from Altria Pinnacle LLC, a subsidiary of Altria (“Altria Pinnacle”). As of June 30, 2020, the accrual for these consulting services was $281 (December 31, 2019 – $1,152). No consulting services were provided by Altria Pinnacle for the three and six months ended June 30, 2019.
During 2019, the Company purchased machinery and equipment amounting to $1,258 from a subsidiary of Altria. Refer to Note 19 for additional information.
Refer to Note 11 for further information on the derivative liabilities related to the Altria Investment.
There were no other material related party transactions for the six months ended June 30, 2020 or June 30, 2019.

18. Segment Information
Segment reporting is prepared on the same basis that the Company’s chief operating decision makers (the “CODMs”) manage the business, make operating decisions and assess the Company’s performance. The Company determined that it has the following two reportable segments: United States and Rest of World. The United States operating segment consists of the manufacture and distribution of hemp-derived CBD infused products. The Rest of World operating segment is involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. These two segments represent the geographic regions in which the Company operates and the different product offerings within each geographic region. The results of each segment are regularly reviewed by the CODMs to assess the performance of the segment and make decisions regarding the allocation of resources. The CODMs review operating income (loss) as the measure of segment profit or loss to evaluate performance of and allocate resources for its reportable segments. Operating income (loss) is defined as net revenue less cost of sales and operating expenses.
Reporting by operating segments follows the same accounting policies as those used to prepare the consolidated financial statements. The operating segments are presented in accordance with the same criteria used for internal reporting prepared for the CODMs. Intersegment transactions are recorded at the stated values as agreed to by the segments.
25

Cronos Group Inc.
Notes to Condensed Consolidated Financial Statements
For the six months ended June 30, 2020
(In thousands of U.S. dollars, except for gram and share amounts, unaudited)
Segment data was as follows for the three months ended June 30, 2020:
Three months ended June 30, 2020
United StatesRest of WorldCorporateTotal
Consolidated statements of net income (loss) and comprehensive income (loss)
Net revenue
Cannabis flower$  $5,674  $  $5,674  
Cannabis extracts2,174  1,917    4,091  
Other  118    118  
Net revenue$2,174  $7,709  $  $9,883  
Share of loss from investments in equity accounted investees$  $794  $  $794  
Interest income8  3,811  (2) 3,817  
Interest expense  (83)   (83) 
Interest income, net$8  $3,728  $(2) $3,734  
Impairment loss on goodwill and intangible assets40,000  $  $  $40,000  
Depreciation and amortization36  654  (6) 684  
Income tax expense        
Net income (loss)(47,762) (52,899) (7,042) (107,703) 
26

Cronos Group Inc.
Notes to Condensed Consolidated Financial Statements
For the six months ended June 30, 2020
(In thousands of U.S. dollars, except for gram and share amounts, unaudited)
Segment data was as follows for the six months ended June 30, 2020:
Six months ended June 30, 2020
United StatesRest of WorldCorporateTotal
Consolidated statements of net income (loss) and comprehensive income (loss)
Net revenue
Cannabis flower$  $8,415  $  $8,415  
Cannabis extracts4,350  5,317    9,667  
Other  233    233  
Net revenue$4,350  $13,965  $  $18,315  
Share of loss from investments in equity accounted investees$  $1,966  $  $1,966  
Interest income13  11,562    11,575  
Interest expense  (90)   (90) 
Interest income, net$13  $11,472  $  $11,485  
Impairment loss on goodwill and intangible assets40,000  $  $  $40,000  
Depreciation and amortization69  1,302    1,371  
Income tax expense        
Net income (loss)(57,567) 39,257  (13,712) (32,022) 
Consolidated balance sheets
Total assets$250,470  $348,569  $1,311,248  $1,910,287  
Investments in equity accounted investees  933    933  
Goodwill178,414  1,322    179,736  
Purchase of property, plant and equipment, net219  13,125    13,344  
Sources of net revenue for the three and six months ended June 30, 2020 and 2019 were as follows:
Three months ended June 30,Six months ended June 30,
2020201920202019
Cannabis flower5,674  6,096  $8,415  $7,921  
Cannabis extracts4,091  1,535  9,667  2,638  
Other118  22  233  98  
Net revenue$9,883  $7,653  $18,315  $10,657  
Net revenue attributed to a geographic region based on the location of the customer were as follows:
Three months ended June 30,Six months ended June 30,
2020201920202019
Canada7,416  7,340  $13,507  $10,323  
United States2,174    4,350    
Other countries293  313  458  334  
Total$9,883  $7,653  $18,315  $10,657  
27

Cronos Group Inc.
Notes to Condensed Consolidated Financial Statements
For the six months ended June 30, 2020
(In thousands of U.S. dollars, except for gram and share amounts, unaudited)
Property, plant and equipment assets were physically located in the following geographic regions:
As of June 30, 2020As of December 31, 2019
Canada$140,357  $141,021  
United States2,253  2,103  
Other countries21,680  18,685  
Total$164,290  $161,809  
The Company sells products through a limited number of major customers. Major customers are defined as customers that each individually accounted for greater than 10% of the Company’s revenues and greater than 10% of accounts receivable.
United States
During the three and six months ended June 30, 2020, the U.S. segment had no major customers.
As of June 30, 2020, $46 (December 31, 2019 – $12) in expected credit losses has been recognized on receivables from contracts with customers.
Rest of World
During the three months ended, June 30, 2020, the Rest of World segment earned a total net revenue before excise taxes of $7,040 from four major customers, BC Liquor Distribution Branch, Alberta Gaming, Liquor and Cannabis Commission, Ontario Cannabis Retail Corporation, and Société Québécoise du Cannabis accounting for 26%, 19%, 16% and 12% of the Company’s total revenues, respectively (three months ended June 30, 2019 – $4,118 from one major customer accounting for 54% of the Company’s total revenues).
During the six months ended, June 30, 2020, the Rest of World segment earned a total net revenue before excise taxes of $11,819 from the same four major customers as mentioned above, representing 19%, 22%, 13%, and 13% of the Company’s total revenues, respectively (six months ended June 30, 2019 – $5,800 from two major customers, together accounting for 54% of the Company’s total revenues).
As of June 30, 2020, $34 (December 31, 2019 – $124) in expected credit losses has been recognized on receivables from contracts with customers.

19. Commitments
(a)R&D Commitments
(i) Ginkgo. On September 4, 2018, the Company announced an R&D partnership with Ginkgo to develop scalable and consistent production of eight target cannabinoids, including THC, CBD and a variety of other lesser known and rarer cannabinoids. As part of this partnership, Cronos Group has agreed to issue up to 14,674,903 common shares of the Company (aggregate value of approximately $100,000 as of July 17, 2018 assuming all milestones are met) (collectively the “Ginkgo Equity Milestones”) in tranches and $22,000 in cash subject to Ginkgo’s achievement of certain milestones and to fund certain R&D expenses, including foundry access fees.
(ii) Technion. On October 15, 2018, the Company entered into a sponsored research agreement with the Technion Research and Development Foundation of the Technion – Israel Institute of Technology (“Technion”). Research will be focused on the use of cannabinoids and their role in regulating skin health and skin disorders. The Company has committed to $1,784 of research funding over a period of three years. An additional $4,900 of cash payments will be paid to Technion upon the achievement of certain milestones.
28

Cronos Group Inc.
Notes to Condensed Consolidated Financial Statements
For the six months ended June 30, 2020
(In thousands of U.S. dollars, except for gram and share amounts, unaudited)
(b)Altria Consulting Services
On February 18, 2019, the Company entered into an agreement with a wholly owned subsidiary of Altria (which agreement was subsequently amended and restated to substitute Altria Pinnacle as a party thereto), to receive strategic advisory and project management services from Altria Pinnacle (the “Services Agreement”). Pursuant to the Services Agreement, the Company will pay Altria Pinnacle a monthly fee equal to the product of one hundred and five percent (105%) and the sum of: (i) all costs directly associated with the services incurred during the monthly period, and (ii) a reasonable and appropriate allocation of indirect costs incurred during the monthly period. The Company will also pay all third-party direct charges incurred during the monthly period in connection with the services, including any reasonable and documented costs, fees and expenses associated with obtaining any consent, license or permit. The Services Agreement will remain in effect until terminated by either party.
(c)Use of Publicity Rights in Brand Development
On December 23, 2019, the Company issued 856,017 restricted common shares to an accredited investor in a private placement (“Private Placement – 2019”) in reliance on Section 4(a)(2) of the Securities Act of 1933 in connection with the use of certain publicity rights in brand development. One-third of such common shares vested on January 31, 2020 with the remaining shares vesting in two equal installments on June 23, 2021, and December 23, 2022. The issuance did not involve a public offering and was made without general solicitation or advertising. The total fair value of the consideration paid for the issuance of such common shares was approximately $6,000. The fair value of the shares was calculated using the ten-day volume weighted average price per share of the Company’s common shares on Nasdaq.
Additional restricted common shares are issued when certain performance milestones are achieved:
(i) First Performance Issuance: if, prior to December 23, 2022, the product line generates at least $50,000 in net revenue, additional common shares with an aggregate value of $1,000 will be issued.
(ii) Second Performance Issuance: if, prior to December 23, 2022, the product line generates at least $100,000 in net revenue, additional common shares with an aggregate value of $1,000 will be issued (together with the First Performance Issuance noted above).
The number of common shares that would be issued upon achieving the foregoing milestones will be determined based on the ten-day volume weighted average price per share of the Company’s common shares on Nasdaq as of the trading day immediately prior to the date of filing with the SEC of the Company’s audited year-end financial statements for the first fiscal year during which such milestones are achieved.
(d)Take or Pay Supply Agreement
In January 2020, the Company entered into a take or pay supply agreement with a supplier of dried cannabis flower. The Company agreed to purchase a minimum of approximately C$1,734 ($1,290) of dried cannabis flower over 6 months from the date of the agreement and, subject to the supplier’s satisfaction of certain conditions and the availability of additional product, potentially up to a maximum of approximately C$4,284 ($3,188) over 6 months from the date of the agreement. As at June 30, 2020, the Company is committed to purchase approximately C$1,230 ($906) of dried cannabis flower remaining under this agreement which, due to delays in deliveries from the supplier, are expected to be made during the remainder of 2020.


29

Cronos Group Inc.
Notes to Condensed Consolidated Financial Statements
For the six months ended June 30, 2020
(In thousands of U.S. dollars, except for gram and share amounts, unaudited)
20. Contingencies
The Company is subject to various legal proceedings in the ordinary course of business and in connection with its marketing, distribution and sale of its products. Many of these legal proceedings are in the early stages of litigation and seek damages that are unspecified or not quantified. Although the outcome of these matters cannot be predicted with certainty, the Company does not believe these legal proceedings, individually or in the aggregate, will have a material adverse effect on the Company’s financial condition but could be material to the Company’s results of operations for a quarterly period depending, in part, on the results for that quarter.
(a)Class Action Complaints Relating to Restatements
On March 11 and 12, 2020, two alleged shareholders of the Company separately filed two putative class action complaints in the U.S. District Court for the Eastern District of New York against the Company and its Chief Executive Officer and Chief Financial Officer alleging violations of Section 10(b) of the Securities Exchange Act of 1934 (the “Exchange Act”) and Rule 10b-5 promulgated thereunder against all defendants, and Section 20(a) of the Exchange Act against the individual defendants. The complaints generally allege that certain of the Company’s prior public statements about revenues and internal controls were incorrect based on the Company’s March 2, 2020, disclosure that the Audit Committee of its Board of Directors was conducting a review of the appropriateness of revenue recognized in connection with certain bulk resin purchases and sales of products through the wholesale channel. The complaints do not quantify a damage request. Defendants have not yet responded to the complaints.
On June 3, 2020, an alleged shareholder filed a Statement of Claim in the Ontario Superior Court of Justice in Toronto, Ontario, Canada, seeking, among other things, an order certifying the action as a class action on behalf of a putative class of shareholders and damages of an unspecified amount. The Statement of Claim names the Company, its Chief Executive Officer, Chief Financial Officer, former Chief Financial Officer and Chief Commercial Officer, and current and former members of its Board of Directors as defendants and alleges breaches of the Ontario Securities Act, oppression under the Ontario Business Corporations Act and common law misrepresentation. The Statement of Claim generally alleges that certain of the Company’s prior public statements about revenues and internal controls were misrepresentations based on the Company’s March 2, 2020 disclosure that the Audit Committee of its Board of Directors was conducting a review of the appropriateness of revenue recognized in connection with certain bulk resin purchases and sales of products through the wholesale channel, and the Company’s subsequent restatements. The Statement of Claim does not quantify its damage request. The Company and the other named defendants have not yet filed a response to the Statement of Claim.
(b)Regulatory Reviews Relating to Restatements
The Company has been responding to requests for information from various regulatory authorities relating to its previously disclosed restatement of its financial statements for the first three quarters of 2019. The Company is responding to all such requests for information and cooperating with all regulatory authorities. The Company cannot predict the outcome of any such regulatory review or investigation and it is possible that additional investigations or one or more formal proceedings may be commenced against the Company and its current and former officers and directors in connection with these regulatory reviews.
(c)Litigation Relating to Marketing, Distribution and Sale of Products
On June 16, 2020, an alleged consumer filed a Statement of Claim on behalf of a class in the Court of Queen’s Bench of Alberta in Alberta, Canada, against the Company and other Canadian cannabis manufacturers and/or distributors. The Statement of Claim alleges claims related to the defendants’ advertised content of cannabinoids in cannabis products for medicinal use on or after June 16, 2010 and cannabis products for adult use on or after October 17, 2018. The Statement of Claim seeks a total of C$500 million for breach of contract, compensatory damages, and unjust enrichment or such other amount as may be proven in trial and C$5 million in punitive damages against each defendant, including the Company. The Statement of Claim also seeks interest and costs associated with the action. The Company has not responded to the Statement of the Claim.
A number of claims, including purported class actions, have been brought in the U.S. against companies engaged in the U.S. hemp business alleging, among other things, violations of state consumer protection, health and advertising laws. On April 8, 2020, a putative class action complaint was filed in the U.S. District Court for the Central District of California against Redwood, alleging violations of California’s Unfair Competition Law, False Advertising Law, Consumers Legal Remedies Act, and breaches of the California Commercial Code for breach of express warranties and implied warranty of merchantability with respect to Redwood’s marketing and sale of U.S. hemp products. The complaint does not quantify a damage request. On April 14, 2020, the class action complaint was dismissed for certain pleading deficiencies and the plaintiff was granted leave until April 24, 2020 to amend the complaint to establish federal subject matter jurisdiction. As of the date of this Quarterly Report, the plaintiff has not refiled the complaint and the complaint has been dismissed without prejudice
The Company expects litigation and regulatory proceedings relating to the marketing, distribution and sale of its products to increase.
30

Cronos Group Inc.
Notes to Condensed Consolidated Financial Statements
For the six months ended June 30, 2020
(In thousands of U.S. dollars, except for gram and share amounts, unaudited)

21. Financial Instruments
The Company’s activities expose it to a variety of financial risks, including credit risk, liquidity risk, and market risk (including interest rate risk) and foreign currency risk.
(a)Credit Risk
Credit risk is the risk of financial loss to the Company if a customer or counterparty to a financial instrument fails to meet its contractual obligations. The Company is exposed to credit risk from its operating activities, primarily accounts receivable and other receivables, and its investing activities, including cash held with banks and financial institutions, short-term investments, loan receivable, and advances to joint ventures. The Company’s maximum exposure to this risk is equal to the carrying amount of these financial assets, which amounted to $1,424,786 as of June 30, 2020 (December 31, 2019 – $1,586,978).
(i)Accounts receivable
An impairment analysis is performed at each reporting date using a provision matrix to measure expected credit losses. The provision rates are based on the days past due for groupings of various customer segments with similar loss patterns. The calculation reflects the probability-weighted outcome, the time value of money and reasonable and supportable information that is available at the reporting date about past events, current conditions and forecasts of future economic conditions. Accounts receivable are written off when there is no reasonable expectation of recovery. Indicators that there is no reasonable expectation of recovery include, among others, the failure of a debtor to engage in a repayment plan, and a failure to make contractual payments for a period of greater than 120 days past due. For the three months ended June 30, 2020, the Company recorded a current expected credit loss allowance of $80 (December 31, 2019 – $136). The Company has assessed that there is a concentration of credit risk, as 78% of the Company’s accounts receivable were due from four customers as of June 30, 2020 (December 31, 2019 – 56% due from two customers) with an established credit history with the Company.
(ii)Cash and cash equivalents, short-term investments, and other receivables
The Company held cash and cash equivalents of $1,109,700 as of June 30, 2020 (December 31, 2019 – $1,199,693). The short-term investments and related interest receivable of $213,614 as of June 30, 2020 (December 31, 2019 – $306,347) represents short-term investments with a maturity of less than a year and accrued interest as of period end. The cash and cash equivalents and short-term investments, including guaranteed investment certificates and bankers’ acceptances, are held with central banks and financial institutions that are highly rated. In addition to interest receivable, other receivables include sales taxes receivable from the government. As such, the Company has assessed an insignificant loss allowance on these financial instruments.
(iii)Advances to joint ventures
The Company has assessed the credit risk of advances to joint ventures based on the financial position of the borrowers, and the regulatory and economic environment of the borrowers. Based on historical information, and adjusted for forward-looking expectations, the Company has assessed an expected credit loss allowance on these advances as of June 30, 2020 of $nil (December 31, 2019 – $nil).
(b) Liquidity risk
Liquidity risk is the risk that the Company will not be able to meet its financial obligations as they become due and arises principally from the Company’s accounts payable and other liabilities. The Company’s policy is to review liquidity resources and ensure that sufficient funds are available to meet financial obligations as they become due. Further, the Company’s management is responsible for ensuring funds exist and are readily accessible to support business opportunities as they arise. The Company’s funding is primarily provided in the form of capital raised through the issuance of common shares and warrants. As of June 30, 2020, 14% of the Company’s payables were due to one vendor (December 31, 2019 – 42% due to three vendors).
31

Cronos Group Inc.
Notes to Condensed Consolidated Financial Statements
For the six months ended June 30, 2020
(In thousands of U.S. dollars, except for gram and share amounts, unaudited)
(c)Market risk
Market risk is the risk that the fair value of, or future cash flows from, the Company’s financial instruments will significantly fluctuate due to changes in market prices. The value of financial instruments can be affected by changes in interest rates, market and economic conditions, and equity and commodity prices. The Company is exposed to market risk in divesting its investments, such that, unfavorable market conditions could result in dispositions of investments at less than their carrying values. Further, the revaluation of securities classified as fair value through net income, could result in significant write-downs of the Company’s investments, which would have an adverse impact on the Company’s financial position, unless these would flow through other comprehensive income.
The Company manages market risk by having a portfolio of securities from multiple issuers so that the Company is not materially exposed to any one issuer.
(d) Interest rate risk
Interest rate risk is the risk that the value or yield of fixed-income investments may decline if interest rates change. Fluctuations in interest rates may impact the level of income and expense recorded on the cash equivalents and short-term investments, and the market value of all interest-earning assets, other than those which possess a short-term to maturity. A 10% change in the interest rate in effect on June 30, 2020 and December 31, 2019, would not have a material effect on (i) fair value of the cash equivalents and short-term investments as the majority of the portfolio has a maturity date of three months or less, or (ii) interest income. Management continues to monitor external interest rates and revise the Company’s investment strategy as a result.
During the six months ended June 30, 2020, the Company had net interest income of $11,485 (June 30, 2019 – $11,528). During the three and six months ended June 30, 2020, the Company’s average variable interest rate fell 0.73% and 1.45%, respectively. Had the interest rates been consistent, net interest income would have increased by $2,090 and $7,292, respectively for the three and six months ended June 30, 2020.
(e) Currency rate risk
Currency rate risk is the risk that the fair value of, or future cash flows from, the Company’s financial instruments will significantly fluctuate due to changes in foreign exchange rates. The Company is exposed to this risk on advances to joint ventures denominated in A$ and C$. The Company is further exposed to this risk through subsidiaries operating in Israel and the U.S. as the Company’s functional currency is in Canadian dollars. The Company does not currently use foreign exchange contracts to hedge its exposure to currency rate risk. As such, the Company’s financial position and financial results may be adversely affected by the unfavorable fluctuations in currency exchange rates.
As of June 30, 2020, the Company had foreign currency gain (loss) on translation of $(61,821) (June 30, 2019 – $21,845). A 10% change in the exchange rates for the U.S. dollar would affect the carrying value of net assets by approximately $166,395 as of June 30, 2020 (December 31, 2019 – $174,902).

32

Cronos Group Inc.
Notes to Condensed Consolidated Financial Statements
For the six months ended June 30, 2020
(In thousands of U.S. dollars, except for gram and share amounts, unaudited)
22. Fair Value Measurement
The Company complies with ASC 820, Fair Value Measurements, for its financial assets and liabilities that are re-measured and reported at fair value at each reporting period, and non-financial assets and liabilities that are re-measured and reported at fair value at least annually. In general, fair values are determined by:
Level 1 inputs utilize quoted prices (unadjusted) in active markets for identical assets or liabilities.
Level 2 inputs utilize data points that are observable such as quoted prices, interest rates and yield curves.
Level 3 inputs are unobservable data points for the asset or liability, and includes situations where there is little, if any, market activity for the asset or liability.
The following tables present information about the Company’s assets that are measured at fair value on a recurring basis as of June 30, 2020 and December 31 2019, and indicates the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value.
June 30, 2020Level 1Level 2Level 3Total
Cash and cash equivalents$1,109,700  $  $  $1,109,700  
Short-term investments213,614      213,614  
Derivative liabilities    205,714  205,714  

December 31, 2019Level 1Level 2Level 3Total
Cash and cash equivalents$1,199,693  $  $  $1,199,693  
Short-term investments306,347      306,347  
Derivative liabilities    297,160  297,160  
There were no transfers between categories during the periods presented.

23. Supplementary Cash Flow Information
The net changes in non-cash working capital items are as follows:
For the six months ended June 30,
20202019
Accounts receivable$1,161  $(3,986) 
Other receivables(2,336) (7,681) 
Prepaids and other assets1,568  (2,564) 
Inventory(23,913) (15,105) 
Accounts payable and other liabilities(6,985) 9,877  
Cumulative effect from foreign exchange(65) (2,132) 
Total$(30,570) $(21,591) 

24. Non-monetary Transactions
During the six months ended June 30, 2020, the Company had no non-monetary transactions.
On March 28, 2019, the Company entered into two transactions to simultaneously purchase and sell inventory to a third party. The Company purchased cannabis resin from the third party and in turn sold cannabis dry flower to the third party. The transactions involved the exchange of work in progress inventory and were accounted for at the carrying value of inventory transferred by the Company, which equaled the value of the cannabis resin received. No revenue was recognized as a result of this transaction and no gain or loss was recognized in the condensed consolidated statements of operations and comprehensive income (loss).
33

Cronos Group Inc.
Notes to Condensed Consolidated Financial Statements
For the six months ended June 30, 2020
(In thousands of U.S. dollars, except for gram and share amounts, unaudited)

25. Subsequent Events
(a)On July 24, 2020, the Company entered into an amendment to the Series A Loan with Natuera to increase the principal amount of the Series A Loan by $6,350, to an aggregate principal amount of $15,500, of which the Company has committed to fund 50% and its joint venture partner has committed to fund the remaining 50%. Outstanding principal amounts continue to bear interest at a fixed annual rate of 5.67% and the maturity date of the Series A Loan has been extended to March 1, 2021. As of June 30, 2020, the Company has a loan receivable (net of credit allowance) of $2,984 from Natuera. Refer to Note 10 for details.
(b)On July 20, 2020, the Company entered into separation agreements with Robert Rosenheck and another Redwood employee pursuant to which they resigned from their employment with Redwood Wellness, LLC. In connection with such separation agreements, the 732,972 outstanding and unvested RSUs as of July 20, 2020 to which they were entitled were accelerated and vested as of July 20, 2020. A total of $6.2 million of share-based compensation costs will be recognized in the third quarter of 2020.
34


Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.
The following discussion and analysis should be read together with other information, including Cronos Group’s condensed consolidated financial statements and the related notes to those statements, included in Part I, Item 1 of this Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2020 (this “Quarterly Report”), consolidated financial statements appearing in the Company’s Annual Report on Form 10-K/A for the year ended December 31, 2019 (as amended, the “Annual Report”), Part I, Item 1A, Risk Factors, of the Annual Report and Part 2, Item 1A, Risk Factors, of this Quarterly Report.
Forward-Looking Statements
This Quarterly Report, the documents incorporated into this Quarterly Report by reference, other reports we file with, or furnish to, the U.S. Securities and Exchange Commission (“SEC”) and other regulatory agencies, and statements by our directors, officers, other employees and other persons authorized to speak on our behalf contain information that may constitute forward-looking information and forward-looking statements within the meaning of applicable securities laws (collectively, “Forward-Looking Statements”), which are based upon our current expectations, estimates, projections, assumptions and beliefs. All information that is not clearly historical in nature may constitute Forward-Looking Statements. In some cases, Forward-Looking Statements can be identified by the use of forward-looking terminology, such as “expect”, “likely”, “may”, “will”, “should”, “intend”, “anticipate”, “potential”, “proposed”, “estimate” and other similar words, expressions and phrases, including negative and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussion of strategy. Forward-Looking Statements include estimates, plans, expectations, opinions, forecasts, projections, targets, guidance or other statements that are not statements of historical fact.
Forward-Looking Statements include, but are not limited to, statements with respect to:
the uncertainties associated with the COVID-19 pandemic, including our ability, and the abilities of our joint ventures and our suppliers and distributors, to effectively deal with the restrictions, limitations and health issues presented by the COVID-19 pandemic, the ability to continue our production, distribution and sale of our products, and demand for and the use of our products by consumers;
laws and regulations and any amendments thereto applicable to our business and the impact thereof, including uncertainty regarding the application of United States (“U.S.”) state and federal law to U.S. hemp (including CBD) products and the scope of any regulations by the U.S. Federal Drug Administration (the “FDA”), the U.S. Federal Trade Commission (the “FTC”), the U.S. Patent and Trademark Office (the “PTO”) and any state equivalent regulatory agencies over U.S. hemp (including CBD) products;
expectations regarding the regulation of the U.S. hemp industry in the U.S., including the promulgation of regulations for the U.S. hemp industry by the U.S. Department of Agriculture (the “USDA”);
the grant, renewal and impact of any license or supplemental license to conduct activities with cannabis or any amendments thereof;
our international activities and joint venture interests, including required regulatory approvals and licensing, anticipated costs and timing, and expected impact;
the ability to successfully create and launch brands and further create, launch and scale U.S. hemp-derived consumer products, including through the Redwood Acquisition (as defined herein), and cannabis products in jurisdictions where such products are legal and that we currently operate in;
the benefits, viability, safety, efficacy, dosing and social acceptance of cannabis, including CBD and other cannabinoids;
the anticipated benefits and impact of the Altria Investment (as defined herein);
the potential exercise of the Altria Warrant (as defined herein), pre-emptive rights and/or top-up rights in connection with the Altria Investment, including proceeds to us that may result therefrom;
expectations regarding the use of proceeds of equity financings, including the proceeds from the Altria Investment;
the legalization of the use of cannabis for medical or adult-use in jurisdictions outside of Canada, the related timing and impact thereof and our intentions to participate in such markets, if and when such use is legalized;
expectations regarding the potential success of, and the costs and benefits associated with, our joint ventures, strategic alliances and equity investments, including the strategic partnership (the “Ginkgo Strategic Partnership”) with Ginkgo Bioworks, Inc. (“Ginkgo”);
our ability to execute on our strategy and the anticipated benefits of such strategy;
expectations of the amount or frequency of impairment losses, including as a result of the write-down of intangible assets, including goodwill;
35


the ongoing impact of the legalization of additional cannabis product types and forms for adult-use in Canada, including federal, provincial, territorial and municipal regulations pertaining thereto, the related timing and impact thereof and our intentions to participate in such markets;
the future performance of our business and operations;
our competitive advantages and business strategies;
the competitive conditions of the industry;
the expected growth in the number of customers using our products;
our ability or plans to identify, develop, commercialize or expand our technology and R&D initiatives in cannabinoids, or the success thereof;
expectations regarding acquisitions and the anticipated benefits therefrom, including the Redwood Acquisition and the acquisition of certain assets from Apotex Fermentation Inc., including a GMP-compliant fermentation and manufacturing facility in Winnipeg, Manitoba (operating as “Cronos Fermentation”);
expectations regarding revenues, expenses and anticipated cash needs;
expectations regarding cash flow, liquidity and sources of funding;
expectations regarding capital expenditures;
the expansion of our production and manufacturing, the costs and timing associated therewith and the receipt of applicable production and sale licenses;
the expected growth in our growing, production and supply chain capacities;
expectations regarding the resolution of litigation and other legal and regulatory proceedings, reviews and investigations;
expectations with respect to future production costs;
expectations with respect to future sales and distribution channels;
the expected methods to be used to distribute and sell our products;
our future product offerings;
the anticipated future gross margins of our operations;
accounting standards and estimates;
our ability to timely and effectively remediate material weaknesses in our internal control over financial reporting;
expectations regarding our distribution network; and
expectations regarding the costs and benefits associated with our contracts and agreements with third parties, including under our third-party supply and manufacturing agreements.
Certain of the Forward-Looking Statements contained herein concerning the industries in which we conduct our business are based on estimates prepared by us using data from publicly available governmental sources, market research, industry analysis and on assumptions based on data and knowledge of these industries, which we believe to be reasonable. However, although generally indicative of relative market positions, market shares and performance characteristics, such data is inherently imprecise. The industries in which we conduct our business involve risks and uncertainties that are subject to change based on various factors, which are described further below.
36


The Forward-Looking Statements contained herein are based upon certain material assumptions that were applied in drawing a conclusion or making a forecast or projection, including: (i) our ability, and the abilities of our joint ventures and our suppliers and distributors, to effectively deal with the restrictions, limitations and health issues presented by the COVID-19 pandemic and the ability to continue our production, distribution and sale of our products and customer demand for and use of our products; (ii) management’s perceptions of historical trends, current conditions and expected future developments; (iii) our ability to generate cash flow from operations; (iv) general economic, financial market, regulatory and political conditions in which we operate; (v) the production and manufacturing capabilities and output from our facilities and our joint ventures, strategic alliances and equity investments; (vi) consumer interest in our products; (vii) competition; (viii) anticipated and unanticipated costs; (ix) government regulation of our activities and products including but not limited to the areas of taxation and environmental protection; (x) the timely receipt of any required regulatory authorizations, approvals, consents, permits and/or licenses; (xi) our ability to obtain qualified staff, equipment and services in a timely and cost-efficient manner; (xii) our ability to conduct operations in a safe, efficient and effective manner; (xiii) our ability to realize anticipated benefits, synergies or generate revenue, profits or value from our recent acquisitions into our existing operations; and (xiv) other considerations that management believes to be appropriate in the circumstances. While our management considers these assumptions to be reasonable based on information currently available to management, there is no assurance that such expectations will prove to be correct.
By their nature, Forward-Looking Statements are subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct and that objectives, strategic goals and priorities will not be achieved. A variety of factors, including known and unknown risks, many of which are beyond our control, could cause actual results to differ materially from the Forward-Looking Statements in this Quarterly Report and other reports we file with, or furnish to, the SEC and other regulatory agencies and made by our directors, officers, other employees and other persons authorized to speak on our behalf. Such factors include, without limitation, the risk that the COVID-19 pandemic may disrupt our operations and those of our suppliers and distribution channels and negatively impact the demand for and use of our products; the risk that cost savings and any other synergies from the Altria Investment may not be fully realized or may take longer to realize than expected; disruption of production, distribution and sales as a result of the COVID-19 pandemic and any adverse effects the COVID-19 pandemic has on the demand for and use of our products; disruption from the Altria Investment making it more difficult to maintain relationships with customers, employees or suppliers; future levels of revenues; consumer demand for cannabis and U.S. hemp products; our ability to manage disruptions in credit markets or changes to our credit rating; future levels of capital, environmental or maintenance expenditures, general and administrative and other expenses; the success or timing of completion of ongoing or anticipated capital or maintenance projects; business strategies, growth opportunities and expected investment; the adequacy of our capital resources and liquidity, including but not limited to, availability of sufficient cash flow to execute our business plan (either within the expected timeframe or at all); the potential effects of judicial, regulatory or other proceedings on our business, financial condition, results of operations and cash flows; volatility in and/or degradation of general economic, market, industry or business conditions; compliance with applicable environmental, economic, health and safety, energy and other policies and regulations and in particular health concerns with respect to vaping and the use of cannabis and U.S. hemp products in vaping devices; the anticipated effects of actions of third parties such as competitors, activist investors or federal (including U.S. federal), state, provincial, territorial or local regulatory authorities, self-regulatory organizations, plaintiffs in litigation or persons threatening litigation; changes in regulatory requirements in relation to our business and products; and the factors discussed under Part I, Item 1A, Risk Factors, of the Annual Report and Item 1A, Risk Factors in Part II of this Quarterly Report. Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on Forward-Looking Statements.
Forward-Looking Statements are provided for the purposes of assisting the reader in understanding our financial performance, financial position and cash flows as of and for periods ended on certain dates and to present information about management’s current expectations and plans relating to the future, and the reader is cautioned that the Forward-Looking Statements may not be appropriate for any other purpose. While we believe that the assumptions and expectations reflected in the Forward-Looking Statements are reasonable based on information currently available to management, there is no assurance that such assumptions and expectations will prove to have been correct. Forward-Looking Statements are made as of the date they are made and are based on the beliefs, estimates, expectations and opinions of management on that date. We undertake no obligation to update or revise any Forward-Looking Statements, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such Forward-Looking Statements. The Forward-Looking Statements contained in this Quarterly Report and other reports we file with, or furnish to, the SEC and other regulatory agencies and made by our directors, officers, other employees and other persons authorized to speak on our behalf are expressly qualified in their entirety by these cautionary statements.
37


Foreign currency exchange rates
All currency amounts in this Quarterly Report are stated in U.S. dollars, which is the Company’s reporting currency, unless otherwise noted. All references to “dollars” or “$” are to U.S. dollars. The assets and liabilities of the Company’s foreign operations are translated into dollars at the exchange rate in effect as of June 30, 2020 and December 31, 2019. Transactions affecting the shareholders’ equity (deficit) are translated at historical foreign exchange rates. The consolidated statements of net income (loss) and comprehensive income (loss) and consolidated statements of cash flows of the Company’s foreign operations are translated into dollars by applying the average foreign exchange rate in effect for the reporting period using Bloomberg.
The exchange rates used to translate from Canadian dollars (“C$”) to dollars is shown below:
(Exchange rates are shown as C$ per $)As of
June 30, 2020March 31, 2020December 31, 2019
Average rate(i)
1.38561.34371.3268
Spot rate1.35761.40621.2990

(i) Average rates are three months ended. The year-to-date average rates used for the six months ended June 30, 2020 was 1.3646.



(Exchange rates are shown as C$ per $)As of
June 30, 2019March 31, 2019December 31, 2018
Average rate(i)
1.33771.32961.2955
Spot rate1.30951.33491.3639
(i) Average rates are three months ended. The year-to-date average rates used for the six months ended June 30, 2019 was 1.3337.

Business Overview
We are an innovative global cannabinoid company with international production and distribution across five continents. We are committed to building disruptive intellectual property by advancing cannabis research, technology and product development and are building an iconic brand portfolio. Cronos Group’s brand portfolio includes PEACE NATURALS, a global wellness platform; two adult-use brands, COVE and Spinach; and two U.S. hemp-derived consumer products brands, Lord Jones and PEACE+. Cronos Group reports through two primary business segments: “United States” and “Rest of World.”
Strategy
We seek to create value for shareholders by focusing on four core strategic priorities:
growing a portfolio of iconic brands that resonate with consumers;
developing a diversified global sales and distribution network;
establishing an efficient global supply chain; and
creating and monetizing disruptive intellectual property in the industries in which we operate.
Business Segments
Cronos Group reports through two primary business segments: “United States” and “Rest of World.” These two segments represent the geographic regions in which the Company operates and the different product offerings within each geographic region. On September 5, 2019, as a result of the acquisition (the “Redwood Acquisition”) of four Redwood Holding Group, LLC subsidiaries (collectively, “Redwood”), the Company established the United States business segment, which includes only the results of Redwood since the date of acquisition. Redwood manufactures, markets and distributes U.S. hemp-derived supplements and cosmetic products through e-commerce, retail and hospitality partner channels in the United States under the brand Lord Jones.
The Rest of World operating segment is involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. In Canada, Cronos Group operates a wholly owned license holder under the Cannabis Act (Canada) - Peace Naturals Project Inc. (“Peace Naturals”), which has production facilities near Stayner, Ontario (“Peace Naturals Campus”). Cronos Group has established four strategic joint ventures in Canada, Israel and Colombia. Cronos Group additionally holds approximately 31% of the issued capital of Cronos Australia Limited, which is listed on the Australian Securities Exchange under the trading symbol “CAU.” Cronos Group currently exports cannabis products to countries that permit the import of such products, such as Germany, Israel and Australia.

38


Recent Developments
COVID-19 Pandemic
In December 2019, an outbreak of a novel strain of coronavirus, COVID-19, was identified in Wuhan, China. Since then, COVID-19 has spread across the globe, including the U.S., Canada, and other countries in which the Company or its affiliates operate (including Australia, Colombia, and Israel) and has subsequently been recognized as a pandemic by the World Health Organization. The COVID-19 pandemic has resulted in a sharp contraction in many areas of the global economy and increased volatility and uncertainty in the capital markets. In response to the pandemic, in the first half of 2020, the governments of many countries, states, cities, and other geographic regions took preventative or protective actions, including closures of certain businesses, mandatory quarantines, limits on individuals’ time outside of their homes, travel restrictions and social distancing or other preventative measures. In recent weeks, such measures have been eased or lifted in varying degrees by different governments of various countries, states and cities depending on the status of infection rates; however, the continued spread of COVID-19 has caused, and may continue to cause, some jurisdictions to roll back reopening plans that had been underway. There can be no guarantee that governments will continue to ease such restrictions, and jurisdictions may pause plans to permit businesses to reopen or roll back the reopening of businesses. Governments in certain countries such as the U.S., Canada, and those in Europe have responded to the acute economic and market consequences with certain monetary and fiscal policy actions.
Impact on Operating Results
During the three months ended June 30, 2020, the effects of the COVID-19 pandemic on retail stores and increase of costs in production and sales in the U.S. had a material impact on the rate of growth of revenue in the U.S. segment, with revenue for the segment remaining flat from the three months ended March 31, 2020. In the U.S., a significant number of the Company’s retail customers have experienced temporary retail store closures in connection with the COVID-19 pandemic, which has negatively impacted sales and demand in the segment. Gross margins have compressed in the U.S. segment during the three months ended June 30, 2020 as the Company implemented pay increases to the Company’s production workers as a result of the pandemic and implemented various discounts and initiatives (such as free shipping) and promotional events. These measures increased the cost of sales and had a material negative impact on the gross margin in the U.S. segment. The Company expects revenue growth and operating results in the U.S. segment to continue to be negatively impacted as the decrease in customer demand and retail closures are expected to continue as a result of the pandemic. The Company does not expect the negative impact to be temporary in nature. As a result of these impacts and expectation of future impacts, for the three months ended June 30, 2020, the Company recorded $35 million of impairment charges on its U.S. reporting unit and $5 million on the Lord Jones brand (refer to Note 13 to the Company’s condensed consolidated financial statements for more information regarding intangibles assets and goodwill).
Revenue and the growth in revenue in the Rest of World segment was not materially impacted by the effects of COVID-19 during the three and six months ended June 30, 2020. In both segments there was no material increase in the current expected credit loss as of June 30, 2020 in connection with COVID-19. The Company will continue to closely monitor the effects of COVID-19 on its operating results.
Production and Supply Chain
The Company’s global production facilities currently remain operational. To comply with governmental orders or other health and safety requirements, the Company has: (i) reduced the number of personnel working on-site at its production facilities to only the roles that are necessary to be performed on site, (ii) implemented work-from-home policies for other employees whose work can be performed off-site, and (iii) implemented other additional health and safety measures such as, among other things, enhanced hygiene and sanitation procedures, modified work schedules and social distancing protocols at its production facilities. The Company will continue to act in accordance with guidance from local, federal, and international health and governmental authorities, such as any government-mandated requirements for people to wear facemasks in all indoor communal spaces or at businesses, and is prepared to make additional operational adjustments, as necessary. Although the Company’s production facilities currently remain operational, governmental requirements, guidance and health and safety requirements continue to evolve as governmental and health authorities respond to the spread of the virus, reopening plans in certain jurisdictions may be suspended, delayed or quarantines re-imposed and production facilities may experience temporary closures or quarantines if governmental or health authorities make changes to the businesses and workforces allowed to remain operational, which would result in reduced production or suspension of production if such closures are mandated. In addition, if the Company’s employees contract the disease and test positive for COVID-19, depending on the employee’s job duties and access to facilities, this may impact the Company’s ability to keep production and manufacturing facilities open for health and safety reasons.
39


The impacts of certain closures of the facilities of suppliers and other vendors or these preventative and protective measures in the Company’s supply chain remain uncertain. Earlier closures at manufacturers in China have resulted in delays of deliveries of batteries and cartridges for cannabis vaporizers and personal protective equipment such as masks and gowns used in Cronos Group’s manufacturing facilities certified in accordance with Good Manufacturing Practices (“GMP”), from such manufacturers in China. Most delays have been ameliorated as manufacturers are now operational in China but other vendors or suppliers along the Company’s supply chain could be potentially impacted. Closures or other restrictions on the conduct of business operations on third-party manufacturers, suppliers or vendors may cause disruption in Cronos Group’s supply chain. The Company has experienced some minor delays in shipping and expects that the increased global demand on shipping and transport services, in addition to customs and border control policies put in place in response to the COVID-19 pandemic that require that shipments to undergo a quarantine period may cause the Company to experience further delays in the future which could impact the Company’s ability to obtain materials or deliver products in a timely manner. In addition, work-from-home policies for certain employees and the effects of the Company’s work-from-home policies may negatively impact productivity, disrupt access to books and records and disrupt the Company’s business. Even if the Company’s production facilities continue to remain open, mandatory or voluntary self-quarantines and travel restrictions may limit the Company’s employees’ ability to access facilities, and this, together with impacts on the Company’s supply chain and the uncertainty produced by the rapidly evolving nature of the COVID-19 pandemic, may result in reduced or suspended production.
Customers
Retailers in the U.S. and Canada have been required to close at times or have curtailed their operations (such as reduced opening hours, reduced staff and reduced traffic in stores) due to the implementation of health and safety measures. The slowdown or disruption faced by retailers, in addition to quarantine measures and travel restrictions, impacts the ability of customers to be able to access Cronos Group’s products. These restrictions on retail stores are mandated by, and differ from, each state or province and continue to change and evolve, which creates uncertainty in forecasting customer demand and sales velocity. In the U.S., while online sales have continued, certain beauty and other retailers have temporarily closed physical boutiques. In Canada, retailers have implemented a combination of measures from closing stores, offering curbside delivery (to the extent permitted by a province) and online sales only, reduced store opening hours and reduced number of customers in stores in light of social distancing measures. Recent suspensions of the ability of private retailers to offer click-and-collect or curbside delivery in certain provinces in Canada may further impact customer demand for products. Provincial purchasers have also similarly, among other things, reduced staff on-site leading to a decrease in delivery time slots for producers to deliver products or reduced frequency or size of their purchase orders. In addition, while various provinces in Canada have continued to increase the number of retail stores during the COVID-19 pandemic, we expect that the expansion of retail stores in various provinces in Canada will be delayed or slowed down in the current circumstances. We anticipate that uncertainty created by these measures on forecasting customer demand and sales will continue as long as such measures are in place. Demand for the Company’s products could also be negatively impacted should the effects of COVID-19 lead to changes in consumer behavior, including as a result of a potential decline in the level of demand for vaporizer products or in discretionary spending as result of a general economic slowdown.
Macroeconomic Impacts
The impacts of these current restrictions and measures on certain strategic projects continue to be uncertain. Existing R&D initiatives continue to proceed, with reduced activity at Ginkgo during the three months ended June, 30, 2020, although the Company still anticipates being able to meet its previously disclosed expected timing for the successful completion of the equity milestones set out in the Ginkgo Strategic Partnership. Other facility design and expansion projects are currently expected to proceed as planned. However, requirements and restrictions on the operation of businesses and workforces continue to evolve as governmental and health authorities respond to the spread of the virus and changes may result in delays or suspensions if authorities require such activities to be suspended.
In addition, a recession or market correction resulting from the spread of COVID-19 would likely materially affect the Company’s business and the value of its common shares. Collectively, effects of the COVID-19 pandemic have adversely affected the Company’s results of operations and, if the effects continue unabated, could continue to do so as long as these measures to combat the COVID-19 pandemic stay in effect. At this time, neither the duration nor scope of the disruption can be predicted, therefore, the ultimate impact to the Company’s business cannot be reasonably estimated but such impact could materially adversely affect the Company’s business and financial results.
Liquidity and Capital Resource Impact
Despite the impacts of the COVID-19 pandemic, the Company believes that the significant cash on hand and short-term investments will be adequate to meet liquidity and capital requirements for at least the next twelve months. The impact of reduced interest rates has inhibited the Company’s ability to generate interest income in the short-term but this has not, and is not expected to have, a material impact on the liquidity or capital resources of the Company.
40


Brand Portfolio
During the second quarter of 2020, we continued to expand distribution of cannabis vaporizer devices in the Canadian adult-use market under the COVE and Spinach brands, and for the direct-to-consumer market in Canada under the PEACE NATURALS brand.
Global Sales and Distribution
In June 2020, following the successful export of bulk dried flower from Cronos Group to Cronos Israel in April 2020, Cronos Israel commenced sales of PEACE NATURALS branded cannabis to the Israeli medical market. Cronos Israel will continue to build distribution capabilities for dried flower while it awaits final licensing for the sale of oils and pre-rolls, which is currently expected to be received later in 2020. Cronos Israel will continue to build its distribution network and brand presence in this rapidly growing medical market.
Global Supply Chain
During the second quarter of 2020, Natuera, the Company’s contract manufacturing joint venture in Latin America, a fully licensed operation in Colombia for hemp- and cannabis-derived bulk, consumer, and medicinal cannabinoid products, continued to achieve significant operational milestones. At the end of April 2020, Natuera completed its first harvest of a non-psychoactive (hemp) cultivar registered with the Colombian Agricultural Institute. Between May 2020 and July 2020, Natuera successfully completed three test exports of hemp-derived CBD extract to the U.S. for business development and R&D purposes.
With its extraction facility coming online in the first quarter of 2020, Natuera is currently focused on accessing new markets and product development, including developing additional bulk offerings of hemp-derived CBD distillate and water-soluble hemp-derived CBD solutions.
During the second quarter of 2020, the Company amended its previously announced bulk resin supply agreement with MediPharm Labs Inc. Pursuant to the amendment, the Company’s aggregate remaining purchase commitment for the remainder of the term of the agreement was reduced to approximately C$3.0 million ($2.2 million) from C$8.1 million ($6.0 million). The Company received the remaining committed bulk resin supply during the second quarter of 2020.
Enterprise Initiatives
Subsequent to the second quarter of 2020, the Company successfully implemented a new ERP system across the Canadian business. Cronos Group has also commenced work to broaden the reach of the ERP system to the U.S. business, which is currently expected to be launched in the first half of 2021. The new ERP system will be a meaningful component of the Company’s internal control over financial reporting and is expected to enable the Company to realize efficiencies throughout the finance, supply chain and operations processes.
Appointment
Cronos Group continues to build and fortify a seasoned management team. Subsequent to the second quarter, following the resignation of Robert Rosenheck on July 20, 2020, Summer Frein was named General Manager of the U.S. hemp-derived CBD business, with oversight of sales, marketing, and operations. Ms. Frein joined Cronos Group in January of this year; however, she worked with Cronos Group in various capacities since 2018. Previously Ms. Frein was employed with Altria, where she led the Strategy and Business Development team’s due diligence in the cannabis space which culminated in Cronos Group’s strategic investment from Altria. Most recently, she was responsible for leading our U.S. sales efforts, including managing brand and retail partnerships for Lord Jones. Under Ms. Frien’s leadership, the Company plans to further expand its U.S. hemp-derived business including introducing new product formats under Lord Jones and launching new brands that will target different retail channels and consumers.

41


Consolidated Results of Operations: Q2 2020 compared with Q2 2019
Summary of financial results consolidated
(In thousands of U.S. dollars)For the three months ended June 30,ChangeFor the six months ended June 30,Change
20202019$%20202019$%
Net revenue$9,883  $7,653  $2,230  29 %$18,315  $10,657  $7,658  72 %
Gross profit (loss)(2,953) 4,093  (7,046) (172)%(9,429) 5,648  (15,077) (267)%
Gross margin(30)%53 %N/A(83)pp(51)%53 %N/A(104)pp
Reported operating loss$(34,755) $(16,755) $(18,000) 107 %$(79,815) $(26,881) $(52,934) 197 %
Adjusted operating loss (i)
(31,296) (16,755) (14,541) 87 %(71,949) (26,881) (45,068) 168 %
(i) See “Non-GAAP Measures” for information related to Non-GAAP Measures.

Net revenue consolidated
(In thousands of U.S. dollars)For the three months ended June 30,ChangeFor the six months ended June 30,Change
20202019$%20202019$%
Net revenue, before excise taxes (i)
$11,432  $8,064  $3,368  42 %$20,776  $11,455  $9,321  81 %
Excise taxes(1,549) (411) (1,138) 277 %(2,461) (798) (1,663) 208 %
Net revenue$9,883  $7,653  $2,230  29 %$18,315  $10,657  $7,658  72 %
(i) Net revenue, before excise taxes, is calculated net of sales returns and discounts as described under Note 4 to the condensed consolidated financial statements.
For the three months ended June 30, 2020 (“Q2 2020”), we reported net revenues of $9.9 million, representing an increase of $2.2 million from the three months ended June 30, 2019 (“Q2 2019”). This change was primarily due to:
The Redwood Acquisition in the third quarter of 2019, which resulted in an increase in net revenue of $2.2 million in Q2 2020.
An increase in sales in the Rest of World segment in Q2 2020 compared to Q2 2019 due to the continued growth of the adult-use market in Canada and the launch of cannabis vaporizer devices in December 2019, partially offset by non-recurring wholesale revenue in the Canadian market in Q2 2019.

For the six months ended June 30, 2020 (“YTD 2020”), we reported net revenues of $18.3 million, representing an increase of $7.7 million from the six months ended June 30, 2019 (“YTD 2019”). This change was primarily due to:
The Redwood Acquisition in the third quarter of 2019, which resulted in an increase in net revenue of $4.4 million in YTD 2020.
An increase in sales in the Rest of World segment in YTD 2020 compared to YTD 2019 due to the continued growth of the adult-use market in Canada and the launch of cannabis vaporizer devices in December 2019, partially offset by non-recurring wholesale revenue in the Canadian market in Q2 2019.
42


Cost of sales and gross profit (loss) - consolidated
(In thousands of U.S. dollars)For the three months ended June 30,ChangeFor the six months ended June 30,Change
20202019$%20202019$%
Cost of sales$9,774  $3,560  $6,214  175 %$16,720  $5,009  $11,711  234 %
Inventory write-down3,062  —  3,062  N/A11,024  —  11,024  N/A
Gross profit (loss)$(2,953) $4,093  $(7,046) (172)%$(9,429) $5,648  $(15,077) (267)%
Gross margin(30)%53 %N/A(83)pp(51)%53 %N/A(104)pp
For Q2 2020, we reported gross profit (loss) of $(3.0) million, representing a decrease of $7.0 million from Q2 2019. This change was primarily due to:
An increase in cost of sales primarily driven by a higher volume of adult-use sales and a decline in wholesale sales.
An inventory write-down of $3.1 million on dried cannabis and cannabis extracts, primarily driven by cannabis product price compression in the Canadian market. If not for the inventory write-down, gross profit (loss) would have been $0.1 million, representing a gross margin of 1%. We anticipate further inventory write-downs due to pricing pressures in the marketplace, as well as increased marginal production costs at the Peace Naturals Campus.
The offsetting impact of the Redwood Acquisition in the third quarter of 2019, which contributed $0.6 million of gross profit.

For YTD 2020, we reported gross profit (loss) of $(9.4) million, representing a decrease of $15.1 million from YTD 2019. This change was primarily due to:
An inventory write-down of $11.0 million on dried cannabis and cannabis extracts, primarily driven by fixed-price supply contracts negotiated prior to cannabis product price compression due to broader trends of oversupply in the Canadian market and the impact of the Company's operational repurposing of the Peace Naturals Campus. If not for the inventory write-down, gross profit (loss) would have been $1.6 million, representing a gross margin of 9%. We anticipate further inventory write-downs in the short-term due to pricing pressures in the marketplace.
An increase in cost of sales primarily driven by a higher volume of adult-use sales and a decline in wholesale sales.
The offsetting impact of the Redwood Acquisition in the third quarter of 2019, which contributed $1.7 million of gross profit.

43


Operating loss consolidated
(In thousands of U.S. dollars)For the three months ended June 30,ChangeFor the six months ended June 30,Change
20202019$%20202019$%
Sales and marketing$6,504  $4,005  $2,499  62 %$13,616  $5,133  $8,483  165 %
Research and development3,631  2,300  1,331  58 %8,221  3,471  4,750  137 %
General and administrative18,437  11,488  6,949  60 %42,196  18,781  23,415  125 %
Share-based payments2,546  2,647  (101) (4)%4,982  4,418  564  13 %
Depreciation and amortization684  408  276  68 %1,371  726  645  89 %
Operating expenses31,802  20,848  10,954  53 %70,386  32,529  37,857  116 %
Reported operating loss$(34,755) $(16,755) $(18,000) 107 %$(79,815) $(26,881) $(52,934) 197 %
Adjusted operating loss (i)
(31,296) (16,755) (14,541) 87 %(71,949) (26,881) (45,068) 168 %
(i) See “Non-GAAP Measures” for information related to Non-GAAP Measures.
For Q2 2020, we reported an operating loss of $34.8 million, representing an increase in losses of $18.0 million from Q2 2019. This change was primarily due to:
A decrease in gross profit (loss) from Q2 2019, as described above.
An increase in general and administrative costs driven by review costs and costs related to the Company’s responses to requests for information from various regulatory authorities related to the previously disclosed restatement of the Company’s 2019 interim financial statements of $3.5 million and an increase in salaries and wages as a result of increased headcount to support the Company’s growth strategy.
An increase in sales and marketing costs, primarily related to building and developing brands.
An increase in R&D costs of $1.3 million primarily related to increased spending at the Cronos Device Labs R&D center.
The Redwood Acquisition in the third quarter of 2019, which resulted in an increase in operating loss of $5.6 million in Q2 2020, driven by increased investments in sales and marketing and general and administrative expenses.
Activity at Cronos Fermentation’s facilities since the third quarter of 2019, which resulted in an increase in operating loss of $1.2 million in Q2 2020, driven by investments in R&D.

For YTD 2020, we reported an operating loss of $79.8 million, representing an increase in losses of $52.9 million from YTD 2019. This change was primarily due to:
A decrease in gross profit (loss) from YTD 2019, as described above.
An increase in general and administrative costs driven primarily by an increase in salaries and wages of $8.5 million as a result of increased headcount in order to support the Company’s growth strategy, review costs and costs related to the Company’s responses to requests for information from various regulatory authorities related to the previously disclosed restatement of the Company’s 2019 interim financial statements of $7.9 million.
An increase in sales and marketing costs, primarily related to building and developing brands.
An increase in R&D costs of $4.8 million primarily related to the Ginkgo Strategic Partnership and increased spending at the Cronos Device Labs R&D center.
The Redwood Acquisition in the third quarter of 2019, which resulted in an increase in operating loss of $12.1 million in YTD 2020, driven by increased investments in sales and marketing and general and administrative expenses.
Activity at Cronos Fermentation’s facilities since the third quarter of 2019, which resulted in an increase in operating loss of $2.3 million in YTD 2020, driven by investments in R&D.

44


Results of Operations by Business Segment: Q2 2020 compared with Q2 2019
Summary of financial results Rest of World
(In thousands of U.S. dollars)For the three months ended June 30,ChangeFor the six months ended June 30,Change
20202019$%20202019$%
Net revenue$7,709  $7,653  $56  %$13,965  $10,657  $3,308  31 %
Gross profit (loss)(3,540) 4,093  (7,633) (186)%(11,098) 5,648  (16,746) (296)%
Gross margin(46)%53 %N/A(99)pp(79)%53 %N/A(132)pp
Reported and adjusted operating loss (i)
$(22,138) $(16,755) $(5,383) 32 %$(54,005) $(26,881) $(27,124) 101 %
(i) See “Non-GAAP Measures” for information related to Non-GAAP Measures.

Net revenue Rest of World
(In thousands of U.S. dollars)For the three months ended June 30,ChangeFor the six months ended June 30,Change
20202019$%20202019$%
Cannabis flower$5,674  $6,096  $(422) (7)%$8,415  $7,921  $494  %
Cannabis extracts1,917  1,535  382  25 %5,317  2,638  2,679  102 %
Other118  22  96  436 %233  98  135  138 %
Net revenue$7,709  $7,653  $56  %$13,965  $10,657  $3,308  31 %
For Q2 2020, we reported net revenue of $7.7 million, representing an increase of $0.1 million from Q2 2019. This change was primarily due to:
An increase in sales due to the continued growth of the adult-use market in Canada and the launch of cannabis vaporizer devices in December 2019, partially offset by non-recurring wholesale revenue in the Canadian market in Q2 2019.

For YTD 2020, we reported net revenue of $14.0 million, representing an increase of $3.3 million from YTD 2019. This change was primarily due to:
An increase in sales due to the continued growth of the adult-use market in Canada and the launch of cannabis vaporizer devices in December 2019, partially offset by non-recurring wholesale revenue in the Canadian market in Q2 2019.

45


Cost of sales and gross profit (loss) Rest of World
(In thousands of U.S. dollars)For the three months ended June 30,ChangeFor the six months ended June 30,Change
20202019$%20202019$%
Cost of sales$8,187  $3,560  $4,627  130 %$14,039  $5,009  $9,030  180 %
Inventory write-down3,062  —  3,062  N/A11,024  —  11,024  N/A
Gross profit (loss)(3,540) 4,093  (7,633) (186)%(11,098) 5,648  (16,746) (296)%
Gross margin(46)%53 %N/A(99)pp(79)%53 %N/A(132)pp
For Q2 2020, we reported gross profit (loss) of $(3.5) million, representing a decrease of $7.6 million from Q2 2019. This change was primarily due to:
An increase in cost of sales primarily driven by a higher volume of adult-use sales and a decline in wholesale sales.
An inventory write-down of $3.1 million on dried cannabis and cannabis extracts, primarily driven by cannabis product price compression in the Canadian market. If not for the inventory write-down, segment gross profit (loss) would have been $(0.5) million, representing a gross margin of (6)%. We anticipate further inventory write-downs due to pricing pressures in the marketplace, as well as increased marginal production costs at the Peace Naturals Campus.

For YTD 2020, we reported gross profit (loss) of $(11.1) million, representing a decrease of $16.7 million from YTD 2019. This change was primarily due to:
An inventory write-down of $11.0 million on dried cannabis and cannabis extracts, primarily driven by fixed-price supply contracts negotiated prior to cannabis product price compression due to broader trends of oversupply in the Canadian market and the impact of the Company's operational repurposing of the Peace Naturals Campus. If not for the inventory write-down, segment gross profit (loss) would have been $(0.1) million, representing a gross margin of (1)%. We anticipate further inventory write-downs in the short-term due to pricing pressures in the marketplace.
An increase in cost of sales primarily driven by a higher volume of adult-use sales and a decline in wholesale sales.
46


Operating loss Rest of World
(In thousands of U.S. dollars)For the three months ended June 30,ChangeFor the six months ended June 30,Change
20202019$%20202019$%
Reported and adjusted operating loss (i)
$(22,138) $(16,755) $(5,383) 32 %$(54,005) $(26,881) $(27,124) 101 %
(i) See “Non-GAAP Measures” for information related to Non-GAAP Measures.
For Q2 2020, we reported an operating loss of $22.1 million representing an increase in losses of $5.4 million from Q2 2019. This change was primarily due to:
A decrease in gross profit (loss) from Q2 2019, as described above.
An increase in R&D costs primarily related to increased spending at the Cronos Device Labs R&D center.
Activity at Cronos Fermentation’s facilities since the third quarter of 2019, which resulted in an increase in operating loss in Q2 2020, driven by investments in R&D.
A partially offsetting decrease in professional and consulting fees from Q2 2019.

For YTD 2020, we reported an operating loss of $54.0 million, representing an increase in losses of $27.1 million from YTD 2019. This change was primarily due to:
A decrease in gross profit (loss) from YTD 2019, as described above.
An increase in general and administrative costs from YTD 2019 driven by an increase in salaries and wages as a result of increased headcount to support the Company’s growth strategy.
An increase in sales and marketing costs primarily related to building and developing brands and products for the first full year of sales into the Canadian adult-use market.
An increase in R&D costs primarily related to the Ginkgo Strategic Partnership and increased spending at the Cronos Device Labs R&D center.
Activity at Cronos Fermentation’s facilities from since third quarter of 2019, which resulted in an increase in operating loss in YTD 2020, driven by investments in R&D.
47


Summary of financial results United States
(In thousands of U.S. dollars)For the three months ended June 30,ChangeFor the six months ended June 30,Change
20202019$%20202019$%
Net revenue$2,174  $—  N/AN/A$4,350  $—  N/AN/A
Gross profit587  —  N/AN/A1,669  —  N/AN/A
Gross margin27 %N/AN/AN/A38 %N/AN/AN/A
Reported and adjusted operating loss (i)
$(5,575) $—  N/AN/A$(12,098) $—  N/AN/A
(i) See “Non-GAAP Measures” for information related to Non-GAAP Measures.

Net revenue United States
(In thousands of U.S. dollars)For the three months ended June 30,ChangeFor the six months ended June 30,Change
20202019$%20202019$%
Net revenue$2,174  —  N/AN/A$4,350  —  N/AN/A
The U.S. segment reported net revenue of $2.2 million for Q2 2020 and $4.4 million for YTD 2020. These results were primarily due to:
The temporary closure of a significant number of customers’ physical retail stores as a result of preventive measures undertaken in response to the COVID-19 pandemic negatively impacted revenue growth for Q2 2020 despite an increase in product offerings.

(In thousands of U.S. dollars)For the three months ended June 30,ChangeFor the six months ended June 30,Change
20202019$%20202019$%
Cost of sales$1,587  $—  N/AN/A$2,681  $—  N/AN/A
Gross profit587  —  N/AN/A1,669  —  N/AN/A
Gross margin27 %N/AN/AN/A38 %N/AN/AN/A
The U.S. segment reported gross profits of $0.6 million for Q2 2020 and $1.7 million for YTD 2020, with gross profit margins of 27% and 38%, respectively. The results are primarily due to:
A decrease in gross margin of 23pp for Q2 2020 compared to the three months ended March 31, 2020 due to an increase in labor costs during the COVID-19 pandemic as well as increased discounts, sales and other promotions in the direct-to-consumer channel to drive online sales growth in an effort to offset the negative impact of retail store closures during the COVID-19 pandemic.
48


Operating loss United States
(In thousands of U.S. dollars)For the three months ended June 30,ChangeFor the six months ended June 30,Change
20202019$%20202019$%
Reported and adjusted operating loss (i)
$(5,575) $—  N/AN/A$(12,098) $—  N/AN/A
(i) See “Non-GAAP Measures” for information related to Non-GAAP Measures.
For Q2 2020, the U.S. segment reported operating loss of $5.6 million. These results were primarily due to:
A decrease in the gross margin for YTD 2020, as described above.
Sales and marketing costs incurred in relation to the continued roll-out of new U.S. hemp-derived CBD products under the Lord Jones brand.
Increased general and administration costs in Q2 2020 driven by salaries and wages costs incurred to support the Company’s growth strategy across a variety of functions.

For YTD 2020, the U.S. segment reported operating loss of $12.1 million. These results were primarily due to:
A decrease in the gross margin for YTD 2020, as described above.
Sales and marketing costs incurred in relation to the continued roll-out of new U.S. hemp-derived CBD products under the Lord Jones brand.
Increased general and administration costs in YTD 2020 driven by salaries and wages costs incurred to support the Company’s growth strategy across a variety of functions.

Non-GAAP Measures
Cronos Group reports its financial results in accordance with Generally Accepted Accounting Principles in the United States (“U.S. GAAP”). This Quarterly Report refers to measures not recognized under U.S. GAAP (“non-GAAP measures”). These non-GAAP measures do not have a standardized meaning prescribed by GAAP and are therefore unlikely to be comparable to similar measures presented by other companies. Rather, these non-GAAP measures are provided as a supplement to corresponding GAAP measures to provide additional information regarding the results of operations from management’s perspective. Accordingly, non-GAAP measures should not be considered a substitute for, or superior to, the financial information prepared and presented in accordance with GAAP. All non-GAAP measures presented in this Quarterly Report are reconciled to their closest reported GAAP measure. Reconciliations of historical adjusted financial measures to corresponding GAAP measures are provided below.
Adjusted operating loss
Management reviews operating loss on an adjusted basis, which excludes certain income and expense items that management believes are not part of underlying operations. These items typically include non-recurring charges such as the financial statement review costs related to the restatement of the 2019 financial statements and the Company’s responses to the reviews of such interim financial statement by various regulatory authorities (see Part II, Item 1, Legal Proceedings, of this Quarterly Report for a discussion of the regulatory reviews relating to the restatement of the 2019 interim financial statements). Management does not view either of these items to be part of underlying results as they may be highly variable, may be unusual or infrequent, are difficult to predict or can distort underlying business trends and results.

49


Management believes that adjusted operating loss provides useful insight into underlying business trends and results and provides a more meaningful comparison of year-over-year results. Management uses adjusted operating loss for planning, forecasting and evaluating business and financial performance, including allocating resources and evaluating results relative to employee compensation targets.
(In thousands of U.S. dollars)For the three months ended June 30,For the six months ended June 30,
2020201920202019
Reported operating loss$(34,755) $(16,755) $(79,815) $(26,881) 
Adjustments
Review costs related to restatement of 2019 interim financial statements3,459  —  7,866  —  
Adjusted operating loss$(31,296) $(16,755) $(71,949) $(26,881) 

Adjusted operating loss by business segment
Management reviews operating loss by business segment, which excludes corporate expenses, and adjusted operating loss by business segment, which further excludes certain income and expense items that management believes are not part of the underlying segment’s operations. Corporate expenses are expenses that relate to the consolidated business and not to an individual operating segment while the income and expense items typically include non-recurring charges such as the financial statement review costs related to the restatement of the 2019 financial statements and the reviews of such interim financial statement by various regulatory authorities (see Part II, Item 1, Legal Proceedings, of this Quarterly Report for a discussion of the regulatory reviews relating to the restatement of the 2019 interim financial statements). Management does not view the income and expense items above to be part of underlying results of the segment as they may be highly variable, may be unusual or infrequent, are difficult to predict and can distort underlying business trends and results.
Management believes that adjusted operating loss by business segment provides useful insight into underlying segment trends and results and will provide a more meaningful comparison of year-over-year results going forward. Management uses adjusted operating loss by business segment for planning, forecasting and evaluating segment performance, including allocating resources and evaluating results relative to employee compensation targets.
(In thousands of U.S. dollars)For the three months ended June 30, 2020
U.S.Rest of WorldTotal SegmentsCorporate ExpensesTotal
Reported operating loss$(5,575) $(22,138) $(27,713) $(7,042) $(34,755) 
Adjustments
Review costs related to restatement of 2019 interim financial statements—  —  —  3,459  3,459  
Adjusted operating loss$(5,575) $(22,138) $(27,713) $(3,583) $(31,296) 

(In thousands of U.S. dollars)For the six months ended June 30, 2020
U.S.Rest of WorldTotal SegmentsCorporate ExpensesTotal
Reported operating loss$(12,098) $(54,005) $(66,103) $(13,712) $(79,815) 
Adjustments
Review costs related to restatement of 2019 interim financial statements—  —  —  7,866  7,866  
Adjusted operating loss$(12,098) $(54,005) $(66,103) $(5,846) $(71,949) 

50


Liquidity and capital resources
As of June 30, 2020, we had $1,109.7 million in cash and cash equivalents and $213.6 million in short-term investments which comprise the majority of the Company’s cash position. Cronos Group believes that the existing cash and cash equivalents and the short-term investments will be sufficient to fund the business operations and capital expenditures over the next twelve months.
Summary of cash flows
(In thousands of U.S. dollars)For the six months ended June 30,
20202019
Cash provided/(used) in operating activities$(77,193) $(56,769) 
Cash provided/(used) in investing activities39,799  (588,609) 
Cash provided/(used) by financing activities(1,183) 1,791,431  
Effect of foreign currency translation on cash and cash equivalents(51,416) 36,079  
Net change in cash$(89,993) $1,182,132  
2020 cash flows vs 2019 cash flows
Operating activities
During the six months ended June 30, 2020, we used $77.2 million of cash in operating activities as compared to cash used of $56.8 million in the six months ended June 30, 2019, representing an increase in cash used of $20.4 million. This change is primarily driven by an increase of $37.9 million in operating expenses from the six months ended June 30, 2019.
Investing activities
During the six months ended June 30, 2020, we generated $39.8 million of cash through investing activities, as compared to $588.6 million of cash used in investing activities in the six months ended June 30, 2019, representing an increase of $628.4 million in cash provided. This change is primarily driven by cash received from proceeds from the disposal of short-term investments of $203.7 million (2019 – $nil) partially offset by purchases of short-term investments of $124.6 million (2019 – $556.9 million). Additionally, during the six months ended June 30, 2020, purchases of property, plant and equipment were $13.3 million compared to $20.9 million in the six months ended June 30, 2019.
The increase was partially offset by advances on loans receivable of $24.0 million (2019 – $12.2 million) primarily related to an increase in drawdowns on the GrowCo Credit Facility.
Financing activities
During the six months ended June 30, 2020, cash used by financing activities was $1.2 million, as compared to $1,791.4 million of cash provided by financing activities in the six months ended June 30, 2019, representing a decrease of $1,792.6 million in cash provided. This change is primarily driven by proceeds from the strategic investment from Altria of $1,809.6 million that was partially offset by the transaction costs paid on the construction loan payable of $16.0 million in the six months ended June 30, 2019, which were not present in the six months ended June 30, 2020.

Critical Accounting Policies and Estimates
The Company’s critical accounting policies and estimates are discussed in the Annual Report on Form 10-K/A for the year ended December 31, 2019. There have no material changes to these critical accounting policies and estimates.

51


Item 3. Quantitative and Qualitative Disclosures About Market Risk.
Interest rate risk
Interest rate risk is the risk that the value or yield of fixed-income investments may decline if interest rates change. Fluctuations in interest rates may impact the level of income and expense recorded on the cash equivalents and short-term investments, and the market value of all interest-earning assets, other than those which possess a short-term to maturity. A 10% change in the interest rate in effect on June 30, 2020 and December 31, 2019, would not have a material effect on (i) fair value of the cash equivalents and short-term investments as the majority of the portfolio has a maturity date of three months or less, or (ii) interest income. Management continues to monitor external interest rates and revise the Company’s investment strategy as a result.
During the six months ended June 30, 2020, the Company had net interest income of $11.5 million (June 30, 2019 – $11.5 million). During the three and six months ended June 30, 2020, the Company’s average variable interest rate fell 0.73% and 1.45%, respectively. Had the interest rates been consistent, net interest income would have increased by $2.1 million and $7.3 million, respectively for the three and six months ended June 30, 2020.
Foreign currency risk
The Company’s consolidated financial statements included in Part I, Item 1 of this Quarterly Report are expressed in U.S. dollars. In addition the Company has net assets, liabilities and revenues denominated in foreign currencies, including Canadian dollars and Israeli new shekels. As a result, we are exposed to foreign currency translation gains and losses. Revenue and expenses of all foreign operations are translated into U.S. dollars at the foreign currency exchange rates that approximate the rates in effect at the dates when such items are recognized. Appreciating foreign currencies relative to the U.S. dollar will adversely impact operating income and net earnings, while depreciating foreign currencies relative to the U.S. dollar will have a positive impact.
A 10% change in the exchange rates for the Canadian dollar would affect the carrying value of net assets by approximately $166.3 million as of June 30, 2020. The same change to exchange rates for the Canadian dollar as of December 31, 2019 would affect the carrying value of net assets by approximately $174.9 million. The corresponding impact would be recorded in accumulated other comprehensive income. We have not historically engaged in hedging transactions and do not currently contemplate engaging in hedging transactions to mitigate foreign exchange risks. As we continue to recognize gains and losses in foreign currency transactions, depending upon changes in future currency rates, such gains or losses could have a significant, and potentially adverse, effect on the results of operations.

Item 4. Controls and Procedures.
(a)Evaluation of Disclosure Controls and Procedures.
The Company’s management, with the participation of the Chief Executive Officer and the Chief Financial Officer, performed an evaluation of the disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934 (the “Exchange Act”), as of June 30, 2020. Based on that evaluation, management has concluded that, as of June 30, 2020, due to the existence of the material weaknesses in the Company’s internal control over financial reporting described below, the disclosure controls and procedures were not effective to provide reasonable assurance that the information required to be disclosed by us in reports we file or submit under the Exchange Act were recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC, and to ensure that the information required to be disclosed by us in reports that we file or submit under the Exchange Act, is accumulated and communicated to management, including the principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure.
Material Weaknesses in Internal Controls Over Financial Reporting
A material weakness is a deficiency, or combination of deficiencies in internal controls over financial reporting, such that there is a reasonable possibility that a material misstatement of the annual or interim financial statements will not be prevented or detected on a timely basis. As previously disclosed in the Company’s Annual Report on Form 10-K/A for the year ended December 31, 2019, we have identified the following material weaknesses in the following areas:
Risk Assessment: The Company did not appropriately design controls to monitor and respond to changes in business in relation to transactions in the wholesale market.
Segregation of Duties: The Company did not maintain adequately designed controls on segregation of purchase and sale responsibilities to ensure accurate recognition of revenue in accordance with GAAP.
Non-Routine Transactions: The Company’s controls were not effective to ensure that non-routine transactions, including deviations from contractually established sales terms, were authorized, communicated, identified and evaluated for their potential effect on revenue recognition.
52


These deficiencies create a reasonable possibility that a material misstatement to the consolidated financial statements will not be prevented or detected on a timely basis.
Remediation Plan and Status
The Company’s management, with oversight from the Audit Committee of the Board of Directors, has initiated a plan to remediate the material weaknesses, previously disclosed in the Annual Report on Form 10-K/A for the period ended December 31, 2019. During the first half of 2020, the Company implemented all remediation controls identified in its remediation plan as disclosed in the table below. During the six months ended June 30, 2020, the Company enhanced its quarterly review risk assessment model and its risk control matrices, established a risk committee, which reviews the risk assessment for changes in the business, enhanced its delegation of authority policy, conducted revenue recognition training, created and implemented a non-routine transaction policy, established a review process for and reviewed its vendor and customer transactions to identify potential related transactions, implemented procedures for the preparation of business cases for all non-routine business-to-business unbranded sales and purchases, and enhanced its sub-certification processes to identify non-routine transactions. The Company has completed internal testing on six of the eight controls identified in its remediation plan and expects to complete internal testing on the remaining controls during the third quarter of 2020. However, the Company does not expect full remediation until year end 2020.
The plan and progress to date is described below:
Material WeaknessControl, Control Enhancement or MitigantImplementation StatusManagement Testing StatusRemediation Status
Risk Assessment
Enhance quarterly review of risk assessment model and risk control matrices
ImplementedTested
Establish a risk committee which reviews the risk assessment for changes in the business on a quarterly basis
ImplementedTested
Segregation of Duties
Enhance Delegation of Authority matrix to further limit groups that may authorize sales or purchases of inventory
ImplementedTested
Establish review process and internal database to identify entities that are both vendors and customers of the Company
ImplementedTesting in Q3
Create and implement revenue recognition training
ImplementedTested
Non-Routine Transactions
Create and implement a Non-Routine Transactions Policy to include:
ImplementedTested
Definition of Non-Routine Transactions
Accounting memorandum completion
CEO/CFO approval
Formalization of business cases for all non-routine business to business unbranded sales and purchases to be reviewed on a quarterly basis to ensure alignment with the objectives of the business
ImplementedTesting in Q3
Expand the sub-certification process to additional members of management to ensure that non routine transactions are identified
ImplementedTested


53


Cronos Group will continue to review, optimize, and enhance its financial reporting controls and procedures. As the Company continues to evaluate and work to improve its internal control over financial reporting, the Company may implement additional measures to address the material weaknesses or certain of the remediation measures described above may be enhanced or modified. These material weaknesses will not be considered remediated until the applicable remediated controls operate for a sufficient period of time and management has concluded, through further testing, that these controls are operating effectively.
(b)Changes in Internal Control over Financial Reporting
Subsequent to the second quarter of 2020, the Company successfully implemented a new ERP system across the Canadian business. The new ERP system will be a meaningful component of our internal control over financial reporting and is expected to enable us to realize efficiencies throughout our finance, supply chain and operations processes.
Other than the ERP system and those measures described above to remediate the material weaknesses, there were no further changes in the Company’s internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act), that occurred during the quarter ended June 30, 2020, that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.
54


PART II
OTHER INFORMATION

Item 1: Legal Proceedings.
The Company is subject to various legal proceedings in the ordinary course of its business and in connection with its marketing, distribution and sale of its products. Many of these legal proceedings are in the early stages of litigation and seek damages that are unspecified or not quantified. Although the outcome of these matters cannot be predicted with certainty, the Company does not believe that these legal proceedings, individually or in the aggregate, will have a material adverse effect on its financial condition but could be material to its results of operations for a quarterly period depending, in part, on its results for that quarter. 
Class Action Complaints Relating to Restatements
On March 11 and 12, 2020, two alleged shareholders of the Company separately filed two putative class action complaints in the U.S. District Court for the Eastern District of New York against the Company and its Chief Executive Officer and Chief Financial Officer alleging violations of Section 10(b) of the Exchange Act and Rule 10b-5 promulgated thereunder against all defendants, and Section 20(a) of the Exchange Act against the individual defendants. The complaints generally allege that certain of the Company’s prior public statements about revenues and internal controls were incorrect based on the Company’s March 2, 2020, disclosure that the Audit Committee of its Board of Directors was conducting a review of the appropriateness of revenue recognized in connection with certain bulk resin purchases and sales of products through the wholesale channel. The complaints do not quantify a damage request. Defendants have not yet responded to the complaints.
On June 3, 2020, an alleged shareholder filed a Statement of Claim in the Ontario Superior Court of Justice in Toronto, Ontario, Canada, seeking, among other things, an order certifying the action as a class action on behalf of a putative class of shareholders and damages of an unspecified amount. The Statement of Claim names the Company, its Chief Executive Officer, Chief Financial Officer, former Chief Financial Officer and Chief Commercial Officer, and current and former members of its Board of Directors as defendants and alleges breaches of the Ontario Securities Act, oppression under the Ontario Business Corporations Act and common law misrepresentation. The Statement of Claim generally alleges that certain of the Company’s prior public statements about revenues and internal controls were misrepresentations based on the Company’s March 2, 2020 disclosure that the Audit Committee of its Board of Directors was conducting a review of the appropriateness of revenue recognized in connection with certain bulk resin purchases and sales of products through the wholesale channel, and the Company’s subsequent restatements. The Statement of Claim does not quantify its damage request. The Company and the other named defendants have not yet filed a response to the Statement of Claim.
Regulatory Reviews Relating to Restatements
The Company has been responding to requests for information from various regulatory authorities relating to its previously disclosed restatement of its financial statements for the first three quarters of 2019. The Company is responding to all such requests for information and cooperating with all regulatory authorities. The Company cannot predict the outcome of any such regulatory review or investigation and it is possible that additional investigations or one or more formal proceedings may be commenced against the Company and its current and former officers and directors in connection with these regulatory reviews.
Litigation Relating to Marketing, Distribution and Sale of Products
On June 16, 2020, an alleged consumer filed a Statement of Claim on behalf of a class in the Court of Queen’s Bench of Alberta in Alberta, Canada, against the Company and other Canadian cannabis manufacturers and/or distributors. The Statement of Claim alleges claims related to the defendants’ advertised content of cannabinoids in cannabis products for medicinal use on or after June 16, 2010 and cannabis products for adult use on or after October 17, 2018. The Statement of Claim seeks a total of C$500 million for breach of contract, compensatory damages, and unjust enrichment or such other amount as may be proven in trial and C$5 million in punitive damages against each defendant, including the Company. The Statement of Claim also seeks interest and costs associated with the action. The Company has not responded to the Statement of the Claim.
A number of claims, including purported class actions, have been brought in the U.S. against companies engaged in the U.S. hemp business alleging, among other things, violations of state consumer protection, health and advertising laws. On April 8, 2020, a putative class action complaint was filed in the U.S. District Court for the Central District of California against Redwood, alleging violations of California’s Unfair Competition Law, False Advertising Law, Consumers Legal Remedies Act, and breaches of the California Commercial Code for breach of express warranties and implied warranty of merchantability with respect to Redwood’s marketing and sale of U.S. hemp products. The complaint does not quantify a damage request. On April 14, 2020, the class action complaint was dismissed for certain pleading deficiencies and the plaintiff was granted leave until April 24, 2020 to amend the complaint to establish federal subject matter jurisdiction. As of the date of this Quarterly Report, the plaintiff has not refiled the complaint and the complaint has been dismissed without prejudice.
We expect litigation and regulatory proceedings relating to the marketing, distribution and sale of our products to increase.
55



Item 1A. Risk Factors.
An investment in us involves a number of risks. A detailed discussion of our risk factors appears in Part I, Item 1A. Risk Factors of the Annual Report. Any of the matters highlighted in the risk factors described in the Annual Report and the risk factors below could adversely affect our business, results of operations and financial condition, causing an investor to lose all, or part of, its, his or her investment. The risks and uncertainties described in the Annual Report and below are those we currently believe to be material, but they are not the only ones we face. If any of the risks described in the Annual Report, the following risks, or any other risks and uncertainties that we have not yet identified or that we currently consider not to be material, actually occur or become material risks, our business, prospects, financial condition, results of operations and cash flows and consequently the price of our securities could be materially and adversely affected.
Our business and results of operations have been adversely affected and will likely continue to be materially adversely impacted by the coronavirus pandemic (COVID-19).
The COVID-19 pandemic has severely restricted the level of economic activity around the world and in all countries in which we or our affiliates operate (including the U.S., Canada, Australia, Colombia, and Israel). In response to the COVID-19 pandemic the governments of many countries, states, cities and other geographic regions have taken preventative or protective actions, such as imposing restrictions on travel and business operations and advising or requiring individuals to limit or forego their time outside of their homes. Temporary closures of businesses have been ordered and numerous other businesses have temporarily closed voluntarily. The duration and ultimate impact of the COVID-19 pandemic, including the extent to which the virus may re-emerge following the current outbreak, are highly uncertain.
The effects of the COVID-19 pandemic had a material impact on the growth of revenues and sales during the six months ended June 30, 2020 related to the Company’s U.S. segment. With the U.S. currently in an economic contraction and a significant number of temporary closures impacting many of the Company’s customers’ stores, the U.S. segment is experiencing slower than expected revenue growth. The prolonged closures of retail stores as well as the changes in consumer purchasing during the COVID-19 pandemic have adversely affected our financial results. We anticipate further adverse effects on our financial results so long as the measures implemented to combat the COVID-19 pandemic stay in effect.
The effect of the COVID-19 pandemic could include closures of our facilities or the facilities of our suppliers and other vendors in our supply chain and other preventive and protective measures in our supply chain. For example, as a result of the COVID-19 pandemic, earlier closures of manufacturers in China resulted in delays of deliveries of batteries and cartridges for our cannabis vaporizers and personal protective equipment, such as masks and gowns used in our GMP manufacturing processes, from such manufacturers in China. If the pandemic persists, closures or other restrictions on the conduct of business operations of our third-party manufacturers, suppliers or vendors could disrupt our supply chain. We have experienced minor delays in shipping and the increased global demand on shipping and transport services, in addition to customs and border control policies put in place in response to COVID-19 that require shipments to undergo quarantine periods, may cause us to experience delays or increased costs in the future which could impact our ability to obtain materials or deliver our products in a timely manner, could otherwise disrupt our operations and could have an adverse effect on our business, financial condition and results of operations. In various provinces in Canada, cannabis retailers have been reducing opening hours, staff onsite and reducing the number of customers allowed in-store for cannabis retailers that continue to be open. Further, retailers of our products in the U.S. and Canada have in some cases determined to, and may in other cases be required to close or choose to suspend or significantly curtail their operations due to health and safety concerns for their employees. Even if our production facilities remain open, mandatory or voluntary self-quarantines and travel restrictions may limit our employees’ ability to get to our facilities, and this, together with impacts on our supply chain and the uncertainty produced by the rapidly evolving nature of the COVID-19 pandemic, may result in reduced or suspended production. Those type of restrictions could also impact the abilities of customers in the U.S. or certain Canadian provinces to continue to have access to our products. Quarantines, shelter-in-place and similar government orders, or the perception that such orders, shutdowns or other restrictions on the conduct of business operations could occur could impact personnel at third-party manufacturing facilities in the U.S. and Canada and other countries, or the availability or cost of materials, which would disrupt our supply chain, in particular in relation to our supply of masks, gowns and other protective equipment used at our GMP facilities due to the global shortage of such protective equipment and materials. As a result of COVID-19, we have implemented work-from-home policies for certain employees and the effects of our work-from-home policies may negatively impact productivity, disrupt access to books and records, increase cybersecurity risks and disrupt our business. In addition, the effects of the COVID-19 pandemic may delay our R&D programs and our ability to execute on certain of our strategic plans involving construction.
56


The global impact of the COVID-19 pandemic continues to evolve rapidly, and the extent of its effect on our operational and financial performance will depend on future developments, which are highly uncertain, including the duration, scope and severity of the pandemic, the actions taken to contain or mitigate its impact, and the direct and indirect economic effects of the pandemic and related containment measures, among others. Even after the COVID-19 pandemic subsides, our businesses could also be negatively impacted should the effects of the COVID-19 pandemic lead to changes in consumer behavior, including as a result of a decline in the level of vaping or demand for inhalable products in light of certain recent published articles and studies on the potential increased susceptibility of individuals who smoke or vaporize nicotine or cannabis to COVID-19, in light of changes in consumer behavior such as reduced spending on certain product formats historically used in shared experiences such as pre-rolls or in reductions in discretionary spending. In addition, a severe or prolonged recession resulting from the COVID-19 pandemic would likely materially affect our business and the value of our common shares.
We have been and may in the future be required to write down intangible assets, including goodwill, due to impairment, which could have a material adverse effect on our results of operations or financial position.
The Company has been and may in the future be required to write down intangible assets, including goodwill, due to impairment, which would reduce earnings. We periodically calculate the fair value of our reporting units and intangible assets to test for impairment. This calculation may be affected by several factors, including general economic conditions, regulatory developments, changes in category growth rates as a result of changing adult consumer preferences, success of planned new product introductions, and competitive activity. Certain events can also trigger an immediate review of goodwill and intangible assets. If the carrying value of our reporting unit and other intangible assets exceed their fair value and the loss in value is other than temporary, the goodwill and other intangible assets are considered impaired, which would result in impairment losses and could have a material adverse effect on our consolidated financial position or results of operations. We cannot provide any assurance that the U.S. segment will successfully execute its business plans and strategies.
The ongoing impact of the COVID-19 pandemic on the Company’s operating results for the U.S. segment has been difficult, if not impossible to predict. The longer than anticipated closures of retail stores have resulted in slower than anticipated revenue growth. As a result, the Company reassessed its estimates and forecasts using a discounted cash flow during the second quarter to determine the fair value of the goodwill and intangible asset relating to the U.S. segment. Based on the forecast of the U.S. segment at this time, there was an indication that fair value of the goodwill and intangible asset may not exceed carrying value. In the second quarter of 2020, we performed an interim impairment test due to the triggering events noted above. The Company incurred $35 million of impairment charges on the U.S. reporting unit and $5 million on the Lord Jones brand.
It is possible that estimates in the Company’s financial statements will continue to change in the near-term as a result of the COVID-19 pandemic and the effect of any such changes could be material, which could result in, among other things, further impairment of goodwill and intangible assets.
We have been and may in the future be required to write down inventory due to downward pressure on market prices, which could have a material adverse effect on our results of operations or financial position.
At the end of each reporting period, management performs an assessment of inventory obsolescence to measure inventory at the lower of cost and net realizable value. Net realizable value is defined as the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation. We also consider factors such as slow-moving or non-marketable products in our determination of obsolescence. As a result of this assessment, inventory write-downs may occur from period to period. Due to continued pricing pressures in the Canadian marketplace, we may incur further inventory write-downs in the future.We have had a series of inventory write-downs due to price compression in the cannabis market. We expect these write-downs to continue as pricing pressures remain elevated. These inventory write-downs have in the past and may in the future materially adversely affect our results of operations and financial position.
57


We identified material weaknesses in our internal control over financial reporting. If we are unable to remediate the material weaknesses, or if we experience additional material weaknesses in the future, our business may be harmed.
Our management is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) and for evaluating and reporting on the effectiveness of our system of internal control. Effective internal controls are necessary for us to provide timely, reliable and accurate financial reports, identify and proactively correct any deficiencies, material weaknesses or fraud and meet our reporting obligations. As disclosed in Part I, Item 4, we have commenced remediation efforts to improve our internal control over financial reporting. Remediation efforts place a significant burden on management and add increased pressure on our financial reporting resources and processes. If we are unable to successfully remediate our existing material weaknesses, or any additional material weaknesses in our internal control over financial reporting are identified, in a timely manner, the accuracy of our financial reporting and our ability to timely file with the SEC may be adversely impacted. In addition, if our remedial efforts are insufficient, or if additional material weaknesses or significant deficiencies in our internal controls occur in the future, we could be required to further restate our financial results, which could materially and adversely affect our business, results of operations and financial condition, restrict our ability to access the capital markets, require us to expend significant resources to correct the material weaknesses or deficiencies, subject us to regulatory investigations and penalties, harm our reputation, cause a decline in investor confidence or otherwise cause a decline in our stock price.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.
None.

Item 3. Defaults Upon Senior Securities.
None.

Item 4. Mine Safety Disclosures.
Not applicable.
Item 5. Other Information.
None.
58


Item 6. Exhibits
The exhibits listed in the Exhibit Index immediately below are filed as part of this Quarterly Report, which Exhibit Index is corporate by reference herein.
Exhibit NumberExhibit Index
3.1*
10.1†*
10.2†*
10.3†*
10.3†
31.1*
31.2*
32.1**
32.2**
101.INS*XBRL Instance Document
101.SCH*XBRL Taxonomy Extension Schema Document.
101.CAL*XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF*XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB*XBRL Taxonomy Extension Label Linkbase Document.
101.PRE*XBRL Taxonomy Extension Presentation Linkbase Document.

† Management contract or compensatory plan or arrangement.
* Filed herewith.
** Furnished herewith and not “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.
59


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
CRONOS GROUP INC.
By:/s/ Michael Gorenstein
Michael Gorenstein
President and Chief Executive Officer
Date: August 6, 2020


60
EX-3.1 2 exhibit31q2.htm EX-3.1 Document

Exhibit 3.1
image61.jpg Number: C1256453

CERTIFICATE
OF
CONTINUATION
BUSINESS CORPORATIONS ACT

I Hereby Certify that Cronos Group Inc., has continued into British Columbia from the Jurisdiction of ONTARIO, under the Business Corporations Act, with the name CRONOS GROUP INC. on July 9, 2020 at 01:15 PM Pacific Time.



image51.jpgimage41.jpg
ELECTRONIC CERTIFICATE






image31.jpg image21.jpg
image11.jpg
This Notice of Articles was issued by the Registrar on: July 9, 2020 01:15 PM Pacific Time
Incorporation Number: C1256453
Recognition Date and Time: Continued into British Columbia on July 9, 2020 01:15 PM Pacific Time

NOTICE OF ARTICLES
Name of Company:
CRONOS GROUP INC.
REGISTERED OFFICE INFORMATION
Mailing Address:Delivery Address:
SUITE 2600, THREE BENTALL CENTRE SUITE 2600, THREE BENTALL CENTRE
595 BURRARD STREET, P.O. BOX 49314 595 BURRARD STREET, P.O. BOX 49314
VANCOUVER BC V7X 1L3VANCOUVER BC V7X 1L3
CANADACANADA

RECORDS OFFICE INFORMATION:

Mailing Address:Delivery Address:
SUITE 2600, THREE BENTALL CENTRE SUITE 2600, THREE BENTALL CENTRE
595 BURRARD STREET, P.O. BOX 49314 595 BURRARD STREET, P.O. BOX 49314
VANCOUVER BC V7X 1L3VANCOUVER BC V7X 1L3
CANADACANADA



Page 1 of 3


DIRECTOR INFORMATION:

Last Name, First Name, Middle Name:
Begley, Jody
Mailing Address:Delivery Address:
111 PETER STREET, SUITE 300 111 PETER STREET, SUITE 300
TORONTO ON M5V 2G9 TORONTO ON M5V 2G9
CANADACANADA
Last Name, First Name, Middle Name:
Garnick, Murray
Mailing Address:Delivery Address:
111 PETER STREET, SUITE 300111 PETER STREET, SUITE 300
TORONTO ON M5V 2G9TORONTO ON M5V 2G9
CANADACANADA
Last Name, First Name, Middle Name:
Adler, Jason
Mailing Address:Delivery Address:
111 PETER STREET, SUITE 300111 PETER STREET, SUITE 300
TORONTO ON M5V 2G9TORONTO ON M5V 2G9
CANADACANADA
Last Name, First Name, Middle Name:
Gorenstein, Michael
Mailing Address:Delivery Address:
111 PETER STREET, SUITE 300111 PETER STREET, SUITE 300
TORONTO ON M5V 2G9TORONTO ON M5V 2G9
CANADACANADA
Last Name, First Name, Middle Name:
Newman, Heather
Mailing Address:Delivery Address:
111 PETER STREET, SUITE 300111 PETER STREET, SUITE 300
TORONTO ON M5V 2G9TORONTO ON M5V 2G9
CANADACANADA
Last Name, First Name, Middle Name:
Evans, Bronwen
Mailing Address:Delivery Address:
111 PETER STREET, SUITE 300111 PETER STREET, SUITE 300
TORONTO ON M5V 2G9TORONTO ON M5V 2G9
CANADACANADA

Page 2 of 3


Last Name, First Name, Middle Name:
Rudyk, James
Mailing Address:Delivery Address:
111 PETER STREET, SUITE 300111 PETER STREET, SUITE 300
TORONTO ON M5V 2G9TORONTO ON M5V 2G9
CANADACANADA

AUTHORIZED SHARE STRUCTURE
1.No MaximumCommon SharesWithout Par Value
Without Special Rights of Restrictions attached




Page 3 of 3


Certificate of Continuation Number C1256453


ARTICLES
OF
Cronos Group Inc.


BUSINESS CORPORATIONS ACT
BRITISH COLUMBIA






TABLE OF CONTENTS
Page
Article 1 
INTERPRETATION

1.1 Definitions............................................................................................................................1
1.2 Business Corporations Act and Interpretation Act Definitions Applicable.........................2

Article 2 
SHARES AND SHARE CERTIFICATES

2.1 Authorized Share Structure.......................................................................................…...... 2
2.2 Form of Share Certificate.................................................................................................... 2
2.3 Shareholder Entitled to Certificate or Acknowledgement.................................................. 2
2.4 Delivery by Mail................................................................................................................. 2
2.5 Replacement of Worn Out or Defaced Certificate or Acknowledgement.......................... 2
2.6 Replacement of Lost, Stolen or Destroyed Certificate or Acknowledgement.................... 3
2.7 Splitting Share Certificates................................................................................................. 3
2.8 Certificate Fee..................................................................................................................... 3
2.9 Recognition of Trusts......................................................................................................… 3
2.10 Shares may be Uncertificated.........................................................................................… 3

Article 3 
ISSUE OF SHARES

3.1 Directors Authorized........................................................................................................... 4
3.2 Commissions and Discounts............................................................................................... 4
3.3 Brokerage............................................................................................................................ 4
3.4 Conditions of Issue............................................................................................................. 4
3.5 Share Purchase Warrants, Options and Rights................................................................... 4

Article 4 
SHARE REGISTERS

4.1 Central Securities Register.................................................................................................. 4
4.2 Closing Register.................................................................................................................. 5

Article 5 
SHARE TRANSFERS

5.1 Registering Transfers.......................................................................................................... 5
5.2 Form of Instrument of Transfer.......................................................................................... 5
-1-



5.3 Transferor Remains Shareholder........................................................................................ 5
5.4 Signing of Instrument of Transfer....................................................................................... 5
5.5 Enquiry as to Title Not Required........................................................................................ 6
5.6 Transfer Fee........................................................................................................................ 6

Article 6 
TRANSMISSION OF SHARES

6.1 Legal Personal Representative Recognized on Death........................................................ 6
6.2 Rights of Legal Personal Representative............................................................................ 6

Article 7 
PURCHASE OF SHARES

7.1 Company Authorized to Purchase Shares........................................................................... 7
7.2 No Purchase, Redemption or Other Acquisition When Insolvent...................................... 7
7.3 Sale and Voting of Purchased, Redeemed or Otherwise Acquired Shares......................... 7

Article 8 
BORROWING POWERS

8.1 Borrowing Powers.............................................................................................................. 7

Article 9 
ALTERATIONS

9.1 Alteration of Authorized Share Structure........................................................................... 8
9.2 Special Rights and Restrictions.......................................................................................... 8
9.3 Change of Name................................................................................................................. 8
9.4 Other Alterations................................................................................................................. 8

Article 10 
MEETINGS OF SHAREHOLDERS

10.1 Annual General Meetings................................................................................................... 9
10.2 Resolution Instead of Annual General Meeting.................................................................. 9
10.3 Calling of Meetings of Shareholders.................................................................................. 9
10.4 Notice for Meetings of Shareholders.................................................................................. 9
10.5 Record Date for Notice and Voting.................................................................................. 10
10.6 Failure to Give Notice and Waiver of Notice................................................................... 10
10.7 Notice of Special Business at Meetings of Shareholders.................................................. 10
10.8 Location of Meetings of Shareholders.............................................................................. 10

Article 11 
PROCEEDINGS AT MEETINGS OF SHAREHOLDERS





11.1 Special Business................................................................................................................ 11
11.2 Special Majority................................................................................................................ 11
11.3 Quorum............................................................................................................................. 11
11.4 One Shareholder May Constitute Quorum......................................................................................................................................... 11
11.5 Persons Entitled to Attend Meeting..............................................................…................ 12
11.6 Requirement of Quorum................................................................................................... 12
11.7 Lack of Quorum................................................................................................................ 12
11.8 Lack of Quorum at Succeeding Meeting.......................................................................... 12
11.9 Chair.................................................................................................................................. 12
11.10 Selection of Alternate Chair.............................................................................................. 13
11.11 Adjournments.................................................................................................................... 13
11.12 Notice of Adjourned Meeting........................................................................................... 13
11.13 Decision by Show of Hands or Poll.................................................................................. 13
11.14 Declaration of Result........................................................................................................ 13
11.15 Motion Need Not be Seconded......................................................................................... 14
11.16 Casting Vote...................................................................................................................... 14
11.17 Manner of Taking Poll...................................................................................................... 14
11.18 Demand for Poll on Adjournment..................................................................................... 14
11.19 Organization...................................................................................................................... 14
11.20 Chair Must Resolve Dispute............................................................................................. 14
11.21 Casting of Votes................................................................................................................ 14
11.22 No Demand for Poll on Election of Chair........................................................................ 14
11.23 Demand for Poll Not to Prevent Continuance of Meeting................................................ 15
11.24 Retention of Ballots and Proxies....................................................................................... 15
11.25 Meeting by Telephone or Other Communications Medium............................................. 15

Article 12 
VOTES OF SHAREHOLDERS

12.1 Number of Votes by Shareholder or by Shares................................................................ 15
12.2 Votes of Persons in Representative Capacity................................................................... 15
12.3 Votes by Joint Holders...................................................................................................... 15
12.4 Legal Personal Representatives as Joint Shareholders..................................................... 16
12.5 Representative of a Corporate Shareholder...................................................................... 16
12.6 When Proxy Provisions Do Not Apply to the Company.................................................. 16
12.7 Appointment of Proxy Holders......................................................................................... 16
12.8 Alternate Proxy Holders................................................................................................... 17
12.9 When Proxy Holder Need Not Be Shareholder................................................................ 17
12.10 Deposit of Proxy............................................................................................................... 17
12.11 Validity of Proxy Vote...................................................................................................... 17
12.12 Form of Proxy................................................................................................................... 18
12.13 Revocation of Proxy......................................................................................................... 18
12.14 Revocation of Proxy Must Be Signed............................................................................... 18




12.15 Production of Evidence of Authority to Vote................................................................... 18

Article 13 
DIRECTORS

13.1 First Directors; Number of Directors................................................................................ 18
13.2 Change in Number of Directors........................................................................................ 19
13.3 Directors’ Acts Valid Despite Vacancy............................................................................ 19
13.4 Qualifications of Directors................................................................................................ 19
13.5 Remuneration of Directors................................................................................................ 19
13.6 Reimbursement of Expenses of Directors......................................................................... 19
13.7 Special Remuneration for Directors.................................................................................. 19

Article 14 
ELECTION AND REMOVAL OF DIRECTORS

14.1 Election at Annual General Meeting................................................................................. 20
14.2 Consent to be a Director................................................................................................... 20
14.3 Failure to Elect or Appoint Directors................................................................................ 20
14.4 Places of Retiring Directors Not Filled............................................................................. 21
14.5 Directors May Fill Casual Vacancies............................................................................... 21
14.6 Remaining Directors Power to Act................................................................................... 21
14.7 Shareholders May Fill Vacancies..................................................................................... 21
14.8 Additional Directors.......................................................................................................... 21
14.9 Ceasing to be a Director.................................................................................................... 21
14.10 Removal of Director by Shareholders............................................................................... 22
14.11 Removal of Director by Directors..................................................................................... 22

Article 15 
ADVANCE NOTICE FOR NOMINATION OF DIRECTORS

15.1 Limitation on Nominations of Directors........................................................................... 22
15.2 Nomination Procedures..................................................................................................... 22
15.3 Nominations by a Nominating Shareholder...................................................................... 23

Article 16 
DISCLOSURE OF INTEREST OF DIRECTORS

16.1 Director Holding Other Office in the Company............................................................... 27
16.2 No Disqualification........................................................................................................... 27
16.3 Professional Services by Director or Officer.................................................................... 27
16.4 Director or Officer in Other Corporations........................................................................ 27

Article 17 
PROCEEDINGS OF DIRECTORS





17.1 Meetings of Directors....................................................................................................... 27
17.2 Voting at Meetings............................................................................................................ 27
17.3 Chair of Meetings............................................................................................................. 27
17.4 Meetings by Telephone or Other Communications Medium........................................... 28
17.5 Calling of Meetings........................................................................................................... 28
17.6 Notice of Meetings..........….............................................................................................. 28
17.7 When Notice Not Required............................................................................................... 28
17.8 Meeting Valid Despite Failure to Give Notice................................................................. 28
17.9 Waiver of Notice of Meetings.......................................................................................... 29
17.10 Quorum............................................................................................................................. 29
17.11 Validity of Acts Where Appointment Defective.............................................................. 29
17.12 Consent Resolutions in Writing........................................................................................ 29

Article 18 
EXECUTIVE AND OTHER COMMITTEES

18.1 Appointment and Powers of Committees......................................................................... 29
18.2 Obligations of Committees............................................................................................... 30
18.3 Powers of Board................................................................................................................ 30
18.4 Committee Meetings......................................................................................................... 30

Article 19 
OFFICERS

19.1 Directors May Appoint Officers....................................................................................... 31
19.2 Functions, Duties and Powers of Officers........................................................................ 31
19.3 Qualifications.................................................................................................................... 31
19.4 Remuneration and Terms of Appointment....................................................................... 31
19.5 Duties of Officers May be Delegated............................................................................... 31

Article 20 
INDEMNIFICATION

20.1 Mandatory Indemnification of Directors and Officers..................................................... 32
20.2 Further Indemnification of Directors and Officers........................................................... 32
20.3 Deemed Contract.............................................................................................................. 34
20.4 Indemnification of Other Persons..................................................................................... 34
20.5 Non-Compliance with Business Corporations Act........................................................... 35
20.6 Company May Purchase Insurance................................................................................... 35

Article 21 
DIVIDENDS

21.1 Payment of Dividends Subject to Special Rights............................................................. 35




21.2 Declaration of Dividends.................................................................................................. 35
21.3 No Notice Required.......................................................................................................... 35
21.4 Record Date...................................................................................................................... 35
21.5 Manner of Paying Dividend.............................................................................................. 35
21.6 Settlement of Difficulties.................................................................................................. 36
21.7 When Dividend Payable................................................................................................... 36
21.8 Dividends to be Paid in Accordance with Number of Shares........................................... 36
21.9 Receipt by Joint Shareholders........................................................................................... 36
21.10 Dividend Bears No Interest............................................................................................... 37
21.11 Fractional Dividends......................................................................................................... 37
21.12 Payment of Dividends....................................................................................................... 37
21.13 Capitalization of Retained Earnings or Surplus................................................................ 37

Article 22 
DOCUMENTS, RECORDS AND REPORTS

22.1 Recording of Financial Affairs......................................................................................... 37

Article 23 
NOTICES

23.1 Method of Giving Notice.................................................................................................. 38
23.2 Deemed Receipt of Mailing.............................................................................................. 38
23.3 Certificate of Sending....................................................................................................... 38
23.4 Notice to Joint Shareholders............................................................................................. 38
23.5 Notice to Legal Personal Representatives Trustees.......................................................... 38

Article 24 
EXECUTION OF DOCUMENTS

24.1 Execution of Documents Generally.................................................................................. 39

Article 25 
PROHIBITIONS

25.1 Definitions......................................................................................................................... 39
25.2 Application........................................................................................................................ 39
25.3 Consent Required for Transfer of Transfer Restricted Securities..................................... 40






Article 26 
General Provisions

26.1 Information Available to Shareholders............................................................................. 40




Certificate of Continuation Number C1256453
BUSINESS CORPORATIONS ACT
ARTICLES
of
CRONOS GROUP INC.
ARTICLE 1
INTERPRETATION
1.1Definitions. In these Articles, unless the context otherwise requires:
Applicable Securities Laws” means the securities legislation in Canada, the United States and any other relevant jurisdiction, as amended from time to time, the rules, regulations and forms made or promulgated under any such statutes and the published national instruments, multilateral instruments, policies, bulletins and notices of the securities commissions and similar regulatory authorities, in each case, applicable to the Company;
board” means the directors or sole director of the Company, as the case may be;
Business Corporations Act” means the Business Corporations Act (British Columbia) in force from time to time and all amendments thereto and includes all regulations and amendments thereto made pursuant to that act;
Company” means Cronos Group Inc.;
Interpretation Act means the Interpretation Act (British Columbia) in force from time to time and all amendments thereto and includes all regulations and amendments thereto made pursuant to that act;
legal personal representative” means the personal or other legal representative of the shareholder;
meeting of shareholders” or “Shareholders Meeting” means an annual meeting of shareholders and a special meeting of shareholders of the Company;
registered address” of a shareholder means the shareholder’s address as recorded in the central securities register;
Securities Transfer Act means the Securities Transfer Act (British Columbia) in force from time to time and all amendments thereto and includes all regulations and amendments thereto made pursuant to that Act.
-1-



1.1Business Corporations Act and Interpretation Act Definitions Applicable. The definitions in the Business Corporations Act and the definitions and rules of construction in the Interpretation Act, with the necessary changes, so far as applicable, and unless the context requires otherwise, apply to these Articles as if they were an enactment. If there is a conflict between a definition in the Business Corporations Act and a definition or rule in the Interpretation Act relating to a term used in these Articles, the definition in the Business Corporations Act will prevail in relation to the use of the term in these Articles. If there is a conflict between these Articles and the Business Corporations Act, the Business Corporations Act will prevail.
ARTICLE 2
SHARES AND SHARE CERTIFICATES
2.1Authorized Share Structure. The authorized share structure of the Company consists of shares of the class or classes and series, if any, described in the Notice of Articles of the Company.
2.2Form of Share Certificate. Each share certificate issued by the Company must comply with, and be signed as required by, the Business Corporations Act.
2.3Shareholder Entitled to Certificate or Acknowledgement. Unless the shares of which the shareholder is the registered owner are uncertificated shares within the meaning of the Business Corporations Act, each shareholder is entitled, without charge, to (a) one share certificate representing the shares of each class or series of shares registered in the shareholder’s name or (b) a non-transferable written acknowledgement of the shareholder’s right to obtain such a share certificate, provided that in respect of a share held jointly by several persons, the Company is not bound to issue more than one share certificate or acknowledgement and delivery of a share certificate or an acknowledgement to one of several joint shareholders or to one of the shareholders’ duly authorized agents will be sufficient delivery to all.
2.4Delivery by Mail. Any share certificate or non-transferable written acknowledgement of a shareholder’s right to obtain a share certificate may be sent to the shareholder by mail at the shareholder’s registered address and neither the Company nor any director, officer or agent of the Company is liable for any loss to the shareholder because the share certificate or acknowledgement is lost in the mail or stolen.
2.5Replacement of Worn Out or Defaced Certificate or Acknowledgement. If the board or the secretary of the Company, if any, is satisfied that a share certificate or a non-transferable written acknowledgement of the shareholder’s right to obtain a share certificate is worn out or defaced, they must, on production to them of the share certificate or acknowledgement, as the case may be, and on such other terms, if any, as they think fit:
(a)order the share certificate or acknowledgement, as the case may be, to be cancelled; and
-2-



(b)issue a replacement share certificate or acknowledgement, as the case may be.
2.6Replacement of Lost, Stolen or Destroyed Certificate or Acknowledgement. If a share certificate or a non-transferable written acknowledgement of a shareholder’s right to obtain a share certificate is lost, stolen or destroyed, a replacement share certificate or acknowledgement, as the case may be, must be issued to the person entitled to that share certificate or acknowledgement, as the case may be, if the board or the secretary, if any, of the Company receives:
(a)proof satisfactory to them (which, if requested, shall include an affidavit) that the share certificate or acknowledgement is lost, stolen or destroyed; and
(b)any indemnity the board considers adequate.
2.7Splitting Share Certificates. If a shareholder surrenders a share certificate to the Company, or to any transfer agent or other agent duly appointed for such purpose, together with a written request that the Company issue in the shareholder’s name two or more share certificates, each representing a specified number of shares and in the aggregate representing the same number of shares as the share certificate so surrendered, the Company, or its agent duly appointed for such purpose, as the case may be, must cancel the surrendered share certificate and issue replacement share certificates in accordance with that request.
2.8Certificate Fee. There must be paid to the Company, in relation to the issue of any share certificate under Articles 2.5, 2.6, or 2.7, the amount, if any, and which must not exceed the amount prescribed under the Business Corporations Act, determined by the board.
2.9Recognition of Trusts. Except as required by law or statute or these Articles, no person will be recognized by the Company as holding any share upon any trust, and the Company is not bound by or compelled in any way to recognize (even when having notice thereof) any equitable, contingent, future or partial interest in any share or fraction of a share or (except as required by law or statute or these Articles or as ordered by a court of competent jurisdiction) any other rights in respect of any share except an absolute right to the entirety thereof in the shareholder.
2.10Shares may be Uncertificated. Notwithstanding any other provision of this Article 2, the board may, by resolution, provide that
(a)the shares of any or all of the classes or series of the Company’s shares may be uncertificated shares; or
(b)any specified shares may be uncertificated shares.
-3-



ARTICLE 3
ISSUE OF SHARES
3.1Directors Authorized. Subject to the Business Corporations Act and the rights, if any, of the holders of issued shares of the Company, the Company may issue, allot, sell or otherwise dispose of the unissued shares, and issued shares held by the Company, at the times, to the persons, including directors, in the manner, on the terms and conditions and for the issue prices (including any premium at which shares with par value may be issued) that the board may determine. The issue price for a share with par value must be equal to or greater than the par value of the share.
3.2Commissions and Discounts. The Company may at any time pay a reasonable commission or allow a reasonable discount to any person in consideration of that person purchasing or agreeing to purchase shares of the Company from the Company or any other person or procuring or agreeing to procure purchasers for shares of the Company.
3.3Brokerage. The Company may pay such brokerage fee or other consideration as may be lawful for or in connection with the sale or placement of its securities.
3.4Conditions of Issue. Except as provided for by the Business Corporations Act, no share may be issued until it is fully paid. A share is fully paid when:
(a)consideration is provided to the Company for the issue of the share by one or more of the following:
(i)past services performed for the Company;
(ii)property; or
(iii)money; and
(b)the value of the consideration received by the Company equals or exceeds the issue price set for the share under Article 3.1.
3.5Share Purchase Warrants, Options and Rights. Subject to the Business Corporations Act, the Company may issue share purchase warrants, options and rights upon such terms and conditions as the board determines, which share purchase warrants, options and rights may be issued alone or in conjunction with debentures, debenture stock, bonds, shares or any other securities issued or created by the Company from time to time.
ARTICLE 4
SHARE REGISTERS
4.1Central Securities Register. As required by and subject to the Business Corporations Act, the Company must maintain a central securities register, which may be kept in electronic form. The board may, subject to the Business Corporations Act, appoint an agent to maintain the central securities register. The board may also appoint one or more
-4-



agents, including the agent which keeps the central securities register, as transfer agent for its shares or any class or series of its shares, as the case may be, and the same or another agent as registrar for its shares or such class or series of its shares, as the case may be. The board may terminate such appointment of any agent at any time and may appoint another agent in its place.
4.2Closing Register. The Company must not at any time close its central securities register.
ARTICLE 5
SHARE TRANSFERS
5.1Registering Transfers. A transfer of a share of the Company must not be registered unless:
(a)a duly signed instrument of transfer in respect of the share has been received by the Company;
(b)if a share certificate has been issued by the Company in respect of the share to be transferred, that share certificate has been surrendered to the Company;
(c)if a non-transferable written acknowledgement of the shareholder’s right to obtain a share certificate has been issued by the Company in respect of the share to be transferred, that acknowledgement has been surrendered to the Company; and
(d)the satisfaction of any other conditions precedent, in favour of the Company, to which such transfer has validly been made subject (including any conditions precedent required to be satisfied in order to ensure compliance with Applicable Securities Laws).
5.2Form of Instrument of Transfer. The instrument of transfer in respect of any share of the Company must be either in the form, if any, on the back of the Company’s share certificates or in any other form that may be approved by the Company or the transfer agent for the class or series of shares to be transferred.
5.3Transferor Remains Shareholder. Except to the extent that the Business Corporations Act otherwise provides, the transferor of shares is deemed to remain the holder of the shares until the name of the transferee is entered in a central securities register of the Company in respect of the transfer.
5.4Signing of Instrument of Transfer. If a shareholder, or such shareholder’s duly authorized attorney, signs an instrument of transfer in respect of shares registered in the name of the shareholder, the signed instrument of transfer constitutes a complete and sufficient authority to the Company and its directors, officers and agents of the Company to register the number of shares specified in the instrument of transfer or specified in any other manner, or, if no number is specified, all the shares represented by the share
-5-



certificates or set out in the written acknowledgements deposited with the instrument of transfer:
(a)in the name of the person named as transferee in that instrument of transfer; or
(b)if no person is named as transferee in that instrument of transfer, in the name of the person on whose behalf the instrument is deposited for the purpose of having the transfer registered.
5.5Enquiry as to Title Not Required. Neither the Company nor any director, officer or agent of the Company is bound to inquire into the title of the person named in the instrument of transfer as transferee or, if no person is named as transferee in the instrument of transfer, of the person on whose behalf the instrument is deposited for the purpose of having the transfer registered or is liable for any claim related to registering the transfer by the shareholder or by any intermediate owner or holder of the shares, of any interest in the shares, of any share certificate representing such shares or of any written acknowledgement of a right to obtain a share certificate for such shares.
5.6Transfer Fee. Subject to the applicable rules of any stock exchange on which the securities of the Company may be listed, there must be paid to the Company, in relation to the registration of any transfer, a fee, if any, in the amount, if any, determined by the board.
ARTICLE 6
TRANSMISSION OF SHARES
6.1Legal Personal Representative Recognized on Death. In the case of the death of a shareholder, the legal personal representative of the shareholder, or if the shareholder was a joint holder, the surviving joint holder, will be the only person recognized by the Company as having any title to the shareholder’s interest in the shares. Before recognizing a person as a legal personal representative of a shareholder, the board may require proof of appointment by a court of competent jurisdiction, a grant of letters probate, letters of administration or such other evidence or documents as the board, officers or duly authorized agents of the Company consider appropriate.
6.2Rights of Legal Personal Representative. The legal personal representative of a shareholder has the rights, privileges and obligations that attach to the shares held by the shareholder, including the right to transfer the shares in accordance with these Articles and Applicable Securities Laws, if appropriate evidence of appointment or incumbency within the meaning of the Securities Transfer Act has been deposited with the Company. This Article 6.2 does not apply in the case of the death of a shareholder with respect to shares registered in the shareholder’s name and the name of another person in joint tenancy.
-6-



ARTICLE 7
PURCHASE OF SHARES
7.1Company Authorized to Purchase Shares. Subject to Article 7.2, the special rights and restrictions attached to the shares of any class or series and the Business Corporations Act, the Company may, if authorized by the board, purchase or otherwise acquire any of its shares at the price and upon the terms determined by the board.
7.2No Purchase, Redemption or Other Acquisition When Insolvent. The Company must not make a payment or provide any other consideration to purchase, redeem or otherwise acquire any of its shares if there are reasonable grounds for believing that:
(a)the Company is insolvent; or
(b)making the payment or providing the consideration would render the Company insolvent.
7.3Sale and Voting of Purchased, Redeemed or Otherwise Acquired Shares. If the Company retains a share redeemed, purchased or otherwise acquired by it, the Company may sell, gift or otherwise dispose of the share, but, while such share is held by the Company, it:
(a)is not entitled to vote the share at a meeting of shareholders;
(b)must not pay a dividend in respect of the share; and
(c)must not make any other distribution in respect of the share.
ARTICLE 8
BORROWING POWERS
8.1Borrowing Powers. The Company, if authorized by the board (it being understood, for the avoidance of doubt, that the board may delegate its power to provide such authorization to a committee, under Article 18.1, or to an officer, under Article 19.2), may:
(a)borrow money in the manner and amount, on the security, from the sources and on the terms and conditions that the board considers appropriate;
(b)issue bonds, debentures and other debt obligations either outright or as security for any liability or obligation of the Company or any other person and at such discounts or premiums and on such other terms as the board considers appropriate;
(c)guarantee the repayment of money by any other person or the performance of any obligation of any other person, provided that any director or authorized officer of
-7-



the Company may authorize the Company to guarantee the performance of an obligation of a wholly-owned subsidiary of the Company; and
(d)mortgage, charge, whether by way of specific or floating charge, grant a security interest in, or give other security on, the whole or any part of the present and future assets and undertaking of the Company.
ARTICLE 9
ALTERATIONS
9.1Alteration of Authorized Share Structure. Subject to Article 9.2, the special rights or restrictions attached to the shares of any class or series of shares and the Business Corporations Act, the Company may by special resolution:
(a)create one or more classes or series of shares or, if none of the shares of a class or series of shares are allotted or issued, eliminate that class or series of shares;
(b)increase, reduce or eliminate the maximum number of shares that the Company is authorized to issue out of any class or series of shares or establish a maximum number of shares that the Company is authorized to issue out of any class or series of shares for which no maximum is established;
(c)subdivide or consolidate all or any of its unissued, or fully paid and issued, shares;
(d)if the Company is authorized to issue shares of a class of shares with par value:
(i)decrease the par value of those shares; or
(ii)if none of the shares of that class of shares are allotted or issued, increase the par value of those shares;
(e)change all or any of its unissued, or fully paid and issued, shares with par value into shares without par value or any of its unissued shares without par value into shares with par value;
(f)alter the identifying name of any of its shares; or
(g)otherwise alter its shares or authorized share structure when required or permitted to do so by the Business Corporations Act;
and, if applicable, alter its Notice of Articles and Articles accordingly.
9.2Special Rights and Restrictions. Subject to the special rights or restrictions attached to the shares of any class or series of shares and the Business Corporations Act, the Company may by special resolution:
-8-



(a)create special rights or restrictions for, and attach those special rights or restrictions to, the shares of any class or series of shares, whether or not any or all of those shares have been issued; or
(b)vary or delete any special rights or restrictions attached to the shares of any class or series of shares, whether or not any or all of those shares have been issued;
and alter its Notice of Articles and Articles accordingly.
9.3Change of Name. The Company may by special resolution authorize an alteration of its Notice of Articles in order to change its name.
9.4Other Alterations. If the Business Corporations Act does not specify the type of resolution and these Articles do not specify another type of resolution, the Company may by ordinary resolution alter these Articles.
ARTICLE 10
MEETINGS OF SHAREHOLDERS
10.1Annual General Meetings. Unless an annual general meeting is deferred or waived in accordance with the Business Corporations Act, the Company must hold its first annual general meeting within 18 months after the date on which it was incorporated or otherwise recognized, and after that must hold an annual general meeting at least once in each calendar year and not more than 15 months after the last annual reference date at such time and place as may be determined by the board.
10.2Resolution Instead of Annual General Meeting. If all the shareholders who are entitled to vote at an annual general meeting consent by unanimous resolution under the Business Corporations Act to all of the business that is required to be transacted at that annual general meeting, the annual general meeting is deemed to have been held on the date of the unanimous resolution. The shareholders must, in any unanimous resolution passed under this Article 10.2, select as the Company’s annual reference date a date that would be appropriate for the holding of the applicable annual general meeting.
10.3Calling of Meetings of Shareholders. Subject to the Business Corporations Act, only the board may, whenever it thinks fit, call a meeting of shareholders.
10.4Notice for Meetings of Shareholders. The Company must send notice of the date, time and location of any meeting of shareholders, in the manner provided in these Articles, or in such other manner, if any, as may be prescribed by ordinary resolution (whether previous notice of the resolution has been given or not), to each shareholder entitled to attend the meeting, to each director and to the auditor of the Company, unless these Articles otherwise provide, at least the following number of days before the meeting:
(a)if and for so long as the Company is a public company, 21 days, and not more than 60 days;
-9-



(b)otherwise, 10 days.
10.5Record Date for Notice and Voting. The board may set a date as the record date for the purpose of determining shareholders entitled to notice of, and to vote at, any meeting of shareholders. The record date must not precede the date on which the meeting is to be held by more than two months or, in the case of a general meeting requisitioned by shareholders under the Business Corporations Act, by more than four months. The record date must not precede the date on which the meeting is held by fewer than:
(a)if and for so long as the Company is a public company, 30 days;
(b)otherwise, 10 days.
If no record date is set, the record date is 5 p.m. on the day immediately preceding the first date on which the notice is sent or, if no notice is sent, the beginning of the meeting.
10.6Failure to Give Notice and Waiver of Notice. The accidental omission to send notice of any meeting of shareholders to, or the non-receipt of any notice by, any of the persons entitled to notice does not invalidate any proceedings at that meeting. Any person entitled to notice of a meeting of shareholders may, in writing or otherwise, waive that entitlement or agree to reduce the period of that notice. Attendance of a persons at a meeting of shareholders is a waiver of entitlement to the meeting unless that person attends the meeting for the express purpose of objecting to the transaction of any business on the grounds that the meeting is not lawfully called.
10.7Notice of Special Business at Meetings of Shareholders. If a meeting of shareholders is to consider special business within the meaning of Article 11.1, the notice of meeting must:
(a)state the general nature of the special business; and
(b)if the special business includes considering, approving, ratifying, adopting or authorizing any document or the signing of or giving of effect to any document, have attached to it a copy of the document or state that a copy of the document will be available for inspection by shareholders:
(i)at the Company’s records office, or at such other reasonably accessible location in British Columbia as is specified in the notice; and
(ii)during statutory business hours on any one or more specified days before the day set for the holding of the meeting.
10.8Location of Meetings of Shareholders. Meetings of shareholders may be held anywhere within Canada, the United States, or at such other location that the board, by resolution, may determine. To the extent not prohibited by the Business Corporations Act, such other location may include a virtual meeting, which shall be deemed to be held at the registered office of the Company.
-10-



ARTICLE 11
PROCEEDINGS AT MEETINGS OF SHAREHOLDERS
11.1Special Business. At a meeting of shareholders, the following business is special business:
(a)at a meeting of shareholders that is not an annual general meeting, all business is special business except business relating to the conduct of or voting at the meeting;
(b)at an annual general meeting, all business is special business except for the following:
(i)business relating to the conduct of or voting at the meeting;
(ii)consideration of any financial statements of the Company presented to the meeting;
(iii)consideration of any reports of the board or auditor;
(iv)the setting or changing of the number of directors;
(v)the election or appointment of directors;
(vi)the appointment of an auditor;
(vii)the setting of the remuneration of an auditor;
(viii)any non-binding advisory vote;
(ix)business arising out of a report of the board not requiring the passing of a special resolution or an exceptional resolution;
(x)any other business which, under these Articles or the Business Corporations Act, may be transacted at a meeting of shareholders without prior notice of the business being given to the shareholders.
11.2Special Majority. The majority of votes required for the Company to pass a special resolution at a meeting of shareholders is two-thirds of the votes cast on the resolution.
11.3Quorum. Subject to the special rights and restrictions attached to the shares of any class or series of shares, the quorum for the transaction of business at a meeting of shareholders is any persons who are, or who represent by proxy, the holders of at least 33 1/3%, in the aggregate, of the issued shares entitled to be voted at the meeting.
11.4One Shareholder May Constitute Quorum. If there is only one shareholder entitled to vote at a meeting of shareholders:
-11-



(a)the quorum is one person who is, or who represents by proxy, that shareholder; and
(b)that shareholder, present in person or by proxy, may constitute the meeting.
11.5Persons Entitled to Attend Meeting. In addition to those persons who are entitled to vote at a meeting of shareholders, the only other persons entitled to be present at the meeting are the directors, the officers of the Company, any counsel for the Company, the auditor of the Company and any other persons invited by the board or by the chair of the meeting and any persons entitled or required under the Business Corporations Act or these Articles to attend any meeting of shareholders, but if any of those persons does attend a meeting of shareholders, that person is not to be counted in the quorum and is not entitled to vote at the meeting unless that person is a shareholder or proxy holder entitled to vote at the meeting.
11.6Requirement of Quorum. No business, other than the election of a chair of the meeting and the adjournment of the meeting of shareholders, may be transacted at any meeting of shareholders unless a quorum of shareholders entitled to vote is present at the commencement of the meeting, but such quorum need not be present throughout the meeting.
11.7Lack of Quorum. If, within one-half hour from the time set for the holding of a meeting of shareholders, a quorum is not present:
(a)in the case of a meeting requisitioned by shareholders, the meeting is dissolved, and
(b)in the case of any other meeting of shareholders, the meeting stands adjourned to the same day in the next week at the same time and place.
11.8Lack of Quorum at Succeeding Meeting. If, at the meeting to which the meeting referred to in Article 11.7(b) was adjourned, a quorum is not present within one-half hour from the time set for the holding of the meeting, the person or persons present and being, or representing by proxy, one or more shareholders entitled to attend and vote at the meeting constitute a quorum.
11.9Chair. The following individual is entitled to preside as chair at a meeting of shareholders:
(a)the chair of the board, if any; or
(b)if the chair of the board is absent or unwilling to act as chair of the meeting, the lead director of the board, if any; or
(c)if the lead director of the board is absent or unwilling to act as chair of the meeting, the individual whom the Chief Executive Officer (or, if the Chief
-12-



Executive Officer is absent, the Chief Financial Officer) of the Company appoints.
11.10Selection of Alternate Chair. If, at any meeting of shareholders, the chair of the board, the lead director of the board or the individual whom the Chief Executive Officer (or, if the Chief Executive Officer is absent, the Chief Financial Officer) of the Company appoints, as the case may be, is not present within 15 minutes after the time set for holding the meeting, or if the chair of the board, the lead director of the board or the individual whom the Chief Executive Officer (or, if the Chief Executive Officer is absent, the Chief Financial Officer) of the Company appoints, as the case may be, is unwilling to act as chair of the meeting, or if the chair of the board, the lead director of the board or the individual whom the Chief Executive Officer (or, if the Chief Executive Officer is absent, the Chief Financial Officer) of the Company appoints, as the case may be, has advised the secretary of the Company, if any, or any director present at the meeting, that they will not be present at the meeting, the directors present must choose one of their number to be chair of the meeting or if all of the directors present decline to take the chair or fail to so choose or if no director is present, the shareholders entitled to vote at the meeting who are present in person or by proxy may choose any person present at the meeting to chair the meeting.
11.11Adjournments. The chair of a meeting of shareholders may, and if so directed by the meeting must, adjourn the meeting from time to time and from place to place, but no business may be transacted at any adjourned meeting other than the business left unfinished at the meeting from which the adjournment took place.
11.12Notice of Adjourned Meeting. It is not necessary to give any notice of an adjourned meeting of shareholders or of the business to be transacted at an adjourned meeting of shareholders except that, when a meeting is adjourned for 30 days or more, notice of the adjourned meeting must be given in the same manner as the original meeting.
11.13Decision by Show of Hands or Poll. Subject to the Business Corporations Act, every motion put to a vote at a meeting of shareholders will be decided on a show of hands unless a poll, before or on the declaration of the result of the vote by show of hands, is directed by the chair of the meeting or demanded by at least one shareholder entitled to vote who is present in person or by proxy.
11.14Declaration of Result. The chair of a meeting of shareholders must declare to the meeting the decision on every question in accordance with the result of the show of hands or the poll, as the case may be, and that decision must be entered in the minutes of the meeting. A declaration of the chair of the meeting that a resolution is carried by the necessary majority or is defeated is, unless a poll is directed by the chair of the meeting or demanded under Article 11.13, conclusive evidence without proof of the number or proportion of the votes recorded in favour of or against the resolution.
-13-



11.15Motion Need Not be Seconded. No motion proposed at a meeting of shareholders need be seconded unless the chair of the meeting rules otherwise, and the chair of the meeting is entitled to propose or second a motion.
11.16Casting Vote. In the case of an equality of votes, the chair of a meeting of shareholders does not, either on a show of hands or on a poll, have a second or casting vote in addition to the vote or votes to which the chair of the meeting may be entitled as a shareholder.
11.17Manner of Taking Poll. Subject to Article 11.18, if a poll is duly demanded at a meeting of shareholders:
(a)the poll must be taken:
(i)at the meeting, or within seven days after the date of the meeting, as the chair of the meeting directs; and
(ii)in the manner, at the time and at the place that the chair of the meeting directs;
(b)the result of the poll is deemed to be the decision of the meeting at which the poll is demanded; and
(c)the demand for the poll may be withdrawn by the person who demanded it.
11.18Demand for Poll on Adjournment. A poll demanded at a meeting of shareholders on a question of adjournment must be taken immediately at the meeting.
11.19Organization.  The order of business at a meeting of shareholders shall be determined by the chair of a meeting of shareholders. The chair of a meeting of shareholders shall have the right and authority to prescribe such rules, regulations and procedures and to do all such acts and things as are necessary or desirable for the proper conduct of the meeting of shareholders, including, without limitation, the establishment of procedures for the maintenance of order and safety, limitations on the time allotted to questions or comments on the affairs of the Company, restrictions on entry to such meeting of shareholders after the time prescribed for the commencement thereof and the opening and closing of voting polls for each item on which a vote is to be taken.
11.20Chair Must Resolve Dispute. In the case of any dispute as to the admission or rejection of a vote given on a poll, the chair of a meeting of shareholders must determine the dispute, and his or her determination made in good faith is final and conclusive.
11.21Casting of Votes. On a poll, a shareholder entitled to more than one vote need not cast all the votes in the same way.
11.22No Demand for Poll on Election of Chair. No poll may be demanded in respect of the vote by which a chair of a meeting of shareholders is elected.
-14-



11.23Demand for Poll Not to Prevent Continuance of Meeting. The demand for a poll at a meeting of shareholders does not, unless the chair of the meeting so rules, prevent the continuation of a meeting for the transaction of any business other than the question on which a poll has been demanded.
11.24Retention of Ballots and Proxies. The Company or its agents must, for at least three months after a meeting of shareholders, keep each ballot cast on a poll and each proxy voted at the meeting, and, during that period, make them available for inspection during normal business hours by any shareholder or proxy holder entitled to vote at the meeting. At the end of such three-month period, the Company or its agents may destroy such ballots and proxies.
11.25Meeting by Telephone or Other Communications Medium. A shareholder or proxy holder may participate in a meeting of shareholders in person, by telephone or other communications medium if all shareholders or proxy holders participating in the meeting, whether in person, by telephone or other communications medium, are able to communicate with each other. A shareholder or proxy holder who participates in a meeting in a manner contemplated by this Article 11.25 is deemed, for all purposes of the Business Corporations Act and these Articles, to be present at the meeting.
ARTICLE 12
VOTES OF SHAREHOLDERS
12.1Number of Votes by Shareholder or by Shares. Subject to any special rights or restrictions attached to any shares and to the restrictions imposed on joint shareholders under Article 12.3:
(a)on a vote by show of hands, every person present who is a shareholder or proxy holder and entitled to vote on the matter has one vote; and
(b)on a poll, every shareholder entitled to vote on the matter has one vote in respect of each share entitled to be voted on the matter and held by that shareholder and may exercise that vote either in person or by proxy.
12.2Votes of Persons in Representative Capacity. A person who is not a shareholder may vote at a meeting of shareholders, whether on a show of hands or on a poll, and may appoint a proxy holder to act at the meeting, if, before doing so, the person satisfies the chair of the meeting, or the board, that the person is a legal personal representative or a trustee in bankruptcy for a shareholder who is entitled to vote at the meeting.
12.3Votes by Joint Holders. If there are joint shareholders registered in respect of any share:
(a)any one of the joint shareholders may vote at any meeting of shareholders, either personally or by proxy, in respect of the share as if that joint shareholder were solely entitled to it; or
-15-



(b)if more than one of the joint shareholders is present at any meeting of shareholders, personally or by proxy, and more than one of them votes in respect of that share, then only the vote of the joint shareholder present whose name stands first on the central securities register in respect of the share will be counted.
12.4Legal Personal Representatives as Joint Shareholders. Two or more legal personal representatives of a shareholder in whose sole name any share is registered are, for the purposes of Article 12.3, deemed to be joint shareholders.
12.5Representative of a Corporate Shareholder. If a corporation that is not a subsidiary of the Company is a shareholder, that corporation may appoint a person to act as its representative at any meeting of shareholders, and:
(a)for that purpose, the instrument appointing a representative must be received:
(i)at the registered office of the Company or at any other place specified in the notice calling the meeting for the receipt of proxies on the date that is at least the number of business days specified in the notice for the receipt of proxies or, if no number of days is specified, two business days, before the day set for the holding of the meeting; or
(ii)at the meeting by the chair of the meeting or to a person designated by the chair of the meeting;
(b)if a representative is appointed under this Article 12.5:
(i)the representative is entitled to exercise in respect of and at that meeting the same rights on behalf of the corporation that the representative represents as that corporation could exercise if it were a shareholder who is an individual, including, without limitation, the right to appoint a proxy holder; and
(ii)the representative, if present at the meeting, is to be counted for the purpose of forming a quorum and is deemed to be a shareholder present in person at the meeting.
Evidence of the appointment of any such representative may be sent to the Company or its transfer agent by written instrument or any other method of transmitting legibly recorded messages.
12.6When Proxy Provisions Do Not Apply to the Company. If and for so long as the Company is a public company, Articles 12.7 to 12.15 apply only insofar as they are not inconsistent with any Applicable Securities Laws or any rules of any exchange on which the securities of the Company are listed.
12.7Appointment of Proxy Holders. Every shareholder of the Company, including a corporation that is a shareholder but not a subsidiary of the Company, entitled to vote at a
-16-



meeting of shareholders may, by proxy, appoint one or more (but not more than five) proxy holders to attend and act at the meeting in the manner, to the extent and with the powers conferred by the proxy.
12.8Alternate Proxy Holders. A shareholder may appoint one or more alternate proxy holders to act in the place of an absent proxy holder.
12.9When Proxy Holder Need Not Be Shareholder. A person must not be appointed as a proxy holder unless the person is a shareholder, although a person who is not a shareholder may be appointed as a proxy holder if:
(a)the person appointing the proxy holder is a corporation or a representative of a corporation appointed under Article 12.5;
(b)the Company has at the time of the meeting of shareholders for which the proxy holder is to be appointed only one shareholder entitled to vote at the meeting;
(c)the shareholders present in person or by proxy at and entitled to vote at the meeting for which the proxy holder is to be appointed, by a resolution on which the proxy holder is not entitled to vote but in respect of which the proxy holder is to be counted in the quorum, permit the proxy holder to attend and vote at the meeting;
(d)the Company is a public company; or
(e)if approved by the board, the person is a director or officer of the Company.
12.10Deposit of Proxy. A proxy for a meeting of shareholders must:
(a)be received at the registered office of the Company or at any other place specified in the notice calling the meeting for the receipt of proxies on the date that is at least the number of business days specified in the notice, or, if no number of days is specified, two business days, before the day set for the holding of the meeting; or
(b)unless the notice provides otherwise, be provided at the meeting to the chair of the meeting or to a person designated by the chair of the meeting.
12.11Validity of Proxy Vote. A vote given in accordance with the terms of a proxy is valid notwithstanding the death or incapacity of the shareholder giving the proxy and despite the revocation of the proxy or the revocation of the authority under which the proxy is given, unless notice in writing of that death, incapacity or revocation is received:
(a)at the registered office of the Company at any time up to and including the date that is at least the number of business days specified in the notice calling the meeting of shareholders at which the proxy is to be used, or, if no number of days
-17-



is specified, two business days, before the day set for the holding of such meeting; or
(b)by the chair of the meeting, before any vote in respect of which the proxy has been given has been taken.
12.12Form of Proxy. A proxy, whether for a specified meeting of shareholders or otherwise, must be in such form as is approved by the board or the chair of the meeting.
12.13Revocation of Proxy. Subject to Article 12.14, every proxy may be revoked by an instrument in writing that is received:
(a)at the registered office of the Company at any time up to and including the date that is at least the number of business days specified in the notice calling the meeting of shareholders at which the proxy is to be used, or, if no number of days is specified, two business days before the day set for the holding of such meeting; or
(b)by the chair of the meeting, before any vote in respect of which the proxy has been given has been taken.
12.14Revocation of Proxy Must Be Signed. An instrument referred to in Article 12.13 must be signed as follows:
(a)if the shareholder for whom the proxy holder is appointed is an individual, the instrument must be signed by the shareholder or his or her legal personal representative or trustee in bankruptcy;
(b)if the shareholder for whom the proxy holder is appointed is a corporation, the instrument must be signed by the corporation or by a representative appointed for the corporation under Article 12.5.
12.15Production of Evidence of Authority to Vote. The board or the chair of any meeting of shareholders may, but need not, inquire into the authority of any person to vote at the meeting and may, but need not, demand from that person production of evidence as to the existence of the authority to vote.
ARTICLE 13
DIRECTORS
13.1First Directors; Number of Directors. The first directors are the persons designated as directors of the Company in the Notice of Articles that applies to the Company when it is recognized under the Business Corporations Act. The number of directors, excluding additional directors appointed under Article 14.8, is set at:
(a)subject to paragraphs (b) and (c), the number of directors that is equal to the number of the Company’s first directors;
-18-



(b)if the Company is a public company, the greater of three and the number of directors most recently set either:
(i)by ordinary resolution (whether or not previous notice of the resolution was given); or
(ii)under Article 14.4;
(c)if the Company is not a public company, the number of directors most recently set either:
(i)by ordinary resolution (whether or not previous notice of the resolution was given); or
(ii)under Article 14.4.
13.2Change in Number of Directors. If the number of directors is set under Articles 13.1(b)(i) or 13.1(c)(i):
(a)the shareholders may elect or appoint the directors needed to fill any vacancies in the board up to that number; or
(b)the board, subject to Article 14.8, may appoint, or the shareholders may elect or appoint, directors to fill those vacancies.
13.3Directors’ Acts Valid Despite Vacancy. An act or proceeding of the board is not invalid merely because fewer than the number of directors set or otherwise required under these Articles is in office.
13.4Qualifications of Directors. A director is not required to hold a share of the Company as qualification for his or her office but must be qualified as required by the Business Corporations Act to become, act or continue to act as a director.
13.5Remuneration of Directors. The directors are entitled to the remuneration for acting as directors, if any, as the board may from time to time determine. That remuneration may (only to the extent permitted by any applicable policies adopted by the board or any duly authorized committee thereof) be in addition to any salary or other remuneration paid to any officer or employee of the Company as such, who is also a director.
13.6Reimbursement of Expenses of Directors. The Company may reimburse each director for the reasonable expenses that he or she may incur in and about the business of the Company.
13.7Special Remuneration for Directors. If any director performs any professional or other services for the Company that in the opinion of the board are outside the ordinary duties of a director, or if any director is otherwise specially occupied in or about the Company’s business, he or she may be paid remuneration fixed by the board (but only to the extent
-19-



permitted by any applicable policies adopted by the board or any duly authorized committee thereof, including but not limited to any policy of the Company applicable to related party transactions), and such remuneration may be either in addition to, or in substitution for, any other remuneration that he or she may be entitled to receive.
ARTICLE 14
ELECTION AND REMOVAL OF DIRECTORS
14.1Election at Annual General Meeting. Subject to Article 15, at every annual general meeting and in every unanimous resolution contemplated by Article 10.2:
(a)the shareholders entitled to vote at the annual general meeting for the election of directors must elect, or by unanimous resolution appoint, a board consisting of the number of directors that has then been set under these Articles; and
(b)all the directors cease to hold office immediately before the election or appointment of directors under paragraph (a), but are eligible for re-election or re-appointment.
14.2Consent to be a Director. No election, appointment or designation of an individual as a director is valid unless:
(a)that individual consents to be a director in the manner provided for in the Business Corporations Act;
(b)that individual is elected or appointed at a meeting of shareholders at which the individual is present and the individual does not refuse, at the meeting, to be a director; or
(c)with respect to first directors, the designation is otherwise valid under the Business Corporations Act.
14.3Failure to Elect or Appoint Directors. If:
(a)the Company fails to hold an annual general meeting, and all the shareholders who are entitled to vote at an annual general meeting fail to pass the unanimous resolution contemplated by Article 10.2, on or before the date by which the annual general meeting is required to be held under the Business Corporations Act; or
(b)the shareholders fail, at the annual general meeting or in the unanimous resolution contemplated by Article 10.2, to elect or appoint any directors;
then each director then in office continues to hold office until the earlier of:
(a)the date on which his or her successor is elected or appointed; and
-20-



(b)the date on which he or she otherwise ceases to hold office under the Business Corporations Act or these Articles.
14.4Places of Retiring Directors Not Filled. If, at any meeting of shareholders at which there should be an election of directors, the places of any of the retiring directors are not filled by that election, those retiring directors who are not re-elected and who are asked by the newly elected directors to continue in office will, if willing to do so, continue in office to complete the number of directors that has then been set pursuant to these Articles until further new directors are elected at a meeting of shareholders convened for that purpose. If any such election or continuance of directors does not result in the election or continuance of the number of directors that has then been set pursuant to these Articles, the number of directors is deemed to be set at the number of directors actually elected or continued in office.
14.5Directors May Fill Casual Vacancies. Any casual vacancy occurring in the board may be filled by the board.
14.6Remaining Directors Power to Act. The board may act notwithstanding any vacancy in the board, but if the Company has fewer directors in office than the number set pursuant to these Articles as the quorum of directors, the board may only act for the purpose of appointing directors up to that number or of summoning a meeting of shareholders for the purpose of filling any vacancies on the board or, subject to the Business Corporations Act, for any other purpose.
14.7Shareholders May Fill Vacancies. Subject to Article 15, if the Company has no directors or fewer directors in office than the number set pursuant to these Articles as the quorum of directors, the shareholders may elect or appoint directors to fill any vacancies on the board.
14.8Additional Directors. Subject to Article 15 and notwithstanding Articles 13.1 and 13.2, between annual general meetings or unanimous resolutions contemplated by Article 10.2, the board may appoint one or more additional directors, but the number of additional directors appointed under this Article 14.8 must not at any time exceed:
(a)one-third of the number of first directors, if, at the time of the appointments, one or more of the first directors have not yet completed their first term of office; or
(b)in any other case, one-third of the number of the current directors who were elected or appointed as directors other than under this Article 14.8.
Any director so appointed ceases to hold office immediately before the next election or appointment of directors under Article 14.1(a), but is eligible for re-election or re-appointment.
14.9Ceasing to be a Director. A director ceases to be a director when:
-21-



(a)the term of office of the director expires;
(b)the director dies;
(c)the director resigns as a director by notice in writing provided in the manner required by the Business Corporations Act; or
(d)the director is removed from office pursuant to Articles 14.10 or 14.11.
14.10Removal of Director by Shareholders. The Company may remove any director before the expiration of his or her term of office by ordinary resolution. In that event, the shareholders may elect, or appoint by ordinary resolution, a director to fill the resulting vacancy, subject to Article 15. If the shareholders do not elect or appoint a director to fill the resulting vacancy contemporaneously with the removal, then the board may appoint or the shareholders may elect, or appoint by ordinary resolution, a director to fill that vacancy.
14.11Removal of Director by Directors. The board may remove any director before the expiration of his or her term of office if the director is indicted or convicted in a court of law for, or upon the entering by such director of a plea of guilty or nolo contendere to, (x) a felony offense under U.S. state or federal law, an indictable offence under the Criminal Code (Canada) or a comparable offence under the law of any other jurisdiction, or (y) any crime involving moral turpitude, fraud, dishonesty, bribery or theft or if the director ceases to be qualified to act as a director of a company in accordance with the Business Corporations Act and does not promptly resign, and the board may appoint a director to fill the resulting vacancy.
ARTICLE 15
ADVANCE NOTICE FOR NOMINATION OF DIRECTORS
15.1Limitation on Nominations of Directors. Subject only to the Business Corporations Act, only individuals who are nominated in accordance with the procedures set out in this Article 15 and who, at the discretion of the board, satisfy the qualifications of a director as set out in the Business Corporations Act shall be eligible for election as directors.
15.2Nomination Procedures. Nominations of individuals for election to the board may be made at any annual Shareholders Meeting or at any special Shareholders Meeting if one of the purposes for which the special Shareholders Meeting was called was the election of directors. Such nominations may be made in the following manner:
(a)by or at the direction of the board, including pursuant to a notice of meeting, including, for clarity, any nominees of a shareholder who are proposed by the board for election in the notice of meeting, whether pursuant to an agreement with such shareholder or otherwise;
-22-



(b)by or at the direction or request of one or more shareholders pursuant to a proposal made in accordance with the provisions of the Business Corporations Act, or a requisition of meeting of shareholders made in accordance with the provisions of the Business Corporations Act; or
(c)by any person (a “Nominating Shareholder”):
(i)who, at the close of business on the date of the giving of the notice provided below in Article 15.3 and on the record date for notice of such meeting, is entered in the central securities register as a holder of one or more shares carrying the right to vote at such meeting or who beneficially owns shares that are entitled to be voted at such meeting; and
i.who complies with the notice procedures set forth below in this Article 15.3.
15.3Nominations by a Nominating Shareholder.
(a)In addition to any other applicable requirements, for a nomination to be made by a Nominating Shareholder, the Nominating Shareholder must have given timely notice thereof in proper written form to the secretary of the Company at the principal executive offices of the Company. To be timely, a Nominating Shareholder’s notice to the secretary of the Company must be made:
i.in the case of an annual Shareholders Meeting, not less than 30 nor more than 65 days prior to the date of the annual Shareholders Meeting; provided, however, that in the event that the annual Shareholders Meeting is to be held on a date that is less than 50 days after the date on which the first public announcement by the Company by press release (the “Notice Date”) of the date of the annual Shareholders Meeting was made, notice by the Nominating Shareholder may be made not later than the close of business on the 10th day following the Notice Date; and
ii.in the case of a special Shareholders Meeting (which is not also an annual Shareholders Meeting) called for the purpose of electing directors (whether or not called for other purposes), not later than the close of business on the 15th day following the day on which the first public announcement by the Company by press release of the date of the special Shareholders Meeting was made.
(b)In no event shall any adjournment or postponement of a Shareholder Meeting or the announcement thereof commence a new time period for the giving of a Nominating Shareholder’s notice as described above.
(c)To be in proper written form, a Nominating Shareholder’s notice to the secretary of the Company must set forth:
-23-



i.the identity of the Nominating Shareholder and the number of voting securities held by the Nominating Shareholder;
ii.if the Nominating Shareholder is not the beneficial owner of all of those voting securities, the identity of the beneficial owner and the number of voting securities beneficially owned by that beneficial owner;
iii.with respect to the Nominating Shareholder and, if applicable, any beneficial owner, the following:
(A)the class or series and number of any securities in the capital of the Company which are controlled, or over which control or direction is exercised, directly or indirectly, by the Nominating Shareholder or beneficial owner, and each person acting jointly or in concert with any of them (and for each such person any options or other rights to acquire shares in the capital of the Company, any derivatives or other securities, instruments or arrangements for which the price or value or delivery, payment or settlement obligations are derived from, referenced to, or based on any such shares, and any hedging transactions, short positions and borrowing or lending arrangements relating to such shares) as of the record date for the meeting of shareholders (if such date shall then have been made publicly available and shall have occurred) and as of the date of such notice;
(B)any proxy, contract, agreement, arrangement, understanding or relationship pursuant to which the Nominating Shareholder or beneficial owner has a right to vote any shares in the capital of the Company on the election of directors.
(C)in the case of a special Shareholders Meeting called for the purpose of electing directors, a statement as to whether the Nominating Shareholder or beneficial owner intends to send an information circular and form of proxy to any shareholders in connection with the individual’s nomination; and
(D)any other information relating to the Nominating Shareholder or beneficial owner that would be required to be disclosed in a dissident’s proxy circular or other filings to be made in connection with solicitations of proxies for election of directors pursuant to the Business Corporations Act and Applicable Securities Laws; and
(E)as to each individual whom the Nominating Shareholder proposes to nominate for election as a director:
-24-



(I)the name, age, business address and residential address of the individual;
(II)confirmation that the individual would consent to serve as a director if elected;
(III)the principal occupation or employment of the individual;
(IV)the class or series and number of securities in the capital of the Company which are beneficially owned, or over which control or direction is exercised, directly or indirectly, by such individual as of the record date for the Shareholders Meeting (if such date shall then have been made publicly available and shall have occurred) and as of the date of such notice; and
(V)any other information relating to the individual that would be required to be disclosed in a dissident’s proxy circular or other filings to be made in connection with solicitations of proxies for election of directors pursuant to the Business Corporations Act and Applicable Securities Laws.
(d)A Nominating Shareholder’s notice to the secretary of the Company must also state:
i.whether, in the opinion of the Nominating Shareholder and the proposed nominee, the proposed nominee would qualify to be an independent director under sections 5605(a)(2), 5605(c)(2) and 5605(d)(2) of the Nasdaq Listing Rules and the commentary relating thereto and Rule 10A-3(b) and Rule 10C-1(b) under the United States Securities Exchange Act of 1934, as amended, as well as any other applicable independence criterion of a stock exchange or regulatory authority that may be applicable to the Company; and
ii.whether, with respect to the Company, the proposed nominee has one or more of the relationships described in sections 5605(a)(2), 5605(c)(2) and 5605(d)(2) of the Nasdaq Listing Rules and the commentary relating thereto and Rule 10A-3(b) and Rule 10C-1(b) under the United States Securities Exchange Act of 1934, as amended, as well as any other applicable independence criterion of a stock exchange or regulatory authority that may be applicable to the Company.
(e)The Company may require any proposed director nominee to furnish such other information as may reasonably be required by the Company to determine the eligibility of such proposed director nominee to serve as an independent director or that could be material to a reasonable shareholder’s understanding of the independence, or lack thereof, of such proposed director nominee.
-25-



(f)In addition to the provisions of this Article 15, a Nominating Shareholder and any individual nominated by the Nominating Shareholder shall also comply with all of the applicable requirements of the Business Corporations Act, Applicable Securities Laws and applicable stock exchange rules regarding the matters set forth herein.
(g)Except as otherwise provided by the special rights or restrictions attached to the shares of any class or series of the Company, no individual shall be eligible for election as a director unless nominated in accordance with the provisions of this Article 15; provided, however, that nothing in this Article 15 shall be deemed to preclude discussion by a shareholder (as distinct from the nomination of directors) at a Shareholders Meeting of any matter in respect of which it would have been entitled to submit a proposal pursuant to the provisions of the Business Corporations Act. The chairperson of the meeting shall have the power and duty to determine whether a nomination was made in accordance with the procedures set forth in the foregoing provisions and, if any proposed nomination is not in compliance with such foregoing provisions, to declare that such defective nomination shall be disregarded. A duly appointed proxyholder of a Nominating Shareholder shall be entitled to nominate at a Shareholders Meeting the directors nominated by the Nominating Shareholder, provided that all of the requirements of this Article 15 have been satisfied. If the Nominating Shareholder or its duly appointed proxyholder does not attend at the Shareholders Meeting to present the nomination, the nomination shall be disregarded notwithstanding that proxies in respect of such nomination may have been received by the Company.
(h)In addition to the provisions of this Article 15, a Nominating Shareholder and any individual nominated by the Nominating Shareholder shall also comply with all of the applicable requirements of the Business Corporations Act, Applicable Securities Laws and applicable stock exchange rules regarding the matters set forth herein.
(i)Notwithstanding any other provision of this Article 15, notice given to the secretary of the Company may only be given by personal delivery, and shall be deemed to have been given and made only at the time it is served by personal delivery to the secretary of the Company at the address of the principal executive offices of the Company; provided that if such delivery is made on a day which is a not a business day or later than 5:00 p.m. (Toronto time) on a day which is a business day, then such delivery shall be deemed to have been made on the subsequent day that is a business day.
(j)Notwithstanding the foregoing, the board may, in its sole discretion, waive any requirement in this Article 15.
(k)For greater certainty, nothing in this Article 15 shall limit the right of the board to fill a vacancy among the directors in accordance with these Articles.
-26-



ARTICLE 16
DISCLOSURE OF INTEREST OF DIRECTORS
16.1Director Holding Other Office in the Company. A director may hold any office or place of profit with the Company, other than the office of auditor of the Company, in addition to his or her office of director for the period and on the terms (as to remuneration or otherwise) that the board may determine.
16.2No Disqualification. No director or intended director is disqualified by his or her office from contracting with the Company either with regard to the holding of any office or place of profit the director holds with the Company or as vendor, purchaser or otherwise, and no contract or transaction entered into by or on behalf of the Company in which a director is in any way interested is liable to be voided for that reason, in each case subject to the requirements of Applicable Securities Laws.
16.3Professional Services by Director or Officer. Subject to the Business Corporations Act and Applicable Securities Laws, a director or officer of the Company, or any person in which a director or officer has an interest, may act in a professional capacity for the Company, except as auditor of the Company, and subject to the requirements of Applicable Securities Laws, the director or officer or such person is entitled to remuneration for professional services as if that director or officer were not a director or officer.
16.4Director or Officer in Other Corporations. Subject to the requirements of Applicable Securities Laws, a director or officer of the Company may be or become a director, officer or employee of, or otherwise interested in, any person in which the Company may be interested as a shareholder or otherwise, and, subject to the Business Corporations Act and Applicable Securities Laws, the director or officer of the Company is not accountable to the Company for any remuneration or other benefits received by him or her as director, officer or employee of, or from his or her interest in, such other person.
ARTICLE 17
PROCEEDINGS OF DIRECTORS
17.1Meetings of Directors. The board may meet together for the conduct of business, adjourn and otherwise regulate their meetings as they think fit, and meetings of directors held at regular intervals may be held at the place, at the time and on the notice, if any, as the board may from time to time determine.
17.2Voting at Meetings. Questions arising at any meeting of directors are to be decided by a majority of votes and, in the case of an equality of votes, the chair of the meeting does not have a second or casting vote.
17.3Chair of Meetings. The following individual is entitled to preside as chair at a meeting of directors:
-27-



(a)the chair of the board, if any;
(b)the lead director of the board, if any;
(c)any other director chosen by the board if:
i.the chair of the board is not present at the meeting within 15 minutes after the time set for holding the meeting;
ii.the chair of the board is not willing to chair the meeting; or
iii.the chair of the board has advised the secretary of the Company, if any, or any other director, that he or she will not be present at the meeting.
17.4Meetings by Telephone or Other Communications Medium. A director may participate in a meeting of directors or of any committee of the board in person, by telephone, or by other communications medium if all directors participating in the meeting, whether in person or by telephone or other communications medium, are able to communicate with each other. A director who participates in a meeting in a manner contemplated by this Article 17.4 is deemed for all purposes of the Business Corporations Act and these Articles to be present at the meeting and to have agreed to participate in that manner.
17.5Calling of Meetings. The chair of the board or the lead director of the board may, and the secretary or an assistant secretary of the Company, if any, on the request of such chair of the board or the lead director of the board must, call a meeting of directors at any time.
17.6Notice of Meetings. Other than for meetings held at regular intervals as determined by the board pursuant to Article 17.1 or as provided in Article 17.7, upon reasonable notice of each meeting of directors specifying the place, day and time of that meeting must be given to each of the directors by any method set out in Article 23.1 or orally or by telephone.
17.7When Notice Not Required. It is not necessary to give notice of a meeting of directors to a director if:
(a)the meeting is to be held immediately following a meeting of shareholders at which that director was elected or appointed, or is the meeting of directors at which that director is appointed; or
(b)the director has waived notice of the meeting.
17.8Meeting Valid Despite Failure to Give Notice. The accidental omission to give notice of any meeting of directors to, or the non-receipt of any notice by, any director does not invalidate any proceedings at that meeting.
-28-



17.9Waiver of Notice of Meetings. Any director may send to the Company a document signed by him or her waiving notice of any past, present or future meeting or meetings of directors and may at any time withdraw that waiver with respect to meetings held after that withdrawal. After sending a waiver with respect to all future meetings and until that waiver is withdrawn, no notice of any meeting of directors need be given to such director and all meetings of directors so held are deemed not to be improperly called or constituted by reason of notice not having been given to such director.
Attendance of a director at a meeting of the board is a waiver of notice of the meeting, unless that director attends the meeting for the express purpose of objecting to the transaction of any business on the grounds that the meeting is not lawfully called.
17.10Quorum. The quorum necessary for the transaction of the business of the board is a majority of the number of directors in office or such greater number as the board may determine from time to time.
17.11Validity of Acts Where Appointment Defective. Subject to the Business Corporations Act, an act of a director or officer of the Company is not invalid merely because of an irregularity in the election or appointment or a defect in the qualification of that director or officer.
17.12Consent Resolutions in Writing. A resolution of the board or of any committee of the board consented to in writing by all of the directors entitled to vote on it, whether by signed document, fax, email or any other method of transmitting legibly recorded messages, is as valid and effective as if it had been passed at a meeting of directors or of the committee of the board duly called and held. Such resolution may be in two or more counterparts which together are deemed to constitute one resolution in writing. A resolution passed in that manner is effective on the date stated in the resolution or on the latest date stated on any counterpart. A resolution of the board or of any committee of the board passed in accordance with this Article 17.12 is deemed to be a proceeding at a meeting of the board or of the committee of the board and to be as valid and effective as if it had been passed at a meeting of directors or of the committee of the board that satisfies all the requirements of the Business Corporations Act and all the requirements of these Articles relating to meetings of directors or of a committee of the board.
ARTICLE 18
EXECUTIVE AND OTHER COMMITTEES
18.1Appointment and Powers of Committees. The board may, by resolution:
(a)appoint one or more committees consisting of the director or directors that they consider appropriate;
(b)delegate to a committee appointed under paragraph (a) any of the board’s powers, except:
-29-



i.the power to fill vacancies in the board;
ii.the power to remove a director or appoint additional directors;
iii.the power to change the membership of, or fill vacancies in, any committee of the board; and
iv.the power to appoint or remove officers of the Company appointed by the board; and
(c)make any delegation referred to in paragraph (b) subject to the conditions set out in the resolution or any subsequent directors’ resolution.
18.2Obligations of Committees. Any committee appointed under Article 18.1, in the exercise of the powers delegated to it, must:
(a)conform to any rules that may from time to time be imposed on it by the board; and
(b)report every act or thing done in exercise of those powers at such times as the board may require.
18.3Powers of Board. The board may, at any time, with respect to a committee appointed under Article 18.1:
(a)revoke or alter the authority given to the committee, or override a decision made by the committee, except as to acts done before such revocation, alteration or overriding;
(b)terminate the appointment of, or change the membership of, the committee; and
(c)fill vacancies in the committee.
18.4Committee Meetings. Subject to Article 18.2(a) and unless the board otherwise provides in the resolution appointing the committee or in any subsequent resolution, with respect to a committee appointed under Article 18.1:
(a)the committee may meet and adjourn as it thinks proper;
(b)the committee may elect a chair of its meetings but, if no chair of a meeting is elected, or if at a meeting the chair of the meeting is not present within 15 minutes after the time set for holding the meeting, the directors present who are members of the committee may choose one of their number to chair the meeting;
(c)a majority of the members of the committee constitutes a quorum of the committee; and
-30-



(d)questions arising at any meeting of the committee are determined by a majority of votes of the members present, and in the case of an equality of votes, the chair of the meeting does not have a second or casting vote.
ARTICLE 19
OFFICERS
19.1Directors May Appoint Officers. The board may, from time to time, appoint such officers, if any, as the board determines and the board may, at any time, terminate any such appointment.
19.2Functions, Duties and Powers of Officers. The board may for each officer:
(a)determine the functions and duties of the officer;
(b)delegate to the officer any of the powers exercisable by the board on such terms and conditions and with such restrictions as the board thinks fit; and
(c)revoke, withdraw, alter or vary all or any of the functions, duties and powers of the officer.
In the absence of such resolution, the respective officers shall have the powers and shall discharge the duties customarily and usually held and performed by like officers of companies similar in organization and business purposes to the Company, subject to the control of the board.
19.3Qualifications. No officer may be appointed unless that officer is qualified in accordance with the Business Corporations Act. One person may hold more than one position as an officer of the Company. Any person appointed as the chair of the board or as the managing director must be a director. Any other officer need not be a director.
19.4Remuneration and Terms of Appointment. All appointments of officers are to be made on the terms and conditions and at the remuneration (whether by way of salary, fee, commission, participation in profits or otherwise) that the board thinks fit and are subject to termination at the pleasure of the board, and an officer may in addition to such remuneration be entitled to receive, after he or she ceases to hold such office or leaves the employment of the Company, a pension or gratuity. An appointment as an officer does not create any rights of employment.
19.5Duties of Officers May be Delegated. In case any officer is absent or for any other reason that the board may deem sufficient, the Chief Executive Officer or the board may delegate for the time being the powers or duties of such officer to any other officer or to any director.
-31-



ARTICLE 20
INDEMNIFICATION
20.1Mandatory Indemnification of Directors and Officers. Subject to the Business Corporations Act, the Company must indemnify an eligible party (as defined in the Business Corporations Act) and his or her heirs and legal personal representatives against all eligible penalties (as defined in the Business Corporations Act) to which such person is or may be liable, and the Company must, after the final disposition of an eligible proceeding (as defined in the Business Corporations Act), pay the expenses (as defined in the Business Corporations Act) actually and reasonably incurred by such person in respect of that proceeding to the fullest extent permitted by the Business Corporations Act.
20.2Further Indemnification of Directors and Officers. In addition to the Company’s obligations under Article 20.1, and subject to the Business Corporations Act, the Company shall, except as provided in this Article 20.2, indemnify Indemnitees to the full extent permitted by law. Expenses reasonably incurred by an Indemnitee in defending any action, suit, or proceeding, as described in this Article 20.2, shall be paid or reimbursed by the Company promptly upon receipt by it of an undertaking of such Indemnitee to repay such Expenses if it shall ultimately be determined that he or she is not entitled to be indemnified by the Company. Indemnitee’s obligation to reimburse the Company shall be unsecured, and no interest shall be charged thereon. The Company shall not indemnify any Indemnitee or advance or reimburse any Indemnitee’s Expenses if the action, suit or proceeding alleges (1) claims under Section 16(b) of the United States Securities Exchange Act of 1934, as amended, (2) violations of the Company’s Code of Business Conduct and Ethics, Insider Trading Policy or Conflicts of Interest Policy or (3) violations of Canadian, United States or other applicable federal, provincial or state insider trading laws, unless, in each case, such Indemnitee has been successful on the merits, received the written consent to incurring the Expenses or settled the case with the written consent of the Company, in which case the Company shall indemnify and reimburse such Indemnitee.
No claim for indemnification under this Article 20.2 shall be paid by the Company unless the Company has determined that the relevant Indemnitee acted in good faith and in a manner the Indemnitee reasonably believed to be in or not opposed to the best interest of the Company and, with respect to any criminal action or proceeding, had no reasonable cause to believe that his or her conduct was unlawful. Unless ordered by a court, such determinations shall be made by (1) a majority vote of the directors who are not parties to the action, suit or proceeding for which indemnification is sought, even though less than a quorum, or (2) by a committee of such directors designated by a majority vote of directors, even though less than a quorum, or (3) if there are no such directors, or if such directors so direct, by independent legal counsel in a written opinion, or (4) by shareholders. An Indemnitee shall be presumed to have met the relevant standard, and, if the determination is not made by the Company within 30 days of a demand by such
-32-



Indemnitee for indemnification, such Indemnitee shall be deemed to have met such standard.
An Indemnitee shall promptly notify the Company in writing upon the sooner of (a) becoming aware of an action, suit or proceeding where indemnification or the advance payment or reimbursement of Expenses may be sought, or (b) being served with any summons, citation, subpoena, complaint, indictment, information or other document relating to any matter which may be subject to indemnification or the advance payment or reimbursement of Expenses covered by this Article 20.2. The failure of an Indemnitee to so notify the Company shall not relieve the Company of any obligation which it may have to such Indemnitee pursuant to this Article 20.2. No claim for indemnification or the advance payment or reimbursement of Expenses shall be made by an Indemnitee or paid by the Company unless the Indemnitee gives notice to the Company in writing of such claim for indemnification within two years after the Indemnitee received notice of the claim, action, suit or proceeding.
As a condition to indemnification or the advance payment or reimbursement of Expenses under this Article 20.2, any demand for payment by an Indemnitee under this Article 20.2 shall be in writing and shall provide reasonable accounting by such Indemnitee’s legal counsel for the Expenses to be paid by the Company.
For the purposes of this Article 20.2, the term “Indemnitee” shall mean any person made or threatened to be made a party, or otherwise involved in any civil, criminal, administrative or investigative action, suit or proceeding by reason of the fact that such person or such person’s testator or intestate is or was a director, officer, employee or agent of the Company or serves or served at the request of the Company any other enterprise as a director or officer; the term “Company” shall include any predecessor of the Company and any constituent corporation (including any constituent of a constituent) absorbed by the Company in an arrangement, amalgamation or similar transaction; the term “other enterprise” shall include any corporation, limited liability company, unlimited liability company, public limited company, partnership, limited partnership, joint venture, trust, employee benefit plan, fund or other enterprise; service “at the request of the Company” shall include service as a director or officer of the Company which imposes duties on, or involves services by, such director or officer with respect to an employee benefit plan, its participants or beneficiaries, provided, however that such request for service is in writing; and action by a person with respect to an employee benefit plan which such person reasonably believes to be in the interest of the participants and beneficiaries of such plan shall be deemed to be action not opposed to the best interests of the Company; the term “Expenses” shall include all reasonable out of pocket fees, costs and expenses, including without limitation, legal counsel fees, retainers, court costs, transcript costs, fees of experts, witness fees, travel expenses, duplicating costs, printing and binding costs, telephone charges, postage, delivery service fees, Employee Retirement Income Security Act of 1974 excise taxes or penalties assessed on an Indemnitee with respect to an employee benefit plan, Canadian or United States federal, provincial, state, local or foreign taxes imposed as a result of the actual or deemed receipt
-33-



of any payments under this Article 20.2, penalties and all other disbursements or expenses of the types customarily incurred in connection with defending, preparing to defend, or investigating an actual or threatened action, suit or proceeding (including Indemnitee’s counterclaims that directly respond to and negate the affirmative claim made against Indemnitee (“Permitted Counterclaims”) in such action, suit or proceeding, whether civil, criminal, administrative or investigative) but shall exclude the costs of any of an Indemnitee’s counterclaims, other than Permitted Counterclaims; and action, suit or proceeding shall be deemed to include the class action complaint filed in the Eastern District of New York by Donald Finch, individually and on behalf of all others similarly situated against the Company Michael Gorenstein and Jerry F. Barbato, Finch v. Cronos Group et al., 2:20-cv-01324-JMA-ST (E.D.N.Y. Mar. 12, 2020) (Dkt. No. 1),  and the class action complaint filed in the Eastern District of New York by Jill Witte, individually and on behalf of all others similarly situated against the Company, Michael Gorenstein and Jerry F. Barbato, Witte v. Cronos Group et al., 1:20-cv-01310-ENV-SIL (E.D.N.Y. Mar. 11, 2020) (Dkt. No. 1) (together, the “Existing Actions”), and with respect to the Existing Actions the officers and directors party thereto or subject thereto shall be deemed entitled to advancement of expenses and indemnification in accordance with this Article 20.2.
Any action, suit or proceeding regarding indemnification or advance payment or reimbursement of Expenses arising out of this Article 20.2 must be brought and heard in the Courts of the Province of Ontario. In the event of any payment under this Article 20.2, the Company shall be subrogated to the extent of such payment to all of the rights of recovery of the Indemnitee (under any insurance policy or otherwise), who shall execute all papers required and shall do everything necessary to secure such rights, including the execution of such documents necessary to enable the Company to effectively bring suit to enforce such rights. Except as required by law or as otherwise becomes public (other than as a result of a breach by an Indemnitee of such Indemnitee’s confidentiality obligation under this Article 20), any Indemnitee will keep confidential any information that arises in connection with this Article 20, including but not limited to, claims for indemnification or the advance payment or reimbursement of Expenses, amounts paid or payable hereunder and any communications between the parties. No amendment of these Articles shall impair the rights of any Indemnitee arising at any time with respect to events occurring prior to such amendment.
20.3Deemed Contract. Each eligible party (as defined in the Business Corporations Act) and each Indemnitee (as defined in Article 20.2) is deemed to have contracted with the Company on the terms of the indemnity contained in this Article 20.
20.4Indemnification of Other Persons. Subject to any restrictions in the Business Corporations Act, the Company may indemnify any person to the extent permitted by applicable law.
-34-



20.5Non-Compliance with Business Corporations Act. The failure of a director or officer of the Company to comply with the Business Corporations Act or these Articles does not invalidate any indemnity to which he or she is entitled under this Article 20.
20.6Company May Purchase Insurance. The Company may purchase and maintain insurance for the benefit of any person (or his or her heirs or legal personal representatives) who:
(a)is or was a director or officer of the Company;
(b)is or was a director or officer of a corporation at a time when the corporation is or was an affiliate of the Company;
(c)at the request of the Company, is or was a director or officer of a corporation or of a partnership, trust, joint venture or other unincorporated entity;
(d)at the request of the Company, holds or held a position equivalent to that of a director or officer of a partnership, trust, joint venture or other unincorporated entity;
against any liability incurred by him or her as such director or officer or person who holds or held such equivalent position.
ARTICLE 21
DIVIDENDS
21.1Payment of Dividends Subject to Special Rights. The provisions of this Article 21 are subject to the rights, if any, of shareholders holding shares with special rights as to dividends.
21.2Declaration of Dividends. Subject to the Business Corporations Act and the rights of the holders of issued shares of the Company, the board may from time to time declare and authorize payment of such dividends as they may consider appropriate.
21.3No Notice Required. The board need not give notice to any shareholder of any declaration under Article 21.2.
21.4Record Date. The board may set a date as the record date for the purpose of determining shareholders entitled to receive payment of a dividend. The record date must not precede the date on which the dividend is to be paid by more than two months. If no record date is set, the record date is 5 p.m. (Toronto time) on the date on which the board passes the resolution declaring the dividend.
21.5Manner of Paying Dividend. A resolution declaring a dividend may direct payment of the dividend wholly or partly by the distribution of specific assets or of fully paid shares or of bonds, debentures or other securities of the Company, or in any one or more of those ways.
-35-



21.6Settlement of Difficulties. If any difficulty arises in regard to a distribution under Article 21.5, the board may settle the difficulty as they deem advisable, and, in particular, may:
(a)set the value for distribution of specific assets;
(b)determine that cash payments in substitution for all or any part of the specific assets to which any shareholders are entitled may be made to any shareholders on the basis of the value so fixed in order to adjust the rights of all parties; and
(c)vest any such specific assets in trustees for the persons entitled to the dividend.
21.7When Dividend Payable. Any dividend declared by the board may be made payable on such date as is fixed by the board.
21.8Dividends to be Paid in Accordance with Number of Shares. All dividends on shares of any class or series of shares must be declared and paid according to the number of such shares held.
21.9Receipt by Joint Shareholders. If several persons are joint shareholders of any share, any one of them may give an effective receipt for any dividend, bonus or other money payable in respect of the share.
21.10Dividend Bears No Interest. No dividend bears interest against the Company.
21.11Fractional Dividends. If a dividend to which a shareholder is entitled includes a fraction of the smallest monetary unit of the currency of the dividend, that fraction may be disregarded in making payment of the dividend and that payment represents full payment of the dividend.
21.12Payment of Dividends. Any dividend or other distribution payable in money in respect of shares may be paid by cheque, made payable to the order of the person to whom it is sent, and mailed to the registered address of the shareholder, or in the case of joint shareholders, to the registered address of the joint shareholder who is first named on the central securities register, or to the person and to the address the shareholder or joint shareholders may direct in writing or by electronic transfer, if so authorized by the shareholder. The mailing of such cheque or the forwarding by electronic transfer will, to the extent of the sum represented by the cheque (plus the amount of the tax required by law to be deducted), discharge all liability for the dividend unless such cheque is not paid on presentation or the amount of tax so deducted is not paid to the appropriate taxing authority.
21.13Capitalization of Retained Earnings or Surplus. Notwithstanding anything contained in these Articles, the board may from time to time capitalize any retained earnings or surplus of the Company and may from time to time issue, as fully paid, shares or any
-36-



bonds, debentures or other securities of the Company as a dividend representing the retained earnings or surplus or any part thereof.
ARTICLE 22
DOCUMENTS, RECORDS AND REPORTS
22.1Recording of Financial Affairs. The board must cause adequate accounting records to be kept to properly record the financial affairs and condition of the Company and to comply with the Business Corporations Act.
ARTICLE 23
NOTICES
23.1Method of Giving Notice. Unless the Business Corporations Act or these Articles provide otherwise, a notice, statement, report or other record required or permitted by the Business Corporations Act or these Articles to be sent by or to a person may be sent by any one of the following methods:
(a)mail addressed to the person at the applicable address for that person as follows:
i.for a record mailed to a shareholder, the shareholder’s registered address;
ii.for a record mailed to a director or officer, the prescribed address for mailing shown for the director or officer in the records kept by the Company or the mailing address provided by the recipient for the sending of that record or records of that class;
iii.in any other case, the mailing address of the intended recipient;
(b)delivery at the applicable address for that person as follows, addressed to the person:
i.for a record delivered to a shareholder, the shareholder’s registered address;
ii.for a record delivered to a director or officer, the prescribed address for delivery shown for the director or officer in the records kept by the Company or the delivery address provided by the recipient for the sending of that record or records of that class;
iii.in any other case, the delivery address of the intended recipient;
(c)unless the intended recipient is the Company or the auditor of the Company, sending the record by fax to the fax number provided by the intended recipient for the sending of that record or records of that class;
-37-



(d)unless the intended recipient is the auditor of the Company, sending the record by email to the email address provided by the intended recipient for the sending of that record or records of that class;
(e)physical delivery to the intended recipient;
(f)creating and providing a record posted on or made available through an electronic source that is generally accessible by the intended recipient and providing written notice by and of the foregoing methods as to the availability of such record; or
(g)as otherwise permitted by any Applicable Securities Laws.
23.2Deemed Receipt of Mailing. A notice, statement, report or other record that is:
(a)mailed to a person by ordinary mail to the applicable address for that person referred to in Article 23.1 is deemed to be received by the person to whom it was mailed on the day, Saturdays, Sundays and holidays excepted, following the date of mailing.
(b)faxed to a person to the fax number provided by that person referred to in Article 23.1 is deemed to be received by the person to whom it was faxed on the day it was faxed;
(c)emailed to a person to the email address provided by that person referred to in Article 23.1 is deemed to be received by the person to whom it was emailed on the day it was emailed; and
(d)delivered in accordance with Article 23.1(f), is deemed to be received by the person on the day such written notice is sent.
23.3Certificate of Sending. A certificate signed by the secretary of the Company, if any, or other officer of the Company or of any other corporation acting in that capacity on behalf of the Company stating that a notice, statement, report or other record was sent in accordance with Article 23.1 is conclusive evidence of that fact.
23.4Notice to Joint Shareholders. A notice, statement, report or other record may be provided by the Company to the joint shareholders of a share by providing such record to the joint shareholder first named in the central securities register in respect of the share.
23.5Notice to Legal Personal Representatives Trustees. A notice, statement, report or other record may be provided by the Company to the persons entitled to a share as a consequence of the death, bankruptcy or incapacity of a shareholder by:
(a)mailing the record, addressed to them:
-38-



i.by name, by the title of the legal personal representative of the deceased or incapacitated shareholder, by the title of trustee of the bankrupt shareholder or by any similar description; and
ii.at the address, if any, supplied to the Company for that purpose by the persons claiming to be so entitled; or
(b)if an address referred to in paragraph (a)(ii) has not been supplied to the Company, by giving the notice in a manner in which it might have been given if the death, bankruptcy or incapacity had not occurred.
ARTICLE 24
EXECUTION OF DOCUMENTS
24.1Execution of Documents Generally. The board may from time to time by resolution authorize any one or more persons, directors or officers of the Company for the purpose of executing, or delegating authority (with such limitations or restrictions on such authority as he or she deems appropriate) to execute, any instrument or document in the name of and on behalf of the Company (for which no seal need be affixed), and if no such person, director or officer is appointed, then any one officer or director may execute (or so delegate authority to execute) such instrument or document.
ARTICLE 25
PROHIBITIONS
25.1Definitions. In this Article 25:
(a)transfer restricted security” means:
i.a share of the Company;
ii.a security of the Company that is convertible into shares of the Company; or
iii.any other security of the Company which must be subject to restrictions on transfer in order for the Company to satisfy the requirement for restrictions on transfer under the “private issuer” exemption of Canadian securities legislation or under any other exemption from prospectus or registration requirements of Canadian securities legislation similar in scope and purpose to the “private issuer” exemption.
(b)security” has the meaning assigned in the Securities Act (British Columbia).
25.2Application. Article 25.3 does not apply to the Company if and for so long as it is a public company.
-39-



25.3Consent Required for Transfer of Transfer Restricted Securities. No share or other transfer restricted security may be sold, transferred or otherwise disposed of without the consent of the board and the board is not required to give any reason for refusing to consent to any such sale, transfer or other disposition.
ARTICLE 26
GENERAL PROVISIONS
26.1Information Available to Shareholders.
(a.)Except as provided by the Business Corporations Act, no shareholder shall be entitled to discovery of any information respecting any details or conduct of the Company’s business which in the opinion of the board it would be inexpedient in the interests of the Company to communicate to the public.
(b.)The board may from time to time, subject to rights conferred by the Business Corporations Act, determine whether and to what extent and at what time and place and under what conditions or regulations the documents, books and registers and accounting records of the Company or any of them shall be open to the inspection of shareholders and no shareholder shall have any right to inspect any document or book or register or accounting record of the Company except as conferred statute or authorized by the board or by a resolution of the shareholders.
[signature page follows]

-40-



The Company has as its articles these articles.
Full name and signature of a directorDate of signing
(signed) “Michael Gorenstein
July 9, 2020
Director
-41-

EX-10.1 3 ex101omnibusplan1.htm EX-10.1 Document

Exhibit 10.1
CRONOS GROUP INC.
2020 OMNIBUS EQUITY INCENTIVE PLAN
ARTICLE I
GENERAL
1.1 Purpose
The purpose of the Cronos Group Inc. 2020 Omnibus Equity Incentive Plan (as amended from time to time, the “Plan”) is to help Cronos Group Inc., a corporation formed under the Business Corporations Act (Ontario) (“Cronos”): (1) attract, retain and motivate key employees (including prospective employees), non-employee directors and consultants; (2) align the interests of such persons with Cronos’ shareholders; and (3) promote ownership of Cronos’ equity. This Plan shall be effective for Awards granted effective on or after the Effective Date. Beginning on the Effective Date, no new awards shall be granted or awarded under the 2018 Amended and Restated Stock Option Plan or the 2015 Amended and Restated Stock Option Plan (together, the “Option Plans”) and the Cronos Group Inc. Employment Inducement Award Plan #1 (the “Employment Inducement Award Plan”). Awards granted under the Option Plans and the Employment Inducement Award Plan prior to the Effective Date shall remain outstanding under such plans in accordance with their terms and this Plan shall not affect the terms or conditions of any such award.
1.2 Definitions of Certain Terms
For purposes of this Plan, the following terms have the meanings set forth below:
1.2.1 “Acquisition Awards” has the meaning set forth in Section 1.6.1.
1.2.2 “Award” means an award made pursuant to the Plan.
1.2.3 “Award Agreement” means the written document by which each Award is evidenced, and which may, but need not be (as determined by the Committee), executed or acknowledged by a Grantee as a condition to receiving an Award or the benefits under an Award, and which sets forth the terms and provisions applicable to Awards granted under the Plan to such Grantee. Any reference herein to an agreement in writing shall be deemed to include an electronic writing to the extent permitted by applicable law.
1.2.4 “Board” means the Board of Directors of Cronos.

1.2.5 “Certificate” means a stock certificate or other appropriate document or evidence of ownership representing Common Shares.
1.2.6 “Change of Control” means:
(a) the consummation of any transaction or series of transactions, including any reorganization, recapitalization, statutory share exchange, consolidation, amalgamation, arrangement, merger or issue of voting shares in the capital of Cronos, the result of which is that any individual, corporation (including not-for-profit), general or limited partnership, limited liability company, joint venture, association, joint-stock company, estate, trust, organization, governmental authority or other entity of any kind or nature (“Person”), or group of Persons acting jointly or in concert for purposes of such transaction or series of transactions, becomes the beneficial owner, directly or indirectly, of more than 50% of the voting securities in the capital of the entity resulting from such transaction or series of transactions or the entity that acquired all or substantially all of the business or assets of Cronos in a transaction or series of transactions described in paragraph (b) below (in each case, the “Surviving Company”) or the ultimate parent entity that has beneficial ownership of sufficient voting power to elect a majority of the board of directors (or analogous governing body) of the Surviving Company (the “Parent Company”), measured by voting power of the outstanding voting securities eligible to elect members of the board of directors (or the analogous governing body) of the Parent Company (or, if there is no Parent Company, the Surviving Company) rather than the number of securities (but shall not include the creation of a holding company or other transaction that does not involve any substantial change in the proportion of direct or indirect beneficial ownership of the voting securities of Cronos prior to the consummation of the transaction or series of transactions); provided that the exercise
-1-



by Altria Summit LLC (or any of its affiliates as of the Effective Date) of the Purchased Warrant (as defined in the Subscription Agreement, by and among the Company, Altria Summit LLC and Altria Group, Inc., dated as of December 7, 2018) shall not constitute a Change of Control pursuant to this clause (a); provided further that in the event of a change of control of Altria Summit LLC, the Board has discretion to determine whether such change of control constitutes a Change of Control pursuant to this clause (a);
(b) the direct or indirect sale, transfer or other disposition, in one or a series of transactions, of all or substantially all of the business or assets of Cronos, taken as a whole, to any Person or group of Persons acting jointly or in concert for purposes of such transaction or series of transactions (other than to any affiliates of Cronos); or
(c) Incumbent Directors during any consecutive twelve (12) month period ceasing to constitute a majority of the Board (for the purposes of this paragraph, an “Incumbent Director” shall mean any member of the Board who is a member of the Board immediately prior to the occurrence of a contested election of directors of Cronos or any person becoming a director whose election or nomination for election was approved by a vote of at least two thirds of the Incumbent Directors then on the Board (either by a specific vote or by approval of the proxy statement of Cronos in which such person is named as a nominee for director, without written objection to such nomination)).
1.2.7 “Code” means the Internal Revenue Code of 1986, as amended from time to time, or any successor thereto, and the applicable rulings and regulations thereunder.
1.2.8 “Committee” has the meaning set forth in Section 1.3.1.
1.2.9 “Common Shares” means the common shares in the capital of Cronos, no par value per share, and any other securities or property issued in exchange therefor or in lieu thereof pursuant to Section 1.6.3.
1.2.10 “Company” means Cronos and any Subsidiary, and any successor entity thereto.
1.2.11 “Consent” has the meaning set forth in Section 3.3.2.
1.2.12 “Consultant” means any individual (other than a non-employee Director), corporation, partnership, limited liability company or other entity that provides bona fide consulting or advisory services to the Company.
1.2.13 “Covered Person” has the meaning set forth in Section 1.3.4.
1.2.14 “Cronos” has the meaning set forth in Section 1.1.
1.2.15 “Director” means a member of the Board.
1.2.16 “Disability” means a physical or mental incapacity of the Grantee that has prevented the Grantee from performing the duties, with any accommodation required by applicable law, customarily assigned to the Grantee for 180 calendar days, whether or not consecutive, out of any twelve (12) consecutive months and that in the opinion of the Company, acting on the basis of advice from a duly qualified medical practitioner, is likely to continue to a similar degree.
1.2.17 “Effective Date” has the meaning set forth in Section 3.24.
1.2.18 “Employee” means a regular employee of the Company, but does not include a non-employee Director.
1.2.19 “Employment” means a Grantee’s performance of services for the Company, as determined by the Committee. The terms “employ” and “employed” shall have their correlative meanings. Unless otherwise addressed in a Grantee’s employment or similar agreement with the Company, and subject to the requirements of applicable law, the Committee in its sole discretion may determine (a) whether and when a Grantee’s leave of absence results in a termination of Employment, (b) whether and when a change in a Grantee’s association with the Company results in a termination of Employment and (c) the impact, if any, of any such leave of absence or change in association on outstanding Awards. Unless expressly provided otherwise, any references in the Plan or any Award Agreement to a Grantee’s Employment being terminated shall include both voluntary and involuntary terminations, and the involuntary termination of a Grantee’s Employment shall occur on the date that the Grantee ceases performing services for the Company on a permanent basis, whether such termination is lawful or otherwise, without regard to any required period of notice, pay in lieu of notice,
-2-



severance pay or similar compensation or benefits (and without regard for any claim for damages in respect thereof), except as expressly required by applicable employment or labour standards legislation. Notwithstanding the foregoing, with respect to any Award subject to Section 409A (and not exempt therefrom), a Grantee’s termination of Employment means a Grantee’s “separation from service” (as such term is defined and used in Section 409A).
1.2.20 “Employment Inducement Award Plan” has the meaning set forth in Section 1.1.
1.2.21 “Exchange” means the Toronto Stock Exchange, the NASDAQ Global Market or any other stock exchange on which the Common Shares are listed and posted for trading or quoted.
1.2.22 “Exchange Act” means the Securities Exchange Act of 1934, as amended from time to time, or any successor thereto, and the applicable rules and regulations thereunder.
1.2.23 “Fair Market Value” means, with respect to a particular date, (a) if the Common Shares are traded on one or more Exchanges, the closing price of a Common Share as reported by any one such Exchange (as selected by the Committee in good faith, taking into account applicable legal and tax requirements) on the immediately preceding trading day, and (b) if the Common Shares are not traded on an Exchange, the value of a Common Share as determined by the Committee in good faith, taking into account applicable legal and tax requirements and any valuation performed by a third party valuation expert, in accordance with Section 409A of Code or in the case of Incentive Stock Options Section 422 of the Code, as applicable.
1.2.24 “Grantee” means an Employee, Director or Consultant who receives an Award.
1.2.25 “Incentive Stock Option” means a Stock Option to purchase Common Shares that is intended to be an “incentive stock option” within the meaning of Sections 421 and 422 of the Code, as now constituted or subsequently amended, or pursuant to a successor provision of the Code, and which is designated as an Incentive Stock Option in the applicable Award Agreement.
1.2.26 “Incumbent Directors” has the meaning provided in the definition of Change of Control.
1.2.27 “Just Cause” means: (a) with respect to a Grantee employed pursuant to a written employment agreement which agreement includes a definition of “Just Cause” or “Cause”, “Just Cause” or “Cause” as defined in that agreement or (b) with respect to any other Grantee, the occurrence of any of the following: (i) any act or omission by such Grantee that constitutes “just cause” or “cause” under applicable law (including applicable common law); (ii) such Grantee’s repeated failure or refusal to perform his or her principal duties and responsibilities after notice from his or her manager or other officer of the Company; (iii) misappropriation of the funds or property of the Company; (iv) use of alcohol or drugs in violation of the Company’s policies on such use or interfering with his or her obligations to the Company, continuing after a single warning (subject to the Company’s obligations under applicable law); (v) the indictment, arrest or conviction in a court of law for, or the entering of a plea of guilty to, a summary or indictable offense or any crime involving moral turpitude, fraud, dishonesty or theft (subject to the Company’s obligations under applicable law); (vi) the misuse of Company computers or computer network systems for non-Company business; (vii) engaging in any act (including without restriction, an act of sexual or other harassment as determined by the Company) which is a violation of any law, regulation or Company policy; or (viii) any willful or intentional act which injures or could reasonably be expected to injure the reputation, business or business relationships of the Company.
1.2.28 “Option Plans” has the meaning set forth in Section 1.1.
1.2.29 “Other Stock-Based or Cash-Based Awards” has the meaning set forth in Section 2.8.
1.2.30 “Plan” has the meaning set forth in Section 1.1.
1.2.31 “Plan Action” has the meaning set forth in Section 3.3.1.
1.2.32 “Restricted Shares” has the meaning set forth in Section 2.5.1.
1.2.33 “Restricted Share Units” has the meaning set forth in Section 2.6.
-3-



1.2.34 “Section 409A” means Section 409A of the Code, including any amendments or successor provisions to that section, and any regulations and other administrative guidance thereunder, in each case as they may be from time to time amended or interpreted through further administrative guidance.
1.2.35 “Securities Act” means the Securities Act of 1933, as amended from time to time, or any successor thereto, and the applicable rules and regulations thereunder.
1.2.36 “Share Appreciation Rights” has the meaning set forth in Section 2.4.1.
1.2.37 “Share Limit” has the meaning set forth in Section 1.6.1.
1.2.38 “Stock Options” has the meaning set forth in Section 2.3.1.
1.2.39 “Subsidiary” means any corporation, partnership, limited liability company or other legal entity in which Cronos, directly or indirectly, owns shares or other equity interests possessing more than 50% of the total combined voting power of all classes of the then-outstanding shares or other equity interests.
1.2.40 “Ten Percent Shareholder” means a person owning shares possessing more than 10% of the total combined voting power of all classes of shares of Cronos and of any Subsidiary or parent corporation of Cronos.
1.2.41 “Treasury Regulations” means the regulations promulgated under the Code by the United States Treasury Department, as amended.
1.3 Administration
1.3.1 The Compensation Committee of the Board (as constituted from time to time, and including any successor committee, the “Committee”) shall administer the Plan, unless a different committee is appointed by the Board. In particular, the Committee shall have the authority, in its sole discretion, to:
(a) exercise all of the powers granted to it under the Plan;
(b) construe, interpret and implement the Plan and all Award Agreements;
(c) prescribe, amend and rescind rules and regulations relating to the Plan, including rules governing the Committee’s own operations;
(d) make all determinations necessary or advisable in administering the Plan;
(e) correct any defect, supply any omission and reconcile any inconsistency in the Plan;
(f) amend the Plan to reflect changes in applicable law;
(g) grant, or recommend to the Board for approval to grant, Awards and determine who shall receive Awards, when such Awards shall be granted and the terms of such Awards, including setting forth provisions with regard to the effect of a termination of Employment on such Awards and conditioning the vesting of, or the lapsing of any applicable vesting restrictions or other vesting conditions on, Awards upon the attainment of performance goals and/or upon continued service;
(h) amend any outstanding Award Agreement in any respect, including, without limitation, to
(1) accelerate the time or times at which the Award becomes vested, unrestricted or may be exercised (and, in connection with such acceleration, the Committee may provide that any Common Shares acquired pursuant to such Award shall be Restricted Shares, which are subject to vesting, transfer, forfeiture or repayment provisions similar to those in the Grantee’s underlying Award);
-4-



(2) accelerate the time or times at which Common Shares are delivered under the Award (and, without limitation on the Committee’s rights, in connection with such acceleration, the Committee may provide that any Common Shares delivered pursuant to such Award shall be Restricted Shares, which are subject to vesting, transfer, forfeiture or repayment provisions similar to those in the Grantee’s underlying Award);
(3) waive or amend any goals, restrictions, vesting provisions or conditions set forth in such Award Agreement, or impose new goals, restrictions, vesting provisions and conditions, subject to Section 3.1; or
(4) reflect a change in the Grantee’s circumstances (e.g., a change to part-time employment status or a change in position, duties or responsibilities); and
(i) determine at any time whether, to what extent and under what circumstances and method or methods, subject to Section 3.14 and except as expressly provided in the applicable Award Agreement,
(1) Awards may be:
(A) settled in cash, Common Shares, other securities, other Awards or other property (in which event, the Committee may specify what other effects such settlement shall have on the Grantee’s Award, including the effect on any repayment provisions under the Plan or Award Agreement);
(B) exercised; or
(C) canceled, forfeited or suspended;
(2) delivery of Common Shares, other securities, other Awards or other property and other amounts payable with respect to an Award may be deferred either automatically or at the election of the Grantee thereof or of the Committee; and
(3) the exercise price for any Stock Option (other than an Incentive Stock Option, unless the Committee determines that such a Stock Option shall no longer constitute an Incentive Stock Option) or Share Appreciation Right may be reset.
1.3.2 Actions of the Committee may be taken by the vote of a majority of its members present at a meeting (which may be held telephonically). Any action may be taken by a written instrument signed by a majority of the Committee members, and action so taken shall be as fully effective as if it had been taken by a vote at a meeting. The determination of the Committee on all matters relating to the Plan or any Award Agreement shall be final, binding and conclusive. To the extent permitted by applicable law, the Committee may allocate among its members and delegate to any person who is not a member of the Committee, or to any administrative group within the Company, any of its powers, responsibilities or duties. In delegating its authority, the Committee shall consider the extent to which any delegation may cause Awards to fail to meet the requirements of Rule 16(b)-3(d)(1) or Rule 16(b)-3(e) under the Exchange Act. Except as specifically provided to the contrary, references to the Committee include any administrative group, individual or individuals to whom the Committee has delegated its duties and powers.
1.3.3 Notwithstanding anything to the contrary contained herein, the Board may, in its sole discretion, at any time and from time to time, grant Awards or administer the Plan. In any such case, the Board shall have all of the authority and responsibility granted to the Committee herein.
1.3.4 No member of the Committee or any person to whom the Committee delegates its powers, responsibilities or duties in writing, including by resolution (each such person, a “Covered Person”), shall have any liability to any person (including any Grantee) for any action taken or omitted to be taken or any determination made in good faith with respect to the Plan or any Award, except as expressly provided by statute. Each Covered Person shall be indemnified and held harmless by the Company against and from:
-5-



(a) any loss, cost, liability or expense (including attorneys’ fees) that may be imposed upon or incurred by such Covered Person in connection with or resulting from any action, suit or proceeding to which such Covered Person may be a party or in which such Covered Person may be involved by reason of any action taken or omitted to be taken under the Plan or any Award Agreement, in each case, in good faith; and
         (b) any and all amounts paid by such Covered Person, with the Company’s approval, in settlement thereof, or paid by such Covered Person in satisfaction of any judgment in any such action, suit or proceeding against such Covered Person, provided that the Company shall have the right, at its own expense, to assume and defend any such action, suit or proceeding and, once the Company gives notice of its intent to assume the defense, the Company shall have sole control over such defense with counsel of the Company’s choice.
The foregoing right of indemnification shall not be available to a Covered Person to the extent that a court of competent jurisdiction in a final judgment or other final adjudication, in either case, not subject to further appeal, determines that the acts or omissions of such Covered Person giving rise to the indemnification claim resulted from such Covered Person’s bad faith, fraud or willful misconduct. The foregoing right of indemnification shall not be exclusive of any other rights of indemnification to which Covered Persons may be entitled under Cronos’ articles of incorporation or bylaws, as amended from time to time, pursuant to any individual indemnification agreements between such Covered Person and the Company, as a matter of law, or otherwise, or any other power that the Company may have to indemnify such persons or hold them harmless.
1.4 Persons Eligible for Awards
Awards under the Plan may be made to Employees, Directors and Consultants.
1.5 Types of Awards Under the Plan
Awards may be made under the Plan in the form of cash-based or share-based Awards. Share-based Awards may be in the form of any of the following, in each case in respect of Common Shares:
(a) Stock Options;
(b) Share Appreciation Rights;
(c) Restricted Shares;
(d) Restricted Share Units;
(e) Dividend Equivalent Rights; and
(f) Other share-based or cash-based Awards (as further described in Section 2.8) that the Committee determines to be consistent with the purposes of the Plan and the interests of the Company.
1.6 Common Shares Available for Awards
1.6.1 Common Shares Subject to the Plan. Subject to the other provisions of this Section 1.6, the total number of Common Shares that may be granted under the Plan shall be (a) 19,999,273 plus (b) the number of Common Shares (not exceeding 14,149,502) underlying any award outstanding under the Option Plans as of the Effective Date which, on or after the Effective Date, expires or is forfeited, terminated or canceled for any reason without having been exercised or settled in full plus (c) the number of Common Shares (not exceeding 732,972) underlying any award outstanding under the Employment Inducement Award Plan as of the Effective Date which, on or after the Effective Date, expires or is forfeited, terminated or canceled for any reason without having been exercised or settled in full (the sum of (a), (b) and (c), the “Share Limit”). For the avoidance of doubt, the Share Limit shall not exceed 34,881,747. Common Shares subject to awards that are assumed, converted or substituted under the Plan as a result of the Company’s acquisition of another company (including by way of merger, combination or similar transaction) (“Acquisition Awards”) shall not count against the number of Common Shares that may be granted under the Plan. Available shares under a shareholder-approved plan of an acquired
-6-



company (as appropriately adjusted to reflect the transaction) may be used for Awards under the Plan and do not reduce the maximum number of shares available for grant under the Plan, subject to applicable stock exchange requirements.
1.6.2 Replacement of Shares. Common Shares subject to an Award that is forfeited (including any Restricted Shares repurchased by the Company at the same price paid by the Grantee so that such Common Shares are returned to the Company) or expires, to the extent of such forfeiture or expiration, shall be available for future grants of Awards under the Plan and shall be added back in the same number of Common Shares as were deducted in respect of the grant of such Award. The payment of Dividend Equivalent Rights in cash in conjunction with any outstanding Awards shall not be counted against the Common Shares available for issuance under the Plan. Common Shares tendered by a Grantee or withheld by the Company in payment of the exercise price of a Stock Option or to satisfy any tax withholding obligation with respect to an Award shall also be available for Awards. With respect to Awards of share-settled Share Appreciation Rights, the Share Limit shall be reduced by the full number of Common Shares underlying the exercised portion of such Award (rather than only the Common Shares actually delivered upon exercise).
1.6.3 Adjustments. The Committee shall:
         (a) adjust the number of Common Shares authorized pursuant to Section 1.6.1;
         (b) adjust the number of Common Shares set forth in Section 2.3.2 that can be issued through Incentive Stock Options; and
(c) adjust the terms of any outstanding Awards (including, without limitation, the number of Common Shares covered by each outstanding Award, the type of property or securities to which the Award relates and the exercise or strike price of any Award);
in such manner as it deems appropriate (including, without limitation, by payment of cash) to prevent the enlargement or dilution of rights, as a result of any increase or decrease in the number of issued Common Shares (or issuance of shares of stock other than Common Shares) resulting from a recapitalization, stock split, reverse stock split, stock dividend, spinoff, split-up, combination, reclassification or exchange of Common Shares, merger, consolidation, arrangement, rights offering, separation, reorganization or liquidation or any other change in the corporate structure or Common Shares, including any extraordinary dividend or extraordinary distribution; provided that no such adjustment may be made if or to the extent that it would cause an outstanding Award to cease to be exempt from, or to fail to comply with, Section 409A.
1.6.4 Assumption or Substitution of Awards. The Committee may, without affecting the number of Common Shares available pursuant to Section 1.6.1, authorize the issuance or assumption of benefits under the Plan in connection with any merger, consolidation, acquisition of property or shares, reorganization or similar transaction upon such terms and conditions as it may deem appropriate, subject to compliance with Section 409A and any other applicable provisions of the Code.
1.7 Minimum Vesting
Notwithstanding any other provision of the Plan to the contrary, all Awards, and all portions of Awards, shall be subject to a minimum vesting schedule of at least twelve (12) months following the date of grant of the Award; provided, however, that the foregoing limitations shall not preclude the acceleration of vesting of any such Award upon the death or Disability of the Grantee, as determined by the Committee in its discretion, and shall not apply to Awards that are granted in lieu of earned cash compensation or earned Awards that are otherwise settled in cash. Notwithstanding the foregoing, Awards with respect to 5% of the maximum aggregate number of Common Shares that may be granted under the Plan pursuant to Section 1.6.1 may be granted under the Plan to any one or more Grantees without respect to such minimum vesting provisions.
1.8 Limits on Compensation to Non-Employee Directors
No non-employee Director of Cronos may be granted (in any calendar year) compensation, solely with respect to his or her service as a member of the Board, with a value in excess of $500,000, with the value of any equity based awards based on the accounting grant date value of such award; provided, however, that the foregoing limitation shall be
-7-



$1,000,000 for the calendar year in which a non-employee Director is newly appointed as a member of the Board or is designated the Chairman or Lead Director of the Board.

ARTICLE II
AWARDS UNDER THE PLAN
2.1 Agreements Evidencing Awards
Each Award granted under the Plan shall be evidenced by an Award Agreement that shall contain such provisions and conditions as the Committee deems appropriate. Unless otherwise provided herein or in the Award Agreement, the Committee may grant Awards in tandem with or, subject to Section 3.14, in substitution for or satisfaction of any other Award or Awards granted under the Plan or any award granted under any other plan of the Company. By accepting an Award pursuant to the Plan, a Grantee thereby agrees that the Award shall be subject to all of the terms and provisions of the Plan and the applicable Award Agreement.
2.2 No Rights as a Shareholder
No Grantee (or other person having rights pursuant to an Award) shall have any of the rights of a shareholder of Cronos with respect to Common Shares subject to an Award until the delivery of such Common Shares. Except as otherwise provided in Section 1.6.3, no adjustments shall be made for dividends, distributions or other rights (whether ordinary or extraordinary, and whether in cash, Common Shares, other securities or other property) for which the record date is before the date the Certificates for the Common Shares are delivered, or in the event the Committee elects to use another system, such as book entries by the transfer agent, before the date in which such system evidences the Grantee’s ownership of such Common Shares.
2.3 Stock Options
2.3.1 Grant. Stock options may be granted to eligible recipients in such number and at such times during the term of the Plan as the Committee may determine (“Stock Options”).
2.3.2 Incentive Stock Options. At the time of grant, the Committee shall determine:
(a) whether all or any part of a Stock Option granted to an eligible Employee shall be an Incentive Stock Option and
(b) the number of Common Shares subject to such Incentive Stock Option; provided, however, that
(1) the aggregate Fair Market Value (determined as of the time the Stock Option is granted) of the stock with respect to which Incentive Stock Options are exercisable for the first time by an eligible Employee during any fiscal year (under all such plans of Cronos and of any Subsidiary or parent corporation of Cronos) may not exceed $100,000; and
(2) no Incentive Stock Option (other than an Incentive Stock Option that may be assumed or issued by the Company in connection with a transaction to which Section 424(a) of the Code applies) may be granted to a person who is not eligible to receive an Incentive Stock Option under the Code.
The form of any Stock Option which is entirely or in part an Incentive Stock Option shall clearly indicate that such Stock Option is an Incentive Stock Option or, if applicable, the number of Common Shares subject to the Incentive Stock Option. No more than 5,000,000 Common Shares (as adjusted pursuant to the provisions of Section 1.6.3) that can be delivered under the Plan may be issued through Incentive Stock Options.
2.3.3 Exercise Price. The exercise price per share with respect to each Stock Option shall be determined by the Committee but, except as otherwise permitted by Section 1.6.3, may never be less than the Fair Market Value (or, in the case of an Incentive Stock Option granted to a Ten Percent Shareholder, 110% of the Fair Market Value). Unless otherwise noted
-8-



in the Award Agreement, the Fair Market Value shall be determined with respect to the date of grant of the Award of Stock Options.
2.3.4 Term of Stock Option. In no event shall any Stock Option be exercisable after the expiration of ten (10) years (or, in the case of an Incentive Stock Option granted to a Ten Percent Shareholder, five (5) years) from the date on which the Stock Option is granted.
2.3.5 Vesting and Exercise of Stock Option and Payment for Common Shares. A Stock Option may vest and be exercised at such time or times and subject to such terms and conditions as shall be determined by the Committee at the time the Stock Option is granted and set forth in the Award Agreement. Subject to any limitations in the applicable Award Agreement, any Common Shares not acquired pursuant to the exercise of a Stock Option on the applicable vesting date may be acquired thereafter at any time before the final expiration of the Stock Option.
To exercise a Stock Option, the Grantee must give written notice to the Company specifying the number of Common Shares to be acquired and accompanied by payment of the full purchase price therefor in cash or in another form as determined by the Committee, which may, subject to the terms of the applicable Award Agreement, include:
(a) bank transfer;
(b) Common Shares, based on the Fair Market Value as of the exercise date;
(c) any other form of consideration approved by the Company and permitted by applicable law; and
(d) any combination of the foregoing.
The Committee may also make arrangements for the cashless exercise of a Stock Option. Any person exercising a Stock Option shall make such representations and agreements and furnish such information as the Committee may, in its sole discretion, deem necessary or desirable to effect or assure compliance by the Company on terms acceptable to the Company with the provisions of the Securities Act, the Exchange Act and any other applicable legal requirements. The Committee may, in its sole discretion, also take whatever additional actions it deems appropriate to effect such compliance, including, without limitation, placing legends on share certificates and issuing stop-transfer notices to agents and registrars. If a Grantee so requests, Common Shares acquired pursuant to the exercise of a Stock Option may be issued in the name of the Grantee and another jointly with the right of survivorship.
2.3.6 No Repricing or Reloads. Except as otherwise permitted by Section 1.6.3, reducing the exercise price of Stock Options issued and outstanding under the Plan, including through amendment, cancellation in exchange for the grant of a substitute Award or repurchase for cash or other consideration (in each case that has the effect of reducing the exercise price), shall require the approval of Cronos’ shareholders. The Company shall not grant any Stock Options with automatic reload features.
2.4 Share Appreciation Rights
2.4.1 Grant. Share appreciation rights may be granted to eligible recipients in such number and at such times during the term of the Plan as the Committee may determine (“Share Appreciation Rights”).
2.4.2 Exercise Price. The exercise price per share with respect to each Share Appreciation Right shall be determined by the Committee but, except as otherwise permitted by Section 1.6.3, may never be less than the Fair Market Value. Unless otherwise noted in the Award Agreement, the Fair Market Value shall be determined with respect to the date of grant of the Award of Share Appreciation Rights.
2.4.3 Term of Share Appreciation Right. In no event shall any Share Appreciation Right be exercisable after the expiration of ten (10) years from the date on which the Share Appreciation Right is granted.
2.4.4 Vesting and Exercise of Share Appreciation Right and Delivery of Common Shares. Each Share Appreciation Right may vest and be exercised in such installments as may be determined in the Award Agreement at the time the Share Appreciation Right is granted. Subject to any limitations in the applicable Award Agreement, any Share
-9-



Appreciation Right not exercised on the applicable vesting date may be exercised thereafter at any time before the final expiration of the Share Appreciation Right.
To exercise a Share Appreciation Right, the Grantee must give written notice to the Company specifying the number of Share Appreciation Rights to be exercised. Upon exercise of Share Appreciation Rights, Common Shares, cash or other securities or property, or a combination thereof, as specified by the Committee, equal in value to:
(a) the excess of:
(1)  the Fair Market Value of the Common Shares on the date of exercise over
(2)  the exercise price of such Share Appreciation Right
multiplied by
(b) the number of Share Appreciation Rights exercised, shall be delivered to the Grantee.
Any person exercising a Share Appreciation Right shall make such representations and agreements and furnish such information as the Committee may, in its sole discretion, deem necessary or desirable to effect or assure compliance by the Company on terms acceptable to the Company with the provisions of the Securities Act, the Exchange Act and any other applicable legal requirements. If a Grantee so requests, Common Shares acquired pursuant to the exercise of a Share Appreciation Right may be issued in the name of the Grantee and another jointly with the right of survivorship.
2.4.5 No Repricing or Reloads. Except as otherwise permitted by Section 1.6.3, reducing the exercise price of Share Appreciation Rights issued and outstanding under the Plan, including through amendment, cancellation in exchange for the grant of a substitute Award or repurchase for cash or other consideration (in each case that has the effect of reducing the exercise price), shall require the approval of Cronos’ shareholders. The Company shall not grant any Share Appreciation Rights with automatic reload features.
2.5 Restricted Shares
2.5.1 Grants. The Committee may grant or offer for sale restricted shares in such amounts and subject to such terms and conditions as the Committee may determine (“Restricted Shares”). Upon the delivery of such Common Shares, the Grantee shall have the rights of a shareholder with respect to the Restricted Shares, subject to any other restrictions and conditions as the Committee may include in the applicable Award Agreement. Each Grantee of an Award of Restricted Shares shall be issued a Certificate in respect of such Restricted Shares, unless the Committee elects to use another system, such as book entries by the transfer agent, as evidencing ownership of such Restricted Shares. In the event that a Certificate is issued in respect of Restricted Shares, such Certificate may be registered in the name of the Grantee, and shall, in addition to such legends required by applicable securities laws, bear an appropriate legend referring to the terms, conditions, and restrictions applicable to such Award, but shall be held by the Company or its designated agent until the time the restrictions lapse.
2.5.2 Right to Vote and Receive Dividends on Restricted Shares. Each Grantee of an Award of Restricted Shares shall, during the period of restriction, be the beneficial and record owner of such Restricted Shares and shall have full voting rights with respect thereto. During the period of restriction, all ordinary cash dividends or other ordinary distributions paid upon any Restricted Share shall be retained by the Company and shall be paid to the relevant Grantee (without interest) when the Award of Restricted Shares vests and shall revert back to the Company if for any reason the Restricted Share upon which such dividends or other distributions were paid reverts back to the Company (any extraordinary dividends or other extraordinary distributions shall be treated in accordance with Section 1.6.3).
2.6 Restricted Share Units
The Committee may grant Awards of restricted share units (“Restricted Share Units”) in such amounts and subject to such terms and conditions as the Committee may determine. A Grantee of a Restricted Share Unit shall have only the rights of a general unsecured creditor of the Company until delivery of Common Shares, cash or other securities or property is made as specified in the applicable Award Agreement. On the delivery date specified in the Award Agreement,
-10-



the Grantee of each Restricted Share Unit not previously forfeited or terminated shall receive one share of Common Shares, cash or other securities or property equal in value to a share of Common Shares or a combination thereof, as specified by the Committee unless otherwise prescribed in the Award Agreement.
2.7 Dividend Equivalent Rights
The Committee may include in the Award Agreement with respect to any Award, other than an Award of Stock Options or Share Appreciation Rights, a dividend equivalent right entitling the Grantee to receive amounts equal to all or any portion of the regular cash dividends that would be paid on the Common Shares covered by such Award if such Common Shares had been delivered pursuant to such Award (“Dividend Equivalent Right”). The grantee of a Dividend Equivalent Right shall have only the rights of a general unsecured creditor of the Company until payment of such amounts is made as specified in the applicable Award Agreement. In the event such a provision is included in an Award Agreement, the Committee shall determine, and specify in the Award Agreement, whether such payments shall be made in cash, in Common Shares or in another form, the time or times at which they shall be made, and such other terms and conditions as the Committee shall deem appropriate, including whether the amounts subject to a Dividend Equivalent Right may be notionally reinvested in the form of Award to which the Award Agreement relates; provided that in no event may such payments be made unless and until the Award to which they relate vests.
2.8 Performance-Based and Other Share-Based or Cash-Based Awards
The Committee may grant other types of equity-based, equity-related or cash-based Awards (including the grant or offer for sale of unrestricted Common Shares, performance share awards and performance units settled in cash) (“Other Share-Based or Cash-Based Awards”) in such amounts and subject to such terms and conditions as the Committee may determine. The terms and conditions set forth by the Committee in the applicable Award Agreement may relate to the achievement of performance goals, as determined by the Committee at the time of grant. Such Awards may entail the transfer of actual Common Shares to Award recipients and may include Awards designed to comply with or take advantage of the applicable local laws of jurisdictions other than the United States.
2.9 Repayment If Conditions Not Met
If the Committee determines that all terms and conditions of the Plan and a Grantee’s Award Agreement were not satisfied, and that the failure to satisfy such terms and conditions is material, then the Grantee shall be obligated to pay the Company immediately upon demand therefor, (a) with respect to a Stock Option and a Share Appreciation Right, an amount equal to the excess of the Fair Market Value (determined at the time of exercise) of the Common Shares that were delivered in respect of such exercised Stock Option or Share Appreciation Right, as applicable, over the exercise price paid therefor, (b) with respect to Restricted Shares, an amount equal to the Fair Market Value (determined at the time such Common Shares became vested) of such Restricted Shares and (c) with respect to Restricted Share Units, an amount equal to the Fair Market Value (determined at the time of delivery) of the Common Shares delivered with respect to the applicable delivery date, in each case with respect to clauses (a), (b) and (c) of this Section 2.9, after reducing for any amount applied to satisfy withholding tax or other obligations in respect of such Award.
ARTICLE III
MISCELLANEOUS
3.1 Amendment of the Plan
3.1.1 Unless otherwise provided in the Plan or in an Award Agreement, the Board may, at any time and from time to time, suspend, discontinue, revise or amend the Plan in any respect whatsoever, but, subject to Sections 1.3 and 1.6.3, no such amendment may materially adversely impair the rights of a Grantee with respect to any outstanding Award without the Grantee’s consent. Subject to Sections 1.3 and 1.6.3, an Award Agreement may not be amended to materially adversely impair the rights of a Grantee without the Grantee’s consent.
3.1.2 Unless otherwise determined by the Board, shareholder approval of any suspension, discontinuance, revision or amendment shall be obtained only to the extent necessary to comply with any applicable laws, regulations or rules of a securities exchange or self-regulatory agency; provided, however, if and to the extent the Board determines it is
-11-



appropriate for the Plan to comply with the provisions of Section 422 of the Code, no amendment that would require shareholder approval under Section 422 of the Code shall be effective without the approval of Cronos’ shareholders.
3.2 Tax Withholding
Grantees shall be solely responsible for any applicable taxes (including, without limitation, income and excise taxes) and penalties, and any interest that accrues thereon, that they incur in connection with the receipt, vesting or exercise of any Award. As a condition to the delivery of any Common Shares, cash or other securities or property pursuant to any Award or the lifting or lapse of restrictions on any Award, or in connection with any other event that gives rise to a federal or other governmental tax or other statutory withholding obligation on the part of the Company relating to an Award (including, without limitation, the Federal Insurance Contributions Act (FICA) tax):
(a) the Company may deduct or withhold (or cause to be deducted or withheld) from any payment or distribution to a Grantee, whether or not pursuant to the Plan (including, subject to the applicable Award Agreement, Common Shares otherwise deliverable);
(b) the Committee shall be entitled to require that the Grantee remit cash to the Company (through payroll deduction or otherwise); or
(c) the Company may enter into any other suitable arrangements;
in each case in the Company’s discretion, to withhold (i) the minimum amounts of such taxes required by law to be withheld based on the individual tax rates applicable to Grantee or (ii) if provided in an Award Agreement, the minimum or maximum individual tax rate applicable to the Grantee.
3.3 Required Consents and Legends
3.3.1 If the Committee at any time determines that any Consent (as hereinafter defined) is necessary or desirable as a condition of, or in connection with, the granting of any Award, the delivery of Common Shares or the delivery of any cash, securities or other property under the Plan, or the taking of any other action thereunder (each such action, a “Plan Action”), then, subject to Section 3.14, such Plan Action shall not be taken, in whole or in part, unless and until such Consent shall have been effected or obtained to the full satisfaction of the Committee. The Committee may direct that any Certificate evidencing Common Shares delivered pursuant to the Plan shall bear a legend setting forth such restrictions on transferability as the Committee may determine to be necessary or desirable, and may advise the transfer agent to place a stop transfer order against any legended shares.
3.3.2 The term “Consent” as used in this Article III with respect to any Plan Action includes:
(a) any and all listings, registrations or qualifications in respect thereof upon any securities exchange or under any federal, state or local law, or law, rule or regulation of a jurisdiction outside the United States;
(b) any and all written agreements and representations by the Grantee with respect to the disposition of Common Shares, or with respect to any other matter, which the Committee may deem necessary or desirable to comply with the terms of any such listing, registration or qualification or to obtain an exemption from the requirement that any such listing, qualification or registration be made;
(c) any and all other consents, clearances and approvals in respect of a Plan Action by any governmental or other regulatory body or any stock exchange or self-regulatory agency;
(d) any and all consents by the Grantee to:
(i) the Company’s supplying to any third-party recordkeeper of the Plan such personal information as the Committee deems advisable to administer the Plan;
-12-



(ii) the Company’s deducting amounts from the Grantee’s wages, or another arrangement satisfactory to the Committee, to reimburse the Company for advances made on the Grantee’s behalf to satisfy certain withholding and other tax obligations in connection with an Award; and
(iii) the Company’s imposing sales and transfer procedures and restrictions and hedging restrictions on Common Shares delivered under the Plan; and
(e) any and all consents or authorizations required to comply with, or required to be obtained under, applicable law or otherwise required by the Committee. Nothing herein shall require the Company to list, register or qualify the Common Shares on any securities exchange.
3.4 Right of Offset
The Company shall have the right to offset against its obligation to deliver Common Shares (or other property or cash) under the Plan or any Award Agreement any outstanding amounts (including, without limitation, travel and entertainment or advance account balances, loans, repayment obligations under any Awards, or amounts repayable to the Company pursuant to tax equalization, housing, automobile or other employee programs) that the Grantee then owes to the Company and any amounts the Committee otherwise deems appropriate pursuant to any tax equalization policy or agreement. Notwithstanding the foregoing, (i) if an Award provides for the deferral of compensation within the meaning of Section 409A, the Committee shall have no right to offset against its obligation to deliver Common Shares (or other property or cash) under the Plan or any Award Agreement if such offset could subject the Grantee to the additional tax imposed under Section 409A in respect of an outstanding Award; and (ii) no such offset shall be applied to Common Shares issuable on the exercise of Stock Options.
3.5 Nonassignability; No Hedging
Unless otherwise provided in an Award Agreement, no Award (or any rights and obligations thereunder) granted to any person under the Plan may be sold, exchanged, transferred, assigned, pledged, hypothecated or otherwise disposed of or hedged, in any manner (including through the use of any cash-settled instrument), whether voluntarily or involuntarily and whether by operation of law or otherwise, other than (a) by will, (b) by the laws of descent and distribution or (c) to any trust established for the benefit of the applicable Grantee or any parent, grandparent, sibling or child (including any adopted sibling or child) of the Grantee, and all such Awards (and any rights thereunder) shall be exercisable during the life of the Grantee only by the Grantee or the Grantee’s legal representative or the trustee, as applicable. Notwithstanding the foregoing, the Committee may permit, under such terms and conditions that it deems appropriate in its sole discretion, a Grantee to transfer any Award to any person or entity that the Committee so determines. Any sale, exchange, transfer, assignment, pledge, hypothecation or other disposition in violation of the provisions of this Section 3.5 shall be null and void and any Award which is hedged in any manner shall immediately be forfeited. All of the terms and conditions of the Plan and the Award Agreements shall be binding upon any permitted successors and assigns.
3.6 Change of Control
3.6.1 Unless otherwise provided in the applicable Award Agreement or employment agreement, if a Grantee’s Employment is terminated by the Company or any successor entity thereto without Just Cause on or within one (1) year after a Change of Control, (i) each Award granted to such Grantee prior to such Change of Control shall become fully vested (including the lapsing of all restrictions and conditions) and, as applicable, exercisable, and (ii) any Common Shares deliverable pursuant to Restricted Share Units shall be delivered promptly (but no later than fifteen (15) days) following such Grantee’s termination of Employment. Notwithstanding the foregoing, if, in connection with a Change of Control, any outstanding Awards are not assumed by, or replaced with comparable awards or rights by, the surviving corporation (or a parent or subsidiary of the surviving corporation), then upon such Change of Control each Award granted to such Grantee prior to such Change of Control shall become fully vested (including the lapsing of all restrictions and conditions) and, as applicable, exercisable. As of the Change of Control date, any outstanding performance-based Awards shall be deemed earned at the actual performance level as of the date of the Change of Control (or target performance if the Committee determines that the actual performance level is unable to be determined) with respect to all open performance periods and shall cease to be subject to any further performance conditions but shall continue to be subject to time-based vesting following the Change of Control in accordance with the original performance period.
-13-



3.6.2 Notwithstanding the foregoing, in the event of a Change of Control, a Grantee’s Award may be treated, to the extent determined by the Committee to be permitted under Section 409A and subject to the Award Agreement applicable to the Award, in accordance with one or more of the following methods as determined by the Committee in its sole discretion: (i) settle such Awards for an amount of cash or securities equal to their value, where in the case of Stock Options and Share Appreciation Rights, the value of such awards, if any, shall be equal to their in-the-money spread value (if any) of such awards, as determined in the sole discretion of the Committee; (ii) provide for the assumption of or the issuance of substitute awards that shall substantially preserve the otherwise applicable terms of any affected Awards previously granted under the Plan, as determined by the Committee in its sole discretion; or (iii) provide that for a period of at least twenty (20) days prior to the Change of Control, any Stock Options or Share Appreciation Rights that would not otherwise become exercisable prior to the Change of Control shall be exercisable as to all Common Shares subject thereto (but any such exercise shall be contingent upon and subject to the occurrence of the Change of Control, and if the Change of Control does not take place within a specified period after giving such notice for any reason whatsoever, the exercise shall be null and void) and that any Stock Options or Share Appreciation Rights not exercised prior to the consummation of the Change of Control shall terminate and be of no further force and effect as of the consummation of the Change of Control. In the event that the consideration paid in the Change of Control includes contingent value rights, earnout or indemnity payments or similar payments, then the Committee shall determine if Awards settled under clause (i) above are (a) valued at closing taking into account such contingent consideration (with the value determined by the Committee in its sole discretion) or (b) entitled to a share of such contingent consideration. For the avoidance of doubt, in the event of a Change of Control where all Stock Options and Share Appreciation Rights are settled for an amount (as determined in the sole discretion of the Committee) of cash or securities, the Committee may, in its sole discretion, terminate any Stock Option or share appreciation right for which the exercise price is equal to or exceeds the per share value of the consideration to be paid in the Change of Control transaction without payment of consideration therefor. Similar actions to those specified in this Section 3.6.2 may be taken in the event of a merger or other corporate reorganization that does not constitute a Change of Control.
3.7 No Continued Employment or Engagement; Right of Discharge Reserved
Neither the adoption of the Plan nor the grant of any Award (or any provision in the Plan or Award Agreement) shall confer upon any Grantee any right to continued Employment, or other engagement, with the Company, nor shall it interfere in any way with the right of the Company to terminate, or alter the terms and conditions of, such Employment or other engagement at any time.
3.8 Nature of Payments
3.8.1 Any and all grants of Awards and deliveries of Common Shares, cash, securities or other property under the Plan shall be in consideration of services performed or to be performed for the Company by the Grantee. Awards under the Plan may, in the discretion of the Committee, be made in substitution in whole or in part for cash or other compensation otherwise payable to a Grantee. Only whole Common Shares shall be delivered under the Plan. Awards shall, to the extent reasonably practicable, be aggregated in order to eliminate any fractional shares. Fractional shares may, in the discretion of the Committee, be forfeited or be settled in cash or otherwise as the Committee may determine.
3.8.2 All such grants and deliveries of Common Shares, cash, securities or other property under the Plan shall constitute a special discretionary incentive payment to the Grantee, shall not entitle the Grantee to the grant of any future Awards and shall not be required to be taken into account in computing the amount of salary or compensation of the Grantee for the purpose of determining any contributions to or any benefits under any pension, retirement, profit-sharing, bonus, life insurance, severance or other benefit plan of the Company or under any agreement with the Grantee, unless the Company specifically provides otherwise.
3.9 Non-Uniform Determinations
3.9.1 The Committee’s determinations under the Plan and Award Agreements need not be uniform, and any such determinations may be made by it selectively among persons who receive, or are eligible to receive, Awards under the Plan (whether or not such persons are similarly situated). Without limiting the generality of the foregoing, the Committee shall be entitled, among other things, to make non-uniform and selective determinations under Award Agreements, and to enter into non-uniform and selective Award Agreements, as to (a) the persons to receive Awards, (b) the terms and provisions of Awards and (c) whether a Grantee’s Employment has been terminated for purposes of the Plan.
-14-



3.9.2 To the extent the Committee deems it necessary, appropriate or desirable to comply with foreign law or practices and to further the purposes of the Plan, the Committee may, in its sole discretion and without amending the Plan, (a) establish special rules applicable to Awards to Grantees who are foreign nationals, are employed outside the United States or both, and grant Awards (or amend existing Awards) in accordance with those rules, and (b) cause the Company to enter into an agreement with any local Subsidiary pursuant to which such Subsidiary shall reimburse the Company for the cost of such equity incentives.
3.10 Other Payments or Awards
Nothing contained in the Plan shall be deemed in any way to limit or restrict the Company from making any award or payment to any person under any other plan, arrangement or understanding, whether now existing or hereafter in effect.
3.11 Plan Headings
The headings in the Plan are for the purpose of convenience only and are not intended to define or limit the construction of the provisions hereof.
3.12 Termination of the Plan
The Board reserves the right to terminate the Plan at any time; provided, however, that in any case, the Plan shall terminate on the day before the tenth (10th) anniversary of the Effective Date, and provided further, that all Awards made under the Plan before its termination shall remain in effect until such Awards have been satisfied or terminated in accordance with the terms and provisions of the Plan and the applicable Award Agreements.
3.13 Clawback/Recapture Policy
Awards under the Plan shall be subject to any clawback or recapture policy that the Company may adopt from time to time to the extent provided in such policy and, in accordance with such policy, may be subject to the requirement that the Awards be repaid to the Company after they have been distributed to the Grantee.
3.14 Section 409A
3.14.1 Notwithstanding anything to the contrary contained herein, all Awards made under the Plan that are intended to be “deferred compensation” subject to Section 409A shall be interpreted, administered and construed to comply with Section 409A, and all Awards made under the Plan that are intended to be exempt from Section 409A shall be interpreted, administered and construed to comply with and preserve such exemption. The Board and the Committee shall have full authority to give effect to the intent of the foregoing sentence. To the extent necessary to give effect to this intent, in the case of any conflict or potential inconsistency between the Plan and a provision of any Award or Award Agreement with respect to an Award, the Plan shall govern.
3.14.2 Without limiting the generality of Section 3.14.1, with respect to any Award made under the Plan that is intended to be “deferred compensation” subject to Section 409A:
(a) any payment due upon a Grantee’s termination of Employment shall be paid only upon such Grantee’s separation from service from the Company within the meaning of Section 409A;
(b) any payment due upon a Change of Control of Cronos shall be paid only if such Change of Control constitutes a “change in ownership” or “change in the effective control” within the meaning of Section 409A, and in the event that such Change of Control does not constitute a “change in the ownership” or “change in the effective control” within the meaning of Section 409A, such Award shall be vested and non-forfeitable upon the Change of Control and any payment shall be made at the earliest time permitted under Section 409A;
(c) if the Grantee is a “specified employee” (within the meaning of Section 409A and as determined by the Company), any payment to be made with respect to such Award in connection with the Grantee’s separation from service from the Company within the meaning of Section 409A (and any other payment that would be subject to the
-15-



limitations in Section 409A(a)(2)(B) of the Code) shall be delayed until six (6) months after the Grantee’s separation from service (or earlier death) in accordance with the requirements of Section 409A;
(d) to the extent necessary to comply with Section 409A, any other securities, other Awards or other property that the Company may deliver in lieu of Common Shares in respect of an Award shall not have the effect of deferring delivery or payment beyond the date on which such delivery or payment would occur with respect to the Common Shares that would otherwise have been deliverable (unless the Committee elects a later date for this purpose in accordance with the requirements of Section 409A);
(e) with respect to any required Consent described in Section 3.3 or the applicable Award Agreement, if such Consent has not been effected or obtained as of the latest date provided by such Award Agreement for payment in respect of such Award and further delay of payment is not permitted in accordance with the requirements of Section 409A, such Award or portion thereof, as applicable, shall be forfeited and terminate notwithstanding any prior earning or vesting;
(f) if the Award includes a “series of installment payments” (within the meaning of Section 1.409A-2(b)(2)(iii) of the Treasury Regulations), the Grantee’s right to the series of installment payments shall be treated as a right to a series of separate payments and not as a right to a single payment;
(g) if the Award includes “dividend equivalents” (within the meaning of Section 1.409A-3(e) of the Treasury Regulations), the Grantee’s right to the dividend equivalents shall be treated separately from the right to other amounts under the Award;
(h) in the event any payments under the Award cannot be made at the time specified under the Award without triggering an excise tax under Section 409A, such payments shall be vested and non-forfeitable upon such event and shall be made at the earliest time permitted under Section 409A; and
(i) for purposes of determining whether the Grantee has experienced a separation from service from the Company within the meaning of Section 409A, “subsidiary” shall mean a corporation or other entity in a chain of corporations or other entities in which each corporation or other entity, starting with the Company, has a controlling interest in another corporation or other entity in the chain, ending with such corporation or other entity. For purposes of the preceding sentence, the term “controlling interest” has the same meaning as provided in Section 1.414(c)-2(b)(2)(i) of the Treasury Regulations, provided that the language “at least 20 percent” is used instead of “at least 80 percent” each place it appears in Section 1.414(c)-2(b)(2)(i) of the Treasury Regulations.
3.15 Governing Law
THE PLAN AND ALL AWARDS MADE AND ACTIONS TAKEN THEREUNDER SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF DELAWARE, WITHOUT REFERENCE TO THE PRINCIPLES OF CONFLICT OF LAWS.
3.16 Disputes; Choice of Forum
3.16.1 The Company and each Grantee, as a condition to such Grantee’s participation in the Plan, hereby irrevocably submit to the exclusive jurisdiction the Delaware Court of Chancery, over any suit, action or proceeding arising out of or relating to or concerning the Plan or, to the extent not otherwise specified in any individual agreement between the Company and the Grantee, any aspect of the Grantee’s Employment with the Company or the termination of that Employment. The Company and each Grantee, as a condition to such Grantee’s participation in the Plan, acknowledge that the forum designated by this Section 3.16.1 has a reasonable relation to the Plan and to the relationship between such Grantee and the Company. Notwithstanding the foregoing, nothing herein shall preclude the Company from bringing any action or proceeding in any other court for the purpose of enforcing the provisions of this Section 3.16.1.
3.16.2 The agreement by the Company and each Grantee as to forum is independent of the law that may be applied in the action, and the Company and each Grantee, as a condition to such Grantee’s participation in the Plan, (i) agree to such forum even if the forum may under applicable law choose to apply non-forum law, (ii) hereby waive, to the fullest extent permitted by applicable law, any objection which the Company or such Grantee now or hereafter may have to personal jurisdiction or to the laying of venue of any such suit, action or proceeding in any court referred to in Section 3.16.1, (iii)
-16-



undertake not to commence any action arising out of or relating to or concerning the Plan in any forum other than the forum described in this Section 3.16 and (iv) agree that, to the fullest extent permitted by applicable law, a final and non-appealable judgment in any such suit, action or proceeding in any such court shall be conclusive and binding upon the Company and each Grantee.
3.16.3 Each Grantee, as a condition to such Grantee’s participation in the Plan, hereby irrevocably appoints the Corporate Secretary, of the Company as such Grantee’s agent for service of process in connection with any action, suit or proceeding arising out of or relating to or concerning the Plan, who shall promptly advise such Grantee of any such service of process.
3.16.4 Each Grantee, as a condition to such Grantee’s participation in the Plan, agrees to keep confidential the existence of, and any information concerning, a dispute, controversy or claim described in Section 3.18, except that a Grantee may disclose information concerning such dispute, controversy or claim to the court that is considering such dispute, controversy or claim or to such Grantee’s legal counsel (provided that such counsel agrees not to disclose any such information other than as necessary to the prosecution or defense of the dispute, controversy or claim).
3.17 Waiver of Jury Trial
EACH GRANTEE WAIVES ANY RIGHT IT MAY HAVE TO TRIAL BY JURY IN RESPECT OF ANY LITIGATION BASED ON, ARISING OUT OF, UNDER OR IN CONNECTION WITH THE PLAN.
3.18 Waiver of Claims
Each Grantee of an Award recognizes and agrees that before being selected by the Committee to receive an Award the Grantee has no right to any benefits under the Plan. Accordingly, in consideration of the Grantee’s receipt of any Award hereunder, the Grantee expressly waives any right to contest the amount of any Award, the terms of any Award Agreement, any determination, action or omission hereunder or under any Award Agreement by the Committee, the Company or the Board, or any amendment to the Plan or any Award Agreement (other than an amendment to the Plan or an Award Agreement to which his or her consent is expressly required by the express terms of an Award Agreement). Nothing contained in the Plan, and no action taken pursuant to its provisions, shall create or be construed to create a trust of any kind or a fiduciary relationship between the Company and any Grantee. The Plan is not intended to be subject to the Employee Retirement Income Security Act of 1974 (ERISA), as amended.
3.19 Severability; Entire Agreement
If any of the provisions of the Plan or any Award Agreement is finally held to be invalid, illegal or unenforceable (whether in whole or in part), such provision shall be deemed modified to the extent, but only to the extent, of such invalidity, illegality or unenforceability and the remaining provisions shall not be affected thereby; provided that if any such provision is finally held to be invalid, illegal, or unenforceable because it exceeds the maximum scope determined to be acceptable to permit such provision to be enforceable, such provision shall be deemed to be modified to the minimum extent necessary to modify such scope in order to make such provision enforceable hereunder. The Plan and any Award Agreements contain the entire agreement of the parties with respect to the subject matter thereof and supersede all prior agreements, promises, covenants, arrangements, communications, representations and warranties between them, whether written or oral, with respect to the subject matter thereof.
3.20 No Liability With Respect to Tax Qualification or Adverse Tax Treatment
Notwithstanding anything to the contrary contained herein, in no event shall the Company be liable to a Grantee on account of an Award’s failure to (a) qualify for favorable United States, Canadian or other tax treatment or (b) avoid adverse tax treatment under United States, Canadian or other law, including, without limitation, Section 409A.
3.21 No Third-Party Beneficiaries
Except as expressly provided in an Award Agreement, neither the Plan nor any Award Agreement shall confer on any person other than the Company and the Grantee of any Award any rights or remedies thereunder. The
-17-



exculpation and indemnification provisions of Section 1.3.4 shall inure to the benefit of a Covered Person’s estate and beneficiaries and legatees.
3.22 Successors and Assigns of the Company
The terms of the Plan shall be binding upon and inure to the benefit of the Company and any successor entity, including as contemplated by Section 3.6.
3.23 Date of Adoption and Approval of Shareholders
The Plan was adopted by the Board on March 29, 2020 and was approved by Cronos’ shareholders on June 25, 2020 (the “Effective Date”).

-18-

EX-10.2 4 a102rsuawardagreement.htm EX-10.2 Document

Exhibit 10.2
FORM OF
CRONOS GROUP INC.
RESTRICTED SHARE UNIT AGREEMENT

This Restricted Share Unit Award Agreement (hereinafter referred to as the “Agreement”) is made and entered into this ________ day of _______, 20__ (the “Grant Date”) by and between Cronos Group Inc. (hereinafter referred to as “Cronos”) and [●] (hereinafter referred to as the “Grantee”), pursuant to the Cronos Group Inc. 2020 Omnibus Equity Incentive Plan (hereinafter referred to as the “Plan”). All terms and provisions of the Plan are hereby incorporated into and shall govern the Agreement except where general provisions of the Plan are superseded by particular provisions of the Agreement. To the extent the Grantee is party to an employment agreement with the Company and any terms set forth herein conflict or are otherwise inconsistent with any terms or conditions set forth in Grantee’s employment agreement with the Company, the terms and conditions set forth in such employment agreement shall govern. All capitalized terms used in the Agreement shall have the same meaning given the terms in the Plan.
1.Grant of Restricted Share Units. Cronos hereby grants the Grantee [●] Restricted Share Units (hereinafter referred to as the “Award”), which are subject to terms and conditions set forth below.
2.Vesting and Settlement of Restricted Share Units. Subject to the terms and conditions of this Agreement and the Plan:
(a)the Award shall vest [over three (3) years, with one-third (1/3rd) of the Award vesting on the first anniversary of the Grant Date, one-third (1/3rd) of the Award vesting on the second anniversary of the Grant Date, and the remaining one-third (1/3rd) of the Award vesting on the third anniversary of the Grant Date] (each, a “Vesting Date”), provided, that the Grantee remains employed at the Company through such applicable Vesting Date;
(b)upon each Vesting Date, the vested portion of the Award shall promptly (but not later than sixty (60) calendar days thereafter) be paid out in Common Shares, cash or a combination of Common Shares or cash, as determined by the Committee; and
(c) where the Committee decides to settle all or a portion of the Grantee’s vested Awards in Common Shares, settlement shall be made by the issuance and delivery of one Common Share for each Restricted Share Unit which the Committee decides to settle in Common Shares. Where the Committee decides to settle all or a portion of the Grantee’s vested Awards in cash, a cash payment shall be made to the Grantee equal to the Fair Market Value determined as of the applicable [Vesting Date][settlement date] of the Award multiplied by the number of vested Restricted Share Units that the Committee wishes to settle in cash.
1



3.Termination of Employment. In the event that prior to the final Vesting Date, the Grantee’s Employment terminates because of death, the full Award shall vest and promptly (but not later than sixty (60) calendar days thereafter) be settled in the same manner as provided for in Section 2. In the event that prior to the final Vesting Date, the Grantee’s Employment terminates because of Disability, the Award shall remain outstanding and continue to vest and be settled in the same manner as provided for in Section 2. [In the event that prior to the final Vesting Date, the Grantee’s Employment terminates without Just Cause or for Good Reason (as defined in Grantee’s employment agreement with the Company) on or within one (1) year after a Change of Control, the Award will become fully vested and settled in accordance with Section 3.6 of the Plan.] Except as set forth in [Section 3.6 of the Plan in connection with a Change of Control and] this Section 3, in the event that prior to the final Vesting Date, the Grantee’s Employment terminates for any reason other than death or Disability, then the unvested portion of the Award shall be forfeited for no consideration. Notwithstanding anything to the contrary, to the extent the Grantee is party to an employment agreement with the Company and any payments or benefits in connection with an applicable termination of employment are contingent on the delivery of an effective release and waiver of claims, any accelerated vesting of the Award upon such termination of employment shall also be contingent on such release and waiver of claims.
4.Employment. Nothing in the Agreement shall interfere with or limit in any way the right of the Company to terminate the Grantee’s employment nor confer upon any Grantee any right to continue in the employ of the Company. For greater certainty, a Grantee’s termination of Employment will include both voluntary and involuntary terminations, and the involuntary termination of a Grantee’s Employment shall occur on the date that the Grantee ceases performing services for the Company on a permanent basis, whether such termination is lawful or otherwise, without regard to any required period of notice, pay in lieu of notice, severance pay or similar compensation or benefits (and without regard for any claim for damages in respect thereof), except as expressly required by applicable employment or labor standards legislation.
5.Non-Transferable. The rights or interests of the Grantee under this Agreement, including, without limitation, the Restricted Share Units, shall not be assignable or transferable, otherwise than in the case of death of the Grantee as set out in the Plan, and such rights or interests shall not be encumbered by any means.
6.Not Shares. The RSUs are not Common Shares, and the RSUs shall not entitle the Grantee to exercise voting rights or any other rights attaching to the ownership of Common Shares, including, without limitation, rights on liquidation
7.Withholding Taxes. The Grantee acknowledges and agrees that the Company has the right to deduct from any payments due to the Grantee any federal, state, provincial or local taxes required by law to be withheld with respect to the Award.
8.[Section 409A. Payments under this Agreement are intended to be exempt from or comply with Section 409A of the Internal Revenue Code (“Section 409A”) to the extent
2



applicable, and this Agreement shall be administered accordingly. Notwithstanding anything to the contrary contained in this Agreement or any employment agreement the Grantee has entered into with the Company (“Employment Agreement”), to the extent that any payment under this Agreement is determined by the Company to constitute “non-qualified deferred compensation” subject to Section 409A and is payable to the Grantee by reason of termination of the Grantee’s Employment, then (a) such payment shall be made to the Grantee only upon a “separation from service” as defined for purposes of Section 409A under applicable regulations and (b) if the Grantee is a “specified employee” (within the meaning of Section 409A and as determined by the Company), such payment shall not be made before the date that is six (6) months after the date of the Grantee’s separation from service (or the Grantee’s earlier death). Each payment under this Agreement shall be treated as a separate payment for purposes of Section 409A.]
9.Governing Law. The Plan and this Agreement shall be construed in accordance with and governed by the laws of the State of Delaware.
10.Binding Effect. This Agreement shall be binding upon and inure to the benefit of any successors to the Company and all persons lawfully claiming under Grantee. By accepting the Award on the terms set forth herein, the Grantee acknowledges and agrees to the matters and conditions set forth herein and in the Plan. The Grantee hereby further confirms and acknowledges receipt of a copy of the Plan.

3



IN WITNESS WHEREOF, this Agreement is executed by Cronos and by Grantee as of this _____ day of _________, 20__.

CRONOS GROUP INC.

        
By: [●]


The Grantee (a) accepts the Award, (b) agrees to be bound by, and comply with, the terms of the Plan and this Agreement, and (c) agrees that all decisions and determinations of the Administrator with respect to the Award shall be final and binding on the Grantee and any other person having or claiming an interest under the Award.


GRANTEE




        
(Name)

4

EX-10.3 5 a103rsuawardagreementi.htm EX-10.3 Document

Exhibit 10.3
FORM OF
CRONOS GROUP INC.
RESTRICTED SHARE UNIT AWARD AGREEMENT
(Applicable for Israeli Grantees)
This Restricted Share Unit Award Agreement (hereinafter referred to as the “Agreement”) is made and entered into this ________ day of _______, 20__ (the “Grant Date”) by and between Cronos Group Inc. (hereinafter referred to as “Cronos”) and [●] (hereinafter referred to as the “Grantee”), pursuant to the Cronos Group Inc. 2020 Omnibus Equity Incentive Plan (the “Plan”) and the Cronos Group Inc. Israeli Sub Plan (the “Sub-Plan” and, together with the Cronos Group Inc. 2020 Omnibus Equity Incentive Plan, the “Plans”). All terms and provisions of the Plan are hereby incorporated into and shall govern the Agreement except where general provisions of the Plan are superseded by particular provisions of the Agreement. All capitalized terms used in the Agreement shall have the same meaning given the terms in the Sub-Plan or, if not defined therein, the Plan. To the extent the Grantee is party to an employment agreement with the Company and any terms set forth herein conflict or are otherwise inconsistent with any terms or conditions set forth in Grantee’s employment agreement with the Company, the terms and conditions set forth in such employment agreement shall govern. In the event of a conflict or inconsistency between the terms of this Agreement and the terms of either the Plan or the Sub-Plan, the terms of this Agreement shall control.
1.Grant of Restricted Share Units. Cronos hereby grants the Grantee [●] Restricted Share Units (hereinafter referred to as the “RSUs” or the “Award”), which are subject to terms and conditions set forth below.
2.Tax Track of RSUs. The Award is granted as Capital Gain Award (CGA) under Section 102.
3.Expiration Date. [ _________ ]
4.Vesting and Settlement of RSUs. Subject to the terms and conditions of this Agreement and the Plans:
(a)the Award shall vest on [over three (3) years, with one-third (1/3rd) of the Award vesting on the first anniversary of the Grant Date, one-third (1/3rd) of the Award vesting on the second anniversary of the Grant Date, and the remaining one-third (1/3rd) of the Award vesting on the third anniversary of the Grant Date] (each, a “Vesting Date”), provided, that the Grantee remains employed at the Company through such applicable Vesting Date;
(b)upon each Vesting Date, the vested portion of the Award shall promptly (but not later than sixty (60) calendar days thereafter) be paid out in Common Shares, provided that Cronos shall have no obligation to issue Shares pursuant to the Agreement unless and until the Grantee has satisfied any applicable tax withholding obligations pursuant to
1



Section 10 below and such issuance otherwise complies with all applicable law. Cronos shall issue and register the Common Shares in the name of the Trustee for the benefit of the Grantee; and
(c)where the Committee settles the Grantee’s vested Awards in Common Shares, settlement shall be made by the issuance and delivery of one Common Share for each RSU.
5.Termination of Employment. In the event that prior to the final Vesting Date, the Grantee’s Employment terminates because of death, the full Award shall vest and promptly (but not later than sixty (60) calendar days thereafter) be settled in the same manner as provided for in Section 4. In the event that prior to the final Vesting Date, the Grantee’s Employment terminates because of Disability, the Award shall remain outstanding and continue to vest and be settled in the same manner as provided for in Section 4. [In the event that prior to the final Vesting Date, the Grantee’s Employment terminates without Just Cause or for Good Reason (as defined in Grantee’s employment agreement with the Company) on or within one (1) year after a Change of Control, the Award will become fully vested and settled in accordance with Section 3.6 of the Plan.] Except as set forth in [Section 3.6 of the Plan in connection with a Change of Control], in the event that prior to the final Vesting Date, the Grantee’s Employment terminates for any reason other than death or Disability, then the unvested portion of the Award shall be forfeited for no consideration. Notwithstanding anything to the contrary, to the extent the Grantee is party to an employment agreement with the Company and any payments or benefits in connection with an applicable termination of employment are contingent on the delivery of an effective release and waiver of claims, any accelerated vesting of the Award upon such termination of employment shall also be contingent on such release and waiver of claims.
6.Employment. Nothing in the Agreement shall interfere with or limit in any way the right of the Company to terminate the Grantee’s employment nor confer upon any Grantee any right to continue in the employ of the Company. For greater certainty, a Grantee’s termination of Employment will include both voluntary and involuntary terminations, and the involuntary termination of a Grantee’s Employment shall occur on the date that the Grantee ceases performing services for the Company on a permanent basis, whether such termination is lawful or otherwise, without regard to any required period of notice, pay in lieu of notice, severance pay or similar compensation or benefits (and without regard for any claim for damages in respect thereof), except as expressly required by applicable employment or labour standards legislation.
7.Non-Transferable. The rights or interests of the Grantee under this Agreement, including, without limitation, the RSUs, shall not be assignable or transferable, otherwise than in the case of death of the Grantee as set out in the Plan, and such rights or interests shall not be encumbered by any means.
2



8.Not Shares. The RSUs are not Common Shares, and the RSUs shall not entitle the Grantee to exercise voting rights or any other rights attaching to the ownership of Common Shares, including, without limitation, rights on liquidation.
9.Section 102 Awards.
Without derogating from the generality of the foregoing, to the extent and with respect to any RSUs that are granted as a Capital Gain Award (CGA), and as required by Section 102, the Grantee acknowledges, undertakes and confirms in writing the following:
(a)the Grantee shall comply with all terms and conditions set forth in Section 102 with regard to Capital Gain Award (CGA) and with the applicable rules and regulations promulgated thereunder, as amended from time to time;
(b)the Grantee is familiar with, and understand the provisions of, Section 102 in general, and the tax arrangement regarding the Capital Gain Award (CGA) in particular, and its tax consequences (including the marginal tax component that may apply pursuant to Section 102(b)(3) of the Ordinance); the Grantee agrees that the RSUs and Common Shares that may be issued upon settlement thereof (or otherwise in relation thereto), will be held by a Trustee for at least the duration of the Holding Period, as defined in Section 102. The Grantee understands that any release of such RSUs or Common Shares from the trust, or any sale of the Common Share prior to the termination of the Holding Period, will result in taxation at marginal tax rate, in addition to deductions of appropriate social security, health tax contributions or other compulsory payments; and
(c)the Grantee agrees to the Trust Agreement signed between Cronos, the relevant Affiliate and the Trustee appointed pursuant to Section 102 and shall sign all documents requested by Cronos, the relevant Affiliate or the Trustee, in accordance with and under the Trust Agreement.
10.Withholding Taxes. The Grantee acknowledges and agrees that Cronos and/or an Affiliate and/or the Trustee has the right to deduct from any payments due to the Grantee any taxes required by law to be withheld with respect to the Award and in accordance with the Plans and Applicable Law. Cronos and/or the Trustee shall not be required to release any Common Share certificate to the Grantee until all required payments have been fully made.
11.Trust. The RSUs and any Common Shares issued upon conversion thereof shall be held or controlled by the Trustee, as required under Section 102 in accordance with the provisions of Section 102, the Plans and this Agreement.
12.Tax Matters and Consultation.
(a)The Grantee is advised to consult with a tax advisor with respect to the tax consequences of receiving or exercising RSUs hereunder. Cronos or the relevant
3



Affiliate does not assume any responsibility to advise the Grantee on such matters, which shall remain solely the responsibility of the Grantee.
(b)Notwithstanding anything to the contrary herein or in the Plans and notwithstanding anything to the contrary, Cronos or an Affiliate shall be under no duty to ensure, and no representation or commitment is made, that the RSU qualifies or will qualify under any particular tax treatment (such as Section 102, CGA, OIA or any other treatment), nor shall Cronos or an Affiliate be required to take any action for the qualification of any RSU under such tax treatment. If the RSUs do not qualify under any particular tax treatment it could result in adverse tax consequences to the Grantee.
(c)By signing below, the Grantee agrees that Cronos, its Affiliates and their respective employees, directors, officers and shareholders shall not be liable for any tax, penalty, interest or cost incurred by the Grantee as a result of such determination, nor will any of them have any liability of any kind or nature in the event that, for any reason whatsoever, an RSU does not qualify for any particular tax treatment.
13.Governing Law. This Agreement shall be construed in accordance with and governed by the laws of the State of Israel.
14.Binding Effect. This Agreement shall be binding upon and inure to the benefit of any successors to the Company and all persons lawfully claiming under Grantee. By accepting the Award on the terms set forth herein, the Grantee acknowledges and agrees to the matters and conditions set forth herein and in the Plan. The Grantee hereby further confirms and acknowledges receipt of a copy of the Plan.

[Remainder of page intentionally left blank]

4



IN WITNESS WHEREOF, this Agreement is executed by Cronos and by Grantee as of this _____ day of _________, 20__.

CRONOS GROUP INC.

        
By: [●]




GRANTEE




        
(Name)
5

EX-31.1 6 a10-q22020311.htm EX-31.1 Document


Exhibit 31.1

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
PURSUANT TO SECTION 302 OF
THE SARBANES-OXLEY ACT OF 2002

I, Michael Gorenstein, certify that:
1.I have reviewed this Quarterly Report on Form 10-Q of Cronos Group Inc.;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

/s/ Michael Gorenstein
Michael Gorenstein
President and Chief Executive Officer
(Principal Executive Officer)

Date: August 6, 2020


EX-31.2 7 a10-q22020312.htm EX-31.2 Document


Exhibit 31.2

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER
PURSUANT TO SECTION 302 OF
THE SARBANES-OXLEY ACT OF 2002

I, Jerry Barbato, certify that:
1.I have reviewed this Quarterly Report on Form 10-Q of Cronos Group Inc.;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under  our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

/s/ Jerry Barbato
Jerry Barbato
Chief Financial Officer
(Principal Financial Officer)

Date: August 6, 2020


EX-32.1 8 a10-q22020321.htm EX-32.1 Document

Exhibit 32.1
 
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002
 
In connection with the Quarterly Report on Form 10-Q for the period ended June 30, 2020 of Cronos Group Inc. (the “Company”) as filed with the U.S. Securities and Exchange Commission (the “SEC”) on the date hereof (the “Report”), I, Michael Gorenstein, President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:
 
1.The Report fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and

2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
 
/s/ Michael Gorenstein
Michael Gorenstein
President and Chief Executive Officer
(Principal Executive Officer)

Date: August 6, 2020

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the SEC or its staff upon request.

This certification accompanies the Form 10-Q to which it relates, is not deemed filed with the SEC and is not to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Form 10-Q), irrespective of any general incorporation language contained in such filing.


EX-32.2 9 a10-q22020322.htm EX-32.2 Document

Exhibit 32.2
 
CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002
 
In connection with the Quarterly Report on Form 10-Q for the period ended June 30, 2020 of Cronos Group Inc. (the “Company”) as filed with the U.S. Securities and Exchange Commission (the “SEC”) on the date hereof (the “Report”), I, Jerry Barbato, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:
 
1.The Report fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and

2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
 
/s/ Jerry Barbato
Jerry Barbato
Chief Financial Officer
(Principal Financial Officer)

Date: August 6, 2020

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the SEC or its staff upon request.

This certification accompanies the Form 10-Q to which it relates, is not deemed filed with the SEC and is not to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Form 10-Q), irrespective of any general incorporation language contained in such filing.

EX-101.SCH 10 cron-20200630.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0001001 - Document - Cover Page link:presentationLink link:calculationLink link:definitionLink 1001002 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 1002003 - Statement - Condensed Consolidated Balance Sheet (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 1003004 - Statement - Condensed Consolidated Statements of Net Income and Comprehensive Income (Loss) link:presentationLink link:calculationLink link:definitionLink 1004005 - Statement - Condensed Consolidated Statements of Changes in Equity (Deficit) link:presentationLink link:calculationLink link:definitionLink 1005006 - Statement - Condensed Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 2101101 - Disclosure - Background link:presentationLink link:calculationLink link:definitionLink 2402401 - Disclosure - Background (Details) link:presentationLink link:calculationLink link:definitionLink 2103102 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 2204201 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 2305301 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 2406402 - Disclosure - Summary of Significant Accounting Policies (Details) link:presentationLink link:calculationLink link:definitionLink 2107103 - Disclosure - New Accounting Pronouncements link:presentationLink link:calculationLink link:definitionLink 2108104 - Disclosure - Revenues from Contracts with Customers link:presentationLink link:calculationLink link:definitionLink 2409403 - Disclosure - Revenues from Contracts with Customers (Details) link:presentationLink link:calculationLink link:definitionLink 2110105 - Disclosure - Inventory link:presentationLink link:calculationLink link:definitionLink 2311302 - Disclosure - Inventory (Tables) link:presentationLink link:calculationLink link:definitionLink 2412404 - Disclosure - Inventory (Details) link:presentationLink link:calculationLink link:definitionLink 2113106 - Disclosure - Investments and Advances to Joint Ventures link:presentationLink link:calculationLink link:definitionLink 2314303 - Disclosure - Investments and Advances to Joint Ventures (Tables) link:presentationLink link:calculationLink link:definitionLink 2415405 - Disclosure - Investments and Advances to Joint Ventures - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2416406 - Disclosure - Investments and Advances to Joint Ventures - Schedule of Equity Method Investments (Details) link:presentationLink link:calculationLink link:definitionLink 2417407 - Disclosure - Investments and Advances to Joint Ventures - Schedule of Advances to Joint Ventures (Details) link:presentationLink link:calculationLink link:definitionLink 2118107 - Disclosure - Other Investments link:presentationLink link:calculationLink link:definitionLink 2419408 - Disclosure - Other Investments (Details) link:presentationLink link:calculationLink link:definitionLink 2120108 - Disclosure - Accumulated Other Comprehensive Income (Loss) link:presentationLink link:calculationLink link:definitionLink 2321304 - Disclosure - Accumulated Other Comprehensive Income (Loss) (Tables) link:presentationLink link:calculationLink link:definitionLink 2422409 - Disclosure - Accumulated Other Comprehensive Income (Loss) (Details) link:presentationLink link:calculationLink link:definitionLink 2123109 - Disclosure - Leases link:presentationLink link:calculationLink link:definitionLink 2424410 - Disclosure - Leases (Details) link:presentationLink link:calculationLink link:definitionLink 2125110 - Disclosure - Loans Receivable, net link:presentationLink link:calculationLink link:definitionLink 2326305 - Disclosure - Loans Receivable, net (Tables) link:presentationLink link:calculationLink link:definitionLink 2427411 - Disclosure - Loans Receivable, net (Details) link:presentationLink link:calculationLink link:definitionLink 2128111 - Disclosure - Derivative Liabilities link:presentationLink link:calculationLink link:definitionLink 2329306 - Disclosure - Derivative Liabilities (Tables) link:presentationLink link:calculationLink link:definitionLink 2430412 - Disclosure - Derivative Liabilities - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2431413 - Disclosure - Derivative Liabilities - Schedule of Reconciliation of Carrying Amounts (Details) link:presentationLink link:calculationLink link:definitionLink 2432414 - Disclosure - Derivative Liabilities - Schedule of Fair Values of Derivative Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 2433415 - Disclosure - Derivative Liabilities - Schedule of Sensitivity Analysis (Details) link:presentationLink link:calculationLink link:definitionLink 2134112 - Disclosure - Property, Plant and Equipment link:presentationLink link:calculationLink link:definitionLink 2335307 - Disclosure - Property, Plant and Equipment (Tables) link:presentationLink link:calculationLink link:definitionLink 2436416 - Disclosure - Property, Plant and Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 2137113 - Disclosure - Intangible Assets and Goodwill link:presentationLink link:calculationLink link:definitionLink 2338308 - Disclosure - Intangible Assets and Goodwill (Tables) link:presentationLink link:calculationLink link:definitionLink 2439417 - Disclosure - Intangible Assets and Goodwill - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2440418 - Disclosure - Intangible Assets and Goodwill - Schedule of Intangible Assets (Details) link:presentationLink link:calculationLink link:definitionLink 2441419 - Disclosure - Intangible Assets and Goodwill - Schedule of Goodwill (Details) link:presentationLink link:calculationLink link:definitionLink 2142114 - Disclosure - General and Administrative Expenses link:presentationLink link:calculationLink link:definitionLink 2343309 - Disclosure - General and Administrative Expenses (Tables) link:presentationLink link:calculationLink link:definitionLink 2444420 - Disclosure - General and Administrative Expenses (Details) link:presentationLink link:calculationLink link:definitionLink 2145115 - Disclosure - Share-based Payments link:presentationLink link:calculationLink link:definitionLink 2346310 - Disclosure - Share-based Payments (Tables) link:presentationLink link:calculationLink link:definitionLink 2447421 - Disclosure - Share-based Payments - Summary of Changes in Warrants (Details) link:presentationLink link:calculationLink link:definitionLink 2448422 - Disclosure - Share-based Payments - Summary of Outstanding Warrants (Details) link:presentationLink link:calculationLink link:definitionLink 2449423 - Disclosure - Share-based Payments - Stock Options Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2450424 - Disclosure - Share-based Payments - Summary of the Changes in Options (Details) link:presentationLink link:calculationLink link:definitionLink 2451425 - Disclosure - Share-based Payments - Summary of Fair Value of Options Issued (Details) link:presentationLink link:calculationLink link:definitionLink 2452426 - Disclosure - Share-based Payments - Restricted Share Units Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2453427 - Disclosure - Share-based Payments - Summary of Restricted Share Units Activity (Details) link:presentationLink link:calculationLink link:definitionLink 2454428 - Disclosure - Share-based Payments - Summary of Deferred Share Units Activity (Details) link:presentationLink link:calculationLink link:definitionLink 2455429 - Disclosure - Share-based Payments - Deferred Share Units Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2156116 - Disclosure - Earnings (loss) Per Share link:presentationLink link:calculationLink link:definitionLink 2357311 - Disclosure - Earnings (loss) Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 2458430 - Disclosure - Earnings (loss) Per Share - Schedule of Earnings (Loss) Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 2459431 - Disclosure - Earnings (loss) Per Share - Schedule of Antidilutive Securities Excluded from Computation of Diluted Shares Outstanding (Details) link:presentationLink link:calculationLink link:definitionLink 2160117 - Disclosure - Related Party Transactions and Balances link:presentationLink link:calculationLink link:definitionLink 2461432 - Disclosure - Related Party Transactions and Balances (Details) link:presentationLink link:calculationLink link:definitionLink 2162118 - Disclosure - Segment Information link:presentationLink link:calculationLink link:definitionLink 2363312 - Disclosure - Segment Information (Tables) link:presentationLink link:calculationLink link:definitionLink 2464433 - Disclosure - Segment Information - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2465434 - Disclosure - Segment Information - Schedule of Segment Data (Details) link:presentationLink link:calculationLink link:definitionLink 2466435 - Disclosure - Segment Information - Schedule of Revenue from External Customers by Geographic Areas (Details) link:presentationLink link:calculationLink link:definitionLink 2467436 - Disclosure - Segment Information - Schedule of Long-lived Assets by Geographic Areas (Details) link:presentationLink link:calculationLink link:definitionLink 2168119 - Disclosure - Commitments link:presentationLink link:calculationLink link:definitionLink 2469437 - Disclosure - Commitments - R&D Commitments and Altria Consulting Services (Details) link:presentationLink link:calculationLink link:definitionLink 2470438 - Disclosure - Commitments - Use of Publicity Rights in Brand Development (Details) link:presentationLink link:calculationLink link:definitionLink 2471439 - Disclosure - Commitments - Take or Pay (Details) link:presentationLink link:calculationLink link:definitionLink 2172120 - Disclosure - Contingencies link:presentationLink link:calculationLink link:definitionLink 2473440 - Disclosure - Contingencies (Details) link:presentationLink link:calculationLink link:definitionLink 2174121 - Disclosure - Financial Instruments link:presentationLink link:calculationLink link:definitionLink 2475441 - Disclosure - Financial Instruments - Credit Risk Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2476442 - Disclosure - Financial Instruments - Liquidity Risk Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2477443 - Disclosure - Financial Instruments - Interest Rate Risk Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2478444 - Disclosure - Financial Instruments - Currency Rate Risk Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2179122 - Disclosure - Fair Value Measurement link:presentationLink link:calculationLink link:definitionLink 2380313 - Disclosure - Fair Value Measurement (Tables) link:presentationLink link:calculationLink link:definitionLink 2481445 - Disclosure - Fair Value Measurement (Details) link:presentationLink link:calculationLink link:definitionLink 2182123 - Disclosure - Supplementary Cash Flow Information link:presentationLink link:calculationLink link:definitionLink 2383314 - Disclosure - Supplementary Cash Flow Information (Tables) link:presentationLink link:calculationLink link:definitionLink 2484446 - Disclosure - Supplementary Cash Flow Information (Details) link:presentationLink link:calculationLink link:definitionLink 2185124 - Disclosure - Non-monetary Transactions link:presentationLink link:calculationLink link:definitionLink 2486447 - Disclosure - Non-monetary Transactions (Details) link:presentationLink link:calculationLink link:definitionLink 2187125 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 2488448 - Disclosure - Subsequent Events (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 11 cron-20200630_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 12 cron-20200630_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 13 cron-20200630_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Related Party Transactions [Abstract] Related Party Transactions [Abstract] Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table] Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table] Private Placements Private Placement [Member] Total shareholders’ equity Beginning balance Ending balance Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Transaction costs paid on construction loan payable Payments of Debt Issuance Costs Land Land [Member] Level 3 Fair Value, Inputs, Level 3 [Member] Rest of World Rest Of World Segment [Member] Rest Of World Segment [Member] Cronos Group, Inc. Cronos Group, Inc. [Member] Cronos Group, Inc. [Member] Establishment of a Commercial Cannabis Analytical Testing Laboratory Collaborative Arrangement, Transaction with Party to Collaborative Arrangement [Member] 2021 Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months Total current liabilities Liabilities, Current Number of milestones remaining Investment Owned, Number Of Milestones Remaining Investment Owned, Number Of Milestones Remaining Goodwill [Line Items] Goodwill [Line Items] One Major Customer One Major Customer [Member] One Major Customer [Member] Interest costs capitalized Interest Costs Capitalized Net Indefinite-lived Intangible Assets (Excluding Goodwill) Variable Interest Entity, Classification [Domain] Variable Interest Entity, Classification [Domain] Additions Goodwill, Acquired During Period Maximum additional subscription percentage Class Of Warrant Or Right, Maximum Additional Subscription Percentage Class Of Warrant Or Right, Maximum Additional Subscription Percentage Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Share issuance costs Stock Issued During Period, Value, New Issues, Issuance Costs Stock Issued During Period, Value, New Issues, Issuance Costs Purchase of Machinery and Equipment Purchase Of Machinery And Equipment [Member] Purchase Of Machinery And Equipment [Member] Property, Plant and Equipment, Type [Axis] Property, Plant and Equipment, Type [Axis] Loss Contingency [Abstract] Loss Contingency [Abstract] Issuances (in shares) Issuance of RSUs (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period Concentration Risk [Line Items] Concentration Risk [Line Items] Long term portion Financing Receivable, after Allowance for Credit Loss, Noncurrent [Abstract] New Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Exercise of warrants (in shares) Liabilities settled (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period Credit loss allowance Investments In And Advances To Affiliates, At Fair Value, Credit Loss, Expense (Reversal) Investments In And Advances To Affiliates, At Fair Value, Credit Loss, Expense (Reversal) Current Fiscal Year End Date Current Fiscal Year End Date United States United States Segment [Member] United States Segment [Member] Proceeds from Altria Investment Proceeds from Issuance of Common Stock Share price Sensitivity Analysis, Impact Of 10 Percent Decrease (Increase) In Share Price On Net Income (Loss) Sensitivity Analysis, Impact Of 10 Percent Decrease (Increase) In Share Price On Net Income (Loss) Cronos GrowCo Cronos Growing Company Inc. [Member] Cronos Growing Company Inc. [Member] Derivative [Line Items] Derivative [Line Items] Recorded Unconditional Purchase Obligation [Line Items] Recorded Unconditional Purchase Obligation [Line Items] Sensitivity Analysis, Impact of 10 Percent Decrease (Increase) on Net Income (Loss) [Abstract] Sensitivity Analysis, Impact Of 10 Percent Decrease (Increase) On Net Income (Loss) [Abstract] Sensitivity Analysis, Impact Of 10 Percent Decrease (Increase) On Net Income (Loss) [Abstract] Diluted (in shares) Weighted average number of common shares for computation of diluted income (loss) per share (in shares) Weighted Average Number of Shares Outstanding, Diluted Entity Address, Postal Zip Code Entity Address, Postal Zip Code Number of adult-use brands Number Of Adult-use Brands Number Of Adult-use Brands Top-up rights exercised (in shares) Stock Issued During Period, Shares, Top-up Rights Exercised Stock Issued During Period, Shares, Top-up Rights Exercised Derivative liability, additional subscription (in shares) Class Of Warrant Or Right, Additional Subscription, Number Of Securities Called By Warrants Or Rights Class Of Warrant Or Right, Additional Subscription, Number Of Securities Called By Warrants Or Rights Number of options outstanding (in shares) Balance at beginning of period (in shares) Balance at end of period (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Impairment charges Indefinite-lived Intangible Assets (Excluding Goodwill), Accumulated Impairment Indefinite-lived Intangible Assets (Excluding Goodwill), Accumulated Impairment Shares issued Stock Issued During Period, Value, New Issues Canada CANADA Sale of Stock, Performance Milestone Two Sale Of Stock, Performance Milestone Two [Member] Sale Of Stock, Performance Milestone Two Accelerated share-based compensation costs Share-based Payment Arrangement, Accelerated Cost Advance from non-controlling interests Proceeds from Noncontrolling Interests Property, plant and equipment Total Property, Plant and Equipment, Net Accumulated other comprehensive income (loss) AOCI Attributable to Parent [Member] Total assets Total assets Assets Consolidated balance sheets Segment Reporting Information, Additional Information [Abstract] Exercise of options (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Entity Shell Company Entity Shell Company Cover page. Cover [Abstract] Altria Pinnacle LLC. Altria Pinnacle LLC. [Member] Altria Pinnacle LLC. [Member] Derivative Instruments [Roll Forward] Derivative Instruments [Roll Forward] Derivative Instruments [Roll Forward] Commitments Commitments Disclosure [Text Block] Document Type Document Type Litigation Relating to Marketing, Distribution and Sale of Products Unfavorable Regulatory Action [Member] Cronos Group, Inc. Subsidiaries [Member] Pending Litigation Pending Litigation [Member] Prepaids and other assets Increase (Decrease) Prepaid Expenses And Other Assets Increase (Decrease) Prepaid Expenses And Other Assets Subsequent Event Subsequent Event [Member] Summary of Outstanding Warrants Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block] Loss Contingencies [Line Items] Loss Contingencies [Line Items] NatuEra Series A Loan NatuEra Series A Loan [Member] NatuEra Series A Loan [Member] Scenario [Domain] Scenario [Domain] Construction in progress Construction in Progress [Member] Purchase of property, plant and equipment, net Property, Plant and Equipment, Additions Share-based Payment Arrangement [Abstract] Share-based Payment Arrangement [Abstract] Subscription price (per share in C$) Measurement Input, Subscription Price [Member] Measurement Input, Subscription Price [Member] Derivative Instruments and Hedging Activities Disclosure [Abstract] Derivative Instruments and Hedging Activities Disclosure [Abstract] Ownership percentage Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage Accounts receivable Increase (Decrease) in Accounts Receivable Current liabilities Liabilities, Current [Abstract] Property, Plant and Equipment, Type [Domain] Property, Plant and Equipment, Type [Domain] Collaboration agreement, percentage of profits to be received, triggering event, subsequent to maximum percentage of amounts advanced being met Collaborative Arrangement, Percentage Of Profits To Be Received, Triggering Event, Subsequent To Maximum Percentage Of Amounts Advanced Being Met Collaborative Arrangement, Percentage Of Profits To Be Received, Triggering Event, Subsequent To Maximum Percentage Of Amounts Advanced Being Met Segment Information Segment Reporting Disclosure [Text Block] Effect of foreign currency translation on cash and cash equivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Equity [Abstract] Equity [Abstract] Cancellation, forfeiture and expiry of options (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period Top-up Rights – market price Top-Up Rights - Market Price [Member] Top-Up Rights - Market Price [Member] Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Document Quarterly Report Document Quarterly Report Commitments and contingencies Commitments and Contingencies Expected annualized volatility Sensitivity Analysis, Impact Of 10 Percent Decrease (Increase) In Expected Annualized Volatility On Net Income (Loss) Sensitivity Analysis, Impact Of 10 Percent Decrease (Increase) In Expected Annualized Volatility On Net Income (Loss) Debt and Equity Securities, FV-NI [Line Items] Debt and Equity Securities, FV-NI [Line Items] Litigation Status [Domain] Litigation Status [Domain] Cash and cash equivalents, beginning of period Cash and cash equivalents, end of period Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Schedule of Variable Interest Entities [Table] Schedule of Variable Interest Entities [Table] Number of hemp-derived cannabidiol personal care brands Number Of Hemp-derived Personal Care Brands Number Of Hemp-derived Personal Care Brands Dry Cannabis Inventory, Dry Cannabis [Member] Inventory, Dry Cannabis [Member] Consolidation Items [Domain] Consolidation Items [Domain] Exercise price (in dollars per share) Class of Warrant or Right, Exercise Price of Warrants or Rights Purchased Cannabis Resin and Sold Cannabis Dry Flower Exchange of Product Held-for-sale for Similar Product [Member] Exercisable (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number Risks and Uncertainties [Abstract] Risks and Uncertainties [Abstract] Long term portion of loans receivable, before accrued interest Financing Receivable, Before Accrued Interest, Noncurrent Financing Receivable, Before Accrued Interest, Noncurrent Sale of stock, price per share (in aud per share) Sale of Stock, Price Per Share Entity File Number Entity File Number Vesting period Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period Lessee, Lease, Description [Line Items] Lessee, Lease, Description [Line Items] Net income (loss) per share Earnings Per Share, Basic and Diluted [Abstract] Schedule of Consolidated Entities Schedule of Sale of Stock by Subsidiary or Equity Method Investee Disclosure [Table Text Block] Indefinite-lived intangible assets acquired, fair value Indefinite-lived Intangible Assets Acquired Impairment of intangible assets, indefinite-lived (excluding goodwill) Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) Segments [Axis] Segments [Axis] Cumulative effect from adoption of ASU 2016-01 Cumulative Effect of New Accounting Principle in Period of Adoption Collaboration agreement, profits to be received, maximum percentage of amounts advanced Collaborative Arrangement, Profits To Be Received, Maximum Percentage Of Amounts Advanced Collaborative Arrangement, Profits To Be Received, Maximum Percentage Of Amounts Advanced Net income (loss) attributable to: Net Income (Loss), Including Portion Attributable to Noncontrolling Interest [Abstract] Document Fiscal Period Focus Document Fiscal Period Focus Depreciation expense included in costs of sales Cost, Depreciation Take or pay supply agreement, term of agreement Recorded Unconditional Purchase Obligation, Term Of Agreement Recorded Unconditional Purchase Obligation, Term Of Agreement Punitive damages sought Loss Contingency, Punitive Damages Sought, Value Loss Contingency, Punitive Damages Sought, Value Goodwill [Roll Forward] Goodwill [Roll Forward] Ownership percentage, if warrant exercised Subsidiary Or Equity Method Investee, Cumulative Percentage Ownership After All Transactions, If Warrants Exercised Subsidiary Or Equity Method Investee, Cumulative Percentage Ownership After All Transactions, If Warrants Exercised Product and Service [Domain] Product and Service [Domain] Exercise price, volume-weighted average price, measurement period Class Of Warrant Or Right, Exercise Price, Volume-Weighted Average Price, Measurement Period Class Of Warrant Or Right, Exercise Price, Volume-Weighted Average Price, Measurement Period Advances to joint ventures, allowance for credit loss Advances To Affiliate, Allowance For Credit Loss Advances To Affiliate, Allowance For Credit Loss Summary of Fair Value of Options Issued Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Derivative Instruments, Gain (Loss) [Table] Derivative Instruments, Gain (Loss) [Table] Exercise of warrants (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Operating loss Operating Income (Loss) Beginning balance Ending balance Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis with Unobservable Inputs Accounts, Notes, Loans and Financing Receivable [Line Items] Accounts, Notes, Loans and Financing Receivable [Line Items] Goodwill Balance at beginning of period Balance at end of period Goodwill Goodwill Summary of Restricted Share Units Activity Share-based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block] Measurement Frequency [Domain] Measurement Frequency [Domain] Segments [Domain] Segments [Domain] Adjustments for New Accounting Pronouncements [Axis] Adjustments for New Accounting Pronouncements [Axis] Statement [Line Items] Statement [Line Items] Net revenue Net revenue Revenue from Contract with Customer, Excluding Assessed Tax Goodwill and Intangible Assets Disclosure [Abstract] Goodwill and Intangible Assets Disclosure [Abstract] Societe Quebecoise Du Cannabis Societe Quebecoise du Cannabis [Member] Societe Quebecoise du Cannabis Other comprehensive income (loss) Other Comprehensive Income (Loss), Net of Tax [Abstract] Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Basic (in dollars per share) Basic earnings per share (in dollars per share) Earnings Per Share, Basic Inventory Inventory Disclosure [Text Block] Advances to joint ventures recovered from (applied to) carrying amount of investments Investments In And Advances To Affiliates, At Fair Value, Recovered From (Applied To) Equity Method Investment Investments In And Advances To Affiliates, At Fair Value, Recovered From (Applied To) Equity Method Investment Credit Concentration Risk Credit Concentration Risk [Member] Balance at beginning of period (in dollars per share) Balance at end of period (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Advances on loans receivable Draw downs Payments to Acquire Loans Receivable Cronos Group Comprehensive Income (Loss), Net of Tax, Attributable to Parent Plan Name [Axis] Plan Name [Axis] Vesting of options APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Subsequent Event Type [Axis] Subsequent Event Type [Axis] Supplies and consumables Inventory, Supplies, Net of Reserves Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Subsidiary or Equity Method Investee [Line Items] Subsidiary or Equity Method Investee [Line Items] Amendment Flag Amendment Flag Schedule of Finite-Lived Intangible Assets Schedule of Finite-Lived Intangible Assets [Table Text Block] Cronos Australia Cronos Australia Limited [Member] Cronos Australia Limited [Member] Schedule of Net Changes in Non-Cash Working Capital Cash Flow, Operating Capital [Table Text Block] Weighted average exercise price (C$) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Inventory, Current [Table] Inventory, Current [Table] Increase (Decrease) in Operating Capital [Abstract] Increase (Decrease) in Operating Capital [Abstract] Beginning balance (in shares) Ending balance (in shares) Common Stock, Shares, Outstanding Level 1 Fair Value, Inputs, Level 1 [Member] Consolidation Items [Axis] Consolidation Items [Axis] Customer [Axis] Customer [Axis] Derivative transaction costs Class Of Warrant Or Right, Expense Class Of Warrant Or Right, Expense Interest expense Interest Expense Research and Development Arrangement Research and Development Arrangement [Member] Exercise of Rights Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Settlements Adjustment for gain (loss) on revaluation of derivative liabilities Dilutive Securities, Effect on Basic Earnings Per Share Plan Name [Domain] Plan Name [Domain] Nonmonetary Transaction Type [Axis] Nonmonetary Transaction Type [Axis] Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items] Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items] Inventory write-down Inventory Write-down Share of loss from investments in equity accounted investees Share of loss from investments in equity accounted investees Share of earnings (loss) from investments in equity accounted investees Share of loss from investments in equity accounted investees Income (Loss) from Equity Method Investments Loss Contingency Nature [Axis] Loss Contingency Nature [Axis] Local Phone Number Local Phone Number Long-term Purchase Commitment, Category of Item Purchased [Domain] Long-term Purchase Commitment, Category of Item Purchased [Domain] Proceeds from sale of equity securities, FV-NI Proceeds From Sale Of Equity Securities, FV-NI Proceeds From Sale Of Equity Securities, FV-NI Accounts payable and other liabilities Increase (Decrease) in Accounts Payable and Other Operating Liabilities Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] Advance of loans payable Proceeds from Notes Payable Vesting of common shares issued in connection with the use of certain publicity rights in brand development Stock Issued During Period, Value, Issued for Services Equity Method Investments and Joint Ventures [Abstract] Equity Method Investments and Joint Ventures [Abstract] Schedule of Property, Plant & Equipment, Useful Lives Property, Plant and Equipment [Table Text Block] Investments in and Advances to Affiliates [Line Items] Investments in and Advances to Affiliates [Line Items] Accounts receivable Accounts Receivable, after Allowance for Credit Loss, Current Due on demand, intended demand term, minimum Financing Receivable, Due On Demand, Intended Demand Term, Minimum Financing Receivable, Due On Demand, Intended Demand Term, Minimum Property, Plant and Equipment [Abstract] Property, Plant and Equipment [Abstract] Fair Value Measurement Inputs and Valuation Techniques [Line Items] Fair Value Measurement Inputs and Valuation Techniques [Line Items] Total other income (loss) Nonoperating Income (Expense) Additional paid-in capital Additional Paid in Capital Finished goods Inventory, Finished Goods, Net of Reserves Equity Securities Equity Securities [Member] Work-in-progress Inventory, Work in Process, Net of Reserves Disposal of intangible assets Indefinite-lived Intangible Assets, Written off Related to Sale of Business Unit Schedule of Revenues from External Customers and Long-Lived Assets [Table] Schedule of Revenues from External Customers and Long-Lived Assets [Table] Payments subject to milestones Long-term Purchase Commitment, Payments Subject To Milestones Long-term Purchase Commitment, Payments Subject To Milestones Prepaids and other assets Prepaid Expense and Other Assets, Current Issuance of options (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross Cannasoul Cannasoul Analytics Ltd. [Member] Cannasoul Analytics Ltd. Options exercised (in shares) Exercise of options (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Non-controlling interests Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest Altria Warrant Altria Warrant Altria Warrant [Member] Altria Warrant [Member] Number of alleged shareholders Loss Contingency, Number of Plaintiffs Operating lease, extension term (up to) Lessee, Operating Lease, Renewal Term Total current assets Assets, Current Entity Current Reporting Status Entity Current Reporting Status Pre-emptive Rights Pre-emptive Rights Pre-emptive Rights [Member] Pre-emptive Rights [Member] New Accounting Pronouncements and Changes in Accounting Principles [Abstract] New Accounting Pronouncements and Changes in Accounting Principles [Abstract] Increase (decrease) in cash and cash equivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Expected annualized volatility Measurement Input, Price Volatility [Member] Cronos Group Net Income (Loss) Attributable to Parent ERP System Enterprise Resource Planning System [Member] Enterprise Resource Planning System Share capital Common Shares Common Stock [Member] Current portion of loans receivable Total current portion of loans receivable Financing Receivable, after Allowance for Credit Loss, Current Current assets Assets, Current [Abstract] 2025 Finite-Lived Intangible Assets, Amortization Expense, Year Five Amount of commitment Long-term Purchase Commitment, Amount Leases [Abstract] Leases [Abstract] Interest income, net Interest income, net Interest Income (Expense), Nonoperating, Net Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Long-term Purchase Commitment [Table] Long-term Purchase Commitment [Table] Weighted average number of outstanding shares Earnings Per Share, Basic and Diluted, Other Disclosures [Abstract] Net income (loss) Net (loss) income Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Loss Contingency, Nature [Domain] Loss Contingency, Nature [Domain] Product and Service [Axis] Product and Service [Axis] Affiliated Entity Affiliated Entity [Member] Net Income (Loss) Available to Common Stockholders, Diluted [Abstract] Net Income (Loss) Available to Common Stockholders, Diluted [Abstract] Entity Small Business Entity Small Business Top-up Rights – fixed price Top-Up Rights - Fixed Price [Member] Top-Up Rights - Fixed Price [Member] Scenario [Axis] Scenario [Axis] Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Gain (loss) recognized on transfer Nonmonetary Transaction, Gain (Loss) Recognized on Transfer Research funding period Long-term Purchase Commitment, Period Entity Filer Category Entity Filer Category October 8 – 28, 2015 Granted Range 1 [Member] Granted Range 1 Sale Of Stock, Performance Milestone [Axis] Sale Of Stock, Performance Milestone [Axis] Sale Of Stock, Performance Milestone Share-based payments Vesting of issued RSUs Share-based Payment Arrangement, Expense Corporate Corporate, Non-Segment [Member] Related Party Transaction [Domain] Related Party Transaction [Domain] Total liabilities and shareholders’ equity Liabilities and Equity Entity Address, City or Town Entity Address, City or Town Impact of change in average variable rate, amount Sensitivity Analysis Of Interest Rate Risk Income Statement Impact, Impact Of Change In Average Variable Rate On Interest Income Sensitivity Analysis Of Interest Rate Risk Income Statement Impact, Impact Of Change In Average Variable Rate On Interest Income Investments in and Advances to Affiliates, at Fair Value [Roll Forward] Investments in and Advances to Affiliates, at Fair Value [Roll Forward] Concentration risk, percentage Concentration Risk, Percentage Receivable Type [Axis] Receivable Type [Axis] Financing and transaction costs Debt Related Commitment Fees and Debt Issuance Costs Loss Contingencies [Table] Loss Contingencies [Table] Lease obligation Operating Lease, Liability, Noncurrent Other Other General and Administrative Expense Variable Interest Entities [Axis] Variable Interest Entities [Axis] Operating expenses Operating Expenses [Abstract] Loss (gain) on revaluation Share-based Payment Arrangement, Gain (Loss) On Revaluation Share-based Payment Arrangement, Gain (Loss) On Revaluation Basis of Consolidation Consolidation, Policy [Policy Text Block] Document Fiscal Year Focus Document Fiscal Year Focus Sale of stock, number of shares issued in transaction (in shares) Sale of Stock, Number of Shares Issued in Transaction Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Number of transactions Nonmonetary Transaction, Number Of Transactions Nonmonetary Transaction, Number Of Transactions Derivative liabilities Derivative Liability Subsequent Events Subsequent Events [Text Block] Supplementary Cash Flow Information Cash Flow, Supplemental Disclosures [Text Block] May 13 – 27, 2016 Granted Range Two [Member] Granted Range Two Cost Intangible Assets, Gross (Excluding Goodwill) Weighted Average Amortization Period (in years) Finite-Lived Intangible Asset, Useful Life Net unrealized gain (loss) on revaluation and disposal of other investments AOCI, Accumulated Gain (Loss), Revaluation And Disposal Of Other Investments, Parent [Member] [Member] AOCI, Accumulated Gain (Loss), Revaluation And Disposal Of Other Investments, Parent [Member] Litigation Case [Domain] Litigation Case [Domain] Nonmonetary Transaction, by Type [Table] Nonmonetary Transaction, by Type [Table] Financial Instruments Concentration Risk Disclosure [Text Block] Nonmonetary Transaction [Line Items] Nonmonetary Transaction [Line Items] Fair Value, Recurring Fair Value, Recurring [Member] Effect from foreign exchange Investments In And Advances To Affiliates, At Fair Value, Changes Due To Currency Translation Investments In And Advances To Affiliates, At Fair Value, Changes Due To Currency Translation Current expected credit loss Accounts Receivable, Allowance for Credit Loss, Current Schedule of Antidilutive Securities Excluded from Computation of Diluted Shares Outstanding Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Albert Gaming, Liquor and Cannabis Commission Albert Gaming, Liquor And Cannabis Commission [Member] Albert Gaming, Liquor And Cannabis Commission Award Type [Axis] Award Type [Axis] Recorded Unconditional Purchase Obligation [Table] Recorded Unconditional Purchase Obligation [Table] Three Vendors Three Vendors [Member] Three Vendors [Member] Other income (loss) Other Nonoperating Income (Expense) Schedule of Equity Method Investments [Table] Schedule of Equity Method Investments [Table] Subsequent Events [Abstract] Revenues from External Customers and Long-Lived Assets [Line Items] Revenues from External Customers and Long-Lived Assets [Line Items] Israeli Codes Israeli Codes, Licensing Agreements [Member] Israeli Codes, Licensing Agreements [Member] Balance as of January 1, 2020 Balance as of June 30, 2020 Deferred Compensation Share-based Arrangements, Liability, Current and Noncurrent Related Party Transactions and Balances Related Party Transactions Disclosure [Text Block] Non-cash sales and marketing Noncash Selling And Marketing Expense Noncash Selling And Marketing Expense Non-controlling interests Net Income (Loss) Attributable to Noncontrolling Interest Accumulated other comprehensive income (loss) Accumulated Other Comprehensive Income (Loss), Net of Tax Allowance for credit loss Financing Receivable, Allowance for Credit Loss Impact of change in average variable rate, percent Sensitivity Analysis Of Interest Rate Risk Income Statement Impact, Impact Of Change In Average Variable Rate On Interest Income, Percent Sensitivity Analysis Of Interest Rate Risk Income Statement Impact, Impact Of Change In Average Variable Rate On Interest Income, Percent Geographical [Axis] Geographical [Axis] Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Inventory [Line Items] Inventory [Line Items] Retained earnings Retained Earnings [Member] Collaboration agreement, amount of advances Collaborative Arrangement, Amount Of Advances Collaborative Arrangement, Amount Of Advances Subsequent Event Type [Domain] Subsequent Event Type [Domain] Land, Buildings and Equipment Land, Buildings And Equipment [Member] Land, Buildings And Equipment Subsequent Event [Line Items] Subsequent Event [Line Items] Leases Lessee, Operating Leases [Text Block] Weighted average risk-free interest rate Measurement Input, Risk Free Interest Rate [Member] Cronos GrowCo Credit Facility Cronos GrowCo Credit Facility [Member] Cronos GrowCo Credit Facility [Member] Liabilities Liabilities [Abstract] Document Period End Date Document Period End Date Weighted Average Number of Shares Outstanding Reconciliation [Abstract] Weighted Average Number of Shares Outstanding Reconciliation [Abstract] Interest received Interest Received, Net Interest Received, Net Statement [Table] Statement [Table] Entity Registrant Name Entity Registrant Name Investment, Name [Domain] Investment, Name [Domain] Intangible Assets and Goodwill Goodwill and Intangible Assets Disclosure [Text Block] Variable Interest Entity, Primary Beneficiary Variable Interest Entity, Primary Beneficiary [Member] Impairment loss on goodwill and intangible assets Impairment loss on goodwill and intangible assets Goodwill and Intangible Asset Impairment Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] 2645485 Ontario Inc. Mucci Promissory Note 2645485 Ontario Inc. Mucci Promissory Note [Member] 2645485 Ontario Inc. Mucci Promissory Note [Member] Weighted average Black-Scholes value at grant date (per option) (in dollars per share) Share-based Compensation Arrangement By Share-based Payment Award, Fair Value Assumptions, Weighted Average Grant Date Fair Value Share-based Compensation Arrangement By Share-based Payment Award, Fair Value Assumptions, Weighted Average Grant Date Fair Value Repayment of lease obligations Payments For Lease Obligations, Financing Activities Payments For Lease Obligations, Financing Activities Investing activities Net Cash Provided by (Used in) Investing Activities [Abstract] Maximum Maximum [Member] Sale Of Stock, Performance Milestone [Domain] Sale Of Stock, Performance Milestone [Domain] Sale Of Stock, Performance Milestone Investments by Consolidated and Nonconsolidated Entities [Domain] Investments by Consolidated and Nonconsolidated Entities [Domain] Investments by Consolidated and Nonconsolidated Entities Trademarks Trademarks [Member] Measurement Input Type [Domain] Measurement Input Type [Domain] Receivables [Abstract] Receivables [Abstract] Related Party [Domain] Related Party [Domain] Damages sought Loss Contingency, Damages Sought, Value Face amount Financing Receivable, Face Amount Financing Receivable, Face Amount Net income (loss) attributable to common shareholders of Cronos Group Net income (loss) used in the computation of basic earnings per share Net Income (Loss) Available to Common Stockholders, Basic Share price at grant date (in dollars per share) Share Price Outstanding Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Cannasoul Collaboration Loan Cannasoul Collaboration Loan [Member] Cannasoul Collaboration Loan Short-term investments Debt Securities, Available-for-sale Ownership [Axis] Ownership [Axis] Cannabis flower Cannabis Flower [Member] Cannabis Flower [Member] Supplier Concentration Risk Supplier Concentration Risk [Member] Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Add: Accrued interest Financing Receivable, Accrued Interest, Noncurrent Financing Receivable, Accrued Interest, Noncurrent Schedule of Loan Receivable Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block] Retained earnings Retained Earnings (Accumulated Deficit) Accounts payable and other liabilities Accounts Payable and Other Accrued Liabilities, Current Payment of accrued interest on construction loan payable Interest Paid, Capitalized, Investing Activities Accounts receivable, threshold period past due, writeoff Accounts Receivable, Noncurrent, Threshold Period Past Due, Writeoff Face amount Debt Instrument, Face Amount Diluted (in dollars per share) Diluted earnings per share (in dollars per share) Earnings Per Share, Diluted Long-lived assets Long-Lived Assets Shareholders’ equity Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract] Number of reportable segments Number of Reportable Segments Class of Warrant or Right [Axis] Class of Warrant or Right [Axis] Net changes in non-cash working capital Total Increase (Decrease) in Operating Capital Sales and marketing Selling and Marketing Expense Accrual for consulting services Accounts Payable, Related Parties, Current Trading Symbol Trading Symbol Deferred Share Units (DSUs) Deferred Share Units (DSUs) [Member] Deferred Share Units (DSUs) [Member] Minimum Minimum [Member] Warrants exercised (in shares) Share-based Compensation Arrangement By Share-based Payment Award, Warrants, Exercises In Period Share-based Compensation Arrangement By Share-based Payment Award, Warrants, Exercises In Period Non-controlling interests Stockholders' Equity Attributable to Noncontrolling Interest Take or pay supply agreement, purchase amount Recorded Unconditional Purchase Obligation Other Product and Service, Other [Member] Accounts Payable Accounts Payable [Member] Nonmonetary Transactions [Abstract] 2022 Finite-Lived Intangible Assets, Amortization Expense, Year Two Investments, Debt and Equity Securities [Abstract] Investments, Debt and Equity Securities [Abstract] Foreign exchange gain (loss) on translation Foreign exchange gain (loss) on translation Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Gain on disposal of other investments Equity Method Investment, Realized Gain (Loss) on Disposal Recorded Unconditional Purchase Obligation by Category of Item Purchased [Axis] Recorded Unconditional Purchase Obligation by Category of Item Purchased [Axis] Raw materials Inventory, Raw Materials, Net of Reserves Legal Entity [Axis] Legal Entity [Axis] Triggering event, shares issued, value Sale Of Stock, Performance Milestone, Triggering Event, Shares Issued, Value Sale Of Stock, Performance Milestone, Triggering Event, Shares Issued, Value Statistical Measurement [Domain] Statistical Measurement [Domain] Review costs related to restatement of 2019 interim financial statements Restatement Review Expense Restatement Review Expense Weight average expected life (in years) Measurement Input, Expected Term [Member] 2020 Omnibus Plan 2020 Omnibus Plan [Member] 2020 Omnibus Plan Cash flows provided (used) in financing activities Net Cash Provided by (Used in) Financing Activities General and Administrative Expenses Additional Financial Information Disclosure [Text Block] OGBC OGBC Reporting Unit [Member] OGBC Reporting Unit [Member] Expected dividend yield Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate Entity [Domain] Entity [Domain] Excise taxes Excise and Sales Taxes Inventory Disclosure [Abstract] Inventory Disclosure [Abstract] Income tax expense Income tax expense Income Tax Expense (Benefit) Share-based Payments Share-based Payment Arrangement [Text Block] Altria Group, Inc. Altria Group, Inc. [Member] Altria Group, Inc. [Member] Subsidiary, Sale of Stock [Line Items] Subsidiary, Sale of Stock [Line Items] Vesting [Axis] Vesting [Axis] Technion Technion Research And Development Foundation [Member] Technion Research And Development Foundation [Member] Contingencies Contingencies Disclosure [Text Block] Health Canada licenses Health Canada Licensing Agreements [Member] Health Canada Licensing Agreements [Member] Computer equipment Computer Equipment [Member] Revenue from Contract with Customer [Abstract] Revenue from Contract with Customer [Abstract] Cannabis extracts Cannabis Extracts [Member] Cannabis Extracts [Member] Class of Warrant or Right [Domain] Class of Warrant or Right [Domain] Four Customers Four Customers [Member] Four Customers City Area Code City Area Code Weighted average remaining contractual term (years) Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Lord Jones brand Trade Names [Member] Summary of Changes in Warrants and DSUs Share-based Payment Arrangement, Outstanding Award, Activity, Excluding Option [Table Text Block] Proceeds from sale of other investments Proceeds From Equity Securities, FV-NI And Equity Securities Without Determinable Fair Value Proceeds From Equity Securities, FV-NI And Equity Securities Without Determinable Fair Value Intangible assets Net Intangible Assets, Net (Excluding Goodwill) Title of 12(b) Security Title of 12(b) Security Related Party [Axis] Related Party [Axis] Weighted average exercise price of options exercisable (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price Add: Accrued interest Financing Receivable, Accrued Interest, Current Financing Receivable, Accrued Interest, Current Risk-free interest rate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Investments by Consolidated and Nonconsolidated Entities [Axis] Investments by Consolidated and Nonconsolidated Entities [Axis] Investments by Consolidated and Nonconsolidated Entities Counterparty Name [Axis] Counterparty Name [Axis] Earnings Per Share [Abstract] Earnings Per Share [Abstract] Schedule of Fair Values of Derivative Liabilities Fair Value Measurement Inputs and Valuation Techniques [Table Text Block] Triggering event, minimum revenue Sale Of Stock, Performance Milestone, Triggering Event, Minimum Revenue Sale Of Stock, Performance Milestone, Triggering Event, Minimum Revenue Concentration Risk [Table] Concentration Risk [Table] Revenue recognized Nonmonetary Transaction, Gross Operating Revenue Recognized Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] 2018 Stock Option Plan 2018 Stock Option Plan [Member] 2018 Stock Option Plan [Member] Schedule of Goodwill [Table] Schedule of Goodwill [Table] Other, net Other Noncash Income (Expense) Derivative liabilities Derivative Liability, Current Operating lease, number of contracts Lessee, Operating Lease, Number Of Contracts Lessee, Operating Lease, Number Of Contracts Effect of foreign exchange Goodwill, Foreign Currency Translation Gain (Loss) Software Computer Software, Intangible Asset [Member] Award Date [Axis] Award Date [Axis] Income (loss) before income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Furniture and equipment Furniture and Fixtures [Member] Fair Value Measurement Inputs and Valuation Techniques [Table] Fair Value Measurement Inputs and Valuation Techniques [Table] Assets Assets [Abstract] Expected life Derivative Liability, Useful Life, Term Derivative Liability, Useful Life, Term Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Table] Two Customers Two Customers [Member] Two Customers 2015 Stock Option Plan 2015 Stock Option Plan [Member] 2015 Stock Option Plan [Member] Schedule of Accounts, Notes, Loans and Financing Receivable [Table] Schedule of Accounts, Notes, Loans and Financing Receivable [Table] 2023 Finite-Lived Intangible Assets, Amortization Expense, Year Three Schedule of Accumulated Other Comprehensive Income (Loss) Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Loans Receivable, net Loans, Notes, Trade and Other Receivables, Excluding Allowance for Credit Losses [Text Block] Schedule of Reconciliation of Carrying Amounts Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Operating activities Net Cash Provided by (Used in) Operating Activities [Abstract] Background Nature of Operations [Text Block] Other Investments Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block] Total operating expenses Operating Expenses Schedule of Equity Method Investments Equity Method Investments [Table Text Block] Cronos Israel G.S. Pharmacies Ltd. Cronos Israel G.S. Pharmacies Ltd. [Member] Cronos Israel G.S. Pharmacies Ltd. [Member] Other income (expense) Nonoperating Income (Expense) [Abstract] Consulting Services Consulting Services [Member] Consulting Services [Member] Number of strategic joint ventures Number Of Strategic Joint Ventures Number Of Strategic Joint Ventures Shares received (in shares) Investment Owned, Number Of Shares Received Investment Owned, Number Of Shares Received Number of continents with international production and distribution Number Of Continents With International Production And Distribution Number Of Continents With International Production And Distribution Schedule of Segment Data Schedule of Segment Reporting Information, by Segment [Table Text Block] Segment Reporting [Abstract] Segment Reporting [Abstract] Peace Naturals Peace Naturals Reporting Unit [Member] Peace Naturals Reporting Unit [Member] Options exercised Stock Issued During Period, Value, Stock Options Exercised Cumulative effect from foreign exchange Increase (Decrease) In Cumulative Foreign Exchange Effect Increase (Decrease) In Cumulative Foreign Exchange Effect Net Finite-Lived Intangible Assets, Net Depreciation and amortization Depreciation and amortization Depreciation, Depletion and Amortization, Nonproduction Number of warrants issued Class Of Warrant Or Right, Number Of Warrants Issued Class Of Warrant Or Right, Number Of Warrants Issued Shares sold, percentage of shares issued and outstanding Investment Owned, Shares Sold, Percentage Of Shares Issued And Outstanding Investment Owned, Shares Sold, Percentage Of Shares Issued And Outstanding Customer [Domain] Customer [Domain] Redwood Redwood Reporting Unit [Member] Redwood Reporting Unit [Member] Debt Securities, Trading, and Equity Securities, FV-NI [Table] Debt Securities, Trading, and Equity Securities, FV-NI [Table] Schedule of Inventory Schedule of Inventory, Current [Table Text Block] Derivative Instrument [Axis] Derivative Instrument [Axis] Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Schedule of Subsidiary or Equity Method Investee [Table] Schedule of Subsidiary or Equity Method Investee [Table] Consulting fees Related Party Transaction, Expenses from Transactions with Related Party Statistical Measurement [Axis] Statistical Measurement [Axis] Supplemental cash flow information Supplemental Cash Flow Information [Abstract] Sale of Stock, Performance Milestone One Sale Of Stock, Performance Milestone One [Member] Sale Of Stock, Performance Milestone One Accumulated Other Comprehensive Income (Loss) [Line Items] Accumulated Other Comprehensive Income (Loss) [Line Items] Net revenue, before excise taxes Revenue from Contract with Customer, Including Assessed Tax Accumulated Other Comprehensive Income (Loss) Comprehensive Income (Loss) Note [Text Block] Variable Interest Entity [Line Items] Variable Interest Entity [Line Items] Number of options Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Inventory [Axis] Inventory [Axis] Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Reporting Unit [Axis] Reporting Unit [Axis] Exercise rights, minimum ownership percentage Class Of Warrant Or Right, Minimum Ownership Percentage Required Class Of Warrant Or Right, Minimum Ownership Percentage Required Share of accumulated net losses in excess of its equity investment and advances Investments in and Advances to Affiliates, Amount of Equity U.S. District Court of Eastern District of New York Vs. Cronos U.S. District Court of Eastern District of New York Vs. Cronos [Member] U.S. District Court of Eastern District of New York Vs. Cronos Ginkgo Ginkgo Bioworks Inc. [Member] Ginkgo Bioworks Inc. [Member] Forfeiture rate Share-based Compensation Arrangement By Share-based Payment Award, Fair Value Assumptions, Forfeiture Rate Share-based Compensation Arrangement By Share-based Payment Award, Fair Value Assumptions, Forfeiture Rate Gain (loss) on revaluation of derivative liabilities Gain on revaluation of derivative liabilities Gain (Loss) on Derivative Instruments, Net, Pretax Ownership percentage Ownership percentage (Whistler - less than) Equity Method Investment, Ownership Percentage Gain on revaluation (Gain) / Loss on revaluation Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Gain (Loss) Included in Earnings Schedule of Finite-Lived Intangible Assets [Table] Schedule of Finite-Lived Intangible Assets [Table] Litigation Status [Axis] Litigation Status [Axis] Schedule of Revenue from External Customers by Geographic Areas Revenue from External Customers by Geographic Areas [Table Text Block] Accounting Standards Update 2016-01 Accounting Standards Update 2016-01 [Member] Investment, Name [Axis] Investment, Name [Axis] Top-up Rights Top-up Rights [Member] Top-up Rights [Member] Vesting on December 23, 2022 Share-based Payment Arrangement, Tranche Three [Member] Accumulated Amortization Finite-Lived Intangible Assets, Accumulated Amortization Current portion Financing Receivable, after Allowance for Credit Loss, Current [Abstract] Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Entity Central Index Key Entity Central Index Key Balance at beginning of period (in shares) Balance at end of period (in shares) Number of warrants (in shares) Outstanding awards (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number Entity Emerging Growth Company Entity Emerging Growth Company Non-controlling interests Noncontrolling Interest [Member] Advances to joint ventures Balance at beginning of period Balance at end of period Advances to Affiliate Cronos Israel G.S. Cultivations Ltd. Cronos Israel G.S. Cultivations Ltd. [Member] Cronos Israel G.S. Cultivations Ltd. [Member] Sale of Stock [Domain] Sale of Stock [Domain] Share-based payments Share-based Payment Arrangement, Noncash Expense Current portion of lease obligation Operating Lease, Liability, Current Schedule of Earnings (Loss) Per Share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Derivative Liabilities Derivative Instruments and Hedging Activities Disclosure [Text Block] Derivative [Table] Derivative [Table] Share issuance costs Payments of Stock Issuance Costs BC Liquor Distribution Branch BC Liquor Distribution Branch [Member] BC Liquor Distribution Branch Stock issued during period, new issues, measurement input Stock Issued During Period, New Issues, Weighted Average Price, Period Stock Issued During Period, New Issues, Weighted Average Price, Period Level 2 Fair Value, Inputs, Level 2 [Member] Operating lease, term Lessee, Operating Lease, Term of Contract Purchase of intangible assets Payments to Acquire Intangible Assets Altria Ventures Altria Ventures Inc. [Member] Altria Ventures Inc. [Member] New Accounting Pronouncements New Accounting Pronouncements and Changes in Accounting Principles [Text Block] Category of Item Purchased [Axis] Category of Item Purchased [Axis] Antidilutive Securities [Axis] Antidilutive Securities [Axis] Building Office Premises Building [Member] Purchase of short-term investments Payments to Acquire Marketable Securities Concentration Risk Type [Axis] Concentration Risk Type [Axis] Effect from foreign exchange Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Gain (Loss) Included in Other Comprehensive Income (Loss) Unconditional Purchase Obligation, Category of Goods or Services Acquired [Domain] Unconditional Purchase Obligation, Category of Goods or Services Acquired [Domain] Warrants Warrant [Member] Revenue Benchmark Revenue from Contract with Customer Benchmark [Member] Loan Receivable, Name [Axis] Loan Receivable, Name [Axis] Loan Receivable, Name [Axis] Measurement Input Type [Axis] Measurement Input Type [Axis] Share price at valuation date (per share in C$) Measurement Input, Share Price [Member] Intangible Assets, Net (Excluding Goodwill) [Abstract] Intangible Assets, Net (Excluding Goodwill) [Abstract] Financing activities Net Cash Provided by (Used in) Financing Activities [Abstract] Total other comprehensive income (loss) Other comprehensive income (loss) Other Comprehensive Income (Loss), Net of Tax Type of Adoption [Domain] Type of Adoption [Domain] Inventory [Domain] Inventory [Domain] Derivative Contract [Domain] Derivative Contract [Domain] Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Professional and consulting Professional And Consulting Expense Professional And Consulting Expense Nonmonetary Transaction Type [Domain] Nonmonetary Transaction Type [Domain] Schedule of Indefinite-Lived Intangible Assets [Table] Schedule of Indefinite-Lived Intangible Assets [Table] 2024 Finite-Lived Intangible Assets, Amortization Expense, Year Four Advances (repayments) Investments In And Advances To Affiliates, At Fair Value, Advances (Repayments) Investments In And Advances To Affiliates, At Fair Value, Advances (Repayments) Loan Receivable, Name [Domain] Loan Receivable, Name [Domain] [Domain] for Loan Receivable, Name [Axis] Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Purchase of property, plant and equipment Payments to Acquire Property, Plant, and Equipment Award Date [Domain] Award Date [Domain] Reporting Unit [Domain] Reporting Unit [Domain] Liabilities settled Share-based Payment Arrangement, Liabilities Settled Share-based Payment Arrangement, Liabilities Settled Additional principal amount Financing Receivable, Additional Face Amount, Including Third Party Amount Financing Receivable, Additional Face Amount, Including Third Party Amount Current portion of loans receivable, before accrued interest Financing Receivable, Before Accrued Interest, Current Financing Receivable, Before Accrued Interest, Current Consulting Services Arrangement Consulting Services Arrangement [Member] Consulting Services Arrangement Additional interest rate if past due Debt Instrument, Past Due, Additional Interest Rate, Stated Percentage Debt Instrument, Past Due, Additional Interest Rate, Stated Percentage Variable Interest Entity, Not Primary Beneficiary Variable Interest Entity, Not Primary Beneficiary [Member] Impact of ten percent change in exchange rate Sensitivity Analysis Of Carrying Value, Net Assets, Impact Of 10 Percent Change In Exchange Rate Sensitivity Analysis Of Carrying Value, Net Assets, Impact Of 10 Percent Change In Exchange Rate Schedule of Advances to Joint Ventures Investments in and Advances to Affiliates [Table Text Block] Investments and Advances to Joint Ventures Equity Method Investments and Joint Ventures Disclosure [Text Block] Sale of Stock [Axis] Sale of Stock [Axis] Provision for doubtful accounts Accounts Receivable, Credit Loss Expense (Reversal) Subsequent Event [Table] Subsequent Event [Table] Accounting Policies [Abstract] Accounting Policies [Abstract] Additional paid-in capital Additional Paid-in Capital [Member] Revenues from Contracts with Customers Revenue from Contract with Customer [Text Block] Interest income Investment Income, Interest Summary of the Changes in Options Schedule of Stock Options Roll Forward [Table Text Block] Altria Investment Altria Investment [Member] Altria Investment [Member] Receivable [Domain] Receivable [Domain] Office and general Office And General Expense Office And General Expense Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table] Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table] Accounts Receivable Accounts Receivable [Member] Vesting rights, number of common shares per award Share-based Compensation Arrangement By Share-based Payment Award, Award Vesting Rights, Number Of Common Shares Per Award Share-based Compensation Arrangement By Share-based Payment Award, Award Vesting Rights, Number Of Common Shares Per Award United States UNITED STATES Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract] Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract] Vesting of restricted share units APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition Top-up rights exercised Stock Issued During Period, Value, Top-up Rights Exercised Stock Issued During Period, Value, Top-up Rights Exercised Interest rate Debt Instrument, Interest Rate, Stated Percentage Loans Receivable Loans Receivable [Member] Other receivables Increase (Decrease) in Other Receivables Entity Address, Address Line One Entity Address, Address Line One Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Proceeds from exercise of Top-up Rights Proceeds From Right Exercises Proceeds From Right Exercises Dilutive effect of derivative liabilities (in shares) Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants Cost Property, Plant and Equipment, Gross Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Gross profit (loss) Gross Profit Geographical [Domain] Geographical [Domain] Property, Plant and Equipment Property, Plant and Equipment Disclosure [Text Block] Repayment of loans payable Repayments of Notes Payable Entity Address, State or Province Entity Address, State or Province Business Acquisition [Axis] Business Acquisition [Axis] Schedule of Sensitivity Analysis Sensitivity Analysis, Impact On Net Income (Loss) [Table Text Block] Sensitivity Analysis, Impact On Net Income (Loss) [Table Text Block] Customer Concentration Risk Customer Concentration Risk [Member] Operating Segments Operating Segments [Member] IPO IPO [Member] Weighted Average Weighted Average [Member] Vested on January 31, 2020 Share-based Payment Arrangement, Tranche One [Member] Cash flows provided (used) in investing activities Net Cash Provided by (Used in) Investing Activities Fair Value, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Related Party Transaction [Line Items] Related Party Transaction [Line Items] Vesting on June 23, 2021 Share-based Payment Arrangement, Tranche Two [Member] License term Variable Interest Entity, Qualitative Or Quantitative Information, License Term Variable Interest Entity, Qualitative Or Quantitative Information, License Term Lessee, Lease, Description [Table] Lessee, Lease, Description [Table] Number of subsidiaries acquired Number of Businesses Acquired Investments, All Other Investments [Abstract] Mucci Mucci [Member] Mucci [Member] Ownership interest Subsidiary or Equity Method Investee, Cumulative Percentage Ownership after All Transactions General and administrative Total General and Administrative Expense Net unrealized (loss) gain Other Comprehensive Income (Loss), before Reclassifications, Net of Tax Indefinite-lived Intangible Assets [Line Items] Indefinite-lived Intangible Assets [Line Items] One Vendor One Vendor [Member] One Vendor [Member] Dried Cannabis Flower Inventories [Member] Due to non-controlling interests Due to Related Parties, Noncurrent Entity Interactive Data Current Entity Interactive Data Current Common stock, shares issued (in shares) Common Stock, Shares, Issued Entity Common Stock, Shares Outstanding (in shares) Entity Common Stock, Shares Outstanding Weighted average expected life Sensitivity Analysis, Impact Of 10 Percent Decrease (Increase) In Weighted Average Expected Life On Net Income (Loss) Sensitivity Analysis, Impact Of 10 Percent Decrease (Increase) In Weighted Average Expected Life On Net Income (Loss) Four Major Customers Four Major Customers [Member] Four Major Customers [Member] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Net income (loss) used in the computation of diluted income per share Net Income (Loss) from Continuing Operations Available to Common Shareholders, Diluted Warrants exercised Stock Issued During Period, Value, Warrants Exercised Stock Issued During Period, Value, Warrants Exercised Schedule of Long-lived Assets by Geographic Areas Long-lived Assets by Geographic Areas [Table Text Block] Balance at beginning of period (in dollars per share) Balance at end of period (in dollars per share) Weighted average exercise price (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Schedule of Equity Method Investments [Line Items] Schedule of Equity Method Investments [Line Items] Withholding taxes paid on options Payment, Tax Withholding, Share-based Payment Arrangement Inventory Total Inventory, Net Items not affecting cash: Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Number of cannabinoids targeted to develop scalable and consistent production Long-term Purchase Commitment, Number Of Targeted Units To Develop Production Long-term Purchase Commitment, Number Of Targeted Units To Develop Production Other countries Other Countries [Member] Other Countries [Member] Derivative liability, measurement input Derivative Liability, Measurement Input Measurement Frequency [Axis] Measurement Frequency [Axis] Other receivables Other Receivables, Net, Current Number of reporting units for impairment testing Number of Reporting Units Earnings (loss) Per Share Earnings Per Share [Text Block] Depreciation expense included in operating expenses Depreciation, Nonproduction Future awards to be granted (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant Less: accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Award Type [Domain] Award Type [Domain] Exercise price (per option) (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price Salaries and wages Labor and Related Expense Cronos Israel G.S. Manufacturing Ltd. Cronos Israel G.S. Manufacturing Ltd. [Member] Cronos Israel G.S. Manufacturing Ltd. [Member] Issuance of options (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Leasehold improvements Leasehold Improvements [Member] Indefinite-lived Intangible Assets, Major Class Name [Domain] Indefinite-lived Intangible Assets, Major Class Name [Domain] Shares issued (in shares) Stock Issued During Period, Shares, New Issues Derivative Instruments, Gain (Loss) [Line Items] Derivative Instruments, Gain (Loss) [Line Items] Award vesting rights, percentage Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage Long-term Purchase Commitment [Line Items] Long-term Purchase Commitment [Line Items] Shares accelerated and vested (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Accelerated Vesting, Number Ownership [Domain] Ownership [Domain] Purchases Related Party Transaction, Purchases from Related Party Exercisable Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term Restricted share units Restricted Stock Units (RSUs) [Member] Funding commitment percentage Financing Receivable, Funding Commitment Percentage Financing Receivable, Funding Commitment Percentage Goodwill and indefinite life intangible assets Goodwill and Intangible Assets, Policy [Policy Text Block] Indefinite-lived Intangible Assets [Axis] Indefinite-lived Intangible Assets [Axis] Summary of Significant Accounting Policies Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block] Consolidated Entities [Axis] Consolidated Entities [Axis] Aurora Aurora Cannabis Inc. [Member] Aurora Cannabis Inc. [Member] Proceeds from exercise of warrants and options Proceeds From Warrant Exercises And Stock Options Exercised Proceeds From Warrant Exercises And Stock Options Exercised Investments [Domain] Investments [Domain] Collaboration agreement, percentage of profits to be received Collaborative Arrangement, Percentage Of Profits To Be Received Collaborative Arrangement, Percentage Of Profits To Be Received Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Total liabilities Liabilities Share capital Common Stock, Value, Issued Expected dividend yield Measurement Input, Expected Dividend Rate [Member] Research and development (“R&D”) Research and Development Expense Whistler Whistler Medical Marijuana Company [Member] Whistler Medical Marijuana Company [Member] Vesting [Domain] Vesting [Domain] Comprehensive income (loss) attributable to: Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest [Abstract] Counterparty Name [Domain] Counterparty Name [Domain] Share-based reserve Financial liability Deferred Compensation Share-based Arrangements, Liability [Roll Forward] Deferred Compensation Share-based Arrangements, Liability [Roll Forward] Cancellation, forfeiture and expiry of options (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price Statement of Comprehensive Income [Abstract] Statement of Comprehensive Income [Abstract] Inventory Increase (Decrease) in Inventories Due on demand, term Financing Receivable, Due On Demand, Term Financing Receivable, Due On Demand, Term Common shares issuable (up to) (in shares) Long-term Purchase Commitment, Equity Interest Issued Or Issuable, Number Of Shares Long-term Purchase Commitment, Equity Interest Issued Or Issuable, Number Of Shares Two Major Customers Two Major Customers [Member] Two Major Customers [Member] Expected annualized volatility Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Dilutive effect of awards (in shares) Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements Loss (gain) on unrealized foreign exchange Foreign Currency Transaction Gain (Loss), Unrealized Total aggregate principal amount Financing Receivable, Face Amount, Including Third Party Amount Financing Receivable, Face Amount, Including Third Party Amount Common shares issuable, value assigned Long-term Purchase Commitment, Equity Interest Issued Or Issuable, Value Assigned Long-term Purchase Commitment, Equity Interest Issued Or Issuable, Value Assigned Schedule of Goodwill Schedule of Goodwill [Table Text Block] Basic (in shares) Weighted average number of common shares outstanding used in the computation of basic earnings per share (in shares) Weighted Average Number of Shares Outstanding, Basic Natuera Natuera [Member] Natuera [Member] Right-of-use assets Operating Lease, Right-of-Use Asset Monthly fee, percentage of direct and indirect service costs Long-term Purchase Commitment, Monthly Fee, Percentage Long-term Purchase Commitment, Monthly Fee, Percentage Equity Components [Axis] Equity Components [Axis] Weighted average exercise price (C$) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Total loans receivable Financing Receivable, after Allowance for Credit Loss Investments in equity accounted investees Payments to Acquire Equity Method Investments Schedule of General and Administrative Expenses General And Administrative Expenses [Table Text Block] General And Administrative Expenses [Table Text Block] Maximum loss exposure Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount Total equity attributable to shareholders of Cronos Group Stockholders' Equity Attributable to Parent Amortization of intangible assets Amortization of Intangible Assets Concentration Risk Type [Domain] Concentration Risk Type [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Supplemental Cash Flow Elements [Abstract] Supplemental Cash Flow Elements [Abstract] Advances to joint ventures Payments to Acquire Interest in Joint Venture Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Exercise price, volume-weighted average price, measurement period, days preceding exercise Class Of Warrant Or Right, Exercise Price, Volume-Weighted Average Price, Measurement Period, Days Preceding Exercise Class Of Warrant Or Right, Exercise Price, Volume-Weighted Average Price, Measurement Period, Days Preceding Exercise Fair Value Measurement Fair Value Disclosures [Text Block] Schedule of Related Party Transactions, by Related Party [Table] Schedule of Related Party Transactions, by Related Party [Table] Schedule of Indefinite-Lived Intangible Assets Schedule of Indefinite-Lived Intangible Assets [Table Text Block] MedMen Canada MedMen Canada Inc. [Member] MedMen Canada Inc. [Member] Non-monetary Transactions Nonmonetary Transactions Disclosure [Text Block] Finite-Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets [Line Items] Maximum exposure to credit risk Concentration Risk, Credit Risk, Financial Instrument, Maximum Exposure Net foreign exchange gain (loss) on translation Accumulated Foreign Currency Adjustment Attributable to Parent [Member] Cost of sales Other Cost Of Goods And Services Sold Other Cost Of Goods And Services Sold Depreciation and amortization Depreciation, Depletion and Amortization Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Investment Type [Axis] Investment Type [Axis] Cost Finite-Lived Intangible Assets, Gross Interest paid Interest Paid, Excluding Capitalized Interest, Operating Activities Forecast Forecast [Member] Ownership interest Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners Stock issued during period, new issues, fair value Stock Issued During Period, New Issues, Fair Value Stock Issued During Period, New Issues, Fair Value Investments in and Advances to Affiliates [Abstract] Investments in and Advances to Affiliates [Abstract] Cash and cash equivalents Cash and Cash Equivalents, Fair Value Disclosure Ginkgo Equity Milestones Ginkgo Equity Milestones [Member] Ginkgo Equity Milestones [Member] Security Exchange Name Security Exchange Name Total anti-dilutive securities (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Redwood Redwood Holding Group, LLC [Member] Redwood Holding Group, LLC [Member] Related Party Transaction [Axis] Related Party Transaction [Axis] Litigation Case [Axis] Litigation Case [Axis] Loan receivable, net Total long-term portion of loans receivable Financing Receivable, after Allowance for Credit Loss, Noncurrent Ontario Cannabis Retail Corporation Ontario Cannabis Retail Corporation [Member] Ontario Cannabis Retail Corporation Investments in equity accounted investees Investments in equity accounted investees Equity Method Investments Comprehensive income (loss) Comprehensive income (loss) Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Cash flows used in operating activities Net Cash Provided by (Used in) Operating Activities Number of awards Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Equity Component [Domain] Equity Component [Domain] Expected life of options (in years) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term Collaboration agreement, term of agreement Collaborative Arrangement, Term Of Agreement Collaborative Arrangement, Term Of Agreement Document Transition Report Document Transition Report Number of putative class action complaints Loss Contingency, New Claims Filed, Number Stock options Share-based Payment Arrangement, Option [Member] Investments in and Advances to Affiliates [Table] Investments in and Advances to Affiliates [Table] Short-term investments Short-term Investments Stated interest rate Financing Receivable, Interest Rate, Stated Percentage Financing Receivable, Interest Rate, Stated Percentage Goodwill, impairment loss Impairment charges Goodwill, Impairment Loss Pre-emptive Rights and Top-up Rights Pre-Emptive Rights And Top-Up Rights [Member] Pre-Emptive Rights And Top-Up Rights Consolidated Entities [Domain] Consolidated Entities [Domain] Proceeds from disposal of short-term investments Proceeds from Sale and Maturity of Marketable Securities Number of shares sold (in shares) Investment Owned, Number Of Shares Sold Investment Owned, Number Of Shares Sold Consolidated statements of net income (loss) and comprehensive income (loss) Segment Reporting Information, Profit (Loss) [Abstract] Collaborative arrangement, installment received Collaborative Arrangement, Installments Received Collaborative Arrangement, Installments Received Cronos Israel G.S. Store Ltd. Cronos Israel G.S. Store Ltd. [Member] Cronos Israel G.S. Store Ltd. [Member] Cannabis Extracts Inventory, Cannabis Extracts [Member] Inventory, Cannabis Extracts [Member] Income Statement [Abstract] Income Statement [Abstract] Canopy Canopy Growth Corporation [Member] Canopy Growth Corporation [Member] AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward] AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward] EX-101.PRE 14 cron-20200630_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 15 image11.jpg begin 644 image11.jpg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end GRAPHIC 16 image21.jpg begin 644 image21.jpg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end GRAPHIC 17 image31.jpg begin 644 image31.jpg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

GRAPHIC 18 image41.jpg begin 644 image41.jpg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image51.jpg begin 644 image51.jpg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

XML 23 R2.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Balance Sheets - USD ($)
Jun. 30, 2020
Dec. 31, 2019
Current assets    
Cash and cash equivalents $ 1,109,700,000 $ 1,199,693,000
Short-term investments 213,614,000 306,347,000
Accounts receivable [1] 3,477,000 4,638,000
Other receivables 9,568,000 7,232,000
Current portion of loans receivable 4,458,000 4,664,000
Prepaids and other assets 7,827,000 9,395,000
Inventory 53,216,000 38,043,000
Total current assets 1,401,860,000 1,570,012,000
Investments in equity accounted investees 933,000 557,000
Advances to joint ventures 18,598,000 19,437,000
Loan receivable, net 65,371,000 44,967,000
Property, plant and equipment 164,290,000 161,809,000
Right-of-use assets 10,100,000 6,546,000
Intangible assets 69,399,000 72,320,000
Goodwill 179,736,000 214,794,000
Total assets 1,910,287,000 2,090,442,000
Current liabilities    
Accounts payable and other liabilities 28,316,000 35,301,000
Current portion of lease obligation 1,206,000 427,000
Derivative liabilities 205,714,000 297,160,000
Total current liabilities 235,236,000 332,888,000
Due to non-controlling interests 3,048,000 1,844,000
Lease obligation 8,958,000 6,680,000
Total liabilities 247,242,000 341,412,000
Commitments and contingencies [2]
Shareholders’ equity    
Share capital [3],[4] 565,211,000 561,165,000
Additional paid-in capital 27,046,000 23,234,000
Retained earnings 1,106,709,000 1,137,646,000
Accumulated other comprehensive income (loss) (33,970,000) 27,838,000
Total equity attributable to shareholders of Cronos Group 1,664,996,000 1,749,883,000
Non-controlling interests (1,951,000) (853,000)
Total shareholders’ equity 1,663,045,000 1,749,030,000
Total liabilities and shareholders’ equity $ 1,910,287,000 $ 2,090,442,000
[1] Net of current expected credit loss allowance of $80 as of June 30, 2020 (December 31, 2019 – $136)
[2] Refer to Note 19 and Note 20 in the notes to condensed consolidated financial statements.
[3] Authorized for issuance as of June 30, 2020: unlimited (December 31, 2019 – unlimited).
[4] Shares issued as of June 30, 2020: 349,886,402 (as of December 31, 2019: 348,817,472)
XML 24 R3.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Balance Sheet (Parenthetical) - USD ($)
$ in Thousands
Jun. 30, 2020
Dec. 31, 2019
Statement of Financial Position [Abstract]    
Current expected credit loss $ 80 $ 136
Common stock, shares issued (in shares) 349,886,402 348,817,472
XML 25 R4.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Net Income and Comprehensive Income (Loss) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Income Statement [Abstract]        
Net revenue, before excise taxes $ 11,432,000 $ 8,064,000 $ 20,776,000 $ 11,455,000
Excise taxes (1,549,000) (411,000) (2,461,000) (798,000)
Net revenue 9,883,000 7,653,000 18,315,000 10,657,000
Cost of sales 9,774,000 3,560,000 16,720,000 5,009,000
Inventory write-down 3,062,000 0 11,024,000 0
Gross profit (loss) (2,953,000) 4,093,000 (9,429,000) 5,648,000
Operating expenses        
Sales and marketing 6,504,000 4,005,000 13,616,000 5,133,000
Research and development (“R&D”) 3,631,000 2,300,000 8,221,000 3,471,000
General and administrative 18,437,000 11,488,000 42,196,000 18,781,000
Share-based payments 2,546,000 2,647,000 4,982,000 4,418,000
Depreciation and amortization 684,000 408,000 1,371,000 726,000
Total operating expenses 31,802,000 20,848,000 70,386,000 32,529,000
Operating loss (34,755,000) (16,755,000) (79,815,000) (26,881,000)
Other income (expense)        
Interest income, net 3,734,000 9,442,000 11,485,000 11,528,000
Share of loss from investments in equity accounted investees (794,000) (741,000) (1,966,000) (939,000)
Gain (loss) on revaluation of derivative liabilities (35,880,000) 197,310,000 77,488,000 525,526,000
Impairment loss on goodwill and intangible assets (40,000,000) 0 (40,000,000) 0
Financing and transaction costs 0 (3,368,000) 0 (25,601,000)
Other income (loss) (8,000) 0 786,000 16,243,000
Total other income (loss) (72,948,000) 202,643,000 47,793,000 526,757,000
Income (loss) before income taxes (107,703,000) 185,888,000 (32,022,000) 499,876,000
Income tax expense 0 0 0 0
Net income (loss) (107,703,000) 185,888,000 (32,022,000) 499,876,000
Net income (loss) attributable to:        
Cronos Group (106,977,000) 185,999,000 (30,937,000) 500,090,000
Non-controlling interests (726,000) (111,000) (1,085,000) (214,000)
Net income (loss) (107,703,000) 185,888,000 (32,022,000) 499,876,000
Other comprehensive income (loss)        
Foreign exchange gain (loss) on translation 51,871,000 17,947,000 (61,821,000) 21,845,000
Total other comprehensive income (loss) 51,871,000 17,947,000 (61,821,000) 21,845,000
Comprehensive income (loss) (55,832,000) 203,835,000 (93,843,000) 521,721,000
Comprehensive income (loss) attributable to:        
Cronos Group (55,070,000) 203,947,000 (92,745,000) 521,932,000
Non-controlling interests (762,000) (112,000) (1,098,000) (211,000)
Comprehensive income (loss) $ (55,832,000) $ 203,835,000 $ (93,843,000) $ 521,721,000
Net income (loss) per share        
Basic (in dollars per share) $ (0.31) $ 0.56 $ (0.09) $ 1.57
Diluted (in dollars per share) $ (0.31) $ 0.16 $ (0.09) $ 0.41
Weighted average number of outstanding shares        
Basic (in shares) 349,075,408 334,665,873 348,946,439 317,940,749
Diluted (in shares) [1] 349,075,408 374,676,595 348,946,439 364,872,093
[1] In computing diluted earnings per share, incremental common shares are not considered in periods in which a net loss is reported, as the inclusion of the common share equivalents would be anti-dilutive.
XML 26 R5.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Changes in Equity (Deficit) - USD ($)
$ in Thousands
Total
Share capital
Additional paid-in capital
Retained earnings
Accumulated other comprehensive income (loss)
Non-controlling interests
Beginning balance (in shares) at Dec. 31, 2018   178,720,022        
Beginning balance at Dec. 31, 2018 $ 148,549 $ 175,001 $ 11,263 $ (27,945) $ (9,870) $ 100
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Shares issued (in shares)   149,831,154        
Shares issued 248,302 $ 248,302        
Share issuance costs (3,718) $ (3,718)        
Warrants exercised (in shares)   7,390,961        
Warrants exercised 1,438 $ 2,034 (596)      
Vesting of options $ 4,418   4,418      
Options exercised (in shares) 227,342 151,468        
Options exercised $ (823) $ 318 (306) (835)    
Top-up rights exercised (in shares)   50,938        
Top-up rights exercised 1,171 $ 1,171        
Net (loss) income 499,876     500,090   (214)
Other comprehensive income (loss) 21,845       21,843 2
Ending balance (in shares) at Jun. 30, 2019   336,144,543        
Ending balance at Jun. 30, 2019 921,058 $ 423,108 14,779 471,310 11,973 (112)
Beginning balance (in shares) at Mar. 31, 2019   333,020,377        
Beginning balance at Mar. 31, 2019 713,345 $ 421,340 12,244 285,736 (5,975) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Share issuance costs (76) $ (76)        
Warrants exercised (in shares)   3,000,000        
Warrants exercised 550 $ 617 (67)      
Vesting of options 2,647   2,647      
Options exercised (in shares)   73,228        
Options exercised (414) $ 56 (45) (425)    
Top-up rights exercised (in shares)   50,938        
Top-up rights exercised 1,171 $ 1,171        
Net (loss) income 185,888     185,999   (111)
Other comprehensive income (loss) 17,947       17,948 (1)
Ending balance (in shares) at Jun. 30, 2019   336,144,543        
Ending balance at Jun. 30, 2019 921,058 $ 423,108 14,779 471,310 11,973 (112)
Beginning balance (in shares) at Dec. 31, 2019   348,817,472        
Beginning balance at Dec. 31, 2019 1,749,030 $ 561,165 23,234 1,137,646 27,838 (853)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Vesting of options $ 3,500   3,500      
Options exercised (in shares) 1,807,909 1,068,930        
Options exercised $ 1 $ 1,329 (1,328)      
Vesting of restricted share units 1,482   1,482      
Top-up rights exercised 717 717        
Vesting of common shares issued in connection with the use of certain publicity rights in brand development 2,158 $ 2,000 158      
Net (loss) income (32,022)     (30,937)   (1,085)
Other comprehensive income (loss) (61,821)       (61,808) (13)
Ending balance (in shares) at Jun. 30, 2020   349,886,402        
Ending balance at Jun. 30, 2020 1,663,045 $ 565,211 27,046 1,106,709 (33,970) (1,951)
Beginning balance (in shares) at Mar. 31, 2020   348,817,472        
Beginning balance at Mar. 31, 2020 1,715,268 $ 563,165 25,483 1,213,686 (85,877) (1,189)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Vesting of options 1,770   1,770      
Options exercised (in shares)   1,068,930        
Options exercised 1 $ 1,329 (1,328)      
Vesting of restricted share units 776   776      
Top-up rights exercised 717 $ 717        
Vesting of common shares issued in connection with the use of certain publicity rights in brand development 345   345      
Net (loss) income (107,703)     (106,977)   (726)
Other comprehensive income (loss) 51,871       51,907 (36)
Ending balance (in shares) at Jun. 30, 2020   349,886,402        
Ending balance at Jun. 30, 2020 $ 1,663,045 $ 565,211 $ 27,046 $ 1,106,709 $ (33,970) $ (1,951)
XML 27 R6.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Cash Flows - USD ($)
6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Operating activities    
Net (loss) income $ (32,022,000) $ 499,876,000
Items not affecting cash:    
Inventory write-down 11,024,000 0
Share-based payments 4,982,000 4,418,000
Depreciation and amortization 2,879,000 1,174,000
Share of loss from investments in equity accounted investees 1,966,000 939,000
Gain on revaluation of derivative liabilities (77,488,000) (525,526,000)
Gain on disposal of other investments (769,000) (15,498,000)
Impairment loss on goodwill and intangible assets 40,000,000 0
Loss (gain) on unrealized foreign exchange (1,097,000) 184,000
Provision for doubtful accounts 1,437,000 0
Non-cash sales and marketing 2,158,000 0
Other, net 307,000 (745,000)
Net changes in non-cash working capital (30,570,000) (21,591,000)
Cash flows used in operating activities (77,193,000) (56,769,000)
Investing activities    
Purchase of short-term investments (124,576,000) (556,876,000)
Proceeds from disposal of short-term investments 203,678,000 0
Investments in equity accounted investees 0 (1,658,000)
Proceeds from sale of other investments 769,000 19,614,000
Advances to joint ventures 0 (15,990,000)
Purchase of property, plant and equipment (13,344,000) (20,918,000)
Payment of accrued interest on construction loan payable 0 (89,000)
Purchase of intangible assets (2,754,000) (470,000)
Advances on loans receivable (23,974,000) (12,222,000)
Cash flows provided (used) in investing activities 39,799,000 (588,609,000)
Financing activities    
Advance from non-controlling interests 0 85,000
Repayment of lease obligations (1,184,000) (160,000)
Proceeds from Altria Investment 0 1,809,556,000
Proceeds from exercise of Top-up Rights 0 619,000
Proceeds from exercise of warrants and options 1,000 1,450,000
Withholding taxes paid on options 0 (836,000)
Share issuance costs 0 (3,718,000)
Advance of loans payable 0 48,715,000
Repayment of loans payable 0 (48,309,000)
Transaction costs paid on construction loan payable 0 (15,971,000)
Cash flows provided (used) in financing activities (1,183,000) 1,791,431,000
Effect of foreign currency translation on cash and cash equivalents (51,416,000) 36,079,000
Increase (decrease) in cash and cash equivalents (89,993,000) 1,182,132,000
Cash and cash equivalents, beginning of period 1,199,693,000 23,927,000
Cash and cash equivalents, end of period 1,109,700,000 1,206,059,000
Supplemental cash flow information    
Interest paid 90,000 589,000
Interest received $ 11,575,000 $ 7,871,000
XML 28 R7.htm IDEA: XBRL DOCUMENT v3.20.2
Background
6 Months Ended
Jun. 30, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Background Background
Cronos Group Inc. (“Cronos Group” or the “Company”) was incorporated on August 21, 2012 under the Business Corporations Act (Ontario). Effective July 9, 2020, the Company’s legal existence was continued to the Province of British Columbia and under the British Columbia Business Corporations Act. The Company’s common shares are currently listed on the Toronto Stock Exchange (“TSX”) and Nasdaq Global Market (“Nasdaq”) under the ticker symbol “CRON.”
Cronos Group is an innovative global cannabinoid company, with international production and distribution across five continents. The Company is committed to building disruptive intellectual property by advancing cannabis research, technology and product development and is building an iconic brand portfolio. Cronos Group’s brand portfolio includes PEACE NATURALS, a global wellness platform; two adult-use brands, COVE and Spinach; and two U.S. hemp-derived consumer products brands, Lord Jones and PEACE+.
Cronos Group has established four strategic joint ventures in Canada, Israel, and Colombia. One of these strategic joint ventures, Cronos Israel (as defined herein) is consolidated for financial reporting purposes. The Company also holds approximately 31% of the issued capital of Cronos Australia Limited (“Cronos Australia”) and accounts for its investment in Cronos Australia under the equity method of accounting. For additional discussion regarding the joint ventures and strategic investment, see Note 6.
XML 29 R8.htm IDEA: XBRL DOCUMENT v3.20.2
Summary of Significant Accounting Policies
6 Months Ended
Jun. 30, 2020
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies Summary of Significant Accounting Policies
(a)Basis of Presentation
The interim condensed consolidated financial statements of Cronos Group are unaudited. They have been prepared in accordance with Generally Accepted Accounting Principles in the United States (“U.S. GAAP”) for interim financial information and with applicable rules and regulations of the U.S. Securities and Exchange Commission relating to interim financial statements. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three and six months ended June 30, 2020 are not necessarily indicative of the results that may be expected for any other reporting period.
These condensed consolidated financial statements should be read in conjunction with the Company’s consolidated financial statements and related notes included in its Annual Report on Form 10-K/A for the year ended December 31, 2019 (the “Annual Financial Statements”).
(b)Basis of Consolidation
The accompanying condensed consolidated financial statements include the accounts of the Company, and all entities in which the Company has a controlling voting interest and/or is the primary beneficiary of a variable interest as of and for the period presented. The Company consolidates the financial results of the following entities, which the Company controls:
SubsidiariesJurisdiction of IncorporationIncorporation Date
Ownership Interest (ii)
Cronos Israel G.S. Cultivations Ltd. (i)
IsraelFebruary 4, 201870%
Cronos Israel G.S. Manufacturing Ltd. (i)
IsraelSeptember 4, 201890%
Cronos Israel G.S. Store Ltd. (i)
IsraelJune 28, 201890%
Cronos Israel G.S. Pharmacies Ltd. (i)
IsraelFebruary 15, 201890%
(i) These Israeli entities are collectively referred to as “Cronos Israel.”
(ii) “Ownership interest” is defined as the proportionate share of net income to which the Company is entitled; equity interest may differ from ownership interest.
In the condensed consolidated statements of net income (loss) and comprehensive income (loss), the net income (loss) and comprehensive income (loss) are attributed to the equity holders of the Company and to the non-controlling interests. Non-controlling interests in the equity of Cronos Israel are presented separately in the shareholders’ equity (deficit) section of the condensed consolidated balance sheets and condensed consolidated statements of changes in equity (deficit). All intercompany transactions and balances are eliminated upon consolidation.
(c)  Goodwill and indefinite life intangible assets
Goodwill and indefinite life intangible assets are reviewed for impairment annually or more frequently when events or changes in circumstances indicate that fair value of the reporting unit has been reduced to less than its carrying value. The Company performs an impairment test annually in the fourth quarter, by comparing the fair value of the reporting unit with its carrying amount, including goodwill. If the fair value of the reporting unit exceeds its carrying amount, goodwill is not considered to be impaired. An impairment charge would be recognized for the amount by which the carrying amount exceeds the reporting unit’s fair value. The Company determined that it has two reporting units: the U.S. reporting unit and the Rest of World reporting unit.
During the three months ended June 30, 2020, the Company concluded that the projected impact of the COVID-19 pandemic on its sales and revenues in the near term, together with the volatility in the market conditions during the quarter represented potential indicators of impairment for the U.S. reporting unit. Accordingly, the Company performed an interim impairment analysis during the second quarter of 2020. See Note 13 for more information regarding intangibles assets and goodwill.
XML 30 R9.htm IDEA: XBRL DOCUMENT v3.20.2
New Accounting Pronouncements
6 Months Ended
Jun. 30, 2020
New Accounting Pronouncements and Changes in Accounting Principles [Abstract]  
New Accounting Pronouncements New Accounting Pronouncements
(a)Adoption of new accounting pronouncements
On January 1, 2020, the Company adopted ASU No. 2018-13, Disclosure Framework – Changes to the Disclosure Requirements for Fair Value Measurement (Topic 820) (“ASU No. 2018-13”). ASU No. 2018-13 adds, modifies, and removes certain fair value measurement disclosure requirements. The adoption of this standard was applied prospectively and did not have a material impact on the Company’s condensed consolidated financial statements.
On January 1, 2020, the Company adopted ASU No. 2018-15, Intangibles – Goodwill and Other Internal-use-software (Subtopic 350-40): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract (“ASU No. 2018-15”). ASU No. 2018-15 amends current guidance to align the accounting for costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing costs associated with developing or obtaining internal-use software. The guidance in ASU No. 2018-15 is effective for annual and interim periods beginning after December 15, 2019, with early adoption permitted. The adoption of this standard was applied prospectively and did not have a material impact on the Company’s condensed consolidated financial statements.
On January 1, 2020, the Company adopted ASU No. 2017-04, Intangibles – Goodwill and Other (Topic 350) – Simplifying the Test for Goodwill Impairment (“ASU No. 2017-04”). ASU No. 2017-04 eliminates step 2 from the goodwill impairment test and instead requires an entity to measure the impairment of goodwill assigned to a reporting unit if the carrying value of assets and liabilities assigned to the reporting unit, including goodwill, exceeds the reporting unit’s fair value. The guidance in ASU No. 2017-04 is effective for annual and interim goodwill tests completed by the Company beginning on January 1, 2020. The adoption of this standard was applied prospectively and the Company follows a one-step model for goodwill impairment.
(b)New accounting pronouncements not yet adopted
In January 2020, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2020-01, Investments-Equity Securities (Topic 321), Investments-Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815) (“ASU No. 2020-01”). ASU No. 2020-01 clarifies the interaction of accounting for the transition into and out of the equity method. The new standard also clarifies the accounting for measuring certain purchased options and forward contracts to acquire investments. The guidance in ASU No. 2020-01 is effective for annual and interim periods beginning after December 15, 2020, with early adoption permitted. The Company is currently evaluating the effect of the adoption of ASU No. 2020-01, but anticipates that the adoption will not have a material impact on its condensed consolidated financial statements.
In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes (“ASU No. 2019-12”). ASU No. 2019-12 eliminates certain exceptions and simplifies the application of U.S. GAAP-related changes in enacted tax laws or rates and employee stock option plans. ASU No. 2019-12 is effective for annual and interim periods beginning after December 15, 2020. Early adoption is permitted. The Company is currently evaluating the effect of the adoption of ASU No. 2019-12, but anticipates that the adoption will not have a material impact on its condensed consolidated financial statements.
XML 31 R10.htm IDEA: XBRL DOCUMENT v3.20.2
Revenues from Contracts with Customers
6 Months Ended
Jun. 30, 2020
Revenue from Contract with Customer [Abstract]  
Revenues from Contracts with Customers Revenues from Contracts with Customers
Cronos Group disaggregates net revenues based on product type. For further discussion, see Note 18. Receivables were $3,477 as of June 30, 2020 (December 31, 2019 – $4,638). The Company recorded a current expected credit loss allowance on receivables of $80 as of June 30, 2020 (December 31, 2019 – $136).
The Company offers discounts to customers for prompt payment and calculates cash discounts as a percentage of the list price based on historical experience and agreed-upon payment terms. The Company records an allowance for cash discounts, which is included as a contra-asset against receivables on the Company’s condensed consolidated balance sheets.
Revenue is measured net of returns. As a result, the Company is required to estimate the amount of returns based on the historical data by customer and product type, adjusted for forward-looking information. This is recorded as a provision against accounts receivable on the Company’s consolidated balance sheets. The Company estimates sales returns based principally on historical volume and return rates, as a reduction to revenues. The difference between actual sales and estimated sales returns is recorded in the period in which the actual amounts become known. These differences, if any, have not had a material impact on the Company’s condensed consolidated financial statements.
Upon return, products can be extracted from dried cannabis, resold, or destroyed depending on the nature of the product. The Company has assessed that the amount recoverable from returned products for the six months ended June 30, 2020 is not material.
XML 32 R11.htm IDEA: XBRL DOCUMENT v3.20.2
Inventory
6 Months Ended
Jun. 30, 2020
Inventory Disclosure [Abstract]  
Inventory Inventory
Inventory is comprised of the following items:
As of
June 30, 2020December 31, 2019
Raw materials$5,488  $2,469  
Work-in-progress – dry cannabis21,772  11,538  
Work-in-progress – cannabis extracts19,210  17,975  
Finished goods – dry cannabis4,505  1,798  
Finished goods – cannabis extracts1,716  2,624  
Supplies and consumables525  1,639  
Total$53,216  $38,043  
Inventory is written down for any obsolescence such as slow-moving or non-marketable products, or when the net realizable value of inventory is less than the carrying value. For the three and six months ended June 30, 2020, the Company recorded write-downs related to inventory of $3,062 and $11,024, respectively.
There were no inventory write-downs for the six months ended June 30, 2019.
XML 33 R12.htm IDEA: XBRL DOCUMENT v3.20.2
Investments and Advances to Joint Ventures
6 Months Ended
Jun. 30, 2020
Equity Method Investments and Joint Ventures [Abstract]  
Investments and Advances to Joint Ventures Investments and Advances to Joint Ventures
Variable Interest Entities
The Company holds variable interests in Cronos Growing Company Inc. (“Cronos GrowCo”), Natuera S.à.r.l (“Natuera”), MedMen Canada Inc. (“MedMen Canada”) and Cannasoul Lab Services Ltd. (“CLS”).
Cronos GrowCo is a joint venture incorporated under the Canada Business Corporations Act (“CBCA”) on June 14, 2018 with the objective of building a cannabis production greenhouse, applying for cannabis licenses under the Cannabis Act (Canada), and growing, cultivating, extracting, producing and selling cannabis in accordance with such licenses. Cronos Group holds variable interests in Cronos GrowCo through its ownership of 50% of Cronos GrowCo’s common shares and senior secured debt in Cronos GrowCo. The Company has also agreed to purchase a minimum amount of Cronos GrowCo’s cannabis product annually, subject to Cronos GrowCo’s receipt of all applicable licenses and permits. Cronos GrowCo’s economic performance is driven by the quantity and strains of cannabis grown. The joint venture partners mutually determine the quantity and strains of cannabis grown.
Natuera is a joint venture registered in Luxembourg with the objective of cultivating and commercializing medical cannabis to serve the export market. Cronos holds variable interests in Natuera through its ownership of 50% of Natuera’s common shares and other debt in the entity. Natuera’s economic performance is driven by the quantity and strains of cannabis to be grown. The joint venture partners mutually determine the quantity and strains of cannabis grown.
MedMen Canada is a joint venture incorporated under the CBCA on March 13, 2018, with the objective of the retail sale and marketing of cannabis products in Canada. MedMen Canada holds the exclusive license to the MedMen brand in Canada for a minimum term of 20 years. Cronos holds variable interests in MedMen Canada through its ownership of 50% of MedMen Canada’s common shares and other subordinated debt in the entity. MedMen Canada’s economic performance is driven by the quantity and strains of cannabis sold. Subject to applicable law, the joint venture partners mutually determine the quantity and strains of cannabis to be sold in MedMen Canada’s retail stores, if and when stores are opened.
The Company’s investments in Cronos GrowCo, Natuera and MedMen Canada are exposed to economic variability from each entity’s performance, however the Company does not consolidate the entities as it does not have the power to direct the activities that most significantly impact the joint ventures’ economic performance. Thus, Cronos Group is not considered the primary beneficiary of the entity. These investments are accounted for as equity method investments classified as “Investments in equity accounted investees” in the consolidated balance sheets.
CLS is a wholly owned subsidiary of Cannasoul Analytics Ltd., incorporated with the purpose of establishing a commercial cannabis analytical testing laboratory located on the premises of Cronos Israel (the “Cannasoul Collaboration”). Cronos Israel will advance ILS 8,297 (approximately $2,446) by a non-recourse loan to CLS over a period of two years from April 1, 2020 for the capital and operating expenditures of the laboratory. The loan will bear interest at 3.5% annually. Cronos Israel will receive 70% of the profits of the laboratory until such time as it has recovered 150% of the amounts advanced to CLS, after which time it will receive 50% of the laboratory profits. As a result, the Company is exposed to economic variability from CLS’s performance. The Company does not consolidate CLS as it does not have the power to direct the activities that most significantly impact the entity’s economic performance; thus, the Company is not considered the primary beneficiary of the entity. The carrying amount of the non-recourse loan is recorded under loans receivable and the full loan amount, ILS 8,297, represents the Company’s maximum potential exposure to losses through the Cannasoul Collaboration. See Note 10 for further information regarding loans receivable.
(a)Net investment in equity accounted investees
A reconciliation of the carrying amount of the investments in associates and joint ventures is as follows:
Carrying Amount
Ownership %June 30, 2020December 31, 2019
Cronos Australia(i)
31%$—  $(346) 
Cronos GrowCo50%933  1,501  
MedMen Canada50%—  —  
Natuera50%—  (598) 
$933  $557  
(i) On October 25, 2019, Cronos Australia issued 40 million new shares in an initial public offering at an offering price of A$0.50 per share. The Company’s ownership in Cronos Australia decreased from 50% to 31% on November 7, 2019 when Cronos Australia began trading on the Australian Securities Exchange. This resulted in a reconsideration event, which required the reassessment of the Company’s VIE conclusion. Upon reconsideration, the Company determined that the entity was no longer a VIE as of December 31, 2019 and is now reported under the equity method.
The Company’s share of net earnings (losses) from equity investments accounted for under the equity method of accounting:
For the three months ended June 30,For the six months ended June 30,
2020201920202019
Whistler Medicinal Marijuana Company (“Whistler”)$—  $—  $—  $29  
Cronos Australia(i)
(235) (397) (235) (641) 
Cronos GrowCo(190) (38) (501) (27) 
MedMen Canada—  (2) —   
Natuera(ii)
(369) (304) (1,230) (304) 
$(794) $(741) $(1,966) $(939) 
(i) The Company’s share of accumulated net losses in excess of its equity investment and advances in Cronos Australia was $512 for the six months ended June 30, 2020 (June 30, 2019 – $nil).
(ii) The Company’s share of accumulated net losses in excess of its equity investment in Natuera has been applied as a loss allowance on the loan receivable. See Note 6(b) and Note 10.
(b)Advances to Joint Venture
MedMen Canada(i)
Cronos GrowCo
Cronos Australia (ii)
NatueraTotal
As of January 1, 2020$471  $18,966  $—  $—  $19,437  
Credit loss allowance (iii)
—  —  —  —  —  
Effect from foreign exchange(20) (819) —  —  (839) 
As of June 30, 2020$451  $18,147  $—  $—  $18,598  
As of January 1, 2019$1,244  $2,970  $475  $—  $4,689  
Advances (repayment)(852) 15,494  274  219  15,135  
Advances to joint ventures recovered from (applied to) carrying amount of investments35  22  (779) (224) (946) 
Effect from foreign exchange44  480  30   559  
As of December 31, 2019$471  $18,966  $—  $—  $19,437  
(i) Advance is unsecured, non-interest bearing, and there are no terms of repayment.
(ii) A$1,500 is governed by an unsecured loan bearing interest at a rate of 12% per annum, calculated and compounded daily, in arrears, on the amounts advanced from the date of each advance. The loan is due on January 1, 2022. If the loan is overdue, the outstanding amount bears interest at an additional 2% per annum.
(iii) For the three months ended June 30, 2020, a reversal of $917 related to the credit loss allowance for Cronos GrowCo was recorded as the Company assessed its recoverability. As of June 30, 2020, total credit losses were $nil.
XML 34 R13.htm IDEA: XBRL DOCUMENT v3.20.2
Other Investments
6 Months Ended
Jun. 30, 2020
Investments, Debt and Equity Securities [Abstract]  
Other Investments Other Investments
Other investments consist of investments in common shares and warrants of several companies in the cannabis industry. As of June 30, 2020, the Company did not hold any other investments.
During the six months ended June 30, 2020, in connection with the achievement of a milestone related to the Whistler transaction described below, the Company received 578,101 shares of Aurora Cannabis Inc. (“Aurora”). The Company sold all of the Aurora shares on March 6, 2020 for gross proceeds of $769 recorded as an other item in other income (expenses). The Company expects to further receive Aurora common shares upon the satisfaction of one milestone remaining, which has not been recognized in these condensed consolidated financial statements. The exact number of Aurora common shares to be issued to the Company following the satisfaction of such milestone will be determined in reference to the five-day volume weighted average price of Aurora common shares immediately prior to the achievement of the applicable milestone. No transactions occurred during the three months ended June 30, 2020.
On March 4, 2019, the Company sold all 2,563 shares of Whistler, representing approximately 19.0% of Whistler’s issued and outstanding common shares, to Aurora, in connection with Aurora's acquisition of Whistler (the “Whistler Transaction”). As a result of the closing of the Whistler Transaction, the Company received 2,524,341 Aurora common shares. During the six months ended June 30, 2019, the Company sold all 2,524,341 common shares of Aurora, for gross proceeds of $19,259 recorded as an other item in other income (expenses). No transactions occurred during the three months ended June 30, 2019.
During the six months ended June 30, 2019, the Company sold all remaining 11,062 common shares of Canopy Growth Corporation (“Canopy”) for gross proceeds of $355. The gains and losses on the Canopy investment were classified as fair value through net income. No transactions occurred during the three months ended June 30, 2019.
XML 35 R14.htm IDEA: XBRL DOCUMENT v3.20.2
Accumulated Other Comprehensive Income (Loss)
6 Months Ended
Jun. 30, 2020
Equity [Abstract]  
Accumulated Other Comprehensive Income (Loss) Accumulated Other Comprehensive Income (Loss)
The following are continuity schedules of accumulated other comprehensive income (loss):

Three months ended June 30,Six months ended June 30,
2020201920202019
Net unrealized gain (loss) on revaluation and disposal of other investments
Balance beginning of period    
Cumulative effect from adoption of ASU 2016-01—  —  —  —  
Balance as of June 30    
Net foreign exchange gain (loss) on translation
Balance beginning of period(85,882) (5,980) 27,833  (9,875) 
Net unrealized (loss) gain51,907  17,948  (61,808) 21,843  
Balance as of June 30(33,975) 11,968  (33,975) 11,968  
Total accumulated other comprehensive income (loss)$(33,970) $11,973  $(33,970) $11,973  
XML 36 R15.htm IDEA: XBRL DOCUMENT v3.20.2
Leases
6 Months Ended
Jun. 30, 2020
Leases [Abstract]  
Leases Leases
The Company has entered into leases primarily for land-use rights, office premises and equipment used in the production of cannabis and related products. The Company’s leases have terms which range from three years to six years, excluding land use rights, which generally extend to 15 years. These leases often include options to extend the term of the lease for up to 10 years. When it is reasonably certain that the option will be exercised, the impact of the option is included in the lease term for purposes of determining total future lease payments.
Operating leases greater than one year are included in right-of-use assets and operating lease liabilities. Finance leases are included in property, plant and equipment on the Company’s consolidated balance sheet.
During the six months ended June 30, 2020, the Company recognized two new operating leases for office premises which are included within the lease obligation and right-of-use lines in the condensed consolidated balance sheet.
In June 2020, the Company terminated an operating lease for office premises. The lease was removed from the lease obligation and right-of-use balances in the condensed consolidated balance sheet.
The Company’s finance leases were not material as of June 30, 2020 and December 31, 2019.
XML 37 R16.htm IDEA: XBRL DOCUMENT v3.20.2
Loans Receivable, net
6 Months Ended
Jun. 30, 2020
Receivables [Abstract]  
Loans Receivable, net Loans Receivable, net
As of
June 30, 2020December 31, 2019
Current portion
Natuera Series A loan (i)
$2,984  $4,575  
Cronos GrowCo Credit Facility (ii)
1,474  —  
Add: Accrued interest—  89  
Total current portion of loans receivable4,458  4,664  
Long term portion
Cronos GrowCo Credit Facility (ii)
50,582  31,678  
2645485 Ontario Inc. (Mucci) Promissory Note (iii)
11,793  12,587  
Cannasoul Collaboration Loan (iv)
1,174  —  
Add: Accrued interest1,822  702  
Total long-term portion of loans receivable65,371  44,967  
Total loans receivable$69,829  $49,631  
(i)On September 27, 2019, the Company entered into a master loan agreement (the “Series A Loan”) for $4,575 with Natuera with effect as of August 29, 2019. The total aggregate principal amount of the Series A Loan is $9,150, of which the Company has committed to fund 50% and its joint venture partner has committed to fund the remaining 50%. Outstanding principal amounts bear interest at a fixed annual rate of 5.67% with a maturity date of August 29, 2020. As of June 30, 2020, accrued interest is recorded in other receivables. Subsequent to June 30, 2020, an amendement to the agreement was executed. Refer to Note 25.
For the six months ended June 30, 2020, a loss allowance of $1,591 was recorded against the Natuera Series A Loan related to the Company’s share of net loss from Natuera in excess of the carrying value of the equity method investment. Refer to Note 6.
(ii)On August 23, 2019, the Company entered into a credit agreement with Cronos GrowCo in respect of a C$100,000 ($73,660) secured non-revolving term loan credit facility (the “GrowCo Credit Facility”). The GrowCo Credit Facility will mature on March 31, 2031 and will bear interest at varying rates based on the Canadian prime rate as announced by the Bank of Montreal. Interest began to accrue as of the closing date of the GrowCo Credit Facility and is payable on a quarterly basis until maturity, except that any interest accrued prior to March 31, 2021 will be payable no later than December 31, 2021. Repayment of principal will be made on a quarterly basis commencing on March 31, 2021. The credit facility is secured by substantially all present and after acquired property of Cronos GrowCo and its subsidiaries. Mucci, the other 50% shareholder of Cronos GrowCo, has provided a limited recourse guarantee in favor of Cronos GrowCo, secured by Mucci’s shares in Cronos GrowCo. As of June 30, 2020, Cronos GrowCo had drawn C$72,150 ($53,145) from the Cronos GrowCo Credit Facility.
For the six months ended June 30, 2020, a current expected credit loss allowance of $1,089 was recorded against the GrowCo Facility.
(iii)On June 28, 2019, the Company entered into a promissory note receivable agreement (the “Mucci Promissory Note”) for C$16,350 ($12,043) with Mucci. The outstanding principal amount of the Mucci Promissory Note bears interest at 3.95% annually and is due within 90 days of demand. The Company does not intend to demand the loan within 12 months. Interest accrued under the Mucci Promissory Note until July 1, 2021 is payable by way of capitalization on the principal amount and interest thereafter must be paid in cash on a quarterly basis. The Mucci Promissory Note is secured by a general security agreement covering all the assets of Mucci.
For the six months ended June 30, 2020, a current expected credit loss allowance of $250 has been recorded against the Mucci loan.
(iv)On April 1, 2020, Cronos Israel entered into the Cannasoul Collaboration. Cronos Israel has agreed to advance approximately ILS 8,297 (approximately $2,446) by a non-recourse loan to CLS over a period of two years for the capital and operating expenditures of the laboratory. The outstanding principal on the loan bears interest at 3.5% annually and will be repaid through the profits generated from the Cannasoul Collaboration. As of June 30, 2020, CLS has received the first installment of ILS 4,149 (approximately $1,198).
For the six months ended June 30, 2020, a current expected credit loss allowance of $24 has been recorded against the Cannasoul Collaboration loan.
XML 38 R17.htm IDEA: XBRL DOCUMENT v3.20.2
Derivative Liabilities
6 Months Ended
Jun. 30, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative Liabilities Derivative Liabilities
On March 8, 2019, the Company closed the previously announced investment in the Company (the “Altria Investment”) by Altria Group, Inc. (“Altria”), pursuant to a subscription agreement dated December 7, 2018. As of the closing date of the Altria Investment, the Altria Investment consisted of 149,831,154 common shares of the Company as of the closing date, issued to a wholly owned subsidiary of Altria and one warrant of the Company (the “Altria Warrant”), refer to Note 15(a), issued to a wholly owned subsidiary of Altria. As of the closing date of the Altria Investment, Altria beneficially held an approximately 45% ownership interest in the Company (calculated on a non-diluted basis). As summarized in this note, if exercised in full on such date, the exercise of the Altria Warrant would have resulted in Altria holding a total ownership interest in the Company of approximately 55% (calculated on a non-diluted basis). Pursuant to the investor rights agreement between the Company and Altria, entered into in connection with the closing of the Altria Investment (the “Investor Rights Agreement”), the Company granted Altria certain rights, among others, summarized in this note.
The summaries below are qualified entirely by the terms and conditions fully set out in the Investor Rights Agreement and the Altria Warrant, as applicable.
a.The Altria Warrant entitles the holder, subject to certain qualifications and limitations, to subscribe for and purchase up to an additional 10% of the common shares of Cronos (approximately 77.8 million common shares at June 30, 2020) at a per share exercise price of C$19.00 which expires on March 8, 2023.
b.The Company granted to Altria, subject to certain qualifications and limitations, upon the occurrence of certain issuances of common shares of the Company executed by the Company (including issuances pursuant to the R&D partnership with Ginkgo Bioworks Inc. (“Ginkgo”) (the “Ginkgo Strategic Partnership”), which is discussed in Note 19(a)(i) below, the right to purchase up to such number of common shares of the Company in order to maintain their ownership percentage of issued and outstanding common shares of the Company immediately preceding any issuance of shares by the Company (“Pre-emptive Rights”), at the same price per common share of the Company at which the common shares are sold in the relevant issuance. The price per common share of the Company to be paid by Altria pursuant to its exercise of its Pre-emptive Rights related to the Ginkgo Strategic Partnership will be C$16.25 per common share. These rights may not be exercised if Altria’s ownership percentage of the issued and outstanding shares of the Company falls below 20%.
c.In addition to (and without duplication of) the Pre-emptive Rights, the Company granted to Altria, subject to certain qualifications and limitations, the right to subscribe for common shares of the Company issuable in connection with the exercise, conversion or exchange of convertible securities of the Company issued prior to March 8, 2019 or thereafter (excluding any convertible securities of the Company owned by Altria or any of its subsidiaries), a share incentive plan of the Company, the exercise of any right granted by the Company pro rata to all shareholders of the Company to purchase additional common shares and/or securities of the Company, bona fide bank debt, equipment financing or non-equity interim financing transactions that contemplate an equity component or bona fide acquisitions (including acquisitions of assets or rights under a license or otherwise), mergers or similar business combination transactions or joint ventures involving the Company in order to maintain their ownership percentage of issued and outstanding common shares of the Company immediately preceding any such transactions (“Top-up Rights”).
The price per common share to be paid by Altria pursuant to the exercise of its Top-up Rights will be, subject to certain limited exceptions, the 10-day volume-weighted average price of the common shares of the Company on the TSX for the ten full days preceding such exercise by Altria, provided that the price per common share of the Company to be paid by Altria pursuant to the exercise of its Top-up Rights in connection with the issuance of common shares of the Company pursuant to the exercise of options or warrants that were outstanding as of March 8, 2019 will be C$16.25 per common share without any set off, counterclaim, deduction, or withholding. These rights may not be exercised if Altria’s ownership percentage of the issued and outstanding shares of the Company falls below 20%. The Altria Warrant, Pre-emptive Rights, and fixed price Top-up Rights have been classified as derivative liabilities; related transaction costs of $22,355 were expensed as financing costs during the year ended December 31, 2019.
A reconciliation of the carrying amounts of the derivative liability is presented below:
April 1, 2020(Gain) / Loss on revaluationExercise of RightsEffect from foreign exchangeAs of June 30, 2020
(a) Altria Warrant$132,366  $30,052  $—  $3,540  $165,958  
(b) Pre-emptive Rights13,070  2,610  —  500  16,180  
(c) Top-up Rights20,740  3,218  (727) 1,072  23,576  
$166,176  $35,880  $(727) $5,112  $205,714  

January 1, 2020(Gain) / Loss on revaluationExercise of RightsEffect from foreign exchangeAs of June 30, 2020
(a) Altria Warrant$234,428  $(58,052) $—  $(10,418) $165,958  
(b) Pre-emptive Rights12,787  3,925  —  (532) 16,180  
(c) Top-up Rights49,945  (23,361) (727) (2,281) 23,576  
$297,160  $(77,488) $(727) $(13,231) $205,714  

Fluctuations in the Company’s share price are a primary driver for the changes in the derivative valuations during each reporting period. As the share price decreases for each of the related derivative instruments, the liability of the instrument generally decreases. Share price is one of the significant observable inputs used in the fair value measurement of each of the Company’s derivative instruments. During the six months ended June 30, 2020, the Company’s share price decreased from December 31, 2019 resulting in a gain on revaluation of $77,488.
The fair values of the derivative liabilities were determined using the Black-Scholes pricing model as of June 30, 2020 and December 31, 2019 applying the following inputs:
As of June 30, 2020As of December 31, 2019
Altria WarrantPre-emptive RightsTop-up RightsAltria WarrantPre-emptive RightsTop-up Rights
Share price at valuation date (per share in C$)$8.18$8.18$8.18$9.97$9.97$9.97
Subscription price (per share in C$)$19.00$16.25$16.25$19.00$16.25$16.25
Weighted average risk-free interest rate (i)
0.30%0.29%0.26%1.69%1.73%1.71%
Weighted average expected life (in years) (ii)
2.682.001.113.181.251.66
Expected annualized volatility (iii)
91%91%91%82%82%82%
Expected dividend yield—%—%—%—%—%—%
(i) The risk-free interest rate was based on Bank of Canada government treasury bills and bonds with a remaining term equal to the expected life of the derivative liabilities. The risk-free interest rate uses a range of approximately 0.21% to 0.61% as of June 30, 2020 (December 31, 2019 – 1.66% to 1.73%) for the Pre-emptive rights and Top-up rights.
(ii) The expected life in years represents the period of time that the derivative liabilities are expected to be outstanding. The expected life of the Pre-emptive Rights and Top-up Rights is determined based on the expected term of the underlying options, warrants, and shares, to which the Pre-emptive Rights and Top-up Rights are linked. The expected life uses a range of approximately 0.25 year to 5.5 years as of June 30, 2020 (December 31, 2019 – 0.25 year to 6 years).
(iii) Volatility was based on an equally weighted blended historical volatility level of the underlying equity securities of the Company and peer companies.
The following table quantifies each of the significant inputs described above and provides a sensitivity analysis of the impact on the reported values of the derivative liabilities. The sensitivity analysis for each significant input is performed by assuming a 10% decrease in the input while other significant inputs remain constant at management’s best estimate as of the respective dates. A decrease in the inputs noted below would cause a decrease in derivative liability and as of June 30, 2020, there would be an equal but opposite impact on net income (loss).
Decrease as of June 30, 2020Decrease as of December 31, 2019
Altria WarrantPre-emptive RightsTop-up RightsAltria WarrantPre-emptive RightsTop-up Rights
Share price$26,300  $2,779  $4,939  $36,436  $2,743  $9,577  
Weighted average expected life14,249  1,744  1,272  17,471  2,366  2,178  
Expected annualized volatility27,711  2,652  4,769  33,343  2,180  7,714  
These inputs are classified in Level 3 on the fair value hierarchy and are subject to volatility and several factors outside of the Company’s control, which could significantly affect the fair value of these derivative liabilities in future periods.
XML 39 R18.htm IDEA: XBRL DOCUMENT v3.20.2
Property, Plant and Equipment
6 Months Ended
Jun. 30, 2020
Property, Plant and Equipment [Abstract]  
Property, Plant and Equipment Property, Plant and Equipment
Property, plant and equipment, net consisted of the following:
As of
June 30, 2020December 31, 2019
Cost
Land$3,618  $3,727  
Building146,685  150,324  
Furniture and equipment11,394  10,156  
Computer equipment651  687  
Leasehold improvements3,116  2,789  
Construction in progress12,492  3,569  
Less: accumulated depreciation(13,666) (9,443) 
Total$164,290  $161,809  
Depreciation expense included in cost of sales relating to manufacturing equipment and production facilities for the six months ended June 30, 2020 was $759 (June 30, 2019 – $448). Depreciation expense included in operating expenses related to general office space and equipment for six months ended June 30, 2020 was $1,025 (June 30, 2019 – $425). The remaining depreciation is included in inventory.
For the six months ended June 30, 2020, there is $nil (June 30, 2019 – $367) of capitalized interest included in construction in progress.
XML 40 R19.htm IDEA: XBRL DOCUMENT v3.20.2
Intangible Assets and Goodwill
6 Months Ended
Jun. 30, 2020
Goodwill and Intangible Assets Disclosure [Abstract]  
Intangible Assets and Goodwill Intangible Assets and Goodwill
The ongoing restrictions and closures experienced by retail stores in the U.S. as a result of the COVID-19 pandemic have negatively impacted sales and demand which has resulted in slower than expected revenue growth in the U.S. reporting unit for the three months ended June 30, 2020. The Company expects the revenue growth and operating results in the U.S. reporting unit to continue to be negatively impacted as the decrease in customer demand and retail closures are expected to continue as a result of the pandemic. The Company performed an interim impairment test during the three months ended June 30, 2020 on the U.S. reporting unit, which holds the Redwood goodwill, as well as the indefinite-lived intangible asset (Lord Jones™ brand) to determine whether the carrying amount of the reporting unit and intangible asset exceeded their respective fair values. The Company reassessed its estimates and forecasts during the second quarter to determine the fair values of the reporting unit and intangible asset. The fair values were determined using a discounted cash flow method on the reporting unit and the relief-from-royalty method on the Lord Jones™ brand. Based on these valuations, the carrying value exceeded the fair value resulting in an impairment on both the reporting unit as well as the Lord Jones™ brand. The Company does not believe the declines in fair values are temporary. The Company recorded $35.0 million of impairment charges on the U.S. reporting unit and $5.0 million on the Lord Jones™ brand for the three and six months ended June 30, 2020.
No impairment loss was recorded for either goodwill or intangible assets during the three and six months ended June 30, 2019.
(a)Intangible Assets
Intangible assets are comprised of the following items:

Weighted Average Amortization Period (in years)As of June 30, 2020
CostAccumulated AmortizationImpairment chargesNet
Software (i)
N/A$612  $(298) $—  $314  
Enterprise Resource Planning (“ERP”) system (ii)
52,570  —  —  2,570  
Health Canada licenses 178,255  (1,167) —  7,088  
Lord Jones brand
N/A64,000  —  (5,000) 59,000  
TrademarksN/A140  —  —  140  
Israeli Codes (iii)
25297  (10) —  287  
$75,874  $(1,475) $(5,000) $69,399  
(i)Software amortizes using a double declining method.
(ii)During the six months ended June 30, 2020, the Company capitalized costs for the ERP system. As of June 30, 2020, the system is not yet available for use, resulting in no amortization being recorded against the asset.
(iii)The preliminary licenses granted to Kibbutz Gan Shmuel (the Cronos Israel joint venture partner) by the Medical Cannabis Unit of the Israeli Ministry of Health in early 2017 (the “Israeli Codes”) were transferred by non-controlling interests to Cronos Israel in exchange for their equity interests in the Cronos Israel entities specified above.
Weighted Average Amortization Period (in years)As of December 31, 2019
CostAccumulated AmortizationNet
Software (i)
N/A$541  $(202) $339  
Health Canada licenses 178,627  (976) 7,651  
Lord Jones brand
N/A64,000  —  64,000  
TrademarksN/A36  —  36  
Israeli Codes (ii)
25298  (4) 294  
$73,502  $(1,182) $72,320  
(i)Software amortizes using a double declining method.
(ii)  The Israeli Codes were transferred by non-controlling interests to Cronos Israel in exchange for their equity interests in the Cronos Israel entities specified above.
The aggregate amortization for the six months ended June 30, 2020 was $346 (June 30, 2019 – $301). Intangible asset additions in 2020 included the ERP system for $2,570. There was $37 related to disposals of software during the six months ended June 30, 2020.
The amortization expense for the next five years on intangible assets in use is estimated to be as follows: 2021 – $565; 2022 – $553; 2023: $536; 2024 – $520; 2025 – $506.
(b)Goodwill
As of December 31, 2019AdditionsImpairment chargesEffect of foreign exchangeAs of June 30, 2020
OGBC$302  $—  $—  $(13) $289  
Peace Naturals1,078  —  —  (45) 1,033  
Redwood213,414  —  (35,000) —  178,414  
$214,794  $—  $(35,000) $(58) $179,736  
XML 41 R20.htm IDEA: XBRL DOCUMENT v3.20.2
General and Administrative Expenses
6 Months Ended
Jun. 30, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
General and Administrative Expenses General and Administrative Expenses
General and administrative expense are comprised of the following items:
Three months ended June 30,Six months ended June 30,
2020201920202019
Salaries and wages$6,337  $3,354  $13,803  $5,348  
Professional and consulting3,263  5,051  8,849  7,254  
Office and general3,545  2,622  6,620  5,523  
Review costs related to restatement of 2019 interim financial statements (i)
3,459  —  7,866  —  
Other1,833  461  5,058  656  
Total$18,437  $11,488  $42,196  $18,781  
(i)These financial statement review costs include costs related to the restatement of the Company’s 2019 interim financial statements and costs related to the Company’s responses to request for information from various regulatory authorities relating to such restatement.
XML 42 R21.htm IDEA: XBRL DOCUMENT v3.20.2
Share-based Payments
6 Months Ended
Jun. 30, 2020
Share-based Payment Arrangement [Abstract]  
Share-based Payments Share-based Payments
(a)Warrants
The following is a summary of the changes in warrants during the six months ended June 30, 2020 and 2019:
Weighted average exercise price (C$)Number of warrants
Balance as of January 1, 2020$0.26  $18,066,662  
Balance as of June 30, 2020$0.26  $18,066,662  
Balance as of January 1, 2019$0.26  $25,457,623  
Exercise of warrants0.36  (7,390,961) 
Balance as of June 30, 2019$0.22  $18,066,662  

As of June 30, 2020, the Company had outstanding warrants as follows. For a description of the Altria Warrant, see Note 11.
Grant DateExpiry dateWeighted average exercise price (C$)Number of warrants
October 8 – 28, 2015October 8 – 28, 2020$0.31  $2,976,610  
May 13 – 27, 2016May 13 – 27, 20210.25  15,090,052  
As of June 30, 2020$0.26  $18,066,662  
(b)Stock options
(i)Stock option plans
The Company adopted an amended and restated stock option plan dated May 26, 2015 (the “2015 Stock Option Plan”) which was approved by shareholders of the Company at the annual general meeting of shareholders held on June 28, 2017. The 2015 Stock Option Plan allowed the Company’s Board of Directors (the “Board”) to award options to purchase shares to directors, officers, key employees and service providers of the Company. As of June 28, 2018, no further awards will be granted under the 2015 Stock Option Plan; however, shares may be purchased via option exercise by the holders of any outstanding options previously issued under the 2015 Stock Option Plan. As of June 30, 2020, options to purchase 10,486,569 Company common shares were outstanding under the 2015 Stock Option Plan.
On June 28, 2018, the shareholders of the Company approved a stock option plan (the “2018 Stock Option Plan”), which replaced the 2015 Stock Option Plan. As of June 25, 2020, the date on which the 2020 Omnibus Plan (as defined below) was approved by the shareholders of the Company, no further awards will be granted under the 2018 Stock Option Plan; however, shares may be purchased via option exercise by the holders of any outstanding options previously issued under the 2018 Stock Option Plan. As of June 30, 2020, options to purchase 1,727,979 Company common shares were outstanding under the 2018 Stock Option Plan.
On March 29, 2020, the Board adopted a new omnibus equity incentive plan (the “2020 Omnibus Plan”), which was approved by the shareholders of the Company at the annual and special meeting of shareholders held on June 25, 2020. The 2020 Omnibus Plan provides for grants of stock options, share appreciation rights, restricted shares, restricted share units and other share-based or cash-based awards, which are subject to terms as determined by the Compensation Committee of the Board, and awards may be granted to eligible employees, non-employee directors and consultants. As of June 30, 2020, no grants of options have been made under the 2020 Omnibus Plan.
For the three and six months ended June 30, 2020, the total stock-based compensation expense associated with the stock option plans was $1,770 (June 30, 2019 – $2,647) and $3,500 (June 30, 2019 – $4,418), respectively.
(ii) Summary of changes
The following is a summary of the changes during the six months ended June 30, 2020 and 2019:
Weighted average exercise price (C$)Number of optionsWeighted average remaining contractual term (years)
Balance as of January 1, 2020$4.84  14,149,502  2.56
Exercise of options2.05  (1,807,909) 
Cancellation, forfeiture and expiry of options15.78  (127,045) 
Balance as of June 30, 2020$5.13  12,214,548  2.05
Exercisable at June 30, 20203.42  8,688,645  1.78
Balance as of January 1, 2019$2.99  12,902,995  3.35
Issuance of options20.81  1,315,787  
Exercise of options3.76  (227,342) 
Cancellation, forfeiture and expiry of options1.63  (2,895) 
Balance as of June 30, 2019$4.66  13,988,545  3.04
Exercisable as of June 30, 20192.406,580,238  2.69
(iii)Fair value of options issued
The fair value of the options issued was determined using the Black-Scholes option pricing model, using the following inputs:
For the six months ended June 30, 2019
Share price at grant date (per share)
C$20.65 - C$24.75
Exercise price (per option)
C$20.65 - C$24.75
Risk-free interest rate
1.51% - 1.62%
Expected life of options (in years)5
Expected annualized volatility80%
Expected dividend yield—%
Weighted average Black-Scholes value at grant date (per option)
C$13.29 - C$15.91
Forfeiture rate—%
No stock options were granted under the 2018 Stock Option Plan or the 2020 Omnibus Plan during the six months ended June 30, 2020. During the six months ended June 30, 2019, the weighted average fair value per share at grant date of options was C$13.35.
The expected life of the awards represents the period of time stock options are expected to be outstanding and is estimated considering vesting terms and employees’ and non-employees’ historical exercise and post-vesting employment termination behavior. Volatility was estimated by using the historical volatility of the Company, adjusted for the Company’s expectation of volatility going forward. The risk-free interest rate was based on the Bank of Canada government bonds with a remaining term equal to the expected life of the options at the grant date.
(c)Restricted share units
On May 11, 2020, the Company issued an aggregate of 279,277 restricted stock units (“RSUs”) to certain employees in connection with the 2020 Omnibus Plan. Each RSU entitles the holder to receive upon vesting one common share of the Company. The fair value of these RSUs has been determined based on the quoted market price of the applicable exchange on the date of issuance of C$7.52 per share on TSX or $5.42 per share on NASDAQ. The RSUs vest annually in equal installments over a three-year period following the grant date and have no performance requirements.
On September 5, 2019, the Company issued an aggregate of 732,972 RSUs to certain employees in connection with the acquisition of four Redwood Holding Group, LLC subsidiaries (collectively, “Redwood”) and pursuant to Employment Inducement Award Plan. Each RSU entitles the holder to receive upon vesting one common share of the Company. The fair value of these RSUs has been determined based on the quoted market price on the date of issuance of C$15.34 per share. Under the terms of the corresponding RSU agreement, the RSUs vest on the third anniversary following the grant date and have no performance requirements.
On July 20, 2020, the Company entered into separation agreements with Robert Rosenheck and another Redwood Wellness, LLC (“Redwood”) employee pursuant to which they resigned from their employment with Redwood. In connection with such separation agreements, the 732972 outstanding and unvested RSUs as of July 20, 2020 to which they were entitled were accelerated and vested as of July 20, 2020. Refer to Note 25 for further information.
For the three and six months ended June 30, 2020, the Company recorded $776 and $1,482 (June 30, 2019 – $nil) in share-based compensation expense related to these RSUs, respectively.
The following is a summary of the changes in RSUs from January 1, 2020 to June 30, 2020:
Number of RSUsShare-based reserve
Balance as of January 1, 2020732,972  $889  
Issuance of RSUs279,277  —  
Vesting of issued RSUs —  1,482  
Balance as of June 30, 20201,012,249  $2,371  
No RSUs were granted or outstanding during the six months ended June 30, 2019.
(d)Deferred share units
On August 10, 2019, the Company established a cash-settled deferred share unit plan (“DSU Plan”) pursuant to which its non-executive directors receive deferred share units (“DSUs”). The DSU Plan is designed to promote a greater alignment of long-term interests between non-executive directors and shareholders. The number of DSUs granted under the DSU Plan (including fractional DSUs) is determined by dividing the amount of remuneration payable by the closing price as reported by the TSX on the trading day immediately preceding the day of grant. DSUs are payable at the time a non-executive director ceases to hold the office of director for any reason and are settled by a lump-sum cash payment, in accordance with the terms of the DSU Plan, based on the fair value of the DSUs at such time. The fair value of the cash payout is determined by multiplying the number of DSUs vested at the payout date by the closing price as reported by the TSX on the trading day immediately preceding the payout date. The fair value of the cash payout is determined at each reporting date based on the fair value of the Company’s common shares at the reporting date and is recorded within other liabilities.
The following is a summary of the changes in DSUs from January 1, 2020 to June 30, 2020:
Number of DSUsFinancial liability
Balance as of January 1, 202033,397  $255  
Liabilities settled(8,484) (46) 
Loss (gain) on revaluation —  (56) 
Balance as of June 30, 202024,913  $153  
No DSUs were granted or outstanding during the six months ended June 30, 2019.
XML 43 R22.htm IDEA: XBRL DOCUMENT v3.20.2
Earnings (loss) Per Share
6 Months Ended
Jun. 30, 2020
Earnings Per Share [Abstract]  
Earnings (loss) Per Share Earnings (loss) Per Share
Basic and diluted earnings (loss) per share are calculated using the following numerators and denominators:
For the three months ended June 30,For the six months ended June 30,
2020201920202019
Basic earnings per share computation
Net income (loss) attributable to common shareholders of Cronos Group$(106,977) $185,999  $(30,937) $500,090  
Weighted average number of common shares outstanding349,075,408  334,665,873  348,946,439  317,940,749  
 Basic earnings per share $(0.31) $0.56  $(0.09) $1.57  
Diluted earnings per share computation(i)
Net income (loss) used in the computation of basic earnings per share$(106,977) $185,999  $(30,937) $500,090  
Adjustment for gain (loss) on revaluation of derivative liabilities(729) (126,032) (729) (350,758) 
Net income (loss) used in the computation of diluted income per share$(107,706) $59,967  $(31,666) $149,332  
Weighted average number of common shares outstanding used in the computation of basic earnings per share349,075,408  334,665,873  348,946,439317,940,749
Dilutive effect of warrants (i)
—  19,287,262  —  21,239,056
Dilutive effect of stock options (i)
—  10,992,464  —  11,291,914
Dilutive effect of restricted share units (i)
—  —  —  —  
Dilutive effect of Altria Warrant (i)
—  9,100,465  —  13,633,605
Dilutive effect of Top-up Rights – exercised and exercisable fixed price (i)
—  630,531  —  766,769
Weighted average number of common shares for computation of diluted income (loss) per share349,075,408  374,676,595  348,946.439  364,872,093  
Diluted earnings per share$(0.31) $0.16  $(0.09) $0.41  
(i) In computing diluted earnings per share, incremental common shares are not considered in periods in which a net loss is reported, as the inclusion of the common share equivalents would be anti-dilutive.
The following securities were not included in the computation of diluted shares outstanding because the effect would be anti-dilutive or because conditions for contingently issuable shares were not satisfied at the end of the reporting periods.
Three months ended June 30,Six months ended June 30,
2020201920202019
Ginkgo Equity Milestones14,674,904  14,674,904  14,674,904  14,674,904  
Pre-emptive Rights12,006,740  12,006,740  12,006,740  12,006,740  
Top-up Rights – fixed price26,686,413  —  26,686,413  —  
Top-up Rights – market price1,941,349  25,150,434  1,941,349  25,150,434  
Altria Warrant77,752,533  1,076,553  77,752,533  1,076,553  
Stock options10,495,235  51,830  10,547,256  51,830  
Warrants17,536,558  —  17,521,903  —  
Restricted share units1,012,249  —  1,012,249  —  
Total anti-dilutive securities162,091,326  52,960,461  162,158,002  52,960,461  
XML 44 R23.htm IDEA: XBRL DOCUMENT v3.20.2
Related Party Transactions and Balances
6 Months Ended
Jun. 30, 2020
Related Party Transactions [Abstract]  
Related Party Transactions and Balances Related Party Transactions and Balances
On March 8, 2019, in connection with the Altria Investment, Altria, through certain of its wholly owned subsidiaries, purchased a 45% equity interest in the Company. During the three and six months ended June 30, 2020, the Company incurred $281 and $953 respectively, for consulting services from Altria Pinnacle LLC, a subsidiary of Altria (“Altria Pinnacle”). As of June 30, 2020, the accrual for these consulting services was $281 (December 31, 2019 – $1,152). No consulting services were provided by Altria Pinnacle for the three and six months ended June 30, 2019.
During 2019, the Company purchased machinery and equipment amounting to $1,258 from a subsidiary of Altria. Refer to Note 19 for additional information.
Refer to Note 11 for further information on the derivative liabilities related to the Altria Investment.
There were no other material related party transactions for the six months ended June 30, 2020 or June 30, 2019.
XML 45 R24.htm IDEA: XBRL DOCUMENT v3.20.2
Segment Information
6 Months Ended
Jun. 30, 2020
Segment Reporting [Abstract]  
Segment Information Segment Information
Segment reporting is prepared on the same basis that the Company’s chief operating decision makers (the “CODMs”) manage the business, make operating decisions and assess the Company’s performance. The Company determined that it has the following two reportable segments: United States and Rest of World. The United States operating segment consists of the manufacture and distribution of hemp-derived CBD infused products. The Rest of World operating segment is involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. These two segments represent the geographic regions in which the Company operates and the different product offerings within each geographic region. The results of each segment are regularly reviewed by the CODMs to assess the performance of the segment and make decisions regarding the allocation of resources. The CODMs review operating income (loss) as the measure of segment profit or loss to evaluate performance of and allocate resources for its reportable segments. Operating income (loss) is defined as net revenue less cost of sales and operating expenses.
Reporting by operating segments follows the same accounting policies as those used to prepare the consolidated financial statements. The operating segments are presented in accordance with the same criteria used for internal reporting prepared for the CODMs. Intersegment transactions are recorded at the stated values as agreed to by the segments.
Segment data was as follows for the three months ended June 30, 2020:
Three months ended June 30, 2020
United StatesRest of WorldCorporateTotal
Consolidated statements of net income (loss) and comprehensive income (loss)
Net revenue
Cannabis flower$—  $5,674  $—  $5,674  
Cannabis extracts2,174  1,917  —  4,091  
Other—  118  —  118  
Net revenue$2,174  $7,709  $—  $9,883  
Share of loss from investments in equity accounted investees$—  $794  $—  $794  
Interest income 3,811  (2) 3,817  
Interest expense—  (83) —  (83) 
Interest income, net$ $3,728  $(2) $3,734  
Impairment loss on goodwill and intangible assets40,000  $—  $—  $40,000  
Depreciation and amortization36  654  (6) 684  
Income tax expense—  —  —  —  
Net income (loss)(47,762) (52,899) (7,042) (107,703) 
Segment data was as follows for the six months ended June 30, 2020:
Six months ended June 30, 2020
United StatesRest of WorldCorporateTotal
Consolidated statements of net income (loss) and comprehensive income (loss)
Net revenue
Cannabis flower$—  $8,415  $—  $8,415  
Cannabis extracts4,350  5,317  —  9,667  
Other—  233  —  233  
Net revenue$4,350  $13,965  $—  $18,315  
Share of loss from investments in equity accounted investees$—  $1,966  $—  $1,966  
Interest income13  11,562  —  11,575  
Interest expense—  (90) —  (90) 
Interest income, net$13  $11,472  $—  $11,485  
Impairment loss on goodwill and intangible assets40,000  $—  $—  $40,000  
Depreciation and amortization69  1,302  —  1,371  
Income tax expense—  —  —  —  
Net income (loss)(57,567) 39,257  (13,712) (32,022) 
Consolidated balance sheets
Total assets$250,470  $348,569  $1,311,248  $1,910,287  
Investments in equity accounted investees—  933  —  933  
Goodwill178,414  1,322  —  179,736  
Purchase of property, plant and equipment, net219  13,125  —  13,344  
Sources of net revenue for the three and six months ended June 30, 2020 and 2019 were as follows:
Three months ended June 30,Six months ended June 30,
2020201920202019
Cannabis flower5,674  6,096  $8,415  $7,921  
Cannabis extracts4,091  1,535  9,667  2,638  
Other118  22  233  98  
Net revenue$9,883  $7,653  $18,315  $10,657  
Net revenue attributed to a geographic region based on the location of the customer were as follows:
Three months ended June 30,Six months ended June 30,
2020201920202019
Canada7,416  7,340  $13,507  $10,323  
United States2,174  —  4,350  —  
Other countries293  313  458  334  
Total$9,883  $7,653  $18,315  $10,657  
Property, plant and equipment assets were physically located in the following geographic regions:
As of June 30, 2020As of December 31, 2019
Canada$140,357  $141,021  
United States2,253  2,103  
Other countries21,680  18,685  
Total$164,290  $161,809  
The Company sells products through a limited number of major customers. Major customers are defined as customers that each individually accounted for greater than 10% of the Company’s revenues and greater than 10% of accounts receivable.
United States
During the three and six months ended June 30, 2020, the U.S. segment had no major customers.
As of June 30, 2020, $46 (December 31, 2019 – $12) in expected credit losses has been recognized on receivables from contracts with customers.
Rest of World
During the three months ended, June 30, 2020, the Rest of World segment earned a total net revenue before excise taxes of $7,040 from four major customers, BC Liquor Distribution Branch, Alberta Gaming, Liquor and Cannabis Commission, Ontario Cannabis Retail Corporation, and Société Québécoise du Cannabis accounting for 26%, 19%, 16% and 12% of the Company’s total revenues, respectively (three months ended June 30, 2019 – $4,118 from one major customer accounting for 54% of the Company’s total revenues).
During the six months ended, June 30, 2020, the Rest of World segment earned a total net revenue before excise taxes of $11,819 from the same four major customers as mentioned above, representing 19%, 22%, 13%, and 13% of the Company’s total revenues, respectively (six months ended June 30, 2019 – $5,800 from two major customers, together accounting for 54% of the Company’s total revenues).
As of June 30, 2020, $34 (December 31, 2019 – $124) in expected credit losses has been recognized on receivables from contracts with customers.
XML 46 R25.htm IDEA: XBRL DOCUMENT v3.20.2
Commitments
6 Months Ended
Jun. 30, 2020
Commitments and Contingencies Disclosure [Abstract]  
Commitments Commitments
(a)R&D Commitments
(i) Ginkgo. On September 4, 2018, the Company announced an R&D partnership with Ginkgo to develop scalable and consistent production of eight target cannabinoids, including THC, CBD and a variety of other lesser known and rarer cannabinoids. As part of this partnership, Cronos Group has agreed to issue up to 14,674,903 common shares of the Company (aggregate value of approximately $100,000 as of July 17, 2018 assuming all milestones are met) (collectively the “Ginkgo Equity Milestones”) in tranches and $22,000 in cash subject to Ginkgo’s achievement of certain milestones and to fund certain R&D expenses, including foundry access fees.
(ii) Technion. On October 15, 2018, the Company entered into a sponsored research agreement with the Technion Research and Development Foundation of the Technion – Israel Institute of Technology (“Technion”). Research will be focused on the use of cannabinoids and their role in regulating skin health and skin disorders. The Company has committed to $1,784 of research funding over a period of three years. An additional $4,900 of cash payments will be paid to Technion upon the achievement of certain milestones.
(b)Altria Consulting Services
On February 18, 2019, the Company entered into an agreement with a wholly owned subsidiary of Altria (which agreement was subsequently amended and restated to substitute Altria Pinnacle as a party thereto), to receive strategic advisory and project management services from Altria Pinnacle (the “Services Agreement”). Pursuant to the Services Agreement, the Company will pay Altria Pinnacle a monthly fee equal to the product of one hundred and five percent (105%) and the sum of: (i) all costs directly associated with the services incurred during the monthly period, and (ii) a reasonable and appropriate allocation of indirect costs incurred during the monthly period. The Company will also pay all third-party direct charges incurred during the monthly period in connection with the services, including any reasonable and documented costs, fees and expenses associated with obtaining any consent, license or permit. The Services Agreement will remain in effect until terminated by either party.
(c)Use of Publicity Rights in Brand Development
On December 23, 2019, the Company issued 856,017 restricted common shares to an accredited investor in a private placement (“Private Placement – 2019”) in reliance on Section 4(a)(2) of the Securities Act of 1933 in connection with the use of certain publicity rights in brand development. One-third of such common shares vested on January 31, 2020 with the remaining shares vesting in two equal installments on June 23, 2021, and December 23, 2022. The issuance did not involve a public offering and was made without general solicitation or advertising. The total fair value of the consideration paid for the issuance of such common shares was approximately $6,000. The fair value of the shares was calculated using the ten-day volume weighted average price per share of the Company’s common shares on Nasdaq.
Additional restricted common shares are issued when certain performance milestones are achieved:
(i) First Performance Issuance: if, prior to December 23, 2022, the product line generates at least $50,000 in net revenue, additional common shares with an aggregate value of $1,000 will be issued.
(ii) Second Performance Issuance: if, prior to December 23, 2022, the product line generates at least $100,000 in net revenue, additional common shares with an aggregate value of $1,000 will be issued (together with the First Performance Issuance noted above).
The number of common shares that would be issued upon achieving the foregoing milestones will be determined based on the ten-day volume weighted average price per share of the Company’s common shares on Nasdaq as of the trading day immediately prior to the date of filing with the SEC of the Company’s audited year-end financial statements for the first fiscal year during which such milestones are achieved.
(d)Take or Pay Supply Agreement
In January 2020, the Company entered into a take or pay supply agreement with a supplier of dried cannabis flower. The Company agreed to purchase a minimum of approximately C$1,734 ($1,290) of dried cannabis flower over 6 months from the date of the agreement and, subject to the supplier’s satisfaction of certain conditions and the availability of additional product, potentially up to a maximum of approximately C$4,284 ($3,188) over 6 months from the date of the agreement. As at June 30, 2020, the Company is committed to purchase approximately C$1,230 ($906) of dried cannabis flower remaining under this agreement which, due to delays in deliveries from the supplier, are expected to be made during the remainder of 2020.
XML 47 R26.htm IDEA: XBRL DOCUMENT v3.20.2
Contingencies
6 Months Ended
Jun. 30, 2020
Loss Contingency [Abstract]  
Contingencies Contingencies
The Company is subject to various legal proceedings in the ordinary course of business and in connection with its marketing, distribution and sale of its products. Many of these legal proceedings are in the early stages of litigation and seek damages that are unspecified or not quantified. Although the outcome of these matters cannot be predicted with certainty, the Company does not believe these legal proceedings, individually or in the aggregate, will have a material adverse effect on the Company’s financial condition but could be material to the Company’s results of operations for a quarterly period depending, in part, on the results for that quarter.
(a)Class Action Complaints Relating to Restatements
On March 11 and 12, 2020, two alleged shareholders of the Company separately filed two putative class action complaints in the U.S. District Court for the Eastern District of New York against the Company and its Chief Executive Officer and Chief Financial Officer alleging violations of Section 10(b) of the Securities Exchange Act of 1934 (the “Exchange Act”) and Rule 10b-5 promulgated thereunder against all defendants, and Section 20(a) of the Exchange Act against the individual defendants. The complaints generally allege that certain of the Company’s prior public statements about revenues and internal controls were incorrect based on the Company’s March 2, 2020, disclosure that the Audit Committee of its Board of Directors was conducting a review of the appropriateness of revenue recognized in connection with certain bulk resin purchases and sales of products through the wholesale channel. The complaints do not quantify a damage request. Defendants have not yet responded to the complaints.
On June 3, 2020, an alleged shareholder filed a Statement of Claim in the Ontario Superior Court of Justice in Toronto, Ontario, Canada, seeking, among other things, an order certifying the action as a class action on behalf of a putative class of shareholders and damages of an unspecified amount. The Statement of Claim names the Company, its Chief Executive Officer, Chief Financial Officer, former Chief Financial Officer and Chief Commercial Officer, and current and former members of its Board of Directors as defendants and alleges breaches of the Ontario Securities Act, oppression under the Ontario Business Corporations Act and common law misrepresentation. The Statement of Claim generally alleges that certain of the Company’s prior public statements about revenues and internal controls were misrepresentations based on the Company’s March 2, 2020 disclosure that the Audit Committee of its Board of Directors was conducting a review of the appropriateness of revenue recognized in connection with certain bulk resin purchases and sales of products through the wholesale channel, and the Company’s subsequent restatements. The Statement of Claim does not quantify its damage request. The Company and the other named defendants have not yet filed a response to the Statement of Claim.
(b)Regulatory Reviews Relating to Restatements
The Company has been responding to requests for information from various regulatory authorities relating to its previously disclosed restatement of its financial statements for the first three quarters of 2019. The Company is responding to all such requests for information and cooperating with all regulatory authorities. The Company cannot predict the outcome of any such regulatory review or investigation and it is possible that additional investigations or one or more formal proceedings may be commenced against the Company and its current and former officers and directors in connection with these regulatory reviews.
(c)Litigation Relating to Marketing, Distribution and Sale of Products
On June 16, 2020, an alleged consumer filed a Statement of Claim on behalf of a class in the Court of Queen’s Bench of Alberta in Alberta, Canada, against the Company and other Canadian cannabis manufacturers and/or distributors. The Statement of Claim alleges claims related to the defendants’ advertised content of cannabinoids in cannabis products for medicinal use on or after June 16, 2010 and cannabis products for adult use on or after October 17, 2018. The Statement of Claim seeks a total of C$500 million for breach of contract, compensatory damages, and unjust enrichment or such other amount as may be proven in trial and C$5 million in punitive damages against each defendant, including the Company. The Statement of Claim also seeks interest and costs associated with the action. The Company has not responded to the Statement of the Claim.
A number of claims, including purported class actions, have been brought in the U.S. against companies engaged in the U.S. hemp business alleging, among other things, violations of state consumer protection, health and advertising laws. On April 8, 2020, a putative class action complaint was filed in the U.S. District Court for the Central District of California against Redwood, alleging violations of California’s Unfair Competition Law, False Advertising Law, Consumers Legal Remedies Act, and breaches of the California Commercial Code for breach of express warranties and implied warranty of merchantability with respect to Redwood’s marketing and sale of U.S. hemp products. The complaint does not quantify a damage request. On April 14, 2020, the class action complaint was dismissed for certain pleading deficiencies and the plaintiff was granted leave until April 24, 2020 to amend the complaint to establish federal subject matter jurisdiction. As of the date of this Quarterly Report, the plaintiff has not refiled the complaint and the complaint has been dismissed without prejudice
The Company expects litigation and regulatory proceedings relating to the marketing, distribution and sale of its products to increase.
XML 48 R27.htm IDEA: XBRL DOCUMENT v3.20.2
Financial Instruments
6 Months Ended
Jun. 30, 2020
Risks and Uncertainties [Abstract]  
Financial Instruments Financial Instruments
The Company’s activities expose it to a variety of financial risks, including credit risk, liquidity risk, and market risk (including interest rate risk) and foreign currency risk.
(a)Credit Risk
Credit risk is the risk of financial loss to the Company if a customer or counterparty to a financial instrument fails to meet its contractual obligations. The Company is exposed to credit risk from its operating activities, primarily accounts receivable and other receivables, and its investing activities, including cash held with banks and financial institutions, short-term investments, loan receivable, and advances to joint ventures. The Company’s maximum exposure to this risk is equal to the carrying amount of these financial assets, which amounted to $1,424,786 as of June 30, 2020 (December 31, 2019 – $1,586,978).
(i)Accounts receivable
An impairment analysis is performed at each reporting date using a provision matrix to measure expected credit losses. The provision rates are based on the days past due for groupings of various customer segments with similar loss patterns. The calculation reflects the probability-weighted outcome, the time value of money and reasonable and supportable information that is available at the reporting date about past events, current conditions and forecasts of future economic conditions. Accounts receivable are written off when there is no reasonable expectation of recovery. Indicators that there is no reasonable expectation of recovery include, among others, the failure of a debtor to engage in a repayment plan, and a failure to make contractual payments for a period of greater than 120 days past due. For the three months ended June 30, 2020, the Company recorded a current expected credit loss allowance of $80 (December 31, 2019 – $136). The Company has assessed that there is a concentration of credit risk, as 78% of the Company’s accounts receivable were due from four customers as of June 30, 2020 (December 31, 2019 – 56% due from two customers) with an established credit history with the Company.
(ii)Cash and cash equivalents, short-term investments, and other receivables
The Company held cash and cash equivalents of $1,109,700 as of June 30, 2020 (December 31, 2019 – $1,199,693). The short-term investments and related interest receivable of $213,614 as of June 30, 2020 (December 31, 2019 – $306,347) represents short-term investments with a maturity of less than a year and accrued interest as of period end. The cash and cash equivalents and short-term investments, including guaranteed investment certificates and bankers’ acceptances, are held with central banks and financial institutions that are highly rated. In addition to interest receivable, other receivables include sales taxes receivable from the government. As such, the Company has assessed an insignificant loss allowance on these financial instruments.
(iii)Advances to joint ventures
The Company has assessed the credit risk of advances to joint ventures based on the financial position of the borrowers, and the regulatory and economic environment of the borrowers. Based on historical information, and adjusted for forward-looking expectations, the Company has assessed an expected credit loss allowance on these advances as of June 30, 2020 of $nil (December 31, 2019 – $nil).
(b) Liquidity risk
Liquidity risk is the risk that the Company will not be able to meet its financial obligations as they become due and arises principally from the Company’s accounts payable and other liabilities. The Company’s policy is to review liquidity resources and ensure that sufficient funds are available to meet financial obligations as they become due. Further, the Company’s management is responsible for ensuring funds exist and are readily accessible to support business opportunities as they arise. The Company’s funding is primarily provided in the form of capital raised through the issuance of common shares and warrants. As of June 30, 2020, 14% of the Company’s payables were due to one vendor (December 31, 2019 – 42% due to three vendors).
(c)Market risk
Market risk is the risk that the fair value of, or future cash flows from, the Company’s financial instruments will significantly fluctuate due to changes in market prices. The value of financial instruments can be affected by changes in interest rates, market and economic conditions, and equity and commodity prices. The Company is exposed to market risk in divesting its investments, such that, unfavorable market conditions could result in dispositions of investments at less than their carrying values. Further, the revaluation of securities classified as fair value through net income, could result in significant write-downs of the Company’s investments, which would have an adverse impact on the Company’s financial position, unless these would flow through other comprehensive income.
The Company manages market risk by having a portfolio of securities from multiple issuers so that the Company is not materially exposed to any one issuer.
(d) Interest rate risk
Interest rate risk is the risk that the value or yield of fixed-income investments may decline if interest rates change. Fluctuations in interest rates may impact the level of income and expense recorded on the cash equivalents and short-term investments, and the market value of all interest-earning assets, other than those which possess a short-term to maturity. A 10% change in the interest rate in effect on June 30, 2020 and December 31, 2019, would not have a material effect on (i) fair value of the cash equivalents and short-term investments as the majority of the portfolio has a maturity date of three months or less, or (ii) interest income. Management continues to monitor external interest rates and revise the Company’s investment strategy as a result.
During the six months ended June 30, 2020, the Company had net interest income of $11,485 (June 30, 2019 – $11,528). During the three and six months ended June 30, 2020, the Company’s average variable interest rate fell 0.73% and 1.45%, respectively. Had the interest rates been consistent, net interest income would have increased by $2,090 and $7,292, respectively for the three and six months ended June 30, 2020.
(e) Currency rate risk
Currency rate risk is the risk that the fair value of, or future cash flows from, the Company’s financial instruments will significantly fluctuate due to changes in foreign exchange rates. The Company is exposed to this risk on advances to joint ventures denominated in A$ and C$. The Company is further exposed to this risk through subsidiaries operating in Israel and the U.S. as the Company’s functional currency is in Canadian dollars. The Company does not currently use foreign exchange contracts to hedge its exposure to currency rate risk. As such, the Company’s financial position and financial results may be adversely affected by the unfavorable fluctuations in currency exchange rates.
As of June 30, 2020, the Company had foreign currency gain (loss) on translation of $(61,821) (June 30, 2019 – $21,845). A 10% change in the exchange rates for the U.S. dollar would affect the carrying value of net assets by approximately $166,395 as of June 30, 2020 (December 31, 2019 – $174,902).
XML 49 R28.htm IDEA: XBRL DOCUMENT v3.20.2
Fair Value Measurement
6 Months Ended
Jun. 30, 2020
Fair Value Disclosures [Abstract]  
Fair Value Measurement Fair Value Measurement
The Company complies with ASC 820, Fair Value Measurements, for its financial assets and liabilities that are re-measured and reported at fair value at each reporting period, and non-financial assets and liabilities that are re-measured and reported at fair value at least annually. In general, fair values are determined by:
Level 1 inputs utilize quoted prices (unadjusted) in active markets for identical assets or liabilities.
Level 2 inputs utilize data points that are observable such as quoted prices, interest rates and yield curves.
Level 3 inputs are unobservable data points for the asset or liability, and includes situations where there is little, if any, market activity for the asset or liability.
The following tables present information about the Company’s assets that are measured at fair value on a recurring basis as of June 30, 2020 and December 31 2019, and indicates the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value.
June 30, 2020Level 1Level 2Level 3Total
Cash and cash equivalents$1,109,700  $—  $—  $1,109,700  
Short-term investments213,614  —  —  213,614  
Derivative liabilities—  —  205,714  205,714  

December 31, 2019Level 1Level 2Level 3Total
Cash and cash equivalents$1,199,693  $—  $—  $1,199,693  
Short-term investments306,347  —  —  306,347  
Derivative liabilities—  —  297,160  297,160  
There were no transfers between categories during the periods presented.
XML 50 R29.htm IDEA: XBRL DOCUMENT v3.20.2
Supplementary Cash Flow Information
6 Months Ended
Jun. 30, 2020
Supplemental Cash Flow Elements [Abstract]  
Supplementary Cash Flow Information Supplementary Cash Flow Information
The net changes in non-cash working capital items are as follows:
For the six months ended June 30,
20202019
Accounts receivable$1,161  $(3,986) 
Other receivables(2,336) (7,681) 
Prepaids and other assets1,568  (2,564) 
Inventory(23,913) (15,105) 
Accounts payable and other liabilities(6,985) 9,877  
Cumulative effect from foreign exchange(65) (2,132) 
Total$(30,570) $(21,591) 
XML 51 R30.htm IDEA: XBRL DOCUMENT v3.20.2
Non-monetary Transactions
6 Months Ended
Jun. 30, 2020
Nonmonetary Transactions [Abstract]  
Non-monetary Transactions Non-monetary Transactions
During the six months ended June 30, 2020, the Company had no non-monetary transactions.
On March 28, 2019, the Company entered into two transactions to simultaneously purchase and sell inventory to a third party. The Company purchased cannabis resin from the third party and in turn sold cannabis dry flower to the third party. The transactions involved the exchange of work in progress inventory and were accounted for at the carrying value of inventory transferred by the Company, which equaled the value of the cannabis resin received. No revenue was recognized as a result of this transaction and no gain or loss was recognized in the condensed consolidated statements of operations and comprehensive income (loss).
XML 52 R31.htm IDEA: XBRL DOCUMENT v3.20.2
Subsequent Events
6 Months Ended
Jun. 30, 2020
Subsequent Events [Abstract]  
Subsequent Events Subsequent Events
(a)On July 24, 2020, the Company entered into an amendment to the Series A Loan with Natuera to increase the principal amount of the Series A Loan by $6,350, to an aggregate principal amount of $15,500, of which the Company has committed to fund 50% and its joint venture partner has committed to fund the remaining 50%. Outstanding principal amounts continue to bear interest at a fixed annual rate of 5.67% and the maturity date of the Series A Loan has been extended to March 1, 2021. As of June 30, 2020, the Company has a loan receivable (net of credit allowance) of $2,984 from Natuera. Refer to Note 10 for details.
(b)On July 20, 2020, the Company entered into separation agreements with Robert Rosenheck and another Redwood employee pursuant to which they resigned from their employment with Redwood Wellness, LLC. In connection with such separation agreements, the 732,972 outstanding and unvested RSUs as of July 20, 2020 to which they were entitled were accelerated and vested as of July 20, 2020. A total of $6.2 million of share-based compensation costs will be recognized in the third quarter of 2020.
XML 53 R32.htm IDEA: XBRL DOCUMENT v3.20.2
Summary of Significant Accounting Policies (Policies)
6 Months Ended
Jun. 30, 2020
Accounting Policies [Abstract]  
Basis of Presentation Basis of Presentation
The interim condensed consolidated financial statements of Cronos Group are unaudited. They have been prepared in accordance with Generally Accepted Accounting Principles in the United States (“U.S. GAAP”) for interim financial information and with applicable rules and regulations of the U.S. Securities and Exchange Commission relating to interim financial statements. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three and six months ended June 30, 2020 are not necessarily indicative of the results that may be expected for any other reporting period.
These condensed consolidated financial statements should be read in conjunction with the Company’s consolidated financial statements and related notes included in its Annual Report on Form 10-K/A for the year ended December 31, 2019 (the “Annual Financial Statements”).
Basis of Consolidation Basis of ConsolidationThe accompanying condensed consolidated financial statements include the accounts of the Company, and all entities in which the Company has a controlling voting interest and/or is the primary beneficiary of a variable interest as of and for the period presented. In the condensed consolidated statements of net income (loss) and comprehensive income (loss), the net income (loss) and comprehensive income (loss) are attributed to the equity holders of the Company and to the non-controlling interests. Non-controlling interests in the equity of Cronos Israel are presented separately in the shareholders’ equity (deficit) section of the condensed consolidated balance sheets and condensed consolidated statements of changes in equity (deficit). All intercompany transactions and balances are eliminated upon consolidation.
Goodwill and indefinite life intangible assets Goodwill and indefinite life intangible assets
Goodwill and indefinite life intangible assets are reviewed for impairment annually or more frequently when events or changes in circumstances indicate that fair value of the reporting unit has been reduced to less than its carrying value. The Company performs an impairment test annually in the fourth quarter, by comparing the fair value of the reporting unit with its carrying amount, including goodwill. If the fair value of the reporting unit exceeds its carrying amount, goodwill is not considered to be impaired. An impairment charge would be recognized for the amount by which the carrying amount exceeds the reporting unit’s fair value. The Company determined that it has two reporting units: the U.S. reporting unit and the Rest of World reporting unit.
During the three months ended June 30, 2020, the Company concluded that the projected impact of the COVID-19 pandemic on its sales and revenues in the near term, together with the volatility in the market conditions during the quarter represented potential indicators of impairment for the U.S. reporting unit. Accordingly, the Company performed an interim impairment analysis during the second quarter of 2020. See Note 13 for more information regarding intangibles assets and goodwill.
New Accounting Pronouncements New Accounting Pronouncements
(a)Adoption of new accounting pronouncements
On January 1, 2020, the Company adopted ASU No. 2018-13, Disclosure Framework – Changes to the Disclosure Requirements for Fair Value Measurement (Topic 820) (“ASU No. 2018-13”). ASU No. 2018-13 adds, modifies, and removes certain fair value measurement disclosure requirements. The adoption of this standard was applied prospectively and did not have a material impact on the Company’s condensed consolidated financial statements.
On January 1, 2020, the Company adopted ASU No. 2018-15, Intangibles – Goodwill and Other Internal-use-software (Subtopic 350-40): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract (“ASU No. 2018-15”). ASU No. 2018-15 amends current guidance to align the accounting for costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing costs associated with developing or obtaining internal-use software. The guidance in ASU No. 2018-15 is effective for annual and interim periods beginning after December 15, 2019, with early adoption permitted. The adoption of this standard was applied prospectively and did not have a material impact on the Company’s condensed consolidated financial statements.
On January 1, 2020, the Company adopted ASU No. 2017-04, Intangibles – Goodwill and Other (Topic 350) – Simplifying the Test for Goodwill Impairment (“ASU No. 2017-04”). ASU No. 2017-04 eliminates step 2 from the goodwill impairment test and instead requires an entity to measure the impairment of goodwill assigned to a reporting unit if the carrying value of assets and liabilities assigned to the reporting unit, including goodwill, exceeds the reporting unit’s fair value. The guidance in ASU No. 2017-04 is effective for annual and interim goodwill tests completed by the Company beginning on January 1, 2020. The adoption of this standard was applied prospectively and the Company follows a one-step model for goodwill impairment.
(b)New accounting pronouncements not yet adopted
In January 2020, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2020-01, Investments-Equity Securities (Topic 321), Investments-Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815) (“ASU No. 2020-01”). ASU No. 2020-01 clarifies the interaction of accounting for the transition into and out of the equity method. The new standard also clarifies the accounting for measuring certain purchased options and forward contracts to acquire investments. The guidance in ASU No. 2020-01 is effective for annual and interim periods beginning after December 15, 2020, with early adoption permitted. The Company is currently evaluating the effect of the adoption of ASU No. 2020-01, but anticipates that the adoption will not have a material impact on its condensed consolidated financial statements.
In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes (“ASU No. 2019-12”). ASU No. 2019-12 eliminates certain exceptions and simplifies the application of U.S. GAAP-related changes in enacted tax laws or rates and employee stock option plans. ASU No. 2019-12 is effective for annual and interim periods beginning after December 15, 2020. Early adoption is permitted. The Company is currently evaluating the effect of the adoption of ASU No. 2019-12, but anticipates that the adoption will not have a material impact on its condensed consolidated financial statements.
XML 54 R33.htm IDEA: XBRL DOCUMENT v3.20.2
Summary of Significant Accounting Policies (Tables)
6 Months Ended
Jun. 30, 2020
Accounting Policies [Abstract]  
Schedule of Consolidated Entities The Company consolidates the financial results of the following entities, which the Company controls:
SubsidiariesJurisdiction of IncorporationIncorporation Date
Ownership Interest (ii)
Cronos Israel G.S. Cultivations Ltd. (i)
IsraelFebruary 4, 201870%
Cronos Israel G.S. Manufacturing Ltd. (i)
IsraelSeptember 4, 201890%
Cronos Israel G.S. Store Ltd. (i)
IsraelJune 28, 201890%
Cronos Israel G.S. Pharmacies Ltd. (i)
IsraelFebruary 15, 201890%
(i) These Israeli entities are collectively referred to as “Cronos Israel.”
(ii) “Ownership interest” is defined as the proportionate share of net income to which the Company is entitled; equity interest may differ from ownership interest.
XML 55 R34.htm IDEA: XBRL DOCUMENT v3.20.2
Inventory (Tables)
6 Months Ended
Jun. 30, 2020
Inventory Disclosure [Abstract]  
Schedule of Inventory
Inventory is comprised of the following items:
As of
June 30, 2020December 31, 2019
Raw materials$5,488  $2,469  
Work-in-progress – dry cannabis21,772  11,538  
Work-in-progress – cannabis extracts19,210  17,975  
Finished goods – dry cannabis4,505  1,798  
Finished goods – cannabis extracts1,716  2,624  
Supplies and consumables525  1,639  
Total$53,216  $38,043  
XML 56 R35.htm IDEA: XBRL DOCUMENT v3.20.2
Investments and Advances to Joint Ventures (Tables)
6 Months Ended
Jun. 30, 2020
Equity Method Investments and Joint Ventures [Abstract]  
Schedule of Equity Method Investments Net investment in equity accounted investees
A reconciliation of the carrying amount of the investments in associates and joint ventures is as follows:
Carrying Amount
Ownership %June 30, 2020December 31, 2019
Cronos Australia(i)
31%$—  $(346) 
Cronos GrowCo50%933  1,501  
MedMen Canada50%—  —  
Natuera50%—  (598) 
$933  $557  
(i) On October 25, 2019, Cronos Australia issued 40 million new shares in an initial public offering at an offering price of A$0.50 per share. The Company’s ownership in Cronos Australia decreased from 50% to 31% on November 7, 2019 when Cronos Australia began trading on the Australian Securities Exchange. This resulted in a reconsideration event, which required the reassessment of the Company’s VIE conclusion. Upon reconsideration, the Company determined that the entity was no longer a VIE as of December 31, 2019 and is now reported under the equity method.
The Company’s share of net earnings (losses) from equity investments accounted for under the equity method of accounting:
For the three months ended June 30,For the six months ended June 30,
2020201920202019
Whistler Medicinal Marijuana Company (“Whistler”)$—  $—  $—  $29  
Cronos Australia(i)
(235) (397) (235) (641) 
Cronos GrowCo(190) (38) (501) (27) 
MedMen Canada—  (2) —   
Natuera(ii)
(369) (304) (1,230) (304) 
$(794) $(741) $(1,966) $(939) 
(i) The Company’s share of accumulated net losses in excess of its equity investment and advances in Cronos Australia was $512 for the six months ended June 30, 2020 (June 30, 2019 – $nil).
(ii) The Company’s share of accumulated net losses in excess of its equity investment in Natuera has been applied as a loss allowance on the loan receivable. See Note 6(b) and Note 10.
Schedule of Advances to Joint Ventures Advances to Joint Venture
MedMen Canada(i)
Cronos GrowCo
Cronos Australia (ii)
NatueraTotal
As of January 1, 2020$471  $18,966  $—  $—  $19,437  
Credit loss allowance (iii)
—  —  —  —  —  
Effect from foreign exchange(20) (819) —  —  (839) 
As of June 30, 2020$451  $18,147  $—  $—  $18,598  
As of January 1, 2019$1,244  $2,970  $475  $—  $4,689  
Advances (repayment)(852) 15,494  274  219  15,135  
Advances to joint ventures recovered from (applied to) carrying amount of investments35  22  (779) (224) (946) 
Effect from foreign exchange44  480  30   559  
As of December 31, 2019$471  $18,966  $—  $—  $19,437  
(i) Advance is unsecured, non-interest bearing, and there are no terms of repayment.
(ii) A$1,500 is governed by an unsecured loan bearing interest at a rate of 12% per annum, calculated and compounded daily, in arrears, on the amounts advanced from the date of each advance. The loan is due on January 1, 2022. If the loan is overdue, the outstanding amount bears interest at an additional 2% per annum.
(iii) For the three months ended June 30, 2020, a reversal of $917 related to the credit loss allowance for Cronos GrowCo was recorded as the Company assessed its recoverability. As of June 30, 2020, total credit losses were $nil.
XML 57 R36.htm IDEA: XBRL DOCUMENT v3.20.2
Accumulated Other Comprehensive Income (Loss) (Tables)
6 Months Ended
Jun. 30, 2020
Equity [Abstract]  
Schedule of Accumulated Other Comprehensive Income (Loss)
The following are continuity schedules of accumulated other comprehensive income (loss):

Three months ended June 30,Six months ended June 30,
2020201920202019
Net unrealized gain (loss) on revaluation and disposal of other investments
Balance beginning of period    
Cumulative effect from adoption of ASU 2016-01—  —  —  —  
Balance as of June 30    
Net foreign exchange gain (loss) on translation
Balance beginning of period(85,882) (5,980) 27,833  (9,875) 
Net unrealized (loss) gain51,907  17,948  (61,808) 21,843  
Balance as of June 30(33,975) 11,968  (33,975) 11,968  
Total accumulated other comprehensive income (loss)$(33,970) $11,973  $(33,970) $11,973  
XML 58 R37.htm IDEA: XBRL DOCUMENT v3.20.2
Loans Receivable, net (Tables)
6 Months Ended
Jun. 30, 2020
Receivables [Abstract]  
Schedule of Loan Receivable
As of
June 30, 2020December 31, 2019
Current portion
Natuera Series A loan (i)
$2,984  $4,575  
Cronos GrowCo Credit Facility (ii)
1,474  —  
Add: Accrued interest—  89  
Total current portion of loans receivable4,458  4,664  
Long term portion
Cronos GrowCo Credit Facility (ii)
50,582  31,678  
2645485 Ontario Inc. (Mucci) Promissory Note (iii)
11,793  12,587  
Cannasoul Collaboration Loan (iv)
1,174  —  
Add: Accrued interest1,822  702  
Total long-term portion of loans receivable65,371  44,967  
Total loans receivable$69,829  $49,631  
(i)On September 27, 2019, the Company entered into a master loan agreement (the “Series A Loan”) for $4,575 with Natuera with effect as of August 29, 2019. The total aggregate principal amount of the Series A Loan is $9,150, of which the Company has committed to fund 50% and its joint venture partner has committed to fund the remaining 50%. Outstanding principal amounts bear interest at a fixed annual rate of 5.67% with a maturity date of August 29, 2020. As of June 30, 2020, accrued interest is recorded in other receivables. Subsequent to June 30, 2020, an amendement to the agreement was executed. Refer to Note 25.
For the six months ended June 30, 2020, a loss allowance of $1,591 was recorded against the Natuera Series A Loan related to the Company’s share of net loss from Natuera in excess of the carrying value of the equity method investment. Refer to Note 6.
(ii)On August 23, 2019, the Company entered into a credit agreement with Cronos GrowCo in respect of a C$100,000 ($73,660) secured non-revolving term loan credit facility (the “GrowCo Credit Facility”). The GrowCo Credit Facility will mature on March 31, 2031 and will bear interest at varying rates based on the Canadian prime rate as announced by the Bank of Montreal. Interest began to accrue as of the closing date of the GrowCo Credit Facility and is payable on a quarterly basis until maturity, except that any interest accrued prior to March 31, 2021 will be payable no later than December 31, 2021. Repayment of principal will be made on a quarterly basis commencing on March 31, 2021. The credit facility is secured by substantially all present and after acquired property of Cronos GrowCo and its subsidiaries. Mucci, the other 50% shareholder of Cronos GrowCo, has provided a limited recourse guarantee in favor of Cronos GrowCo, secured by Mucci’s shares in Cronos GrowCo. As of June 30, 2020, Cronos GrowCo had drawn C$72,150 ($53,145) from the Cronos GrowCo Credit Facility.
For the six months ended June 30, 2020, a current expected credit loss allowance of $1,089 was recorded against the GrowCo Facility.
(iii)On June 28, 2019, the Company entered into a promissory note receivable agreement (the “Mucci Promissory Note”) for C$16,350 ($12,043) with Mucci. The outstanding principal amount of the Mucci Promissory Note bears interest at 3.95% annually and is due within 90 days of demand. The Company does not intend to demand the loan within 12 months. Interest accrued under the Mucci Promissory Note until July 1, 2021 is payable by way of capitalization on the principal amount and interest thereafter must be paid in cash on a quarterly basis. The Mucci Promissory Note is secured by a general security agreement covering all the assets of Mucci.
For the six months ended June 30, 2020, a current expected credit loss allowance of $250 has been recorded against the Mucci loan.
(iv)On April 1, 2020, Cronos Israel entered into the Cannasoul Collaboration. Cronos Israel has agreed to advance approximately ILS 8,297 (approximately $2,446) by a non-recourse loan to CLS over a period of two years for the capital and operating expenditures of the laboratory. The outstanding principal on the loan bears interest at 3.5% annually and will be repaid through the profits generated from the Cannasoul Collaboration. As of June 30, 2020, CLS has received the first installment of ILS 4,149 (approximately $1,198).
For the six months ended June 30, 2020, a current expected credit loss allowance of $24 has been recorded against the Cannasoul Collaboration loan.
XML 59 R38.htm IDEA: XBRL DOCUMENT v3.20.2
Derivative Liabilities (Tables)
6 Months Ended
Jun. 30, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of Reconciliation of Carrying Amounts
A reconciliation of the carrying amounts of the derivative liability is presented below:
April 1, 2020(Gain) / Loss on revaluationExercise of RightsEffect from foreign exchangeAs of June 30, 2020
(a) Altria Warrant$132,366  $30,052  $—  $3,540  $165,958  
(b) Pre-emptive Rights13,070  2,610  —  500  16,180  
(c) Top-up Rights20,740  3,218  (727) 1,072  23,576  
$166,176  $35,880  $(727) $5,112  $205,714  

January 1, 2020(Gain) / Loss on revaluationExercise of RightsEffect from foreign exchangeAs of June 30, 2020
(a) Altria Warrant$234,428  $(58,052) $—  $(10,418) $165,958  
(b) Pre-emptive Rights12,787  3,925  —  (532) 16,180  
(c) Top-up Rights49,945  (23,361) (727) (2,281) 23,576  
$297,160  $(77,488) $(727) $(13,231) $205,714  
Schedule of Fair Values of Derivative Liabilities
The fair values of the derivative liabilities were determined using the Black-Scholes pricing model as of June 30, 2020 and December 31, 2019 applying the following inputs:
As of June 30, 2020As of December 31, 2019
Altria WarrantPre-emptive RightsTop-up RightsAltria WarrantPre-emptive RightsTop-up Rights
Share price at valuation date (per share in C$)$8.18$8.18$8.18$9.97$9.97$9.97
Subscription price (per share in C$)$19.00$16.25$16.25$19.00$16.25$16.25
Weighted average risk-free interest rate (i)
0.30%0.29%0.26%1.69%1.73%1.71%
Weighted average expected life (in years) (ii)
2.682.001.113.181.251.66
Expected annualized volatility (iii)
91%91%91%82%82%82%
Expected dividend yield—%—%—%—%—%—%
(i) The risk-free interest rate was based on Bank of Canada government treasury bills and bonds with a remaining term equal to the expected life of the derivative liabilities. The risk-free interest rate uses a range of approximately 0.21% to 0.61% as of June 30, 2020 (December 31, 2019 – 1.66% to 1.73%) for the Pre-emptive rights and Top-up rights.
(ii) The expected life in years represents the period of time that the derivative liabilities are expected to be outstanding. The expected life of the Pre-emptive Rights and Top-up Rights is determined based on the expected term of the underlying options, warrants, and shares, to which the Pre-emptive Rights and Top-up Rights are linked. The expected life uses a range of approximately 0.25 year to 5.5 years as of June 30, 2020 (December 31, 2019 – 0.25 year to 6 years).
(iii) Volatility was based on an equally weighted blended historical volatility level of the underlying equity securities of the Company and peer companies.
Schedule of Sensitivity Analysis
The following table quantifies each of the significant inputs described above and provides a sensitivity analysis of the impact on the reported values of the derivative liabilities. The sensitivity analysis for each significant input is performed by assuming a 10% decrease in the input while other significant inputs remain constant at management’s best estimate as of the respective dates. A decrease in the inputs noted below would cause a decrease in derivative liability and as of June 30, 2020, there would be an equal but opposite impact on net income (loss).
Decrease as of June 30, 2020Decrease as of December 31, 2019
Altria WarrantPre-emptive RightsTop-up RightsAltria WarrantPre-emptive RightsTop-up Rights
Share price$26,300  $2,779  $4,939  $36,436  $2,743  $9,577  
Weighted average expected life14,249  1,744  1,272  17,471  2,366  2,178  
Expected annualized volatility27,711  2,652  4,769  33,343  2,180  7,714  
XML 60 R39.htm IDEA: XBRL DOCUMENT v3.20.2
Property, Plant and Equipment (Tables)
6 Months Ended
Jun. 30, 2020
Property, Plant and Equipment [Abstract]  
Schedule of Property, Plant & Equipment, Useful Lives
Property, plant and equipment, net consisted of the following:
As of
June 30, 2020December 31, 2019
Cost
Land$3,618  $3,727  
Building146,685  150,324  
Furniture and equipment11,394  10,156  
Computer equipment651  687  
Leasehold improvements3,116  2,789  
Construction in progress12,492  3,569  
Less: accumulated depreciation(13,666) (9,443) 
Total$164,290  $161,809  
XML 61 R40.htm IDEA: XBRL DOCUMENT v3.20.2
Intangible Assets and Goodwill (Tables)
6 Months Ended
Jun. 30, 2020
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Finite-Lived Intangible Assets
Intangible assets are comprised of the following items:

Weighted Average Amortization Period (in years)As of June 30, 2020
CostAccumulated AmortizationImpairment chargesNet
Software (i)
N/A$612  $(298) $—  $314  
Enterprise Resource Planning (“ERP”) system (ii)
52,570  —  —  2,570  
Health Canada licenses 178,255  (1,167) —  7,088  
Lord Jones brand
N/A64,000  —  (5,000) 59,000  
TrademarksN/A140  —  —  140  
Israeli Codes (iii)
25297  (10) —  287  
$75,874  $(1,475) $(5,000) $69,399  
(i)Software amortizes using a double declining method.
(ii)During the six months ended June 30, 2020, the Company capitalized costs for the ERP system. As of June 30, 2020, the system is not yet available for use, resulting in no amortization being recorded against the asset.
(iii)The preliminary licenses granted to Kibbutz Gan Shmuel (the Cronos Israel joint venture partner) by the Medical Cannabis Unit of the Israeli Ministry of Health in early 2017 (the “Israeli Codes”) were transferred by non-controlling interests to Cronos Israel in exchange for their equity interests in the Cronos Israel entities specified above.
Weighted Average Amortization Period (in years)As of December 31, 2019
CostAccumulated AmortizationNet
Software (i)
N/A$541  $(202) $339  
Health Canada licenses 178,627  (976) 7,651  
Lord Jones brand
N/A64,000  —  64,000  
TrademarksN/A36  —  36  
Israeli Codes (ii)
25298  (4) 294  
$73,502  $(1,182) $72,320  
(i)Software amortizes using a double declining method.
(ii)  The Israeli Codes were transferred by non-controlling interests to Cronos Israel in exchange for their equity interests in the Cronos Israel entities specified above.
Schedule of Indefinite-Lived Intangible Assets
Intangible assets are comprised of the following items:

Weighted Average Amortization Period (in years)As of June 30, 2020
CostAccumulated AmortizationImpairment chargesNet
Software (i)
N/A$612  $(298) $—  $314  
Enterprise Resource Planning (“ERP”) system (ii)
52,570  —  —  2,570  
Health Canada licenses 178,255  (1,167) —  7,088  
Lord Jones brand
N/A64,000  —  (5,000) 59,000  
TrademarksN/A140  —  —  140  
Israeli Codes (iii)
25297  (10) —  287  
$75,874  $(1,475) $(5,000) $69,399  
(i)Software amortizes using a double declining method.
(ii)During the six months ended June 30, 2020, the Company capitalized costs for the ERP system. As of June 30, 2020, the system is not yet available for use, resulting in no amortization being recorded against the asset.
(iii)The preliminary licenses granted to Kibbutz Gan Shmuel (the Cronos Israel joint venture partner) by the Medical Cannabis Unit of the Israeli Ministry of Health in early 2017 (the “Israeli Codes”) were transferred by non-controlling interests to Cronos Israel in exchange for their equity interests in the Cronos Israel entities specified above.
Weighted Average Amortization Period (in years)As of December 31, 2019
CostAccumulated AmortizationNet
Software (i)
N/A$541  $(202) $339  
Health Canada licenses 178,627  (976) 7,651  
Lord Jones brand
N/A64,000  —  64,000  
TrademarksN/A36  —  36  
Israeli Codes (ii)
25298  (4) 294  
$73,502  $(1,182) $72,320  
(i)Software amortizes using a double declining method.
(ii)  The Israeli Codes were transferred by non-controlling interests to Cronos Israel in exchange for their equity interests in the Cronos Israel entities specified above.
Schedule of Goodwill
As of December 31, 2019AdditionsImpairment chargesEffect of foreign exchangeAs of June 30, 2020
OGBC$302  $—  $—  $(13) $289  
Peace Naturals1,078  —  —  (45) 1,033  
Redwood213,414  —  (35,000) —  178,414  
$214,794  $—  $(35,000) $(58) $179,736  
XML 62 R41.htm IDEA: XBRL DOCUMENT v3.20.2
General and Administrative Expenses (Tables)
6 Months Ended
Jun. 30, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of General and Administrative Expenses
General and administrative expense are comprised of the following items:
Three months ended June 30,Six months ended June 30,
2020201920202019
Salaries and wages$6,337  $3,354  $13,803  $5,348  
Professional and consulting3,263  5,051  8,849  7,254  
Office and general3,545  2,622  6,620  5,523  
Review costs related to restatement of 2019 interim financial statements (i)
3,459  —  7,866  —  
Other1,833  461  5,058  656  
Total$18,437  $11,488  $42,196  $18,781  
(i)These financial statement review costs include costs related to the restatement of the Company’s 2019 interim financial statements and costs related to the Company’s responses to request for information from various regulatory authorities relating to such restatement.
XML 63 R42.htm IDEA: XBRL DOCUMENT v3.20.2
Share-based Payments (Tables)
6 Months Ended
Jun. 30, 2020
Share-based Payment Arrangement [Abstract]  
Summary of Changes in Warrants and DSUs
The following is a summary of the changes in warrants during the six months ended June 30, 2020 and 2019:
Weighted average exercise price (C$)Number of warrants
Balance as of January 1, 2020$0.26  $18,066,662  
Balance as of June 30, 2020$0.26  $18,066,662  
Balance as of January 1, 2019$0.26  $25,457,623  
Exercise of warrants0.36  (7,390,961) 
Balance as of June 30, 2019$0.22  $18,066,662  
The following is a summary of the changes in DSUs from January 1, 2020 to June 30, 2020:
Number of DSUsFinancial liability
Balance as of January 1, 202033,397  $255  
Liabilities settled(8,484) (46) 
Loss (gain) on revaluation —  (56) 
Balance as of June 30, 202024,913  $153  
Summary of Outstanding Warrants
As of June 30, 2020, the Company had outstanding warrants as follows. For a description of the Altria Warrant, see Note 11.
Grant DateExpiry dateWeighted average exercise price (C$)Number of warrants
October 8 – 28, 2015October 8 – 28, 2020$0.31  $2,976,610  
May 13 – 27, 2016May 13 – 27, 20210.25  15,090,052  
As of June 30, 2020$0.26  $18,066,662  
Summary of the Changes in Options
The following is a summary of the changes during the six months ended June 30, 2020 and 2019:
Weighted average exercise price (C$)Number of optionsWeighted average remaining contractual term (years)
Balance as of January 1, 2020$4.84  14,149,502  2.56
Exercise of options2.05  (1,807,909) 
Cancellation, forfeiture and expiry of options15.78  (127,045) 
Balance as of June 30, 2020$5.13  12,214,548  2.05
Exercisable at June 30, 20203.42  8,688,645  1.78
Balance as of January 1, 2019$2.99  12,902,995  3.35
Issuance of options20.81  1,315,787  
Exercise of options3.76  (227,342) 
Cancellation, forfeiture and expiry of options1.63  (2,895) 
Balance as of June 30, 2019$4.66  13,988,545  3.04
Exercisable as of June 30, 20192.406,580,238  2.69
Summary of Fair Value of Options Issued
The fair value of the options issued was determined using the Black-Scholes option pricing model, using the following inputs:
For the six months ended June 30, 2019
Share price at grant date (per share)
C$20.65 - C$24.75
Exercise price (per option)
C$20.65 - C$24.75
Risk-free interest rate
1.51% - 1.62%
Expected life of options (in years)5
Expected annualized volatility80%
Expected dividend yield—%
Weighted average Black-Scholes value at grant date (per option)
C$13.29 - C$15.91
Forfeiture rate—%
Summary of Restricted Share Units Activity
The following is a summary of the changes in RSUs from January 1, 2020 to June 30, 2020:
Number of RSUsShare-based reserve
Balance as of January 1, 2020732,972  $889  
Issuance of RSUs279,277  —  
Vesting of issued RSUs —  1,482  
Balance as of June 30, 20201,012,249  $2,371  
XML 64 R43.htm IDEA: XBRL DOCUMENT v3.20.2
Earnings (loss) Per Share (Tables)
6 Months Ended
Jun. 30, 2020
Earnings Per Share [Abstract]  
Schedule of Earnings (Loss) Per Share
Basic and diluted earnings (loss) per share are calculated using the following numerators and denominators:
For the three months ended June 30,For the six months ended June 30,
2020201920202019
Basic earnings per share computation
Net income (loss) attributable to common shareholders of Cronos Group$(106,977) $185,999  $(30,937) $500,090  
Weighted average number of common shares outstanding349,075,408  334,665,873  348,946,439  317,940,749  
 Basic earnings per share $(0.31) $0.56  $(0.09) $1.57  
Diluted earnings per share computation(i)
Net income (loss) used in the computation of basic earnings per share$(106,977) $185,999  $(30,937) $500,090  
Adjustment for gain (loss) on revaluation of derivative liabilities(729) (126,032) (729) (350,758) 
Net income (loss) used in the computation of diluted income per share$(107,706) $59,967  $(31,666) $149,332  
Weighted average number of common shares outstanding used in the computation of basic earnings per share349,075,408  334,665,873  348,946,439317,940,749
Dilutive effect of warrants (i)
—  19,287,262  —  21,239,056
Dilutive effect of stock options (i)
—  10,992,464  —  11,291,914
Dilutive effect of restricted share units (i)
—  —  —  —  
Dilutive effect of Altria Warrant (i)
—  9,100,465  —  13,633,605
Dilutive effect of Top-up Rights – exercised and exercisable fixed price (i)
—  630,531  —  766,769
Weighted average number of common shares for computation of diluted income (loss) per share349,075,408  374,676,595  348,946.439  364,872,093  
Diluted earnings per share$(0.31) $0.16  $(0.09) $0.41  
(i) In computing diluted earnings per share, incremental common shares are not considered in periods in which a net loss is reported, as the inclusion of the common share equivalents would be anti-dilutive.
Schedule of Antidilutive Securities Excluded from Computation of Diluted Shares Outstanding
The following securities were not included in the computation of diluted shares outstanding because the effect would be anti-dilutive or because conditions for contingently issuable shares were not satisfied at the end of the reporting periods.
Three months ended June 30,Six months ended June 30,
2020201920202019
Ginkgo Equity Milestones14,674,904  14,674,904  14,674,904  14,674,904  
Pre-emptive Rights12,006,740  12,006,740  12,006,740  12,006,740  
Top-up Rights – fixed price26,686,413  —  26,686,413  —  
Top-up Rights – market price1,941,349  25,150,434  1,941,349  25,150,434  
Altria Warrant77,752,533  1,076,553  77,752,533  1,076,553  
Stock options10,495,235  51,830  10,547,256  51,830  
Warrants17,536,558  —  17,521,903  —  
Restricted share units1,012,249  —  1,012,249  —  
Total anti-dilutive securities162,091,326  52,960,461  162,158,002  52,960,461  
XML 65 R44.htm IDEA: XBRL DOCUMENT v3.20.2
Segment Information (Tables)
6 Months Ended
Jun. 30, 2020
Segment Reporting [Abstract]  
Schedule of Segment Data
Segment data was as follows for the three months ended June 30, 2020:
Three months ended June 30, 2020
United StatesRest of WorldCorporateTotal
Consolidated statements of net income (loss) and comprehensive income (loss)
Net revenue
Cannabis flower$—  $5,674  $—  $5,674  
Cannabis extracts2,174  1,917  —  4,091  
Other—  118  —  118  
Net revenue$2,174  $7,709  $—  $9,883  
Share of loss from investments in equity accounted investees$—  $794  $—  $794  
Interest income 3,811  (2) 3,817  
Interest expense—  (83) —  (83) 
Interest income, net$ $3,728  $(2) $3,734  
Impairment loss on goodwill and intangible assets40,000  $—  $—  $40,000  
Depreciation and amortization36  654  (6) 684  
Income tax expense—  —  —  —  
Net income (loss)(47,762) (52,899) (7,042) (107,703) 
Segment data was as follows for the six months ended June 30, 2020:
Six months ended June 30, 2020
United StatesRest of WorldCorporateTotal
Consolidated statements of net income (loss) and comprehensive income (loss)
Net revenue
Cannabis flower$—  $8,415  $—  $8,415  
Cannabis extracts4,350  5,317  —  9,667  
Other—  233  —  233  
Net revenue$4,350  $13,965  $—  $18,315  
Share of loss from investments in equity accounted investees$—  $1,966  $—  $1,966  
Interest income13  11,562  —  11,575  
Interest expense—  (90) —  (90) 
Interest income, net$13  $11,472  $—  $11,485  
Impairment loss on goodwill and intangible assets40,000  $—  $—  $40,000  
Depreciation and amortization69  1,302  —  1,371  
Income tax expense—  —  —  —  
Net income (loss)(57,567) 39,257  (13,712) (32,022) 
Consolidated balance sheets
Total assets$250,470  $348,569  $1,311,248  $1,910,287  
Investments in equity accounted investees—  933  —  933  
Goodwill178,414  1,322  —  179,736  
Purchase of property, plant and equipment, net219  13,125  —  13,344  
Sources of net revenue for the three and six months ended June 30, 2020 and 2019 were as follows:
Three months ended June 30,Six months ended June 30,
2020201920202019
Cannabis flower5,674  6,096  $8,415  $7,921  
Cannabis extracts4,091  1,535  9,667  2,638  
Other118  22  233  98  
Net revenue$9,883  $7,653  $18,315  $10,657  
Schedule of Revenue from External Customers by Geographic Areas
Net revenue attributed to a geographic region based on the location of the customer were as follows:
Three months ended June 30,Six months ended June 30,
2020201920202019
Canada7,416  7,340  $13,507  $10,323  
United States2,174  —  4,350  —  
Other countries293  313  458  334  
Total$9,883  $7,653  $18,315  $10,657  
Schedule of Long-lived Assets by Geographic Areas
Property, plant and equipment assets were physically located in the following geographic regions:
As of June 30, 2020As of December 31, 2019
Canada$140,357  $141,021  
United States2,253  2,103  
Other countries21,680  18,685  
Total$164,290  $161,809  
XML 66 R45.htm IDEA: XBRL DOCUMENT v3.20.2
Fair Value Measurement (Tables)
6 Months Ended
Jun. 30, 2020
Fair Value Disclosures [Abstract]  
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis
The following tables present information about the Company’s assets that are measured at fair value on a recurring basis as of June 30, 2020 and December 31 2019, and indicates the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value.
June 30, 2020Level 1Level 2Level 3Total
Cash and cash equivalents$1,109,700  $—  $—  $1,109,700  
Short-term investments213,614  —  —  213,614  
Derivative liabilities—  —  205,714  205,714  

December 31, 2019Level 1Level 2Level 3Total
Cash and cash equivalents$1,199,693  $—  $—  $1,199,693  
Short-term investments306,347  —  —  306,347  
Derivative liabilities—  —  297,160  297,160  
XML 67 R46.htm IDEA: XBRL DOCUMENT v3.20.2
Supplementary Cash Flow Information (Tables)
6 Months Ended
Jun. 30, 2020
Supplemental Cash Flow Elements [Abstract]  
Schedule of Net Changes in Non-Cash Working Capital The net changes in non-cash working capital items are as follows:
For the six months ended June 30,
20202019
Accounts receivable$1,161  $(3,986) 
Other receivables(2,336) (7,681) 
Prepaids and other assets1,568  (2,564) 
Inventory(23,913) (15,105) 
Accounts payable and other liabilities(6,985) 9,877  
Cumulative effect from foreign exchange(65) (2,132) 
Total$(30,570) $(21,591) 
XML 68 R47.htm IDEA: XBRL DOCUMENT v3.20.2
Background (Details)
Jun. 30, 2020
brand
venture
continent
Schedule of Equity Method Investments [Line Items]  
Number of continents with international production and distribution | continent 5
Number of adult-use brands 2
Number of hemp-derived cannabidiol personal care brands 2
Number of strategic joint ventures | venture 4
Cronos Australia  
Schedule of Equity Method Investments [Line Items]  
Ownership percentage 31.00%
XML 69 R48.htm IDEA: XBRL DOCUMENT v3.20.2
Summary of Significant Accounting Policies (Details)
6 Months Ended
Jun. 30, 2020
reportingUnit
Subsidiary or Equity Method Investee [Line Items]  
Number of reporting units for impairment testing 2
Cronos Israel G.S. Cultivations Ltd.  
Subsidiary or Equity Method Investee [Line Items]  
Ownership interest 70.00%
Cronos Israel G.S. Manufacturing Ltd.  
Subsidiary or Equity Method Investee [Line Items]  
Ownership interest 90.00%
Cronos Israel G.S. Store Ltd.  
Subsidiary or Equity Method Investee [Line Items]  
Ownership interest 90.00%
Cronos Israel G.S. Pharmacies Ltd.  
Subsidiary or Equity Method Investee [Line Items]  
Ownership interest 90.00%
XML 70 R49.htm IDEA: XBRL DOCUMENT v3.20.2
Revenues from Contracts with Customers (Details) - USD ($)
$ in Thousands
Jun. 30, 2020
Dec. 31, 2019
Revenue from Contract with Customer [Abstract]    
Accounts receivable [1] $ 3,477 $ 4,638
Current expected credit loss $ 80 $ 136
[1] Net of current expected credit loss allowance of $80 as of June 30, 2020 (December 31, 2019 – $136)
XML 71 R50.htm IDEA: XBRL DOCUMENT v3.20.2
Inventory (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Dec. 31, 2019
Inventory [Line Items]          
Raw materials $ 5,488,000 $ 2,469,000 $ 5,488,000 $ 2,469,000  
Supplies and consumables 525,000 1,639,000 525,000 1,639,000  
Total 53,216,000 38,043,000 53,216,000 38,043,000 $ 38,043,000
Inventory write-down 3,062,000 0 11,024,000 0  
Dry Cannabis          
Inventory [Line Items]          
Work-in-progress 21,772,000 11,538,000 21,772,000 11,538,000  
Finished goods 4,505,000 1,798,000 4,505,000 1,798,000  
Cannabis Extracts          
Inventory [Line Items]          
Work-in-progress 19,210,000 17,975,000 19,210,000 17,975,000  
Finished goods $ 1,716,000 $ 2,624,000 $ 1,716,000 $ 2,624,000  
XML 72 R51.htm IDEA: XBRL DOCUMENT v3.20.2
Investments and Advances to Joint Ventures - Narrative (Details)
₪ in Thousands, $ in Thousands
6 Months Ended
Apr. 01, 2020
ILS (₪)
Jun. 14, 2018
Mar. 13, 2018
Jun. 30, 2020
ILS (₪)
Jun. 30, 2020
USD ($)
Apr. 01, 2020
USD ($)
Cronos GrowCo | Variable Interest Entity, Not Primary Beneficiary            
Variable Interest Entity [Line Items]            
Ownership percentage   50.00%        
Natuera | Variable Interest Entity, Not Primary Beneficiary            
Variable Interest Entity [Line Items]            
Ownership percentage       50.00%    
MedMen Canada | Variable Interest Entity, Not Primary Beneficiary            
Variable Interest Entity [Line Items]            
Ownership percentage     50.00%      
Cannasoul | Establishment of a Commercial Cannabis Analytical Testing Laboratory | Variable Interest Entity, Primary Beneficiary            
Variable Interest Entity [Line Items]            
Collaboration agreement, amount of advances       ₪ 8,297 $ 2,446  
Collaboration agreement, term of agreement       2 years    
Interest rate       3.50% 3.50%  
Collaboration agreement, percentage of profits to be received       70.00% 70.00%  
Collaboration agreement, profits to be received, maximum percentage of amounts advanced       150.00% 150.00%  
Collaboration agreement, percentage of profits to be received, triggering event, subsequent to maximum percentage of amounts advanced being met       50.00% 50.00%  
Maximum loss exposure       ₪ 8,297    
Cannasoul | Establishment of a Commercial Cannabis Analytical Testing Laboratory | Variable Interest Entity, Primary Beneficiary | Cannasoul Collaboration Loan | Loans Receivable            
Variable Interest Entity [Line Items]            
Collaboration agreement, amount of advances ₪ 8,297         $ 2,446
Collaboration agreement, term of agreement 2 years          
Interest rate 3.50%         3.50%
Minimum | MedMen Canada | Variable Interest Entity, Not Primary Beneficiary            
Variable Interest Entity [Line Items]            
License term     20 years      
XML 73 R52.htm IDEA: XBRL DOCUMENT v3.20.2
Investments and Advances to Joint Ventures - Schedule of Equity Method Investments (Details) - USD ($)
3 Months Ended 6 Months Ended
Nov. 07, 2019
Nov. 06, 2019
Oct. 25, 2019
Jun. 14, 2018
Mar. 13, 2018
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Dec. 31, 2019
Schedule of Equity Method Investments [Line Items]                    
Investments in equity accounted investees           $ 933,000   $ 933,000   $ 557,000
Share of earnings (loss) from investments in equity accounted investees           (794,000) $ (741,000) (1,966,000) $ (939,000)  
IPO | Cronos Australia                    
Schedule of Equity Method Investments [Line Items]                    
Sale of stock, number of shares issued in transaction (in shares)     40,000,000              
Sale of stock, price per share (in aud per share)     $ 0.50              
Whistler                    
Schedule of Equity Method Investments [Line Items]                    
Share of earnings (loss) from investments in equity accounted investees           $ 0 0 $ 0 29,000  
Cronos Australia                    
Schedule of Equity Method Investments [Line Items]                    
Ownership percentage (Whistler - less than)           31.00%   31.00%    
Investments in equity accounted investees           $ 0   $ 0   (346,000)
Share of earnings (loss) from investments in equity accounted investees           (235,000) (397,000) (235,000) (641,000)  
Share of accumulated net losses in excess of its equity investment and advances           $ 512,000 0 $ 512,000 0  
Cronos Australia | Variable Interest Entity, Not Primary Beneficiary                    
Schedule of Equity Method Investments [Line Items]                    
Ownership percentage 31.00% 50.00%                
Cronos GrowCo                    
Schedule of Equity Method Investments [Line Items]                    
Ownership percentage (Whistler - less than)           50.00%   50.00%    
Investments in equity accounted investees           $ 933,000   $ 933,000   1,501,000
Share of earnings (loss) from investments in equity accounted investees           $ (190,000) (38,000) $ (501,000) (27,000)  
Cronos GrowCo | Variable Interest Entity, Not Primary Beneficiary                    
Schedule of Equity Method Investments [Line Items]                    
Ownership percentage       50.00%            
MedMen Canada                    
Schedule of Equity Method Investments [Line Items]                    
Ownership percentage (Whistler - less than)           50.00%   50.00%    
Investments in equity accounted investees           $ 0   $ 0   0
Share of earnings (loss) from investments in equity accounted investees           $ 0 (2,000) $ 0 4,000  
MedMen Canada | Variable Interest Entity, Not Primary Beneficiary                    
Schedule of Equity Method Investments [Line Items]                    
Ownership percentage         50.00%          
Natuera                    
Schedule of Equity Method Investments [Line Items]                    
Ownership percentage (Whistler - less than)           50.00%   50.00%    
Investments in equity accounted investees           $ 0   $ 0   $ (598,000)
Share of earnings (loss) from investments in equity accounted investees           $ (369,000) $ (304,000) $ (1,230,000) $ (304,000)  
Natuera | Variable Interest Entity, Not Primary Beneficiary                    
Schedule of Equity Method Investments [Line Items]                    
Ownership percentage               50.00%    
XML 74 R53.htm IDEA: XBRL DOCUMENT v3.20.2
Investments and Advances to Joint Ventures - Schedule of Advances to Joint Ventures (Details)
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2020
USD ($)
Jun. 30, 2020
USD ($)
Dec. 31, 2019
USD ($)
Jun. 30, 2020
AUD ($)
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]        
Balance at beginning of period   $ 19,437,000 $ 4,689,000  
Credit loss allowance   0    
Advances (repayments)     15,135,000  
Advances to joint ventures recovered from (applied to) carrying amount of investments     (946,000)  
Effect from foreign exchange   (839,000) 559,000  
Balance at end of period $ 18,598,000 18,598,000 19,437,000  
MedMen Canada        
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]        
Balance at beginning of period   471,000 1,244,000  
Credit loss allowance   0    
Advances (repayments)     (852,000)  
Advances to joint ventures recovered from (applied to) carrying amount of investments     35,000  
Effect from foreign exchange   (20,000) 44,000  
Balance at end of period 451,000 451,000 471,000  
Cronos GrowCo        
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]        
Balance at beginning of period   18,966,000 2,970,000  
Credit loss allowance 917,000 0    
Advances (repayments)     15,494,000  
Advances to joint ventures recovered from (applied to) carrying amount of investments     22,000  
Effect from foreign exchange   (819,000) 480,000  
Balance at end of period 18,147,000 18,147,000 18,966,000  
Cronos Australia        
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]        
Balance at beginning of period   0 475,000  
Credit loss allowance   0    
Advances (repayments)     274,000  
Advances to joint ventures recovered from (applied to) carrying amount of investments     (779,000)  
Effect from foreign exchange   0 30,000  
Balance at end of period 0 0 0  
Face amount       $ 1,500,000
Interest rate       12.00%
Additional interest rate if past due       2.00%
Natuera        
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]        
Balance at beginning of period   0 0  
Credit loss allowance   0    
Advances (repayments)     219,000  
Advances to joint ventures recovered from (applied to) carrying amount of investments     (224,000)  
Effect from foreign exchange   0 5,000  
Balance at end of period $ 0 $ 0 $ 0  
XML 75 R54.htm IDEA: XBRL DOCUMENT v3.20.2
Other Investments (Details) - Equity Securities
$ in Thousands
6 Months Ended
Mar. 04, 2019
shares
Jun. 30, 2020
d
milestone
shares
Jun. 30, 2019
USD ($)
shares
Whistler      
Debt and Equity Securities, FV-NI [Line Items]      
Number of milestones remaining | milestone   1  
Number of shares sold (in shares) 2,563    
Shares sold, percentage of shares issued and outstanding 19.00%    
Aurora      
Debt and Equity Securities, FV-NI [Line Items]      
Shares received (in shares) 2,524,341 578,101  
Proceeds from sale of equity securities, FV-NI | $     $ 19,259
Stock issued during period, new issues, measurement input | d   5  
Number of shares sold (in shares)     2,524,341
Canopy      
Debt and Equity Securities, FV-NI [Line Items]      
Proceeds from sale of equity securities, FV-NI | $     $ 355
Number of shares sold (in shares)     11,062
XML 76 R55.htm IDEA: XBRL DOCUMENT v3.20.2
Accumulated Other Comprehensive Income (Loss) (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Apr. 01, 2020
Jan. 01, 2020
Apr. 01, 2019
Jan. 01, 2019
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]                
Beginning balance $ 1,715,268 $ 713,345 $ 1,749,030 $ 148,549        
Ending balance 1,663,045 921,058 1,663,045 921,058        
Accumulated other comprehensive income (loss)                
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]                
Beginning balance (85,877) (5,975) 27,838 (9,870)        
Ending balance (33,970) 11,973 (33,970) 11,973        
Net unrealized gain (loss) on revaluation and disposal of other investments                
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]                
Beginning balance 5 5 5 5        
Ending balance 5 5 5 5        
Net unrealized gain (loss) on revaluation and disposal of other investments | Accounting Standards Update 2016-01                
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]                
Cumulative effect from adoption of ASU 2016-01         $ 0 $ 0 $ 0 $ 0
Net foreign exchange gain (loss) on translation                
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]                
Beginning balance (85,882) (5,980) 27,833 (9,875)        
Net unrealized (loss) gain 51,907 17,948 (61,808) 21,843        
Ending balance $ (33,975) $ 11,968 $ (33,975) $ 11,968        
XML 77 R56.htm IDEA: XBRL DOCUMENT v3.20.2
Leases (Details)
6 Months Ended
Jun. 30, 2020
lease
Land, Buildings and Equipment  
Lessee, Lease, Description [Line Items]  
Operating lease, term 15 years
Operating lease, extension term (up to) 10 years
Building  
Lessee, Lease, Description [Line Items]  
Operating lease, number of contracts 2
Minimum | Land, Buildings and Equipment  
Lessee, Lease, Description [Line Items]  
Operating lease, term 3 years
Maximum | Land, Buildings and Equipment  
Lessee, Lease, Description [Line Items]  
Operating lease, term 6 years
XML 78 R57.htm IDEA: XBRL DOCUMENT v3.20.2
Loans Receivable, net (Details)
₪ in Thousands
6 Months Ended 7 Months Ended
Apr. 01, 2020
USD ($)
Jun. 28, 2019
USD ($)
Jun. 30, 2020
USD ($)
Jun. 30, 2019
USD ($)
Mar. 31, 2020
USD ($)
Mar. 31, 2020
CAD ($)
Jun. 30, 2020
ILS (₪)
Apr. 01, 2020
ILS (₪)
Dec. 31, 2019
USD ($)
Sep. 27, 2019
USD ($)
Aug. 23, 2019
USD ($)
Aug. 23, 2019
CAD ($)
Jun. 28, 2019
CAD ($)
Current portion                          
Total current portion of loans receivable     $ 4,458,000           $ 4,664,000        
Long term portion                          
Total long-term portion of loans receivable     65,371,000           44,967,000        
Draw downs     23,974,000 $ 12,222,000                  
Establishment of a Commercial Cannabis Analytical Testing Laboratory | Cannasoul | Variable Interest Entity, Primary Beneficiary                          
Long term portion                          
Collaboration agreement, amount of advances     $ 2,446,000       ₪ 8,297            
Collaboration agreement, term of agreement     2 years                    
Interest rate     3.50%       3.50%            
Mucci | Cronos GrowCo                          
Long term portion                          
Ownership interest     50.00%       50.00%            
Loans Receivable                          
Current portion                          
Add: Accrued interest     $ 0           89,000        
Total current portion of loans receivable     4,458,000           4,664,000        
Long term portion                          
Add: Accrued interest     1,822,000           702,000        
Total long-term portion of loans receivable     65,371,000           44,967,000        
Total loans receivable     69,829,000           49,631,000        
NatuEra Series A Loan | Loans Receivable                          
Current portion                          
Current portion of loans receivable, before accrued interest     2,984,000           4,575,000        
Long term portion                          
Face amount                   $ 4,575,000      
Total aggregate principal amount                   $ 9,150,000      
Funding commitment percentage                   50.00%      
Stated interest rate                   5.67%      
Allowance for credit loss     1,591,000                    
NatuEra Series A Loan | Loans Receivable | Natuera                          
Long term portion                          
Funding commitment percentage                   50.00%      
Cronos GrowCo Credit Facility | Loans Receivable                          
Current portion                          
Current portion of loans receivable, before accrued interest     1,474,000           0        
Long term portion                          
Long term portion of loans receivable, before accrued interest     50,582,000           31,678,000        
Face amount                     $ 73,660,000 $ 100,000,000  
Allowance for credit loss     1,089,000                    
Draw downs         $ 53,145,000 $ 72,150,000              
2645485 Ontario Inc. Mucci Promissory Note | Loans Receivable                          
Long term portion                          
Long term portion of loans receivable, before accrued interest     11,793,000           12,587,000        
Face amount   $ 12,043,000                     $ 16,350,000
Stated interest rate   3.95%                     3.95%
Allowance for credit loss     250,000                    
Due on demand, term   90 days                      
Due on demand, intended demand term, minimum   12 months                      
Cannasoul Collaboration Loan | Loans Receivable                          
Long term portion                          
Long term portion of loans receivable, before accrued interest     1,174,000           $ 0        
Cannasoul Collaboration Loan | Loans Receivable | Establishment of a Commercial Cannabis Analytical Testing Laboratory | Cannasoul | Variable Interest Entity, Primary Beneficiary                          
Long term portion                          
Allowance for credit loss     24,000                    
Collaboration agreement, amount of advances $ 2,446,000             ₪ 8,297          
Collaboration agreement, term of agreement 2 years                        
Interest rate 3.50%             3.50%          
Collaborative arrangement, installment received     $ 1,198,000       ₪ 4,149            
XML 79 R58.htm IDEA: XBRL DOCUMENT v3.20.2
Derivative Liabilities - Narrative (Details)
$ in Thousands
3 Months Ended 6 Months Ended
Mar. 08, 2019
day
warrant
$ / shares
shares
Jun. 30, 2020
USD ($)
shares
Jun. 30, 2020
USD ($)
shares
Derivative [Line Items]      
Gain on revaluation   $ (35,880) $ 77,488
Altria Group, Inc. | Cronos Group, Inc.      
Derivative [Line Items]      
Ownership percentage 45.00%    
Altria Investment      
Derivative [Line Items]      
Shares issued (in shares) | shares 149,831,154    
Cronos Group, Inc. | Altria Group, Inc.      
Derivative [Line Items]      
Ownership percentage, if warrant exercised 55.00%    
Altria Investment      
Derivative [Line Items]      
Maximum additional subscription percentage 10.00%    
Derivative liability, additional subscription (in shares) | shares   77,800,000 77,800,000
Altria Warrant      
Derivative [Line Items]      
Exercise price (in dollars per share) | $ / shares $ 19.00    
Gain on revaluation   $ (30,052) $ 58,052
Pre-emptive Rights      
Derivative [Line Items]      
Exercise price (in dollars per share) | $ / shares $ 16.25    
Exercise rights, minimum ownership percentage 20.00%    
Gain on revaluation   (2,610) (3,925)
Top-up Rights      
Derivative [Line Items]      
Exercise price (in dollars per share) | $ / shares $ 16.25    
Exercise rights, minimum ownership percentage 20.00%    
Exercise price, volume-weighted average price, measurement period 10 days    
Exercise price, volume-weighted average price, measurement period, days preceding exercise | day 10    
Derivative transaction costs     22,355
Gain on revaluation   $ (3,218) $ 23,361
Altria Warrant | Cronos Group, Inc.      
Derivative [Line Items]      
Number of warrants issued | warrant 1    
XML 80 R59.htm IDEA: XBRL DOCUMENT v3.20.2
Derivative Liabilities - Schedule of Reconciliation of Carrying Amounts (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2020
Derivative Instruments [Roll Forward]    
Beginning balance $ 166,176 $ 297,160
(Gain) / Loss on revaluation 35,880 (77,488)
Exercise of Rights (727) (727)
Effect from foreign exchange 5,112 (13,231)
Ending balance 205,714 205,714
Altria Warrant    
Derivative Instruments [Roll Forward]    
Beginning balance 132,366 234,428
(Gain) / Loss on revaluation 30,052 (58,052)
Exercise of Rights 0 0
Effect from foreign exchange 3,540 (10,418)
Ending balance 165,958 165,958
Pre-emptive Rights    
Derivative Instruments [Roll Forward]    
Beginning balance 13,070 12,787
(Gain) / Loss on revaluation 2,610 3,925
Exercise of Rights 0 0
Effect from foreign exchange 500 (532)
Ending balance 16,180 16,180
Top-up Rights    
Derivative Instruments [Roll Forward]    
Beginning balance 20,740 49,945
(Gain) / Loss on revaluation 3,218 (23,361)
Exercise of Rights (727) (727)
Effect from foreign exchange 1,072 (2,281)
Ending balance $ 23,576 $ 23,576
XML 81 R60.htm IDEA: XBRL DOCUMENT v3.20.2
Derivative Liabilities - Schedule of Fair Values of Derivative Liabilities (Details)
6 Months Ended 12 Months Ended
Jun. 30, 2020
$ / shares
Dec. 31, 2019
$ / shares
Altria Warrant | Share price at valuation date (per share in C$)    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Derivative liability, measurement input 8.18 9.97
Altria Warrant | Subscription price (per share in C$)    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Derivative liability, measurement input 19.00 19.00
Altria Warrant | Expected annualized volatility    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Derivative liability, measurement input 0.91 0.82
Altria Warrant | Expected dividend yield    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Derivative liability, measurement input 0 0
Altria Warrant | Weighted Average | Weighted average risk-free interest rate    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Derivative liability, measurement input 0.0030 0.0169
Altria Warrant | Weighted Average | Weight average expected life (in years)    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Expected life 2 years 8 months 4 days 3 years 2 months 4 days
Pre-emptive Rights | Share price at valuation date (per share in C$)    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Derivative liability, measurement input 8.18 9.97
Pre-emptive Rights | Subscription price (per share in C$)    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Derivative liability, measurement input 16.25 16.25
Pre-emptive Rights | Expected annualized volatility    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Derivative liability, measurement input 0.91 0.82
Pre-emptive Rights | Expected dividend yield    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Derivative liability, measurement input 0 0
Pre-emptive Rights | Weighted Average | Weighted average risk-free interest rate    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Derivative liability, measurement input 0.0029 0.0173
Pre-emptive Rights | Weighted Average | Weight average expected life (in years)    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Expected life 2 years 1 year 3 months
Top-up Rights | Share price at valuation date (per share in C$)    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Derivative liability, measurement input 8.18 9.97
Top-up Rights | Subscription price (per share in C$)    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Derivative liability, measurement input 16.25 16.25
Top-up Rights | Expected annualized volatility    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Derivative liability, measurement input 0.91 0.82
Top-up Rights | Expected dividend yield    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Derivative liability, measurement input 0 0
Top-up Rights | Weighted Average | Weighted average risk-free interest rate    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Derivative liability, measurement input 0.0026 0.0171
Top-up Rights | Weighted Average | Weight average expected life (in years)    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Expected life 1 year 1 month 9 days 1 year 7 months 28 days
Pre-emptive Rights and Top-up Rights | Minimum | Weighted average risk-free interest rate    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Derivative liability, measurement input 0.0021 0.0166
Pre-emptive Rights and Top-up Rights | Minimum | Weight average expected life (in years)    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Expected life 3 months 3 months
Pre-emptive Rights and Top-up Rights | Maximum | Weighted average risk-free interest rate    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Derivative liability, measurement input 0.0061 0.0173
Pre-emptive Rights and Top-up Rights | Maximum | Weight average expected life (in years)    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Expected life 5 years 6 months 6 years
XML 82 R61.htm IDEA: XBRL DOCUMENT v3.20.2
Derivative Liabilities - Schedule of Sensitivity Analysis (Details) - USD ($)
$ in Thousands
Jun. 30, 2020
Dec. 31, 2019
Altria Warrant    
Sensitivity Analysis, Impact of 10 Percent Decrease (Increase) on Net Income (Loss) [Abstract]    
Share price $ 26,300 $ 36,436
Weighted average expected life 14,249 17,471
Expected annualized volatility 27,711 33,343
Pre-emptive Rights    
Sensitivity Analysis, Impact of 10 Percent Decrease (Increase) on Net Income (Loss) [Abstract]    
Share price 2,779 2,743
Weighted average expected life 1,744 2,366
Expected annualized volatility 2,652 2,180
Top-up Rights    
Sensitivity Analysis, Impact of 10 Percent Decrease (Increase) on Net Income (Loss) [Abstract]    
Share price 4,939 9,577
Weighted average expected life 1,272 2,178
Expected annualized volatility $ 4,769 $ 7,714
XML 83 R62.htm IDEA: XBRL DOCUMENT v3.20.2
Property, Plant and Equipment (Details) - USD ($)
6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Dec. 31, 2019
Property, Plant and Equipment [Line Items]      
Less: accumulated depreciation $ (13,666,000)   $ (9,443,000)
Total 164,290,000   161,809,000
Depreciation expense included in costs of sales 759,000 $ 448,000  
Depreciation expense included in operating expenses 1,025,000 425,000  
Interest costs capitalized 0 $ 367,000  
Land      
Property, Plant and Equipment [Line Items]      
Cost 3,618,000   3,727,000
Office Premises      
Property, Plant and Equipment [Line Items]      
Cost 146,685,000   150,324,000
Furniture and equipment      
Property, Plant and Equipment [Line Items]      
Cost 11,394,000   10,156,000
Computer equipment      
Property, Plant and Equipment [Line Items]      
Cost 651,000   687,000
Leasehold improvements      
Property, Plant and Equipment [Line Items]      
Cost 3,116,000   2,789,000
Construction in progress      
Property, Plant and Equipment [Line Items]      
Cost $ 12,492,000   $ 3,569,000
XML 84 R63.htm IDEA: XBRL DOCUMENT v3.20.2
Intangible Assets and Goodwill - Narrative (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Finite-Lived Intangible Assets [Line Items]        
Goodwill, impairment loss     $ 35,000,000  
Impairment loss on goodwill and intangible assets $ 40,000,000 $ 0 40,000,000 $ 0
Amortization of intangible assets     346,000 $ 301,000
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]        
2021 565,000   565,000  
2022 553,000   553,000  
2023 536,000   536,000  
2024 520,000   520,000  
2025 506,000   506,000  
Lord Jones brand        
Finite-Lived Intangible Assets [Line Items]        
Impairment of intangible assets, indefinite-lived (excluding goodwill) 5,000,000.0      
United States        
Finite-Lived Intangible Assets [Line Items]        
Goodwill, impairment loss $ 35,000,000.0      
Software        
Finite-Lived Intangible Assets [Line Items]        
Indefinite-lived intangible assets acquired, fair value     2,570,000  
Disposal of intangible assets     $ 37,000  
XML 85 R64.htm IDEA: XBRL DOCUMENT v3.20.2
Intangible Assets and Goodwill - Schedule of Intangible Assets (Details) - USD ($)
$ in Thousands
6 Months Ended 12 Months Ended
Jun. 30, 2020
Dec. 31, 2019
Finite-Lived Intangible Assets [Line Items]    
Accumulated Amortization $ (1,475) $ (1,182)
Indefinite-lived Intangible Assets [Line Items]    
Cost 75,874 73,502
Impairment charges (5,000)  
Intangible Assets, Net (Excluding Goodwill) [Abstract]    
Cost 75,874 73,502
Accumulated Amortization (1,475) (1,182)
Net 69,399 72,320
Lord Jones brand    
Indefinite-lived Intangible Assets [Line Items]    
Cost 64,000 64,000
Impairment charges (5,000)  
Net 59,000 64,000
Intangible Assets, Net (Excluding Goodwill) [Abstract]    
Cost 64,000 64,000
Trademarks    
Indefinite-lived Intangible Assets [Line Items]    
Cost 140 36
Net 140 36
Intangible Assets, Net (Excluding Goodwill) [Abstract]    
Cost 140 36
Software    
Finite-Lived Intangible Assets [Line Items]    
Cost 612 541
Accumulated Amortization (298) (202)
Net 314 339
Intangible Assets, Net (Excluding Goodwill) [Abstract]    
Accumulated Amortization $ (298) $ (202)
ERP System    
Finite-Lived Intangible Assets [Line Items]    
Weighted Average Amortization Period (in years) 5 years  
Cost $ 2,570  
Accumulated Amortization 0  
Net 2,570  
Intangible Assets, Net (Excluding Goodwill) [Abstract]    
Accumulated Amortization $ 0  
Health Canada licenses    
Finite-Lived Intangible Assets [Line Items]    
Weighted Average Amortization Period (in years) 17 years 17 years
Cost $ 8,255 $ 8,627
Accumulated Amortization (1,167) (976)
Net 7,088 7,651
Intangible Assets, Net (Excluding Goodwill) [Abstract]    
Accumulated Amortization $ (1,167) $ (976)
Israeli Codes    
Finite-Lived Intangible Assets [Line Items]    
Weighted Average Amortization Period (in years) 25 years 25 years
Cost $ 297 $ 298
Accumulated Amortization (10) (4)
Net 287 294
Intangible Assets, Net (Excluding Goodwill) [Abstract]    
Accumulated Amortization $ (10) $ (4)
XML 86 R65.htm IDEA: XBRL DOCUMENT v3.20.2
Intangible Assets and Goodwill - Schedule of Goodwill (Details)
$ in Thousands
6 Months Ended
Jun. 30, 2020
USD ($)
Goodwill [Roll Forward]  
Balance at beginning of period $ 214,794
Additions 0
Impairment charges (35,000)
Effect of foreign exchange (58)
Balance at end of period 179,736
OGBC  
Goodwill [Roll Forward]  
Balance at beginning of period 302
Additions 0
Impairment charges 0
Effect of foreign exchange (13)
Balance at end of period 289
Peace Naturals  
Goodwill [Roll Forward]  
Balance at beginning of period 1,078
Additions 0
Impairment charges 0
Effect of foreign exchange (45)
Balance at end of period 1,033
Redwood  
Goodwill [Roll Forward]  
Balance at beginning of period 213,414
Additions 0
Impairment charges (35,000)
Effect of foreign exchange 0
Balance at end of period $ 178,414
XML 87 R66.htm IDEA: XBRL DOCUMENT v3.20.2
General and Administrative Expenses (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]        
Salaries and wages $ 6,337 $ 3,354 $ 13,803 $ 5,348
Professional and consulting 3,263 5,051 8,849 7,254
Office and general 3,545 2,622 6,620 5,523
Review costs related to restatement of 2019 interim financial statements 3,459 0 7,866 0
Other 1,833 461 5,058 656
Total $ 18,437 $ 11,488 $ 42,196 $ 18,781
XML 88 R67.htm IDEA: XBRL DOCUMENT v3.20.2
Share-based Payments - Summary of Changes in Warrants (Details) - Warrants - $ / shares
6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Weighted average exercise price (C$)    
Balance at beginning of period (in dollars per share) $ 0.26 $ 0.26
Exercise of warrants (in dollars per share)   0.36
Balance at end of period (in dollars per share) $ 0.26 $ 0.22
Number of awards    
Balance at beginning of period (in shares) 18,066,662 25,457,623
Exercise of warrants (in shares)   (7,390,961)
Balance at end of period (in shares) 18,066,662 18,066,662
XML 89 R68.htm IDEA: XBRL DOCUMENT v3.20.2
Share-based Payments - Summary of Outstanding Warrants (Details) - Warrants - $ / shares
Jun. 30, 2020
Dec. 31, 2019
Jun. 30, 2019
Dec. 31, 2018
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Weighted average exercise price (in dollars per share) $ 0.26 $ 0.26 $ 0.22 $ 0.26
Number of warrants (in shares) 18,066,662 18,066,662 18,066,662 25,457,623
October 8 – 28, 2015        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Weighted average exercise price (in dollars per share) $ 0.31      
Number of warrants (in shares) 2,976,610      
May 13 – 27, 2016        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Weighted average exercise price (in dollars per share) $ 0.25      
Number of warrants (in shares) 15,090,052      
XML 90 R69.htm IDEA: XBRL DOCUMENT v3.20.2
Share-based Payments - Stock Options Narrative (Details)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2020
USD ($)
shares
Jun. 30, 2019
USD ($)
Jun. 30, 2020
USD ($)
shares
Jun. 30, 2019
USD ($)
shares
Dec. 31, 2019
shares
Jun. 30, 2019
$ / shares
shares
Dec. 31, 2018
shares
Jun. 28, 2018
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Number of options outstanding (in shares) 12,214,548   12,214,548   14,149,502 13,988,545 12,902,995  
Share-based payments | $ $ 2,546 $ 2,647 $ 4,982 $ 4,418        
Issuance of options (in shares)       1,315,787        
2015 Stock Option Plan                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Number of options outstanding (in shares) 10,486,569   10,486,569          
2018 Stock Option Plan                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Number of options outstanding (in shares) 1,727,979   1,727,979          
Issuance of options (in shares)     0          
2020 Omnibus Plan                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Number of options outstanding (in shares) 0   0          
Stock options                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Share-based payments | $ $ 1,770 $ 2,647 $ 3,500 $ 4,418        
Stock options | 2015 Stock Option Plan                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Future awards to be granted (in shares)               0
Weighted Average | Stock options                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Share price at grant date (in dollars per share) | $ / shares           $ 13.35    
XML 91 R70.htm IDEA: XBRL DOCUMENT v3.20.2
Share-based Payments - Summary of the Changes in Options (Details)
6 Months Ended 12 Months Ended
Jun. 30, 2020
$ / shares
$ / shares
shares
Jun. 30, 2019
$ / shares
$ / shares
shares
Dec. 31, 2019
$ / shares
shares
Dec. 31, 2018
$ / shares
shares
Weighted average exercise price (C$)        
Balance at beginning of period (in dollars per share) | $ / shares $ 4.84 $ 2.99 $ 2.99  
Issuance of options (in dollars per share) | $ / shares   20.81    
Exercise of options (in dollars per share) | $ / shares 2.05 3.76    
Cancellation, forfeiture and expiry of options (in dollars per share) | $ / shares 15.78 1.63    
Balance at end of period (in dollars per share) | $ / shares $ 5.13 $ 4.66 $ 4.84 $ 2.99
Weighted average exercise price of options exercisable (in dollars per share) | $ / shares $ 3.42 $ 2.40    
Number of options        
Balance at beginning of period (in shares) | shares 14,149,502 12,902,995 12,902,995  
Issuance of options (in shares) | shares   1,315,787    
Exercise of options (in shares) | shares (1,807,909) (227,342)    
Cancellation, forfeiture and expiry of options (in shares) | shares (127,045) (2,895)    
Balance at end of period (in shares) | shares 12,214,548 13,988,545 14,149,502 12,902,995
Exercisable (in shares) | shares 8,688,645 6,580,238    
Weighted average remaining contractual term (years)        
Outstanding 2 years 18 days 3 years 14 days 2 years 6 months 21 days 3 years 4 months 6 days
Exercisable 1 year 9 months 10 days 2 years 8 months 8 days    
XML 92 R71.htm IDEA: XBRL DOCUMENT v3.20.2
Share-based Payments - Summary of Fair Value of Options Issued (Details) - Stock options
6 Months Ended
Jun. 30, 2019
$ / shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Expected life of options (in years) 5 years
Expected annualized volatility 80.00%
Expected dividend yield 0.00%
Forfeiture rate 0.00%
Minimum  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Share price at grant date (in dollars per share) $ 20.65
Exercise price (per option) (in dollars per share) $ 20.65
Risk-free interest rate 1.51%
Weighted average Black-Scholes value at grant date (per option) (in dollars per share) $ 13.29
Maximum  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Share price at grant date (in dollars per share) 24.75
Exercise price (per option) (in dollars per share) $ 24.75
Risk-free interest rate 1.62%
Weighted average Black-Scholes value at grant date (per option) (in dollars per share) $ 15.91
XML 93 R72.htm IDEA: XBRL DOCUMENT v3.20.2
Share-based Payments - Restricted Share Units Narrative (Details)
3 Months Ended 6 Months Ended
Jul. 20, 2020
shares
May 11, 2020
$ / shares
shares
Sep. 05, 2019
subsidiary
$ / shares
shares
Jun. 30, 2020
USD ($)
shares
Jun. 30, 2019
USD ($)
shares
Jun. 30, 2020
USD ($)
shares
Jun. 30, 2019
USD ($)
shares
May 11, 2020
$ / shares
Dec. 31, 2019
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Share-based payments | $       $ 2,546,000 $ 2,647,000 $ 4,982,000 $ 4,418,000    
Redwood                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Number of subsidiaries acquired | subsidiary     4            
Restricted share units                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Issuances (in shares)   279,277 732,972     279,277 0    
Vesting rights, number of common shares per award   1 1            
Share price at grant date (in dollars per share) | (per share)   $ 5.42 $ 15.34         $ 7.52  
Vesting period           3 years      
Share-based payments | $       $ 776,000 $ 0 $ 1,482,000 $ 0    
Outstanding awards (in shares)       1,012,249 0 1,012,249 0   732,972
Restricted share units | Subsequent Event                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Shares accelerated and vested (in shares) 732,972                
XML 94 R73.htm IDEA: XBRL DOCUMENT v3.20.2
Share-based Payments - Summary of Restricted Share Units Activity (Details) - USD ($)
3 Months Ended 6 Months Ended
May 11, 2020
Sep. 05, 2019
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Share-based reserve            
Vesting of issued RSUs     $ 2,546,000 $ 2,647,000 $ 4,982,000 $ 4,418,000
Restricted share units            
Number of awards            
Balance at beginning of period (in shares)         732,972  
Issuance of RSUs (in shares) 279,277 732,972     279,277 0
Balance at end of period (in shares)     1,012,249 0 1,012,249 0
Share-based reserve            
Balance as of January 1, 2020         $ 889,000  
Vesting of issued RSUs     $ 776,000 $ 0 1,482,000 $ 0
Balance as of June 30, 2020     $ 2,371,000   $ 2,371,000  
XML 95 R74.htm IDEA: XBRL DOCUMENT v3.20.2
Share-based Payments - Summary of Deferred Share Units Activity (Details) - Deferred Share Units (DSUs) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Number of awards    
Balance at beginning of period (in shares) 33,397  
Liabilities settled (in shares) (8,484)  
Balance at end of period (in shares) 24,913 0
Financial liability    
Balance as of January 1, 2020 $ 255  
Liabilities settled (46)  
Loss (gain) on revaluation (56)  
Balance as of June 30, 2020 $ 153  
XML 96 R75.htm IDEA: XBRL DOCUMENT v3.20.2
Share-based Payments - Deferred Share Units Narrative (Details) - Deferred Share Units (DSUs) - shares
6 Months Ended
Jun. 30, 2019
Jun. 30, 2020
Dec. 31, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Issuances (in shares) 0    
Outstanding awards (in shares) 0 24,913 33,397
XML 97 R76.htm IDEA: XBRL DOCUMENT v3.20.2
Earnings (loss) Per Share - Schedule of Earnings (Loss) Per Share (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Net Income (Loss) Available to Common Stockholders, Diluted [Abstract]        
Net income (loss) attributable to common shareholders of Cronos Group $ (106,977) $ 185,999 $ (30,937) $ 500,090
Weighted average number of common shares outstanding used in the computation of basic earnings per share (in shares) 349,075,408 334,665,873 348,946,439 317,940,749
Basic earnings per share (in dollars per share) $ (0.31) $ 0.56 $ (0.09) $ 1.57
Weighted Average Number of Shares Outstanding Reconciliation [Abstract]        
Net income (loss) used in the computation of basic earnings per share $ (106,977) $ 185,999 $ (30,937) $ 500,090
Adjustment for gain (loss) on revaluation of derivative liabilities (729) (126,032) (729) (350,758)
Net income (loss) used in the computation of diluted income per share $ (107,706) $ 59,967 $ (31,666) $ 149,332
Weighted average number of common shares outstanding used in the computation of basic earnings per share (in shares) 349,075,408 334,665,873 348,946,439 317,940,749
Weighted average number of common shares for computation of diluted income (loss) per share (in shares) [1] 349,075,408 374,676,595 348,946,439 364,872,093
Diluted earnings per share (in dollars per share) $ (0.31) $ 0.16 $ (0.09) $ 0.41
Altria Warrant        
Weighted Average Number of Shares Outstanding Reconciliation [Abstract]        
Dilutive effect of derivative liabilities (in shares) 0 9,100,465 0 13,633,605
Top-up Rights        
Weighted Average Number of Shares Outstanding Reconciliation [Abstract]        
Dilutive effect of derivative liabilities (in shares) 0 630,531 0 766,769
Warrants        
Weighted Average Number of Shares Outstanding Reconciliation [Abstract]        
Dilutive effect of awards (in shares) 0 19,287,262 0 21,239,056
Stock options        
Weighted Average Number of Shares Outstanding Reconciliation [Abstract]        
Dilutive effect of awards (in shares) 0 10,992,464 0 11,291,914
Restricted share units        
Weighted Average Number of Shares Outstanding Reconciliation [Abstract]        
Dilutive effect of awards (in shares) 0 0 0 0
[1] In computing diluted earnings per share, incremental common shares are not considered in periods in which a net loss is reported, as the inclusion of the common share equivalents would be anti-dilutive.
XML 98 R77.htm IDEA: XBRL DOCUMENT v3.20.2
Earnings (loss) Per Share - Schedule of Antidilutive Securities Excluded from Computation of Diluted Shares Outstanding (Details) - shares
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total anti-dilutive securities (in shares) 162,091,326 52,960,461 162,158,002 52,960,461
Ginkgo Equity Milestones        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total anti-dilutive securities (in shares) 14,674,904 14,674,904 14,674,904 14,674,904
Pre-emptive Rights        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total anti-dilutive securities (in shares) 12,006,740 12,006,740 12,006,740 12,006,740
Top-up Rights – fixed price        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total anti-dilutive securities (in shares) 26,686,413 0 26,686,413 0
Top-up Rights – market price        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total anti-dilutive securities (in shares) 1,941,349 25,150,434 1,941,349 25,150,434
Altria Warrant        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total anti-dilutive securities (in shares) 77,752,533 1,076,553 77,752,533 1,076,553
Stock options        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total anti-dilutive securities (in shares) 10,495,235 51,830 10,547,256 51,830
Warrants        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total anti-dilutive securities (in shares) 17,536,558 0 17,521,903 0
Restricted share units        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total anti-dilutive securities (in shares) 1,012,249 0 1,012,249 0
XML 99 R78.htm IDEA: XBRL DOCUMENT v3.20.2
Related Party Transactions and Balances (Details) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Dec. 31, 2019
Mar. 08, 2019
Cronos Group, Inc. | Altria Group, Inc.            
Related Party Transaction [Line Items]            
Ownership percentage           45.00%
Altria Pinnacle LLC. | Consulting Services | Affiliated Entity            
Related Party Transaction [Line Items]            
Consulting fees $ 281,000 $ 0 $ 953,000 $ 0    
Accrual for consulting services $ 281,000   $ 281,000   $ 1,152,000  
Altria Pinnacle LLC. | Purchase of Machinery and Equipment | Affiliated Entity            
Related Party Transaction [Line Items]            
Purchases         $ 1,258,000  
XML 100 R79.htm IDEA: XBRL DOCUMENT v3.20.2
Segment Information - Narrative (Details)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2020
USD ($)
Jun. 30, 2019
USD ($)
Jun. 30, 2020
USD ($)
segment
Jun. 30, 2019
USD ($)
Dec. 31, 2019
USD ($)
Segment Reporting Information [Line Items]          
Number of reportable segments | segment     2    
Current expected credit loss $ 80   $ 80   $ 136
Net revenue, before excise taxes 11,432 $ 8,064 20,776 $ 11,455  
United States          
Segment Reporting Information [Line Items]          
Current expected credit loss 46   46   12
Rest of World          
Segment Reporting Information [Line Items]          
Current expected credit loss 34   34   $ 124
Four Major Customers | Rest of World          
Segment Reporting Information [Line Items]          
Net revenue, before excise taxes $ 7,040   $ 11,819    
Customer Concentration Risk | Revenue Benchmark | BC Liquor Distribution Branch | Rest of World          
Segment Reporting Information [Line Items]          
Concentration risk, percentage 26.00%   19.00%    
Customer Concentration Risk | Revenue Benchmark | Albert Gaming, Liquor and Cannabis Commission | Rest of World          
Segment Reporting Information [Line Items]          
Concentration risk, percentage 19.00%   22.00%    
Customer Concentration Risk | Revenue Benchmark | Ontario Cannabis Retail Corporation | Rest of World          
Segment Reporting Information [Line Items]          
Concentration risk, percentage 16.00%   13.00%    
Customer Concentration Risk | Revenue Benchmark | Societe Quebecoise Du Cannabis | Rest of World          
Segment Reporting Information [Line Items]          
Concentration risk, percentage 12.00%   13.00%    
Customer Concentration Risk | Revenue Benchmark | One Major Customer | Rest of World          
Segment Reporting Information [Line Items]          
Net revenue, before excise taxes   4,118      
Concentration risk, percentage 54.00%        
Customer Concentration Risk | Revenue Benchmark | Two Major Customers | Rest of World          
Segment Reporting Information [Line Items]          
Net revenue, before excise taxes   $ 5,800      
Concentration risk, percentage       54.00%  
XML 101 R80.htm IDEA: XBRL DOCUMENT v3.20.2
Segment Information - Schedule of Segment Data (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Dec. 31, 2019
Consolidated statements of net income (loss) and comprehensive income (loss)          
Net revenue $ 9,883,000 $ 7,653,000 $ 18,315,000 $ 10,657,000  
Share of loss from investments in equity accounted investees 794,000 741,000 1,966,000 939,000  
Interest income 3,817,000   11,575,000    
Interest expense (83,000)   (90,000)    
Interest income, net 3,734,000 9,442,000 11,485,000 11,528,000  
Impairment loss on goodwill and intangible assets 40,000,000 0 40,000,000 0  
Depreciation and amortization 684,000 408,000 1,371,000 726,000  
Income tax expense 0 0 0 0  
Net (loss) income (107,703,000) 185,888,000 (32,022,000) 499,876,000  
Consolidated balance sheets          
Total assets 1,910,287,000   1,910,287,000   $ 2,090,442,000
Investments in equity accounted investees 933,000   933,000   557,000
Goodwill 179,736,000   179,736,000   $ 214,794,000
Purchase of property, plant and equipment, net     13,344,000    
Operating Segments | United States          
Consolidated statements of net income (loss) and comprehensive income (loss)          
Net revenue 2,174,000   4,350,000    
Share of loss from investments in equity accounted investees 0   0    
Interest income 8,000   13,000    
Interest expense 0   0    
Interest income, net 8,000   13,000    
Impairment loss on goodwill and intangible assets 40,000,000   40,000,000    
Depreciation and amortization 36,000   69,000    
Income tax expense 0   0    
Net (loss) income (47,762,000)   (57,567,000)    
Consolidated balance sheets          
Total assets 250,470,000   250,470,000    
Investments in equity accounted investees 0   0    
Goodwill 178,414,000   178,414,000    
Purchase of property, plant and equipment, net     219,000    
Operating Segments | Rest of World          
Consolidated statements of net income (loss) and comprehensive income (loss)          
Net revenue 7,709,000   13,965,000    
Share of loss from investments in equity accounted investees 794,000   1,966,000    
Interest income 3,811,000   11,562,000    
Interest expense (83,000)   (90,000)    
Interest income, net 3,728,000   11,472,000    
Impairment loss on goodwill and intangible assets 0   0    
Depreciation and amortization 654,000   1,302,000    
Income tax expense 0   0    
Net (loss) income (52,899,000)   39,257,000    
Consolidated balance sheets          
Total assets 348,569,000   348,569,000    
Investments in equity accounted investees 933,000   933,000    
Goodwill 1,322,000   1,322,000    
Purchase of property, plant and equipment, net     13,125,000    
Corporate          
Consolidated statements of net income (loss) and comprehensive income (loss)          
Net revenue 0   0    
Share of loss from investments in equity accounted investees 0   0    
Interest income (2,000)   0    
Interest expense 0   0    
Interest income, net (2,000)   0    
Impairment loss on goodwill and intangible assets 0   0    
Depreciation and amortization (6,000)   0    
Income tax expense 0   0    
Net (loss) income (7,042,000)   (13,712,000)    
Consolidated balance sheets          
Total assets 1,311,248,000   1,311,248,000    
Investments in equity accounted investees 0   0    
Goodwill 0   0    
Purchase of property, plant and equipment, net     0    
Cannabis flower          
Consolidated statements of net income (loss) and comprehensive income (loss)          
Net revenue 5,674,000 6,096,000 8,415,000 7,921,000  
Cannabis flower | Operating Segments | United States          
Consolidated statements of net income (loss) and comprehensive income (loss)          
Net revenue 0   0    
Cannabis flower | Operating Segments | Rest of World          
Consolidated statements of net income (loss) and comprehensive income (loss)          
Net revenue 5,674,000   8,415,000    
Cannabis flower | Corporate          
Consolidated statements of net income (loss) and comprehensive income (loss)          
Net revenue 0   0    
Cannabis extracts          
Consolidated statements of net income (loss) and comprehensive income (loss)          
Net revenue 4,091,000 1,535,000 9,667,000 2,638,000  
Cannabis extracts | Operating Segments | United States          
Consolidated statements of net income (loss) and comprehensive income (loss)          
Net revenue 2,174,000   4,350,000    
Cannabis extracts | Operating Segments | Rest of World          
Consolidated statements of net income (loss) and comprehensive income (loss)          
Net revenue 1,917,000   5,317,000    
Cannabis extracts | Corporate          
Consolidated statements of net income (loss) and comprehensive income (loss)          
Net revenue 0   0    
Other          
Consolidated statements of net income (loss) and comprehensive income (loss)          
Net revenue 118,000 $ 22,000 233,000 $ 98,000  
Other | Operating Segments | United States          
Consolidated statements of net income (loss) and comprehensive income (loss)          
Net revenue 0   0    
Other | Operating Segments | Rest of World          
Consolidated statements of net income (loss) and comprehensive income (loss)          
Net revenue 118,000   233,000    
Other | Corporate          
Consolidated statements of net income (loss) and comprehensive income (loss)          
Net revenue $ 0   $ 0    
XML 102 R81.htm IDEA: XBRL DOCUMENT v3.20.2
Segment Information - Schedule of Revenue from External Customers by Geographic Areas (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Revenues from External Customers and Long-Lived Assets [Line Items]        
Net revenue $ 9,883 $ 7,653 $ 18,315 $ 10,657
Canada        
Revenues from External Customers and Long-Lived Assets [Line Items]        
Net revenue 7,416 7,340 13,507 10,323
United States        
Revenues from External Customers and Long-Lived Assets [Line Items]        
Net revenue 2,174 0 4,350 0
Other countries        
Revenues from External Customers and Long-Lived Assets [Line Items]        
Net revenue $ 293 $ 313 $ 458 $ 334
XML 103 R82.htm IDEA: XBRL DOCUMENT v3.20.2
Segment Information - Schedule of Long-lived Assets by Geographic Areas (Details) - USD ($)
$ in Thousands
Jun. 30, 2020
Dec. 31, 2019
Revenues from External Customers and Long-Lived Assets [Line Items]    
Long-lived assets $ 164,290 $ 161,809
Canada    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Long-lived assets 140,357 141,021
United States    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Long-lived assets 2,253 2,103
Other countries    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Long-lived assets $ 21,680 $ 18,685
XML 104 R83.htm IDEA: XBRL DOCUMENT v3.20.2
Commitments - R&D Commitments and Altria Consulting Services (Details)
$ in Thousands
Feb. 18, 2019
Oct. 15, 2018
USD ($)
Sep. 04, 2018
USD ($)
cannabinoid
shares
Jul. 17, 2018
USD ($)
Ginkgo | Research and Development Arrangement        
Long-term Purchase Commitment [Line Items]        
Number of cannabinoids targeted to develop scalable and consistent production | cannabinoid     8  
Common shares issuable (up to) (in shares) | shares     14,674,903  
Common shares issuable, value assigned       $ 100,000
Payments subject to milestones     $ 22,000  
Technion | Research and Development Arrangement        
Long-term Purchase Commitment [Line Items]        
Payments subject to milestones   $ 4,900    
Amount of commitment   $ 1,784    
Research funding period   3 years    
Altria Ventures | Consulting Services Arrangement        
Long-term Purchase Commitment [Line Items]        
Monthly fee, percentage of direct and indirect service costs 105.00%      
XML 105 R84.htm IDEA: XBRL DOCUMENT v3.20.2
Commitments - Use of Publicity Rights in Brand Development (Details) - Common Shares
6 Months Ended
Dec. 23, 2022
Jun. 23, 2021
Jan. 31, 2020
Dec. 23, 2019
USD ($)
d
shares
Jun. 30, 2019
shares
Subsidiary, Sale of Stock [Line Items]          
Shares issued (in shares) | shares         149,831,154
Private Placements          
Subsidiary, Sale of Stock [Line Items]          
Shares issued (in shares) | shares       856,017  
Stock issued during period, new issues, fair value       $ 6,000,000  
Stock issued during period, new issues, measurement input | d       10  
Private Placements | Sale of Stock, Performance Milestone One          
Subsidiary, Sale of Stock [Line Items]          
Triggering event, minimum revenue       $ 50,000,000  
Triggering event, shares issued, value       1,000,000  
Private Placements | Sale of Stock, Performance Milestone Two          
Subsidiary, Sale of Stock [Line Items]          
Triggering event, minimum revenue       100,000,000  
Triggering event, shares issued, value       $ 1,000,000  
Vested on January 31, 2020 | Private Placements          
Subsidiary, Sale of Stock [Line Items]          
Award vesting rights, percentage     33.33%    
Vesting on June 23, 2021 | Private Placements | Forecast          
Subsidiary, Sale of Stock [Line Items]          
Award vesting rights, percentage   33.33%      
Vesting on December 23, 2022 | Private Placements | Forecast          
Subsidiary, Sale of Stock [Line Items]          
Award vesting rights, percentage 33.33%        
XML 106 R85.htm IDEA: XBRL DOCUMENT v3.20.2
Commitments - Take or Pay (Details) - Dried Cannabis Flower
$ in Thousands, $ in Thousands
1 Months Ended
Jan. 31, 2020
CAD ($)
Jun. 30, 2020
CAD ($)
Jun. 30, 2020
USD ($)
Jan. 31, 2020
USD ($)
Recorded Unconditional Purchase Obligation [Line Items]        
Take or pay supply agreement, purchase amount   $ 1,230 $ 906  
Take or pay supply agreement, term of agreement 6 months      
Minimum        
Recorded Unconditional Purchase Obligation [Line Items]        
Take or pay supply agreement, purchase amount $ 1,734     $ 1,290
Maximum        
Recorded Unconditional Purchase Obligation [Line Items]        
Take or pay supply agreement, purchase amount $ 4,284     $ 3,188
XML 107 R86.htm IDEA: XBRL DOCUMENT v3.20.2
Contingencies (Details) - Pending Litigation
$ in Millions
Jun. 16, 2020
CAD ($)
Mar. 12, 2020
shareholder
complaint
Litigation Relating to Marketing, Distribution and Sale of Products    
Loss Contingencies [Line Items]    
Damages sought $ 500  
Punitive damages sought $ 5  
U.S. District Court of Eastern District of New York Vs. Cronos    
Loss Contingencies [Line Items]    
Number of alleged shareholders | shareholder   2
Number of putative class action complaints | complaint   2
XML 108 R87.htm IDEA: XBRL DOCUMENT v3.20.2
Financial Instruments - Credit Risk Narrative (Details) - USD ($)
6 Months Ended 12 Months Ended
Jun. 30, 2020
Dec. 31, 2019
Concentration Risk [Line Items]    
Maximum exposure to credit risk $ 1,424,786,000 $ 1,586,978,000
Accounts receivable, threshold period past due, writeoff 120 days  
Current expected credit loss $ 80,000 136,000
Cash and cash equivalents 1,109,700,000 1,199,693,000
Short-term investments 213,614,000 306,347,000
Advances to joint ventures, allowance for credit loss $ 0 $ 0
Four Customers | Accounts Receivable | Credit Concentration Risk    
Concentration Risk [Line Items]    
Concentration risk, percentage 78.00%  
Two Customers | Accounts Receivable | Credit Concentration Risk    
Concentration Risk [Line Items]    
Concentration risk, percentage   56.00%
XML 109 R88.htm IDEA: XBRL DOCUMENT v3.20.2
Financial Instruments - Liquidity Risk Narrative (Details) - Accounts Payable - Supplier Concentration Risk
6 Months Ended 12 Months Ended
Jun. 30, 2020
Dec. 31, 2019
One Vendor    
Concentration Risk [Line Items]    
Concentration risk, percentage 14.00%  
Three Vendors    
Concentration Risk [Line Items]    
Concentration risk, percentage   42.00%
XML 110 R89.htm IDEA: XBRL DOCUMENT v3.20.2
Financial Instruments - Interest Rate Risk Narrative (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Investments, All Other Investments [Abstract]        
Interest income, net $ 3,734 $ 9,442 $ 11,485 $ 11,528
Impact of change in average variable rate, percent (0.73%)   (1.45%)  
Impact of change in average variable rate, amount $ 2,090   $ 7,292  
XML 111 R90.htm IDEA: XBRL DOCUMENT v3.20.2
Financial Instruments - Currency Rate Risk Narrative (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Dec. 31, 2019
Risks and Uncertainties [Abstract]          
Foreign exchange gain (loss) on translation $ 51,871 $ 17,947 $ (61,821) $ 21,845 $ 21,845
Impact of ten percent change in exchange rate $ 166,395   $ 166,395   $ 174,902
XML 112 R91.htm IDEA: XBRL DOCUMENT v3.20.2
Fair Value Measurement (Details) - Fair Value, Recurring - USD ($)
$ in Thousands
Jun. 30, 2020
Dec. 31, 2019
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash and cash equivalents $ 1,109,700 $ 1,199,693
Short-term investments 213,614 306,347
Derivative liabilities 205,714 297,160
Level 1    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash and cash equivalents 1,109,700 1,199,693
Short-term investments 213,614 306,347
Derivative liabilities 0 0
Level 2    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash and cash equivalents 0 0
Short-term investments 0 0
Derivative liabilities 0 0
Level 3    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash and cash equivalents 0 0
Short-term investments 0 0
Derivative liabilities $ 205,714 $ 297,160
XML 113 R92.htm IDEA: XBRL DOCUMENT v3.20.2
Supplementary Cash Flow Information (Details) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Increase (Decrease) in Operating Capital [Abstract]    
Accounts receivable $ 1,161 $ (3,986)
Other receivables (2,336) (7,681)
Prepaids and other assets 1,568 (2,564)
Inventory (23,913) (15,105)
Accounts payable and other liabilities (6,985) 9,877
Cumulative effect from foreign exchange (65) (2,132)
Total $ (30,570) $ (21,591)
XML 114 R93.htm IDEA: XBRL DOCUMENT v3.20.2
Non-monetary Transactions (Details)
6 Months Ended
Mar. 28, 2019
USD ($)
transaction
Jun. 30, 2020
transaction
Nonmonetary Transaction [Line Items]    
Number of transactions | transaction   0
Purchased Cannabis Resin and Sold Cannabis Dry Flower    
Nonmonetary Transaction [Line Items]    
Number of transactions | transaction 2  
Revenue recognized | $ $ 0  
Gain (loss) recognized on transfer | $ $ 0  
XML 115 R94.htm IDEA: XBRL DOCUMENT v3.20.2
Subsequent Events (Details) - USD ($)
3 Months Ended
Jul. 20, 2020
Sep. 30, 2020
Jul. 24, 2020
Jun. 30, 2020
Dec. 31, 2019
Sep. 27, 2019
NatuEra Series A Loan | Loans Receivable            
Subsequent Event [Line Items]            
Total aggregate principal amount           $ 9,150,000
Funding commitment percentage           50.00%
Stated interest rate           5.67%
Current portion of loans receivable, before accrued interest       $ 2,984,000 $ 4,575,000  
NatuEra Series A Loan | Loans Receivable | Natuera            
Subsequent Event [Line Items]            
Funding commitment percentage           50.00%
Subsequent Event | Restricted share units            
Subsequent Event [Line Items]            
Shares accelerated and vested (in shares) 732,972          
Subsequent Event | Restricted share units | Forecast            
Subsequent Event [Line Items]            
Accelerated share-based compensation costs   $ 6,200,000        
Subsequent Event | NatuEra Series A Loan | Loans Receivable            
Subsequent Event [Line Items]            
Additional principal amount     $ 6,350,000      
Total aggregate principal amount     $ 15,500,000      
Funding commitment percentage     50.00%      
Stated interest rate     5.67%      
Subsequent Event | NatuEra Series A Loan | Loans Receivable | Natuera            
Subsequent Event [Line Items]            
Funding commitment percentage     50.00%      
EXCEL 116 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 118 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 119 FilingSummary.xml IDEA: XBRL DOCUMENT 3.20.2 html 471 451 1 true 143 0 false 23 false false R1.htm 0001001 - Document - Cover Page Sheet http://thecronosgroup.com/role/CoverPage Cover Page Cover 1 false false R2.htm 1001002 - Statement - Condensed Consolidated Balance Sheets Sheet http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 1002003 - Statement - Condensed Consolidated Balance Sheet (Parenthetical) Sheet http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheetParenthetical Condensed Consolidated Balance Sheet (Parenthetical) Statements 3 false false R4.htm 1003004 - Statement - Condensed Consolidated Statements of Net Income and Comprehensive Income (Loss) Sheet http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeandComprehensiveIncomeLoss Condensed Consolidated Statements of Net Income and Comprehensive Income (Loss) Statements 4 false false R5.htm 1004005 - Statement - Condensed Consolidated Statements of Changes in Equity (Deficit) Sheet http://thecronosgroup.com/role/CondensedConsolidatedStatementsofChangesinEquityDeficit Condensed Consolidated Statements of Changes in Equity (Deficit) Statements 5 false false R6.htm 1005006 - Statement - Condensed Consolidated Statements of Cash Flows Sheet http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows Condensed Consolidated Statements of Cash Flows Statements 6 false false R7.htm 2101101 - Disclosure - Background Sheet http://thecronosgroup.com/role/Background Background Notes 7 false false R8.htm 2103102 - Disclosure - Summary of Significant Accounting Policies Sheet http://thecronosgroup.com/role/SummaryofSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 8 false false R9.htm 2107103 - Disclosure - New Accounting Pronouncements Sheet http://thecronosgroup.com/role/NewAccountingPronouncements New Accounting Pronouncements Notes 9 false false R10.htm 2108104 - Disclosure - Revenues from Contracts with Customers Sheet http://thecronosgroup.com/role/RevenuesfromContractswithCustomers Revenues from Contracts with Customers Notes 10 false false R11.htm 2110105 - Disclosure - Inventory Sheet http://thecronosgroup.com/role/Inventory Inventory Notes 11 false false R12.htm 2113106 - Disclosure - Investments and Advances to Joint Ventures Sheet http://thecronosgroup.com/role/InvestmentsandAdvancestoJointVentures Investments and Advances to Joint Ventures Notes 12 false false R13.htm 2118107 - Disclosure - Other Investments Sheet http://thecronosgroup.com/role/OtherInvestments Other Investments Notes 13 false false R14.htm 2120108 - Disclosure - Accumulated Other Comprehensive Income (Loss) Sheet http://thecronosgroup.com/role/AccumulatedOtherComprehensiveIncomeLoss Accumulated Other Comprehensive Income (Loss) Notes 14 false false R15.htm 2123109 - Disclosure - Leases Sheet http://thecronosgroup.com/role/Leases Leases Notes 15 false false R16.htm 2125110 - Disclosure - Loans Receivable, net Sheet http://thecronosgroup.com/role/LoansReceivablenet Loans Receivable, net Notes 16 false false R17.htm 2128111 - Disclosure - Derivative Liabilities Sheet http://thecronosgroup.com/role/DerivativeLiabilities Derivative Liabilities Notes 17 false false R18.htm 2134112 - Disclosure - Property, Plant and Equipment Sheet http://thecronosgroup.com/role/PropertyPlantandEquipment Property, Plant and Equipment Notes 18 false false R19.htm 2137113 - Disclosure - Intangible Assets and Goodwill Sheet http://thecronosgroup.com/role/IntangibleAssetsandGoodwill Intangible Assets and Goodwill Notes 19 false false R20.htm 2142114 - Disclosure - General and Administrative Expenses Sheet http://thecronosgroup.com/role/GeneralandAdministrativeExpenses General and Administrative Expenses Notes 20 false false R21.htm 2145115 - Disclosure - Share-based Payments Sheet http://thecronosgroup.com/role/SharebasedPayments Share-based Payments Notes 21 false false R22.htm 2156116 - Disclosure - Earnings (loss) Per Share Sheet http://thecronosgroup.com/role/EarningslossPerShare Earnings (loss) Per Share Notes 22 false false R23.htm 2160117 - Disclosure - Related Party Transactions and Balances Sheet http://thecronosgroup.com/role/RelatedPartyTransactionsandBalances Related Party Transactions and Balances Notes 23 false false R24.htm 2162118 - Disclosure - Segment Information Sheet http://thecronosgroup.com/role/SegmentInformation Segment Information Notes 24 false false R25.htm 2168119 - Disclosure - Commitments Sheet http://thecronosgroup.com/role/Commitments Commitments Notes 25 false false R26.htm 2172120 - Disclosure - Contingencies Sheet http://thecronosgroup.com/role/Contingencies Contingencies Notes 26 false false R27.htm 2174121 - Disclosure - Financial Instruments Sheet http://thecronosgroup.com/role/FinancialInstruments Financial Instruments Notes 27 false false R28.htm 2179122 - Disclosure - Fair Value Measurement Sheet http://thecronosgroup.com/role/FairValueMeasurement Fair Value Measurement Notes 28 false false R29.htm 2182123 - Disclosure - Supplementary Cash Flow Information Sheet http://thecronosgroup.com/role/SupplementaryCashFlowInformation Supplementary Cash Flow Information Notes 29 false false R30.htm 2185124 - Disclosure - Non-monetary Transactions Sheet http://thecronosgroup.com/role/NonmonetaryTransactions Non-monetary Transactions Notes 30 false false R31.htm 2187125 - Disclosure - Subsequent Events Sheet http://thecronosgroup.com/role/SubsequentEvents Subsequent Events Notes 31 false false R32.htm 2204201 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://thecronosgroup.com/role/SummaryofSignificantAccountingPolicies 32 false false R33.htm 2305301 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://thecronosgroup.com/role/SummaryofSignificantAccountingPolicies 33 false false R34.htm 2311302 - Disclosure - Inventory (Tables) Sheet http://thecronosgroup.com/role/InventoryTables Inventory (Tables) Tables http://thecronosgroup.com/role/Inventory 34 false false R35.htm 2314303 - Disclosure - Investments and Advances to Joint Ventures (Tables) Sheet http://thecronosgroup.com/role/InvestmentsandAdvancestoJointVenturesTables Investments and Advances to Joint Ventures (Tables) Tables http://thecronosgroup.com/role/InvestmentsandAdvancestoJointVentures 35 false false R36.htm 2321304 - Disclosure - Accumulated Other Comprehensive Income (Loss) (Tables) Sheet http://thecronosgroup.com/role/AccumulatedOtherComprehensiveIncomeLossTables Accumulated Other Comprehensive Income (Loss) (Tables) Tables http://thecronosgroup.com/role/AccumulatedOtherComprehensiveIncomeLoss 36 false false R37.htm 2326305 - Disclosure - Loans Receivable, net (Tables) Sheet http://thecronosgroup.com/role/LoansReceivablenetTables Loans Receivable, net (Tables) Tables http://thecronosgroup.com/role/LoansReceivablenet 37 false false R38.htm 2329306 - Disclosure - Derivative Liabilities (Tables) Sheet http://thecronosgroup.com/role/DerivativeLiabilitiesTables Derivative Liabilities (Tables) Tables http://thecronosgroup.com/role/DerivativeLiabilities 38 false false R39.htm 2335307 - Disclosure - Property, Plant and Equipment (Tables) Sheet http://thecronosgroup.com/role/PropertyPlantandEquipmentTables Property, Plant and Equipment (Tables) Tables http://thecronosgroup.com/role/PropertyPlantandEquipment 39 false false R40.htm 2338308 - Disclosure - Intangible Assets and Goodwill (Tables) Sheet http://thecronosgroup.com/role/IntangibleAssetsandGoodwillTables Intangible Assets and Goodwill (Tables) Tables http://thecronosgroup.com/role/IntangibleAssetsandGoodwill 40 false false R41.htm 2343309 - Disclosure - General and Administrative Expenses (Tables) Sheet http://thecronosgroup.com/role/GeneralandAdministrativeExpensesTables General and Administrative Expenses (Tables) Tables http://thecronosgroup.com/role/GeneralandAdministrativeExpenses 41 false false R42.htm 2346310 - Disclosure - Share-based Payments (Tables) Sheet http://thecronosgroup.com/role/SharebasedPaymentsTables Share-based Payments (Tables) Tables http://thecronosgroup.com/role/SharebasedPayments 42 false false R43.htm 2357311 - Disclosure - Earnings (loss) Per Share (Tables) Sheet http://thecronosgroup.com/role/EarningslossPerShareTables Earnings (loss) Per Share (Tables) Tables http://thecronosgroup.com/role/EarningslossPerShare 43 false false R44.htm 2363312 - Disclosure - Segment Information (Tables) Sheet http://thecronosgroup.com/role/SegmentInformationTables Segment Information (Tables) Tables http://thecronosgroup.com/role/SegmentInformation 44 false false R45.htm 2380313 - Disclosure - Fair Value Measurement (Tables) Sheet http://thecronosgroup.com/role/FairValueMeasurementTables Fair Value Measurement (Tables) Tables http://thecronosgroup.com/role/FairValueMeasurement 45 false false R46.htm 2383314 - Disclosure - Supplementary Cash Flow Information (Tables) Sheet http://thecronosgroup.com/role/SupplementaryCashFlowInformationTables Supplementary Cash Flow Information (Tables) Tables http://thecronosgroup.com/role/SupplementaryCashFlowInformation 46 false false R47.htm 2402401 - Disclosure - Background (Details) Sheet http://thecronosgroup.com/role/BackgroundDetails Background (Details) Details http://thecronosgroup.com/role/Background 47 false false R48.htm 2406402 - Disclosure - Summary of Significant Accounting Policies (Details) Sheet http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesDetails Summary of Significant Accounting Policies (Details) Details http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesTables 48 false false R49.htm 2409403 - Disclosure - Revenues from Contracts with Customers (Details) Sheet http://thecronosgroup.com/role/RevenuesfromContractswithCustomersDetails Revenues from Contracts with Customers (Details) Details http://thecronosgroup.com/role/RevenuesfromContractswithCustomers 49 false false R50.htm 2412404 - Disclosure - Inventory (Details) Sheet http://thecronosgroup.com/role/InventoryDetails Inventory (Details) Details http://thecronosgroup.com/role/InventoryTables 50 false false R51.htm 2415405 - Disclosure - Investments and Advances to Joint Ventures - Narrative (Details) Sheet http://thecronosgroup.com/role/InvestmentsandAdvancestoJointVenturesNarrativeDetails Investments and Advances to Joint Ventures - Narrative (Details) Details 51 false false R52.htm 2416406 - Disclosure - Investments and Advances to Joint Ventures - Schedule of Equity Method Investments (Details) Sheet http://thecronosgroup.com/role/InvestmentsandAdvancestoJointVenturesScheduleofEquityMethodInvestmentsDetails Investments and Advances to Joint Ventures - Schedule of Equity Method Investments (Details) Details 52 false false R53.htm 2417407 - Disclosure - Investments and Advances to Joint Ventures - Schedule of Advances to Joint Ventures (Details) Sheet http://thecronosgroup.com/role/InvestmentsandAdvancestoJointVenturesScheduleofAdvancestoJointVenturesDetails Investments and Advances to Joint Ventures - Schedule of Advances to Joint Ventures (Details) Details 53 false false R54.htm 2419408 - Disclosure - Other Investments (Details) Sheet http://thecronosgroup.com/role/OtherInvestmentsDetails Other Investments (Details) Details http://thecronosgroup.com/role/OtherInvestments 54 false false R55.htm 2422409 - Disclosure - Accumulated Other Comprehensive Income (Loss) (Details) Sheet http://thecronosgroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails Accumulated Other Comprehensive Income (Loss) (Details) Details http://thecronosgroup.com/role/AccumulatedOtherComprehensiveIncomeLossTables 55 false false R56.htm 2424410 - Disclosure - Leases (Details) Sheet http://thecronosgroup.com/role/LeasesDetails Leases (Details) Details http://thecronosgroup.com/role/Leases 56 false false R57.htm 2427411 - Disclosure - Loans Receivable, net (Details) Sheet http://thecronosgroup.com/role/LoansReceivablenetDetails Loans Receivable, net (Details) Details http://thecronosgroup.com/role/LoansReceivablenetTables 57 false false R58.htm 2430412 - Disclosure - Derivative Liabilities - Narrative (Details) Sheet http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails Derivative Liabilities - Narrative (Details) Details 58 false false R59.htm 2431413 - Disclosure - Derivative Liabilities - Schedule of Reconciliation of Carrying Amounts (Details) Sheet http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofReconciliationofCarryingAmountsDetails Derivative Liabilities - Schedule of Reconciliation of Carrying Amounts (Details) Details 59 false false R60.htm 2432414 - Disclosure - Derivative Liabilities - Schedule of Fair Values of Derivative Liabilities (Details) Sheet http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails Derivative Liabilities - Schedule of Fair Values of Derivative Liabilities (Details) Details 60 false false R61.htm 2433415 - Disclosure - Derivative Liabilities - Schedule of Sensitivity Analysis (Details) Sheet http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofSensitivityAnalysisDetails Derivative Liabilities - Schedule of Sensitivity Analysis (Details) Details 61 false false R62.htm 2436416 - Disclosure - Property, Plant and Equipment (Details) Sheet http://thecronosgroup.com/role/PropertyPlantandEquipmentDetails Property, Plant and Equipment (Details) Details http://thecronosgroup.com/role/PropertyPlantandEquipmentTables 62 false false R63.htm 2439417 - Disclosure - Intangible Assets and Goodwill - Narrative (Details) Sheet http://thecronosgroup.com/role/IntangibleAssetsandGoodwillNarrativeDetails Intangible Assets and Goodwill - Narrative (Details) Details 63 false false R64.htm 2440418 - Disclosure - Intangible Assets and Goodwill - Schedule of Intangible Assets (Details) Sheet http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetails Intangible Assets and Goodwill - Schedule of Intangible Assets (Details) Details 64 false false R65.htm 2441419 - Disclosure - Intangible Assets and Goodwill - Schedule of Goodwill (Details) Sheet http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofGoodwillDetails Intangible Assets and Goodwill - Schedule of Goodwill (Details) Details 65 false false R66.htm 2444420 - Disclosure - General and Administrative Expenses (Details) Sheet http://thecronosgroup.com/role/GeneralandAdministrativeExpensesDetails General and Administrative Expenses (Details) Details http://thecronosgroup.com/role/GeneralandAdministrativeExpensesTables 66 false false R67.htm 2447421 - Disclosure - Share-based Payments - Summary of Changes in Warrants (Details) Sheet http://thecronosgroup.com/role/SharebasedPaymentsSummaryofChangesinWarrantsDetails Share-based Payments - Summary of Changes in Warrants (Details) Details 67 false false R68.htm 2448422 - Disclosure - Share-based Payments - Summary of Outstanding Warrants (Details) Sheet http://thecronosgroup.com/role/SharebasedPaymentsSummaryofOutstandingWarrantsDetails Share-based Payments - Summary of Outstanding Warrants (Details) Details 68 false false R69.htm 2449423 - Disclosure - Share-based Payments - Stock Options Narrative (Details) Sheet http://thecronosgroup.com/role/SharebasedPaymentsStockOptionsNarrativeDetails Share-based Payments - Stock Options Narrative (Details) Details 69 false false R70.htm 2450424 - Disclosure - Share-based Payments - Summary of the Changes in Options (Details) Sheet http://thecronosgroup.com/role/SharebasedPaymentsSummaryoftheChangesinOptionsDetails Share-based Payments - Summary of the Changes in Options (Details) Details 70 false false R71.htm 2451425 - Disclosure - Share-based Payments - Summary of Fair Value of Options Issued (Details) Sheet http://thecronosgroup.com/role/SharebasedPaymentsSummaryofFairValueofOptionsIssuedDetails Share-based Payments - Summary of Fair Value of Options Issued (Details) Details 71 false false R72.htm 2452426 - Disclosure - Share-based Payments - Restricted Share Units Narrative (Details) Sheet http://thecronosgroup.com/role/SharebasedPaymentsRestrictedShareUnitsNarrativeDetails Share-based Payments - Restricted Share Units Narrative (Details) Details 72 false false R73.htm 2453427 - Disclosure - Share-based Payments - Summary of Restricted Share Units Activity (Details) Sheet http://thecronosgroup.com/role/SharebasedPaymentsSummaryofRestrictedShareUnitsActivityDetails Share-based Payments - Summary of Restricted Share Units Activity (Details) Details 73 false false R74.htm 2454428 - Disclosure - Share-based Payments - Summary of Deferred Share Units Activity (Details) Sheet http://thecronosgroup.com/role/SharebasedPaymentsSummaryofDeferredShareUnitsActivityDetails Share-based Payments - Summary of Deferred Share Units Activity (Details) Details 74 false false R75.htm 2455429 - Disclosure - Share-based Payments - Deferred Share Units Narrative (Details) Sheet http://thecronosgroup.com/role/SharebasedPaymentsDeferredShareUnitsNarrativeDetails Share-based Payments - Deferred Share Units Narrative (Details) Details 75 false false R76.htm 2458430 - Disclosure - Earnings (loss) Per Share - Schedule of Earnings (Loss) Per Share (Details) Sheet http://thecronosgroup.com/role/EarningslossPerShareScheduleofEarningsLossPerShareDetails Earnings (loss) Per Share - Schedule of Earnings (Loss) Per Share (Details) Details http://thecronosgroup.com/role/EarningslossPerShareTables 76 false false R77.htm 2459431 - Disclosure - Earnings (loss) Per Share - Schedule of Antidilutive Securities Excluded from Computation of Diluted Shares Outstanding (Details) Sheet http://thecronosgroup.com/role/EarningslossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofDilutedSharesOutstandingDetails Earnings (loss) Per Share - Schedule of Antidilutive Securities Excluded from Computation of Diluted Shares Outstanding (Details) Details http://thecronosgroup.com/role/EarningslossPerShareTables 77 false false R78.htm 2461432 - Disclosure - Related Party Transactions and Balances (Details) Sheet http://thecronosgroup.com/role/RelatedPartyTransactionsandBalancesDetails Related Party Transactions and Balances (Details) Details http://thecronosgroup.com/role/RelatedPartyTransactionsandBalances 78 false false R79.htm 2464433 - Disclosure - Segment Information - Narrative (Details) Sheet http://thecronosgroup.com/role/SegmentInformationNarrativeDetails Segment Information - Narrative (Details) Details 79 false false R80.htm 2465434 - Disclosure - Segment Information - Schedule of Segment Data (Details) Sheet http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails Segment Information - Schedule of Segment Data (Details) Details 80 false false R81.htm 2466435 - Disclosure - Segment Information - Schedule of Revenue from External Customers by Geographic Areas (Details) Sheet http://thecronosgroup.com/role/SegmentInformationScheduleofRevenuefromExternalCustomersbyGeographicAreasDetails Segment Information - Schedule of Revenue from External Customers by Geographic Areas (Details) Details 81 false false R82.htm 2467436 - Disclosure - Segment Information - Schedule of Long-lived Assets by Geographic Areas (Details) Sheet http://thecronosgroup.com/role/SegmentInformationScheduleofLonglivedAssetsbyGeographicAreasDetails Segment Information - Schedule of Long-lived Assets by Geographic Areas (Details) Details 82 false false R83.htm 2469437 - Disclosure - Commitments - R&D Commitments and Altria Consulting Services (Details) Sheet http://thecronosgroup.com/role/CommitmentsRDCommitmentsandAltriaConsultingServicesDetails Commitments - R&D Commitments and Altria Consulting Services (Details) Details 83 false false R84.htm 2470438 - Disclosure - Commitments - Use of Publicity Rights in Brand Development (Details) Sheet http://thecronosgroup.com/role/CommitmentsUseofPublicityRightsinBrandDevelopmentDetails Commitments - Use of Publicity Rights in Brand Development (Details) Details 84 false false R85.htm 2471439 - Disclosure - Commitments - Take or Pay (Details) Sheet http://thecronosgroup.com/role/CommitmentsTakeorPayDetails Commitments - Take or Pay (Details) Details 85 false false R86.htm 2473440 - Disclosure - Contingencies (Details) Sheet http://thecronosgroup.com/role/ContingenciesDetails Contingencies (Details) Details http://thecronosgroup.com/role/Contingencies 86 false false R87.htm 2475441 - Disclosure - Financial Instruments - Credit Risk Narrative (Details) Sheet http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskNarrativeDetails Financial Instruments - Credit Risk Narrative (Details) Details 87 false false R88.htm 2476442 - Disclosure - Financial Instruments - Liquidity Risk Narrative (Details) Sheet http://thecronosgroup.com/role/FinancialInstrumentsLiquidityRiskNarrativeDetails Financial Instruments - Liquidity Risk Narrative (Details) Details 88 false false R89.htm 2477443 - Disclosure - Financial Instruments - Interest Rate Risk Narrative (Details) Sheet http://thecronosgroup.com/role/FinancialInstrumentsInterestRateRiskNarrativeDetails Financial Instruments - Interest Rate Risk Narrative (Details) Details 89 false false R90.htm 2478444 - Disclosure - Financial Instruments - Currency Rate Risk Narrative (Details) Sheet http://thecronosgroup.com/role/FinancialInstrumentsCurrencyRateRiskNarrativeDetails Financial Instruments - Currency Rate Risk Narrative (Details) Details 90 false false R91.htm 2481445 - Disclosure - Fair Value Measurement (Details) Sheet http://thecronosgroup.com/role/FairValueMeasurementDetails Fair Value Measurement (Details) Details http://thecronosgroup.com/role/FairValueMeasurementTables 91 false false R92.htm 2484446 - Disclosure - Supplementary Cash Flow Information (Details) Sheet http://thecronosgroup.com/role/SupplementaryCashFlowInformationDetails Supplementary Cash Flow Information (Details) Details http://thecronosgroup.com/role/SupplementaryCashFlowInformationTables 92 false false R93.htm 2486447 - Disclosure - Non-monetary Transactions (Details) Sheet http://thecronosgroup.com/role/NonmonetaryTransactionsDetails Non-monetary Transactions (Details) Details http://thecronosgroup.com/role/NonmonetaryTransactions 93 false false R94.htm 2488448 - Disclosure - Subsequent Events (Details) Sheet http://thecronosgroup.com/role/SubsequentEventsDetails Subsequent Events (Details) Details http://thecronosgroup.com/role/SubsequentEvents 94 false false All Reports Book All Reports cron-20200630.htm a10-q22020311.htm a10-q22020312.htm a10-q22020321.htm a10-q22020322.htm a102rsuawardagreement.htm a103rsuawardagreementi.htm cron-20200630.xsd cron-20200630_cal.xml cron-20200630_def.xml cron-20200630_lab.xml cron-20200630_pre.xml ex101omnibusplan1.htm exhibit31q2.htm http://xbrl.sec.gov/dei/2019-01-31 http://fasb.org/srt/2019-01-31 http://fasb.org/us-gaap/2019-01-31 http://xbrl.sec.gov/country/2017-01-31 true true JSON 122 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "cron-20200630.htm": { "axisCustom": 3, "axisStandard": 45, "contextCount": 471, "dts": { "calculationLink": { "local": [ "cron-20200630_cal.xml" ] }, "definitionLink": { "local": [ "cron-20200630_def.xml" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-eedm-def-2019-01-31.xml", "http://xbrl.fasb.org/srt/2019/elts/srt-eedm1-def-2019-01-31.xml" ] }, "inline": { "local": [ "cron-20200630.htm" ] }, "labelLink": { "local": [ "cron-20200630_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml", "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-doc-2019-01-31.xml" ] }, "presentationLink": { "local": [ "cron-20200630_pre.xml" ] }, "referenceLink": { "remote": [ "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-ref-2019-01-31.xml", "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml" ] }, "schema": { "local": [ "cron-20200630.xsd" ], "remote": [ "http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-roles-2019-01-31.xsd", "https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd", "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-parts-codification-2019-01-31.xsd" ] } }, "elementCount": 746, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2019-01-31": 3, "http://xbrl.sec.gov/dei/2019-01-31": 5, "total": 8 }, "keyCustom": 86, "keyStandard": 365, "memberCustom": 71, "memberStandard": 61, "nsprefix": "cron", "nsuri": "http://thecronosgroup.com/20200630", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia4c322fc29a04c15b629703327ea873d_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001001 - Document - Cover Page", "role": "http://thecronosgroup.com/role/CoverPage", "shortName": "Cover Page", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia4c322fc29a04c15b629703327ea873d_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia4c322fc29a04c15b629703327ea873d_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2108104 - Disclosure - Revenues from Contracts with Customers", "role": "http://thecronosgroup.com/role/RevenuesfromContractswithCustomers", "shortName": "Revenues from Contracts with Customers", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia4c322fc29a04c15b629703327ea873d_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia4c322fc29a04c15b629703327ea873d_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2110105 - Disclosure - Inventory", "role": "http://thecronosgroup.com/role/Inventory", "shortName": "Inventory", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia4c322fc29a04c15b629703327ea873d_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia4c322fc29a04c15b629703327ea873d_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2113106 - Disclosure - Investments and Advances to Joint Ventures", "role": "http://thecronosgroup.com/role/InvestmentsandAdvancestoJointVentures", "shortName": "Investments and Advances to Joint Ventures", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia4c322fc29a04c15b629703327ea873d_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia4c322fc29a04c15b629703327ea873d_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2118107 - Disclosure - Other Investments", "role": "http://thecronosgroup.com/role/OtherInvestments", "shortName": "Other Investments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia4c322fc29a04c15b629703327ea873d_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia4c322fc29a04c15b629703327ea873d_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ComprehensiveIncomeNoteTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2120108 - Disclosure - Accumulated Other Comprehensive Income (Loss)", "role": "http://thecronosgroup.com/role/AccumulatedOtherComprehensiveIncomeLoss", "shortName": "Accumulated Other Comprehensive Income (Loss)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia4c322fc29a04c15b629703327ea873d_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ComprehensiveIncomeNoteTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia4c322fc29a04c15b629703327ea873d_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2123109 - Disclosure - Leases", "role": "http://thecronosgroup.com/role/Leases", "shortName": "Leases", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia4c322fc29a04c15b629703327ea873d_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia4c322fc29a04c15b629703327ea873d_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LoansNotesTradeAndOtherReceivablesExcludingAllowanceForCreditLossesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2125110 - Disclosure - Loans Receivable, net", "role": "http://thecronosgroup.com/role/LoansReceivablenet", "shortName": "Loans Receivable, net", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia4c322fc29a04c15b629703327ea873d_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LoansNotesTradeAndOtherReceivablesExcludingAllowanceForCreditLossesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia4c322fc29a04c15b629703327ea873d_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2128111 - Disclosure - Derivative Liabilities", "role": "http://thecronosgroup.com/role/DerivativeLiabilities", "shortName": "Derivative Liabilities", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia4c322fc29a04c15b629703327ea873d_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia4c322fc29a04c15b629703327ea873d_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2134112 - Disclosure - Property, Plant and Equipment", "role": "http://thecronosgroup.com/role/PropertyPlantandEquipment", "shortName": "Property, Plant and Equipment", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia4c322fc29a04c15b629703327ea873d_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia4c322fc29a04c15b629703327ea873d_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2137113 - Disclosure - Intangible Assets and Goodwill", "role": "http://thecronosgroup.com/role/IntangibleAssetsandGoodwill", "shortName": "Intangible Assets and Goodwill", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia4c322fc29a04c15b629703327ea873d_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "i97622ad211d44be6bd47f4066fbfe89a_I20200630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1001002 - Statement - Condensed Consolidated Balance Sheets", "role": "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets", "shortName": "Condensed Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "i97622ad211d44be6bd47f4066fbfe89a_I20200630", "decimals": "-3", "lang": "en-US", "name": "us-gaap:OtherReceivablesNetCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia4c322fc29a04c15b629703327ea873d_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AdditionalFinancialInformationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2142114 - Disclosure - General and Administrative Expenses", "role": "http://thecronosgroup.com/role/GeneralandAdministrativeExpenses", "shortName": "General and Administrative Expenses", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia4c322fc29a04c15b629703327ea873d_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AdditionalFinancialInformationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia4c322fc29a04c15b629703327ea873d_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2145115 - Disclosure - Share-based Payments", "role": "http://thecronosgroup.com/role/SharebasedPayments", "shortName": "Share-based Payments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia4c322fc29a04c15b629703327ea873d_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia4c322fc29a04c15b629703327ea873d_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2156116 - Disclosure - Earnings (loss) Per Share", "role": "http://thecronosgroup.com/role/EarningslossPerShare", "shortName": "Earnings (loss) Per Share", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia4c322fc29a04c15b629703327ea873d_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia4c322fc29a04c15b629703327ea873d_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2160117 - Disclosure - Related Party Transactions and Balances", "role": "http://thecronosgroup.com/role/RelatedPartyTransactionsandBalances", "shortName": "Related Party Transactions and Balances", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia4c322fc29a04c15b629703327ea873d_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia4c322fc29a04c15b629703327ea873d_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2162118 - Disclosure - Segment Information", "role": "http://thecronosgroup.com/role/SegmentInformation", "shortName": "Segment Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia4c322fc29a04c15b629703327ea873d_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia4c322fc29a04c15b629703327ea873d_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2168119 - Disclosure - Commitments", "role": "http://thecronosgroup.com/role/Commitments", "shortName": "Commitments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia4c322fc29a04c15b629703327ea873d_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia4c322fc29a04c15b629703327ea873d_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LossContingencyDisclosures", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2172120 - Disclosure - Contingencies", "role": "http://thecronosgroup.com/role/Contingencies", "shortName": "Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia4c322fc29a04c15b629703327ea873d_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LossContingencyDisclosures", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia4c322fc29a04c15b629703327ea873d_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2174121 - Disclosure - Financial Instruments", "role": "http://thecronosgroup.com/role/FinancialInstruments", "shortName": "Financial Instruments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia4c322fc29a04c15b629703327ea873d_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia4c322fc29a04c15b629703327ea873d_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2179122 - Disclosure - Fair Value Measurement", "role": "http://thecronosgroup.com/role/FairValueMeasurement", "shortName": "Fair Value Measurement", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia4c322fc29a04c15b629703327ea873d_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia4c322fc29a04c15b629703327ea873d_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CashFlowSupplementalDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2182123 - Disclosure - Supplementary Cash Flow Information", "role": "http://thecronosgroup.com/role/SupplementaryCashFlowInformation", "shortName": "Supplementary Cash Flow Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia4c322fc29a04c15b629703327ea873d_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CashFlowSupplementalDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "i97622ad211d44be6bd47f4066fbfe89a_I20200630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1002003 - Statement - Condensed Consolidated Balance Sheet (Parenthetical)", "role": "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheetParenthetical", "shortName": "Condensed Consolidated Balance Sheet (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "link:footnote", "span", "div", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "i97622ad211d44be6bd47f4066fbfe89a_I20200630", "decimals": "INF", "lang": "en-US", "name": "us-gaap:CommonStockSharesIssued", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia4c322fc29a04c15b629703327ea873d_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NonmonetaryTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2185124 - Disclosure - Non-monetary Transactions", "role": "http://thecronosgroup.com/role/NonmonetaryTransactions", "shortName": "Non-monetary Transactions", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia4c322fc29a04c15b629703327ea873d_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NonmonetaryTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia4c322fc29a04c15b629703327ea873d_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2187125 - Disclosure - Subsequent Events", "role": "http://thecronosgroup.com/role/SubsequentEvents", "shortName": "Subsequent Events", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia4c322fc29a04c15b629703327ea873d_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia4c322fc29a04c15b629703327ea873d_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2204201 - Disclosure - Summary of Significant Accounting Policies (Policies)", "role": "http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesPolicies", "shortName": "Summary of Significant Accounting Policies (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia4c322fc29a04c15b629703327ea873d_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia4c322fc29a04c15b629703327ea873d_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSaleOfStockBySubsidiaryOrEquityMethodInvesteeDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2305301 - Disclosure - Summary of Significant Accounting Policies (Tables)", "role": "http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesTables", "shortName": "Summary of Significant Accounting Policies (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia4c322fc29a04c15b629703327ea873d_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSaleOfStockBySubsidiaryOrEquityMethodInvesteeDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia4c322fc29a04c15b629703327ea873d_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2311302 - Disclosure - Inventory (Tables)", "role": "http://thecronosgroup.com/role/InventoryTables", "shortName": "Inventory (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia4c322fc29a04c15b629703327ea873d_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia4c322fc29a04c15b629703327ea873d_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EquityMethodInvestmentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2314303 - Disclosure - Investments and Advances to Joint Ventures (Tables)", "role": "http://thecronosgroup.com/role/InvestmentsandAdvancestoJointVenturesTables", "shortName": "Investments and Advances to Joint Ventures (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia4c322fc29a04c15b629703327ea873d_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EquityMethodInvestmentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia4c322fc29a04c15b629703327ea873d_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2321304 - Disclosure - Accumulated Other Comprehensive Income (Loss) (Tables)", "role": "http://thecronosgroup.com/role/AccumulatedOtherComprehensiveIncomeLossTables", "shortName": "Accumulated Other Comprehensive Income (Loss) (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia4c322fc29a04c15b629703327ea873d_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia4c322fc29a04c15b629703327ea873d_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2326305 - Disclosure - Loans Receivable, net (Tables)", "role": "http://thecronosgroup.com/role/LoansReceivablenetTables", "shortName": "Loans Receivable, net (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia4c322fc29a04c15b629703327ea873d_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia4c322fc29a04c15b629703327ea873d_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2329306 - Disclosure - Derivative Liabilities (Tables)", "role": "http://thecronosgroup.com/role/DerivativeLiabilitiesTables", "shortName": "Derivative Liabilities (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia4c322fc29a04c15b629703327ea873d_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia4c322fc29a04c15b629703327ea873d_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2335307 - Disclosure - Property, Plant and Equipment (Tables)", "role": "http://thecronosgroup.com/role/PropertyPlantandEquipmentTables", "shortName": "Property, Plant and Equipment (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia4c322fc29a04c15b629703327ea873d_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "i1cfb8c36894845519a7339d02647887a_D20200401-20200630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1003004 - Statement - Condensed Consolidated Statements of Net Income and Comprehensive Income (Loss)", "role": "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeandComprehensiveIncomeLoss", "shortName": "Condensed Consolidated Statements of Net Income and Comprehensive Income (Loss)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "i1cfb8c36894845519a7339d02647887a_D20200401-20200630", "decimals": "-3", "lang": "en-US", "name": "us-gaap:ExciseAndSalesTaxes", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia4c322fc29a04c15b629703327ea873d_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2338308 - Disclosure - Intangible Assets and Goodwill (Tables)", "role": "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillTables", "shortName": "Intangible Assets and Goodwill (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia4c322fc29a04c15b629703327ea873d_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia4c322fc29a04c15b629703327ea873d_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "cron:GeneralAndAdministrativeExpensesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2343309 - Disclosure - General and Administrative Expenses (Tables)", "role": "http://thecronosgroup.com/role/GeneralandAdministrativeExpensesTables", "shortName": "General and Administrative Expenses (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia4c322fc29a04c15b629703327ea873d_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "cron:GeneralAndAdministrativeExpensesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia4c322fc29a04c15b629703327ea873d_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfOtherShareBasedCompensationActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2346310 - Disclosure - Share-based Payments (Tables)", "role": "http://thecronosgroup.com/role/SharebasedPaymentsTables", "shortName": "Share-based Payments (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia4c322fc29a04c15b629703327ea873d_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfOtherShareBasedCompensationActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia4c322fc29a04c15b629703327ea873d_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2357311 - Disclosure - Earnings (loss) Per Share (Tables)", "role": "http://thecronosgroup.com/role/EarningslossPerShareTables", "shortName": "Earnings (loss) Per Share (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia4c322fc29a04c15b629703327ea873d_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia4c322fc29a04c15b629703327ea873d_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2363312 - Disclosure - Segment Information (Tables)", "role": "http://thecronosgroup.com/role/SegmentInformationTables", "shortName": "Segment Information (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia4c322fc29a04c15b629703327ea873d_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia4c322fc29a04c15b629703327ea873d_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2380313 - Disclosure - Fair Value Measurement (Tables)", "role": "http://thecronosgroup.com/role/FairValueMeasurementTables", "shortName": "Fair Value Measurement (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia4c322fc29a04c15b629703327ea873d_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia4c322fc29a04c15b629703327ea873d_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CashFlowOperatingCapitalTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2383314 - Disclosure - Supplementary Cash Flow Information (Tables)", "role": "http://thecronosgroup.com/role/SupplementaryCashFlowInformationTables", "shortName": "Supplementary Cash Flow Information (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia4c322fc29a04c15b629703327ea873d_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CashFlowOperatingCapitalTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "i97622ad211d44be6bd47f4066fbfe89a_I20200630", "decimals": "INF", "first": true, "lang": "en-US", "name": "cron:NumberOfContinentsWithInternationalProductionAndDistribution", "reportCount": 1, "unique": true, "unitRef": "continent", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2402401 - Disclosure - Background (Details)", "role": "http://thecronosgroup.com/role/BackgroundDetails", "shortName": "Background (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "i97622ad211d44be6bd47f4066fbfe89a_I20200630", "decimals": "INF", "first": true, "lang": "en-US", "name": "cron:NumberOfContinentsWithInternationalProductionAndDistribution", "reportCount": 1, "unique": true, "unitRef": "continent", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia4c322fc29a04c15b629703327ea873d_D20200101-20200630", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:NumberOfReportingUnits", "reportCount": 1, "unique": true, "unitRef": "reportingunit", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2406402 - Disclosure - Summary of Significant Accounting Policies (Details)", "role": "http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesDetails", "shortName": "Summary of Significant Accounting Policies (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia4c322fc29a04c15b629703327ea873d_D20200101-20200630", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:NumberOfReportingUnits", "reportCount": 1, "unique": true, "unitRef": "reportingunit", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "i97622ad211d44be6bd47f4066fbfe89a_I20200630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AccountsReceivableNetCurrent", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2409403 - Disclosure - Revenues from Contracts with Customers (Details)", "role": "http://thecronosgroup.com/role/RevenuesfromContractswithCustomersDetails", "shortName": "Revenues from Contracts with Customers (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R5": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ifba180d3643d472595017371db3539fa_I20181231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:CommonStockSharesOutstanding", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1004005 - Statement - Condensed Consolidated Statements of Changes in Equity (Deficit)", "role": "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofChangesinEquityDeficit", "shortName": "Condensed Consolidated Statements of Changes in Equity (Deficit)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ifba180d3643d472595017371db3539fa_I20181231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:CommonStockSharesOutstanding", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "i97622ad211d44be6bd47f4066fbfe89a_I20200630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:InventoryRawMaterialsNetOfReserves", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2412404 - Disclosure - Inventory (Details)", "role": "http://thecronosgroup.com/role/InventoryDetails", "shortName": "Inventory (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R51": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "i7cdcef7027a0434eb34d5082aae00e88_D20180614-20180614", "decimals": "2", "first": true, "lang": "en-US", "name": "us-gaap:VariableInterestEntityOwnershipPercentage", "reportCount": 1, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2415405 - Disclosure - Investments and Advances to Joint Ventures - Narrative (Details)", "role": "http://thecronosgroup.com/role/InvestmentsandAdvancestoJointVenturesNarrativeDetails", "shortName": "Investments and Advances to Joint Ventures - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "i8416573f0e4e43d18c2ac94ef5723310_I20200630", "decimals": "-3", "lang": "en-US", "name": "us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount", "reportCount": 1, "unique": true, "unitRef": "ils", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "i97622ad211d44be6bd47f4066fbfe89a_I20200630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:EquityMethodInvestments", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2416406 - Disclosure - Investments and Advances to Joint Ventures - Schedule of Equity Method Investments (Details)", "role": "http://thecronosgroup.com/role/InvestmentsandAdvancestoJointVenturesScheduleofEquityMethodInvestmentsDetails", "shortName": "Investments and Advances to Joint Ventures - Schedule of Equity Method Investments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ib4bd21dd65264220836f427625c009a5_D20191025-20191025", "decimals": "INF", "lang": "en-US", "name": "us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "i0e5600a0f1524555b16d3f0018845b97_I20191231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AdvancesToAffiliate", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2417407 - Disclosure - Investments and Advances to Joint Ventures - Schedule of Advances to Joint Ventures (Details)", "role": "http://thecronosgroup.com/role/InvestmentsandAdvancestoJointVenturesScheduleofAdvancestoJointVenturesDetails", "shortName": "Investments and Advances to Joint Ventures - Schedule of Advances to Joint Ventures (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ida088be6a7874885b9ee34d94cad69a7_I20181231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:AdvancesToAffiliate", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "i7959be856a6a4a8c83af503735acdd0e_I20200630", "decimals": "INF", "first": true, "lang": "en-US", "name": "cron:InvestmentOwnedNumberOfMilestonesRemaining", "reportCount": 1, "unique": true, "unitRef": "milestone", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2419408 - Disclosure - Other Investments (Details)", "role": "http://thecronosgroup.com/role/OtherInvestmentsDetails", "shortName": "Other Investments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "i7959be856a6a4a8c83af503735acdd0e_I20200630", "decimals": "INF", "first": true, "lang": "en-US", "name": "cron:InvestmentOwnedNumberOfMilestonesRemaining", "reportCount": 1, "unique": true, "unitRef": "milestone", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "id86a924347d14aacac05e96342ae2cf1_I20200331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2422409 - Disclosure - Accumulated Other Comprehensive Income (Loss) (Details)", "role": "http://thecronosgroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails", "shortName": "Accumulated Other Comprehensive Income (Loss) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "i15888195e62e47169a833fcccac5f493_I20200331", "decimals": "-3", "lang": "en-US", "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "i890be93ed3924ee19fab305e7b9498ef_I20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseTermOfContract", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2424410 - Disclosure - Leases (Details)", "role": "http://thecronosgroup.com/role/LeasesDetails", "shortName": "Leases (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "i890be93ed3924ee19fab305e7b9498ef_I20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseTermOfContract", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "i97622ad211d44be6bd47f4066fbfe89a_I20200630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:NotesAndLoansReceivableNetCurrent", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2427411 - Disclosure - Loans Receivable, net (Details)", "role": "http://thecronosgroup.com/role/LoansReceivablenetDetails", "shortName": "Loans Receivable, net (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "i592c39a8381b48509e8e3500620a5081_I20200630", "decimals": "-3", "lang": "en-US", "name": "cron:FinancingReceivableAccruedInterestCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "i1cfb8c36894845519a7339d02647887a_D20200401-20200630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2430412 - Disclosure - Derivative Liabilities - Narrative (Details)", "role": "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails", "shortName": "Derivative Liabilities - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "i75915c912a6545689539cea87eb2f03c_D20190308-20190308", "decimals": "INF", "lang": "en-US", "name": "us-gaap:StockIssuedDuringPeriodSharesNewIssues", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R59": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "id86a924347d14aacac05e96342ae2cf1_I20200331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2431413 - Disclosure - Derivative Liabilities - Schedule of Reconciliation of Carrying Amounts (Details)", "role": "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofReconciliationofCarryingAmountsDetails", "shortName": "Derivative Liabilities - Schedule of Reconciliation of Carrying Amounts (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "id86a924347d14aacac05e96342ae2cf1_I20200331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia4c322fc29a04c15b629703327ea873d_D20200101-20200630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1005006 - Statement - Condensed Consolidated Statements of Cash Flows", "role": "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows", "shortName": "Condensed Consolidated Statements of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia4c322fc29a04c15b629703327ea873d_D20200101-20200630", "decimals": "-3", "lang": "en-US", "name": "us-gaap:ShareBasedCompensation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R60": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "i9a130f0adabf4270a4d30c47d7abf6cd_I20200630", "decimals": "2", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeLiabilityMeasurementInput", "reportCount": 1, "unique": true, "unitRef": "cadPerShare", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2432414 - Disclosure - Derivative Liabilities - Schedule of Fair Values of Derivative Liabilities (Details)", "role": "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails", "shortName": "Derivative Liabilities - Schedule of Fair Values of Derivative Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "i9a130f0adabf4270a4d30c47d7abf6cd_I20200630", "decimals": "2", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeLiabilityMeasurementInput", "reportCount": 1, "unique": true, "unitRef": "cadPerShare", "xsiNil": "false" } }, "R61": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "cron:SensitivityAnalysisImpactOnNetIncomeLossTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "i7f38a620d966430986f05e1b2ad01050_I20200630", "decimals": "-3", "first": true, "lang": "en-US", "name": "cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2433415 - Disclosure - Derivative Liabilities - Schedule of Sensitivity Analysis (Details)", "role": "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofSensitivityAnalysisDetails", "shortName": "Derivative Liabilities - Schedule of Sensitivity Analysis (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "cron:SensitivityAnalysisImpactOnNetIncomeLossTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "i7f38a620d966430986f05e1b2ad01050_I20200630", "decimals": "-3", "first": true, "lang": "en-US", "name": "cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R62": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:PropertyPlantAndEquipmentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "i97622ad211d44be6bd47f4066fbfe89a_I20200630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2436416 - Disclosure - Property, Plant and Equipment (Details)", "role": "http://thecronosgroup.com/role/PropertyPlantandEquipmentDetails", "shortName": "Property, Plant and Equipment (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:PropertyPlantAndEquipmentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "i97622ad211d44be6bd47f4066fbfe89a_I20200630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R63": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfGoodwillTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia4c322fc29a04c15b629703327ea873d_D20200101-20200630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:GoodwillImpairmentLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2439417 - Disclosure - Intangible Assets and Goodwill - Narrative (Details)", "role": "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillNarrativeDetails", "shortName": "Intangible Assets and Goodwill - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia4c322fc29a04c15b629703327ea873d_D20200101-20200630", "decimals": "INF", "lang": "en-US", "name": "us-gaap:AmortizationOfIntangibleAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R64": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "i97622ad211d44be6bd47f4066fbfe89a_I20200630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2440418 - Disclosure - Intangible Assets and Goodwill - Schedule of Intangible Assets (Details)", "role": "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetails", "shortName": "Intangible Assets and Goodwill - Schedule of Intangible Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "i97622ad211d44be6bd47f4066fbfe89a_I20200630", "decimals": "-3", "lang": "en-US", "name": "cron:IndefiniteLivedIntangibleAssetsExcludingGoodwillAccumulatedImpairment", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R65": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "i0e5600a0f1524555b16d3f0018845b97_I20191231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:Goodwill", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2441419 - Disclosure - Intangible Assets and Goodwill - Schedule of Goodwill (Details)", "role": "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofGoodwillDetails", "shortName": "Intangible Assets and Goodwill - Schedule of Goodwill (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfGoodwillTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia4c322fc29a04c15b629703327ea873d_D20200101-20200630", "decimals": "-3", "lang": "en-US", "name": "us-gaap:GoodwillAcquiredDuringPeriod", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R66": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "cron:GeneralAndAdministrativeExpensesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "i1cfb8c36894845519a7339d02647887a_D20200401-20200630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LaborAndRelatedExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2444420 - Disclosure - General and Administrative Expenses (Details)", "role": "http://thecronosgroup.com/role/GeneralandAdministrativeExpensesDetails", "shortName": "General and Administrative Expenses (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "cron:GeneralAndAdministrativeExpensesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "i1cfb8c36894845519a7339d02647887a_D20200401-20200630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LaborAndRelatedExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R67": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfOtherShareBasedCompensationActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "if324795cc8c442e6a67952cce5de0741_I20191231", "decimals": "2", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "reportCount": 1, "unitRef": "cadPerShare", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2447421 - Disclosure - Share-based Payments - Summary of Changes in Warrants (Details)", "role": "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofChangesinWarrantsDetails", "shortName": "Share-based Payments - Summary of Changes in Warrants (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfOtherShareBasedCompensationActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "i55b6d5c27b544deeb9b7dfbb29fa8361_D20190101-20190630", "decimals": "2", "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue", "reportCount": 1, "unique": true, "unitRef": "cadPerShare", "xsiNil": "false" } }, "R68": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfOtherShareBasedCompensationActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "id849f57928f54a70b04e9a9982a5c0ba_I20200630", "decimals": "2", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "reportCount": 1, "unitRef": "cadPerShare", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2448422 - Disclosure - Share-based Payments - Summary of Outstanding Warrants (Details)", "role": "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofOutstandingWarrantsDetails", "shortName": "Share-based Payments - Summary of Outstanding Warrants (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "i52a028e99d5845fea4e3d8edaeacc6c6_I20200630", "decimals": "2", "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "reportCount": 1, "unique": true, "unitRef": "cadPerShare", "xsiNil": "false" } }, "R69": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "i97622ad211d44be6bd47f4066fbfe89a_I20200630", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2449423 - Disclosure - Share-based Payments - Stock Options Narrative (Details)", "role": "http://thecronosgroup.com/role/SharebasedPaymentsStockOptionsNarrativeDetails", "shortName": "Share-based Payments - Stock Options Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "idc38f18a83ed4f7593a9c5a2d52d35f0_D20200101-20200630", "decimals": "INF", "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia4c322fc29a04c15b629703327ea873d_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NatureOfOperations", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2101101 - Disclosure - Background", "role": "http://thecronosgroup.com/role/Background", "shortName": "Background", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia4c322fc29a04c15b629703327ea873d_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NatureOfOperations", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R70": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "i0e5600a0f1524555b16d3f0018845b97_I20191231", "decimals": "2", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "reportCount": 1, "unitRef": "cadPerShare", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2450424 - Disclosure - Share-based Payments - Summary of the Changes in Options (Details)", "role": "http://thecronosgroup.com/role/SharebasedPaymentsSummaryoftheChangesinOptionsDetails", "shortName": "Share-based Payments - Summary of the Changes in Options (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "iad7b47332cf04a01909af1ddb592eb33_D20190101-20190630", "decimals": "2", "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "reportCount": 1, "unique": true, "unitRef": "cadPerShare", "xsiNil": "false" } }, "R71": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "i9e558b1c0a46406b8959f665ff1d683e_D20190101-20190630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2451425 - Disclosure - Share-based Payments - Summary of Fair Value of Options Issued (Details)", "role": "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofFairValueofOptionsIssuedDetails", "shortName": "Share-based Payments - Summary of Fair Value of Options Issued (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "i9e558b1c0a46406b8959f665ff1d683e_D20190101-20190630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R72": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "i1cfb8c36894845519a7339d02647887a_D20200401-20200630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2452426 - Disclosure - Share-based Payments - Restricted Share Units Narrative (Details)", "role": "http://thecronosgroup.com/role/SharebasedPaymentsRestrictedShareUnitsNarrativeDetails", "shortName": "Share-based Payments - Restricted Share Units Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "i5ff7c97c06e440a9befd608010e17eab_D20190905-20190905", "decimals": "INF", "lang": "en-US", "name": "us-gaap:NumberOfBusinessesAcquired", "reportCount": 1, "unique": true, "unitRef": "subsidiary", "xsiNil": "false" } }, "R73": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "i1cfb8c36894845519a7339d02647887a_D20200401-20200630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2453427 - Disclosure - Share-based Payments - Summary of Restricted Share Units Activity (Details)", "role": "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofRestrictedShareUnitsActivityDetails", "shortName": "Share-based Payments - Summary of Restricted Share Units Activity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "i8e651ff5cc18466ba889aa20f9cf186d_I20191231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R74": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "icde847004b6844f9ac7301cc6ff859a4_I20191231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2454428 - Disclosure - Share-based Payments - Summary of Deferred Share Units Activity (Details)", "role": "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofDeferredShareUnitsActivityDetails", "shortName": "Share-based Payments - Summary of Deferred Share Units Activity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "i9d4ebaf2d263466dadb8e75ea2e9b6fb_D20200101-20200630", "decimals": "0", "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R75": { "firstAnchor": { "ancestors": [ "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "ix:continuation", "span", "div", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "i749841f459994e7a86b0c85b2d9bc05e_D20190101-20190630", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2455429 - Disclosure - Share-based Payments - Deferred Share Units Narrative (Details)", "role": "http://thecronosgroup.com/role/SharebasedPaymentsDeferredShareUnitsNarrativeDetails", "shortName": "Share-based Payments - Deferred Share Units Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "ix:continuation", "span", "div", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "i749841f459994e7a86b0c85b2d9bc05e_D20190101-20190630", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R76": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "i1cfb8c36894845519a7339d02647887a_D20200401-20200630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2458430 - Disclosure - Earnings (loss) Per Share - Schedule of Earnings (Loss) Per Share (Details)", "role": "http://thecronosgroup.com/role/EarningslossPerShareScheduleofEarningsLossPerShareDetails", "shortName": "Earnings (loss) Per Share - Schedule of Earnings (Loss) Per Share (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "i1cfb8c36894845519a7339d02647887a_D20200401-20200630", "decimals": "-3", "lang": "en-US", "name": "us-gaap:DilutiveSecurities", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R77": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "i1cfb8c36894845519a7339d02647887a_D20200401-20200630", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2459431 - Disclosure - Earnings (loss) Per Share - Schedule of Antidilutive Securities Excluded from Computation of Diluted Shares Outstanding (Details)", "role": "http://thecronosgroup.com/role/EarningslossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofDilutedSharesOutstandingDetails", "shortName": "Earnings (loss) Per Share - Schedule of Antidilutive Securities Excluded from Computation of Diluted Shares Outstanding (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "i1cfb8c36894845519a7339d02647887a_D20200401-20200630", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R78": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "idb484995050e45c9b03e6f248314ca18_I20190308", "decimals": "2", "first": true, "lang": "en-US", "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage", "reportCount": 1, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2461432 - Disclosure - Related Party Transactions and Balances (Details)", "role": "http://thecronosgroup.com/role/RelatedPartyTransactionsandBalancesDetails", "shortName": "Related Party Transactions and Balances (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "i1e1bca7c74584e978fb1e62ac8b4aaa8_D20200401-20200630", "decimals": "-3", "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R79": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia4c322fc29a04c15b629703327ea873d_D20200101-20200630", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:NumberOfReportableSegments", "reportCount": 1, "unique": true, "unitRef": "segment", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2464433 - Disclosure - Segment Information - Narrative (Details)", "role": "http://thecronosgroup.com/role/SegmentInformationNarrativeDetails", "shortName": "Segment Information - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia4c322fc29a04c15b629703327ea873d_D20200101-20200630", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:NumberOfReportableSegments", "reportCount": 1, "unique": true, "unitRef": "segment", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia4c322fc29a04c15b629703327ea873d_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2103102 - Disclosure - Summary of Significant Accounting Policies", "role": "http://thecronosgroup.com/role/SummaryofSignificantAccountingPolicies", "shortName": "Summary of Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia4c322fc29a04c15b629703327ea873d_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R80": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "i1cfb8c36894845519a7339d02647887a_D20200401-20200630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2465434 - Disclosure - Segment Information - Schedule of Segment Data (Details)", "role": "http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails", "shortName": "Segment Information - Schedule of Segment Data (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "i1cfb8c36894845519a7339d02647887a_D20200401-20200630", "decimals": "-3", "lang": "en-US", "name": "us-gaap:InvestmentIncomeInterest", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R81": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "i1cfb8c36894845519a7339d02647887a_D20200401-20200630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2466435 - Disclosure - Segment Information - Schedule of Revenue from External Customers by Geographic Areas (Details)", "role": "http://thecronosgroup.com/role/SegmentInformationScheduleofRevenuefromExternalCustomersbyGeographicAreasDetails", "shortName": "Segment Information - Schedule of Revenue from External Customers by Geographic Areas (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "i9bbb4e3a9334464cbb204abbe76feac0_D20200401-20200630", "decimals": "-3", "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R82": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "i97622ad211d44be6bd47f4066fbfe89a_I20200630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:NoncurrentAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2467436 - Disclosure - Segment Information - Schedule of Long-lived Assets by Geographic Areas (Details)", "role": "http://thecronosgroup.com/role/SegmentInformationScheduleofLonglivedAssetsbyGeographicAreasDetails", "shortName": "Segment Information - Schedule of Long-lived Assets by Geographic Areas (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "i97622ad211d44be6bd47f4066fbfe89a_I20200630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:NoncurrentAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R83": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "i5264fefdbe79408ebefb912fe3f98db5_I20180904", "decimals": "INF", "first": true, "lang": "en-US", "name": "cron:LongTermPurchaseCommitmentNumberOfTargetedUnitsToDevelopProduction", "reportCount": 1, "unique": true, "unitRef": "cannabinoid", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2469437 - Disclosure - Commitments - R&D Commitments and Altria Consulting Services (Details)", "role": "http://thecronosgroup.com/role/CommitmentsRDCommitmentsandAltriaConsultingServicesDetails", "shortName": "Commitments - R&D Commitments and Altria Consulting Services (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "i5264fefdbe79408ebefb912fe3f98db5_I20180904", "decimals": "INF", "first": true, "lang": "en-US", "name": "cron:LongTermPurchaseCommitmentNumberOfTargetedUnitsToDevelopProduction", "reportCount": 1, "unique": true, "unitRef": "cannabinoid", "xsiNil": "false" } }, "R84": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "iad069c550b2b4f68bbff9b6c2f89584c_D20190101-20190630", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:StockIssuedDuringPeriodSharesNewIssues", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2470438 - Disclosure - Commitments - Use of Publicity Rights in Brand Development (Details)", "role": "http://thecronosgroup.com/role/CommitmentsUseofPublicityRightsinBrandDevelopmentDetails", "shortName": "Commitments - Use of Publicity Rights in Brand Development (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "i230d6c49dcd04637866d448d6984c0b6_D20191223-20191223", "decimals": "INF", "lang": "en-US", "name": "us-gaap:StockIssuedDuringPeriodSharesNewIssues", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R85": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "i94f4d200b6644f91b6a33808ef1068ce_I20200630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RecordedUnconditionalPurchaseObligation", "reportCount": 1, "unique": true, "unitRef": "cad", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2471439 - Disclosure - Commitments - Take or Pay (Details)", "role": "http://thecronosgroup.com/role/CommitmentsTakeorPayDetails", "shortName": "Commitments - Take or Pay (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "i94f4d200b6644f91b6a33808ef1068ce_I20200630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RecordedUnconditionalPurchaseObligation", "reportCount": 1, "unique": true, "unitRef": "cad", "xsiNil": "false" } }, "R86": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "i6c7e52bcb7ac44498ae97b9ce777c312_D20200616-20200616", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:LossContingencyDamagesSoughtValue", "reportCount": 1, "unique": true, "unitRef": "cad", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2473440 - Disclosure - Contingencies (Details)", "role": "http://thecronosgroup.com/role/ContingenciesDetails", "shortName": "Contingencies (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "i6c7e52bcb7ac44498ae97b9ce777c312_D20200616-20200616", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:LossContingencyDamagesSoughtValue", "reportCount": 1, "unique": true, "unitRef": "cad", "xsiNil": "false" } }, "R87": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia4c322fc29a04c15b629703327ea873d_D20200101-20200630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2475441 - Disclosure - Financial Instruments - Credit Risk Narrative (Details)", "role": "http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskNarrativeDetails", "shortName": "Financial Instruments - Credit Risk Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia4c322fc29a04c15b629703327ea873d_D20200101-20200630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R88": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia7f07f63eea54925bdbf8fa681b77240_D20200101-20200630", "decimals": "2", "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskPercentage1", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2476442 - Disclosure - Financial Instruments - Liquidity Risk Narrative (Details)", "role": "http://thecronosgroup.com/role/FinancialInstrumentsLiquidityRiskNarrativeDetails", "shortName": "Financial Instruments - Liquidity Risk Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia7f07f63eea54925bdbf8fa681b77240_D20200101-20200630", "decimals": "2", "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskPercentage1", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R89": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "i1cfb8c36894845519a7339d02647887a_D20200401-20200630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:InterestIncomeExpenseNonoperatingNet", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2477443 - Disclosure - Financial Instruments - Interest Rate Risk Narrative (Details)", "role": "http://thecronosgroup.com/role/FinancialInstrumentsInterestRateRiskNarrativeDetails", "shortName": "Financial Instruments - Interest Rate Risk Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "i1cfb8c36894845519a7339d02647887a_D20200401-20200630", "decimals": "4", "lang": "en-US", "name": "cron:SensitivityAnalysisOfInterestRateRiskIncomeStatementImpactImpactOfChangeInAverageVariableRateOnInterestIncomePercent", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock", "span", "div", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia4c322fc29a04c15b629703327ea873d_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2107103 - Disclosure - New Accounting Pronouncements", "role": "http://thecronosgroup.com/role/NewAccountingPronouncements", "shortName": "New Accounting Pronouncements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock", "span", "div", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia4c322fc29a04c15b629703327ea873d_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R90": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "i1cfb8c36894845519a7339d02647887a_D20200401-20200630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2478444 - Disclosure - Financial Instruments - Currency Rate Risk Narrative (Details)", "role": "http://thecronosgroup.com/role/FinancialInstrumentsCurrencyRateRiskNarrativeDetails", "shortName": "Financial Instruments - Currency Rate Risk Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "i9496c11cf8ea4e428d78bd9fd53f62e9_D20190101-20191231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R91": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia695de935ac944658bcb5dc2cd9b1191_I20200630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2481445 - Disclosure - Fair Value Measurement (Details)", "role": "http://thecronosgroup.com/role/FairValueMeasurementDetails", "shortName": "Fair Value Measurement (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia695de935ac944658bcb5dc2cd9b1191_I20200630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R92": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia4c322fc29a04c15b629703327ea873d_D20200101-20200630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:IncreaseDecreaseInAccountsReceivable", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2484446 - Disclosure - Supplementary Cash Flow Information (Details)", "role": "http://thecronosgroup.com/role/SupplementaryCashFlowInformationDetails", "shortName": "Supplementary Cash Flow Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia4c322fc29a04c15b629703327ea873d_D20200101-20200630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:IncreaseDecreaseInAccountsReceivable", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R93": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia4c322fc29a04c15b629703327ea873d_D20200101-20200630", "decimals": "INF", "first": true, "lang": "en-US", "name": "cron:NonmonetaryTransactionNumberOfTransactions", "reportCount": 1, "unique": true, "unitRef": "transaction", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2486447 - Disclosure - Non-monetary Transactions (Details)", "role": "http://thecronosgroup.com/role/NonmonetaryTransactionsDetails", "shortName": "Non-monetary Transactions (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "ia4c322fc29a04c15b629703327ea873d_D20200101-20200630", "decimals": "INF", "first": true, "lang": "en-US", "name": "cron:NonmonetaryTransactionNumberOfTransactions", "reportCount": 1, "unique": true, "unitRef": "transaction", "xsiNil": "false" } }, "R94": { "firstAnchor": { "ancestors": [ "span", "div", "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "i473ddda2526140c3a4fe437947bd4c5a_I20190927", "decimals": "INF", "first": true, "lang": "en-US", "name": "cron:FinancingReceivableFaceAmountIncludingThirdPartyAmount", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2488448 - Disclosure - Subsequent Events (Details)", "role": "http://thecronosgroup.com/role/SubsequentEventsDetails", "shortName": "Subsequent Events (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cron-20200630.htm", "contextRef": "i980171d43e904c4d84100ffef465649f_D20200701-20200930", "decimals": "-5", "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } } }, "segmentCount": 143, "tag": { "country_CA": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "CANADA", "terseLabel": "Canada" } } }, "localname": "CA", "nsuri": "http://xbrl.sec.gov/country/2017-01-31", "presentation": [ "http://thecronosgroup.com/role/SegmentInformationScheduleofLonglivedAssetsbyGeographicAreasDetails", "http://thecronosgroup.com/role/SegmentInformationScheduleofRevenuefromExternalCustomersbyGeographicAreasDetails" ], "xbrltype": "domainItemType" }, "country_US": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "UNITED STATES", "terseLabel": "United States" } } }, "localname": "US", "nsuri": "http://xbrl.sec.gov/country/2017-01-31", "presentation": [ "http://thecronosgroup.com/role/SegmentInformationScheduleofLonglivedAssetsbyGeographicAreasDetails", "http://thecronosgroup.com/role/SegmentInformationScheduleofRevenuefromExternalCustomersbyGeographicAreasDetails" ], "xbrltype": "domainItemType" }, "cron_A2015StockOptionPlanMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "2015 Stock Option Plan [Member]", "label": "2015 Stock Option Plan [Member]", "terseLabel": "2015 Stock Option Plan" } } }, "localname": "A2015StockOptionPlanMember", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/SharebasedPaymentsStockOptionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "cron_A2018StockOptionPlanMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "2018 Stock Option Plan [Member]", "label": "2018 Stock Option Plan [Member]", "terseLabel": "2018 Stock Option Plan" } } }, "localname": "A2018StockOptionPlanMember", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/SharebasedPaymentsStockOptionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "cron_A2020OmnibusPlanMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "2020 Omnibus Plan", "label": "2020 Omnibus Plan [Member]", "terseLabel": "2020 Omnibus Plan" } } }, "localname": "A2020OmnibusPlanMember", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/SharebasedPaymentsStockOptionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "cron_A2645485OntarioInc.MucciPromissoryNoteMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "2645485 Ontario Inc. Mucci Promissory Note [Member]", "label": "2645485 Ontario Inc. Mucci Promissory Note [Member]", "terseLabel": "2645485 Ontario Inc. Mucci Promissory Note" } } }, "localname": "A2645485OntarioInc.MucciPromissoryNoteMember", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/LoansReceivablenetDetails" ], "xbrltype": "domainItemType" }, "cron_AOCIAccumulatedGainLossRevaluationAndDisposalOfOtherInvestmentsParentMemberMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "AOCI, Accumulated Gain (Loss), Revaluation And Disposal Of Other Investments, Parent [Member]", "label": "AOCI, Accumulated Gain (Loss), Revaluation And Disposal Of Other Investments, Parent [Member] [Member]", "verboseLabel": "Net unrealized gain (loss) on revaluation and disposal of other investments" } } }, "localname": "AOCIAccumulatedGainLossRevaluationAndDisposalOfOtherInvestmentsParentMemberMember", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails" ], "xbrltype": "domainItemType" }, "cron_AdvancesToAffiliateAllowanceForCreditLoss": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Advances To Affiliate, Allowance For Credit Loss", "label": "Advances To Affiliate, Allowance For Credit Loss", "terseLabel": "Advances to joint ventures, allowance for credit loss" } } }, "localname": "AdvancesToAffiliateAllowanceForCreditLoss", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "cron_AlbertGamingLiquorAndCannabisCommissionMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Albert Gaming, Liquor And Cannabis Commission", "label": "Albert Gaming, Liquor And Cannabis Commission [Member]", "terseLabel": "Albert Gaming, Liquor and Cannabis Commission" } } }, "localname": "AlbertGamingLiquorAndCannabisCommissionMember", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/SegmentInformationNarrativeDetails" ], "xbrltype": "domainItemType" }, "cron_AltriaGroupInc.Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Altria Group, Inc. [Member]", "label": "Altria Group, Inc. [Member]", "terseLabel": "Altria Group, Inc." } } }, "localname": "AltriaGroupInc.Member", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails", "http://thecronosgroup.com/role/RelatedPartyTransactionsandBalancesDetails" ], "xbrltype": "domainItemType" }, "cron_AltriaInvestmentMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Altria Investment [Member]", "label": "Altria Investment [Member]", "terseLabel": "Altria Investment" } } }, "localname": "AltriaInvestmentMember", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "cron_AltriaPinnacleLLC.Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Altria Pinnacle LLC. [Member]", "label": "Altria Pinnacle LLC. [Member]", "terseLabel": "Altria Pinnacle LLC." } } }, "localname": "AltriaPinnacleLLC.Member", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/RelatedPartyTransactionsandBalancesDetails" ], "xbrltype": "domainItemType" }, "cron_AltriaVenturesInc.Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Altria Ventures Inc. [Member]", "label": "Altria Ventures Inc. [Member]", "terseLabel": "Altria Ventures" } } }, "localname": "AltriaVenturesInc.Member", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/CommitmentsRDCommitmentsandAltriaConsultingServicesDetails" ], "xbrltype": "domainItemType" }, "cron_AltriaWarrantMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Altria Warrant [Member]", "label": "Altria Warrant [Member]", "terseLabel": "Altria Warrant", "verboseLabel": "Altria Warrant" } } }, "localname": "AltriaWarrantMember", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails", "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails", "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofReconciliationofCarryingAmountsDetails", "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofSensitivityAnalysisDetails", "http://thecronosgroup.com/role/EarningslossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofDilutedSharesOutstandingDetails", "http://thecronosgroup.com/role/EarningslossPerShareScheduleofEarningsLossPerShareDetails" ], "xbrltype": "domainItemType" }, "cron_AuroraCannabisInc.Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Aurora Cannabis Inc. [Member]", "label": "Aurora Cannabis Inc. [Member]", "terseLabel": "Aurora" } } }, "localname": "AuroraCannabisInc.Member", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/OtherInvestmentsDetails" ], "xbrltype": "domainItemType" }, "cron_BCLiquorDistributionBranchMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "BC Liquor Distribution Branch", "label": "BC Liquor Distribution Branch [Member]", "terseLabel": "BC Liquor Distribution Branch" } } }, "localname": "BCLiquorDistributionBranchMember", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/SegmentInformationNarrativeDetails" ], "xbrltype": "domainItemType" }, "cron_CannabisExtractsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cannabis Extracts [Member]", "label": "Cannabis Extracts [Member]", "terseLabel": "Cannabis extracts" } } }, "localname": "CannabisExtractsMember", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails" ], "xbrltype": "domainItemType" }, "cron_CannabisFlowerMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cannabis Flower [Member]", "label": "Cannabis Flower [Member]", "terseLabel": "Cannabis flower" } } }, "localname": "CannabisFlowerMember", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails" ], "xbrltype": "domainItemType" }, "cron_CannasoulAnalyticsLtdMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cannasoul Analytics Ltd.", "label": "Cannasoul Analytics Ltd. [Member]", "terseLabel": "Cannasoul" } } }, "localname": "CannasoulAnalyticsLtdMember", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/InvestmentsandAdvancestoJointVenturesNarrativeDetails", "http://thecronosgroup.com/role/LoansReceivablenetDetails" ], "xbrltype": "domainItemType" }, "cron_CannasoulCollaborationLoanMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cannasoul Collaboration Loan", "label": "Cannasoul Collaboration Loan [Member]", "terseLabel": "Cannasoul Collaboration Loan" } } }, "localname": "CannasoulCollaborationLoanMember", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/InvestmentsandAdvancestoJointVenturesNarrativeDetails", "http://thecronosgroup.com/role/LoansReceivablenetDetails" ], "xbrltype": "domainItemType" }, "cron_CanopyGrowthCorporationMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Canopy Growth Corporation [Member]", "label": "Canopy Growth Corporation [Member]", "terseLabel": "Canopy" } } }, "localname": "CanopyGrowthCorporationMember", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/OtherInvestmentsDetails" ], "xbrltype": "domainItemType" }, "cron_ClassOfWarrantOrRightAdditionalSubscriptionNumberOfSecuritiesCalledByWarrantsOrRights": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Class Of Warrant Or Right, Additional Subscription, Number Of Securities Called By Warrants Or Rights", "label": "Class Of Warrant Or Right, Additional Subscription, Number Of Securities Called By Warrants Or Rights", "terseLabel": "Derivative liability, additional subscription (in shares)" } } }, "localname": "ClassOfWarrantOrRightAdditionalSubscriptionNumberOfSecuritiesCalledByWarrantsOrRights", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails" ], "xbrltype": "sharesItemType" }, "cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriod": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Class Of Warrant Or Right, Exercise Price, Volume-Weighted Average Price, Measurement Period", "label": "Class Of Warrant Or Right, Exercise Price, Volume-Weighted Average Price, Measurement Period", "terseLabel": "Exercise price, volume-weighted average price, measurement period" } } }, "localname": "ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriod", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails" ], "xbrltype": "durationItemType" }, "cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriodDaysPrecedingExercise": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Class Of Warrant Or Right, Exercise Price, Volume-Weighted Average Price, Measurement Period, Days Preceding Exercise", "label": "Class Of Warrant Or Right, Exercise Price, Volume-Weighted Average Price, Measurement Period, Days Preceding Exercise", "terseLabel": "Exercise price, volume-weighted average price, measurement period, days preceding exercise" } } }, "localname": "ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriodDaysPrecedingExercise", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails" ], "xbrltype": "integerItemType" }, "cron_ClassOfWarrantOrRightExpense": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Class Of Warrant Or Right, Expense", "label": "Class Of Warrant Or Right, Expense", "terseLabel": "Derivative transaction costs" } } }, "localname": "ClassOfWarrantOrRightExpense", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "cron_ClassOfWarrantOrRightMaximumAdditionalSubscriptionPercentage": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Class Of Warrant Or Right, Maximum Additional Subscription Percentage", "label": "Class Of Warrant Or Right, Maximum Additional Subscription Percentage", "terseLabel": "Maximum additional subscription percentage" } } }, "localname": "ClassOfWarrantOrRightMaximumAdditionalSubscriptionPercentage", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails" ], "xbrltype": "percentItemType" }, "cron_ClassOfWarrantOrRightMinimumOwnershipPercentageRequired": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Class Of Warrant Or Right, Minimum Ownership Percentage Required", "label": "Class Of Warrant Or Right, Minimum Ownership Percentage Required", "terseLabel": "Exercise rights, minimum ownership percentage" } } }, "localname": "ClassOfWarrantOrRightMinimumOwnershipPercentageRequired", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails" ], "xbrltype": "percentItemType" }, "cron_ClassOfWarrantOrRightNumberOfWarrantsIssued": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Class Of Warrant Or Right, Number Of Warrants Issued", "label": "Class Of Warrant Or Right, Number Of Warrants Issued", "terseLabel": "Number of warrants issued" } } }, "localname": "ClassOfWarrantOrRightNumberOfWarrantsIssued", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails" ], "xbrltype": "integerItemType" }, "cron_CollaborativeArrangementAmountOfAdvances": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Collaborative Arrangement, Amount Of Advances", "label": "Collaborative Arrangement, Amount Of Advances", "terseLabel": "Collaboration agreement, amount of advances" } } }, "localname": "CollaborativeArrangementAmountOfAdvances", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/InvestmentsandAdvancestoJointVenturesNarrativeDetails", "http://thecronosgroup.com/role/LoansReceivablenetDetails" ], "xbrltype": "monetaryItemType" }, "cron_CollaborativeArrangementInstallmentsReceived": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Collaborative Arrangement, Installments Received", "label": "Collaborative Arrangement, Installments Received", "terseLabel": "Collaborative arrangement, installment received" } } }, "localname": "CollaborativeArrangementInstallmentsReceived", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/LoansReceivablenetDetails" ], "xbrltype": "monetaryItemType" }, "cron_CollaborativeArrangementPercentageOfProfitsToBeReceived": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Collaborative Arrangement, Percentage Of Profits To Be Received", "label": "Collaborative Arrangement, Percentage Of Profits To Be Received", "terseLabel": "Collaboration agreement, percentage of profits to be received" } } }, "localname": "CollaborativeArrangementPercentageOfProfitsToBeReceived", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/InvestmentsandAdvancestoJointVenturesNarrativeDetails" ], "xbrltype": "percentItemType" }, "cron_CollaborativeArrangementPercentageOfProfitsToBeReceivedTriggeringEventSubsequentToMaximumPercentageOfAmountsAdvancedBeingMet": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Collaborative Arrangement, Percentage Of Profits To Be Received, Triggering Event, Subsequent To Maximum Percentage Of Amounts Advanced Being Met", "label": "Collaborative Arrangement, Percentage Of Profits To Be Received, Triggering Event, Subsequent To Maximum Percentage Of Amounts Advanced Being Met", "terseLabel": "Collaboration agreement, percentage of profits to be received, triggering event, subsequent to maximum percentage of amounts advanced being met" } } }, "localname": "CollaborativeArrangementPercentageOfProfitsToBeReceivedTriggeringEventSubsequentToMaximumPercentageOfAmountsAdvancedBeingMet", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/InvestmentsandAdvancestoJointVenturesNarrativeDetails" ], "xbrltype": "percentItemType" }, "cron_CollaborativeArrangementProfitsToBeReceivedMaximumPercentageOfAmountsAdvanced": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Collaborative Arrangement, Profits To Be Received, Maximum Percentage Of Amounts Advanced", "label": "Collaborative Arrangement, Profits To Be Received, Maximum Percentage Of Amounts Advanced", "terseLabel": "Collaboration agreement, profits to be received, maximum percentage of amounts advanced" } } }, "localname": "CollaborativeArrangementProfitsToBeReceivedMaximumPercentageOfAmountsAdvanced", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/InvestmentsandAdvancestoJointVenturesNarrativeDetails" ], "xbrltype": "percentItemType" }, "cron_CollaborativeArrangementTermOfAgreement": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Collaborative Arrangement, Term Of Agreement", "label": "Collaborative Arrangement, Term Of Agreement", "terseLabel": "Collaboration agreement, term of agreement" } } }, "localname": "CollaborativeArrangementTermOfAgreement", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/InvestmentsandAdvancestoJointVenturesNarrativeDetails", "http://thecronosgroup.com/role/LoansReceivablenetDetails" ], "xbrltype": "durationItemType" }, "cron_ConsultingServicesArrangementMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Consulting Services Arrangement", "label": "Consulting Services Arrangement [Member]", "terseLabel": "Consulting Services Arrangement" } } }, "localname": "ConsultingServicesArrangementMember", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/CommitmentsRDCommitmentsandAltriaConsultingServicesDetails" ], "xbrltype": "domainItemType" }, "cron_ConsultingServicesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Consulting Services [Member]", "label": "Consulting Services [Member]", "terseLabel": "Consulting Services" } } }, "localname": "ConsultingServicesMember", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/RelatedPartyTransactionsandBalancesDetails" ], "xbrltype": "domainItemType" }, "cron_CronosAustraliaLimitedMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cronos Australia Limited [Member]", "label": "Cronos Australia Limited [Member]", "terseLabel": "Cronos Australia" } } }, "localname": "CronosAustraliaLimitedMember", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/BackgroundDetails", "http://thecronosgroup.com/role/InvestmentsandAdvancestoJointVenturesScheduleofAdvancestoJointVenturesDetails", "http://thecronosgroup.com/role/InvestmentsandAdvancestoJointVenturesScheduleofEquityMethodInvestmentsDetails" ], "xbrltype": "domainItemType" }, "cron_CronosGroupInc.Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cronos Group, Inc. [Member]", "label": "Cronos Group, Inc. [Member]", "terseLabel": "Cronos Group, Inc." } } }, "localname": "CronosGroupInc.Member", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails", "http://thecronosgroup.com/role/RelatedPartyTransactionsandBalancesDetails" ], "xbrltype": "domainItemType" }, "cron_CronosGrowCoCreditFacilityMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cronos GrowCo Credit Facility [Member]", "label": "Cronos GrowCo Credit Facility [Member]", "terseLabel": "Cronos GrowCo Credit Facility" } } }, "localname": "CronosGrowCoCreditFacilityMember", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/LoansReceivablenetDetails" ], "xbrltype": "domainItemType" }, "cron_CronosGrowingCompanyInc.Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cronos Growing Company Inc. [Member]", "label": "Cronos Growing Company Inc. [Member]", "terseLabel": "Cronos GrowCo" } } }, "localname": "CronosGrowingCompanyInc.Member", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/InvestmentsandAdvancestoJointVenturesNarrativeDetails", "http://thecronosgroup.com/role/InvestmentsandAdvancestoJointVenturesScheduleofAdvancestoJointVenturesDetails", "http://thecronosgroup.com/role/InvestmentsandAdvancestoJointVenturesScheduleofEquityMethodInvestmentsDetails", "http://thecronosgroup.com/role/LoansReceivablenetDetails" ], "xbrltype": "domainItemType" }, "cron_CronosIsraelG.S.CultivationsLtd.Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cronos Israel G.S. Cultivations Ltd. [Member]", "label": "Cronos Israel G.S. Cultivations Ltd. [Member]", "terseLabel": "Cronos Israel G.S. Cultivations Ltd." } } }, "localname": "CronosIsraelG.S.CultivationsLtd.Member", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "cron_CronosIsraelG.S.ManufacturingLtd.Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cronos Israel G.S. Manufacturing Ltd. [Member]", "label": "Cronos Israel G.S. Manufacturing Ltd. [Member]", "terseLabel": "Cronos Israel G.S. Manufacturing Ltd." } } }, "localname": "CronosIsraelG.S.ManufacturingLtd.Member", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "cron_CronosIsraelG.S.PharmaciesLtd.Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cronos Israel G.S. Pharmacies Ltd. [Member]", "label": "Cronos Israel G.S. Pharmacies Ltd. [Member]", "terseLabel": "Cronos Israel G.S. Pharmacies Ltd." } } }, "localname": "CronosIsraelG.S.PharmaciesLtd.Member", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "cron_CronosIsraelG.S.StoreLtd.Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cronos Israel G.S. Store Ltd. [Member]", "label": "Cronos Israel G.S. Store Ltd. [Member]", "terseLabel": "Cronos Israel G.S. Store Ltd." } } }, "localname": "CronosIsraelG.S.StoreLtd.Member", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "cron_DebtInstrumentPastDueAdditionalInterestRateStatedPercentage": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Debt Instrument, Past Due, Additional Interest Rate, Stated Percentage", "label": "Debt Instrument, Past Due, Additional Interest Rate, Stated Percentage", "terseLabel": "Additional interest rate if past due" } } }, "localname": "DebtInstrumentPastDueAdditionalInterestRateStatedPercentage", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/InvestmentsandAdvancestoJointVenturesScheduleofAdvancestoJointVenturesDetails" ], "xbrltype": "percentItemType" }, "cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Deferred Compensation Share-based Arrangements, Liability [Roll Forward]", "label": "Deferred Compensation Share-based Arrangements, Liability [Roll Forward]", "terseLabel": "Share-based reserve", "verboseLabel": "Financial liability" } } }, "localname": "DeferredCompensationSharebasedArrangementsLiabilityRollForward", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofDeferredShareUnitsActivityDetails", "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofRestrictedShareUnitsActivityDetails" ], "xbrltype": "stringItemType" }, "cron_DeferredShareUnitsDSUsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Deferred Share Units (DSUs) [Member]", "label": "Deferred Share Units (DSUs) [Member]", "terseLabel": "Deferred Share Units (DSUs)" } } }, "localname": "DeferredShareUnitsDSUsMember", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/SharebasedPaymentsDeferredShareUnitsNarrativeDetails", "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofDeferredShareUnitsActivityDetails" ], "xbrltype": "domainItemType" }, "cron_DerivativeInstrumentsRollForward": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Derivative Instruments [Roll Forward]", "label": "Derivative Instruments [Roll Forward]", "terseLabel": "Derivative Instruments [Roll Forward]" } } }, "localname": "DerivativeInstrumentsRollForward", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofReconciliationofCarryingAmountsDetails" ], "xbrltype": "stringItemType" }, "cron_DerivativeLiabilityUsefulLifeTerm": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Derivative Liability, Useful Life, Term", "label": "Derivative Liability, Useful Life, Term", "terseLabel": "Expected life" } } }, "localname": "DerivativeLiabilityUsefulLifeTerm", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails" ], "xbrltype": "durationItemType" }, "cron_EnterpriseResourcePlanningSystemMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Enterprise Resource Planning System", "label": "Enterprise Resource Planning System [Member]", "terseLabel": "ERP System" } } }, "localname": "EnterpriseResourcePlanningSystemMember", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "cron_FinancingReceivableAccruedInterestCurrent": { "auth_ref": [], "calculation": { "http://thecronosgroup.com/role/LoansReceivablenetDetails": { "order": 2.0, "parentTag": "us-gaap_NotesAndLoansReceivableNetCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Financing Receivable, Accrued Interest, Current", "label": "Financing Receivable, Accrued Interest, Current", "terseLabel": "Add: Accrued interest" } } }, "localname": "FinancingReceivableAccruedInterestCurrent", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/LoansReceivablenetDetails" ], "xbrltype": "monetaryItemType" }, "cron_FinancingReceivableAccruedInterestNoncurrent": { "auth_ref": [], "calculation": { "http://thecronosgroup.com/role/LoansReceivablenetDetails": { "order": 2.0, "parentTag": "us-gaap_NotesAndLoansReceivableNetNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Financing Receivable, Accrued Interest, Noncurrent", "label": "Financing Receivable, Accrued Interest, Noncurrent", "terseLabel": "Add: Accrued interest" } } }, "localname": "FinancingReceivableAccruedInterestNoncurrent", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/LoansReceivablenetDetails" ], "xbrltype": "monetaryItemType" }, "cron_FinancingReceivableAdditionalFaceAmountIncludingThirdPartyAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Financing Receivable, Additional Face Amount, Including Third Party Amount", "label": "Financing Receivable, Additional Face Amount, Including Third Party Amount", "terseLabel": "Additional principal amount" } } }, "localname": "FinancingReceivableAdditionalFaceAmountIncludingThirdPartyAmount", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/SubsequentEventsDetails" ], "xbrltype": "monetaryItemType" }, "cron_FinancingReceivableBeforeAccruedInterestCurrent": { "auth_ref": [], "calculation": { "http://thecronosgroup.com/role/LoansReceivablenetDetails": { "order": 1.0, "parentTag": "us-gaap_NotesAndLoansReceivableNetCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Financing Receivable, Before Accrued Interest, Current", "label": "Financing Receivable, Before Accrued Interest, Current", "terseLabel": "Current portion of loans receivable, before accrued interest" } } }, "localname": "FinancingReceivableBeforeAccruedInterestCurrent", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/LoansReceivablenetDetails", "http://thecronosgroup.com/role/SubsequentEventsDetails" ], "xbrltype": "monetaryItemType" }, "cron_FinancingReceivableBeforeAccruedInterestNoncurrent": { "auth_ref": [], "calculation": { "http://thecronosgroup.com/role/LoansReceivablenetDetails": { "order": 1.0, "parentTag": "us-gaap_NotesAndLoansReceivableNetNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Financing Receivable, Before Accrued Interest, Noncurrent", "label": "Financing Receivable, Before Accrued Interest, Noncurrent", "terseLabel": "Long term portion of loans receivable, before accrued interest" } } }, "localname": "FinancingReceivableBeforeAccruedInterestNoncurrent", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/LoansReceivablenetDetails" ], "xbrltype": "monetaryItemType" }, "cron_FinancingReceivableDueOnDemandIntendedDemandTermMinimum": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Financing Receivable, Due On Demand, Intended Demand Term, Minimum", "label": "Financing Receivable, Due On Demand, Intended Demand Term, Minimum", "terseLabel": "Due on demand, intended demand term, minimum" } } }, "localname": "FinancingReceivableDueOnDemandIntendedDemandTermMinimum", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/LoansReceivablenetDetails" ], "xbrltype": "durationItemType" }, "cron_FinancingReceivableDueOnDemandTerm": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Financing Receivable, Due On Demand, Term", "label": "Financing Receivable, Due On Demand, Term", "terseLabel": "Due on demand, term" } } }, "localname": "FinancingReceivableDueOnDemandTerm", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/LoansReceivablenetDetails" ], "xbrltype": "durationItemType" }, "cron_FinancingReceivableFaceAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Financing Receivable, Face Amount", "label": "Financing Receivable, Face Amount", "terseLabel": "Face amount" } } }, "localname": "FinancingReceivableFaceAmount", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/LoansReceivablenetDetails" ], "xbrltype": "monetaryItemType" }, "cron_FinancingReceivableFaceAmountIncludingThirdPartyAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Financing Receivable, Face Amount, Including Third Party Amount", "label": "Financing Receivable, Face Amount, Including Third Party Amount", "terseLabel": "Total aggregate principal amount" } } }, "localname": "FinancingReceivableFaceAmountIncludingThirdPartyAmount", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/LoansReceivablenetDetails", "http://thecronosgroup.com/role/SubsequentEventsDetails" ], "xbrltype": "monetaryItemType" }, "cron_FinancingReceivableFundingCommitmentPercentage": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Financing Receivable, Funding Commitment Percentage", "label": "Financing Receivable, Funding Commitment Percentage", "terseLabel": "Funding commitment percentage" } } }, "localname": "FinancingReceivableFundingCommitmentPercentage", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/LoansReceivablenetDetails", "http://thecronosgroup.com/role/SubsequentEventsDetails" ], "xbrltype": "percentItemType" }, "cron_FinancingReceivableInterestRateStatedPercentage": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Financing Receivable, Interest Rate, Stated Percentage", "label": "Financing Receivable, Interest Rate, Stated Percentage", "terseLabel": "Stated interest rate" } } }, "localname": "FinancingReceivableInterestRateStatedPercentage", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/LoansReceivablenetDetails", "http://thecronosgroup.com/role/SubsequentEventsDetails" ], "xbrltype": "percentItemType" }, "cron_FourCustomersMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Four Customers", "label": "Four Customers [Member]", "terseLabel": "Four Customers" } } }, "localname": "FourCustomersMember", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskNarrativeDetails" ], "xbrltype": "domainItemType" }, "cron_FourMajorCustomersMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Four Major Customers [Member]", "label": "Four Major Customers [Member]", "terseLabel": "Four Major Customers" } } }, "localname": "FourMajorCustomersMember", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/SegmentInformationNarrativeDetails" ], "xbrltype": "domainItemType" }, "cron_GeneralAndAdministrativeExpensesTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "General And Administrative Expenses [Table Text Block]", "label": "General And Administrative Expenses [Table Text Block]", "terseLabel": "Schedule of General and Administrative Expenses" } } }, "localname": "GeneralAndAdministrativeExpensesTableTextBlock", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/GeneralandAdministrativeExpensesTables" ], "xbrltype": "textBlockItemType" }, "cron_GinkgoBioworksInc.Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Ginkgo Bioworks Inc. [Member]", "label": "Ginkgo Bioworks Inc. [Member]", "terseLabel": "Ginkgo" } } }, "localname": "GinkgoBioworksInc.Member", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/CommitmentsRDCommitmentsandAltriaConsultingServicesDetails" ], "xbrltype": "domainItemType" }, "cron_GinkgoEquityMilestonesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Ginkgo Equity Milestones [Member]", "label": "Ginkgo Equity Milestones [Member]", "terseLabel": "Ginkgo Equity Milestones" } } }, "localname": "GinkgoEquityMilestonesMember", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/EarningslossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofDilutedSharesOutstandingDetails" ], "xbrltype": "domainItemType" }, "cron_GrantedRange1Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Granted Range 1", "label": "Granted Range 1 [Member]", "terseLabel": "October 8 \u2013 28, 2015" } } }, "localname": "GrantedRange1Member", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofOutstandingWarrantsDetails" ], "xbrltype": "domainItemType" }, "cron_GrantedRangeTwoMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Granted Range Two", "label": "Granted Range Two [Member]", "terseLabel": "May 13 \u2013 27, 2016" } } }, "localname": "GrantedRangeTwoMember", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofOutstandingWarrantsDetails" ], "xbrltype": "domainItemType" }, "cron_HealthCanadaLicensingAgreementsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Health Canada Licensing Agreements [Member]", "label": "Health Canada Licensing Agreements [Member]", "terseLabel": "Health Canada licenses" } } }, "localname": "HealthCanadaLicensingAgreementsMember", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "cron_IncreaseDecreaseInCumulativeForeignExchangeEffect": { "auth_ref": [], "calculation": { "http://thecronosgroup.com/role/SupplementaryCashFlowInformationDetails": { "order": 6.0, "parentTag": "us-gaap_IncreaseDecreaseInOperatingCapital", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Increase (Decrease) In Cumulative Foreign Exchange Effect", "label": "Increase (Decrease) In Cumulative Foreign Exchange Effect", "terseLabel": "Cumulative effect from foreign exchange" } } }, "localname": "IncreaseDecreaseInCumulativeForeignExchangeEffect", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/SupplementaryCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "cron_IncreaseDecreasePrepaidExpensesAndOtherAssets": { "auth_ref": [], "calculation": { "http://thecronosgroup.com/role/SupplementaryCashFlowInformationDetails": { "order": 2.0, "parentTag": "us-gaap_IncreaseDecreaseInOperatingCapital", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Increase (Decrease) Prepaid Expenses And Other Assets", "label": "Increase (Decrease) Prepaid Expenses And Other Assets", "negatedTerseLabel": "Prepaids and other assets" } } }, "localname": "IncreaseDecreasePrepaidExpensesAndOtherAssets", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/SupplementaryCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "cron_IndefiniteLivedIntangibleAssetsExcludingGoodwillAccumulatedImpairment": { "auth_ref": [], "calculation": { "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetails": { "order": 3.0, "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Indefinite-lived Intangible Assets (Excluding Goodwill), Accumulated Impairment", "label": "Indefinite-lived Intangible Assets (Excluding Goodwill), Accumulated Impairment", "negatedTerseLabel": "Impairment charges" } } }, "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwillAccumulatedImpairment", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "cron_InterestReceivedNet": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Interest Received, Net", "label": "Interest Received, Net", "terseLabel": "Interest received" } } }, "localname": "InterestReceivedNet", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "cron_InventoryCannabisExtractsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Inventory, Cannabis Extracts [Member]", "label": "Inventory, Cannabis Extracts [Member]", "terseLabel": "Cannabis Extracts" } } }, "localname": "InventoryCannabisExtractsMember", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/InventoryDetails" ], "xbrltype": "domainItemType" }, "cron_InventoryDryCannabisMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Inventory, Dry Cannabis [Member]", "label": "Inventory, Dry Cannabis [Member]", "terseLabel": "Dry Cannabis" } } }, "localname": "InventoryDryCannabisMember", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/InventoryDetails" ], "xbrltype": "domainItemType" }, "cron_InvestmentOwnedNumberOfMilestonesRemaining": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Investment Owned, Number Of Milestones Remaining", "label": "Investment Owned, Number Of Milestones Remaining", "terseLabel": "Number of milestones remaining" } } }, "localname": "InvestmentOwnedNumberOfMilestonesRemaining", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/OtherInvestmentsDetails" ], "xbrltype": "integerItemType" }, "cron_InvestmentOwnedNumberOfSharesReceived": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Investment Owned, Number Of Shares Received", "label": "Investment Owned, Number Of Shares Received", "terseLabel": "Shares received (in shares)" } } }, "localname": "InvestmentOwnedNumberOfSharesReceived", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/OtherInvestmentsDetails" ], "xbrltype": "sharesItemType" }, "cron_InvestmentOwnedNumberOfSharesSold": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Investment Owned, Number Of Shares Sold", "label": "Investment Owned, Number Of Shares Sold", "terseLabel": "Number of shares sold (in shares)" } } }, "localname": "InvestmentOwnedNumberOfSharesSold", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/OtherInvestmentsDetails" ], "xbrltype": "sharesItemType" }, "cron_InvestmentOwnedSharesSoldPercentageOfSharesIssuedAndOutstanding": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Investment Owned, Shares Sold, Percentage Of Shares Issued And Outstanding", "label": "Investment Owned, Shares Sold, Percentage Of Shares Issued And Outstanding", "terseLabel": "Shares sold, percentage of shares issued and outstanding" } } }, "localname": "InvestmentOwnedSharesSoldPercentageOfSharesIssuedAndOutstanding", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/OtherInvestmentsDetails" ], "xbrltype": "percentItemType" }, "cron_InvestmentsByConsolidatedAndNonconsolidatedEntitiesAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Investments by Consolidated and Nonconsolidated Entities", "label": "Investments by Consolidated and Nonconsolidated Entities [Axis]", "terseLabel": "Investments by Consolidated and Nonconsolidated Entities [Axis]" } } }, "localname": "InvestmentsByConsolidatedAndNonconsolidatedEntitiesAxis", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/InvestmentsandAdvancestoJointVenturesNarrativeDetails", "http://thecronosgroup.com/role/InvestmentsandAdvancestoJointVenturesScheduleofEquityMethodInvestmentsDetails", "http://thecronosgroup.com/role/LoansReceivablenetDetails" ], "xbrltype": "stringItemType" }, "cron_InvestmentsByConsolidatedAndNonconsolidatedEntitiesDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Investments by Consolidated and Nonconsolidated Entities", "label": "Investments by Consolidated and Nonconsolidated Entities [Domain]", "terseLabel": "Investments by Consolidated and Nonconsolidated Entities [Domain]" } } }, "localname": "InvestmentsByConsolidatedAndNonconsolidatedEntitiesDomain", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/InvestmentsandAdvancestoJointVenturesNarrativeDetails", "http://thecronosgroup.com/role/InvestmentsandAdvancestoJointVenturesScheduleofEquityMethodInvestmentsDetails", "http://thecronosgroup.com/role/LoansReceivablenetDetails" ], "xbrltype": "domainItemType" }, "cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Investments In And Advances To Affiliates, At Fair Value, Advances (Repayments)", "label": "Investments In And Advances To Affiliates, At Fair Value, Advances (Repayments)", "terseLabel": "Advances (repayments)" } } }, "localname": "InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/InvestmentsandAdvancestoJointVenturesScheduleofAdvancestoJointVenturesDetails" ], "xbrltype": "monetaryItemType" }, "cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueChangesDueToCurrencyTranslation": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Investments In And Advances To Affiliates, At Fair Value, Changes Due To Currency Translation", "label": "Investments In And Advances To Affiliates, At Fair Value, Changes Due To Currency Translation", "terseLabel": "Effect from foreign exchange" } } }, "localname": "InvestmentsInAndAdvancesToAffiliatesAtFairValueChangesDueToCurrencyTranslation", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/InvestmentsandAdvancestoJointVenturesScheduleofAdvancestoJointVenturesDetails" ], "xbrltype": "monetaryItemType" }, "cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueCreditLossExpenseReversal": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Investments In And Advances To Affiliates, At Fair Value, Credit Loss, Expense (Reversal)", "label": "Investments In And Advances To Affiliates, At Fair Value, Credit Loss, Expense (Reversal)", "negatedLabel": "Credit loss allowance" } } }, "localname": "InvestmentsInAndAdvancesToAffiliatesAtFairValueCreditLossExpenseReversal", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/InvestmentsandAdvancestoJointVenturesScheduleofAdvancestoJointVenturesDetails" ], "xbrltype": "monetaryItemType" }, "cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueRecoveredFromAppliedToEquityMethodInvestment": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Investments In And Advances To Affiliates, At Fair Value, Recovered From (Applied To) Equity Method Investment", "label": "Investments In And Advances To Affiliates, At Fair Value, Recovered From (Applied To) Equity Method Investment", "terseLabel": "Advances to joint ventures recovered from (applied to) carrying amount of investments" } } }, "localname": "InvestmentsInAndAdvancesToAffiliatesAtFairValueRecoveredFromAppliedToEquityMethodInvestment", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/InvestmentsandAdvancestoJointVenturesScheduleofAdvancestoJointVenturesDetails" ], "xbrltype": "monetaryItemType" }, "cron_IsraeliCodesLicensingAgreementsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Israeli Codes, Licensing Agreements [Member]", "label": "Israeli Codes, Licensing Agreements [Member]", "terseLabel": "Israeli Codes" } } }, "localname": "IsraeliCodesLicensingAgreementsMember", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "cron_LandBuildingsAndEquipmentMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Land, Buildings And Equipment", "label": "Land, Buildings And Equipment [Member]", "terseLabel": "Land, Buildings and Equipment" } } }, "localname": "LandBuildingsAndEquipmentMember", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/LeasesDetails" ], "xbrltype": "domainItemType" }, "cron_LesseeOperatingLeaseNumberOfContracts": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Lessee, Operating Lease, Number Of Contracts", "label": "Lessee, Operating Lease, Number Of Contracts", "terseLabel": "Operating lease, number of contracts" } } }, "localname": "LesseeOperatingLeaseNumberOfContracts", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/LeasesDetails" ], "xbrltype": "integerItemType" }, "cron_LoanReceivableNameAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Loan Receivable, Name [Axis]", "label": "Loan Receivable, Name [Axis]", "terseLabel": "Loan Receivable, Name [Axis]" } } }, "localname": "LoanReceivableNameAxis", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/InvestmentsandAdvancestoJointVenturesNarrativeDetails", "http://thecronosgroup.com/role/LoansReceivablenetDetails", "http://thecronosgroup.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "cron_LoanReceivableNameDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "[Domain] for Loan Receivable, Name [Axis]", "label": "Loan Receivable, Name [Domain]", "terseLabel": "Loan Receivable, Name [Domain]" } } }, "localname": "LoanReceivableNameDomain", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/InvestmentsandAdvancestoJointVenturesNarrativeDetails", "http://thecronosgroup.com/role/LoansReceivablenetDetails", "http://thecronosgroup.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "cron_LongTermPurchaseCommitmentNumberOfTargetedUnitsToDevelopProduction": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Long-term Purchase Commitment, Number Of Targeted Units To Develop Production", "label": "Long-term Purchase Commitment, Number Of Targeted Units To Develop Production", "terseLabel": "Number of cannabinoids targeted to develop scalable and consistent production" } } }, "localname": "LongTermPurchaseCommitmentNumberOfTargetedUnitsToDevelopProduction", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/CommitmentsRDCommitmentsandAltriaConsultingServicesDetails" ], "xbrltype": "integerItemType" }, "cron_LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableNumberOfShares": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Long-term Purchase Commitment, Equity Interest Issued Or Issuable, Number Of Shares", "label": "Long-term Purchase Commitment, Equity Interest Issued Or Issuable, Number Of Shares", "terseLabel": "Common shares issuable (up to) (in shares)" } } }, "localname": "LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableNumberOfShares", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/CommitmentsRDCommitmentsandAltriaConsultingServicesDetails" ], "xbrltype": "sharesItemType" }, "cron_LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableValueAssigned": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Long-term Purchase Commitment, Equity Interest Issued Or Issuable, Value Assigned", "label": "Long-term Purchase Commitment, Equity Interest Issued Or Issuable, Value Assigned", "terseLabel": "Common shares issuable, value assigned" } } }, "localname": "LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableValueAssigned", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/CommitmentsRDCommitmentsandAltriaConsultingServicesDetails" ], "xbrltype": "monetaryItemType" }, "cron_LongtermPurchaseCommitmentMonthlyFeePercentage": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Long-term Purchase Commitment, Monthly Fee, Percentage", "label": "Long-term Purchase Commitment, Monthly Fee, Percentage", "terseLabel": "Monthly fee, percentage of direct and indirect service costs" } } }, "localname": "LongtermPurchaseCommitmentMonthlyFeePercentage", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/CommitmentsRDCommitmentsandAltriaConsultingServicesDetails" ], "xbrltype": "percentItemType" }, "cron_LongtermPurchaseCommitmentPaymentsSubjectToMilestones": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Long-term Purchase Commitment, Payments Subject To Milestones", "label": "Long-term Purchase Commitment, Payments Subject To Milestones", "terseLabel": "Payments subject to milestones" } } }, "localname": "LongtermPurchaseCommitmentPaymentsSubjectToMilestones", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/CommitmentsRDCommitmentsandAltriaConsultingServicesDetails" ], "xbrltype": "monetaryItemType" }, "cron_LossContingencyPunitiveDamagesSoughtValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Loss Contingency, Punitive Damages Sought, Value", "label": "Loss Contingency, Punitive Damages Sought, Value", "terseLabel": "Punitive damages sought" } } }, "localname": "LossContingencyPunitiveDamagesSoughtValue", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/ContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "cron_MeasurementInputSubscriptionPriceMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Measurement Input, Subscription Price [Member]", "label": "Measurement Input, Subscription Price [Member]", "terseLabel": "Subscription price (per share in C$)" } } }, "localname": "MeasurementInputSubscriptionPriceMember", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "cron_MedMenCanadaInc.Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "MedMen Canada Inc. [Member]", "label": "MedMen Canada Inc. [Member]", "terseLabel": "MedMen Canada" } } }, "localname": "MedMenCanadaInc.Member", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/InvestmentsandAdvancestoJointVenturesNarrativeDetails", "http://thecronosgroup.com/role/InvestmentsandAdvancestoJointVenturesScheduleofAdvancestoJointVenturesDetails", "http://thecronosgroup.com/role/InvestmentsandAdvancestoJointVenturesScheduleofEquityMethodInvestmentsDetails" ], "xbrltype": "domainItemType" }, "cron_MucciMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Mucci [Member]", "label": "Mucci [Member]", "terseLabel": "Mucci" } } }, "localname": "MucciMember", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/LoansReceivablenetDetails" ], "xbrltype": "domainItemType" }, "cron_NatuEraSeriesALoanMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "NatuEra Series A Loan [Member]", "label": "NatuEra Series A Loan [Member]", "terseLabel": "NatuEra Series A Loan" } } }, "localname": "NatuEraSeriesALoanMember", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/LoansReceivablenetDetails", "http://thecronosgroup.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "cron_NatueraMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Natuera [Member]", "label": "Natuera [Member]", "terseLabel": "Natuera" } } }, "localname": "NatueraMember", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/InvestmentsandAdvancestoJointVenturesNarrativeDetails", "http://thecronosgroup.com/role/InvestmentsandAdvancestoJointVenturesScheduleofAdvancestoJointVenturesDetails", "http://thecronosgroup.com/role/InvestmentsandAdvancestoJointVenturesScheduleofEquityMethodInvestmentsDetails", "http://thecronosgroup.com/role/LoansReceivablenetDetails", "http://thecronosgroup.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "cron_NoncashSellingAndMarketingExpense": { "auth_ref": [], "calculation": { "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Noncash Selling And Marketing Expense", "label": "Noncash Selling And Marketing Expense", "terseLabel": "Non-cash sales and marketing" } } }, "localname": "NoncashSellingAndMarketingExpense", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "cron_NonmonetaryTransactionNumberOfTransactions": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Nonmonetary Transaction, Number Of Transactions", "label": "Nonmonetary Transaction, Number Of Transactions", "terseLabel": "Number of transactions" } } }, "localname": "NonmonetaryTransactionNumberOfTransactions", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/NonmonetaryTransactionsDetails" ], "xbrltype": "integerItemType" }, "cron_NumberOfAdultuseBrands": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Number Of Adult-use Brands", "label": "Number Of Adult-use Brands", "terseLabel": "Number of adult-use brands" } } }, "localname": "NumberOfAdultuseBrands", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/BackgroundDetails" ], "xbrltype": "integerItemType" }, "cron_NumberOfContinentsWithInternationalProductionAndDistribution": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Number Of Continents With International Production And Distribution", "label": "Number Of Continents With International Production And Distribution", "terseLabel": "Number of continents with international production and distribution" } } }, "localname": "NumberOfContinentsWithInternationalProductionAndDistribution", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/BackgroundDetails" ], "xbrltype": "integerItemType" }, "cron_NumberOfHempDerivedPersonalCareBrands": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Number Of Hemp-derived Personal Care Brands", "label": "Number Of Hemp-derived Personal Care Brands", "terseLabel": "Number of hemp-derived cannabidiol personal care brands" } } }, "localname": "NumberOfHempDerivedPersonalCareBrands", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/BackgroundDetails" ], "xbrltype": "integerItemType" }, "cron_NumberOfStrategicJointVentures": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Number Of Strategic Joint Ventures", "label": "Number Of Strategic Joint Ventures", "terseLabel": "Number of strategic joint ventures" } } }, "localname": "NumberOfStrategicJointVentures", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/BackgroundDetails" ], "xbrltype": "integerItemType" }, "cron_OGBCReportingUnitMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "OGBC Reporting Unit [Member]", "label": "OGBC Reporting Unit [Member]", "terseLabel": "OGBC" } } }, "localname": "OGBCReportingUnitMember", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofGoodwillDetails" ], "xbrltype": "domainItemType" }, "cron_OfficeAndGeneralExpense": { "auth_ref": [], "calculation": { "http://thecronosgroup.com/role/GeneralandAdministrativeExpensesDetails": { "order": 3.0, "parentTag": "us-gaap_GeneralAndAdministrativeExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Office And General Expense", "label": "Office And General Expense", "terseLabel": "Office and general" } } }, "localname": "OfficeAndGeneralExpense", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/GeneralandAdministrativeExpensesDetails" ], "xbrltype": "monetaryItemType" }, "cron_OneMajorCustomerMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "One Major Customer [Member]", "label": "One Major Customer [Member]", "terseLabel": "One Major Customer" } } }, "localname": "OneMajorCustomerMember", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/SegmentInformationNarrativeDetails" ], "xbrltype": "domainItemType" }, "cron_OneVendorMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "One Vendor [Member]", "label": "One Vendor [Member]", "terseLabel": "One Vendor" } } }, "localname": "OneVendorMember", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/FinancialInstrumentsLiquidityRiskNarrativeDetails" ], "xbrltype": "domainItemType" }, "cron_OntarioCannabisRetailCorporationMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Ontario Cannabis Retail Corporation", "label": "Ontario Cannabis Retail Corporation [Member]", "terseLabel": "Ontario Cannabis Retail Corporation" } } }, "localname": "OntarioCannabisRetailCorporationMember", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/SegmentInformationNarrativeDetails" ], "xbrltype": "domainItemType" }, "cron_OtherCostOfGoodsAndServicesSold": { "auth_ref": [], "calculation": { "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeandComprehensiveIncomeLoss": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Other Cost Of Goods And Services Sold", "label": "Other Cost Of Goods And Services Sold", "terseLabel": "Cost of sales" } } }, "localname": "OtherCostOfGoodsAndServicesSold", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeandComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "cron_OtherCountriesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Other Countries [Member]", "label": "Other Countries [Member]", "terseLabel": "Other countries" } } }, "localname": "OtherCountriesMember", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/SegmentInformationScheduleofLonglivedAssetsbyGeographicAreasDetails", "http://thecronosgroup.com/role/SegmentInformationScheduleofRevenuefromExternalCustomersbyGeographicAreasDetails" ], "xbrltype": "domainItemType" }, "cron_PaymentsForLeaseObligationsFinancingActivities": { "auth_ref": [], "calculation": { "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Payments For Lease Obligations, Financing Activities", "label": "Payments For Lease Obligations, Financing Activities", "negatedTerseLabel": "Repayment of lease obligations" } } }, "localname": "PaymentsForLeaseObligationsFinancingActivities", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "cron_PeaceNaturalsReportingUnitMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Peace Naturals Reporting Unit [Member]", "label": "Peace Naturals Reporting Unit [Member]", "terseLabel": "Peace Naturals" } } }, "localname": "PeaceNaturalsReportingUnitMember", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofGoodwillDetails" ], "xbrltype": "domainItemType" }, "cron_PreEmptiveRightsAndTopUpRightsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Pre-Emptive Rights And Top-Up Rights", "label": "Pre-Emptive Rights And Top-Up Rights [Member]", "terseLabel": "Pre-emptive Rights and Top-up Rights" } } }, "localname": "PreEmptiveRightsAndTopUpRightsMember", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "cron_PreemptiveRightsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Pre-emptive Rights [Member]", "label": "Pre-emptive Rights [Member]", "terseLabel": "Pre-emptive Rights", "verboseLabel": "Pre-emptive Rights" } } }, "localname": "PreemptiveRightsMember", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails", "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails", "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofReconciliationofCarryingAmountsDetails", "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofSensitivityAnalysisDetails", "http://thecronosgroup.com/role/EarningslossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofDilutedSharesOutstandingDetails" ], "xbrltype": "domainItemType" }, "cron_ProceedsFromEquitySecuritiesFVNIAndEquitySecuritiesWithoutDeterminableFairValue": { "auth_ref": [], "calculation": { "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Proceeds From Equity Securities, FV-NI And Equity Securities Without Determinable Fair Value", "label": "Proceeds From Equity Securities, FV-NI And Equity Securities Without Determinable Fair Value", "terseLabel": "Proceeds from sale of other investments" } } }, "localname": "ProceedsFromEquitySecuritiesFVNIAndEquitySecuritiesWithoutDeterminableFairValue", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "cron_ProceedsFromRightExercises": { "auth_ref": [], "calculation": { "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Proceeds From Right Exercises", "label": "Proceeds From Right Exercises", "terseLabel": "Proceeds from exercise of Top-up Rights" } } }, "localname": "ProceedsFromRightExercises", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "cron_ProceedsFromSaleOfEquitySecuritiesFVNI": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Proceeds From Sale Of Equity Securities, FV-NI", "label": "Proceeds From Sale Of Equity Securities, FV-NI", "terseLabel": "Proceeds from sale of equity securities, FV-NI" } } }, "localname": "ProceedsFromSaleOfEquitySecuritiesFVNI", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/OtherInvestmentsDetails" ], "xbrltype": "monetaryItemType" }, "cron_ProceedsFromWarrantExercisesAndStockOptionsExercised": { "auth_ref": [], "calculation": { "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Proceeds From Warrant Exercises And Stock Options Exercised", "label": "Proceeds From Warrant Exercises And Stock Options Exercised", "terseLabel": "Proceeds from exercise of warrants and options" } } }, "localname": "ProceedsFromWarrantExercisesAndStockOptionsExercised", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "cron_ProfessionalAndConsultingExpense": { "auth_ref": [], "calculation": { "http://thecronosgroup.com/role/GeneralandAdministrativeExpensesDetails": { "order": 2.0, "parentTag": "us-gaap_GeneralAndAdministrativeExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Professional And Consulting Expense", "label": "Professional And Consulting Expense", "terseLabel": "Professional and consulting" } } }, "localname": "ProfessionalAndConsultingExpense", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/GeneralandAdministrativeExpensesDetails" ], "xbrltype": "monetaryItemType" }, "cron_PurchaseOfMachineryAndEquipmentMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Purchase Of Machinery And Equipment [Member]", "label": "Purchase Of Machinery And Equipment [Member]", "terseLabel": "Purchase of Machinery and Equipment" } } }, "localname": "PurchaseOfMachineryAndEquipmentMember", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/RelatedPartyTransactionsandBalancesDetails" ], "xbrltype": "domainItemType" }, "cron_RecordedUnconditionalPurchaseObligationTermOfAgreement": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Recorded Unconditional Purchase Obligation, Term Of Agreement", "label": "Recorded Unconditional Purchase Obligation, Term Of Agreement", "terseLabel": "Take or pay supply agreement, term of agreement" } } }, "localname": "RecordedUnconditionalPurchaseObligationTermOfAgreement", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/CommitmentsTakeorPayDetails" ], "xbrltype": "durationItemType" }, "cron_RedwoodHoldingGroupLLCMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Redwood Holding Group, LLC [Member]", "label": "Redwood Holding Group, LLC [Member]", "terseLabel": "Redwood" } } }, "localname": "RedwoodHoldingGroupLLCMember", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/SharebasedPaymentsRestrictedShareUnitsNarrativeDetails" ], "xbrltype": "domainItemType" }, "cron_RedwoodReportingUnitMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Redwood Reporting Unit [Member]", "label": "Redwood Reporting Unit [Member]", "terseLabel": "Redwood" } } }, "localname": "RedwoodReportingUnitMember", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofGoodwillDetails" ], "xbrltype": "domainItemType" }, "cron_RestOfWorldSegmentMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Rest Of World Segment [Member]", "label": "Rest Of World Segment [Member]", "terseLabel": "Rest of World" } } }, "localname": "RestOfWorldSegmentMember", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/SegmentInformationNarrativeDetails", "http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails" ], "xbrltype": "domainItemType" }, "cron_RestatementReviewExpense": { "auth_ref": [], "calculation": { "http://thecronosgroup.com/role/GeneralandAdministrativeExpensesDetails": { "order": 5.0, "parentTag": "us-gaap_GeneralAndAdministrativeExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Restatement Review Expense", "label": "Restatement Review Expense", "verboseLabel": "Review costs related to restatement of 2019 interim financial statements" } } }, "localname": "RestatementReviewExpense", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/GeneralandAdministrativeExpensesDetails" ], "xbrltype": "monetaryItemType" }, "cron_SaleOfStockPerformanceMilestoneAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Sale Of Stock, Performance Milestone", "label": "Sale Of Stock, Performance Milestone [Axis]", "terseLabel": "Sale Of Stock, Performance Milestone [Axis]" } } }, "localname": "SaleOfStockPerformanceMilestoneAxis", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/CommitmentsUseofPublicityRightsinBrandDevelopmentDetails" ], "xbrltype": "stringItemType" }, "cron_SaleOfStockPerformanceMilestoneDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Sale Of Stock, Performance Milestone", "label": "Sale Of Stock, Performance Milestone [Domain]", "terseLabel": "Sale Of Stock, Performance Milestone [Domain]" } } }, "localname": "SaleOfStockPerformanceMilestoneDomain", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/CommitmentsUseofPublicityRightsinBrandDevelopmentDetails" ], "xbrltype": "domainItemType" }, "cron_SaleOfStockPerformanceMilestoneOneMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Sale Of Stock, Performance Milestone One", "label": "Sale Of Stock, Performance Milestone One [Member]", "terseLabel": "Sale of Stock, Performance Milestone One" } } }, "localname": "SaleOfStockPerformanceMilestoneOneMember", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/CommitmentsUseofPublicityRightsinBrandDevelopmentDetails" ], "xbrltype": "domainItemType" }, "cron_SaleOfStockPerformanceMilestoneTriggeringEventMinimumRevenue": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Sale Of Stock, Performance Milestone, Triggering Event, Minimum Revenue", "label": "Sale Of Stock, Performance Milestone, Triggering Event, Minimum Revenue", "terseLabel": "Triggering event, minimum revenue" } } }, "localname": "SaleOfStockPerformanceMilestoneTriggeringEventMinimumRevenue", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/CommitmentsUseofPublicityRightsinBrandDevelopmentDetails" ], "xbrltype": "monetaryItemType" }, "cron_SaleOfStockPerformanceMilestoneTriggeringEventSharesIssuedValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Sale Of Stock, Performance Milestone, Triggering Event, Shares Issued, Value", "label": "Sale Of Stock, Performance Milestone, Triggering Event, Shares Issued, Value", "terseLabel": "Triggering event, shares issued, value" } } }, "localname": "SaleOfStockPerformanceMilestoneTriggeringEventSharesIssuedValue", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/CommitmentsUseofPublicityRightsinBrandDevelopmentDetails" ], "xbrltype": "monetaryItemType" }, "cron_SaleOfStockPerformanceMilestoneTwoMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Sale Of Stock, Performance Milestone Two", "label": "Sale Of Stock, Performance Milestone Two [Member]", "terseLabel": "Sale of Stock, Performance Milestone Two" } } }, "localname": "SaleOfStockPerformanceMilestoneTwoMember", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/CommitmentsUseofPublicityRightsinBrandDevelopmentDetails" ], "xbrltype": "domainItemType" }, "cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Sensitivity Analysis, Impact Of 10 Percent Decrease (Increase) In Expected Annualized Volatility On Net Income (Loss)", "label": "Sensitivity Analysis, Impact Of 10 Percent Decrease (Increase) In Expected Annualized Volatility On Net Income (Loss)", "terseLabel": "Expected annualized volatility" } } }, "localname": "SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofSensitivityAnalysisDetails" ], "xbrltype": "monetaryItemType" }, "cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Sensitivity Analysis, Impact Of 10 Percent Decrease (Increase) In Share Price On Net Income (Loss)", "label": "Sensitivity Analysis, Impact Of 10 Percent Decrease (Increase) In Share Price On Net Income (Loss)", "terseLabel": "Share price" } } }, "localname": "SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofSensitivityAnalysisDetails" ], "xbrltype": "monetaryItemType" }, "cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Sensitivity Analysis, Impact Of 10 Percent Decrease (Increase) In Weighted Average Expected Life On Net Income (Loss)", "label": "Sensitivity Analysis, Impact Of 10 Percent Decrease (Increase) In Weighted Average Expected Life On Net Income (Loss)", "terseLabel": "Weighted average expected life" } } }, "localname": "SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofSensitivityAnalysisDetails" ], "xbrltype": "monetaryItemType" }, "cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseOnNetIncomeLossAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Sensitivity Analysis, Impact Of 10 Percent Decrease (Increase) On Net Income (Loss) [Abstract]", "label": "Sensitivity Analysis, Impact Of 10 Percent Decrease (Increase) On Net Income (Loss) [Abstract]", "terseLabel": "Sensitivity Analysis, Impact of 10 Percent Decrease (Increase) on Net Income (Loss) [Abstract]" } } }, "localname": "SensitivityAnalysisImpactOf10PercentDecreaseIncreaseOnNetIncomeLossAbstract", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofSensitivityAnalysisDetails" ], "xbrltype": "stringItemType" }, "cron_SensitivityAnalysisImpactOnNetIncomeLossTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Sensitivity Analysis, Impact On Net Income (Loss) [Table Text Block]", "label": "Sensitivity Analysis, Impact On Net Income (Loss) [Table Text Block]", "terseLabel": "Schedule of Sensitivity Analysis" } } }, "localname": "SensitivityAnalysisImpactOnNetIncomeLossTableTextBlock", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/DerivativeLiabilitiesTables" ], "xbrltype": "textBlockItemType" }, "cron_SensitivityAnalysisOfCarryingValueNetAssetsImpactOf10PercentChangeInExchangeRate": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Sensitivity Analysis Of Carrying Value, Net Assets, Impact Of 10 Percent Change In Exchange Rate", "label": "Sensitivity Analysis Of Carrying Value, Net Assets, Impact Of 10 Percent Change In Exchange Rate", "terseLabel": "Impact of ten percent change in exchange rate" } } }, "localname": "SensitivityAnalysisOfCarryingValueNetAssetsImpactOf10PercentChangeInExchangeRate", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/FinancialInstrumentsCurrencyRateRiskNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "cron_SensitivityAnalysisOfInterestRateRiskIncomeStatementImpactImpactOfChangeInAverageVariableRateOnInterestIncome": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Sensitivity Analysis Of Interest Rate Risk Income Statement Impact, Impact Of Change In Average Variable Rate On Interest Income", "label": "Sensitivity Analysis Of Interest Rate Risk Income Statement Impact, Impact Of Change In Average Variable Rate On Interest Income", "terseLabel": "Impact of change in average variable rate, amount" } } }, "localname": "SensitivityAnalysisOfInterestRateRiskIncomeStatementImpactImpactOfChangeInAverageVariableRateOnInterestIncome", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/FinancialInstrumentsInterestRateRiskNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "cron_SensitivityAnalysisOfInterestRateRiskIncomeStatementImpactImpactOfChangeInAverageVariableRateOnInterestIncomePercent": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Sensitivity Analysis Of Interest Rate Risk Income Statement Impact, Impact Of Change In Average Variable Rate On Interest Income, Percent", "label": "Sensitivity Analysis Of Interest Rate Risk Income Statement Impact, Impact Of Change In Average Variable Rate On Interest Income, Percent", "terseLabel": "Impact of change in average variable rate, percent" } } }, "localname": "SensitivityAnalysisOfInterestRateRiskIncomeStatementImpactImpactOfChangeInAverageVariableRateOnInterestIncomePercent", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/FinancialInstrumentsInterestRateRiskNarrativeDetails" ], "xbrltype": "percentItemType" }, "cron_ShareBasedPaymentArrangementGainLossOnRevaluation": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Share-based Payment Arrangement, Gain (Loss) On Revaluation", "label": "Share-based Payment Arrangement, Gain (Loss) On Revaluation", "negatedTerseLabel": "Loss (gain) on revaluation" } } }, "localname": "ShareBasedPaymentArrangementGainLossOnRevaluation", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofDeferredShareUnitsActivityDetails" ], "xbrltype": "monetaryItemType" }, "cron_ShareBasedPaymentArrangementLiabilitiesSettled": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Share-based Payment Arrangement, Liabilities Settled", "label": "Share-based Payment Arrangement, Liabilities Settled", "negatedTerseLabel": "Liabilities settled" } } }, "localname": "ShareBasedPaymentArrangementLiabilitiesSettled", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofDeferredShareUnitsActivityDetails" ], "xbrltype": "monetaryItemType" }, "cron_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsNumberOfCommonSharesPerAward": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Share-based Compensation Arrangement By Share-based Payment Award, Award Vesting Rights, Number Of Common Shares Per Award", "label": "Share-based Compensation Arrangement By Share-based Payment Award, Award Vesting Rights, Number Of Common Shares Per Award", "terseLabel": "Vesting rights, number of common shares per award" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsNumberOfCommonSharesPerAward", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/SharebasedPaymentsRestrictedShareUnitsNarrativeDetails" ], "xbrltype": "pureItemType" }, "cron_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsForfeitureRate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Share-based Compensation Arrangement By Share-based Payment Award, Fair Value Assumptions, Forfeiture Rate", "label": "Share-based Compensation Arrangement By Share-based Payment Award, Fair Value Assumptions, Forfeiture Rate", "terseLabel": "Forfeiture rate" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsForfeitureRate", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofFairValueofOptionsIssuedDetails" ], "xbrltype": "percentItemType" }, "cron_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Share-based Compensation Arrangement By Share-based Payment Award, Fair Value Assumptions, Weighted Average Grant Date Fair Value", "label": "Share-based Compensation Arrangement By Share-based Payment Award, Fair Value Assumptions, Weighted Average Grant Date Fair Value", "terseLabel": "Weighted average Black-Scholes value at grant date (per option) (in dollars per share)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsWeightedAverageGrantDateFairValue", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofFairValueofOptionsIssuedDetails" ], "xbrltype": "perShareItemType" }, "cron_SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsExercisesInPeriod": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Share-based Compensation Arrangement By Share-based Payment Award, Warrants, Exercises In Period", "label": "Share-based Compensation Arrangement By Share-based Payment Award, Warrants, Exercises In Period", "terseLabel": "Warrants exercised (in shares)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsExercisesInPeriod", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofChangesinEquityDeficit" ], "xbrltype": "sharesItemType" }, "cron_SocieteQuebecoiseDuCannabisMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Societe Quebecoise du Cannabis", "label": "Societe Quebecoise du Cannabis [Member]", "terseLabel": "Societe Quebecoise Du Cannabis" } } }, "localname": "SocieteQuebecoiseDuCannabisMember", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/SegmentInformationNarrativeDetails" ], "xbrltype": "domainItemType" }, "cron_StockIssuedDuringPeriodNewIssuesFairValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Stock Issued During Period, New Issues, Fair Value", "label": "Stock Issued During Period, New Issues, Fair Value", "terseLabel": "Stock issued during period, new issues, fair value" } } }, "localname": "StockIssuedDuringPeriodNewIssuesFairValue", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/CommitmentsUseofPublicityRightsinBrandDevelopmentDetails" ], "xbrltype": "monetaryItemType" }, "cron_StockIssuedDuringPeriodNewIssuesWeightedAveragePricePeriod": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Stock Issued During Period, New Issues, Weighted Average Price, Period", "label": "Stock Issued During Period, New Issues, Weighted Average Price, Period", "terseLabel": "Stock issued during period, new issues, measurement input" } } }, "localname": "StockIssuedDuringPeriodNewIssuesWeightedAveragePricePeriod", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/CommitmentsUseofPublicityRightsinBrandDevelopmentDetails", "http://thecronosgroup.com/role/OtherInvestmentsDetails" ], "xbrltype": "decimalItemType" }, "cron_StockIssuedDuringPeriodSharesTopupRightsExercised": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Stock Issued During Period, Shares, Top-up Rights Exercised", "label": "Stock Issued During Period, Shares, Top-up Rights Exercised", "terseLabel": "Top-up rights exercised (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesTopupRightsExercised", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofChangesinEquityDeficit" ], "xbrltype": "sharesItemType" }, "cron_StockIssuedDuringPeriodValueNewIssuesIssuanceCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Stock Issued During Period, Value, New Issues, Issuance Costs", "label": "Stock Issued During Period, Value, New Issues, Issuance Costs", "negatedTerseLabel": "Share issuance costs" } } }, "localname": "StockIssuedDuringPeriodValueNewIssuesIssuanceCosts", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofChangesinEquityDeficit" ], "xbrltype": "monetaryItemType" }, "cron_StockIssuedDuringPeriodValueTopupRightsExercised": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Stock Issued During Period, Value, Top-up Rights Exercised", "label": "Stock Issued During Period, Value, Top-up Rights Exercised", "terseLabel": "Top-up rights exercised" } } }, "localname": "StockIssuedDuringPeriodValueTopupRightsExercised", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofChangesinEquityDeficit" ], "xbrltype": "monetaryItemType" }, "cron_StockIssuedDuringPeriodValueWarrantsExercised": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Stock Issued During Period, Value, Warrants Exercised", "label": "Stock Issued During Period, Value, Warrants Exercised", "terseLabel": "Warrants exercised" } } }, "localname": "StockIssuedDuringPeriodValueWarrantsExercised", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofChangesinEquityDeficit" ], "xbrltype": "monetaryItemType" }, "cron_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactionsIfWarrantsExercised": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Subsidiary Or Equity Method Investee, Cumulative Percentage Ownership After All Transactions, If Warrants Exercised", "label": "Subsidiary Or Equity Method Investee, Cumulative Percentage Ownership After All Transactions, If Warrants Exercised", "terseLabel": "Ownership percentage, if warrant exercised" } } }, "localname": "SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactionsIfWarrantsExercised", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails" ], "xbrltype": "percentItemType" }, "cron_TechnionResearchAndDevelopmentFoundationMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Technion Research And Development Foundation [Member]", "label": "Technion Research And Development Foundation [Member]", "terseLabel": "Technion" } } }, "localname": "TechnionResearchAndDevelopmentFoundationMember", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/CommitmentsRDCommitmentsandAltriaConsultingServicesDetails" ], "xbrltype": "domainItemType" }, "cron_ThreeVendorsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Three Vendors [Member]", "label": "Three Vendors [Member]", "terseLabel": "Three Vendors" } } }, "localname": "ThreeVendorsMember", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/FinancialInstrumentsLiquidityRiskNarrativeDetails" ], "xbrltype": "domainItemType" }, "cron_TopUpRightsFixedPriceMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Top-Up Rights - Fixed Price [Member]", "label": "Top-Up Rights - Fixed Price [Member]", "terseLabel": "Top-up Rights \u2013 fixed price" } } }, "localname": "TopUpRightsFixedPriceMember", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/EarningslossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofDilutedSharesOutstandingDetails" ], "xbrltype": "domainItemType" }, "cron_TopUpRightsMarketPriceMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Top-Up Rights - Market Price [Member]", "label": "Top-Up Rights - Market Price [Member]", "terseLabel": "Top-up Rights \u2013 market price" } } }, "localname": "TopUpRightsMarketPriceMember", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/EarningslossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofDilutedSharesOutstandingDetails" ], "xbrltype": "domainItemType" }, "cron_TopupRightsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Top-up Rights [Member]", "label": "Top-up Rights [Member]", "verboseLabel": "Top-up Rights" } } }, "localname": "TopupRightsMember", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails", "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails", "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofReconciliationofCarryingAmountsDetails", "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofSensitivityAnalysisDetails", "http://thecronosgroup.com/role/EarningslossPerShareScheduleofEarningsLossPerShareDetails" ], "xbrltype": "domainItemType" }, "cron_TwoCustomersMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two Customers", "label": "Two Customers [Member]", "terseLabel": "Two Customers" } } }, "localname": "TwoCustomersMember", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskNarrativeDetails" ], "xbrltype": "domainItemType" }, "cron_TwoMajorCustomersMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two Major Customers [Member]", "label": "Two Major Customers [Member]", "terseLabel": "Two Major Customers" } } }, "localname": "TwoMajorCustomersMember", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/SegmentInformationNarrativeDetails" ], "xbrltype": "domainItemType" }, "cron_USDistrictCourtOfEasternDistrictOfNewYorkVsCronosMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "U.S. District Court of Eastern District of New York Vs. Cronos", "label": "U.S. District Court of Eastern District of New York Vs. Cronos [Member]", "terseLabel": "U.S. District Court of Eastern District of New York Vs. Cronos" } } }, "localname": "USDistrictCourtOfEasternDistrictOfNewYorkVsCronosMember", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/ContingenciesDetails" ], "xbrltype": "domainItemType" }, "cron_UnitedStatesSegmentMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "United States Segment [Member]", "label": "United States Segment [Member]", "terseLabel": "United States" } } }, "localname": "UnitedStatesSegmentMember", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillNarrativeDetails", "http://thecronosgroup.com/role/SegmentInformationNarrativeDetails", "http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails" ], "xbrltype": "domainItemType" }, "cron_VariableInterestEntityQualitativeOrQuantitativeInformationLicenseTerm": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Variable Interest Entity, Qualitative Or Quantitative Information, License Term", "label": "Variable Interest Entity, Qualitative Or Quantitative Information, License Term", "terseLabel": "License term" } } }, "localname": "VariableInterestEntityQualitativeOrQuantitativeInformationLicenseTerm", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/InvestmentsandAdvancestoJointVenturesNarrativeDetails" ], "xbrltype": "durationItemType" }, "cron_WhistlerMedicalMarijuanaCompanyMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Whistler Medical Marijuana Company [Member]", "label": "Whistler Medical Marijuana Company [Member]", "terseLabel": "Whistler" } } }, "localname": "WhistlerMedicalMarijuanaCompanyMember", "nsuri": "http://thecronosgroup.com/20200630", "presentation": [ "http://thecronosgroup.com/role/InvestmentsandAdvancestoJointVenturesScheduleofEquityMethodInvestmentsDetails", "http://thecronosgroup.com/role/OtherInvestmentsDetails" ], "xbrltype": "domainItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover page." } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CoverPage" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CoverPage" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CoverPage" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CoverPage" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r451" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report", "terseLabel": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r452" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report", "terseLabel": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CoverPage" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CoverPage" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r453" ], "lang": { "en-US": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CoverPage" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding (in shares)" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CoverPage" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.", "label": "Entity [Domain]", "terseLabel": "Entity [Domain]" } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails", "http://thecronosgroup.com/role/InvestmentsandAdvancestoJointVenturesScheduleofEquityMethodInvestmentsDetails", "http://thecronosgroup.com/role/LoansReceivablenetDetails", "http://thecronosgroup.com/role/RelatedPartyTransactionsandBalancesDetails", "http://thecronosgroup.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r453" ], "lang": { "en-US": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CoverPage" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r453" ], "lang": { "en-US": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CoverPage" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CoverPage" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r454" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r453" ], "lang": { "en-US": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r453" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r453" ], "lang": { "en-US": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Legal Entity [Axis]", "terseLabel": "Legal Entity [Axis]" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails", "http://thecronosgroup.com/role/InvestmentsandAdvancestoJointVenturesScheduleofEquityMethodInvestmentsDetails", "http://thecronosgroup.com/role/LoansReceivablenetDetails", "http://thecronosgroup.com/role/RelatedPartyTransactionsandBalancesDetails", "http://thecronosgroup.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r449" ], "lang": { "en-US": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CoverPage" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r450" ], "lang": { "en-US": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CoverPage" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CoverPage" ], "xbrltype": "tradingSymbolItemType" }, "srt_AffiliatedEntityMember": { "auth_ref": [ "r253", "r374", "r375", "r447" ], "lang": { "en-US": { "role": { "label": "Affiliated Entity [Member]", "terseLabel": "Affiliated Entity" } } }, "localname": "AffiliatedEntityMember", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/RelatedPartyTransactionsandBalancesDetails" ], "xbrltype": "domainItemType" }, "srt_ConsolidatedEntitiesAxis": { "auth_ref": [ "r447" ], "lang": { "en-US": { "role": { "label": "Consolidated Entities [Axis]", "terseLabel": "Consolidated Entities [Axis]" } } }, "localname": "ConsolidatedEntitiesAxis", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails", "http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "srt_ConsolidatedEntitiesDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Consolidated Entities [Domain]", "terseLabel": "Consolidated Entities [Domain]" } } }, "localname": "ConsolidatedEntitiesDomain", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails", "http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "srt_ConsolidationItemsAxis": { "auth_ref": [ "r144", "r154" ], "lang": { "en-US": { "role": { "label": "Consolidation Items [Axis]", "terseLabel": "Consolidation Items [Axis]" } } }, "localname": "ConsolidationItemsAxis", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails" ], "xbrltype": "stringItemType" }, "srt_ConsolidationItemsDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Consolidation Items [Domain]", "terseLabel": "Consolidation Items [Domain]" } } }, "localname": "ConsolidationItemsDomain", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails" ], "xbrltype": "domainItemType" }, "srt_CounterpartyNameAxis": { "auth_ref": [ "r51", "r112" ], "lang": { "en-US": { "role": { "label": "Counterparty Name [Axis]", "terseLabel": "Counterparty Name [Axis]" } } }, "localname": "CounterpartyNameAxis", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CommitmentsRDCommitmentsandAltriaConsultingServicesDetails", "http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskNarrativeDetails", "http://thecronosgroup.com/role/FinancialInstrumentsLiquidityRiskNarrativeDetails", "http://thecronosgroup.com/role/RelatedPartyTransactionsandBalancesDetails" ], "xbrltype": "stringItemType" }, "srt_EquityMethodInvesteeNameDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Investment, Name [Domain]", "terseLabel": "Investment, Name [Domain]" } } }, "localname": "EquityMethodInvesteeNameDomain", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/BackgroundDetails", "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails", "http://thecronosgroup.com/role/InvestmentsandAdvancestoJointVenturesNarrativeDetails", "http://thecronosgroup.com/role/InvestmentsandAdvancestoJointVenturesScheduleofAdvancestoJointVenturesDetails", "http://thecronosgroup.com/role/InvestmentsandAdvancestoJointVenturesScheduleofEquityMethodInvestmentsDetails", "http://thecronosgroup.com/role/LoansReceivablenetDetails", "http://thecronosgroup.com/role/OtherInvestmentsDetails", "http://thecronosgroup.com/role/RelatedPartyTransactionsandBalancesDetails" ], "xbrltype": "domainItemType" }, "srt_LitigationCaseAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Litigation Case [Axis]", "terseLabel": "Litigation Case [Axis]" } } }, "localname": "LitigationCaseAxis", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/ContingenciesDetails" ], "xbrltype": "stringItemType" }, "srt_LitigationCaseTypeDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Litigation Case [Domain]", "terseLabel": "Litigation Case [Domain]" } } }, "localname": "LitigationCaseTypeDomain", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/ContingenciesDetails" ], "xbrltype": "domainItemType" }, "srt_MajorCustomersAxis": { "auth_ref": [ "r162", "r245", "r249", "r432" ], "lang": { "en-US": { "role": { "label": "Customer [Axis]", "terseLabel": "Customer [Axis]" } } }, "localname": "MajorCustomersAxis", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SegmentInformationNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_MaximumMember": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Maximum [Member]", "terseLabel": "Maximum" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CommitmentsTakeorPayDetails", "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails", "http://thecronosgroup.com/role/LeasesDetails", "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofFairValueofOptionsIssuedDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Minimum [Member]", "terseLabel": "Minimum" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CommitmentsTakeorPayDetails", "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails", "http://thecronosgroup.com/role/InvestmentsandAdvancestoJointVenturesNarrativeDetails", "http://thecronosgroup.com/role/LeasesDetails", "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofFairValueofOptionsIssuedDetails" ], "xbrltype": "domainItemType" }, "srt_NameOfMajorCustomerDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Customer [Domain]", "terseLabel": "Customer [Domain]" } } }, "localname": "NameOfMajorCustomerDomain", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SegmentInformationNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_OwnershipAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Ownership [Axis]", "terseLabel": "Ownership [Axis]" } } }, "localname": "OwnershipAxis", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/LoansReceivablenetDetails" ], "xbrltype": "stringItemType" }, "srt_OwnershipDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Ownership [Domain]", "terseLabel": "Ownership [Domain]" } } }, "localname": "OwnershipDomain", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/LoansReceivablenetDetails" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r157", "r245", "r247", "r429", "r430" ], "lang": { "en-US": { "role": { "label": "Product and Service [Axis]", "terseLabel": "Product and Service [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Product and Service [Domain]", "terseLabel": "Product and Service [Domain]" } } }, "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statistical Measurement [Axis]", "terseLabel": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CommitmentsTakeorPayDetails", "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails", "http://thecronosgroup.com/role/InvestmentsandAdvancestoJointVenturesNarrativeDetails", "http://thecronosgroup.com/role/LeasesDetails", "http://thecronosgroup.com/role/SharebasedPaymentsStockOptionsNarrativeDetails", "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofFairValueofOptionsIssuedDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statistical Measurement [Domain]", "terseLabel": "Statistical Measurement [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CommitmentsTakeorPayDetails", "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails", "http://thecronosgroup.com/role/InvestmentsandAdvancestoJointVenturesNarrativeDetails", "http://thecronosgroup.com/role/LeasesDetails", "http://thecronosgroup.com/role/SharebasedPaymentsStockOptionsNarrativeDetails", "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofFairValueofOptionsIssuedDetails" ], "xbrltype": "domainItemType" }, "srt_RepurchaseAgreementCounterpartyNameDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Counterparty Name [Domain]", "terseLabel": "Counterparty Name [Domain]" } } }, "localname": "RepurchaseAgreementCounterpartyNameDomain", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CommitmentsRDCommitmentsandAltriaConsultingServicesDetails", "http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskNarrativeDetails", "http://thecronosgroup.com/role/FinancialInstrumentsLiquidityRiskNarrativeDetails", "http://thecronosgroup.com/role/RelatedPartyTransactionsandBalancesDetails" ], "xbrltype": "domainItemType" }, "srt_ScenarioForecastMember": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Forecast [Member]", "terseLabel": "Forecast" } } }, "localname": "ScenarioForecastMember", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CommitmentsUseofPublicityRightsinBrandDevelopmentDetails", "http://thecronosgroup.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "srt_ScenarioUnspecifiedDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Scenario [Domain]", "terseLabel": "Scenario [Domain]" } } }, "localname": "ScenarioUnspecifiedDomain", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CommitmentsUseofPublicityRightsinBrandDevelopmentDetails", "http://thecronosgroup.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": { "auth_ref": [ "r175" ], "lang": { "en-US": { "role": { "label": "Investment, Name [Axis]", "terseLabel": "Investment, Name [Axis]" } } }, "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/BackgroundDetails", "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails", "http://thecronosgroup.com/role/InvestmentsandAdvancestoJointVenturesNarrativeDetails", "http://thecronosgroup.com/role/InvestmentsandAdvancestoJointVenturesScheduleofAdvancestoJointVenturesDetails", "http://thecronosgroup.com/role/InvestmentsandAdvancestoJointVenturesScheduleofEquityMethodInvestmentsDetails", "http://thecronosgroup.com/role/LoansReceivablenetDetails", "http://thecronosgroup.com/role/OtherInvestmentsDetails", "http://thecronosgroup.com/role/RelatedPartyTransactionsandBalancesDetails" ], "xbrltype": "stringItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Geographical [Domain]", "terseLabel": "Geographical [Domain]" } } }, "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SegmentInformationScheduleofLonglivedAssetsbyGeographicAreasDetails", "http://thecronosgroup.com/role/SegmentInformationScheduleofRevenuefromExternalCustomersbyGeographicAreasDetails" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [ "r161", "r245", "r248", "r431", "r445", "r446" ], "lang": { "en-US": { "role": { "label": "Geographical [Axis]", "terseLabel": "Geographical [Axis]" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SegmentInformationScheduleofLonglivedAssetsbyGeographicAreasDetails", "http://thecronosgroup.com/role/SegmentInformationScheduleofRevenuefromExternalCustomersbyGeographicAreasDetails" ], "xbrltype": "stringItemType" }, "srt_StatementScenarioAxis": { "auth_ref": [ "r229", "r381" ], "lang": { "en-US": { "role": { "label": "Scenario [Axis]", "terseLabel": "Scenario [Axis]" } } }, "localname": "StatementScenarioAxis", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CommitmentsUseofPublicityRightsinBrandDevelopmentDetails", "http://thecronosgroup.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "srt_SubsidiariesMember": { "auth_ref": [ "r253", "r374", "r375" ], "lang": { "en-US": { "role": { "label": "Subsidiaries [Member]", "terseLabel": "Cronos Group, Inc." } } }, "localname": "SubsidiariesMember", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_WeightedAverageMember": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Weighted Average [Member]", "terseLabel": "Weighted Average" } } }, "localname": "WeightedAverageMember", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails", "http://thecronosgroup.com/role/SharebasedPaymentsStockOptionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Accounting Policies [Abstract]", "terseLabel": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_AccountingStandardsUpdate201601Member": { "auth_ref": [ "r351" ], "lang": { "en-US": { "role": { "documentation": "Accounting Standards Update 2016-01 Financial Instruments-Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities.", "label": "Accounting Standards Update 2016-01 [Member]", "terseLabel": "Accounting Standards Update 2016-01" } } }, "localname": "AccountingStandardsUpdate201601Member", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsNotesAndLoansReceivableLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Accounts, Notes, Loans and Financing Receivable [Line Items]", "terseLabel": "Accounts, Notes, Loans and Financing Receivable [Line Items]" } } }, "localname": "AccountsNotesAndLoansReceivableLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/LoansReceivablenetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis": { "auth_ref": [ "r44" ], "lang": { "en-US": { "role": { "documentation": "Information by type of receivable.", "label": "Receivable Type [Axis]", "terseLabel": "Receivable Type [Axis]" } } }, "localname": "AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/InvestmentsandAdvancestoJointVenturesNarrativeDetails", "http://thecronosgroup.com/role/LoansReceivablenetDetails", "http://thecronosgroup.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent": { "auth_ref": [], "calculation": { "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer.", "label": "Accounts Payable and Other Accrued Liabilities, Current", "terseLabel": "Accounts payable and other liabilities" } } }, "localname": "AccountsPayableAndOtherAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsPayableMember": { "auth_ref": [ "r10" ], "lang": { "en-US": { "role": { "documentation": "Obligations incurred and payable to vendors for goods and services received.", "label": "Accounts Payable [Member]", "terseLabel": "Accounts Payable" } } }, "localname": "AccountsPayableMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/FinancialInstrumentsLiquidityRiskNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsPayableRelatedPartiesCurrent": { "auth_ref": [ "r37", "r115", "r374", "r375", "r376" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount for accounts payable to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable, Related Parties, Current", "terseLabel": "Accrual for consulting services" } } }, "localname": "AccountsPayableRelatedPartiesCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/RelatedPartyTransactionsandBalancesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Due from customers or clients for goods or services that have been delivered or sold.", "label": "Accounts Receivable [Member]", "terseLabel": "Accounts Receivable" } } }, "localname": "AccountsReceivableMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r4", "r18", "r164", "r165", "r246" ], "calculation": { "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "verboseLabel": "Accounts receivable" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets", "http://thecronosgroup.com/role/RevenuesfromContractswithCustomersDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDueWriteoff": { "auth_ref": [ "r183" ], "lang": { "en-US": { "role": { "documentation": "Threshold period for when accounts receivable, classified as noncurrent, is considered past due to write off as uncollectible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Accounts Receivable, Noncurrent, Threshold Period Past Due, Writeoff", "terseLabel": "Accounts receivable, threshold period past due, writeoff" } } }, "localname": "AccountsReceivableNoncurrentThresholdPeriodPastDueWriteoff", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r36", "r219" ], "calculation": { "http://thecronosgroup.com/role/PropertyPlantandEquipmentDetails": { "order": 1.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "negatedTerseLabel": "Less: accumulated depreciation" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/PropertyPlantandEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]", "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r55", "r56", "r57" ], "calculation": { "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "terseLabel": "Accumulated other comprehensive income (loss)" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).", "label": "Accumulated Other Comprehensive Income (Loss) [Table]", "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r54", "r57", "r58", "r299" ], "lang": { "en-US": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "AOCI Attributable to Parent [Member]", "terseLabel": "Accumulated other comprehensive income (loss)" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails", "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofChangesinEquityDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedTranslationAdjustmentMember": { "auth_ref": [ "r53", "r57", "r58", "r299" ], "lang": { "en-US": { "role": { "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.", "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]", "verboseLabel": "Net foreign exchange gain (loss) on translation" } } }, "localname": "AccumulatedTranslationAdjustmentMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AdditionalFinancialInformationDisclosureTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The entire disclosures of supplemental information, including descriptions and amounts, related to the balance sheet, income statement, and/or cash flow statement.", "label": "Additional Financial Information Disclosure [Text Block]", "terseLabel": "General and Administrative Expenses" } } }, "localname": "AdditionalFinancialInformationDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/GeneralandAdministrativeExpenses" ], "xbrltype": "textBlockItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r19" ], "calculation": { "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.", "label": "Additional Paid in Capital", "terseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofChangesinEquityDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": { "auth_ref": [ "r118" ], "lang": { "en-US": { "role": { "documentation": "Information by new accounting pronouncement.", "label": "Adjustments for New Accounting Pronouncements [Axis]", "terseLabel": "Adjustments for New Accounting Pronouncements [Axis]" } } }, "localname": "AdjustmentsForNewAccountingPronouncementsAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Items not affecting cash:" } } }, "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for restricted stock unit under share-based payment arrangement.", "label": "APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition", "terseLabel": "Vesting of restricted share units" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofChangesinEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement.", "label": "APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition", "terseLabel": "Vesting of options" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofChangesinEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdvancesToAffiliate": { "auth_ref": [ "r8", "r434" ], "calculation": { "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets": { "order": 8.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Long-Term advances receivable from a party that is affiliated with the reporting entity by means of direct or indirect ownership. This does not include advances to clients.", "label": "Advances to Affiliate", "periodEndLabel": "Balance at end of period", "periodStartLabel": "Balance at beginning of period", "terseLabel": "Advances to joint ventures" } } }, "localname": "AdvancesToAffiliate", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets", "http://thecronosgroup.com/role/InvestmentsandAdvancestoJointVenturesScheduleofAdvancestoJointVenturesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r256", "r278", "r281" ], "calculation": { "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeandComprehensiveIncomeLoss": { "order": 4.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "Share-based Payment Arrangement, Expense", "terseLabel": "Share-based payments", "verboseLabel": "Vesting of issued RSUs" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeandComprehensiveIncomeLoss", "http://thecronosgroup.com/role/SharebasedPaymentsRestrictedShareUnitsNarrativeDetails", "http://thecronosgroup.com/role/SharebasedPaymentsStockOptionsNarrativeDetails", "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofRestrictedShareUnitsActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": { "auth_ref": [ "r24", "r167", "r179" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.", "label": "Accounts Receivable, Allowance for Credit Loss, Current", "verboseLabel": "Current expected credit loss" } } }, "localname": "AllowanceForDoubtfulAccountsReceivableCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheetParenthetical", "http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskNarrativeDetails", "http://thecronosgroup.com/role/RevenuesfromContractswithCustomersDetails", "http://thecronosgroup.com/role/SegmentInformationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfIntangibleAssets": { "auth_ref": [ "r102", "r202", "r210" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Amortization of Intangible Assets", "terseLabel": "Amortization of intangible assets" } } }, "localname": "AmortizationOfIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r132" ], "lang": { "en-US": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "terseLabel": "Total anti-dilutive securities (in shares)" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/EarningslossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofDilutedSharesOutstandingDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "auth_ref": [ "r132" ], "lang": { "en-US": { "role": { "documentation": "Information by type of antidilutive security.", "label": "Antidilutive Securities [Axis]", "terseLabel": "Antidilutive Securities [Axis]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/EarningslossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofDilutedSharesOutstandingDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]", "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/EarningslossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofDilutedSharesOutstandingDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "auth_ref": [ "r132" ], "lang": { "en-US": { "role": { "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.", "label": "Antidilutive Securities, Name [Domain]", "terseLabel": "Antidilutive Securities, Name [Domain]" } } }, "localname": "AntidilutiveSecuritiesNameDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/EarningslossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofDilutedSharesOutstandingDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]", "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]" } } }, "localname": "ArrangementsAndNonarrangementTransactionsMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/InvestmentsandAdvancestoJointVenturesNarrativeDetails", "http://thecronosgroup.com/role/LoansReceivablenetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r150", "r402", "r419" ], "calculation": { "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "terseLabel": "Total assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets", "http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Assets [Abstract]", "terseLabel": "Assets" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r6", "r7", "r48" ], "calculation": { "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Assets, Current [Abstract]", "terseLabel": "Current assets" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtSecurities": { "auth_ref": [ "r170", "r172", "r185" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Debt Securities, Available-for-sale", "terseLabel": "Short-term investments" } } }, "localname": "AvailableForSaleSecuritiesDebtSecurities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/FairValueMeasurementDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AwardDateAxis": { "auth_ref": [ "r257", "r279" ], "lang": { "en-US": { "role": { "documentation": "Information by date or year award under share-based payment arrangement is granted.", "label": "Award Date [Axis]", "terseLabel": "Award Date [Axis]" } } }, "localname": "AwardDateAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofOutstandingWarrantsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AwardDateDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Date or year award under share-based payment arrangement is granted.", "label": "Award Date [Domain]", "terseLabel": "Award Date [Domain]" } } }, "localname": "AwardDateDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofOutstandingWarrantsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r257", "r279" ], "lang": { "en-US": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]", "terseLabel": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/EarningslossPerShareScheduleofEarningsLossPerShareDetails", "http://thecronosgroup.com/role/SharebasedPaymentsDeferredShareUnitsNarrativeDetails", "http://thecronosgroup.com/role/SharebasedPaymentsRestrictedShareUnitsNarrativeDetails", "http://thecronosgroup.com/role/SharebasedPaymentsStockOptionsNarrativeDetails", "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofChangesinWarrantsDetails", "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofDeferredShareUnitsActivityDetails", "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofFairValueofOptionsIssuedDetails", "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofOutstandingWarrantsDetails", "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofRestrictedShareUnitsActivityDetails", "http://thecronosgroup.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of Accounting, Policy [Policy Text Block]", "terseLabel": "Basis of Presentation" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BuildingMember": { "auth_ref": [ "r218" ], "lang": { "en-US": { "role": { "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities.", "label": "Building [Member]", "terseLabel": "Building", "verboseLabel": "Office Premises" } } }, "localname": "BuildingMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/LeasesDetails", "http://thecronosgroup.com/role/PropertyPlantandEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.", "label": "Business Acquisition, Acquiree [Domain]", "terseLabel": "Business Acquisition, Acquiree [Domain]" } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SharebasedPaymentsRestrictedShareUnitsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r285", "r286" ], "lang": { "en-US": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]", "terseLabel": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SharebasedPaymentsRestrictedShareUnitsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r2", "r33", "r104" ], "calculation": { "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "terseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets", "http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsFairValueDisclosure": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash and Cash Equivalents, Fair Value Disclosure", "terseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/FairValueMeasurementDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r98", "r104", "r106" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents", "periodEndLabel": "Cash and cash equivalents, end of period", "periodStartLabel": "Cash and cash equivalents, beginning of period" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r98", "r355" ], "calculation": { "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Increase (decrease) in cash and cash equivalents" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowOperatingCapitalTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the net increase (decrease) in operating capital in the operating section of the statement of cash flows, represents the entire footnote disclosure that provides details regarding the net change during the reporting period of all assets and liabilities used in operating activities.", "label": "Cash Flow, Operating Capital [Table Text Block]", "terseLabel": "Schedule of Net Changes in Non-Cash Working Capital" } } }, "localname": "CashFlowOperatingCapitalTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SupplementaryCashFlowInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashFlowSupplementalDisclosuresTextBlock": { "auth_ref": [ "r107" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Cash Flow, Supplemental Disclosures [Text Block]", "terseLabel": "Supplementary Cash Flow Information" } } }, "localname": "CashFlowSupplementalDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SupplementaryCashFlowInformation" ], "xbrltype": "textBlockItemType" }, "us-gaap_ClassOfWarrantOrRightAxis": { "auth_ref": [ "r114", "r243", "r255" ], "lang": { "en-US": { "role": { "documentation": "Information by type of warrant or right issued.", "label": "Class of Warrant or Right [Axis]", "terseLabel": "Class of Warrant or Right [Axis]" } } }, "localname": "ClassOfWarrantOrRightAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails", "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails", "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofReconciliationofCarryingAmountsDetails", "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofSensitivityAnalysisDetails", "http://thecronosgroup.com/role/EarningslossPerShareScheduleofEarningsLossPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightDomain": { "auth_ref": [ "r110" ], "lang": { "en-US": { "role": { "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months.", "label": "Class of Warrant or Right [Domain]", "terseLabel": "Class of Warrant or Right [Domain]" } } }, "localname": "ClassOfWarrantOrRightDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails", "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails", "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofReconciliationofCarryingAmountsDetails", "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofSensitivityAnalysisDetails", "http://thecronosgroup.com/role/EarningslossPerShareScheduleofEarningsLossPerShareDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r113" ], "lang": { "en-US": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights", "terseLabel": "Exercise price (in dollars per share)" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ClassificationOfVariableInterestEntityDomain": { "auth_ref": [ "r300", "r302", "r304", "r306" ], "lang": { "en-US": { "role": { "documentation": "Categorization of Variable Interest Entities (VIE) for consolidation and (or) disclosure purposes, whether individually or in aggregate, by: (1) VIEs consolidated because the entity is the primary beneficiary, (2) VIEs not consolidated because the entity is not the primary beneficiary, and (3) VIEs or potential VIEs that are not consolidated because necessary information is not available. In general, a VIE is a corporation, partnership, trust, or any other legal structure used for business purposes that either (a) does not have equity investors with voting rights or (b) has equity investors that do not provide sufficient financial resources for the entity to support its activities. A VIE often holds financial assets, including loans or receivables, real estate or other property. A VIE may be essentially passive or it may engage in research and development or other activities on behalf of another company.", "label": "Variable Interest Entity, Classification [Domain]", "terseLabel": "Variable Interest Entity, Classification [Domain]" } } }, "localname": "ClassificationOfVariableInterestEntityDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/InvestmentsandAdvancestoJointVenturesScheduleofEquityMethodInvestmentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember": { "auth_ref": [ "r289" ], "lang": { "en-US": { "role": { "documentation": "Collaborative arrangement transaction between parties to collaborative arrangement.", "label": "Collaborative Arrangement, Transaction with Party to Collaborative Arrangement [Member]", "terseLabel": "Establishment of a Commercial Cannabis Analytical Testing Laboratory" } } }, "localname": "CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/InvestmentsandAdvancestoJointVenturesNarrativeDetails", "http://thecronosgroup.com/role/LoansReceivablenetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r42", "r228", "r410", "r424" ], "calculation": { "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies", "terseLabel": "Commitments and contingencies" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]", "terseLabel": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsDisclosureTextBlock": { "auth_ref": [ "r227" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for significant arrangements with third parties, which includes operating lease arrangements and arrangements in which the entity has agreed to expend funds to procure goods or services, or has agreed to commit resources to supply goods or services, and operating lease arrangements. Descriptions may include identification of the specific goods and services, period of time covered, minimum quantities and amounts, and cancellation rights.", "label": "Commitments Disclosure [Text Block]", "terseLabel": "Commitments" } } }, "localname": "CommitmentsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/Commitments" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common Shares", "verboseLabel": "Share capital" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CommitmentsUseofPublicityRightsinBrandDevelopmentDetails", "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofChangesinEquityDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r16" ], "lang": { "en-US": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common stock, shares issued (in shares)" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheetParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r16", "r241" ], "lang": { "en-US": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "periodEndLabel": "Ending balance (in shares)", "periodStartLabel": "Beginning balance (in shares)" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofChangesinEquityDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r16" ], "calculation": { "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "terseLabel": "Share capital" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r61", "r63", "r64" ], "calculation": { "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeandComprehensiveIncomeLoss": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "totalLabel": "Cronos Group" } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeandComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": { "auth_ref": [ "r61", "r63", "r293", "r294", "r310" ], "calculation": { "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeandComprehensiveIncomeLoss": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest", "terseLabel": "Non-controlling interests" } } }, "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeandComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r61", "r63", "r292", "r310" ], "calculation": { "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeandComprehensiveIncomeLoss": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest", "totalLabel": "Comprehensive income (loss)", "verboseLabel": "Comprehensive income (loss)" } } }, "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeandComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest [Abstract]", "terseLabel": "Comprehensive income (loss) attributable to:" } } }, "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeandComprehensiveIncomeLoss" ], "xbrltype": "stringItemType" }, "us-gaap_ComprehensiveIncomeNoteTextBlock": { "auth_ref": [ "r85" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.", "label": "Comprehensive Income (Loss) Note [Text Block]", "terseLabel": "Accumulated Other Comprehensive Income (Loss)" } } }, "localname": "ComprehensiveIncomeNoteTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/AccumulatedOtherComprehensiveIncomeLoss" ], "xbrltype": "textBlockItemType" }, "us-gaap_ComputerEquipmentMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems.", "label": "Computer Equipment [Member]", "terseLabel": "Computer equipment" } } }, "localname": "ComputerEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/PropertyPlantandEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ComputerSoftwareIntangibleAssetMember": { "auth_ref": [ "r203", "r208", "r288" ], "lang": { "en-US": { "role": { "documentation": "Collection of computer programs and related data that provide instructions to a computer, for example, but not limited to, application program, control module or operating system, that perform one or more particular functions or tasks.", "label": "Computer Software, Intangible Asset [Member]", "terseLabel": "Software" } } }, "localname": "ComputerSoftwareIntangibleAssetMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillNarrativeDetails", "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r139", "r140", "r347", "r348" ], "lang": { "en-US": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.", "label": "Concentration Risk Benchmark [Domain]", "terseLabel": "Concentration Risk Benchmark [Domain]" } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskNarrativeDetails", "http://thecronosgroup.com/role/FinancialInstrumentsLiquidityRiskNarrativeDetails", "http://thecronosgroup.com/role/SegmentInformationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r139", "r140", "r347", "r348", "r433" ], "lang": { "en-US": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk Benchmark [Axis]", "terseLabel": "Concentration Risk Benchmark [Axis]" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskNarrativeDetails", "http://thecronosgroup.com/role/FinancialInstrumentsLiquidityRiskNarrativeDetails", "http://thecronosgroup.com/role/SegmentInformationNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskByTypeAxis": { "auth_ref": [ "r139", "r140", "r347", "r348", "r433" ], "lang": { "en-US": { "role": { "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.", "label": "Concentration Risk Type [Axis]", "terseLabel": "Concentration Risk Type [Axis]" } } }, "localname": "ConcentrationRiskByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskNarrativeDetails", "http://thecronosgroup.com/role/FinancialInstrumentsLiquidityRiskNarrativeDetails", "http://thecronosgroup.com/role/SegmentInformationNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure": { "auth_ref": [ "r349" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Maximum amount of loss due to credit risk that, based on the gross fair value of the financial instrument, the entity would incur if parties to the financial instruments that make up the concentration failed completely to perform according to the terms of the contracts and the collateral or other security, if any, for the amount due proved to be of no value to the entity.", "label": "Concentration Risk, Credit Risk, Financial Instrument, Maximum Exposure", "terseLabel": "Maximum exposure to credit risk" } } }, "localname": "ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConcentrationRiskDisclosureTextBlock": { "auth_ref": [ "r142" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.", "label": "Concentration Risk Disclosure [Text Block]", "terseLabel": "Financial Instruments" } } }, "localname": "ConcentrationRiskDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/FinancialInstruments" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Concentration Risk [Line Items]", "terseLabel": "Concentration Risk [Line Items]" } } }, "localname": "ConcentrationRiskLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskNarrativeDetails", "http://thecronosgroup.com/role/FinancialInstrumentsLiquidityRiskNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskPercentage1": { "auth_ref": [ "r139", "r140", "r347", "r348" ], "lang": { "en-US": { "role": { "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.", "label": "Concentration Risk, Percentage", "terseLabel": "Concentration risk, percentage" } } }, "localname": "ConcentrationRiskPercentage1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskNarrativeDetails", "http://thecronosgroup.com/role/FinancialInstrumentsLiquidityRiskNarrativeDetails", "http://thecronosgroup.com/role/SegmentInformationNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ConcentrationRiskTable": { "auth_ref": [ "r137", "r139", "r140", "r141", "r347", "r350" ], "lang": { "en-US": { "role": { "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.", "label": "Concentration Risk [Table]", "terseLabel": "Concentration Risk [Table]" } } }, "localname": "ConcentrationRiskTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskNarrativeDetails", "http://thecronosgroup.com/role/FinancialInstrumentsLiquidityRiskNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskTypeDomain": { "auth_ref": [ "r139", "r140", "r347", "r348" ], "lang": { "en-US": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.", "label": "Concentration Risk Type [Domain]", "terseLabel": "Concentration Risk Type [Domain]" } } }, "localname": "ConcentrationRiskTypeDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskNarrativeDetails", "http://thecronosgroup.com/role/FinancialInstrumentsLiquidityRiskNarrativeDetails", "http://thecronosgroup.com/role/SegmentInformationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConsolidationPolicyTextBlock": { "auth_ref": [ "r108", "r295", "r311", "r313" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.", "label": "Consolidation, Policy [Policy Text Block]", "terseLabel": "Basis of Consolidation" } } }, "localname": "ConsolidationPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConstructionInProgressMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.", "label": "Construction in Progress [Member]", "terseLabel": "Construction in progress" } } }, "localname": "ConstructionInProgressMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/PropertyPlantandEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CorporateNonSegmentMember": { "auth_ref": [ "r156" ], "lang": { "en-US": { "role": { "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.", "label": "Corporate, Non-Segment [Member]", "terseLabel": "Corporate" } } }, "localname": "CorporateNonSegmentMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CostOfGoodsAndServicesSoldDepreciation": { "auth_ref": [ "r74", "r217" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of expense for allocation of cost of tangible asset over its useful life directly used in production of good and rendering of service.", "label": "Cost, Depreciation", "terseLabel": "Depreciation expense included in costs of sales" } } }, "localname": "CostOfGoodsAndServicesSoldDepreciation", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/PropertyPlantandEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CreditConcentrationRiskMember": { "auth_ref": [ "r350" ], "lang": { "en-US": { "role": { "documentation": "Reflects the percentage that a specified receivable or amount at risk from a counterparty under a contractual arrangement is to a specified benchmark, such as total receivables, net revenues, pretax results. Risk is the materially adverse effects of loss attributable to (a) the failure to collect a significant receivable from a major customer or group of homogeneous accounts, or (b) a failure by a counterparty to perform under terms of a contractual arrangement.", "label": "Credit Concentration Risk [Member]", "terseLabel": "Credit Concentration Risk" } } }, "localname": "CreditConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax of increase (decrease) to equity or (increase) decrease to net assets, resulting from the cumulative effect adjustment of a new accounting principle applied in the period of adoption.", "label": "Cumulative Effect of New Accounting Principle in Period of Adoption", "terseLabel": "Cumulative effect from adoption of ASU 2016-01" } } }, "localname": "CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CustomerConcentrationRiskMember": { "auth_ref": [ "r138" ], "lang": { "en-US": { "role": { "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.", "label": "Customer Concentration Risk [Member]", "terseLabel": "Customer Concentration Risk" } } }, "localname": "CustomerConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SegmentInformationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r359", "r361" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt Instrument, Face Amount", "terseLabel": "Face amount" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/InvestmentsandAdvancestoJointVenturesScheduleofAdvancestoJointVenturesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r40" ], "lang": { "en-US": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Debt Instrument, Interest Rate, Stated Percentage", "terseLabel": "Interest rate" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/InvestmentsandAdvancestoJointVenturesNarrativeDetails", "http://thecronosgroup.com/role/InvestmentsandAdvancestoJointVenturesScheduleofAdvancestoJointVenturesDetails", "http://thecronosgroup.com/role/LoansReceivablenetDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts": { "auth_ref": [ "r83" ], "calculation": { "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeandComprehensiveIncomeLoss": { "order": 2.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Represents the charge against earnings during the period for commitment fees and debt issuance expenses.", "label": "Debt Related Commitment Fees and Debt Issuance Costs", "negatedTerseLabel": "Financing and transaction costs" } } }, "localname": "DebtRelatedCommitmentFeesAndDebtIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeandComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for stock option plans and other equity-based compensation arrangements.", "label": "Deferred Compensation Share-based Arrangements, Liability, Current and Noncurrent", "periodEndLabel": "Balance as of June\u00a030, 2020", "periodStartLabel": "Balance as of January 1, 2020" } } }, "localname": "DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofDeferredShareUnitsActivityDetails", "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofRestrictedShareUnitsActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationAndAmortization": { "auth_ref": [ "r102", "r217" ], "calculation": { "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeandComprehensiveIncomeLoss": { "order": 5.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.", "label": "Depreciation, Depletion and Amortization, Nonproduction", "terseLabel": "Depreciation and amortization", "verboseLabel": "Depreciation and amortization" } } }, "localname": "DepreciationAndAmortization", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeandComprehensiveIncomeLoss", "http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationDepletionAndAmortization": { "auth_ref": [ "r102", "r147" ], "calculation": { "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.", "label": "Depreciation, Depletion and Amortization", "verboseLabel": "Depreciation and amortization" } } }, "localname": "DepreciationDepletionAndAmortization", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationNonproduction": { "auth_ref": [ "r102", "r217" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The expense recognized in the current period that allocates the cost of nonproduction tangible assets over their useful lives.", "label": "Depreciation, Nonproduction", "terseLabel": "Depreciation expense included in operating expenses" } } }, "localname": "DepreciationNonproduction", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/PropertyPlantandEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeContractTypeDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.", "label": "Derivative Contract [Domain]", "terseLabel": "Derivative Contract [Domain]" } } }, "localname": "DerivativeContractTypeDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DerivativeInstrumentRiskAxis": { "auth_ref": [ "r321", "r322", "r324", "r325" ], "lang": { "en-US": { "role": { "documentation": "Information by type of derivative contract.", "label": "Derivative Instrument [Axis]", "terseLabel": "Derivative Instrument [Axis]" } } }, "localname": "DerivativeInstrumentRiskAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]", "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": { "auth_ref": [ "r331" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.", "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]", "terseLabel": "Derivative Liabilities" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/DerivativeLiabilities" ], "xbrltype": "textBlockItemType" }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": { "auth_ref": [ "r319", "r321", "r324", "r325", "r326", "r329", "r330" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.", "label": "Derivative Instruments, Gain (Loss) [Table]", "terseLabel": "Derivative Instruments, Gain (Loss) [Table]" } } }, "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofReconciliationofCarryingAmountsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsGainLossLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivative Instruments, Gain (Loss) [Line Items]", "terseLabel": "Derivative Instruments, Gain (Loss) [Line Items]" } } }, "localname": "DerivativeInstrumentsGainLossLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofReconciliationofCarryingAmountsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeLiabilities": { "auth_ref": [ "r49", "r50", "r346" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Liability", "terseLabel": "Derivative liabilities" } } }, "localname": "DerivativeLiabilities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/FairValueMeasurementDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilitiesCurrent": { "auth_ref": [ "r49" ], "calculation": { "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Liability, Current", "terseLabel": "Derivative liabilities" } } }, "localname": "DerivativeLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilityMeasurementInput": { "auth_ref": [ "r337" ], "lang": { "en-US": { "role": { "documentation": "Value of input used to measure derivative liability.", "label": "Derivative Liability, Measurement Input", "terseLabel": "Derivative liability, measurement input" } } }, "localname": "DerivativeLiabilityMeasurementInput", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails" ], "xbrltype": "decimalItemType" }, "us-gaap_DerivativeLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivative [Line Items]", "terseLabel": "Derivative [Line Items]" } } }, "localname": "DerivativeLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails", "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofSensitivityAnalysisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeTable": { "auth_ref": [ "r116", "r316", "r317", "r318", "r319", "r320", "r323", "r324", "r327", "r328", "r330" ], "lang": { "en-US": { "role": { "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.", "label": "Derivative [Table]", "terseLabel": "Derivative [Table]" } } }, "localname": "DerivativeTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails", "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofSensitivityAnalysisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DilutiveSecurities": { "auth_ref": [ "r133" ], "calculation": { "http://thecronosgroup.com/role/EarningslossPerShareScheduleofEarningsLossPerShareDetails": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) to net income used for calculating diluted earnings per share (EPS), resulting from the assumed exercise stock options, restrictive stock units (RSUs), convertible preferred stock of an employee stock ownership plan (ESOP), and other dilutive convertible securities.", "label": "Dilutive Securities, Effect on Basic Earnings Per Share", "terseLabel": "Adjustment for gain (loss) on revaluation of derivative liabilities" } } }, "localname": "DilutiveSecurities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/EarningslossPerShareScheduleofEarningsLossPerShareDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "auth_ref": [ "r282" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for share-based payment arrangement.", "label": "Share-based Payment Arrangement [Text Block]", "terseLabel": "Share-based Payments" } } }, "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SharebasedPayments" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Share-based Payment Arrangement [Abstract]", "terseLabel": "Share-based Payment Arrangement [Abstract]" } } }, "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock": { "auth_ref": [ "r257", "r279" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of share-based payment arrangement.", "label": "Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]", "terseLabel": "Summary of Outstanding Warrants" } } }, "localname": "DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SharebasedPaymentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DueToRelatedPartiesNoncurrent": { "auth_ref": [ "r41", "r115", "r373" ], "calculation": { "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Portion of the carrying amount as of the balance sheet date of obligations due all related parties that is payable after one year or beyond the normal operating cycle if longer.", "label": "Due to Related Parties, Noncurrent", "terseLabel": "Due to non-controlling interests" } } }, "localname": "DueToRelatedPartiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Earnings Per Share [Abstract]", "terseLabel": "Earnings Per Share [Abstract]" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r72", "r119", "r124", "r129", "r130", "r131", "r134", "r414", "r427" ], "lang": { "en-US": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "terseLabel": "Basic (in dollars per share)", "verboseLabel": "Basic earnings per share (in dollars per share)" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeandComprehensiveIncomeLoss", "http://thecronosgroup.com/role/EarningslossPerShareScheduleofEarningsLossPerShareDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareBasicAndDilutedAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Earnings Per Share, Basic and Diluted [Abstract]", "terseLabel": "Net income (loss) per share" } } }, "localname": "EarningsPerShareBasicAndDilutedAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeandComprehensiveIncomeLoss" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Earnings Per Share, Basic and Diluted, Other Disclosures [Abstract]", "terseLabel": "Weighted average number of outstanding shares" } } }, "localname": "EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeandComprehensiveIncomeLoss" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r72", "r119", "r124", "r129", "r130", "r131", "r134", "r414", "r427" ], "lang": { "en-US": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "terseLabel": "Diluted (in dollars per share)", "verboseLabel": "Diluted earnings per share (in dollars per share)" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeandComprehensiveIncomeLoss", "http://thecronosgroup.com/role/EarningslossPerShareScheduleofEarningsLossPerShareDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDilutedLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]", "terseLabel": "Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]" } } }, "localname": "EarningsPerShareDilutedLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/EarningslossPerShareScheduleofEarningsLossPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r135" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Earnings Per Share [Text Block]", "terseLabel": "Earnings (loss) Per Share" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/EarningslossPerShare" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r355" ], "calculation": { "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents", "terseLabel": "Effect of foreign currency translation on cash and cash equivalents" } } }, "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeStockOptionMember": { "auth_ref": [ "r277" ], "lang": { "en-US": { "role": { "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.", "label": "Share-based Payment Arrangement, Option [Member]", "terseLabel": "Stock options" } } }, "localname": "EmployeeStockOptionMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/EarningslossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofDilutedSharesOutstandingDetails", "http://thecronosgroup.com/role/EarningslossPerShareScheduleofEarningsLossPerShareDetails", "http://thecronosgroup.com/role/SharebasedPaymentsStockOptionsNarrativeDetails", "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofFairValueofOptionsIssuedDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Equity [Abstract]", "terseLabel": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r241" ], "lang": { "en-US": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]", "terseLabel": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails", "http://thecronosgroup.com/role/CommitmentsUseofPublicityRightsinBrandDevelopmentDetails", "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofChangesinEquityDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestmentOwnershipPercentage": { "auth_ref": [ "r175" ], "lang": { "en-US": { "role": { "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.", "label": "Equity Method Investment, Ownership Percentage", "terseLabel": "Ownership percentage (Whistler - less than)", "verboseLabel": "Ownership percentage" } } }, "localname": "EquityMethodInvestmentOwnershipPercentage", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/BackgroundDetails", "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails", "http://thecronosgroup.com/role/InvestmentsandAdvancestoJointVenturesScheduleofEquityMethodInvestmentsDetails", "http://thecronosgroup.com/role/RelatedPartyTransactionsandBalancesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal": { "auth_ref": [ "r76", "r77", "r102" ], "calculation": { "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of gain (loss) on sale or disposal of an equity method investment.", "label": "Equity Method Investment, Realized Gain (Loss) on Disposal", "negatedTerseLabel": "Gain on disposal of other investments" } } }, "localname": "EquityMethodInvestmentRealizedGainLossOnDisposal", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityMethodInvestments": { "auth_ref": [ "r34", "r151", "r174" ], "calculation": { "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.", "label": "Equity Method Investments", "terseLabel": "Investments in equity accounted investees", "verboseLabel": "Investments in equity accounted investees" } } }, "localname": "EquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets", "http://thecronosgroup.com/role/InvestmentsandAdvancestoJointVenturesScheduleofEquityMethodInvestmentsDetails", "http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Equity Method Investments and Joint Ventures [Abstract]", "terseLabel": "Equity Method Investments and Joint Ventures [Abstract]" } } }, "localname": "EquityMethodInvestmentsAndJointVenturesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_EquityMethodInvestmentsDisclosureTextBlock": { "auth_ref": [ "r178", "r314" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group.", "label": "Equity Method Investments and Joint Ventures Disclosure [Text Block]", "terseLabel": "Investments and Advances to Joint Ventures" } } }, "localname": "EquityMethodInvestmentsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/InvestmentsandAdvancestoJointVentures" ], "xbrltype": "textBlockItemType" }, "us-gaap_EquityMethodInvestmentsTextBlock": { "auth_ref": [ "r177" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.", "label": "Equity Method Investments [Table Text Block]", "terseLabel": "Schedule of Equity Method Investments" } } }, "localname": "EquityMethodInvestmentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/InvestmentsandAdvancestoJointVenturesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_EquitySecuritiesMember": { "auth_ref": [ "r11", "r14", "r173", "r407", "r417", "r443" ], "lang": { "en-US": { "role": { "documentation": "Ownership interest or right to acquire or dispose of ownership interest in corporations and other legal entities for which ownership interest is represented by shares of common or preferred stock, convertible securities, stock rights, or stock warrants.", "label": "Equity Securities [Member]", "terseLabel": "Equity Securities" } } }, "localname": "EquitySecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/OtherInvestmentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ExchangeOfProductHeldForSaleForSimilarProductMember": { "auth_ref": [ "r367" ], "lang": { "en-US": { "role": { "documentation": "The exchange of a product held for sale in the ordinary course of business for similar property as an accommodation, to satisfy an immediate inventory need or otherwise reduce costs or facilitate ultimate sales.", "label": "Exchange of Product Held-for-sale for Similar Product [Member]", "terseLabel": "Purchased Cannabis Resin and Sold Cannabis Dry Flower" } } }, "localname": "ExchangeOfProductHeldForSaleForSimilarProductMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/NonmonetaryTransactionsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ExciseAndSalesTaxes": { "auth_ref": [ "r68" ], "calculation": { "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeandComprehensiveIncomeLoss": { "order": 2.0, "parentTag": "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The amount of excise and sales taxes included in sales and revenues, which are then deducted as a cost of sales. Includes excise taxes, which are applied to specific types of transactions or items (such as gasoline or alcohol); and sales, use and value added taxes, which are applied to a broad class of revenue-producing transactions involving a wide range of goods and services.", "label": "Excise and Sales Taxes", "negatedTerseLabel": "Excise taxes" } } }, "localname": "ExciseAndSalesTaxes", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeandComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/FairValueMeasurementDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "auth_ref": [ "r332", "r333", "r334", "r344" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.", "label": "Fair Value, Recurring and Nonrecurring [Table]", "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/FairValueMeasurementDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]", "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable": { "auth_ref": [ "r335" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.", "label": "Fair Value Measurement Inputs and Valuation Techniques [Table]", "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": { "auth_ref": [ "r335" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.", "label": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]", "terseLabel": "Schedule of Fair Values of Derivative Liabilities" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/DerivativeLiabilitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r251", "r252", "r254", "r333", "r383" ], "lang": { "en-US": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]", "terseLabel": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/FairValueMeasurementDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "auth_ref": [ "r332", "r333", "r336", "r337", "r345" ], "lang": { "en-US": { "role": { "documentation": "Information by measurement frequency.", "label": "Measurement Frequency [Axis]", "terseLabel": "Measurement Frequency [Axis]" } } }, "localname": "FairValueByMeasurementFrequencyAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/FairValueMeasurementDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Fair Value Disclosures [Abstract]", "terseLabel": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r342" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "Fair Value Disclosures [Text Block]", "terseLabel": "Fair Value Measurement" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/FairValueMeasurement" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r251", "r252", "r254", "r333", "r384" ], "lang": { "en-US": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value, Inputs, Level 1 [Member]", "terseLabel": "Level 1" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/FairValueMeasurementDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r251", "r252", "r254", "r333", "r385" ], "lang": { "en-US": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value, Inputs, Level 2 [Member]", "terseLabel": "Level 2" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/FairValueMeasurementDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r251", "r252", "r254", "r333", "r386" ], "lang": { "en-US": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Inputs, Level 3 [Member]", "terseLabel": "Level 3" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/FairValueMeasurementDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementFrequencyDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Measurement frequency.", "label": "Measurement Frequency [Domain]", "terseLabel": "Measurement Frequency [Domain]" } } }, "localname": "FairValueMeasurementFrequencyDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/FairValueMeasurementDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Hierarchy and NAV [Domain]", "terseLabel": "Fair Value Hierarchy and NAV [Domain]" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/FairValueMeasurementDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsRecurringMember": { "auth_ref": [ "r342", "r345" ], "lang": { "en-US": { "role": { "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.", "label": "Fair Value, Recurring [Member]", "terseLabel": "Fair Value, Recurring" } } }, "localname": "FairValueMeasurementsRecurringMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/FairValueMeasurementDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock": { "auth_ref": [ "r338", "r343" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of financial instrument classified as a derivative asset (liability) after deduction of derivative liability (asset) using recurring unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]", "terseLabel": "Schedule of Reconciliation of Carrying Amounts" } } }, "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/DerivativeLiabilitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings": { "auth_ref": [ "r339", "r343" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of gain (loss) recognized in income from derivative asset (liability) after deduction of derivative liability (asset), measured at fair value on recurring basis using unobservable input (level 3).", "label": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Gain (Loss) Included in Earnings", "negatedTerseLabel": "(Gain) / Loss on revaluation", "terseLabel": "Gain on revaluation" } } }, "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails", "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofReconciliationofCarryingAmountsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss": { "auth_ref": [ "r340", "r343" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of gain (loss) recognized in other comprehensive income from derivative asset (liability) after deduction of derivative liability (asset), measured at fair value on recurring basis using unobservable input (level 3).", "label": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Gain (Loss) Included in Other Comprehensive Income (Loss)", "negatedTerseLabel": "Effect from foreign exchange" } } }, "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofReconciliationofCarryingAmountsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements": { "auth_ref": [ "r341", "r343" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of settlements of financial instrument classified as a derivative asset (liability) after deduction of derivative liability, measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Settlements", "negatedTerseLabel": "Exercise of Rights" } } }, "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofReconciliationofCarryingAmountsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs": { "auth_ref": [ "r332", "r343" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Fair value of financial instrument classified as derivative asset (liability) after deduction of derivative liability (asset), measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis with Unobservable Inputs", "negatedPeriodEndLabel": "Ending balance", "negatedPeriodStartLabel": "Beginning balance" } } }, "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofReconciliationofCarryingAmountsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinancingReceivableAllowanceForCreditLosses": { "auth_ref": [ "r166", "r179", "r180", "r182", "r408" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of allowance for credit loss on financing receivable. Excludes allowance for financing receivable covered under loss sharing agreement.", "label": "Financing Receivable, Allowance for Credit Loss", "terseLabel": "Allowance for credit loss" } } }, "localname": "FinancingReceivableAllowanceForCreditLosses", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/LoansReceivablenetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetUsefulLife": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Finite-Lived Intangible Asset, Useful Life", "terseLabel": "Weighted Average Amortization Period (in years)" } } }, "localname": "FiniteLivedIntangibleAssetUsefulLife", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "auth_ref": [ "r209" ], "calculation": { "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetails": { "order": 2.0, "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "negatedLabel": "Accumulated Amortization" } } }, "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": { "auth_ref": [ "r211" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months", "terseLabel": "2021" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": { "auth_ref": [ "r211" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Finite-Lived Intangible Assets, Amortization Expense, Year Five", "terseLabel": "2025" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": { "auth_ref": [ "r211" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Finite-Lived Intangible Assets, Amortization Expense, Year Four", "terseLabel": "2024" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": { "auth_ref": [ "r211" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Finite-Lived Intangible Assets, Amortization Expense, Year Three", "terseLabel": "2023" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": { "auth_ref": [ "r211" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Finite-Lived Intangible Assets, Amortization Expense, Year Two", "terseLabel": "2022" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r203", "r205", "r209", "r213", "r387" ], "lang": { "en-US": { "role": { "documentation": "Information by major type or class of finite-lived intangible assets.", "label": "Finite-Lived Intangible Assets by Major Class [Axis]", "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]" } } }, "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillNarrativeDetails", "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]", "terseLabel": "Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]" } } }, "localname": "FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "auth_ref": [ "r209", "r387" ], "calculation": { "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetails": { "order": 1.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Gross", "terseLabel": "Cost" } } }, "localname": "FiniteLivedIntangibleAssetsGross", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Finite-Lived Intangible Assets [Line Items]", "terseLabel": "Finite-Lived Intangible Assets [Line Items]" } } }, "localname": "FiniteLivedIntangibleAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillNarrativeDetails", "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r203", "r208" ], "lang": { "en-US": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.", "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]", "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]" } } }, "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillNarrativeDetails", "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "auth_ref": [ "r209" ], "calculation": { "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Net", "totalLabel": "Net" } } }, "localname": "FiniteLivedIntangibleAssetsNet", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyTransactionGainLossUnrealized": { "auth_ref": [ "r103", "r352", "r353", "r354" ], "calculation": { "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount before tax of foreign currency transaction unrealized gain (loss) recognized in the income statement.", "label": "Foreign Currency Transaction Gain (Loss), Unrealized", "negatedTerseLabel": "Loss (gain) on unrealized foreign exchange" } } }, "localname": "ForeignCurrencyTransactionGainLossUnrealized", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_FurnitureAndFixturesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.", "label": "Furniture and Fixtures [Member]", "terseLabel": "Furniture and equipment" } } }, "localname": "FurnitureAndFixturesMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/PropertyPlantandEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GainLossOnDerivativeInstrumentsNetPretax": { "auth_ref": [ "r321" ], "calculation": { "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeandComprehensiveIncomeLoss": { "order": 3.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Aggregate net gain (loss) on all derivative instruments recognized in earnings during the period, before tax effects.", "label": "Gain (Loss) on Derivative Instruments, Net, Pretax", "negatedTerseLabel": "Gain on revaluation of derivative liabilities", "terseLabel": "Gain (loss) on revaluation of derivative liabilities" } } }, "localname": "GainLossOnDerivativeInstrumentsNetPretax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows", "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeandComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r80" ], "calculation": { "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeandComprehensiveIncomeLoss": { "order": 3.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 }, "http://thecronosgroup.com/role/GeneralandAdministrativeExpensesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and Administrative Expense", "terseLabel": "General and administrative", "totalLabel": "Total" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeandComprehensiveIncomeLoss", "http://thecronosgroup.com/role/GeneralandAdministrativeExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r191", "r193" ], "calculation": { "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill", "periodEndLabel": "Balance at end of period", "periodStartLabel": "Balance at beginning of period", "terseLabel": "Goodwill", "verboseLabel": "Goodwill" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets", "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofGoodwillDetails", "http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAcquiredDuringPeriod": { "auth_ref": [ "r194" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.", "label": "Goodwill, Acquired During Period", "verboseLabel": "Additions" } } }, "localname": "GoodwillAcquiredDuringPeriod", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofGoodwillDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetImpairment": { "auth_ref": [], "calculation": { "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeandComprehensiveIncomeLoss": { "order": 6.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill.", "label": "Goodwill and Intangible Asset Impairment", "negatedLabel": "Impairment loss on goodwill and intangible assets", "terseLabel": "Impairment loss on goodwill and intangible assets" } } }, "localname": "GoodwillAndIntangibleAssetImpairment", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows", "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeandComprehensiveIncomeLoss", "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillNarrativeDetails", "http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Abstract]", "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": { "auth_ref": [ "r216" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for goodwill and intangible assets.", "label": "Goodwill and Intangible Assets Disclosure [Text Block]", "terseLabel": "Intangible Assets and Goodwill" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/IntangibleAssetsandGoodwill" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": { "auth_ref": [ "r108", "r197", "r206" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.", "label": "Goodwill and Intangible Assets, Policy [Policy Text Block]", "terseLabel": "Goodwill and indefinite life intangible assets" } } }, "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": { "auth_ref": [ "r196" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill, Foreign Currency Translation Gain (Loss)", "terseLabel": "Effect of foreign exchange" } } }, "localname": "GoodwillForeignCurrencyTranslationGainLoss", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofGoodwillDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillImpairmentLoss": { "auth_ref": [ "r102", "r192", "r195", "r199" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill, Impairment Loss", "negatedTerseLabel": "Impairment charges", "verboseLabel": "Goodwill, impairment loss" } } }, "localname": "GoodwillImpairmentLoss", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillNarrativeDetails", "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofGoodwillDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Goodwill [Line Items]", "terseLabel": "Goodwill [Line Items]" } } }, "localname": "GoodwillLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofGoodwillDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GoodwillRollForward": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Goodwill [Roll Forward]", "terseLabel": "Goodwill [Roll Forward]" } } }, "localname": "GoodwillRollForward", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofGoodwillDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r78" ], "calculation": { "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeandComprehensiveIncomeLoss": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "totalLabel": "Gross profit (loss)" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeandComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_IPOMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "First sale of stock by a private company to the public.", "label": "IPO [Member]", "terseLabel": "IPO" } } }, "localname": "IPOMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/InvestmentsandAdvancestoJointVenturesScheduleofEquityMethodInvestmentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill": { "auth_ref": [ "r102", "r214" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.", "label": "Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)", "terseLabel": "Impairment of intangible assets, indefinite-lived (excluding goodwill)" } } }, "localname": "ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r69", "r119", "r400", "r412", "r428" ], "calculation": { "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeandComprehensiveIncomeLoss": { "order": 1.0, "parentTag": "us-gaap_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "totalLabel": "Income (loss) before income taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeandComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromEquityMethodInvestments": { "auth_ref": [ "r70", "r102", "r148", "r174", "r411", "r425" ], "calculation": { "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeandComprehensiveIncomeLoss": { "order": 4.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).", "label": "Income (Loss) from Equity Method Investments", "negatedLabel": "Share of loss from investments in equity accounted investees", "negatedTerseLabel": "Share of loss from investments in equity accounted investees", "terseLabel": "Share of loss from investments in equity accounted investees", "verboseLabel": "Share of earnings (loss) from investments in equity accounted investees" } } }, "localname": "IncomeLossFromEquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows", "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeandComprehensiveIncomeLoss", "http://thecronosgroup.com/role/InvestmentsandAdvancestoJointVenturesScheduleofEquityMethodInvestmentsDetails", "http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Income Statement [Abstract]", "terseLabel": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r109", "r149", "r284" ], "calculation": { "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeandComprehensiveIncomeLoss": { "order": 2.0, "parentTag": "us-gaap_ProfitLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "terseLabel": "Income tax expense", "verboseLabel": "Income tax expense" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeandComprehensiveIncomeLoss", "http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities": { "auth_ref": [ "r101" ], "calculation": { "http://thecronosgroup.com/role/SupplementaryCashFlowInformationDetails": { "order": 4.0, "parentTag": "us-gaap_IncreaseDecreaseInOperatingCapital", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in obligations incurred but not paid, and operating obligations classified as other.", "label": "Increase (Decrease) in Accounts Payable and Other Operating Liabilities", "terseLabel": "Accounts payable and other liabilities" } } }, "localname": "IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SupplementaryCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r101" ], "calculation": { "http://thecronosgroup.com/role/SupplementaryCashFlowInformationDetails": { "order": 1.0, "parentTag": "us-gaap_IncreaseDecreaseInOperatingCapital", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedTerseLabel": "Accounts receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SupplementaryCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r101" ], "calculation": { "http://thecronosgroup.com/role/SupplementaryCashFlowInformationDetails": { "order": 3.0, "parentTag": "us-gaap_IncreaseDecreaseInOperatingCapital", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedTerseLabel": "Inventory" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SupplementaryCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapital": { "auth_ref": [ "r101" ], "calculation": { "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://thecronosgroup.com/role/SupplementaryCashFlowInformationDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The increase (decrease) during the reporting period of all assets and liabilities used in operating activities.", "label": "Increase (Decrease) in Operating Capital", "negatedTerseLabel": "Net changes in non-cash working capital", "negatedTotalLabel": "Total" } } }, "localname": "IncreaseDecreaseInOperatingCapital", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows", "http://thecronosgroup.com/role/SupplementaryCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "terseLabel": "Increase (Decrease) in Operating Capital [Abstract]" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SupplementaryCashFlowInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOtherReceivables": { "auth_ref": [ "r101" ], "calculation": { "http://thecronosgroup.com/role/SupplementaryCashFlowInformationDetails": { "order": 5.0, "parentTag": "us-gaap_IncreaseDecreaseInOperatingCapital", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in receivables classified as other.", "label": "Increase (Decrease) in Other Receivables", "negatedLabel": "Other receivables" } } }, "localname": "IncreaseDecreaseInOtherReceivables", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SupplementaryCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]" } } }, "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofChangesinEquityDeficit" ], "xbrltype": "stringItemType" }, "us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants": { "auth_ref": [ "r131" ], "calculation": { "http://thecronosgroup.com/role/EarningslossPerShareScheduleofEarningsLossPerShareDetails": { "order": 3.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-US": { "role": { "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of call options and warrants using the treasury stock method.", "label": "Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants", "terseLabel": "Dilutive effect of derivative liabilities (in shares)" } } }, "localname": "IncrementalCommonSharesAttributableToCallOptionsAndWarrants", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/EarningslossPerShareScheduleofEarningsLossPerShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": { "auth_ref": [ "r125", "r133" ], "calculation": { "http://thecronosgroup.com/role/EarningslossPerShareScheduleofEarningsLossPerShareDetails": { "order": 2.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-US": { "role": { "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.", "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements", "terseLabel": "Dilutive effect of awards (in shares)" } } }, "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/EarningslossPerShareScheduleofEarningsLossPerShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r204", "r212" ], "lang": { "en-US": { "role": { "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.", "label": "Indefinite-lived Intangible Assets [Axis]", "terseLabel": "Indefinite-lived Intangible Assets [Axis]" } } }, "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillNarrativeDetails", "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Indefinite-lived Intangible Assets [Line Items]", "terseLabel": "Indefinite-lived Intangible Assets [Line Items]" } } }, "localname": "IndefiniteLivedIntangibleAssetsByMajorClassLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": { "auth_ref": [ "r212" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.", "label": "Indefinite-lived Intangible Assets (Excluding Goodwill)", "terseLabel": "Net" } } }, "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r204", "r212" ], "lang": { "en-US": { "role": { "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.", "label": "Indefinite-lived Intangible Assets, Major Class Name [Domain]", "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]" } } }, "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillNarrativeDetails", "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsWrittenOffRelatedToSaleOfBusinessUnit": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of divestiture of an asset lacking physical substance and having a projected indefinite period of benefit to fair value. Excludes financial assets and goodwill.", "label": "Indefinite-lived Intangible Assets, Written off Related to Sale of Business Unit", "verboseLabel": "Disposal of intangible assets" } } }, "localname": "IndefiniteLivedIntangibleAssetsWrittenOffRelatedToSaleOfBusinessUnit", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IndefinitelivedIntangibleAssetsAcquired": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase in assets, excluding financial assets and goodwill, lacking physical substance with an indefinite life, from an acquisition.", "label": "Indefinite-lived Intangible Assets Acquired", "terseLabel": "Indefinite-lived intangible assets acquired, fair value" } } }, "localname": "IndefinitelivedIntangibleAssetsAcquired", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntangibleAssetsGrossExcludingGoodwill": { "auth_ref": [], "calculation": { "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetails": { "order": 1.0, "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill.", "label": "Intangible Assets, Gross (Excluding Goodwill)", "terseLabel": "Cost" } } }, "localname": "IntangibleAssetsGrossExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r201", "r207" ], "calculation": { "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 }, "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Intangible Assets, Net (Excluding Goodwill)", "terseLabel": "Intangible assets", "totalLabel": "Net" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets", "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Intangible Assets, Net (Excluding Goodwill) [Abstract]", "terseLabel": "Intangible Assets, Net (Excluding Goodwill) [Abstract]" } } }, "localname": "IntangibleAssetsNetExcludingGoodwillAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_InterestCostsCapitalized": { "auth_ref": [ "r358" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of interest capitalized during the period.", "label": "Interest Costs Capitalized", "terseLabel": "Interest costs capitalized" } } }, "localname": "InterestCostsCapitalized", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/PropertyPlantandEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r67", "r146", "r357", "r360", "r415" ], "calculation": { "http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails": { "order": 2.0, "parentTag": "us-gaap_InterestIncomeExpenseNonoperatingNet", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest Expense", "negatedLabel": "Interest expense" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestIncomeExpenseNonoperatingNet": { "auth_ref": [], "calculation": { "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeandComprehensiveIncomeLoss": { "order": 1.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 }, "http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The net amount of nonoperating interest income (expense).", "label": "Interest Income (Expense), Nonoperating, Net", "terseLabel": "Interest income, net", "totalLabel": "Interest income, net" } } }, "localname": "InterestIncomeExpenseNonoperatingNet", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeandComprehensiveIncomeLoss", "http://thecronosgroup.com/role/FinancialInstrumentsInterestRateRiskNarrativeDetails", "http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidCapitalized": { "auth_ref": [ "r88", "r105" ], "calculation": { "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of cash paid for interest capitalized, classified as investing activity.", "label": "Interest Paid, Capitalized, Investing Activities", "negatedTerseLabel": "Payment of accrued interest on construction loan payable" } } }, "localname": "InterestPaidCapitalized", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r96", "r99", "r105" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities", "terseLabel": "Interest paid" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoriesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Tangible personal property held for sale in the ordinary course of business, or in process of, or to be consumed in, production for sale.", "label": "Inventories [Member]", "terseLabel": "Dried Cannabis Flower" } } }, "localname": "InventoriesMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CommitmentsTakeorPayDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InventoryCurrentTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about inventory expected to be sold or consumed within one year or operating cycle, if longer.", "label": "Inventory, Current [Table]", "terseLabel": "Inventory, Current [Table]" } } }, "localname": "InventoryCurrentTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/InventoryDetails" ], "xbrltype": "stringItemType" }, "us-gaap_InventoryDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Inventory Disclosure [Abstract]", "terseLabel": "Inventory Disclosure [Abstract]" } } }, "localname": "InventoryDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_InventoryDisclosureTextBlock": { "auth_ref": [ "r190" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.", "label": "Inventory Disclosure [Text Block]", "terseLabel": "Inventory" } } }, "localname": "InventoryDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/Inventory" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryFinishedGoodsNetOfReserves": { "auth_ref": [ "r25", "r189" ], "calculation": { "http://thecronosgroup.com/role/InventoryDetails": { "order": 3.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.", "label": "Inventory, Finished Goods, Net of Reserves", "terseLabel": "Finished goods" } } }, "localname": "InventoryFinishedGoodsNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/InventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Inventory [Line Items]", "terseLabel": "Inventory [Line Items]" } } }, "localname": "InventoryLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/InventoryDetails" ], "xbrltype": "stringItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r3", "r47", "r186" ], "calculation": { "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets": { "order": 7.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://thecronosgroup.com/role/InventoryDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory, Net", "terseLabel": "Inventory", "totalLabel": "Total" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets", "http://thecronosgroup.com/role/InventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryRawMaterialsNetOfReserves": { "auth_ref": [ "r27", "r189" ], "calculation": { "http://thecronosgroup.com/role/InventoryDetails": { "order": 1.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.", "label": "Inventory, Raw Materials, Net of Reserves", "terseLabel": "Raw materials" } } }, "localname": "InventoryRawMaterialsNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/InventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventorySuppliesNetOfReserves": { "auth_ref": [ "r46", "r188" ], "calculation": { "http://thecronosgroup.com/role/InventoryDetails": { "order": 4.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of products used directly or indirectly in the manufacturing or production process, which may or may not become part of the final product. May also include items used in the storage, presentation or transportation of physical goods.", "label": "Inventory, Supplies, Net of Reserves", "terseLabel": "Supplies and consumables" } } }, "localname": "InventorySuppliesNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/InventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryWorkInProcessNetOfReserves": { "auth_ref": [ "r26", "r189" ], "calculation": { "http://thecronosgroup.com/role/InventoryDetails": { "order": 2.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.", "label": "Inventory, Work in Process, Net of Reserves", "terseLabel": "Work-in-progress" } } }, "localname": "InventoryWorkInProcessNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/InventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryWriteDown": { "auth_ref": [ "r187" ], "calculation": { "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeandComprehensiveIncomeLoss": { "order": 3.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.", "label": "Inventory Write-down", "terseLabel": "Inventory write-down" } } }, "localname": "InventoryWriteDown", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows", "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeandComprehensiveIncomeLoss", "http://thecronosgroup.com/role/InventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentIncomeInterest": { "auth_ref": [ "r81", "r145" ], "calculation": { "http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails": { "order": 1.0, "parentTag": "us-gaap_InterestIncomeExpenseNonoperatingNet", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.", "label": "Investment Income, Interest", "terseLabel": "Interest income" } } }, "localname": "InvestmentIncomeInterest", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentTypeAxis": { "auth_ref": [ "r435", "r436", "r437", "r442" ], "lang": { "en-US": { "role": { "documentation": "Information by type of investments.", "label": "Investment Type [Axis]", "terseLabel": "Investment Type [Axis]" } } }, "localname": "InvestmentTypeAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/OtherInvestmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentTypeCategorizationMember": { "auth_ref": [ "r435", "r436", "r437", "r442" ], "lang": { "en-US": { "role": { "documentation": "Asset obtained to generate income or appreciate in value.", "label": "Investments [Domain]", "terseLabel": "Investments [Domain]" } } }, "localname": "InvestmentTypeCategorizationMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/OtherInvestmentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InvestmentsAllOtherInvestmentsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Investments, All Other Investments [Abstract]" } } }, "localname": "InvestmentsAllOtherInvestmentsAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Investments, Debt and Equity Securities [Abstract]", "terseLabel": "Investments, Debt and Equity Securities [Abstract]" } } }, "localname": "InvestmentsDebtAndEquitySecuritiesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_InvestmentsInAndAdvancesToAffiliatesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Investments in and Advances to Affiliates [Abstract]", "terseLabel": "Investments in and Advances to Affiliates [Abstract]" } } }, "localname": "InvestmentsInAndAdvancesToAffiliatesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_InvestmentsInAndAdvancesToAffiliatesAmountOfEquity": { "auth_ref": [ "r438", "r439", "r440" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of Equity in net profit and loss for the period. Give totals for each group. If operations of any controlled companies are different in character from those of the company, group such affiliates (1) within divisions and (2) by type of activities.", "label": "Investments in and Advances to Affiliates, Amount of Equity", "terseLabel": "Share of accumulated net losses in excess of its equity investment and advances" } } }, "localname": "InvestmentsInAndAdvancesToAffiliatesAmountOfEquity", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/InvestmentsandAdvancestoJointVenturesScheduleofEquityMethodInvestmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Investments in and Advances to Affiliates, at Fair Value [Roll Forward]", "terseLabel": "Investments in and Advances to Affiliates, at Fair Value [Roll Forward]" } } }, "localname": "InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/InvestmentsandAdvancestoJointVenturesScheduleofAdvancestoJointVenturesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentsInAndAdvancesToAffiliatesLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Investments in and Advances to Affiliates [Line Items]", "terseLabel": "Investments in and Advances to Affiliates [Line Items]" } } }, "localname": "InvestmentsInAndAdvancesToAffiliatesLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/InvestmentsandAdvancestoJointVenturesScheduleofAdvancestoJointVenturesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentsInAndAdvancesToAffiliatesTable": { "auth_ref": [ "r441" ], "lang": { "en-US": { "role": { "documentation": "Listing of investments in affiliates and investments that are advances to affiliates.", "label": "Investments in and Advances to Affiliates [Table]", "terseLabel": "Investments in and Advances to Affiliates [Table]" } } }, "localname": "InvestmentsInAndAdvancesToAffiliatesTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/InvestmentsandAdvancestoJointVenturesScheduleofAdvancestoJointVenturesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentsInAndAdvancesToAffiliatesTextBlock": { "auth_ref": [ "r441" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of investments in and advances to affiliates. Does not include the tabular disclosure of the disaggregation of investments in and advances to affiliates across legal entities.", "label": "Investments in and Advances to Affiliates [Table Text Block]", "verboseLabel": "Schedule of Advances to Joint Ventures" } } }, "localname": "InvestmentsInAndAdvancesToAffiliatesTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/InvestmentsandAdvancestoJointVenturesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": { "auth_ref": [ "r173", "r401", "r416", "r444" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for investments in certain debt and equity securities.", "label": "Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]", "terseLabel": "Other Investments" } } }, "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/OtherInvestments" ], "xbrltype": "textBlockItemType" }, "us-gaap_LaborAndRelatedExpense": { "auth_ref": [ "r75" ], "calculation": { "http://thecronosgroup.com/role/GeneralandAdministrativeExpensesDetails": { "order": 1.0, "parentTag": "us-gaap_GeneralAndAdministrativeExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit.", "label": "Labor and Related Expense", "terseLabel": "Salaries and wages" } } }, "localname": "LaborAndRelatedExpense", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/GeneralandAdministrativeExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LandMember": { "auth_ref": [ "r247" ], "lang": { "en-US": { "role": { "documentation": "Part of earth's surface not covered by water.", "label": "Land [Member]", "terseLabel": "Land" } } }, "localname": "LandMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/PropertyPlantandEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LeaseholdImprovementsMember": { "auth_ref": [ "r218" ], "lang": { "en-US": { "role": { "documentation": "Additions or improvements to assets held under a lease arrangement.", "label": "Leasehold Improvements [Member]", "terseLabel": "Leasehold improvements" } } }, "localname": "LeaseholdImprovementsMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/PropertyPlantandEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LeasesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Leases [Abstract]", "terseLabel": "Leases [Abstract]" } } }, "localname": "LeasesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_LesseeLeaseDescriptionLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Lessee, Lease, Description [Line Items]", "terseLabel": "Lessee, Lease, Description [Line Items]" } } }, "localname": "LesseeLeaseDescriptionLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/LeasesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LesseeLeaseDescriptionTable": { "auth_ref": [ "r365" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about lessee's leases.", "label": "Lessee, Lease, Description [Table]", "terseLabel": "Lessee, Lease, Description [Table]" } } }, "localname": "LesseeLeaseDescriptionTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/LeasesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LesseeOperatingLeaseRenewalTerm": { "auth_ref": [ "r364" ], "lang": { "en-US": { "role": { "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Lessee, Operating Lease, Renewal Term", "terseLabel": "Operating lease, extension term (up to)" } } }, "localname": "LesseeOperatingLeaseRenewalTerm", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/LeasesDetails" ], "xbrltype": "durationItemType" }, "us-gaap_LesseeOperatingLeaseTermOfContract": { "auth_ref": [ "r364" ], "lang": { "en-US": { "role": { "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Lessee, Operating Lease, Term of Contract", "terseLabel": "Operating lease, term" } } }, "localname": "LesseeOperatingLeaseTermOfContract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/LeasesDetails" ], "xbrltype": "durationItemType" }, "us-gaap_LesseeOperatingLeasesTextBlock": { "auth_ref": [ "r366" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.", "label": "Lessee, Operating Leases [Text Block]", "terseLabel": "Leases" } } }, "localname": "LesseeOperatingLeasesTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/Leases" ], "xbrltype": "textBlockItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r38" ], "calculation": { "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Liabilities [Abstract]", "terseLabel": "Liabilities" } } }, "localname": "LiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r23", "r404", "r422" ], "calculation": { "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total liabilities and shareholders\u2019 equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r39" ], "calculation": { "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "Current liabilities" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LitigationStatusAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by status of pending, threatened, or settled litigation.", "label": "Litigation Status [Axis]", "terseLabel": "Litigation Status [Axis]" } } }, "localname": "LitigationStatusAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/ContingenciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LitigationStatusDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Status of pending, threatened, or settled litigation.", "label": "Litigation Status [Domain]", "terseLabel": "Litigation Status [Domain]" } } }, "localname": "LitigationStatusDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/ContingenciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LoansNotesTradeAndOtherReceivablesExcludingAllowanceForCreditLossesTextBlock": { "auth_ref": [ "r169" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for claims held for amounts due a company, excluding disclosure for allowance for credit losses. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Also excludes disclosure for financing receivables.", "label": "Loans, Notes, Trade and Other Receivables, Excluding Allowance for Credit Losses [Text Block]", "terseLabel": "Loans Receivable, net" } } }, "localname": "LoansNotesTradeAndOtherReceivablesExcludingAllowanceForCreditLossesTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/LoansReceivablenet" ], "xbrltype": "textBlockItemType" }, "us-gaap_LoansReceivableMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "An amount of money or property, or a portion thereof, leant to a borrower (debtor) in exchange for a promise to repay the amount borrowed plus interest at a date certain in the future.", "label": "Loans Receivable [Member]", "terseLabel": "Loans Receivable" } } }, "localname": "LoansReceivableMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/InvestmentsandAdvancestoJointVenturesNarrativeDetails", "http://thecronosgroup.com/role/LoansReceivablenetDetails", "http://thecronosgroup.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock": { "auth_ref": [ "r160" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of long-lived assets, excluding financial instruments, long-term customer relationships of a financial institution, mortgage rights, deferred policy acquisition costs, and deferred tax assets, by geographic areas located in the entity's country of domicile and foreign countries in which the entity holds assets.", "label": "Long-lived Assets by Geographic Areas [Table Text Block]", "terseLabel": "Schedule of Long-lived Assets by Geographic Areas" } } }, "localname": "LongLivedAssetsByGeographicAreasTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SegmentInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LongTermPurchaseCommitmentAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The minimum amount the entity agreed to spend under the long-term purchase commitment.", "label": "Long-term Purchase Commitment, Amount", "terseLabel": "Amount of commitment" } } }, "localname": "LongTermPurchaseCommitmentAmount", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CommitmentsRDCommitmentsandAltriaConsultingServicesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by category of items purchased under a long-term purchase commitment.", "label": "Category of Item Purchased [Axis]", "terseLabel": "Category of Item Purchased [Axis]" } } }, "localname": "LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CommitmentsRDCommitmentsandAltriaConsultingServicesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "General description of the goods or services to be purchased from the counterparty to the long-term purchase commitment.", "label": "Long-term Purchase Commitment, Category of Item Purchased [Domain]", "terseLabel": "Long-term Purchase Commitment, Category of Item Purchased [Domain]" } } }, "localname": "LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CommitmentsRDCommitmentsandAltriaConsultingServicesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LongTermPurchaseCommitmentLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Long-term Purchase Commitment [Line Items]", "terseLabel": "Long-term Purchase Commitment [Line Items]" } } }, "localname": "LongTermPurchaseCommitmentLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CommitmentsRDCommitmentsandAltriaConsultingServicesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongTermPurchaseCommitmentTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Schedule setting forth key provisions of an arrangement under which the entity has agreed to purchase goods or services over a period of time greater than one year or the normal operating cycle, if longer, including the item for which expenditures will be made, minimum quantities, milestones, time period and committed amount.", "label": "Long-term Purchase Commitment [Table]", "terseLabel": "Long-term Purchase Commitment [Table]" } } }, "localname": "LongTermPurchaseCommitmentTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CommitmentsRDCommitmentsandAltriaConsultingServicesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermPurchaseCommitmentPeriod": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Period covered by the long-term purchase commitment, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Long-term Purchase Commitment, Period", "terseLabel": "Research funding period" } } }, "localname": "LongtermPurchaseCommitmentPeriod", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CommitmentsRDCommitmentsandAltriaConsultingServicesDetails" ], "xbrltype": "durationItemType" }, "us-gaap_LossContingenciesByNatureOfContingencyAxis": { "auth_ref": [ "r228", "r229", "r230", "r232", "r233", "r234", "r236", "r239", "r240" ], "lang": { "en-US": { "role": { "documentation": "Information by type of existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur.", "label": "Loss Contingency Nature [Axis]", "terseLabel": "Loss Contingency Nature [Axis]" } } }, "localname": "LossContingenciesByNatureOfContingencyAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/ContingenciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingenciesLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Loss Contingencies [Line Items]", "terseLabel": "Loss Contingencies [Line Items]" } } }, "localname": "LossContingenciesLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/ContingenciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingenciesTable": { "auth_ref": [ "r228", "r229", "r230", "r232", "r233", "r234", "r236", "r239", "r240" ], "lang": { "en-US": { "role": { "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.", "label": "Loss Contingencies [Table]", "terseLabel": "Loss Contingencies [Table]" } } }, "localname": "LossContingenciesTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/ContingenciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingencyAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Loss Contingency [Abstract]", "terseLabel": "Loss Contingency [Abstract]" } } }, "localname": "LossContingencyAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_LossContingencyDamagesSoughtValue": { "auth_ref": [ "r228", "r231", "r235" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The value (monetary amount) of the award the plaintiff seeks in the legal matter.", "label": "Loss Contingency, Damages Sought, Value", "terseLabel": "Damages sought" } } }, "localname": "LossContingencyDamagesSoughtValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/ContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LossContingencyDisclosures": { "auth_ref": [ "r237", "r238" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for loss and gain contingencies. Describes any existing condition, situation, or set of circumstances involving uncertainty as of the balance sheet date (or prior to issuance of the financial statements) as to a probable or reasonably possible loss incurred by an entity that will ultimately be resolved when one or more future events occur or fail to occur, and typically discloses the amount of loss recorded or a range of possible loss, or an assertion that no reasonable estimate can be made.", "label": "Contingencies Disclosure [Text Block]", "terseLabel": "Contingencies" } } }, "localname": "LossContingencyDisclosures", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/Contingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_LossContingencyNatureDomain": { "auth_ref": [ "r228", "r229", "r230", "r232", "r233", "r234", "r236", "r239", "r240" ], "lang": { "en-US": { "role": { "documentation": "An existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur. Resolution of the uncertainty may confirm the incurrence of a loss or impairment of an asset or the incurrence of a liability.", "label": "Loss Contingency, Nature [Domain]", "terseLabel": "Loss Contingency, Nature [Domain]" } } }, "localname": "LossContingencyNatureDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/ContingenciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LossContingencyNewClaimsFiledNumber": { "auth_ref": [ "r231" ], "lang": { "en-US": { "role": { "documentation": "The total number of new claims filed pertaining to a loss contingency during the period.", "label": "Loss Contingency, New Claims Filed, Number", "terseLabel": "Number of putative class action complaints" } } }, "localname": "LossContingencyNewClaimsFiledNumber", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/ContingenciesDetails" ], "xbrltype": "integerItemType" }, "us-gaap_LossContingencyNumberOfPlaintiffs": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Number of plaintiffs that have filed claims pertaining to a loss contingency.", "label": "Loss Contingency, Number of Plaintiffs", "terseLabel": "Number of alleged shareholders" } } }, "localname": "LossContingencyNumberOfPlaintiffs", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/ContingenciesDetails" ], "xbrltype": "integerItemType" }, "us-gaap_MeasurementInputExpectedDividendRateMember": { "auth_ref": [ "r335" ], "lang": { "en-US": { "role": { "documentation": "Measurement input using expected dividend rate to be paid to holder of share per year.", "label": "Measurement Input, Expected Dividend Rate [Member]", "terseLabel": "Expected dividend yield" } } }, "localname": "MeasurementInputExpectedDividendRateMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputExpectedTermMember": { "auth_ref": [ "r335" ], "lang": { "en-US": { "role": { "documentation": "Measurement input using period financial instrument is expected to be outstanding. Excludes maturity date.", "label": "Measurement Input, Expected Term [Member]", "terseLabel": "Weight average expected life (in years)" } } }, "localname": "MeasurementInputExpectedTermMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputPriceVolatilityMember": { "auth_ref": [ "r335" ], "lang": { "en-US": { "role": { "documentation": "Measurement input using rate at which price of security will increase (decrease) for given set of returns.", "label": "Measurement Input, Price Volatility [Member]", "terseLabel": "Expected annualized volatility" } } }, "localname": "MeasurementInputPriceVolatilityMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputRiskFreeInterestRateMember": { "auth_ref": [ "r335" ], "lang": { "en-US": { "role": { "documentation": "Measurement input using interest rate on instrument with zero risk of financial loss.", "label": "Measurement Input, Risk Free Interest Rate [Member]", "terseLabel": "Weighted average risk-free interest rate" } } }, "localname": "MeasurementInputRiskFreeInterestRateMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputSharePriceMember": { "auth_ref": [ "r335" ], "lang": { "en-US": { "role": { "documentation": "Measurement input using share price of saleable stock.", "label": "Measurement Input, Share Price [Member]", "terseLabel": "Share price at valuation date (per share in C$)" } } }, "localname": "MeasurementInputSharePriceMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputTypeAxis": { "auth_ref": [ "r335" ], "lang": { "en-US": { "role": { "documentation": "Information by type of measurement input used to determine value of asset and liability.", "label": "Measurement Input Type [Axis]", "terseLabel": "Measurement Input Type [Axis]" } } }, "localname": "MeasurementInputTypeAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_MeasurementInputTypeDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Measurement input used to determine value of asset and liability.", "label": "Measurement Input Type [Domain]", "terseLabel": "Measurement Input Type [Domain]" } } }, "localname": "MeasurementInputTypeDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MinorityInterest": { "auth_ref": [ "r45", "r403", "r421" ], "calculation": { "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).", "label": "Stockholders' Equity Attributable to Noncontrolling Interest", "terseLabel": "Non-controlling interests" } } }, "localname": "MinorityInterest", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.", "label": "Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners", "terseLabel": "Ownership interest" } } }, "localname": "MinorityInterestOwnershipPercentageByNoncontrollingOwners", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/LoansReceivablenetDetails" ], "xbrltype": "percentItemType" }, "us-gaap_NatureOfOperations": { "auth_ref": [ "r136", "r142" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.", "label": "Nature of Operations [Text Block]", "verboseLabel": "Background" } } }, "localname": "NatureOfOperations", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/Background" ], "xbrltype": "textBlockItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r98" ], "calculation": { "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Cash flows provided (used) in financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "Financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r98" ], "calculation": { "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Cash flows provided (used) in investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "Investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r98", "r100", "r103" ], "calculation": { "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 4.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Cash flows used in operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r59", "r62", "r71", "r103", "r133", "r413", "r426" ], "calculation": { "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeandComprehensiveIncomeLoss": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "totalLabel": "Cronos Group" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeandComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": { "auth_ref": [ "r59", "r62", "r297", "r309" ], "calculation": { "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeandComprehensiveIncomeLoss": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.", "label": "Net Income (Loss) Attributable to Noncontrolling Interest", "terseLabel": "Non-controlling interests" } } }, "localname": "NetIncomeLossAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeandComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAttributableToReportingEntityAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest [Abstract]", "terseLabel": "Net income (loss) attributable to:" } } }, "localname": "NetIncomeLossAttributableToReportingEntityAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeandComprehensiveIncomeLoss" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "auth_ref": [ "r119", "r122" ], "calculation": { "http://thecronosgroup.com/role/EarningslossPerShareScheduleofEarningsLossPerShareDetails": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.", "label": "Net Income (Loss) Available to Common Stockholders, Basic", "terseLabel": "Net income (loss) attributable to common shareholders of Cronos\u00a0Group", "verboseLabel": "Net income (loss) used in the computation of basic earnings per share" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/EarningslossPerShareScheduleofEarningsLossPerShareDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Net Income (Loss) Available to Common Stockholders, Diluted [Abstract]", "terseLabel": "Net Income (Loss) Available to Common Stockholders, Diluted [Abstract]" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersDilutedAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/EarningslossPerShareScheduleofEarningsLossPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted": { "auth_ref": [ "r122", "r123", "r128", "r131" ], "calculation": { "http://thecronosgroup.com/role/EarningslossPerShareScheduleofEarningsLossPerShareDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) from continuing operations available to common shareholders.", "label": "Net Income (Loss) from Continuing Operations Available to Common Shareholders, Diluted", "totalLabel": "Net income (loss) used in the computation of diluted income per share" } } }, "localname": "NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/EarningslossPerShareScheduleofEarningsLossPerShareDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "New Accounting Pronouncements and Changes in Accounting Principles [Abstract]", "terseLabel": "New Accounting Pronouncements and Changes in Accounting Principles [Abstract]" } } }, "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": { "auth_ref": [ "r120" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.", "label": "New Accounting Pronouncements and Changes in Accounting Principles [Text Block]", "terseLabel": "New Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/NewAccountingPronouncements" ], "xbrltype": "textBlockItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "New Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NoncontrollingInterestMember": { "auth_ref": [ "r290" ], "lang": { "en-US": { "role": { "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.", "label": "Noncontrolling Interest [Member]", "terseLabel": "Non-controlling interests" } } }, "localname": "NoncontrollingInterestMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofChangesinEquityDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_NoncurrentAssets": { "auth_ref": [ "r158" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets.", "label": "Long-Lived Assets", "terseLabel": "Long-lived assets" } } }, "localname": "NoncurrentAssets", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SegmentInformationScheduleofLonglivedAssetsbyGeographicAreasDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonmonetaryTransactionByTypeTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Transactions involving exchanges with other entities that involve principally nonmonetary assets or liabilities or relate to a transfer of nonmonetary assets for which the Entity receives no assets in return.", "label": "Nonmonetary Transaction, by Type [Table]", "terseLabel": "Nonmonetary Transaction, by Type [Table]" } } }, "localname": "NonmonetaryTransactionByTypeTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/NonmonetaryTransactionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NonmonetaryTransactionGainLossRecognizedOnTransfer": { "auth_ref": [ "r369" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Disclosure of the difference in values (gain (loss)) between the nonmonetary assets or liabilities exchanged with another entity inclusive of boot (small monetary consideration).", "label": "Nonmonetary Transaction, Gain (Loss) Recognized on Transfer", "terseLabel": "Gain (loss) recognized on transfer" } } }, "localname": "NonmonetaryTransactionGainLossRecognizedOnTransfer", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/NonmonetaryTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonmonetaryTransactionGrossOperatingRevenueRecognized": { "auth_ref": [ "r370" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The amount of gross operating revenue recognized in a nonmonetary transaction.", "label": "Nonmonetary Transaction, Gross Operating Revenue Recognized", "terseLabel": "Revenue recognized" } } }, "localname": "NonmonetaryTransactionGrossOperatingRevenueRecognized", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/NonmonetaryTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonmonetaryTransactionLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Nonmonetary Transaction [Line Items]", "terseLabel": "Nonmonetary Transaction [Line Items]" } } }, "localname": "NonmonetaryTransactionLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/NonmonetaryTransactionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NonmonetaryTransactionTypeAxis": { "auth_ref": [ "r368" ], "lang": { "en-US": { "role": { "documentation": "Information by nature of the nonmonetary transaction or group of similar transactions, such as a barter or exchange.", "label": "Nonmonetary Transaction Type [Axis]", "terseLabel": "Nonmonetary Transaction Type [Axis]" } } }, "localname": "NonmonetaryTransactionTypeAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/NonmonetaryTransactionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NonmonetaryTransactionTypeDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Identifies the nature of the nonmonetary transaction or group of similar transactions, such as a barter or exchange.", "label": "Nonmonetary Transaction Type [Domain]", "terseLabel": "Nonmonetary Transaction Type [Domain]" } } }, "localname": "NonmonetaryTransactionTypeDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/NonmonetaryTransactionsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NonmonetaryTransactionsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Nonmonetary Transactions [Abstract]" } } }, "localname": "NonmonetaryTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_NonmonetaryTransactionsDisclosureTextBlock": { "auth_ref": [ "r371" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for exchanges with other entities that involve principally nonmonetary assets or liabilities or relate to a transfer of nonmonetary assets for which the entity receives no assets in return.", "label": "Nonmonetary Transactions Disclosure [Text Block]", "terseLabel": "Non-monetary Transactions" } } }, "localname": "NonmonetaryTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/NonmonetaryTransactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r82" ], "calculation": { "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeandComprehensiveIncomeLoss": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "Nonoperating Income (Expense)", "totalLabel": "Total other income (loss)" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeandComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Nonoperating Income (Expense) [Abstract]", "terseLabel": "Other income (expense)" } } }, "localname": "NonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeandComprehensiveIncomeLoss" ], "xbrltype": "stringItemType" }, "us-gaap_NotesAndLoansReceivableNetCurrent": { "auth_ref": [ "r4", "r5", "r17", "r164", "r165", "r409" ], "calculation": { "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://thecronosgroup.com/role/LoansReceivablenetDetails": { "order": 1.0, "parentTag": "us-gaap_NotesReceivableNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, after allowance for credit loss, of financing receivable, classified as current. Includes, but is not limited to, notes and loan receivable.", "label": "Financing Receivable, after Allowance for Credit Loss, Current", "terseLabel": "Current portion of loans receivable", "totalLabel": "Total current portion of loans receivable" } } }, "localname": "NotesAndLoansReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets", "http://thecronosgroup.com/role/LoansReceivablenetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesAndLoansReceivableNetCurrentAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Financing Receivable, after Allowance for Credit Loss, Current [Abstract]", "terseLabel": "Current portion" } } }, "localname": "NotesAndLoansReceivableNetCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/LoansReceivablenetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NotesAndLoansReceivableNetNoncurrent": { "auth_ref": [ "r18" ], "calculation": { "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets": { "order": 7.0, "parentTag": "us-gaap_Assets", "weight": 1.0 }, "http://thecronosgroup.com/role/LoansReceivablenetDetails": { "order": 2.0, "parentTag": "us-gaap_NotesReceivableNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, after allowance for credit loss, of financing receivable, classified as noncurrent.", "label": "Financing Receivable, after Allowance for Credit Loss, Noncurrent", "terseLabel": "Loan receivable, net", "totalLabel": "Total long-term portion of loans receivable" } } }, "localname": "NotesAndLoansReceivableNetNoncurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets", "http://thecronosgroup.com/role/LoansReceivablenetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesAndLoansReceivableNetNoncurrentAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Financing Receivable, after Allowance for Credit Loss, Noncurrent [Abstract]", "terseLabel": "Long term portion" } } }, "localname": "NotesAndLoansReceivableNetNoncurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/LoansReceivablenetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NotesReceivableNet": { "auth_ref": [ "r18", "r164", "r184" ], "calculation": { "http://thecronosgroup.com/role/LoansReceivablenetDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, after allowance for credit loss, of financing receivable. Excludes financing receivable covered under loss sharing agreement.", "label": "Financing Receivable, after Allowance for Credit Loss", "totalLabel": "Total loans receivable" } } }, "localname": "NotesReceivableNet", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/LoansReceivablenetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NumberOfBusinessesAcquired": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The number of businesses acquired by the entity during the period.", "label": "Number of Businesses Acquired", "terseLabel": "Number of subsidiaries acquired" } } }, "localname": "NumberOfBusinessesAcquired", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SharebasedPaymentsRestrictedShareUnitsNarrativeDetails" ], "xbrltype": "integerItemType" }, "us-gaap_NumberOfReportableSegments": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.", "label": "Number of Reportable Segments", "terseLabel": "Number of reportable segments" } } }, "localname": "NumberOfReportableSegments", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SegmentInformationNarrativeDetails" ], "xbrltype": "integerItemType" }, "us-gaap_NumberOfReportingUnits": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Number of reporting units tested for impairment of goodwill. A reporting unit is an operating segment or one level below an operating segment.", "label": "Number of Reporting Units", "terseLabel": "Number of reporting units for impairment testing" } } }, "localname": "NumberOfReportingUnits", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "integerItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeandComprehensiveIncomeLoss": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Operating Expenses", "totalLabel": "Total operating expenses" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeandComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Operating Expenses [Abstract]", "terseLabel": "Operating expenses" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeandComprehensiveIncomeLoss" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [], "calculation": { "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeandComprehensiveIncomeLoss": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Operating loss" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeandComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r363" ], "calculation": { "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Operating Lease, Liability, Current", "verboseLabel": "Current portion of lease obligation" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r363" ], "calculation": { "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Operating Lease, Liability, Noncurrent", "verboseLabel": "Lease obligation" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r362" ], "calculation": { "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating Lease, Right-of-Use Asset", "verboseLabel": "Right-of-use assets" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingSegmentsMember": { "auth_ref": [ "r144", "r154" ], "lang": { "en-US": { "role": { "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Operating Segments [Member]", "terseLabel": "Operating Segments" } } }, "localname": "OperatingSegmentsMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]", "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r1", "r117", "r142", "r315" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows. Describes procedure if disclosures are provided in more than one note to the financial statements.", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]", "terseLabel": "Summary of Significant Accounting Policies" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SummaryofSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": { "auth_ref": [ "r57", "r65" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax", "verboseLabel": "Net unrealized (loss) gain" } } }, "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": { "auth_ref": [ "r52", "r356" ], "calculation": { "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeandComprehensiveIncomeLoss": { "order": 1.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax", "terseLabel": "Foreign exchange gain (loss) on translation", "verboseLabel": "Foreign exchange gain (loss) on translation" } } }, "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeandComprehensiveIncomeLoss", "http://thecronosgroup.com/role/FinancialInstrumentsCurrencyRateRiskNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r60", "r63", "r65", "r241" ], "calculation": { "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeandComprehensiveIncomeLoss": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss), Net of Tax", "totalLabel": "Total other comprehensive income (loss)", "verboseLabel": "Other comprehensive income (loss)" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofChangesinEquityDeficit", "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeandComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]", "terseLabel": "Other comprehensive income (loss)" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeandComprehensiveIncomeLoss" ], "xbrltype": "stringItemType" }, "us-gaap_OtherGeneralAndAdministrativeExpense": { "auth_ref": [ "r80" ], "calculation": { "http://thecronosgroup.com/role/GeneralandAdministrativeExpensesDetails": { "order": 4.0, "parentTag": "us-gaap_GeneralAndAdministrativeExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of general and administrative expense classified as other.", "label": "Other General and Administrative Expense", "terseLabel": "Other" } } }, "localname": "OtherGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/GeneralandAdministrativeExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNoncashIncomeExpense": { "auth_ref": [ "r103" ], "calculation": { "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.", "label": "Other Noncash Income (Expense)", "negatedLabel": "Other, net" } } }, "localname": "OtherNoncashIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNonoperatingIncomeExpense": { "auth_ref": [ "r84" ], "calculation": { "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeandComprehensiveIncomeLoss": { "order": 5.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.", "label": "Other Nonoperating Income (Expense)", "terseLabel": "Other income (loss)" } } }, "localname": "OtherNonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeandComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherReceivablesNetCurrent": { "auth_ref": [], "calculation": { "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.", "label": "Other Receivables, Net, Current", "terseLabel": "Other receivables" } } }, "localname": "OtherReceivablesNetCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDebtIssuanceCosts": { "auth_ref": [ "r94" ], "calculation": { "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.", "label": "Payments of Debt Issuance Costs", "negatedTerseLabel": "Transaction costs paid on construction loan payable" } } }, "localname": "PaymentsOfDebtIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfStockIssuanceCosts": { "auth_ref": [ "r95" ], "calculation": { "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.", "label": "Payments of Stock Issuance Costs", "negatedLabel": "Share issuance costs" } } }, "localname": "PaymentsOfStockIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": { "auth_ref": [ "r92" ], "calculation": { "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.", "label": "Payment, Tax Withholding, Share-based Payment Arrangement", "negatedTerseLabel": "Withholding taxes paid on options" } } }, "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireEquityMethodInvestments": { "auth_ref": [ "r87" ], "calculation": { "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.", "label": "Payments to Acquire Equity Method Investments", "negatedTerseLabel": "Investments in equity accounted investees" } } }, "localname": "PaymentsToAcquireEquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireIntangibleAssets": { "auth_ref": [ "r88" ], "calculation": { "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.", "label": "Payments to Acquire Intangible Assets", "negatedTerseLabel": "Purchase of intangible assets" } } }, "localname": "PaymentsToAcquireIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireInterestInJointVenture": { "auth_ref": [ "r87" ], "calculation": { "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow associated with the investment in or advances to an entity in which the reporting entity shares control of the entity with another party or group.", "label": "Payments to Acquire Interest in Joint Venture", "negatedTerseLabel": "Advances to joint ventures" } } }, "localname": "PaymentsToAcquireInterestInJointVenture", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireLoansReceivable": { "auth_ref": [ "r86" ], "calculation": { "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow for the purchase of loan receivable arising from the financing of goods and services.", "label": "Payments to Acquire Loans Receivable", "negatedTerseLabel": "Advances on loans receivable", "terseLabel": "Draw downs" } } }, "localname": "PaymentsToAcquireLoansReceivable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows", "http://thecronosgroup.com/role/LoansReceivablenetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireMarketableSecurities": { "auth_ref": [ "r171" ], "calculation": { "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of cash outflow for purchase of marketable security.", "label": "Payments to Acquire Marketable Securities", "negatedTerseLabel": "Purchase of short-term investments" } } }, "localname": "PaymentsToAcquireMarketableSecurities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r88" ], "calculation": { "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedTerseLabel": "Purchase of property, plant and equipment" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PendingLitigationMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Risk of loss associated with the outcome of pending litigation against the entity, for example, but not limited to, litigation in arbitration or within the trial process.", "label": "Pending Litigation [Member]", "terseLabel": "Pending Litigation" } } }, "localname": "PendingLitigationMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/ContingenciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PlanNameAxis": { "auth_ref": [ "r257", "r279" ], "lang": { "en-US": { "role": { "documentation": "Information by plan name for share-based payment arrangement.", "label": "Plan Name [Axis]", "terseLabel": "Plan Name [Axis]" } } }, "localname": "PlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SharebasedPaymentsStockOptionsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PlanNameDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Plan name for share-based payment arrangement.", "label": "Plan Name [Domain]", "terseLabel": "Plan Name [Domain]" } } }, "localname": "PlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SharebasedPaymentsStockOptionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "auth_ref": [ "r6", "r31", "r32" ], "calculation": { "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.", "label": "Prepaid Expense and Other Assets, Current", "terseLabel": "Prepaids and other assets" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrivatePlacementMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts.", "label": "Private Placement [Member]", "terseLabel": "Private Placements" } } }, "localname": "PrivatePlacementMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CommitmentsUseofPublicityRightsinBrandDevelopmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "auth_ref": [ "r89" ], "calculation": { "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The cash inflow from the additional capital contribution to the entity.", "label": "Proceeds from Issuance of Common Stock", "terseLabel": "Proceeds from Altria Investment" } } }, "localname": "ProceedsFromIssuanceOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromMinorityShareholders": { "auth_ref": [ "r91" ], "calculation": { "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow from a noncontrolling interest. Includes, but is not limited to, purchase of additional shares or other increase in noncontrolling interest ownership.", "label": "Proceeds from Noncontrolling Interests", "terseLabel": "Advance from non-controlling interests" } } }, "localname": "ProceedsFromMinorityShareholders", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromNotesPayable": { "auth_ref": [ "r90" ], "calculation": { "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The cash inflow from a borrowing supported by a written promise to pay an obligation.", "label": "Proceeds from Notes Payable", "terseLabel": "Advance of loans payable" } } }, "localname": "ProceedsFromNotesPayable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities": { "auth_ref": [], "calculation": { "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period.", "label": "Proceeds from Sale and Maturity of Marketable Securities", "terseLabel": "Proceeds from disposal of short-term investments" } } }, "localname": "ProceedsFromSaleAndMaturityOfMarketableSecurities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductAndServiceOtherMember": { "auth_ref": [ "r247" ], "lang": { "en-US": { "role": { "documentation": "Article or substance produced by nature, labor or machinery and act of providing assistance, classified as other.", "label": "Product and Service, Other [Member]", "terseLabel": "Other" } } }, "localname": "ProductAndServiceOtherMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r59", "r62", "r97", "r150", "r155", "r292", "r296", "r298", "r309", "r310" ], "calculation": { "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeandComprehensiveIncomeLoss": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "terseLabel": "Net (loss) income", "totalLabel": "Net income (loss)" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows", "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofChangesinEquityDeficit", "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeandComprehensiveIncomeLoss", "http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Property, Plant and Equipment [Abstract]", "terseLabel": "Property, Plant and Equipment [Abstract]" } } }, "localname": "PropertyPlantAndEquipmentAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentAdditions": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of acquisition of long-lived, physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.", "label": "Property, Plant and Equipment, Additions", "terseLabel": "Purchase of property, plant and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentAdditions", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r36", "r220" ], "lang": { "en-US": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Property, Plant and Equipment, Type [Axis]", "terseLabel": "Property, Plant and Equipment, Type [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/LeasesDetails", "http://thecronosgroup.com/role/PropertyPlantandEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "auth_ref": [ "r222" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, accounting policies and methodology, roll forwards, depreciation, depletion and amortization expense, including composite depreciation, accumulated depreciation, depletion and amortization expense, useful lives and method used, income statement disclosures, assets held for sale and public utility disclosures.", "label": "Property, Plant and Equipment Disclosure [Text Block]", "terseLabel": "Property, Plant and Equipment" } } }, "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/PropertyPlantandEquipment" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r35", "r218" ], "calculation": { "http://thecronosgroup.com/role/PropertyPlantandEquipmentDetails": { "order": 2.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Gross", "terseLabel": "Cost" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/PropertyPlantandEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property, Plant and Equipment [Line Items]", "terseLabel": "Property, Plant and Equipment [Line Items]" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/PropertyPlantandEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r12", "r13", "r220", "r423" ], "calculation": { "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 }, "http://thecronosgroup.com/role/PropertyPlantandEquipmentDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Net", "totalLabel": "Total", "verboseLabel": "Property, plant and equipment" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets", "http://thecronosgroup.com/role/PropertyPlantandEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "auth_ref": [ "r12", "r220" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table Text Block]", "verboseLabel": "Schedule of Property, Plant & Equipment, Useful Lives" } } }, "localname": "PropertyPlantAndEquipmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/PropertyPlantandEquipmentTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r12", "r218" ], "lang": { "en-US": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.", "label": "Property, Plant and Equipment, Type [Domain]", "terseLabel": "Property, Plant and Equipment, Type [Domain]" } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/LeasesDetails", "http://thecronosgroup.com/role/PropertyPlantandEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ProvisionForDoubtfulAccounts": { "auth_ref": [ "r73", "r181" ], "calculation": { "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.", "label": "Accounts Receivable, Credit Loss Expense (Reversal)", "terseLabel": "Provision for doubtful accounts" } } }, "localname": "ProvisionForDoubtfulAccounts", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PublicUtilitiesInventoryAxis": { "auth_ref": [ "r28" ], "lang": { "en-US": { "role": { "documentation": "Information by type of inventory held.", "label": "Inventory [Axis]", "terseLabel": "Inventory [Axis]" } } }, "localname": "PublicUtilitiesInventoryAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/InventoryDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PublicUtilitiesInventoryTypeDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Tangible personal property that is held for sale in the ordinary course of business, in process of production for such sale or is to be currently consumed in the production of goods or services to be available for sale.", "label": "Inventory [Domain]", "terseLabel": "Inventory [Domain]" } } }, "localname": "PublicUtilitiesInventoryTypeDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/InventoryDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ReceivableTypeDomain": { "auth_ref": [ "r44" ], "lang": { "en-US": { "role": { "documentation": "Financing arrangement representing a contractual right to receive money either on demand or on fixed and determinable dates.", "label": "Receivable [Domain]", "terseLabel": "Receivable [Domain]" } } }, "localname": "ReceivableTypeDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/InvestmentsandAdvancestoJointVenturesNarrativeDetails", "http://thecronosgroup.com/role/LoansReceivablenetDetails", "http://thecronosgroup.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ReceivablesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Receivables [Abstract]", "terseLabel": "Receivables [Abstract]" } } }, "localname": "ReceivablesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]", "terseLabel": "AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]" } } }, "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RecordedUnconditionalPurchaseObligation": { "auth_ref": [ "r226" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of the recorded obligation to transfer funds in the future for fixed or minimum amounts or quantities of goods or services at fixed or minimum prices (for example, as in take-or-pay contracts or throughput contracts).", "label": "Recorded Unconditional Purchase Obligation", "terseLabel": "Take or pay supply agreement, purchase amount" } } }, "localname": "RecordedUnconditionalPurchaseObligation", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CommitmentsTakeorPayDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RecordedUnconditionalPurchaseObligationByCategoryOfItemPurchasedAxis": { "auth_ref": [ "r225", "r226" ], "lang": { "en-US": { "role": { "documentation": "Pertinent information about recorded unconditional purchase arrangements to acquire goods or services, by category of goods or services.", "label": "Recorded Unconditional Purchase Obligation by Category of Item Purchased [Axis]", "terseLabel": "Recorded Unconditional Purchase Obligation by Category of Item Purchased [Axis]" } } }, "localname": "RecordedUnconditionalPurchaseObligationByCategoryOfItemPurchasedAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CommitmentsTakeorPayDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RecordedUnconditionalPurchaseObligationLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Recorded Unconditional Purchase Obligation [Line Items]", "terseLabel": "Recorded Unconditional Purchase Obligation [Line Items]" } } }, "localname": "RecordedUnconditionalPurchaseObligationLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CommitmentsTakeorPayDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RecordedUnconditionalPurchaseObligationTable": { "auth_ref": [ "r225", "r226" ], "lang": { "en-US": { "role": { "documentation": "Describes each recorded unconditional purchase obligation arrangement to purchase goods and services that extend over multiple periods, any assets pledged to secure payment, and the fixed or determinable amount of payments due in each of the next five years and thereafter.", "label": "Recorded Unconditional Purchase Obligation [Table]", "terseLabel": "Recorded Unconditional Purchase Obligation [Table]" } } }, "localname": "RecordedUnconditionalPurchaseObligationTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CommitmentsTakeorPayDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r379" ], "lang": { "en-US": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Domain]", "terseLabel": "Related Party [Domain]" } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/RelatedPartyTransactionsandBalancesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionAxis": { "auth_ref": [ "r253", "r374", "r375" ], "lang": { "en-US": { "role": { "documentation": "Information by type of related party transaction.", "label": "Related Party Transaction [Axis]", "terseLabel": "Related Party Transaction [Axis]" } } }, "localname": "RelatedPartyTransactionAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/RelatedPartyTransactionsandBalancesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Transaction between related party.", "label": "Related Party Transaction [Domain]", "terseLabel": "Related Party Transaction [Domain]" } } }, "localname": "RelatedPartyTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/RelatedPartyTransactionsandBalancesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty": { "auth_ref": [ "r372" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.", "label": "Related Party Transaction, Expenses from Transactions with Related Party", "terseLabel": "Consulting fees" } } }, "localname": "RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/RelatedPartyTransactionsandBalancesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyTransactionLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Related Party Transaction [Line Items]", "terseLabel": "Related Party Transaction [Line Items]" } } }, "localname": "RelatedPartyTransactionLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/RelatedPartyTransactionsandBalancesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Purchases during the period (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.", "label": "Related Party Transaction, Purchases from Related Party", "terseLabel": "Purchases" } } }, "localname": "RelatedPartyTransactionPurchasesFromRelatedParty", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/RelatedPartyTransactionsandBalancesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Related Party Transactions [Abstract]", "terseLabel": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r253", "r374", "r375", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r397", "r398", "r399" ], "lang": { "en-US": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]", "terseLabel": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/RelatedPartyTransactionsandBalancesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r379" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Related Party Transactions Disclosure [Text Block]", "terseLabel": "Related Party Transactions and Balances" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/RelatedPartyTransactionsandBalances" ], "xbrltype": "textBlockItemType" }, "us-gaap_RepaymentsOfNotesPayable": { "auth_ref": [ "r93" ], "calculation": { "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation.", "label": "Repayments of Notes Payable", "negatedLabel": "Repayment of loans payable" } } }, "localname": "RepaymentsOfNotesPayable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReportingUnitAxis": { "auth_ref": [ "r198", "r199" ], "lang": { "en-US": { "role": { "documentation": "Information by reporting unit.", "label": "Reporting Unit [Axis]", "terseLabel": "Reporting Unit [Axis]" } } }, "localname": "ReportingUnitAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillNarrativeDetails", "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofGoodwillDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ReportingUnitDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Level of reporting at which goodwill is tested for impairment.", "label": "Reporting Unit [Domain]", "terseLabel": "Reporting Unit [Domain]" } } }, "localname": "ReportingUnitDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillNarrativeDetails", "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofGoodwillDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ResearchAndDevelopmentArrangementMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Contractual obligation to provide funding of research and development costs over periods that initially exceed one year or the normal operating cycle, if longer.", "label": "Research and Development Arrangement [Member]", "terseLabel": "Research and Development Arrangement" } } }, "localname": "ResearchAndDevelopmentArrangementMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CommitmentsRDCommitmentsandAltriaConsultingServicesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r283", "r448" ], "calculation": { "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeandComprehensiveIncomeLoss": { "order": 2.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Research and Development Expense", "terseLabel": "Research and development (\u201cR&D\u201d)" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeandComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedStockUnitsRSUMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.", "label": "Restricted Stock Units (RSUs) [Member]", "terseLabel": "Restricted share units" } } }, "localname": "RestrictedStockUnitsRSUMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/EarningslossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofDilutedSharesOutstandingDetails", "http://thecronosgroup.com/role/EarningslossPerShareScheduleofEarningsLossPerShareDetails", "http://thecronosgroup.com/role/SharebasedPaymentsRestrictedShareUnitsNarrativeDetails", "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofRestrictedShareUnitsActivityDetails", "http://thecronosgroup.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r20", "r242", "r420" ], "calculation": { "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Retained earnings" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Retained earnings" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofChangesinEquityDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Revenue from Contract with Customer [Abstract]", "terseLabel": "Revenue from Contract with Customer [Abstract]" } } }, "localname": "RevenueFromContractWithCustomerAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r244", "r245" ], "calculation": { "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeandComprehensiveIncomeLoss": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "Revenue from Contract with Customer, Excluding Assessed Tax", "totalLabel": "Net revenue", "verboseLabel": "Net revenue" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeandComprehensiveIncomeLoss", "http://thecronosgroup.com/role/SegmentInformationScheduleofRevenuefromExternalCustomersbyGeographicAreasDetails", "http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax": { "auth_ref": [ "r244", "r245" ], "calculation": { "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeandComprehensiveIncomeLoss": { "order": 1.0, "parentTag": "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.", "label": "Revenue from Contract with Customer, Including Assessed Tax", "terseLabel": "Net revenue, before excise taxes" } } }, "localname": "RevenueFromContractWithCustomerIncludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeandComprehensiveIncomeLoss", "http://thecronosgroup.com/role/SegmentInformationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerMember": { "auth_ref": [ "r139" ], "lang": { "en-US": { "role": { "documentation": "Revenue from satisfaction of performance obligation by transferring promised product and service to customer, when it serves as benchmark in concentration of risk calculation.", "label": "Revenue from Contract with Customer Benchmark [Member]", "terseLabel": "Revenue Benchmark" } } }, "localname": "RevenueFromContractWithCustomerMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SegmentInformationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerTextBlock": { "auth_ref": [ "r250" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.", "label": "Revenue from Contract with Customer [Text Block]", "terseLabel": "Revenues from Contracts with Customers" } } }, "localname": "RevenueFromContractWithCustomerTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/RevenuesfromContractswithCustomers" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock": { "auth_ref": [ "r159" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.", "label": "Revenue from External Customers by Geographic Areas [Table Text Block]", "terseLabel": "Schedule of Revenue from External Customers by Geographic Areas" } } }, "localname": "RevenueFromExternalCustomersByGeographicAreasTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SegmentInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Revenues from External Customers and Long-Lived Assets [Line Items]", "terseLabel": "Revenues from External Customers and Long-Lived Assets [Line Items]" } } }, "localname": "RevenuesFromExternalCustomersAndLongLivedAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SegmentInformationScheduleofLonglivedAssetsbyGeographicAreasDetails", "http://thecronosgroup.com/role/SegmentInformationScheduleofRevenuefromExternalCustomersbyGeographicAreasDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RisksAndUncertaintiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Risks and Uncertainties [Abstract]", "terseLabel": "Risks and Uncertainties [Abstract]" } } }, "localname": "RisksAndUncertaintiesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.", "label": "Sale of Stock [Domain]", "terseLabel": "Sale of Stock [Domain]" } } }, "localname": "SaleOfStockNameOfTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CommitmentsUseofPublicityRightsinBrandDevelopmentDetails", "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails", "http://thecronosgroup.com/role/InvestmentsandAdvancestoJointVenturesScheduleofEquityMethodInvestmentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.", "label": "Sale of Stock, Number of Shares Issued in Transaction", "terseLabel": "Sale of stock, number of shares issued in transaction (in shares)" } } }, "localname": "SaleOfStockNumberOfSharesIssuedInTransaction", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/InvestmentsandAdvancestoJointVenturesScheduleofEquityMethodInvestmentsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_SaleOfStockPricePerShare": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.", "label": "Sale of Stock, Price Per Share", "terseLabel": "Sale of stock, price per share (in aud per share)" } } }, "localname": "SaleOfStockPricePerShare", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/InvestmentsandAdvancestoJointVenturesScheduleofEquityMethodInvestmentsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable": { "auth_ref": [ "r44" ], "lang": { "en-US": { "role": { "documentation": "Schedule itemizing specific types of trade accounts and notes receivable, and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.", "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]", "terseLabel": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]" } } }, "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/LoansReceivablenetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": { "auth_ref": [ "r44" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.", "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]", "terseLabel": "Schedule of Loan Receivable" } } }, "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/LoansReceivablenetTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": { "auth_ref": [ "r57" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).", "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]", "terseLabel": "Schedule of Accumulated Other Comprehensive Income (Loss)" } } }, "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/AccumulatedOtherComprehensiveIncomeLossTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "auth_ref": [ "r132" ], "lang": { "en-US": { "role": { "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]", "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/EarningslossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofDilutedSharesOutstandingDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": { "auth_ref": [ "r132" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]", "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Diluted Shares Outstanding" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/EarningslossPerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r133" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "terseLabel": "Schedule of Earnings (Loss) Per Share" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/EarningslossPerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable": { "auth_ref": [ "r79", "r124", "r126", "r127", "r131", "r134" ], "lang": { "en-US": { "role": { "documentation": "Complete disclosure pertaining to an entity's diluted earnings per share.", "label": "Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table]", "terseLabel": "Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table]" } } }, "localname": "ScheduleOfEarningsPerShareDilutedByCommonClassTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/EarningslossPerShareScheduleofEarningsLossPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEquityMethodInvestmentsLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Schedule of Equity Method Investments [Line Items]", "terseLabel": "Schedule of Equity Method Investments [Line Items]" } } }, "localname": "ScheduleOfEquityMethodInvestmentsLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/BackgroundDetails", "http://thecronosgroup.com/role/InvestmentsandAdvancestoJointVenturesScheduleofEquityMethodInvestmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEquityMethodInvestmentsTable": { "auth_ref": [ "r176" ], "lang": { "en-US": { "role": { "documentation": "Summarization of information required and determined to be disclosed concerning equity method investments in common stock. The summarized information includes: (a) the name of each investee or group of investees for which combined disclosure is appropriate, (2) the percentage ownership of common stock, (3) the difference, if any, between the carrying amount of an investment and the value of the underlying equity in the net assets and the accounting treatment of difference, if any, and (4) the aggregate value of each identified investment based on its quoted market price, if available.", "label": "Schedule of Equity Method Investments [Table]", "terseLabel": "Schedule of Equity Method Investments [Table]" } } }, "localname": "ScheduleOfEquityMethodInvestmentsTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/BackgroundDetails", "http://thecronosgroup.com/role/InvestmentsandAdvancestoJointVenturesScheduleofEquityMethodInvestmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": { "auth_ref": [ "r332", "r333" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]", "terseLabel": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis" } } }, "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/FairValueMeasurementTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": { "auth_ref": [ "r203", "r208" ], "lang": { "en-US": { "role": { "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Schedule of Finite-Lived Intangible Assets [Table]", "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillNarrativeDetails", "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": { "auth_ref": [ "r203", "r208" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.", "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]", "verboseLabel": "Schedule of Finite-Lived Intangible Assets" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfGoodwillTable": { "auth_ref": [ "r197", "r200" ], "lang": { "en-US": { "role": { "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.", "label": "Schedule of Goodwill [Table]", "terseLabel": "Schedule of Goodwill [Table]" } } }, "localname": "ScheduleOfGoodwillTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofGoodwillDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfGoodwillTextBlock": { "auth_ref": [ "r197", "r200" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.", "label": "Schedule of Goodwill [Table Text Block]", "terseLabel": "Schedule of Goodwill" } } }, "localname": "ScheduleOfGoodwillTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable": { "auth_ref": [ "r212", "r215" ], "lang": { "en-US": { "role": { "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity.", "label": "Schedule of Indefinite-Lived Intangible Assets [Table]", "terseLabel": "Schedule of Indefinite-Lived Intangible Assets [Table]" } } }, "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock": { "auth_ref": [ "r212", "r215" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment.", "label": "Schedule of Indefinite-Lived Intangible Assets [Table Text Block]", "terseLabel": "Schedule of Indefinite-Lived Intangible Assets" } } }, "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "auth_ref": [ "r9", "r28", "r29", "r30" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.", "label": "Schedule of Inventory, Current [Table Text Block]", "terseLabel": "Schedule of Inventory" } } }, "localname": "ScheduleOfInventoryCurrentTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/InventoryTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock": { "auth_ref": [ "r266" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of activity for outstanding award under share-based payment arrangement excluding share and unit options and nonvested award.", "label": "Share-based Payment Arrangement, Outstanding Award, Activity, Excluding Option [Table Text Block]", "terseLabel": "Summary of Changes in Warrants and DSUs" } } }, "localname": "ScheduleOfOtherShareBasedCompensationActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SharebasedPaymentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r36", "r220" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table]", "terseLabel": "Property, Plant and Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/PropertyPlantandEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "auth_ref": [ "r111", "r374", "r375", "r376", "r377", "r378" ], "lang": { "en-US": { "role": { "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Schedule of Related Party Transactions, by Related Party [Table]", "terseLabel": "Schedule of Related Party Transactions, by Related Party [Table]" } } }, "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/RelatedPartyTransactionsandBalancesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable": { "auth_ref": [ "r66", "r68", "r161" ], "lang": { "en-US": { "role": { "documentation": "Schedule of material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries.", "label": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]", "terseLabel": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]" } } }, "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SegmentInformationScheduleofLonglivedAssetsbyGeographicAreasDetails", "http://thecronosgroup.com/role/SegmentInformationScheduleofRevenuefromExternalCustomersbyGeographicAreasDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSaleOfStockBySubsidiaryOrEquityMethodInvesteeDisclosureTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of sales of stock or previously unissued stock made by subsidiary or equity method investee to investors outside the consolidated group. This includes stock issued in a business combination in exchange for shares of an acquired entity.", "label": "Schedule of Sale of Stock by Subsidiary or Equity Method Investee Disclosure [Table Text Block]", "terseLabel": "Schedule of Consolidated Entities" } } }, "localname": "ScheduleOfSaleOfStockBySubsidiaryOrEquityMethodInvesteeDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "auth_ref": [ "r143", "r150", "r152", "r153", "r197" ], "lang": { "en-US": { "role": { "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table]", "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SegmentInformationNarrativeDetails", "http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "auth_ref": [ "r143", "r150", "r152", "r153", "r197" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]", "terseLabel": "Schedule of Segment Data" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SegmentInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r257", "r279" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]", "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SharebasedPaymentsDeferredShareUnitsNarrativeDetails", "http://thecronosgroup.com/role/SharebasedPaymentsRestrictedShareUnitsNarrativeDetails", "http://thecronosgroup.com/role/SharebasedPaymentsStockOptionsNarrativeDetails", "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofChangesinWarrantsDetails", "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofDeferredShareUnitsActivityDetails", "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofFairValueofOptionsIssuedDetails", "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofOutstandingWarrantsDetails", "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofRestrictedShareUnitsActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": { "auth_ref": [ "r260" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.", "label": "Share-based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]", "terseLabel": "Summary of Restricted Share Units Activity" } } }, "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SharebasedPaymentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": { "auth_ref": [ "r272" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.", "label": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]", "terseLabel": "Summary of Fair Value of Options Issued" } } }, "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SharebasedPaymentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the change in stock options.", "label": "Schedule of Stock Options Roll Forward [Table Text Block]", "terseLabel": "Summary of the Changes in Options" } } }, "localname": "ScheduleOfStockOptionsRollForwardTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SharebasedPaymentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable": { "auth_ref": [ "r312" ], "lang": { "en-US": { "role": { "documentation": "Schedule of subsidiary's sales of previously unissued stock made to investors outside the consolidated group. This includes stock issued in a business combination in exchange for shares of an acquired entity.", "label": "Schedule of Subsidiary or Equity Method Investee [Table]", "terseLabel": "Schedule of Subsidiary or Equity Method Investee [Table]" } } }, "localname": "ScheduleOfSubsidiaryOrEquityMethodInvesteeTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt and Equity Securities, FV-NI [Line Items]", "terseLabel": "Debt and Equity Securities, FV-NI [Line Items]" } } }, "localname": "ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/OtherInvestmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security with change in fair value recognized in net income (FV-NI).", "label": "Debt Securities, Trading, and Equity Securities, FV-NI [Table]", "terseLabel": "Debt Securities, Trading, and Equity Securities, FV-NI [Table]" } } }, "localname": "ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/OtherInvestmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfVariableInterestEntitiesTable": { "auth_ref": [ "r300", "r302", "r304", "r306", "r307" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of qualitative and quantitative information related to variable interests the entity holds, whether or not such variable interest entity (VIE) is included in the reporting entity's consolidated financial statements. Includes, but is not limited to, description of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a tabular comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.", "label": "Schedule of Variable Interest Entities [Table]", "terseLabel": "Schedule of Variable Interest Entities [Table]" } } }, "localname": "ScheduleOfVariableInterestEntitiesTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/InvestmentsandAdvancestoJointVenturesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SegmentDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Segments [Domain]", "terseLabel": "Segments [Domain]" } } }, "localname": "SegmentDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SegmentInformationNarrativeDetails", "http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SegmentReportingAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Segment Reporting [Abstract]", "terseLabel": "Segment Reporting [Abstract]" } } }, "localname": "SegmentReportingAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingDisclosureTextBlock": { "auth_ref": [ "r163" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.", "label": "Segment Reporting Disclosure [Text Block]", "terseLabel": "Segment Information" } } }, "localname": "SegmentReportingDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SegmentInformation" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingInformationAdditionalInformationAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Segment Reporting Information, Additional Information [Abstract]", "terseLabel": "Consolidated balance sheets" } } }, "localname": "SegmentReportingInformationAdditionalInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingInformationLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Segment Reporting Information [Line Items]", "terseLabel": "Segment Reporting Information [Line Items]" } } }, "localname": "SegmentReportingInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SegmentInformationNarrativeDetails", "http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingInformationProfitLossAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Segment Reporting Information, Profit (Loss) [Abstract]", "terseLabel": "Consolidated statements of net income (loss) and comprehensive income (loss)" } } }, "localname": "SegmentReportingInformationProfitLossAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SellingAndMarketingExpense": { "auth_ref": [], "calculation": { "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeandComprehensiveIncomeLoss": { "order": 1.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services.", "label": "Selling and Marketing Expense", "terseLabel": "Sales and marketing" } } }, "localname": "SellingAndMarketingExpense", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeandComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r101" ], "calculation": { "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share-based Payment Arrangement, Noncash Expense", "terseLabel": "Share-based payments" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of additional cost recognized for award under share-based payment arrangement from occurrence of event accelerating recognition of cost.", "label": "Share-based Payment Arrangement, Accelerated Cost", "terseLabel": "Accelerated share-based compensation costs" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SubsequentEventsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "auth_ref": [ "r258" ], "lang": { "en-US": { "role": { "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period", "terseLabel": "Vesting period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SharebasedPaymentsRestrictedShareUnitsNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "auth_ref": [ "r268" ], "lang": { "en-US": { "role": { "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period", "terseLabel": "Issuance of RSUs (in shares)", "verboseLabel": "Issuances (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SharebasedPaymentsDeferredShareUnitsNarrativeDetails", "http://thecronosgroup.com/role/SharebasedPaymentsRestrictedShareUnitsNarrativeDetails", "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofRestrictedShareUnitsActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "auth_ref": [ "r267" ], "lang": { "en-US": { "role": { "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number", "periodEndLabel": "Balance at end of period (in shares)", "periodStartLabel": "Balance at beginning of period (in shares)", "terseLabel": "Outstanding awards (in shares)", "verboseLabel": "Number of warrants (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SharebasedPaymentsDeferredShareUnitsNarrativeDetails", "http://thecronosgroup.com/role/SharebasedPaymentsRestrictedShareUnitsNarrativeDetails", "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofChangesinWarrantsDetails", "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofDeferredShareUnitsActivityDetails", "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofOutstandingWarrantsDetails", "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofRestrictedShareUnitsActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]", "terseLabel": "Number of awards" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofChangesinWarrantsDetails", "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofDeferredShareUnitsActivityDetails", "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofRestrictedShareUnitsActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "auth_ref": [ "r267" ], "lang": { "en-US": { "role": { "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value", "periodEndLabel": "Balance at end of period (in dollars per share)", "periodStartLabel": "Balance at beginning of period (in dollars per share)", "terseLabel": "Weighted average exercise price (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofChangesinWarrantsDetails", "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofOutstandingWarrantsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]", "terseLabel": "Weighted average exercise price (C$)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofChangesinWarrantsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "auth_ref": [ "r269" ], "lang": { "en-US": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period", "negatedLabel": "Exercise of warrants (in shares)", "negatedTerseLabel": "Liabilities settled (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofChangesinWarrantsDetails", "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofDeferredShareUnitsActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r269" ], "lang": { "en-US": { "role": { "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Exercise of warrants (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofChangesinWarrantsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price", "terseLabel": "Exercise price (per option) (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofFairValueofOptionsIssuedDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "auth_ref": [ "r275" ], "lang": { "en-US": { "role": { "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate", "terseLabel": "Expected dividend yield" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofFairValueofOptionsIssuedDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "auth_ref": [ "r276" ], "lang": { "en-US": { "role": { "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate", "terseLabel": "Risk-free interest rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofFairValueofOptionsIssuedDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate": { "auth_ref": [ "r274" ], "lang": { "en-US": { "role": { "documentation": "Rate of weighted-average expected volatility for award under share-based payment arrangement.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate", "terseLabel": "Expected annualized volatility" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofFairValueofOptionsIssuedDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SharebasedPaymentsDeferredShareUnitsNarrativeDetails", "http://thecronosgroup.com/role/SharebasedPaymentsRestrictedShareUnitsNarrativeDetails", "http://thecronosgroup.com/role/SharebasedPaymentsStockOptionsNarrativeDetails", "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofChangesinWarrantsDetails", "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofDeferredShareUnitsActivityDetails", "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofFairValueofOptionsIssuedDetails", "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofOutstandingWarrantsDetails", "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofRestrictedShareUnitsActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": { "auth_ref": [ "r279" ], "lang": { "en-US": { "role": { "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant", "terseLabel": "Future awards to be granted (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SharebasedPaymentsStockOptionsNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "auth_ref": [ "r263" ], "lang": { "en-US": { "role": { "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number", "verboseLabel": "Exercisable (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SharebasedPaymentsSummaryoftheChangesinOptionsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "auth_ref": [ "r263" ], "lang": { "en-US": { "role": { "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price", "terseLabel": "Weighted average exercise price of options exercisable (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SharebasedPaymentsSummaryoftheChangesinOptionsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": { "auth_ref": [ "r265" ], "lang": { "en-US": { "role": { "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period", "negatedTerseLabel": "Cancellation, forfeiture and expiry of options (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SharebasedPaymentsSummaryoftheChangesinOptionsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r265" ], "lang": { "en-US": { "role": { "documentation": "Weighted average price of options that were either forfeited or expired.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price", "terseLabel": "Cancellation, forfeiture and expiry of options (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SharebasedPaymentsSummaryoftheChangesinOptionsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross", "terseLabel": "Issuance of options (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SharebasedPaymentsStockOptionsNarrativeDetails", "http://thecronosgroup.com/role/SharebasedPaymentsSummaryoftheChangesinOptionsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r262", "r279" ], "lang": { "en-US": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number", "periodEndLabel": "Balance at end of period (in shares)", "periodStartLabel": "Balance at beginning of period (in shares)", "verboseLabel": "Number of options outstanding (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SharebasedPaymentsStockOptionsNarrativeDetails", "http://thecronosgroup.com/role/SharebasedPaymentsSummaryoftheChangesinOptionsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]", "terseLabel": "Number of options" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SharebasedPaymentsSummaryoftheChangesinOptionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r261" ], "lang": { "en-US": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "periodEndLabel": "Balance at end of period (in dollars per share)", "periodStartLabel": "Balance at beginning of period (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SharebasedPaymentsSummaryoftheChangesinOptionsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]", "terseLabel": "Weighted average exercise price (C$)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SharebasedPaymentsSummaryoftheChangesinOptionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r255", "r259" ], "lang": { "en-US": { "role": { "documentation": "Award under share-based payment arrangement.", "label": "Award Type [Domain]", "terseLabel": "Award Type [Domain]" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/EarningslossPerShareScheduleofEarningsLossPerShareDetails", "http://thecronosgroup.com/role/SharebasedPaymentsDeferredShareUnitsNarrativeDetails", "http://thecronosgroup.com/role/SharebasedPaymentsRestrictedShareUnitsNarrativeDetails", "http://thecronosgroup.com/role/SharebasedPaymentsStockOptionsNarrativeDetails", "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofChangesinWarrantsDetails", "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofDeferredShareUnitsActivityDetails", "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofFairValueofOptionsIssuedDetails", "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofOutstandingWarrantsDetails", "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofRestrictedShareUnitsActivityDetails", "http://thecronosgroup.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.", "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price", "terseLabel": "Exercise of options (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SharebasedPaymentsSummaryoftheChangesinOptionsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.", "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price", "terseLabel": "Issuance of options (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SharebasedPaymentsSummaryoftheChangesinOptionsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationAwardTrancheOneMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "First portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.", "label": "Share-based Payment Arrangement, Tranche One [Member]", "terseLabel": "Vested on January 31, 2020" } } }, "localname": "ShareBasedCompensationAwardTrancheOneMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CommitmentsUseofPublicityRightsinBrandDevelopmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationAwardTrancheThreeMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Third portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.", "label": "Share-based Payment Arrangement, Tranche Three [Member]", "terseLabel": "Vesting on December 23, 2022" } } }, "localname": "ShareBasedCompensationAwardTrancheThreeMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CommitmentsUseofPublicityRightsinBrandDevelopmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationAwardTrancheTwoMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Second portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.", "label": "Share-based Payment Arrangement, Tranche Two [Member]", "terseLabel": "Vesting on June 23, 2021" } } }, "localname": "ShareBasedCompensationAwardTrancheTwoMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CommitmentsUseofPublicityRightsinBrandDevelopmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SharePrice": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Price of a single share of a number of saleable stocks of a company.", "label": "Share Price", "terseLabel": "Share price at grant date (in dollars per share)" } } }, "localname": "SharePrice", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SharebasedPaymentsRestrictedShareUnitsNarrativeDetails", "http://thecronosgroup.com/role/SharebasedPaymentsStockOptionsNarrativeDetails", "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofFairValueofOptionsIssuedDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Number of shares for which recognition of cost was accelerated for award under share-based payment arrangement.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Accelerated Vesting, Number", "terseLabel": "Shares accelerated and vested (in shares)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SharebasedPaymentsRestrictedShareUnitsNarrativeDetails", "http://thecronosgroup.com/role/SubsequentEventsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": { "auth_ref": [ "r258" ], "lang": { "en-US": { "role": { "documentation": "Percentage of vesting of award under share-based payment arrangement.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage", "terseLabel": "Award vesting rights, percentage" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CommitmentsUseofPublicityRightsinBrandDevelopmentDetails" ], "xbrltype": "percentItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "auth_ref": [ "r273", "r280" ], "lang": { "en-US": { "role": { "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term", "terseLabel": "Expected life of options (in years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofFairValueofOptionsIssuedDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]", "terseLabel": "Weighted average remaining contractual term (years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SharebasedPaymentsSummaryoftheChangesinOptionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r270" ], "lang": { "en-US": { "role": { "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term", "verboseLabel": "Outstanding" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SharebasedPaymentsSummaryoftheChangesinOptionsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1": { "auth_ref": [ "r271" ], "lang": { "en-US": { "role": { "documentation": "Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term", "terseLabel": "Exercisable" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SharebasedPaymentsSummaryoftheChangesinOptionsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ShortTermInvestments": { "auth_ref": [ "r14", "r405", "r406", "r407", "r418" ], "calculation": { "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.", "label": "Short-term Investments", "terseLabel": "Short-term investments" } } }, "localname": "ShortTermInvestments", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets", "http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StatementBusinessSegmentsAxis": { "auth_ref": [ "r0", "r150", "r197", "r221", "r223", "r224", "r429" ], "lang": { "en-US": { "role": { "documentation": "Information by business segments.", "label": "Segments [Axis]", "terseLabel": "Segments [Axis]" } } }, "localname": "StatementBusinessSegmentsAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SegmentInformationNarrativeDetails", "http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r43", "r241" ], "lang": { "en-US": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]", "terseLabel": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails", "http://thecronosgroup.com/role/CommitmentsUseofPublicityRightsinBrandDevelopmentDetails", "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofChangesinEquityDeficit" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]", "terseLabel": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofChangesinEquityDeficit" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statement of Cash Flows [Abstract]", "terseLabel": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statement of Financial Position [Abstract]", "terseLabel": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statement of Comprehensive Income [Abstract]", "terseLabel": "Statement of Comprehensive Income [Abstract]" } } }, "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeandComprehensiveIncomeLoss" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statement of Stockholders' Equity [Abstract]", "terseLabel": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]", "terseLabel": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofChangesinEquityDeficit" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r15", "r16", "r241", "r242" ], "lang": { "en-US": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Stock Issued During Period, Shares, New Issues", "terseLabel": "Shares issued (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CommitmentsUseofPublicityRightsinBrandDevelopmentDetails", "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofChangesinEquityDeficit", "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r15", "r16", "r241", "r242", "r264" ], "lang": { "en-US": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period", "negatedTerseLabel": "Exercise of options (in shares)", "terseLabel": "Options exercised (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofChangesinEquityDeficit", "http://thecronosgroup.com/role/SharebasedPaymentsSummaryoftheChangesinOptionsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.", "label": "Stock Issued During Period, Value, Issued for Services", "terseLabel": "Vesting of common shares issued in connection with the use of certain publicity rights in brand development" } } }, "localname": "StockIssuedDuringPeriodValueIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofChangesinEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r15", "r16", "r241", "r242" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Stock Issued During Period, Value, New Issues", "terseLabel": "Shares issued" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofChangesinEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": { "auth_ref": [ "r43", "r241", "r242" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Value of stock issued as a result of the exercise of stock options.", "label": "Stock Issued During Period, Value, Stock Options Exercised", "terseLabel": "Options exercised" } } }, "localname": "StockIssuedDuringPeriodValueStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofChangesinEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r16", "r21", "r22", "r168" ], "calculation": { "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "totalLabel": "Total equity attributable to shareholders of Cronos Group" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r290", "r291", "r308" ], "calculation": { "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.", "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance", "totalLabel": "Total shareholders\u2019 equity" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails", "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets", "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofChangesinEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]", "terseLabel": "Shareholders\u2019 equity" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.", "label": "Subsequent Event [Line Items]", "terseLabel": "Subsequent Event [Line Items]" } } }, "localname": "SubsequentEventLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]", "terseLabel": "Subsequent Event" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SharebasedPaymentsRestrictedShareUnitsNarrativeDetails", "http://thecronosgroup.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTable": { "auth_ref": [ "r380" ], "lang": { "en-US": { "role": { "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.", "label": "Subsequent Event [Table]", "terseLabel": "Subsequent Event [Table]" } } }, "localname": "SubsequentEventTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r380" ], "lang": { "en-US": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]", "terseLabel": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SharebasedPaymentsRestrictedShareUnitsNarrativeDetails", "http://thecronosgroup.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r380" ], "lang": { "en-US": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Domain]", "terseLabel": "Subsequent Event Type [Domain]" } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SharebasedPaymentsRestrictedShareUnitsNarrativeDetails", "http://thecronosgroup.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r382" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events [Text Block]", "terseLabel": "Subsequent Events" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Percentage of subsidiary's or equity method investee's stock owned by parent immediately after all stock transactions.", "label": "Subsidiary or Equity Method Investee, Cumulative Percentage Ownership after All Transactions", "terseLabel": "Ownership interest" } } }, "localname": "SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Subsidiary or Equity Method Investee [Line Items]", "terseLabel": "Subsidiary or Equity Method Investee [Line Items]" } } }, "localname": "SubsidiaryOrEquityMethodInvesteeLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Different names of stock transactions and the different attributes of each transaction.", "label": "Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]", "terseLabel": "Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]" } } }, "localname": "SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CommitmentsUseofPublicityRightsinBrandDevelopmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsidiarySaleOfStockAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by type of sale of the entity's stock.", "label": "Sale of Stock [Axis]", "terseLabel": "Sale of Stock [Axis]" } } }, "localname": "SubsidiarySaleOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CommitmentsUseofPublicityRightsinBrandDevelopmentDetails", "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails", "http://thecronosgroup.com/role/InvestmentsandAdvancestoJointVenturesScheduleofEquityMethodInvestmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsidiarySaleOfStockLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Subsidiary, Sale of Stock [Line Items]", "terseLabel": "Subsidiary, Sale of Stock [Line Items]" } } }, "localname": "SubsidiarySaleOfStockLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CommitmentsUseofPublicityRightsinBrandDevelopmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SupplementalCashFlowElementsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Supplemental Cash Flow Elements [Abstract]", "terseLabel": "Supplemental Cash Flow Elements [Abstract]" } } }, "localname": "SupplementalCashFlowElementsAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Supplemental Cash Flow Information [Abstract]", "terseLabel": "Supplemental cash flow information" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_SupplierConcentrationRiskMember": { "auth_ref": [ "r138" ], "lang": { "en-US": { "role": { "documentation": "Reflects the percentage that purchases in the period from one or more significant suppliers is to cost of goods or services, as defined by the entity, such as total cost of sales or services, product line cost of sales or services, segment cost of sales or services. Risk is the materially adverse effects of loss of a material supplier or a supplier of critically needed goods or services.", "label": "Supplier Concentration Risk [Member]", "terseLabel": "Supplier Concentration Risk" } } }, "localname": "SupplierConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/FinancialInstrumentsLiquidityRiskNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TradeNamesMember": { "auth_ref": [ "r287" ], "lang": { "en-US": { "role": { "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.", "label": "Trade Names [Member]", "terseLabel": "Lord Jones brand" } } }, "localname": "TradeNamesMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillNarrativeDetails", "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TrademarksMember": { "auth_ref": [ "r287" ], "lang": { "en-US": { "role": { "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style.", "label": "Trademarks [Member]", "terseLabel": "Trademarks" } } }, "localname": "TrademarksMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TypeOfAdoptionMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Adoption and early adoption of sources of change to generally accepted accounting principles (GAAP) in the United States. The FASB released the FASB Accounting Standards Codification as the authoritative source of literature effective for interim and annual periods ending after September 15, 2009. As part of the Codification process, the FASB issues Accounting Standards Updates to amend the Codification but otherwise the Accounting Standards Updates are not authoritative in their own right. All previous accounting standards (such as FASB Statements of Financial Accounting Standards, FASB Interpretations, FASB Staff Positions, Emerging Issues Task Force Consensuses, other pronouncements of the FASB or other designated bodies, or other forms of GAAP are considered accounting pronouncements) were superseded upon the adoption of the Codification. For an interim period, references to the superseded standards are included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.", "label": "Type of Adoption [Domain]", "terseLabel": "Type of Adoption [Domain]" } } }, "localname": "TypeOfAdoptionMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TypeOfArrangementAxis": { "auth_ref": [ "r289" ], "lang": { "en-US": { "role": { "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]", "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]" } } }, "localname": "TypeOfArrangementAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/InvestmentsandAdvancestoJointVenturesNarrativeDetails", "http://thecronosgroup.com/role/LoansReceivablenetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_UnconditionalPurchaseObligationCategoryOfGoodsOrServicesAcquiredDomain": { "auth_ref": [ "r226" ], "lang": { "en-US": { "role": { "documentation": "General description of the goods or services to be purchased from the counterparty to the unconditional purchase arrangement.", "label": "Unconditional Purchase Obligation, Category of Goods or Services Acquired [Domain]", "terseLabel": "Unconditional Purchase Obligation, Category of Goods or Services Acquired [Domain]" } } }, "localname": "UnconditionalPurchaseObligationCategoryOfGoodsOrServicesAcquiredDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CommitmentsTakeorPayDetails" ], "xbrltype": "domainItemType" }, "us-gaap_UnfavorableRegulatoryActionMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A enacted or proposed action, ruling or regulation that is likely to or possibly will have an adverse effect on the entity's financial position or results of operations, excluding tax matters.", "label": "Unfavorable Regulatory Action [Member]", "terseLabel": "Litigation Relating to Marketing, Distribution and Sale of Products" } } }, "localname": "UnfavorableRegulatoryActionMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/ContingenciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis": { "auth_ref": [ "r300", "r302", "r306" ], "lang": { "en-US": { "role": { "documentation": "Information by category of Variable Interest Entity (VIE).", "label": "Variable Interest Entities [Axis]", "terseLabel": "Variable Interest Entities [Axis]" } } }, "localname": "VariableInterestEntitiesByClassificationOfEntityAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/InvestmentsandAdvancestoJointVenturesScheduleofEquityMethodInvestmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount": { "auth_ref": [ "r301", "r305" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The reporting entity's maximum amount of exposure to loss as a result of its involvement with the Variable Interest Entity (VIE).", "label": "Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount", "terseLabel": "Maximum loss exposure" } } }, "localname": "VariableInterestEntityEntityMaximumLossExposureAmount", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/InvestmentsandAdvancestoJointVenturesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_VariableInterestEntityLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Variable Interest Entity [Line Items]", "terseLabel": "Variable Interest Entity [Line Items]" } } }, "localname": "VariableInterestEntityLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/InvestmentsandAdvancestoJointVenturesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Variable Interest Entities (VIE) in which the entity does not have a controlling financial interest (as defined) and of which it is therefore not the primary beneficiary. VIEs of which the entity is not the primary beneficiary because it does not have the power to direct the activities of the VIE that most significantly impact the VIE's economic performance and for which it does not have the obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE are not included in the consolidated financial statements of the entity.", "label": "Variable Interest Entity, Not Primary Beneficiary [Member]", "terseLabel": "Variable Interest Entity, Not Primary Beneficiary" } } }, "localname": "VariableInterestEntityNotPrimaryBeneficiaryMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/InvestmentsandAdvancestoJointVenturesNarrativeDetails", "http://thecronosgroup.com/role/InvestmentsandAdvancestoJointVenturesScheduleofEquityMethodInvestmentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_VariableInterestEntityOwnershipPercentage": { "auth_ref": [ "r303" ], "lang": { "en-US": { "role": { "documentation": "Percentage of the Variable Interest Entity's (VIE) voting interest owned by (or beneficial interest in) the reporting entity (directly or indirectly).", "label": "Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage", "terseLabel": "Ownership percentage" } } }, "localname": "VariableInterestEntityOwnershipPercentage", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/InvestmentsandAdvancestoJointVenturesNarrativeDetails", "http://thecronosgroup.com/role/InvestmentsandAdvancestoJointVenturesScheduleofEquityMethodInvestmentsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_VariableInterestEntityPrimaryBeneficiaryMember": { "auth_ref": [ "r300" ], "lang": { "en-US": { "role": { "documentation": "Variable Interest Entities (VIE) in which the entity has a controlling financial interest (as defined) and of which it is therefore the primary beneficiary. A controlling financial interest is determined based on both: (a) the entity's power to direct activities of the VIE that most significantly impact the VIE's economic performance and (b) the entity's obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE. VIEs of which the entity is the primary beneficiary are included in the consolidated financial statements of the entity.", "label": "Variable Interest Entity, Primary Beneficiary [Member]", "terseLabel": "Variable Interest Entity, Primary Beneficiary" } } }, "localname": "VariableInterestEntityPrimaryBeneficiaryMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/InvestmentsandAdvancestoJointVenturesNarrativeDetails", "http://thecronosgroup.com/role/LoansReceivablenetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_VestingAxis": { "auth_ref": [ "r279" ], "lang": { "en-US": { "role": { "documentation": "Information by vesting schedule of award under share-based payment arrangement.", "label": "Vesting [Axis]", "terseLabel": "Vesting [Axis]" } } }, "localname": "VestingAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CommitmentsUseofPublicityRightsinBrandDevelopmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_VestingDomain": { "auth_ref": [ "r279" ], "lang": { "en-US": { "role": { "documentation": "Vesting schedule of award under share-based payment arrangement.", "label": "Vesting [Domain]", "terseLabel": "Vesting [Domain]" } } }, "localname": "VestingDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CommitmentsUseofPublicityRightsinBrandDevelopmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.", "label": "Warrant [Member]", "terseLabel": "Warrants" } } }, "localname": "WarrantMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/EarningslossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofDilutedSharesOutstandingDetails", "http://thecronosgroup.com/role/EarningslossPerShareScheduleofEarningsLossPerShareDetails", "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofChangesinWarrantsDetails", "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofOutstandingWarrantsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r123", "r131" ], "calculation": { "http://thecronosgroup.com/role/EarningslossPerShareScheduleofEarningsLossPerShareDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-US": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "terseLabel": "Diluted (in shares)", "totalLabel": "Weighted average number of common shares for computation of diluted income (loss) per share (in shares)" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeandComprehensiveIncomeLoss", "http://thecronosgroup.com/role/EarningslossPerShareScheduleofEarningsLossPerShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r121", "r131" ], "calculation": { "http://thecronosgroup.com/role/EarningslossPerShareScheduleofEarningsLossPerShareDetails": { "order": 1.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-US": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "Weighted average number of common shares outstanding used in the computation of basic earnings per share (in shares)", "verboseLabel": "Basic (in shares)" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeandComprehensiveIncomeLoss", "http://thecronosgroup.com/role/EarningslossPerShareScheduleofEarningsLossPerShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Weighted Average Number of Shares Outstanding Reconciliation [Abstract]", "terseLabel": "Weighted Average Number of Shares Outstanding Reconciliation [Abstract]" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://thecronosgroup.com/role/EarningslossPerShareScheduleofEarningsLossPerShareDetails" ], "xbrltype": "stringItemType" } }, "unitCount": 23 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760" }, "r1": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "http://asc.fasb.org/topic&trid=2122149" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(19)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3536-108585" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3044-108585" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=98513485&loc=d3e4297-108586" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=98513485&loc=SL98516268-108586" }, "r107": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "230", "URI": "http://asc.fasb.org/topic&trid=2134446" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(12))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(i))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(k))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(1)(iii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(i)(4))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(i))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(k)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(n)(2))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r117": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "http://asc.fasb.org/topic&trid=2122369" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r120": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "250", "URI": "http://asc.fasb.org/topic&trid=2122394" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1448-109256" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1377-109256" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1505-109256" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1252-109256" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "28A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1500-109256" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1278-109256" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1311-109256" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=SL5780133-109256" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=SL5780133-109256" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1337-109256" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=117327953&loc=d3e4984-109258" }, "r135": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "http://asc.fasb.org/topic&trid=2144383" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(2))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592" }, "r142": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "http://asc.fasb.org/topic&trid=2134479" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8721-108599" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8813-108599" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8813-108599" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8906-108599" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8933-108599" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8933-108599" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8475-108599" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e9031-108599" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e9038-108599" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "a", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e9038-108599" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "b", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e9038-108599" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e9038-108599" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e9054-108599" }, "r163": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "280", "URI": "http://asc.fasb.org/topic&trid=2134510" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=118952595&loc=d3e4428-111522" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=118952595&loc=d3e4531-111522" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "11B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=118936363&loc=SL6953423-111524" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=118936363&loc=d3e5074-111524" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707" }, "r169": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/subtopic&trid=2196772" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=118954083&loc=d3e26610-111562" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=118954083&loc=d3e26853-111562" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(aa)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27161-111563" }, "r173": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "320", "URI": "http://asc.fasb.org/topic&trid=2196928" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(b)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r178": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "323", "URI": "http://asc.fasb.org/topic&trid=2196965" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=118955202&loc=SL82895884-210446" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=119407570&loc=SL82919249-210447" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=119407570&loc=SL82919249-210447" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=119407570&loc=SL82919249-210447" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=119407570&loc=SL82919253-210447" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=119407570&loc=SL82919230-210447" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=118942338&loc=SL82898722-210454" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=116846819&loc=d3e3927-108312" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4542-108314" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.BB)", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.BB)", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "330", "URI": "http://asc.fasb.org/topic&trid=2126998" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=77989000&loc=SL49117168-202975" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=108376223&loc=SL108378252-109267" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13854-109267" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13854-109267" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b),(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275" }, "r216": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "350", "URI": "http://asc.fasb.org/topic&trid=2144416" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r222": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "360", "URI": "http://asc.fasb.org/topic&trid=2155823" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(d))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=77896938&loc=d3e25287-109308" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=77896938&loc=d3e25383-109308" }, "r227": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "http://asc.fasb.org/topic&trid=2144648" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14326-108349" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14615-108349" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14394-108349" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14435-108349" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14435-108349" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14453-108349" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14472-108349" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14557-108349" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14557-108349" }, "r237": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/subtopic&trid=2127163" }, "r238": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "30", "Topic": "450", "URI": "http://asc.fasb.org/subtopic&trid=2127197" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=118943654&loc=d3e12021-110248" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(4)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=118943654&loc=d3e12053-110248" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "50", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130543-203045" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130545-203045" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130549-203045" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118944142&loc=SL49130690-203046-203046" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118944142&loc=SL49130690-203046-203046" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118944142&loc=SL49130690-203046-203046" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "606", "URI": "http://asc.fasb.org/topic&trid=49130388" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5047-113901" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5047-113901" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5047-113901" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a),(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)-(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(3)-(4)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)-(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.F)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809" }, "r282": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "http://asc.fasb.org/topic&trid=2228938" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=109238882&loc=d3e38679-109324" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=77890550&loc=d3e5263-128473" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "38", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=77890550&loc=d3e5504-128473" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "808", "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568447-111683" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568740-111683" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569643-111683" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4613674-111683" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(c))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=118582676&loc=d3e5710-111685" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "b", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=118582676&loc=d3e5728-111685" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=118582676&loc=d3e5728-111685" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=118582676&loc=SL6759159-111685" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=118582676&loc=SL6759159-111685" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=118582676&loc=d3e5747-111685" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=118582676&loc=d3e5747-111685" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=118582676&loc=SL6228884-111685" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "4I", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116874947&loc=SL4590271-111686" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116874947&loc=SL4591551-111686" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116874947&loc=SL4591552-111686" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3A-02)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116822174&loc=d3e355033-122828" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116822174&loc=d3e355033-122828" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3A-03)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116822174&loc=d3e355100-122828" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3A-04)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116822174&loc=d3e355119-122828" }, "r315": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "http://asc.fasb.org/topic&trid=2197479" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5579240-113959" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5579245-113959" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5580258-113959" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41620-113959" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(8))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41638-113959" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5618551-113959" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624163-113959" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624163-113959" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624171-113959" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624177-113959" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "4E", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624181-113959" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41641-113959" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41678-113959" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "182", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=116861445&loc=SL5629052-113961" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "25", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109977999&loc=d3e76258-113986" }, "r331": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "815", "URI": "http://asc.fasb.org/topic&trid=2229140" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(1)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.12)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1a)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL6742756-110258" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=118260190&loc=d3e13433-108611" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=118260190&loc=d3e13531-108611" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=118260190&loc=d3e13537-108611" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=118260190&loc=d3e13537-108611" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.13)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=118260190&loc=d3e13537-108611" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=117336053&loc=SL75039408-165497" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=109240200&loc=d3e30690-110894" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=109240200&loc=d3e30700-110894" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450222&loc=d3e30840-110895" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b,c)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775744&loc=d3e28551-108399" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.14)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775744&loc=d3e28555-108399" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888419&loc=SL77918627-209977" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888419&loc=SL77918627-209977" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918673-209980" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918673-209980" }, "r366": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/subtopic&trid=77888251" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "845", "URI": "http://asc.fasb.org/extlink&oid=108781845&loc=d3e29515-108402" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "845", "URI": "http://asc.fasb.org/extlink&oid=68069686&loc=d3e32049-108421" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "845", "URI": "http://asc.fasb.org/extlink&oid=68069686&loc=d3e32049-108421" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "845", "URI": "http://asc.fasb.org/extlink&oid=68069686&loc=d3e32049-108421" }, "r371": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "845", "URI": "http://asc.fasb.org/topic&trid=2127423" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39622-107864" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39678-107864" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864" }, "r379": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "http://asc.fasb.org/topic&trid=2122745" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662" }, "r382": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "http://asc.fasb.org/topic&trid=2122774" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61929-109447" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61929-109447" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62059-109447" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62059-109447" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62395-109447" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62395-109447" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62479-109447" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62479-109447" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=SL6807758-109447" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=SL6807758-109447" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61872-109447" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61872-109447" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "http://asc.fasb.org/extlink&oid=68072869&loc=d3e41242-110953" }, "r401": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "320", "Topic": "940", "URI": "http://asc.fasb.org/subtopic&trid=2176304" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(4))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(5))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(6))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(7)(d))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(7))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.23)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(13)(f))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260" }, "r416": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "320", "Topic": "942", "URI": "http://asc.fasb.org/subtopic&trid=2209399" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(1)(b))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(1)(g))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(24))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(10))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(19))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=117419784&loc=SL117783719-158441" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=117419784&loc=SL117783719-158441" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=117419784&loc=SL117783719-158441" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=99380617&loc=SL75241803-196195" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04.2)", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=6488278&loc=d3e603758-122996" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(2)(i))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=50485924&loc=d3e611133-123010" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12C(1)(a))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=50485924&loc=d3e611225-123010" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13(1))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=50485924&loc=d3e611282-123010" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(2))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=50485924&loc=d3e611322-123010" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(6))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=50485924&loc=d3e611322-123010" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.3,4)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column C))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=50485924&loc=d3e611322-123010" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14)", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=50485924&loc=d3e611322-123010" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column A))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=50485924&loc=d3e611379-123010" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15)", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=50485924&loc=d3e611379-123010" }, "r444": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "320", "Topic": "946", "URI": "http://asc.fasb.org/subtopic&trid=2324412" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "http://asc.fasb.org/extlink&oid=6589523&loc=d3e617274-123014" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=6590653&loc=d3e638233-123024" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 4))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=6590653&loc=d3e638233-123024" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756" }, "r449": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r450": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r451": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-13" }, "r452": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1-" }, "r453": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r454": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a)(5))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.9)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a),(b),(c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e637-108580" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e681-108580" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669686-108580" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "17B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL34724394-108580" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669625-108580" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669625-108580" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e557-108580" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118951672&loc=d3e1436-108581" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-03(e))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868656-224227" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6801-107765" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(12))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(21))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(5))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(b)(2))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(b)(4))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(b)(7)(c))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(b)(9)(a))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.21)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6812-107765" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(b))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.8)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.9)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r85": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "220", "URI": "http://asc.fasb.org/topic&trid=2134417" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3213-108585" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3213-108585" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3213-108585" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3367-108585" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3000-108585" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3521-108585" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3536-108585" } }, "version": "2.1" } ZIP 123 0001656472-20-000073-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001656472-20-000073-xbrl.zip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�(T4P[18>5.NU\,6TY M#0R&'V.*[UG[GE0MBI80X!73>ZR:+Q\QBH1M07( D;B'?X& M)RYK&ZUL+9H7OFH) I$(8+L\]ES?%K\K32*JH#YC:V?=>G0V!A9@\-8D3X1< M0\!M_^5KX,ZIC&.@M/U$#?T)?;,1,;A.N_ERCQ =JPBE%Q#FB0"XE,5A]5,Y M>D/XYO -'/W2T.):R'E@HZ!X@_@>X9Y<320U:A\;%4]83C>;%&;HW7Y:"S[( MC=,@XM<(PY3 :!2@3X9Q9F,-*IYMN<$_5,3QG,<-@X%*S&RK1L^.-D^-]N4] MEI)$7TF5KHG ,791Z>!TH=@^)'>!"D-(OJ"W0QQ*<&:Y0&[%Y?G>XP&<0L$ M#U@1G<.C]C,SL1M-T2\WCZ*[]U/-(]'S.O48"N,NV^%)GJ1H&[&J^E MR?SG%47'FR>*_@XN!L:MT+"Z5=XG')U8+TU[6S$35\605L=S*.CZTXM7;T^? MJ6T[;Q=)_-7QII#XKMQK_J'7<'_<9DKVA;G%H;4[H&QA&I8K77>]A;%58!I@ M(;'[WMQE'#T\5UF#Z/%19GC&4]*LRD(0F3)VKER%AQ%)=#%U%B*>M7$*)OK0%Z3J4_F M8G>0>:J/2*0G8U.FPNE[#[^\/MP3H#A4&DN+%?Z.:R=U MBL0W@:4H<>9*\F7J#4G-2B5':H09 /%P6 X\2>U>6 6X JU3 M[3BL-B+N+'],#IQ),J].\_Z[AQV+S6]J6U5.\ !K3S1?\I]C6V!)CM3^ (CK MZS[1UXE,9D!Q.S^JXW-#Y5F9S> 4'5=[H1Y _I)I5"TWBD $)!I6YU(C8,T* MNR1RUJ[S+7,H3FC5""MY;*YU2L;/"[!2+-(*8J=O 9V*F]_P\T"E:JA]S5Q3 MK)!J#1-_8JT4K9]6XJ@0EPWF9*$]GKNC.*>K'W8H50N*BC236Z)&7!DC92($ MK4/]:(,YS5=0-1).K!+T!<@1 $^M-A=1'VG+WNVG]C;/=_9J\X+K?65!0\C< MY.D618O-WRG%U6L5E&0W3:U&H6E"E"F5R1)C;Y&GRGU3:!XQ G .5"0S1T(Y M5M*/^=EA!CSU((P;2HO_=0.1V;>HZ>7277#981XPU0H;<4@%HD4J_O@_B(L/ MVLF!3K0/!;%57+"?A0:N\X"2/&^#1:0Z!54(L!3H^E0^0\E'#24 MT-_Y'Q#[XH)IR-*)7AH3BYZ2#HYT%XX[KS;_WO+L/0QS&6[(0!H$=;;;X0R MX$I$*2Z %4=$Q1>&ZIJK)#S3I"W!QF,NG^>ZEBS"DE1E!.(U)AU*,.1T^;+] MNEKKWRQML?:QM"YW6401CN.FG")M7<4W!(_(+5T/% MYR$39_!0ZO#1HX_!L:VE ^!>-TMJ_EMJZ=;-J 9A0;)A15N9QNC:$)U6SJI; MD6CP6TDS B/-)/N9?,U98*$BSFY*H;A4>E:8*>7^+5B)>0^?SV41B5):P)O2 MNLPE.,VQL'1;_ +SC>AR-IA760^&*HI:^0 &O\HI8@M!IU&2H3\-:!)W)LE2 MCZDT9&F=EI\KL[@R,;IB!'=_/:)*&/4FBC);"#O&X4*F(T+Y I(:CLC@]"-0 ME_9.1T$'50\#<8H#@6APB8%T&DLEQMS7^D#4@?Q/Y P,(SSR(B36*BP\JT8H M)TD[H*+[(]/8]0$+:##T#+44 APMU 5X5(E66?5K!YK7DE6% V -!V2%;9$8 M=%.I"XBJZ(]=$J/UY7-%2S*5/L5R(D<<9[/*3:D,"WTN,]QKY;V;8%6H^RG\ M[)(*Z(-:-+Q"FDCS1/HM)Q4RE>2.6\6X@EA]+^>@%B*\@ZP$3)YB3L"6%L_V(59BO()XQY M@.$CG0/J):9!D5/!6:L22R?K-XCL2%;B+(N@!9,_9,URX[Y5!NJ7;:\&D$JC M;#)0.4^#>,!N:+>:3[>)JT<:>-8M1E6?WLQ2 M9=U83SG448/B";F>+X-&&MA"\=:JX?-]MWD,5FGF"SG%YF^QVNSU>)G"YI#> MY\"F<)8&:W" SX?63(C3PYTS>+U0,)W [U$C0_Q=#^CE'E/I"K&[1N*(G$F4 M6Y5>4+FR&Y1E&0RI^DL5%_&(9\*?G92'-T_?J5$55H.$\XK"R8[F@=P2@ MXLS;+ FT!Y-D25[4!AR5)2,* E.,@.BT17P #A'E(HGI %W$6/ W5^%L:7.- MZT(7LARTL):<26R%PDF@ XKU$"'5+NIJU0@3Z"^(X]+6PSI*:2VFG2A\Q'2; M"[F5M L?R\O!>#:,>N%LF-X!J0M^+:!FM[#F:#XF'9B0!TZF)BTR6A/)(:UY MK7ZS C^<(K9-!35R@U!B2&Z/J;PFT#%*X,H )!N] &.]NJU8=L"E1RK/I)1E M2B$:)W:K<44.UR6AV!5'>(,W;W".5HQ5PKY\K58.EL+\"@,49U964V:_ABK6 MCQ20)*:NI)QKEQKT%P,C=/2Y@J3H)N=Q8&J*0-#F 8#ZW@L%[1'&5FZV.YFH M2G2Z++BJY1L7HL/+=D#(@(6RA",C\IZ'$\8K1& I68GQ^9@%*ZX!PBR+BLY3 M( IK8'V,*3L3:7C2J2BSE(T<*YF@"&7"\U8/LO!@.# BLRQQQI:9OFUUXB94 M)R[C>%/6J%:30W!$:O%.]5;H!DO4'%<.FZ"<)P>9\,32(0L25FXMJ^@H1/ZRG6[]X+/.X28YPAU"^.=* MHT-?WJ]5P&F9D\7>645)A\IT^)KZ,$D9U3DR_[[*F.-P95N1;66]P;JM5MD1 M.4:H;6> TI#+R; ,>RL] MSCH;=9,F2P^BK>;O"B5&OVJL+Y*ZJQGI8.UAIW!A@J.YFY><$=]RB086T27, MVS7-6HT-/;@Z;!57UR]!?A!/*IF^GJO<\M599Z.NU@M\!3['[]*#,Y0[ERFZ M.Z&L<>M9K&]$L&JW "/+&+B>U7#$9YS7ZU+T!'\-M=V+=L*#> B(#:LBI>^H MAM/F233\1'*O".R5=P<'"Z'P%K:% =]!BP_?J]GPPH -E0FE31\;F!8-70E* M?1+*)H%[L#B<2\TI_T.L5[-J\WKE"8O>_,;;6I,/$+)*0JUG?-J*V68E3AU8R5"T) (8@_,J"N(79UDX:!=?B;>5B,O=SB+1VH M;SS6$?/K-OG*$%>W5"\NSUOBYNJ\7JE1/+77HNIFWM2*'2_XII@L#8T*M$Q> MS!N C\HR8L[F!MBYBK<*,78*#LN(?6Q(0'S#CK4'E&9)7(D\@P3!-YH\5,5U M9WDK"=8Z%OSSG$*OR+9T4\)"@O]!J*E%Z:J"HG.O36F;FW#8FA.NY,&J@!B( M/?(&]8V!IZ+4&F76 MEHYJI\2HA;XIRWV?(^6F1U?C=2R:*)G!6EZK>>TC?#\&:^+;F?=3;JOFI?=!V$QH8$.R1WT0S*+*M3Y4%Y!%8#,YT'_Y@%H7+5Y! M!@H0 Z/'4M/E_UK[NWM^+SK]U>]^:7UD(Z"%U]=:^BK%83 MPO?.S*N&?W[K/K_J(I8D6HIW7[3$T>&7+\^S- C5WV16/$/FK+9BCEXUR4!9 M]5;EWLWUS:VX[-U\^BBNKB^^VV:K[?8)^5,W*EXW"$O?:A^AU.Z\/CQ]_I^; M04TKV/[G.?4!U'?:"("_]:6./Y#\MS,UG8PO>^?7_6ZW8=A:OYFV@GY3.63W M6D[4WM;#^ [4O?H^#^-@8.(Y_#7VD^3L_P!02P,$% @ G#P&42$(@Z9: MI , R;8W !$ !CR]6Y<31](N?/_^"G^^WCWD M(3(STFO&>V&,_;(WIQ?P>..;61&9D2#<+3%2-Z;]Z[](]<$-QF,P:E656@QF M="B52O4\$?%$'B+^_K_?'AU^\4:6J]EB_H\O[=_,EU_\[Z___O\='/R_;Y[< M_^+;13DYDOGQ%W>60L=2O_AE=OSRBQ^KK'[^HBT71U_\N%C^/'M#!P?KS]Q9 MO#Y=SEZ\//["&6?>>W/YE6_%U4)R$'PP!U 2'.22\$!?MB@^F13]_WKQ58,6 MF@1_ !GUGQ;I($MP!Z0?A5JCE C_JWY5?&LY>RLM$91F&T+_V MY;'^.OV%\]57J^7Q/[Y\>7S\^JM;MQJM^&^+Y8M;^N(M9VP^,/; VR_/#YV] M_>W07W[YY6]O>7FX/GPV/YS-I=^96\=+FJ_:8GE$QWKG^DG"@7$'+EZ^_\_R-#W[OA[]6C_17OOOR\-4"G$U_]!FCGSD[XN(#_MC;<[YUOK=BT/+LC/G_,CCE]*?+U8OEHN3UW\KBZ-; MG0HF>G-Y_.)D?KP\??VM_[?@_M/ MRTLYHH/9?'5,\R(7G_K=SWCW!O6WF59R]0[-_M,-?>_T)\?+/SPZW])W+PZL M,OOP#]8W/LS SWBG7-??.+/2(B_G>>/ >R&L3[HJT.:O_C'ES(_^.'IEVHP M0O7KOQ_),7W1/WH@_SZ9O?G'EW<6\V-U P?/3E_K;R]GS_[QY;&\/;ZU/M6M MK__KO_[K[\>SXT/YNA/@X +UO]\Z>_'OM\Y.S8MZ^O7?Z^S-%ZOCTT/YQY=U MMGI]2*=?S1=ST0N8O?VJ'RC+LX>S6F6^?JCO/U1?M)R5L^]_>_Q$VC^^G*GM M>^?4A60R4&S@Z'(RWKLDA,G7?WV[OA2K]_ZM=A?WW2&] M^/*+6=535O_/4_YV\>:^>_+FN7]P4E_=??/3]_G5HZ,'O_YT]#P\>O;@[4\_ M/O?/GSUY]=.KN^'AK__GU<,??SA]^.L_7_[TZH'YZ=4+<]\_/'S^Z^M7#]Q/ M1X^>_?SK@Q__>?30W37/W?.WCYZ5T^>__O/PP:MBG__X_->'WS^'A]^AN>]^ M.GW^8XD/?GW^RT/WPR\_O;IG'CS[Z>7#;\O;Y[\>OGK^Z\_V^;,"#[Z]=_KH MV^^.'O[Z_$W]_KL9?_]#?/#L>7C^ZH5]^/W=7Q[^>GCT\-L??GWPZXNW/SW[ M[N<'O_[/KP]?/;=ZS7K^!^>?^:<^#O.?GBW>/GQU.'OT[0_F^;/;_M&/S\W# M9P]^U?,?/OA1/_?M _?PU3\/?WKU?UX^M_C+_6=WCQ\\-6_O/[O]+R%@J,8? M)!!UU-Z9 W84#J*KF1'5A -_^76CPY7\_=8[$%XGHAW>N<>+TCH*[ MI,-[\RIO_Z^<[F'],UC-55C!4$*T\:!*5EB]D0-.C >6!6/Q^HYW7WYM%(08 M(J1MPGOG9+E\QR??G==O-:/8(_QG"-NK"'/S%0J02CQ7-(,R<( Q*M:%O&L8 M$;M7/CBP3H_X WB_6U+I91PWL$;(1L@U M"$IR":5= .[/ ;===58ILR.-]__X$B[0/T]WOGKZDI;2M7:]LSAZ+?/56K/> M7JJ$?2'=J7]S^MLAC^FTOW3[%UK6]3__E-7Q;/[B24\N5^KXB[Y++Y0^G4_Z M+698(L&C._FH''TW?W3TT]%/S^XI(?33KWY0XCR9/?CQXOWJBI.C_U?;P?_Y54@FYM*J&WB,TJ>61\^6@(:-W9#193E]^_3>O?RZ8 M< ']IU)!8X+'W')Q#"H 5! M2A.-W$56'Q@MZ,,G7ZW6(R]*CB_6PT)?'9^^UAN_FAV]/NSC).O77BX[=]X9 M&/C;VY4R\N^WWCW'V??_]J7GU[!:G"S7S]8#-%^=$_(,VK^B3"Y.)&O5>?%L M5OOS-I/E%^L+D@^.O]RY]W_?%5'O?_CKBY?>/?OK=;IR\6QU3,OCKH#6.50? M_3'VXG._O7=YF?7*H?&@#ZN\^\[%\XLON?7.C;HX3[?L]4U;=8M:7=Z&(Z'5 MR5*^/O_Z]9L7I[AX[^)Y/\<'<0B1F5,P[)% G4)&L)0Q03-9I/A_W5O??C1A M!+?_;"#O^/R.XH$)ERO?GCZ[2??S9RB]5$0( MG%._ S9;I[IS3'? Y@OU_=EWP);&6'S$#/J3@\V4O,_5.+U0#;MT[ME@W)X- MMN'9WK4=9+:A^AA*AER 6ZQB(6573:@Q]OMF\_E]TP?CNV]]/N C[UL_=$/W MC6IB4(JYTDS/)[+)U&RM'+(3]O[\OMEQW[>/C*2?=]^N^GV5G6N%>GDOZNR- M_H:KAZY3<#I>+/]BB/C=Y_N+W\I\<32;?^BT'QO(WSG%K7>O_L\BE$E8C4TH M0=5FHYI]-(D4R,JY>L#S".6OWS^?_UIYT7.#LZ=5O^SMZ\-9F1T_D)[%?%%G M^N[9+/=EZG&L@/?/W/WW21]\U/QC,=>GJ]MO9RJ.+@[3UX\6\Z?'B_+SV;G^ M?NN#7W%YRRZOY)-#I]],X @-R8=FK5/-H$D:E>:RZY/L"80J[PPTMVN=];2% M#A_3K-Z;WZ'7LV,ZG A,#&HPE+D9\5 :9B/)2W.(7J(ENS,P/9%CFLVEWJ7E M7+/UU43P"11*B*EH/A.@=V*2=')X=]A<^CXY>R[,?_AR<7BH M%G5/;X&&^N.)H%0Q4G;@52M8("I43) $CZ*UXTX+% M"C5YU2B:2L1@C:%D)>T,/B,8A=H09*4XT;M8*(0$TC):$07.1I,3I+8[06F8 M4:A-Q2X!.LB, MY##@%E]28,,M0 %.+N=6O(TE^%8#%[=[X&YW FL85%THK'(N9 #]ZQQ+JR;W ME06V>HX[B.H0$UC#8-M,5ED17?*DF90&5XM1:H06:XC6IMW#=O )K('BKLHG M#VJ[1O_/N(2NB7%9_34I =I%CC9]?+5;"F0A-AQ M*6C]SD ST"C4AF ")BM<2\T>5*]60A-;WS 'Z,"6NC,P;7L4:D/XH.81+C5K MD2*4EI'5B*HFSLP4G=\A,QI^%&I3>R^;SX(A268$AP:#*0$(HJF%X^7 [O0A M&V84:E,36 7Z[F"0'I\2:[:>?+00.;8'N&=$4^;VKQ,+=1(P=9,&5HC_6.HB.EU0HS#W8%F&/&T*9C">C]3 MKF);@%"B@N5MU/B,-8'([L"T9?&T*7R*[\M5D\DFD:I;QV@SD,DN ^?L8&?P M&5X\;0RRC%4,0!.JP,:R[\7W"BEPJ66N.P/9(.)I4RCY6G.S0EFBT2PQH&B& M+X;[7G;,J0Q0-FA7 M4@M8W>!=<9+*GZC*H+C8+JA(ND4KD634'=[H&[U1U8 MVP<470D: 8-B)R"AYLH ME1(U8\@I[1ZJ0^W VCZV3:4J*HPM!0NM6BK>!^:A%V,KT-/8 T$-)-% M4WT$7_7&AQR,33[9RC[XOG"DRUW< ;F[K3$8W)C&!;WM35A#I6IP,/D./P6P.LA2Y9H123)\4CB;GW*O10G7%6R.[ M ]D 8S";0ZF2062)&ID2( ;.(AYJ5K]78Z:T/92&N@-43/K@JS*R)?8%M*\".LG$>4" E,I$$=P_<[2^CWCZJ16+UKED(D0!"49O% M0$T1Y=+(\NZA.M0RZNUC*Y0:^9B;HP1<,>=J4.%ES*0>>@E)Z+>?7*D0_L[I MSM_\I!.>M^9Y_WSGM^TCS_;N0A#7)ZD-):X)*""5V-"D#$YB1!QQM9[5\OBK MWOZWGAS*HW9F'0_D^.5"Q<@;]6N_VTI&:DER^/W?GO[MSLGA\>S-NF'4ZOYQ_=LN#J^K^3DRC!X\ X9U M1A&J$:.2$U.9PAS97T#V H?F<^+95"KPY2PM,)7B M:X$4''M;)9)/:M]6;!O_;I@1XK/)#68B!B/G%$N&:C6U=[FH115I*H1I A42 M/P6?"W#NOCWN33NG8D08T0?? "@U4,&#+7BL8-8SJ2'EW3*B;8*T04M*I:K1 M).,2&? @[*$&@XY(C!$\&RY#$RT<7#P8&UJ7.)PE_JMO3J^*F=OS>C;X^0?R MY@+K?])R1GPH%V.CZZ-.'RZ.'R]G1[0\_4;FTO0"].&?0/M1>FMCPQ??+Q>_ MJ SI@WXT/[TW+]>LQBQV[EGXF,&^]P[]G'D8FP4: 3N.O?LOBO[GO#33MT!6 M/P&5?5-I^I".3V1).Y(CO)O.YYJ=3[T5>X2&@J55IZ\@VV@Q^'/GZ:T_N'BP M9^4X6/F@#_3.-6A3I8]PFA]U64]Z _NS[^A/'\SFLZ.3H^MWQ_[ ^H]TQU3EV,SO\?9?[BYZ[]^X_ M_?2A&E#2)=^,@(#77+,/WV:0%I+SWIKQIIK7R?#1TGN=AJT6)X>WYW1X>CPK M?8#RR.OE_0^PO=#@^)%TLZGKV1*T<]TTB[1EJPH25HX+ER,IPAB@6"A#?$^K:+WP;MKPE:C$W% M1A8( MF+/LP18O/5I!%/ITXFJ;N>&:*^ASB(L8H>%/+H/5'CUHICS,@[;W?; MQ&V#]I8(:XS!VYP28(B4JS7@)+.1G$K9>7N[MC'M:S$S6UORI3%[AEXPDM#W M'FC9HD^6JMUY,]L"7!NT+@:NSM8:@XO@G$$?&[@47>^_DBF<[6"PQH6#BP=C MPZW*[*O[\H(.SY+AS]7Y'YU_/CWAU:SV;/LI=<:L-QV^FX/>>_SHVG=#6'/@ MPL<,>;YWZ&
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�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

    _7B"T:MB;#\$.9%CNX'>3!9DFW4E>X:AUX(:C-QQ-A MZO[31^4;G08T>Z 8%KPQSS:21$L[5-"?B=.7F"+"*GNU"OR?8JHJ RYQ:1T M),]RQ,=/"T"A,(8H@X%<)24\\'GP0+L<8 L\C():B.GP+J]).CE-YM%YJF7' M5]L!! TY#B5AUWHE-1=S<'* %ZT8:9@6"&3?EM$G__,DE 03(//AU!W)M+(U'N "$,\:T&=!Q&\ MK'/)$E<<7]PGM3^"FW@ 2Y: MQ<7\E@P&=O"M '>?-]ZH<>.EDG?QBB?$DVP;OS'F/9QSKI>+7),8)%_$(WGY MGMDZ_(')#[R.S8%I/%CBQ*Q\'CC)7'P",UIN7B*P3P"Z4)LUW"J1_1X.NY'\ M%N% 7P<_[D6![THU^YCG":P;AIQ?=W1KC7,VXJ+H66;5V(/*I:YDW M]ALURK5.(WQ#/ #U?<'[OW*(37;%SG,)OKT*T>WI<%&X8ECVK3&XH6_D[';@)'\EC_T. M= 8R1/]KZD[>R^W3QL3JDQO^)?_X+XR+A_HQV($OY'3'73A=?UD+0< M.\6D 0:43%+X-_<_DA?=9+&B.,X W$^6KLKR6D_4_L'/(5@O:._F>Y(T4<)* M>1K!>OX4B'D0=WT.#6!; ]T0R B*: M..#5*>N$*O.X(DCI!SS_EJSK3[,WRPQ"+,8G:16N?\YC;G"]83R%8(& 125G M+&R(5I"6AC^:))I/]+@#YT<3\%E#,E_C3X8_N,8GG(S U+BJ,M\)"<]0@#M? MK_4%0N7XO7P$8:9D?_WP_[=W7]G(>M!>&V8%!E2F$&1!F9P M[P %Z0Z$BB**PHR(;.M!4D>27L";[$4^KN?K9R!M+TM* ='B^,W&R]>]P^X1 MK39ZQN%0H@,03_5Z3&SQ'KSV'"D82(@=B XG(]:5D?5 @X?CAF/I@6PO^+5C M.C ]HHB9B_$5)3K7V"&4<3-.0)SP(^V"?0Z*Z#,CC2LU0KG'Z)X%:B*OO?68 MX,IJHB&0B0_+8@ RG$LF*G"X+,RI/&^=(,"N/3SQ3#W"4D-V?EFFM;?DLWGD\SF)=RX3()I8>5\=!'V] M'E-/KG48Z : Y%<*I2[IBABUDJL[*GQBKEL>J7 776\K&H4V M;,0EK$O Z.5]B7P.$KJ"]2J>7Q+"G/T=+149WF43@TX+S*Z#.R=AGBMC%OX] M\=. '1L O*"= +ZCT3E$!&9S(&5BLK^4EUPU&90["RT+*UD2V'C:G.S@!+\- MPS1#"WDTQ/'/!]^%DVE$BX*3B"(S?,Y?$D;J,"NT^>19Z3*:.?H-JG/A#K)D M]"Z-Z=81@BH>HR :T*O_-*%&N(QP8"B4V#>Z,3PZ4!&==!HI_JIM]+ =:3C M/7#YMJ\ODFW7657\?"=>V7D);H6CD[J]BSOE\<)@'#%=) ) /,HJF:%<$ <% M85,-I)(S)?,8(RN)":=>:I!CSALI<>=7$9D\3T:&MZD;&#.,(Y/L!8$ R M09-X)99 #L7,D5-,/FM9E'(&Z[@WS&%.U=1/S0(9[7Y V M[)C+B[@/;PV,&$9F=9TTS:Z#TK9D17]G@,67,): ETN\&.79-8F(W9)Y8RSY MDY&2R"VVBN:2:8_J&AQZ@1."JMM1EP20#7(:G'Y3[8LXX&'"Q\:^)7 #8D. M,Z$C#0M=[^_)#1S M$QZ00+K03(TO=X;%A60P!RIR-@VMREJ= %O,9L"9V:$ M,8ZX*Q2/'F95?]\2:VQY-=:Q[W8/FUB?/$;?[<.7W9/C.W? 7O@CS'=1X^VU M??+1ZC?7U&^\2P_CIV\2NVE]8.<\B2M4TFQ7=6E7&.9,'>V(]=XQ>V877^I] MHEA%Z^MH%_L>BWVN93!FVA45L%W9^X"#B4/Z*D)8N[H/MKJN 6/E9;T5%TR3 M&_Y\O]8%=]R621@$D5I0[W7C*L\W>*H?F I6;&;Q0,M[2S_7VBHP>^OGPEHT MU'J'E8@)\W8@]%\VFH)JS4 54_RC']'G@@'GUN+S=/3_7!87I8R5UO6>'8#N MNV0/K*;6WO.S&$K+-M9XJ UL0QO!Y\S]][/VLT?1,B-R*JX58]DXA%L_]K%Q M2_A43.)I68'1U7Z*"KU]HD1MZ&2KL:T9/]M\UBL:V]N2)_S4>,))'?M!]36* ME'+GHQ!3L7!>4TG4PHI=)II.7+S E$MEL;$$4YPGZ6RMV.\6X<7Z,>8M6MQ6 MKVOUNI:YW$.OJP0V49R4CH\)?+@*LR/(\/N&E+1&M\\GW>Q>_;^@HO17?M12RX;2RZM$>#1C0!8@03V\-]W*=% 99A7*M$@!9M-&8JZ ML%JW@AT>*FYWKVNI)_U_<94OXZS5;V[M^JU=_Z<;#EIO;T/.*G\XCM\_W* M/4+^B**W]^O^'.MX.^0'&_(:4=E:C473^E*27]>-W:XAKQ.PK>WZ;_C UHG\ MUVDL/QV*-OQWUP\_J"B+K;% MXQ]L;<_2)$XR[P,F?W)!]W([8K0/=[QDFH<3>&RILB\5SZUKP=C08I'Z?+G5 M;O6;V-(L/1GHIILD_4YQ;1-T&?&;5FX!62ZIBZFL3C2=:\[P,RJ-S%8.KBO; MT)42"U( 7&&C&#%VNT5YS9-L+5J_C\/&=_>5K80,CYDD 1E J*!Q5O\VMZX^ M5N$/002C@M52ZSR0,L#4EFTZC0!%^Y%R?[>=:Z@!LV*O@9<50VX2D.NBYCB; M4/K!-_7XQ/6$XS$:FX1AJ7_<,?WE,K>O9JJP[=H.C%MVE+W-^B MML1GMF9+M>\C$^N3MWW4MIHG@].KHI^I/PNGC4:FL.1\M?YW&:.R8H#V5JSV M/:M6FX>!O;O\XF6S#)M^^X,T$9PZ W(%N4&PI(^M@(!E,*L&W@) MA:Z >,3-'9,BO45[70I.SJ0^N9(&L00_1<8< YV7"NG>MB,1_$B*G-[&SU78 MHQ+0:X:U?D(N\&W[Q=OZ\/>H;[Y6O=P;3LP%(^K8YT)'[EZ3?3Y!)M'$8%;K M@,$-0*4_DP'Q2H6ENW=<_F5!%^MAJ8LU_%7?\/=7824)=DJC1KJV?KZFG$7- M*_RZFX1_V"SA MX[S"X&\OPL'![G_8LWT M EG^-914G++"-1ORY?3RJW=^C@1PL/_FXNO?WUUZYY_?7UQ^.OUZ?O%Y%4A> M-O4FA7C5O3YZ4?/^-<;_AI4^1ZCOO?8^JA$ R1?D>@IEJVQ9^\>UEX57[\89 M4H,8C"="3+[V4^S7Y$6T(E.[(II5)=AUW4]1@2S2C/I&H8)H(I^X%@5B=:RX M-P]%+>$UW)>6=)<@S'+@I05=8-IXRK/@K=@F*.LRK_F$HV3-#]XW/S!R;O/@ ME(\!5%GNCS@R*J+"^O8E2GWW G]"/YM*&$6<@3S%76F 7:'N!VQ/?.6@-T<@ M!Z "1K,OG)BBBG%76$1%9K;=R::+6!FH*T0+L,HYS"KQW]8OT<[H?D MY_IFV>CM(+D&J#F+?*".4R8)/ 41GHH,E+&(E758ZTME&_QMQV(TR=VQ]\E/ M!V.OUV,1==^(DS<)1EBJ$89.CH$\QTD4S!>E 5*F3EHH20[#"'4AN'%:Y"3< M>0-:;.D--K"++63SK7O5]=X2! VP!QX(Y:9'USL_0W'3_HRI.S#M_T6KF#^" MYV1Y:22Z^]K9.%1#$*S5H* Q7* 2IKBS&/]F-7#S&\X4-_\Z3"(A*WC?E2!G M;^^7_J]ZYJ[(3@]%61\NZ>\<(59,BFC$'1#KO,[RCE0,Z$#R/&TA$WG%>%<5[Z> &EC=KA^% \]I M< E*5F%J6%1J')7[WH;Q($FQ6R&&SG(\;=V+^,29DR8]_$SP5$-31-S:^::( MW@T;Z9!/D6;N5&87RZ#N_N< V&8#69^@I?/5*Y;U+/=(2\] M=;O;H %:H>;K'>BC@QW1YC%*@,BG[AW2VV?H >Z'$PT\%W&.\I5W51"S3 5[ MX+)_X.(,2)#YFJ0PIJ2CK^ZPMP.-PPIE6 MX04%X;SZ95Q$KJ]TNTR_"I[P70E_\>QIT0FOCTMR$PRHB',^;#73C_V)*KD? M.HL@L].$EQU$:6S0V(BG!FN1AE5:OIFKG %2Q R@\C GM+*!V-G&HHD";^7M M![$75-O!V(;AFPV&*:5<<>T4[1H)X '@ '<1U$88??'O6G8^2])IHL4K#?-8 MO!MNB_P;[!2<*GR0[F[4N.!5),Z>"(KG1IC= I.?"21W/!W\6UV-S!JP4T<4 M;-QEHT08-*A L@SPUGC/M<4#"O'W1M3C/3:&!'I4Q9F?L!\+NT14[2'DR*#5G!;5+ M:)@5P[/UMQ)<<&OINAF6WR<6 S$75*T+XID:NX_2>)92^>>L9-H C(0)<)OY M2.#3\;>7;B"7>A(K=HFGY*">5(PJXCU'YJ/(?;Y(]:EAJ@DS79$;#$;7P"O; M/.:FN2TR90.H?+26*1=,/ED3V=NJB>Q*3&1?A,MLQ_HLD;E[QS5"-\9E%)/% M$G=%NF6AUKC;1.K^9P$89MCO[W#2QU2O/>HCS\?+Y:.5P9OH@#FJ\0LC=?O] M$ DI+H8@<8-0P]2P"U1GS)] $XW<74MN _PKLQW'F0M;KBWC9V-?'F82@B+/ MDH'$21@P^>F!&6$%40W=F(,0D:) FVY,?CMTV+B[T-MCQ*M]@A\443YW]P60 M/2R@UWM)#SAIG"RJ-JBAY$D.@\"O_W*TMP?R9!01_X GLJQ-Y&E50 M%6<,'**>L'Q5Q'CV/16GX6"L&ZT2HO).L<:"HKU '04[Q71$V':*NL1?CLP0 M2.S#&,J>FE]Y(XR&9;;L]'*=>7*!:!W-FXS)3D;LU(,2CXQC)Q5&+ MX1*2@DFZZ9,8GY?LAGK/![3N*+BH>.2/6'R4^.C?=+SW M0!Z@!CKSI:_/9($R<=YQ^U2M;^,2575S9YB.=> L"50%7M0/4M9A8=(4]2JM M\L*"H:U#OB:?%#X%M+H<\##"_AY$H4B!XDZ3=3"3-"ZPDM/+GACC^BJ;[6HT MO7F[G=G[WF''B7-:L.O AD!A1X8Q=((LIY'RB4 PKL2$$6G-D6\/AT-ZP@A7 M NZ'6ZZ51$;R(/9E$"1) _H$99,AQ2Z9>O9#%:"YPC@BV:OF_:M(PPRE8P*[ M4[.3 5((?08N]$_C@.*XMDYEF!87Q5%0&H8_-S"CVMC5P5U%"P@CAM/O?5*EMQN"3F,Q69#<"DRI0-GX.HFP MY(UO93MJ7XG)#<"L@'DAOJ.MJ&!3N^ ,M;@<^F++GTZ5SY:(+\ XO/..5[N^ MFM>2E"E-]JX4?FU]$C#@4KW]%64W$A A@1Q MF"A)FI,6+3L-P1EDBIF/\P"-R2\REC]DA5&P2SRTKJ&P1A&;&+0!SR,G#4B= M(1F,4&*U>\(""JV^J%LZT"54*TV99^B3J1_??:.T&0E+(.F@F,0-1^E0E H\ M;D;W(5,GJUF,,3$QYFXH7$#5]<[9@*;316B4B\?$4L,PB6!4N#QT#X>OXH-( M7F^:+1G;X-TEZ[DMM^'I:)?2%'5N"4^C,D^T%W"H#\;DX@/ZBBR#)C)'CZ]T M%("ADN0)'VOWOOFH#'R4PF#N\B?:^\D1@9&Z*$YA$W%-3YEU;LV%#$4SJYXX M9U8%FXY7C3D:#:!]X>R,"$]UBV]US?DEXVPLC.N2F&DW.ZRRYN9FT%)\NKD_ M$\$V36+_.DP!0;'JC)J$ ^^7LXO_/G^[TWOUZY:; KE<$WY,!"E-'$KP:5:=K5.Y\FA@[]9(T"G2LHT^)>Z#\I"&']'.7 MY1LRL"/!P(:">@B[97/"?BF;B% #M#;&4UAN4(="-#O"2DWZ^ E?=IZEOHI@ MT\[C.;?<_#3QVQ$&R\?L$^':03,[U@X;&^#?06C47,:ZD4I MYO"1%#JMT+UZAZ?2Y/#2-^+MP%$DM!7OY(S']! MD5I]"O @1"(6HC6&BNI.5@V*0)B2Y,0G#;]C"D=;9JIV%(QSY+(S0@+QTL"B MD!+0(2Y*TLO,,#!L%GC:L-F!FX0K=X<&, G,R9 M+/SA36! X\Q)GO%TWDS5FE^-!""+4*9&+&K]H>V^]+65(2AQRP*5-HOKX^7# M($8Q51:#;;\I$P?@"11$I.3QZ',E(1[>1V"RHT"S/4YI,C)I;)64P[0("N6 MW9.ZK4;(FN>\-E..,XR(=<-&8+)N'@["*>7U2C)7.K"4#@WM@3] PVS(:>0D MXCO?B#B+B9"A]E4SM.O&F&%L+RGE2M)5P@:)[7&VO>:"=FOG']#UWL-8U \? M=[W#@7E\0A8P ,QL"#&XSYE@V;4(;SH;PY&39[&>$P#,S.AB^ 0#2V7>?=)= M-XO&U3'_B:U5IE-P M,R\R'@\^^L.G+\[0R1.CTTT['"A"3ZF?'>EVI)'H X C"C/4>>S:I%ICJXH< M)!!3B%BINJ\C=LBAR,=A&NR@(CPKCZ3CG)?$'A0^AD&8I<4TK]GR/T0]-*@( MZS$)8_0%\Q;!!+-Q.)UJWP!'7;-1%%8Q2OH4>SVATU>]%FL]DF8-E'8-FAKY MN4S\!V$*03=O25_B1"6=FK)379=LTZH,DV>LX*?1(PYHPBFC=P! F\T0R0!EA%035@O@M/!'S MS4'>+5(6\X?PFC@+I<:'N1 7V$H&M@>PCY(CT>P.<5WV$,V_F\-*RWHIOAQ MCKECQ[FX:OVH-Y6P#1=#]*#"&8<)#;%$,E*D.)29HPY)#5&62^ 27%/.VR-*,S+- M'"/$_;/6L)G,U9H?0(<, [A#H>T6#USL$S4WZ<"9T%1 M:*2MG4T5"XK.HHCY%*,K!# H=J+O\'][X-VSZ#A#34"/)4:2T.R!9QP8Z)J] M[@'ODG-2]@ZH<*R +Z<[0%.,L72:8-T)_E&P'RCK:H+&2R)M\P'!2XHG1Z..9 ;XQ<3L\F^RE+)ZY$-R_5L/#B MYT9X<68KZ$"*(;/H; Q\&/WR&,J!.U7[2 8PF1ZYMET94%-%QUB570T!ZS/M MH)RT@]8,R[Y='[Y! $.DCM:+\VAZ"%)?C"FE5#7(' ,A.#2#=( MU6_>XHA'J2\"3T5.4)1P0H%J3D($G8\!'#3JMD_HN M3NKCS7=2K^O:?K4 M,266"W\ABY5S:5M9HI8&"7"OBS:&KXA09)6P(4?*)0< MQ7KR6W N.-XH0GR UO6$=0:-ZG56R*K%4YM-@>$-X/V2S8_Z;&ZL55:$L"&2 MF1BLA6<3J:>@>%%8BY2VH_6R4^=@=;'MRQ_&Q%9!([.H#'V1J?\&+R*@!D^0[J0;: MO.'%X2 AG=75ZH+U,D80+;MF4A#!93BR )QZ@9E7(:I96)(5R4"L M)92 &3C*/4W5#BCOD2C._"X^\2&%KL%:$(VB%B'OKW!77WQ@XL 1LRLN M/D=/\#:3>(=&F?H#Q"*9^"?G"CJ5#J^A,"PV:9S)DMY(4[U;V16JCXUA/&N( MVJM[C7M'$GKG>(2MENO802I*[DV*.CVJ !@\#J>2\G]\P(J\%.T\2I( ,;FC M95;$BS!ELYUK6UE>0X1B:FJ]V8EK]=9"S;;:J'G'JB'X/V7GF H9;]!4'',- MHS^T!4YP!?Z/JI&4JZ-PZQ(MVK)RF.A@$GW+0R-]!U,4"-'-4% 3#S/S"BK- MRHD5QJG2GS'BP-F0.*?2-#EEN>3.8JBB("<3>5H6(5P@1M$=KQ 774H.]PK' MHNN)DU&^BA-FKX: A3'93J4D)*7T1F@?#*BRH\;L$.VF&FX[.DF;H];% XZ* M4M<[T]K8-=E(!Y3"!(P;U-_1B-+580%U!4&;K:PWO'[]C05\X*LGK22M0JB>J5* M/RB7OH49&QMZ#?K/T7"5>N>"_,L1"K^[11[T8/6#2QO$=L2,W"^F.BJ"=$Q" MNC1!(_JZ[1#)=@4;+;A6QD<2?FL6QM0$OE%:?Z5H'T[%P](M%H:([3DF/\%Q M*K7-$ ^OU_5A*]GEL117_"8&MPM!81*]PD0X+FGW^$)=5HNINN-9A[U=MW:R$F> MY'E-00&+20UUBVM+,SX?^.T-EO>A-$SR%L:25,:!Z-EC:ZS; M9H983.JG+,J2I7;(N>R6Y; "V7$;5 B;))[-,HLIQV*V,D%'ALH&%.*!M;[9 M$.I<(0(TBTV4U"]I[S%)&]2&&RE,N/?GFF\1H73Q3&MR=X7G/(@D8MF]Z3CK3I2W MPSYC)%/V^I*)3RJXHG1,G[K>6T%L0>^ 5I-7E4G3L@+M*.Z0+K8F#W6J<>#@:',DQ36G\C/NPUS_ M/EE:JS.6R T5J6L\:;J;3/W0=# +NPNRO $>:W,Y'"/J*EE>*\!7ZY]RSTV904.PFFY\&MZ1J$\S;$11,2376(=!@8VH^Z-A5A%(TDK)-%B1$ M\LO>I_^)T_ZDH>&)-JGHOF=Z+/:QHE2;!EJZ8B0%B7"'&&)&Y6%VO7?ZAIH" MF92S2MXU%$#P]1P+JRV,')"*MNXHI--*.1S(G2G9H#)YM)TSO[,^'[F\E(K3NA0>RUHI2*SI]S4P?;,TZB\ M9'W*<;WE"C8-:Y>)!%R!<$S6UG8$5W'50JP4HJS/]"GKITMRH^^7SZ^C/:L[ MHX/S2/J=(A\6X9=>P>'[-A:? E'MNMDC3\(PHTD#O^08#Q=D=!4?W93,N.XJ M52@YGP2V@D.0D4%JZ"ERWY8K4.4X$U.V %9AB&=[H$SP*X7NU]S#P7W)X#OK M" _#A>]9L>2DMT5-=/:[WK<8,X6Q>X+B8I5TAM_!48,3Z13$QFW_ENE2EFBJ M7V _VS@1Z',2V^.U%@-MV+9F)?'1#OSA%AWX VJ4X!-4?P,1%TYXC,%?]J O M4,,W^U0_W8%YN44'YK#K?4)N=,7I0V]-K?OM0K_Z<>FZ+H6_17A/8;1%X-Y[=UBB\W"A\\B#-45\=K$5SU!J\@949[,"N M8.&0UUDQ@4MF:[,IBT#HN.N]^S$.^^&R2OC2VWZU1O:]D_6G9RJ+(5/W(M2X M3$T[61$ YD#]L,&E7%)/ZNU)T?Q,E_GS&LKHL@FC\D2,KN F10KC>4W4+)8' M5.$BUU/].K.S4R\T9;7B(D?^-%.O]8>''4/CO=7 MO'F7%H07!987]^IO+PY>6$@*,!B;/$O[TQ]O]-^R:_C5BM0PC_25_>)'FC=$ M:@@'' Z%_B+E(S]/CDOP8F7"*]/KBM-Z\9LFB,]4-<$<=UGYFC6]_8+A6MQK MN1:,IMWAE7>8(*^TP>M#/8AV I?D!9[F'H6Z>WJV#[KJAT^PZ@?=WE];:FH: M,.[W:J,U$N'=Q9?A\''$%^3)-,\ JP20VOB:?;1X&0[>W[A!E^1GDO/#& M(!G][87\?=#[<[\[SB%3 M-ZE7__$L5H%V/DWB)/,^P.RFP&@&*#C[5?5M_5C.QG&5'LC5:/_8/WS36 MNVS:H)< 2V^OETSBL%^@>ASWA,?,00M5G+W@"[5#%GZ0TI5?X-9NBSZ/A#[[ M+?JTZ+.-Z./W]O;3K/ Q4\VM+Z5UC?P_N&^8NGE-MS MJF^A(BLM9*T19!VTD-5"UI9"UL$<9(5WP:Q?I!-'"U[K"EXM=K78M6HA= MXSR?9J]W=V]N;KIP77>47.^>IH,Q($JVJX*1G^X&?N[O]HZ/C@]?[N_"-.3C M/A'1\=$N/!(41H:[*S7UI1.-0;6.QY5R? K<_4<1S;S]/=U*MB_!ZY0Q?XE- MO7/X)U/Q6 V^=W2C6^\/%44FY:N-TRN 51<>?/ M?82-@UZOZKN1#'P$IB\I8%DX]2. +2SUA0+>!28M<1.B#-MU4R/P ET=E)EX M^(O/&8B]HT#^DHWG =M^ M"VPML&W0]5I@VSA@0TOQ^>>K%MH> -K6:%O_Y_?+C]YYG.54QOYM M,BC0\K_&20X;M\)(.%=G?V\)9PL)YZO_ YN3S$".SU5,%4:O!F,U\0TE=5M2 M>EA2.CO]V)+2\R"E,Z=WT,=/71[ZNH):E')ZDOE^]:DGH>)/4E51D[1W?L6+,XA^/NX>O%A2J6=,G'^VM>O,2 M0!;[.38R>U! D4.CS^,="W8L )S'&G@[L$<Q=>M-)DD7W"'PT^V M\C[56J>VGRGWRHTS+@F.>M810WKZ#^W-="+4*1QF(V=A>".8$GNT RT>?>&^JA,2W2:9)QK7'C M7#RY0_Q8\Y+_U/J8:UV?L:EHYJN'*9IY_!!%,U_AH.]3-+.,Y@?4XG1]ZYC. ME8ASOCK_\/GTZ[?+=U>W0):EU3(/[BA4;P D?7'B$1!)I&<&MS1=%5WX M1FR*D/K2G#K E"3J4!%PX4WNKX*OZ2MJPL&-E*ECN!K[T1 3I/!!%+LA%U#? MY"+&9IGX/+_(QTD*TUNMOY0P6VEBBA,.)KN% MEGJPKCI5.[ F96^]2?TGV"\WE=1_G[U>@;C;95RRC+O9KOMI?6\T\BRQ M=:RH::_PI+8S3[.!YGBOVYG;V2)7OBE&TIMFR80C=>GD:CT6@T?OF?MYEOO6 >$$:_'-F?VD<6IB[S")U\.?KV=-TZ M/_J?7W_ZZ9?_:+7^#']:8LYGU&^,_ MR MJM7Z51'TV7W RF896I]UI;_[*/W?';L=S$6Z==$_:+<<](4MTC :?WX(O1],PG'\^/GY]??WTVOW$^.2XTV[;Q_^XNWV418^2LCZA M/]9*OSUS/RW?/8:?GU& T^(NAR%+BH=3#'^S8,)9-/_DLMDQ=+A]VFVGY8$; M4? G- @1=9?\*:,TFA43>"$_#A=S?"P*M40IS(F;K<<+EW392DZ.XQ^7553S M3WFC,.3D.0KQ->.S 1ZCR!=U1/3W"/ED3+ G!,?'(!IK!3(_AXA/<'B/9CB8 M(Q=K#=VO/UD68$IF<\9#B^:(QRAXEBT.>"C([(M6VVYU[2,KEH);YJ*09'"2 M/0 MV=)FY$50EF_!/UMVQZS:,EG6KUO\U4KI=M&&U7PU:T-*]\XV%$]1G:9D*>]C M0FC+!;3%/GU?6[9KQ[:-*-8]FG"D!%#MB4F% 78_3=C+LU7:)KC.6=SS$."@^QJ*1E,.1Y_.0)%WTJU^S]= MY'\2+4F+Y"I8GYSP\[$@<2-?=O=VU9^4 TCKEZ- 0.+C>(3VN?L>'IMV7Y 0 M2OXM>N^C9]/>"Q+L_^D[/N?8M..")!"6U39B#_1/XG>+>%^.^DR8^B,T$>V# M[]\>;E16F*QZ19+R33FO9/'7MK"GQ?^LUFI_T+(DI06DOQQO$FRPB@+L#>FO M\M^;?4V(DR(*P@W5H$VW/J<*R9*/Z5@J1YAZF IB\8^ ^<2#3=(E\L&H>9QB M' 8F0U_)2X&)+3'I"" >Q6#B)2@)3RO+U$JX6C'; UZK,1XA+GHWQ2$1[=TA M=NM\U3B"(M@"1^OGM4K^J^FP+L M_1Z1<#$0E;LDW*% E%2@E@%'[(.VD8&D,HM0*Z[.^CFI\ !Z%A,43*]]]KK+ MB;_BJ8;V1)B&6T$K^%NR@@8A>8G<'P $]?21RM HD.C8;=N.[5@2N#X+(H[% M'ROB1H[R (>(^ ;3(D^J&G.G+?ZG&'/05I)+D[358S2;(;Y@XT8_>;>3Z>8]?,Z,- $74C>UF?0Q53-0KY9DM/39KB EN:_"L\6L0 M- _X!=,(!Q N(K8V(4=N&$ 823\*0C;#W A#5YJH,YMZ5=9 RIE&@>T+-G& MH2Y+Q@?$,J-LK![U6:I5XX63GVAZ^#52+=Y0,30AXPM]I%8DRIDDMLW2.[6& MQ)*VB4-L:@5N$BH-/=ONYFV")8"YQ!"37[-T9H^%U\%H-DB$$K#T-2SE;(+,G; M2ID?L%L?[&U4F2Y3M9ISNOGU71_'INK!RK&_1YR+=K[@K92E.7NU1CUQBDT' M39#%UBJM[Z!^RR"!4' =SB<,B]#^C&2H%VM6D).G?>H&4Q]"+/?B6P#M>XM1H')7$S*JW5FU\Y#$1,V;F2-Y\0ZF5KD'<=N%X]S,V69(1H\ M8!>3%U#1%!N$'!?0JF7\Q"X8>V!BK;C\Q1)\&@V Z5)?RD&]JI]V\QZP0C": MN'KGQ]1<*96R4"NH,\?.A5.5X-) ?37 7 P!^%UO"7HF/@F-HAF+R=5:Z]S. M [+B8V48-1T'4\VE8J)67A?=O'.V&),F:J_"<=W^_$6/G5*KB1VDG8L=* &L MZ6.5$O1SWJ^ MUVN/KQ_%]5M) PXBDL?L&A'^'?D1#MBXL.BNA42[0K68=!P[YVC2$A.HWXH; M '^6K00'2=D$[A&<.N)7$BYZ%/F+@.Q<-A15J*6AZ]BY#8J6-&1JM-(J&PG^ M*,X2LACY2/2!>G */8?3$GUPRUDHC6:!77Z]3WG]Q9+$& 9 MY_&5,>^5^ :)5%1,U%KOS,[;N2MN5LQ.PI0R/& #HV >[%G%2JWZSKOY VHU M3DW4?8I1?D\PISY3M4:\<.R"$"LEB$UW+2@&?V6P;Q;:)<35M2@Q=]J.;3IQ MU_<&^<('.2A!*/WR,?AO5'F\@W%\QQ1S2M'D];R;8!F&L M Z_>YI#NQP#:2DY*^\CIV'D'3\(RB8C-,K52K@>HE@-L:BEI\E.:2TZWFX]- MT8"MB393U7@;*U-=AFK]Z3B=7.2%%H(-U):/4\0QI+OU1FAA&&!>0*O6B"=V MWLDIF;0D%RMET^CQ-TYN4\9!K>9.N_GPI"(LFJC7\D.ZS#:S3"SY&^RMMCF" MW(:Y6M^="5-#"\JUK#:9K)5I=0<-N([', KAN0QXK.CTW#A.9I>37Z<>M1!TG4[N9*=: 93(0UKU M01S681K@,>;\HX6ANA:U*#A.)W?@4RT*::T'02@7A#PRNUP*-+BK@3]Q.CF? MQFX0IR*36T@ABX882X'1A_.0FJE'_/DU,Z')Z5LK)]]>5=8L(HA M:C@0INY,!0^E0_/DK)N_N50*2A.]FD4CFTD?E?QZF_G56#5N7X5:/YX[W9RS MNAS;C6Q4RW*WFS)PT)4;"/5H2#SB1["4/&(WXC+B_.K-]2,/>W$NX=D\"I/K M,0,HFBQ[0<:]N&.YV7&KU*)VX70-U,A&ZJI,0ZU52ZVTJ6G"Y&5CI?D6-S=F M&*QY:9LHH ]89N,8(1XNGCBB 7*E=R.Y^8B97ATNCA-XX(*..@-*!/N]W\+:8"*)IH.N=']!WN@VI> M:GWF.-W\R6 !3DV/_\X/=/:>IOQM@$*T P"5?-5@GCC=_.%?(9CKES[C$E#/ M =L-#)+G2<#6OGH+,:?(7SY*\KSXBMF$H_F4N#V.T18GP+NN62T?ITXW?SQ8 M*1])0^+]1MJ4S-,LSPMKU1I+-N<@1AM@WC(Z\87N].)X^X^5'-W*U,)RYG3S MYXF5P@)UMV3EZ=6"@WBD3QK/9L0T[7*62&W[GMOY>QX9ZF8.],,@\P<$@OLA M)PB>:(Y\>-?M$?,7LLU^\AUUJ&?=A=/-N0@R_&&W^9]H-O_OP=I7&8@NZ[56 M%5MIS4V?;M\"H11'T3.\L!@N'LAD&@:$7HI]NC<0:YO/MKN6OG4-2@DX:SO= MW"9V70)$;:!JE_59<840N26KM#)U-AW[)_0#,SY"YD?S*B9J!&VGJU+%XB]@ M:#$.1[$-!4@^JXFIV8O*ZV3*]? ,DJGG0L#!O)*56%!+PWUT11#.DW.PER&=5F5!70>T2Y1UQ+DP(A8?@W8E=S7: MYXZ3\\"7*NZDJ@/:*=KIW9<[C&#LS/(M%E*K[:,+.W_U,7,9)L.HX2B8'AHK M>"B/C<_;W7P:N&)$FGAR7#2LYEI/P42IW,YMQ\D='Y6!TT#U]1C-Y[[L/N*+ M/@JFUSY[W2[PI8J34JV=PYM(N9.;+$L+>%K M*EA,14#;!PDH\=/K?NZW7R* M)PW8FJ@(J\;;_#A5DZ%:00KC+W]DJH-@ [7E/:,S1C&,2C9B4A^R,@9JW7AB MY^_'"TZME-5:^.8!#N.)5,%'/7].'2=W^%D*3B-GS6/T'.#?(]&!JQ?Q!<<+[,2+H#@GU\A*Q'V'B"OB7V'9\^8'UGH&7+UN>&7HY!' M^,BB:(:_'!46I<3WP;1*B[X]M^W+D13PQ[0,!2DC""/[Z"LA_ M.8J+DQ#/CJQ0%J>,TFCVV6,S1.B-^ &X'!V7=N 1^7@XEAEY1IA+>X&Z^(X( M:R\4*O&)D\E$M(9.I!S$=W[BM!UR1Y;M[!CYP;*W[^9;/3*$PL6C,/WI.;X# M ?V"TPK-\8J_I-I?8\ 25QN=K![\N\2B?[CGNJ*A7NI@%8N**[UO8>D8;<-J M^V'Q\//'C4K?1T$P'"=INH90.Q]T:"LFYOS6X' ^&%GSTR M@Q>,8GC7@8<,)W2B,2(0P2JF]BQ%ZTHCWHH\J<2@KO3]HWT6N2]13>:U([1-VA)$K1C(4M?C! YXS#E$U MD+FC0B%5TM7>M8(EM^=YTF!$_K5H?OQPX0V%"]"BV-.4\/A*9_R#R5INR'A/ M5_8XYC=9"11<+T4N\-##B\8Y'ZT%F1,4)N: _2O[_("]A/K#<>RQ=1A=41+M%,$E\. M(OS$TC-YZ6CRD[:7C-2NJ]G7X7R:!$AJP+?@M+=V7,\7Z(A6S\0\AP SQH4$]Q&EZ)D$TD@-P+*J6E., MF-0N"KV(,X[2!HKE_E-%_TK+U]Z58C_[?03-&X[73U1*Q-F$Q0?MQ@D-\01S MC?X.X?R,L!2+!^GP[#,N[%A9K1I(7>K:8>UUVO9Y)M$WO$Y9(:,*BMJ[4[[[ M!4](N$B=:+%S<A05"I,! M-LUJS,O+UX[X'?;N,!43#7FH6L&6E:Z]&U\)_3%AEX2],OY#8Z4H+U][5PI> M$;^9S44/AF.[/8IW%@/LPKUL+!J>_%=.#>F;'=)[#%MC-L-@X)1;1[NN9U\/ M&?KR>$_P>Q5F#VPA$5U42T@55>UR\NUQ0.(TT'T6<8':%0H@UT/Z=3B^QZ__ M*\3[>Q#W1=W?K=G5/A"PKZ,A@SB@V%RX>I/]J^AP)5GM';OLQT9Z#,&S9 X7 MAMVINF?5=+5W+7_=/K,WJYB8.J2U=W X'HNFB>U5\O9<\LYXR_BV\1F+'5N^72\K5W92"J>I$7:S)7;D"A_/B 7PA^K5(,Y03[JAF>7MD=^A?CRXQ3 M%4[(LN*U2Z&IPUA:L6 +)Q!!(BX>(']G'NGR"O;6;[DRH_LL;O\U1Z%)^00W96.PS?J ZL19R[&7G -:>ZDTV:5 MZOKZ^_U-$C23_?P;":RMPE =VMP284/ZL@>/. Q]7![=9LIF;\=CM48, M7RGVUEVAL!@9SCN"^6X$*V5UO ]#N-DO[D#GSCHZ89>O;GR7^K MO)U7M+='2(G[$FX"@UK2<76NEZU=*IY>F;Y#9O_6D_0$OQTAV@T%CV.P!EY&WI:1YP: MY'N'_HCC.2)>X@8#2V\83C&/=8TV\A5<]G9+6+:[>1(VQ'"\-/F-=T,>]K[!5:3T!L#RKM;2QZ';\VW9U3\0FW.U#T>@+[&#QWRFEU'7/M&S M^[FU"XD*SY>"9%\5]W>QHX%VI0%O\F[=XN\1\DDH9^60BS_@8W*8M!?377O"DR_:%PC,ZK1BSTPVRF08XC=1_36)+8(9.Z95)O3++JI08$T [I,BI?==VS,XE2E#$K,S%- MH"]@2Z9[:9GB\ F_A9>^F&NEO35E\U&*.DRKV(%16AW;8,!A3VV. 1YC817% MSZR#>S\8/'ZK<"NJ:>I?@AEU43!]Q+X/YZ;4B^T$6 LJ(O0T*/?5E*I8#X>T MPJS2IZ\=W^5*E)SUWV.5B[B@[+YB6!0_MDR1811UEJ':4[VS=2H(^7_?!:30 M8[D-6%G',]& ."!&R'!O,[QX-ZDH3.O_(%?#/.)82[T_AZL ZA$*PD&4R<"2 M->JD*>=I''*_BV>]83EQH/R(4(I<']_>]K4"ZXO*UZX%X?;QB?%]Y3**VKN3 MR4-W0^=1"*DV74[BAE9[!;3):^]H8;*^5(4D7Y.4CV8)_\IXU)Y H"@'U+L= M?'\RUYZ8>YWV<$;)6-86J/9TO8]IO:ZN)^Q.J6#W@ ., MA"$'80'X!?M,9L$7ZQ#U--+WF7*I70[4!CR8KM03\WEISB>1 5MN"!3\ZM\E MP+5(+-. RG/95;:=JF.P:L)]/4$Q3,, 0<3"K,0>1)SVYG.?8+&>Q;N<.QQ. MF;=BN*O4#V9U[NM +Z\?PS$_GA#W;XS0,,U 4QD34496=S!$[.]? :!S.I O M7;L2O*')@T_X%@X]A982.R\"7E-Y(>+J+3'!(5KP532VY[KQQ1E1=C87DEHA M\#OAOJ_^@3\T^BFQ%_8C%&O9F)JOI1IJU/1GL=U*4F?L2E<7<=Y7C;QY,43L M7C@VOT^2(]L#9:9(?*&,B]:@K#M=1IR]-EG]EZ\0Z62\+:.I':^2;7,\ZD]L M'B7>@JTWX"I.=>,9FP22FV[:OESA^A$43(E'A-X9\KQABO'JEFTF"XN883R8 MDGEO+):4GN]GL]C?C V\+G](Y?7NS;=+V R[+U<^Z$;A MC_8>\[@Y& 5&H? MFRK:J.9]M>N&7R_[!C[\-[P_Y-9C.0/MR2>;8E MOKLR9P'RAV-YK2ECL8T07VZR*A3K[BNJ?? V#;616))FR"5XBTO#Q;3U=S$] M896J*20N-$_S4+:(I/8.5015J_,3:Q+7WDE(:SL<_\:X[VGE$"HO7WM7X'4/ ML4NN?@(D4ZCV1F^9(6_SJ>DH?=K\B24G'%D&\1%MD&R(O4LLZ.X4H$4PXD)2/'D4$3/Y8Q[%+JFZ]M#:U*71\R(_ MC +=*XF;Q>MVN\N@'NP]@): ).)J]T=QX=KU\*T8R\N(R$QR@?YSY95DM7=L M^;S*8/7"BN:#+ 44M7*564YS*/@[SB(+0_)%E2.->W M8+6O"U&O<^J<..A_7NC56R3Y:'4&H)MK?2.G5&<#E NQ^YA,/R8,O#W*# M9+Y<0=)%84ZJ?;CO8%C[=+B"V* Y)_ X5< BL<["550*^Z!%(,C5AR(O#P:7QGZ#UALB;CI]7(=?C7[72M2PE4Y MEO3I:T=\ZQMVFZ$0P0T=5:19_8"JZH[241EJNXA04C#Z$ZQ]:\%RJP"S!PS" M:>!D4+*HV^5\BX, XZ&H$(%K3[ZTEDVS*=^V+;\BK4==^_G ZA75I7'Y+<#C MR+\E8W7F:0W*^F^X;!?-M''BDP8W0<<^-HS*I.)]C:(J.]B%A%#(]Z6IN_6C M;L5,]O1:<.Q(UPSU+"E!Y,M#A;Z0 M6NQ=+E*;)R%7Y%CYF-H^9E75MZO4%G3OC01;&M\QZ0ZFBQ=^]L@,U'>\PFSI M%2D0^:URZ1GSJ7>+!:EAG@I3PZ12^H3X!(?P+HL,[4DN"Z^RDRNSSKR7==U& M96G44S[2J3J?_A]02P,$% @ G#P& M4<=Q;)RR*0 [KT! !4 !C,O?_G/_T7(?[_^\N'%FTF MY&YR\N+W2??'\,P3\H_^EXXFI^?=\/OQ[ 6GG-[^:?= MS_\0_:>9<^YE_]/+CTZ']WT0EV4O__O7#U_C,9QX,AQ/9WXRO/Z?IEW_\Y<6+!3FZR0B^0'Y1_OWM MR_O++6?'$+O)>#+]WDWFIW^-DY.7Y2,OCR8H$)_]]P)PO\#L_!3^_LMT>'(Z MNOS><0?Y[[^4WR>%LU0+6K;]CZM??GD%0?2C.!_U"'_ KR^6*)MM"PS\G,$X M0;J^R^9XX@KC*23\G^ED-$Q%H%_[4>'5UV. V70[ CRZ:BW*; ;^)3;OF;(Q]@U']W,)^2[]Z?#CX,?1B.AK,A3%^-T]?9)/YQ/!DE M5"%O_ST?SLX'.4;(R3,\S0G_$CF0$*,CUHBL\83K[,Q-(EX@V@MW]M/02_C% M?BCIS+V$T6RZ_ XIWR&470CZ?ZP+V(+LVR-^=\7WXSB:%U7Y>=(5#KZ:S;IA MF,]\&,&WR<<)*M+Q#'F%*WY_/YY!!]/90%NF5*::1)-L466*6.8320DUGN52 MYNA;D*<.^#>)>$UZ7W7QQ:3#Q?$6^>7%#R@Z_^)"6>#BNWA#K.^JLXM/O)S. M3T[Z-G-L+040J["JIUP@S$"RXD'@@$1P"X"(E5OI MO.7:1@A4,M?X-*XC,_S/(#/;TKT:XX\F)R?#6;'/"G9X+\Q0%M&>*P!);325 MB!,P&XCDSA./")&DI-#.>).AB5I^ *9U!$/\&02C%E^J"$'6@J4HC6(/48>A(46,'% M$(T'CGEK HM-%-T-* [I>MR"Q[?E=GL*5Y/4Q>G[%6;'D_1^?(9W:G^,!L%H MYU,&PFCD1":!8*6<2?1*IA!8!AI:L'L%/(=TQU5@? VJ5Q.!S]WD%+K9^6=T M;6:H/PMPIP6>CS ;&*^\8I(1H]"LDIEGXIS6A(.7S&@5.8TMY. AH [I7JL@ M#-7H7TTBT+SVX^]#-+P7Z"$@;W]>6.?_G$S2C^%H-,C*.T9=)ES'4$)+EE@5 M @&D T,"@ ?90C+6 6X="9'/1T*J\Z.:I'Q"R?7%VOH ?@I?"CD_Y=^F"S@' MT4((5'DTXI)&G(4@@2%'64S:&K#)1F@A(@]"M8YLJ.EX@2_E.L\C,_ZF-,LR/?=>=XY_[+C^8PR-F#T1;9%9PDB'>)6BG$ M5VB?M J2JR:^\EK0'5[(9!L)N1/QJ\Z8:L?@Z_&DFWV#[N2Z8Y]]\BDY1GB6 M&8US_,O2;(G(":]O%Y,2;5ZE[@'F\&(I-21B9[+7TX,Q3N:X^XT[>8FB0GPR MJF$B!.ICR?H(MX[$.VV5S^BUR28NT4- '5X\I89 5&-#/6=Y=@S=%3C3:_#$ M@%9:4D <"&4&D)1B05[<*J68(&C-F>- MIIS.J,*<0Q5F,R79"9HEYVC/B?UZ5!L(R'[C*#4$I"Y#*L;HX=0/T]N?IR4E M">'K!?DFVD[CUC3@[6:"0<"R($Y83PPXE4T.$D23%[HU8#N\0$P-6:G-E(KQ M^S/<>]*=EQ<$&ERF*@/Q+'@BN40-)UD17PK::S203!-'[#H0AQ=ZJ<'_KX)X\B"R-TM,13F8A,R1#G12*,.XU0>"X9WT_^6XULF\FX7W?ASCGGA*+: M$6 1-6]2:*]QK0CSD8<2!457KU6*S75 #LFEWE$"[LNDV9KF%0.(:5AP]Z// MJ%_?CX_\Z7#F1P,#EH$.R""K I%*X-4K!;KWC#'K\=X5H^FX\''^?HF 8C;3A&;P?Q\D) M?)A,B^_W*7_S/P<^AVP3I21H0!L &"=>,OPR.!$]:,9$DQR7#>$\)(^\MKII MR+$F:=\V:R.ESB2GC'*= 2U&GB))GH:2=9ZE3BU$9F7:]T[H7!K#@0KF)26J M9)Y)CVZ+M5J3S/"J+U3-LDF^ZEU0#LG$VI;O#Z2O;T/P:G+\9@[?)E^@/VV? M?5?@N?9B7&H"<]*6A(1G66IAB3,!B&0&!'6"*]%$!AZ$ZI LK5KB4(\-C;*Y MEHB>7P,KHANK>%#$\,S0_HN,A)*J"AG5+\TTT=CDJ?-1R [)S*HE(779T>(> MO(QR 46!M4!R0!6&=S\GMO@&X+4T+#OI:),8TV,7Q_:/=Y_]>8G[7@;U8NSF MD.Y!W3/N35'<5-'RQAQ],45*%(DGFH5U7#6I^]D4T .]4;>1H%4O?4UX5N_: MA6YXAM0Y@WL@"CF@0VV .)<1?3")6.HM$4%P[052QS9Q01X"ZD OW1H24XT7 MK:_>)4Q2+>:D- *-2$#'ANDVO0HD*^RI.)< Q)45I[9!E13D"C M%24E*:<=M! Z6_843R:']K+07-H>;Q*P$:^J';Q?A^-)UQ/@ BEK&9K>-A/) M!?ID&8^_"UFC&Q^MD59$JYL\LMT&Y)"NZ .0EYWX=$M:_O/E;9I^P*\;=L/Y M[,O-<@RS(>YY$ZA*G7%N[K"G+CD/H-6LR=#7&?[=9X!.\D>8+0+(OG0&N#>L M7(W8F^[;D 4[D:!2*Z.U0ODI4VE<2$1+X'A$0R0V^T 2"YDE(9173>*-F[^X MU"7 NTF'6GF\,"CC^;?.CZ<^]FIRG/JO+C1Y^K_S13KS)U8"&)K4T;= Y))NGNL3>FW_ZM!)1,7=U/%EZ20LL+C+A!HPA M09QP! )0--*D)2&HDH"?M#;1B0A-7L=60E2A(+XW*&XL>GVWD@&&AHG1%K$V MBT=)Y4B(61)##:!5*F+R3;!>![A#.F1UY.:>&OFZ+*H8^ NSBW>>JT9%[Z!/ M,RX_>S^=SHNY=#29SDIC*\=4"(+$[!@>Y?)@$($14$98D4KU7I,T-"AJ<[^M =TA)4>UNN!J,ZEN8=MJK'DQ0"T/1%.+MZZW MK#RH&%2.@4M-J4UM:AX?!NN0ZI?:2$Q%ME3O#8.WZ*VN1N]/3OVP*U(\L"P' MZQ0ERFE%I.7H81D/!"@(*8P*S#1Y4U\'N U+F9ZCZ5.=1_5%5TQ">A"!IB8)C4AK6)@]R HBI*:T7(!?HPD@8@Z,.4COU1D%". M<1]_L-SEE'-SM!LTLVY\5+86G3LEHDTY5K.M8Q[.>FP-C2E:C_9 .; 2C"#. M&DU8EI1[EY)737S**Q .Z:&JGB1L2>+Z22/7\,D^2VLAH-D'@)ZH",0KV[D@18"J9BAX@LCM@@.1,]+2>+FCZ5!S5H\J69&5AM6=!4-[GJ MK\%P2"JL-L>W)76C",2B@_L<\;M =#*>OH8\Z2Y>2[[YGS!]^W/6>:3[<.R[ M\_=(KNF*VS*5\LXHAMY&H]RW>^$YJ/RD MJK*T&^G;Q.8D&*!X1XC26QN! >*\DYK5V56QNQ+Z,Z&$:9?)Z,T M"#9S*4,B/% @4FN#2AS091>@H?^C;UG"=TM1UMGHH!3BKB)0G;+U&Z_^WB$) MWDQ^C ?9\LR9C<0P4QK 1DV"!4D<&(FP!&=MV_:KEZ!LF&5YV#)0B>+U8YZ7 M;V80%?"H'2H;P+M>.G2R*4:H?87>\,0#]JOO_H!K M2P],=,PFP8A*)A!9K*2$V&U.O5.NH_ ^GKL>_@M>_+F$\*0#V!+M-98^0\ M:T:H@=*3!_U;%X,G+&M ,]XDZIKD/*X'WB$5']25F0;LJ5A7=]I!'/J+"ME7 M)R5&_C_]EP.F LO>(\Y<0QG\%%"J\5I,E@H)7BB=FLC+ S =4KU!72&IQ8A] M/!H/'-79&66(X1)%521)+%!'T"4T'I1GM$WKE@=@:HCN6@]&.2H6>"HM5XK# ME+TH8_(X#RH'LY;(W3.086^\/=BDCY2I_I4J:!6L%]YPW^21 M: M8#RF$U%H2-WQ5V9FUU8XH8C[L9ZY]]2.8]B_G Z&F;7!/WP')0[RW[%J)=>?,4G?BN]TL[.O;C[S =CA=%]LM!/C>@ MJ]0E;L56>VH,MPZB>VG25^9XOQM-?K1IQ7>U^K[H>C\ZE=KJE5FDN,'G;G(V MQ-5>G_^&H+P?OQN._3B68QQGP[.+Z0/"&+3P!4%S+A)IK47_WE+"#$6'/GD9 MH(E1LCZ(.R<,^O.>Z)_RW:8\1COC@R[]GU&12:"!^"@8H4ZP2!7*3YL7N =@ M.BB?M9$@WDFFEP#U/6MO0I2$5SI(0V) 0T9J:A&B4A0L=636.["- M:J4? .J@K(F]2\V.3*HN-A==P;Y-T+(I=E3I>8QXOYMT]P?)!\Q J2+WA!7Y MEJY,>6*Y?*DY+3])N4VZ^Y8 'U2BR)[%K2ESZ^24(2DB0.I3BK\4%KS]"5VQ MN*<#*H.WOHSG1&2)5.5<*(U?&JDB E)20M=*)UN]QR&]=366C9K4KEDA<0G/ M4BE^RD=7P/IWVU0G+[Z>!-L(SE0*A-G $DPL2%5)55T876A>=7/6?H41L/OB\*H^[ 7CCG@ MD(F1VA')&!!K,D5=*:GA3LNHY7I*:*-]UY$5^R>QAUNSI>(;W>FEA_AQ,H/E M]+^!YII+H!PU@M;E]9(B-%01&Q0/*0J93)-LAE4 K2,][D\B/569T^22N@%- MS#J!3JD4"92628P2IQ@CC+J LVX:M.49!5 :T4'Z9_W5MJ:.34;C-Z']&6^ MW#6DM9$BB@3EQ5,0:8PC7AOT_J55.0MGM6LR1F]]$"L6XZO 51"IC!61"L^M M*5:!T21%4%%:3:-M$TK?J&/#WB98M)&2!YHQ;$+_EM5L3&H1&'JKT7E$!UPD M(6H@+CB%V'#AH(G&W*Z:;8\=1?ABBFR5)&5$(]X"N<\R M=(0[$33^Q%K7IABL1A#[SR ?%?C2)#D?_W\$]R:'QP194$VH"(%(C;=[@)P( MC2H$:P'_-"D!6@>X9Q#GKBT_U7FVYP$E+&=ED@P$'/=$QLR($V@V*E!EUH$T MC8:H5QM0HI[8#:Q_8=5F6[W\P7N!^0)^-/P?2-?&]0RGIY.I'PU$!A/ZM\^.ICX5R2RO^MW%WX1PBA-IZK8$DDT(I=,M( M D\)'@/!P#/'39-+;!,@UQ*OI\[(KBU?S;C8^K%X$8&X28@@ PTR!F(-ZE8I MLB1HW;/2"\6*[+32NLU8G;5!K%4=\6WR*OY[/NQ@8<"6I_RO$.?=1:8 LS)Z M*HCWY5$_I=*5TW BI029+'- FT3\UX+N.11G[2IZK&M>KW-)6BK LA9 M>P[2)L*U+=VGG"86'".1"JM]EH;E)G7?ZP+X',JWFLM5#>:U$ZUEOY'WX_\S M&8YG_\(?SCL8>$M9AJ2(4[8,2LE @O:>F)+P*'(*+#6IGUT3ON=0J-55T1]JHR+QE-)[7[D MZC9DS^$!?!_*:GMVM9.B#Q-TKKY A.%9GWN;$W7,^$18B1=*H?LHD"=1ZQ!2 MDJ6>:"]"= NPY_"XW5R&=F%6Q1?'Q:W[V0_3Q8M5[XB#"3E:O'8]#V7L@O4D MH(P3&K6*R0&+;2RF%? \AZ?JV@)3@S7U*TT7]O^53_GN7Q_?7]RGU[]=:NXG M\]D;0!Q.AN,BX._\L/N7'\T!J6*E,SJ2X&PDDA7K+H$FV2H'V7A/V:V4^S6* M4"L MN$+]G,6LB?G:Y.JH-*HK']SG15PSS_E>Z,@B7+T')Q"!S67'LE>$">L M(XQJ7,BYY'.3(-[&D#Z#Q_/JMV13;M;KC(ND*/^5XW&&8/8=1Z:S;AAGD,H/ M$.Z;W[CVR<_0#4OPY';JR$7[OK<_8]_/[8N?P5OT=^-LP"P32-%$O$@&34PG M26G#1X0SP#G(#+3-M..]HKES+FB_RJ=\?>5/XYUP&(B<1,J\U%*780HA>>*! M::(]2T)8;F*;ZK &N!Q2Y=4!GY\[2:E/+%6MG[GN*P1U3BGMT0M1W)77 91/ MQR2J<0&2(K-VJ;@N"$B

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

    _R(L2@A,J&&5E$25;?;;/'%K+_/ DLX$CCR+_ 0]".=Z,B#74#Q:H9+3 MF!,(.;VRV MU('O*J%T$G0'MW4STO^9SQ:+=U^PWG*8?OR53./I!2UF:?9Q.OD_6OY424)Y M=*S4SDL:+;"HHF60HO(Z*F/ZE#4X".WST*OQ".O@]FX!3;*L/6&_X7PW7?US MJ??TK0$>4;-D_D=9&.E(HZO,(>*_[$D#6Z>U>U- M\LA+*884W82:'>"]8Q:3[@6LNR2GN$CUZ&-:IPN&-56"0@AU$Q6A;VYV+ MY4/P]8QH[P)XFB!V2U('Z\L1C)Q"UN=9@S$2P190% ?W( MB\P)H]*G5)A]B.B@*#__.WV"Z4=\5][/9_DB+?^&Y_GZCE+]:_)Y<@[SZW^[ M*3GAO;*FUMA5/-?K @0>,#/#0;MJ\I?0)3!] -;'8C\?2OAL7+;&*A#RX2(N M5BF1RY^_UB#<80?K:V,T.D%_"-G:*2,'3\(S(EBCM5 90N$N8A%:)P\"SQ[" M>*S,CHI);!ZJBP2''-<0OG MKR'AB\^UEN$OTW1^D>G7?OLTF>?WM7#SU3^".,RBE9B]K M =%FK6+8I7)-D(R_FC?1D._;SH_)1NLBYAO #X%L+;H4A&(^.$<&5+T[+ZH! M98Q540I1UL](ABO0CZLVK27?NFW!)L@7TPKSU>SSY\FR'J5\:^ET)@QZ7[/5 MD4QJIAVA!(.K'@X!4!C/UVN+[*$DVY_[7)6CD:0;GJEN@WJWBMF')7W)=[!F MY I16&:CK>F7",S7XKI8%!D,A>PN=_#>\]"#GZE:-)-UPTJUV["^Q#*;XXN4 MYA>8;X!?E4M;GCDE17!D1('2@FEN/?-(FR)* "O)6R_RX"WEH0<_4[UH)NO[ M>J&/+D'Z">8888&95K,O2"[UE<#GU1.N2]O+RV^_\AXNZX]>_ GS3-/!\QJV MQ/P/F@Y-^"I*?A9DK=\3,LO:RMI]G;-0I&.9<[*@5 3!N[3I:SZ3)ZZ-CX/A M^RIKFJCLR]T3>OG A.[^SU>SQ9*V;=J<44<&#H!IHVNE5TCT+M*V;8*"@J&; MUC:>S'-2W%/R?%]W[?$5G[\3U,U5TDS+O# L\'H$;@R]3S(B2\&DDKUQNG3I MZ[L)S%B![3X:WTB-\$2E1TOD!0+*I'V\E![8!3%N-8R*H;,*I6[ @\CZL4^\B\OS)C1!^, MT4R!H\W4)4>6>D$6N1-:)$"MQ]@O3A4N;L36PSIP@*A;1P[>S&#Z[;CAMG%O MUC)'<)Z)5"+3L20&/)"M6Q1$H$ES'':,LWG\)[_[MY)=ZV/<^Y!N;\WN!K5Y MUQ],["EV\68\/,SK$4)L';W9"H[\3UVL! 9>*:8!:)?RGC,KT:6HLU 6'B&S M6W;B<8G=1W:M"7T+RXN?Y_ !YQ-X,?X?SGZ7*RO*JH[$TQM346\_1PIEV-W$:PC.SPI+D5 MD.V&U-O%C:P7F/[SX^SK?]'05V33-^L<;WCLDSWPIS,=HF1"Y*)0\F;"A M1L,C9'++!MV-R'T$U^, .=PO>1+84/TN3"G2>C:FL \.LZ\+S(GPWV*.^^1 MW!]VO!WR.-&N>_>'R:6'2U^S0VYM/"\*AJ@<"ZY8 B,] ]J2&6T)*M?*=:ET M2?GY#L63WQN/E^TI4L066W.';J_/87KGA&O(G+K&W#M,ZD1>_.&ZLF^. MV%A$]PCI]I@;9JY5DIH5'FL97:B]$&LW,MI@%23G'?1)#7@RRKOK6.%QZ^X^ M_'8YBEHLYY.TQ/QA.4M__$Z$+'[]\/M-=5[RA'5PR+PMF6D9,PM%>6:YY[&@ M<-%VV7$?1'6"M(23$W_OQ*H5:PV-ML5\>;:Z15-G_R'A%.:3V>JEL])E*4-B M*+ 6JRJ>Q02:6:UB$<@-3T-:\=(#[J@0?5I7GZT(GKS1UD:V#?.C5X"N1A<)P'4[LWLXBUW*9 M0ZYCK$>IPD1O?0 ])$G^,7*_Q>(8D_I]I-N)\M>S.298W%96,5H9KV@7TV"8 M3CX0-@S,&D20)6N9AM@*>_']/83Q#(.&W&Q@^PC![ENRYOK']4N]3O;?__'_ M4$L#!!0 ( )P\!E$=.=!GR6,! * "#P 5 8W)O;BTR,#(P,#8S,%]L M86(N>&ULY+U[<]RXDB?Z_WP*[)F-W3X10CG9D-6;;/.,)M>6QW]][; ML5&!I\3I$JDAJVQK/OT%^*B'JHH%L$B*/7=BCMN62"#SE\0/B020^4__^_O# M$GR519GFV3__Q?_1^PN0&<]%FMW]\U]^^?(6DK_\[W_YAW_XI_\&X?]Y]>D] M>)WS]8/,5N"FD'0E!?B6KN[!;T*6?P!5Y _@M[SX(_U*(?R7ZJ6;_/&I2._N M5R#P N_Y;XN_A8H'@E,)<8@]B'B,8,)C O6/?2+#V(NC\.KN;PHIK"0.(4J( M_D-%%"82!Y#J5Y$0D>01JAI=IMD??S-_,%I*H)7+RNJ?__R7^]7J\6\__?3M MV[W/T4>%[X4_OT7YK'OQ\\_RVLGO:3)/FI^NWFT3(]]J!NUO_I M__S\_C._EP\4IEFYHADW'93IW\KJA^]S3E<5YF?E B>?,/^"[6/0_ CZ 0S] M'[^7XB__\@\ U' 4^5)^D@J8__[RZ=W)+I.?S!,_9?+.6/:C+-) M,KG4TE>MK9X>Y3__I4P?'I>R_=E](=7Q9I=%L=>JD3(Q4OJ1D?(?3W7VTP7B M#R3OZE#6 82KU/TPE(Q=F'X83-POFA_D^ +O='.QR/4']2834WV[FZXN%GU\ MB8?Z+/(574[P66R[V1%Y:7[P7O^MZ<8TU$&F53\-=>^(*K^O9"9DS99[38-4 M_/-?]-\6ZQ+>4?JX^"27E;4U13U]*6A64FX(O+QFY:K0?U\HI1"*.8,"*S-' M>0%D.(HA(BH6! F$J5RL-M_X0F;PE\^M.%6?;AW^Q4'SU8D17,@R7Q=\._<] M+(]-:'HN,[,?^2FC#[)\I,T+6FKC)M2*_$LC+Z@$!KL2@]];F?_O/_VT57< MS)>3([F<,X@YWQ-L:9R,O'B.3,Z=D=D;Q!4JBI:L4JMI2D/D)S_)Y:IL?P+- M3Z#G-P[)/UKW^=/!AW%=M(K1@I^Q4O/$3SS7+M?C"NX9S+BH_1!8Y?V^J=H2 M6JB_@+P0LM!.]A$%#[Y\XSJ*]5+>JC>TR+0W7NIIYO,]+>3K=+G6';]ZNLD? M'O+L9DG+\@ME2[E *,)^C#7CA I#%"3:249(0ID$DF.D.(J%"P'UD&%NG-2J M '(%6B6 U@)4:ER!1I$KP)Y K0NHE+D"[S*^7)ME$/CR+:]_"'Z6J_M<@-\K M51VIK(]![=AM9#.-3'@O8B%GGKP XR&ILX\8D[+I!3@])]A+FNK'N1^+]*OF M](]+_:6:&,?/\H')8L$$2;Q$:AY%.( (X0A2#T4P$H%'"!.>[SO1ZO%NYL:< MC91@(V;IQGIJ4.;JU?4X.9Y[N MZ7.MW?5J5:1LO3)D\R7_H#7+LY764C=Z M]R[3PU*6JX7GQU$0Q1[T&0V-+Q9 (G (A2\$H:'P>$(6J\VB]OS\/HA83OQR M8F$_Y BJ5O6@-'S>Z/8__I$$?OR_@*QT=/2NAC$=C["DL8@A)TR[T5(ED H9 MP40JS"F5#&O3/3Z+5<[0@,]%',^,K^1=FIG9&3"Z-$'N%[&;0H1B&G/H!SZ# M2+ $ZF_)AXG^!4E(G/"-W=HXW6RM=CQF.:3-= \O;3#+EL^U$GVJ M%@6WZK5DJW=EN39<A\LP2Q>Z<Z#CEN=UJ?=)@>:O5\5!YYHM\@?$O3XE>Z7,MWV>-Z M5;Z77^4R;#ZW.(X"KK@/!>=ZF1P%"!*1(,@($2SBDJ'8[43Y480CE& !F?;W(0J4GK8I\V 0!AQ[BDN< MA#8$T=G+W*C!R&D%'BC_\C+ MOQ?Y^O%=QG]LMXR13!#R*<2488@PB2&)DP@BGPO"(C_P8F7-?T>[F!OYU4*" M2LHJHOFCP\@^#J(%_5T,SI1[K)\'%*XN?'JF])$\=/ROIK]M7=) MJU-PLN I78(;FF64I26XSNCR:95R_;,O>I8SFT3O:R7SPG$K?5!3VZUN7\J M8[/_KJ!@1]*KW8/=]0VZ^KSW*@5;](U^AC(/E_4C])' MSV!AFJ4K^5ZW+-YI+R&[2]E27I>E7)77#V9/\C\KS^'-]T>9E?*#_+[Z\DTN MO\J?\VQU7RX\(GC"/0HEIQPB#PE(>!Q P6/?]^. $.YTPO(R<>8V!6A?Q'>, M-UYF#LN0Y&0@CQVUK!2!E29@JPJH=;D"N]J 1ITK8!0"M4:@5FG R.8@T X: M_+Q,HFGCHX.@=Q!"':;5GCNBJ?;RENDJE>7-NB@T;2^"@"+?%P+Z-%(0:=<9 M4AYIPQ'&PSCT&9;"Y93I81=./#C9B5%>"P>66WD=MTT/L;0CO,L0&IG$=H2[ M HUX ^ZFGE1]T%W5PUZFW5T]J>7!+NOI)WO$$-]E7_6:S3ACM]\R*3ZLC4=V MJWY.E_K'>2;+3_*!IN:0[2),.%9($>AY D,4^4*/>OVW0'"6(,XD2JP\)<=^ MY^82U:*:Y?##1EA0M-(ZA-83@T[CH M.D0SQT%YHA#G8&B[Q3W=,>L,ACHT-UV$U%W'O;!IC]?[.7-_SW/Q+5V:Y!7R MW4H^E L>T(2$-(22))K591Q"IA?$4$9^*"7Q0YP$+NO?@Q[FQM^M@.!W(R*H M9'2\3WV(HIT7=Q$V(U.Q&RS.7MQ)U8=TX@X[F=2'.ZGCPC&GM4#^DPU<D4 :Q!Z,F$=XR&+*0ZMSWYB2P=M[-$'"-OMYLD*ID M!#<62#E[.N=@&-+A.=G7I'[/.8V?NS]GG^_+"T*JTY'R-]^;BXJM][5(&/&H M-.FJ$-)_^!'22Q\:0$^%B =(<)];G93K*\#<>.2#/!VV'09Q6R(9#\?1":85 M'2Z/[^F!'S;R@U:!OP[)/OVP&Y:5'&68F*WZ(73(8CW;Z7D*SF2:2E5:IVZ^ M5;_2(C67=ELR?9.MTM73Z]S$B19)$ 8AC0FD*DS,!IV$3%$!!8M#03%*8D:< M3KDY=#XW5FMEW60N +6T5V!?*_![+;]C+,C)+G;\-Q;:(W/?<$"['R;K@=B@ MA\5<^I_V,%@/9 X.>_5IX[+X]#7_CW5:2/%Z79C4$E5RFH7"/$XB[:4%"580 MR8! (KP(JCF+H% MKB_%::(8]A5H!06UI* 6=?AP=A<@8T2VC_;W(D'N+LU/Q;L[W^ES LY$7Z:/ZE^^0F?G@G%W[@QX)H^J"^ M60)ZADT0QM"+8Z&T_Q2@.+&_)W6!)'-SF!JQ =W(#T27F,HB M"#^5 49FL#J3L+EY62L";@M0J7(%6K-LM0&[ZH"/DYO%Y1;81.:9ZK+8J&9R MO%8V +3=M\\NZ6#"2VH#X+!_EVV(!ONYP3MW),KK3'S0'1V]8U&V=WXE#31@ M"DI)]7H_T.YQXB<"RD &E/JA3SRG6VV._<]M!CM]C\DD_-G]]^WJ7A9@=4^S M9Y>?^@4#7.UFYWV/:(VQI[,)#.'LN_>$X4H8]C&=+00]PA M3V1/,:R&ZO2Y(ZM*!R!M\QSRSCR'@YC#PL,?"=T)D^^"6OK]F,15F[1*ZU _ M8,J+V*68' 1Z!R]^7!-,Y+N/8PHWG[T_D)V>>H]FI_//^^N\YY5?T$R/F>6C M_NKN:2EOU<^4WZ>9+)[T7&8R'S_N)I6@BB(O]*%@)@5\''%(DS"&H<*(>#2D MW(^M0TE67<[-XVZ%-M=B-F)73MY&< <6LT/=8LX8',N1IXD-C+>[,%[OPMCG MZ*8=G@X3P>"X3L3]@^#K1O5.4'6RNUU+TQ&ZDV9['.[V9M^"6OFC+%9/'_4' ML-IM_=73%]WB]?=4NSZ&FB,10$KC *(0*4B"&,&(1A@%+$@B8I4JTJ'/V1%W M(_(5J(3>I^PK8,0&OQO!'2,A-O#;13\&!G5L!K\,^2?R;*]DJ[0>(F?S"96RKG=R=L^NII^TA3\>+Z&RU$6WC' M5'&IRV"8X/F7>YK=5MM0Y=_-AE7Y+FO.^,0!\G#$8RAQJ)>G)#1%1 ,)8^83 MI)@72DS=SDU-)?K\SF"UD842_)!F=0G!\O3Q[9>U>X(]HH2/( Y,:C-?A) R M3$VI!"P"DE#L.[FW<[3Z)/>KVA!@KL"GS[_\&4QO-_O-T:!C!^*-/I 9A<"N MTGN;D>P)[#[7: XJU:^:TGE@1_O=WK71D^#DMVO.\W457/IHJF>LM9J5*_8Q M7Z;\J?[SB_R^>J75_&.1) E'24!@3+!QE&(/)EQZ4"2,!XIB[40YY6MS%6!N M1&?.ZFP5 /L:.)*>JRTLB6]$A$0EYBRZG:LSJ%SS\V.:6,W2'*ZA;12G5W6!"RW6/1M-;X6IZSZ4>K*H M#F"W6H$O.=CJ=06N5\"HUE[-V0NR-0J"'UH5+7V.84W8JWS$=*:DW9/:4$"-O8+MD*=W=S&W(UX*"6E('-^DTCA:NZR#HC#S.]X !C91];EF>1LK! M0QP$L8E]#].*C'38#7WL\T^G4 MEQ[M,#ARY='RQ3X9F?2J+5VE7]/5TW5&ET]E6KY[T%_-ZE;Y7I,F[[7DA:2E M?)>U_ZT"L1^+5 N2?9 K_8O\09IEX"+D,>-Q**"7D @BE$A3VD=!W7.]&@D=SM*. M*:?&,45W/JJ!^YPP6=4X:.UGLAJICSZ)U,UIK_+O1?XMS>[,/BG-GG3+/S;K M5ZQ$%+,@A#A&,42>7A0D@BN(?8FP)W@<"/M:HMU]S6TRK:4%1MR;W"6Q=C>B M%K/C<#B-'2C=0F0.B3:B&A+[L4\8Y0QR+DG'!T-PJK3BER#IF#7<"IONO.#= M34R8^=M*E_WH%C$ >9)Q)2!!' MA"(4Q+[O$EPYTL? M"#%GT1.HO!BSB"4JB*TVF_L*,#>.:.4'>PJ ;9[&C0H7<(BSE>P(9DSL1V:? MH6%W9J>^V U)7"F&(S5%6)25D M811#I@E4]QS@4%HQY=""S8U!.P-0^=D 5'XDXN2!!XE/]S3M ? :EBX/#Y]KOM\;Y39JZ M9U)I\NU.:A2W?6[7:_*%EL:K<@'=%2([L]&R,UHH,/&R/58H,=N:] H]%P MR]&>R VY&G458=+%:$]\GJ]%^S;C?MOC3562_EH(W6+Y,=)"AA$&.!0X290,IJ,[.[F[E-0[6DH!'5I&XQP@(M+3#B MVE_ZZ$"VFZ6&PVMD,NH+E=/=C_-(7'#[HZ/QR>Y_G%=P]P:(Q=,]XE$MP5R+ M]7*U+N6K0A-+N5 ^CR+MG4(J I,/G2/(O-B#PJ,!85(HX7"#-/*8;_#1:_#K#3ZO!L+'(?QQ.4X313)ZX.46 MA>A&HC.@<.+5Z6(#W;+O+?///#I<+=S:N?J2/ZX?JSKF99O)22R\.. Q\PB4 M./*U0T0Q9'[H01FB@$5<2!Y:E0GHU_W/H*BD!+(5TWVMU],:-J'O M,3$>.\#=47VU5N *-":HE0 ;+4:%_?(JN,/ /X,BN'W-,$@)W/,H]JF V]'J MBQ? /:^Q3?U;BU;ZG M>TK*\5;_5F?YNBZII[:4WV\B?UZSD15JE0VIGLL^2 M:[%,3K@;NEQ*\>JI>;ML7B\7,E!^S)""/E<11)03R(C'88"3F F" II$]L>) MQQ!Q;I/2SFFQ99-T[^E*N_*;DQOECIH]IZIQ;&TQG;VX!4>>\BK]C*O M; JB!@PJ%GJ2L(0%+)ZH6N$I&5VX9IJRA-OX7E[+#/*MT"^0E/>D=7&B&&;, MAR(.)$2A+R%3B;9SB&E(M5L8*K)XK%W:%2U6?P(+/Y=V/"N_HLLJH0)= 2;O MTBPSQM4VKR68DYDE]QD/F';LJZK& 8HAC:0>Q";)&L+:S@%KS/PF&SOK^G!& M;F6=Q,0R$_,TKMUIA!^=;*@UG4$^['-&F$7BZY-"_CDR M7)_#>+!4UF<[ZI6S6DB5FF15[].O)@VV;ODN94MY79;2A)_XBV_I MMC^;\;UJ)[;CRL4+9Y-TWQ?UJN0=<;[C -.@:PJKC:=<% M+E@<^/I.+SOZ[Z;&7_&TN+E>))(EF 8>C(7B$'F(P\2C'+(H0E0@E=#(ZK+. MMLFY\<<-S:B@EB[7%I@S7FXO=9[S^@#/Y$"YCJ/(S<-FH,;M/\P8 MC7?&Z$Z#TS@0!PIL'(##W_0Y8D>7\E95(U2/2I47#R9D]W.ZE.4JS^27;WF3 MJRH)0QXAP2&-60010X$>6(1"1HD7*.%'?N20M=2RU[D-0"-W=9''2'X%=F0' M&^&!EM[E>)>M 2S6JF/ .O;<;A"]/8]HG^QKUM"Z')@; >*ISLE90CW4H3A' MI+K/PMDV-N$1.$?]]D^^N;X\\8ZV7BC*I2S,0G'WS9N\7"VH2!)*%8:^+R1$ MA""8A!&%?BPC/_8#Y+E5;1]#R+E-'#NBUCM?S48*W]UPX5IPQS+OHQAXY#VQ M@>?8[O+ NG!=KQL^KJ\CLK/ M:987Z:J6X3Y?ZE;*!8T3*@+)H<]BO:2.2 *I3R2,413%/%$():)O&95C'ER8$E69:!.E,V6=!MZ/?(:$5HGR]62*4+@:XZ*IWO]>:;1UFLGC[JSV-UG55EJ1\-SWV0 MJT7$.:>81\C7.40Q]%&/L>U(@)5URZ@R%\A0)=+Z8/@;$ MTIJJ!T%H?)IN/L"/FP]P(ZK98AG0Q;6!9&!Z/MW?U-1\5O,CM'S^G7Z4O+,C M?+NZEX7Q,#7=FXQM7V6=?ZT)DOF(AXG9P0U(I$PN-*E]P9#"D*J8QEAA(:QN MNCGW/#NG<.<416XDKU;Q&]'W,VRYD8V]->R89Q2,1Z:AZ]N;=^!ZM2I2MEY1 ML5>#%L/<[>" W)2O:=3TI1SI@\YROW!GJ25W7*92$DHEY *40RT)XC M]0-( LF@\#4_J2@@<:)XU[OZP32FMUV$1%Z$Y,DZ::V1$ MQB$D88VDF_RK,R7J:@<+=;<)2KOI?/ [FT9RXV0"? > M>[.CJ7>^T0'LR+MWPWOGYX.FZQX*S$'W-_K*,NT>QH6('>Q37-K>2%O5Y9D; M06V2F/)=5I\O?):AM?U]56]R$8<8(<80C&F@72!?1-IG-*2KI/)0Z F56.5- M?!GQYT;5K7"[E[;-)4^1+Y>T*+=IIH>^[SGL1S'0QO>+F7K"+?%3-T5+VZNB M&Q" _D[:T]P'N;,W'];'SA+@PV^QCV+#23??A]5@7MORHUC'><-^'"GZ)@C_ M?"^7RZ;\Y\)C+.(2Z[5^2!E$6"_S&4I\&&-/!HGO*VYWW>9X\[.;?NHLUY6( M;:59URS@>_!U3P27@S(R43OAT2/5]S&U+T[QO=?HQ*F]CRETF-+[Z%/NP_4F MU\-_L\8,O#B,E%[])U)X$(E03YP)2:!/%%'8%XD76D7E#EJ>VR"MA ./FO=^ MM!^;^UB='Y:]$1AY1-;*#[E@/JGM!0-QO[W)QN!1-7:'W_$'>MQVN5ZNBI1^ M3+.,\J5\__ZFK<3."8VQ*2\4!@F'B 8!9 (K2$/?CV.])I2"6]]N.=7+W$9D M+2=H!05&4H?K%2?![!ZF@T$T=D#]"#I];J&('&$>9B("%GSX;G>YL:+.QF*=P0&OQN102.S"P.<1=N" M,(?$<&3BG!P^!R(=$L:)"/4R.-V(U1:>3H(]V\AT1&NKSQ[A6K_4;Z-#+R ? MTE75Z.NTY,N\7!?RB_R^>J7%_F-!&0I"R3 44@F(,"*0R(A"Q63B)S(0H>]T M2J.[N[E1[XZT;CL%9U"UB^P/A]7HR\F-H& K*?C=R HJ80? M)XU%VVG_/'9L^99[\.AU,^E\T:\N3) 7A]I!PUHSDY-!0>+[&(8LY+Y9Q'K* MZDCN\X;GQ@JM;, (9Q\\VL/J?.RH+P)CNU-6RCO%C8YI>D'8:*^YR:)&QY38 M#1H=_7V_*?N73-&O>6$.(W^2=^9@:UX\77/C][7947P:!5XL8"P5T>NE.(1, MKYH@\R*$(OT_BHG+K'VVQ[D-T??I*KVK=X,_22VN.4.TRL'/M/A#KII"QV5] MIML\8^Z6M,E4/A:Y6'/7"?^\3>SF_$&1'ID*=F0%6V%!+>T(A^.ML1ER\C_? MZ:3SOS4&SUT ^Q?=2*DL5@M3'B,5*2U26;81;$RX%%S"(*0*(B%CF"1>H)<1 M/D^('_ 06U4^/-[\W.CF1B_4\A+\OX8\_K%G?&N__5\K)]H>9*!W:U5.XK//-7S_K.L$I9OY\KF\R/FH+?2 M?KSV(:HR,=I[B",%N>!1'%*1J,CI,.*)?N8VB!LQP59.QZNY)^"TF_@' &GD M87V(SPAS_!D8!KV$>Z*K:>_?=NM[(12Z0GW:L*.$A@-2"F MKQ[0R%Q62XGZ&J[+I:\>EK#8I1D>V*F* M3R@A]:R?\*&ME!*SS0TH-*?'#F MKMFE0#NE^!\)\,E2^0\)O&O"_A[8G4G,[]+BE GX>VCZ+-%^GQ9ZWH31;J?\ MC[7^^-Y\U7\T3HV22 1(>##V*($(*0\F8>CI.5:$(8I#%O/$Z<+*L5[FYB%N MA025E(ZW1XX":><=7@S/!$N^761&\ P[(1CT*L/1CJ:]<="EZ\'%@,Z'^PWZ M[2[1K>I_\6"[X:F9F>,DC*&O4 !1:.ZW"8_#$&.IK>!A&3EE[AM8OOD1S<,# M+9Y,.'JGLMBF1+$;[PQM2SO&>D$+C;T#MMWA-KG7+[Z%!G[_4H701]DM'\D, M0_+MT").RM0CX?N)N6F\UH_IQF+-WI$&#_0U?I-03]+LW-Q_3ZG M;61<*H\$)(Z@"CV]B/09@T3B!$;8IR'U/)\CJVNAG;W,C2<:.4$M*+@&1E2' MX-5)-"T"@D-@-#(G'(6GST67DS@YQ/.&P&NBT%U/W-QB=.?PZ S'G7QYNLC; M.?GW@FQG'^YQ4(++C!9I_DM6/DJ>JE2*U_D#3;.%+UD0,:$@,2GQ$)$*4NPS MF$321X$*I?:GK,]+G.IE;E38"@I^K^6S'-[=2';3X !U0LX;&[?S$.=4O M/D9QLH/I3E.JZ@N:U3GJ]YE'XO\3G\=[?D>7TC%*0\@XAA! M%% $DX 2J/T=A"2.J>=ZJ>)T9W,;\[NRFEP[CXVTKOZ^BH[^);U6HNW SR35%[:]SJ,&PP$*UI48#M^\?!]P-]I<7:HP >AR55:Q M9K83:RXW&7(BWR/(TXY.+$2BO9TD@HDD(?2\F$=Q@J3"3BQUF3AS8[ S-?UL M\O.,833W_;UQ33'V2NMR*URT*]"NI^X3>;5%UB,2/@.Y$@?F!4'8+U#O"U1FWMVUKNC"^HW9[47W7=WOZS<>2 MMF@'_5^EN$NS.W/O\JMVT.5..H:-_Y4(I,P"'LK8CR%**(<,DP!&7$1$)BB. ML'1RFOO+,C?V/Y%\R"Q4&VW 5IV]5"1]7>D+[&CI1T]CG9&GDC$-X^Y=7P[I MH*[U!>),ZU=?CMN!4SU D_T8^%=:I.9895O0N$,STZ M@SHD&=IW/BGU.6/RG.C<&^A':\]O?KW+KCG/UR8EH.12%C*80,I<:? M85-36\ DP1(JXN. <(GCR.62KDO?5@-Q^NNYK:"@V$CJQFQ6N-N1VF POMQE MW#0#&T0_G4?4F:)<(!J2G:SZG9287)!XSDE.[_:\":!)+UU6'MS-NC!%D3?+ M'^JQ.(ZY!R,/Z65LX%%($R(AC@0FBE(AL=M-@)-=SP(>05:S,98#YY'8]#3_Z=[F_;T_UFM#T[_GW]CX/,L)AEBQT.X]S+8V>S? M+M-NE19!I:OR2_Y*UNZ27JD4Z=V=+-+LKKIIO[UX_R7_F7Y/']8/NPUS7"TTEZF0(0HE,NG50A%"%H448E_%<<@\3S&KY*POKLG< M^','"Y/3]:Z0LA[GVW!6*[=9+?3##S4P MSUJC-3: -N#H-DT+#[9'#E_V!:1.DU)O!3>?V!>3G[C^Q/9;:X !+3*@@@;\_.?YQ!PV^O\L MG]I$IP?^/)^&+C_1E;S-;FAY;_YGELY?Z5)687]3\X*;T\SZ%WI9O?^#G2<7H?!" MQ7 $J8\(1+%/(/428RN]?&62)''H%(X;0<:Y\5JMHED3:EZ3Z5T&>!5%Y4]Z M:4FST1)#$OH88DXZ 8R(\_,)8\RN>DXPNJ75 MT_96GQ=+H0B#DGC<;-5(2*5O4I=XDN XHI&TNH=RO/G9T7HE7>\3Q,^PL^37 MWHB,38W68+@SV5&=!R6A_1ZFY8^CVAT,_>-/]5R.GLL3>2I-Y&UU&:)\FQ=* MIBOMJ)H3NV^^/Z9U9+U\E^FU=)J+!4&$O4J,$0X1##Q$8,D4:PE^2+/ZVEMI>>-MN@_# MIJ;PZIEA>M'4$L+_L<_DL#W_Q=XJ,2NKTP[;!MV0FRQ M"FISN!"(E8LB".(*^# ,9,N+'=N>7 M7#J=&\<>;L7L2'U!WGWCO;[HOM;74B< MV^#J?->-EX1,%Z^;J>O?UK300WOY5'>T()Z4,E 4LI"')OB (8V4QAK' <:A M*4(1V]!01Q]S8YU63+"1LQDN=B33A68WIPR$T<@4X@Z/-6-8 + EB+)EB%+R M'^_RKS_IMVMRT']YS@E=+4]" 1:JM2/>YM&^Z9(?'M)5FQU@KP3% DF/82X5 M#(D>[2A2$628<8A0( .]R@NPYW21K*.ON0WX'5'K_>)=85TS)I]&V,ZA& BW MD4G@.60W5I#UR)5\%HQA4R6?[F[B3,EG]3Y,E'S^E1[!G\\R*],J?<]AO>_.U_:\ID6HV2*^SS&1C^$\I?LU-Q'UI;NMG'^1* M/YH_2%,(9X&P0(Q$ @J!S/:&KY<\L>0P9$&""0FP"JW.ZDTC[MRXJQ5=C\)6 M=O!U([Q#+&5\0UO$L69EOM&78AM=0:OL%:C5-8?#?:\]+0Y:E<$/K=)_U>LV ML+']5G&PU1S<9D#K#FKEP0]&?9>DC>-_$ X1NEE]&!.%^>;U@;B%#2>S5V?L M<7PII@M@3H;H7A1TNEY[AE+YO13KI;Q57PIJJO=^EGQ=5)?KV_+LS2_J*NW; M\![C".- A5!$+##K'06IQ.:R@,=]''+)E=-ZI[YA'J//I MGA'BBZZU>(@3$5 .B2^5]JE,3NW(4Y#$U%.QII D0(O'ZD"2EKE864:2I[KP M\ERR$<.GIZXF70$F[](L,SNS)HE&]R'#$4Q((T2B@/E0QHQ"1%6LK8&;3,S2@*U<+V(^J7_Z(H:SW%WX+W)Y;'8WQ&9W%^Q/=.MKE/M= M+WF3:^O%'TU8K)WY+U4FVP@E4D:)24J5$).CRH,)\A4,5.)SZE&EE-@:_5\+WCCATF\(UOC 8P&/O,@R#[071!"NDQHD=='?] M0I$"*SQ.QP7L7N^QT_MA;8ZVWJI_E0^/54$)*3[JP9]G='ECKAX4>BXM%PF/ MXM#G(90>9=H_Q!02%E 8D]CCBE(6$VR]6VO5Y=S8JA;:C*=[+384M=S:%=-SM+6&RG#H[OR&350'NKP+_N0MO*#(S0X-4X M<#IL1@X.ZT0;BD/ Z[8-Z(14YU:>74O3;<;V9@\B?Y>9W%QY\?2Z M>+JI6:DIF+Y(PDCY* YA(CQ3U%QR2(.008(QP8H(29#5IM>9?N9&V5I T$KH M0!P=0%J0[S#PC,RX&R&OP"Y(?2YC=:#EP*W#H#81H?9&SXU%SV/229T=KT_' ME^=UV"-)B\?=F+$L5HN;/"OS92JJKZ+:-6MV9&B4$!3S .(X5A!)+X$$D41S M(PI50'R$L=4V5UFS;@-"Q+M:O M[ZR)];^>KX<[VY]DY-MHV Y[JV=[;FHM:5G>JM^HN4^_NBVJ6YUOOLN"IZ6L MKG5N?EDVORW]A:?BA#,I(5='#A=B.@CQ=Q8HY6W M+0J>9D"85+)%"3;UP1WSI/2SCN5VQ]B8CTU 1GX3:FB$- 4-*RFOP,82];7O M[3/EYJ$AMS@DR[G7$)5@?;&!ZE.8_Z4.J1WSSN\;%]T7",?,9Y%*%$"E3ARR(A2DLY,N0\\3SE5.V.G<9 MYL:5'W5#]W4JHG9A\$F6FC'-IN3G?+GS<[-Z>+O,O\G",>U=#TO9,>?(^(_, MFYN,HGF5LM_("(P"4.4%++4*)N\7:)38/#':@O9*0)&$,8\I%R!,58^(4;.CL;6Z.'D_*6E>[/.ZV)<9?25,/XYKS M8BU%>SCH@U:NKC&\\"4+(Q(BB!A6$,4X@$P%D?8I4>"%OL RL#IKV+/_N7'. M^SR[ [JC!U#ETS(50Q18YC0KFUJ5M8O!*JT K=4"::.7P[9H#U-9;"Z/:X"1 M.6LC//BT W4M/V@4V)Q1U&[>1H=Q87?8I1X7_HEVKX[>S0[ MW39X?YWWML?5SG_HPHZ?Y1%Y3TO!,;: D$ $0\E1 @CF"A. MS*99I +" ^0Y.:ZG.IK;_&'D-%-&:22]:K;#-EM@50""KD7O3;&3>%N&$P9 M<>RH0 /@YQK >A=+RUF' 09 MN.[Q?BD<8V_#V"/AE"/TE,H7) <]:'*RK*"GE-E-!WKRF8EW+*H_?M6.A78] MZL(2_@*'48 #[$%&B*?= $]"YH<*\D0B;NKM>IY;HO(!A9L;-332];H>/*C1 M1MZ5N- 4\]^0J/X#6G/.IA90!^ZSV(,X)M^?8_NA ]G!=AZZ^NB9UD>6I93O M35:VU[+D1?JX7^- HB#1*S0.E3 ).Y V=>)[!#(1B(#ZB>9PIPO(9_J;&QW7 MXEZ!2N KL"/R!3G.SF%N1[T#(CDRFUX*HGM2(#MH!LT.=*;+:=,$V>E_D"_( M\K6>9P9I89+6E.WB49-;RJ\S\3I=KDTFR';W31%&*"815*&*(<)4,P[7_Q0L M%"QB,?69=#HG:-?OW)C'Y%U-F[RK2Y-W=1LIN,@.;82\Q&XFWH MZ I44E=[HHWX;/#8^#H%)TE$PR0Z$_3K*9BZ5[ MH7PT0Z%Z.F7-8#WTX_QWF5[1$Z);]SHVMMV+#2FYSZ*41'-!*$YSKZSW9Z^%1CS$3([Q5S[MX)L&;[WRY-KG!_Y[GXENZ7"Z4%!'#00!Q MDIA\+UX B0H8#*(XB/TXC#V[VDI#"#,[GMOH8ER? Y*[TC]Z-D9_D*U.X*Y1 MRO%8QT7&M.3"B4PT-D'N6>> ':_ 8/^L%$'_/VL==RYH=HLV<$8:67KM4NSKI,,UF636'>\OI[6BX"HA*)? )#ZDGM0PH$$^)[ M, J3,(R1\#WE= VZL[>Y,6HK&_C=2.>:J+435\N%^E!HC;WVM@3*?:UL \"@ MR]_.#J==T=KH?K!(M7JI9]J9] M/II,KO5F[ZVZ%GFU*;,(*&(DC&+H>9& B',"2: )1012^V_Z9U%B577[??P'ZSX:1HSC$Q>.Q:HM3"8 M:SW 5A&PT40[T[AK5\-WN_K#W'9O-= MO78/0)HK&;4QO^3@E02?-L9L] -;!4U*Z49%E<)P>^JV<]BH$7Z]6115!0FF"9ZQ:2747Y,(A]9U:7H+\+<)NG#(V9T1PT] M1?_-;774PRAVJZ)QH1YY_CPHH&XBTVT<^F.36N!Z'_CJ*G6>K;1\2_/8IAS/ M&,?4^J,[Y,JHAQ23KHCZH_1\)71!2^[W+%\W?L3;M.1T62^MWNJ?E8M8$1_[ M,88WO8)X&M9O/ M!H-J9,KJA9+3_:;W^\;47Y"E$H1^80TT!"B'UJ =Y$OD^$S%&GM,-'[MN M9T<,.[(!^=U< -=J58FV37)8Q_.HEI:P#!$/CN_H 023'&97 MN &CNTY@#!K)M>MYVJBM$QH'$5JWMWM$8_7RT#QKLIWEF4A-,DCB&,5,$(J$]E81R!:5(PH3@6 6>U8V@"V28&UU] MH7](<_#ZD3Z!-+ *DXR,_,I&U"H ]#4"K M MCJ< 6,%E5<;#H3.(0UQS?%1/'+<4SB%J.\#,S.8&3/IJ>+.EZF^UYX\<*F M>DQ'9OU]DU?;CS+C3Q_766I"FZ_I [TS$]_Z[G[UJSFYOL !H;%OO)#1NVK(EIW.[=)IY44B%I44%:R.C";/>(6\\DH.(X\A1B9 MP8[05V #:B,WJ 6_ K_:WYEPQ-9AHA@%XXGFAL&P=IL.G"'KG 'L6YN.])TU MW.-Y][?[A3_:T[R?\N7R;5Z8S"D+',CX/,W0]VL.).W=;='ON;&\WYIM#@[IY+4R&=(81X@A!,D#)WLXW7P7T%B1?Z.)(B5'9Y@WNAY%1W_BP*EQ:>/]W!9)7GS^JX6WK^ M_,-][J><+=[\:[[4\_5OTOQ"BNNOLM#T5/WF9TE-$ISJ"&YU:&3ALY FB$30 M(YHUD$]BF"B)(4D"E+#$XUA8'>D:7K2YL1QG#!-WW40;M<<+[*&,@M7\?990>>DSBS9V6\DM^ MK52Z3.E*ZA5#_LW\\&U>W!12I"NS[;%0G 8H\@6DE&B//F$4$NZ'VBWR8P]S MA:EO'T>T[G9NDV\KN+GH\.]YJL?H5VT';0Z]LJ>M!D#E!>"5#L!<3G$@:'M[ M6$RFHZ \\D2Y ?A+#C927X&-W&:C ]22@_=C8>LPL8V"\423UF!8NTU$SI!U M3C+VK4TW@3AKN#XVW; ? MWCEM4 \KWMPFDL_KAXK8 M@/E7HQ%XIS6QW3T8R:)VV^0O9Z>Q-XMVDTB?KI94YY5N%*S/XS0%E[8Z3I5# M>D #C)1'>@@)7RJ7](#H=N23'K*7?A/#:[VL^%KM*KS+RE51N2+EWVF:F4GG MU=._2G%75>==5E*8K8973_6UT$W&L??FJ]6_?/5TK#%3.KZ2>(%HQ%4B$BAC MQB$2,84)YP(&0GC42RB1S&I5,;WH>-AYY,AK"O,XSR_1(#SGK3"C]I#/2]%9Y/EN]@ 03UX*M-]MWM+M=W/W8ZNC%?*&PZDAT'"9=>A/G8 MD=)^PKUXD/0B3&WBHY=UT&]>N-6K!VKN?V[3X"U8J&1 ]8(N\"($4<@83!0- M89RP "<1)H&O&3Y?T:4=PQ_IPXFK-SV--\8W(CJ<;^B"T(XM+P1F9-[;8K*7 M,G,XXNI0?T@*.M;-I&32H>=S6NAZM-\ WSB0'^1J&YFJBB^]3RE+E]4=C.H$ MEKC-/DF^+@K=ORGH7/Z6KNY_R7)6RN*KX9IWV>-Z52YDXD<>XHGV )D/D8\Q M3)*(0>YY2/\?$]SS%YF\,U6#:^_V\XH6*SNR&%Y>JR&5U$/JA-3C#;)7\B[- M3"EMP.C2'(APXYX1K)L$,1^KG%C35?LH/^4J: M:U3OU*^=$7D.0LZOW]9MJF%PIR%OB"0QS*&>F$B(441 MAX&*8R8E"3W-75]EP7+7)%,N@V6W@_'&3"M9OV12"\^CR ^(.:U&-,US%$": M< 51%",O#$*48&_QZ+J8ZP/7\TY&7'O5KCF@*\ VR[!<.=TJ/0 R44%(%8FA MD%$($0JK$Q)ZK2P]S'T-) ]E Z3UNJD_C.,OQQC*&'(F:& M+(-$A IJ.4P2?*1P;)5?^A+HIDP%UQ,FNZE_AI7BS^K=.ZW;&-/PR]1@/U=/ M?:C:Z&>V(#[)O.@%R[/;%50B3/1D 4,92\U\ M)BP8^"%4-&%>' 4H\MRJJ0\KW]P88.?"S%:3>M\05+J 5H]AMWQ=S3K,QN^( MQAI[^_?83NYN<<9=ZU579XQR5QOK37Y59@#8I]P!=A5Q5OO /?%UW0WNV\V% M6T8[-_/?%O(_UB9'<).Z*0RC!&/E0Z&J/6+LPZJ@(_(DP0B)),:!"]E;]#DW M M]-;+$1U3$_E@ODCA'\88 E5$"Y!W=ODS$^SP.)T/8%J_V M=$CEG6FT^=Q]/Y84HP *FD2:88B"!(<2QGI)':,XIA'F3N[D;NMSXY)&N+(G M?>PC9^FQ]<5C;'_+&@IW;^F8RH/Z.GL=3.NI'-/MP,\X^E#/'23Q[^MR59GJ M;5Y\D-^:Z&Z:W7TL\DS_E=?'UZZ_I^5"!3XG/ J@PI1 %$02)HB&4 ]RX2&/ M^)A2IVTDE][G-MIWA*]2ZVCQP59^L*\ ^-VHX+J'Y&0S=I2+3= M=Y'ZH#;H5I*3 -/N)_7!YF!3J5VTDO&"/^PB0EE[+1?",[;JX(>/NOYQ4?E GYK"7 M:3V9DUH>N#.GG^PWOC_)KS);R[=:)E,6R=1[-Z=O;C3!Y ^R>//=U"#6Q&(. M[NC_%U_H]X7P,%;"#V#B1>8^%(H@\5 "8XDQB8) _\IW.2W?0P8GAIC@-+TY M7%?4:KC10A_\(T*I%^B%H0PE-SN& C+, QAS' HF?"((<=OD']D"TYP'F-0& M=MP],JXCDWLC/3"$!5KYZZ.@K08F-VZC VB5 %J+X6: "R <9>)>M]#>8LF5]5K1\G99\F9OPVS4K*UD6?DAP3(,0QB$1 MYN0.A]1+,/2],$*^IR*%XCXG)JQZGYMONBDB9\X*;L6OSW>78*N 7N";&>![B:LX>$;>T5^B)S8(@=^KP6VG (L M(70I2#YF55*NW-UA%RJ:9-IC 8B@>Y%X9K^<)S=UOONMP,V<#' M)(F]&%)?F7R;3$ 2\@@F 4>::55 J<-]*[.YD:@.P4%=J3MO83OQ-F.&H=" M;V32ZP]<_Q-V'8B,]XO_1B6*?97*J!E8VP6U1'Q-J.ER_&;V1";N4S M273KNSY754X1/AP1=T(P) ,?[VA2ZNW4]3GG=C_C>RNHW]3CSM*& HE$9F M@HV8>]LDHUP2LT%D2&+H[&]2?K#1_#E-6+W38Y/#M-N<4WR776?B2%6\\GJU M<0P_29[KR5P*L_%\_?BX3*7XDM=9I7^6JWNS"FT;7& > M5M] H[-^ZZ]MV81:;[#M8R;6=]B$FLE7,-'VU4R^!K?ML E,U+F1-F;_TVW! M38#BWN;=%/WU6[;4)7=O#&;F1%MUQ3PM_V@VL*4>.6$@"*1A$D,4X1"2P"/: MTR,AYDB$*& NZY;.WN;F$C3EH?>D!49 MX*8BX([V1XH!;LI65A#,H I@/YO-HL:?H^A_C@I^_>PQ6'V^GMWW"$4CRC&%''EFJTA0R$RF8I\$(=5_4P'A;=&-+_8KKW/]6C'3 M?OF,+U.&934Q+:O4W\5&9+?YYBSP7B0)I=SD/9811-07D+$D@20)(Q62V/,8 M=EGK#H+XA,O=UP7]IF?U;YECT:NSP-K-P$/"-?+4V8IJ]@H:89N\])_.?YS. MTYPM,$/.3V?[G'1BL47@^8Q@_5[/T-GA ='V<.B"R,1'3!-X[,E0KT22&"9! MH*&6B(E81H3*T"450$=?3CPRP97_&Y-JI01_+_+UHV.DK -0RSC9,#"-'26S M.WINMAU61H?XV M/NBOIW&8XW/S>$PL@$C7*^\ M9GNP6;H8/<$8VYVPQ<'==3BB\*!NPF[[T[H$1S0[F/Z//7-QAD/M3 B1FA4C M77ZDJ7B7W=#'5$^KQ]>?59;F9H7Y26HOI$Q7\K,LONJE9'V%Q&SVW655BPLO MB)D?$P$34U03(<0A0T!IE([KDQRZ^R7#51[+Q6H7?.Q%'- M;4=;,S3BR(QX_?'=S=7QR.-NNOU:LRO07L*JY.4*[*@U2O[&*>PP4N;' M445_J9R14]BC(]OD)-WW7:0^V^Y])3-^_T"+/YH4T5CQ),"$0!]'"B)A+FW' M<0P#)#D+?).WSJFJX[D.YS97'#FKL)&X9P[NLYC;+F:'0W+T%>TE(/98M]HA M,^SB]4R?$Z]@[1 X7,9:OG=I(:GK;)6*=+DVQ6T_FR*VFLQD6:=(J\^U&49< MUV<\;]7S&SE5%9-%P#"+?>Q#CR"3ZX<'D!$<0N6Q&/EA1$*WD/RPXLV-R5KM MC-N[JQ_8*@A:#=O\5-3P%KR;*7PS4V M7?9!RIWONG$8E+A.=#4M W7K>T E9QZ_\(KUYW5U)Z+.Q?-)EGKI+,N%,,47 M1"B@GX@$HL3DQ2$!A33P8ZH8\[AR*D37W=W\&*(6LLK JJU:KA\,#3M&/L] M;$<2PP$W,E=L!+T"K:B;#=A6W!$N7W?",LKUZ^,]OLP%[$[M3U[![G[KPAHN MMZH*R=WG2_UR6=^SVJ2!$HAZU"<2^BS$FE:0V9+5M.+[6 HN/8J)VR+4IM?9 ML&KMB_\_VPF/?%%QV1K#T3H:&=FQ?90A4^]>.L4%IE'(RG1V_3(49 M&RQ.%IVQ>KG_.DBOQ6CQ=%L<7@"5\OVF:A(./$H23&$4A)Y9&84PB7D(@Y ) M@CEG6#CE];+N>79PZGWQUYH3)L?6:6P-N;"9DNKC63"FJ4L%+>K? 6$I)!8&2F3PUDA&8!"R" M1/-4:"B+*JMB>0>"DKMMQ7K8# MO93\Q[O\ZT_ZG7J,Z[\\']J'[4TR=$^JT0[-TP]M7#S/X;ES&D8:C7/U*/TD2*D"C/+:ME#REQ-Y+HY-@KL$^Z =>/=;&R!49+G70#B.!M9]F*\T&Z5,TZG MMZ3*0]2I@HE9CZZ/IO(4*04%]Y)%+:QW0*I-MU.S3+7K>=KSJ4YH')Q2=7M[UBG+/N7+IT<,6O$['>G MXCBD=C/'Q4"-3.X],.I_^.X8!J.0)NZ,/]QW_^U4QWV7/ M/?GMZ;I$8B$3#R*?A! IRB")$P9%P%@0)2(BV.GZJ7W7\V.*YA;[#ZWL?S5! M@2.KV)XG[1RL8LLK8V ].MD,!W,/%G)%;%AJLNY]8KYR1>60Q)Q;Z)WS[:&Y MP%^Y7+N^U2)!&'LQ8S"@7J0)3>F5B,E5+FD@. XXY<1S3T[>U:7+N)HPH_@F MC3AK,DB;A-%5DFC7"N>=>#,OHE'""(QQ'$-$-/+$]P)(91AQHJ@?>L(UW?>P M:(^?H_M-)=G(0%O&B@>";NP(<25F?=RZ23*S'Q08-+_>640&3K!WNK^I,^R= MU?Q(BKWS[UQ83_U=]J@;?2^_RJ7?[*E2G/B8>!QB'QL6T<@FRL:*(N5R8Q2YLM45+&UZJQS=2V:,93(.$X@%R2 B"4" M$HH0#*)8J9AZ,6%6MRI.=S$W4MB3LCZ^[W31O /,;GH8!J+1O0=G=*RYX#P M'12@7]X9_OI?SX=^1^N3C/CSVK4#W>))]_'],_WWO+A9EZO\00^BZG.,_5 2 MCC$D@BB($A5"XNE1[N&(A%@OWS"U.I!RO/G9C>M&..?!? 2Y\P/Y,CS&'L26 M4#B-W-,:7SIJC[0\V8@]K=7N:.UXJL\QW"4MRUOU&S4[7*O;XI/9LWKSW>Q\ MR47"PI!A$4$/!1(B4P:.D(1!A"/.?!YZ3'GVQW [>IK;^'TMB_0KK3(_K;2T M)>75%,3STJG0=">XW>-Z4,C&'N)&3'"K0",HN"U )>H5:(0="C.7,[D#83?5 MF=S^&#H>RK7 I?M0;E<#$Q[*M=!C_U"NS0M]]^ T*Q# M%" *DP![4"$E!8H2@9.HK2MEN]6VUX/5![Q?06KT';5:0"!=1OPI &WWQ-Q! MF6KCJT%CL+%[1N=AMZ[VNYAX?^JH?H>;4,FPA'_E@= MZ]D>^FE";DS**(IY !4VXYHF%+(P#J# W-<_%THIIU/UEOW.S3MJQ:[27^T( MOGM T&W\VQK CA=&@'5DOK!!=(1 J"-00Y*,;=>3DH\C'L])R?7U"_=7/LC5 M=IU27<]\GU*6+JN,$K1<%U+<9I],2M$BS>Y>T3(M?\ER9M)YF7-'=4379+_/ MN'ZISI8O5ZME)6JYH)P($G)A4M1SB 339&=2_#')<9@0E/A<]"B..9'X/3RD M*6IL;DX\FZQWQ@%UO+8^E?$=-Y=F8,OI-ZK,C;*=0$&E-OAAH_A?0:NZ*:BZ M41Y4VE^!7?V;/2^PC\ 5V,%@A-VO:8PVRD[:R**_S*[<-/8XN<,W4??])KW7 M!QFR%[Z/.(L" AG7ZVNDE ^93[1O;F*3H9*2)$XYV Z[F)O?O:V"4U5?NJ-I M!GY8FE*6AF$*^56;<9.)7FR9:=G8,77-4'L$=;N)X3(L1^;PUX=)_:_ &Z4D M7QDZ6527CNMY7,*ZGCRLC*?30F@*(@IP0FJ;K_H M9;MGMC$X@I[P? ]SC+EPN@RSW_S<6&*GQ&6OBDK/P+,;\/TA&7FP.Z#1N^3G M>(60GO7P(F4_NXL297M'CZLMUVVY1-8 1%,8H0]"57$#$1 M0DK" (:*!$C1D!//:1QW=S>W<;TC+=@1MW]UBC-HVPW\X3 Q0 M&9(ISO0X*7/8:?^<22S?ZL?W# M-B5Q_V3/9VUDQTA#(C\R)TT+NC.+V2(Y)(^=[7-2)K-%X#F76;]WX9W_W_1R M2;M>W_0:1W*2F U)ST?:-XK-^4H3$L$)"0F)I H]Q[N]S[N8&V-M) 3?C(A0 M:!E[WO/?PFA[\. 2<$8_>]#B\MMY7/K?[3]0?92+_=M>7N96_X&6)Z_T'S[9 M^SY__B#?YV5I:O\=)HBO]V<0C2DU-S'UL&^N\B?&9T$TP7X2("*4D[MBU>O< M&*"NKYDK8&*@=3G.="NMN6DNZVH)E/-\G9G,0VF39-^Y5)>-46B$DI!$/@P2 MQB$*8Q\F'DU@R)E>K HIL9(]=DR'L\WT^YUS,Y''$8E1R"%7-(8H0A&D7 75 MIK8712SQ]#3IE&5]\)$S45[UUC"R]4&;G827MU$8#Q]8Y&GA C.XO&7G!#^^WG_^Q(CL#[\([H31P M8A*+CJ?.26*/Q9%T) XO]_/)3.LW>692G,B,I[)\]?2!KM:%O%7;'S]54=-$ MH0B+0.BYA8?FHDQ@THYB&*@818E'?(25BV-FW_7K3@7OKKO3;O\N-]GLD/Z^K, MM R3R$\4A5C&"*)8AI!QGD",,??]6$FBK&II'&M\?IRCY0.5@*"6T+X(V %P MW4QR*1RC MEM*$^-/*2;G1*XJ[O'BZ529$W/Y>-,0*M+J819319O.4Z'DXIJ_Y;+V2T8TR M.NV,9H\>;LQ%: [KT_0396('YR*\#KV=RYKKDCVX M/5CX]M4 MM*Z1TX23RIUSL6]_A1_>.5S?MS1!-Q^.!.S(W+?!U$@,C,CF/G\32_H\/J8. MR1&&QW:B- D#8>R6,L$-K<[D"99-39=&P4VWO80*CJ\.E=[\N@YVEQ_ID[EW M73[.C?3];XQ<9B[K#89IC##^QL.Q[.@;LWS<,4NEST[B]/<6 M!AH@8WH/8,=-HNXBT OG5>^!W?E4ZWT:[7F'ILAUHZLG<\!_I?LQW%[=9W^_ M.8_)"8NTY0A," L@(J&$)$&:;&-%8NIS/['+Z6??Y=PHM)7X"E0R5T-U(_4% M1V$MP+?CRF$A'=^!OA1-]SL\U@ ->J_G?*_3WO6Q1N'@_H_]F[UY:.-E?LA7 MLJ6^A11(*(]KSC$>'?)0 )D?8AA+Y?E4<.WBJ(7L3*J@]-&+0V#2.#W7V%31J_$)@NB_WK.CK&E=\+ZJ-E*\W9B"!)_J M)B!-K?+ZU^^6JR]R];WD>F.18DH2$G-(L< 0D8Q!PA&'>9ZFJ""QBIE5(5.O MV:=&('_(JMY#: +A38))T\4$E+7D9@^BGX6%;/+C?I3K;T#;F#*WAFNU- MX8&G#9N7W+A=5G4=&W,;6YE/MMC5/G)L!^NTIG9$-=A*#M=R@D1 TDH-& M])MMHX3F'TTIB$Z!@'U3?7 +VO+428!QNY7Z8'/4:-1K$,_LQ]-1<=I<^S_+ M;4LZE9.DH$D.58XBB'*LB1/E!')%L=2JT"Z'3P[ACHND9V]#<@\@,38&C0W;,?_: +F@SI*,*XN9%^^!RE2GH. M$]BK]57^O7ZCU?O+1-J@A#("F?.\_,#?B]DFHS!Q_*[Z[G!1;K<:6CRPOCUW5T MU6V!@1$XZ@FD4=]=NUFFXNXY0L'9W'=_IG]K=4N#[A9Z@]?947Y>W M2M5U]62U]W!YF?)95D7%/THUW>;U4K//D-%(K*8YY#&4692&$S?8:Y_BHL<)T5> MX%2YF61]TTW/&-N&!*RVXKK15B^Z=BP5"K&!26D+U4[.&T"5_OZ V_E\^:,^ M.C$NL[N5%.4:F)R<&]#J$8Z;;- *246]\XW*/#::OR0:JWL\XH'?E0N]WN7B M83?PVXV\7[R5C_IK97J(+(04S=],J/)OY:)\W#S.B5^&VTE',*.1UB1D>*0!UP9 MM]CD*R'M#5;V'7N\Z.4KM3\(9[YVK, .R:VCG\6IE 2E,$5U@:>"0D;UMPDA MFM*$*VT:.U44N#CCU+X\%[QEGN M.AJQO_'*3E)UMP]SY+(7/GRBYX>^X.-RL3IH ?)'UW/BJ^3?%N7_;/;]7S@2 M>8(D@TF<)Z9%1P0Q2B@L"IZP-*<9BIS.D8<6>&K,M^LVU/42JE_4MEN0>7NW MVH"=.E>X-P=_(NPX=4KK/+2)/^ 2^[>&&ACW07I"#27SZS2#&G@%SG:!&GI> M[\80RR[%I2GXU74*CO5WA$41A3%6VB9.,PEQ)A1,?:*EWZW?TJ=0OR$SF MHL Q55"DG$ DN#9!"R1A%J&,*(ZRA#K513\SS]0LQYV8X$G+"4U,=R.IX\'1 M&5@MSXRN!VOHXZ(=3D9$C*B>[1-Z(+;CB<# #Y@6B8I3R2"*XTP; M&C&".$88RB3*]9:D$!ES.LRSF'-JQ& DU?L1^+1:/NAQ?8V.'I =C8XPT(UG M=!AYS4:EE7@,J^,R1,-T?SH_[2NU@[J(P_G^4)=O]:4=(94V:=;2Y-^80 7] MW)2F.%#MRC5]J=9R<:_T?/.Z[<^R*=;V9E.5"RW+[_K664+C2!6)A((4RB3( M"T@8SF">I"E+F$28.$;8AA#+Y?T;)Q+W;5D]+2OC>%4F!*Y5"=!:)U0Y*B+*(\K)\[4+,S] MW-5.G[:Q4ZL1V*I4'['75_E7.I M!5G46WP914JE>C&%WN)S2B"A@D,L%$]HD4<)L7+W^8LP-3[N1 55(ZLQQ!ZW MTCJD*/@M2#^OC@/SP%QZH>W&=@%:+<#7)?AMO 5PR! 9?"%&R@\99D'<4D.N MPK(W,<1OY/'20J[2_" IY+J1?%-"I(G9:.-BNA+/S3>MR]G%7+"BP#F,(IJ8 M'KDY9!E6D"!*TSR.18J06U+(Q3DG]U5I1*[VRM;[N&%LT+:SS -C./ GHY46 MM.+N59GO7"C!DZ(= J;#G)YVI$30JQQ.$X)L;_5TS-A:H&^,?V8-->96>HO MY>UJI1^>.C;]S?/NDI8$;W_0E;A_,A=6O^H+3;V(IISAKZME5PH"]@SVKVN5!+66-Z#5\P8TFM;G>FV9UUK; M@+Z-X98BJ,-C #'']8(,A_.1:V3 J3S\)7=TL:#Z[9K?+NC\>5WRZL-:M($[ M6$6,9(3!'.781#\4D$9"P"*/$TRQ^=,JUO+21%/C\:VH#KOL/APMG!F!T!F8 M.[=2@JV80,OYC\N14&Z .3@? @$WDHOA'("!O <68/3Z"/KN'\\38*'%P7[? MYOJ@#0MJ?J[J?VQ)^9>_Y8J7FK!G*,E%DJ(88L(RB/*<0AQ%'!8HDK'(F91V M?4K]19@:F[;R =D)>(5-[+X>"D4,2Q7IS4L>0R14!FE14,@E890RI*3,9POY M4)\9O_JRD&99CN09;G4Z^<+L6=S7QW)+,NA;\+]HQ]'IM[?I&+Q_A 7*(S21 MZ)-B"ITD+%"R;"=A,Y+?]\P\?2OY33^ Y7?99'+648U?Z=^WZ_6J9)NU.7_] MNORHH5@NUAJ6>9WSJ;\3LEK/LB)F6*!<+QU!$/$H@1B1 L99J@K%"";4*1+Z M2GFF]J734L(],>MZ>T9.1^_VM:MD1ZDC8C_TKF1?DVVNN"D2^O,VSEIK=0/V M]3+GV8>:@4ZU<(0:"..0['JM2*-2;2#\7O)NJ&$]W"VW\Z/TO<6"=W M^M.B/RMRP9\_;LR8]^K3G&JCL52JFB&2L"A-"<093B"*)(6XD!S*C) <*/SN7S0F^+:)_%M.=(KH3.)RQ:XU-2'/V\J2C&JS6&+PT2>UO].0;6552WG=5G#Y(6LG/CNO#=&<4X8PR@OLY+:^,-_4N&8K*)@;26^ M_'MMM@?+15TD'_RT>=(;1D=OZ"7,+2DG'))#$TXMJ7%6=F!^:,!LQ:UKJ0?D M&SM@@K+-A2G'Y1H[_8^8QO(VSY)N!S&8+*,%8AF"2J@(HJQ((4ZD@AD5:21S M+"3E+H4>_6-;1RONR!OAO,):?0)8IQJJ.EA ZN"AIZ\89&H53AHB<%3(AVZJ&2Z*E,0Y@B*/.41,$4A0FL-(:0,A58S)W,JE M7[_S%X4=Y_6V5[)C ^GH/!_6GE92/3^ORN_QI;IN:FUG+ 5%#22.K@5ST"9 MJRR-5*RI%4TG.(P6?NOKP1F8/H]Q M\7%?GP'(P8-]/5 C.;%] '-S9/=#T>O+/G/K>.[L?MD//-H7+O6L^"]_M%TA M32R+GD;_R.OP)I/I?_?-!#N9KK1[UY0+7C[-9;5MX!2E.,]S)6",(P%1(G)( M69'#)$F+)!9%RA!U<40%D&EJ;*I5 CMYP:%2=4Y@JY:)$3NXL-/,NP%7B!6V MV]>.O&X#$_TX2^;>_2 ;RC^5<[YCGY?JYQD'J"'@1-*(0G7;N)1>=()BY?TYG:SK\MFW03 FP"D61".L^V)]@9$? "=V.M_2G+O(XJ_O%)*0\ MK4H3P-,\$:;K^,*< SY7:_G8?MRR1.G]=!'#+"ZDZ5^20\IQ!)$>D7)*.4+" M^L#);L[)612?/X%&/H=S%4MX+0ZBPH,V_+E^*S#H) :=R"V0/B=5EH@ZG%R% M1W:DDRP+A .=:+E!U'O"93G4>"=>;KH=G( YWNJ=-JH@@RI"$9",*K2-.9IYM:TY6B.Z851U!GM?LULCQ%D*D5Z2\RAY"2' M2-NLD&9I!H6(TD2)E*@B0CW5/(7Z%GZ4*_!9&@W9PN' M$6Z [>M9U0-G8;^89.R\ZM,ZGLB4/G.AYW9SN99-U7^ZJ#Y++LOO9INA+>(N MZEDB09."Y;#@:0R10A1BDA#(<$%3&16(NQ5)OCCCY-[V-I:RCNA;FF9(8&YD M!ZNM\(Z[U8N8JXA(E4@$,TVA$#&"(5%1!AFA*1%YRA*%G+;]03$?/71_1.0M M?0#,S"/O,@?&B3\J1>#P5**7B=$J5?7WA2C0&%$ M[\XW[[M]-%_E[9*_G]+NGJGKYTEBB4YRQGD*"\@BK""E*8*"IRBA%(4 M9]*I#+V?&%-CC21*,C>N\(3?CDR&!W5XJ\5T)OUPKC/IOA9=]XT;8!0!1I-P ME'0=DB$YRU.244GM.K1>LMZ5H_D6@ED\?#W9K$C/N:F[!N4HHIKV&".)MHHB M#)G,*,PY37'.B$")5;J0[813H[I&*K,9XUM)78N_7(#8CN1" C=5A.Z1RV[,K! M#"-763FEW7%1E9-7^;VU79W1)DBD-3<^+A?+KF;+1[F>\5AD49P1F"M*(RH0$IPM.P"4DBRMIIW5 IW0>(EL3O=.W+SQ@_E0KY?R\=J)E!!XUC;=%%D#+M, M*$@346BN$E1O&)7 Q.G0]'J1IO:IN+H'!_C3Z 9JY1PMR0 +;,>+XR[;P*PY MTHJ-UY+Q".1)=&#<2?6_H^'B$8K!^BL>CQS:H_?5'*+.DH@6"F,,4YISB'"D M=^&Q*B I,LZ26%N4F9/E?F&^J3%QKV\*_%G+[+I5OX#XM?X]9QQ?T[UW$<* M[KT#8,;Q[C533L2Y=Z"_O6_O\#8_EOF%KDRLLDEC[>BLY+<+\;:<;]:R:3'^ MMJSX?&ERR'9^+)4AC#A&,"DR!!'!FG@B34%%G(N<<2PCZ11DX2G'U%CI7]*4 M03(II]^U8?\@P6);*WVY65=KNJASWBN/&%S?E;)CK1'P'YC-.@U,V8'&FKL! MM19UH8)6CQM0:P+V5!G$F7DEG"$YT%>44;GQ2KQ>MN;;+,-%F6AJI*$L*SA1S"H7=#3TUCYY)_"Q;A]3<)'ZZL=H> M9HRHO* HTILPQ"!"*H9RK/(Z>N@)Z8C5)Y;=V"U4+GC9D=N?LA M,3!?'V4,[Q>%^=3&3H_>:N\8JI!L_2BJDW*%I02X(X"V0_*X2 9V J\$#&F@,NJ=_SXNM;]UYZ_;>7+_S9 ML4=YRR]IUKW:%Z]S?Y]OE2KG)=7[K:;)0)LY7.11FF0BAY$VZ2'"2FDS7R&H M&(TQIDE"4BO/T?DIIO9.[Z0$C9CVK_(9#"^_S-F;\J7%D:RC4,H).2-=>:H<( M]A-9 %R&/O5R@L2C7]I)Q:]NDW8XZLC=T4ZJ=-P4[?1E'O45ORZ??G]J^N.\ M*_^6HB[ VEKRN$A4D _;X%#():U+8.LT<) MQ3[,'.HF!L)NI&*)5V'H5BW1 IC>$HE]]X]7%]%"BX-BB#;7NSN23#?*.N3R M"Y<+NBJ7M4.S$(SAK&X*S2.(%)>093R%&4]$3GC,$I3;^I%.SC URNQD<_8' MG\;OL@_I:E0&ID1;0)S\1KU*7^LV.CWX:%ZC7MWVG4;]%_K7,&WB%NN.4]OC MHU)6NU"FIG,&-56K$&("I21R2NIP%V%JW&=D[8+E5EMYP7(!UJW$KL4TG1?% MTMD]*-1#>[EWPH,]Z6] W_C^/Y\ /_72_![U-KT13!L\4UG*4:NQNF+TG%Y M3N^1_%/:UB=369HN:C.6Q0IQGD-*DMRD'2.(8YI!3.(XSC-FDI!=<]KZ)IP: MV7V6E=2H?@-JTR2*/-5BNJ>Q]:)LQV.QA_:NS1G@75,H).2-?CL4,$;8_'O'$9YWC,$A*/X[&3BE]] M/'8XZLC'8R=5.CX>.WV9Q_'8K]JX6$OQV236Q^T1A&*2QJF)^,5)#%&6,T@4 M2R"+"Y:2-,5%;+4/.C?!U%[=>[Y>FCQ1O#T*2_ -T,^'97G>LT!:G']="<_ M;W K':C% ['/6=1?:%S>:_JZ!]MSJCEZM$TJ?A-\V2UUONL^M2%*"YIEF=0<=.W*\UR2&*2 M0RD8$WG.<(KLB?:,F=<+(L7I D]M:;Y9 M4G"42R&@2)@IA8*XKVU-2X*J2WZYNVTW7>"-@ R GB()V!+*;>=P604YH'/4, MZ6N\?A[9%-9!06,92;]1S30G:0$$09Q)!EB9% M1$E>)&X]+WIGFQHWM,*"6MK]^ #/ZB7]4-L11S !R:/*[!SY@\K3$)R2/^$ MH_*(E>XON<3N)L]@AY*RMPR[HT9BMW?192_!/(6G['*(A+ M\-O13$A0!V::#R^0_*4?-?>P!TLH@H8]7)ISW+ '2P2.PAYL[_,->[@50C]) MU9W^\7[U=?EC8>HFD3AF'"K.!$0Y3R$1,8:<91'&.!/Z#[?0AZ,YIF:EM&?] MK9PWP$BJ<01&5M]65O_RLC9C/9?574Y-@F[SS_E$_!^V?]^KN MF_& O5_<-I6I_Z"KTA0M,/?>+P[[T\RX2'&,50*%R%)MFN08,HQRF$E,]4:( M(<+MLY)'%7UJI-2H4+<=K94 Y6);&_Q[JP=H? NTOYWF:S\3-N>G4UWIH3W. M.[U!I[@Y/MQV[#+R Z-\5TIFJSYH-+]I_VON:C#05X(6!=#!T(QSOP O6H%- M]IEQ.2B>ZK,SUI'S5)\AQ^/LUUC&_H/Q424:\8C]-9 ^/*Q_%0E\FZ%^UT/5 M!]AZNH6X%=]-9$'U=;DMD%?=KM_1,J8VV4T<;-VM@- *U M2N!/HQ1HM7)T'E^QDG8NGW'69V"39.BE\>@C>BVJ8;N+>DLSF+R_5ES7X_@>D&U/Y,- -_BA_#YJGVO4/EU&S>-, M_C(<88_E>^8;^63^LN;'A_,6]W@&;G)N_"/5QZ5FJ ]+NC"^]'?E0K-7N7CX M++DLOQOC\O>JHZ8CFE0D6%1#!6.(6(%#ED@F8PQ3S#.941R9S:U5TC MS-3X9R2K=OXAEV:]3M9'T&:?WM?51MC^=TMJW4URQFFA)(")G7")-J(W33O-!9WTX*X7;6>B]$(M)#.Z"3 J%7IA M\Y+[_ 8)T76NU-O9NF.W*&),&<]AIC(.D9("$I(I*/-,6W]8JH)9U0CMGV9J M!MV+IFDF'LBS'_I)4.U(Z7JH!F8?#Y2N["GW$H3AVLEM9WK%3G(OM>UO(G=T MM1\/W#])L_=NDD%;@<,QAC4U($KD\Z:A\8HW!2VJQO]&394S_\%_E0L\RKUWHC^6B MK&JOUW?995=FA$0Y,D4>>,PTT1 ."9<*"AD)'+,D30HGE[;-I%.S1&J9'WNMBQUY#8WVP&3F#[0SBUV#5$A6\Y)C M5):[!JF7K'?56%=N[EI2K;8="7"L2(0$@S11VM9*$_V3D@74?\M2P27AL567 M\(LS38W/=ML2V4KJN94[@M1Q"W<-4*-MW3HA!VG=Q5>^FJF=\O/LOO=+YI(M$3+..$1AP6!>,081%#A@F& M1- L48KS7&8.IUU^4DSTN*OVB_[TH"7^V93Y7^T$=DDS<%Z2?KX9$.&)%"7: M;[1POP"?1X+=)4-C2/C'RK(88!D<$R1\4>Q/=<1$!5^-#Y,-O$?Q#E>M MEO-2U&-]TC_QYZ_R[_4;K=9?,Y+P)&69@AF5>FN=%Q02PAA4/.,L19Q1MY2 MOLFF9G+J-2@KD]!X(+1SF.IY<.TLSU"0#@$90\&?[7R,QJ$4.6D7J M,C*!(U;/SS=VQ.I%S4]$K%Z^Q[TNP]OV>_:NK#B=_[>DJW?Z-]4L)FD<\YQ" MRAF&2) "TH*:N%0I:,(+).WJR_7,,37"Z,0$C9S " IJ2>VK,IR#LY\K H$T M,$5XX.-4D^$" E?49#@W\F@U&2ZHME^3X=*E?E;"7KWBCQM3A$[_Q1@JU?NZ M=NO[Q5Y5J9E^MV-#(?_R;%IIZN*<+Y63XM M5\:U]WY1UVTW<[QY;O^QB1Q,$ZPB&4LHDXQH J1Z*YX7$8R3/$KRE$51YE1< MUT.&R?%@JT+]!K:%9;=:@#TU;@![WE[A%<[ILV*65#CL.@S-B(,L@3LS^H,8 ME" ]Q!B7)_UQ.J++*X;R.*2(D1%P)2!@FD*11 MA/*(2T*L'$R.\TZ-'7?6R9X5:+EM=(7SK9U;<._5_J\' M?A MF&$8D$QWZMU?U=99( MD3/"$8R$R3_/)#&6KX0%8ASAR!B^3L' )V>9&GOOA-RO\NR:+WD*3CNS]&J0 MAG;\[?#9QJB'S&_LT3YL'N.IB4;.5^S1]3@OL>]BS]WPAE7R?S;Z _/+=U-: M9W>:Q64>(YP3B%/,($(:/ZJD@FF2RSR3-,ND=-KSGIMI:F__3E#02.JX6SV+ MJ.6>- 1.0^\\7T*D=Y5#G A>Q"+H!O+L9.-N$R_I?+09O'B#9R !K;Z]FR]_ M?-D\/G*65 "4<$S2+B( M8%:D*$]EE.:1593]^2FF1D6_T6<0IZ#N0Q/_$R3%#=#/6N[9>WZ'I(6OZ6I\ M!J:4PW[S6L++_?!LT7%P%EV-TDA^H2.T GE^>O7O=?*NF_XK M?B7#S\NER*'^5@ MEAG\M)4:=&*?CV/QJ+#L@E/8:LI6,X]<.=D%C>,JR4YW^Y'0NW)1KN6'\KN) MS#B8[_=*JLW\0ZGDC$M!VC.:;]=U/[]Y-G>SWV?[?W=^]ON;:,-W7Y MOBZ_9B^[QM3P*ZNG947G]ZJN@+%76/X3-45V&D.MM>GC+-/V)R%01K& B H) MJ1(""A6E/"*J*"BV*[LUC( NK^4X-;H^RC78+%:2SLM_Z_?SH4Y,F]>):8=I MF76I&-'J:F(EEG4AF7*GKL..+/S*6^QU7W4U!R99H]L-V--N/\7P9C_!$-R: MDJ?=.MXKT!0$VE/T!C2J;K?:/GON\"OLL%]_U94>::\_Z(H'\AL,M@Z]/H?P MLX[GKQ@,L0-?QW"SN%D!U6H]^U"NV_*0=[2JJY(W?=%GDA0I)H) P80RU580 MI$E!((UBGJ6\D"BW.M+NFV1J6Y"=G.9$2H(_&S$MB;<7SOX/9"B0!O[,.>-C MS5[L$_;>7.X3>\4?A%QL-.Y:PNM;/'7$Z1.[-LYF@R0:0F!59 M@2.8FV-JE,;ZQ4EVN#SIJ#X':PQ>.ASL;PS4'&YWHKT+SY TIYSGF2FX M$4%$9 IQE"JH,$EC247"1'15D[@3DTZ-@=IF)'J[\'Y1K5<;A_V]$]9VC!,: MP8%)Y[AGW%X$S% !, X0#=I'[M2\K]M/K@>)BWWE^NX-:?Y\*!?R_5H^5C.5 M%E(JFD)1" Q1+ 3$&RH(GJ=.)K\6D4V.;74-J MXS!M174\U[7!VO)<-S""0Y_KG@(OH ?9!Y:@9[DV\XY[ENN Q-%9KLN]'F>Y MC@V_[[Z9.+OJ[49^7=[5W5)XPX3SYG@G%2S#(L^AT/^!*!4)I#).()<1B])( M"(ZMG+\#R#8U$OM%* M8GK_7!^_=;J!KTNPT^X&W*[!/H^V.@*MI+FR4Q/LZ?EZ2^IP /MZ2SO2Z>OK M++';Z>LPB]![]!IXRO'.78?!ZN#0=: I_+8(M_/Y\H>9_MUR]7:Y86NUF7== MI'<]HN_:1GM1G) \R1'D1,40%32')(HX9(7^#*LD)@FV#*ORFG]Z45.M8'4[ M#&YB+_A*BG(-3."48TM[IX6PVT@,!N[ W\U.1K 34M-GIXPQ;L!=@[.)5KAI MN3-@.T0OX(*VL7<28-R^]3[8'#6J]QKDVM*!MXMU*/39MUU$J*KA=X359_DJBYKN#NNB(2B5#^[4,1,[TI(&D-*"[TK MP4E69"J/J'"KLA!YZ:VY0?];6S?T?K.N MUG0AG/TT SP-=F3\NFL\,&-?O;R=DB:]HEGC]DA^F*+UPRW&,,41@TGY2K43 M0Z-\OK1B\)E\\AGF3*[6O])'TQ.X_)_-T?Y.2+M$\@^%^%A1^B[(AXJZ]\&L M/Z+>:<01H^5]-#V,A/<:P=/G\H.NA EEJ_OSRJR($X53R L::_HO3-(_(9!% M,I>94H1)ZK*7.!A]<@QOA&LC+CT:(!\B9^D$\<5C:"ZVAL+=?7%*Y:#NB8,) MQG4_G-+MR+UP\B*_M_6SY.9R\?M"2RA*\YF@\T_Z*?A&*WG/YFUL?!,Y7>!( MO[QI#@O&]:ID;M4^ZLSX4V.K6D+0BNBPXSF!G,4& M\CH\!J:3 RA\=H$G,''8ZEV'S4C[.4>,W#9NYQ'HW9V=N&V\+=AYF0_V63V7 M^9EG=4[RQ^5BV;5Z?Z^I\E&V#=]G1<82'JL=>TY\2__LRG7S[_)];>EV(O6:;.2%9;Z_WIW1Y6V MB_*$0!+E&KZ*0M56U6\U/A2IXJCZWW]JGJTC:S,D?PO?^MOUH+. M[S;56G_/5]7M0GQ8FI.8[U(T)5$_;!,U,Y&A-"E2B..4FV[6!23,Y.53(DU5 M>)7E3LVM? 69VB>YTZ.)K^DT 5M5ZH-THTQ;@K-1YXJ,6N\5M'7&#K\N@SMF MAUL2#T_M=7B&]=IZRC*R!_.YY./5ZVHG)=W2R'U@%SOD_2VZ?9A M)9O,O]8]ER=)HDS041(7B>94BB'F:009*U3..9)Q).S3[&RFG!I[MD*#6FJ7 MW"HK?"UM?IL55&2)S'$A($XE@H@F&.IG2T"&8LDRGN62I[.GNG[]ES5= MK>WLXT#2N;QB+V4<[BU[0^=U3A&MC,/E_]#%QM1+B4WCI21R[1T;9A43H7": MYS'$&8DAPEQ!5M (%H2G-$TI23EK5_$7;3-,>PT["4=;P/ MG<@.?HS+,%OXA(*"-S KM;*"5M@ZMVDK+FCE#0J@@Q,H*) C.8"N ]3-\V.- M3Z_7Y_(HXWE\K#4Z\/;8W^59]5>NFY E4[CD=KU>E6RS-M$ 7Y=FZN5BK16< MUX%-FNMDM9ZE&:$R27*8$F;"L"F!E,01Y&E"$Z_918%\!L%Z"0Q5 IT/ .L*^\ 6M+.PLQ+BU MAGTQ.JH^[#V09^+KKM54'& > _, MA/M0-U'A![(?LN0-,,2Y5$#K$#")UP^\H&F^CB*,FPCLA\]1JK#G,)X5V9M^ M*HN'79&S_5)H354[,Y^L9HS'J>11 1.",HA()" FBD"99IAQI>*((<=6W+9S M3X[Y#FK_>==8=$'?CN$&PG1@=MM*;5=@,6@[;E>X G?EMIY^[.;N_&C_)^T?]'+9_ MWJNFGNW[Q>UWN:(/\@^Z*HVPYM[[13=2,\(GN3)M>&994B1<[WIAGO/$E)V- M(15"P%3;@#*)45JDQ-HA^1H:3(U/&TV,R=*4A]>F(Z"--N![JPY8:7UNP%.C M@8/C[E4>$0MGZM07?F#2WU,?=/J;)M"=W,"HT70I:ZW;+0J@ >"F_:^YJX&B M+GG>/C<=<X]XO=P,UP-^#3_XY'R<&M//5':B1/]?0?+3=O^&LN:Z^#_54$ M&\]G_YJX'QP#O*H@;E:9Z="\E>%7N7Q8T:=O):?SIKARW\0(AM# 9H +.$Y-TR\J?VW7 M]/,3C-8V_:*.^WW3+U]\;9V"3RM3"&']_$FOL(EZ,^G&3V;&)D,^T^\^$@6% MJ9(<(I4S2%F10E8PJ3475"9.#B3;B:?&!YVTVDPP\M8A'5N)KZU1<&$-[-Q( M0R [,(]K%%C>[\=6INS!0J_M\X=M^F\B M"\RY+&"1,VV4,)1#PK,$"IKGN4HYP:7X_0P*_Z%IQM MKY?P/8+[00@;B7YRII&#SONT/8XO[[W:XS#H;CG7/R]-*;;O =BG$ M-X#6@IO3&-J*[N BMUX#BQ.2(9 =F%0.1-[/+;P!C=3&HWP[(*P.IP5#P#N2 MAS\,S&Y>>%>X>CWGUH.-Y^UVU>_ 0^U\UQ;R.\9BP$I^>Y.]9BF_8YTOU/([<8.'&?B!+L2;33DWS3BK??]1NW_! M*J*%2 2,$UY E&4Q) 45$!5(Q4E!J4JYM?5W8;*IL841]P9L!3YTDSK8(Y

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

    $B.AY MFRE2_TG3', ".#$ 7C+D#[M09<9E:VSM=HZ\AEXT>$N. ],EQ%A\,;JO8>?_ MGFF:>X%XW#3-?1#U[['?UED!*1AIN6:UOT,")9@#[Z.%Q)3A/%NARS@SM_Z3 MIMD:YJ-EHNR#N6ZN.=NQYQ]+WMPDS25KK>9*D.2L ^6B!C*QB3NJU+82F#&, MXTT/M, 7FA'S,VW((Q"W_W[TJ_TXQ8L:*?[T L](EH+GJG8=+5C+;!,#GU.& MZO%ZQI6/FK^L'?GOG*W9YY8\!G,_0;8FLT)%)4Q->J(_ZJV_ST6"T8QK3"IB MN==G^3_9FD.Y9*>6WT^5(B14$L)H#5H&1F=GJE-JH@,LMC"FE2ZI223OWSY? M* N5SA!#I*X)68)P5+7 WHV#O5[_/.-C<&C=;\E9 ML*@R&-1DI0>FP16=@?1^)-9;LM_]2S_X!Q_'\+,<_/L(_Z7E!C^\JG\;B#%7 MDV\X:$[P#N]IE@N\[QK[R '.VAFEO(586*QUF[+&! QP9CP&5V@;M/$U?I(< MX"28M2QR**A4;.4..K':T)/(?- O"DD?[GQS@(P&P?V05$7-](GS+],.A9;&Y0Y2WJ/9X28 MA8;"&7?(7 BQK^J3)OE,/:=Q]+G#CL%1OR/0?@WSZ61ZL;B<+>K$^B5O#HEP M/_J<@2+8S],X4(1Z\Z+-2VZB=P6#9:8D8%8X0J27X.HE3/0J>FF-E6VRDK<1 M=*RVO?_<3\3 5_0+?YX3=I5&5;MN(:.5Q@#.U;&7(87HG:TYL:=8Z0U%X]H+ M@R#BOHX:AOLO2Z>%I#_?(8O:VU3 Q(AT:N:;F9C#8;Z,@S$B$4 MDY74]8:WR4#X5EKFUE>]_P8Z?2?I;)I_F5Q>U_R&RNS;7:"2J&4Q"8)3IHY; MU^ D%H@RHLV&?B(:=ZO9B]Y.-=0^:-I^X]1.37)=TN0;?L1T M/5_FF_WZKW1Y31O^-^)Z-2>O5V)]R)5;#NC@LD>-(&2-#VJ?P7LN(%IK!#I6 M6&D3UQI\*>.Z$8UA/8J\7]:)O6'6[&;U;^[\](ADF,-?UO"\/V"UKT^@A"&7!1F2>1:.+83^'.; ^3%Y]ITWW939]?1D6BU60.A:M)->9 MS& =01GZ:IECSJQ.Q7#4@K496;4_K9V: ?N@:'!T%Y"1Y5HD8:YO,T_J!BLXO$YN#8C:4A#J UZ_D.\R^(RY'&:_N7-8+ M2:Z@4[* <3*!*HZ#EZI +#Z+P&VQLHTAO(VBSF_83@V[8237 02?GJ>=O"A9 M& $"0PT_* 9.Q0(!8L^,@\6&E3\<(&]F0/K$% M,ZB8.C!DWN+5[],T^X+UUN[L6YA<+A,39BNF+7V!S[-+DN%BO=*;^Q$5C+X MRGU?%Y\MWEU?+:["-)-"6"U.DXCE[*(YVFY*2-EI6 H)57".9YC'&4QB:NV.N MF74Y#N:.%TL7'LVN6V?-NML^,4M[Z(:31I/2=TH!9IUJFW$/WO $/AB-*6B> M>9-PVC#D]Y4,.JC1.8)\.]"9^YHMOM@2G)<@E=6@@M?@Z@D16/912.&9:*)- M7Y0%.@:4CC1']Y%K%^KXEP=9V^>*L110,?!:RAHCC1"$CE!4L9 M63JUP48TM5VV5<1C+55NTB-UL!6,:[1V@.9QL'#X)IA=AFYR4;M+];'BO?_"6OQV!N9U,.]#:M$WGRX2C<'EG$R[. MKJ[FDWA]M=J>#S.1[B0JG9<@M9)"@@NT;%6" 8]%@PNWU\Q]P/1S[E+161,E \[+9)FK ML^Q.4L6[CT_G?F(8#B&G 0-A)R[E?[KO0?FQ[\%LZ^9L5OT_,'TG:1C0DJ>M M>PSDS(J6*($K0[9!*AY"L!F"2U99D8.*^A3::?@> \=V^%BFV.GB$$FU@,B" MO. H(T0RF8!A#BD7GZ1M/#-CB&7TE3%V$/;:=7+96\X=F,A'KOG5]\U06AR_#D;_-FW] BR M0X4Y:\'9L2'R?H[XY6MET _E0L70XGT1X)T,H*Q&\(JX@QQMJL<#!K$3.!Y_ M_KCI#>U@,0 WQP;$I]G7/]:E8[]-_H7Y_7R2< -L+;D.64+@'$%Q;4BQV@@Y MA&RM,)I0OFL-WK:7C)LKT X:0_&U(WS\/S:NAT@CN5C!][1]HX^QBJAA;20A:2%>%'=SQ2A)!$4 MN:7%F38]RH_JQ=3L:K@)BH:50@=P^G$O&*]TD,Q!$DA^'DL"0N2T%EULD([. M4=DDYKR_\FEV'=L4-H=SNP.H/-W R86 01HRP5.HQ4.L0"A9@8F$?.$$+VUZ MTAS?@JO9E6I3* TGC0Z@=63LZLU-M5$H/F?%/+F$1:^JC8+7%IQFDKLD?;G? MUJ:+$/F;WB98OO1X^&&(>/D[X>S+['IZ=8Z*J5Q9[0SG9--B[=,G,Y#=[Z5# MD11O8@H.0GV/$<[6P!L6_0>@H-\!&!_P,ES5S.#YU?=/9#TM0EKF489I?A4N MPS0=-KMJE\<.E*.R]PH&2BW9]M[;@2W9968<@F-"$40Y60G&B3KJ6BOTD9S? M)CD4SQ%VO*7Z^/-OD]9NI\1$%7104@/3N1 /)(>8>8# 0]".ETCVV2EY\ B- MXRK$05'TT(IM(ZD7K>1:>P)MI$3E46D="IEN@D;TL; MF4T./&7](G7_L@:WN27"OIC>C++.97YZ^K!8KSKY7X&O%8II%D9X7D18%SJ31I_NHVT9 +]EFS60^&U (P/H WZ]GJ?/ M88%G%S4'@!A\?TF;*!HM0V2C@1Y ;HXQM"@Z$ &U"54[4S4. MU(81_*RU%/JX3OU;-61^GZ;_6L=,N7!")4;^L6<6%"-?W3.F(+(HM+99R/NS M3)Z\4+WW^/$ T4B&#^]5CV%H'Y!X/YE.0[K$-V]>;Q81,K,".5%M0R:OHP91 M,AK(,B2=I?<%RQZH>/B&<4*^)P7&D6SM("R[Y<1>ZE:=N&"JCAA8ZM8B-'@4 M-8L %9=&VEB:S,1^@J9>KA%:&SI#BZ=?I*TW(N;$I"Z!?(Y$/D=M6Q--TN , M<<@[';@[9;2JA[SWP62_&Z8.$,389]MKVG'7EU>3Z<5'G'^;I)NT:L.M#"5Y M$*YVDJ&-!P$YAY)%)MV<4=QO-['E;-OVABZ1<8@$9T.SJ S M/H(U*BB%3CH1HZ<(E)T,H&.#-QMZUCO<"ZM)=_#@=(Z@')>U[9J M%HSC-GO'8BZ[-*O9"9I/DS)>J.!T4)@UD/QY:AA3<;% NCHB#C)/S-W@1+G^=7A%WECO# M)".L%QZTSL0);05$*Q4XJU5(4CJKY$/5LMCHE@6F_[J8??MO>O1*M= 7][7* M(Z\=MZKG=&?8L1P?&2PKJM=[AK#M@[41N/=D9J(OX(M%P$)0UUH6;X= RMUW MCJ,_CA;:; .CGU]JRDA@+;%ANB#D2KL=%QT= ]Q MG)B>OVK8AV?]!OGNJ<3EIK"J,!MY!"WJ*:K(/8RJ"$@J%H>,HWCL[&B7O_*0 MQ'&+!;L)-A\KO,Y@N=FG/F6FBZ*=)#4HHPSXK!F@]A&EL5:9YO#K.,I\M-"? MP-8!$AC9PSXK97(YJ0M8Z?JUBN9NC[C!!=0"\QZ-:[_Z:TAL^3[Z^QWFJ KW \^Q%2BY(R+84 MVE$^DD&9=9WNG82W-B71IIA^5PK[46G' ^-^<7T3*74Q(FL+WW[]UU><+G Y MR.;N?O[GY.KSW7]R[I//1F9;KXCJ/5$=^J@EL;6P8!"E#Z+)M.$CZ>[R9F\8 ML)Y2HAUHT+.4:HK8XGWX7D^7.TN9X.+U];S*XSR(D'G,M(A5NS:G(&@NEMUD M92DE9-;$:=B%N'%O]II"<7#9=("W+0S;W*HO]]^C4?\.ML7I.D;NJEI#!2*\7 ZA! )<'!^Y0@E:Q\\#Q% MW"4,L'_MV1:"CJ[ N_?8$FT>])H<\R S>),8>!:Y]E9YQ]TIUMQ= M5?$@*'E053>P1%Z2KEDZ^P?5#&]]5C.]\QBMK;6/9@491H2H>7^#:?76(V]7VEOSZ?A\O7UXFKVI0XX M__XWG%W,P]?/DW0VQ[!8:H3;I>:8F;:605KVY'2B@$N2@XV.U180L;!&1OS! M-(]<28 =@?3.;7KR9?,-\MEC@U;.KLYX.3\82!&_(B5:"'*.4:S_Z M>GOC,C>AB1+=C\R1DYA;0+*AG%Z2L?>V]A&MS<&.:!6SPU.;&8!/T]_:%,08 M;')%@Y>%@[*) "$E':F9T2EJ@HG89)QT)Z;@JC>CHQ5KKT&S.E.QT/8(@:B6 MS,H0E$ZF-+G?.H#63DW ?5!TI FXM\0Z.%%?SZ;UEFZ^7,J'R>+/5]\_T3]= M9L@$I[D.B0/+M36B0@$Q^ PN&^,Y:6FOFT1%GJ"IE]8PC? P:R.<'G%6%[(I MVO,BYA@RH'!U8P9#)[_59(0F*93.SJAX$IS=TC0NS@:3^W-X.E (/>!I[>$\ M6-*F#*4@9XD)T)K7^]J:W6>D@R)D"5&((F*3U*1GZ.H,5X?*_SZN!A1&#]AZ MN/U>X31]_A+F?R[WH./2Y^(]<*R7LSDA>%,2%!N$TS61W3:QRIXCK)=^(J.= MCH>+J4O8;5:SWJ+D):=@R'9EI3;CT5F!2^@AH136"%TR;^(0/4=89TKM*!@\ MB[$C9-(!QN[$"FEI2P^IICIM%/BFZY-&H:Q1(!VO+7P=V1A&T$VD8T?:$'(#U(P.GUJ?75BQWUK#97YPI9G0$LAH5 M*)/K<-$@@:48,;/@'HSB/!P_6ZD8KYC_6+'.AN;QV,6YO\VNYS\R9:TF8W$Z MNJ# %.-K,\0$(2L&QK&,4<6'/;2WU.=N>\-X(!A(C-2U_IA%6HRCQ61/NI0'7\)NH[^?>],X MV!A0DK-6;!T;(V>71/'5W\*72;VBK,LZF^;783H-<;)X/?OR9;)83&[&1+K$ M;:T$A6Q%!,4S(UN+]A/W!:4GVRMYMQ-@]GKM.'Y\(_2T8_C84'I'0IE/9INU M?%A>DKZ>S.B=L( M/ U8/#9J/L[2!*_P_[O&B&DV6> OUYOE;<*E60I9\RU$4,M24$4F?W9@C;1) M9!NUV$WI//NJ<:H;&F%E6,:.#9-W4_R!/>LE%"G0$+8A&-U.6]@TP[ PK%1\.FOV:.;).=IMO!7 M+"6N4>X&@RTO&.<0:82#(9C80>SV(PE@V?W_U?5B,L7%8ATG6D4!JF!9C F2 M=%6W$:IC8*+V-(G:6&<*;]+>_DFJ>NEM=YH+J>$$U /:5K1O]I[D(N4LH>14 MLZA(77JED>PM)V/RP8K[?M"@N7@]W#,-*-W'ZZ$.8/78QU,=9UXGFQ-G-NQ8 MZU:E%6=>!\A>2%+6S@,MK(#'5&HZ@!9FM^YX6U_11;[A(3*;#<[ L6%0A]R_ M*_^2<4;'M#%^4G0&,G-2IZRU\VU&6^Y 7"\M$D]DK@PM MK@X@^/:Z;IS:>:LNJK)HU'9Q<'9#GOM)-9)?[(G$X5^GZ;+ZURK M8!8+>7) 8'91B:<_5+H,AUS[]9+9PA8G9^W>?)TGJ>HS6OBHB M!P=G:^EUH#$?I,G==@/DYX&HCTP@<%?(:$%FR4:V :(E>P6MLRA.D\=ZAZB1 M(U6M(3>8/%Y2^>W&H)YM#.I?PE48M!3WR3=\DRNAC=>2 M(4*)?-FYNPX\+8F6HJ-DFLED=\LS>.SIHXO_6(G-AF1?+_+_]5_+4WF3)!%H M']B<%0B!M"FT"[41HP%D)M7:H\CR;K.%'W_^> E'#3%P! L[\-W7C+GERSMR M33:(5L6&K-%#"17'N1!;!/F*6O&0L[6ZQ"86_U-$C9>L-"R&!A? R-9'G< ^ MNYSDI2B6,8SE,2N50"4J\2:2,59BKC?;$5R*13L5([^?WGJXZ?$X"2^O3OY0 M W8 $70'HO4.2])XXZ2O#J.OUIJ$J.FHE1FU]84EXKUACG]&)SU;C)_'91>X.DCE50H!33X+5*(((HWA83G&R2=;"%GIYP M@'=GPG%Q#$9HDUVZE M:#RSN0F AN%\!Q!Z.DG4*I^).PR"L+RZ@YH6$S08;T-1"EU.;<+E1^=H=]42 MX1!C:'@!]8"V'_(/I43&ZHP@:A]5CQW6>2#%F@KQ00\J4L0C*UD(HJQSPE)/*F7'D]]K\O.0<[;UDMF.. M]AX,'!L&6Y.,HZXUD72N9EW;8S$ZP9V( F(*1ADE5'&[59N^A!SM@T$P"/OZ M.3*>SC01:+G-C@Y8Q@K49,S:^IT!.A,R2[0H=9(14 ?G:'=54G:4N3*TN/J& MX/OYK$RNWLP6BYOD@!R<%2YF6@VOLP%H:SE6#'B>F0V&E*PY-18?4MG%.3<@ M2'9'X9$2ZP".SV1C_OJO1[(QD16FDG2 DDM06.=T:EJLX3D5S'0@2#M"+NUC MM'8+S6.1LU]2[=%B["+O^_=IHL54GBVG_3PZ@'MQ'DPL6C,$3)&6)9B&&'D& MZ:V.RGITL4FT:B?JNK &VZG*X26T/_#\"GA3O*BS6P<"WH;XU0)_GY("IN_0 MEK5%F,* ?.=:HI@C\:KV4- F1QN+"J[)#.EM!+V TH'CX#6 '#HX=#=TK^>O MGY-^]\XBUKE/O!:$%=H0@KBC8Y:><1ERDX[J]^AX 54 QZ'G<*YWHH96"UB! M?[V,M[/I;',!]1:OZAVH4))SX*7V]^&!@_.. ZO-"$T04L4F4PEW(6[D"N-3 M 6PP^1RNJF97X7(0S/UM-LM_32XOSZ9TA%^%Z<6$G/KE7+O?OWP-DWGEZ'G MB(;1@>Y*L: 24Q!]'G1F7A,Y+;'6H//F2C:0.X5"=?D M2%$((S&$4(8G8)"AV2\).H/$O M%C0'\KJ#\^P)UISE/*E_A\N[W]Q$!",=W)FG EF0;ZN62\S$.&.34$Q%(5*; M^:<'$KQ;M)6]6 B>1) = '8UMYH<9&=*'>'#T9::?1; "6&!2R.\EBE+WL25 M7+V^V]#]@**^W[=E?[YW@)9M8=Z20FVA8(!K1L9A':8>T)# M?2&TY_&-)D_ M_])"[^WP-(1D.@#8QL<]USXDY(K33O >%+<1 HL<,&2E0W2Z49 M."D9UQ$E!^'8X&UA>+[-1S_H6OXKDUW\1)<3GFZ[M\?O?<'8Q M#U\_3]+9',.B42N?@V@X0;.?XWG3NAV0+VBLXV2V:4'P#T9"':=06Y(BDR7% M[)K,#6W?#FC-^]6E_GWFTV9],ZO#C;YA7AFPJ\2_9 K9L*L^# +)L MR?6/RD!MK 1>D:O%="ZV[%(=LE.Y[%8J>ND/[$"Q&X^ M5'S8._BX?>N(8!A&=+.C^-B!Y/_X>*X4A$I>(RPE(_BZH64VB7:!X!&' MEOP?'\LE[1/<- $HRD01R6:3I/CHV P9O(T&.'-8 M2[EU\;O- 'GLZ>.U_AE8X(.PKX.HTYZ6U9U;J:^"DGHU);CWD&+MI&T];?VL+,CH MT247?/%-PO,OKB[H-" :H$1H'XD.F)!STJ!K9?;E+;-/%6?=];4G"*T>Q('6 MT50CI,B6M'+.OO;[SQJ"H..?:>9ER=:2$O\WBJ9:RW(H*"!@++6C(H/@3 0; MA;"R5E&'T(0=/V,T=1]L#1Q-W4>.8P>]ML9V7,YDR[,$W#E9\^\X.!L$1,^2 M<8ZAR[OD.OX;1U/W@L%.T=1]9#(VL+8ZCUQYF4HB_R[J0!O3,? E"TA&!<<\ M&JT'Z^W_HJ*I>TEWIVCJ/JSN(*;V^NP>B^(Z!NO4 M(SGZ/V$T=2_1/8RF[L/'#B3_Q\=S8T(QQI+#GFK-7(P1:$,(\-IX0PJ3CNU' MU,)/&$T]1O)[\K'+:&J(++(0&%B9:?W,535H$OB0D6"-POM[*:4O/)IZD, ' M85\_,:C]PR2.V0IS#D;FVI%5<8C&(!2;G,6BN70MASW^>T53#S%E3RKA#I#\ M=C9-JVFKFQ1_3 +KM'0RYQ*=P9*4< X)D"=EG+!1\2:ATON$O- XZ%[BOS^8 M^1A9])M7^GKVYEP0*CR[C\?*.2XE:*!0H=WGD]8J3'MR?0"IXG.NU\F MBW0Y6US/\2;F(S.WPM:!H:D09%P=N.=GM MPS\1OU_1;_UYK@1+=5 *%&4TF?]90TS606%.FQR<*+S)N?@T6>/JH'8H>MCF M?3#AO @U].&7.Q_"-)]=DBT::@?]Z\O5N(3US*##+UB.>-OP2NZH]8ZB$PMY M%3(J!4'7J!(6 ^FB4$8U:5[S#%TO22ON@Z/[6G%(\8P^K.FZ=H B M#E]]?QN^K,9J!F)!E"5#YLG2B1%9[>JI02K#7-",O.Y=[C%W'-3TD(!Q<32H M=&<#LGIDJ'S KVN.G%W,<1GSO[^D=01(.ZZ2*A:$=JQ.$2K@"J\7E@F#M#$0 MOX;"S\Y4C3G!Z5C!SUI+8>S(Z=_HFQ>S5Y/97[/YGXO?I^F_-M.$E+%W2'8"K2P1\-X=S&=[E M2TR2YP*BU)8^SF*]^&)0C B)I>A]:-+T=$?Z>L7G@%AYH0IO71K"2(9U)MD#DIH!VL3KP]5[6[V0>[O"R7D_GX5'5A/T=J+?M/'QS M6RBE0A"^&*"U15 \!0B.C!ZF3.TPC'1V-&D^LP-MXS:1&\<\/$PP8ZNN[>MY M>UTWSKOR*CV8!\+GB07V4C'Z MCW!Y7>>73"ZFF,GL2<')Z, %0B0I"T!H2YT9@LBG=[ZXT,$1_(*?7DWM$ MA!XNKGX!^CY\7R8^?+R._QO3U:?9WR>7M/39M&Y!9")PSB&7&.I=#X.@HZ8% M>V>C,)K)W0H0#GK]N'UA1P+@4.+HVG,Y^U+O#,Y+D5IJ'4&X&M WQI";YP1] MM*$XPX)'=UJW9478N(/;6@&OB5@Z@=F6O83SR2R?2RMTD%*#D%S4R8<1G- M3A+9IQ\F%Y^O%I/IJWGX(78^3&[Y?N\:/K/\B+6.DE=.ZE\;+>M0)5_K3&,$ M.B%=;;=25% $:M5D\LM)\\K)'EU,\B3,O[^;/QRT@O@QU)+*CU>S].>K[P]_ M>?-KFY9T3K""]2ZSUN1KNVDM.SP;*.VUC@H:#U9Q:6.XLAT?J%7)CDKB<4M,'N'AI%[ (T& MA-DP4ND'4.MK3ND88R%S2$KE6E['(&8K0>84/-,R2]UDB.8/5(P+JH-E^3@F M#F!L!ZA8!KQ?U?MO4NMU1.R*_7^%>?Y$5D_ZC.^FN+Z]-H%EQ7T&'[6FI14/ MWGO:/=EE*41AVK7IC+<[C5T@ZA DW#_Y&HGE12#NTU^S]=*#;;"2.:.@((N+1DL JE M(?K,(#%+_\5(BVPS36D?*L>](#LIZ@X430^XNS%$[]BG2W/#JI!*[0<5,=?N MTDG5,KK:",5X'V/QL1'&ME$T]*W4V+L,S 66_; MK)6Q"1,PB;'&P#4X0Q^+=5)SG7F(36H]GB>M%U_S* S<1]:P ND 8N_GDV_A M"M]?AG0WQ340J=9I4;-FZ#3(A8-/I4")+$GN@TZN29.'Q\D9&4H#"_W!)->C M)= !CFY:\:Z4>;4#9M-E<''IF//$ [(,3&&]3;$"G.*:_'05@L? A6T3KGV* MJI&G4W=S6@XFN0Y@>&\-&]LVV)#J !O!L58#&%5GZQ5:DS"&26TXVV6:Y=[P M>Y2:D979<-*>#.Y_CCGI^C_/ED)AIPIM4NU6;%:F4LU(!,E;+ MSLBO#DS:.H =(ZGG&,.][+0M21P[O&S<5,?1#[,F,ND<8^L]* 19@R72'I21 M5N2] .]4'4$5K*#N-YYT"ZO5#(4O",48!1MM3S.Y * MUQJR=0F5I<_"#@&DD6]M.@#283P?>XS1QO7XF' :YI/94F,;E;+4.0)/@EAD M"[&(D^6'(J#VS*1L=[DKS(1O)>2=HJREED60AJLG>A6*CJ8D'6X9&=#L[D3K/PVFV,* MB]L>(99SIDF@PB6R'$E5NSJ;(RDC1 E22+-+Q'LOH/Q(PH@H&4:NCR#E""9W M$ UZ]!+IS4TM JV_2!T3>1=UVJ]W'F(]YZV2Z,F HS4U*0MZFJQQBX)&/\\: MR*X')%;J5\7$OUS/)].+50G4JM#]+?ZU_-'BW(?L8A(:M*"MI5R@_95%G8D@ M74"LLUF:I!CO1EZ'-\(' N+!%7 M_>A1C\?W],UN_BU,YLMN#N?2!+)?/ -3//%9,PD^^T ?18A!">_RO12<;6&/ M75_9R\WU8+!KR/'>>3^?)%S7-Y.AG',D-RT65^N;$X+' MVF/)I>JET8]R&@18VVGHY5KIM$@;2":C0^^9(.)\;4M5WH^!RYC2AZ2R BJ% DQU"Z>P3N%G&7.10,,/B"D%Y=Z3!@>)YT7 MT2+A4_@39W.R9H?I@O#@<<,W.GB:XE%Z&6@C$#-99#JG "H@V6;)5'?,,Z:S M-=PV*4D]:2^##YCJKL]_3--LFB=5BN%RTUGD7;R<7"PENQ[X7&)PK' (1B50 M*2J(WD;ZF&24RLH0FG!D'R)?4B^"?1#VL&-X(\%U$*_9<6U/CPMP$H/39%28 M9*IK94,=D5+J39%ELL@<19-6)$,0/_9P[E;0.@S#P\FY VP_L];;E?YM-LN+ M=_.;YNWI?ZXG\YOKK$ K8X9%,#(4,EFBJ445%FP*0J-)2K@FZ!Z&_!>![P%A M-QL= QT@O]Z(3>E7Z"S<5 8%IF1M9JQ]%%"'Z8$O=!Q*D8HGU] B-BFG?T#) MN'@< PZS(64S]DC5&LI?;DJ50H@ZUX:PCC9EM!PB.@V,T6J8)9=2#I:"=?/6 M<:].FA_6AW.X!UBLT9Q2S-(3Q29&6KAR!:*AC\7HHACSRI1=/)?=@3%V(LR! M$KLO\P/8-[+4UT'&S0Q-*5-*F@/I/P^J]KWT7B+(8I++-FF==BDJWTGN/[QY M9,D?(K?9$$P<6_KA7W<)#\[&.I77<&3UBH/\:T=+X)@SZ3ZGA1_L./CAS2.. ML1U"^@FK8&,$QS4&$U/PMDD7L7T)'?>J MO+>8P&'R>SGX//>6<5>R!6$R\;"D )['.I9(9(]>2EZ:M.39D;X7X<$?")+# M$+F7Q,:^S]QU.^/\R[MR,][Z/''CLTX,A*T-KW(J=>"] F."E\'XHN5N>1R' MO?]%>%K'@>Y4TNGY&O/.I56J@:ZG'PS6RQNW_+]YI*H%%ZP M< $Q!T(1+XQ09#,P9PSI%^X3-AIH^2@]QX\H^>&QM[=BBW,MBS)6*"B1DZ6I M(UF:!0-$I4.,/!?Z<(*5WB%I[,F)QR/BX2B20=C_0M3'4>D/CSRGA3)IF?"P M#4'6B1P,R5:D+&N+S&7JE0+AC68JABC:^#PGT2G$TY4;0MM$!XL(Y.]:4%C/ M7Q/HC^!0>9EY;).@_S@Y?>J2?9#PM"XYB.TCAXO>D&VUN619K,*EPGJGDN"0 M/3>@)"-[K90,42>N(^JO[PDDAPET-AAWN\+&)_H7FQ:)J7BC)(*5 MEOP\E 6.'E8X6Z%1\'KU M['I^]:[\&A;TZ.GFN^_*6_SK_Y_-__S'XO72%EB'5855J ,/M*FL("..UABL M(M\M%,Z8H#W%=G.E#R2@%P0=*O;9B6700>CPEG&U&<+UJM%AT25'G3UPO:QF M9[6RN XR=Y'9Q.@P;^0>/D+,V(.\!SN]!N-XAZA9;S8F?$DL$^Q+S7EGD=7) MIA%LT9P^&4F[\12XZ2$A['@Q/X.; WC> 7+>DPM*F^EV,1NU:0H/CH[Z&&P] M[TT 5XLU2I;$%J<9FB:-1+?0TQ=V#A'U_3[: _"] _@\T,>OOK\E#LWQ7;GK MB=:]QDK07ID,0J("9>D@]E@C6CR$% R7KM58XEU)'/?VM<71UD8ZW>%NO:I- M&[L0"BK:0L'7I7"GP<>(4+1(NG"="P=-AYX-ET@&\_IB6 M\&TVKQOP UY<7]9?_WZ6[NAIK0SW6B80HG9_YLF!]S%!*;AL2N;0-QDY\2QE M/4'M" P\R*8?4B =(.S!GGQSU =FQ,ND/9K^$+^$" M%Q]GUQ>?K]8-' 23LC:O*=$Q.N -!R=T[64C1-8\IG2*8_$1RCIS&YM [$AY MC'V!+J_GULC/$(>E(CSYGH'2DYVD<*!WI MPV3Q9^V+\<Y*4Y'$248SB6H(CAX7>K\:IEU(49( M;'(7LPMQ(R?Z#X:8AT.[!A;,R])!KXFZR55=]]LPKTP@'7QXLN2>;VBHMW9= MUTDT6B'8>(L."*AD9V=A(.9:#)4D)EDR]_(GT&BKD$O@RF0ZF2&$.D"/*P\N M<[YAQ"OIG5& MQ1-'#CG5##*#&GS) 5)A1127K%.[)+'LE%+W& %C-PT[7JBS 3D\=M\&_+HN M=;HI;;J_I,VM0?1(GB0#$4G,"D.MK2)I>ZL#N2>:NSA<5X==J1HOL>YXP<]: M2V%L9_^WV?7\]?7B:O:%GG,P&)VF?F5KRHAQQ*":>@"4?8V8R"OFL ;3M MX2.V@6@CO]F S!P;#)_^FMTG7["2-2/*HRP<%*OSI$R2X")S7F!QRNS6I_?A MLT?L"=$>"D>RLH,@\X-#^-7W5SA-G[^$^9^K/CJF%(%6U<0K1\BFI02-";C1 M+$FG5&1-JHF>(VS<6XP!;9=2<(E@37*P.JL^F# I5*#YX85 METW1Z$^#K!\)Z\PJ/@H&SV+L")ET@+&SE*I&7WS A)-O=0MNNO=8.H]C\<"7 M/0CH7X)WGFQ 88Q/4AA5FB2\;2.H-TP=(_99 QET@*5'-EXMTEDEQ3ME<^2U MLXDF_D2?(2CAZ(^D2W;)9-4D8>0)FL:]8CW-^7<0_WN$TIUJ+R.S5:ZD.G6F MCM#RB;::M,!*,-R+&()I,N'O"9IZ4TX'ROW9F.%A0N@!3\OH_H,%;?K=Q<*T M,744FZ?%))G(]R2K0*(PB-8EZ]LHIZ>HZ@Q3A\K^/J8&$T0/J+J_C#0X\ MDO<:8R1?N);Q>+6L$"4>L>)EEKE6\YQ$2;WI(]_V%,?=8=SO$4>WEY&/7%6N MNVS^^J^ORTOG<^>,0HD>,B,G1M6B0Q=MAAB3SH9KE?EID@#VH;HS[78@=)Y# M9#,Y=@#:AU[+6UK^];SR_Q/A;/%Y=IE7(P/?A\75+]?XS_GD"F>EG$?%<@B> M]'HJFAB=+*TTSA)'<6*QL&KB>28 ]8O;R<_55'N_TVF_\R MNXY7Y?KRX>I?KY9^7G)@,J<,,M3I2M(33Y,UP%FL];))\N*:P',?*COS7@=" M9#,Y'0S";SB/LU;G_.U@:'[.$WIRTB*M(1#?I"[@LR73VLNH'6J?Q&FN">X0 MU9G-V.B4/E0*'2BVUV'QN72 =@^?I[-KVKOX#KT M9[$:5GB>@F,Z+P=!US5(9B (C."-D#)%XI)N<@?U&#'C#JEM!*6CN3YVML19 M_E:/],6GV5DID\M)N,*[Y_S*1ZKE'>=>*\L)].!T4M4#"F15ULXY1D29I.;, MW#L"MR11[/S*G1!C7PAB&G+[9>6HOYF0SJ5E?F^9IO[T2QIFJN^QNI,DJ\?B MG"O((<9 >-5<@T^*@96Z#N86-FML<0*,D:SNDF%". 52& LJ.S(/%;?T413B M0Y :_Y.LOCI["?799/4]./QBDM4QIY@DYV!XJN-AI 3/-((7EDYJBRKC+E=)/W>R^CZ" M/RA9?1\IC&UQOYOB/^C^2:*.%5*N'3([()8;$V$YV M];T'OX0D];WD-AN(B6,#H$;OU]1OLJIUL(:Q+ &-IQUB+)&O$^W_8A3I7R>5 MW3%!_<&S7T*"^L$P.)*5'81MGLV'9<274%M=15<** (TN"P0N+3*,<]3\4T, M^!>9H'Z(O=)$$ETBZUY6K(Y5*UH!/C#:=48J\)XS"#)EK8Q*JLT@E1>>H+X7 M#/9-4-]')AU@;'/]]SY\OY,9+;!F5),*SL+HVE]!@RMD_B7N@_#.Y>";=))^ ME)K>T'2,P+>D"!S._0X@]&1^;(I>8>"U[-"3XR!3O4..P(U,.G"9=9N^OB\M M+WW@8^\@_O<(I3MIL3;*HE7BY"#D#$J+ -Y$!2)I8YU ^L9_\M(/DOL>>>G[ M"*$#/'V\_OKUDZ.WW0 M0^\P[O>(H[OY4I*V&2LF08J)3,%4,Z=4C8]%$\B%T9&+)E.DCLY:&R.W?"_! M[Y.UMH\47M95_N\UF(>+JP_A"EO>YC_[GH87^ONM<: [_3O91&>7E^^(WOG= M;VVN<27CSN2 X)87*R'2Z:=H1THZ [ETD>78)(*S&WG'JK8-YW^?DH#PUW]] MQ>FB)L'/OF*5P/3B+5Z=&Z/KT =+FVM50ED@:#H%BE-,E)Q+<4WL^EV(&U?5 M-<#0?;4WN(3&OIKY2 NHG8LG5]_/IN'R^V*R>%?N:X#5:NM/BWVC#GJ(VV$2,8IY%\/+L!EV=*KNJGTO;4M_>Q[6K9QWFN-)\F/9;*D M% (';K" \E%!2$P %T:*E&VU7%Y?2'Y?:[;\QNNMD_-+/]M-L?) MQ70CBD_S,%V$Y5@UHF;YZ7*EF_+_OEXI"3+BWI5/X5_G2O*8D.PW&3QYR"$G MB!@<>$6J0VF/JC2QM=LLI^?\W'U0>=\H[T#XH]9S;C^5?JCOHH6=+19(#O[Z M&.)L;8!MSJ-?_Y667U5M=6ZB9YR; $G5Z)"I@69/RX\V%&,=HZ/H"-/C",K& M-<"'A_'XXNO8;@B3^7+U?\=0NU+4#7J07?#89%MR,^[B"/ M2^]RCK4Y$2$O.5D[_CG@"I'EFB+(FW0)>(JH8T_UQYY].]0$>4&!W (AE@$I MY0A.N@"1<1MD3M6,/]6*.QDS,QA"[A^QPTGB9>F:Y<7;89[(]J7^*[BJ7N$G'H(+M7+ MMF*99,[JR%MP:-!5=*S=]D'@@TR+T23]LK3A,8&9)Q[74!^V#+,\"4>.+#IG M,Q19NZ=)8\$54_/+;*V71QE]DXO*DYAC.VX.^H6WL^G\X5XYMRHPJ[D H1F9 M(I*35XW*@!$R&)1"B)B: M4/G8@M89IHHK2?L]$LMXG1W*-,1"7AT30@;+_S7!.1'U^?L;_(:7RXT:HC2&>56O83BQ+60(%@.0AY63 MLBI[T:1_^6[DC7LCT=WQ.Y0@>X+GW2WW<'WKS9T5;6&C(A16ZB0"QR H'4!$ M7YQP$75CE.Y"92DJ .9 ME0-G4^W4%YU17F1CVP9A']+4"=B&1\(VS!TIEDX1)C8#470*(3H-/LH$BFD% M+DL#MD21>(X^J+97;@]IZN3L'05AAXBE4X3)]5)\9)*4NP>R.\@CTYY,D.@3 M1!9T;=5R$'2*6GA!VA$G\YJ9.+A:#Q#U;F1I *>,A,,S@ MDI,H?'*E31;@H*OH!,5]^"@GAT4'>^+Q'O"/7"6<)U6XU5& +IPVN[017*"/ MP1K,P3+5J)O-SA1V8E6>'D4[M?4_5J0=8/7L6YA#*P5+RH M^DW66;:*6;H&8?Z]'@>_7<[^^GU:9O,ORZKE*[8BTZET??2*UUC+=>B=,*BXP),,@9\%!L50]1^% E^0S%BFC M:.)YG4*O_3Y-+BRAQ.1SV64'M$*<(5 0L:H A]< .\4 M(Z-49-:FT?XNQ(W=HZP-,)[%WY%2VA]Y?H6\*5Z$*\R?&@)PV?_A=EV+U84)R$[&7$JR(C>9(/(\:6,W#QL)?$=)Z%CH'=];X_Z"WL_Q M:YCD=?N_&M1<+G 5XCRW/ 11M(18LWL5MQDBBQ+0.D<\U"I(\YQ=M_]KQ^ZY MU119C:70LW*KK3:4=*I>>L79OO,IF1]UP].[%"=-D'GB;(,A ^ROH#"[*6M=@R9 H"66; M>O:CJ-X)J_JGPVHKN8[=B_/A2E]??[F^7%[RK1M_;7HB_5H*5I\N*XE"<>*K M0Z"O/=D==$@(,D>XTTA+Y >=S<^^>B?HF1<*O1-(HTO7]SX3SV-P44F>H92: MOL XV;7*6Q ^\* D;:P?WM;?'NO$EAB,A+^DRR2-H'4$&O'&AF5B<'*Z'R3S(;=21PW M2CN:);556RSNNYW#G3.*6D7LI?!WYI1'!!2:A M..T\YH"&-1F4-8KF6HWG6V7]1UF<12LAH*W1G#I20R8%6C%G;=;*VB:%9\]2 MUK>>V@DLX*V'T3KZ#3/)H,7-A,>#*(H&-"=&& ] M- 08$@0[X^L B72 L$WTY%UY/Y_EZW3UO_ RKPLJZE^3+Y/+,%__;#,DU#EI MM%>T*UFN&?.TV( 9- O*2J=B\4UZ AQ :Z\X/ 0LL]-*K@-P/LZ_-S>E&REY MI/]#O8"CC8RU 8*QM*]=+,8HJW@\H07W9J^RV&87\F.)9.Q0_^-K>7M= MM\J[Z9W MJZW^-I\M%C<1XP_X#:?7^ '3[&(Z^3^8SV5)7#JT0'^3.X4F0)310$BQ*F2I M=9NTMH.H[5&S'8?)TPFO7X22)5+'&MVNZ]UT^6.B\5P8'5A$!IR@H^=BW'ON M[7V%#N2FR"3 *45'?TH&?-0&I% 8N-=D).13K+236Z1!$/%@5L4@W'\Y>N2H MXJC'']5(J[0M?MH"I>""B9P,;8TD;Z64K7T%$2P&GS $[5F3A),3*9=-SZ>L M76U0?F\OTU;.+' M,EM60BW=DBF 8IY4;2D2F%(B2<6T-TU2IK?0TQ5Z#A#T,\@YA.M]@F<=]&4N MH"TR [.RMH>Q F*.=,1ZJ5-B3#/9I!7:5HKZ M!!\GX>0P;+QZT6+RRH!,SYS-,7K^\4%VRZVMKRA*R0<(KG9 MT&SLP*S8%&^]G5WAHBZC5KK^-IF&:5K>J*:1V6!,^2U_1V" MYVC!B MP&=A03--JPLJ9FRBX!ZE9EQT'2_DV= <'Q$V&2?G;_ B7/XZO9IBT3!DGYL.O?>0+C[ MSG%TP]%"FPW P1X<*IR'M?X2W/CH<@&K:M;PPEQPOZ*"UX6\B_,\)!H+,)2,M)E2\4W M\7GN4C%NIY'AG9B#.=P!/#Y^)J:]"@O,KV=?:K.HM1SF-25_V?/QU??;WWD? MOM?O+5=\N^QI?G\9IG?B$IB9DDDH*"S6F6NACJRHHPA(>\J0K+.AS&R)KNO^8+KYBFI0)YLV5,/.ZSH*"B+6@A*,F$S366 /7T1GG@]HE MYVLWF&RC8AS--)!D9T.SN1.LU%YB*2QNZB2UDMI)4K"J-JQ+SM-:T(/1B*$F MTXJTRY&V%U!^)&%$E PCUT>0<@23.S""[BG9-S>E'8X[S2SQ0: DMGA.YZA4 M"-X9)4QR7(0FY=#;"!JW*UOK?,##^#YVN.B1"YFSG"=5*.'RMY#P[$N]Q?E] MFBZO,_W:I\^3.=F%\ZOOJQ^<*Y60-H0!,O-$3>]G$$JI+305#]%D4M;W--*6 M"-.QE'25[G4@&&9C2:9#&.ZR1&/0)L\E.&\M*%>'O/+:,$-K(Z/@O-SOE+0[ M^(:"W*FRRMI ;F@I] BTZVE=%CG$7R97U0I]C_-4!7F!YURC\C2 MJD)M+"4*]P&Y=NS^-/0] +;]O5UEA30"UD!<[Q!0OT_IV;BX^D!>S=*UR7?6 MEI%)1&[ 1.-K&^ 3A@-6"2Z6+2BY1Z*J*=>W-7%;!M(#<;W#C'U"@LY*6F7]NI>#>DBT>I*K#FXPC_X<.?A0A&%'(PA4''X-/O;BK>Y\V MF!J,[STXBC6P&Y\(_JYCO_%![#G[CJV7G7<,N#NOWP]6UR1 M:4(&"*H(P88 2BL!T81$^YY,$^UE*-CD3JG%8KJ*QPP(^C%EWK[7P/H']8^Z M=?_?_^?_ E!+ P04 " "$^ZOA= # "@, %0 &5X,3 Q;VUN M:6)UV]:7,;U[4N_/W^BK[..;E %2B+%#79N:ZB*=IF7D72 MD>BX\NG6!GH#:*O1C?1 BOGU[YKVU ,(RK(--)&J6 30PQ[77L.SGO6W__WJ M[?G5O]Y=1,MJE4;O?O[^]>5Y]-71UU__\N3\ZZ]?7;V*?KKZQ^OH]-'CX^BJ M4%F95$F>J?3KKR_>?!5]M:RJ]3=??WUS<_/HYLFCO%A\??7^:WS4Z==IGI?Z M45S%7WWW-_P&_JM5_-W_^MO_/CJ*7N6S>J6S*IH56E4ZCNHRR1;1+[$N/T9' M1W+5>;Z^+9+%LHI.'I\\CG[)BX_)M>+?JZ1*]7?F.7_[FC__[6MZR=^F>7S[ MW=_BY#I*XO_[51(_4>KQDUG\Y-G+X]/I[,F+T_CX\=/CV30^>7K\^/'S_W<, MC?P:+N=[RNHVU?_WJU62'2TUOO^;IZ?KZMN;)*Z6W\#U__WM5^&%JEC M=.\ MJO+5-\,56SCXLBK[/X:):G>?%-L9B.3IX^G9C_1X\? M/1Y_R[_]Y3'][UM\P-%,,#\QR>DR:9-@-U?/P41^?BTS*9)M5?_W+\[/&WQX\?'8=C MT.P]]VP&(Z"+7>_:^?NW;]Y^B'Y\__;G=]'EF_-']^A:_T+9O=Z>T#*GC??V M'V\NO__Y0W3Q/S]?7OT+.WWQYNKRGQ?1N]=G;X8PL]S7L_=7E^>O+Z++0<_H MCQ=O+MZ?O>[MX_[UZ/C1,0N:=W6QAD-G\_2)I'V.'=OAOIYV]_5JJ:,U=S/* MYU$%'\^+/,O+Z$=HY3JZS&:/^+1\N\J2:5U&%_^ND^H6?X!N)]I>J+!JI M,E)PAM5JDBRG+[Z- MHM'QF,65JJI"S:I)5.A*)5FDLCA:Y;!'02../NK;2*_6:7ZKH2FC))NE-6J% MT;K(R[6>T5:V%XPG499G1^9S%"<%7)(7)3UT!HN@3BN5526TX>6WT>C$- '/ M,EHY"1YGNJQ*%"ME/5M&:UV4N'INDFHI2Q%[R]B_L+Z]@ .'1WVL0[AF.69YU7(%#%F4PQXK? M8-]O7H5/QY^"'7;R^/A%=":2$WO]'@:-3)@/53[[&+U=T\ZD'N7VEJ?;WC*J M\H6&FXH]D\%??>?U8J]V)H:C.ZPJV<$8"F5_* M(I->AZ)\!H=6K$#G8O$)STO@P;I8F=:$4B_+*Y!D^#YZ-5\(30')'2=\B(,( M5=DMOX?$4K_AN<-J;:\*?\)'QRL]3S+7XW-=T-%XA0,R9+W^!YALT>M+5NQE M@? Y,,_3-+_!U<9+8ZE@6>(/*ZWPA(/32U=X7,):FVJXE'2-K0:,7$[[-V"P M8HS9MS?2=Z,^>S8#E8C=JR+6=JI#FT4Q+,C27X_>K-5@L2E]U-D525SJ+81!FGM]'-,@'% M62OX#_<1]"M]G<#BF^EX0DHY7[)2MY-H6E=1IL&B0,5\JLE=&FO4O>#],3Z/ M+,9\M<(WZ?$DTI_TK#9>@]G'++])=;S@:Q48E6B@Z B]KDZIQVU2Z)E.KO'( M5'+N&[?!5&>@#%>E&!CF9[^M<,J6^<:+$^%N, ME[+K2N,M.H6C%,SL9&9O$$D!:Q*?M,81KBH9-M?R5-W<0X[L@= X'9+0^#[? MR[.+'.8Y[;AY],IZ3*VO\OXKKB/K/-JMZ>\_5GKKZ1DK"9'C^4&ANM>)P MKKAX*\39J1E_543X'G$*NA_*2>1"@HJ4M+Q8J"SY#ST*8XHSM4XJE=IO,.94 MPPEWR^$[4+EFM%@FU(@\36*Y4*U4NE K\ZDH\"H4'Q.8H6(!L@5:E91E3>OL M.C>*'P@+5 6I6_QN=Y:R&Q.NJ-,*OV7]%6/=2U51!V!200^.:Y5.@ABW%_H$ M9?P(M-TC$&R@&(/2O0 5N<#7%%&:@.((>N-:%94(M8G],DW4-$D1!C'+5VMX MVR3Z-4]@B5Q#K^H"AD"593Y+I,OTVY'(5G,#Q^R@'T5=PDB$H[W(KW61X1A! M:U1=+?,"WV:%,0I6_,P3_!'ZBK]E"E\^E(#\.XH7[U0G[H@?X2Q&"XKWP;3!!^SR@OT]H,!]?3Q?QO8C]EW8':B*=6Y]\BRXJ7'6P_O(+C/]NTVYJ@\ MA_HKAL JZ QV@+_GE4X-'0:NX)'/5B@2*DVW9AEB7LR*9 MPAOA)MCB8'NJ]3(:3<<<[D IP<;]3)6#PB]]J(MK]@^EB&I\%H+$Q^:^UCCO661_LVCF8=_#%80JARKK@CU"P2*0 MB?-#\6V9J--DD8COBY?,2J^FNBCO6"_XTYUK)AQ6O ^T,OH)Y#7H-EG>N&32 MO=3&$4S:DAQQBF5X5F,C:0NXOHS0*^GP L:O1C(?TRB,"ADA,@L?+[J+4T-\ M84N;+\YU*0^[SM-K+1 #*\TC5A'-T8(695Z8%_&(^>=5[T;N/K#<41 +YHZ M,;DVMSDFQHQ%V_WUO7&SDN\VUGOA4-OWL<9-L/M=@'%F'[DN9DFI^P.[H)92 M8.&;0J<*H4M^SI(\\=GIHQ=L)'?=J*9@"=:5_E8,ZL?]64][E0S1,ZY'QT=? MPKW5F^;%_UT6=IS50A]-05A_/"+@ZCCDKB?',* M\LF9]P%.0[ ]&$]H Z,3"E"!&:]6.4:Q.!K(9WR[C7BA?$OPTHF@^6-" 7,[ M7^D9:2;1\PF!C,?>48\G(FC,L"_A=&^Y^!IA=U \9JFJ2XQ:'D[$PXEXO[&> MUP6JBKO?B_T?ZKU1/D02ZFL*(:&%,;,R:"8R"/YLR;V)%V)%,S].0))J@WRP M>(KH9DDI#^R4:C_:2;_RMXF_NZ,).WL M8*=1]EZJ9Z'[*$#<1*++<^HA!TQH1=J+L44@VMUS"E"0X1J;#^M^NE$E@R"N M#0KOFI(2H455E,+2A0/CADX,1,1)S[JV!7R?F11"6UT0!CY]NJ4(+"/F@B"(8/E#PK%D<=["$?B_0-*708+_SUJBS5:Q3'MN>.7+YY- MHLVL [+[8?'.0+'@TP+TQ7QB,_@\2&A1IY3XA#\5>E&GDNQ.]]!@#G[-OQC6 MFAK(G&4]#W^\OA[;?+0@GTJ!( ,XM4=M.=61+)@ _ MAR,(NJB0G,YX5L=!HL=DR]2-5E(% 1D%(E!&TSQ3T1S^-*QWQ/]61"J^3DI* M?M'%=3+3I7%6BQ8P_)TR*)Z"P= MY^L#V>T']_"?W3G:ZX-B9MA'1(6A9>A 2PQ_]0V*1^%54HK=L5,=V7+]K9>W M93+CQ'A)2D^RF5JKF8?*,IQ4-@MS71#"4\?!SQ2G7^L"N>83@;K'-88I&(/" M>+H9Q4*802 JM*0'MTB/(^B!SF)5 M1+&ZQ;<)3)0P/Y4/49M@%J"E3_#@:CZ,C:!KAGY7529>DZ^3S$LTLRA^02,* M[F>JRH0Y>&.T'GE4% P$=./?8.\F\P3Z@7@H'/8U\KH3W!(SN^'&-/F(*"D& MRL%S:T(]J*@$*S?%#FI,+!B^C!@42B?,*MFISARTTNC)HY/],$&CP1.U'@\* MJ'0A?LR=ZL:6B@$#Y0I;.*1UZF&*N9<4+LR-W?[;X1]7@P+N MZ(92/Z8T&JD2D+GUZILD Z?';61NI0HTACE5YID7NFD ZHO!#SH. ?2&BS_! M<@V%R;RVS/SPAI^SE!)E4'N]P01N%<<%?,.PGG;?M*M3@5DMHB,ZOE534L+K M)#2RK D!;I1I4<+Q!E9<&XIX, S8#LR>+?-4^VE:*W7KY6E9YC*CB3,3K>[J M0ZIQ6/"]TY(R 9B R+#^T!,MPX-;FI/(YCAUO,2Q4;1?Z#%XM09HRY=S%:/9 MF LBP9U8G"DAJV(2U-]H=0Y+=;BV>2W)PUHA3+_KEH3^A+2+)250<(ZK6R43 MX743\ET+,#.EA?#7!ETS&Q7-D?$Z.-6FA@0. +R-E[ 1]""?E]%UGM98*XSS MFXD81#Y[ U1 U+ _LU7J:UW0T8P;PSO#,(:OLU*9W"W+<3XB*1]N MN[D(N5FJDA5G/ZD5S M)0A";:RF7A+A78F"?Z76%Y[V3JCV>J/" 3=4TKW'F M%3J;8CR[%DG)^20@JM_D%3;,RG"NQP-MS.&3^,!L:W)/+'L'LC%*3Q^_/..^ MHGZM/T%#I OH4!I/.B1F_VG5IQJ)ME)JS*ODO#BB_&.A:907I+JP A$EH>&] MP-;5HIOX[1Y^#MG)H."M ZKT]B <5HG?U/]&.:3U4:_4,5'W5E["+)J*&[;-I,;E*MC>EK MTX\BY,-.$TI1I_(I.?U)UD6A8H$0_KO.X=OAK_]!06K-FL$BV#O5E:WWP >7 M%^9WAI.JGYQ^Z:1J_:!3JD\&A9+]026%D8S_Q.S#G>K/-CN@P[XBG'@RHSA& M3)3\(S46WMT.L8X"'-UJEO6(V-3-3I+"!+,T+[FX>F)(2_PGX18K-%+?BBE) MKB;-]I/=E&11$?U(AZ,9%=5%GL,65= A(DC"%R9XNB%ZHD;WH^>B!1,XY1VJ M/@6^W+%QEH7T*WJFV3J5\RI6XA9&CO3>P4$KU V0RAI'+&>L=@['!I_Z%^NJ MS6;#=K E*TY P^A"Y"VT(/R+P/[7137I*L0<&.+$(19K2:/EY-V2^GN9H:<, MW?A^B?;2W7YRXD)GL689;+LT?"DY*%2Q^$]VJA?;%M\TP>B)CAG[=BO18NG6J/ M'"ZQ(\(V7K[F"LW\-I3T(M"-PPB$M^X;(3\AK^5!X4K M[N"7VZD>W=,/:Z/6LDXIAI"86$6+JG7XBW50 ->_UV45G2.7[DYU9.LJ@F08 MMNU'@RLP<)Z&(#>$BEZ0T(/>D #W2Q\3<@+/MG#MRPIP0VB:!P>$_.9_/;GO M#5&3J5[YS81[T.[KBDVR:U3&8-+%UYG9%(%YGJ;Y#6QT&D.^2DHZ MYJ:W0=EH;HS/VBSM_Q7[-NON6_!US16O \227PC0^T4XF. "X>\=)8D B/PV MV> HF/&:CETP3E.LO@=-*/2\+L$&186$[8^ Q:T6/B%SCG6M7(:0P%=L!TP/8(!=&5=/H9C# M (4L4=T/NAYC))?9G&?Y,B><2US4"PJA7R=Y&CS6WFTP=GF*U;=*] W08-+# M"E++BKDFLF!:8EY7\VF:+(S?,,BPGYCM4C,&K@6#%<6)[.*<64*5GA)ZQ::<9W,C'J%]+1U0>Y47&5SY%9U)>^X MD^0!6:=:X5^+.DF1=@ ]J!$5*BILT;Y912V!Z=49CQ4!& KTR'*))7S<*L>B ME55=K&%_H&HX+U0=8PG *R>\7>O@'655\ 00 MX;-B9W:I/]7*(;% URA46;+\[?$WBCFID#(,E^K0LM(U:G* ]4"==,P428:G) D1<0 M)HTO%4@FC*V07?CTZ?9O1H/!5"Z3==G8EJDKA8:/*I7QB[/=.=?(@"Z*31R]VOR;-K[A^3P M^R:'/WFXR>%#.2@&A2CV4>8[U96M8)I-C+R#,'H(C$RPD,(O4W3A'P4!H"JL M;67"O;%P:;CT(OR.0[XJAEV3P"'+%#J+.F'HODM (E"_5E@G'&&C?)S=$D_- M5+?3GVQBE$$MK O-!).MOR@T(5!5O).]>6PZ>&PBV_@W5*?W=6-_'?-#ZDTIB)@GDM9 M@MDLJ1F:BU8^??S?QOE5Y5A!!9HTI?R#ZYPJ@ZSS&\[@01K;6:KP&?:.IN M!5S" O8X\X(I#A4YS%T+FCYW^DHR]2R[M:/#\LL $DF83S#2X *=H^H."O32.95OJ-S$4:+J M>ITGF4<3QR4BH^@R\]CMFC4ZPG(CD:JK95Z %CGIJ=X!]^>4N-^/-%$QKK&C M5,]AWD[V<@_:HB3Z$RAD5%T%RTKPGB.-I(P61 + Z;B5)[=QMB@!>-@C9"JJ MD-PI:@KD2RRUH7V8)?AO9PB5\5I(PIA[PL")P M/&/#=J$^\N8UN?XRK)G&PT\L!*R_65(8&TD&K/ UP_E =K2V.[I 5PG,9/=[75N95 MR)0X1_Y6*>;$]:(".HWAR[^%# Z=F1.FQT'EA88J]S19*L^"[#373)TC-W": M,ZTX5SD,62A9?1$N2KELPI6]B%Q&;N3+IMH>V@;!PC7:T)W@KO:E:ZDK$KX< M3O! :,*"9$HY$;,+E6YE7I?^ BMYV#)L"&R:F#"V1N!7U55*LFX@?.@#MXB5RDU\Z]_.7W^ M+3R7[C$5AV-7 6;P.WP9[' 2AI&JO#H*/)93%!'P$RYA9,>LL\+E2B#GMA)> M'%;18ZJ!1'8+K,Y,XF:T3VG#V=?S> =6$#Y*: >%]0RFKL%L/3.%VCQB-[>3 MG8AI97)-#,%;H?WR3;(S)\B5G95SA*'"IIMKL.$-@]A:LD4R)R^U M.66;E&1L"M_:E3F^8X,>T@/NF1YP^G#3 P8AD$ZV%4AM@OM8I[!#BL!;RT* M)5!;OAMZ_;9A5A"J\G>36JZIPQ1;0UB)3\;1C4+U%75?JUN0WC4)M+J)U>:\ MD67N0:/;!= 7;YJM7D(*9;):XQQDT(-M7Q/HJ>7$7Q&[[V#=,K-_+_ UEEMP MV)OB=&SM9K]$T>[,8GTXF] _(.9MDV']:/%H]UH^>9V M3MQT(+.M*JHC.C<]8F.8B:HFP>3/G%$4)X;QEHZ*D/!6>$5!U@S:&V*8>)TK M0\YN&DDI+(TF(?RML*)K9>J(L[Y!WX:K'G]].6K[W!& MNJH'-]GM^ZLP;"KU/001?SPV;BBVY.\15CQ^_&(_^WPV)I=BRO,_4^5R$FKL M$U-FTJ;LF6]DK*QGS])TCRQR45_3LFE;">B#2N:W+#D$+$C>2BG7S&UBZ>T" MPGGW>4L-\9VDOO/3>+TZ;( P1(H=:2SX^RC[>[L"OA\[C]4]=;F][?/Y&)9Z MAH9L;*U%4P<'EB:"EG@HABWP3L;&'K\5KO3?M.^]%/<5UK\K01V[I8.D7:)! MMIJX3#&J5Z!3 .:![J]A#.'0G<'6YX H1^VI[J#'Y>]J,>A"PW>Y7VS .#9$ M@QOX7#YAYGN+#^$BCW/)F0[*+8UXD@CNVEN4R>)[0N%M542I7\4^H?#Y++&S M/$KS# M"."18_^O&.'=]2;YFF< *TD.O!?7DD=#(G9G(V;SC_(3!J-1'G1EH MU75>20G+E?J5\%+X">%2*[V:(CH(U3W2VM%^76E-_I01']/RQ*5.XZB"/;9> MYAGOO?&C*#KC(@FWIM$+;I>09?#CRUP>;9V MH*G.:Y0!?)SCJH&O$NP:J 08DH&KO>;0./A=A/9?+74(MF@W!K4$>"&('"H1 MT05Q,>P#S;":;>H%IC'_"+9AM#,9,C(_ MR0%,.!!^G"Q**JQC3B:X$.O>X+^X"@3>[%5+!4#G&?2AX4!-<&3UQ2+1%>$S&-MU?5AV=L\&)4<-IO\@I7L V+ MPR#C>EXTIXC^4)3H@\KP?'M #L3RL-3G#KPM+Q+! ?- MQ#]^"SPKR$-^VEW4+M=TZ^-!&ZN#^C?X!7!J%D"?Z#,B7:1E]U8RVZC<4MI1 MVAXJS!B27HQ1P*S)W#>^^H7SO5F3NP[I-@DV%9 M)9NH&1ZKHS!O08R0L56V19MAM81+R%65K>]JO^9CS-=+5BINU!5O64Z=ZLAD MLV,/*]>A"[Q"->1"40C9GR2GP^"F7V5PG DBC31"4,I79 F$):DBM5"H]5F9 MQ^7S#HB.+X;H>/IP$1U#B*J8E T2)7E98FG LIIX8@7V,!91PR)ZODR!+A:9 MOBW%P1G-M2[';&Z+ <;Q\IBACZ014FW+V!:I;&SP#C '1[OJE-&DJ+(XT85Q MFJ22THLSK6/1EUC][GJ!M$M1 $X2U.^^G(L%>[__VO09&GW)BW%NO*1O:3&XJ+-HHX%-TZ![#GUQUG%U M\?XGTUUP4)1S97U^V+A?ZWCA UH%E=2[;LTQU=GXW==/-BI;YHC?C6[<%V*P M[Z./$GGWNP#C[&MMC?Q*@ON1#8OF#69ER8E$X7Y5EK58M>BB%R38G3L.,8>Y M4-K:%R] Y2M-[6!Q'G'=4>]-%9=7EP9T-YL,<#+;L=3OM2ZX07(;RZ,9C'ZI M4\_D"T33;)E#*T ;'C*LXXIJ6Q=ZD5,V!CG2<=R-CC]3@;>^H@/\6B4I.2*I M2GA#(E>!"Y,1GJZP,++9:/KEU[I(RMBO/DS.42>Z;>R(OUKS4>+LV(!/E%9DS7;%+#7$9-HT>P*'EP2FUZUQR?6:J2E>A* M)I6]XU%V;4V5:!=2\1C;84KM0G,0LUB3#_%SY@?L/'8HVQKF-!8,VNVZVVIM M86M+FZR 7$.I10XS"8E1/"E).]7RX("OI(!3.U4WY5V\\I;>OK%4\+'(+\9F917(!%G2"TF!NP!'ED"6F24(+#0O9 M*>2<@<7!J7,:X^&OB((K+W:+\J5GP#[R]]0C;TF@49,]B25 @L+3TV986+8DH_\*#A%/[2^=-Z%X%D2 ML^2OTC2_$0^]5V@!/AA7:Q,.QI$L1ZL@(AU^^3PX0R$<8[T MLM#?@18;YJ@8$I%6IM:#'(VX9S2X?MJ#'!)#X/$*57[T'ES\NTZN58HFH+]O MAIY?8:@XWC*BTCNQ\L(_X^3\&A'JB:W<6/AYXD%11^]%-?IQ8"1VX!\I%F$) M9BKG"0>C%^,S%KMGR:;8OV 8>4/GU"9OU ZO^5YM5\K/A.F_9]:_=$^+?2%;AX_.']:>.IKHK#88LW"G^&%[@\AK&+T6?F,-KN.7DYZJ"D7%H'_"I'F%%7 ,!]YU^<&RAI>A<"T=2(U 4 \ MV52KB24D,THP9V-9#)W 00QSR5)1G(;@_HY?"7U"+GD1$P4.2_&/6HJS>RW% MYT].)B^?WV\=>AQUEQ@S8_0(XWM8H]ZSM3G"1I0U>2-!U$]H/Z-9 (,Y)*;K M_2S5AJE./PBYH;K.I2@O3%69E'3TXG+UX<3YZ?/H!+[$5>8H"0\@\"\& M G_V<$'@^S=;5L(J@;^NBP34""2JCG^M2T$P&QXI,AY]N2H;LRY%V>C&(Q : M+Z>-#WNM%IC=2GU*5J!;N)TOFU<%+C?.1 N?&-#R>+FH)87]M,E\]%,H04K< M(YBQ?Q.)?KN30?CMWFL0T*([PZ+@%CR5%) MB!$DQ'\:2&7(MDD7"Y+3I?$',FA>T\4DBGP@3(><6I;HQ/!J"4E BEG3=Z MW$$B0KP2 <,'4P9P=@878:C4)WX!:(=$"S\%O4NY$>DB?Y':0FF9M]>(Q??\ MTKC;)%'+^79DC.Q>:$:?Y49\(GA\V@$A([UO17F."W^(,)V^,(:6QV\Z@CU@ M25;R++WMFM]951-M@,??BPE=YMGC?OC;$. !>,8^&<09>T;*'2E&N]&3@9ZL M5VVFD,T\_FFM)*W.@"$,Z(_S0HN'=__K>-'.X3;?)AY4ZW7[D! ME_CNS_&66*@GCTYVOR^41(@DOZ#-(+0:=%&T%9;0P,6RA]*MW"*]>@CHOEE[ M!=LJ3CV&P.BNXCL;=L%,TJ% :27D>NOQ@DJX79/F;MD96%5;96!+ED MA2,JL +P3C!'/_KV@,FT'P].CIDZ!?"D#+W>2/P#&KI>!2Z].Z<0IL>SJM!2 M'!-!>4&4:[3I$)^)%BDI0Z_Y ^Q MF-3P>9UD^7P^X=^/D.C,BS[A0ZB\NLL0)/>">"/;?*4N@I65>9K$\A15%'@# MDT'81,DY55.$5V/%:ON^O%BH3'J$;TL3,/MC^]$E$88% $QF)/:WJ&?&%=)H M7^CB <%7J+R ST@^9@:%NQC^@GMO2BLCW&N[NXGVB+/@P%#PYWQ$$"BKZ55 @]NFY&09, V'&NK=45RS'!?&K9( M#-^DMR3.)Y'1T$X?OSP;.%?>,Y/WNU-KY3/\,(BEL![*#P9#(6?J_H3XQ0\= M4, Z+4,QC$DX9S2HPW4!#@"MO M='H-MMWQR3@"60JM=;GBS$VDF&?=!@^M^?S7O[QX>7I0SO]0V;K[K=PXV,O\ M!LWDW>\%9[H(SL!1%CEWAQ_:Q@ LT9DS$9.K%HK;Q142=TQBK*7;RM^Q5DQ/ M^2HI+5%F4.Z#W"(V$=./9UM"=>8\]TFZ+9B V/#7J.>[:+)%XQI,)#PA372- M+]:**JZQTW@C^K?D42SW4K*T$BEU3# 9#:NN@-V/F3__;C('!>:G% MHF#._]^0>710#?]$FW?SU A?5IZ1KKB"%6*6?VDM 6^!L,NR<<8Y16I8RM,+ M5IX(S5%BFL>YOR]A--[DV9'A:6JS- U3NP+!EAWI9J=)+!"I6W.]C80_=8:H MIAC4_UN09N- Q$V(:U$\(OYJPU139$.C^E#%-08%F(4M(-JGR@5"$*NB:Y76 M))HQ7:(DC>V_GCY^/(&!\4AD^2HY'A!P"M*?R1$D<4)X$S)SO""*"MTC"^6EO'\D):Q/[/U7\=TRL#_"5M*;@7_ MU'-D]:KG%,4J6OHFI5)=><*XW9X#3]))8XUUT"B'E(R3I4J*%=/4O]8J#@YH M>V];3>N=EIX%=XQ[M+W#=F6">E2ZL_=7E^>O+Z++R]_2R1U>F'W]_N7L_:L/ MT<]O7EV\CZY^NHC>O3Y[,R!5_<20WYPY;M\+BG3/'!IFR&HY5=MA!\==Y!^: MQT6 ^P8C[PH-7A8$)>:8VJ&:0*"YWA;0JIE$W%D:'6?]_]KJ"22 O&"XGB48C1GXX:&UZA M7UL6N^Q;P:;J5<PG7% 0%YH^^5@]9/D.O MS:H:N8+63#0OO!X"&0N)[ 7\V*P8)^O(T?$'.?/.%[-3 F-_69V^^J[IF+H[ M]Q+=1:D$&ESI\W969%#DM>-T' X$G?*P=K\O>(1EN8<0*YVH)Y#8G#"TC*,L M)P%PTJM6+WMS=+/4]-D"+9O(2XX9FH5UU:B[6=LVO3!B>>DN;@Q4XSTT@W0)AO!LE) MHV_+2J\FXB6%EN3Y1ZP'4F W)*9&D) YGN0+TOB:K0VKO/$3K29;^D$[2TZ3 MWV0@7Y?)NF??#>IP?=)!H#YD+"&FLPR#[Y26[4[UH1\LR,LKY^75C// KM>F MC OF1J\3DIW&?)3H,0%JA!V@HO;%=6'BTZ@SASIRT[)D))A$Y(?"#]6Y:W>B M+WC70%/(S2=##(F4&Q]=T9+%::<79/4J_[*D5;-/' MC;9+_A)VWV!!WPX&$.]T@?/ 'C 6=.&(6[*>]-#A)X::U.:-.GJD1Q, $NB1-Q M;L%!CIZAH(JK\4!Y@$'$82H0%3@O[J4%*[93(VVNY M'%)P8'35< $W ]UA1'KW.S>L\-(XH#CR.!D[RT%O1X$T>$_<, @<+PS5T3LD M.-J-S@S4 7?5YI==FZ*8+2.%"*XZCM.IWIC_-ZVK"6FRK>@]WE)5?,_NC]:P MY.N$C0QT0N $$NR0= Z/;2)EZXWC+C0D:,R'>A9?,G'BQ2%Q8G]F:Q/PM[UCNV1S4Z)O)E&@"@4/ M2G\:!O'2E0 $_+G;C2X-5(NZS! +QU@OH=%O^BNFH0?7E<%S%1IH[\%9.3I^ M/"8O;?F[G+ISO&_T5%XQ9@I))P@R#QS7X\L>O!AX.@@Q("Q&Y"^V)E5#+-"/ M[X09==YDR=R- 1BHT#@+)P*U<62*H!F9^B4M?" 84212,XA"I1&N[B,'V\I, M4]56@2Q^L<_]W:&3( K.1WO?!NPT$;@E==4048RK:-5UUVEO>S>(H MK9<9/@Z2=R8V8)Y,V2PLG9$^!FNI4'C-(6WG2:;2IMA>MORX@_;,YV[$P^&> M^"#C:(4,W L\;VX*7&1X3%;H8PC+&D6HCR;SV[M(%)DQU$X5@21G7.0MX17= MJ)Q#)61,I29Q;] $SW.+(9>X@8%A4\!A,Z'11$Y(HH%LN/4MU?A="YSIAQ\2 MFFFJLH\6P4Z1S$%WV\"-&AD* 6%*VVAS@ *[P5!,W4'K/H3QLKS]-DG1Q/Z0 M5#.)#6V9K73:K+N&.82^0]';?:FZ>2#5#V)O%(/:P?.0D&3H!U0+#D]US5;J MH_89Z$N/@*)14I9H=>P\^%MHOW0L>42 M\/'CO"ZRI)2TG23#A2^+O0/9/S&$>L@&%;#J$?EKII'/25 F2'M1*($7:&(J M-ERWA?;Y8!N;">43ZY*4#VR>X%]B.:+:B;L?7/[5V4S\4Q>F4@!\T\\UF^H% MZ%:-TJ:MR>P? 9KE"H?^9@EB$WW;B(?!'^&YC.+HJ2#A!HAFP8V-5RJ@N[8$ M5O0DCA^]P%RWB-< CJ^?.(9]QB@EL9U6^?K()G.Q3D3J#>5U\;6P43%E#DQT M&(++N9=P7>8T0J#%EI-F'MIG*,AA!-64KE",R/:U.9XUGK-?D78E]58!)?)Q M#EEQG5SGE%,V>$?!LT$X"C#97*-V3%R@!7Q(<[4WW.R=><&'R.*?&5FD2I[- MVIRN7%$(;A7!0TA)KUI$B//PZ[48D >(J"QF:VJ&@CI-^=!D4D,^;IX>KYTAW&+I3J,H'^B42-% @G?RQA5)9R3)L#=KYI ,:&$EM..6,I MPBFJ4H&M5#1(5VC[#DE*PKZ.Y5E@39V"Y MO1*ZZ2T\.^RCZ/20YWMP.V^U5GB#*'^#" G#(5/Y2V4JWR6#=J)?#SMK^70@ M6?6)^,\#?&T"8_6]Z<$ LTX'@L_L!6;US3!>^,KC1SR M/ZH17>Q48WK MQVP9*SG)2AB25$)]UL;V3O%N/:"-QMIB]W\)T!6_YY!A\<4R+%X>,BSV9[8Z M]A?3,)A]O1V:T%W_&^"$/1M^Z,B-$%K8,PA?&&;8:Q>Y(N4\GVC.K1WZ8^.I MW0S.3QIAI9"EUO#3$GFL"K [M(;R.=59Y"XDG:A$_>\:5A+(>:ZX5>4/"%S( MBK54,KM'OT\?$T-*P)JRI_KQZ'@N8301+46TF>U\.'MZ7O<":#<'2@Y@VB\&IOW22-)- MKI'?"U7:+V[V;T>@5W,8Z:8'%.DASOJ'HDA[C]L#HO1+(DI[A_DAH4M%1+_7 M6,5HAB(A#+X,,^#V=$BHTATYB08:*&MGW(F 1--HSMF<4:D(2VKW4,FZI@F6 MJ17TI[H?M<$#@)/V"IV=Z,]=,%+QF).7<6.)O]"G[Y5RM(9 1PW'+@Q4:[R" M+'UG*IF%F&Q3K!=7EN3LWQU*17T2#W33&6;ML3"L5@.=5\"H+G[1.7R?Z:(9 MN8X^UIE@T7Z?6G-PF7:UHMMEXUHM0F,S+(*'$;"P8Z5G('I=[)Q!7"_>O6)@ MD;ZB"@KISC3(N@03UTE>4*%2$KS]0M<).CX[B0'G.J^\ MTLGAD8FQY2J' 7]U9[NX#)749R6#-G9KSYBV]H*PX.M:)7%4KXEP[+;5;"?A MH#&J@8:W[![V(GJ82%>P.O4U*IJV<+1)T4\0,00O&F/56!]DU3D["./P1Z] M@'<5X9)K.FN3.2FS^&>A52G*3:M/U%NO'&O'8(5C= /-Y;[QR\O.MX_P/T%I MW*XG-R_PWV/'L8+F"Q0=>92*F+S7M#YV?_L-R]NU(=UJAX_=7G?)LVYW2?1S MEFR9B;NG :X^,Y@D3^F+5&/^PKI%_6V@MFHXXSO1J3L,UM_+&X'T08&RT#XQ M<*S\PSO/TMN6]0O*O2Y )Z@SLDK@YAG\)ZG(T1*<%&P!Q'VX\>WP:&BC43WW M 'RVC07\MF'T$\:H]8@6"/D /?YBT./CQP?L\?Y,E^_]0BB>ZM#O641@@&8- M.F*2UR5("%!&YSJIN+(92QLEQPLILFPGYIF6 ^!A:?-0'/ME1?#4IN>L]ID3/KHXM]U J.-[IQ[D)@,1G5J^%N;*3)-WR^> M>>(U"VL#=A,]@VKX1S M7O@X_T(OZE0538.:O*4W>9W&UN(50S/<:K.<062PEYS;$$W4MH,=E I\&-C" M#GOFHWN\^P>BC?9NI)WJU]T1E"N#-S"J8V_'OKCZZ#$J!UKQ9ZN%04R '^E0 M;Q01X%W/;HFL.T&^MSJ\>/HYT:-7QS2%U;GT+??0\XM0QX0>FN(%K=.M01@] M<7YVQ\]>N=S=V_#9TDA\N0BJK3*3-&WE63H%7/S:@AY>3QM,=0NV4PZNBX/E=+_+"3V[C9RXUCCL;?[78!Q M3CPV -P[H2@Q0D046MS9+A[7WCZWLE_8"[TI*+?#:EVO5ON"M=IWNB L=C;3 M1]\3"SH.RUL26"19Y5LL0@*"5SZQX^QAZ;V"G&%1?KO6='2C$EK='A%__,1\ MXF5#8X:'%?]JG(TC'^"H>_$X\.PZ\[R2#=MP[:9-S#W%CQ?"=?LC^S%+754I M'QG8HO%05,G[K=.=Z.2?Y^B\,K"'YIVN;DS+]K]3=Z2WB)R4F)B:+1,0P49! M]5?C(E=I.;FCDD? LF!8DXA&P5A"S-B ^28&3&%@,:A-SRHT[UI%2KCA'F1?_0U9!/C\MY8TG;Y2X^ M!+09.O=BP,N)23C&D2% \;+M<,$ -3H?2Q"0)5I\;,G0>\A @%V"N5 H/>B2 MVPU2A"Q(^"51*=E/60?^#_2H?)HF"R6$I##-82A^M0+C%7Z%K4/Q]EBON$5< MY&<2C=2X[2AJET#;1#6 XT,BTKES@G3S'LJVD2=X&G+&X/?'W4G9[/O!P7:. MF@X,H&.9" M>];NU2!XZ(3*)T'G4E5[!" LWB-/V('9@]'H&:ONAZ?!93?4, M\7QLB([O +Z,9G>WDR.27Z"QT!03V^J91S=[73!53Y@',3+R.+A\D.:MLU35 M)3P<%C9/C.DX-0$VU>[K(-M -UBP@X3?_>Y@KA)3O-@D'8,/DA5&4\T2S,A% MG%;$,)-VKCYY "J6=X:SJ;GI229OER-\C*'0=B!S5PZTGD/][/W5Y?GKB^CR M\O*W]'*'3_*>CO_C\L/YQ>O79V\NWO[\84!:VA.31'1FLNM\U6/(\&/HN>E[ MBP36.!6-W4-JF/$L=SN]O\_Q2TI:][FD*.>=:",)YYW3OPB8!\&1@8:&2>W0 MUB2K->947E/N=L&YCN[522: 1A8W6#ZIS!&&.&$>8L\PW'V)O,T!LQ>V^KZ/ M]?%^H"^#NH"[V] [AGI/H*X3=)R+X\D<".@<,<8@F'(J!L%3HE&7@)V7%*TH MIK$2NR ?LHWRU&#"/?L2VOC8BIVJV#Q[@_C0<+MR%@?)-Q!PG68@RT5CJL& MY,0+3G*/S<'/%7IWB[.A*]8G/8IUV]U/>O,D2!OVV3&(^(*4Y9*)GZR^S-4_ M2646QYH[L3S_I&0L,=S&^ 8KO,C11S4\_.0;".H3EQ-!@EEL6E&GVF0\.T2F MY2'!\)U.YT=R5PXOP<3/V>T!<_&';_?=;^7&P5[F-WI/F#,G"&TD#W^PT9QY M[(4_$B)'/^03?+E\@N-#/L'^3)?/36!(J\C5TSB+JA;MH,F>/#TY<8$-A"V" MX>9.0 ^A;(BG.H]8IMWJ>:8[1YGJBDB\/?UF2QJK0;E+1;.Y4I^B7UR48,A! M;-%B/0@NTG&F[(Y$KC14DFQ,Q>/*4)^TCW/JKL\./^?B)P7M"75$NF\L"*9, MI:A932R1IDDHR6,+^F(FZ]M15V(JP+J:V (! M>1%R9YIL!4P,+"E?)G.L)$VZ'+SZ9U[*//*LCGZX/#\; M8V/'#XQ8WPPOP[SBFGEOS?1$(T(?UCS7Q&R,ES!"CB[2:3SF$ 7EOYB,@I#_ M@!>*)>PQ4':XBM+=&BRT=)#Y,^O%)S;#R)I$M[[E2/L-;QJ3$37H"9Z&$QSD M&.!Q3"E.[*1PO)(J\#K #W ;"Z(F2X6AU(39+G)*6\!%(6:T'7,>9_QJT&,] MZ]E,9 G@>>/3DI5UPAS1JBC0TB=$>6C4#W&0 M!+DOFKR7JW?'YNQ,];"92, MZ7JP!9)5O;*(5@.:8#W!)_=*U8U(*R.A(L9.R^D"8XFI,K6<3@5")QLL7397 MMX#W0P/ ,/6#NGU17--&N&VE/M&?'2]KO,O;=,/2=9\8 *=,S3G[+QG.]9I9 MV8;MR;3PB!:2TP_RMU"=I _26$4C54:HG"89HY!B/4>'Y!B]'ST$]BI4.#$S MNU.[F[C, =+"YKX^V-116UER74HLY]2%VBK+/:NS-GF:Y4F5^NBU0=CN9RZ] MG&\;D1#A\*+AK8J&D8) .L\9=6JG>G)'G@&#>P>(((E@ZY[N?E?0:4K[P5L_ M'M/WE':6)CL9M&XL@\&B VL23N#33"Z+'J\;&-*+&5+/XP#U"$G[D+>=AH/1KI2DV M$MK")O=#39,T 4%U!_TPZQ?=$GAB$&3P1[YZJ&=;!*ZM\[:6> M%.1@6RBL+LJ%/JD/EE%YT'6 \<@T+C+),QJ(@)==M5.]V"S<<0O4I4$Q@KYQ M!IMS!B+D\O*R$YSCRR#)ABK)FS)DT\8Z4PR3)4J?-"&W(,=]T0_B(K^8C\ B MKHD"9R?DW#%I]D2&61?""\3S-B&_&OUF,\8A^]H/3-XJ>34#W^US3I6FZL;@RMM$H&,5>2HEA)H$B9KIHRH0. BJ3D\ M,_"]6_/+PY%,\_C6L!65E%JV)>IDT-,2=TR+F9#F-K]7[=WCQT^HT.<>CDG2 M=FQ:9UU9KT&XV&@,#E!2Q$=H5MP*F_5'K=>Z\--!A$>#2@02V]R&\GTHW$K6 MGXU 4S&ZU[ >@'WB'9[3 PKDWBB0DX>+ AG*MMVT;R52@W4YQ8UNS_ FVO0& MIH95%,.&Y<4LG*V?%[=>?,B4*Z? 4K*:@H&N@]@1!?J1^@!/-Z+1R;/.UT\U MV/%S/ZMRI@M20?S0,96!8T8$C#.'Z97M:#9[-UEJ^*#IX:Z%38LA6:&<@U%$ MJAC6-:P; E2.&:P5DWS=*J>SU/&"Z@XTW"A]KIK0[WO/&=A7K4)OTBIP(]35 M,B^2_\B2M3&L4'N?L+;L?O.!R32NDP;>. C#!J&QIDON#5R&T\@AAHY2@V;? MPFM1E3>V @?O6:=W3PU*S_=8L,,*<9U*B N_157G[7Q>#IN3Y,I;%%UUO,A6 MI%&P3DRDCO(P/G"!R(7&HAFUPT7"?35NR ]CP#3S,)HI8N:0NQ,F5$ ?N!0+ MJ6ZXN0R.14XKJJ*!^?Y3E=+I-8G27&7DXK&H%^_\<5X:)@3BDU3:0[=TU8H. M/-IPHA%]A0B(203M+JD/5)@SGR;LV1&$%@B,_%83WG-1J%4Y;F,ZB(DEOV$F M(_^]!AYG&A@JXSZ,AM1R#WW:!*$U6QVM' B[$Q53$&I%SEU M<,0Q=QMGE^![:<&N,57B8NPHRDJ=E]((P6&F52531(E0?OSSK9AFE59SE M.["(#;^O-&!&*%P;8 LYB0D.)07/!&% I[H] 5)!] Y-04JDV#B+Q:+[)HY]86QKR MN;"1!*$++Y,9+K61J;?$Z7"DTGN"U,7_Q\*3'!M9PZZ$YK82MELPW)%+4=2. M>&)UVX*HK4JF9YM$ZQ0F!_]8WJZQ]3-#NNA)/7+B:J(9AQ^6 ME# (5AAS-3.+V/6440]'Q?#0@N8>YS$V'Q !+DCEV3))?5 OGTEQOJ:2!XWK M+#%34 @2)53I4?R-S-$FR\M?3@X0R6**^9IGO M3A]G&L17L'Q%DKL85SOY94 <6A&<.KO?DZ^^64IF;"MZ)#Q ^- \G+3YDFO/5L():W&,F@>H;Q MMKR0T PMU($I,U+?[5R"0G-.E\C38>-.GFW-YK2!Q38W9AA;HT[92>8=%)P7 M[E)8^5YQGW858(FG\MISUJ+]N]X/I]3L@:+2+&%L#K0Z'@W46[*;TKE:!)?>J3VQ-HOSN'6Z(FG:?)NUFT+2"0,/;5; ?%30FQ'6;0;U M%=F*1<6:)S"L8%N/CI^.HUC=0HOG>9KF-^1>]4;/3KZ9;CFKW%IX=)<*D,PG MG=[MKBGMY,R!412N5Y!?H(+B@A,G(V'2A-(2S6HED&*I<%@8+0IOP&:5=7&= M7..3X;!:RWG%&KTH>Q15KJ=E J*;D<*]]PF:E.5NS^+:T_7)>8 &$]EJ$E.# M-B?+H[P.R=^]Q:EQ^F!?>P2FPESM$V:GFMQ;M@54KJ^W-2/BJ"X68/'[#TGN M8B/>^/($76+&Y37UJ3PZ.'SQ.%_#2O ?PX6+_3*^,ZUL7II?"07#3'7!/ACO M 9X^X JO&_:\]F,0FB_#;K(\W9;N'KB.6KMX80Z;)LD:H\+=V<3EWSMZ M_>00O=YS)>S$>-(V'X%^G2F"0G6=?3V6'EM1-"*PUZ7US>50>AV[QG#),%^;!;*O"< M<$Z^H3E&/[LDI?M1/8]>.RFX>B2YLPJ;YT>[R9L BQY^.,(-#^LS 6/5K$\:<2WCEN/#,=/FMT8KE8^ _MVG<8I M5H+UB9%JM3:WRI?D'L?)I29,X52IZLJJ5W2(T>5*714$+[P@O0 MD%%&1H*%P=HXB'TF*QZ4"R)^AI;@R&>PST"'GO7K:FSW)+UZ90XMPV&@DB.< M<")&H?)*^\DTL6FX8+VH9NSH2]YQ+;+DK MA!#,%L(HZM4J\/7US:"UK*DA4[H"S#>C(T+O9L(@0AO'TY.W>DNS[J'5A?'N M)#9>>BJ[8'*?.U1'SI?PUP6+K4)$(BKY:.537"#6JPQ= +8H&8KE! YEL/#- M=U[AC=Z2BKATC%$A@0D6#5R)@%P":IICU5.8(YOK0"TC@V.6,H1($C@YW5TB MY;2$O/Z$XS&R^C'W\_[R9TRR9SH.^ R\NL4;WP^S]H,1U;A*C5B.\WI:;:5A MR#&'XWF/LXT&THQU>,2./NL@&GMBB-2&1(J>=DJ83^D: 'HUKO?EZ^^L^HYYJUV;,.5+A:,/C-I$^P_0IQ; M7BQ49G G)(;M 8A+P6A;'2)\4 [\Y\:&HNZA=R/V?5+:F+469/OE*L*),30LHK>@P)%K7@E3<.BSTT MS+ZQ)!_6RTS=Q7B:)%DRHT1(QJYCO;"[F&+[C M1GDY8869=S_<@,+0G >,6DM-SD5/<$URT,,UUFRJ3WDQK/TF-5#?J*IFQ>.= M:&##CIB]L+5?/'@S[932%I+FQ2(QE(0ICSNH[NY%&N+,#(Z">$<\*GT@M1), M+A!G*V-YK.=&OC)6NEGS(: #O?7<^C:TR*J&&U2RB5]HW-KY(B.:- S4EI#O M+P T>H%(AQE57E/?(B*%G]HP2=LQK+ _KI]T:=,5QN8>O!*E'*I*$M= . " MY!I7[L, (W$6P,T:0;56CYP7K%^IU% 7@,[=_.Y>8VIC_CA64]TL2!NBMNZH M9#KTS2F>U#.#AY*=^;OMQT##(CT:YMA-* ;_P,A%4^U:6R4]I+\R7CVR^]FF MZP*\!J?QO":IZTF;@/ZDD3=AM$K/2B4ALEK7E?$S.X=GJ5+)K YW9(@(,[)D M71>($F1$':\R V'#\]P13K)!1&*'@7,^6MQ2U>.P%7+(P\C#94>X8\C_/G_:W[C!\UV$F]I&5QWK#S -Y;@KC#,W ,!]LO?EJ)+=$NF6 O,PG0F5%/B)Z(SN2D6.A9X:C>SJ:,R"U?7.?I;+_ MD1UWDQ1#8+'X9>PW@J66JF1&*@\RA4)8 M!' ]^L71(?P^KW#ZZ>'\/J>"W+#K=4JL-%D7DB\ C>3 "V^B6<&I1NL<9.. M(%:#R2UV(1=/70IVZSVM,?%J8J1TBI^YP7?> H'[2R55'&T990?H I],@))]+R- ME#J.7.*$,&4,9;B2D()BQ0%$,D5,'0//2FRE>SF>K#4C&#QR"F/8&/B02[#* M\ANW[2B5"XZ7.6\<"?\.;,6*ZDZ3])-6.!R#7J9HHRREG\$*%7G>--5A.5_K M+&&4129I=@8?C=YS4\V/F9>)5H]6LXE85D4=,)YZ^BT3^@UL01D5(L2OFV$> M^M+B0F2"QRJ]((H?-?$6G8MY'$KW??%NT(N_22HPK&;;<27O1KL?1C$_3CC- M3.JSGC2U!;=?A"T@)B\/*MWB,\A =1T=/S;]+>OU']W=9T3]=&=_KY&X&M1K ML?&K? U#4"W_]C4T>;?G"=%Y&48#2B\]Y\+6:WLEF2E[7V!XMR37L.MFBYF_ M^[T ,;4;C;SO2;8'*P3E'ZH_(.C%\T'>^X:W7<0].GC\C$CC>%@AX9\US?PJ M!?),5YZ :0(3B?<[SW!/4E:?0SH(7%0;TWV'YMR0>CWGJ;K!UOWU+Z?/OWVO M9VI-$=9WQ.,T9/V^.Q[DRE:&*88S&29V:YA1$K8KGP+#5@0CB)D0;F+='TDR M;* N_'1SCCWQ(RG#M&,Q>]=,+/=-F$C0HN>NEC9B3C%R0MDV*<'F@OJZ]3:9 MI8=QI3\&6;KJ6(C]_-RN80=YCT]-E+>9>P>+@3U_+O6B*E!9=)Y IH^$LZ2+CSP&"P7M>%IIP^QQ6M8X-71$]- MBURSP0QG8&R?T0FFQ>?M_45;R&>49("9;").+7L4.9^$.:\ZB>VH/H_0C5;D MDL4JKN98E8FE#E6M2'6$Y$7H'\,2/H&H=X64*>&?:_$?;T='N M\QX7[]T6:(7=US"WKN/UZ'CW.X,>DZY:("9GN4<0F4WV183I RI][!/SM65J<5"?=B2('CK>D^9A2(Y.*JYDB(&5'OFZ4KKO92X=?+#:HR-,Q1^TT M,/RSR+.\[)H50Z?:OLTA5DM71U)JH2"J^0;$8;E,UF;7P '3NHA.0^LMF_&3 MS0W;<-%2_FXK?;2GQ=WI3)V-^F-:[TQQ-_1"IH,=0TB98+;)@*89[$[E,^@_ M,^'V<23ZQ&;1"L2[QBQRM)LV$3$,OV2-J224A&CDQ%O++IO1D$.;N1W=/;E" M<->=EXO":CP))HQ/'YJMYCGFK9(.XBJO];^'P'0,H (7,.UU1 %MB_F &OQR MJ,&G#Q2B3QW WYQ9 MUK]&_D^G=]/0X<,DP9S5[:+A+?9Y7V] I<86DA O B72H!6#4MW5&GPO"=BE&VZH_3C9Q-IA,%V9P^!;J7VN@>P1A8;UXAQDB8H3C 5 S;SM4KOORZ>C/1O7@]= MK6BO C/7Z:U7=]D\1@HT2O4FYRCVBOH,>K:79K9]3YKGG6B-2313F22@^@XF M\BLYMTGS)I-O5,' +W3!HABIK5 QQ.)+;4>4G 7MW7V7FXPC?=>F,,MO]H>] M>'E*E9T&O0X,&VY(+[7#!42_0EY$#'0&9.0_6(>J(D]D&QFE0W$ MT*SB??!*GT+=(]"I.*,*+U@B'(J2%NR59>/2A"TMMH.(+7W#8V%Q5JJ@ &"; M1VA)9X@XA5-A]].8P<.HWI!_JZ?1%/;%9D\B2=%SH)4-MPH[7S-'$!GH=.S' MI"<6S&6]VQT--L.]%$Z04JW<;*DRP-QX O[X=#0;NZ-_HZ#?>VSY 2#[QXTU M.A9VOPLPSFR 98M:+6QDV5+YGCS&(V=&^B3O+R3Y+Z6X&1(OPWYIWO2B=1,) M*>:F38@=&TZU\C?LQ($AT:2VX(^$4$%Y]5K=#/D,O_KI(GKW^NQ-=/;F573V M^G5T]LO9^UO+^AN>,T/KR_/K_!O?.+ %J+4A7J5E&L,F;-5<;[,$R;.A?.Z7@T2#'-U"$5Q8H;$9H$::P0B^ULR2];*4,,Y]@)T%"'/35'HZWQ&%&R@ M/%+:J?'R@R5;8M3^U[I(RICKTM!/KW2*&=38P+H@WQ=&VV<:B1Q0B C)#M8, M%.K<7.J]LVJEX'FDQ=:54-=SK),1H$2&A4_+?+X%^+K)'A>RKP?$NM@ K+$& M^@82!#NN A_PYP^OIZISR$)9OUZ7=>W!=)IJK:V_V$Q?A0/*K\$4_=XS#(L[ MRV^HN*&+I\QQ#Q&]QL*K!#8D%F+<0KO?&=!\V/JQ%(A:-@%/=I@D8D#VHG\L MD[5=R$%A*@^AB\OJ[F*?F5 N,+Q:C$6T@=")U:90F*)#PI(H=&UMV7O&?J>#!WV!;A>3$ MQ=2P)[-EGG/%,_SAUO@-X1;X=<(EVT5SN%%$<2>R">'_Z+T 5L?QZYYO4H.&KH9(" M?_'[NW-@9L'(JPQBT!2Q@>5?Z(I(-QMLW:KL?JU:&."3"5$BF@G705EVUHFV M,FE"R^<+>'\F1)AIS%.IDJWB:W+\^+IBH-ZU6CO\Y77Z^RPO$CID"WW4>DVI MM0@HH8Q:]LAQ1JVF6BTF'2+)J!@Q/G,)IWJA,.VNSDJ=1J/='_!#P'Q'QGIO N9&W:(5+G)9K *[/^T1Z&]43[M' M<+2?O2%>6$S0,'H>YD5DI:V!$?@[ @"N"CCMAAP7 MOS@[_RGZ\?W9FZN+B^B7L\M_7GR(SM[\*WI_^>-/5]'E5?2/LW]%/YW]DX/3 M[R_/7F/X^^\_O_\71KW?7WQX=\&A:;SI]>75Y8]G&$>/OC_[OMF$IV] MO_QP^>;'"$/=;W^81!Q5?_L>[S]_^^;-!07>7=0[!U-LE MD8R2BZ7** L#<>Q<%*!5^JT3:(WO7S=J-Z(Y1H\/P-D( "U ZJ;B/2_;-1D) M:KOT2T39ASH@8AF^S$N#P2^#\BR^Z9ZODI)(;6SKP@)-S527YFA/FE[ZRE # M34RY*2H[X-?=,K4JNYX_\D^D;-.]K5MM/0'T1W%L@&9+\FO<.-L\+NF,_.(/ M8ZN.)H=-^ZGH)^(\,4/+);_\6@>XNEQ4TZ3?S AG+X7E0C(F_D5%\$UI9_TC M;'OJ?P3&5CVC>@F=,>"F1\6K^LG\3>SJ*UN,X^VT] M)XX_>V^)@T65&=>T_ M#8R^ MHZ3EV"0]6**N9GF(51XS&BC #$VB*7J=D+6E\;U)X)-V$71=FD9T54'K:!78 MF"Z3B**X\ 8FJ!&H3 )BQ7ZZ U/[P3H=IG6:>/Y7KW#U5B)@TI8!4\V5B)** MW%(Z9F_V2GU*5O4J*F?Y6OO\,?Q@-4,/EJF^Q.&09I.$4M&]ZTZ)(O0S#;F" M*3_8E"Y2!+K6.*.IJ7XI6ZJRUWBGWW>KI0E6T/$3MH5L:305EFE\,CF8BY'; MZ.#%XE,=O 1&#UBI2G@T,)&8$\-J!%EH3 HC]SMF!2NO5!\ZY).2*KOFUSI3 M7+_/5&Q[5Z'5B3B,D7 2MS0[&E?H4_4\-&VPNPT[TE3%Z;C3]B)D-U= 5 ME]] -0N;"71\SH^4G@VB($U:Q;*1(,24_?6,"VLLSE62(HFSE+;\-\T/ M5SJ;J^N:"5F3W\&DNVP>U)C#$QFN#P$K;Q[GPN M!8@Y@YEK6OD:M<<-Q' M^>:SG[;8MI0G<-PE-M.5SJ>LQPBP%;SGZ'7(_&IK#=1)#RH_='E8OTG)\6,X MGQ,NEA2>F0?$V)=#C#T_(,;V9[I 6ZY3B>0S 6BL5YG3!4(3?O=-BZUB[,>/ MGCPZW?V^8!"/Q&&2B2Z $VW[.Q*15GW H:655YP9\]*S& J&Q"F(1_/5[[SWYZWUD@-(':\X[L75Y>S MN#2#:UD;K!:(^@ %)E;KU"2,[?X6VQ*2LQ?0SX'M9P% OJ)0R!PLTGQM3ZDS MK )^K8AOFQ@2EWF*57:'OJ]I*]]@" 5'PT6KN.X&#,X_5#%;1BGHY*G?%'V#1?3_/X%OY95JOTN_\?4$L#!!0 M ( )P\!E'HH-C[*IX $FU!P / 97AH:6)I=#,Q<3(N:'1M[+UK<]M( MDC;Z_?P*O-VQ\]H1M%JDKF[/=(0LT=V:L"4O1;OWG"\;1: H5AL$V+A(UOSZ MDYEU00$$*4K6A475;*Q;$D&@D)69E97/G>-??CD9G@1_##]]#':WMKO!,&-)+@J1)BS^Y9?^V4_!3Y.B MF/WZRR_7U]=;USM;:7;YRW#P"]YJ]Y5)$8099P6/@C(7R67P9\3S;\&;-^JJXW1VDXG+21'TMGO;P9]I M]DU<,?EY(8J8_Z;O\\]?Y.___(4>\L]1&MW\]L](7 4B^M=/(CP8=<<'A]W1 MX=NWNR'?&>WMC2*^N[/3W>]V]T?\?[M[N[#,7^ +\EMY<1/S?_TT%78NHF/S:W=[^KW<_U2XL^/?BC4@B6(J\X0W>C-E4Q#>__M^AF/(\../7P2"=LN3_ M=G+8VSCL])$7_^T2,1/&/G[O[ MV^]VMKKUUZ-_Q/0R8'$!FS%EEWR_N_77[/*G(,_"YE_D&ZK[O]V9?3=4[\'/ M#TZ(HTRP>-'K]QJOO]O^^L%C_T_3\PE??7>U5S\KIR.>_>/GO<-WP7&WM[>_ MN['PW[@>OOS[QME3#2 MXWX5!:PE7$4\WW^Y.#WK7UP$Q^>#S^<#>O.+X.AX^#"OO[+@_E7FA1C?K)GZ M?GN -#H-_N 9']T$QSS#10;%A!7!<98F:1[\#JN;!:=)N-4))BP/0KB=2$JP M6$12I,'[#.RA? *62@R*4+!@G*53N $/_EUF(H]$B.92D(X#8+VCP>EY)X"7 MY1E=\AZ-'I[G\.ULEF8,+\V#H[#H!->BF- U"9ORX'AP?G9^$?P^./_R.3@] M.]X*X)[_+N.;X&U'FD:PX.TN:>'N7O#Y4_"9A6(LP@"/^:U[;-!]-_9AO]>T M&O;FK(:]5JNAM[MKS(;>?E>:#?5;[<[=:K?]5H<]Z;:;Q_<[R62H=B%\S'@._7W';I+8M[9_: MO\9&.4A:P=^ILV9[WB2_Q0_/:L? ML%PH5A>8G3DNWVGE=VV^]IY;4(T[AV;3][I-/;YVF[Z]U5V\J=M;!P>]91\O_:YK-U[._[VM[O[^/;_L M'BUNO?'NBM]=317LM:J"T0[^WXJJ0,D+<#Z*?0"GMX@"U";Z$ZTC[(_NH#^> M;_U^D7Z1?I$/L4AUJ5ECV\4++(Q+$EW7[0V=\W'#PO/+7+=E^K4X MO7W/KG_6F,Q^:?=9VKK8LD\-.6LSDFO ' EA.$W""L$8V)#PY\>Q-U^A"0U6 MK]".7?<&]9HOS9N/?IEKMTR_%J>W[]GUSQJ3V2_-9?/QV4.A QZFEPE!^8,3 M5O" )1%%,%4!X2W%-><6SQ@1_]E4Z@23R MBWRI:M,-A:1;/&P6[''IR_DW\&_@WV =WV#%=?Z 9ITK3%ZEQ\':%!$_=>7X MVR<]O%>N''^6CCW-E@9S:4=9JGMV/CP][@?G'X*C ?STL7^QH-_#NF1+U;*Q M*TTZ#H[3*;#"#47AUFOABM=1BM>+Y[M[2,-!__?3BV%_T#\! M'>^A4'ODT9I9Y5G2*H*F_BR^GPW[0V]_>[@3#/P;] M?O"^?S8\^O@Q.(;_#JR>F1O*LNM"6L^^]Z'QWMN]X/V7P>!H>M\*WA__C_![MN=[JYGX"CIF?2^Y#U^.CLZ.3(L^4#TL]',GT,Y,%B(,?G@Y.+E@#(LA#@)C"9CY X M[-/["(F/D*S_T>TC)&M"6L^^/D+B.'$]"_L(R=I3TS.ICY"L!?WN'B%9DUDW M+6BG^PW6>Z0IDS\X]87>\S.[Y$$7T4;-Y@SNS/-Q*];A VI/%E [.1WTCX?G M Q]*\Z$T)X(_'UE>! C_[ 0?1&9^_B2B"+@,?UDUNO8,U-OX?7\\J^D]OXSY M32?X=QK=N+NY>MQ=VVGT1"MA:[?;#3[WA_V!"1[* MB/C.]K8/RCX&53W/_GC;]//!^=GP/#@_"S[M?0UZO[_UK/J Q/0_ M%3MS]M;5@'_6E?W(?.=G:;'QM$O99"7G S[K2;TU6$'+U(]-EH3'.ZY^9UDB MPF_ ^V66L36-@CT_OSW_"N[.\Z8]\UOES%9M\H'B8\=N4-/'CI\W MRNF)ZD/':T+=6Z*=GI8^K=5>K5EVX?EI M]/PKN*M$^-U/BB>K33VM"79]^\NFGM2:J3S_Y])./ MQ_J])(77"3(_N&$ M\=AS_>9PO4]M//<*?!;*Y:W:Y$/%9Z'AUH2Z/@OELU!K M352?A?)9*!^6]7OETE[Y+)0+N^0W9XTW9Y.-)9^%6D_JK<$*7I@D/)Y..>/7 M4Y9T@C\X*R8\\QR_.1SOTQK/O0*?@7)YJS;Y0/$9*#>HZ3-0SYLL\43U&:@U MH:[/0/D,U%H3U6>@7E@&:GWS+3Z[X$P VV_.&F_.)A^$/KNPGM1;@Q6\,$EX M/)W2OX);=(+W69I<<]]D;8,8W@U S4O;-+]7[NS5)I\H/KW@!C5]>L&G%S:. MJ)YE?7IAK6GI&=2G%]:"?NOMXZVO1^/3"\Y$L/WFK/'FD C]4K!1S.&_D;CZ M[9_PC]'C:2X*D2:_9CQF!?@I[ZY%5$Q^[6YO_]<[O8/[DL!M7V.C/(W+@K]3 MBG_;_G[].]9>T[YIBOWVSU%6+;FYP$7?NF,PLT[06ZAO[5VO9>_ -^9OC':D M]_S,+GG0"])QL%-_$_O?25:=GI?\S2CC[-L;-BYX]BN+K]E-7J?75"1O[!U8 M3EB11#Q15];D97>G-UM&ZSF*3UEV"8]6&ZKVGOC'T#S-(IXAO6,VR_FO^H=W MD96M;O8[2\>H!ZO,M^9G6,;4/=P_-=UL_7_KE MA[OS)IN9/GFWGM1;@Q6\L%#KXYW8@S*Z^8;SD:8\]^R^.>SNBTV>>P6^+LCE MK=KDT\0G[MR@ID_<^<3=QA'5LZQ/W*TU+3V#^L3=6M"O/7"^2LS:C0CJVP>, MG_U__)+CXXVC0QS/ZR_'PRZ#O M>6BU?*':F2?B(;UN[O[&)F0[J/E6'J]K6?K<&?GT=;<6^.\ MD,R//L(QO/UT7LS6NILP^VM+N[,T^,2^BVDY77<:KB__':?3:9H$%Q.6K6L^ MQF_J73?U3U%,TK((/K,L^,KBDM\'G_=,Z8$5\'E^97YE3X*V7"^"^=6XLAI_ M+"T]EBYF/(1;!@-\7HX8P@'/BTR$"+#, U84+)SPZ Z@3C?*/_T(*RDZ M*4H"YP01RV$S MSMEQ9GV.B 87M$][Z?>7CUP\.K=VZ!5^-;B>A?/XGP8-0= M'QQV1X=OW^Z&?&>TMS>*^.[.3G>_V]T?\?_=Z_WTXYCL@UX;)GMUF/4M* MH+<[?TS]^&8,Q93GP1F_#@;IE"4_N"W'*)!C$,F"X]XWO[NWL[JS!@R!.@>X,.W>7H]6>_T[/OS:*4PV!X>ORQ?['1+WG^8:-? M[SA+DS0/?HO/]R<7K6O[@(CL\'G\\' M1\/3\[.+X.AXZ#@=;GGKP>GP].(/>.F/7SZ]/SUZ%D/IH/=#AM+M2WQJZA^N M=LS^X^>=[KL'L7OVULON<4\<>CN4 !P>O?_8#\X_@#R<#?MGPY5.V4>RKQ_( MI%-OAI;V'339NKS-(B,('49PHKO!/WX^A#=\=PK;-?@\Z ]);]_]1==)>ZQJ MI7>WNH'\WPD?BX3T9;[UC/_K.D? GB+@^S*'C_,<7)ULEF9,1NB.PB)@2006 M&G#*+..%](#PSQ;%@Z/9#&P,##XLI$SO7F>GLV+9TV))H"BPHLXT/NJX#^[+ MA]/CH^&=/!B'I;1GI/2H+"9I!M^-9!XZN"BR,BS*;#'?_-C_:!.VW\E?@D4\ MN+Z$T]+Y(05+."$X]$M]K_'*3;CJ(;T6N2QA'/@GY2B"(&UBO2H!;> MR4"??4O2:_CLDD]!W%X$B7;-R:E*@48W 199/3S_;![M]A3M!GP6LY!X!J7S MSS1+@O.R0):"XQ$^B>[-:0Y29;^=*A_3O.B ID]CGDC*Y$66WMR+-LT@N0-4 M.="J"$RDHL 2QCDE_O@FJX-T.U1TLYGD W^2 V\3R/?6"&.87DH['85QF)5Y M\40NDC*^'"1>=[NR'O)@RN!PY,&7)*Q8,7HVJFVHP[1CXA@7%U\H "4]IY?A M(NU4@0R1\;!(L]QREAZ-U^;_%^PZ1SGM(R' 6>2Y1!8E$5 R#V&=CZ[M'"29 M=H_>9^DWGK'+YSE5W:7?KF&Y)%(A,#A;3_.\?%I*.D@Z[3I)(_ASF843EO/@ M3Y9E#&2U$YS/"B/"$C?XF(3:T--TMQ9^# ;]WT\OAOW!"SE-=\UI>@SODK$X MN.!AF8&DPD,&_%+D\((/P%7W9;KUI9LY2^,T1U?UZ8@U1[R]ER6Q>W6)'0Z. MSBX^O!B)W3,2JSD.N6\(1T(^YMD3IO06LMWZ4JZ9(SA-\B(K=?1-T_!)2?:$ MT)?U%_P%&_>F^V9U#?D+^7W>" M:?_E L0%%>U3:PT'2:;]EG[R=RFRFX#EF$<<8D8Q.$L+8#C\^^/%:H)]YTBV MWQ#+9PO?+R/?AIJ3^]J<)$/RT^G%Q>GYV4N+JNX;J_(COP0O\#.8DFF"]8A\ MEO$S]:61MA^K(LVEU/)2>7^I/-!2^?G+X/B/ MHXL7E^E,IG.S MX+R8< 1.@.TA7:;@SPE/T)A+XZN5D4P.TL8 O!B(%8:*OZ:%LF0UK2))+#Y% MM:Y(=2V MXA!C.^K>#4,;P*T]">)P%7 M!X?.44L?HXUF))1?M+J1/""1W*>9/EZ/)RRYI IXG%SU>"3:',KIT)JRS(R$ M/GU94@OQ7NIAT=W6I\6G?G\(ULN%<;S^./]X\F+LF.ZV.CN.DJ0$5?@[3SBF MQS]QCM;S4_!H\-8]FO549I*247C:8K"00^ M^,MFN@*Z=T93WSVL"*\BY,XUS=!=,S3I/K&_TDP4-YYT*Y!..@G_7:99.7UJ M@KE//>DSG">\UMK@$[O!6I2\$ 4HYG4@KOT_)PDMO0V)@J_X%B^\H_H^2J!A(^&2LZ23+I>WR$A3TIK=PGW&$+X=!1NRC# MD'/LD?UPD3BG"?56IW'$,]3P; 0%J1? !8]Y:!*MF-1), #U!'0-NJZU3T": MH6MQ%/V5EEF")\&S].1SDW*]6C!*T9 _D+FQ@?1"=^($W#"L^\<65A>3]!HI M]P=+HAQQ7Y_3^!%Z6KE)K%U)K)A5J)$!S\OX'AW/7A+9T!?XE,K>_V!=4+W' MB&-1<9I$C]B>(^BZ5D&,U-JG'&!.<,ROZ=.T*-P4VJ%#\(DEB4S,#-DWB31\ M# VV.40[)*TVQ:366"E\K..P[ ]/+$,L= C.LTN6B/_0&? HI-E,VO6VM2L5 M?"KS0@)"KC@V&IJ5CZSGW"18USH*0)_A:? ,^047*2?=@#:UUK<\T0?U/]TD MU$Z+\D?[#(N),HXU,&9X4R)]JGMZ4D'7M:)E),\NA60+((-BF?%5MA7WFRD2$JD7^)QZ).T9M%U-F4\$+ MIAW^U_-A_Z6";W4??#4_3A^(,FI1)?. T?1??E@T'91!W?1>T@;K^50.3B3- MNNUC-F/AP^3=G234CD4H8)E_IP*6^\=C848WAFR[M[<$R+&_AZ3G#\/;@JYK M/0&Z/0.VKEGYN4FVWG6HR4H_Z7UPF#YZJ;2.5+[/8 MR"ZCR&/H% %71:4)P/>O1,157%GUWRC(TG^@XV&Q+&YJI-#,@3DY'?2/A^O"+Q5R'O>[!.YSGFTL;%Z?SS00XGE]9R)+P0:T.)RFVJ\J5@#ACD_-Y"OYR MFFHZ?#@M$ZM#E:?9,IKI^ADQ'959;BIH^M]G/,GY(S&=DY0ZJ%5?UK@,,0"/ MR&:+R;6I]IB9)-3_".88-I'&4>:#_J?SKT80>*835J:C0P#4:\8 9&7UP&FT(U7::[5N(W6A*LLRE/*(CX"*]I)GV M&>=.Y[*LH1 T0ZB:IXF)@ \BCA\X"A3TG*MNWE7V644;+"!'VB!:$S69M/X? M'AOF)+&T88839>HL13V J28\? R,N9/44L:9A9JHN.NQV,IAE:G?!;1Z M7#%=3*Y-]3/-_,NCDZ]'9\?]X.Q\> K_^7 ^@!\_G9Y1B_>7Z'#JV9@?Q504 M*I:6@#4[%TF8,5@7O(;K+2YGP\ MQCX8(ODQX&R#[YQ#4^T;I8:EIG_;J:B'D,1-)IQ4;' $C'F>2__J@F=7(I05 M$X;O4LUL#Z+=G"35;ET2*XJ@_.G*-PG]?\AQ%HMIM:GGP$%;(]^5E+^'E/G. MO2"K>HBBW83[J:-&#JJX@ZJP$$T,JZW[$]',7<+M:)B5R.SN[T])-S<)MUL7 MU,'W<'*;8H:W &A#1]N$R+Y-.J@2Q,5/G:?1:T',.PW<@\U!KT*C>3>(U M:Q()P UZ#:31KK4^X6,$J5W]H%"Z2:.>!3NK9O=1'Y$_,_&8S707TVM38QIF M/GC_?_K'7X:G7_L$$ST?_M$?!,?GGSZ=#H?]_DL):^MQX;8H4K\M&AE.C=O MY!=%P1\P*>6@D!XJC_Q\!#M?Y3(?@3@+2+;C'-+Q4(>T#2N]3UGVV*;K9E!N M5R&1%7<]O<>YF&J;>BZ\U>?"^8K?'BCG.X MM+?J)/A0)E14D7>"$S#7>-XX-Q^:FS$P;.,.9AL#]]18R&Q-O2([&WK(_+T[*3_Z>P4 MSDF".KZ,D[*WK9.9((4,3LJ;X#2)^#0QJJV6W219_:%#(-AQ#9\')-*'8T;Y MHL7II>>RH% ME[Q!3&(LJ+/\M2@FU=!X&RKU@]5AP8YK/7:!1/O:UT;()AD-G\LLG+"< Y_E M988D>S F6H56FVH^="M4\=?3D_[9R0MQL7MZ?OEG=J-;99P(:L<5Y<%%.?H+ MZZ6+M&H3@=_^,276QET>F[>1[=YZ>L9[8UR>8;$'4EAWY+:U)YJN)-$)\"?" M5KA.-AV5"-,L"D[8LPW-]I_5%/SX$"05?I24CW%YB@FC;,+7A0QK\Y. M=!K+N'B\@4 ULKG6F[W7M=%CFKF0V=@H?@IQ=9)DARH+HNTR6:;_F8D(81A' M(>J[RGNJNC?>>?J-D]1YJ[4^%[.BFN#RB&7XSI-,MK'7TO>>,VKL SXE6*H\ M?^Q@3[#C&@:]IX:Q?\!0F&XP\F0FK--DZRUP+CW1EA!MAT#],U& ?_H?:\AX MP01.L>^S+)$E2QGXZ-DL+G]\Q-E".FUJR,<,TSLY/_[RJ7\VO.@$@_[Q^>#D M0C5G_'P^&+Z4.)">JB>=)U5,\D$DV&@*M-W1>,S$8TX9>G'L9SJTGU&'EI?" M9SNFZK*8I!$RV>]P(@"[/5#9PPJ!G/JDOY2C-]AHTNV4FYC K\Q^#92^F MTJ:>EKN-R@C5PTQ;;B_D\#1-L[_SL#2YE#0LT;O*=>/L^!&&7 4[+ZP6I[=G M]1?YX_3]*?+<2^$SW2OOA(]%(IX-&7L+YZTQ^7JZ<"E^^@Y3[E-/V6ZFZ%#F M/FDHQ3"#>X]E=-O\/.!YD8FP@&LN0#%B5>**IVNP^\"E),N_YM$-#]UYZ-FY M^+9CQ+0KU%,MJKG6+^0PT=T)3Q,0X*D,9AY=@>.*&3^"%CV6<]$FW1LBBGA[ M$?WK)Q$>C+KC@\/NZ/#MV]V0[XSV]D81W]W9Z>YWN_LC_K][AS^ME?QF>,-W M4Y9=PNT5\7J[DM#KS,>-4 +BHD522G96&=?@N-O;V]_=FV_)NI@5ZH3H]M:( M$ M4V_LO%Z=G_8N+X/A\\/E\0%46%\'1\7"CW_IH,#P]_GBG,*U[+YF.-_KU MC@?G9^<7P>^#\R^?@].SXZWE;RN2"-[TU^XAW'T37E^Q<- UE5+#_N#SH#]< MH5!*T>+-SCX\:\8B#*.^B?FX^)7^8I'GKS('/7GS\/3I/C9]NENF:&Y]M[%& M^UZ7J&J[Z6OU!@N.4K0%L1=US@-E)^>=H$QBK/C %M4AW (8*DBQ;N9:P&69 M] %QC._AN\4VW;/PY:.3"\6UM_UNK79VD8J1$0\T["M///C(KO.U6OTR0G?? M!5,.=R%.S*N7B/FER&-I[XDD.&8)BUB'KOH"PH>QAP)L0UDZB-4ZQ+W N3&_ M8O#.?\&-\D@0?*@3,+ANRD&I1L$X2Z=! 2^"OA#^5]XT*TDL,GY9QJH "N^, M/E0>3%E$G2]G\-TRI@IB$"!PH.C)>1E.@,:L*/5Z\(:SZ+Q"4,UATR')X?59Q$9*D:EI/4[R]^#__4A>(_PB; MZ*S50E>6],B4_H)8@6M?_46SM^)!DETZI; *;TIU_)XOGWNI].!?"2\7KN3$ M+JHP78_7N2OWKL>J%V["@O=P>A."5^_Q],HGL/JXG(X$>XW'&)S/(9\_TZ55 M$,?RU)?I6K0/.'R.'XDDC,L(3VNXIGGFMWR'#(!9F>4ED^. BPDK A867A6M MR5(7Q2#D*;)62UU)S1QG:9+FP>^PP!GX;^&6Y[3G7NI=#STJ[YB!_E!)&#<4 MK6+#M5KJ @*OR3F\G)ZN6PWS7+PF+[)\V=Y<6)NM6"LEOERCQ 0EG6DH:5:# MDJ[5"ZSLJYB70=>:8F3R)>OO9H)*%3C \^J:+'4!KT[5> O8.6O7G(K\ DLZ M1' ;.*/;,*_5NE?2"0Q;AR8E:( %#"0/M2!7'8@6754/TWEEL29+7<"[&:93 ML-H1!-@PL5* MGFC2>!9^[J7>U<&VCW$PZ=60K/21[PD/@,Y;= M!.&$)9<(5\O38,PR O$9)="A#6Q!L6KL:@5GE0BW&P5NLU"P>$=!88R;X!JG M4+(DX D+Y1R5X'0L;8I P)5X_S$\NPA&O+CF/($_5>SD-L^X+]RUO4@S$FRW M]\1-.0ZD 9USV;KDM0=<"/"O@-:P2Q7V0FPA[ MHN# L(,ZW$L[.K>9M^K*IMY5Y_%Z4.=%;7;'$WX-I.R%EL+U5"GJP[^D2PR^0]6YV!>)K@@IZK,7/+96?42E%P* M8TB+W*3&S59T3!F.94VT _JQ,-E4?7-.*#"AHCG829&57)*M33# M>8[ZI*P_<36UL>&RT5LK5EI9-CZD8#GI)O%VIT1'1*./!6-2($*K-X/(\Q(X M>'13DXPI\!=6I:';C9Z]]-9'($O ?9B#SK6?CE_U-LDS[:K7)Z!/=M9JIU;6 M)Q8:*>@GA2ABD"5PV&J-4S!E^"U)K^&S2QJ:XHBR^5+%]:J#]7HBPDD3]($. M)]7O5@"7]!IGZJ"B*A-+547Z5JB0U(F+26(%;O(JZ)G\46X.EFI'N6)H&1=. MRP*#P=DEUFJGP2OV.D@3WG(8&4PK1:!JS"/KG;59)DTQRVZSV$>Q1ANP*&%3 M$JI7H]5.HU#Q53U]GHB@P,ER7N59LK;HCM6?"ETI'.&Q UI*S^5?K M8.TYCG*(9#J;HC0(T2LL<%0PX7$4_(4MA.'0%70"=Y,$WA/O"(9 &)X>V;KX='>\1C <^ZL5?3_-H\8?"]$S)X]4II M\0V@869=UZ!CK@@91&5\8UON[)(P >1SH]E1XIPH@<\T*\4(9;RB)[[A1^#N M6FF*.S1B45LYNJ'6[(X<;D?8,Z)-0NZB4-A*ZJ1-%&4-?9!SC8ZIGZ= RRG& M@4')+%1:&;JZOP-KIS'?I!$N+>UHJ:58T-N/U7?C M-,];5\I#AJ%I\_?;%!7>.LT+K>'I-?$P*-*8)UX1@"+86RL)6ED1#/@L9J&1 MC3_3+ G.P6B S3WA8_@DV@RS6&99 NK[0>>B; .#64)Y]-8:9^@X$[!]#D9A M/A;:>EAT0C^*2=/V,%C2-6Y2*C(959V92@V M_-8,Q\1=W=8S=5V.D4=G2X?-17 [,"))+A,+J7NF=C]>40Z"> #SE\#CR.# M:G&LZY0HSCD>BXA=B>*UY,6[1BA:!>EVD_/E,)?#-@K%N&"/IHDH;BQ%0V 2 M67\? 6O9P("7;($9NIG-,/.CQDY1=&969N ,D^M]R>EZJA%AQH11 M&KA2L54(&=V V_)XQ76*2Z&$U]S;Y"HO6SR M,N.7[0E)?/+\=_,%1T2>5E17\;$:@461KTK%A1:5C&G(!53/:ED,O2&1=JD] M1Y5N+,2^"WAG7=G#"KUA7J^!7CM<*R6PLEZS':8/W!7LVI!*$[3_,&,BFM-6 M+64/DM?3L6SR/B<.L@&\06KVMN#%P&,FN81S2PHKFP(="BNZ##(D<2RT&DS M\^\AYY%U-8+$-3)4/L1C4YX)FQ)QS Z(I$(XDK'F-1AHL+=KM85WB V%Z:6N M%!S+Z="NF&1]4!6SHH&>#6)V+=/8-(%"12QJI79)JL,D&A"322K\9QZZ"S=' M:XGL':/WREF:*%..DG.Z@*L52P0W1.0[?$2I$C('X)IK1GZT>7+PBE^!%7<] M@7\FX"S# Q,UTQO5=3I^35_#%RUDQ2^6^,)E%+@9EQ*1GX$ZA_>D&1H(29#I M_6KE<,$X8Z'>;E;]^16_%S7);<=_I9D$W\!ZMS(K9!TYO'3!&_-'7ML#2G!' M\R9^RRQ7KPE>0>5_J@ <$AQ-R8Q+QQ%IU&+E>N6$!33;:R71MVNG[EZ%ZLTU M1N=+#;_JB)(Z2PLT^4& $J-%)._/]"Q6&3L%I:&$ZA\_=_>WW_4Z5C@$*-!! MX0)JH!C0%!\%@21G8NV#8#XAOSC"6H?F$H-DU-[)+I_B#:1NK=ND!&1M2'[VC1X5>7'SI!^LJHUVQ(Z[*$=_H7^B/(_U6/2+BC\9-ULZC7/0 ZL5M\)$ MU*O037"S5IK+5(*D@Q97BKEF'E?3 6C^:R1R3!KH^Y1)[?:=*A-@GDB51_5( M0D>7$&"3S[Q3QVO0$$K,EZ.'8(8!=BIH?I+PC$# NNN,S+"$*3@5M?&<5JAV MEM%\S%?5G?&%9QF?BG**JY&15ZL,$(,'P16+2U,6(5_+RML;=Z0*!FY1GP#K MF;)40;GPS?NJJ#/F=&/"T63!)1R/!<5UF7S!ZG(;X.P]>5#\CI;['S=&LIZ( M/,3@OBNAQF%#96#5 ,;_L&'O#'\'SYSA8!$$E57S9Y4CEU[7+XC4V^N,L(I& M@K1KV ,K3%P 'J4^GY59.&$Y5>ABNCCC7/464Y_P=HVGF@Q;?U"E1"H.(>\N M!_IBE^66^],'W#P'M"RE5-N>YL44Q-31*OKW6?H-F._2H4QF32Q1%"G//](O M$HPYKR 6=?%BQF>.V?6XC(FG$49 5+07[>HKFC"-24.7!3%4\W/E MT S_MH_N+H_OU,T=80EH'W32\MUII)^:0$V[P M>>JS<8JF)3SQAYBDNWVX,5PBG..2W:W]MQ)FS\ QACM>D=,.-CFPPY17/OU* MD\5>TE:[M]?=+=H2*JF #2YN?C09MUG[Z=R&=@^WMG>(M%/0SC?N5*3XW.J2 MW"HJVUKPL7Z J\*V.: 8!30I1R\1K'DS$@O*O3#:7.'(;,QLL+/5]?XC^(^. M=EV1E2V?=23N3Y9E+,$TQ?FLBM /*'7AB%_I4U[/O0<+&TO\K$BJ=%? 2:K*3T MF?D9RSS#;QU82Q+E'1-=MF/5UJ!2]1C$UE+^:$XCSXW6>Z%MYG?M-O/!H/_[ MZ<6P/_ PBM]V7851'*NQO=90S(%J0N?(T7)41YE3/WA_VJS7:8.9^BD3B>IS ML616M#XLU 'P#:/1\!T>PWYF:2)"M'NG$B=@X9G]CC__CJL:62JQN%0],,VF M%\M'A#Q[/>SQ4N%T;H"*G*GL@ANM #":[ JF96X)&G)ONW9H[ MZI7H5:IF O;/B/.%^9\?RLMO$'LXG/@3[8U#S0(/S++-U:W*L!X+04P;.7ZJ0B92/UD8OL= 6['.&4+F2K*8NX M"0XWRM?:GEFE$B0'5^,]1!*H:0=IP),<=/'X6 :@F$FEXGK3,)YTXG+YX@ MGHX6FFE!A(T><,PWY8$UP=41\51U-[H7V7?J=&8JI=?C'5Y4.M.JV5=%%FK( M9U&Q6Z501!Y$G$^EV9 1%UI]!&JF<:XJ=_ /LXARM)[P NJMARDX;(8FY'ZJKN BOP"?5#KP6-:D,(^\C@(_@:,U8 M/\' -769!SMQB"/[L&%T,% !;4=$TSK!562^W MFNLB7%G(*XCZHGMVGE*Z*!C4R6 M7-S(&0'P]H+F[UTG\L.V^$='1YGML0(M'\_G(FLSGRJWD4PS]:6E0SA7R7>. M:QZI[\*$&M'16;4Z..+0.*5&F2RK$HI9&5<]W:FX$8O#)RRYY%)K8#*4I*@* M$C83.*I!F9"S-8M[C6[2V&\[A5MI,X8]TJITD)[:UAC5]$.S?S8.W;JOT*V$ M:_UT>G%Q>G[F.U17=-IW%>3ZD5^R./A,)SO\,-"G%\6[@D$U)P@DZ82S8N*( MDCI-JO(-I6(B7/[$G.PES+J)#8"^Z=C M_H WCD!)6]I>648R4LPQ)X;0%YRDG(:EC'S9+0"LF#9>TXSFMX:X=8,4F?*? M9<)/ZY4ZT%'LC&Q2@KN\5!LZHOF&JZBS^FC?B9((W6@>6/I*P#VX3/2D(^!, ME1F7 ,FBP.FXMMJI]X"O:89Z&6$USTQ;OM8]6D?'UL:OX7H60]BD^59)I:4 MZBJ(T#PA9HV2\(8>I%O/_O+?.PQ;IXCSLPD'2NA)5QT%U26?5Y%P>^7#$ 5N^H+:OJUF%:%&-!W> M+NK!QK5XMU6"5+4IDP=;:LXD 470-I+&'[7U C\ID^Y'KFRL9)([#B83M\UZE:N]5&'K%0^JL$,K(;0>@I1K*E)6XS]9>C MG .UE_,SPA?K04?]P;-*Z77 !XSX=*9C"^=DVATAMTBK*_@3!UB?)F!Z7<&. M.J(=6SL]3-DWCD$@=J-=)#UQMU8"9?6&M2;Q=$![(KIX5;&2L3/\B*)09E20 MI), J6<@*#T-R'8;42'X++30>4K0)D")0'SK&,Z="] =U]7&=EC%: M7=05NEX@T%2G+_D4=;3DZ0+'1Z'!]#4M5$1-GZJ1/%:I%D4?JG1>'(6JL-4I M7^.TGA[(>$$%7AJYD:E7K6S/J/64) -2%/,]D'%"9R>X%.-BZ9Q.>EHG&)4% M]:>,N84107W;.J13^'/5^7-5R- G8HZ*6'JL5VG!K1('C-D'4\ZU(%K!S-SW MVG#_Z-4FO!S-"=N'68]H4>,+WZQB$SJL-/PVXZ)%F P7< H(F7UHXX 7BF(Z M5%'K]^>#P?F?IV>_!Y_/__1-^F!QAZ[&K-^G648SX8+/Z;4[_?F&-1ML8;@R M>"40^(BO1[-S\B)-P8[4J&IVE0J9*@?ACM)R5'2"ULGEB ;^(Z3$YU+@J$2M;G]G2!60C_1-.<-7YF[JJW6[W7'7R^-S!=-S!' M)&0!3?W2^7!9A"L+@15T5L7%%;@7&-O,X&LS285X<+U5Y^U5.=1'C;VI1N-(]I!&#!\5-=R1JKA)RT("B%(J==&L9@I%L&Y$Q/@7 M])3-]YL(OK9Y\,3)A52'>F!]+D-8?"K*J>%>"U^HF#CW/+OIUO9ER1"-RKDJ M,# ASK%2BZK$J,92NOA)#C?5!S5=5F/-YA<[ULSO*B'/2=:$8]#9,WVXO417%.N)JRA<6*<7SS!NO]:.H2J&?! MLINYWF\^*+(!'3RG:59<@D!V@G "A.<8"N>D6D%!@UA2]%/VB E1E8[CE%%4 M5%\NBPY895I8%13D]5P2A+JPIO/AL'(9M4=6X]JZF+',1%T4_II,B'%)P_]8 MGG,%/"+/J9#YLSI7OM! S5L5J#GZ..P/CH:GYV<^1O/;6U=C-$=QP:MB3 M= M*$?(7A19&:)(.!*[F8<6!F\7H K3[$= A57/+ \O7!]X(1XD9ILY6<;P/C[( MY7J02T[5K2B&ZF0GB"0UC\1NLGHE//(L[GJX#-QLB4*@>>4IXOE$ MA,R-33EU]%4"@LM$:T!TQ\H8B^"QSP>U'U6?>,VW(>ZYF&N!U:9'6@Y2HSZH M8!-<:QRA4?(?,KNZVX<;PQ/".9[8W=I_2X2-N#P-%718[:PTJA#>: G_#X#$ M-VJSW=OM[A9MB>H\V68SVU;OK<:RMJ!6X!E_8+SBSK&+<(5 MQC98AC9H7,PLI=CC#J? MD[Q%(8\Q%RGAR[(OHPR!+/]2D7;NHKTK'!5\2(WV%(P:/?-ZU 7[TW)['K?W MBS8A:7E%F,F,JHD*67#X.(;"C[/:"W1%O.MQ;]?#T?X:QVJNPC@X8U-7L'/# M5 M**2_NZTP_9_Z_>'IV>\7IF7P'^X5.^A.R;12+LQSU1>YYJ)*S63>GY8@5?ZSQ[> MQ,8XV-R*3,"QR/)BT<:JP0_=0RSB+2; V.=\8TD&%Q!545!HWU$$BKR-'NX M50-[5"A&W8@5UGH6Q:ADJIYD%E MC9PF><%91(Y3J\)V1%^#=8VQH,94CARK+PDP-M<(CTKH%XD>HI/55*HR88F8 MIF5NVW"E:4^Z'M1Y49J=>@SIN!^H(_TN6(L.^ZI.2G5RMQXC)Q+WTNE M';0%T*EZU$S@PTXGB4K"ONZ@BB6OU!Z?9YO:#(?:1VJ* MHK:RU'=,]RH*NZK!X64DJ*%5K28,^TC&TL2K!6@NQA!*5F%5-E83 K1W "TX1AXJQ> MEUBBTQ)*V=^FCVY!,GL$W&($W%N/@%M;27<8=F3T?@>\8))1;R2BD;BW5CMZ MAW D9DR"$QUZ4$9C-2?&(1.QZK"=\T)'6O0H;?F>D1UBF969GM>B(^UHK]2B M1+9!92RTCC:;5#2SL\S$E*$G^_G5> CX*X]X2W[#LH[PZ)31-#TPICHEB^M4 M9QRH_TU]S#*;BZ11>$X>?M(TK;VKCZP^J]M>V]EQ6F9J:Q^"@33KC/FU3(/Y M!EDOU>C>6<6R?CG[_T),L0U%6I]B]XJ:;A38A5X-;6O\?2^8;4VWJI01",AT MRB-,NV"[ M*E>C*BA"G,ZU1E ]!3:**BZCK7^$ ^?\2!G(F5Q?&Y&LMBWE\K MP5O98O[ 1(SEY6"3_8ZMARV+^4\$(E&D2_[1(=N9A2'U5 !C,9V*/%=C9QJ! MUB5F+A4P*<,Z29,W*$UB9OK/J7N,;CJZ3X-J%I[3-(EY*]O@1D5RQ72S,NSB MG*4A)SG-34Y9BU5PA!?(7O^MAOOB3(<:5 ZBG@GYN84FZDB(F7R8NK$>J,HN M,T[,H%H'JM<2:62:Z,C'P^HH(&LZHYNW7S8-4)[AUX:Q[*>KN*W^IHG3POWT M# UZ8EZ[3'L__#M&J7/;"THI=TS M:]D.!C--W&.72/4=K)5BN&M&"9-(JDC$N%RP^8XGF4Z7:0?I@^M9,J9&Q@B# M BY*_F?ZR%?)DG_\W-W??M?MXI@NRX; 427J<>C0>8?,=8,4%$+*_AKE,ZTV:&K M[0B'C).&TK#4U@8]"+9:*1@Y_D+]PL=CA;RQO]61B#F[]E<4-$YP9LPP^PF: MB=G"BZY%'!-J[0HL84*DC2DU3F--T5)HQ!5]3U#W>X+6^TT;C*-TL',U]8KL M?PUJEQ ); J9)L D-^AA@%0(Y!<#SH C\SW:V_D$;AV7TY%@&,-")UK.A#%( M#'5H_K#*W"A^?C,$8=)\P/S7H$"Y]BR.6<(B)OV' M+XE 1/T%GM1YB](UZK4^OI4R3';1K)Q%K$J,MH)AJN("!9[R,KV43L2('K:9 MC1+7XW5N2PRV;2WNG3(PP4Z[$EE1VM44,F -W"5-M:I\PO!7H2+DER+'>6IZ MO>C8>!KWQ=:"EU7:]^; MH4E'K(*C)4F 3@-17848\K:@D@\C.AU&7)H.TH66L@_;PFI*.O>7< E8>2&? M%=7O\A2O,C]AFD1E6*@@TU6JJ^+KL'V/('$[=+FL$'MU)M)NMU%0/N+G?L3O MV33#1NV_>PQ@(G0Z:U$KHQN+A"6D!"A/@/F O.$RZMG:59]1SQ5-KG".+;J' M>@9+*UMD?)9F%2=((#ZELJBDT.^\WODK!S=>'0B4>N2%SE)25T\KR&Y5>:K: MTA^#&&_2MCNWZY6%2!'A6"5V4:)GLU0DALLTSD)-IJ\KNRS.N&.<8.9:,V7>V"G"I48@* M]\#OS2%%GH&0@9SC'RL.B% ;2C!7B&;,('>JFN!:[Q=?)?QL8 %$JEW5ER< M+S 3S9,+X+F)4.=;3?K$Z'?F)_I9DH;AQ)APZI M)Y=<,O(KFBI6>U&=+OBJ M#D*1SY^)>>U01#Q_)=^^3G0CP%;-;>UHI 0:.(H]@"TJ/D!7/ZP..&_'-.P8 M1ULN?E;V<=\ZXF5K$-?FOH!K#:]7J%XQ;>DV8WJV"'[\OXG&R>SH6_J][J2SO+C\I"M8:OQF3K M?:;N1OHFRZ2AZN6C0-]2 )!KBZHX6ID:R$WJLC:QNZ59$'4:LGV0-),G4;#$ M)_&'4N-0;%MB*VC';D^P@J=D]?3<4>7M:?X,8O'U/4A&&?I5(:?<8S+ M@HX.2XY+9OG(UR.IC19 MPKAC2UU+_6%>,&Q:J8Y\*V?&IJHSL.HZ!-L<7'/^31_"=$%]8*\_0/$ =;6O M3.T Q5V^*$/58-:U<,RXT_3R@*OGQP%D>G0ZMH)+JIFF8 2!0J"YVD8N%IZI M/W" U^S6J@LPN9O*/3:6;Q))<%)'!D34WZD&WH1):SVB%MG4QF&/6MUA*\RJ M7]B+-8KUV[7B_=4'JJ*CYXC<#FN]'1"C?24B+,@6=19&YA<13;21?NS]4\(O MQ\)QU^:=BQFK)EXRI"AS@FGFM]AI(W8\GQJ0>0,,QH[4B(F@3+#GJCK0F1PY MWA;*DL=IS%E4#?CTS+.4>4('F>? YIW%N_TC/&2=0M<39=,=3P0?!_WO/"P1 M112T&1>LY!D9Y'*SSZ5LSSN!&ECL7F'TPS#'79Z[E$ ML2RF]144LJ'<]EKIVMN="5E<=V'GD(YB$*L$6Z2[Y&*HT,#2=/4B>_.60T;Y M]S]V8#RXP'7T*#R*#\IL76=!"*.[%X!*++'B@Y3F? !#!R]JQR3VO%]DOFT: MU58W'EX,5284)KL2.9?9XYR'&2]8=M.XC;:Y99]F',R@7[T=Q*1 '_"7&SEI MH9'$G;_:PCN9JVA":#A):;!3HBO^8#]4FQ:%(FE+A\L=Q-YO>O##W-TC'J*: MH: Y^\;M["EW1R+*EZ$D)GI3/KP!6 MBX!C.-N'UN_SXLTSV[4NL/+,/JJP'*XT@!W:.O.6.74$]!JCB$F1JE"']D2I MCH[CUSZ1,7H\WE!\=2:+_DKI+ HUX@\25))4X)K%J)3;3@#?A.-(& MSWR0&2R?MT==JDXZ\Y+1$&C+"-)"(D_GIIBM<"_5D!4M")P!P!-+D0@[W8U6 MK1H$K7-GG49W@/FGD5$!"Y.- E2&G!+B0-8$Q%W926DF0)RJ3K)>7DE>72N9 MEO)ZPD.1JZE>%Y/T&MGC#P)/ -]\3N/8$:EM%%.OQZ)?%)*^$_ K#KIRFE(P M95;*676W5X68B7/@=X@(BR,20JI+9IP0,QI\[0Q8LJ.'0Z%N5=.^P65A58^S M0K9T*&.#I*55$(#,NFU'HL;J)M8BKRGB0*-(7F<*V6^MZY4%@0/B.D>4YJH^"1H&4L)XJRT72@1593,Z[->8$Q<\*RK+GE I-G&O]^^EFA_L&6>]NFZ^@_LDJ3=F5XCWDCW@V2432:X' M2MW>)\=G 9=E 7>0A]DC;7&58%GHTJRDUH88M[H6N3E&%EP]A\VC-CN3\$DR4<\R-4%ZE A-%B!=K(F78$EM4^O[Y M#S?^VBAV<8]?S"PU'6^B\\U4Z9GDN_I=I=_UT/9;.<,?#B[7?LR'.8V-8$]K MK\=/&YU+"LM)K3:3QLH4 MA?>*R"MRK49=)Y#,]J,_A.ZV!6]SQ#TZDFR[DNVO5'*U\"L7GR/+ 14OCLRPF,BNI:LS#3&#< M')N)44R\ V;*91DKL FU/=LS(N;CG737$-)I-D>QZ 'I)6F-14% M0V67ML);I:@Z-PA\ VF#UTI0SFO!($M1"Y2KR4J[D!\(XF1:3A*4[/0 M&*B00S94_)IY.*-D:U?K-X(6A[1OE4B[5!@-;V.'4ZJ028(&VHR'<_A@;0VM M<$(@1B0F#)_'PMT/"[?KL7#KK,%NK/CV):4Q@41OB$1FJ<5B&C-$4N5%EM[(KX\L M1IHU&.EE:PE'0>M*.(#;AF!(SR:JT^\YG1G %-,R$:$*SG[BD7!F L+14M%! MQIXQ!!&*&5.PV<5.ABX8[%#2P*:3/%O#.IVF1"?=XJ59B6ZO([<6(3O3UK7+ M]833 ^ZW@@XE!4CS8/<5@+I;R!1+,R0VB_B>"O!X>]J,IAG;^PAG!UEDZ"6TWM=QO@ M..45KW&_P@4J_F@P/#W^V ^ZO7_\?-C;Z;W[>C[L7P3G'X*+/XX&_3_./Y[T M!Q?^*.SVMER+):M^YF>J.E/%DF4SAII.U']QQ7:V\/)D2M:'VU.N9L%L>V-Y MFNRS@M)5EXNIK! #._8O[.'6G,55*Y3M;>UXK+WK6'ORC!;T<) EYXT.<*KO MPO*)A^1E-1V95(-Y"_3A,#"ADR >>_U&E$+FL3)4ZY.CZ4/T$OAWGH4B5Z!Q>J:JU/-]1!:: *[EW90)( ]^ MX",]/QJV>* GXE#J*#AF,Q:*XL81$^#(1BNKEFIU?8P\OL+0:.V)WEJ>JN5& MM7;%O]OJ7C>W;831Q-@T%(I2&0BO#2[*@?KY6/#%H?..;EIB^N#JD@]K]&[, M+\$ DG]!2ZB^MQ3-+S(0/$Z*9<22;UDY*\(;%>FWZ:8(Z@?VKJ .7$MBU=0! M:/9_$R?_H>"@:_4R2_J12V@BQ8!:+/2,7XKA[A12_8VT$:V(L2N&XO Z-;-= ME_I'N80>V=(C$B4X>(I+Z3'F(^H R\@DR3252%;"SPX2=^J%V?.*Q0L1"I%K M6 ,E1(U0"G&3SI5R6W09"65(RJ>H0K$)H?H MLNZ,AQQ^_S%VV*B^-\[Q0[--DG70IC1KJZER)$R2?I*./#7"H93P6%3MFM5\ MBI"I463VW!AU=A/WS'2U+R( 30-X5.-:!UJ@S*KSL56O3?V;%CU_V;/D,+(D MM6Y*]Q+6[4 LKM/ZLTQ\6:[TQDR>P]_U]+EZ2/E'9_ANE(BX)R.F-51C -(M MS;YI8((Z<+&&_C)AM[0(]YVB-B&T,7== T MM]X.2!L,0#-3HNH!X!][%@,5X6J450+GSH3%9@C G+_0\GCS:RY; \@S M MX\A:U!C< 1E,;TU1LL0:][E26P_9N00586L2U_=,W)"#<9[UR+9:- ?5-"91 M$/;+0UU-$])@X M*86ZQPY%V*AU4,.]DP76N9SDV%;50U6"8P0W87D/E5IGHBAHTISQ(-4,7>DF M3#EH"*H>HN^"FB M%X.[,8IOJGDE4^P[=.F+@61\SK5._"H^]R?F33Z3HH=_ MKZ@?9AZS2;Q3<-OG(H3J>J=?,TB%-43_E\0&Y6CF(18IV,;!^EZR#0 MT#O -T=L^QY*(Z:J,+T$4I..F1[*>"-[<*6HR4*@'#KDB1R!3A*%%!0AE>-< M5&FDC^PZUS*GYF-($>??P==(+GE5ITNV1?7-YBQMC-_C,WVFB830M?[\2@B/ MZLI>BJ-;T*/^'*)W;EZ[MD$7!-#K!H**QP -([@4@V7<.0+*A MIN#2$>465D+Y::HFE'*YK[385""*,?#YZT8!*GIY: )&TIV=P^8&C<;JR@( MXI*+ -\Q$P5GZ37>$'0L-!B(/,F:O#XB'PM^W+/YNXA/,,4?E/A- MY$S"*J1-<[UJQ1E6=R*[:J*&5 QF:3EY:1*DBPM+;GEB6+L,0FN8Q(L=K'0 M!^;@-UN=-XQ]*JEIEN T(37-#$PC^>+S;F[GW>P !M9UVF-[EOT9TXC]RTVOCR M6CRO^6T\1>>>CYY%!:*0N2@*+2H MVI9X]X^"G39HD[F#FWQ@8"PSD.RK*OABRJ'K-KT<)B+B*LNWM<"2SY&YL_-?L0Z._-PV&9O!9 5X%I/0VD%? 721SAVS@ ) ML*6),[: -3L*>\R&B#6CF0$FXX@SGU19JC0<0+%>X4NC^.!55,NMSX"(,_@> M]> .51NG6L6VT%V#MR&[#R9OGGT MK7@@V]Z>4>J-^TTP[I=8V88I4(VW]#6="_?K43W2.C*_^HFQE%0^@SVZW5[0F ]4GY82D1];K(VX/:VM[V;NM"&7"M M\:8>764[4"Y)@M5QWP*J='=-@W32W@H7A5[;-\G3K%:!9;E]VF#W/IWWZ1SV MZ6ZQB;U)[$UB;Q(_OCG@6O/%A>9 \ EM101EPZ98!8]K\5Z+[>3:*9]Q526# M'8\3;2_\X^?N_O8[LMV,09S32Z(I/$[C.+W.O17@NA4@YM,.$E683MN1TP;( M.M_0H]$!KL$U2L4V1O!@'QO\#_QVZTR$UHD('A#H_.'[8SQHH_17Y,$&^%_A M8NM-+,TSM/UG?VF^!, ?['2PN]805A[L<)1'I9E9;G<].3()4S@<')'^7 GLH)PK14:60UR>XW@F65^6^U,W"ZDEC[]"5O4,O;![HCIH'>G(ZZ!\/S_T,4-!( M.Z[. /U /?]/%#8ZET&&:C"H^< A=23'&&BX=TYM8BHP>&[#P$#]@QR'=E05$ ]\*_ &+ M@*M#9L6K\'6G$6.N>$0'H_G?X)IJ;5!=:.D&/#:[!^_RIH):[EAZ#- R#-"A M.:*63T:]^+?S-:#L^9 MCKL^DNQZEX7Y\T'V FH[(_Q1X(\"?Q3XHZ#U*/#9'(R=N@9<5K'38]FM6B0. M!TSET/360TK%MVI,FRNTQLY6%_P[4-.HSNBW$'_SD3#7(V%S_:,0NLMC@J!E MIHLHP18-HV"V3:)ZQC@ F.!K+&1)*.30X@J_+F&=%#*3'.=!C9L0+K&Z[N0M M>'"*EEM-:#LZ5WPKHW7L0*MBKX+&[QH&\R4!% M_,&)JC__2COM2CW$44*]DU,<\I.&H!BMQB52!RIG422R;'_*,QYC=43(2N#K M,;^F3"%+%I[+>"C;=43@,Q!TPDHSPA]-ME*0#I:0>R\L*"RN@8*5L/QW";2' M75395P>-S:.J"9N2 L.ZH-WQ(-#]E.=J0_+@;_OU"2QG03I510EB?S023UTO ML_SF.0J8MQ[T>E%I>%DW$Z93WM$J,DRQGD7. MF(CTA:;79A;PZ2Q.;WB;=L=*MXZ9WQGGJ=<$#4W@Z(B] 1?349GE7,_WZG^? M\23G3AHP0XMI420S_7(!9^&DLFZJGHL,:TQ0&KE^;8I^3*C.))_(&98B"7%P=-C=!18%LS@8-(\/UT3A5(+R#=@5'06[$0XN2Q-!)CS>=B<1J)"$ET5B>L/I)RLIL%N-\A# L9ZHX'$]$(WM-S)Z6Q4Y#=+$S)1YV M=7- ?&\>MS2;K.4 ][B_>^'^WCJ'^]O0<7V/;X#:LS/U@#\:W\Z-B4D/:@[( MM%<"UY$8P5=F+,,2'ISMS*C^)W_=H7-7#9AN&-T@WQ*:T;"!I9)):#XG. :E MUN,=JU=S[68MQ_ZH[E6HCBGYV?!T=E),.A_.O]Z]#$X M_Q#X(0?>'R4)0N9_YR@C21 85$RTS2WJGC4)/5U M(*BZH>0>4WD5@&S+.FX*O,+>"S3BQM3W^XU]1_C5NJD/C*!EX"J8#M0/,H8: M)F?B(8[8 V>I8?5.G=$S4W"L5'6MF4T]YU5U\Y=M\?U9[_Y93Z$ML]VA9',S M--':>GOJ?#7N9%Q]M!XT>%%):U^JX[S]TI1 K-5&3L^:SIP2\'#8#2@.HUD]NF\GH59KY?X=-9FG ML@EJN0E]_/N&(<_7,,3[$>!'. HI_L!$7&;DGO8UFOQ(E2VXEV/U#H#[#D"5 MD1H#;^85U#59$."3^2@==ZG9(0B0:J+1=,1PX?WHN;*WC1JU>.>@"0X=ZV6,3MF3./#EN"#NMM.X<.>SDR[?AQVQ!J M@^>J CB4'6U1\][:?3Y/.FUB$WR(!T,\CA;"?HY9*$'? S!I,S1J360'^S4' M'T0<.S,CYW3:%L&PQ?Z(Y9_JY"_";^.;XS)4^OM8&I! M*YOY&M9#)73X \UJ2X,H#?*TTW8UW0,<%ZYFUM\!O30KL[QD$GS0J)Z7YOFX MS C1"^MOE@7J5UZ6/8+57O'$C/A@]$2PQ?B6+J,@\+&-;%$OR-0 @NJA5DXI M+V-3-K'DNP]&C,7][ 1V5>=3$^"1?;$77L["HJ3R"\OXU3L:^6X%=27M: 5P MI9$_L1O2R,$QRS$@\76N=E1] MY%D96=G9$M8I$TG=S/B<4I^6%$U@1_AX6.-3[+< QP@FJ_,"#FP)3+\Q+&XS MM@1C-IJ>XLDAN]58YT!U&C,5:V2+W+66JK :P"LOI@>:?O61B^ M([LRF&HL;7)Y30R:V-7J:5LXC5WAFD&QK':H1G KK9T!38HQMG,MD*FF0U=WKE298%9B&LAMSRG(QZEXO M8U#4BXA_Q]:%/@WI>AH2^.@-;#G:I,TXT!PJ58P-6QY+,HF),>H>Y&VM4.&:/_ M80B%UXP(C!E?R38OF75.X2< &7[=Y%\OP[5J)_NIUF\!;*C?C8MVFU9*VDI)Z81Z. M=%UN"GDTSC(T3M>C<9Y=[6R>:4MV:LV.U':%$5S^?08_WC)?]>7LM:(8QN]' T<"ZN,T$I&E,87Z^7]PW>G_VD]WZ\$"GX?]LT#@Q^Z'J?CKKT;:\5']SNU+W5 M@(?T"COW5AVZ4:_:V3='W+OYAMW(S?76P':W*K083:,>JV2C86FVS_C<"DY5 MGT]^Q;&UVN(D6L?.HK7?K6,?A=7P*ZZ ?W@6*JQ&V]0MG>/8TA/^:NN(4HK0 MSI=RK?A$G=2 (RKA:9G'-P%U/5"#$9!Y.A)6N""_L6S^U_UI Y2_:DR+>MGJ MQ[4NH4O5CVN)QSK>ZH$TCVCXN#3=*Q(6BO9*_H+Q>/BUS"AH&[-KV9T8TY0S ME9:G^!&U558 9'-7ZJ<^BSG#GRY+$1U%F,U&4$>^ E<[*"*=FYI,4',D" M;(-1)D9<3NJ!FX\+-1VAID5JH>]J<%K;6"ZI&]2$>](R80@G-!4;&!M@/7;H M17G?!%4QQ2$S\-9F17RC(BL=TYULWA9;U>9[J7WI]U1?^J.3KT=GQ_W@[!P^ MZ 9O!FJBXY3I! M0]_LN3/KL>X7I9H[<@.JQI!VX20QF++76TY2FB(L\8(V'>NYYCH,]GV KL%&C$[J! MT]BP*!_VP*/'T0[HU6$3?#92[\A)TS@H;5578U9U"-7*):G?[E93*'*=QG%Z3MT:I2H^J=AUZ0C'IZI3-*M:P#MEJ:)F=+6,ZHPT7FVZ/ MYE)9LA;&+!/HN2.K$W-Q/>+0"I@;$P(L!.3PQG2UFM0I3FQY]/6$Z^*X:HUP MIEQF7 YL)4.$@H/VL_5(1VQXLQR*X:%QRZ!Q/0^-6UO]Y#!<:I&"DC 9GE-* MP"[EJ"7BZOI*JA>L=%)GV@(OY4KD^O3WCL)SN9D8:B8DE-2>EJK''YOY5K^? M:[V?'D^U 3!'-15W!A('\OB*!1A-[FV_6ZOW6>!*:Z<.M(?E)ZW5RA>*#A"Y M^^ZU][6D_ CGY&=W:U^"0>R(9ABK)BQZ&KMN,""[[M;S\[2*7S-^()'PL]R/X: M#C9U*P)"-:<$C#C=+&K>[8Y3.G=[6SL[34GI;A]NBJ@(!\!%\Y%;$A-9;(UL M9^RXBOOM) *P-7QN)*%>.0OBX*/(&$5V=/Z-'8E%XR-H/\7OO<<;="JZ&X$\ M34R[#QFQT\@A-@,-$!+.2%7$J,8-U O+"E6K(X&M52+H!B"!BQA%.Q@.M@+5.="8##,N,%HGO3>N3/,I&$ M8@;'*O\.YRI&$!44,F]\8RL8TBO)5706OA+:AMV#=[E9YRT+H;=4I+J#/>D/ MRC43'G50:F.-J9:!R;*<4X? 5#B)5[::V-F&/RB[C?ZPOP>6X@T.@102/]6T M1I?<7%I>VC+M@'EXS:^DR+&JK^\5#46>U&>ZM">^-("/QBMA9EBN1-XNMUYC M;UNNFB+&UI(3*T,F.[7,RA'H$WPL[&DH4P(JSZ#E W[%$9AH[,8T&/P5?NJ4 MFTMZX 1(L%;+O<6W->7.JW$;I3)1AW6TXE/[N$BY6YE,$@)6Z(8K2UVQ[C;8 MEL!=5MY3/L40^:X>Q][6_IP5LDF*=%,TZ?*D^BNI6H3$I[(X3V_1O:]U#KZE M":O,;-;:O+[2J4SIL]M?KO7_S%]W[L;/>ZW\'%$KV@?1ERUR?"L\ <72F_!. M)^G AD]2=;Y+B!>9O=%?:9DELMD2,&V:%[,TX;KY$JOI: L9H[1_Q77:_ [3 MZ93J#1A-+Z#6;F",B[02K"IBMJK-C)@SGH=861 %;)1>>69T.DLA/:=V3^V! M/2D3@/(ME>Z/&]EQ&S?B?>/G9Z,VBPZ%5424-3#"N\ ]T/5$54O'JY0NLK(? MY(Y^ B29?A=DJU;0XCB6CH?4]QT$R^MCDR+G[ MK,*+S629->>J>;^[,.7AUMNW&\V4KG(EI<# S9I90S@6JS+JNU_%SB7TMLD7 MG3J<^X>P!=W=W4WAD5='KIF]W;=;UH$7QBRG;@MX9YR*@$WAJZ[J6&Y0J1$3 M\Y@A"*UIX,IH &;>L=U EF($@E!YX"#IZ@/U29!F%C(3P03?>1:*G%/U-OX] MOI&CNO5OG5L"=M1/HLFQ^#(TEUH!D)@,F_R%E;_Z ;BDD&<*ZUV-"IP&K_#K MA"3'6Q!J0-\'KYJI>@\=82'40BZKQBGWI $)2ZDFA0W>0%R1H6_=T#X)1)(7 M64G9+,(Y9AE++F5VJU';,(QW#C#!XU8S?:M09'I(B58ST" M&50Y4]P]6HSJ>=4!+3(&5QI(A#@*VLX10[R](D,%CL\EO6EN!X\N*50$J\P9 M;3)\FD_ \0FTCR)9;91FF0PKP8UCK@8QV6\G/2#98M=ZV&OTPLU0QSIHA1KC M+9AI]$HH* M=+2,/U*J',GDT!I""OC*4A<.6KIB(*:6(ZY5?H&OE%#0>O9:O MG3O+'][]=XU9=G;U@$KPC%FZ?<;.7XS8]BJR52*=&RF[X(EB9H/]JFHPK3B=AG_<,0>WV>Q^XAJ[5P9LA?RQ&!F&H-J;L8_)J3\$8)<6T$16.ZF2]3>?IH-&FIHPIW=E%Y2Q_9=>XUC:5I M^JYI&CA8%0Y?'GCD"%8G"^+0I\M4C"I.IN_J7B=S[2NJCB,^)W3_G-"NVSFA M>PO^O@-R?^J^8$%G"IA@3O>2="AX#5Q.*!;4_-IFC(#UH!/UWY7/9 M5NCCAP!^G!=:B'R4P7O], >XQP)=;62"G386VK8T4%3[%"![$2[+N33%X/%7 MO-$W4HSU6+>7S@G.L4+WT-8&%20? X SIGL+X)#3]$8CE;SP6UO^U;D=W]=V MW^TIDGND1^:SL0^;)J'(LZ6@ED?*V_&JSQ8F?P)G:7U%Q3E)J+,6Y,A::P:W% M/WBA?%RA]$;6;Z^X@T:6JG2:- <"2J2B C=)X3/'G)9"'(Q29HG(%0IRWLUC MN;H=R],$N.:FYM(U2D#A=A''P5YP9IVUWI_&T&R@MTPTSP@8A6MBV&]=9]BY?=V+!<JFS) XE>:'ZN&%^961<@@7&LDCW4X#CJ<#P>]6? M#L\5D7AKZ[=7E\XI&1/2 K.>SP@M:^8%6+TX;VK-+E3Y"!GG>9$)Y<8 8[!P M(N/B=+F$>*O:G&9JJEE;DJ2V0KI]E ZS8QS4,6F5$4VW:,WEG9X2( WU;UHP MU\DL.D*D/=%A!DN,RTAF" 526HIHKA,[<'"!ZJKB\YC5,DQN_=H7HZFHK";R3=S";[A^+-+\$^_ M;='(8E#2(E-E7FHO="F1E=2D30,VEN=^5!8-KT8CXVL]!W7GFA6'G[,>J*J/*?^%O5&KQY&KTG;/CGP/',*B6J?)+# ?HY*X MJ@E0)9DBE\<9C[:"(R!';.9KPH(H4UP6K12)>ERG)S 5S]=&H_&/#W<<0EUS/Q25#5)I)M MK\U MJ<%<];JQMJ73U'-MVX1/048P3BX102=!ZSHNKT]Y(D>_>GV@.Z=JP;J3[PV7 MWUY-W#5;7#6.(.JO(;1-8M5C0(#J-;+MT$"J%VAC$K+ M;XST4!+01%5]? 5=J_D;U6DGOXR7D2%']U2G-+66$]1JEL+34>LS5FW\W,"1 MK]X'NNYLR7/=8/GT(D2NUT]=1R0A_\:X#NU.DQL_M%[A&B8GL[F&U- MMX)7PS2#_4_I_5^WWM&^5T>B".O+64IRO5"B6CG*<807AOJ92EC-/<)KA=]> M_;4Y6J'F_4CCULQ/)40(&M5Y&ML3GSO@:Z&(H$!9)L&B&(/GF-]>?7..8XRQ M^@'TTV7&24-A)Q<&GA7%OE8)+,4X\5[Z?=1.P1YC2HE/@=9G<,5"\)Y!/4_3 M.9>SW9W/N7[B$F"B3_TM2_WM.YWZZS:01XKJ#ZX;'FXC%G2(/QH,3X\_]H/N M/F;(=WKO3DXOCC^>7WP9](/S#\'IV; _Z%\,\>>3TT'_>'@^N/ S=+K[6]VU M4JDKS] YT2F /\ #1PUZ3D;Y.=F;.B#9C/.LQ2LNPHUC4%*_%(6OX,54JZ^Q MZI8UBYF<M$M4S77QT'K(P$@4X:R1=1#Z+@&01749-V M\UVS+-.$13:GMD:R84PYIW0&W 0,F3+AF:DZ,WFEUU5I8C5>W@2D_4PKE,?> M6C'K'69:!2%Q-*WNF>6S0" MH"&; 1JE,-[QBHE282N(MEG?;I*-OY?./26F2X16\0XH)A#(+)RQO MS(.7080D-0LF+%K5!\\:FX@8<[HIIB\Y6*/C9C! Z!$+K$8R(5OO@25#),5\ M,=XP!V-6(S9IWB%% ,8:"R=!;Z26J(\%-8D"C_HO"XW;C)\^0K'-1FD41Z?D M?0:>YY0WQ]9@/+NB0!(PXXDEK?*\SQQ1-1=U1EZ/13]8T']-WF?YZI=7YW5L M)99JY3YO-:&2K49&MVE Z\L3C0&66K!#5@\J7:H:G=EL'K(9"Q%AK"TM\T1N M4#J++#F*"]]74W;J9XO]ZEFMJZRYU<2RTLFWJ0LZ+U&== M&!73;?G8:W'4XKMK)5UW]],J98U\+[TU6X.XJ<+O(F&KJ!9=VD)]_\)TRJUO M=6R9E)T\.%J'G9IM5[.VDDZKGFIYH/4M@MCE=5!(W73L-!7->NR=/\E64N@- M\UVA><(07JUH*::2$<%R!@UD!Z"44&+7$I\J;9EPS2)2@G7TZGPCAZF)V.)Y@Q3I9^$8169!K>2'0E_ MP:2Z2+X%H':DV3NU*%>EO&BV$<44+JG]"FF4*Q;G^LS3%U!($T,MG1I.P@IO M2B"'QK%VU#JL-Y;8;?R60AGXL&9=)AT-:WZ54XJ +;1T.B*0_UW"V:FF98A< MO0/9>U7%0"4J!*26/8UXJ L_&'#V7[+J6LYKXAK-/3>?FU-TU+I0FA^$4V\B MU V F. S#%%&*4I:]O^W=ZW-;1M9]J^@9JNVI"J$HX<=V^/=5"F2G%$JEKRV MDNQ^!,&FB#4(Y_=#8"D*$\R)BA\2$4F":#1??OV?9Q[+MZ0?H%W M&'8-[IJ>AN[.==U[MFEN9U[S*!\'W(IZ+)A-%8\!%G$"_J_:60-;\MMQ_RG=-@O-0Y*F4J/*/VJO/GBD0X?A?G<87B,!E)"? MW"-%^<8Z)Q?ODPQ(\[@1;H@99>O*F2&1(MD:FS4Z:8AJ8%2CIZEL&Y\'^^+6 MI&8Q$]9'36;/YW4FV$>L@9\D];P'&V<%]'@185%(LL (/(%45@8-<]M]&;":/V=P.R9;+V%T56BH+^T1Y M1.4OTX;GA10!U>2G^XE4RA 4D2X?^5/U,,O]J2J;<\7_B+*,'II5F/!TI>2N MUB? '4$@4RXLI'1KFFJGRZ%$_!MN#&%7]X'GP<#FK4@Y[9A.:1T%4E@E6 MQ%;;&%29A4\AQD,97+YN4#6"*F-BX%B3WN+4%SI]PX[#'??]3LGI$XI,*BE) MZMF&NW%E67B\6[S">H@"PJ8403!I1K1\8C;/ACB6T@]+JP!'C??UJS"H%]3L MQM(*9W8ZR0W0S_ M"SX*"W=/MO-5I5&DS,1@W$;,F7+'W'.ZJ=8<1D3N[;5J\S$?U.*5JO M3ST$4NW)'/U+L/O3I0=))V7!! MVH;/JOLA'8W>XVFQSKV6P)XG/5UE*/;AB B+[;31$(5L'9VO=VJQGQJ%#'Z# M)9@$%Z9<))4)WD5)6C.([R<\A?AL[<:2N S!6 M>:B>8I9GWU$MPJ+22^0&XR67P]B-8J&(27:/TTDZ<(W.Z4HMGVX@RD$8/TSJUHC,8ZE3.=[13JOSQTXDY0O^KSHO> #0 M!/\'#=@+::GPMP2;-IL5[,[F\XN&R!ZOYV/>C TV2L=R1#I.N3'EUYT".]>V MHE-J-^P2VB5]JWKE74)NK$C+65R5P>](FXZ%[1B>(I/G0OMZ]&0O[3?+SVZ\ MSF/4_IB.YE+CK5@WDD88 $[EPA 1>QS5ML8Q*21+A](J "3;ELI%9>=B;$?2 MCT9_VJ#&LSFS@>YFG3KK6\$PJ[-SV"4H !\-!7-HTX _([,'%[P:"?>:0,: ML+##[X Q-D/^8GY_QCTAWPR_."5[73,49PCX5958]HN&,E;U*Z /KA./5SW@ M,)A&7\+ S"-P QNX7,DDXS/08,'AX:-3@VWDT.E"^FN#NQO,FSNL44XHS\Y[ M'ET^,]4.4DQ8E:!7-F&7#+QIQ NOK?0,'"QES=Q04R7Q"?%IZ$..X+2(9_Y\ M6SZ>H'K(;4]Q(F%%=36I*[MW9+<>HN<3R:DUH&M6\ MVOD0_X4BI&6EK?88PN-$I=#?(="QK!H_SS.1&_LBHW]&T-R8N[3F36SE\8D' MKF0?/?(BO!M\R4=75.!^8_.O%"-N>"8-O4K:5JN8J ;3X]M!1C>LB0\EY40! M!Q!61YID&ZP1A>=*@O1:2) N__OR_-?;J]\N@[/KB^#F]N^7'X/SF_?OKVYO M+R\'*J0?CE_WE0K)=_]P0WW -I:T-\YU)_0EP-]@1@HY^JMGW@#]Z3OT1YR^ M0$I,Q%93$25C+"E]R\)W^+STM<2#EWP%=2-<8!ZA0/#04*O>>WS.Q( ;0H1F M>>,X=SU68?S(;A@5T5T1+68!; IA@W<'/IY[QZ_>EMS6MU16X(%DYNMQ"6_Z MC4L8" N^O1BMJSSFWMO:GHN;= MR*ML?8H$#$0#?1 !:1+,Z7W,9I:S9&%ICMNZ(-P0Y6)L-CA 6\O'?A\&]_L@ M'M9E*%192.*GW277,P[]^J\G"L5>>P3]9:^:1Y\9:RR>04*E>5-3%#9WXOD" MX\,VXSYRIB8<&?5*Y[H!>7R$WY'8'3OD2GB_'O*.&##K6]I1 F8W8YAZB93W M,4IVUC@#VUZQS>:\'AU;^F'SQ11Q4MH3DWUBW4^RB[#;#HCC$&CK>Z -]-TT M+^9T@&(OBIJX.#A=N8I^G9&X>NOL]".2MM+2;T6.6*<)EH.N6Z\F+RA;8S]T)I[L+!,GN^EEE3 M4&SS.T*!:FN[$N,/U+*.V-D6IAB,I/X;29V%IV(@W/I*8HE=42VN=UQ71'^9 MY>X'D5__*P1/S.DT;2+$US93:W5 ^&=:'C0[QI;NGK.<2@S$TNNBT_'=XUE. M9=&9AF,36\JYEF!_D/\>6X7=.M^U\N$J4K \6*J,V[]ZW%<8<&P;<&RG1_W& ML>WU+I_T<)?+*?>/+=J(-G<[5Z/YS+6K^HBV=(:<-O=.:-E,[< MO'MW=7XY] L'Y_U-7XMD;(_PX#U88%(R$]P(F*@GCGPKW]%)Y(86+T41:(5* MK6G%;15/:5GJUR537)"3_7JXN1?I'*):N#%Z"H9Y5V?$R@!28N0]R:$ZO060PBI[R$D1VV$^FJJPDM".V'Y%1O'+?G@/?<[>N37@WDKZU=\ M"5)%("S4L*'1!B+/!,("PL/"XF%"\9\4E):\;5D5B8J5?V!*5'*:5$.R;A_" M,@P4""TAIN3IT?VY1THW(F%IB-G4'983=U@N[&'I2>>SXY^\8D\T&H-SRBR2 M99.M)=04TD)Y4A3*7\YPJLD']38S3BU_,TE*<%\+R:++S, ]+W6<; MS#799L,54/.JR"UYSQ.H)_;=/NXI,NZ_?"JROEC!U[D])(4BR4^L.CI7_5%2 M*N7:.IJ@@1_G&RSD*+@!0U>:=.)"8B:*>1.H/19FD#1DCZ9*E 6K.?M&5#,@ M-W*B(-;-ZD9R\B6\171'L4)+O"TMJUS9)M^>B<5T $0:+?U]HRU8F9^3*NPI M .:CF=>9XACQ=+PE:QK)2%<$@W;BW=;7T& #1#=J>@MK'D3<'&1L&/XI/&UK M?0>AIR[\Z3GP2/D>(C(@RPBL# S;(8"4<@#4N2/TV_4R\]RBR*>8#]<^O(C% M.70\V&UOA =!N%-GBTC$CI:*+UND)BJ1(M[?Z9Q%\!0'JAD\ :3ZVO*J-]X. M9L8G(Z0.(O<8?J0$^LPV^8[AB6PSD>;RHI+X"QC/O6$M@_U^\Z7 )IL&5@1Z M*RL%.GL' ZB3BA1: VS9U'XVKQ$34S)7P: T#J[APWJ"-513UO*7MAPC\8H M*;8/LGFA96T]44;@.E$"CSU-:Y*1*\7-*!K=JB;-8+G,N#K/]+,7/+;Q(FY]HT'JSIB&0V\^W M:,TPP!8VP!:.>PU;V+O\\,F1Y(>OKB\NWU]?O;LZ/[N]NKD>SI23H[ZFB=^# M-12!BEJ"3IZ8>=8@(;]H-/WI66)L(-K_UFL0-OA*R(M.1,B6!-R!79]@Y@+] M@65P0%VMIP0,$I3/;KSELUHT+I% EFQI'X9H758 :"RE$E2!/PHCP"PR7. G M=U&2P1IC -LMK8&?DNTT+.]N+"_H0Z:()TM60F2\W!(Z31/,)X86)./OX-## MC,-:$E=9:4-R LBSB^]XU(?5WXG5Q]C+4@A2,,HP[,M=61DLJN9\'FX[]G@C M[$R19'%-O$_C97/+9K:F3/O%>/M-K![L%X>]%L#(1L]Z@4&RRN,,VXVI>58K M/83@T%WJ+7BPH%C/OCE+5\T N'?J6U;IW",1:]:JHO?+UD(Y^%P[Y7,1FL0G M[Y#Z9CGIO58XN"5#SST3 2>>>N\L67F0I-'#* @NU:!8ANBL_'#FC2 MYCH.,X)Q3TP9%\EX[= 9.#-&9S*9,'UF,A_71>D..YT5 MN/-\4<'PZ@7Q*G(W>/A1(CWA6;ZKZ+/4L-"QZPV>,D!H2-$7]L6YF0\/I :G M9QY5W"C.+WFA@]HEC*1$TT\N47\G42^=P8^\<:S8FCPT>?&N*."]:Q@KK(J1 M3%B&;)(P.K02[&\8?$36?V'R;$0HX^:=N".>\^9]D:%L^N2>6_-Z*]'ZF1V_ M/X,$J?)DH2D*Z%R:.[1:CP^#.(V2N2JC3])K[_A[Y,.4G-JO^)Q)\ F;3)7X MDQI;7!E\HK"4G+'Y=/SF] 6)630'F<2Y.3@Y#.Z3/'6TB:N4XGD^H?2BIS.R M21USAO(2Q#0N0WAC;MIP6T3T#A]RT$1+?#'X]13^YBS=E2Z#^_[@M#V(\RB# MFT0P.+5W6%7Y?7">>5+9>[]D!&:]SWDJ4 M!DM:E@WOKH[";>G;EH;U&#;THQGI\*8:9!!!:D!35+Y\1;&TD+O+\TDPC5 MI/8OT@9T>*UWB7?HC$V:F'M/EZ)4H;K*%TSY*.?9V%! 4C9=FUTYFZP@[D > MTB*94]PCLKT]_9,*6[EEN1L.RC!V":6QT+CD!' !MEA4QD.$NHR;?(]@>],4 M8E-"/4"Q/5Y1R7;4N1358)=#^;M007JUE=P^L=U@4:OWB24 01GNM-^@@U%, M>*.UA05>JLQK$*T0>1=1(^"_ L7?9;;"FTYX5+'R7AZ_>:.I/9W[L+NBJE,M MJF]D?[K=,T&C\BE3&'GUUA.58J$UCC*7?U"7)GSQA2%73<*BV+JP-"G+J&JJ M?)%D-(OXY!?TMK!0A4%P"#H'".KPA-CM*1"Z6CH2$DIX;EJ[!91X-E$X2Z@' M9T,HU+;P&=U4O(4*XO0HF$3+4CKAFCDA@,6L&7+67Y6S/NE=SGI/3S5O7ZTX MU[I&C=U\KAFHW7KT6]URS\X^6*6DK \%&@8M*E^Y>)U]ROV:2.@'?4TP"'3]MK6ME. G34P)<6AIQ3JY?&A M0'Y@?M!L>&!S ]7@?$ZE+W%26:$9+W*3181G7(#1A)@C&!?8\-Q^."$B:L=\ M23:Y=B=N]/2DC$I483*%#U,=FHNA_!$O'"/YIKJ1+2-NQ.6C8&"EM5V&II\+ MQ]Z*%78N8&&-&O>M].;UO%*Q%IB.F\M>\LX&7,#XZRB3Z%%WJ!O-U*^9FH[- MU'Q[%,'-MJWWXSM*@>)4Q:850?/W@]HWZU]$3F9L[[PT4>%S-#7,77&OY(E* MM(&W#3?LI.>GNTJR+S,7V_PC)&>-4Q1*SPZRHZ8D/WRSCFP]ZE5Y,N/*PB1Z MYWL76+A29]I%O;6E;)BB::(JVM&^#CM**X3]V8G+.YD:6_U&&ZNSS(J.#W"& M3X[>[E1D>$W2Q8G%3HUVS4+0Q!Z_%<&?FX@9-FUIT,3PQB6X>V:=??HB8D!1 MV"@G@!UUGZ?W4NZ%CGQRGZ2A]>=A[T[@CZ2LBHB+-5$WWR/!T1U_L,$^H;Z] MA%'6NEEL.,"]V+V4+4:WW#_M[JP,AN2X&1S&(R1 1P$"# JX:J)00<:A8/HE MUGK7#8=Q**VXUZ :F38VYD+,3=V8AT*9R==:%#AMC>=SRW%',]#+C2"ONU-# MW6H7)%F\W;I6]2W[*TS'HH&[%+904'?!]-O/@_DW;R]H-# MA.3GQ;B;0Z%-%$1%@5%T-GVC>93>1<[VU3)CV%!9R9MGM="T96[]6WNO$08I MW!_#0@A72H@ +-9(,-AHZ[]M(1M$S8CB?Z=N_'E=<*$Q7&V:B[C2CG^19Q$ M18*<=YK:#8-9_H!=;[SS1]=L*DD:FY??0L#;%6N78VG:8*W"%W;!\ MZ<+R.*OM^'OC)2DGT]S]2,WZFQ/NU 2U/? MI\%VA; XBSS^C(3$!J4[SDL1" 4NAH$[QU!"\2K2VGH\-'T>NDMAJBC)B"&. MB0V%$)0Y;>9TVW='N%I'EHO',S$[TBZQQR MSAG6)(\Y!XU=8\!3E-%I+S92P9CZ2*T^8%0DE>#Q)E>XQI">^*KTQ.F0GMB- MI9 @J42(-H24O'V+QS-2-'%0.2EM<(HVN$5TR]:IEHL6:Y"%8R4$HL@$,D.[ MWJ*Q<.,:.(8E3,V?ARUWF+2:MSD]1WR#F^QY'BN"5!3(,H6@>LAX8:,I79). M0J)>TDF3(!-Z-%008$M1P/U>PI\2 Y!B%$^Y'?3H3/]@\77G_JSLU- W'_&' M*&1,G+I6(,) 22.>&HPYQ(X)8D7 04=6!+-1B65G\Q"/2EHH^XFP FOFO6T> MKY3N%>:H&C@2FP?S0:Q3FSW"EN^N\.(R*N&967"1,"4?O@*NR__DQ6736%)?R"7\$95Q.60O>'[]F\!^L] JOF M)SB2 M]@*E'08G1.=ZG0^7WY)N%W &=-C M[M28'SF80\?_ZKEZG!!LOA5]Z$BBD''8-0"BFFW"T<'5E-D0W()\U#X.?8B[ M)%LUKVHM5P9YMC"%J]CYVNB YY:G/&M53+1,D0+LXX+^6I'M?E*F6QM[2$RF MF[%6 $!8Y,2&I3$O!B@T^_\!#X>Q'61<\ MB1:K[XC+0L+5JG&*+$0_(1$=%F.TY/610-'OIWD1-YX] MPLH)J26R[\$E0$*AZ!*N!/(RI>9;#CPSNQ7HB0*,)\!#NAB<3O&-9\1GTP0! MN(ET?W%PHZ[,L.4#!U#8+E5Y0 OFLS&+Q@UEE1V6B]Q1W RF7.4]KWJ6OT[H MK6!$6M-*:+6(H_L'H9DP_X8N2VD+H. J6F_4QRJZFAF:LUPJS<0<6RU3Q_:^G!QK%4A"U , MA46)V8$,Q;-8/-M39N$+-@3.X=H"#J]>&+D!N$ @@ -5S0ZN#5/5T,'A']/- MM?&-AD-,>K;@W;%(HP)_&Q :GP=5# )1U00HR"B;U*E(U0-@4%:HK'K*_;NB MPO^&#)@/E-GN2V&_QX)&G+!^KX]!<^U&E3XS$/NEU(*>:+HPC9I[K\P7R^^' M;.A794-?]"X;^IQ.CI[2-%_GV7>XM=/$1:S6:JN>'"/M,J%M@'+8VANG83FT MU/B6:\>Q!-]UMV3Q278/3?TW>Q]W\TM%CQJE-)@2%L"VC,) MH/M?>_?+"*@&)J&C81GDIB$W_6VKN;$P)EQ9R+=1JG+YK%%[),5&C1(D5UY4 M9TFFM]!<^R!9(EF3'DJ6:*1'1 MYA,0XP1Z@KC<>IF;!MC?*IA!5&]VV/UO6 M]A2%81GOLZ57:.B37LZ2N=J.L/_7%H)1>0;76LWRUJK21=YZZAIOYVKM7Q.: M8VE"!X%&3@>1[.8M/"T.TE1\9?;)3 M+[G1!:7BI])1AW9")<>=!H860T%T;J3?$?[B\<619A"H.?B;TL-=IDCP%Q$5 M6$YT,H> #.Z.GK*-7Y@XC0J;?[SH+.I.O,[0@6EWUT"Q_@ZS))JJV;G%,@?F MD&:"&(BC!2C+18&N\:"M4%OU%-YUG0?7S$;V49"A/=%3MU;*;0]OI'/SV-P$ M8ZP'L0:))YY^;K5$.-X$2G].PMQ3^,]'@R4'P86OE';B#;:08M2N)=81!9S: M*R6&0&\T\?O="LT9T2@+=; U+_606-'WVM?PD57OW"7 ?PS5!A"W-%XH=9#T MC>6$9#YJO@%&RII4=/.\,(P81S[$.4S#K!P%5U.FV'8/0MYI(]U_6Y^_#!:C M^2@XN,T+N)S/K4-%]G7'PC.X((H$N1T!8'"+\W97V+U][6&;PS;O*5;C/9/) M@QR#)XHK>]%>U9UXG[6;_FRU?+I-R7VN*>3D[]K&MGN K9XNN62@P&I[X?J: M4-'GV-66H*<>J%4F?CW.P^)#-9,P!1*]'1>D:<;0M M3BJ&X.KMC&*.I +H5ZBH$%LU@-V^#NSV<@"[[; "[2EFY!-U:W$Q/ QHUT17 MTA,->B6FO(Y\Z55Y<1DE.0!-9=@P]C6@-WK9=IBYE8WH4G=_<8*Q$ %+O)+2 MMENE'C9,@5:#*@_Q+@..I.\XDE*:=]Q':5@LA+@")$6W\@&NA&C&"P3=NFW:O=DH@MC;M?D=(F_K#Z!^CF=(3J^Z, M3#H9NF0I+(>U,]!416JI?"Z491HW ^7(RM"_C[FP- G"FKT1>Z13,2^8IYYB3TB?B#*+R:!5CIE_H'2N-B] M@BD]"NHP^8[74SZS4\/G!-\ L4K#SL"=\6:G1.4I&0_M@_PS ?\^^9T*=^J= M-CGS)1+IV-H,-HL9R-@T@*?.* Y=O)$LX3F=#90"1 )DY<>QU,-3L=-UHX48 MZZR]^.8<[K6TAPH%$ICI1(UZ?.JP60BW=K13DO7X;GG3.$:"'ZE'UW5NNS?W M9*=<.XP8J'U\!\O$OX*+<9!5DM6^@2Q95M\5S!0'2K%O"+(K/[_LQ3X:8 R_ M,E4(=['48EIHAV91NG/L'0]RC=JY0DJT.DNL2B;(=A8OV\FQD.,W]F;B-4R2 MDH/#'"B91Y^)M&I-@HU16)'+P-EZP9+29^LN'+8=;;N^H3??K(4V]V3;-;QG MU\74#UI[Q@U;.TTK1[T*WBT*YXAG6,<2-GUN\2HXUJA=8"S_R<,LGV/C4$)X M4)QEM#,,NWUB"$O7;,P?/R>G8NH9(," M!06B7:(Y-]:@!QGDEDK]?+?>F,8C#Y.WC3+[2OK,UDO@-2ML62_%[[<:+7#* M30H?%WF6Q-SD9(J/QN[FN0-LVO"&=U<&\^!$-]J6T@(J/2'8P0]",[KZ242N M&+9H;'1MZKE3@VX(\H2#15KSZS.KH>UI$'WI\$ZR(P^:N$86K\,0!96[JE"( MVA7F:-32BK:T71C8MU)1VX%7].X R> M]VJPJEB]]PWNRNK]/%H0B/S_+#S_HQ$ZN,NH0!@=.82?Z@)%N2>*_SJO,/I% MG:IY'E:UUI=^#81.^QC*$6>/6(6M;MY]7@*:>-SSZ7,M,SW1 M,M.;\U_?7U[??@J#CY?G-Q\O/@5GUQ?P]X>;C[=#[>D/)R=]K3UEB+^8M^^2 M+*)>=<'9=!HEO8EX>ZA_S.#$48U41Q.P92F%Z;K#,RQ>TUZ?D<,=_D3CU!34 M8(M0\V36VZF(>"KH% 8+8)+X\13_B!ZHWG9!&IZKJCX557U] Q]<#CKYAY/3 MONKD]P9\XPFJF)_ @@&UQ16%/5'&OW(\85!_WV;^NTR7TA/;-24!AU'*.J4G M+;>N!RLY+RIG7'%=Z5%69S!AT<7!>.J=K&Y1)^UF^;6?Y@ MFJ=I_H!*9DY:IQR0]GU'VF.\6H/G+D&@\?5*([+*G*YA=@X,1Y7]92G"\121 M>'$R.CUM2\7QT>M]$8ND!X=PUY[[RP^$UE&-[C)'43,[U$I_V"Y3W430$XHS M7KP!B2=AV,WRUWE.?(T:,-3S@%LDBP3--GU=RYVX^V*)*7RPO[./T&P* /D6" M7X_>O-EK">ZK"&N5--FKF-$.5PJ/[5I4@8R8B1.>H<9L#VK,TH1Z57Z-91.N MLY,&DV>_3!Z1DL'J&:R>#6+Q5,/'ZIX_TO)Q"FTP?0;3YZFF3T=Z!MMG;TN5 M:Q=I[RXO\8AUM4M43Y(J;[?M"*T*\MQ\82LE\S2M8BA"K8!H/US]S53+\Q%%TT-1Y.-N,5N6 MX-FGSL81$1ILFW6+/>W=8K\8'9W2Q,9P#E4,OYZ(6F!21]GG<*I77&1"$>@) M**%[T"1<33.#M[N;4>&R*\@H\[J(A8H(]-:=R;!&.ETB0 QT#W6V7Z]VFL/ M^A+XB;(CCQD!9G.JA;G+O9RJ]",@3I6#5;XF8M.?G+@Y5^BAZ%'!2&V^E;E:'M4&*QX4_8(V-?O.071@^ " M,^ANCP<2_3G@1/8!)Z*13\F,$'H(?HJ%X;Z1OD52I3!34T@D%:F$M ? Z>@8 M3]L)[Q!&*@F#NK7RNY6NV"A0QF=9RL&?^!15=0%_E? GS"W\0>?N+,<&SO / M\R4V"U"WH8=KRND>]MI9VV5._F7E,02=*UQ-E]2***50#QK&91>FT?3-T MF-C,I#[HV_M1J*H)E/_(OL;=&.=(Z50B_YZAFN;8V.CV%(8\[%33:"> MU_T&]0S8^&\O1JO HZ#VT10*5?^3FE=-GM+IN-#3L6B$.&M$7R]POS\QJC7 \'=4 K5:AP\+ MY[N7-:::7#F.6B8NW23=>AL!K1(Q7B LW)]A3 V W8RM<1-M"MR M4@5S'"/<&'0@W15;(V0HM]M8O[.(6ZKG,7%L;TEJO7\L12^$I>CROR_/?[V] MNKD.;MX%EEUN\*Y/7O25M.CRBXEM*\>+/*ZYR]]/BK+KP3G5;2#?95P=+_UF MTY8]NM.L6NL/SF=U1/'MBT"JK&LS)P0'%BBG\E<+A M5PF/#2&@D:4\EG]+/R]W882=BHCRDE27F9<^1?,AOBP_7KK"8">,HF8B=QB+ M+*[&T="2Y(#Z9'V8_ !?D75IE@>E <,R,QB ,$BPA^W%#IG6/*&^]C1@GL-P M=3T=#1G#?(;:$QBO7[9&_0MW)2ZFO%)P@"^>ZY0:;U[<>Q_R"%:_^'-5WB]% M>7_X>//WJQ^O4'T/*ON'DY=]5=D79IID%$7I2ZCS"C4.;/TF;.?E$$CL>R 1 M-!YZ+WL3Q-S#0- MKH&J8@]B9%:OM*UIK6&*\^P>@3+_R\B&$ NV@ZA/<1L@WMU0;U4< D.93E5TA%B@9UK!>[:&\+\&;Z3 MG.G@5-ZCFT6]2@H]?<#/FB\T7' >9=$DB3(?BI$B%".U/8?XMFX&W/7DHX/S M2FB-6MQ?A'$(HLL;>;G-PS3I #-3QOG"<.6?..820=SNU88R@UZ'G'MDD_;1 M_L00/9'U@1U*<:U2<)X25MJ-=WDJM;17U=D7/NF#'W' Y0Q4?UK/QTET.,#< M,*K3TUI4*3%N'$ [\0;K 6R*=GXY.@TFN>'4'=8<+MMIX(3#S%,.X:8YZ0UI MC1G!*3V&5Z0NV_HOZ<5J6WB -D78@G2@C+ 4C)VY*7;$N.,65GQ7A/QF M4AY61JEQ VPT0U:=^%QS8M]+3NRGR^O+CV>_!!\^WOQV]6G(C)&V^KZOF;&K M#+;%G.,!9XY6*%]=F_.,W?MHU#?__OB-I)PNB2L"S<=V-<1NO-%3/<]>-S4* M"?3A@8#A[S3%P]&O0<&>YCDQOTG]9N+M4ZG7DH[-P01;O*84#L2NC;6KY+)1 M<>'Y'NO$"=2/PP_Y(LF\1H]RGE;!0UZG!%N!:[XLS"3QD#"(1L%SOH/OX=:0 M\SKC@E8MLR%W95 C/QR,^ZA&)$SX"&(L;(3A\6Z4MA%#;] XWT[C@(9 >K;, MP,8W9,]*%]<'S*[!OE+:/_@7?43+2MF -(KY+TY+T+>V-ZRF(.I49H0 PHJ( M#$%8\L_,6Z3EIORO%7UJNX7K]#_Z=.YT9+XPEH\DR5@-LNIJ%-#B0U:J60(U MDT] &&<"57/Q*VE2Q?MA80:,W658V!?HC+L];&-/6B?X6*J(8#R\7D&4=COP M=I(Z$!]OZ=?B;F>%[;R?\=1-]^__]N;X+4;*D0H+SI#HSK@^;6].NSG_M6&4 M(2"V74#LQ5$_ V)_LE7PIT_\K:=",%E$@5[XG^UZ24TP]9_K]4#SS3F5_A\5 M>73ZYI0"Q[=.HT5I_J9_O,4 1QHM_Y9D-#ZZZ"TA+N(HE0FN\H5;JM&1+%<% M:U1-] 'R_8B_^VLUZ7[Y\G1T\OKU^N\W7GPT.MYTY:N3TZ^^=L-37QR-7KU^ ML^7%?Z49X5F!^2UA6?_S+Z=_<3N$C2N8S;^=++Y88TM6#3_:4CX]V4=+;=5R M-2TYSZXN6/ZZ>^.1H,+6NZ"Y>;9\H[_\\*Z&4YIP]GB&.^U/1?4*W:/#X@V+]T\IVUTY:9\T[IXURA;= :.3#H.=@H5M[SWR6[Q/XEED MTN"GO# 9./!)MAOOL7G4 AEK.3T[9>;LDK;:I;%LK3EW4RWMT%3^7*?+X$T8 MG!R='#W%&/Q73ZPXT_BX8V1V06[V -^V?U-^L=.>U0Y-U$Z-96N5,XA]/U>3 M%-Y?*1@WQ+*?&,L^_LI8]E_'^60)_YM5\_2'_P=02P$"% ,4 " "4YH& 8) $0 @ &6& 83$P+7$R M,C R,#,R,BYH=&U02P$"% ,4 " "@ &0 M @ %?'P 83$P,G)S=6%W87)D86=R965M96YT+FAT;5!+ 0(4 Q0 M ( )P\!E$J\K9?Z!( $25 : " >4N !A,3 S&UL4$L! A0#% @ G#P&41TYT&?)8P$ H (/ !4 M ( !%^0$ &-R;VXM,C R,# V,S!?;&%B+GAM;%!+ 0(4 Q0 ( )P\ M!E&Q0 +>I>H !SC"@ 5 " 1-(!@!C$^ZOA= # "@, %0 M @ 'K,@< 97@Q,#%O;6YI8G5S<&QA;C$N:'1M4$L! A0#% @ G#P& M4>B@V/LJG@ 2;4' \ ( !%I$' &5X:&EB:70S,7$R+FAT 7;5!+!08 #@ . )4# !M+P@ ! end

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

    A"IT\3Z^[#HLY=^U:_^ M6S^N?HQ>]2NGYZ.K^I/2S.)_>?+SDTYJJ&4\Z77RZY@;Z)SY=OZB_L#IY".6 M?RMR^S2OW>$EBQ0Z=_"NM^S:CUD%*SKW!(V['RL*\P0%WI$5E_JBJ72K[OF] M[ G_['=2]]/4,/:AYC)4MD80NP5;.B+//4UNEFH!-!&;N5&'L9X=7$UF*6@ M1M/SRL)-M6>3.%TU9YM9\<]KCK=CCD]$0&J'+>#08-%6\ M?O.[Y>F]_-TU-189Z[R^6B0\GCR?V;USR9+G-:5)=[IOI%O_, / M8^[X:>?8C^-Y1_)Y0K@=[1L?+S UO^%.Z_.8L8EQ8[/B'HM/3FIFO$:3@DL2 M[=G13+ L)5^4Y1V=?+>$,._I3%3P\W04_VJM"N_-R3O)R4_U-2_?_/'G8/#' MZ0_]/TY?G)^<_G'^_+__5*_]CO__9_O!L^_/W[U3H7WY[$ZJ5\_$;^( MX]]^>O/[GS_]\_S9B_[O__QP_L>S]-?S^A[UO<3S[X_XARJ\XW_^XK]?'#4* MO==_/*L_X]DQGGS_PY_'%]_]=2)^PC_^/*^_5_W^/W\MQZ'=^="U%,P>5;Q,UTUNRW632Q'T M$HS2JG5[U!ML5H,'6\.Y5Y/T*(0+<@F^G3'MM1<[5SH<-3J_9OU^'(V;!SR< M3L?]<#6KHYZ.:BRS$,H<74URWKZ626)E8N06W.SQ>C9^XGKA^$UROBO52%&&\VP- S/ *63X'6J__1:%VV-5UQW#X3JH6U1 M&QQ1/5$]!>!$ROM'R@%KO.U=*"Q+C,4ZEHW,15@KL^:>$REO*RD_?Y\:]X*% M((J%5-TO0*8C[^Y3T?FU2"C@$*BF]E R77KJ5+R7#I9=NY4NW>J;A)MRM7VN@T#33CTIG=-EXKI_N MIE_/S=S;>;7;__Y?5G#Q]<;N5][YF[EVY^IY,G R\)V:&4;'YE'RBC)ZH:-" M$4U"%8SW6C"/*C)DUK#X+[=&+Y5@/$Q_7DVFLS'=IZ/W4\U^]/UT-'PZ'VDV MFQOQC9_D]'1T<9F'$]^\:)::?#[W%%XTTUHF_6G^.8__[L?\X^PJC! KY=C_D6Q2=I*B=8UQ 0*D )]/D%VD@6_?6@#-DET&[O\\7)PE&S+:P)0$%I5I M9LEZ\$)JX%98=-4/$%HT:,^T[3FY#L2_W[EK*5H]JL*_=2[T?D+D1]38#\/' MY679M^'Q5S^XRI]'1W*&[XB.[^L?2M@:#ED#MG &R*L;;+U#X%(Q;^H7DG(- M.DIQNR&*D'&;D;&55>J=QMME^E(?H4Q]SP950MX5(N]"Y=DKET-E5##)%D"9 M"SA?!-AL$3-#F;2?(^_MMI<-MJ(2Z)([NF4E"S)P,O!V;!T9.!DX&3@9.!GX M=AKX>HO.%)RM.2VV4"/6NA0=L@-E> 8T2D(0J,$S6V14S6BH)CJCG!B-':"7 M[N=+J0EVR<-_.KJ$J\O.[.G6(&_8:?D;Z3M)W[G3!K[>XO3SL''&FGT MXIV+.8M ?VD<3!IM])C!Y_.?F?R?ZZNGCY_]]?KY3V>1HTPF*H@^1,"FK=NA M=F!L$()'6;^H:OQI-&E7B;GVC;F(8\A_)10@%" 4(!0@%" 4(!0@%" 4(!0@ M%&B+8(&R3EN1=7I]\G;"ZNFA.C[]Z\RG8J1Q!0K33=HI1_!H%"A7G,;@17T! MI9W:*WO8Z<[3!=E#'%U<5"B;3X'N]&>BJ$Y_V*#9,,]A[E5_>MZ9GN?.U23/ MOJ6N@:\ON;P*@W[L3]^\;6&MGPMC/TP5R/[.@]%E@U;4S=HF=W/7!5 D_20# M)P.GKL4=/3:;+'M_3C0]__1WH_%U.#&A\&$IQ?3QXB!<8WF,)7O@2B*@3LT( M\N @JQI16,5\TK)[(%&18'JGX)2 C_P%,G R<#)P,G R<#)P,O"M,O"VSL*E MV.RAL=F-.;B,\U W"I@7M@9G;-;-&L"Z'% &[2439 O[80O!!N%B#L T,X!8 M) 16&!AG7$PB*IT_$:A3Y-[*FM].MSJ?Y&FG/XRCB]SY8C":3&[=F402$!*" M;=Z-I2L=-KUU9.!;;^"MK,S1L:%CT^YC0P;^.)>UZB0ZY\SMB5UT#RLAW\XA'U$[&?A.&_@RU,Z+B#Q;)Z4MZ++U MD;F410C,\TH6:AEJ)_Y^)/X^/CU^EY2V+%M=,$+V*@!F[L!'S2"@=IZ)NDF( MW0,C;O>=$'D3MNTWMCV\%$=ARUIA[WTMC@LMO.(2"DH)Z#T#ZWE%010HT413 MF&[B%M,S3!+TM:WRMM/==L^GYWG<--I=CO-Y'D[Z?^?U5.)V6F]#@C(2E)&! MDX&WV\!;68FC8T/'IMW'A@R<#)P,?$\-?(F4C0@YB>P+ZFPPQ>*5-5E9)41F M.?.[7'5]YTS-+(Q[NAC%'&[9NO64[\@$WBX+OZWC- M6$Q9?7>0R"6@LAZ\S *,U'7OI,&LSIT&5=C33A=$XY?'L'>K*=2:C03]UFM]Q9^!_/J?T P9(R48N76#% MLYF?I(OR-NA8,3^$%,Z./@;\1R??+8'\3V=S4F?-U;,QRY/G5]/)U ^;17R' M^(P0_PZ(__LUVL\$YS+'NDTF0E+,5<"7 7Q!A*B*YS*H(IUIFJA=SUK=0R9: M-R_YWP]=2[&LG;*VM5'/$F#9JFW[K_:;^M;0R>UHXGY#0;U)4?U89N[ MRBG,6)9TWH_8Y,Q:B=("LEQ)AUL+5F@%%EFTL6 17M8H0U@>"--CV+YK9HC%*&PBOMD5OC%&UK )@_'!5O\%XS M'L(P1Y1#E$.4TVY3;QOE+"-VRE;R+%E1W"9,1KJ4F=):<<:\X=E\FG.6;],E M\ME,SFY!'BH:&6@2",8R 9B\AQK\S"8;2!6B*ZSD[H&4/6=8FSI\B76(=8AU M=H9U8A19:8Q>*8.Y.,MSKMQ3CXHS:,IG"D3$.EO#.N]EN3$;EC)F$#I4U@G- M*!V6')A8@UW&$W+GFIC'J=N%(B(=(ATBG;:8>MM(9PG.<48+X9/@%6\P9!U2 M91ID6I=0LG6>LFO;2S7OM<_&5!)A08((Q0-*D<$CMR!=02X9AN1*0S5:RQY; MR_6?^\LY_R*,/I\_'+?U:3<]6.(1GV5A!V7=P32ZJF?]3@+BM3YFFYYE7Y;L M,<>7T$:TXUEHR6C):,EV=LG^Q8?9LRF,;7J4MY[FOR8Y[N6U?S?[;W$;8V[B MLQ5LI/U@]@O^U,_ M($O?$4M?33!%Y^?VGAS6IVN28W[0N?3]!/WA@P[3[=5:D8?TX5IMT$/:R*,0 M:3Q@]5[DJ>\/<^ID/Q[6YYQTR-C)V'?4V ]CO+JX&OAIM??1O2?MTSEHP:/0 M.7A(6#P:PD)%MMK]O"1[O_B8;)YLOOTV?SJJCOP\#70M7?@_G3P3+W2^2+GT M8W_ZW\N4=>^UQCN=-5V8=W7LQ_&\(WDS\(J[=MQ9LZ<#KTI&P51.K,2$(BK/ M?$DBHG(J*Q%GW=W<,2DY#;QJ@';TY$^BY,": \TP".L 7'@(7!=002?)/*KBL7N @O@*1R)[(?N_)GFB9 M:'F3;;!HA6$A2)\4!N^]C2$ZXZR7.B,2+6\M+3]?S(\KKWV,)D)@P@)B,>"9 MS,!$YN@Q2(TU"!=6])EXF7B9>7M],).^+SL5Y+Z)'Q= +-,YP MJ4K1 @7_-#'33*0M8>CWD_A^>G/\\HP'Z9BR 8SP"E"KRM$.#; DE^*R\R6*)D)&+H5#'246U>2V)8N>,MG;R\R_W(B3 M+5.*"PLQ"@W(-(=@HH=F>J<,$4V0H7M@N.S)M4QTW%]F_I?6G]6,9*"7TDL? M^M)5]*RM8%1V>P[_?&9.?S*YFK6NQ='GFF ?V*ZVW(3<+6M*NPX8-SU7N.7F MUJZ)]>U9ES8]RK]HEPD$'NEN%*4B8U$SP316US=H[S&Z*$3D*LA\]FP6UB#C M,/O+1P;6SX.8.!X-YQ',487QG)Y=C9NXI?X>H_2K'USE^BO.OC(YNH;YIPW* M4[2R3+3RS[;>SO'^>;M@Z_;^G1T<9F'$S\32C9[_C)?Y.'TFS?O7_*C?]-\ZO"5'Z>W M=O'MM5E,CH9SBJ!1N4OQP-'-4;G)2I$P6G V864!GL&JD@&S%X$[QV+$[H'L M5>-K_MY[O+"?++-)Y- MI8A*/K>Y9X,C4%J.KD0[VT\[1! ;J&02"A *$ H0"A *$ H0"A *$ H0"A * M; $*M%+41(FB!U2DM>Q02J1,(; \(4%!'ZH*] MP);UB@ON/&KV,/UY-9DV6NC)Z>BP+F#S<'[PH^^GH^%3?]F?^L%,-OW-A\KJ M60CZ?.YROLC_N>I/^M/\QG5(Y8C,B,Q:169$.^32$@H0"A *$ H0 M"A *$ H0"A *$ H0"FQ>LT")J"U/1'V@A0@E&N\Y RT;+007#H(6$G*1*JN" MR19.J:@VJR%VNOO_&@9HQ,NNC7BY<37>;>';C!DFBTQP6_U&4USN@O@_W9SB M8I YHZT#;;T!5*Z M8Z!*%+G$GGFJ9GE)7M"6)*_K2W2V&D0;].CD#AZJT:X M_ M-S/31GV<)B@ONR!*+!6J;1<'Z 3+C&M + =:C!PR928F&8]#= W5[XB,Q M!/7/[#A%M%)JM=/$L]E!+D1!ZZ*@&QHIHU-.C2A*9N$ >0G@@@D@;=9!UFWU MS6W='[FHF^:Y$/OL+OL03SS2]:@R&A58* HC!B.<*U%R'94L284HB"?:RQ// M%Q-:G%L=!%/ B[> V4AP-EO(F'FPT=E@<^4)041!1$%$041!PSX(!0@%" 4( M!0@%" 4(!=9\D1D%C9NJ;]W4O?$<6O+(Z>@2KBX[LZ=;@^QM/Y71F[[9['.:MVH 5YB#*%&>1D#-R Q"4#,%KRI>\@%&N5$])SG[@'O M<<.).S;('919(C'<7E 2-7T3MNP'MA *$ H0"A *$ H0"A *$ H0"A *$ H0 M"A */#!5O8XQ4)2J7DNJ^H.+K8K@+/L,*10):%% 8!Y!QN!EB<+$("E9W69M MRT[/ 3G)TTY_&$<7N?/%8#29W%)2D6"19,N;=_=V^@RVZ5%(M4P@L#T@0#$? M59@)6PA;"%MV!EL(!1Y'^OCP61IWGA?[XWA4^M/_J=$C)8N62A;%FV,SI$7F MHI3 .4^ V18(22$('TI*7J/"1M=H5<\Y1V/^B!N(&X@;R$,D%" 4(!18OG-> MJ!B9)!OV <6OD$-[;(3P^/5ZL'A:/HL3J S+?3-RT M-H(M=4.2%R%H%:/1HKJ$_';MD%KBB0.( _:1 UJF.B%2> 12N"$IL9'KXK" M?J\G/K7E%5>*JO\$@1SKWT-*IL34/>"F MYY!&LA)M$&T0;;1,=D(LL1*6N"%(P21$;H:M"IX%H,H10N02)$-IC!3!,5=9 M8K5R%.(&X@;BABWAAI;*48@L5D(6-X0J*)DH7C)(61E 5VP-*;P!9U&$8IU5 M-EZ'%(9"BE;J5'9Z\,(W?N"',7?\M//#U3!W).MU&F!IA^PPC,8ICV?O4%>N M,QD-^JG3_(X[PP ?O?-':N2RXD-F]0\FC!4E,^&B45X*5_C9T?VO^GD+_A7W M+T;#V2BL^0T_SZ^FDZD?-HM(%_LL!?I_W;S8A\FB2E8.0G(.:HC'FQ[& B&4 M(D.*W!36/9!2]SAB3Z%LG3[QWX]=2]&,QNML:QRQ-H)>@E):M6[_U7XXV!K2 MO1UVW8]QEXJV9E1[/AK4I9Q\^Y^K_O1-C;8&5\WZ_3@:-P]X.)V.^^%JZL,@ MGXY.1L/F$<>CP:"^Y*@^;"7I*<5CRU+SXK5)RKIBG#3 ; W$L"@+-CL-I3@7 MM)"HI>T>H) ]SMK7-D"T3/F]W1 E$ML3VV^0[77R)9DHEQX@F^R!" MC)9+8OMM9?N31;9'[7GF(8,-6@&F^L&9S !==LEGQ8WBW0../6/:-TN(R)[( MGH+PEFTAT?(J:1E#Q>N08G(2T:OD+=-%AX1H!?*8B):WE99OS/ASMD;@*M<@ M7(L,:'4&IW.$+!UZC:&@=34(-[PG.2->)EXF7B9>)E[>'"_;J+PPA7-;X3D6 M9T,-EE,I&(+70E*XO+6\_$'_0U;>H[42BDBEALDI@F66@^8I.EX8J^3-4LQ:#2?9N9/](\0#V^( MAV]TF+CJ7Q7),W >&*!6&BHK2Q!.IA*2MSJ9AH=%FT:>$O\2_Q+_MFP+B7]7 MVO\?D2=$S$T=V03ET4C-40==G HB4V"\O81\HXLGH;(IN 2><0D864/(/H'C M:)7-/@=?"=D)WF.*=&,;;/ YGS^'Q3JU#G]U+^\$"FLWMY48>Y7'V\C9\?78O:<.V;,/H\.W. M7M*&;8>DFH[T3EO(DK[1BES9#]=H@Z[L1AZ%7%DZ>G3TZ.C1T6OE7M+1VZKM MHJ-'1X^.'AV]S>_EIH[>K)KQY:QT5_],_;\/_N_LP_PE8?SE^Y??_.(G)0D? M?_>;CWSGW_3SA8-!?YCAVNZXF)5Q?\ZY,QQ-ZP^OKBAI;_ DWO^?V >EN9KDYN]MZZYOKMOBQ M^;5FI=XHF^D6DN=B/,;"G1%196&4+Q*+Q3,ANF^_Z7S\OBSY,D,89_\7^%)7 MXBL_>.7?3+I?WEBPB_[P[1.YYI$_N;(7?ORROK:!%/9$J?__SKYWXR M_]H'%=KY%YU]PMAGOG[CFU=4>D\/??#E_6=^\/.7'C2^>)9 M+OW8G_XW+?^#EO^[T;@S/:_@UG_=N:CO=3[IY+HA:3:!?WGR\Y/JZU9B&4]ZG?PZ MY@8XF]&8'7]1?^"T?O9JZ*]2OYZ5CQR!6V[Z*LO!]S"O-$.GE'YESJB^8)OS,E?_A%]H1_]CN5NO_W?OJ+^HESG_G! M:WOBU=0@MV\=Z(GIB1_RQ*8&!>+NW[N"8_@O&X]U"_9P-2(CLHS;EG%8GZ[)/?I!Y]+W M$]00>GO,A#;T]H:^R%-?HZ34R7X\K,])D+V=^W@8X]7%U6"6[1HUMQ_5A5NX M_JC3G]U_U/EB,)I,;K72TAYOQ1Z?C(:PT )7]W3> T=G=COW\W0T;6J%C;-U MW0T-7R;8I#?W](8IS,;%I)+(Q2+GR7MF?8Y"*\9<$G[>N]_?LN/F\^?GO_U^V\G?_U^ M^HOZL"'YY,^_V(GX_9_?+WXX__UTT#]Y-OCK^,_S_O'I+Z].FN?]OKY>-$W1 M@_+V=JGZYZLSE;+W7 = @1E0RP V(H?$ZQ+?SUE(@>]0[:A_-AU@][RP)DJW:LT>=?K$"(]\:#OG(K.9[$<@^C[[8$J;Y MYQW39".,PB2A9)3-%"H$[V2$Y%"4W-!-4=T#I7F/:T4LL\,LL])J,7$7<==Z MN:OB5M)>\>2\PU)\_8_YF)FSCC-AB;NVE;OD>^YRPHG$(DAE!&!,#BR*#%&4 M$)UFB#9U#X3L"8E$73M,740R1#(;(1GEK&71I(9XII5& MOL4\$V7.%6"88\8C>A$L=^A9]7\Q.">0>&9+>>;UN[+/X9G(/D?E,^3 *M-( M:\ F)\%8B0PKTP3&:CAC>E:N8_PLT0S1#-',]M/,,E>-1&=39H@E^X2!\2!U ME#;ZRC:FN) ^S3/[<=7(UK#*FW>LXGQ,P7@%5AH.6,,5"-%;R#64<=Y'9"YV M#ZRZ?=?7HUXS0FQ";$)LLOULLLR]55EIQCPK7 E42@6NDRR,<6M1!6CEY'[24(%TQ*4!(2@-:8\ ;AQ ,XS&@=I5DFO280==CF/7#RXN64O-[%'O_GU\O369-IGVCIKV:FB8 M#LS#D[,R)5=X]BYKACPJFZ5,F06/Q5MGXMFSIG>;<<9A]I>'7&]\F/Z\FDQG M,V=/1^_'YOSH^^EH^'0^,V?6//R-G^3T='1QF8<3W[QHEM]]/G<-7C23 ";] M:?XYC__NQ_QC7:E1>I'CZ.5P]A,IC;M$&O=D44BON6?"(X*P5@ R6R!PYH'; M9%1@Z(R)W0/94VP="5Q"9W(\-KUOY'B0:9-IDVF3:9-IDVF3:6]/8.Q4X*Y1U;FE1Z1I5.OEU'L=^Q9T6#"#<%;KYZ)A!*9B-)DEGBZU/%[S( M(6834T@18Q'_PCC+S1N<$TQ[?56IBD$6V\I8*&0[!7WR:H,S@H-&+P"QY5I1CYPGK1&R7,-PBCEM2]% MY'WI3&PFQ(S[L;E-=%;^G$$<-2JVQPG:0U$)R?-:MF]DVMMMVJVL[NSN@=FY M1L47[YR$6>#Q2^,BD*[U4<.1-PL5(9FBU$([D"XJ0.\YA"0*%%U#$>F5*EDU M%2&TZ[@9E5":')!-[QLY(&3:9-IDVF3:9-IDVF3:VQ/@;4?#(@5X:PCP%NM- M 9EK;A^!TDRB02\Y^"P51!&#\S;S^B>%>'M6<]KIQL73T25<779F3T?MBVWT MJ_:P\DQRFU;MVWK;S^;.4QR/AI_5VE3@NKI\,8,MDMKMZ9GN?.U23/ MOJ6N@:\ON;P*@W[L3]^\+?K4SX6Q'Z8*:G_GP>BRJ513IU%KG*D]K *3KJ95 M^[:%XP?GG_YN-+Y6R4S(SUK&S_IYH304A!+.!81@4@+,]4/@)H+PR;@D8JH; MWCT0/4;#O'<)#5M9'"*,?9SF- +2M0'IPH5WV0D6B@/7Q*QHO007O 7T3D?/ MN?):=P^XNCU/D&!T:V&4 (_B)3)M,FTR;3)M,FTR;3+MMIIV2[O'*#A;87"V M6$VTHEAT,@)G1@%JI2$(DT!EB29ZR[(639Z+ K0]JB?N=._729YV^L,XNLB= M+P:CR>36M06D,R$)5;LD5/>UF]:M2IL>Y>W6T.&GPT^'GPY_Z\N !"D$*00I MVPHI=/@?X?I!*YHK0;V*163,*@6%J227HW8,#5>=-+(CHL3CLIN?$F1HVE.&/( M+6R76WA\>MR(0QO7\-7S9T?JS-:M,D5FB,%&0)$R6)XS"&>SCLKHC(U(M,>L M(K>0F(&8@9AA;9H58H:U,L,O"\QP_.9,!\146 MDP3D&,!+(R")PIU@E>%] MZ1Y(T6/B]G!BHH;=TZ;L=*_[\^EY'C=M[I?C?)Z'D_[?>3U:E=T5.))V=[W: M77(5M\Y5I,-/AY\._[8>_E9J50A2"%((4K854NCPT^&GPT^'GP[_??/.101K ML2Z$41Q+XCY*J82T*HI2LKK+M)KE\\ZS[-'3Q>31T2QWU&2B3_+T>3GUKRDC MO71&^MOKC'14)Z?'9XY'SVUP4(K5@#9X<-)$\+F$*'E,RO+N@>8]RVYW3#YJ M0IHX@SB#.&-W..,Q52Q$#&L4L51B^/.7,^E$$E*XR@DZ 7+FP.64H;D^E:<0 M TN^>\ ED0*1 I$"D4*+!2S$%RN5MLSY(@AL=I$!AF( E740O,R@N/?9>XX) MTSR0$)PX8P^4+3L]=>4;/_##F#M^VOGA:I@[DO4Z#6"U0/X81N.4Q[,?7Y>M M,QD-^JG3_(+;QBN?I)7YA1D?,$M*-G+I BN564*)5A?E;= 1&0\AA;.CCQ'* MT8PW)-#B?"DCCBC%2V9!5]T"BZUFK>\AN2R,WVE3U[R>NI2C6SHO15D\Z M2\)DJ_;LOUINY%O#(K>#D_M1R/*#(,]'@[J4DV__<]6?OJFAR."J6;\?1^/F M 0^GTW$_7$U]&.33T#08U)<MK#.E8&59KGGSCFND,IX+S2$4 MV00K*)J"1X'D6(Y2YGHBQUT;8JX2*7NBX M#B*B$24XY)B]*TYK'Y@C]MI6]CI98"^>8]*L@$)F 450X%1,H$+$>A:<2B)V M#X3I,=1$7CM,7D0S1#,;H1EC9 V2,!@?+!81G&8Z1LF,U%(4D8AFMI5FGK]/ MR*$NP@K,@,8UJC 5P'&OZC^EC<4[9Z1K!EAPIGN&.6(:8AIBFE8:>=N89AFQ M0+;5W96L*&X3I@HY*3.EM>*,><.S^335+*\1(,[93&+NG1SY\$P4%5W,!72* ME7FD"6!E$A"YK:S#-/>%=0^D[#ES^Y+B3P,%=;(^Q.R\;1A&:]EC>'L0+.70MEDR?3[_E;FH M:W#?J7^/I6IXQ&=9L M9[2*-KBI\W$E=O-;';-.S[,N2/>:X)MJ(=CP++1DM M&2W9GBW9BCVC3>_"(_44QMP$20]ZR(][S?8#K]FLP6L^N;H(>=P9EYWH+_M3/R!+WQ%+7TWX0>?G]IXS_]W6:H/S33;R*$0:#UB]%WGJ^\.<.MF/A_4Y'\M%(ELG M6V^;K1_&>'5Q-?#3:NZC>U_A0N>@!8]"Y^ A4?%H" M5T6KW\[(H83_9_*[: M_.FH^O'S+-"U?& V)-Y\W# M'U[Y\9L.;V93<=>"R89[.INJ!,\M2U*C3&B$-[=V3E]?OKMZY-79\5D'3Q3H!UG4#0S0N:*E3J#&]HQ@ M'[VZF]LM#*Y+%4)A;D@B..WE>-/;G*\0AXM+P*L3P[0H017T(&U MVKF(29O$*\?SGM"W;Z$ABB>*WQ^*)S(F,M[,V 0;I0JE>,:"QB"MRX;Y@B5@ M]"RJ^&DVIK$)6T++SV\FPV/ULA1G EB1HH;>6,"ER*!P%DW$Q@[L; 2I^TA3 MZZ8N^B%&)D8F1F[-HA$CKXZ1L<%AQ@O6D!B="%Z'7*3/.H2H15+$R%O/R.^G MYOWU^O@TGJ68.;?:@I(^ HIB($3;5*JCU.B-T4YW#US/KGIP'C$R,?+F'X48 MF1BY10EKHT-R%F-D3B)JYIQ#[ATFT5Q[ES]#R$2VK2#;XQMD*UPL159VS74G MF])S %<8!RME*(4QI3AV#SB[3;64DR:^);XEOB6^7>TUCIY9&[+VQAJT5@67 ML\3D,/JDG3=4(-Y>*O[E!A7;R+.PFH$JV0)JZ< JU"#J/YE,14;1J,#0]A2N MXY(2HN.6-__L])WT\[:/3G\RN T,9G]YT+WS,[HYFNWKLZMQ0S+U%QVE^8;719A]:4)=/DO1 MR>\?=OEX;ER.R8!S-@+F%,%C#M"$==QJ88QK1L(WM]!+WN,*VS6RM^7H]*@S MX"F,6[]ZF(CCX:') UEC^1CE-FG\Z@=7^39G4 AR1\ZXJ5'5S;6[ADMP,21 M)A58M A1,EW9Q' ;<_= U A$LG5TA1)?$%^TA"]6,YJ/6.B3Y\4*+KXF2"%( MV5E(H<-/AY\./QU^.OQT^.GPT^&GPT^'GPX_'?Y]/?Q+99Y-0".EB(6A;W++ MSA>>4E!.Y" E99Y;GWG^0/P2&<-L7 ;KA 9,)8*5QH!6)=7/NQR$I]3SWDE< M=GJ^[?SJGD;A,AMS&T>?&\:]OK&V6T8;*_,9[[%D+34T$IWOM\^XNX=_F5;B M=<@5XG@TO)O'>'0-^T\;U"?W<2GW,7XH7 C><.8TAVR3!]3*02@Q@$F.9VLY M-\IV#V3/<-N:EN&6HR-QQI9S1BL5"[O+1.2&$J3L.J30X:?#3X>?#C\=?CK\ M=/CI\-/AI\-/AY\._[X>_N6RSZN7+%#V>4W9YP_$"SH6HWF4H*(L@-QZ"#)8 M*$HB9I^$#XK2S_NC6MCIP1R_^?'8#Z>33GZ=Q[$_H>D<.S&=8\X=S=L'7_?T MZ>CB,@\G?C;]J=GPE_DB#Z??O'G_DA_]F^93AZ_\.+TUBF^O;6)R-)S3#HWQ M6(I;7GXXQH,)ZYD, IQ6$M#Z #87!,9TB-9ZK,S3/3 ]Z5C/Z75<#KB'RCB2 M4N]D8+*'_-)25,* W.?$DL#CG9)'9*)F48479? G?G M"_'.FGCG@UM.DU?)1I8AE^:64YX00MU7""FY@,HJ;5+W0#F]VCP8$0X13DL( MAZB!>KWI\-/AI\-/AY\./QU^.OQT^.GPT^'?U\._;9(I2A$]N#3Q@5K*.9&B MDP%$,HU:2B$X8SWPXIU+R2:6FILI>BAOJZ6(,W94,K73@UY^S9-I?;S.J'1& MEXT=TYB7]CB->ZB9)*']3CJ-=/CI\-/AW];#WTIEPNY"RGJ%"7>>-GJ8_KR: M3!M=]>1T=%@7L'DX/_C1]]/1\*F_[$_]8";!_N9#E?8LB'T^=R]?Y/]<]2?] M:?XYC__NQSR/9U_D.'HYG/U$"F*7"F+_^E#G()17'J6'P$.-8?\_>^_:%$>N MK(W^E0K.NT_,Q&FQ=*V2QF\0P1A[7N8,,+;QS+&_.'2%LILN5G4W&/_ZDZKJ M.V#3F$O3:,=>#*:[JE3*U)-/IE*9B@JD>1#("R.4 I>6&O!A>8=?<>(G6;%D MQ=;6BB5[DRAL6OQI\:?%GQ9_6OQI\:?%GQ9_6OQI\3_7Q;]BZ0XIS+3:8:9+ MN1*^P 47'H6 ,>*VB UR D'",(^MH=A+D>),SRQ78JW+RXR@)5676:OJ,C]H MIM:8FOZL:;F<;I<*R-S A'S>7BP@8T!R,L\Y*I3AB OJD&2<(E$PZW21"TK! M@A!!.CQ/^78I1SLY+53> M>DG %4%,&XJX$AJ\$TE1L,)I)W3@%(/QP:E>3+([S\/N) MQ!Q9"^8+@W&J: M!\L-U0I3QJ7G1:%QKKU,%F)U+<3!?/R*"V6XQ0P)QPIP3V2.E' <46Z)Y\X: MJ_W&EF0B68AD(9*%>,X6(M4528L_+?ZT^-/B3XL_+?[GM/@?N!%;\@T?:^MJ M(3W.>LNQ\A()113B(M?(2&I17L@"O$-ME;?@'%*6G,-GD!>WUC6$#JM3-#S- MFM$]0';<,\S(?NS>:]]+C0/I#T_?-K)/F7&WLQZO%C/CN+0YP4(A0JQ!W'"# MC,48Z4)RI1E0 LXWM@3NJ H>U8T;YJWS4;R>FXH=F8 M3UG0Q.2&1\10C+XDF1#ICL(KE2TGQ$-TXD]5(5F-%K,9*9LRM MKRU*Q\H3I*P[I*3%GQ9_6OQI\:?%GQ9_6OQI\:?%GQ9_6OQI\3_7Q;]BU:12 M_/E!XL\+22^,%RJGSB 9?$#<886D"0(5,K>6%H4.FJ< ]#/+?5GKFE#[?I"5 M/5N=^.R7;M7O7TK>2AF2*3TZI4:J0 MDA;_SX>A[J 2QXV+R_Y=5Z$<_ 4.8HHQ+15CVETLNI$7)/?8.T2<$XA31I'2 MMD!2YH+F+*=&R9@:CSM8X507,!F%9!2>O5%(C# M_K3XG^GB7^8 OO6Y8S20 M>%R; M2*2Q#BAW5A/)C.-!;VQQI3KPK10.>((Y)W>Y9Y*^FKZZZE]-Y8>6!*J#P;&O M8:I.3FM_['O]\LP_3$K6^B;SIDS^E,F?G*:T^-/B3XM_+1?_2J9D)4A)D)(@ MY:E"2EK\:?&GQ9\6?UK\M]R!\;H(FN4J4%UPXZ12#DLFA9%*$T?O-!^SB1F] MG T9[381H[@GL^\'!^%0?TU[,TOMS;P9[!V^FMN;R27EO @>&2X9XL9RI&5P M*)B<,>Q$X)[&C?J.Y)>KX"=SDKF;^5+,6]6(KYS*X0<%%HCI&U M5H/WX C2F@5$@_.\<(XP[D?>P^4&R\E':Z%RLETA;^:4S00152AX)M;#&6=PCG'?$@<:@[774KBF3I2,G3 M=$GNWS0O:4Q6:M+^UXK#P).QM9?=M]L9VJ6\ML;"'E==F,K^J_\.R\$%>&W= M89R_OZLZ#G![,*A+,QQHT_6'U7[5BT.LJVX7OK(+@P7;/$A^W;(6>;Y'&M+\Y19W$0C'AW<86IZQ#\$/TMDS6.%GCQQ_*0Z8K)AN?;/RC MV/C *RP3SDC/F-+&6%UX;:JR5A"4;_U1M_/Z\C0=37EA'"V0U8X@SRI#A M B/,',$Y=1X7=&.+\$Y1J&3BDXE_QB8^&>-DC!_%&'.CB3?..L4XU\)IB?.0 M&\>YI)Q8EXSQ4S7&"P4SK0B64Y4CHA1'/+<":8$M4EXR24S(M2/@DP\B* M% MBN"<%LHZAQS58(Y5H9&QA"/F.>=.<">Y -^8=%21-J.3-4[6.%GC9(T?N@XP M#@S<(U%X922G$DMPF 37/,?.FIP7UYOC:\K_)N/[2,9WX?0)5TZJO$!@<0/B MDEMDA TH-]P:EN=%CG4TOI?/GSQ6Z>!D=)/1349W928M&=U[@DAJ2W:<+2A*4)N^\)NQ,N])_&F8#_NO)LZW_#C_$E M)[H^*GLMEZ27^>(-J=T\'[PQC?P^&P5WQZ.1C AMG,IWWF>]:@ W'%31<7.^ MU_=Q*GH-"=8#^$[IG2]V%=X _G/C>H+\YX9R+[W]:]E>?]OUOXU]>C)=;V6NFKKGH*G^M'7.>;TI"FV&//)/1 M_4>OM-F^TH(OV7ZHY";&W_E\[N)[J'APM1K>.L3VNOF_.XV;%@_@OKZLJU[5 MS_Z [YYFNSV[.>?)KM*T/[F9G4#YRUDH?S=ZOS?IKW.YKW MUU6=#8X!Z9"$:RI_M-&:MOP'Q9GNNBA$L&Q)IO M_E8.X$GV_C>(=WL@D6H(=W*-UK_??+<)A!),3MWO9/ZK]1%'8XF.3)_ #0?P MUV%/#UT)*^;7R\*Y"?/[L<&<7+V,31U).;\_FPH\8&(8ES:JN=RD17%#H[K< MAW03T]O>&6^2[UW)\_S6U_Y@R.R.&,8C+.E+3I&Z7PP:T?>[1R'Y"%;@W57H M'^L^/7ZD?A54Z9[-V7=5Z=JMGIN'%E9'SR*-N$TNQL_(_ XF,"G$_2G$_=/) M)?)!GAI[/SCUM1[ +.X*WU6#DK?OZ-5\&^'XQ:K(X:KMYOP=5E9FZEYNE.L\9N6(AV86)6,SULF9QLS2VC-%BJ M-.:6")-356#&:.&U+)B+!9XI'A5XAE^^EYQ]XXRQO^LJE(-8UWEELKX.7HZS MOO;./WS>(WLG'\@^_?-D?^<-/OCWX_'^Y^.3CX>OV(=O;^#O[[]^.'E]/,WZ MLN?[_^[R#R=OZ,?#MU_VOKT]_OC'GOBX8\7!S@>\!^/<^P;W.GF%+V5]?=LF M'SX?EQ]W/G;W_W@#XWG]Y<.W[I?];U_X_NZ?_S;_7ONC^T?/Z'G MKY87GC\!M>Z=^=Z@JB^R\[H<>.2J\]XCMQJZF=2?,C?Y>6?TQMQD(M]_HWAW M0+J)HRS!4?;?S?BBCIE #7B@.B<%XEHPI!C&2 G/J2)46V&;ZAN8\D11UL$A M3B M5A2*[K1LS/K,<.O'CF M? M^G*Q0[9 G"WXI&KOD'.[XTQJ H%GDS<$=?1)+"WUK_I#"LNM#:F<%#;]W M?5,_JN>V9^2=4'X9E)]-&@K26^,E101S!BCO&)(Y"4@'866ANY0DH$@G1LX!-,\((4 M&UND0XJT9;6:A'?]@[?QN'0\")"%NCK)RMZ9[P_:Z@%E+_--J/F=^MSD*$G,I7X,RM'56]_S@N'*[4[U(YF )$?/> ?#,)YH09*S& 'LXM(%]AD*&A0(3DA0/8D\(#\BFV0CV%GRSN/5[< M]])Q\"? @?_00',!=6I_IKO#-O8+C-C!/<^:TH99M]2F['[_G'B*?*S,2=$; MD]TH^0CX![V=B;!W>_U!/6S ?M\/_J[]0']-J+\,ZL^F[.;.8N.-1"Q7!/&X MZ:>8P\@)1JS2S@J9;VP518?+RQM^Z?AHB@(_;RQ\P#!PPL+[P<(I [:@)\3E M%$G-%>*%9DAS*5 NF3.T8%B)8F-+4-$1]++WG\ PQ8'OGP/'6G-57W#0>G@._J<]]Y4+\ZBO'6PX1^\VX&\D=B3^"^S/GYP^U19RP ^.U/E B2 M&Q.0XS&O%WN&%'8.>6ZETW.T2':[NV?M?=U1,F;[+UETX M.=5E'9=^F_H '545>Z\[':;Q-^R-]"]HS*67M?]OK\_\KO6P8Y5C?N.)+W= M Q,PEO-V%/-4+1+N+X7[KR94&#[_MG?^B6%O@S06%5(#]ELMD1%4(R>4"T19 MYERQL<5Q!Q0J9;X]Y?#OZLS+*@WEZ@;MR6JL7#K(30I:)(-Q'P;C8LY@!%,4 M@=-8M\)].:QKW[,7AS6\ M:3O"<83K_403DN%:RG#M38/^AT?PV:M/U#L10+!(*Q[S&[5 )KT(9' L&5Y;DW">8G_+M+_)MF^V"P7YAYCQ2+ MM?UH$$@IRA!QFC.0&E>!I@!^"N"G /Y2;5JK'HI]CK(^X%*_R4TZT?47'QL@ MI<#+TV?EMJYZOX&0HXS?^6X7)FZ[Y_;&(G[U-5:=]0<\,U M"J+((R_'P,MC+P4KI 15%42%6(V0B%1S]DG'Z!,,/DE>GA#P?A!PRLP%U8(( M7B":%P9Q$ W2PCCD C8J%$QH)AZ2F:\[!B9F_AQ"Y@?Q?&PGZ_E!BHZO/ ^_ M9@.TD>'(]K0%P)*YN8VY^3!+N"76Q'O)D%&F0)PKAY03.9)$22Q5$80O-K88 M3F'P% 9_+FCWP,=A$\K=$\I-2;4LG ?"+)#P+D=<Y,96 MP44JY;)JF1SK'3#V@ZS-Z&[J=_?&\>/SJOX"P\ZL/BT'NOO(L>-+A2+7#,(? MM,6XK;WN^QW?_G>W=W#J:QUC)R];62>87PKF[5Q6A\])[K%&P6,:^^_&?N/" M(U(HBX/(A2A\)+,=45P^Q_H8V=VS*VM%(2J%C9\! CY@39>$@'>/@%.B&Y0% MM]WG2%L1]\^L05H+APC\/<>Y8)KF&UN4=(0B"0%7BNBN]6G_EY'5AFYUWL^& M_:8Q35:-EWT6U>]L%2IV1V4T5>U\W=P>9C'K5]W29?%]U]H /$;[&G!^HEHT M*7[.N]\OWH-FS)B#[8E:)(NPE$4XFN7$N2^45M(@9RU'/- 8ZF4>";/D&SO]2$U@\1,G$IEKJ#H &OCYYB)+W2P#N.G.;ASSUJB\: MB1Y6V_:_P[+V;8*I-EW_SMMAG=C,TFSF\WS]>YT;*?,QYRJ5$7,4J ME@672 NL4*$%P\+GEO$ /ATX=3*AX'JX;D^$Z]85O)[K9Z&N3N;Z/#TL\UW? MW?%5);XCP<>NUN\ UINS58,(]1<'(<'_3\/_JUD2;#"35 6)A.$YXKF*>^44 M(\&89-8Y8839V**8=?)BA4Z;/DT;\-CQEH2*3^J<:0+$!P/$*1_.'<62<89 MM@7BVA"D#+8H=SSWF 3!_CL408^RZBB?;4]CZZ1#UF9)?LW&8 MUOA,0RZO_]G?W>ZYQ3__6X)U&@YV?-RM*'LQ3/-:E_4_NCM,M0R6,U1S)1)S MS+"DV" O+-!V"X9*4B#PA<+:>EPX*_7&UE5IJ"E"DT+6SQD1'X"Q)[!.OQ[)/>_H]1',9M&Y@GPEP+\N1*-1@I% MM-%("1,0Z!M%L>,FY#PSI!P M)C3-M"@(]\@R;A&G'".E&6"BLY9J19TG+AX_Z2ARSQDG:XV$*<"[+/5M5W]D MOMK:>MBD5K=^;P88!:C4']3#%K"Z%8SZ5%_$_:H4_GWZX=]Q@.-O7;I1-5Z8 M')=@?BF8GZN_J AVNB@8DHX(Q&U!D9&<($!U;VDHBL >]%#-6L MH[;720AW1P@W);(VAVD'@X1BXTH@LEXBJ8-#A@;&+"-&Q JS[$7(D5J4Z0VX=]]4=8$SVEM?GJ78\%HS[K^B MJ-].))ULT3*VZ-M<03JNE':2&B2 ,R#.!]7B!"#'!Q9172@N7(Y(QPAWU!O8Q5 MZ3N4TH1_B8X_]4$_9-B>T"?A1,ST"3T=-33+?HD=0W^--?_*9;H:/5PP:VUZ MW:VHSW%-A[M)CZO4X>Z6UG>NK@CEE@O/,7),%8A;+9$J2 [>!RD*:G.1%V!] MF>H4:L5*BZQ3F[OGN1VP-@CZ5+N%)BR] RR=>C)86BXM%D@9KV)[&?!DC."( MXX"=$ Y+Z3:VA)2='-]S7LPSQ=$5"M\_@7:AK\N>[MD;$NO'CID]Q^YDAH_:(&=M<[M>)[^ MZAKCWYUGKR6DNV.DF[J9Q =-# 7GDE.+N)8:F9#GB/&"8Q48*8C:V)(B@=S: M.)-/@\B^]:?34\1=WQS$,/!".FI?*A3YY+/!VC+'HU2(UU7]5Q3QP53"DWA" M"B?>$N?GSA#GAADOJ$%&\]B;Q'LDA9/(D%QXP'Z9DY@8T2$RY86EO+"$A'?- M91/QIM=P=UJ;-I[[44E%VOH.QNOS^,L?B#\+(Z.:EZ[P:5_9) ?2E0_S(?E562 M>YHC[6-4UCD7*^)()*2T%FLA@[0I*INBL@D '_N$0T+!NT;!F8BM+(22&",5 M\RMY/-V@B0N(NIR >$4!]BQZ\A*KCA!YPL'58[EK';B=9[G^JZ]MV5;1.:Q. MT? T>QN'DB*X3YCM7FI1UXCTU4C4*7"Q#+KO[VS/M?8ASF!E',H558@7RB/M MI$ "YEJ+W'/F4FN?%*Y-L/< T=H$<'<&8@#0FL-;BD\>V?$]5S7M>X-^DW?GNKT7C,04K#B7CO/_]N* M<@+EVSW71"0.6JF._YZJ^2X'\7-%:!3WAEA7H-PS#1R6!J2U5X@$K;%CWDH< M-]]29")%:!/H/7)S^82']X6'4\K+I XBMFY0WAO$O5-(4N&1= K^7SB)'8\1 M6RXNIR,D3'QTTKO6T=I_R\%Q3*./Q\,&^BO<_E27+A9@O&>>FP(6#]^2_:WO MZH%WA]6A_CHC^-=5W1RG^%T#T+^L3DY]K]]DI2707PKT=V=)L&4NJ%P*Y'U. M$!>* >@#_"M7% 9$:@Q[T&2%M8YUI$#N$\#%E:B GB#POB%PIAAC@;5R!BBO ML!AQYB52W!=(24^#*R@O--W8DNQRCD)*PGW.E1A3:'I1\ TV9>4HE0KF+-5P M6"MB?A":H,LX5^YEE&^R/$M9GKE"A*YPE 6*D?,ZMD/."R0]R,H'IJGDAAOM M4J9PBD,_'^Q;]6+H"0'O @%GLH2YU5K@ A4J-B7*@P$$9!*!\3*8%))RPC:V M6*=(G>$3^W[Z@TZ!_>L*P<7J&4TKI5-]D?HHK8G;,+.!NU\-?/_O5K;)8"YE M,.=*OCG,B+3,(JJ#0EQPC%2AP'1*65 L/-/X05V&M8Y:I7C]FN'>(QTN3.#W M,^ WXRV87%/F//)-VR16**0"TP@,&#>XT#0$L;'%);@+#U$);JVQ+P6_EYS# M^4IP#\%EUS<,M'I<=B+=_D%(<'YK.)\K]E9@PI0U&,G<%XAK)Y!FN4=,.ZZT MD<&K5"@CA;^?$>ZM:O@[H=]=H=],NC7+*2Z<04QP#OZ[P$C'Q&LL%,,L9Q9[ MVY!9MD*-[J4P\G,((Q_6<(L19C9I)Y/\<,#,_J >MA]%6IXBS.O#RJ?; MLCO>#-*N[*U-T^%<=8]8J(D+J9# P,XYR14R1E'X(:RB2H9(0#.U&4.N B44D0M=8@SR9'QS"#A+,?]8>=,43V<6YQ[ M(-/"A)CMW73Q4T@$4118@:DT-&)GH4B'LQ6KO+1.(+I"\>6?[!G_$!/X*@1O MF[0.P!-X;"^SP[KV/7N1#6+*DNR$ MF"N F+-LW!&NE4$Y]19Q(@+24@EDO=;64MM'\!)&E^:R+<#\ZNGV. 9N5Y]T_9B[]A:BHWUJ^=D7;!O[O#*)-9 MR]1:JV1@EC(P>W/-O&60S#F,"L(5XEX39!01B!!O@J'!<(XWMJ3J*)5BY2E6 MGJ#X:=#X!,"K#)& ,.WPL>ZK@0QK32SG!JC>+M723N$T11O M?TKT?WWC[2^OX_F=S/BCLM>+22Y5R$X;+$FA]7NT*]B+'&.- Q&4"R$,R1T+ M0.FEY,*HXM-N-">$,O(XYB19AZ6LPUSU06Z8 XJ.@1$4(?9[*&*K!XV<%AZX MA**.^L8Z*-7)KV#H*024(N?/&!J=QE(:G^M"%EQ*0$/O&7>*6^URI5MHE D: MGPXT3HFSHAA+0BBB/'9%4-8CS0)'C/.<,:RX-'ICB[*.HD7"Q=7CQK<-C9-- M^@0..WZ''_O8^?$Z9OPP,[I$^&6E9O5_K;B?^X1-I2IR2K6CA#C.P60:QXO M<9X'$[Q4.IK*'Q\"3:9R14SE^[DB+IPPG',#IA*#J&>>;S8Q573F*]^Z&(7C'8-5K(IS_3(:7LWT\0GS(KN(#UOG@.- MI?5&MN-+;5"_O+" M80ET5 BA&&I,P#]TJ#IP[( M)N0*>6I/%MH>SR5[ZORS]M:79_ZQL\?6'ZGOMA#HE2$Z6U>]"8*_'0DVH?BR M*/YEEI]:L*B:%@()(**(@[B0"AI07!.9&TF"4&)CBY".*%:HUZ/BI[S8SEEU_FAL^='^R-W_'[4]4M>QX= MM_\FM(&I6 ^;T1?OO,]ZL4=&-J@B(CC?ZWO7U*&/NS]Z /\8U>K477@5^$-3 MPG=S,B^+LW!:]+M@CCTSM]1>D \S$;[I[KB_Z&_^9UU%0T-&(5!SR MM3,[H\QX4XC'T^=+,UMNU<%6(SYZ29KI$O.[K_:"HWVZE<@-/V0R4W,?[.YW,7WX.[?+6( M[I*?/4T-:F7R$OA)U<_^@"&=9KL]NX!Q22B/(93]L7%Z.3%.+V>-T^N)<7HW M,4YK)+?5%L[KJLX&QX"PY=?L!+Y^W(\YW2"5/X<]W_(GACM9C)6LD4Q6>"TU M#_ZM',"+V>_3D5: O^SV0(#5$&[K^C$7__WFN\W,1*^;P#WMZZ$I8B;]>)^%YOGR)+\X(Y_.P/RC#Q8O1Q(X$ MW12[?ZR9I3]@[CB0LU?/1C6_B \0'.E#5^Y]WH>QOOJZ M?[(?#@Z/Q/[AAW/X#MD[?/-U__R39YX%B0,*L:\RQ[&*HB06>NAW]CZ?:)I M8_]Y).&M>7V'ST8/:NNKMK+YT<.66PF/Z%7>U+^YQ*&R7Z*G2?&+V4^:/Y$7 MVS ZO&(^M3L#&MOC;SR((MX5]!_ BW3C(9H+BDPXKF&L8X+M! M9;]DXRHE$TD7"07<-#X^B"\'(^@_R^\VN[LF_T]>;'M MGMN9>:U)R!<_,RNV?[B'/QEA"K*NCBT8[1\H*2G/FN]5ITT,^_AVNF3PS MK@88*- @4S?75/4@@,M6;6:+9J"!MH5O1=3O#ATLU[]?;;]\E>UO'[Y_N_W7 MNS&B]&'-/3 NY)OB)L!P1=2H";5R&5L/PKA7&]4ZF1YCUSEH2F.<3KMZ$!'A MQ?48U(COT?!GVPV[@V'?_QY'T7^VR'*P\PI_"IZ:P 1'A984\3PW"#P.A4S MP#^-D-3JC:W!>7496'2<1@3SV*Y&<.U>'OSS*BVY>UYR#7:^.RU[VAZGR;[G MR7[1S/:*XMC_\2>G._!B9][][>M^Y$\O@>4_>UA[+SYQR0+#L:6E$DW^N4+: M$8$,9X61U"E"\#6PU@2TCF%JD6OGMMG;C"[\F,GT)X#W%T@G^[/J35L1II5X MG[#7L+O_)\WU/<_U]7OU:^>)'^M^YOLQX%SVC_UWH/X,W)9A[1\-[-\-8DCK MJ+1_5N"5_=..YAFC_"&@?!&"T+Z(R4N2(XX-N,5:"02")IQ3J:@SX!97P_HR MS/?'\YE]CA.:C>0; XC92]W33G>RW7ZM?;?30,]+4,\8A-O,#GI-\&YP# [O MM;?IC/W6]A[9+Z!GS@?01@?&I?9E[]?6 Y]-FZGJF=29VD?W-CK'I\/ZM.K[ M!?\=-*G*CJNNZV?Z%"S35U N\-8OKE?A7J-*"QHLJ&728ET85W MI+9YD+A0 MG/H\EU)=K<'T4O.3_P[+P<6>'QS'\L=GL*2BGW]PW@-B C^)Z3;ZR$\T M%M%GIK)P/Q[[DAA?4" AR%+FP>.R#"D?#+(%=\)802RE&UM7M ?\GY'6@=[T M8T#9ZM.X;Q?_.M*U[6%4QVZIL[_*D[C%MAA+GWQA+IRKK6WVYAH%+ =Q"8P% MV*R&Q9M/0[J^D7IVTH@]#F1T*]#:S2SN]<8-T5',TI5].^SWHT;6_DC73=PG MWF1A_35;AI-5-1U*)^M[G\7=_2Q?3+18V$NYMMWPRPKOK&N MVY7TWK"_8VP1T"/^\R!,$CBF^1L[H%O=J@_Z ]]^ M!U-=!J!?O<'V1!W_AOO9TOQBEO 7 D*3^PVF<,[ MEN\='I_/&&?#B$^YZ\QW MW_]V]/7@ M#QCC3O?S_N';+_M_P%O\^R=X10!4G_>^[7_;_;K_&0!I^Y,@><$46$]*58PL M"X^,I4+4PC!N+)8B>"$)(%J5@BOU>)FZ+OA"2C[ M182&&;%D4[ED8\%DM]@M_?%HYD>?,Y<[KL'0 5^0!$O 6V^$LH50(1#[A'=7 MKUFWO^A)EL7J#G,NCX;R3<;;B;U?P/E=]\O^05B B(OVYW.%B;W/NVSO_),O M8!*!IZ# #(GM%00R%N;2PT;;0QV?T)*FTC;']O;?T_8:$- 1V\V?869HD(-.VR& #X/ M+-0F7;L>=D>\$8CEL#M*BQB1Y>8A[[P=UDU_\^9KDP2'EW$#=,Q)XX61DE97 M#&'F'$/SI@U[[5XT>2 7F:OBD8CQ)B1X9MT)55\8>JBJ07MZHH[<.4ZON<@F M$]%,0-SX[WJ@N5<_?K>=TNJT[#5MF4,&&@6.5K:V'X-+]VNA/"<0>AM3SUO?[T6['\>@LZ#(&/Z?+=$9- M1B\-^C-*-(.;PC>'W9$_T61^'-= W1MB_^.\ST8MXW2.1P$K")[B0-C-GO1H M9L?/&!SK R7F7RPT=VNRO >0\Q] M>8Z/K@W7$4#SY @@VRSD0Q# .2\ST3[P")G%!16.(N.Y0+R(Z;$BECK!A%KP M%H56X9)'J)@G*E?,*3#3EAA!]C3?[ MPYEW&@9Q5C3TNQ_5*X#[_B=RO MWUQW"N0KL@\#-#.4,+ V@J"S,V ##>6;7MB,J:56K;5H;?R8KD1B<@7*WR^R MO+/'W@$I/0CO=/,SIM7^?O%N:(!AQ;-0Z]^418P6F0&&'* M%.*ZL$@[&1 QV :#"R:-75P-LE!Y+HB5A9=<^Z!9L*0P.?>Y,$[J11R:W4J9 M60RM L[NPK0T6&X MXGD0NG" 6!0*<> !>&'[N_&_9QZ)1A/CJXN?>R5L26.O2Y^B#?)]Z[D>7[K M:[\WI&5.ZJ8A_\R0Z3J?A[ZZG(5\E!+/(W-5^NM;T'^GFL_]S]5W1G,OPAU5 MC%@/\?XYK,N^*ULG'\S;[N3@U"V+=R=YK[2\Y^2;[0#724*^ZP/>*U-=YBH% MN^(T]R0_)YM4CGS$Y$JQ^<-L!'Q=OR M7UU-X JP6;68QWPZW!]QQ^,E>%;EV6B[YJ]!XZD_R7Z[2O6<+J%=;S>^V MB[FY_E]M3Z]4PGLWJ(TJ)R/ZG&3^VIMZ&,.1O-E^DDGZSTGZRV56NSS' A,L MO2,\2&68#3Z7+F!L<^WL#VI#7TJQ_E'X^.7P9-@64)QF6T\(WG:L\+?=[1[6 M, OM\/NKDXI]RSCSJ([JZR\?/__Y9?]PE^P?[I']SV\_?SA\P_?__;/\>/B% M[GU^?7*P\T\7?O^V6$=U[]^W)WLG;\C>Y_=D[]M[NO_'_G%, ?]P\F?WX/## MQ=Z_,+Y__X'?]\/>.TR;&JKO\/FG/.>&Y$JAW+ \1J@],CQX1*74A7#>*^\W MMHK+_4W^9T6:0X\8Z?,CG7NZ-PP@C&&3_O)<6>>#=(.Y_*8 M1/?(HGL7$QZ;)*2?((%)BD^*RU&?4XV-9)P9+H52B@7AL,<:Y[*P1>)R3XO+ ME3-<3EKIM!8$6<48X@939%0(**<&>Z7SH&6XLE?=O7.YGXDU/C]F]VY0U?[9 M,KKG%%5X(\XMK%GDLZ1YDV&O,7$8Z:Y<(_#$%.T[_N<\.]C M79_HYGSY W1(N9!=*>;XU_N?X88URV;+2$GAQ)F73 ?*P*EXMYK]\](]\: MYG)Z>+%ID5$U!>]A.78OLMH'7]=M?7S=S^:+J;677]V\XL?GRF^M( MGSY^6 MCEQ]YNV'9]@6S[P!^&)54 8 #8N8:*9R18E414$4/'R<#GQ)""NOF-?,SP_? MMUUX(_V<9G6/C\F.V^>4TR*4>GS4MFJ*8U0]/?"C5EVQ3HAORIE4)SZJ_N43 MCF6_735=[UZ,JP!.SN3&:ARN#+!TLE!7)UEU:3R;EV5SN1OGDRS#L-R)[Q^> MX!X5>[GFW/9\;9\9F?W2K?K]MKAC//U=^V.XNFWH,?-YV\5HZ:>HR^"746S9\''2M'?S/:O^VA<2&CTD&DEHY&S'XXVA9#ZQ]Z/ M:IS<2#QMR:'F31:?O)D!Q6M?=G18/QO,$+[F&:/'MD8*K-9)V6L>,CRM>C./ MA>]?L;B6,$XWZ<;,GFDO9G5]+^;45CFU55[10VE/2(-26^65%4IJJ[S"PDEM ME5=L+34/?@)ME:]T2Y8KD[RZOMAU)?'LK]DH4'6_9:#^J"IW7G:[VSVWVQL M^R]A_K?[?7 ;GG>YN<5BY'OGG[C*K8S5GAS6#G%--=+$-ET1-"\PE\Q>JCA, M8?$X6Q1!,,R=P@I[:;&G.L]]**Q9+/DTED?;?;+71$)@Q63=,C05Q482RG0C MHEO4;OKA@-8NKK'3F,D98HG< MMEOQ^;$'K_FL=:7K65?:EK4=GH"GW?C&HS*QOJT*VY2M/=/=X4S1V'$EV+@' MU-2E:XK8UMX-;1O*Z,86EG!Y6Y_4ZKIN*NV&F]TU&A8/%N?*&X]O%Z-]L2#O3(7@V"_6C]XZEMC;GIL"D$]]Y+/S M:5E96QWU0*^F5?K:9\1YF 87%P8P&=SE<4]JT$Y?<%XVSL,TGS2!SD851L*^ M=B=PWXQ'%VMFKT^?I44W%SJN+_:-/)+<&4Q^0 M" J#J; 2&>P)REEN%0Y!^N*ZWG[S6M3_;5HA?&%=-.%*^.QM7,RP=/ZMZJY; M^-+F>H>L=X83<&KK=U]R++*Q3]%9K'XX*O+<++W1+L/GMC)W1 D[F$2'#_[9 MW4%$97"A\R? P:H6=_MZ6M(=8'\X+27?B\6@X^*&AU9'OBGP/2E1?5;%F&6W MW8UH_G+2-J>/$=JR#::ZZ7N-X#C*=1([/@4_%^QZ4W:^,295&\R>@;KPR^:B[CUTIM4F)^S?[I[$6OCS@P0H (&/ADG#"-.=ZQG/^J$1%@SFL9> MSM::GW98FAKA_L0*PRTGIN)'H>&?JY ]6XWW)YLK%6O;7(G=>W,E&.E,GY,8 M7AL"7VIB-"O9]>1B;&1BY[1_NOO_?A ?Z'NR%PW*YSTP+N[+WA^[9/^;%7N' M;TLP)&31R.P=OJ(?_WU//G[N?OYX^/X\&I2];V!:,2Y$,#17PEI.L<>.8+HH_ @8<]T/W^/IDILU[(NU[:K3\3YU#QXT[;D8>=:<1JTQ/3WH97_J M7IN<>Q4+U7&68E^B=^^!*FTVV;N(L$XVK;*>@6-PXL$/^])D=A'R(ALAY#A5 M8>:[;]M^/>UV?N1\ FW-E:$J+MP3XI#J#(5E?#S2PVAF?_F3FN6XZU'IFJ*U;K&=49G , M'#,&3!PPQ.Q<]]M62I'ZUE7_=)+[%I_MRJ9Q2]ON1V>QP6S=4.,1B^]=UQCF MIET&UKL5S^UT%(:Y.T/:QZHY%VH[:/R>IF@GN UHV/>H7X7!>0RP_?)N: :- M$C(!_C'^];?L)3=VG#J9='=Z6<64F]U>;!(U:@"6O>Q6 M0]>,?-A(7OF:<;2@HCK,_&J<=CW/B M0M:+ZWS49K?\5C8--.*3P(^J0)&CZ)KK'/BHW=B0ZRA&)RL3U^DD?6DDGVPL MGW9%3MX+!KLX!3&Y+H1V(8Y:635]C=H8:^LXMETN8O@2ED3SL";99-H@:71B M077:(8+7W+V8XL!IC(X-QFW?$CX\&7PH$.8WQH>1+0(8^'7RM7<@FR[,UCC$ M.( K5V_\8)J8%E7(GV:TS0"-#YI&DR_%RJ-:P]>U M&Z^^)J;>))A>Q(4_LG-M1[WIU:"LDYO"D@15&&5J+T;SRC ?7YY$Q&<"(MU2 MFQ@Y*MLXR>1FEX//5T7<.[<)5E^# DCQ&H3>G2Z8*3Q/4YUF:-2[T8KI9[]7<>&,H?/U]KO?)_U-RWY_.(?G%"-, M(IZ/N]SW47M&;+9EZ1C&*?GURJ^VY\F:!?EG!>"0_0.?#NO9*]FOK3.Q _-P MUJ3UMJCW?[P[BJ,?>RU$7.6U-*.\"O2;#S+;U77CL(Q:G@(ZZ4DF]0)5:[83 M8FYSV88?>A&O82#5<+(I,,J./FG>JL6GZ.9.($EW^]7",Q<>TMJ+AJ^-G*;3 M86V/=:0<+=#UQRW#SN,=QRRP\?NT;4P0#&TRT=^#ZW8*[I"R12V[ 66;.8DQ MXLKP91^MRZB-;9S)9DCC>9T%^4L::(;1$ ]*6YZ.NF"-MFXF5S7P_7VRU^PB M)W(W@8Z)9%LBWF 'P,$L#,1/$*&=IOW*"= Q_76Z;HO&>5MD;(N^V]R%EPE; MO/V5A"U^,$O8QFNE33:;+))^^_C)4FO[+H\5:=*Z&(T;O<^CI9M-OH+]F M77W>Y&[4S;/BC3W+?MWW)P/-[J6Y%T'KPW3A@^ M^=@].#SB\)V3CX=_QH3A;Q\.W_./._\<[__Q'N\?6K9//YSO[1RQQ72>CR?O MQ<'.,8SG8W>O21C>/]X_;)*/\ MCE-3FSV.EY,@4A.]&)6.PZ_26H M.YEC9D#7]=%13'F-S"#6LY@D#9LVYM>+,6PW!#=Z<''J-[-HID(\D>'K)G%B MV._#Y'>R_B2O5FYF;[WUY9EN-MG./4#<_[KV^,"P[Q8.#:@BIU0[2HCCW/C< M.%X$CO,\F."ETI]VKSHK@-C<48%X3,!5@]'GBP PB@/UI^/<]X.7;;!B-*.6%5$0H.QKN3,WE),WZ=CPS&0TUUI+9Z MDJSBOYZVIQQL[8$"9;%<3J;CMFBS;]#DY4\Q!;3L81!E03G&XP$0W*F&9A"& MWR/\H#:8GIZM(N,FIPB>*:..4WS@+]4.MQ\G;'U MWBL=>5)Q3D>Y7J[A\2#NV@^&=;,CV&\2N_K#[F ^2PXN&J6--0E;'N;@I#T# M/CEF/+W/5%_BQS,Z Y.NFV/9(V5M-&?6:^ADVL4)'AUB'N4.H&Y5?6ES/2>G M[Z):1>WHSW"$1H_KZJR,CL9$.T9Y"_T9-?F.EERK&W-J/'[_\2'*^1<_;<_[ MM ?MYQ;-6=4%#W64S]/' M_IIQ+W)RBG,\*+&2^KB/:] M6!\ YJ5N,P6:2(JK8[8A?-;3I@1IPJ*ONJX3LP<<*%)=7<#'SI_ZGALE-38' M@W7,>1I;B-$CYI=&+ $0X;G?GSV38<;;A[='M=, M&*OZKV.P6*U2:-P>VG%Y45]QZ5C>EY/8#4B^G1H96)Q%Y, M6?/>YVV^]_DCL-T]\N';&_:![O(/]/67/6#$'W=^+_>_P7<.CRZN8,T7P*8O M]D_>P'7_?-[?<9\_?#[^_.'?-^<'?^S'@YEL_^3]UX.=/\/>MU?BDS<% 9>) M(I5S<+B%TD@5L:Z/)CQG@6A0R4MU?;2PX-78PE'#N?)*2%.(W#JOC?3R4AQV M,N>W*=GSHV?=]XG==_883&O7'X3):XS7;//Q&:XUQABRS,+>*> M*@1""2@P50@:#!:JN'3 >LT,[D0KFE2T6)6Y; CLJ,!/DW3?\$]@)/W??MJD MW$>"#,%XDN6R=(9,SI;(D%G\$&^2[UV98W'K:[\W)+:9*_[TAIS?31[2:G4Y M7(71J,?HN;C4D*_NUK/8M*!X@&8]VS%R>H,V2V,( M/L?Z "5WXU*?%3:!PZ M&O+($(WZ$&:-3YY%U7IRZOV=/*@'$O_/SF52C'M1C$O[0BO2.O1)=GQ[J\\G MD9?^;1;8??;LNW^9+;\X5DM\_VM19'<[98U4;CUGK4Q;.KQ"<[9:N4D3KQ56 MXMYX(>[[0:QK&FMO^/[J;";?+K+1-C$\V?WVX>3-^=Z_>_C#O^]I;&!X<.B. M]W?<\1Y] Z-X]6UO9^]B[_,N66QB^.'S?OEQ9_OKAV]OCS\>?HP-#$4<*_SO MV\<=>./#O?.];[MP[3]AK\07DR:&V!FC9!&0%;E#G.8YDI)H4"[CJ1/.$T,W MMD2'R\LY+),&?2N^O%8/DZZ>N?6W)='^)T.RA*;?;,*>OA4)ED?[P3WSDA=& M:%ZPG/#T_K!&)^RY9&"YP07W#DGN?-<8L99 ;X+U2&W MFMRE_Q(U;K?W=UU94+=D>FYM>BYF'!@5M,L5EB@XQL'T,((D80QI4T@5@BHX MYF!Z2*JN19$(@98)4QFIA8EX>(1UQQ3&D M1P/ V47UA- O;9W<#<4>T^MQMN[*[:OH]E;E216\4=D4I3 M98%Y6Q^48;I(/'OES,S^RQF>K8L0A# "Y40:Q(472.8L("JD")+DG,H 9D9U M*+E\A/&Q=PI6'2=7FO2A4XMFK M"(!3GLVXPLIJA@CU.>+:$&0"+I H8J8^"=H2 0!8=%0A5@< $\]^#J'LUV6O M[!_[MA-C"F0_3X+]@('LL;[%-A_)OMS>OKR;(=A@0%A1@%6Q(G9:TM0BC9E' MQE/)<\9L%<*YTX!_ M!/@U<0[YV$^4@SB9B7'L3J%2&'L5Z?4:A[&OH='?E&-K(2S7/D>VT KQ7!"D!<.HT+3(%=96-(4NGWG09OTY]5V5HIX8CK$F)9MQ:YLQFV#M*/,6$X]R3PJP M&5@C1;E#U+K"8..-P6IC2] 4E4Y1Z125?LR#C0GX[@#XIF39%-YIJ@(RV#O$ M30YDF0'Z!9I3AW'P5NQN!S5PUC*Z M.VRZ[I2S0^C&D\.#8]U>8G5=7\1G-%]NV^_&OP^.:]]VG+I!1YWYIE^3KE'Q M93V*KQI;276;3DV#:F8T2[;9)#88:5DN%9=<"*)TP9ARF.:\D++0HY8>?*ZE MQT\?_HHOL0/O\-01^];]/O8_OX>Q;U,8#X7_DGUP$ZST5E.-M* %XC8PI'D M68.+$,!P&B%4[.*+\\M58AJE6D;LM^KDDL3^TVU>/G^X^(1SIX+@#GF?6\2] M,D@:E2.>%YY@X7#(55,. U^1X]"T!XMM=\LSW[U8_TZ;M6^;D2^CVZXPL%X8 MM0%S'0FFTH$X!]R&>L-8U&WX8ZO;E^GG[O[K.>6&T=NHX.>Q6Z;O+:'=^-EI MM^6@W:'0SF#DC>:("Y(CPT&[6NO M[? TZA.PXBN8D 69S/QWZV:EY!+=K.YA MA^W^^\8\30UJ9?*RKGI5/_L#AG2:[?;L(GXFH3R"4/:KV,L87+J7D[:\+V?; M\KZ>M.5]-VG+NT9R6VWAO+YY1]PUDLD*KZ7FP;^5 W@Q^WT^T@KPE]T8HJF& M<%L7.Z]E[S??;68N6L:ZW\G\5^M/!PWG/*KU21NK.=;UN&LR?&78TT,']-3] M>IV$%R)S2SMF3Z&S<'[OG85?_7=8#B[V/$C+11^K/VB@;O7Z#.^7(R_K\Y_' M>]^V\?Z_'\[W/G\Y/]AY(SY^WB_W_G@O/O[[)GI(Y8<3^'UG&R]Z67M-4/\- M^?AY^^+@<)OO[W1/]NCN^]_VO^U> M[,,S]LX_&1R49B)' EN%XG8+4H(X5#A- Z! @"V^\I_RJKL,C&33+8MN=Z=A]/IJJ/ZNR-\C^@<] +OU;M"7^\6#F!^^% M<$S)0C+I.7=6:5X4N1.RK+F#VV7@BRM%$].&W;$IEF^[ XTLBJA*7XQ\YV75?,W\N+7 M3K:O!T-?Z^S=YO_]?U'*7VS6F]W)-:,/I]_>\V[/P_-T3SL]?_^YC\97-&OE M93R&W:^&W>PO;;)WOCXKX\KY:^!F1O?7N_$UFVLMTCDQQ,T3G7UN\..LQ0\0 MIZWJTZINZ"X,V[><:S3EOP_[<,]^'V3*HU=-.9H==& *\1/S'Z)!^\WO[ M\&9$D8/X;C?^/GD/R],X0]<&8'O#V,=Q(09;6&=]*# M@ P[@WC3F!)M?88>RF;&*S$ M\:#S^)?9&"Q=9 -C^!NC7P-^%P?C ?[MZQ@/TT=^$GQ%])GQ@OW/N_A3'G+N M \L1TTHC;G.*E %B0$T\_$\MQ5YO;(G+]4__)\KX$D*2XD73A1U\G98']T?J MV"M!^?O>PGIU(#3JL+?P9J'5V4O;*D^') MB&1_9R0+2Q,& S2BV[WH@/8WR[EQG*^\MO;6EZ?-S>&*9A6#2Q17PV3IQE<[ M]?4)Z/[F-7?QH.75"=!=^%ZS1Q"7'PS(U0 DO>P[U?4@ZG1V,APT;P:3.XA#ZOFE[KS6%F1LL:^P';4_*OL1 M(EQ4R+^&7_V)J8;UT36P/P._HU.=)\!98W2E_!;_=N)=])NGTPOJU1Q::6[E MOX(!&F1M"L%$8[Z'M>.1WQ'**J(\#YH;&IM;,2H]_(\R'W#,M'+L![NX"65O MXWU9L?]Y6\"S+@YVWG_;/_HDA0^6Q&K3-'C$-5-(YYPCH83B8/$"B?L7UV'N M#,.\!FTKT+5Z K*-XC5RV;QT[1VA$RBY\?>.46L-4?-NPA(D%[AKY*Q[&HQC M1EA+6CO7P%?\0^T'NNQF?5B.S82W:-1D.(5+!K,E?,V@-A=-6$&R:X,#P7E%&6%(\+G/$@O;7 4_B(- MR8D4;,0.&6%H_,OE+7DWK"^\KL<89@%]KP&P-Z"EY:#9FCVHW[3:V?QKM]?> M%!;C7^VK'L+HGQFB[1WN7>R=?^*8%=I@&5- &>+8:60L+9 PWOM #*"#&ZDT4A]&]D_>85[HYLH.$Y]B'HW%O):: :,P._*")XD0N/K]2EA6R/9 67 MUIDWY_OGGZ0.*E";HR"X0EPIBZ2+39JUQ=Q2QXR@UUN^2_&2[]H_(/C@[I:] M!C"O,H97W^Z.3&(?U'HS>S=U,F;]!WW>)FO>L9ELS7!\\J7%,^/5M.@_J&"V M.ED9FKLUR:OMW[*X>5&=^IYW:^X5S+B;D^DI9X+6BP[J-/(7IVP>F^*D17;? M;UW5B1*UN%9VH]A"79UD7H.9;C5P\M 93>L 'I[[L[%Q'SG#KH+7[E6#IHC, M:&-WJLI-A1D8[F#ZO6,]\CA.X6YU')$KZT81X6]Q29VUEPV.-;@C57^0]4&4 M90 %[0U \4IX[NC;/9E?-VNCQPVT:$@'+M=GU ;\K;OO,?=UV=;\/KP3? MU6V!2XI?[,[+=W3U]*[M#7S[HI2\&&.&G=U1-[K;H$+_V'OP_-=ZD;S\ZUW+ M1L_!4(-F1,/K(K:".,=BFT:KMWNZ>S$H;1NJ[LR3U@DE/1W6<:7$2V&R 1)+ M,)-M*'7B3D]138_N"7\;P-?C%[O:Q'O&S+]N99N;5[V18OF3,H9FIB&AW7ZM M?3?[)7X\#OA.!OPR;N2:451X$DY?N/2\C/&?=OLJVX4)N99PE-W^8GDY3G)1 ML( ]]YPY(BW55G$?1$$9(_@G#MTV!';F!<[\=@U,^ZA)\=AN(F,'8;SKMC(9 MU(^Y^[GW[0V)S-4KPV5!D7&> @MQ&"F,%0*7PA$CL P%W]B2':J*RTFGOX A MKZNO((B!A_6P3 Y]TH5'CWA/#E'P/1CSWM$G(P#H@/8CF6N#./$:?E,2,6*Q M X'%@H)-FW=^^:CUKY$-ZN944#QN,ZP!T[I5/--391$WJVC'=321)=BF'[FX MPF!XF@M&YS ,K GSS&BFP=O5)+\Z ^(*%W=4ZL9=J:I*-;?1JSCEH'!52BC2$#9_0]5S;<:LR IM:M#:8U*M78( ,/G7C(&5"W MY3S?V^'/%0[O#GA3NSUP0891;<9N[UM Q";%T"6/]Y)V\?W8;@M;"A) Q)* M>)Y[4"P?D"P\D8P8S#!@#=N\7';N?R8;5U=RDV:KZNP[9U[N1QV^BRU3'3@( M?]=5* ?]P^IW_[8=JDN*,5*,F(Y%XSDN;AT26A @)-3&="R+-"MR7 0'CP#8 M*:X)B[2\MYGARQ ".C"(_G[ MU:B6TO1'C"9ITT2;#K8_L6!%[KU'F L)E"8>J +B@!@5'(!'>*5BUY'KHFQ- MB*"=WK'3XT:,II,U!V? %RS'Z@2Z]%0AZ+ NCX[ ;O>.7L7PQCOP:?U_AY$6 M53_6N-\]7+^_/][4^YX8$H85#A93S*1QDR"C0OX%Q:'&A4O>O# MNPO -8*TS6P[AA^ 8 R[@_DS[DV;DAO$W$:9%5,[05\,<;4%E[[UB&U::F!:>I,4[3@D@]3]JU-.RL4)/G^'DW[<[3:_ZKZ_5=1GX",MZO]V3K*>X='X"2_:JH- M'.Q\.=__MO?)@>OY_[/WIDUM)-O:Z%^IX)[WWNX(DIWST#Y!!&UL'SJVQ+:- M3X?]A.(&\#39;%Z,BM7I.QTI>=^%M5!]CK')*5$4FME<:#^KCH,[%T6T.^K&#.GIS5J;G MS@CNY)RKT1]$'XU>W>[O_7GAE)(R_/"487I[RG#)_BW9OR4YKF3_/MM%*=F_ M#5Z.J8#OG?.X M E7_;M%Y?K/GL][<85[95Y1O,#Z9V"?)EGZI.=+M[:\_VN_WL<"PE31&(N* MN# <:>(]HMH8C(7@5-'9;19H#,XFHJRTW/IDO7/1$&\$;%26W&Q>=#N.+L4I MW1V%](#,Z)\.YR:,;N"6OL78VZJ]4J#1=#N3'SUU8-WBUYJ)Y[/#81^4H=$T M4/1J;%L=YY3KAW6[_>/A'P\(Z[H;*9=A;0%/G9M,]I;LUGR&U0 M\=!K[_[0; BJ'G@QWB!W72FQ>/"U/QDR6Y!1^P0*W3PU[I]@-&:Y^O#4 _8K M0[ZY-+2^0358=F7HUV<8.?%NWZ.+P1D8 07%GPC#C5]=*7%^? &ZM1#YRHG6 M>;)+]7_N(59EIA\^TW>X#AX)J7]U+HM@+$4PMJ./.<2B8F12W7:>;G2_"O1/ M_M6GZ[:WHB[+6SQ>4R?_UC@GF(&-=>X_&1\]]I#EAKC/F&^PC=8V?^MDS\_X MZ(J[;:FBL31-L5D]>VX,XQ+4,^VQ52XH;H6V7B:-E>$T2JFUN3E^XUHUB9M] M4L\QCW;2N.=;&^[7_KZ[O<5:?[\Y;FU_Z+9/_SQH[W6_?_GV^?C+M_\ MM?WV^VSCGA;]=-*B^3/_X_/>UG'[W2?6>O>&[/[]X;#][<_#]O9WUM[^>MSZ M^T-JG> ?YXU[M*4,"R]1I$(AKHA#6CJ!-&8LD.@9Y6)MDY'K(5K+[=>S&'VC M69NHB0W%GE&SL(>ASFS4V&D<](,='MS30;[J(6&/C3P772U= L0A)"#'G4/< M6HFL80(1PH5CH+ 2:W/W*DT)?;4Z/<,:3^6E965ACY?"'K_-TVLR-YC!,2D3 M,+=$NZ )BU%JK'GD,4QZ31+*R"Q]Y(!N>%488RF,<=%D4FD3DV !,2T2,(:6 M2 .YPY_4<>VLAJ4#7?6FS-SF[YWF ^>!\>!]';KR]Y'W(H6N24 M(>:]1MQI@9RA!AFLO80%2LG>4O_KUJU$%[V5[@+WG^RDQNE#-(&BD"A&40:J19!"N[BV2=8%OGY246"O$7;>$IR'#9K$*^4_ MEV7GE5/F*PZ[J(F6"1-L(A>1&Q;AI9%<)A:P(L7.>U+X_GC)SJ..PKH8G#55 MG>L\NUPK@",JG69U#A)/CVOGS>?$>\;:T,-V43DU?=2==&']11%#LMX@)3CL M).X),D%KY*G'@4O,N?/-/35M.@$U\VRT8-Z",4\')@'K, 'DX]XRX"!KDTO) M4Z>-=O>S OF+17S+HP_2Z6DTAH4N$XY1@TC[30&](L\>XDIS\9?P;Q&FW_/ M^YAOV@FB'/ ]AN&GK Y2"D:,4EP+0(9 ,*?1.!R-\KX8?D\*W9U+AI]A*5)B M-2))2\2=PLBRI!!3T6&EX%\6R@'?DRA!#]M%10EZU)UT8?AQY4FT3B.LIDB4LEAPV!EA,RN8J.7&^3Y[.'M MA2< /XT#[^4F5TP_F3Z*'>4*ZN-<_ZBD7CPP?/Q^,]I0SIZ#LHV2E-I "0F< MNRA=X"IQ+&5R*6I3 A$?DZFO)/ Q[*,D'E&+%?*2PS^,:F5<+6M_2 M, 51=8E')K6/\SMW%U=EMU:A?OSR1&*#WJ=D[6WEBHJ*4+,URFXI MN+O;JW;]J)\+BU$Q*2QVWN+]O$I4U1D.QWW&M#=R]0_0_ NSNIH^COO_>K@\9X8]Z4#OU MT'=Z>P.8I"-]DS>NRRSWXMU.W=3H"?.OXJI]2W7DO-[&UO8L_ MCP8=7S>&W[JSL?9_XJ!>O!F!LMP);#0V)'D>J-&* "N(!'=G&K;.E+QODJ-; MA>4_>407SYL*!GYQ@O'IN'6\SX(@1%N%M)1@ J8(_*NX0"$7=F&68IG(VB;> MN.& -W>UFXC$E;Y[YQW ^N<51$%@KN$+K-8@VMS=I.[H-V=Y,BNDE4:*)# H M#MCZ2)SCE"X M\R;7_(G(<^:E$8%$P6]I"#GJS[G*C >L3<3)*<:=,]H(SC%1+"1'O*?GJZS. M5EF55?[U56Y_W3V>(($Z'H&>%28O0BP:=U;'-G3VK;A_&/H"A MYIO;NNW,M=JN=?N"NA'H<6ZMV!^,SMMTUC><=)0XK,W/F3Y=]^IDL#H-(6[B MDDD/'IBW7AQ5T0YZ(#+#ZK=)&\G?)Q0RG:++#2(N&G#DCCZWS&:^[?2+<->Y MND0TL0<$$QM,/KBUP9T?T@W.^7):-;"[>D#\0JN&)0YY6=TE5G26[]MV9 4Z M")06%/?W&9UUQ!L=#&*\HR?>(_2F* +UG 3J[A:+I=5)Z;.P*(E;6LN-%S)_ M31K*V3*6CC5+W3 SO4@*0C[W!2]-B8HHW+SW2Z6A>:?P[X/.<-2-@ZH50\=W M>K9;M>R@\VUL>_;RZ*<%7\X97/<64S1%= MY1Q740O#@Z)<>\-_7RX0]OTT^EL*%9[ M[\WIEV];\+L\?/Z&M=^].?V\]_7'Y]/62>O;VX/6WI?.YV^?V9>]=FI=)/F* MUI[_L6])",I(B9QD$G%.%#+>:"1<=)('HKQ*S:W1L) B[4^QUQ8:\?L+28&- MFY@F#>5FJ[)0;Z'>IZSO[8D4P0G&2.28$9-TTD[+Z'7R*?%)>,24>N%%H=[F M4._I%>H-$L> 77(.XX3D=Q:K0KU-IMZGU.R36&5E\LJU!-% MC8C)2LI#X"X2&9VE+EKLA8E3@XX4@ZYYK')1M2G1X*()"27J*.)@P2'M11VP M&9)F0DFF"Z,41BF,4AAEZ>G_.N0LS2([W*5 &$+Q#@B1@#,DI,L8G9!E35G/IE75KF]04VB@%7.L8Z68&DT_B MIV>S#LXF^0G22^6&N,^8;TLOG2:63L+25[:^W%-LKWG*RS&<%)8J".P=A_\! MX$7F":6&$1P#O\=YUBUUY@IK+9RU3F:.L%3RSG#CD5[.<3SU)U&,AA\60@PV.&2<5M93RI(GQ%'M**7-6 M,<+=/4Y<"CD\'CE1(*<,14P)YB)V5%)=%.*">07SKG<82Y(F:WT2TG-)A75$<6XQB9HIB_4] MO-8%\QY?USO>3]J"5IX\\H%XQ'UTR 8(E!?-*@^DE M3N+4%?UNT#]^W5_YKKA-QV_A"4XJ)"^YYZ"]:N&]J>N*)IV8=\61VQS\;K^> M<>0*I83$PB#":$)<5C-Z /.59H%7K)/HV!>P;PF+-T\ MF)E9UB"HH<"5A1Q[AP" MQ2\B)D#)BX(II>G:)EWR(DY@0K&J 5SHR M D8[=8^:D?C>/>G. GL?$ M.ZF$=EYSCZ/A.@6<^ZVG1(SBI6I'9(*D4FV@"Y%UX>;TW M*D8;D+0NY/ZC'EFN,/(^<1694$3IM4U>P*Z1GMXE'(0UOJ)$VX[&<;"ZA226 M7$FB'#R>!R!K')S$D6G)L:'&IVCA:0[+Y"BS)0"Y090T6PQ=2&94H!R)P&RF M)8D,)1A1FDQ@'M;5X[5-)J\702JGCR4 N3BI"SG\I':W 3,E!&.5,:#G CD$ MGP*\\D$SK$AQ4C>*'*XZJ87#.B5ND>,R(8Z91H83AK@V#!81$XXID .^;K44 M"\:]P*75F'C6*"11^4 _+0RQ 5CI!76S1.!?-EAW1L?AOYH^L4"B8^H M+Q_O6Q>\LH:BD*) W'..C+$1$:* WKQV,7+O?+/ Q]M*#SVRN%3S^9/HK!AZ$_=MWXXMH8S'<< M]JL3NOI$3GQRVC.I#==<"&*L8LP$3"68.%H5=W^#B'QWMMZ(=H(RZ2227&+$ MK17(4IJ;'SCAJ!44R[2VJ>#O9M5\+/Q=3,M"386:[E%^W3-*DZ?&8NZ)<)(:A1FC*EJMV%SEU\NA MV=.YCR]79I?1>D*X0YYCACAV"3F> HJ8)N%E2I30?&AFI"R<53BK<%;AK">? MT/E:)2G'%7"43SA7S3?8V$1"<,+0Z!@KYYJ-(J:+<\U J=?1&J0]<8@+F=OG M48F$M2)B%5+,D<^&+3GRN=#2'>>A_QI9^ EG&1SPS]EPZ^GJ] )L@3\059<( MIH;H^IU+4_IM/!QUTLFK0SOXVNG5TR>G<_#X62UB@_XLJX7>T1[U?*YR:LM3 MY _I^XQ^;7/O(%:O^X]&E;# SN(53]5UOOQX;AK1S%4O3BJNH!R M\.A.KXH_?!P.\WTFR9@ONK8W8W_\^'DR]_AR%$N6X=O3EO;[PE@\M_ME&[#\\*\.O/[>VOZ0VMMOV.[6OF(B&*4)XL%0, VH0TX%B3@/.";B M%'5J;5.0ZU4PLG57C4# AIT?U2&LY@&("J!!J/X:]^)DAS"\7N65JW[+[U63 M/XFI:F$DK^:2$1D4!LO%16H,9](YK[2C2@L=O'?$91FYSNT[[;=7[%#823[; MHL< UVB?.66RB0 0P!W%K##+"1V2(LBX0V,;9&]KK=*]3 M^,8YV3R$6J8\,B7;5:62%\\E\)5IDFMU *SA8NQ5]NBHVX$[P=^VOE5EN]W^ M<=Z)%8!$!IUN'R9J$'WL_)/5DXWJ8XQ5NS^*E?S-_5XS5/T7P3-2EJ4PXTJG M-[:U&-[PSB5)/.H/._G-/P81?EWGG_CJN!-&!Y.DU^D$,7F>37SM,NM /QR/ MXJNIG.++UZ]=%_J)='B8F3B8U0^;DYP\D0C"9J;VTK\'@PN-_&M$;A#M=V03 M_*H_;/?8G@S7_G7EQQ_"5I[>W>3'WSI+E]1'O"'$=2WZR69)W3Q+U364 WLE MR^SY@"=6 PRH:X^&\8^S%Z_.0N@ZO?JV]44WX?SJ5 M&Y.IG+&7)A\:O8'Q'9]?N7@)N?TW+]&",_U74((F:W+1RPO8;:?G9Q&M+,H3 M+$IFEV$UZ@,G9CUE"'0%KVIG0,V";SL]X*N.[58?1_!&K5(^HW5K]N*\O;]I M\HS6I,%[J7[P'YT1_#!_G[HGO^UD-:\_AMN&6GG\M/%QHPJ9&0?#]5JI/!K5 M%NC7@3VLU;V)+FIKXPR^,N[9<>C 3OS]MA6^ZMB:_#NC"DXL.K T+?.2!9$B MQY$YZR)+@GGBF J8W*K&S;B\9DR51NZ?B<:#>.9RF,K"YE4DN'&O__39 M/]OK:\O1[@$7SU7TN=5[+C>P$/=4[^?Z4&T0*1]X+=X@=UT)F_+!UY81K]*( MEY.3UHQY4&PQ5O43:)0-:H/2J+'\I&K1"AD*C?$XSKJ@;S'K;NR&TPB7_XT# MONWT^.Z2B$^ZYQ];FJ=BMWB8NDFBEHT,%WZZX]?]A\3W/;_U?>FV3OLA-"-MP>SOK"0^WN6-IIGUIH95S]//\S )!<1$Z(E]Y9IQJQ-N;\9 M==KH:<0=H8S<'95Y@XM\U:/F)B'SAZT?N^\^?-_=:W=;>U]9>_O]C]:>%RT8 MW^[V&]KZ]N>W+X>MD\_?WIS,ALQ_/GW#O[Q[+UKT$]S;X_;VFQ_MT^\GK;WO MO+7W^:3UKGWX^?2O3FOOK]2ZW+8G&6F35@9ID;./D_7(><\084P9Z35+)/>P M4->SCQ??Q6)IFZ9Q6-/, HF%)0I+/#E+1.ZQ84D0D11/G+G@%':&YQ()EBM] M.TO<.SVX$,@O$\A%SI6PEEJ:$L+<<\2%"L@YYQ'''DNNE&)6K&T2?6,V<.&0 MPB&%0YHI\"O,(8DE27!,R@3,+=$N:,)BE!IK'GD,]^.0VQJ)%OKX9?H@Y_2A MF-06XX2,P0+L#^:1P<$ABZUPL( X:OF8;4,+?Q3^*/SQPOF#A*283\XQQSD@ ME-4L!IP,T4P1&TCACR?F#W91BR@%BV7DB-"ZE+U)2,.*(68U#B2 R8ACX8\G MY8]'.NHKK%18Z5FS$HY"8FQQ(H)R(80C,K"$,=&:"V=4\8PU@9K$.35%9;WQ M)MLRN<&>]QQ>>8R45\09B8/@;&V3F'7.5&&FU6L@OH3J>4^6"7G3,MT8@Q9# M9S1;0^%) ]'T+_437W)#\846]5]AZO*8>">5T,YK[G$T7*> 03WG*1&C^#VJ MP-YE6?E!OW>_6CNCM[8S^%_;'<>)*.=2?&]^'.6$ZP\15F68.;$0WOT)[W+S M\=,W;)]'AI4)$2D:-.+:!60M9HAX3J7SA&JK'M,>>]@.7!UB6W![D2G[KUH0 M7).&LMPNY(51IL%DE!D>G8@B82 3IR4U"2PAPF6R)*G"**O+**=7&,5%38%! M,#(X>L1#8DAC25$@SD:MK.&YVGAAE,(HA5$*HSR<42P73$N;K J.$T6,YXH% M@X-( 0R6^W2J*(S24$8A5Q@%!ZF,D5985QAE=1F%7644(W(:34+,68LX M!6O%4IR3:IPG3 9K_*-&(;Q,1GFL0(,EMDTJ$+QHI?Z7V\\5"&XH!/\X2V2$ M>3AI?=T'Q5T:,-20PDXA3KC/Y^T64:H"(SIXSA\UE/BY@_!/SM27@\;EJ\W\ M:A&&\M4B#.6K@R2[5O4HI^5*5!_S KG_#@NNW-@>U]CG\N(%)IIO?G@VR$>K&'V^.XUW\]'@QBSY_L#6 BNG5MZ6(IS&$IM%]? M*G<%1%Q%R6R/$:$(]&,..F5\6N;N8#2,AN$/FRW-12N%II'6!S^ MJ^CP+^RQN*BDPAY-8X^+6B?*)<5TQ,AHP1"/3"#CJ$2$1VL=EB8$L[:IR9+[ M2Q?Z*/11Z&-%Z&/%(Y *E2R22B[JGM!$%:8N(1\U1SQ)CAPS'BEMM6:1P-+[ M!N:M%TXIG%(XY*::QWFV@%BMXCQK&CM=E$-)VH%MDS12CB4$"\R14<$C M30CC2DH;RV4SRYW3L%8,>:Y M030DCGBT&#FB).(!.U!>5"XVO;;)Q6-T3EG.CFD5@ M&N1#X$P1*J7D=5<9PA^C=F;AU\*O31E*X=?"KXWC5T$]TQY;!<3*@52METEC M93B-4FIM[L>OI6/"TJCU4L<=HAG8IA@QG#SB1C*D.09^]8$*J0FASC0P3;9P M:^'6PJV%6U\>MRJK@Y2"$:,4UT):$P@&8C4.1Z.\+]SZQ-QZ$8'#0S[#!F/5 M:A80EY0C:[D J@4R-9YCQ9M8!^C%<.O350@JC%T8NT'S5AA[F8QME*34!DIR MWKB+T@6N$L=2)I>B-L7;W C:O@A-$H(&991&.%*#N/4"99T+.6>T(($&$U7M M;19&%]8N):7*5QM0..:LO5/N__2$%6((;HX&]C1C^4EX],-7[)ZHQP#U0G_L MNO$6S:OA.-BDH2QM+9]1?:8F#:7LO;*69>\]L_4J>^_YK&79>ZNU7F7O-7V,[.*E(3KG+)=.>Z BG'-3\9&)6 M_C@&"Y&B],0Z8KB-VAKO))=!,*Z2)30?QQ!-*"/E..:)CF-V+Q?I=302YZ)% M5!J"N",:.448HC8E;+#01(>U3;)..6_<:4S#H7>A48@+ZWI4L+Y@_8*PGB3- M8W2468YY2$:G9+RGB05X%0(I6-\$K+](]'(A8,DX1IJ%G#OM!'*1>V2<L+UC_@1IO4O8<(!U!WAW-Q/=2]Y+DL#^4MY+M)[1JQ 0@J/N-(664T% M\H)XY92U/CYJ]?*7"?3/H-]UH8]"'PNBCV"QUBY*J[3B6@MG8F0\&.YMD,:J MXOEI H=<)%U$2P2LD$5<1XUXH KI8")BN?-BU"0EFNOGK4M]O2)L89 %9U8\ M:,Z>=6S$V5ZO?AO$(WN2ZT=?JT-\/I&/4P+\?NFB38/P>4J .QM-%(#C7E*N MN=?!:JZ,<=$0(E+=K8*8:0EP8FX"\P64 #_[^,/9P@\+RL^#\I>KI"9&J2,T MH. X6 J).&0$IX@PGMF:L43QVJ86M!%5OU<6WA_>-&)AJGP!PP67_9!62HT- M9LYP#.#G0^Y C17W2MF([X&%/U5L"SH^!3I>G'X:0:.S*2!-? !TQ!99DT ' M9C)$K>"S[$.C=T(B1J+& ?=XC#8B(ME4(64T$2CIKGTDE4%1PL.%AP\'K< MFR98,H>-4('[&(SS5B5)L(\RZ1@+#C8:!R^.UCPP&B<"@$]9C+CG$FG/$M+" MQ^04QC[E@+@;>LP7'%RM8[6"KBN#KH8;Z0GQ@*261TYU;A\13 J")4FC*;;X MJ@+OQ7D4CBQAE(F\"1=3$@J3GPJG,D:%W;XH0]1NS:<\?>DC7YT .I M4;_ZUN_T1M4_L.'' WAG$'T??F0,51KT#ZO?[-%1MP-_C?J_5]X.!B?PLRI[ M" \9YC@U?#B3B;<@$EL3@=CKO_F_X\[H MI!5'!_UP<<-"&G.01FMO*Q/&Y(AK:U\%!2J!ELA3^(=C'I&.3"#,.0[*IV"5 M7-M\%,IXP*9K*-8U,]:Y@&.SCK<*.#83'$_.P=$2G!S7'C%I+.+"8V2<,$@Y MC,&,\@5 +.-9:0"!4@#P\H$+D:QV$%>%<$>!=P&%: M]G MNWM)-XTN)D\8DMI&,.$315H8CF"AO5"2&<7!A#=<%N!MU%G8LT[.>I-2]*/) M:5?J#^#!O2K^\ >V]S66)*UG?*KUNE[BX?8X[O5?CP>#V/,G>P/X^5V;QUV M?BZ@?W/Y((M++'&(&EE81,1C(LBE"(*C%1A9'FOK'))_4U)*:H035J#^NL\.H73OO) M!A7-/Z*:-+G;CCX>NCBHV%.WN;O4ZQ#FJAKVNYU0G?^JR8?3I\WT0L0WM4-L MU%P_8?G'*AHD)% MSX"*(O?8L"2(2(HGSEQP"CO#923<K2&:M2S@O*D"/&Y1!# M8"E*/;+"1VW >@\:KVT2O6[D]2C#0E2%J I1%:)JR+3.052)Y2.?F)0)F%NB M7="$Q2@UUCSR&.Y'5*7?U?(XZM*!MY!6JB0=(IRIS%$&@365@*,H]B%$;8-I M;L>K0E*%I I)%9)Z0*A"2(KYY!QSG"LFK68QX&2(9HK8:3_U0E)/25(7AI17 MW"::8_9Y,(A;'Y%-CB#G/<5,NP2F52&I9I/4,TBW+=17J.\94!^.0F)L<3Y" MX4((1V1@"6,"BK]P1A5'8B/X[U)0"&/*&!4I I,LEQNC%)G ,(H85)= 5%+4 MKFT2LPXV7*&_)D25_&MDX5? ?T/GG\W_AG_.AEM/6J<78F_T!Z+J$N74<%V_ M75H!U\[O7H2Y70.QD>WDN#-H[WZ$^\],Q<3+#;H#5/<[?0B M.IC\32C@X@VIZVN;OW5^/Y^K\='5)7RL\>O[C/Z\(''5&0**#J,?#V)8KV!+ MP;J-XB .1Y6+=@!KME[97JA&!_!F9>'_>_T*OG!81\B<=]?[>%F]O=P];=.?XRUZW^V7[#6\=_M6!U]];VQ]2>_O3PCR_V>M7MPY_3+5Z= M[WD+_ZL&H,GDW7VKB,!*NCA8G)3<)0H[TZ%]@$%]',$_X3]QX.$#^_5"W4+T MY4D':QWOZ^"LCLSDVH,8<:P=TE(DY"CU5G$28"E .JZ7:/T_U5$<@$# 2JY7 M,(=^W,U36T.][Q\>9:""/X,%Z%D'\0#D'X"L#-UR(%,AG',M_G+]L9V<%+5P964;E0[J;[!V=>RY,)7 MU^LW^^/1< 2CZUP4P\_".[PJNC!.H);\"VWWL<6WCC&_*KO_L#&*M#N.!@6,4:C?X:]^+D9S!<8P;\"VP5X4P M>/UA]6[0/W[=KX[MI#'+(,L=O,[7O@9>M#U0HX;#"/\+56=TWKW%.EC:T.&HNY)\+!]E68,:JBU8J%&[?O5>OHRK;,ZB9LS98=?(^U,VY2 M0O-CMO% Y80-V@NO026PG=[>P.8%WP+<&0VW.T,/$ 2&X!Z,[<]NWW]_XLVY M^_%L:W__3#_]@&N^M=_MP+VS$_H OK^#6^^^P*;^++Z\:YW 9D^[VSNX_:UU MVC[=^=':_DS!U :J9PPK#=93MK=)(,@Q05%2TGJL*"P8G\ Q[+$8MC*$&JR- M(^G$TYF[5+GL[P*P\YPMB%:-E3!>@6EL1H>V-Q<+=NS MQV"[VOPI?'F822G3<,WEL$'R);5B /8#D'C^.\ T#>ZF\DO:0.B$JM?'SS7V>HUZO3C1=8X[HX.)0\$?=&!Q M\HSE:;<5C!5FL-^+LSKP\EV8XU'.QI[J3 'VV:#CLJ,K@EIW=8U 28N= M?^"S6S6MB;C,UC]BC C0MZ1D@4O/K&7,Z^@MO(@FS*MLW:MSZ.YQ+X9V[:#8 M31_K47V8COYNS#;_3\QO5;SFNAN)7DP_K/\BKWR=NJS,I&M8[ MO%L;FEFZICU9->/N_[1U0%6;?_ALV9W\\VH[YP*?3RPK&N;[?&+7^L:6Q??I9@&K/ MX3GP7W^ZN[4O,<.:8H>B\!:!SAN1IM(B9;#U$:O@M07=4%ZO9W#%R 2,GY+' M*!YFG#RC$F"K6/T6)W;5<$8L\]M^5'<63>-!?<44[\XD]"HECH^F+MPAZ!3# M-!7#N]S]YT@\6S;3"..BSM'5EEOM-;-)8*:8L#X$'.]W+G0_&_0*+K;.!@38 M> BZ+?#/BP7'JXKLSFGK_;Y@G%-0#A&A5((X!HULH&!J1DR9T4%P#U )TW== M'"^3[G1FUZOC@P[@V@%(:%9T7(R]6FR_]D!-"%,%:ABS;(0LH*'6SG($1,W: M"8"CYSN@= VSQWNJ$F4)CC_@L=7$&W\)F:^**XBUR\?4P_&%!G F^JF?73CG MVL>,/ _',.J+'W3< >B&6X4IFDV&/H@IYM(N\>S>M^Z":]41%ZL=W+4-/H[ M0-NIIV"B;?T'=+5^ VN?G/X=ZV0@4F2E=NO\3]@2,3)5U[PMO"G^]+I: C. M*1\Y-Y%%@G+U$SL5Y(ZD;5[E_6;4%O\#X7( I5 MN-"U[^4?WWC6EL?NF0X==AHRQ/U4@E# M;)C6G,K>Z+,7RU#Z/\+H7^SF;>UMG>Z^WU<^6L\Y1X:[@'CB&%3^7 I#6,N= M3=[FBGQT74AVE\)_9B^NYW E>"]FA\K7O/4&_1^P*O5&G>^P^!>%Y+:Z9+4< M7*S_Q=GPF51,. T]=V+X_#FG!L_@9AP$!,)^K6(/)\.$1 3AP5R 4N$*;51 M$&($ST$09N-ZA,S_N2P?=6J%>C4\4S:R[^ARV,$5E,_G.5/XO]&E,?GH_P.E MWH-1->R<*27GSHO?,E9-K<[S-_",.8N3Y,IR'0-U@EJ3U ]:6G!2 M@SXF.-98R)G*CLMRK;UPEFWQ]O%^U(0J4(91BCGNWDJ/C &=&3.O,-,2>^/N M%*JKVN^Y5KR^ _8+XK)O=(YKCG'/H(T[*:;7&0OUN?5VGM_"J+BI O!"(*( M-!1$)2:D@1:0XEQ$%@#^HZM3-.@-I3L?Z.I:D"T$]/^L;:&%8/BYSV=.-/?, M4Z5EBC(YKJ)PQ(I$,2<^)@FF=D'SQ]BBGUCKZ[[7$1/0AQ'3L8ZDM,@J GI" M8"E8+& U!&Q1LH[E]4C*ZU#^VO;Z1R=U5!0HM:_[@R- ]EHBSDY,)M\XTU87 M@/F_*$QWG'H48+]!:CZ3UOM]$WSB4470)#7H $D1I%,^:S-).Z\O7[B2?W*\#&Y+!]&M@V/6*8BL_%8?@DXLUW[7#829T)%R3;&53_Y#.E#.3] M\=>#JA='4RY8'@'\/&#JSNRTN6.CSI(1^Q-C\(_Z5!NLFE?'G3 Z * '')]B M.IO>[J;+K .X'H]RRF']9'SY^EM#/[(?(0Z:3F*$SRS1I7_O'UXFZ'EXV<'@ M(@?T:T1N$.UW9!-,Q1^V>VQ/AFO_NC)CA["BTR&9/.9;I_:2,. -(1JD']P2 MF'8]!F7SO^N(L?,!3Y)484!=>S2,?YR]>'56J*#3JV];7W13G/EDKI38D)S4 MTS4M.CZ]_W0J-R93.9.A._G0Z V,[_C\RL5+J&M^\Q(MLLC":DK09$TN J3' M1W70Q,Q>+8OR!(O2[H\F9Z2OSP]?7U\^?'U[?OCZ\?SP]1FM6[,7YRR5Y1YA M<<]H31J\E^H'_]$9P0_S=^LCDP7\;2>KL?TQW'9BQWS:^+A1A>QAK?_6IM-9=N0ZV#EV'#JP$W^_;86O%E&8.VW-3/II/(O@>;WTX/GL M\1C$ P!*4+QW:@,C(VA#@N!)ZSQ#Y:#3IA^^M_9R9@I< ?]M?]L1[>WON'7Z M5;3VMHY;VZWCSWLM.FO][;[;85_>O?^1,U/:W[XT[WMU[?[J[_?U' M:QNN/?WS 'Y)?081D2+;?LXB*Q5%$F.E330,]+EK8>]:6>L8XX(% MKHP"2?)&616P((&P.!OVO@4VV^$TQ7@2S'UE):J=J=\OIP_]7CTD)OYG ]I< MLF1]] WO8O6/#P/DO:$U@FD#3.0/! ^IRF EFA M)%&B/M*:%:0;"&9U?+394W(1LI9Y8BK(G=%)-9P*4,TS]M)^F7C&_97]UP5O*+$"L/JG[=85 M%UW\VNGUIBEL1W6J^JWP1A<]IS5IN&&>9!JM-3$B2AJY(M)8 MS5CRWELO$C=L6JZ#76^),G/4F:L1Y')7<3"1R#?K<+7SDK@=R4D.N'GGU.6J5\.^BV3[=@3*WC+^_:W]M[ M'SJM;W\>?#ELP7M?#MO?/N/6MC]I';['LZU2=M]]8JWM<- Z_?/[9_J>M-_M MG+3>O3W\?!H.VH>?:?O;^^/VZ<[)E^T/Z;S?\D?\H[77.FE]W8^2:\EH0"D0 MC3C% 5EB+0I*&95N;Y97P/#IP?!, M,SS>3R18EV()XL0$Y(QR*#'LF;)<2.X+#!88+#!X(PR"285-U()$DKC" MSL&&8<;ID+1@+M8&,M$%!IL)@Z?G,*A33"(':W.><^"M5,AA95&.9I>!1Z)Y M*C#XV&VPFW7\MR+^TM>3,/ <\PT_-/K1I,^:#?VCLXIB6Q\_Y?1VB7+9Z^6X M4*]/\PME"%"'8U0J&AH9Q\DZ383P.E#OH@G^S(4*YN9=98A.XZ ?[/#@6G;2 M^6*_J==Z-\'OW/(^YY)E[AAT>KYSU(T[O4EQU]VT-96#PA5S<$7[]35G*O8F M$!,#4IP ;03F@2P<1\YKP;7!GA*9\4]30E\] F\\;,,U%<1^07U^C$/( HZ+ M 4>M+:$XAF0]X5J '11!.A(C=\88/=4<20'' M9H/CA;.51VEL"A:Q@"WB6"5DDC(H.$N3TSH&9@HL%E@LL'B7SNB<*Z(U::9J[-KLD@@%S M@!58;*0+]A'S1LM7RUHTYZO-"N4F9%+3J^E8=!;+;<_[Y%;L]CS!1SVD?G#" MW2KK4H1:+T4@-.'$+14:&]"KG!,66Q:$O[D=8SF^;H(&-1/?G;UNBC#K4T+$ M20[:4U+(\=S),1(C)/5:4='$0^R?;[VFXEF)\GGA )JPI50D876*W"B SJ"" M4T8D*VE4<6J,%@!M)(!>/;;XNB^]E2Y0@4!6:,=HK","L"3*=+(./("G04ZF[2J M1?=\(=!YL@'?V MQSYUB91''TN#%KE18[EW.:87+3UE+&4L"QK+*AS:K0"(YG*"J3^ !_9R[Z(# MV_L:9XL*UJTVNW51P:98(PV:P4:-Y1>J CZ&S5B>7Y[?C.>7=-05+M_WO$-E M?YO#122BX4$$+H,P/#%L4E1&4^NUP)&I<'O]OB',$+RZ&C3;&Q^&_FCZQ>)& M>G(W$CR[/KZL74E[;T[A-^PS;!51TB <2$!<>(=T2AB)P+277DIBR-JF%NM: MTVLNI=]+&&W)+GC9D$D]D3$Z;(.(7'MF,0M!T&B4#,XZ?GN5OP*9JP*9G4N0 M>?IU/VD'JB7#R$J>$)>4(.<81](9QKVT/(2XMBG6C<8%,0MBO@3$G">"PP;& M@I'"<<(IR^6P')8<]$HBJ''R]DJ !2<;CI-GJN76/M%2!3 8$$G,(8ZC0H8S MB@AQPJC(H_!I;9.J=U9(G[K4,27G/N.;4.D%)L,2Z&'2D MYO9B@46U7!7(/#F'S.B,FI]CTY"^? C8C=6_5.&.>ZH'$1LQ4=%@+[BRVP1CCN*8L M>4<$WM\^JQZ(;HN3OC=E[.8&<*_[AT>#>!![P\X_$2BC?QC_#@3G-F"+)"Y0+.=W2A34? (-8J MY#(SA(D4./.4:'I'G8MR]K<2?+)SS:?+*>:2J(@$SHW%:##($1:02D+2$(57 M1*UM,K9NFG4"^ +RNE] (,6MJ[B*2#L'T!HC#<'YB-TY'DUT)C@C9:"24<=\ MN+TJ1L'7AN/KC!_849%LUM>=C#@WF5%(4VQ1HL%2Y6@@P:QM$K)NY&/X@9>P M/0O.%IPM&FU!W"?7:+?V5:2,<$R1L88AKH-"3F./5)21Q\BT47REE-F"LP5G MBSY;T/4)T?52K# E)L?X(86U1MP%BW)95)2B3"%2J;B@195]&<[I7S@:7!'G M]%Y_9+N5]7[2:RN&JI^/O6 &+YU[59WZX&L:;;S3LO-6LA_JN!Q2/GFM>&TOL\9E34C$2&DR Z\*"8"1$+*07!N9!#5,6, M6G&B;UT]&#C=VM>Y%(=-$5'-!.*>1.1<$,A+ZAF84MIJ.K6EEIQP_G1[MGE@ MV,QHGD)TA>B:2W3SM&WUPE*5"-%6+IW+M+>W M]@TFCLAH46(Y\=4XCK1Q%"6!\\:1-MCIN8QJ7C!5X;C"<87C"L<58ZZPW=W& MW-8^BXI:I1GR20#1:9V0I9&AZ!UF+-= DJG8<87C"L<5CFLVQQ4[KC#;E?-( M:T*PE"#IM$0\YM!ER1*B.&!#@B/:B6+"-9O>;C^P_%>];^"_H?//YMGRM<>' M,"P_^3MOITYO7">8;?XW?.WLIH=V\+73.YL^>3$[F__M!O^ZZ"Q1WSE?5^\\ MSU(R!E3CI"Q@!C&*>A&I$C8QGC3?%V+M\D4W/HS0ZVMQSUF[.M7W7J%+*TUG M5EK!?0!L(CKK>4-K3#=G$_ D@[Q)'&\8Y$;UI*.\YU3^]Q6QO,I!($2,TN2I ML9A[(IRDH&(S1E6T6K%P8_+Z58[Y=QP.8]P]B@,0\M[7?T<[C,,]>,*?72"? M)V:,]LGGOW?$Y\.WAZV];K>]O4,!^=F7 MOUL,T+\;_^?#R9>_PY&C7+9./Y^T3M]V=O?^_-XZ_ N^VS[X_*W;@>?\V/W[ M$VY]^PS('V!L(>UN[^#VM]8IL,&/UMXG#@P@C#=**X6T-3K;-AKI8 E2RM H MG'5 _1/- ' BAJW,ZRD%;Y5(+OK(A75Y=ROM0]#<,*W56A6!DH]@%4:#<5S; MG$SZ=0"ZC"$S8#19EY\^Z J,7**-;^/AJ)-.7MT*8TW=LWL'L:R.!J!,#>#A6=.JNA;&/A[&JB:RX7K53ZGC(WPK'G;R MU^'S*H)V=70(-ZO@F_ENU>@@?Z4?QA-%L)\J;WL]ZSJ3"P9Q$K Q_,\'%;'!QU_4 WJ]E%IT#^L[MK>GDLG7) &:\F3 M%R80(R27@3)->6"7O2B7E$J87/]'& ^.@>*'L7>?';\'@]M-K[/R",K+"]OU M+1C[/@OA@$&-U$NW@VG:M0 #O6LP0 M981[*4&,YAI;GQ* M*,5C\@"[P\Z/FY=R/;=XF]A9-7Q4E^%CLH._QAY,>1)$RV% XM-7-N^M234, Z+/07N?H*US0%X( RQZA_5=2;R4I\M^L$$US,] MY-?U937KC(\:(A$?0%"/;3<+QDL3A].OI_N@"!,C&4?:*8#UF#0R5%&DE8C< M4*>\]" .^#9Q^/L@"\"H MH?P'3V00. />_!WK:UDF!']<)/1*,Z[G2[E8L@ M'G'@0;D(Z_6G'= *_.A,2*;?A3M.!>M\V3FHAP39P[#ZU4&O?7+DP?[SO>_]NJ*R[>Z9^M%FG'06B\--9@3 M#L8QO'(^%QMPL.6ID]SKGU1VVVF_O0Z\O?'AC"+F!_W>C< +2.+BX(*,A^=^ M6/S"@/BJ5?V>MH[W/05VMMZAD%(N"4$9,EHFY'W$W$HE/).@;1_WKSE5*Z"S MV8T[K.%RUJZ;*&I7]NUQ9W1P!6O[#O;5Q*"NK;K+0)'%>'@&S2!9(?:R;?AB M]_!.;U(_Y_H.G5!3/2$9AF=0]8:UF5C+DX^/;:;6P_X_<'5M$=]O=:8S/]\" MW;H^*[<8-WD;TE7&.HX@^KW^J#K,%-G)F2;G19"NXFT]N]O1QXQ8%2/Y76)F M9FNQ[O"S4Y#^L)-O]D?M3^G\$U\==\+H *8!?N7T%[/I[6ZZS#I8ZO$HOIH^ M&5^^_E;OEZ^]1DU?XFRC7%F 2__.<:*@ST\4#@87AT]?P2(&W>D[LF#B#/ZP MW6-[,ES[U]5%A16=#LGD,=\ZM=/5SP=->$.(!NV>6WSJUX%Z\[_KLZ#S 4]. MQV! 77LTC'^9C.E1(;DI-ZNJ;)<=/[3Z=R8S*5 M,T>#DP^-WL#XCL^O7+R$_+N;EVB1(2&K*4&3-7D-:E]_6+V#(1U5.ST_"Y9E M49Y@4=K]4:S=,Z_/E8'7EY6!B4F7F?#C"-ZH+>9GM&[-7IRW_<%][;]GM"8- MWDOU@__HC."'^;OUDW^&&X;:D7RT\;'C2ID9AP,:Y=Y/!K5VO[7 M@3VL=H$7<8+?AP'6 MT+7=VX/=O3]TN"I3>6""$=Y_G0 MED8KB#?,<@ZWNW;>GU>LNEB@]:H71]4#SO]_^N!E1X]\] +WUI$;2IJ7_>=9I(Q(A'WQB#.2$ V&(JH"59X%AU.UT)% MEF>K ,J?&QQS&RL4/A7BGL;*X]T9;Y"[KN12/OC:NX9,-V S-FW(3S@7>C%6 M[!-HR XJVLU#XTGOC) MOWKCWI&-DM8Y?JQ\>KE^4(&]Q@GU'<;U0F1QH7*U@)DODK0L2;IV/K306G%+ M7J:;A.ZP$P(HQ+^R#C?ZOI:]$*_'@T&.,3F:I("]L/UV^@C7PVVWJFX?!GN>L#4^>NR! MRPUQGY'?X%]9V_RMDSW>XZ,K#N]?QNJF"%J#DD*OY<6?3]OCU.B^W[RMV'GTY:>U_9EW?O^>?#-R>M;^_A.7\=M-]].MU]][^=UO:7 M W@^;>^%;[/)[5_V=G[L;H?O7[8/X%D[)^WM-Z)U^ 9_V6MQ>-9Q^_ -_-;/ MI$W;J76"3_\]:8E[O"\\,2+(A((4#O' #=(N"B23"UAH;>'?M4VZ;C1O3J7M MF?W55!AJ>+^"0B&%0IZ00E1BU''K==) '-X[0PSS 5-*K/$B32JG$,I(H9 & M4@@]IQ KM:32,\1]$HA+$Y#&&"@D]QT3G!/L]-HF7Q!'8>O^Y7DR"9ZJWU.2_L9'7MSZ48H(]:.&Y1-/RPGN+/D(9%B$Y* M*HR@@AN=0.&W/!H;+/%2&U,LN>;2@Q+[F'[:X5HN$E8^-3/+UB\().(8YNDQ2YZQHT(VB4?6& \ M81*UQ/, M)P$%:D04WCM.W6.2T+-WRC4) I_Z^06"%P/!Q EFI4X!4)@'HXPEV&(?1+ ! M.^%OMP8*V"X?;"^=?X"]QJB)R#$!&G\* 6DB'>)J%.,;Z@MG8L=/80.NMJ[H\@R%U NEQ@#)<*HE(_S MN=#-<5_-L^.:BM(OY9"AX'J3I.Y1#)*"ZT^%ZQ=F2B[SX8!^D2"1 ZYS@DQ0 M //$8Z*Q-M;9C.M2-NA\^)GB>K/.+%8AW?'?_5PX.M=$?YR$QQ?AJ2O/?_SG M-\R#4<(W2_CF\PT9>OZ'!$T)W\Q-9XN&/K>&OGLY@E,GETS$'+E /.))$&1= MDB@R4-2]]M$)LK8I\+K0M'$J^@IJX4W"PZ=^?L'C)H5P%CQ^.CR^\)A$$KU7 MVB 2A4 \VH ,LP11YJP25F,JS=HF(^M2-<\5OH)XO")>D=4VC:CD@FM1[?9& M=M#IUUT+JM\:U:C[EM+Q.5R-7HA,(X9ZRR2WQMYW&C70N^:4K,2<_E[]9] _ M[ R'_<%)E<\)5MB.?R1#OD3[K8[BB"5-(FDM;>1<1VH9EM:Y)+!CC&!6#/EF M*XY7PJ\]CX1)AYS"!G&7, +3G:,0B>0A@A(9<[M9LJX,*U&!)?JZX''S\%BX MF!R6004PY*G6A@ X!T,%6//8>E8,^:;C\84A[S#QWF*/5) $\%@ ,C/BD93& M2*P\L50!'M-UH57!XV8:\N6,<_:,T_9Z=M@?=ZO7N=6+ZP\F+8'^O=(54O\I M1YS%I7Z5B35.B;O ,$ XEY%9[@VHT9I9*\!*PL4R:C03M_:V1JT3_".S<7O/ MB];7?0X(8&62B"3B$%+&@N*H5/1LU MEK/E*:NTPJM4"'Y!IC8#U%=2<\,X)]R8%&0BQH%=!@P0'Z/L4>'V!W-[NW.% MVT6@P0NOD ;Y!&Z7 3F!,4H.EM8;&S2V#:Q_M+KLWJQ3\U+_J+A_GP4G+2^' M^9YU.0HE_;*YV=K:QUHE*C5#G$4P-;74R(:4D ?-@GJ'+64NFYJ:/D9([;/W M_#8)"I_Z^06*GSKMN.#MXYH @+=>2T>B,4A$H1#'TB CL$+">,,H,X(YLK:I M<$';AJK^+Z4:4K>?9^920G&IA]2(+/YG2&!/6@^IT-H#:>W-93."4)D2-Q:1 M_Y^]+VUJ*TG6_BLGN'=NM"-4=.V+/4&$NW'[NF/ [39NO_87HE:0+22N%F/X M]6_6.1*20&# +!+4Q#26=+8Z59E/KI6IDD7,%ADL";".2(.9 NC. =V-9LA; M(3PL(N$.T)WSEI'WD1_XM-%]N>(9JV;4W*7].B-X"6O M*267:-&6I,GLG<[Z*HOV^S+37$N1O9LVT$#F5-!F46&Y%ZQE%1KN$ MK%2ZC79Z?40F^ST5<8]OQ)TO2&WM]WJ?3PN4@CJQL%?9ZL .X'MMG%=VKQ_C06[#\DN^8ES3YCT,#T;]LMZ\ M-Z[)\BS#:_7?UP!RKE@(P5)!)>'8,\M3Y$P9KES@7M@&R+&A:A;(WVS_\1-) M:W]8'U\>P(*M/*)WXO_^#K;3LW98:P.^VU8FL/\6[T<^<),87.D5;4'*T11;[J^,\H_;']X M_-1)[!W>[3R X* L< /O]?CR]#Y5^Q[ M^,?NQ5-"0/3)48(GN\FJD#QA2%JF$3<&*$%:CIADR5*=2,0B%XP]1P;_JBRL M;WLXJ+[T0$A5WV Z1WT $>"Q+HBJQ?20*:8?#VR["\MQ3>H(,7K/I:+UZ6:LQ?XZZL;&/&&Z.M"I[9@M.5E#ZT6_1 MCX &UBL@.[@YG%17$Z1B_=1N.VNE7="PL)R M+6XACK(HOWLR7'C7I@7$?^ MXN#):H_;.^_X;J**)RL#4ISEHL;1(Y=5"$<2 M,#W+I8UEWA CS'G?43%[_[P31JZH#V;5G#!X7T&;SRCPB/M60!EU5!D8?Y1,,:!61"LYW9M0[&6E.>7^5DU M +TO0P+\BOKQ6Z_SK3WI*5>[9L<8D29MHF8=M(L[24T\M8U'[H)N4T?M3J?1 MD4%D=:LMV_?[%2,9M!BI[?#ZC',VU3?;"+ML3(')90.Z_-^L]VO&;1V>K_1K8/S^@8&K&3^QS8<,&0L^ MMD%A/LY:,SP]#O) \H39E =M/:@M_?IU>X<@FX_S(.?ET<1%DV_7AN7.FM5Z M59>6;V1=8QQ=S\BVWL0@!:=1:FYYL"SGMSJMN=#2^K!8%:=GU>VM=K>7UW-" M3V^/NK$_V&\?3BWKWXYS<\K3M;>W=CZ0[:-=,*]]#@J UBTH MXLXP9+&7B"GIE8H)&^4O\-G5^O)^KQ-@U<]22ZOVV0$Q?6O7NGG5:1^TL^Z= MU?51?Q"K/:!R(,H8LZ*3[+?>HIO,4'%-:/.Z^B!?.G?%9;;]/#7OVU"%OCWJ M7D^ODMP8%:0/$3/NDC>46T' :M':DTC"[N9$WJ*:<-E/9"G\U<#%8*?WLN'. M,_GV3U;Z;NWXD[?O=C%8BR)YBJCQ$7&LP6K$F* D'<, *)'E35"*+HP\7$_- M*LN^',N.MU_N.JQ%T#0ARIU'G)J(K L$L927W4?&3$8LUB+\?&SS66/3UUK+ M94TY;\_W)A^;[VV\P0/G?')WV#BR^.2NPV-[)Z 5$*)$Y$Z# M5J#!A)71(*V20(PXP%6CZG78("VLS^ND;G:&3B,J%V0DU=K?V8Y+WR:UF";P\VGJYJ[5V4BF/P-K+-H?GR$7LD(W*F"AM MTBGWHY$M]M.*6UGH!UMH4-54(D($Q1%FAH,8X12!59^0>-4[QFO,;-T?ODBR B6MH(5#4WJS!G#OK>FZ*GR"CD@MP$_)YE7&"*D^Y M(AQ9:27B&BA'6V60"YXP'#0/4:UML'5S7L__USCWHW/J%0RC6!-4NSM9^^W1 M <@_/[_2/I@44C0IT<1MY!H>9 "LDB')XB3'EAZL-)HN^0Q4@$SUS\.H'^SQ MC]9^!E@>26VB(JH(O/8&AW7 M-LRI'!@OVD8%$UR[>D(]@0U 3+2-T -E!Q2+FN.[=<"W.:V&B-J[?H^D4-M4 MUR"&-_6@8YB2QE:[VSX8/3T*>7.T=;1+*;-,,8-4PH "I+9%O$2$B22H#41WX@!NWZ^0B;P?["R, #7$O'NN\J]]6 M>[$;^_#L^L&!U9=N800)V(!*;NL&:B1L@6G\?]^CQNWF.S.#:N M#R8?Z-:[7:$N+ M\V==5>(T5PN$=&AP3>#OHV=>5_5.+]A46N[]3/795JJI6VM<-KPK98) M]O"PW_L.?#^,(,_?_.?]Q:9GNS,X&QZ7SF#/O;6U,UP0KL!BL00Y[6.NSA64%D29;)7J%C7GD]2K7^;)X3K:0J&%):.%MV"] M@MBW8" B%GE"W&*%= #K56J K!\N"$LRPY;X1/,=NJ#7&@*94L ML%6/0 @.8O=*A)$M4R"+B7WQQ*CA[>8;O/UEZV3[Y,WWK9,/#"S5J'0TF B$ M&?<(.!4L56MHX^R//&:QI;)2,[X*>^8 MKXJ+ZP99V2?Y7;:_O&%O=]Z=;&^^VN4ZR&""0A);4"L#0*F+*J!Z0[2C47EK MP,@XWYOZ!]ZM"V3Y(G_7&4VU_IYII T*1>-9NU7&G-FOO/%OU_]UXV(0Z W: M>0#/Z[V=@+POCMIAN/^<8."?,2^Q,9\ONLRZ0:\S&N8Z8/63\>SU:^<=?]5,Y9G*1G#2$S*%^+A M8/G3#BTE]ZW:WOFU]T2(':S-7 M2JQ+3NKI&I<@']]_/)7KS52>*9O7'#1Z'>-+CL]=O+#*^<\5(5V\1+=9-74U M*:A9DVGV^>BP>M/U9P&W+,H#+$I=%[3VO_5R0"=O<81/=4W(V@P>:S"V4]4^ MBEKC?T3KMMR+V/_W0^?_F[L[7S1WOKRU>Q]?$# M^;3SBFYO_@,&W$M\UK![NP,&X.8_\.RO<#T\\_6'[UL?WQS#&+Y_WOEG?VOG M$][^^$IL;?Z=MD_>B*V7N\SE#$(94>)"($Z#0%KAB+#CR1O!B:.X,;_!M(KA M979*!2=QC,$:$AB/C%N.E:7"6\F89D:N51&LY<-,WOU17-N8KDKUG[9U>:]- M+H)SWHB;9:$S!MUX<7[XY/F1LA2H2M@$;BFG-FJCA*>.62LY$):XT*!:S&4/ MZ)^YJHWU=K(A?^&NETSS8X?W83]^:P/VU=[W25V$:76@G/\W>^7LWI>7G6&_ M;4%)G)Q\NN_%'5?C@[4>V:H5R>J7N>LF)[>JPU%_,+)-'3);;^/W_?9AO=K3 M),%&T3DM7]#4$]83__Y%!1G.#;&U^.=,+X/V(#_BLGI\S>[N,VXH)0P1WA!J MI>!":B.8\1FJHJ,),S].QV5XG(X+'ZZ_IV.";.^' %%O!@.@[,U13IK\JP[# MOJ\'!L13'YJZJ? 30[.M+WLGNRS(D*LC(LQSG1M-,7*"$!2-Q\1QXZ4T((:X M:6E&6D0L<%#ETA:P\./=_&-BFO# XAH@K:I=+TM#Q4?[O1S0ZAUUX9?3RA1U M=NZ8^.QEE6./;';C#\_UV;&26)&H8)1;2QT-VA)*6>3*$B*N26EU;!VH;6%L MO6,'@[?I8S..M_V_,[ALUX'7TU\'#1T^76([V1.[1EDF@O;(VI00-SS )Y"C MWAL%2HR2CM"UC5XW+MJ/6D_C6?): +'C"9]"9G^N9!L1O]AGUZ2_&R#G^"<7 MNS&U?5.U93]V0EU-T'%E:6)V]^_L@>_[7K!DJ). 2AB@SA/#,%,"T1 ?D5" M4M*2KVTLJ%'PKYJP6#4&38W&Y^5:\/4^PW&U>%__%JYT-U/4+C6.CK#D[%$<:6) MUB"C6$S8!I-WEOZ PFM$?G_*Q&_[YTD]QM]'!Z,FU#"E]%/B?YF=X2\[G1V8 MG4$SY,&;4QQ_-9GPI\L9;S<_'>T&PT2V,I$S42'N<$#:6(584#KQI"EC=FU# M+.*,*]']7S.*;J:N1LWN]:O:N3*8T79='![E^-B(OAV :__('5]Q0VPG/4V?O%D=5]AG]WPA>++5A+F!RV_V, M)>,J=+G"WJ!>95C-4(#.,PI=!-4NG"QJLE6PGDX;-55[PX/.VV? MO5#KYZ-$"_U01)_U0]41R\>P.O:4^)9WE&?[ZV)5S^O.>6F7*6G8R1$".-84 M/LMMPUM96*IRY\UWUOYU+'U[6+M[\QG@'7N]RU(VM%A MK5H"N(6&.D%R7K-R/:@7FL7(&4T\N.22!V4D1!,PQ4K;Q6+P[&[UA:;)EOV> M=Z*^/!W:^QDW0E']P%C9>4>W7NXJ0K!DFB,-!B3B8$\B4+<91.#!7L@Z2 3,;G17E*+4WFN M40YC(=$LII:)E?N^V:D*\/T[F#HQ_'8\T9?&ET_=+/+)$=.'H[?O=I-EABK* M$&,$]"4N>"XTF^NE>,IL(,H*N;:AU/KY_+D*\+*3Z6*>G.QP0=3L6=,ZXQ L MWB;N2&Y\ >>!EC(O8),"I'\/1 MQ/)<2%P3I?JO/,:ISV1".^3INDUV/M#MHUWLJ"(1C$^)54 \.HDT@ ]\LISQ M2+E+.?O2K"^J1=VT9HK?#]LU",TYNRDK"LZ&6SD%!X]W0>XL,#- [YA8/C=0 M:T:'XXTF/=\DHC:8,;D\N\WJ#63UCYZ&VE9[W>Y^W>M5O[5[1[W^U\%\K*0Y>!I8F:NUW5SW?IBW M0NRU??77],Y3JZWAE%QGICWPH\'8J]*X#-==(8>+4%EX=\1NVK MW2^-4O?#:\26;60Y:_GW_5LWU'+B.HTVTY-Y*T*HH8O%.!8<,YZ)_6!2&2(L:)D+@K MDO:.HF&@\Q_M*A9]\,0@'G*#,R\],CA&%*QREG$3EEU&+' M\\]IA'.:SKS+ZW*5(POKG$U_@=*#V@BPU/UH?;V'4^4A=E> M&ED5&NLAH.=F7R.LS6''=L_<\GQ@+M^PF>;)LIU1PP[[O=R5Q=:.1= O9CHW MG!OPK$XZXX$\HV9UPZ_P)A>^=JMR<%65VB%6+G=]"=$-6W5OM,/:@9XF>\'R MA.08SKAM6AT8;!_,'!_.A-*:-BVUN#DX[-1M9KJ3AFLP0+ _ZIW$_9FGUXU- M!F,O_XP!,?=[GL-Q+;33(%%3)"XWKO Y$SP?J0,M1S#IL%0'L;]7SQ[, I!\ MQ\)#1P/@UD'=L,7!^!MFG!T^G#S7X#9OQ#]M_+-,FGUMALP-?:+)[_0.$9@J M\TK\CV3'BLN%2RR&'YH(9WDU<_W<'$XT_H4 .^F:TN1&3T'UTKQ>%CRG5FK- M.SDZU%NM@,$)B1,?!(Y\)V80-IXA[P.SD<>B:5S48%)JBZ8$,?5 MMWIVQZ2:6;V9WZES=F'48$X6-3;QSOO_=UIJY$+=OE[]GZ>K6\R*NRFI;=KC MP5\3=)O]Y2 MK3.%ZNJ[4YE1RXM3F#M%PM:T U0MN8>WYWKY,:Y>H#O..JTNY9;+GM8[/!7H MX^S"L6YR%/OS57B:)-9YM?*G?#Q>ILB,\-'(R!WS%M@/8R^M<3ZE<$&.4_'Q M_&Q*W^;6R=;1KB5<&!0V;)"V R3#=MM29;EMZ,?6>3\T1(*A!4[CZ.G5,='*)6J<3%C %*5@1J+4T ML;Q])"JQ<,/;C0H%+4;6PVQ'+DMEDP>@OT]B.P.H<5RQW&4R<,1##:#4HL0C M+ ?5BB4']$=;;$'^9R->8S.3-=%,_00-281ZLTZ-5+G&WGB'\)ENK,2<-5@O MKV=2:HQ<7&-$75QCI)0+*>5"RF[Z4B[DT2Y**1>RQ(M3RH4L&2^M2KF0A940 M?EC9X$PE!.^U%]P[;'.K"HZ-LC8ZL+0DUY8K?MICY*Y*<_QAV_U_;&<4M^-P M6A#B98YR38I"'(]=I>%M]^\WOG4_:EJN2#4U(AI41 7&F+'"P:8M&;D*P-E)^C#R," TN4 M6!D(Y[F'E3#8ZJ@IDURD=+:FQP+>7IWXV4Y'M]P7M?V96^H[<*;] ME_8[$FEL2)$B\=U M)!@[UXMR #,%GZY1BO-G/)D?V\/]<][,I>DN2<^G>S!]>^.X3RQM?.Y_?G@[X.M+UO?)]? LT:?Z0>Y1;?@73X< M?=[)O[\ZV=[L?'F[^95\WGPCMC:_?M\^^//@\^M/QULG?Z2M]_C[?W9>#>'? MHUTO(P^"4\2H#XA;H9 QRB%FC.6,Q6"96-L@C+:8/-_QLA$1R\^9RP=GBV?N M*OK3%?'^1AI3$4-%##VH&/*! _H0&WD2W$5MF8]Y5T)DN?^@(F>[WB[(Z+M? M>71>%LV'UK)#)#M#WM3[U&)XTWUE^UVXNLBL:\JLDU.9I6DTP0>&O+("\2@I M,H%K)"V+-!%!HF%K&V"X8$&+R"HBJXBL92?V)RZR9B752>SW@AWLWZ>0>A^' MPTZ3S5:DTO6D$CF52M:G("/V2#$#EI0C,5<'MT@*Z1P8TU1BG$%44T)?%+%4 MQ%(12\M.[$]<+"V[)?4V5^_(VQ?[<3]V!W73,M\[B/FL(L>N)\?8U"/(I#:6 M$I!CA"%.?4).>HZ8QF!?>4>,E&!=M00_OZ6P2+$BQ8H46S)B7V4IIA+35E(< M '0XPT;+A$4DCMJ "19X<7GS$I9:32$D3H604A:D#0TH[[9 W'*.3#(@CH(5 MUEA-J5UE M"2*U=L(IS(/$/ %L&"5!<-"HC71:Q)+8\'@D2'LFL2$PB@7Q#,D8-.(^%N;K@\0")HP==;QU=GA7=82V&#Y91% MS:V71#&2B/(,VT?@9RH1^YN!\31B#P)89&&+6" QB1YY)P#*N3!R<@8B&90 MYVE++NB?5;"X8''!XOO"XA**7EFXG8:BG50Z4D>0,LSEDH $=%^E471.>B>P MH%C=8RBZ &X!W *X/U)^2R3U<<#P-)**A9;&>H(\8[FTL*1(>^]0(@E(A ?J M<5C;$ O:-!8(+A!<(/A*$,P2)YP&JVTTG'GMN.-!2A:Y<4EZ42*$CPEZ+QI5"A@F?/9*(CTN=6,T*!SYSH1)FB'B,):!<=H<"FGAE.R M9#EY!6$+PMZ-;G^_$%OB<"N E],X7!( F,%8%"THHEPGBQRF FDO93122TOY MVH:BZAQ:/BM 68#R,0%E445+O.UNX'8:;^-$Y&ZW'@4F'>)><*2#"0B(ADI# M8] J-V-N8;5D96$*ZA;4?6C493HQ)I56WC N-3/P70;JO*0"/J421WM,H#F- MHSGBL?/$(HU31)QK@9P7%&G*(L'4,1+DV@9E+:&6K/[C"J+F\K:S>(C=?)?N ME!P?'#^8P?'0&^5^/T]P8_C-H\NW,\6K+]T"V-J&"@MBQ)(SQ*#&J$(]"(:>=0YY1Z65,T4N;LT1DB]R'>%L. M1EX^L%R%)+XB(8N$?,02DOCD=%W[B6LN!#%6,68"II(KK579Q_ETQ>DT (RM M)TD&@8*Q%G$C,0(Z<8C*Q BVCA 1UC:8:.GE3KHLTK1(TR)-EYRQEDZ:7B?8 M?POBM 3[5T V3H/]E":<3,0@&W5"7&&%K& )8<63P5@E2>+=!_N7@W67#QZ+ M3"PR\1$PUM+)Q&)AEKR.NY&L,WD=T6I-0)Y*ER3B04ADL0<9:XWQQA*,HUS; M$"U"[B&O8SEP8/FPM@C8(F ? 6.MLH U2E)J R4D<.ZB=(&KQ+&4R:6HC2TI M/(])/DY3>!B65"NA4;".(LZC0(X3,#\#U]+$K%N%O/-1M!3A14(ND82L\X%^ M'68F@']#^]O&O^'/9+P'MK_7[C;306' X^_C&9#3%]SXM^O_NG%ZYPON,W]= M_=!3F=S,+8R_8P\'\?GDPXO0'AQV[/'S=K?3[D947[1HY8[:8;C_W)AU16F- MH.,DI_']F\-DO4'7,S0V/BC7*1>7'+_TXDL/TG6#Z0TOQNODLBLEN?FU9 MMYRFUA+)VZ4:RV2Q?KAFA0]^&(;+?K=GU:]5]JI58!+UXS>P1&J77&&*PA1/ MDBE>?8]]WQ[$JI=^5&6J: KN\@I13^L4K]WD#TU\.!N%;_[?=O=BV6Y']UR MOQQD;OYSU(V-ZX#A!9I?*<9W/>7!/JM>=H;]MJT^VG[?=H=WNWNM]+PL/2^O MZ<;G5 J2G&742ZZ,L3(0PTA4RJ9D>>W&)X;0LE?I#MWX;_"GDU=DBVX??/[X M=^?SSM]?MW?VVY\._NQL'<"U.^_H5A[CZW?XG!O_R]]?MG8^G'RBGSN?7__3 M@7/(V]=_PK4?CC]]?/-]>_/3]\\[;_#GS;]SS\O)7J63[9-/1[L\,"X=SE%N M)1"/V"$KJ$8B*EA_2EPDN8@AXRU.EZS&UF/K>WGS"@<+IZ@8C'=F,!:)723V MPV9[&ZED>)*R6XR;Y)SR[ T"A$K,.(T>&2"S-UF;&1"&Z-SHYE[:Z98)/B# M%ATLHJF(IF)KEMU3RR[#V)P,\]8EPHU%6#NP/Q,SR$7%D*56I:>SPND2(Q!&>V#X,;QI+S1C(L \L3';!JIDB'S M>*1(^TR&C'&4Z=S? SY0Q,&@049&#U*$!ZX,P\QD4X:VE#Y?:6F)]KHN.\HM MTQN*:%J*;9H% M=&\_<'\+J%NB\X\#@N>C\XF$*(-Q**GLTM*:(>VP1TK&'*HG2L>PMB'8W::& M%^0MR+M"R'N=UK:)$TZ#U38:SKQVW/$@)8OCP;B/* MI=]Y+12T-)I%K9/.6^XYL]1+3*V*C.B '2TQY,TR)2[WLM7P'+9P'))M?42N+T]J)T/W&H-6"NB0D1: M@;C '%G+/3+1$VTL,"XU,_!=!NJ\ MI (^I1*0?4R8.1^0U299XCA&*F6OAR$8:2(D\L$SDTSB$:O:ZR&4++[WNPW! MEE:\I17O\G;P7&4)AZ.0&%N6HLYIX()T%X8,:HBE8K%E;7-5D2"6ZF<,PG$D1I MH_'"(2&M!(7#6&2$CXC[Y)/QWFIKUS:4:G%]M]4=EX/7EP]/BZI15(VB:A15 MXTFH&B5E9 44B#,I(Y+RH(- /@6'N!"YIIJR"(<@A \D!.[N/F5D.=AW^2!R MF;6'(A>+7"QR<95-\)(=='M2=3X[2 5,M=(:!4L4 HH.2!N>D!18*6$T)4*L M;1#6HNQNTX.6@_^7#V.+8"V"]1$PUM()UNLT,U*24ALH(8%S%Z4+7"6.I4PN M16ULR01[3/)Q/A,L$D$M%PP%RL'J](XC+:5&5@=#E33!!KVV0;%H*<)+G'R) MI&2=5O;K,#,"_!O:WS8FR[,].H!G^8U_PX^3\<],X9?18-A.QR\.;'^OW:UG M3,(KC;^.YTB>GX(K#G;^#:\\,3^8X$Z[&]%^\YW0!FWA;3..M;NC6JUNN-^( MP)Q.Q,I ,VTH<)@JZ.F3'*14E-&D8W+*,Y>O_%'9^2'S>=!U>Y6H)1762FW MW>.Z]*)Z,:@&^[8?JT.8WECE3S9_AJD[K@* 6>QG)*PO]/NVNQ=/[Q-.L:[Z M!O W?D@897"KHO7[53\>]H"JX>LAG-L+Z]7+07WI[",!5?N CG#?_)SZNEZJ MS^K'CAW&,/N@=GO9]Y='M0 M];IQ+7 M^#X'[[= 5!?02DT>@Y?=,"&1=APL(!(X8;O7[<_1S#\3IMB)?K_;_K]1'.QD M^MF!@?[6Z?FO3XP@MD_>B.V7N\K)X%*2B#@L<^'Y@!Q5&HFD!;&*.J;H6A6! M:PZSK.Z/XMH5I??JB.N=.5DPF #_#-!WIN16'<5^/C:,_0.X50"),H']WSKP M8NB]W^]UX+R,XOG(02_$3F7KVYZ7 Y7MA@78;@\/.\>3^Z9>I],[:H ^@]WS M>=ZK_]3:UND$-THE3&#''@[B\\F'%Z$]..S8X^?M;CT-]46+5-:C=ACNP_S! M.N!&HQGO$A@_8'Q\O3EV1KMN#C*VSHF\^/BE%U]Z4*TS+&YX+5XGEUT)H'3C M:R\=L98WO?:A1KQZ<[QZ(UY!JB#TBM==CO#?MM6'VV_;[O#^XXTWL)4%M*X*]*X1@?A0AY/CSRN5@F\B(U'N?A% M;!32*&*CD,=MBHV'Z\9QT ZA$U=O.]IL!-H.I['S*MAAK'XY!&.T">>VN]7O M_WTN8?/N)GDQ.8^G^<[(^8&R]2X*;GL;_HK]>HW.YI19PG#"-EB7.%78\L"P MYRHHF]L]A<4Y9?1L3'(:LSX;KL[Y '54^C38C%JD'.VFR AC3B"-#4<\]Q^U M/ :4DC-)&2,T"VL;>IV<#TS?4FG 2YEHY?ADJ<;R@^+>!0_O%P^E4"DZ%[6+ ME&M)+:=6:6 P;4,D$A<\?"@\/#G%0REU(,Y$A(--B$<>$- $1]12K"UQVF%^ MMWBX;.Z PN?7Y7-JHDR64*<)YR9B0VPD*KC@A I,NL+G#\7GY)3/8^1&R620 M]H0B[G3>$R82BDIRGE0TR>+"YX7/+^-SA8E2BGKK*.=.6BT"\2$('Q*3S)#% MM24+G]\]G[-3/@>#)EC/&.**8,0)2';MN41>!&$)-XY)X'.S;LZ75"A\7OB\ MYG/!G2$$-'3G-!=46*L\Y8E@;IGSVA4^?R@^%Z=\#A(;%SR_C\Z1C\@$+YQS/M&0DI]@R1920R7M;^/S!_)7 XXW/ M\N4NQ28RAS'8Y18X77G@=*XM\D$X17E0)ER)T^\B#I/J_SW:.,S(#7R_?5CS M4Q..N;?@R_F9?5Q^XQOY&4A*+A+%G=#<,:&]3ABS2#EVN;Q]\3,\#%X=S\17 M;"0)1RL0T8DC;CE#3GN/8F*!1L\C,VIM@YAU?+X"_8T4DZM!4*E,NO3AE8)X MYQ$/!V 79H4@,7!JA(M22VLQDR'24"(H#X=XTPB*X$8RHA)B6$3$)07$LTH# M]AF,#7,.E@L03ZY3L;2(5WCY[GG98^ZP)-8E3[@04A-K?$B$J,@== 187=9CAQQC0>>J!5+QPLN%EQ-VA$HB)1:&8XMUX-9: MCI-QG@@:B^?DH7AY&@FAE@<2:4*1XX"XQPD9P10"X$W"6.4,E\MNB11>OGM> M=@HSQS&+6G+.B0=&-H$+'C4S/D5>>/FA>'D:[0A"1DPX1Z26RU);9'0P2,> M#6A/B7I:Y'+A90T*-G:!F" \UTJ[Y#089,P"'E!_,0SD0TG#7<*!Y! MM[88<6,(RC(9$6U)IFGOXM6T[!796C)3U&JF_N0"CENV\E4?ZV\Q5!9>W^[% MJM\>?$6I'W/T Z F#H95/^])F:S*8'1XW^\BU\557F9!*:JUC5_:.7XS.CRM M)?JP$>F5@^@+$;H[RB4SSH*SBSXRI@FFE!,PFKP&),":!>L4L62Q X3_##@C M6M#YA^@\TT?X:!>LHP!4&U&0BB!.P&K2E!A$DP^.QAJ1R59R(5N'LPN)L&;TCT)DI+D=5. M(>XL1]I[BZ01L&:6>2MKN*/FSN!NZ0S+PL9S81LI,QFT,B2$:YU$,,B*.$T4F<(6$(8"X06*'?/<.VV,(YZQH")\B1=$; H;WP,;3T,VS(*>1(-$A(>\&34Q9)*02'DN M@^"2!9K=O.NR2.,GRL8X!2R\)R"(/?>46^R8PY3!2P;,T@4IZX6-[X&-9Z(U M%E!58X8PU0[Q(#ER02AD#/<@E2F1.6.=K"M6V/AILK$U5G.3B/!:<.O [E(" MD!X+&ZUB6A8V?CA7X$R@)F\*XLF"82P-0=SG'FE.$@3XBR4H4SQ%63/R^3:B M_UK%O2>/)U 3OQ]&GW_HM%.L?FEWJ^-H^X-GJQNIN>-0S6./IE_61PE[++2( MU''"N&?>6&,L9LJHE$B48F$?I9EV7# R_SR,^IG$)A#M^[WN(GS^,(AIU/D/ M4.5.[!\42/XQ)+^?C)62^1X,L@+3*543*F\NY^N2WVN+^+M M9,$L;$59-MG,QJ?,M]H;13EG,5G!/97& M:^L2SB5(I.2IJ"4/S+?3\ NC(AF*&5(&<\15(L@1Z9&6D3.N-*8L;X%;)Z3P M[>/G6RJYPX;1I'SD7%N-8\1862&5]5J0S+?$C/EVXN4I?'MO?#N-MR2!B><, MI*PV8$YXHI"+*2+"I(I1<\I#6-M@,T4!"]\^7KX%L4JX)]K>62F]1(C'GA$6L-7 MFLT;T)DBMDV&@[R4<\O&E[N-I[R:A$]LMSN"%S^!C]]Z'>"%S 0K&D.I?FG? M=12E1+GGXBHB81LE849%KDEPG%B!$PN T!SS"S:\_-1NQ!+EO@HFSS6$86#H M2 -&C\DA%9"3R#)ND &85LQA2:-:VS _BG"7[2Y/+J;RZ)?R>GGR*43L@B%& M)1X2=8J")>(Y%TP2XR[8[E+ [A[ ;AI@\=)R:PA!V#$!8,<\6$,-80GICQ0AS-$:.!NMM6L;FA8F?II,+$D@F#!M M,76<>6\2J-,N(DLEL+-BEE-I&,.D M,/'396*MDV"&8@M S[WQ6@D;(Q912&.E386)'\X!.-MAQ<5$O7+(2J. C>&3 MBR1O(8\T6.&9$?(*;+PBFUR6B)M.PRRA_:T=8C=4Q^W8"24)^C[ B49!+'.>XELEHD[(*D MT9F[!\*EL\,*A\]Q>$Q&D"2I#(8G'0TCT5A-&-;$)E\X?/DX?*:V5]!@/_.( M8 5C3M"(R 9BD&...VX9QY(7#G_B'"YD")(;RI4Q0!#9A9XH]MCF>C/<7E#> MJW#X W+X-!9" 'VM21YQ$ACBD5OD N.(:"%9,)IQ*0N'/W$.9SIYC:DF0A/. MN-;, ]V$!!*AE%^'UG7B9*O"S%Z2FE_:W0#+]AQ1-<,(-6?4O\SP MU)?18-A.QR]FMJ"P,:NLU@:.:;N29=X[\S__121^<;I'Y@%&JJ\VT)W]BQO: M'-E!Y>P@A@I@ZS?;_5KU4O6[[=I@J[T>K$XW@T8U[-<(V&RO6Z M85 =M8?[E:T 6VR["Y19P]\!'H?Q2JLP$4/W->^=X^J:QIWR)KCDE(B: M6YPL(5%*[$ EU%@K6TJPGPJ 3OS?OX\_?PR'CG+Y=N>#@&/P[*]P/3SS]8?O M6Q_?',,8OG_>^6\L!4C^2=BJEK DQ?7I(3H:9(A;Q6)A(.%9VP,GO)$E8S4ZPN:SL<75(1SV]!_AD65Y8S[YQ-=18C M999J25UB*9FD-!=E86]G8;>/=J,S(G)BD B8Y5XV"FE./-)*2D^QY3YO[EE< M=OM9-J%J#>2O?D3QX+!606J[LE%K=GJ'"+3EYI?U4V7]EE3S'^CBMZ:AW%() MVOM1I^Y X;YO56_GG)X[J40,JO$AJ+! )X.:[ [A ;U0J\$P /C)#B]1B"O; MG[DQ@)(#S7-? B?\OT'N5DM?(:A'NVW_?[5QY+?%&;V M:PR+WNH2W7^J9B^N&F*9M<0H353B!#M+A%)$4>\48SK04EWOMM#YRQNZ_6[7 M,&U<"J!4:Y^RV&5(!QZ0$U$$QQGH9TV+HG,U>VJ&F9&\"Y?3>(QKM9D;S:/C MA@:B/-6>"6^,UV4Y;V\Y&1A*T7G#)2C03N9"+H:#%B4C1](F0I7CFI&TMB'6 M%Z_F"GA'!C^C]2]&'*H")H3GQH@\2F=S2S50!QWW,'_!ESI%MT:B6T>@Z&L M%88!;"(7%O%H";*$"B3J.LAY3R!U/X$XRDD<+5-,BL1Y("[ =T,%E9YI0DU9 MSMM;SN]@P=L@C0NY1"/+4H1RC&QT B4>=&!":1E!@)RK&S5N_'#K*OO8FSZ. M;\D5=:C/Z/3W/W2Q3F\\]%.E_Z'" 5<4(_^<5LV:]ZG#@&MO.&BI1Y/F):X3 M@0Q#M=\>#'O]_,HS1;>J3OP6.PLT;KA-/@QH,NHWQL'XG-][!S OQ[5.?1A! M6OGZA^Q/GV>&)9=#GN#=O[Q>3]V:I!Z<=0.PWVPUN!] MQ^_.Y+GZ9Z>763?H=4;#^&+,.7CV^K7SG#D7%U[RLFFY3NS]/0^5[ M$;E^M%^13?!6SVWGR!X/UGZ=+Q@'X#*^N\F/OW"69L)Z>%V()2HNIQ;/4G4. MBC?^78!':@\../7[>[M:WK2]:! _-7"FQ+CFI MIVN\*VU\__%4KC=3.4EJF#MH]#K&EQR?N_@.-KXM7J+;S.5830IJUN1W4)-Z M@^HU#.FP>M/U9_&L+,H#+,IV;PAW Z7Y]UY6IK*<@T\ ]NU@LW3[H]VU7=\& MH?9^"#]DO_7@$:W;7IO?:">X>M<)QQ;)0%4TPK+KFV M7/$?]"/BGE$*UK>QF'LBG*1&8<:HBE;GJ/P 5TR6^@];[LVL[Q MH#UX XJM'[[M;L0?Q/;S#8R6^S X_]K=/S7Y^:T7SR1FR]VR4DX@B6 M,\+:^UQO&2.7MY$(Q;7* 5!L@(_CP-O#K'#W1_%"%7RQX%-\\\7H_Y MW&!SW.8P]K./*5N3<,U@,#K(+VTK@O^5X\LY7ZL.0M7CJR\ZVF_#A/3@A_ZB M]V]2N#('Y^C2L++#"I8$3)@LP&NWIWH!=FW.QH+_ZLC+V'/:O/0@AVORVV4M M -[KY>)A#*INK[:!(ZQ3==0;=4#4V!&<9>VE9\!.-C)U<=B57[,;77O)4M<[U)3$PKOXJ+OZ2BXK&!PBJ2 MQA(+C$(>#T\>%XN-%6D#ND052=[7,>'#?MO'&Q65N<,2_/>V:-=CCN5:O_\^ MNVJW.VL+"QI?9]J:E6VO"@-Q\>OF+V0"/XK]C.N3QQ8;[J3?VN^_2NS[9DDA]-= MOVPU$QR:BCT'K^BGDW=X"\:U_?K#,5P#SPW[VQ\_87C"P=;F;_M;7S[AK9V] MX[,5>S[M?/ZRO?GN^^^?, QB-@K 3N >/_=+3U^M7Q]I=WW]]N_IFV MVOAXVOC4AR1R VK,F45:&9K4OWTWX-(L;<^M*.9S+L///&<$\0%MX@+IE"CEB&5#2$\YBT8"#@ M"&]1?@\QIEOASV7%WYO;5 5G'PG.+F?B6,'9N\+9:289"%:MI<>(JQS*#S$B M&YE$AFAK7(%5@]JY@=IHQE60(46&-X / +",1 M.0I?:6[F8AR K]499JFB!68+S!:8?7R)0 5F[PIFIYE!F,@4%*BOC($BRU7D MR&!+$"'$.*LI$2[W9U4MKL[WZBTX6W"VX.S*)[P4G+TKG)W-@ &;)1G.#9(F M;T-ST2"KM$3:>*N9,HHFES-@V()6V 5H"] 6H%WYQ(X"M'<'M--,#VX$LQYK M %H)0,N40,8)A3S#A%HK3.0Z RU1N@#M"J1V//(B41,4J&RW.X)7.4J3T]:J153=7%1M_SZ3L6&QIE+Z@(AS M$7%8?62P%RA$I;C&5'H<05"IEB+WX'NY(4LN*ZPN9]Y[@<\GD8=1X//.X'.: MB,$,H\ECC((A ?&0--(21V292"I$$95D6<^7XAXBA 4]"WHNR=JM?'I%0<\[ M0\]I?H5CQ 06!"+6YH*!0!6BX40=44:)9>O(DU!SX*>2X">RYDU M4=#SSM"3SR0!.^]<4@A8(>N>H':"!(W(!T5%X#BR7,^+L19;POWL!3X+?"X! M?"YG,D2!SSN#S[EL"&.XL1$CJ2Q!'&N+-*<622:,),0:09H@G5Z^.0\'/.\3/:9)#!..=4(]1\"DB;A-%-M" B"3:)Z.\#79M(X>.[F$7 MVN/'SSJMX=>A=9T(_X;VMXW)K&Z/#N!9?N/?\.-D_#/S\&4T&+;3\8L#V]]K M=^M9E?!*XZ_C297GI^"*@YU_PRM/S \FN-/N1K3??">TQLB=_3B(5;M[.!H. MJMS5RG?L8-!.[1C@U^H_\5OL5*P"Q!KNQRK9=K_Z9CNC6.VW8]_V_?YQ9;NA MOG(P&*R?$L/ITN>'MP'B:HZZ^N(3>F[UV73U M-_[M^K]NS#\LW[I&1\]2,MF_D)3E/A&CJ!>1*F$3XTGS7_]4!_/K ,V_Y]+,,._NS D[Z"S#GZO+/'MD[> MG;S=_+R_O?GU9'L3SO_XY\$G^NIH^^/?!R"/.O%__S[^_#$<.LKEIX,/(+'> M@/M+UODT\'G+Y]V7I+/KS^G[9UW)[L\&F$!ZX9"D$01NM!5@%=(*L[=R)\PJ2'=Q,V3DFID<0ZESOA$IG@(PJ)>TT8 M&)1:GB6EGX;%%1#44W8Y/&67.*&85M6-PTR@H,OGE,.Q8$V]3J=W!._^_+SH M&;_FY2)L/"^U?G0Z,4W1,GCQCCT3#R]">P!#.W[>[M;#KR\ZJRG";8&36V.2C,NN'\XN.77HS7R657C*LT$Y[H8:O=@_[E($/,%3Q1$TP M,1H7KLGMG;H"!+BLHWDP;CA?^7+E6.'/43.!BOV(DSS8+BTX8=;>_[/LDJ9F4M'=A=L ME^K_W606Y;H2*["9[#]@[MV(\VX^,W=:Z__GAK5<:W.KY?S/3\S"B,N9F5G] MH"?%FFDG62()<^.3Y8;0(*2TWE+B[$]D+/_0W_:ZOTQ!RQMZW9J@Y9=_OG[^ M$N"_K_3SZS='VYM_'WS>W&]O?WF)MT]>?O^\N2<^[WP2GU]_8&>#EOD^VS0' M.3]__93/?_WYZ]O7;^C6YCNVM?G'U[>;G<[VE\[7SSMAOD"QBE)J%0@BFBG$ MJ0W(..(1%M):@VUT.>.8M22YAWW9/\5 RXV$^DNQ3DOPODG^[4$S)Z(SQ ?>(2<<4HTCQ@Y PVE'JB M'3$9^16]C]XKCQ[YE\MAL2*6TV^C=B3-GFU,:ZR')%)"2PBQ3Y8 M3KUQ2F$FE"4Q4!EBL2"62H[,%M,?5E20%_QX?_AFF&5$DL40Q-XH9FP#W0I)8)^Z5+WKTDN'?5(_& M/G).$T$)\[QI)CAD O$HY,P["Q(MX=SB2> 6HTN4]KVZ^%=B$#>8QS]&?4"? MG#T]EWNV;,ZIVQ(L-S,G'Z-@(=1;C:GB@O.H@D[$I0"217A+9(Q%L5XJP?)^ M1K$.GC BM48\"%"LG2#(8<(1BS)G+]/D- 7!0EK,W(=<>?0>F@)_CP_^8HB6 M6Y%B))&'E!SC$@,@.L<"#K[HUMN-%4.%4U$>>*(N%AG+@!W=P W58PEM=:E M7-S.\IRRISDR/B=N!$.#<@8.80 X?1]I&X\>X(JS^28)[[GJT/[_9^]-F]I( MLK;AOU+!UVOX-HV[@=]A='KD982(P68_SKWY,E"<2. M,!(ER(EH1M92E94G\[K.EN?T.J%J[Q_T>S]BWO6#XFQYX,2AC=$X.JJ="5P' MI1GCUEOI_8JG^5:>YNY@V!^-8:C=K4"O M_M:/@]MIU<4=LSJ\8F44.7N#:1RX8,Q&'EEB.'BN+,.J:-5-XI7MV=3HY(27 M"CL$$(@15Q@4:AD5II3 ^DZ-PWJAK6ZQ%+@[^'!7TA"8Z^ K4Z:8L<$_F52\D%Y[6UV:D@ MFM3-:G71K[BJ;^6J'@R>5M;[T?ZH8W/YS1 /^H 3=7':XK19179Y,D]^M)*4 MVD )"9R[*%W@*G$L)6!4U.8N#AX^/UE<+V?6%KSNQ/P"&.?Y?@\F_E?]_J5L M5(AH'B*:S:3VS#*PG102)FC$O5+(^F!1"MACAZTP(NOA;%W*\^[M/XIOIWBV M'S=(XBC @+4X$4&Y$,(1&5C"F&C-A3._TQ2L@.3]@N2)MDZ"P=)SAIR/"G$5 M##)*!V1(4"Q@19G$:YMFG5_0/+%@Y!TJZDLLNWPOQ9R7[-\G9-PTH.D+9:KKW.X,/0&^66!A?7+FV64.^TR-A\'HS?G=&&ZBW-LNTN MU4-:L:@B\]"LF2&7PE&%HYHUH\TRK0M'W2%'M4ZZ95," HMX-A;@$U@)T_J/HQMWOM?LNM7^'FH]SG==3/;QR?::YK!AWT>V&2 M?@9?F79E!12JN]4-VC^K?1C;[J"*W7R?\ZUUJD,[J/YGGLRGV[1IO.I$6FZ! MLIW>]'IA #CX(?9_M'TFJOL"DV?SR3THQQ7(V2?,+5P%&YM("$X8 M&AUC6>[PYECN\*+(_7?E_HY]M4!E01&#F+$4A!\(LE$R%$P(%!M*F')KFYR? M;P/PQT9U+>1D#62,,I-/)[@#GP+L?(O=NL5T+R403 7@ZL_4*:MQIJ$8M+L_ #5Z_:.-DT:7O],E?G6TOXO[:U_?+_OUS16Y M]?S%?LQSOD2H?=MZ?0IK889\QMM#,%<&L7MV_[W-_13C8)BY?_#"'K2'(-A? M,3S:[0?7(E\#X2S:D)"F7F>L)_XU MZH2C20PYJ3'B/#"D!6AV%EMJHG$!D'AMD\GS52+^R+:A/YE' -/Q!)\Q(B\^ MC[1Q'F+/0/ M 7?SWZ[_K\WSEZI%ZUE*QC 2DP*82<0HZD6D2MC$>-+\JU1K M<]W_$O._?NN: 4U].+U!.S_^T[&!_2.>]$[_O\\FF,TFSW?1SZP;]#JC87PV MN36>_?W:98\QZ2/;<)*:Z?LZ9N69O[O]$R_8MXAVE,KF[R[2^=I1G)X@TA&D3EZN)9.K]O-O]=>[&.!SSVU,& .O9@$)]. M7SR;IF6TN_5EZQ^=]0/"/$SF2HD-R<=]YB=9&Y/KWZ#-O-$;&%_5AGZ.-O.W M\7HNOO7V:JZ@L4Q>]'O=WJ!Z T,ZJ-YV_<:9;5>$<@]":?6&<+5AKWK1 P6[ M.P ^S8=[LP.^=HB\;G=M%^R:3O5A"&^D$P:O)?J&S^M M=5%_M6HQ%N"3MUT08&\$EPV#K,E^W/BP487,C/W!>A5_^G@P=B=^Z]O]VLLX MV+6Y+\(^/-80OC+JVE%HPT[\XS()GXDES:W5SFJ12Y]9>C/E@["-ZM^GHF1W M8,V?-MRR0_ZPW>D\[P:PX6SW6QMF]?E@$(>#E^V![_0&HW[<@3O^V>GY[_=M MQ!U-C+@]?_AYY_//UHX_W/[T>O?+RW='VV]>\1:%>^Z])5M[?W6VWVP=;7UZ M2\X:<:U??^ZV]EZ1UJ_GXO.GU]];+]_RSV (?MD+[:V]CT=;^Q_YYU]O?W[> M^R=M[;S[M?7\*Q?.@WTL$(E$(DXX1DZDB+CV4F"6H@0SKIJ86S$\S[X1L'>, M%SB9Y 4WU&JPC#@+(6+G@E1ZK8I@&1_DE=H?Q;7-D\FOQK-?[XJI=*KJ7+3T MU+:XT-]T_1!.#QD+9KA(08'QQI.11D2KG-=:*2-PY)?:.ROKI\N^S%[W6R][ M,K-Q#1.;IV\\]Y.U/ZBC)?UV['I@('<$7QS:=@<>J9<_;'=KJJH!SL(/\W5& MG3JTF]]_L?W/VY>(F IF(<1]V,"[]D>LNO%;;8YVCG)U/K#YX=+C2'"^,WPQ M_]_A;MOOPO<'DVN.;?Y!IW<8,S_:<92G_FT__H@@1X#3WN%P]]2@^O$@']F M)\S^H.-8\7"W'^-Y=JVFQ#IV].;2VK9[-+G1H/[EF7OED9Y$EL8C'5PU E"Z MINLNOW87SX8=WRQ$W\^%#&MO!RRS'JS^Z?SD_R;".)95)I'C69F]TP6RF8KD M]*/"HV0'9QY"=^QU:>_7PVKWZR#8,#MAPC@X?\5$G@F)]2Z=C_6IG'N=,'[F M]S$_&$$%)A,2AONDMKPVX@Z,&VU//"N+>MOO'^5!C3EX.DEGA)?G M_-S=,I_'_.#P@W8_SW(6 (RL2C!KU0_;&<7!Z5G.0AW$0=:[V[!<8$[;^W8X M6?\P_]'; ;P_,\^#"+(,U7]'MI]KO9]ZCOSYS*WF&/MX5+._/]>-+AVHT MJ">E G/>YXF!MV!LNU6"?5CMP_R!I";2O>!^X[<[[9A0ZO?V4;]W9#O#HS,_ MO$1:&]6?-L_0^%NP"?(0:X ?K)^663WV4W*8>:;)LL_?@UV45_7):H9+ USO M7CC\TXONTC'.BC7T8 :[O2'L:GCF'W&ZAS/VUJ P.]-YKX)I!3>U.49T>GGX M[%8)."(FI,($;*2T)EJN 65#*JJ GVA"_+(PLY@@C3XGY[?%4_F>V M3(5\=(K2H%XI0XSH.(0>?6 MUF+C?.IX!5S?R<*&?3RS5CV8"-_R[KZ<6_*6FV?)4!V% ZTD<2DYZ,Y:$T)J M93H$Y[V]RR5SLE2VTUE5^^TQHM> _NIG]O'#4TV765E8]<+Z>+3][BO&CB3M M+(+UY;,.3I#!\,<#X3KLE-.6K&U>O:ZNA-TS.E)MG5[OB3@;Y'Y@JO(\1WZT M QP.3 IOP +A+LD0"5>&!BR"E)/@(K\DN#AGC/ER _9DPQUO'_S(ML_VR[5Y])RA8C"W!G6:W[&BEC$S MMFMK8FJW5/#667U[<-YTNA&^$K/Q,.#U$D_?$WOLZ&SN,$^YLBG?8+R>V'.N MJW.^J07Z+S_XW1A&G9AUJJD.]9^L0YU5L7:RN_A1.S+??0TA:F(<1H*EA+@+ M!FE0?)'#P-1!X@B\?=8QN33YO2ZRNUQVW[Y*X\"F51$Y[L&>B@: '&QM+N5D?1]@?G*F$U=#504I; C9? \SJL MED=9'MDY<"[VNY"%\4AFLTE#F8KQ6FF6[7/[66[%X3PE;Q=8NVV_'4(G MKMSQA$NRVS_TTO PNRF/(S:C@V6/56Z(FPSV M_EVN:3=C:01P>GOYXRN_.!'6I>AX(4 V2V[W46-QGFE;_4**1FFBHK7*!\:E MC]HJQXU,''//I+FB3>+IH. 5H<"&M0.[72QP4C&QL]?:>=_9HO_L?=E_W?ZR M]^YG73'Q$XQHYSN,M=-N[6P=;K_T]&S%Q.U/6Z3UYN.O+Y]:^Y\__;7?RE42 MW[PE7_:W8*QA=QONL_7K.6_]^I*VVOC723=$K#C+Y7R]LKDB@4ZYIJ^!5PX+ MXAP5T:UM2M*@5HCS;Z'F0<]C+=I;6..QLL9\_;\63ALSGJ991U,ADOF(A!P3 MB3+&X, )DDP)H ]FD-8)*,5:S0-VU'*YMDG-!:4*5V)#-0^("H<4#GE<'%)7 M-J//BN;9%-2X:I96SHW3J+%<[!"_?W MR#H_+#0=5INEF3>J <9J:.'L6 MW M.?';68.<)!1Q3#@RV%(DE,34$J5C[A?)"%\==T[C>:-17=\?2F2-B(R2KW*8 MJ,[\K]['06_4]['*'7/J4M-/LCI(\;-7[_^N7Y%G?U2#H\$P[C<\$)>?[9) MW((C<>?7T,.*Q%UU-@G@R&@GN3%$<^^59=%SS%*P,4GNR(5GD\Z>0PVC?LXH MOCF=?1S$-.K\IYUBH;+KJ>QHTL>IIC(G(@Y:(ZNE19PEC$SB'C$OC'?&&:SB MVJ:XM [6XVQ\?K.=N\HJ*/%<) J+0$7#(Q>&&&5Y3%@JJJ7W=]! M(0;[W93 MGX0;M3:>AT20TR:W%<&@J5HC4 C&,,.4Q<&L;=)UH9;10/1V>ZJIY/<;GIV" M?X\-_W[%?B_8P6X)F2T;#$]"9I%JX02F.? M!0X+'#X:.%Q8H*1^X(=<4L;'1X8@$'?QHTB?\;;6>X6[VP71MLU6G[ M<;O_ G9J[RTV,;F-><2L8%=XQ8BU-41B9L*;.A^.GO'[M;+V;\]-JP MB(/42'A#$)=4()"80%X+H:-WG.BPMDG4G3CJ%YBX>%?ZV)UF2:VR/J:)2'!= M1H+"W!IA?5(F24:UP9114QSUC=O5)XYZS#4H8(XB*X)"W F;BVIKI!4#8#;P M20*-3.>UT;A4DJ:S7S,3MPO^W?4QEOL%P.*NOQ-(/''7>\&2EXDB@HU#/$2& MK$X<46.XE\SS) PH.NODHO;-!0T+&CX\-&S(@8Q'M<2+GWXU_?0/&PE61BTJ M?OJY5: 3/WW0BOK(!"+,,\2-=$A;CY$.F'.LE<0$5""UCO7Y8[Z%)!KAIW^, MQPC^<]S7:T4/!DS:D4W.!C1YJL<=TR[HT5U.,2R\GEA)6UH=)<@K28(WRGO) M.,/:<,FY,\1%#YJ1UW>@!%WH$;^\DV11AFZ@#'V8<9$[(3F5&B.+L45<4(J< MP0(9>)_[9"4A?FU3\G580R5KH61O/AH8+-F;98D_\"4^3QAH@53O^[WNTVOZ M')YC_)G T 4M4HL:<",U8.H3$:V]ST=?HY3)*\:0E2PB+J-&CD:+1%+84!RD M\;D%]86:P)V&A@I"EOSV!^8W?]A$T@P>.3$9YZ.2PAJW8XW#KQ1+JFPRR,<@ M$=B+#AEK'5B0,G%E-#4!C$=ABO'87%?ZPTYYW^G;$/=M__M-FNR4+/<[]..6 MM);5(67&-$TTAB0DY=HEY[4PSBGK"&?$A)L6Q"O.VKOGV]D^!U$J+22W*!(J M$#M"]"M"-"5_+VRQ,L2+TN\I*@65]N# M1X)[T>J+/VV1^OV)/PT+%HB5!*E\0H?K*)#3&B/-O65)8B%SX>NBWS?6F?:X M\E)IC8YO!WT;.^WJ12_,%)-H9FXJO;Q[;*E:O;AJ&,H;BI.(D?G$%2<&1R6- M$QP[("*-2S6,^^>AV:K51@IEJ)3()OC#M=3(&&]0E,Q([E62 7B(EK+5CTVE M-#YPHK%T06-.N7-&1MBP2D7.E:6TM,*]GZU[XB(.SCOL:4+6Y2)DL(&1XS$B MAGD,D1#N LL=#,^?[B[QV)+I^% A;JZ^K8O'N%+5XDY0[Z2JA8R)6N$\,MIX MQ TE^10#08:"LD*XC!9S,)Q+WF+!NT>!=^7P0DG-+?&"@@1-,^Y*W8JYE9R9 MZ #30FN/D57$YOK2.=M6*B1RT6DM'4TFFW:ZF':+CP[<3X[$([W_XM.;)\.Z MO'WKY)/)K1A\&'HC@+723OJ2G7]',_H 6%5)2FV@N142=Q'8E:O$L93)I:B- M+342FDB\VZ?*"%O,J)! M\"_B).4D$O.(!.89RS:Y*5;:4LC2%Q99SQF8N&FO0S#1J+!?'S K9%[)OUHPV M@^LO\Z2VXK#X4>^(S0^_1B8I%LFAX'3,Y0O 'F5"(F:M34IZ+2U=VY1FG1E3 M_*CW'/O\U]#",TQ/P\"?Z7CK^6J#7MP=/D54S1!S#=KU.S-SNC<:#-OIZ-F^ M[7]K=^OY8Y-)6/X1(;%!?^.(T/2 T'V!NHP%\K;+3A0IH"-?*;^W'X6XO;)PN??_[PE]%::^:N/&&E+6\7X[Z693# MW5@-VC^K?;C,[J"*(+10_37JQO&.9WB]RGRY7G_Q10^LU>Y1Y>U!>PCS\"MF MG7XP'&3NK+_QZOW?U>!H,(S[&]7S0=5+EUYK_*VJ/:BZO6%U%(>5_6';G0PG M]=5&@[A>]>-@U!GF<;:[\+WIVJP]OI6+^8-^]!E90V6_V79W,*PO;C,OW_GZ MG(#3!,+EBN+3JBU98C8HK>=Z!R1[T(^=]GZ[:_M')[W)O_4M:("A&O:J_Z_M MW&CXJWH#C_9A=W\4.]63>NGV>]W>H!H?0ZWV>NWNL/H!\A\!XAW8_K ;^W]4 M[JA>/5LQY'G++="[UL$*_0CJ9E[+^\[H?P MK;S%X.%./T2^W4^_"ZIHG.Z_=K^*_QVUAT/+VL U3-S@ '3>U M\_YQO1_Q_)X!!:K>D]-U,E9C8!UT[,$@/IV^>!;:@X../7K:[M;BK']TT1(\ M;(?A+B@QL)SPV,Z8Y$]-;C#Y?&/\V1D-;OPA51M"L\L_O_+'5W_(-J3AM_PQ MWB!7?L;_OBRK,!^[_!L+O(-87?1^7H7 MC.PVQM*U@[_X,/L=N/+.THI:@DWTJ;X5(.=S>!X+(#P;CZ[^ADOW0O4$X#V8[?6_27^HPN='4W?$>\ '-PV4AW!Q.X&@MBY5;#3*#[ M%#N6%5(@XZ1V>!S.1/C#/M*U^CH#(98^TE=0*P@6U.F)CE;&24$[V_M?3_ZO/?\L/7RVU%KI[/;^O29?_[UCFU]>B>VWKPCK5^[:6NV MAT$ :2CL!#*41,0#-DBK@%$*,EEC!:6*KVT*3IJ3 3#_%FH>]#S6Y//"&H^5 M->9)(U\";3SHTTW+(Y*3TTU4D>0%LX@D1A#'P2-K.4%$.6ZLMX[)7 X#TT9D MA1<.*1Q2.&35.*19%/)@JB]B M6MMDK$&9QP^4,^XE%/F8OKHBG2T:M$HG:7XO;-<&>Y)]N*B>L8^Z%X1QWE#X MG["82VL,Y@S^1Z1)EEKND%@@442,H THD \ M)(6TQ?%8HH7_A:[^L0+KU)4+)G<23@2Q"F7R"5#$:,J\D2]3\2O;>IU24LUT26Z M20K^K9#3^/8 6)S&R\6]&:=Q2B DRI$$+11Q9@(RG@7$C<3)1:N3YFN;1LG2 M*:( WF, O)51^(KS(K(8>7 B+,<&1PXNE*#;=0-_@$H050PGXSG5T7+*M69$16#H MO$],6"HX+-D-V]4'DQHA=)ZB=&-.6HEH]J"2 M"A$GIE$T7B,>/4-:LH28D%3 ^TI3O[9)Q9T<5"J!G&;LW)LHFDPYBP7+"=Z8 M2T$LQ3%JPG0T"6OO2TVP^]FZ)]XB$W0,LU9CG,X84&:,)K!]*!(D6<\=A MZQI=0C,E5OUH(&Z>LTA+P+AR%NE.4._D+)(BRB0A(DI,Y':(',QIJP6*)$1K MK4C&R+5-WJ3R507N"MP]#HVN'#>:&]E.'(4)!\K W$(Q*(DXMPPY;@@2)KIH M.=%<9%/,G,>VHL_=M:?P?H(DC_3^BT]ONDF;B"L;$N-'5JSPAI&".YW7U6=8 M'(7$V.)$!.5""$=D8 ECH@&[G;FBFF$YYG)_)+P]6^)%FN2BP1$9F\T+Z12R ME@$)"X9!3PHZIGSFEZV+"TKDWEO$;@'[L'D U\P,AT)>A;R:2U[S>,.6P%[% M4;9H)IMQE&FJB24&I6 I,!F1R(:D4;12&1HU&)1A;9.L$[W@6N^%PPJ'%0Y; MF4W3. YK%H5=X/(LYM=ODM9,O7FI(S'&(LX2F%]1$Z2-Q8@[RG#0@O'(P?RB MZXPNX\1AH:[KG:C_&EIXC&DNW4QJ8SUK[6Z(W>%31-4,"=4 7K\S,[-[H\&P MG8Z>S61$LLDD+#^_4&S0W\@OG*87WD.^[0@Z,9XM1TW2+5C!1SN M-AK URH[7:N B7"M_-9^'.[VPL;ITD=W)OS)+I$K*O_V']7Q;FGT.EC;W-F- MU>FLWL,(*V#8AVNFV._'4+FC"E 69:+M]SJ=+/UV3F>-@^&@&O:J%_U>MS>8 M7 4^JN)/OPL<&3.I5D.X7[^*_QVUATW# ME78',(.ER##ZQ7%%%>'=E =JZA7/N^4]I;VA'-H>)9[1FGR%+0" M[HEPDAJ%6:[ ;;5B(><74SS)+X87DN%95>]MZ_59A6[6V["=SJIWJZ[*=>+_ MOC_Z\BD<.,IEZ]>?NZV]5Z!V/1>?/[W^WGKYEG_>^<:^[(4VJ'9'6_L?03U[ M^_/SWC]I:^?5SQ8H9%S02+Q"$7-0R!)ER'A+D8@JD<"52#0W .+GCZ_<:*G= M\]:JGIS=*,14]8%#\@PVRQS+,BC'%2Q#GS"W.3:KK)CD#VM6JK&RW!H!M=7[_^N!D>#8=RO\7:>99&8X2$2'##Q M'$P7S24E3.(HL70P]&O0ZI9E<3H7^U>!@H'.'_/2$1G06!#&28Z"!)2,HD( ! 3".). M..0<@S5B(TW,"P$R 3PYW]6CZH\G..O!N:M8;P 2JWH)C/^)+15&_:PQWU!+ MVZBNMJ@>@BH[J\#&GP>Y:=BQ(MN%AZP2K.DJ'P"#F>QFF^$47-O=5*"TLTQ91$7,V9)#( M*>.15Y0;XFTTA*YM"BG.[;14183=3%DD>/SN_RL(IP_SX)M=T=V[%Z:48U![:X-^*>U-@[S_NRP'8:[ MH):"UCG10)D\5WOC^&?6#7J=T3 WC:XU:3S[^[7+M/!)48>&J]QY.YV:R)F_ MN_V3Z.BWB%P_VN_()GBJI[9S:(\&:_\Z7:P$C(W)U4V^_:6S-!/#PQM"-,@P M49AV]A0!U[,(A/IR^>37M)M[OU9>L?7107&L^5$AN2 MDWJZ)H=/)M>?3.7&>"K/Q*[''QJ]@?$5GY_Z\0(JX5PLHKO,1UK-%326R222 M]0:&=%"][?JS,:LBE'L02JLWC.,892^'H@ MV =$'SP@N35;.*]O'KQ\0#)I\%ZJ;_RT/80'\U>K%F,!/GF;@_B]$5PVU$[/ MCQL?-JJ0F;$_6,]I /%@6+OVOO7M?@7?J@:[D_R2$>RT=5#<[2B 7AW^N$S" MI[.+QG_/J()CS1H+9KA(07&?>#+2B&B5\UHK903.66,KZTR]1&=YXOYH5(SU MPF&>SOIA&TK7$SO-E+S4VWVA-*ZH.W:KO(#3)MX'OQO#*(=)IJ/;@GY M[X_/>ONU=?@U!:M$2A*97%N(Z]P(0JL !CO'3-M@X;^U*H*)>Y"W5'\4UQ:C M-0/>'*N^%*L[+N%Y[8 O+N@YUY O3NT^F[:IEI#9_;Q6WEY&'_==[%>,C!.A;G-* MJ4BZV9*>9CH5V3XXV;[=/[#M?G9A5!ZLK&^Q"/GA"?E52M$/,UR#60VW/4FV M+\)^<,(>\_(5WK#[+7E_![-Z+P?9MM_\^6*QM=)N>P+Z,1UPOF&%N7FF;?7/ M+PMCF7 D2LPU9Q)K0C5A&.>$82Y-NFF)QH=V$'GW,WV]V]I[2[^\[.Q_V7EW MU'KY9_O+R^^T]?(Y_[R_Q6%<<+V_OI\_B/QZ[_.G5W1K[\OW[4]?.JV7;_'6 MF[^^;^]\QELO=]N??^WN;[]\+C[OOT];'V;JXB=+KG+92!Q>MH4(:C(6>\ZC1K]CO!3O8O8Q9IL>)7M;'&_Z&A^RM_-&B M9;/-2=5!HD*0V 8DCV,B+T;] M?NSZHYUUN89;;,\OAU^1MI-1:) /-=1/@C]8J(IR$D<$0Z@1> MVR3G#V?>1^.EX@HK9%+(9-7(9 XN<8;)H!/HL=+R0+TS*0IL<)2:)^ST38]U MED#)[7CAI&)KY!Q[D3"R4C'$763(&L91HH0P24SP.*UM4FV:8V<\4'981"; M HJ.-V@2_X[6QZIEAZ,^X,.E5/N;#0CG*R)\S22N,FBS1)T$G=''7 :+)B.= M]XJJ($*RD<<[J,Y=\/PV>-Z>"7PSIV6R6@**^X"X=1(Y3RC*)_:I9<"I7.>V M$5@MHZ_T[?9.4_&FF=T?EHQS#[_1J@L^.(JY"$KR)+R1&&L/VXDRRVFXKD9M M"<4N'_].0K$4A!4\3XAPDA#WUB)G<$!*>NT)QHP1LTS?^>UV54' @H"/!P%+ M]/!WL.]L]##HQ'ET,1?>$[D1BT=&2XU"P(H"ZEEF24' @H"/S]:=)]IU!Q!8 MHEWWA(2@!5H>F"(.#&"?VP GBHQC#+&DP"YV6"8EUC;Y^>*S]]@YL2!?0;X& MZ'Y2:(.3 V#SA$M+C M*!.PI2=BXJT(SQL$?&-B[,W'6J:F6BU9*1[^#Y)HJU*.$J98),0(35E@2NM!5%" M8CUO+ZX2E5D\ LY$93@6D4B.= @ @\I99*VQB 5/K9",&>::>Z*A(&!!P";X M).\8 F^D]978S.\@X-G8C+3>&0V:(.99$]0TEZ7 #%E,I$TLQ.3"VB83Z["& M&I&)7Q!P=1#PX5N[2]8!2X1F47AX^-51JYDQ'AE.%>+" 0@R+%#4-.DFXG5>(*5\0SY MQ##BS@6D!6A_"6/A05(N8+^V290NWK^E1&N6&IY>VN&=*T]#33Z'N.!S/FBE7)&1P]Z-C<\1QHXNO*+(-J[F^K-0_#FID^5?BI M\-.#X*=;-1 KX<'[Y*V3\" H$R01BH&WI$0<"XULA']B%:SWCF/'FWAHJ_!6 MX:W"6_>_:1K'6_,$=>^8N$I0=^&\=3:H2YFB6H: X&^VNDQ$EB>-,$T\>,^R MV;R1& M24IMH(0$SEV4+G"5.)8RN12UL26)Y-[X>J9,JR0T 6=/^MD1FY#1F*.DM(PJ MJJ!MS$DD9ETQN3H>TKDV6?-PZ[+DDW\-+3S#YE0.K=$^W,7#OT/[Q_C=O /; MW5&MS6[^&]Z>/M&^[7]K=Z<3(D\>>?/?KO^O$^:IKY1_5^\CSU(RAI&8%.CE MB1A%O8A4"9L83YI_57AM]D>G;U;+A<*M3M^\?NO,A-]P:D[/YXW%,"-.>D:< MN6%OI]V-:'?\;T)KS"5\H_KWJ5F^ ROE-'@]#^.FZ[;SNMVU7=^VG;?=,?3! MNR_; ]_I#4;]N ,W_;/3\]_O%]O8UHLIMK4 3SH=P"7V92=TZON\^:N]_?(C M:^V\@VN]^@F_/6P!A@%.=>+_OC_Z\BD<.,KE%OUK;_O3/X!+H=.B_^RVWK2^ M?]Y_RP$G2>OEUL_/.Z]@G,\Q8%C:!@QK[6W]:OUZ^W-KY]6OUN%7E0(SFD;D M@V&(2Q*1L8(AK4F.Y6CBHQVS$.R!&)YG#G$Q$2RPMD1R3JW57%GI+9!34H8Y MOE9%((\#$,RP/P*L>Q.[L6\[E>V&ZGG8;W?;@V$?1/(C5J]^'L3N(#=0/[O_ MQING$0N:7[R@_WT&',9KZ?K).3V96F*A$J.PKCD/REBJG.*8P#80$?ZN;587 MP- I;+EP'-=?=T&;T?=[W:<3D3_OAM,"G\I[)Z-NV8:3;?CM*PW&1RXXLB(1 MQ"W)54((1Z#;66%8D-+YL]OJ1ERT],US$;E?L'EF,<&>QH0X7B.5[4=8E/L' M_?8@AMR??;@;09'M='J'H&E4[6'<'SP]S[)7S4A-]L=3,E9HX)$[]F 0GTY? M/ OMP4'''CUM=^N!US\ZJRX!$3\[;(?A+CPQS!P>(\(DE75R@\GG&^//SNAR MXP^9W."*7O[YE3_&&^3*7XK?^.T5'](-AD49\N1#)JZX MM)CY*I&HBR-195/\]J8@IBE!V"+41X5T1=R+VL.E?NOS880R3L$=3DBIN&_$8)U7L?:9;.\_Y]LM7AU_VW^*ME^]HZ]=' MT?KTOI.O\>73^[W6CJ=?=E[OGDVJ:.U]_KGU\AO?VOES__/>.[CN9[C/=_+E MS3\Y:M+Y\F:+M'Y]Z6Q]>IVKJ!\=I^_#][;??962FV241Y'KA'@NS*LEURA8 MA5.(0BKJUC;E.F.J<=4Y'EH/W'ODE09-3*/&,.-YR[)$ E7A@8L@I29?8F9L"^\*.Q[W^R+S[ OR(FZ1"R*AGC$$]-($Q&1 MHX82A;5,W*YMLG4FFE<;J[!OL>H*KSQ$7EGFH>S"*W=IU1U^920(HV3.>J,, M\<@]LM03Q C7\!$VV *C$+:N\3*:8Q5**912**50B@W*<044XA/F-ALCQB82 M@A.&1L?8Q%0AQ51I"J7@F7:+TFH38VXGJ\%(B01I4 Q0T%A%QK5W,I^67H>7 MA5%6L!?CPSY _7>_E^)@4!]AJN-Y@$N#46<(8VYLID/IYKLZX:GZ;,[L(@/F M>7&\Q KYW()\CLY%J9PFRIC,/B;WRP@N(A>HR46FI$C>2RMK/QF5I>/O$NV6 MA\T?#KYXKQIW32!":$(],(Q- @T[.*Q"F3#&E MM4V]KKDI*%A0L*#@_7BN"PHN4"/,_=<=5L)*9!AH@)S#*ZN81U8S"=SF,5=B M;5/!"FE>6Z 51,%RWF3>2=Q.J>UC[9W^-B[BTK0P\EW12FE>NFS7]'AM :%, MR@,5-IF?35HOSGFDC:784,81Z-&@67-"$4B-HQAU$, U,E&6/=*"B\8%19L. MA\W*I&G0Q#1J+(OU2!>B6+9'NA#%G1#%64>TM,#J#F-$L.39^#"Y(*%!1!-M MG;"$N[BV2=3*(QXR^#DC4-3. M1$P2)\'FT\62GN\-5L"O@%\!O^7YGPOXW:G^=_@UZ0BL1232W"?$#0X(Y)50 M[HIHB R4,I%3$ 1MWDF<%02_:]S.BZE36KYZFTJ=34E3KPNS!R\$07N<>MKF*>P;^JIVKF[7WJS3MTU$=?V=0 M'3=_&!TL^UGEAKC)PUY0#'YM\TD[=]P;'1PWCRE1]H>IY2PM'/+^9.>,-U=1 M\BOV>\$.=@M)+( DSL9"C!(IY.(4U(;<=UDJ!#*48!8'+I)05#N< MX4Y30I\5FEAIFB@ N.K1D(*"=X&"'V;"(2$R$5.B"*P:A;BD#EE., K>8!L] M==S3G(BJ9?.ZV!;T*^C7!/2[VW!(4?\6"'PGH1"GI0;53R/N<40<"X>THA'A M9)T@!!B,NZ+XE1S\^\S!'^[&?HFF/W#Z6&;#@GI%7=.UN5#*/)1ROC!,"%9* M%0,2!%/$N??(<,*1$HE9983E(:QMDG7-2HQ]M1.,&C0QC1I+2<-?%;=S88=% ML\,Y?[-PS@NI4<+PARMAD$[.(6.H3EHHX:1>V^1R&25@"C<4=;D9LFN8K[D MXN*S- Z_$LRB!?$AQNO06S#(1A.12H11CB,3+(WK836OB&\!PP*&30##WW<] M%\1;5LK!X5&SEB#-742<1I\[&UJ0#3.6"QY/Q#)";0\>[QJ6\$TV MJ%@!1\).;WC+4B\+#%DN3617UN:??#BY&X//0V_D.O%1MA29+UQU-_.Z^GR] M3%]_8?&[8_'M"ZKM:),<2QH1[W/B#-/(8BJ0Y%X::HQV&JP7HM?Y4MH4W]]^ M;![0-2OOID$3TZBQW'T?XT+UA>H;0_7+[(1*: M,>0D,8@I'ZT43NGH@.K).M?+\%06JF\JU1<2*R3VH$ALF<&V0F(+24L[_"IX M,A('@@)./!=]PAKT)?#X2^EMCBN=#7 M0O+F#K]RDJPQ(B!.A$3<6YPSYA1R($+M<(B!Q-K1JG3S^J8].OJJHZ[_&EIX MC&F%)/@S'6\]:^UNB-WA4T35#!'5(%Z_,S.S>Z/!L)V.GNW;_K=VMYY%F*7I M/R?S)B?3$H>GWAJ/LH[Z5O,N[3PJ ;XQ6WLQL' M\:(:7E5_MA98N^L[HQ#/5P8;[L:SU<'R6R]Z^S /1_4)._5L<(.*8>-6V1=< M_>REX&X'/0#=P;@PV7]',Y'#Y,9YGWDC]WG[UP_;;O5'^Q;<17++7/ZKL M:+C;Z[>'[3BY#\Q(OLY@Y'=GGV/C>-V/ZX"-D:3Y/ZR_; =WJ#43]N MI[S(@,EK8;X?K[\7>3%^V+7]^*<=Q/"W/:H7Z@X,X<].SW^_;ZH_FE#]_ENR MO;.[VWKYOO-Y[\_O7_;>L<^_7HGM3Q_)Y[WO0/.O6.OE6['U\C,%VN[$_WU_ M].53.'"4R\]['\7VFU>X]>:?]M:;]_NMEV%O:^>[^++S3WM[Y]71UH['6WO? M#UM[7Q*\!EH'M>#7\Z/6#M#YWL>OS$AK S:(1 KLG0.F)F%8,YPQ9V5,"19@ M-=DH,3S/JA;WW K0TJR!-:LML+PU% =%%!5."+%615"F#O(^ZH^ ^VL)()=% M4$UE<'X_SFZ/,WMS+*;K;WMFF"1Q(0V541%N(G$"%$N1A,2:\TCCVODM?^$. M/[^C[[WVXR4[[HG]X[AJ8V.'>9K$^ ;C]<1^LOV^K1?&F86P0/CXX'=C&'4 M/.J\RA.DF,62YZ"I_F@/CW:RSO18H:.U\_9PZ_E7SI.SH.XC:H5%W":%3-06 M$1&(CS@&P)*SVS R:HB@+$1G0*N))A %AE_0@;'@HCR+%BN[*2]4V6KU#'2; M3J=WF!65-JA)H*KLPV,<334MOVN[WV+6T*K#R2ZHPJA?ZS7P\:#]L]J'^^P. MJ@@J2:C^&G7C6+5G>+W*B[M6O;*"]O2\FC'G5-:FP?%_E^UX[ M8!^SO;* ]*"SYII:@C7_J;X5['\+SV._Q2K^C'W?!MOOH)][03YY\3]_W,95 M7<3>:+&#\N-B/W/%X5D5J91MN4RAEOH,O-YJV58N4>!O^GI@C9R(FB5&NC/!>>\YIE%;"ORA,F0@1*TZ^ MOLU:(*&,S 9*Z#G#YV)+)\/+M]IY]N?1.;?)#5MJ4G$ MY<_V]LO.+HR-??FT=;C]\OW^%["AX+WV9_JETZ*O]S[O/"=?/KWOG(VX;+UY MR[<_O1);OP*,^3EOO?G2@3'#>W_M?=G_R#Y_:NUNO6BW,%1AJ*4SU""S MP^!.R.EMZ_4<8?PE,-=8X2[T-!\]_3JF)Z\,(2V31-*&*"SFC@6]9 /\$7/3-3;A-%DH%Q^[GV*/ M"QG+C C/')QHU#";-):[F;+B@KC#? !B[LW_4)2YF]6Z7!V5[7)? HU$X61" M8M1Q)YCS1G-A;)+&6F98'3C1):K_X+2V]HPOP=$80$D7B%%J$#<4]+?H-8K) M1_!LTK D;+H"5M>KZ>&%RQ+;2S^* MQ1D<0C@9A*?*",3_NEC:. M9LP/#(N &.80B8X@K@A'SB6%O!+4"F>L8+7YP9J75-QTJ&MFWG !UYO([LE\ M.OAO FM3E/'3J%M =3Y0G4F%C4P[3!.*1EG$D[?()4(1-EH1&JEEW*]MJG5F M\+JYH*?DN?.$YTDUTXK2[D9GZTIZ:8/39W8GCWXJ;07,0:"/%,*<:(T M,BIHA!4HE)$YJ:*M0T2KE-(SSTYN'C@^\M!2H;QF;I35H;P+S>C;L5U3K.<2 MROHMOIL)95EBZZK2F/"8_*J,LQ-K0_Y_)*3K^NSI;.K71NJWF@X&-INWC@G MA2+M8%)=[U*PN$./#]=DU%TPJ3SSO#?MM6DQJKZ]4@QJK5&\:*D#-E MLA]"Q4BB-XRB*U77<06'O,CJF41?4>/R]X:L;EHM= &.V<576FQ.V<+:[U-E MQT^I2?G 1/OJYT&[?U2%(MN'6&^TE)E]E&)O;)G9_78(H"K.5WVNZ0;TMA_V M\G3KJFZ*0YY55-?12]'8-*$B[+L6]OGJ1O^EEJ;&T["" __5YYSMKO7G]'<9(MW;>X>U/ M[W=;.^'[UMY?NZU??^YO[<,]7WX^.M=?\E=K%\:$/W]ZO_]E[_//ULMWXLN; M5Z1%WQUM[;]B6V\^'WWY]/&PM?=7+B=YTE\RQ"@WE:?J%KPI?-2-B?3NJ*A'K!T%6]"1B#0+F M-B1$$DZ(8TF0P18CRTU(6DJ2MVFTSORIFN6_:H M(NS$;E6UDT(V6RLH@KXC05.R(H+^O2-LUP[X*L1:8AE$TH0&Z[0N9O@#U6S:,V:X9X1HDR(R&L?<^I4C:PE%5D=-&2=>Q5CG MGHO%*S5WLF&;BL2K8'<7X%VT/7D[S"WVY(- W1-[DG@GM+$<<:\T B-2(9"^ M0"HRA86*G!*ZMDG$.C9X'8LE9$ _-NR]T((TI;_JY9-X64+K#2AM,>>N'V$( M]]0RQX MPF%Q>"Y9TUK.+F _-P\HFUE;JI!@(<$5),'25*0,Y$4_LP[F>#3,,U_/*I[]_:7'6B>'"AI^:'4F,CB> MV)F_N_V35?T-]DL_VN_()GBJI[9S:(\&:_\Z]?#[[>[TZB;?_M)9FCGIBS>$ M:-#17G7Q+%7GSM8NYK2L$AN2D]L=EC7Z^*#M ST3N9HK:"R3%_U>MS>HWL"0 M#JJW77_FM'81RGT()9^<'U3#7O6BUPV@K,607]6$:O/!N=?MKNWZMNU4'X;P M1JV7/2"Y-5LXN09"+GDP:/^L]N'KNX,J@I3"50[IU9=)@_=2?>.G[2$\F+]: MM1@+\,G;+@BP-X++ACJ2\''CPP:HH\",_<%Z%7_Z".HIF%;5M[[=K^!;56VW M578?'FL(7QEU[2BT82?^<9F$SVB%T^HQLZK@V#SB)'$A#951$6XB<2(X(9*0 M6',>Z<17"K^)X?FPKO_L(Q46C$69.'7!!":994I(IHA1_*;53!I8ON02'>>) M.Y[EY@[SU#ZB;$/I>F(_#'O^>]4;6\I7UT%I9Z0?/D5$S^S")MYV0\0[W\!/24AO"'5.WA7HU]<)O?'2O-I(VYFI'V0#/'8^U-\% MG!P38D;.?AP,:YUE<'9JJK$ND_-"J1P?3:Z>9&+-*:(4/ZO?&$_HV-54_0V_ MJC\DS_ZH#G?;?KS_@4NYH#-2[O0X8/8-I;:+C$0[K?]HN '"G M^A:[L0__OQ_C,-<[@B^?^O%N[(0*;II9?7IV6FU4^9$O'EEEML M5_5L4/W9L_V0[_&RW8]^V(,;S#YK_?'QHX'B9P_K[X^!([]Q,.K[73N(XT'6 M;X7II=;APJGM8W[U/1Y5I?<&\;%0G\?3I@\+? M^7R8R00A*0\N*,]MT,XDF:R*W/+ @R?CUF!84GV5#Q,6HL]^S$.P6@>Q>V=. MS+%K'\%;=9WG[FFE[7GP57NM<]A<%2C3B 0NDC?,( M>X-%\$FY!%I%MW?.WUBE43\[@\>+=5 =MCN=RL6L-77SS@:8BF-5^>(-\ZS: MA?T">NGZ=%'O Q; !:9K/50_VG8*&<=%0F"7YVO.;/*\N6=+ETVWS4$__FB# MGM@&0YK="V>+I5VT&><\PN5 PY/2).X)Y\)93K#RV"25&$]$W:NC M?^+.WSZ9QX?AT+_UYMC>>8N_&LVDM\DA0WU$G&B*#.<4>1%L,M)A+]/:)L'K M7,MUT.//;Y(I^_C>/EB+TY5^&,&>F%VSUZ[,!ZU(;'?/TD]M85]%YE/2MQ=H M%F?4"'VY&K$^T2/Z$7[H)^1]/3945,S64,R:3-85QM<:7X+B:GN_VW:CP5@[ M> *:2H@)GAT4E0B:PA_GE)=KGGF]ZO;FPMP+GON^,?>"(2T:;0%FLTP&J M=C='$=L_XD5X>P;YSD+MG*AWQFRK+9J#6#N_;V:Z39!Z:KJ=Q>6)6328.OQR MR=M\P5G/S?K4 0C#SK>N%TCM(86/LH7;;_O:QJW7V?FW:HP:6V.]&KWK=Y&K M\19NZ^U@=_*O,:Y/YRK_=C!R>V#G90P8 MY^LJ!)\S%08'DJNNN&0MQ\D;+@+QQ&E/L!&>WPRM%V5&%K@^!]??#K>^?8W8 M"D6X0RY0@;AD CFGX$_@D0#G>D?=Q1;DR7Z;,OVN!5!Q,79AA89X"J'/[-S+ M->*5 ^)I2&FXVX]Q#''7!Y?&8#WL#0$):[2:((B?18+X,[_.KSC64<_IS8,:F__GTBT[&H0S^U53S"/C,EE8.IXIPY./EA&K8(J=QI.J]_Q4 MU?N3C8O8'%K6\TZGY_,37+Q_7XV?]'@OLD>V%[=?>M':>RZV?CW'6R^WCEK/ MOUJ,A15&(DHTJ%$>)V2$)DAH3A2-,@D_5J/4^3HAU9/S?>^.#^_/LT2PYL'# M"N:>.LX"=0#QU'#J?0A>4CUI6,HO:5A:ELC"E@@'Z"9:2&9-0HP'B;A*$5GN M/0+9@#DL!! OS^5D)%?G>X?62#776E#"*\#F_9[B@KB>3B M:D-+F\92*GZ^X\GS3-NJ%12XO*H.CD)B;'$B@G(AA",RL 0&L]9<.*/&'^<;/E@WX_ NL])?P;'OP^9M_.JV76S^WW[SE+=KZ M_N7E.P%6//^R \_]E09%8! MVB:-M D1I>A52@0KJ@!M"5\GW*P+W* B+05S5Z^!Y:T$N7IFUE5A(,.-](3X MI'/'(TYU4-H%DX)@2=)HSL2#QT![-A& M^0[8Y;3@[4WPEIPT!8@B22PY(I;D@#-).?3,D)($2-:* )^O;=(-(<^77KJY MZV,Q58&;^=5%>(%2_;];@2M= 7R:6JHW<:_^IMY]?B:OXH 'HUI?[L:X51K M[_@S!MV>+ A>WQJV!_VC&K2A8#W!/M&.*$6&2%- A3 MBBTUB3+%,O#C)72#N>6N;"J<_886_1M ORS/Q<-&T"?S>2=^$SWG=%/D)*NW M]:'/EW7BS!@?QT479C.PIA 9"CS.!X\G?@C)6?(:)Z2H\HAC9Y$Q0J*<2!UB M)-'8.K5?8[5N\/D3DN=R H\K@@\SG?_W\"^YDFF46.9KH_F!MA7P;1ZD>/K MG4ZMA*]GJDFQ/1SUQX?@XL^#]C@I<\%6UWR>MU73&5;!ZKK&Z'I]O# &S[OA M55X7]16*$7;76D;KQ8P11C&+L#4"8D1JQ!U-8(0%@S@SS))(H\,F-X?;4.>/ M>]QWH*/IR-?P6$9!U%6UPA8-M05.YX/3$Z,-$Q [-@PYYCGBQB1D+-?(6VL4 M(8P9DXTVJM8Q/^_6NE.3K6#IO<2%%PR4S9-,H\:R))-M 5Z !LWBF9SH:YNP M+FTF2UKTK;Q CRPMVBA)J0V4D,"YB](%KA+'4B:7HC8+;S9:TJ(7IVN=2HM. ME$HK/#+8FVRZ6J2CUBAZ;$SNM^!"6-L4&X0U+G[X6%/T'EQP\1&G1=\.9DM: M]$JA[8EE:Y*(T8J($C<.<>HPRHGP2%L9O H41(^S9;M."5\7?!G>PH*Y3<'< M.S>G2EKT[5R*)2UZM?'V)"U:,.P]RX=/7,((%F/*KQB2DKK(I57)VM/9<;=) MBRXGPB]+!:XK]MCA#=P?]WX@[R9=Z5=5]1P-&F[FSRR78N;?%1"V9].$J0^, M8(<8]Q9Q"2JH-BR'5*2+.,'.I'YMDVWP1I_$>QCMT)L4,2 M7KI42EQ!G6E[]C1+PEZDH"R*W@K$6=#(Z<@0"9I(PRU-B>:@B3E_7/:^S=:F M@WC##=-RF.7._'VW \N2V+-2F'GB[U-26LF]0SB?5N&8.Z2]48@Y1[ S8&9B M5R?V& S_F>8Y_ IRKHY+;^5LEZO\=H%2)U0R(6'+66(F$AI8TE[9Y+5.=>%" M/2U>#5 M^G(%HMJC4*KU+;]N1%".*\:H3YC;7)C5V$1"<,+0Z!B[IGOGW5?K>U,W&"]5 M(NX:ZF:/VAC-->B#"5'G=;:K#7*86"0]CT&*I#"+8%?C#4T:E_?==#!K>&IW MP<\[,ZQ_$SJ7:V&?AM4W_=Y@4/!S/OR<.3RCGS?=@+AJXTAI:"?LT82RGHMV*UTA^I6WZ%K*]2*WUAQ8!W MG@^/V\ ]_ZIOL@J-B MI?3>JL)C*;W7C+$TO_3>*AA7S:B6_DB]M@VRNTJU],9H&:]FS;#(I/>6*"0- M!RT#1XLLL0I9BY-+4C&K&11<^6$!95,$BZ=3$8X M&NN#/HNW90"KU5-0L(A 4GI0O*UQA(&6Q3=D M\X*'-]V0S4.QAOO-[ZM^VGPU>U<'9R\T=&\'L>4LY8HA[4P4TBIJDO((99'-6'.:K= 9S!7;EJ2KI-W1\+&YF M'UD5R7G*I#?$R"]ETA>!A5NS1K[D0OG$"#*$1<1UH,@%1Q#1CB2#8]#*Y>)' M')]3.AL;*+BO9EYS(D6Q4DN%[^9#Q8F52H7DU%.'TO_/WI M%]T12B;WQ9Y'A-NX?=TQ@K&-VP__0^1JA(7$:#&&3_].EB00$MB(M01Y%S<@ M5556GN5WMCQ'$(NX4Q(9IAP"4UH)%D%W8+NV(9M"XR9EM9[E=96DUA7"5R8S M6P\RKIIIMG)N:FGP_,9[%3IZID$-.RD4XDDD9$22*('!YIB.\'/5KE*: M7WNO_QAF6L%_0_O[QN+7X??,DNWNR(XM/OC:F:3W!NW\QQ?]F N/O\>7Q^TP MW 9S2,+R>J <]>?_&:&<7@@1%C?UZ*KREO%X7T MVK+]"QW1:7TK.M'F_LS+_[_7-=^34BUX_V&[()WNJ%[1S;D\': M/RZ\_&&[.[V[R8^_[1=4I?O4N/B)E7_5/QXMN"Q MIH<%=>S1(+Z8_O RM =''7ORHMVM;EM=-(\6L ^3O5)B77)2;=0C#\T>AWCGWQ^X>)[" A=3J*[!//5Y* Q35[W>]W>H/$6EG34>-?U MZW-B5XCR"$39Z@WA;L-> Z ^@&D10_ZI2B98, @:?[:[MNO;MM/X.(0_5.?% MGQ#=ZDV:PA?&77M*+1!$G^_BL)S5F'U[YPI.+;:A?"1"FNHEHE3%TQ@DEFFA&2* M&,7'$2.X!OR [)3PI+E0B3@<-+?6.HQ=\BIQ)8B- E]B]K6S#AF^0%3-T+?P&5]@[?>_MUNO?UP MN 6N++BBXLO.WVUP9T]:.QZW#KX=;QU\25L[[XZWONZ!!"O/7$1*YHE3D7#D M-)=()BJ3$R0I%=8:<>#M49;I_BA>Z=S-27"=)/;G_MX.(&JZP-,98R_R=>/8 M#AHA@I\''AW\.AJ 8%3?^Z,#KX. %WL=6-/XJL81\'O^PF$OQ$YSYML)5'WO M./_6[AZ-AH,7"U[4LCM['SX7H-69X[2TTR7Y.A77=;HN-T6FJP7E$:^\#UXG M5S^$K@NEKO[XI]?^].VH7C>*W8U+^0CFU TVO?8+OQ?#=1*JFEOR83L$$)S; M1*KU):;^?0>JK^TWS!5P_()_E^"8!_SJXYUFN@/N>)0\1F4^59@%CL8PNQ[= M82.[^XW?CF)_[($L'+R\8PVRFO68=W,2ZU>.[PI%T">1O?^^0=62QY99'!-) ME''KM78.W%%#8Y):1*&NK%I:KA[A"=4<';SG6SOP[$-XX@%\MO,>GO&-;U6_ M>['[&?Y&_SIH;6YUYC-86YM?2>OTP^$NO!VX!#^V-O\ZV-[Y2O/O6Z>=?7CF MZ>YAZ[A%_TZMF5'A\R['%GV/8;WMW<-=<"UV?VR]_73ZY>T;>+_WI]MOWXO= MPT^T]1G66&7"OE)P0^#_/=TZ?0=[LKN7;.211H5,T!9Q;AG2BCAD>134,,5] M;E8-M] C1LQFK,Z2N.D"PS>0!+X%6MI2,0X::=-8;2GQ6@GKPH< M728]048X@3B1!&DG N(YCD6Q !]8 :/Q=;7(: \32[UFK<>J&AEG+83'=D9E M68R]Y7LW+5:RB.8N(^?%@+A# ^(F!8TY9)I#D'$F_/@$BZ ?"B=.KL:)[9WW M;.OS.]PZ_48!!P G_OJV>_B.;1W^?=#:^00X\8[ SX=;!YU+#1+&;%"2>J2D M/F2H3H3@XY M7+1JN*PF!GD1-1>6. -P@6-4UDO%G/E%WSQ^KU"0>?Y/8/EW$X[_ Q_A@AH MI0^W/A D;+V^&A)V#][C;5CSUN876/L^_/<]^P+/!5_W>.OSAX/6YW>D!>_? MVLR0\ KV\=./ULXN[)OGK5=[B9F0&%F6NL0L7 J&L*Q-D9P1R+\C[$B*OZK]HZ%39\GFVZ]W_/$>^SR M@).$@4VI4,"A5J# W=K>1 MSY\,2H3FLB7>6XJX=H>93!1".^(!1R3'$EQ289*4(B42I&;Q40XS7>Z:3@XT MK?KAI(=2Z[,3*STU@-TNH41E#HQ'AIP'-](Y)W5(5/@@UC8>?K+YTW8;S[2O M[79'\"JG\./W7CZ4U6D/3XKW>,D2GZ3BO::=?2-5?!]-/BY3OW/'1O\^8^-B M<"^MF6=RH7M@"0=B#5C'7(.=+ )'AM* I+2*BL24L&IM0R\V^?B?FK0\6E79 M/%/.X%^T0^R&QDD[=D(QAY^+.?PP6GFAK"'>S?()H2^O(1-/73-J.GID?# MCFV/N7,9XZ,=EQ2W/E )RDK:V<\Z2W.S$I3;)6NND]+W_5[W;H,F[B[3(')("TR,E3U5@JY1"ABF!!C,)/>9I86ZV8Q2UFR/W=S M-FPZ;_8ARE6*:_OH%*^7:WOWRO^->&JV# M%MDZW@LZ6L,305B3JK5C+ATG$EG!$OS ;.(T-]A:-,T']>@.\W-NSMU4SDI# MCB/8"U4L)3?#Z(8X/F ."* ;5=^5QIA/&O_NP!OUII]2W-@^[+;=:##^((SZ MT\X8U^AIM=[87.+[Q#2K+Q[/1X9F>GV<'6^>"PW-%,'DQA\_<9RN'K7GF+<& M!^NMC5Q8:QAP1 )[5BFC"-/+=.%_$J7V-Y>O'? ?=MZ!S_">YE:KK:][@B!FYS-NJOYD;9 _V*G#JCL@ M","@#?+="=S'=LPR.MGO2;-B0&0*N31-E-OEDLN+!9)O&2X"+9V[UM9ZXNY#M?LNW>VV[-EBX%>BP;O7*KI=;R!VWA_L-"S2= M-&BN=J(1_S."MP%Z#:_BA3,"#ZM?SU7?^M.0C:M:L?F:-&*[=MLURM?-V(7\ M %P";)HI.8:LC$&#IT&N*U39=K?1LB<-0L;XWYP5O&EC+EB]_?JU'[].<'O) M,1C*>,9QC#0Y+D@P ?/D3-"&.ZF-GAC=@DR,;OCA$>9AO/G/"!3)NRXPP*CJ MN+H-&]'?V;?=2ZWQ9VLH;&]ZL77P2K1.7YW"&MG6^SUEK64.,T1(,HA[;I"C MWB!OP9&R1LL0^-H&5:9)E5JTS/LS0E/GRK,HN3E[UG? M^M@?@B(^1SK0[YGANG',C)6ZOM047F^\L7Z_ 3<$M74"\M*WG;'E]S("Q/8.N,H9E9SSJVRQ&&NN,+* M!J]=Y85=P>G%#_N%>MU^M4><3C& /DW&$L0Q%$ZMB\7# M.S/.-Y!RY^/_RV&"FV0H"XGOA<2XM?GJ>.O57HJ>.O5Q\U7[\?ZI-(=&<0F9>^=DXR48[^E#78._*4R=!K9 MX0$'YV>G4S"5."J-$XV4PZH,32H0&K4*WFFB+@V<7G(ZY:XCI;-(-C;,5O1( MRBVXZ1W>.FB=;IV^.VWMO">@,)0 $\P*C$AB"10&%D@'')"0U$0<(B-"K&T, M]\$W1OFXT'R68!JO.&^D>]%_K<($^Q;LI&XO?[>B6/!$G-RK MO::/\6@8L]74$+.AT#MUG7R(P=*04K">8TEUH-J#J4U]3@?J:6+0 (6G/Q37 MJ;:B"@H_X[F*DA$N)+(RGP%S*2*;F$:&8>.<$$Z$C.>,-HVZ1-]7:GT9/\AZ MH,]XIM3/.7#D!NW0MOV3>?!/27FC/):1;Z,,Z/C3UJY$.AXCT8IL3 &14#A?%R%((-U0(D0PJP4 M'#NSMI%ZH_XE'!3#<0_T^_^"WYNU>S4=J-GXU[]>-\YXH W\]%MN;9ZYZ7OL MG#0;4W]\?/692U[%C$?][$,,,U^^.0\9O^N&D:]41Z-2% _GA=^QXBQ>^&-J MS1;>.MY3QE*CP9YQDC/0FCS/5O4,8>L323@P3%--/.\[=J^]T:!RO53)!IX( M=@P,/$*-80E0Q(=)DO,R%BZ^UP(SO>?;[_=8("H9H5#2)!?Y"F KC3DR7FG+ M36 "_)=<$J\_ B^I?']M-.O8'W_-0)WEN++DA95(2$(9;L+6#*(1[8_ MSAB>T6"2TOO0 V4[A/^ 1M^/_ENUL[;;R\;K&49^CIU.MD+&\/C;%1@XM<$N M .'Q?MM7%MA)#G'#AN?,9K]WF/\$^F8FM3I>SOB>ZX":"V;<8 1WNO15QJ^^ MI%M!@Y."960TF(/]X*J)J<$EKHEUP4V\>44QFOYP'=5R(Q#T/G9B3LQ.H?!I MC"&_HT*,W5STY"+7@FD@!I$ ?;ETVWF)D1#>)!Q%X$I7#L.E_L)\,<&H^[V: M33Q60K926A>D:8YWJS*DB:46QK_9-JBHDOMI MU*^DK-T=&UFPT*<=+YA.!ZF"+N.9<[^NQ;JHUL JSN,.PL_CM_/9*&.3D8J[ M* EGE%B.DR4R8B=,))A-))W_K.#QHJ2_ ECRF?*7APOR@=?NX-S 8,],?.$] M\-;.5[R="X(WWV?QE%'AA.4XX=4>YRYP'14259A?VAST<1:%( 1S E-*09&3)M>7Z/'? M%HLO*Y>-OA%-&=))GEN M:#_')+SU=0_L2^S ,@/?)&C$-1>@*;Q!6FE-B'94R_B3NO=%@DMJ&76>,FDI MW(YI\):)BTDHS;$GOSHP6PA^SP0/'#S1R#R2EH$S:IA"A@:)7#Z; +XH5BFM M;73;G4L.Y\W]X?<< ZY,?C0.4_B9K:^J%&'OP9+HV$FQZ7FLHYF=E*-IM&_> M@7SX*:.S3'->EE?5O7_*]4$3[P&6VQZ>//LQHZWC/::<#0Q4!L-YS(]F&FD# M_PA% 624!!/07#9FM-Z&\\[%@9[@L( S?'B8(R338$M5U%)E/RJ/IG*Q_[+= M4?X..7=I%NWK%U='21YL#*@QZUJ2FTT!Y62=F>O.R5QN J> .YL;7OR+P9\2 MZWL9&BK6.;[N^]9O:&B=SJ[6:2U3 ?WEB>D'G%!Z!X1]C FEX\!:5IM93UYC M2Y_M"-H5)?#'&<,O'S_J?X\UZ7BUJJKP#]NIGW[9_/NP]7:7MMZV M^$(+!0K?^?P.7*"_VJW33Q3N?5QYR3O?3K8VM[YM?=X]_G*P>[Q[NI]:'_&/ MLQ8*+A$ADZ6(Y8PN!Y9 !KN )/A DLJB&%7UU.-78)Y6:Z9_-95/UZ^>8_= MK>_QYT]?JGOK1;K_7@F67QV$6HR[W@R>$)N'H,V<0>U?!*#S9/H,% W^U;:N M.@_]>@07 !!U Z",'_^RZHF8AP:8\QX]44C,;?+(WJF[7NYF2R9_&*F[I:2WNXL^$Z6D[ M4P]:.E".FM01\T[.G"J^O?GNQUX*COBH.'+Y> HW!'"/<(4L<(@3A%B;Y-7G M^N\>^VXFKG553 M9S'X,/1&N=CS>112&,I]TE[%:#1G6!KCC$Q4N$2MXE%,NGO5-.17"BENCHU; MKV<+*8PB. F.M/ !<2XTN:]TY&S;BP0J]MT"93B_/O"J8]N+MX[0E6MQ]7].;(P.4:&U]$EADEM0+<>7=$[],)YP<@*U&@4_4(I,+,\W/+K,.L&\TC"\GZAW/7K^R<]#'.$#9W$;. M_+O?/[%J!%: M7C%8:/&T]OTAW?U2GD>SGP>&O??S4Y:$R3U_U>MS<8][MM MO.OZ>?U5B/((1,E]X:J&UJ][ #/=?'@5?JH#2L>C*"17@X[DPX'M9Z"*^5^XN.NG84VB")OU]%X3F' M?=HP:-84'!ON/&DN5"(.!\VMM0YCE[Q*7 EBH\!C=P:NB>%5=D$\>"C$QR U MM5Q2[V2@1(?H!&.Y>=ZEU*JA^W_5I,2P7578>@3J=JYI[I ^/R%?]/E[]>7?V$WCL]W:8 M>K%C-9:?T8^'@%F3!LI']J3R'.#K50^I3J^:53MNX&ZK ;Z]_F2,;?Y"-3IK MTJJ[;\>NLCUIM \/8VC#'G5.X%H@P]ES\Z?PT.J=UL?OEVDR?>YD)FPU#MA> ML6T-'^U@;!KE;1O/E$UI,MSM[%M9=X_[P]I!;@V=FUC#DZ;,!R]@&YW1X1$: MC XKOLR+&+*#GSD.7?"!8:\[2+ M\2K&#\N+_?E6SL\]GAU@<#9/>.Z6DSG19UV",S6!ON-NYIU)8JD=Y^=US*MT(;M)F[G-TF;N*1+X M/" W-2M.&G4^O;8"NK#TF:M)@=A54S@U!\G* ]PY3\9ZQ3#Q7J:DA;&\])E[ M\#*RP]T?K<_OV/8.W/]SB^5K6Z=_[7^!OVWM_/EMEWXX:+W]J]-Z^^YTOHP, MWN''[D$>P?Q&[)YZO/7VTVGK\$]XMB>MS_".;UO'NX>?CGDY$HXKQ(ERR'JKD&+)!:(H]M*M;0"7%' IIU9K?VIU M%7J&_.L\+#[-E]3CI.JJ^5._+7G>-'! E40#E8Q+&6QP.BH1+8W&R>1^T5 ! MU\*O^KMRJIY*D?+#PMYYI[D?K9TW> \ZUZ MB=X9RZZ[=ZG1JMT<;4:BVEQ=Q] ,\E1SUOASKG'I/O][HO M%E'C'%-F[(J/8[.B>$7+P:57LZ#G"E@L*]ZJ#Y=N?8%R3QDQUA#+DU9.:V]TB$0%84,T MI5O?4T68"]WZHI02.TL1-U4#$9Z020Q^"A9[HXS%(:UM4-XTA*U.6Z.EY+NN M.K9><=?Z=.N[F?*N%VWKV+#O!D*S.ABXZ!3=# !+Q4M-(.S<23(\^ES;@J(T M$8"+&&2DB@@KGD*,2@G'UC:(*/CUZ/AU16>^B^V>?MH ZNIC@GD7Y:KV[UL\ M/7F-K@5+V?L@(R;PH!53N2,I"! 0A?);X[]XKL'K^!^[T]V#SKM MK8/W9.O GYPUCJ9_?9N7OB^;W]B7M[NGKW/[^C6YB<*ZYPV MCC[=/?R06J??3O8P 1>#$HDBTPEQ;RVRRB<4!#<2 P K0A=Z%1F'B59&F^0X M]=RHX #O/?< ^RJZM48$A7:46;(_ AT_W?#&;YW>8/![ S:^4>W\0L?C7_=K M^/6S+ZZ5,LFU=XQ:<*"TDX9&2I4+W*6(^8R%V\M4VG00 MO&[83>_\BU8;7.K[:--1EOQ02^9WU.VV#ET@3.D"V"C2_)R5YHR&/A1L>FQOF-,#CG10Z;(?0B7=; M=OL06S@.8YV%KLYC5KYW>#0:5L'<.SK.<3E?3C;N-FWH4*NU7-L8N341 M"YU6@TY%V%:#B/=IB#X@$W&UM#51&*DP4M%&]\%$]3J9)M?5*FB&K3ALM+M@ M$L=IA5$8DV$R^1S;>++?N$ZI&N]WOZ7!R\AYO7;X$8\O MU/P PC+'LHE/3GLFM>&:"T&,58R9@*GD2FME)R4P_"?'LO.\)?AIB3-Y(!SO M*MG(Q[1??;?M3E4_G4 :\:M@T\_6F_?TUWZ5^?+YO[!E\W.A8YD\!X_ME_M.>%%<((C3PA% MG$J)C%<$V224E=I9*?#:!L&R:=1BO^?2>>9A3L?=HC%$_7:F5FNYW# N.%IP M],X.\AGM'!&!2>$--YZ[)$,D7!D:L A23DXN\"M.+F08+>A9#_0\G4'/DZVO M>UYAA@FC2%)L$&?>(YKN%@%1@N,+N5BV: <5X":/F%NLQ-E;"(A.&%H=(S]XG!X<;'J Y[L M GA^W2.2T52 M>I^K1\70L/!.]FO,)S G\X$OCK6?:4A06F??*2IK.5:G0,F=I7$*E-0$2N9S.+FK M#)>>(*(M== M=.1R&Y'[+Q5;N]C:*X$CMXOG%QRI"8[,!_-C "R"L/M#]:.GNY\VWUVM.Z3A6I M.7;^M)YLVE+V;A,?=*:L[.&R%?:Z"M@5M'Z/L[ JPO65JB!:,O0>, MG<_S6&E<"IPCK E&W'&+C*$:&4Z5%Z1BU :^N%'7WM^?T&EAO"6N MU.;F_&"WGW;''HR.'OI%Y+JXSIM<8C6!R]/.=NWH:#I6[KX*F&:$ZR<3QXOU M]N@]8HN%O<(T*E*V(A1\[$[,UW/&;LQ#97=^N;IZ%7>MR&GMQ0;,HP%89NUN M-9]OQAK+Y[?=%25@I:%)[2(9-0]6E-[+SSG(<;'W\DGK_1[0DBGG/2*:6<1# MS/D$;A"QE@2J(A&*EM[+M?(WI>J.?*-=.)!"5\ M0@*P$G'B*-)):]"@>CP? P=H=9D32^VG9WFM8# MS=6/WVUG=);- ]W0_@Z_?8^-3MNZ=J<];,=!Z>FS2OFLBYA0U=4!/3]&/^I7 MU"QJ?PFUO_UZ(2]EI G44(ZH(A9QYTF>"6I0'FJFN4H \FQM0]%[/MSRY!OS ME'[*J^(P%3RX:SRX@\3,\K&W A6WA8KY)(Q)A"HL';(AY>XUF".G-$7! &QH M)7(7F[4-0F43,UK@HO1,+GKP_G(01=G=K;);R"58X3Q/#@4:!>*!6624$HAY M'IPR@F#KBEU<[.)B%Q<\N#$>W#Z:7NSBAX>*^'GXY^;^;/?.WP-2VIW1["GVR KE1A=DJ[.$C1)5T^: Q38709V M/RYD+J14F":A4#0L@8<6*#(X161)I"1H9AGA^42-:BJ\V.:QCJVY:H\CI1!L MA?VW@M<%KY_G^9R"T@^'TO-)(V%=""1$E)C&B%,LD=%4(D&HO5?M\>B9'^DI$/2,(&BUC@$5,'HX,)I/ZDFFK63,("\H0UR;@ QA>21=4\KB,=8/AXK'6#S&>FU<@>NG>=RH@/3#@?1\.I4)[ATW#@6F MPWA(GJ%!(I>4U,(I0IQ8VR#<--DE98;%97RX;.ND4["!Q=ZT,O&P'4(GKN11 MI%JMY=J=1I>DV359?:ZO9;'&5HZ8A6*K1K$B?BM&S/ML47QW2[DU6Y4-N\F& M/5YAVPJ;8)^K1\70L/!.]FML@(?G8C]7L?G*/1M7K@T:O=%P,+3=_#)WT?[Y MKDJA[S3$M3J._I@H=UO,A9=P]:=L\VK,-5L5TVRGRI[P5G'--1(^^B1$!:A[0%]UYIJS6S&%O*US88^/-8B2;'BR72 MC^W3UUT-EB#[4[ K"Y;<&9;NFX;+)V>(9]F)+KK8M6=3D M':K)VQ4A%#59&S4Y:TR>OML+FLDDN5D$]V>SD^>7-!ORG9/4:\K414&\MOS^0@]<-5@Y-_2$;8E^ MF(.VQ[;?M]WAH%&K<5" MQ,L%F4]COQ?L8']>C;_K^G[,/6IM9Z9*;/!J..RWW6@XKA^K_@:*/(9_VY/\ MY5>9C;]6UPV*;E]*M[];"#H3H'1T22',\\"@D C2).0>3DYRY04H=Y&=74T) M??D 08(GWYBC]'%:.2>AX,J=X8IF+D5*O<'47APF8M">^R8\52@I#%%W#N"+/@,B">95##*2IW6-HAI4JV:5#Y$D7+!EP>L M(BJ*\\X4)Z?$1B4P W>;6T9TQ#88IRRFS)Q7?5PS!ET,\MKHS/F8='0X:L\8 MXE2DW"1/(*V-0%SSQ*-*EN9^JL4@KX'"+ ;Y:D;MGSHEEP(6(9P,PE/E!.@$I)SU"2KF21W&+4OZ/+PZ#(7RJ>"&L*]0" # 7%A$W+.6T2-)BFP@%7D M:QN4-,&J:&*Q>+B_)DU&GW\X,O3JBDOBO/N%&>> LBY M% IL<BX,K=X0KCC)@D)&& M*\9:JYTWCHM$'99G14'7C.L77*D/KLR%]$7R&B?ND*&YYQCS#&D6'$K>6>:( MT8847*D'KM0NGE\4YDP\GTH<%8@2C9338 U-*A :M0K>::)*/']%%>9\/)\+ M!2!H)%)4YEX(42 @-D=2.>N88HR;HC#KH3"+(5X,\57'%4DMH\Y3)BWEFC.= M<" N)J$TQYZ8Y<+Y!5?J@ROSD7R/6>"!(BT(1KFJ"EE"+$H):Z$BF03[ M6Y$'3'*\MIW.]OC8S:MNF/!P ;_EP._30G:#)AZ(,!%1HC3B'A#0I420(+GW MO0I4Z%B*I$J15'&J"J#< : P9@1/B7,"@!(] Y,[6$=\B$Q1;!^\"5%!E;M! ME;G7E1 MJ=.28Q 7JPSW5FOE(X[26[#'@E;X ;,;15?>B:Y<.*;@N#&4442I\PB 42)G MM$<^2DZ5"T&J8H'70U,6"[P<4Z@C)9,5LMI09%3DE ?+?<@-0%E3,OA_O&B#E_,) M-0C9[_2.T.BH\2%_;="HC #RLA%_Q+YOYQFQMANFOV5I:J3V#_CK4;_M8XGO MEQSW+YL3&1WR:;7 :>0L8,LH-80E)9*20C_D(88" W< [L+\7UA*1?@,2)" M0CZF%C' @'6(*P5D-M5 M9+<+D53S]F[*(!R9X#"L9+*,4^53_ SML%C$Y)P MGGL5A2WQ_=5$E;GX/F?*+)4!6Z<= 9L-9P\ MR8V)B-$ENK^:L#(7W?<*^$'*< M'RYM=^&#V/BMTQL,?F\DV/6VKG/CD MM&=2&ZZY$,18Q9@)F$JN]/G KVM&Q6\R37USS"$+0]6+WEQ*;_J%<+BG) ]@ ML"@P:_(\=8:,HA%1F0 H$Y,V9T49-TVL1)-C7;N"FVO)95VU9JG&>0KV>L&A M!ZK]U,X1$9@48-$;SUV2(1*N# U8!"GO,)A><.B><6@N@.Y([CIN"6(A@?V> MHD;61HL,^&E$>4D4E8!#BC>EDDUAZE,0W.!>DX$9DHX%(.W^22L1UH!(B4AA!.<9O,"<$CRIE:TB0TK M.+2"W8=N<91A1?(=$P71B+;?A74.KDY7W/\^W@@PZK6=__UX-1U+R'/M8/6W M*W%U- C_COT*O^XVFY-M(-B]_[N&YJ'TS404IL^=B$B!S*4@\^M"CH;K0"5) M&#&3..+>:60%"\NL%2TP>T\P.Y>"2M90Q7D"7!41<1XYO[9:IN>*UW3>6,M1$-0C3EU 1E*)A+$I&.$8 M(2'#"5[,M!6O[2D@28TVIE9K*4Y;P=O:.VVWS$ 6I^V^4'8NG2@3R?/& R+4 M87#:,$7@;WNDDHI<.VF?U.W3\UJ*WRB/^HCKE-6U7-M!^K-J7=#;$[ M?(&HF@'-2M=6?SFT_:_M[G2/V>2E'[Y;EUBGO^K617_2K:LQ:=?U&*W5]'46 MOK;1./^?=]W)<2R@Q=E)K,6L9C.?SIH>;YP[TI7GQ'=[PZQ!!VW@Z>HH5[ZT MW0N#_./Q?MOO-VRC&X>-?+BKT1XT^O&HUX=G-1MVT!CNQWS_SF@P.1*6_S#[ MD$;\SZC]'51E=SAH'/=&G=!PL6&[PS8*DRYQZV?<.&Z3-A;WK=$AK,./?\\J MOMT=V?&AO]GF>+U!.__Q13]V;+[9R^-V&.Z/N[)-MH[)Q9YZT\NL _&%G7LY MX5T\>_W:HB",.<;#V\1^?;OPC7F%\KF-G?EWOW^N,+]&Y/K1?D,VP5N]L)UC M>S)8^\>%ES\$\9[3'7[E+$U60E2->%W7J5:BND*B+FU3]4^G"LP6/U3TL MJ&./!O'%](>7H3TXZMB3%^UN==OJHLMTRWBOE%B7G%3;-:G9F-Q_LI7KXZV< M@[/QAT:O8_R3SR]3Z"Y]KM7DH#%-7O=[W=Z@\1:6= 1:V<_KLT*4 M1R#*5F\(=QOV&J][V7;)+4;AI\I6LQDH_VQW;=>W 1(_#N$/U0#")T2W>A/G MSUZ_,A0&[1\-L!2&^X-&!"J%QE^C;AQ;J PW&SD>^H1H4F-9JA[\H@T68MM? MI\'O;V!\#O=[([@M&(I@]GU:_[C>"!D9^X-F(_[P$3RCW#'@:]\>5LU]Q]:@ M/837&L)71ET["FV0Q-^OHO!%CV3\[YPI.':]*9-<>\>H);9R'6FD>=X =REB M3L19'&%B4MY!?/YBC."CWX]AU(G;Z16L;6K6?HQ^U _ #&=C[SW[O M\/5Y!X7M-!][IZW-_79K M\\/AUN9?[>W/[^C6YB<*Z_RV]7GW^,O![NGNX8?4.OV&]XQ-AADLD'7<($Y) M0L9ZC9Q@BFJ*N;%VK1$'WAYE:[P_BI>*U43,91W$ZN?V^0YHP 0BTSO.'MS@ MC%T:QW'BEU6>51A[91/'ZK+V&Q-OKG=>[0X^EK>C0:RNFC3AOMSY:H",3K\, M'X<2#L$T=P["KF M]4Q\RO5%:_L2K4CH0DQA0L[[,,Q!I9U9UTM;YARO4TJO:9DO]R%9)X;?\&*\ M3GYV)9?RQM>6)==AR?ING,%',(06LGOF?BVW2:SF[A."\Q$[]0#1VYW]?HP_ M,9FOD4*=*D>PA^*E]+C15PLCK18C??RIY_4 ;+0"BNF>7!HE?@>?R-;F*_)EYRO;_=PZ;IU^.-S]_$9L MO_U[O_7V[X,OAV_XEX,_#[Z\?8_G2_RV=C[AUN;?G>W-L+][^@K6\V5_=^<; M__+YS?&7SUN'NSO[AZW/6]^^;'Y(K38^J;UJ?-;1E;KJ@;O_R#T4O-,:[0SM5I+ M+0:Z_8K?GS@P,2FSW46H\($S#7@4@M4Z3ZAU,3E]A]UI"S ] C#A.6 "*@?+ M+$8J>(5XM Q9(QGR3K'DO8H*J]4$IMKKWGH=]'K<@7#/V!6(FH#U'PEH608: M5SFIE?1*6AD)8TS=8;O:HG$?T14XWJ-""YJL1-K8B'B>4&$-> +@_A$1O.<^ MT'KJVB=ZV.?YJ=L2>2'[R' M,:.:!H>"I %QG20R7G/$K382)^&EU_54MT\TYO)X,^E6-7[_[WY$\?"HJDW] MD)]Z;Y'[:W8/OEZ<:\4A@E.!&0N!B^1Y%,8((H.)\!^"@V.D!.=7&2).%H+S MEC&C!)?("4\1Q\HC@[5"CG"IL03Z.P% 09M ZJ;BN#[-O.?$L:YJ[/[G1I3X M>^WC[P5A9F(^EB;"!!B=3'(EK8DR2J>\C)83^+\295]MA)F/LC/FH\")H9@" M UJ9*@A3%X2I77#G3HOMNH\#Y?'8(+!(2#!$LE*,X!%'A+25E'L@G*:TGHJS3E!+$JS MQDKS6=B;-J@0 HN>:\8E929H39-A,BK!=+ EZ+W:2G,FZ"UY,(X*9(&LB"MC MD,Y![V1$#,ERY12II])<74NSU*4ONXD[O2,T.IJ$M!O_Y[]R>=G+1FK_B*%Q MU&_[A?%CCY,F?=J@$"DV7EGGB=!<)>V4L Z4A,:82:%B"7.O,"ALO5X(<[/D MB'0N(!RE1SSAA&QR'%D?<%)"4./8V@:53:EEDY.'F%EY,W&LJU8K9>8ES%T0 M9K:8/!A!+-;".\EI],Y'3ID@WH:4A(W+A;E/8[\7[&"_@$L-P&4^PDT"$%5* MCHB@"G%"/3+, KA0IRD6S!$>* M"&--HH)@^"W*A$T);Z^VWCP/;S,-6*BT1#J1!!K3:V2U,H@K $NC">&XIN;X MTP]O/QVE^2SLS!0\38XYS'*C6^%TT$YQ#UJ2!ZVM7BZ\7>S,&NG+\\BVLJ 7 M-0Z(L5RE9R-&+@F)&*?8&Q%"LJ18F#4/:S_M=H M$*+@.H;@DI$\!N<$D9)0XI+62JE0XMJK# D?%^+:WO@ N* 1"=8B3BE%6G&. M@/(!IT2"Y')M@S0-)TW&%P>5EHQGJ=XN8>T",-<&&*D%H5$R[P/C23K-J$W& M*6523-3B4KV]V@ S']NFVB5NJ4>**8\X(0EIK!3"CB= &J.BTFL;5#2)P$W. M'N(@:4&8)U>(^"S"V\(Q;Y3GTJ8GO%5>=,];8U.'"I M48B@.<$J%T@[^,GRY*VQE)*D:VF5/_WH]M/1F<_"W'1"D^BIHX(1I981P2 8@;&8XRA6)HUC_*_;2+ MMU]UAOVV;7RV_;[M#DL=W?TC@/$8)XT==9)QPK25R4G/DQ#$!N]5B6BO,@(L M=@OGAEI =HF8(8 #/AED/1C041(6<%""2K>VH503?FH*5J/2D-7%@5*I_=Q" MV@5A9LH.K>4X$>F=8%Q[8V,^$:03]HP:$TO;[Q5'F/F0MDPIA, 3\DP"PEB, MD=$D(!NCYMH(+['+T1FL9%.( C"E]K 4;%^N.;UQ0H8DK)":!RL=N.DX:*)) MU."[^Q+17FW->1[1Q@+L;^458I1QL,I)1%IBA9+)O6=R8 [K>EKE3S^D_724 MYK,P-Z421-.4#X8QSCVVBHC(G>0D)>JB+R'MU5::YR'MF VG7;?]<=CSWQJ]H\QQI$N471#%B6*@9KF*'<1*Y9XII[JS$#AT+0$M!>;829 M#V@KS@0UG" ;6>ZPK1,RN0E)T"1H*H627*QM"-+4K/0\++6&I3[[JNEH7-"0 M)Q(HRV7(:<$A$8<^X@LQP*)2!DS+CB!<;$RZQW*?MK%V9.J['N+ M8I?2C]G)[=00EICQ3/*LZ&TB1A"3E)'1,EFBV"NL][=?XQ_3& .\AV@=[UG. MJ9(Z(1630#QRB;1V-'<[M5ZQ$''(4[Q44["X 83H)#VD6/4O0X3_Z!S^G8=:&D:7"- MZC"?(\ 4UZ4@S*HC3&2"2,J]5LIP4#(F)LH=!96O7= ZE9[L*PLN; Y<%(M* M>DJ0MMH"N&B&+'@L*'"'DV?6*$V+ZU+SM,C3KO#_$ ?#?ML/(W!6%OQ*>3UV MJ?^SP $1HPX6JQ@,XR)09XDQ,N4YU%XD3DN29)7!X.-"DB1:Q772 6GL$N)1 M8Z0IY2C*H"WW-AF#JP-?A#9IZ?M8PTK_5=7QM5I++2K]GP7 6*J2-#;A0 BG M.MF@"?>$\NA(=,F6',G*8LM\CD0(Q:Q-!$7C&>+"*.0()TAIR;SCD@7VH#F2 M@BS/PGFHU5H*L#Q%' DC4F*F MD H8(ZX-148P@FR(BCO%A4VN>"XUP9?BN12 676 H9:F1)(/T3EN0G)"&I=4 MT()+(20N*9*5Q9;Y% EV&JOH(S*)!<2M!&SQUB&BA Y)$4N#+9Y+S5,D-Z\$ MD^M*K .[?2&MM.PH##05&,T!F? M3)[%X,/0&[E.;$SWX6FC"?'):<^D-EQS(8BQBC$3,)5<::UL2;2L,J2\7NBI M)#U+PH@\(D9&Q VSR$9E$)<)+ D7><("W!5)F]B0)J,/<8+[P46YKIJTE(,5 M7Z< VQU-O]'.$1&8%-YPX[E+,D3"E:$!BR!E:>6TVL VW\I)&^8YF#$H]^L" M.',4.:$ERF>?P%LVFANYMB%HTTC _X;VM\WI@39&AW" ML_SX]RS,[>ZHDIF-?\+7IF]T:/M?V]WQ;E%XIY7YVC,2DP*I+Q"CJ1:1*V,1XTGQ/F;79BR8/GZ'HP6@P;*>3N>=7 M2YJCP35WZ^(67YLR,Q2F')3A\6.Q:UP69[X#N]P:@?=^!Q?W1Z_MLCJ[OMCQ-U=_".[L*S M6H?PG,%!_QZ"Z.O%_/YQ\^1R.'.6R M=?"EO7O:@M\_'I[5&!$ YRCS;'\5\4*BB2*,B26.6)@W;#8T_;,=V M?6$3 MIQO'ELEQ>[C?&.['QF2B^+ON]S@8'L;NL#GY4Q,^AA?ZNM_P D6+N^E1GLX M:!SO]SJ=DT;ON)M/=(W< "P+VP=SHMDX&L$C[0#^;AM7VD)@J+C8G[.%@N,: M&$Q@@2,7WCC,HDR4:T:XMT3OO:M,((;UK E$YX7ZS7]&[>%)*P[W>^'\E;9A MJ?W!?OL([!D/O]NO\U-+[8.7@DPS$^V-C_A[?=[&3Z4\PQ9&CAP7$Q(YU^IT9H%PJ6F?&V#ZD7; MMV*@9=B "I]4D(E@RKC P,H,>\FLHI)%;^0O8F"%#>Y,U1R\_[&7./66BH"P M21@L!RN043ZB"%HF:)5'A+BU#7/)_+D&Z)>CC%??8^>DF9W=3.?!J#/,"@:0 M\7L;S(%&@NV?PMB_V]VN]>!]_.M?KYL 0F?P=)+1:_*EWW*M%\4OYZZI_DI> M_K[>>#7(W[Y*15GO^R/;J=8#OP_BI:LZMH.EF%8FCJ,B7D:*.254"QQR433E MWG@1> ; Z_#J*^^SKS[XMSW)_LL,'P)"O\XZ=<:1?VX,N;7YYGA/6$N,-Q0% M5\W?SF4FDP,K:K&E7=('FY%*T-B=@";2T# MJ)+:NJ $H1Z$0:= 6!H;.X0R,D_KZP=\"AO\E W$GJ*PW\Y9)"@%CT8SCHQ) M&AD''HZW8&NJ7,/3)&(QH"8ES0RQ3R08#I/9Y,M*O MYB&]V_KS N'!)_"9^,>]?AC$[GV!U6,'^1[>9GF'MPY:IUNG[WZT-K_]R*=2 M< *R*(N(2L BW -T):U0[J;C)*AKQ_1/@KZ7&*B&,BDU%];#?25S4H(:"'DT MEL'J[+SL51'?P@F/Q0G&Y X:A"%,K$*<* J<@'V>I B"[6.@)*QM;/46-,4B MAEQJ+( KU3CJ][ZWLV_D3A;,F8FML8Q'1!R$. MK=^'"\'XRSN6'=>C' YHV"J=47FIO:6 6V/AI60*W,H 0FR=U$PPFDM^\V'H M^=G9MT+P*Z3WWY.WJ\2W>!D5FG]C>V"#F60210HD%0241V089DA%R[4#N,4R M9C2GE[2&'WL0ESL+ZPV@/-A[P"A;O6%L@,6793'G-/*UX :TNV.2PF]@%3QE MB9O;"5+M1!KU0?CZL]O0Z(U#0@&>\]U6)QDZ;>O:G2KI"%[=.,P+-[HT /FT MU=;.?M;UE<+O]AJ]:N]@V^!NP$O3K3FJ(N##V0CX% &N$4EKP%=_B08_36 M ML]&WRV'E[G1/-8>E[SV']3%^S1+S(1[U^AG/:I>[XJUIJO[@C_:7S7<_ML&> MVCK8:K=.W\-U\)RW[T#!=[ZUZ!NX'OYWY_W) AB\_>L; 7?WGE#6_3=Z=;F MAX/=G6]X]^ 5!2"!:V"M!UO[6YM_I?S\K5=[.#D*!II$1!KP\1FU2$?N46#. M:\Y<+FB>3U-PX))Y;%T2@C^]5-9TG_M3+F^T!V L1U"2H/XF6#, MN6@X.X"/AOMV.&L05A$:]7+0 &,PID;O*/9M=9ML> TR(0[MM]@?-'[+%TUB M@Z^W-UN#:400OM"U7V-U4S<:P!('@V9UU25W&R MV)DQ7$,$&#ALY[1:]0[M80,LO>H>J=?I]([S8ZXN,1IOT]W6@R[I<6Y5J;WM M-%9(.? T(=Z@+L[D(RBD3WPO4&$P2"P*24K$DW?(4DT0T988EAC5N59S>+SH M/TZX/F]E8T+AP8O&)R Z<,G'(5@+8W[+33:SU?JYU^^$=7*66X/AE4\/LO![=_K_O45W&&4@'R PA5I0COW/W6CL6F<&OOQ M\ A5MC&\^>L_-K/I/,KNZE&_%T9^.%@=\EW@NDO(!]JXW?W>Z^0W;7=7@GJ9 MRWR.SWRO0#JK^3-R-BMZ H!^B]5KPIM[V^V":S,6PNDO9]2=4O3,>C^,(1?7 MC2$BP&,04'YRQ\$J4/TN>/-!G"S8U@*5JP656P=OZ%X4*5K&, HD<<2C!\M= M>H^X(UA[+:TWX0JHG.)CQLP^,$!W; 9^C;VO?7NT#_Y7/WZM+#301/A#+HRNZJ?@+M'"318>,#;K8 D@X!5T55^; M*L7< AN^-^K8?N<$?OK>CL?CJ&^UFFQXYMC(C 4Y8S%.@?#L9I5"^A9GS$^X MM^V':0V.!SL.1*WXU7$L\74:G%]IA@\T;.>F/[ MBO6 L@TQ568R+*T;LV?P/8*#U.CD#?.],28-0(;&M#Q_L3A)?3SM$--9."#S MU (H#R;.Q.#<;[+C9''^TE&OT_8Y2E=1O0=:M#)-@+03CZNZ*IMEN02\"E8! M*8#,.7PUR&;(7#_:;\@F>*L7MG-L3P9K M_[A8;0_".;F[R8^_JVU47S1SM@'R9[I<2ZY*3:KDG;ILG])UNY/M[*N6,G MXP^-7L?X)Y]?N/@>.D-=3J*[/#VWFAPTILGK?J_;&S3>PI*.0"GZ>?U5B/(( M1,GIL\I:>MWKAFR/A/S3.:#^>0:H'\\ ]0G1K=[$^?/Z>;8G1),:RU+UX!?M M(;R8_[EI,2;@;^]R1J W@MN&ROGZM/YQO1$R,O8'37 !?#P:5O8B.&V'XUJ: M:BS1N"H$OC+JVE'(<:99RI$#MI;;[BK?=[.8KO M4J(H@(@A3I) QBJ'J&16P(=!4KF0<<0\26XDU?8V?BL#534)633@NE"7R.'57A^\8U 2A1\*/TR'.-1X%L8*;.&%2/AY M0CEKWISJGRM-R$57O<.C?MR/W4$^:'+A\_OOOW@EZ]Z)*#Y.<\BR.65SGLCF MW(?V_?_LO6E36TFV+OQ7%+SWW*B*(-TYK)RJ;A#A]G3 J&[?#_D+D"+)! MHB5AC'_]NW)+@!!@(PQB2^0YU5B@:>_,E<^SYK7:\U:WSM.IVC*-MGY__?Y' M__WMTB/5$B#9L]/,_+S?/TZ#^^V=>]7"'71CW$^7-[E=R_1_'J"I\,S*+%LS M[\M](72T-&IA+7@#-&B?J&=*A]( (FP\?O M?[./G_>ZF\]?T$_;7]CFY[?=K0^;)Y\^[^W-]NS^^.&]W.+OOW\J[_N\]WGK M^7_*9QQO;K_%S\3[>O6:??S^KX,WKU[FK6?TV]E G.^;?//O'6^$#C9IXKRT M9@ MO>36\K"V(=>5ADJBE40KB582K20ZOQGJ)7";*#56@ C4@A722,MSR,)15LW0 M9>%/-LN?S$?M72(@?#%#;2)>E08RR4/4VFA=YK)6,[0R:&70RJ"506_+H$E[ M\#X[QQT -]$@DWJJC+8V7A&\ZY//?W&$[^5EO(GL+?T7XW?<2:4R$,,H6D_42.("UV7\;@X\IFR2 M6=O@ZVPAB'^[4]=6L/H%L^E.X:=]*].J:[G:;*I$1S$:P FZ=I-&6X4^6H(H0B?,@B65!%>N&"8 M)0FT(A"-("X5#E'*)1Y"F0FYR"A.99'*(I5%5I-%I 8/.K@<.0 @<60:HD_@ MI?=@/:_FR%)1R6PD0R9!;9K&[!.[>4QUI5( M6A')6.WRJS=ELN%]H?SM(FC*]J*[3>5J@L,F$1 M:K)P7H&4 F$G.Z)@.46^4(S-#NH-L(* M;K*J%D>+ Q"_T*N.+P&O_*"5Y?VOVD32YFMDVJ[UN]."PODBA#=:MN5G06UY M N$@!Z> !^H1,@5X';R*2LE:>[),!'ER*80#@:;$$II1H-&,4@F(T[P4'_IL MJ659)]?6VI,Y3F#[D*MF@BVQK56YN7)S.[B9*R.-#BI""MI[H4I?NB2S9Y;& MRLU+Q@C=&N M&LU+QQT>U_3<#2>+][M==)_C[JCDXX+ 3^NC!\?/Y_2I2ZL M"S.WJD6U^CW'[S@+Z#IOYNM>0+OHWRC\Q61ZT/K\V-0+:0Y+*0W M,^UFMY[N")5=\%80H7@FD',@)II$%.><":&]4[7#4W51/D:;Y^$TDW8MST-P MYLS*K 1G_FIVSA 7!A]5FEP 37Z?H4D%20I-!4F1EPXGD1,GHR0)R=,DIK5. ML+:A;8OR8J\\0NU#ETJ1E2*K65G-RH4ER52^O >^9+-\&5@&RSBA&M"L-"P0 M%Y,BBDE:]M)9W+QJ5E;.K)Q9.;-RYD/FKU2S6V9+HY@2Q7DA">5:@M -M[-J&6#>LSI^J=%'IHM+%A<7[ M;;&![&N=\I4=[H0=MF8,B6"485)JDB A.XC2P0%M!T*]8\&):$#PM0U^B1E^ MKZ102:&2PB,EA98V&J@L<5\M5%#'@BRZ%'*\KR_&VUJ!?"X@?WTI M;N"\3%)*2IC5B@"#1!Q*%G$>)3,A4>>\T*K'E9\&4B='/3;-?[4I8AYWT!V$ M#RH;W"D;S*CU(G@)MG! ,)E B)$XDR@! ,9BU%'*M+9Q18NP._7^5 ZH'% Y M8(DXH(VE;948?H489J,",FM&&3*!LIP1<"$1;Q20P)(1-BMNW4*;.U>*J!11 M*6*)*&(>,^$.(@25#>Z4#6;,!!M%8LI)(B4-!#S-Q&@=B7 J"Q^SIEY4,Z&5 M7O_;UP>H):"+F?J ]4XOC6J__>4J27XD_?;OH;1B+/OC2/>$ZK;ZO?YA&K@1 M+MI6JG'O^9AO\U*X1.C A2U=(5U2!)26Q.$&$I;Q_[G/B7K?QC*+56NA?_O\ MJ54*R*>,4$#LRISPXF,EA- JY,8QP.)2,E9 M**X3324!3?-*QI6,*QE7,JYDW!H'[WV6!57NO7/NG0T&4DC6Y.A)8)FB$L:^U>TKV/FJI%Q;:>YQ 1]KQM6YVS6-:MKMN)KUJXT MG66@A=<'AZX[*&7YXXFNJ+ON]OOQN+N_WW&],KQUY'J[W;(?;CA,HTM#7.\J MY[(V99C8!\$8U/V-M5)D\$D8)1/7B@>=0XKA-!N%W85]\&JRU4][\?791C\M M^WPN%]4^F,L^>#^5J/)>;&Y_W&$!/"0'I:17$RBS9RSCD5@1J+*69XCQ(>N[ MJX0\M(2HQ"377!*NJ2(0?23>T4BTX=IJH_$G7=L NHZ8<\F$;)U-V7;*:Y/QUO:+'94I"](JHI,W! P$8I5C MA&:7 8Q35BRTWJ^2026#2@8/O3+MJ_.N9' /9'">[S$F YNIDCQ'PE+P!"S2 M@G61HU4I!=*!DT!%)8-*!I4,*AD\>/9!983[8(09\T '&QWEG%@=>!EJS8CW M0)$@HC=*&)V8O]9W5 GAKC,,8G=XN.].RBJGG\3/ZDNO?&EML#NOE#Y/AP-$ M8-=@?PG:N8,^WMCWY@^U1\JR58]/;R=2Y].IS:QL>>M(2\G5V]VABC--I222 M:D<@,4Z,R8E(A\_D+&F$TBQ=U;Y9BS.=:M^LUB3>54YH3?REC^DM#H!$'. MM\0)Y4C@44IN>?0V5*JH5%&IHE+%DA1M5*JX&ZJ8#1HX1W/@V1'),B/@HR0V M<4&$\3HJ[KQ4K%)%I8I*%94J6A _J%2Q0*J8L2J\-BHG$XF53A' #2*.)D-\ MUEIQ,%EG4ZFBY5&%U2XPV$JG8_PZOY4N89=2&Q8<$[[9.K8.T^?)%;J#J,)9 MKM"-"_;^&O01T?^-.UQ1?2Y4#Y?""HSQ1!45Q.C$"=@1XQO1>K0S)EJ*Q35U*&J^J]XZM"<-/&K$85*$XNDB5GEWPAN(]=$1Z=1 M^<\2&2(;DJQ(WD2)DJK6-B1?-]:V@B:65^VO-%%IXK'2Q%U6'E2:N'^:F TG M:,:\XT820372!$ B-M%$I(?2$-!2EL+:AEZGT YCHK)$98G*$FU8O'E8X@X" M"94E%LD2,\8$!6MR$"IT,C>!5Y&L;C.IU347EB=H&JLTO MK0M<%WBY7UH7N"[PBI7=[ M1VX\[P5?=J:;]8?=\L<_!FD?G_V:_CSNQM$>:DEHB$SFLPDUUJ>N>IOSP_[^ MT:C, 6V4.3K]_HOOF5+E0BIC96=UM!MJ4Q=5L!MK;C_1 />[O40F-\QX<_%< MG2ELXX6=^KDW.-=N=Q/Q@^2^$)?QKOYP^\?N9+CVCPLW?]#MG7ZZ+5]_[2H= MN,$NOK;HRO2)E)S^;#"]IWA\/TQ^F#/T\% MNMMK/K9YTZQ^C^LP62LMGZ!5TBS7!% FGS]9RB?CI9RQ/<9/6O.$TA\\?^'- M]Y#=<_46W66NSW)*T'A/G@WZO?ZP\PHOZ;#SNA>>S!R[NBD/L"E;_1%^VJC? M>=;OQ9*M&M/@L-5_\1W>$-Q9^K%J,-_"W MUSW

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image61.jpg begin 644 image61.jpg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cron-20200630_htm.xml IDEA: XBRL DOCUMENT 0001656472 2020-01-01 2020-06-30 0001656472 2020-08-05 0001656472 2020-06-30 0001656472 2019-12-31 0001656472 2020-04-01 2020-06-30 0001656472 2019-04-01 2019-06-30 0001656472 2019-01-01 2019-06-30 0001656472 us-gaap:CommonStockMember 2020-03-31 0001656472 us-gaap:AdditionalPaidInCapitalMember 2020-03-31 0001656472 us-gaap:RetainedEarningsMember 2020-03-31 0001656472 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-03-31 0001656472 us-gaap:NoncontrollingInterestMember 2020-03-31 0001656472 2020-03-31 0001656472 us-gaap:AdditionalPaidInCapitalMember 2020-04-01 2020-06-30 0001656472 us-gaap:CommonStockMember 2020-04-01 2020-06-30 0001656472 us-gaap:RetainedEarningsMember 2020-04-01 2020-06-30 0001656472 us-gaap:NoncontrollingInterestMember 2020-04-01 2020-06-30 0001656472 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-04-01 2020-06-30 0001656472 us-gaap:CommonStockMember 2020-06-30 0001656472 us-gaap:AdditionalPaidInCapitalMember 2020-06-30 0001656472 us-gaap:RetainedEarningsMember 2020-06-30 0001656472 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-06-30 0001656472 us-gaap:NoncontrollingInterestMember 2020-06-30 0001656472 us-gaap:CommonStockMember 2019-03-31 0001656472 us-gaap:AdditionalPaidInCapitalMember 2019-03-31 0001656472 us-gaap:RetainedEarningsMember 2019-03-31 0001656472 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-03-31 0001656472 us-gaap:NoncontrollingInterestMember 2019-03-31 0001656472 2019-03-31 0001656472 us-gaap:CommonStockMember 2019-04-01 2019-06-30 0001656472 us-gaap:AdditionalPaidInCapitalMember 2019-04-01 2019-06-30 0001656472 us-gaap:RetainedEarningsMember 2019-04-01 2019-06-30 0001656472 us-gaap:NoncontrollingInterestMember 2019-04-01 2019-06-30 0001656472 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-04-01 2019-06-30 0001656472 us-gaap:CommonStockMember 2019-06-30 0001656472 us-gaap:AdditionalPaidInCapitalMember 2019-06-30 0001656472 us-gaap:RetainedEarningsMember 2019-06-30 0001656472 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-06-30 0001656472 us-gaap:NoncontrollingInterestMember 2019-06-30 0001656472 2019-06-30 0001656472 us-gaap:CommonStockMember 2019-12-31 0001656472 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001656472 us-gaap:RetainedEarningsMember 2019-12-31 0001656472 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0001656472 us-gaap:NoncontrollingInterestMember 2019-12-31 0001656472 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-06-30 0001656472 us-gaap:CommonStockMember 2020-01-01 2020-06-30 0001656472 us-gaap:RetainedEarningsMember 2020-01-01 2020-06-30 0001656472 us-gaap:NoncontrollingInterestMember 2020-01-01 2020-06-30 0001656472 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-06-30 0001656472 us-gaap:CommonStockMember 2018-12-31 0001656472 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0001656472 us-gaap:RetainedEarningsMember 2018-12-31 0001656472 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0001656472 us-gaap:NoncontrollingInterestMember 2018-12-31 0001656472 2018-12-31 0001656472 us-gaap:CommonStockMember 2019-01-01 2019-06-30 0001656472 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-06-30 0001656472 us-gaap:RetainedEarningsMember 2019-01-01 2019-06-30 0001656472 us-gaap:NoncontrollingInterestMember 2019-01-01 2019-06-30 0001656472 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-06-30 0001656472 cron:CronosAustraliaLimitedMember 2020-06-30 0001656472 cron:CronosIsraelG.S.CultivationsLtd.Member 2020-01-01 2020-06-30 0001656472 cron:CronosIsraelG.S.ManufacturingLtd.Member 2020-01-01 2020-06-30 0001656472 cron:CronosIsraelG.S.StoreLtd.Member 2020-01-01 2020-06-30 0001656472 cron:CronosIsraelG.S.PharmaciesLtd.Member 2020-01-01 2020-06-30 0001656472 cron:InventoryDryCannabisMember 2020-06-30 0001656472 cron:InventoryDryCannabisMember 2019-06-30 0001656472 cron:InventoryCannabisExtractsMember 2020-06-30 0001656472 cron:InventoryCannabisExtractsMember 2019-06-30 0001656472 cron:CronosGrowingCompanyInc.Member us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember 2018-06-14 2018-06-14 0001656472 cron:NatueraMember us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember 2020-01-01 2020-06-30 0001656472 srt:MinimumMember cron:MedMenCanadaInc.Member us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember 2018-03-13 2018-03-13 0001656472 cron:MedMenCanadaInc.Member us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember 2018-03-13 2018-03-13 0001656472 cron:CannasoulAnalyticsLtdMember us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2020-06-30 0001656472 cron:CannasoulAnalyticsLtdMember us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2020-01-01 2020-06-30 0001656472 cron:CronosAustraliaLimitedMember 2019-12-31 0001656472 cron:CronosGrowingCompanyInc.Member 2020-06-30 0001656472 cron:CronosGrowingCompanyInc.Member 2019-12-31 0001656472 cron:MedMenCanadaInc.Member 2020-06-30 0001656472 cron:MedMenCanadaInc.Member 2019-12-31 0001656472 cron:NatueraMember 2020-06-30 0001656472 cron:NatueraMember 2019-12-31 0001656472 us-gaap:IPOMember cron:CronosAustraliaLimitedMember 2019-10-25 2019-10-25 0001656472 us-gaap:IPOMember cron:CronosAustraliaLimitedMember 2019-10-25 0001656472 cron:CronosAustraliaLimitedMember us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember 2019-11-06 2019-11-06 0001656472 cron:CronosAustraliaLimitedMember us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember 2019-11-07 2019-11-07 0001656472 cron:WhistlerMedicalMarijuanaCompanyMember 2020-04-01 2020-06-30 0001656472 cron:WhistlerMedicalMarijuanaCompanyMember 2019-04-01 2019-06-30 0001656472 cron:WhistlerMedicalMarijuanaCompanyMember 2020-01-01 2020-06-30 0001656472 cron:WhistlerMedicalMarijuanaCompanyMember 2019-01-01 2019-06-30 0001656472 cron:CronosAustraliaLimitedMember 2020-04-01 2020-06-30 0001656472 cron:CronosAustraliaLimitedMember 2019-04-01 2019-06-30 0001656472 cron:CronosAustraliaLimitedMember 2020-01-01 2020-06-30 0001656472 cron:CronosAustraliaLimitedMember 2019-01-01 2019-06-30 0001656472 cron:CronosGrowingCompanyInc.Member 2020-04-01 2020-06-30 0001656472 cron:CronosGrowingCompanyInc.Member 2019-04-01 2019-06-30 0001656472 cron:CronosGrowingCompanyInc.Member 2020-01-01 2020-06-30 0001656472 cron:CronosGrowingCompanyInc.Member 2019-01-01 2019-06-30 0001656472 cron:MedMenCanadaInc.Member 2020-04-01 2020-06-30 0001656472 cron:MedMenCanadaInc.Member 2019-04-01 2019-06-30 0001656472 cron:MedMenCanadaInc.Member 2020-01-01 2020-06-30 0001656472 cron:MedMenCanadaInc.Member 2019-01-01 2019-06-30 0001656472 cron:NatueraMember 2020-04-01 2020-06-30 0001656472 cron:NatueraMember 2019-04-01 2019-06-30 0001656472 cron:NatueraMember 2020-01-01 2020-06-30 0001656472 cron:NatueraMember 2019-01-01 2019-06-30 0001656472 cron:CronosAustraliaLimitedMember 2019-06-30 0001656472 cron:MedMenCanadaInc.Member 2018-12-31 0001656472 cron:CronosGrowingCompanyInc.Member 2018-12-31 0001656472 cron:CronosAustraliaLimitedMember 2018-12-31 0001656472 cron:NatueraMember 2018-12-31 0001656472 cron:MedMenCanadaInc.Member 2019-01-01 2019-12-31 0001656472 cron:CronosGrowingCompanyInc.Member 2019-01-01 2019-12-31 0001656472 cron:CronosAustraliaLimitedMember 2019-01-01 2019-12-31 0001656472 cron:NatueraMember 2019-01-01 2019-12-31 0001656472 2019-01-01 2019-12-31 0001656472 cron:AuroraCannabisInc.Member us-gaap:EquitySecuritiesMember 2020-01-01 2020-06-30 0001656472 cron:WhistlerMedicalMarijuanaCompanyMember us-gaap:EquitySecuritiesMember 2020-06-30 0001656472 cron:WhistlerMedicalMarijuanaCompanyMember us-gaap:EquitySecuritiesMember 2019-03-04 2019-03-04 0001656472 cron:AuroraCannabisInc.Member us-gaap:EquitySecuritiesMember 2019-03-04 2019-03-04 0001656472 cron:AuroraCannabisInc.Member us-gaap:EquitySecuritiesMember 2019-01-01 2019-06-30 0001656472 cron:CanopyGrowthCorporationMember us-gaap:EquitySecuritiesMember 2019-01-01 2019-06-30 0001656472 cron:AOCIAccumulatedGainLossRevaluationAndDisposalOfOtherInvestmentsParentMemberMember 2020-03-31 0001656472 cron:AOCIAccumulatedGainLossRevaluationAndDisposalOfOtherInvestmentsParentMemberMember 2019-03-31 0001656472 cron:AOCIAccumulatedGainLossRevaluationAndDisposalOfOtherInvestmentsParentMemberMember 2019-12-31 0001656472 cron:AOCIAccumulatedGainLossRevaluationAndDisposalOfOtherInvestmentsParentMemberMember 2018-12-31 0001656472 us-gaap:AccountingStandardsUpdate201601Member cron:AOCIAccumulatedGainLossRevaluationAndDisposalOfOtherInvestmentsParentMemberMember 2020-04-01 0001656472 us-gaap:AccountingStandardsUpdate201601Member cron:AOCIAccumulatedGainLossRevaluationAndDisposalOfOtherInvestmentsParentMemberMember 2019-04-01 0001656472 us-gaap:AccountingStandardsUpdate201601Member cron:AOCIAccumulatedGainLossRevaluationAndDisposalOfOtherInvestmentsParentMemberMember 2020-01-01 0001656472 us-gaap:AccountingStandardsUpdate201601Member cron:AOCIAccumulatedGainLossRevaluationAndDisposalOfOtherInvestmentsParentMemberMember 2019-01-01 0001656472 cron:AOCIAccumulatedGainLossRevaluationAndDisposalOfOtherInvestmentsParentMemberMember 2020-06-30 0001656472 cron:AOCIAccumulatedGainLossRevaluationAndDisposalOfOtherInvestmentsParentMemberMember 2019-06-30 0001656472 us-gaap:AccumulatedTranslationAdjustmentMember 2020-03-31 0001656472 us-gaap:AccumulatedTranslationAdjustmentMember 2019-03-31 0001656472 us-gaap:AccumulatedTranslationAdjustmentMember 2019-12-31 0001656472 us-gaap:AccumulatedTranslationAdjustmentMember 2018-12-31 0001656472 us-gaap:AccumulatedTranslationAdjustmentMember 2020-04-01 2020-06-30 0001656472 us-gaap:AccumulatedTranslationAdjustmentMember 2019-04-01 2019-06-30 0001656472 us-gaap:AccumulatedTranslationAdjustmentMember 2020-01-01 2020-06-30 0001656472 us-gaap:AccumulatedTranslationAdjustmentMember 2019-01-01 2019-06-30 0001656472 us-gaap:AccumulatedTranslationAdjustmentMember 2020-06-30 0001656472 us-gaap:AccumulatedTranslationAdjustmentMember 2019-06-30 0001656472 srt:MinimumMember cron:LandBuildingsAndEquipmentMember 2020-06-30 0001656472 srt:MaximumMember cron:LandBuildingsAndEquipmentMember 2020-06-30 0001656472 cron:LandBuildingsAndEquipmentMember 2020-06-30 0001656472 us-gaap:BuildingMember 2020-01-01 2020-06-30 0001656472 us-gaap:LoansReceivableMember cron:NatuEraSeriesALoanMember 2020-06-30 0001656472 us-gaap:LoansReceivableMember cron:NatuEraSeriesALoanMember 2019-12-31 0001656472 us-gaap:LoansReceivableMember cron:CronosGrowCoCreditFacilityMember 2020-06-30 0001656472 us-gaap:LoansReceivableMember cron:CronosGrowCoCreditFacilityMember 2019-12-31 0001656472 us-gaap:LoansReceivableMember 2020-06-30 0001656472 us-gaap:LoansReceivableMember 2019-12-31 0001656472 us-gaap:LoansReceivableMember cron:A2645485OntarioInc.MucciPromissoryNoteMember 2020-06-30 0001656472 us-gaap:LoansReceivableMember cron:A2645485OntarioInc.MucciPromissoryNoteMember 2019-12-31 0001656472 us-gaap:LoansReceivableMember cron:CannasoulCollaborationLoanMember 2020-06-30 0001656472 us-gaap:LoansReceivableMember cron:CannasoulCollaborationLoanMember 2019-12-31 0001656472 us-gaap:LoansReceivableMember cron:NatuEraSeriesALoanMember 2019-09-27 0001656472 us-gaap:LoansReceivableMember cron:NatuEraSeriesALoanMember cron:NatueraMember 2019-09-27 0001656472 us-gaap:LoansReceivableMember cron:CronosGrowCoCreditFacilityMember 2019-08-23 0001656472 cron:CronosGrowingCompanyInc.Member cron:MucciMember 2020-06-30 0001656472 us-gaap:LoansReceivableMember cron:CronosGrowCoCreditFacilityMember 2019-08-23 2020-03-31 0001656472 us-gaap:LoansReceivableMember cron:A2645485OntarioInc.MucciPromissoryNoteMember 2019-06-28 0001656472 us-gaap:LoansReceivableMember cron:A2645485OntarioInc.MucciPromissoryNoteMember 2019-06-28 2019-06-28 0001656472 cron:CannasoulAnalyticsLtdMember us-gaap:LoansReceivableMember us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember us-gaap:VariableInterestEntityPrimaryBeneficiaryMember cron:CannasoulCollaborationLoanMember 2020-04-01 0001656472 cron:CannasoulAnalyticsLtdMember us-gaap:LoansReceivableMember us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember us-gaap:VariableInterestEntityPrimaryBeneficiaryMember cron:CannasoulCollaborationLoanMember 2020-04-01 2020-04-01 0001656472 cron:CannasoulAnalyticsLtdMember us-gaap:LoansReceivableMember us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember us-gaap:VariableInterestEntityPrimaryBeneficiaryMember cron:CannasoulCollaborationLoanMember 2020-06-30 0001656472 cron:AltriaInvestmentMember 2019-03-08 2019-03-08 0001656472 cron:CronosGroupInc.Member cron:AltriaWarrantMember 2019-03-08 2019-03-08 0001656472 cron:CronosGroupInc.Member cron:AltriaGroupInc.Member 2019-03-08 0001656472 srt:SubsidiariesMember cron:AltriaGroupInc.Member 2019-03-08 0001656472 cron:AltriaInvestmentMember 2019-03-08 0001656472 cron:AltriaInvestmentMember 2020-06-30 0001656472 cron:AltriaWarrantMember 2019-03-08 0001656472 cron:PreemptiveRightsMember 2019-03-08 0001656472 cron:TopupRightsMember 2019-03-08 2019-03-08 0001656472 cron:TopupRightsMember 2019-03-08 0001656472 cron:TopupRightsMember 2020-01-01 2020-06-30 0001656472 cron:AltriaWarrantMember 2020-03-31 0001656472 cron:AltriaWarrantMember 2020-04-01 2020-06-30 0001656472 cron:AltriaWarrantMember 2020-06-30 0001656472 cron:PreemptiveRightsMember 2020-03-31 0001656472 cron:PreemptiveRightsMember 2020-04-01 2020-06-30 0001656472 cron:PreemptiveRightsMember 2020-06-30 0001656472 cron:TopupRightsMember 2020-03-31 0001656472 cron:TopupRightsMember 2020-04-01 2020-06-30 0001656472 cron:TopupRightsMember 2020-06-30 0001656472 cron:AltriaWarrantMember 2019-12-31 0001656472 cron:AltriaWarrantMember 2020-01-01 2020-06-30 0001656472 cron:PreemptiveRightsMember 2019-12-31 0001656472 cron:PreemptiveRightsMember 2020-01-01 2020-06-30 0001656472 cron:TopupRightsMember 2019-12-31 0001656472 cron:AltriaWarrantMember us-gaap:MeasurementInputSharePriceMember 2020-06-30 0001656472 cron:PreemptiveRightsMember us-gaap:MeasurementInputSharePriceMember 2020-06-30 0001656472 cron:TopupRightsMember us-gaap:MeasurementInputSharePriceMember 2020-06-30 0001656472 cron:AltriaWarrantMember us-gaap:MeasurementInputSharePriceMember 2019-12-31 0001656472 cron:PreemptiveRightsMember us-gaap:MeasurementInputSharePriceMember 2019-12-31 0001656472 cron:TopupRightsMember us-gaap:MeasurementInputSharePriceMember 2019-12-31 0001656472 cron:AltriaWarrantMember cron:MeasurementInputSubscriptionPriceMember 2020-06-30 0001656472 cron:PreemptiveRightsMember cron:MeasurementInputSubscriptionPriceMember 2020-06-30 0001656472 cron:TopupRightsMember cron:MeasurementInputSubscriptionPriceMember 2020-06-30 0001656472 cron:AltriaWarrantMember cron:MeasurementInputSubscriptionPriceMember 2019-12-31 0001656472 cron:PreemptiveRightsMember cron:MeasurementInputSubscriptionPriceMember 2019-12-31 0001656472 cron:TopupRightsMember cron:MeasurementInputSubscriptionPriceMember 2019-12-31 0001656472 srt:WeightedAverageMember cron:AltriaWarrantMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2020-06-30 0001656472 srt:WeightedAverageMember cron:PreemptiveRightsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2020-06-30 0001656472 srt:WeightedAverageMember cron:TopupRightsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2020-06-30 0001656472 srt:WeightedAverageMember cron:AltriaWarrantMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2019-12-31 0001656472 srt:WeightedAverageMember cron:PreemptiveRightsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2019-12-31 0001656472 srt:WeightedAverageMember cron:TopupRightsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2019-12-31 0001656472 srt:WeightedAverageMember cron:AltriaWarrantMember us-gaap:MeasurementInputExpectedTermMember 2020-01-01 2020-06-30 0001656472 srt:WeightedAverageMember cron:PreemptiveRightsMember us-gaap:MeasurementInputExpectedTermMember 2020-01-01 2020-06-30 0001656472 srt:WeightedAverageMember cron:TopupRightsMember us-gaap:MeasurementInputExpectedTermMember 2020-01-01 2020-06-30 0001656472 srt:WeightedAverageMember cron:AltriaWarrantMember us-gaap:MeasurementInputExpectedTermMember 2019-01-01 2019-12-31 0001656472 srt:WeightedAverageMember cron:PreemptiveRightsMember us-gaap:MeasurementInputExpectedTermMember 2019-01-01 2019-12-31 0001656472 srt:WeightedAverageMember cron:TopupRightsMember us-gaap:MeasurementInputExpectedTermMember 2019-01-01 2019-12-31 0001656472 cron:AltriaWarrantMember us-gaap:MeasurementInputPriceVolatilityMember 2020-06-30 0001656472 cron:PreemptiveRightsMember us-gaap:MeasurementInputPriceVolatilityMember 2020-06-30 0001656472 cron:TopupRightsMember us-gaap:MeasurementInputPriceVolatilityMember 2020-06-30 0001656472 cron:AltriaWarrantMember us-gaap:MeasurementInputPriceVolatilityMember 2019-12-31 0001656472 cron:PreemptiveRightsMember us-gaap:MeasurementInputPriceVolatilityMember 2019-12-31 0001656472 cron:TopupRightsMember us-gaap:MeasurementInputPriceVolatilityMember 2019-12-31 0001656472 cron:AltriaWarrantMember us-gaap:MeasurementInputExpectedDividendRateMember 2020-06-30 0001656472 cron:PreemptiveRightsMember us-gaap:MeasurementInputExpectedDividendRateMember 2020-06-30 0001656472 cron:TopupRightsMember us-gaap:MeasurementInputExpectedDividendRateMember 2020-06-30 0001656472 cron:AltriaWarrantMember us-gaap:MeasurementInputExpectedDividendRateMember 2019-12-31 0001656472 cron:PreemptiveRightsMember us-gaap:MeasurementInputExpectedDividendRateMember 2019-12-31 0001656472 cron:TopupRightsMember us-gaap:MeasurementInputExpectedDividendRateMember 2019-12-31 0001656472 srt:MinimumMember cron:PreEmptiveRightsAndTopUpRightsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2020-06-30 0001656472 srt:MaximumMember cron:PreEmptiveRightsAndTopUpRightsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2020-06-30 0001656472 srt:MinimumMember cron:PreEmptiveRightsAndTopUpRightsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2019-12-31 0001656472 srt:MaximumMember cron:PreEmptiveRightsAndTopUpRightsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2019-12-31 0001656472 srt:MinimumMember cron:PreEmptiveRightsAndTopUpRightsMember us-gaap:MeasurementInputExpectedTermMember 2020-01-01 2020-06-30 0001656472 srt:MaximumMember cron:PreEmptiveRightsAndTopUpRightsMember us-gaap:MeasurementInputExpectedTermMember 2020-01-01 2020-06-30 0001656472 srt:MinimumMember cron:PreEmptiveRightsAndTopUpRightsMember us-gaap:MeasurementInputExpectedTermMember 2019-01-01 2019-12-31 0001656472 srt:MaximumMember cron:PreEmptiveRightsAndTopUpRightsMember us-gaap:MeasurementInputExpectedTermMember 2019-01-01 2019-12-31 0001656472 us-gaap:LandMember 2020-06-30 0001656472 us-gaap:LandMember 2019-12-31 0001656472 us-gaap:BuildingMember 2020-06-30 0001656472 us-gaap:BuildingMember 2019-12-31 0001656472 us-gaap:FurnitureAndFixturesMember 2020-06-30 0001656472 us-gaap:FurnitureAndFixturesMember 2019-12-31 0001656472 us-gaap:ComputerEquipmentMember 2020-06-30 0001656472 us-gaap:ComputerEquipmentMember 2019-12-31 0001656472 us-gaap:LeaseholdImprovementsMember 2020-06-30 0001656472 us-gaap:LeaseholdImprovementsMember 2019-12-31 0001656472 us-gaap:ConstructionInProgressMember 2020-06-30 0001656472 us-gaap:ConstructionInProgressMember 2019-12-31 0001656472 cron:UnitedStatesSegmentMember 2020-04-01 2020-06-30 0001656472 us-gaap:TradeNamesMember 2020-04-01 2020-06-30 0001656472 us-gaap:ComputerSoftwareIntangibleAssetMember 2020-06-30 0001656472 cron:EnterpriseResourcePlanningSystemMember 2020-01-01 2020-06-30 0001656472 cron:EnterpriseResourcePlanningSystemMember 2020-06-30 0001656472 cron:HealthCanadaLicensingAgreementsMember 2020-01-01 2020-06-30 0001656472 cron:HealthCanadaLicensingAgreementsMember 2020-06-30 0001656472 us-gaap:TradeNamesMember 2020-06-30 0001656472 us-gaap:TrademarksMember 2020-06-30 0001656472 cron:IsraeliCodesLicensingAgreementsMember 2020-01-01 2020-06-30 0001656472 cron:IsraeliCodesLicensingAgreementsMember 2020-06-30 0001656472 us-gaap:ComputerSoftwareIntangibleAssetMember 2019-12-31 0001656472 cron:HealthCanadaLicensingAgreementsMember 2019-01-01 2019-12-31 0001656472 cron:HealthCanadaLicensingAgreementsMember 2019-12-31 0001656472 us-gaap:TradeNamesMember 2019-12-31 0001656472 us-gaap:TrademarksMember 2019-12-31 0001656472 cron:IsraeliCodesLicensingAgreementsMember 2019-01-01 2019-12-31 0001656472 cron:IsraeliCodesLicensingAgreementsMember 2019-12-31 0001656472 us-gaap:ComputerSoftwareIntangibleAssetMember 2020-01-01 2020-06-30 0001656472 cron:OGBCReportingUnitMember 2019-12-31 0001656472 cron:OGBCReportingUnitMember 2020-01-01 2020-06-30 0001656472 cron:OGBCReportingUnitMember 2020-06-30 0001656472 cron:PeaceNaturalsReportingUnitMember 2019-12-31 0001656472 cron:PeaceNaturalsReportingUnitMember 2020-01-01 2020-06-30 0001656472 cron:PeaceNaturalsReportingUnitMember 2020-06-30 0001656472 cron:RedwoodReportingUnitMember 2019-12-31 0001656472 cron:RedwoodReportingUnitMember 2020-01-01 2020-06-30 0001656472 cron:RedwoodReportingUnitMember 2020-06-30 0001656472 us-gaap:WarrantMember 2019-12-31 0001656472 us-gaap:WarrantMember 2020-06-30 0001656472 us-gaap:WarrantMember 2018-12-31 0001656472 us-gaap:WarrantMember 2019-01-01 2019-06-30 0001656472 us-gaap:WarrantMember 2019-06-30 0001656472 cron:GrantedRange1Member us-gaap:WarrantMember 2020-06-30 0001656472 cron:GrantedRangeTwoMember us-gaap:WarrantMember 2020-06-30 0001656472 us-gaap:EmployeeStockOptionMember cron:A2015StockOptionPlanMember 2018-06-28 0001656472 cron:A2015StockOptionPlanMember 2020-06-30 0001656472 cron:A2018StockOptionPlanMember 2020-06-30 0001656472 cron:A2020OmnibusPlanMember 2020-06-30 0001656472 us-gaap:EmployeeStockOptionMember 2020-04-01 2020-06-30 0001656472 us-gaap:EmployeeStockOptionMember 2019-04-01 2019-06-30 0001656472 us-gaap:EmployeeStockOptionMember 2020-01-01 2020-06-30 0001656472 us-gaap:EmployeeStockOptionMember 2019-01-01 2019-06-30 0001656472 2018-01-01 2018-12-31 0001656472 srt:MinimumMember us-gaap:EmployeeStockOptionMember 2019-06-30 0001656472 srt:MaximumMember us-gaap:EmployeeStockOptionMember 2019-06-30 0001656472 srt:MinimumMember us-gaap:EmployeeStockOptionMember 2019-01-01 2019-06-30 0001656472 srt:MaximumMember us-gaap:EmployeeStockOptionMember 2019-01-01 2019-06-30 0001656472 cron:A2018StockOptionPlanMember 2020-01-01 2020-06-30 0001656472 srt:WeightedAverageMember us-gaap:EmployeeStockOptionMember 2019-06-30 0001656472 us-gaap:RestrictedStockUnitsRSUMember 2020-05-11 2020-05-11 0001656472 us-gaap:RestrictedStockUnitsRSUMember 2020-05-11 0001656472 us-gaap:RestrictedStockUnitsRSUMember 2020-01-01 2020-06-30 0001656472 us-gaap:RestrictedStockUnitsRSUMember 2019-09-05 2019-09-05 0001656472 cron:RedwoodHoldingGroupLLCMember 2019-09-05 2019-09-05 0001656472 us-gaap:RestrictedStockUnitsRSUMember 2019-09-05 0001656472 us-gaap:RestrictedStockUnitsRSUMember us-gaap:SubsequentEventMember 2020-07-20 2020-07-20 0001656472 us-gaap:RestrictedStockUnitsRSUMember 2020-04-01 2020-06-30 0001656472 us-gaap:RestrictedStockUnitsRSUMember 2019-04-01 2019-06-30 0001656472 us-gaap:RestrictedStockUnitsRSUMember 2019-01-01 2019-06-30 0001656472 us-gaap:RestrictedStockUnitsRSUMember 2019-12-31 0001656472 us-gaap:RestrictedStockUnitsRSUMember 2020-06-30 0001656472 us-gaap:RestrictedStockUnitsRSUMember 2019-06-30 0001656472 cron:DeferredShareUnitsDSUsMember 2019-12-31 0001656472 cron:DeferredShareUnitsDSUsMember 2020-01-01 2020-06-30 0001656472 cron:DeferredShareUnitsDSUsMember 2020-06-30 0001656472 cron:DeferredShareUnitsDSUsMember 2019-06-30 0001656472 cron:DeferredShareUnitsDSUsMember 2019-01-01 2019-06-30 0001656472 us-gaap:WarrantMember 2020-04-01 2020-06-30 0001656472 us-gaap:WarrantMember 2019-04-01 2019-06-30 0001656472 us-gaap:WarrantMember 2020-01-01 2020-06-30 0001656472 cron:AltriaWarrantMember 2019-04-01 2019-06-30 0001656472 cron:AltriaWarrantMember 2019-01-01 2019-06-30 0001656472 cron:TopupRightsMember 2019-04-01 2019-06-30 0001656472 cron:TopupRightsMember 2019-01-01 2019-06-30 0001656472 cron:GinkgoEquityMilestonesMember 2020-04-01 2020-06-30 0001656472 cron:GinkgoEquityMilestonesMember 2019-04-01 2019-06-30 0001656472 cron:GinkgoEquityMilestonesMember 2020-01-01 2020-06-30 0001656472 cron:GinkgoEquityMilestonesMember 2019-01-01 2019-06-30 0001656472 cron:PreemptiveRightsMember 2020-04-01 2020-06-30 0001656472 cron:PreemptiveRightsMember 2019-04-01 2019-06-30 0001656472 cron:PreemptiveRightsMember 2020-01-01 2020-06-30 0001656472 cron:PreemptiveRightsMember 2019-01-01 2019-06-30 0001656472 cron:TopUpRightsFixedPriceMember 2020-04-01 2020-06-30 0001656472 cron:TopUpRightsFixedPriceMember 2019-04-01 2019-06-30 0001656472 cron:TopUpRightsFixedPriceMember 2020-01-01 2020-06-30 0001656472 cron:TopUpRightsFixedPriceMember 2019-01-01 2019-06-30 0001656472 cron:TopUpRightsMarketPriceMember 2020-04-01 2020-06-30 0001656472 cron:TopUpRightsMarketPriceMember 2019-04-01 2019-06-30 0001656472 cron:TopUpRightsMarketPriceMember 2020-01-01 2020-06-30 0001656472 cron:TopUpRightsMarketPriceMember 2019-01-01 2019-06-30 0001656472 cron:AltriaWarrantMember 2020-04-01 2020-06-30 0001656472 cron:AltriaWarrantMember 2019-04-01 2019-06-30 0001656472 cron:AltriaWarrantMember 2020-01-01 2020-06-30 0001656472 cron:AltriaWarrantMember 2019-01-01 2019-06-30 0001656472 us-gaap:EmployeeStockOptionMember 2020-04-01 2020-06-30 0001656472 us-gaap:EmployeeStockOptionMember 2019-04-01 2019-06-30 0001656472 us-gaap:EmployeeStockOptionMember 2020-01-01 2020-06-30 0001656472 us-gaap:EmployeeStockOptionMember 2019-01-01 2019-06-30 0001656472 us-gaap:WarrantMember 2020-04-01 2020-06-30 0001656472 us-gaap:WarrantMember 2019-04-01 2019-06-30 0001656472 us-gaap:WarrantMember 2020-01-01 2020-06-30 0001656472 us-gaap:WarrantMember 2019-01-01 2019-06-30 0001656472 us-gaap:RestrictedStockUnitsRSUMember 2020-04-01 2020-06-30 0001656472 us-gaap:RestrictedStockUnitsRSUMember 2019-04-01 2019-06-30 0001656472 us-gaap:RestrictedStockUnitsRSUMember 2020-01-01 2020-06-30 0001656472 us-gaap:RestrictedStockUnitsRSUMember 2019-01-01 2019-06-30 0001656472 cron:AltriaPinnacleLLC.Member cron:ConsultingServicesMember srt:AffiliatedEntityMember 2020-04-01 2020-06-30 0001656472 cron:AltriaPinnacleLLC.Member cron:ConsultingServicesMember srt:AffiliatedEntityMember 2020-01-01 2020-06-30 0001656472 cron:AltriaPinnacleLLC.Member cron:ConsultingServicesMember srt:AffiliatedEntityMember 2020-06-30 0001656472 cron:AltriaPinnacleLLC.Member cron:ConsultingServicesMember srt:AffiliatedEntityMember 2019-12-31 0001656472 cron:AltriaPinnacleLLC.Member cron:ConsultingServicesMember srt:AffiliatedEntityMember 2019-04-01 2019-06-30 0001656472 cron:AltriaPinnacleLLC.Member cron:ConsultingServicesMember srt:AffiliatedEntityMember 2019-01-01 2019-06-30 0001656472 cron:AltriaPinnacleLLC.Member cron:PurchaseOfMachineryAndEquipmentMember srt:AffiliatedEntityMember 2019-01-01 2019-12-31 0001656472 us-gaap:OperatingSegmentsMember cron:CannabisFlowerMember cron:UnitedStatesSegmentMember 2020-04-01 2020-06-30 0001656472 us-gaap:OperatingSegmentsMember cron:CannabisFlowerMember cron:RestOfWorldSegmentMember 2020-04-01 2020-06-30 0001656472 us-gaap:CorporateNonSegmentMember cron:CannabisFlowerMember 2020-04-01 2020-06-30 0001656472 cron:CannabisFlowerMember 2020-04-01 2020-06-30 0001656472 us-gaap:OperatingSegmentsMember cron:CannabisExtractsMember cron:UnitedStatesSegmentMember 2020-04-01 2020-06-30 0001656472 us-gaap:OperatingSegmentsMember cron:CannabisExtractsMember cron:RestOfWorldSegmentMember 2020-04-01 2020-06-30 0001656472 us-gaap:CorporateNonSegmentMember cron:CannabisExtractsMember 2020-04-01 2020-06-30 0001656472 cron:CannabisExtractsMember 2020-04-01 2020-06-30 0001656472 us-gaap:OperatingSegmentsMember us-gaap:ProductAndServiceOtherMember cron:UnitedStatesSegmentMember 2020-04-01 2020-06-30 0001656472 us-gaap:OperatingSegmentsMember us-gaap:ProductAndServiceOtherMember cron:RestOfWorldSegmentMember 2020-04-01 2020-06-30 0001656472 us-gaap:CorporateNonSegmentMember us-gaap:ProductAndServiceOtherMember 2020-04-01 2020-06-30 0001656472 us-gaap:ProductAndServiceOtherMember 2020-04-01 2020-06-30 0001656472 us-gaap:OperatingSegmentsMember cron:UnitedStatesSegmentMember 2020-04-01 2020-06-30 0001656472 us-gaap:OperatingSegmentsMember cron:RestOfWorldSegmentMember 2020-04-01 2020-06-30 0001656472 us-gaap:CorporateNonSegmentMember 2020-04-01 2020-06-30 0001656472 us-gaap:OperatingSegmentsMember cron:UnitedStatesSegmentMember 2020-01-01 2020-06-30 0001656472 us-gaap:OperatingSegmentsMember cron:CannabisFlowerMember cron:UnitedStatesSegmentMember 2020-01-01 2020-06-30 0001656472 us-gaap:OperatingSegmentsMember cron:CannabisFlowerMember cron:RestOfWorldSegmentMember 2020-01-01 2020-06-30 0001656472 us-gaap:CorporateNonSegmentMember cron:CannabisFlowerMember 2020-01-01 2020-06-30 0001656472 cron:CannabisFlowerMember 2020-01-01 2020-06-30 0001656472 us-gaap:OperatingSegmentsMember cron:CannabisExtractsMember cron:UnitedStatesSegmentMember 2020-01-01 2020-06-30 0001656472 us-gaap:OperatingSegmentsMember cron:CannabisExtractsMember cron:RestOfWorldSegmentMember 2020-01-01 2020-06-30 0001656472 us-gaap:CorporateNonSegmentMember cron:CannabisExtractsMember 2020-01-01 2020-06-30 0001656472 cron:CannabisExtractsMember 2020-01-01 2020-06-30 0001656472 us-gaap:OperatingSegmentsMember us-gaap:ProductAndServiceOtherMember cron:UnitedStatesSegmentMember 2020-01-01 2020-06-30 0001656472 us-gaap:OperatingSegmentsMember us-gaap:ProductAndServiceOtherMember cron:RestOfWorldSegmentMember 2020-01-01 2020-06-30 0001656472 us-gaap:CorporateNonSegmentMember us-gaap:ProductAndServiceOtherMember 2020-01-01 2020-06-30 0001656472 us-gaap:ProductAndServiceOtherMember 2020-01-01 2020-06-30 0001656472 us-gaap:OperatingSegmentsMember cron:RestOfWorldSegmentMember 2020-01-01 2020-06-30 0001656472 us-gaap:CorporateNonSegmentMember 2020-01-01 2020-06-30 0001656472 us-gaap:OperatingSegmentsMember cron:UnitedStatesSegmentMember 2020-06-30 0001656472 us-gaap:OperatingSegmentsMember cron:RestOfWorldSegmentMember 2020-06-30 0001656472 us-gaap:CorporateNonSegmentMember 2020-06-30 0001656472 cron:CannabisFlowerMember 2019-04-01 2019-06-30 0001656472 cron:CannabisFlowerMember 2019-01-01 2019-06-30 0001656472 cron:CannabisExtractsMember 2019-04-01 2019-06-30 0001656472 cron:CannabisExtractsMember 2019-01-01 2019-06-30 0001656472 us-gaap:ProductAndServiceOtherMember 2019-04-01 2019-06-30 0001656472 us-gaap:ProductAndServiceOtherMember 2019-01-01 2019-06-30 0001656472 country:CA 2020-04-01 2020-06-30 0001656472 country:CA 2019-04-01 2019-06-30 0001656472 country:CA 2020-01-01 2020-06-30 0001656472 country:CA 2019-01-01 2019-06-30 0001656472 country:US 2020-04-01 2020-06-30 0001656472 country:US 2019-04-01 2019-06-30 0001656472 country:US 2020-01-01 2020-06-30 0001656472 country:US 2019-01-01 2019-06-30 0001656472 cron:OtherCountriesMember 2020-04-01 2020-06-30 0001656472 cron:OtherCountriesMember 2019-04-01 2019-06-30 0001656472 cron:OtherCountriesMember 2020-01-01 2020-06-30 0001656472 cron:OtherCountriesMember 2019-01-01 2019-06-30 0001656472 country:CA 2020-06-30 0001656472 country:CA 2019-12-31 0001656472 country:US 2020-06-30 0001656472 country:US 2019-12-31 0001656472 cron:OtherCountriesMember 2020-06-30 0001656472 cron:OtherCountriesMember 2019-12-31 0001656472 cron:UnitedStatesSegmentMember 2020-06-30 0001656472 cron:UnitedStatesSegmentMember 2019-12-31 0001656472 cron:FourMajorCustomersMember cron:RestOfWorldSegmentMember 2020-04-01 2020-06-30 0001656472 cron:BCLiquorDistributionBranchMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember cron:RestOfWorldSegmentMember 2020-04-01 2020-06-30 0001656472 cron:AlbertGamingLiquorAndCannabisCommissionMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember cron:RestOfWorldSegmentMember 2020-04-01 2020-06-30 0001656472 cron:OntarioCannabisRetailCorporationMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember cron:RestOfWorldSegmentMember 2020-04-01 2020-06-30 0001656472 cron:SocieteQuebecoiseDuCannabisMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember cron:RestOfWorldSegmentMember 2020-04-01 2020-06-30 0001656472 cron:OneMajorCustomerMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember cron:RestOfWorldSegmentMember 2019-04-01 2019-06-30 0001656472 cron:OneMajorCustomerMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember cron:RestOfWorldSegmentMember 2020-04-01 2020-06-30 0001656472 cron:FourMajorCustomersMember cron:RestOfWorldSegmentMember 2020-01-01 2020-06-30 0001656472 cron:BCLiquorDistributionBranchMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember cron:RestOfWorldSegmentMember 2020-01-01 2020-06-30 0001656472 cron:AlbertGamingLiquorAndCannabisCommissionMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember cron:RestOfWorldSegmentMember 2020-01-01 2020-06-30 0001656472 cron:OntarioCannabisRetailCorporationMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember cron:RestOfWorldSegmentMember 2020-01-01 2020-06-30 0001656472 cron:SocieteQuebecoiseDuCannabisMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember cron:RestOfWorldSegmentMember 2020-01-01 2020-06-30 0001656472 cron:TwoMajorCustomersMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember cron:RestOfWorldSegmentMember 2019-04-01 2019-06-30 0001656472 cron:TwoMajorCustomersMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember cron:RestOfWorldSegmentMember 2019-01-01 2019-06-30 0001656472 cron:RestOfWorldSegmentMember 2020-06-30 0001656472 cron:RestOfWorldSegmentMember 2019-12-31 0001656472 cron:GinkgoBioworksInc.Member us-gaap:ResearchAndDevelopmentArrangementMember 2018-09-04 0001656472 cron:GinkgoBioworksInc.Member us-gaap:ResearchAndDevelopmentArrangementMember 2018-09-04 2018-09-04 0001656472 cron:GinkgoBioworksInc.Member us-gaap:ResearchAndDevelopmentArrangementMember 2018-07-17 0001656472 cron:TechnionResearchAndDevelopmentFoundationMember us-gaap:ResearchAndDevelopmentArrangementMember 2018-10-15 2018-10-15 0001656472 cron:AltriaVenturesInc.Member cron:ConsultingServicesArrangementMember 2019-02-18 2019-02-18 0001656472 us-gaap:CommonStockMember us-gaap:PrivatePlacementMember 2019-12-23 2019-12-23 0001656472 us-gaap:CommonStockMember us-gaap:PrivatePlacementMember 2019-12-23 0001656472 us-gaap:CommonStockMember us-gaap:PrivatePlacementMember cron:SaleOfStockPerformanceMilestoneOneMember 2019-12-23 0001656472 us-gaap:CommonStockMember us-gaap:PrivatePlacementMember cron:SaleOfStockPerformanceMilestoneTwoMember 2019-12-23 0001656472 srt:MinimumMember us-gaap:InventoriesMember 2020-01-31 0001656472 us-gaap:InventoriesMember 2020-01-01 2020-01-31 0001656472 srt:MaximumMember us-gaap:InventoriesMember 2020-01-31 0001656472 us-gaap:InventoriesMember 2020-06-30 0001656472 us-gaap:CommonStockMember us-gaap:PrivatePlacementMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2020-01-31 2020-01-31 0001656472 srt:ScenarioForecastMember us-gaap:CommonStockMember us-gaap:PrivatePlacementMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2021-06-23 2021-06-23 0001656472 srt:ScenarioForecastMember us-gaap:CommonStockMember us-gaap:PrivatePlacementMember us-gaap:ShareBasedCompensationAwardTrancheThreeMember 2022-12-23 2022-12-23 0001656472 cron:USDistrictCourtOfEasternDistrictOfNewYorkVsCronosMember us-gaap:PendingLitigationMember 2020-03-11 2020-03-12 0001656472 us-gaap:PendingLitigationMember us-gaap:UnfavorableRegulatoryActionMember 2020-06-16 2020-06-16 0001656472 cron:FourCustomersMember us-gaap:AccountsReceivableMember us-gaap:CreditConcentrationRiskMember 2020-01-01 2020-06-30 0001656472 cron:TwoCustomersMember us-gaap:AccountsReceivableMember us-gaap:CreditConcentrationRiskMember 2019-01-01 2019-12-31 0001656472 cron:OneVendorMember us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember 2020-01-01 2020-06-30 0001656472 cron:ThreeVendorsMember us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember 2019-01-01 2019-12-31 0001656472 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2020-06-30 0001656472 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2020-06-30 0001656472 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-06-30 0001656472 us-gaap:FairValueMeasurementsRecurringMember 2020-06-30 0001656472 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001656472 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001656472 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001656472 us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001656472 us-gaap:ExchangeOfProductHeldForSaleForSimilarProductMember 2019-03-28 2019-03-28 0001656472 us-gaap:LoansReceivableMember us-gaap:SubsequentEventMember cron:NatuEraSeriesALoanMember 2020-07-24 0001656472 us-gaap:LoansReceivableMember us-gaap:SubsequentEventMember cron:NatuEraSeriesALoanMember cron:NatueraMember 2020-07-24 0001656472 srt:ScenarioForecastMember us-gaap:RestrictedStockUnitsRSUMember us-gaap:SubsequentEventMember 2020-07-01 2020-09-30 shares iso4217:USD iso4217:USD shares cron:continent cron:brand cron:venture pure cron:reportingUnit iso4217:ILS iso4217:AUD cron:milestone utr:D cron:lease iso4217:CAD cron:warrant iso4217:CAD shares cron:day cron:subsidiary cron:segment cron:cannabinoid cron:shareholder cron:complaint cron:transaction false 2020 Q2 0001656472 --12-31 0.3333 0.3333 0.3333 10-Q true 2020-06-30 false 001-38403 CRONOS GROUP INC. Z4 111 Peter St. Suite 300 Toronto ON M5V 2G9 416 504-0004 Common Shares, no par value CRON NASDAQ Yes Yes Large Accelerated Filer false false false 349886402 1109700000 1199693000 213614000 306347000 3477000 4638000 9568000 7232000 4458000 4664000 7827000 9395000 53216000 38043000 1401860000 1570012000 933000 557000 18598000 19437000 65371000 44967000 164290000 161809000 10100000 6546000 69399000 72320000 179736000 214794000 1910287000 2090442000 28316000 35301000 1206000 427000 205714000 297160000 235236000 332888000 3048000 1844000 8958000 6680000 247242000 341412000 565211000 561165000 27046000 23234000 1106709000 1137646000 -33970000 27838000 1664996000 1749883000 -1951000 -853000 1663045000 1749030000 1910287000 2090442000 80000 136000 349886402 348817472 11432000 8064000 20776000 11455000 1549000 411000 2461000 798000 9883000 7653000 18315000 10657000 9774000 3560000 16720000 5009000 3062000 0 11024000 0 -2953000 4093000 -9429000 5648000 6504000 4005000 13616000 5133000 3631000 2300000 8221000 3471000 18437000 11488000 42196000 18781000 2546000 2647000 4982000 4418000 684000 408000 1371000 726000 31802000 20848000 70386000 32529000 -34755000 -16755000 -79815000 -26881000 3734000 9442000 11485000 11528000 -794000 -741000 -1966000 -939000 -35880000 197310000 77488000 525526000 40000000 0 40000000 0 0 3368000 0 25601000 -8000 0 786000 16243000 -72948000 202643000 47793000 526757000 -107703000 185888000 -32022000 499876000 0 0 0 0 -107703000 185888000 -32022000 499876000 -106977000 185999000 -30937000 500090000 -726000 -111000 -1085000 -214000 -107703000 185888000 -32022000 499876000 51871000 17947000 -61821000 21845000 51871000 17947000 -61821000 21845000 -55832000 203835000 -93843000 521721000 -55070000 203947000 -92745000 521932000 -762000 -112000 -1098000 -211000 -55832000 203835000 -93843000 521721000 -0.31 0.56 -0.09 1.57 -0.31 0.16 -0.09 0.41 349075408 334665873 348946439 317940749 349075408 374676595 348946439 364872093 348817472 563165000 25483000 1213686000 -85877000 -1189000 1715268000 1770000 1770000 1068930 1329000 -1328000 1000 717000 717000 776000 776000 345000 345000 345000 -106977000 -726000 -107703000 51907000 -36000 51871000 349886402 565211000 27046000 1106709000 -33970000 -1951000 1663045000 333020377 421340000 12244000 285736000 -5975000 0 713345000 76000 76000 3000000 617000 -67000 550000 2647000 2647000 73228 56000 -45000 -425000 -414000 50938 1171000 1171000 185999000 -111000 185888000 17948000 -1000 17947000 336144543 423108000 14779000 471310000 11973000 -112000 921058000 348817472 561165000 23234000 1137646000 27838000 -853000 1749030000 3500000 3500000 1068930 1329000 -1328000 1000 1482000 1482000 717000 717000 2000000 158000 2158000 -30937000 -1085000 -32022000 -61808000 -13000 -61821000 349886402 565211000 27046000 1106709000 -33970000 -1951000 1663045000 178720022 175001000 11263000 -27945000 -9870000 100000 148549000 149831154 248302000 248302000 3718000 3718000 7390961 2034000 -596000 1438000 4418000 4418000 151468 318000 -306000 -835000 -823000 50938 1171000 1171000 500090000 -214000 499876000 21843000 2000 21845000 336144543 423108000 14779000 471310000 11973000 -112000 921058000 -32022000 499876000 11024000 0 4982000 4418000 2879000 1174000 -1966000 -939000 77488000 525526000 769000 15498000 40000000 0 1097000 -184000 1437000 0 2158000 0 -307000 745000 30570000 21591000 -77193000 -56769000 124576000 556876000 203678000 0 0 1658000 769000 19614000 0 15990000 13344000 20918000 0 89000 2754000 470000 23974000 12222000 39799000 -588609000 0 85000 1184000 160000 0 1809556000 0 619000 1000 1450000 0 836000 0 3718000 0 48715000 0 48309000 0 15971000 -1183000 1791431000 -51416000 36079000 -89993000 1182132000 1199693000 23927000 1109700000 1206059000 90000 589000 11575000 7871000 Background<div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Cronos Group Inc. (“Cronos Group” or the “Company”) was incorporated on August 21, 2012 under the Business Corporations Act (Ontario). Effective July 9, 2020, the Company’s legal existence was continued to the Province of British Columbia and under the British Columbia Business Corporations Act. The Company’s common shares are currently listed on the Toronto Stock Exchange (“TSX”) and Nasdaq Global Market (“Nasdaq”) under the ticker symbol “CRON.”</span></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Cronos Group is an innovative global cannabinoid company, with international production and distribution across five continents. The Company is committed to building disruptive intellectual property by advancing cannabis research, technology and product development and is building an iconic brand portfolio. Cronos Group’s brand portfolio includes PEACE NATURALS</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">™</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, a global wellness platform; two adult-use brands, COVE</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">™</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> and Spinach</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">™</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">; and two U.S. hemp-derived consumer products brands, Lord Jones</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">™</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> and PEACE+</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">™</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">.</span></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Cronos Group has established four strategic joint ventures in Canada, Israel, and Colombia. One of these strategic joint ventures, Cronos Israel (as defined herein) is consolidated for financial reporting purposes. The Company also holds approximately 31% of the issued capital of Cronos Australia Limited (“Cronos Australia”) and accounts for its investment in Cronos Australia under the equity method of accounting. For additional discussion regarding the joint ventures and strategic investment, see Note 6.</span></div> 5 2 2 4 0.31 Summary of Significant Accounting Policies <div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">(a)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt;">Basis of Presentation</span></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The interim condensed consolidated financial statements of Cronos Group are unaudited. They have been prepared in accordance with Generally Accepted Accounting Principles in the United States (“U.S. GAAP”) for interim financial information and with applicable rules and regulations of the U.S. Securities and Exchange Commission relating to interim financial statements. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three and six months ended June 30, 2020 are not necessarily indicative of the results that may be expected for any other reporting period.</span></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">These condensed consolidated financial statements should be read in conjunction with the Company’s consolidated financial statements and related notes included in its Annual Report on Form 10-K/A for the year ended December 31, 2019 (the “Annual Financial Statements”).</span></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">(b)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt;">Basis of Consolidation</span></div><div style="text-align:justify;margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The accompanying condensed consolidated financial statements include the accounts of the Company, and all entities in which the Company has a controlling voting interest and/or is the primary beneficiary of a variable interest as of and for the period presented. The Company consolidates the financial results of the following entities, which the Company controls:</span></div><div style="text-align:justify;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:33.000%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.466%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:18.000%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.466%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:18.000%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.466%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:18.002%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Subsidiaries</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Jurisdiction of Incorporation</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Incorporation Date</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;">Ownership Interest </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;vertical-align:top;">(ii)</sup></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><div style="margin-top:1pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Cronos Israel G.S. Cultivations Ltd. </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(i)</sup></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Israel</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">February 4, 2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">70%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="margin-top:1pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Cronos Israel G.S. Manufacturing Ltd. </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(i)</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Israel</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 4, 2018</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">90%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="margin-top:1pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Cronos Israel G.S. Store Ltd. </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(i)</sup></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Israel</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28, 2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">90%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="margin-top:1pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Cronos Israel G.S. Pharmacies Ltd. </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(i)</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Israel</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">February 15, 2018</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">90%</span></td></tr></table></div><div style="text-indent:-27pt;padding-left:27pt;text-align:justify;margin-top:3pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(i) </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;">These Israeli entities are collectively referred to as “Cronos Israel.”</span></div><div style="text-indent:-27pt;padding-left:27pt;text-align:justify;margin-bottom:6pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(ii)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;"> “Ownership interest” is defined as the proportionate share of net income to which the Company is entitled; equity interest may differ from ownership interest. </span></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In the condensed consolidated statements of net income (loss) and comprehensive income (loss), the net income (loss) and comprehensive income (loss) are attributed to the equity holders of the Company and to the non-controlling interests. Non-controlling interests in the equity of Cronos Israel are presented separately in the shareholders’ equity (deficit) section of the condensed consolidated balance sheets and condensed consolidated statements of changes in equity (deficit). All intercompany transactions and balances are eliminated upon consolidation.</span></div><div style="margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">(c)  Goodwill and indefinite life intangible assets</span></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Goodwill and indefinite life intangible assets are reviewed for impairment annually or more frequently when events or changes in circumstances indicate that fair value of the reporting unit has been reduced to less than its carrying value. The Company performs an impairment test annually in the fourth quarter, by comparing the fair value of the reporting unit with its carrying amount, including goodwill. If the fair value of the reporting unit exceeds its carrying amount, goodwill is not considered to be impaired. An impairment charge would be recognized for the amount by which the carrying amount exceeds the reporting unit’s fair value. The Company determined that it has two reporting units: the U.S. reporting unit and the Rest of World reporting unit. </span></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">During the three months ended June 30, 2020, the Company concluded that the projected impact of the COVID-19 pandemic on its sales and revenues in the near term, together with the volatility in the market conditions during the quarter represented potential indicators of impairment for the U.S. reporting unit. Accordingly, the Company performed an interim impairment analysis during the second quarter of 2020. See Note 13 for more information regarding intangibles assets and goodwill.</span></div> Basis of Presentation<div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The interim condensed consolidated financial statements of Cronos Group are unaudited. They have been prepared in accordance with Generally Accepted Accounting Principles in the United States (“U.S. GAAP”) for interim financial information and with applicable rules and regulations of the U.S. Securities and Exchange Commission relating to interim financial statements. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three and six months ended June 30, 2020 are not necessarily indicative of the results that may be expected for any other reporting period.</span></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">These condensed consolidated financial statements should be read in conjunction with the Company’s consolidated financial statements and related notes included in its Annual Report on Form 10-K/A for the year ended December 31, 2019 (the “Annual Financial Statements”).</span></div> Basis of ConsolidationThe accompanying condensed consolidated financial statements include the accounts of the Company, and all entities in which the Company has a controlling voting interest and/or is the primary beneficiary of a variable interest as of and for the period presented. In the condensed consolidated statements of net income (loss) and comprehensive income (loss), the net income (loss) and comprehensive income (loss) are attributed to the equity holders of the Company and to the non-controlling interests. Non-controlling interests in the equity of Cronos Israel are presented separately in the shareholders’ equity (deficit) section of the condensed consolidated balance sheets and condensed consolidated statements of changes in equity (deficit). All intercompany transactions and balances are eliminated upon consolidation. The Company consolidates the financial results of the following entities, which the Company controls:<div style="text-align:justify;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:33.000%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.466%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:18.000%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.466%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:18.000%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.466%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:18.002%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Subsidiaries</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Jurisdiction of Incorporation</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Incorporation Date</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;">Ownership Interest </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;vertical-align:top;">(ii)</sup></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><div style="margin-top:1pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Cronos Israel G.S. Cultivations Ltd. </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(i)</sup></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Israel</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">February 4, 2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">70%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="margin-top:1pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Cronos Israel G.S. Manufacturing Ltd. </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(i)</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Israel</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 4, 2018</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">90%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="margin-top:1pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Cronos Israel G.S. Store Ltd. </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(i)</sup></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Israel</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28, 2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">90%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="margin-top:1pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Cronos Israel G.S. Pharmacies Ltd. </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(i)</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Israel</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">February 15, 2018</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">90%</span></td></tr></table></div><div style="text-indent:-27pt;padding-left:27pt;text-align:justify;margin-top:3pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(i) </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;">These Israeli entities are collectively referred to as “Cronos Israel.”</span></div>(ii) “Ownership interest” is defined as the proportionate share of net income to which the Company is entitled; equity interest may differ from ownership interest. 0.70 0.90 0.90 0.90 Goodwill and indefinite life intangible assets<div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Goodwill and indefinite life intangible assets are reviewed for impairment annually or more frequently when events or changes in circumstances indicate that fair value of the reporting unit has been reduced to less than its carrying value. The Company performs an impairment test annually in the fourth quarter, by comparing the fair value of the reporting unit with its carrying amount, including goodwill. If the fair value of the reporting unit exceeds its carrying amount, goodwill is not considered to be impaired. An impairment charge would be recognized for the amount by which the carrying amount exceeds the reporting unit’s fair value. The Company determined that it has two reporting units: the U.S. reporting unit and the Rest of World reporting unit. </span></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">During the three months ended June 30, 2020, the Company concluded that the projected impact of the COVID-19 pandemic on its sales and revenues in the near term, together with the volatility in the market conditions during the quarter represented potential indicators of impairment for the U.S. reporting unit. Accordingly, the Company performed an interim impairment analysis during the second quarter of 2020. See Note 13 for more information regarding intangibles assets and goodwill.</span></div> 2 New Accounting Pronouncements<div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">(a)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt;">Adoption of new accounting pronouncements</span></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">On January 1, 2020, the Company adopted ASU No. 2018-13, Disclosure Framework – Changes to the Disclosure Requirements for Fair Value Measurement (Topic 820) (“ASU No. 2018-13”). ASU No. 2018-13 adds, modifies, and removes certain fair value measurement disclosure requirements. The adoption of this standard was applied prospectively and did not have a material impact on the Company’s condensed consolidated financial statements.</span></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">On January 1, 2020, the Company adopted ASU No. 2018-15, Intangibles – Goodwill and Other Internal-use-software (Subtopic 350-40): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract (“ASU No. 2018-15”). ASU No. 2018-15 amends current guidance to align the accounting for costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing costs associated with developing or obtaining internal-use software. The guidance in ASU No. 2018-15 is effective for annual and interim periods beginning after December 15, 2019, with early adoption permitted. The adoption of this standard was applied prospectively and did not have a material impact on the Company’s condensed consolidated financial statements.</span></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">On January 1, 2020, the Company adopted ASU No. 2017-04, Intangibles – Goodwill and Other (Topic 350) – Simplifying the Test for Goodwill Impairment (“ASU No. 2017-04”). ASU No. 2017-04 eliminates step 2 from the goodwill impairment test and instead requires an entity to measure the impairment of goodwill assigned to a reporting unit if the carrying value of assets and liabilities assigned to the reporting unit, including goodwill, exceeds the reporting unit’s fair value. The guidance in ASU No. 2017-04 is effective for annual and interim goodwill tests completed by the Company beginning on January 1, 2020. The adoption of this standard was applied prospectively and the Company follows a one-step model for goodwill impairment. </span></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">(b)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt;">New accounting pronouncements not yet adopted</span></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In January 2020, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2020-01, Investments-Equity Securities (Topic 321), Investments-Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815) (“ASU No. 2020-01”). ASU No. 2020-01 clarifies the interaction of accounting for the transition into and out of the equity method. The new standard also clarifies the accounting for measuring certain purchased options and forward contracts to acquire investments. The guidance in ASU No. 2020-01 is effective for annual and interim periods beginning after December 15, 2020, with early adoption permitted. The Company is currently evaluating the effect of the adoption of ASU No. 2020-01, but anticipates that the adoption will not have a material impact on its condensed consolidated financial statements.</span></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes (“ASU No. 2019-12”). ASU No. 2019-12 eliminates certain exceptions and simplifies the application of U.S. GAAP-related changes in enacted tax laws or rates and employee stock option plans. ASU No. 2019-12 is effective for annual and interim periods beginning after December 15, 2020. Early adoption is permitted. The Company is currently evaluating the effect of the adoption of ASU No. 2019-12, but anticipates that the adoption will not have a material impact on its condensed consolidated financial statements.</span></div> New Accounting Pronouncements<div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">(a)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt;">Adoption of new accounting pronouncements</span></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">On January 1, 2020, the Company adopted ASU No. 2018-13, Disclosure Framework – Changes to the Disclosure Requirements for Fair Value Measurement (Topic 820) (“ASU No. 2018-13”). ASU No. 2018-13 adds, modifies, and removes certain fair value measurement disclosure requirements. The adoption of this standard was applied prospectively and did not have a material impact on the Company’s condensed consolidated financial statements.</span></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">On January 1, 2020, the Company adopted ASU No. 2018-15, Intangibles – Goodwill and Other Internal-use-software (Subtopic 350-40): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract (“ASU No. 2018-15”). ASU No. 2018-15 amends current guidance to align the accounting for costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing costs associated with developing or obtaining internal-use software. The guidance in ASU No. 2018-15 is effective for annual and interim periods beginning after December 15, 2019, with early adoption permitted. The adoption of this standard was applied prospectively and did not have a material impact on the Company’s condensed consolidated financial statements.</span></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">On January 1, 2020, the Company adopted ASU No. 2017-04, Intangibles – Goodwill and Other (Topic 350) – Simplifying the Test for Goodwill Impairment (“ASU No. 2017-04”). ASU No. 2017-04 eliminates step 2 from the goodwill impairment test and instead requires an entity to measure the impairment of goodwill assigned to a reporting unit if the carrying value of assets and liabilities assigned to the reporting unit, including goodwill, exceeds the reporting unit’s fair value. The guidance in ASU No. 2017-04 is effective for annual and interim goodwill tests completed by the Company beginning on January 1, 2020. The adoption of this standard was applied prospectively and the Company follows a one-step model for goodwill impairment. </span></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">(b)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt;">New accounting pronouncements not yet adopted</span></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In January 2020, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2020-01, Investments-Equity Securities (Topic 321), Investments-Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815) (“ASU No. 2020-01”). ASU No. 2020-01 clarifies the interaction of accounting for the transition into and out of the equity method. The new standard also clarifies the accounting for measuring certain purchased options and forward contracts to acquire investments. The guidance in ASU No. 2020-01 is effective for annual and interim periods beginning after December 15, 2020, with early adoption permitted. The Company is currently evaluating the effect of the adoption of ASU No. 2020-01, but anticipates that the adoption will not have a material impact on its condensed consolidated financial statements.</span></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes (“ASU No. 2019-12”). ASU No. 2019-12 eliminates certain exceptions and simplifies the application of U.S. GAAP-related changes in enacted tax laws or rates and employee stock option plans. ASU No. 2019-12 is effective for annual and interim periods beginning after December 15, 2020. Early adoption is permitted. The Company is currently evaluating the effect of the adoption of ASU No. 2019-12, but anticipates that the adoption will not have a material impact on its condensed consolidated financial statements.</span></div> Revenues from Contracts with Customers<div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Cronos Group disaggregates net revenues based on product type. For further discussion, see Note 18. Receivables were $3,477 as of June 30, 2020 (December 31, 2019 – $4,638). The Company recorded a current expected credit loss allowance on receivables of $80 as of June 30, 2020 (December 31, 2019 – $136). </span></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company offers discounts to customers for prompt payment and calculates cash discounts as a percentage of the list price based on historical experience and agreed-upon payment terms. The Company records an allowance for cash discounts, which is included as a contra-asset against receivables on the Company’s condensed consolidated balance sheets.</span></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Revenue is measured net of returns. As a result, the Company is required to estimate the amount of returns based on the historical data by customer and product type, adjusted for forward-looking information. This is recorded as a provision against accounts receivable on the Company’s consolidated balance sheets. The Company estimates sales returns based principally on historical volume and return rates, as a reduction to revenues. The difference between actual sales and estimated sales returns is recorded in the period in which the actual amounts become known. These differences, if any, have not had a material impact on the Company’s condensed consolidated financial statements. </span></div>Upon return, products can be extracted from dried cannabis, resold, or destroyed depending on the nature of the product. The Company has assessed that the amount recoverable from returned products for the six months ended June 30, 2020 is not material. 3477000 4638000 80000 136000 Inventory<div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Inventory is comprised of the following items:</span></div><div style="text-align:justify;margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:63.000%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.605%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:13.694%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.605%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:13.696%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">As of</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Raw materials</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,488 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,469 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Work-in-progress – dry cannabis</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">21,772 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,538 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Work-in-progress – cannabis extracts</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">19,210 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">17,975 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Finished goods – dry cannabis</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,505 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,798 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Finished goods – cannabis extracts</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,716 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,624 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Supplies and consumables</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">525 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,639 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">53,216 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">38,043 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div><div style="text-align:justify;margin-top:12pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Inventory is written down for any obsolescence such as slow-moving or non-marketable products, or when the net realizable value of inventory is less than the carrying value. For the three and six months ended June 30, 2020, the Company recorded write-downs related to inventory of $3,062 and $11,024, respectively. </span></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">There were no inventory write-downs for the six months ended June 30, 2019.</span></div> <div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Inventory is comprised of the following items:</span></div><div style="text-align:justify;margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:63.000%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.605%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:13.694%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.605%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:13.696%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">As of</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Raw materials</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,488 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,469 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Work-in-progress – dry cannabis</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">21,772 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,538 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Work-in-progress – cannabis extracts</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">19,210 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">17,975 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Finished goods – dry cannabis</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,505 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,798 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Finished goods – cannabis extracts</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,716 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,624 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Supplies and consumables</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">525 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,639 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">53,216 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">38,043 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div> 5488000 2469000 21772000 11538000 19210000 17975000 4505000 1798000 1716000 2624000 525000 1639000 53216000 38043000 3062000 11024000 0 Investments and Advances to Joint Ventures<div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Variable Interest Entities</span></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company holds variable interests in Cronos Growing Company Inc. (“Cronos GrowCo”), Natuera S.à.r.l (“Natuera”), MedMen Canada Inc. (“MedMen Canada”) and Cannasoul Lab Services Ltd. (“CLS”).</span></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Cronos GrowCo is a joint venture incorporated under the Canada Business Corporations Act (“CBCA”) on June 14, 2018 with the objective of building a cannabis production greenhouse, applying for cannabis licenses under the Cannabis Act (Canada), and growing, cultivating, extracting, producing and selling cannabis in accordance with such licenses. Cronos Group holds variable interests in Cronos GrowCo through its ownership of 50% of Cronos GrowCo’s common shares and senior secured debt in Cronos GrowCo. The Company has also agreed to purchase a minimum amount of Cronos GrowCo’s cannabis product annually, subject to Cronos GrowCo’s receipt of all applicable licenses and permits. Cronos GrowCo’s economic performance is driven by the quantity and strains of cannabis grown. The joint venture partners mutually determine the quantity and strains of cannabis grown. </span></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Natuera is a joint venture registered in Luxembourg with the objective of cultivating and commercializing medical cannabis to serve the export market. Cronos holds variable interests in Natuera through its ownership of 50% of Natuera’s common shares and other debt in the entity. Natuera’s economic performance is driven by the quantity and strains of cannabis to be grown. The joint venture partners mutually determine the quantity and strains of cannabis grown.</span></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">MedMen Canada is a joint venture incorporated under the CBCA on March 13, 2018, with the objective of the retail sale and marketing of cannabis products in Canada. MedMen Canada holds the exclusive license to the MedMen brand in Canada for a minimum term of 20 years. Cronos holds variable interests in MedMen Canada through its ownership of 50% of MedMen Canada’s common shares and other subordinated debt in the entity. MedMen Canada’s economic performance is driven by the quantity and strains of cannabis sold. Subject to applicable law, the joint venture partners mutually determine the quantity and strains of cannabis to be sold in MedMen Canada’s retail stores, if and when stores are opened. </span></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company’s investments in Cronos GrowCo, Natuera and MedMen Canada are exposed to economic variability from each entity’s performance, however the Company does not consolidate the entities as it does not have the power to direct the activities that most significantly impact the joint ventures’ economic performance. Thus, Cronos Group is not considered the primary beneficiary of the entity. These investments are accounted for as equity method investments classified as “Investments in equity accounted investees” in the consolidated balance sheets.</span></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">CLS is a wholly owned subsidiary of Cannasoul Analytics Ltd., incorporated with the purpose of establishing a commercial cannabis analytical testing laboratory located on the premises of Cronos Israel (the “Cannasoul Collaboration”). Cronos Israel will advance ILS 8,297 (approximately $2,446) by a non-recourse loan to CLS over a period of two years from April 1, 2020 for the capital and operating expenditures of the laboratory. The loan will bear interest at 3.5% annually. Cronos Israel will receive 70% of the profits of the laboratory until such time as it has recovered 150% of the amounts advanced to CLS, after which time it will receive 50% of the laboratory profits. As a result, the Company is exposed to economic variability from CLS’s performance. The Company does not consolidate CLS as it does not have the power to direct the activities that most significantly impact the entity’s economic performance; thus, the Company is not considered the primary beneficiary of the entity. The carrying amount of the non-recourse loan is recorded under loans receivable and the full loan amount, ILS 8,297, represents the Company’s maximum potential exposure to losses through the Cannasoul Collaboration. See Note 10 for further information regarding loans receivable.</span></div><div style="text-align:justify;margin-top:12pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">(a)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt;">Net investment in equity accounted investees</span></div><div style="margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">A reconciliation of the carrying amount of the investments in associates and joint ventures is as follows:</span></div><div style="text-align:justify;margin-top:12pt;margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:41.888%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:9.250%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:19.527%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.605%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:19.530%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Carrying Amount</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Ownership %</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31, 2019</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Cronos Australia</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(i)</sup></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">31%</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(346)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cronos GrowCo</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">50%</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">933 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,501 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">MedMen Canada</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">50%</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Natuera</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">50%</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(598)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">933 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">557 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div><div style="text-indent:-27pt;padding-left:27pt;text-align:justify;margin-top:3pt;margin-bottom:6pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;vertical-align:top;">(i) </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;">On October 25, 2019, Cronos Australia issued 40 million new shares in an initial public offering at an offering price of A$0.50 per share. The Company’s ownership in Cronos Australia decreased from 50% to 31% on November 7, 2019 when Cronos Australia began trading on the Australian Securities Exchange. This resulted in a reconsideration event, which required the reassessment of the Company’s VIE conclusion. Upon reconsideration, the Company determined that the entity was no longer a VIE as of December 31, 2019 and is now reported under the equity method.</span></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company’s share of net earnings (losses) from equity investments accounted for under the equity method of accounting:</span></div><div style="text-align:justify;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:35.361%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.444%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.327%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.444%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.605%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.444%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.327%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.448%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">For the three months ended June 30,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">For the six months ended June 30,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Whistler Medicinal Marijuana Company (“Whistler”)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">29 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Cronos Australia</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(i)</sup></div></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(235)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(397)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(235)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(641)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cronos GrowCo</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(190)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(38)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(501)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(27)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">MedMen Canada</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Natuera</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(ii)</sup></div></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(369)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(304)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1,230)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(304)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(794)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(741)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1,966)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(939)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div><div style="text-indent:-27pt;padding-left:27pt;text-align:justify;margin-top:6pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;vertical-align:top;">(i) </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;">The Company’s share of accumulated net losses in excess of its equity investment and advances in Cronos Australia was $512 for the six months ended June 30, 2020 (June 30, 2019 – $nil).</span></div><div style="text-indent:-27pt;padding-left:27pt;margin-bottom:6pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;vertical-align:top;">(ii) </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;">The Company’s share of accumulated net losses in excess of its equity investment in Natuera has been applied as a loss allowance on the loan receivable. See Note 6(b) and Note 10.</span></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">(b)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt;">Advances to Joint Venture</span></div><div style="text-align:justify;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:46.055%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:7.166%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.327%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.166%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.327%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.166%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.327%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.166%;"/><td style="width:1.0%;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td style="width:0.1%;"/><td style="width:1.327%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.173%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;">MedMen Canada</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;vertical-align:top;">(i)</sup></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cronos GrowCo</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;">Cronos Australia </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;vertical-align:top;">(ii)</sup></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Natuera</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">As of January 1, 2020</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">471 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18,966 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">19,437 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">Credit loss allowance </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">(iii)</sup></div></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Effect from foreign exchange</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(20)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(819)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(839)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:12pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">As of June 30, 2020</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">451 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18,147 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18,598 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">As of January 1, 2019</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,244 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,970 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">475 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,689 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Advances (repayment)</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(852)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">15,494 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">274 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">219 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">15,135 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Advances to joint ventures recovered from (applied to) carrying amount of investments</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">35 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">22 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(779)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(224)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(946)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Effect from foreign exchange</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">44 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">480 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">30 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">559 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">As of December 31, 2019</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">471 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18,966 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">19,437 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div><div style="text-indent:-27pt;padding-left:27pt;text-align:justify;margin-top:6pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;vertical-align:top;">(i) </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;">Advance is unsecured, non-interest bearing, and there are no terms of repayment. </span></div><div style="text-indent:-27pt;padding-left:27pt;text-align:justify;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;vertical-align:top;">(ii) </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;">A$1,500 is governed by an unsecured loan bearing interest at a rate of 12% per annum, calculated and compounded daily, in arrears, on the amounts advanced from the date of each advance. The loan is due on January 1, 2022. If the loan is overdue, the outstanding amount bears interest at an additional 2% per annum. </span></div><div style="text-indent:-27pt;padding-left:27pt;text-align:justify;margin-bottom:6pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;vertical-align:top;">(iii) </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;">For the three months ended June 30, 2020, a reversal of $917 related to the credit loss allowance for Cronos GrowCo was recorded as the Company assessed its recoverability. As of June 30, 2020, total credit losses were $nil.</span></div> 0.50 0.50 P20Y 0.50 8297000 2446000 P2Y 0.035 0.70 1.50 0.50 8297000 Net investment in equity accounted investees<div style="margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">A reconciliation of the carrying amount of the investments in associates and joint ventures is as follows:</span></div><div style="text-align:justify;margin-top:12pt;margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:41.888%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:9.250%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:19.527%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.605%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:19.530%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Carrying Amount</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Ownership %</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31, 2019</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Cronos Australia</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(i)</sup></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">31%</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(346)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cronos GrowCo</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">50%</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">933 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,501 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">MedMen Canada</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">50%</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Natuera</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">50%</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(598)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">933 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">557 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div><div style="text-indent:-27pt;padding-left:27pt;text-align:justify;margin-top:3pt;margin-bottom:6pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;vertical-align:top;">(i) </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;">On October 25, 2019, Cronos Australia issued 40 million new shares in an initial public offering at an offering price of A$0.50 per share. The Company’s ownership in Cronos Australia decreased from 50% to 31% on November 7, 2019 when Cronos Australia began trading on the Australian Securities Exchange. This resulted in a reconsideration event, which required the reassessment of the Company’s VIE conclusion. Upon reconsideration, the Company determined that the entity was no longer a VIE as of December 31, 2019 and is now reported under the equity method.</span></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company’s share of net earnings (losses) from equity investments accounted for under the equity method of accounting:</span></div><div style="text-align:justify;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:35.361%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.444%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.327%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.444%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.605%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.444%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.327%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.448%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">For the three months ended June 30,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">For the six months ended June 30,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Whistler Medicinal Marijuana Company (“Whistler”)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">29 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Cronos Australia</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(i)</sup></div></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(235)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(397)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(235)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(641)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cronos GrowCo</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(190)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(38)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(501)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(27)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">MedMen Canada</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Natuera</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(ii)</sup></div></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(369)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(304)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1,230)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(304)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(794)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(741)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1,966)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(939)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div><div style="text-indent:-27pt;padding-left:27pt;text-align:justify;margin-top:6pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;vertical-align:top;">(i) </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;">The Company’s share of accumulated net losses in excess of its equity investment and advances in Cronos Australia was $512 for the six months ended June 30, 2020 (June 30, 2019 – $nil).</span></div><div style="text-indent:-27pt;padding-left:27pt;margin-bottom:6pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;vertical-align:top;">(ii) </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;">The Company’s share of accumulated net losses in excess of its equity investment in Natuera has been applied as a loss allowance on the loan receivable. See Note 6(b) and Note 10.</span></div> 0.31 0 -346000 0.50 933000 1501000 0.50 0 0 0.50 0 -598000 933000 557000 40000000 0.50 0.50 0.31 0 0 0 29000 -235000 -397000 -235000 -641000 -190000 -38000 -501000 -27000 0 -2000 0 4000 -369000 -304000 -1230000 -304000 -794000 -741000 -1966000 -939000 512000 0 Advances to Joint Venture<div style="text-align:justify;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:46.055%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:7.166%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.327%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.166%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.327%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.166%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.327%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.166%;"/><td style="width:1.0%;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td style="width:0.1%;"/><td style="width:1.327%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.173%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;">MedMen Canada</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;vertical-align:top;">(i)</sup></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cronos GrowCo</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;">Cronos Australia </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;vertical-align:top;">(ii)</sup></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Natuera</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">As of January 1, 2020</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">471 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18,966 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">19,437 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">Credit loss allowance </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">(iii)</sup></div></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Effect from foreign exchange</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(20)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(819)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(839)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:12pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">As of June 30, 2020</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">451 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18,147 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18,598 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">As of January 1, 2019</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,244 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,970 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">475 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,689 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Advances (repayment)</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(852)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">15,494 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">274 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">219 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">15,135 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Advances to joint ventures recovered from (applied to) carrying amount of investments</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">35 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">22 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(779)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(224)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(946)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Effect from foreign exchange</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">44 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">480 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">30 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">559 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">As of December 31, 2019</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">471 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18,966 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">19,437 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div><div style="text-indent:-27pt;padding-left:27pt;text-align:justify;margin-top:6pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;vertical-align:top;">(i) </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;">Advance is unsecured, non-interest bearing, and there are no terms of repayment. </span></div><div style="text-indent:-27pt;padding-left:27pt;text-align:justify;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;vertical-align:top;">(ii) </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;">A$1,500 is governed by an unsecured loan bearing interest at a rate of 12% per annum, calculated and compounded daily, in arrears, on the amounts advanced from the date of each advance. The loan is due on January 1, 2022. If the loan is overdue, the outstanding amount bears interest at an additional 2% per annum. </span></div><div style="text-indent:-27pt;padding-left:27pt;text-align:justify;margin-bottom:6pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;vertical-align:top;">(iii) </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;">For the three months ended June 30, 2020, a reversal of $917 related to the credit loss allowance for Cronos GrowCo was recorded as the Company assessed its recoverability. As of June 30, 2020, total credit losses were $nil.</span></div> 471000 18966000 0 0 19437000 0 0 0 0 0 -20000 -819000 0 0 -839000 451000 18147000 0 0 18598000 1244000 2970000 475000 0 4689000 -852000 15494000 274000 219000 15135000 35000 22000 -779000 -224000 -946000 44000 480000 30000 5000 559000 471000 18966000 0 0 19437000 1500000 0.12 0.02 -917000 0 Other Investments<div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Other investments consist of investments in common shares and warrants of several companies in the cannabis industry. As of June 30, 2020, the Company did not hold any other investments. </span></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">During the six months ended June 30, 2020, in connection with the achievement of a milestone related to the Whistler transaction described below, the Company received 578,101 shares of Aurora Cannabis Inc. (“Aurora”). The Company sold all of the Aurora shares on March 6, 2020 for gross proceeds of $769 recorded as an other item in other income (expenses). The Company expects to further receive Aurora common shares upon the satisfaction of one milestone remaining, which has not been recognized in these condensed consolidated financial statements. The exact number of Aurora common shares to be issued to the Company following the satisfaction of such milestone will be determined in reference to the five-day volume weighted average price of Aurora common shares immediately prior to the achievement of the applicable milestone. No transactions occurred during the three months ended June 30, 2020.</span></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">On March 4, 2019, the Company sold all 2,563 shares of Whistler, representing approximately 19.0% of Whistler’s issued and outstanding common shares, to Aurora, in connection with Aurora's acquisition of Whistler (the “Whistler Transaction”). As a result of the closing of the Whistler Transaction, the Company received 2,524,341 Aurora common shares. During the six months ended June 30, 2019, the Company sold all 2,524,341 common shares of Aurora, for gross proceeds of $19,259 recorded as an other item in other income (expenses). No transactions occurred during the three months ended June 30, 2019.</span></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">During the six months ended June 30, 2019, the Company sold all remaining 11,062 common shares of Canopy Growth Corporation (“Canopy”) for gross proceeds of $355. The gains and losses on the Canopy investment were classified as fair value through net income. No transactions occurred during the three months ended June 30, 2019.</span></div> 578101 769000 1 5 2563 0.190 2524341 2524341 19259000 11062 355000 Accumulated Other Comprehensive Income (Loss) <div style="margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following are continuity schedules of accumulated other comprehensive income (loss):</span></div><div style="margin-bottom:3pt;"><span><br/></span></div><div style="margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.472%;"><tr><td style="width:1.0%;"/><td style="width:42.710%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:10.552%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.492%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.552%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.492%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.552%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.492%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.558%;"/><td style="width:1.0%;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Three months ended June 30,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Six months ended June 30,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net unrealized gain (loss) on revaluation and disposal of other investments</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:0.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance beginning of period</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:0.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cumulative effect from adoption of ASU 2016-01</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance as of June 30</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net foreign exchange gain (loss) on translation</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:0.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance beginning of period</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(85,882)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(5,980)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">27,833 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(9,875)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:0.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net unrealized (loss) gain</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">51,907 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">17,948 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(61,808)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">21,843 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance as of June 30</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(33,975)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,968 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(33,975)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,968 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total accumulated other comprehensive income (loss)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(33,970)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,973 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(33,970)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,973 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/></tr></table></div> <div style="margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following are continuity schedules of accumulated other comprehensive income (loss):</span></div><div style="margin-bottom:3pt;"><span><br/></span></div><div style="margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.472%;"><tr><td style="width:1.0%;"/><td style="width:42.710%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:10.552%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.492%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.552%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.492%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.552%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.492%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.558%;"/><td style="width:1.0%;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Three months ended June 30,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Six months ended June 30,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net unrealized gain (loss) on revaluation and disposal of other investments</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:0.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance beginning of period</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:0.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cumulative effect from adoption of ASU 2016-01</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance as of June 30</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net foreign exchange gain (loss) on translation</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:0.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance beginning of period</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(85,882)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(5,980)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">27,833 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(9,875)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:0.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net unrealized (loss) gain</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">51,907 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">17,948 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(61,808)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">21,843 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance as of June 30</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(33,975)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,968 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(33,975)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,968 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total accumulated other comprehensive income (loss)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(33,970)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,973 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(33,970)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,973 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/></tr></table></div> 5000 5000 5000 5000 0 0 0 0 5000 5000 5000 5000 -85882000 -5980000 27833000 -9875000 51907000 17948000 -61808000 21843000 -33975000 11968000 -33975000 11968000 -33970000 11973000 -33970000 11973000 Leases<div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company has entered into leases primarily for land-use rights, office premises and equipment used in the production of cannabis and related products. The Company’s leases have terms which range from three years to six years, excluding land use rights, which generally extend to 15 years. These leases often include options to extend the term of the lease for up to 10 years. When it is reasonably certain that the option will be exercised, the impact of the option is included in the lease term for purposes of determining total future lease payments. </span></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Operating leases greater than one year are included in right-of-use assets and operating lease liabilities. Finance leases are included in property, plant and equipment on the Company’s consolidated balance sheet. </span></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">During the six months ended June 30, 2020, the Company recognized two new operating leases for office premises which are included within the lease obligation and right-of-use lines in the condensed consolidated balance sheet. </span></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In June 2020, the Company terminated an operating lease for office premises. The lease was removed from the lease obligation and right-of-use balances in the condensed consolidated balance sheet.</span></div><div style="margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company’s finance leases were not material as of June 30, 2020 and December 31, 2019.</span></div> P3Y P6Y P15Y P10Y 2 Loans Receivable, net <div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:21.055%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:21.055%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.466%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:22.444%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.466%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:1.466%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:22.448%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-bottom:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">As of</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="6" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="6" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2020</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="6" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31, 2019</span></td><td colspan="3" style="display:none;"/></tr><tr><td colspan="6" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Current portion</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="6" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="padding-left:6.75pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Natuera Series A loan </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(i)</sup></div></td><td colspan="3" style="display:none;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,984 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,575 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="6" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="padding-left:6.75pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Cronos GrowCo Credit Facility </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(ii)</sup></div></td><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,474 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="6" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Add: Accrued interest</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">89 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="6" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total current portion of loans receivable</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,458 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,664 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="6" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Long term portion</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="6" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="padding-left:6.75pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Cronos GrowCo Credit Facility </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(ii)</sup></div></td><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">50,582 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">31,678 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="6" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="padding-left:6.75pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">2645485 Ontario Inc. (</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;">“</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Mucci</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;">”</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">) Promissory Note </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(iii)</sup></div></td><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,793 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12,587 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="6" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="padding-left:6.75pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Cannasoul Collaboration Loan </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(iv)</sup></div></td><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,174 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="6" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Add: Accrued interest</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,822 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">702 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="6" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total long-term portion of loans receivable</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">65,371 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">44,967 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="6" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total loans receivable</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">69,829 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">49,631 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div><div style="text-indent:-27pt;padding-left:27pt;text-align:justify;margin-top:12pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;vertical-align:top;">(i)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt;">On September 27, 2019, the Company entered into a master loan agreement (the “Series A Loan”) for $4,575 with Natuera with effect as of August 29, 2019. The total aggregate principal amount of the Series A Loan is $9,150, of which the Company has committed to fund 50% and its joint venture partner has committed to fund the remaining 50%. Outstanding principal amounts bear interest at a fixed annual rate of 5.67% with a maturity date of August 29, 2020. As of June 30, 2020, accrued interest is recorded in other receivables. Subsequent to June 30, 2020, an amendement to the agreement was executed. Refer to Note 25.</span></div><div style="padding-left:27pt;text-align:justify;margin-top:3pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;">For the six months ended June 30, 2020, a loss allowance of $1,591 was recorded against the Natuera Series A Loan related to the Company’s share of net loss from Natuera in excess of the carrying value of the equity method investment. Refer to Note 6.</span></div><div style="text-indent:-27pt;padding-left:27pt;text-align:justify;margin-top:6pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;vertical-align:top;">(ii)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:20.66pt;">On August 23, 2019, the Company entered into a credit agreement with Cronos GrowCo in respect of a C$100,000 ($73,660) secured non-revolving term loan credit facility (the “GrowCo Credit Facility”). The GrowCo Credit Facility will mature on March 31, 2031 and will bear interest at varying rates based on the Canadian prime rate as announced by the Bank of Montreal. Interest began to accrue as of the closing date of the GrowCo Credit Facility and is payable on a quarterly basis until maturity, except that any interest accrued prior to March 31, 2021 will be payable no later than December 31, 2021. Repayment of principal will be made on a quarterly basis commencing on March 31, 2021. The credit facility is secured by substantially all present and after acquired property of Cronos GrowCo and its subsidiaries. Mucci, the other 50% shareholder of Cronos GrowCo, has provided a limited recourse guarantee in favor of Cronos GrowCo, secured by Mucci’s shares in Cronos GrowCo. As of June 30, 2020, Cronos GrowCo had drawn C$72,150 ($53,145) from the Cronos GrowCo Credit Facility.</span></div><div style="padding-left:27pt;text-align:justify;margin-top:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;">For the six months ended June 30, 2020, a current expected credit loss allowance of $1,089 was recorded against the GrowCo Facility.</span></div><div style="text-indent:-27pt;padding-left:27pt;text-align:justify;margin-top:6pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;vertical-align:top;">(iii)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.22pt;">On June 28, 2019, the Company entered into a promissory note receivable agreement (the “Mucci Promissory Note”) for C$16,350 ($12,043) with Mucci. The outstanding principal amount of the Mucci Promissory Note bears interest at 3.95% annually and is due within 90 days of demand. The Company does not intend to demand the loan within 12 months. Interest accrued under the Mucci Promissory Note until July 1, 2021 is payable by way of capitalization on the principal amount and interest thereafter must be paid in cash on a quarterly basis. The Mucci Promissory Note is secured by a general security agreement covering all the assets of Mucci.</span></div><div style="padding-left:27pt;text-align:justify;margin-top:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;">For the six months ended June 30, 2020, a current expected credit loss allowance of $250 has been recorded against the Mucci loan.</span></div><div style="text-indent:-27pt;padding-left:27pt;text-align:justify;margin-top:6pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;vertical-align:top;">(iv)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.5pt;">On April 1, 2020, Cronos Israel entered into the Cannasoul Collaboration. Cronos Israel has agreed to advance approximately ILS 8,297 (approximately $2,446) by a non-recourse loan to CLS over a period of two years for the capital and operating expenditures of the laboratory. The outstanding principal on the loan bears interest at 3.5% annually and will be repaid through the profits generated from the Cannasoul Collaboration. As of June 30, 2020, CLS has received the first installment of ILS 4,149 (approximately $1,198).</span></div><div style="padding-left:27pt;text-align:justify;margin-top:6pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;">For the six months ended June 30, 2020, a current expected credit loss allowance of $24 has been recorded against the Cannasoul Collaboration loan.</span></div> <div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:21.055%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:21.055%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.466%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:22.444%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.466%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:1.466%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:22.448%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-bottom:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">As of</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="6" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="6" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2020</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="6" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31, 2019</span></td><td colspan="3" style="display:none;"/></tr><tr><td colspan="6" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Current portion</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="6" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="padding-left:6.75pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Natuera Series A loan </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(i)</sup></div></td><td colspan="3" style="display:none;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,984 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,575 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="6" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="padding-left:6.75pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Cronos GrowCo Credit Facility </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(ii)</sup></div></td><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,474 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="6" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Add: Accrued interest</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">89 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="6" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total current portion of loans receivable</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,458 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,664 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="6" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Long term portion</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="6" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="padding-left:6.75pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Cronos GrowCo Credit Facility </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(ii)</sup></div></td><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">50,582 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">31,678 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="6" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="padding-left:6.75pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">2645485 Ontario Inc. (</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;">“</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Mucci</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;">”</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">) Promissory Note </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(iii)</sup></div></td><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,793 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12,587 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="6" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="padding-left:6.75pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Cannasoul Collaboration Loan </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(iv)</sup></div></td><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,174 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="6" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Add: Accrued interest</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,822 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">702 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="6" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total long-term portion of loans receivable</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">65,371 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">44,967 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="6" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total loans receivable</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">69,829 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">49,631 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div><div style="text-indent:-27pt;padding-left:27pt;text-align:justify;margin-top:12pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;vertical-align:top;">(i)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt;">On September 27, 2019, the Company entered into a master loan agreement (the “Series A Loan”) for $4,575 with Natuera with effect as of August 29, 2019. The total aggregate principal amount of the Series A Loan is $9,150, of which the Company has committed to fund 50% and its joint venture partner has committed to fund the remaining 50%. Outstanding principal amounts bear interest at a fixed annual rate of 5.67% with a maturity date of August 29, 2020. As of June 30, 2020, accrued interest is recorded in other receivables. Subsequent to June 30, 2020, an amendement to the agreement was executed. Refer to Note 25.</span></div><div style="padding-left:27pt;text-align:justify;margin-top:3pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;">For the six months ended June 30, 2020, a loss allowance of $1,591 was recorded against the Natuera Series A Loan related to the Company’s share of net loss from Natuera in excess of the carrying value of the equity method investment. Refer to Note 6.</span></div><div style="text-indent:-27pt;padding-left:27pt;text-align:justify;margin-top:6pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;vertical-align:top;">(ii)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:20.66pt;">On August 23, 2019, the Company entered into a credit agreement with Cronos GrowCo in respect of a C$100,000 ($73,660) secured non-revolving term loan credit facility (the “GrowCo Credit Facility”). The GrowCo Credit Facility will mature on March 31, 2031 and will bear interest at varying rates based on the Canadian prime rate as announced by the Bank of Montreal. Interest began to accrue as of the closing date of the GrowCo Credit Facility and is payable on a quarterly basis until maturity, except that any interest accrued prior to March 31, 2021 will be payable no later than December 31, 2021. Repayment of principal will be made on a quarterly basis commencing on March 31, 2021. The credit facility is secured by substantially all present and after acquired property of Cronos GrowCo and its subsidiaries. Mucci, the other 50% shareholder of Cronos GrowCo, has provided a limited recourse guarantee in favor of Cronos GrowCo, secured by Mucci’s shares in Cronos GrowCo. As of June 30, 2020, Cronos GrowCo had drawn C$72,150 ($53,145) from the Cronos GrowCo Credit Facility.</span></div><div style="padding-left:27pt;text-align:justify;margin-top:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;">For the six months ended June 30, 2020, a current expected credit loss allowance of $1,089 was recorded against the GrowCo Facility.</span></div><div style="text-indent:-27pt;padding-left:27pt;text-align:justify;margin-top:6pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;vertical-align:top;">(iii)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.22pt;">On June 28, 2019, the Company entered into a promissory note receivable agreement (the “Mucci Promissory Note”) for C$16,350 ($12,043) with Mucci. The outstanding principal amount of the Mucci Promissory Note bears interest at 3.95% annually and is due within 90 days of demand. The Company does not intend to demand the loan within 12 months. Interest accrued under the Mucci Promissory Note until July 1, 2021 is payable by way of capitalization on the principal amount and interest thereafter must be paid in cash on a quarterly basis. The Mucci Promissory Note is secured by a general security agreement covering all the assets of Mucci.</span></div><div style="padding-left:27pt;text-align:justify;margin-top:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;">For the six months ended June 30, 2020, a current expected credit loss allowance of $250 has been recorded against the Mucci loan.</span></div><div style="text-indent:-27pt;padding-left:27pt;text-align:justify;margin-top:6pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;vertical-align:top;">(iv)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.5pt;">On April 1, 2020, Cronos Israel entered into the Cannasoul Collaboration. Cronos Israel has agreed to advance approximately ILS 8,297 (approximately $2,446) by a non-recourse loan to CLS over a period of two years for the capital and operating expenditures of the laboratory. The outstanding principal on the loan bears interest at 3.5% annually and will be repaid through the profits generated from the Cannasoul Collaboration. As of June 30, 2020, CLS has received the first installment of ILS 4,149 (approximately $1,198).</span></div><div style="padding-left:27pt;text-align:justify;margin-top:6pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;">For the six months ended June 30, 2020, a current expected credit loss allowance of $24 has been recorded against the Cannasoul Collaboration loan.</span></div> 2984000 4575000 1474000 0 0 89000 4458000 4664000 50582000 31678000 11793000 12587000 1174000 0 1822000 702000 65371000 44967000 69829000 49631000 4575000 9150000 0.50 0.50 0.0567 1591000 100000000 73660000 0.50 72150000 53145000 1089000 16350000 12043000 0.0395 P90D P12M 250000 250000 8297000 2446000 P2Y 0.035 4149000 1198000 24000 Derivative Liabilities <div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">On March 8, 2019, the Company closed the previously announced investment in the Company (the “Altria Investment”) by Altria Group, Inc. (“Altria”), pursuant to a subscription agreement dated December 7, 2018. As of the closing date of the Altria Investment, the Altria Investment consisted of 149,831,154 common shares of the Company as of the closing date, issued to a wholly owned subsidiary of Altria and one warrant of the Company (the “Altria Warrant”), refer to Note 15(a), issued to a wholly owned subsidiary of Altria. As of the closing date of the Altria Investment, Altria beneficially held an approximately 45% ownership interest in the Company (calculated on a non-diluted basis). As summarized in this note, if exercised in full on such date, the exercise of the Altria Warrant would have resulted in Altria holding a total ownership interest in the Company of approximately 55% (calculated on a non-diluted basis). Pursuant to the investor rights agreement between the Company and Altria, entered into in connection with the closing of the Altria Investment (the “Investor Rights Agreement”), the Company granted Altria certain rights, among others, summarized in this note.</span></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The summaries below are qualified entirely by the terms and conditions fully set out in the Investor Rights Agreement and the Altria Warrant, as applicable. </span></div><div style="text-indent:-18pt;padding-left:36pt;text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">a.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt;">The Altria Warrant entitles the holder, subject to certain qualifications and limitations, to subscribe for and purchase up to an additional 10% of the common shares of Cronos (approximately 77.8 million common shares at June 30, 2020) at a per share exercise price of C$19.00 which expires on March 8, 2023. </span></div><div style="text-indent:-18pt;padding-left:36pt;text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">b.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;">The Company granted to Altria, subject to certain qualifications and limitations, upon the occurrence of certain issuances of common shares of the Company executed by the Company (including issuances pursuant to the R&amp;D partnership with Ginkgo Bioworks Inc. (“Ginkgo”) (the “Ginkgo Strategic Partnership”), which is discussed in Note 19(a)(i) below, the right to purchase up to such number of common shares of the Company in order to maintain their ownership percentage of issued and outstanding common shares of the Company immediately preceding any issuance of shares by the Company (“Pre-emptive Rights”), at the same price per common share of the Company at which the common shares are sold in the relevant issuance. The price per common share of the Company to be paid by Altria pursuant to its exercise of its Pre-emptive Rights related to the Ginkgo Strategic Partnership will be C$16.25 per common share. These rights may not be exercised if Altria’s ownership percentage of the issued and outstanding shares of the Company falls below 20%. </span></div><div style="text-indent:-18pt;padding-left:36pt;text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">c.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt;">In addition to (and without duplication of) the Pre-emptive Rights, the Company granted to Altria, subject to certain qualifications and limitations, the right to subscribe for common shares of the Company issuable in connection with the exercise, conversion or exchange of convertible securities of the Company issued prior to March 8, 2019 or thereafter (excluding any convertible securities of the Company owned by Altria or any of its subsidiaries), a share incentive plan of the Company, the exercise of any right granted by the Company pro rata to all shareholders of the Company to purchase additional common shares and/or securities of the Company, bona fide bank debt, equipment financing or non-equity interim financing transactions that contemplate an equity component or bona fide acquisitions (including acquisitions of assets or rights under a license or otherwise), mergers or similar business combination transactions or joint ventures involving the Company in order to maintain their ownership percentage of issued and outstanding common shares of the Company immediately preceding any such transactions (“Top-up Rights”). </span></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The price per common share to be paid by Altria pursuant to the exercise of its Top-up Rights will be, subject to certain limited exceptions, the 10-day volume-weighted average price of the common shares of the Company on the TSX for the ten full days preceding such exercise by Altria, provided that the price per common share of the Company to be paid by Altria pursuant to the exercise of its Top-up Rights in connection with the issuance of common shares of the Company pursuant to the exercise of options or warrants that were outstanding as of March 8, 2019 will be C$16.25 per common share without any set off, counterclaim, deduction, or withholding. These rights may not be exercised if Altria’s ownership percentage of the issued and outstanding shares of the Company falls below 20%. The Altria Warrant, Pre-emptive Rights, and fixed price Top-up Rights have been classified as derivative liabilities; related transaction costs of $22,355 were expensed as financing costs during the year ended December 31, 2019. </span></div><div style="margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">A reconciliation of the carrying amounts of the derivative liability is presented below:</span></div><div style="margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.722%;"><tr><td style="width:1.0%;"/><td style="width:16.245%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.902%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.610%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.902%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.610%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.902%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.610%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.902%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.610%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.907%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">April 1, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Gain) / Loss on revaluation</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Exercise of Rights</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Effect from foreign exchange</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">As of June 30, 2020</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(a) Altria Warrant</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">132,366 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">30,052 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,540 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">165,958 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(b) Pre-emptive Rights</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13,070 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,610 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">500 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">16,180 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(c) Top-up Rights</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">20,740 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,218 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(727)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,072 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">23,576 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">166,176 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">35,880 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(727)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,112 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">205,714 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div><div style="margin-top:12pt;margin-bottom:6pt;"><span><br/></span></div><div style="margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.722%;"><tr><td style="width:1.0%;"/><td style="width:16.245%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.902%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.610%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.902%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.610%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.902%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.610%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.902%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.610%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.907%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">January 1, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Gain) / Loss on revaluation</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Exercise of Rights</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Effect from foreign exchange</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">As of June 30, 2020</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(a) Altria Warrant</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">234,428 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(58,052)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(10,418)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">165,958 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(b) Pre-emptive Rights</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12,787 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,925 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(532)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">16,180 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(c) Top-up Rights</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">49,945 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(23,361)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(727)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2,281)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">23,576 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">297,160 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(77,488)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(727)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(13,231)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">205,714 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div><div style="text-align:justify;margin-top:6pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">
Fluctuations in the Company’s share price are a primary driver for the changes in the derivative valuations during each reporting period. As the share price decreases for each of the related derivative instruments, the liability of the instrument generally decreases. Share price is one of the significant observable inputs used in the fair value measurement of each of the Company’s derivative instruments. During the six months ended June 30, 2020, the Company’s share price decreased from December 31, 2019 resulting in a gain on revaluation of $77,488.</span></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The fair values of the derivative liabilities were determined using the Black-Scholes pricing model as of June 30, 2020 and December 31, 2019 applying the following inputs:</span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:33.416%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:7.305%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.327%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.861%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.327%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.305%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.327%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.305%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.327%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.861%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.327%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.312%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">As of June 30, 2020</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">As of December 31, 2019</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Altria Warrant</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Pre-emptive Rights</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Top-up Rights</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Altria Warrant</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Pre-emptive Rights</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Top-up Rights</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Share price at valuation date (per share in C$)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$8.18</span></td><td colspan="3" style="background-color:#cceeff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$8.18</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$8.18</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$9.97</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$9.97</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$9.97</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Subscription price (per share in C$)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$19.00</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$16.25</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$16.25</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$19.00</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$16.25</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$16.25</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="margin-top:1pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Weighted average risk-free interest rate </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(i)</sup></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.30%</span></td><td colspan="3" style="background-color:#cceeff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.29%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.26%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.69%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.73%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.71%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="margin-top:1pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Weighted average expected life (in years) </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(ii)</sup></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.68</span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.00</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.11</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.18</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.25</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.66</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="margin-top:1pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Expected annualized volatility</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"> (iii)</sup></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">91%</span></td><td colspan="3" style="background-color:#cceeff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">91%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">91%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">82%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">82%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">82%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Expected dividend yield</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">—%</span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">—%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">—%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">—%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">—%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">—%</span></td></tr></table></div><div style="text-indent:-27pt;padding-left:27pt;text-align:justify;margin-top:3pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(i)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;">The risk-free interest rate was based on Bank of Canada government treasury bills and bonds with a remaining term equal to the expected life of the derivative liabilities. The risk-free interest rate uses a range of approximate</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;">ly 0.21% to 0.61% as of June 30, 2020 (December 31, 2019 – 1.66% to 1.73%) for the Pre-emptive rights and Top-up rights.</span></div><div style="text-indent:-27pt;padding-left:27pt;text-align:justify;"><sup style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(ii)</sup><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;">The expected life in years represents the period of time that the derivative liabilities are expected to be outstanding. The expected life of the Pre-emptive Rights and Top-up Rights is determined based on the expected term of the underlying options, warrants, and shares, to which the Pre-emptive Rights and Top-up Rights are linked. The expected life uses a range of approximately 0.25 year to 5.5 year</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;">s as of June 30, 2020 (December 31, 2019 – 0.25 year to 6 years).</span></div><div style="text-indent:-27pt;padding-left:27pt;text-align:justify;margin-bottom:6pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(iii)</sup><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;vertical-align:top;"> </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;">Volatility was based on an equally weighted blended historical volatility level of the underlying equity securities of the Company and peer companies.</span></div><div style="text-align:justify;margin-bottom:3pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table quantifies each of the significant inputs described above and provides a sensitivity analysis of the impact on the reported values of the derivative liabilities. The sensitivity analysis for each significant input is performed by assuming a 10% decrease in the input while other significant inputs remain constant at management’s best estimate as of the respective dates. A decrease in the inputs noted below would cause a decrease in derivative liability and as of June 30, 2020, there would be an equal but opposite impact on net income (loss).</span></div><div style="margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.583%;"><tr><td style="width:1.0%;"/><td style="width:31.054%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.473%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.483%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.473%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.483%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.473%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.483%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.473%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.483%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.473%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.483%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.473%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.493%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="18" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Decrease as of June 30, 2020</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Decrease as of December 31, 2019</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Altria Warrant</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Pre-emptive Rights</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Top-up Rights</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Altria Warrant</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Pre-emptive Rights</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Top-up Rights</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Share price</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">26,300 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,779 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,939 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">36,436 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,743 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,577 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted average expected life</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14,249 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,744 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,272 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">17,471 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,366 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,178 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Expected annualized volatility</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">27,711 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,652 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,769 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">33,343 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,180 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7,714 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div><div style="text-align:justify;margin-top:6pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">These inputs are classified in Level 3 on the fair value hierarchy and are subject to volatility and several factors outside of the Company’s control, which could significantly affect the fair value of these derivative liabilities in future periods.</span></div> 149831154 1 0.45 0.55 0.10 77800000 19.00 16.25 0.20 P10D 10 16.25 0.20 22355000 <div style="margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">A reconciliation of the carrying amounts of the derivative liability is presented below:</span></div><div style="margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.722%;"><tr><td style="width:1.0%;"/><td style="width:16.245%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.902%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.610%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.902%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.610%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.902%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.610%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.902%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.610%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.907%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">April 1, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Gain) / Loss on revaluation</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Exercise of Rights</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Effect from foreign exchange</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">As of June 30, 2020</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(a) Altria Warrant</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">132,366 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">30,052 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,540 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">165,958 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(b) Pre-emptive Rights</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13,070 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,610 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">500 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">16,180 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(c) Top-up Rights</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">20,740 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,218 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(727)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,072 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">23,576 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">166,176 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">35,880 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(727)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,112 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">205,714 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div><div style="margin-top:12pt;margin-bottom:6pt;"><span><br/></span></div><div style="margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.722%;"><tr><td style="width:1.0%;"/><td style="width:16.245%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.902%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.610%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.902%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.610%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.902%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.610%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.902%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.610%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.907%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">January 1, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Gain) / Loss on revaluation</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Exercise of Rights</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Effect from foreign exchange</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">As of June 30, 2020</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(a) Altria Warrant</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">234,428 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(58,052)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(10,418)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">165,958 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(b) Pre-emptive Rights</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12,787 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,925 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(532)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">16,180 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(c) Top-up Rights</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">49,945 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(23,361)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(727)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2,281)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">23,576 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">297,160 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(77,488)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(727)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(13,231)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">205,714 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div>
 -132366000 -30052000 0 -3540000 -165958000 -13070000 -2610000 0 -500000 -16180000 -20740000 -3218000 727000 -1072000 -23576000 -166176000 -35880000 727000 -5112000 -205714000 -234428000 58052000 0 10418000 -165958000 -12787000 -3925000 0 532000 -16180000 -49945000 23361000 727000 2281000 -23576000 -297160000 77488000 727000 13231000 -205714000 77488000 <div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The fair values of the derivative liabilities were determined using the Black-Scholes pricing model as of June 30, 2020 and December 31, 2019 applying the following inputs:</span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:33.416%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:7.305%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.327%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.861%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.327%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.305%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.327%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.305%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.327%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.861%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.327%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.312%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">As of June 30, 2020</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">As of December 31, 2019</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Altria Warrant</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Pre-emptive Rights</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Top-up Rights</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Altria Warrant</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Pre-emptive Rights</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Top-up Rights</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Share price at valuation date (per share in C$)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$8.18</span></td><td colspan="3" style="background-color:#cceeff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$8.18</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$8.18</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$9.97</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$9.97</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$9.97</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Subscription price (per share in C$)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$19.00</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$16.25</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$16.25</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$19.00</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$16.25</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$16.25</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="margin-top:1pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Weighted average risk-free interest rate </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(i)</sup></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.30%</span></td><td colspan="3" style="background-color:#cceeff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.29%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.26%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.69%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.73%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.71%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="margin-top:1pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Weighted average expected life (in years) </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(ii)</sup></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.68</span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.00</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.11</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.18</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.25</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.66</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="margin-top:1pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Expected annualized volatility</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"> (iii)</sup></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">91%</span></td><td colspan="3" style="background-color:#cceeff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">91%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">91%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">82%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">82%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">82%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Expected dividend yield</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">—%</span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">—%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">—%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">—%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">—%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">—%</span></td></tr></table></div><div style="text-indent:-27pt;padding-left:27pt;text-align:justify;margin-top:3pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(i)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;">The risk-free interest rate was based on Bank of Canada government treasury bills and bonds with a remaining term equal to the expected life of the derivative liabilities. The risk-free interest rate uses a range of approximate</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;">ly 0.21% to 0.61% as of June 30, 2020 (December 31, 2019 – 1.66% to 1.73%) for the Pre-emptive rights and Top-up rights.</span></div><div style="text-indent:-27pt;padding-left:27pt;text-align:justify;"><sup style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(ii)</sup><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;">The expected life in years represents the period of time that the derivative liabilities are expected to be outstanding. The expected life of the Pre-emptive Rights and Top-up Rights is determined based on the expected term of the underlying options, warrants, and shares, to which the Pre-emptive Rights and Top-up Rights are linked. The expected life uses a range of approximately 0.25 year to 5.5 year</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;">s as of June 30, 2020 (December 31, 2019 – 0.25 year to 6 years).</span></div><div style="text-indent:-27pt;padding-left:27pt;text-align:justify;margin-bottom:6pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(iii)</sup><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;vertical-align:top;"> </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;">Volatility was based on an equally weighted blended historical volatility level of the underlying equity securities of the Company and peer companies.</span></div> 8.18 8.18 8.18 9.97 9.97 9.97 19.00 16.25 16.25 19.00 16.25 16.25 0.0030 0.0029 0.0026 0.0169 0.0173 0.0171 P2Y8M4D P2Y P1Y1M9D P3Y2M4D P1Y3M P1Y7M28D 0.91 0.91 0.91 0.82 0.82 0.82 0 0 0 0 0 0 0.0021 0.0061 0.0166 0.0173 P0Y3M P5Y6M P0Y3M P6Y <div style="text-align:justify;margin-bottom:3pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table quantifies each of the significant inputs described above and provides a sensitivity analysis of the impact on the reported values of the derivative liabilities. The sensitivity analysis for each significant input is performed by assuming a 10% decrease in the input while other significant inputs remain constant at management’s best estimate as of the respective dates. A decrease in the inputs noted below would cause a decrease in derivative liability and as of June 30, 2020, there would be an equal but opposite impact on net income (loss).</span></div><div style="margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.583%;"><tr><td style="width:1.0%;"/><td style="width:31.054%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.473%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.483%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.473%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.483%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.473%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.483%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.473%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.483%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.473%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.483%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.473%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.493%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="18" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Decrease as of June 30, 2020</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Decrease as of December 31, 2019</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Altria Warrant</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Pre-emptive Rights</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Top-up Rights</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Altria Warrant</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Pre-emptive Rights</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Top-up Rights</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Share price</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">26,300 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,779 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,939 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">36,436 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,743 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,577 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted average expected life</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14,249 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,744 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,272 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">17,471 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,366 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,178 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Expected annualized volatility</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">27,711 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,652 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,769 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">33,343 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,180 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7,714 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div> 26300000 2779000 4939000 36436000 2743000 9577000 14249000 1744000 1272000 17471000 2366000 2178000 27711000 2652000 4769000 33343000 2180000 7714000 Property, Plant and Equipment<div style="text-indent:-27pt;padding-left:29.25pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Property, plant and equipment, net consisted of the following:</span></div><div style="margin-top:12pt;margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:59.944%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.466%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:15.361%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.466%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:15.363%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="12" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-bottom:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">As of </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2020</span></td><td colspan="6" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31, 2019</span></td><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cost</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Land</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,618 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,727 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Building</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">146,685 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">150,324 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Furniture and equipment</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,394 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,156 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Computer equipment</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">651 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">687 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Leasehold improvements</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,116 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,789 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Construction in progress</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12,492 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,569 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Less: accumulated depreciation</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(13,666)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(9,443)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">164,290 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">161,809 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div><div style="margin-top:12pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Depreciation expense included in cost of sales relating to manufacturing equipment and production facilities for the six months ended June 30, 2020 was $759 (June 30, 2019 – $448). Depreciation expense included in operating expenses related to general office space and equipment for six months ended June 30, 2020 was $1,025 (June 30, 2019 – $425). The remaining depreciation is included in inventory. </span></div>For the six months ended June 30, 2020, there is $nil (June 30, 2019 – $367) of capitalized interest included in construction in progress. <div style="text-indent:-27pt;padding-left:29.25pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Property, plant and equipment, net consisted of the following:</span></div><div style="margin-top:12pt;margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:59.944%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.466%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:15.361%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.466%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:15.363%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="12" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-bottom:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">As of </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2020</span></td><td colspan="6" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31, 2019</span></td><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cost</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Land</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,618 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,727 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Building</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">146,685 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">150,324 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Furniture and equipment</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,394 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,156 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Computer equipment</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">651 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">687 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Leasehold improvements</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,116 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,789 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Construction in progress</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12,492 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,569 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Less: accumulated depreciation</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(13,666)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(9,443)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">164,290 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">161,809 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div> 3618000 3727000 146685000 150324000 11394000 10156000 651000 687000 3116000 2789000 12492000 3569000 13666000 9443000 164290000 161809000 759000 448000 1025000 425000 0 367000 Intangible Assets and Goodwill <div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The ongoing restrictions and closures experienced by retail stores in the U.S. as a result of the COVID-19 pandemic have negatively impacted sales and demand which has resulted in slower than expected revenue growth in the U.S. reporting unit for the three months ended June 30, 2020. The Company expects the revenue growth and operating results in the U.S. reporting unit to continue to be negatively impacted as the decrease in customer demand and retail closures are expected to continue as a result of the pandemic. The Company performed an interim impairment test during the three months ended June 30, 2020 on the U.S. reporting unit, which holds the Redwood goodwill, as well as the indefinite-lived intangible asset (Lord Jones™ brand) to determine whether the carrying amount of the reporting unit and intangible asset exceeded their respective fair values. The Company reassessed its estimates and forecasts during the second quarter to determine the fair values of the reporting unit and intangible asset. The fair values were determined using a discounted cash flow method on the reporting unit and the relief-from-royalty method on the Lord Jones™ brand. Based on these valuations, the carrying value exceeded the fair value resulting in an impairment on both the reporting unit as well as the Lord Jones™ brand. The Company does not believe the declines in fair values are temporary. The Company recorded $35.0 million of impairment charges on the U.S. reporting unit and $5.0 million on the Lord Jones™ brand for the three and six months ended June 30, 2020. </span></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">No impairment loss was recorded for either goodwill or intangible assets during the three and six months ended June 30, 2019.</span></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">(a)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt;">Intangible Assets</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Intangible assets are comprised of the following items: </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:27.583%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:11.194%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.772%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.333%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.772%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.333%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.772%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.333%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.772%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.336%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" rowspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted Average Amortization Period (in years)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="21" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">As of June 30, 2020</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cost</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accumulated Amortization</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Impairment charges</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Software </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(i)</sup></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">N/A</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">612 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(298)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">314 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Enterprise Resource Planning (“ERP”) system </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">(ii)</sup></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,570 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,570 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Health Canada licenses </span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">17</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8,255 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1,167)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7,088 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Lord Jones</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">™</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> brand</span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">N/A</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">64,000 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(5,000)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">59,000 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Trademarks</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">N/A</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">140 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">140 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Israeli Codes </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(iii)</sup></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">25</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">297 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(10)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">287 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">75,874 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1,475)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(5,000)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">69,399 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div><div style="text-indent:-27pt;padding-left:27pt;text-align:justify;margin-top:3pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;vertical-align:top;">(i)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt;">Software amortizes using a double declining method.</span></div><div style="text-indent:-27pt;padding-left:27pt;text-align:justify;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;vertical-align:top;">(ii)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:20.66pt;">During the six months ended June 30, 2020, the Company capitalized costs for the ERP system. As of June 30, 2020, the system is not yet available for use, resulting in no amortization being recorded against the asset.</span></div><div style="text-indent:-27pt;padding-left:27pt;text-align:justify;margin-bottom:6pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;vertical-align:top;">(iii)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.22pt;">The preliminary licenses granted to Kibbutz Gan Shmuel (the Cronos Israel joint venture partner) by the Medical Cannabis Unit of the Israeli Ministry of Health in early 2017 (the “Israeli Codes”) were transferred by non-controlling interests to Cronos Israel in exchange for their equity interests in the Cronos Israel entities specified above.</span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:27.583%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:13.694%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.355%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:14.944%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.466%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:14.944%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.466%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:14.948%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" rowspan="2" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" rowspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted Average Amortization Period (in years)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">As of December 31, 2019</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cost</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accumulated Amortization</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Software </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(i)</sup></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">N/A</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">541 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(202)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">339 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Health Canada licenses </span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">17</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8,627 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(976)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7,651 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Lord Jones</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">™</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> brand</span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">N/A</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">64,000 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">64,000 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Trademarks</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">N/A</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">36 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">36 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="margin-top:1pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Israeli Codes </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(ii)</sup></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">25</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">298 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">294 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">73,502 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1,182)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">72,320 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div><div style="text-indent:-27pt;padding-left:27pt;text-align:justify;margin-top:3pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;vertical-align:top;">(i)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt;">Software amortizes using a double declining method.</span></div><div style="text-indent:-27pt;padding-left:27pt;text-align:justify;margin-bottom:6pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;vertical-align:top;">(ii)  </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;">The Israeli Codes were transferred by non-controlling interests to Cronos Israel in exchange for their equity interests in the Cronos Israel entities specified above.</span></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The aggregate amortization for the six months ended June 30, 2020 was $</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">346</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> (June 30, 2019 – $301). Intangible asset additions in 2020 included the ERP system for $2,570. There was $37 related to disposals of software during the six months ended June 30, 2020. </span></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The amortization expense for the next five years on intangible assets in use is estimated to be as follows: 2021 – $565; 2022 – $553; 2023: $536; 2024 – $520; 2025 – $506. </span></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">(b)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt;">Goodwill</span></div><div style="margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:22.027%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.305%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.911%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.305%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.911%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.305%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.911%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.305%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.911%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.309%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">As of December 31, 2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Additions</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Impairment charges</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Effect of foreign exchange</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">As of June 30, 2020</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">OGBC</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">302 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(13)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">289 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Peace Naturals</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,078 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(45)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,033 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Redwood</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">213,414 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(35,000)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">178,414 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">214,794 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(35,000)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(58)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">179,736 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div> 35000000.0 5000000.0 0 0 <div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Intangible assets are comprised of the following items: </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:27.583%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:11.194%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.772%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.333%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.772%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.333%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.772%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.333%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.772%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.336%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" rowspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted Average Amortization Period (in years)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="21" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">As of June 30, 2020</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cost</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accumulated Amortization</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Impairment charges</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Software </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(i)</sup></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">N/A</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">612 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(298)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">314 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Enterprise Resource Planning (“ERP”) system </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">(ii)</sup></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,570 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,570 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Health Canada licenses </span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">17</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8,255 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1,167)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7,088 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Lord Jones</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">™</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> brand</span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">N/A</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">64,000 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(5,000)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">59,000 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Trademarks</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">N/A</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">140 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">140 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Israeli Codes </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(iii)</sup></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">25</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">297 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(10)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">287 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">75,874 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1,475)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(5,000)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">69,399 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div><div style="text-indent:-27pt;padding-left:27pt;text-align:justify;margin-top:3pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;vertical-align:top;">(i)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt;">Software amortizes using a double declining method.</span></div><div style="text-indent:-27pt;padding-left:27pt;text-align:justify;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;vertical-align:top;">(ii)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:20.66pt;">During the six months ended June 30, 2020, the Company capitalized costs for the ERP system. As of June 30, 2020, the system is not yet available for use, resulting in no amortization being recorded against the asset.</span></div><div style="text-indent:-27pt;padding-left:27pt;text-align:justify;margin-bottom:6pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;vertical-align:top;">(iii)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.22pt;">The preliminary licenses granted to Kibbutz Gan Shmuel (the Cronos Israel joint venture partner) by the Medical Cannabis Unit of the Israeli Ministry of Health in early 2017 (the “Israeli Codes”) were transferred by non-controlling interests to Cronos Israel in exchange for their equity interests in the Cronos Israel entities specified above.</span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:27.583%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:13.694%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.355%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:14.944%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.466%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:14.944%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.466%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:14.948%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" rowspan="2" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" rowspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted Average Amortization Period (in years)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">As of December 31, 2019</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cost</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accumulated Amortization</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Software </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(i)</sup></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">N/A</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">541 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(202)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">339 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Health Canada licenses </span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">17</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8,627 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(976)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7,651 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Lord Jones</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">™</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> brand</span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">N/A</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">64,000 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">64,000 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Trademarks</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">N/A</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">36 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">36 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="margin-top:1pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Israeli Codes </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(ii)</sup></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">25</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">298 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">294 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">73,502 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1,182)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">72,320 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div><div style="text-indent:-27pt;padding-left:27pt;text-align:justify;margin-top:3pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;vertical-align:top;">(i)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt;">Software amortizes using a double declining method.</span></div><div style="text-indent:-27pt;padding-left:27pt;text-align:justify;margin-bottom:6pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;vertical-align:top;">(ii)  </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;">The Israeli Codes were transferred by non-controlling interests to Cronos Israel in exchange for their equity interests in the Cronos Israel entities specified above.</span></div> <div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Intangible assets are comprised of the following items: </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:27.583%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:11.194%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.772%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.333%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.772%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.333%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.772%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.333%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.772%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.336%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" rowspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted Average Amortization Period (in years)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="21" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">As of June 30, 2020</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cost</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accumulated Amortization</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Impairment charges</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Software </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(i)</sup></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">N/A</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">612 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(298)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">314 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Enterprise Resource Planning (“ERP”) system </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">(ii)</sup></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,570 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,570 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Health Canada licenses </span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">17</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8,255 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1,167)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7,088 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Lord Jones</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">™</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> brand</span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">N/A</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">64,000 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(5,000)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">59,000 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Trademarks</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">N/A</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">140 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">140 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Israeli Codes </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(iii)</sup></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">25</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">297 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(10)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">287 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">75,874 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1,475)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(5,000)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">69,399 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div><div style="text-indent:-27pt;padding-left:27pt;text-align:justify;margin-top:3pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;vertical-align:top;">(i)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt;">Software amortizes using a double declining method.</span></div><div style="text-indent:-27pt;padding-left:27pt;text-align:justify;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;vertical-align:top;">(ii)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:20.66pt;">During the six months ended June 30, 2020, the Company capitalized costs for the ERP system. As of June 30, 2020, the system is not yet available for use, resulting in no amortization being recorded against the asset.</span></div><div style="text-indent:-27pt;padding-left:27pt;text-align:justify;margin-bottom:6pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;vertical-align:top;">(iii)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.22pt;">The preliminary licenses granted to Kibbutz Gan Shmuel (the Cronos Israel joint venture partner) by the Medical Cannabis Unit of the Israeli Ministry of Health in early 2017 (the “Israeli Codes”) were transferred by non-controlling interests to Cronos Israel in exchange for their equity interests in the Cronos Israel entities specified above.</span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:27.583%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:13.694%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.355%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:14.944%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.466%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:14.944%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.466%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:14.948%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" rowspan="2" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" rowspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted Average Amortization Period (in years)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">As of December 31, 2019</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cost</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accumulated Amortization</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Software </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(i)</sup></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">N/A</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">541 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(202)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">339 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Health Canada licenses </span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">17</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8,627 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(976)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7,651 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Lord Jones</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">™</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> brand</span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">N/A</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">64,000 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">64,000 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Trademarks</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">N/A</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">36 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">36 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="margin-top:1pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Israeli Codes </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(ii)</sup></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">25</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">298 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">294 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">73,502 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1,182)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">72,320 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div><div style="text-indent:-27pt;padding-left:27pt;text-align:justify;margin-top:3pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;vertical-align:top;">(i)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt;">Software amortizes using a double declining method.</span></div><div style="text-indent:-27pt;padding-left:27pt;text-align:justify;margin-bottom:6pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;vertical-align:top;">(ii)  </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;">The Israeli Codes were transferred by non-controlling interests to Cronos Israel in exchange for their equity interests in the Cronos Israel entities specified above.</span></div> 612000 298000 314000 P5Y 2570000 0 2570000 P17Y 8255000 1167000 7088000 64000000 5000000 59000000 140000 140000 P25Y 297000 10000 287000 75874000 1475000 5000000 69399000 541000 202000 339000 P17Y 8627000 976000 7651000 64000000 64000000 36000 36000 P25Y 298000 4000 294000 73502000 1182000 72320000 346000 301000 2570000 37000 565000 553000 536000 520000 506000 <table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:22.027%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.305%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.911%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.305%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.911%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.305%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.911%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.305%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.911%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.309%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">As of December 31, 2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Additions</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Impairment charges</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Effect of foreign exchange</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">As of June 30, 2020</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">OGBC</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">302 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(13)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">289 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Peace Naturals</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,078 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(45)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,033 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Redwood</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">213,414 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(35,000)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">178,414 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">214,794 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(35,000)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(58)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">179,736 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table> 302000 0 0 -13000 289000 1078000 0 0 -45000 1033000 213414000 0 35000000 0 178414000 214794000 0 35000000 -58000 179736000 General and Administrative Expenses <div style="margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">General and administrative expense are comprised of the following items:</span></div><div style="margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:36.472%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.050%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.305%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.050%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.305%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.355%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.305%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.050%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.308%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Three months ended June 30,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Six months ended June 30,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Salaries and wages</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,337 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,354 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13,803 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,348 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Professional and consulting</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,263 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,051 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8,849 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7,254 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Office and general</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,545 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,622 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,620 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,523 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Review costs related to restatement of 2019 interim financial statements </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(i)</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,459 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7,866 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,833 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">461 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,058 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">656 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18,437 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,488 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">42,196 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18,781 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div><div style="text-indent:-27pt;padding-left:27pt;text-align:justify;margin-top:3pt;margin-bottom:6pt;"><sup style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;vertical-align:top;">(i)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt;">These financial statement review costs include costs related to the restatement of the Company’s 2019 interim financial statements and costs related to the Company’s responses to request for information from various regulatory authorities relating to such restatement.</span></div> <div style="margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">General and administrative expense are comprised of the following items:</span></div><div style="margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:36.472%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.050%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.305%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.050%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.305%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.355%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.305%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.050%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.308%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Three months ended June 30,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Six months ended June 30,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Salaries and wages</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,337 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,354 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13,803 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,348 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Professional and consulting</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,263 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,051 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8,849 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7,254 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Office and general</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,545 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,622 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,620 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,523 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Review costs related to restatement of 2019 interim financial statements </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(i)</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,459 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7,866 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,833 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">461 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,058 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">656 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18,437 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,488 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">42,196 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18,781 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div><div style="text-indent:-27pt;padding-left:27pt;text-align:justify;margin-top:3pt;margin-bottom:6pt;"><sup style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;vertical-align:top;">(i)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt;">These financial statement review costs include costs related to the restatement of the Company’s 2019 interim financial statements and costs related to the Company’s responses to request for information from various regulatory authorities relating to such restatement.</span></div> 6337000 3354000 13803000 5348000 3263000 5051000 8849000 7254000 3545000 2622000 6620000 5523000 3459000 0 7866000 0 1833000 461000 5058000 656000 18437000 11488000 42196000 18781000 Share-based Payments<div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">(a)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt;">Warrants</span></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following is a summary of the changes in warrants during the six months ended June 30, 2020 and 2019:</span></div><div style="text-align:justify;margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:43.000%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:24.666%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.466%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:24.668%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted average exercise price (C$)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Number of warrants</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance as of January 1, 2020</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.26 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18,066,662 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance as of June 30, 2020</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.26 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18,066,662 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance as of January 1, 2019</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.26 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">25,457,623 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:12pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Exercise of warrants</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.36 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(7,390,961)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance as of June 30, 2019</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.22 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18,066,662 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div><div style="padding-left:42.75pt;text-align:justify;margin-bottom:3pt;"><span><br/></span></div><div style="text-align:justify;margin-top:6pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As of June 30, 2020, the Company had outstanding warrants as follows. For a description of the Altria Warrant, see Note 11.</span></div><div style="text-align:justify;margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:18.972%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.466%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:18.972%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.466%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:24.666%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.188%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:24.670%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Grant Date</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Expiry date</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted average exercise price (C$)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Number of warrants</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">October 8 – 28, 2015</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">October 8 – 28, 2020</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.31 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,976,610 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">May 13 – 27, 2016</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">May 13 – 27, 2021</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.25 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">15,090,052 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">As of June 30, 2020</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.26 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18,066,662 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">(b)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt;">Stock options</span></div><div style="text-indent:-18pt;padding-left:47.25pt;text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">(i)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:8.57pt;">Stock option plans</span></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company adopted an amended and restated stock option plan dated May 26, 2015 (the “2015 Stock Option Plan”) which was approved by shareholders of the Company at the annual general meeting of shareholders held on June 28, 2017. The 2015 Stock Option Plan allowed the Company’s Board of Directors (the “Board”) to award options to purchase shares to directors, officers, key employees and service providers of the Company. As of June 28, 2018, no further awards will be granted under the 2015 Stock Option Plan; however, shares may be purchased via option exercise by the holders of any outstanding options previously issued under the 2015 Stock Option Plan. As of June 30, 2020, options to purchase 10,486,569 Company common shares were outstanding under the 2015 Stock Option Plan.</span></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">On June 28, 2018, the shareholders of the Company approved a stock option plan (the “2018 Stock Option Plan”), which replaced the 2015 Stock Option Plan. As of June 25, 2020, the date on which the 2020 Omnibus Plan (as defined below) was approved by the shareholders of the Company, no further awards will be granted under the 2018 Stock Option Plan; however, shares may be purchased via option exercise by the holders of any outstanding options previously issued under the 2018 Stock Option Plan. As of June 30, 2020, options to purchase 1,727,979 Company common shares were outstanding under the 2018 Stock Option Plan. </span></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">On March 29, 2020, the Board adopted a new omnibus equity incentive plan (the “2020 Omnibus Plan”), which was approved by the shareholders of the Company at the annual and special meeting of shareholders held on June 25, 2020. The 2020 Omnibus Plan provides for grants of stock options, share appreciation rights, restricted shares, restricted share units and other share-based or cash-based awards, which are subject to terms as determined by the Compensation Committee of the Board, and awards may be granted to eligible employees, non-employee directors and consultants. As of June 30, 2020, no grants of options have been made under the 2020 Omnibus Plan.</span></div><div style="margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">For the three and six months ended June 30, 2020, the total stock-based compensation expense associated with the stock option plans was $1,770 (June 30, 2019 – $2,647) and $3,500 (June 30, 2019 – $4,418), respectively.</span></div><div style="text-indent:-18pt;padding-left:47.25pt;text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">(ii)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:5.8pt;"> Summary of changes</span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following is a summary of the changes during the six months ended June 30, 2020 and 2019:</span></div><div style="margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:40.916%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:15.916%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.466%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:15.916%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.466%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:15.920%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:9pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted average exercise price (C$)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Number of options</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted average remaining contractual term (years)</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance as of January 1, 2020</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.84 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14,149,502 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.56</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:12pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Exercise of options</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.05 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1,807,909)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:12pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cancellation, forfeiture and expiry of options</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">15.78 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(127,045)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance as of June 30, 2020</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.13 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12,214,548 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.05</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Exercisable at June 30, 2020</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.42 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8,688,645 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.78</span></td></tr><tr><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance as of January 1, 2019</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.99 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12,902,995 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.35</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:12pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Issuance of options</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">20.81 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,315,787 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:12pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Exercise of options</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.76 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(227,342)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:12pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cancellation, forfeiture and expiry of options</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.63 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2,895)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance as of June 30, 2019</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.66 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13,988,545 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.04</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Exercisable as of June 30, 2019</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.40</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,580,238 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.69</span></td></tr></table></div><div style="text-indent:-27pt;padding-left:54pt;text-align:justify;margin-top:12pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">(iii)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:12.03pt;">Fair value of options issued</span></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The fair value of the options issued was determined using the Black-Scholes option pricing model, using the following inputs:</span></div><div style="text-align:justify;margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:64.250%;"/><td style="width:1.0%;"/><td colspan="3" style="display:none;"/><td style="width:0.1%;"/><td style="width:2.577%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:28.973%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">For the six months ended June 30, 2019</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Share price at grant date (per share)</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">C$20.65 - C$24.75</span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Exercise price (per option)</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">C$20.65 - C$24.75</span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Risk-free interest rate</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">1.51% - 1.62%</span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Expected life of options (in years)</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Expected annualized volatility</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">80%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Expected dividend yield</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">—%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted average Black-Scholes value at grant date (per option)</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">C$13.29 - C$15.91</span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Forfeiture rate</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">—%</span></td></tr></table></div><div style="text-align:justify;margin-top:12pt;margin-bottom:6pt;"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">No s</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">tock options were granted under the 2018 Stock Option Plan or the 2020 Omnibus Plan during the six months ended June 30, 2020. During the six months ended June 30, 2019, the weighted average fair value per share at grant date of options was C$13.35. </span></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The expected life of the awards represents the period of time stock options are expected to be outstanding and is estimated considering vesting terms and employees’ and non-employees’ historical exercise and post-vesting employment termination behavior. Volatility was estimated by using the historical volatility of the Company, adjusted for the Company’s expectation of volatility going forward. The risk-free interest rate was based on the Bank of Canada government bonds with a remaining term equal to the expected life of the options at the grant date.</span></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">(c)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.91pt;">Restricted share units</span></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">On May 11, 2020, the Company issued an aggregate of 279,277 restricted stock units (“RSUs”) to certain employees in connection with the 2020 Omnibus Plan. Each RSU entitles the holder to receive upon vesting one common share of the Company. The fair value of these RSUs has been determined based on the quoted market price of the applicable exchange on the date of issuance of C$7.52 per share on TSX or $5.42 per share on NASDAQ. The RSUs vest annually in equal installments over a three-year period following the grant date and have no performance requirements.</span></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">On September 5, 2019, the Company issued an aggregate of 732,972 RSUs to certain employees in connection with the acquisition of four Redwood Holding Group, LLC subsidiaries (collectively, “Redwood”) and pursuant to Employment Inducement Award Plan. Each RSU entitles the holder to receive upon vesting one common share of the Company. The fair value of these RSUs has been determined based on the quoted market price on the date of issuance of C$15.34 per share. Under the terms of the corresponding RSU agreement, the RSUs vest on the third anniversary following the grant date and have no performance requirements. </span></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">On July 20, 2020, the Company entered into separation agreements with Robert Rosenheck and another Redwood Wellness, LLC (“Redwood”) employee pursuant to which they resigned from their employment with Redwood. In connection with such separation agreements, the 732972 outstanding and unvested RSUs as of July 20, 2020 to which they were entitled were accelerated and vested as of July 20, 2020. Refer to Note 25 for further information.</span></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">For the three and six months ended June 30, 2020, the Company recorded $776 and $1,482 (June 30, 2019 – $nil) in share-based compensation expense related to these RSUs, respectively. </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following is a summary of the changes in RSUs from January 1, 2020 to June 30, 2020: </span></div><div style="margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%;"><tr><td style="width:1.0%;"/><td style="width:41.393%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:25.399%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.608%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:25.400%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Number of RSUs</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Share-based reserve</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance as of January 1, 2020</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">732,972 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">889 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Issuance of RSUs</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">279,277 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:12pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Vesting of issued RSUs </span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,482 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance as of June 30, 2020</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,012,249 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,371 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div><div style="margin-top:12pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">No RSUs were granted or outstanding during the six months ended June 30, 2019.</span></div><div style="margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">(d)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt;">Deferred share units</span></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">On August 10, 2019, the Company established a cash-settled deferred share unit plan (“DSU Plan”) pursuant to which its non-executive directors receive deferred share units (“DSUs”). The DSU Plan is designed to promote a greater alignment of long-term interests between non-executive directors and shareholders. The number of DSUs granted under the DSU Plan (including fractional DSUs) is determined by dividing the amount of remuneration payable by the closing price as reported by the TSX on the trading day immediately preceding the day of grant. DSUs are payable at the time a non-executive director ceases to hold the office of director for any reason and are settled by a lump-sum cash payment, in accordance with the terms of the DSU Plan, based on the fair value of the DSUs at such time. The fair value of the cash payout is determined by multiplying the number of DSUs vested at the payout date by the closing price as reported by the TSX on the trading day immediately preceding the payout date. The fair value of the cash payout is determined at each reporting date based on the fair value of the Company’s common shares at the reporting date and is recorded within other liabilities.</span></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following is a summary of the changes in DSUs from January 1, 2020 to June 30, 2020:</span></div><div style="margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:41.194%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:25.361%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.883%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:25.362%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Number of DSUs</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Financial liability </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance as of January 1, 2020</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">33,397 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">255 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:12pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Liabilities settled</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(8,484)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(46)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:12pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Loss (gain) on revaluation </span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(56)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance as of June 30, 2020</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">24,913 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">153 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div>No DSUs were granted or outstanding during the six months ended June 30, 2019. <div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following is a summary of the changes in warrants during the six months ended June 30, 2020 and 2019:</span></div><div style="text-align:justify;margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:43.000%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:24.666%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.466%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:24.668%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted average exercise price (C$)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Number of warrants</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance as of January 1, 2020</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.26 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18,066,662 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance as of June 30, 2020</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.26 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18,066,662 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance as of January 1, 2019</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.26 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">25,457,623 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:12pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Exercise of warrants</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.36 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(7,390,961)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance as of June 30, 2019</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.22 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18,066,662 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following is a summary of the changes in DSUs from January 1, 2020 to June 30, 2020:</span></div><div style="margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:41.194%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:25.361%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.883%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:25.362%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Number of DSUs</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Financial liability </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance as of January 1, 2020</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">33,397 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">255 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:12pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Liabilities settled</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(8,484)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(46)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:12pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Loss (gain) on revaluation </span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(56)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance as of June 30, 2020</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">24,913 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">153 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div> 0.26 18066662 0.26 18066662 0.26 25457623 0.36 7390961 0.22 18066662 <div style="text-align:justify;margin-top:6pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As of June 30, 2020, the Company had outstanding warrants as follows. For a description of the Altria Warrant, see Note 11.</span></div><div style="text-align:justify;margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:18.972%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.466%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:18.972%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.466%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:24.666%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.188%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:24.670%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Grant Date</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Expiry date</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted average exercise price (C$)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Number of warrants</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">October 8 – 28, 2015</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">October 8 – 28, 2020</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.31 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,976,610 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">May 13 – 27, 2016</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">May 13 – 27, 2021</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.25 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">15,090,052 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">As of June 30, 2020</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.26 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18,066,662 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div> 0.31 2976610 0.25 15090052 0.26 18066662 0 10486569 1727979 0 1770000 2647000 3500000 4418000 <div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following is a summary of the changes during the six months ended June 30, 2020 and 2019:</span></div><div style="margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:40.916%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:15.916%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.466%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:15.916%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.466%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:15.920%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:9pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted average exercise price (C$)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Number of options</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted average remaining contractual term (years)</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance as of January 1, 2020</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.84 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14,149,502 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.56</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:12pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Exercise of options</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.05 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1,807,909)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:12pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cancellation, forfeiture and expiry of options</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">15.78 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(127,045)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance as of June 30, 2020</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.13 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12,214,548 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.05</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Exercisable at June 30, 2020</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.42 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8,688,645 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.78</span></td></tr><tr><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance as of January 1, 2019</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.99 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12,902,995 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.35</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:12pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Issuance of options</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">20.81 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,315,787 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:12pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Exercise of options</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.76 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(227,342)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:12pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cancellation, forfeiture and expiry of options</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.63 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2,895)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance as of June 30, 2019</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.66 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13,988,545 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.04</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Exercisable as of June 30, 2019</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.40</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,580,238 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.69</span></td></tr></table></div> 4.84 14149502 P2Y6M21D 2.05 1807909 15.78 127045 5.13 12214548 P2Y18D 3.42 8688645 P1Y9M10D 2.99 12902995 P3Y4M6D 20.81 1315787 3.76 227342 1.63 2895 4.66 13988545 P3Y14D 2.40 6580238 P2Y8M8D <div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The fair value of the options issued was determined using the Black-Scholes option pricing model, using the following inputs:</span></div><div style="text-align:justify;margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:64.250%;"/><td style="width:1.0%;"/><td colspan="3" style="display:none;"/><td style="width:0.1%;"/><td style="width:2.577%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:28.973%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">For the six months ended June 30, 2019</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Share price at grant date (per share)</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">C$20.65 - C$24.75</span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Exercise price (per option)</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">C$20.65 - C$24.75</span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Risk-free interest rate</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">1.51% - 1.62%</span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Expected life of options (in years)</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Expected annualized volatility</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">80%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Expected dividend yield</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">—%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted average Black-Scholes value at grant date (per option)</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">C$13.29 - C$15.91</span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Forfeiture rate</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">—%</span></td></tr></table></div> 20.65 24.75 20.65 24.75 0.0151 0.0162 P5Y 0.80 0 13.29 15.91 0 0 13.35 279277 1 7.52 5.42 P3Y 732972 4 1 15.34 732972 776000 1482000 0 0 <div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following is a summary of the changes in RSUs from January 1, 2020 to June 30, 2020: </span></div><div style="margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%;"><tr><td style="width:1.0%;"/><td style="width:41.393%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:25.399%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.608%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:25.400%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Number of RSUs</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Share-based reserve</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance as of January 1, 2020</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">732,972 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">889 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Issuance of RSUs</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">279,277 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:12pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Vesting of issued RSUs </span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,482 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance as of June 30, 2020</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,012,249 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,371 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div> 732972 889000 279277 1482000 1012249 2371000 0 0 33397 255000 8484 46000 56000 24913 153000 0 0 Earnings (loss) Per Share<div style="margin-bottom:3pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Basic and diluted earnings (loss) per share are calculated using the following numerators and denominators:</span></div><div style="margin-bottom:3pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%;"><tr><td style="width:1.0%;"/><td style="width:41.254%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:10.934%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.468%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.934%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.468%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.934%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.468%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.940%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">For the three months ended June 30,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">For the six months ended June 30,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:2.25pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:2.25pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Basic earnings per share computation</span></td><td colspan="3" style="background-color:#cceeff;text-align:center;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="background-color:#cceeff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="background-color:#cceeff;text-align:center;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:center;vertical-align:middle;border-top:1pt solid #000000;padding-left:47.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:center;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net income (loss) attributable to common shareholders of Cronos Group</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(106,977)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">185,999 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(30,937)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">500,090 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted average number of common shares outstanding</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">349,075,408 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">334,665,873 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">348,946,439 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">317,940,749 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> Basic earnings per share </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.31)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.56 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.09)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.57 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;">Diluted earnings per share computation</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;vertical-align:top;">(i)</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:top;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:top;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net income (loss) used in the computation of basic earnings per share</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(106,977)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">185,999 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(30,937)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">500,090 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Adjustment for gain (loss) on revaluation of derivative liabilities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(729)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(126,032)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(729)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(350,758)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:12.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net income (loss) used in the computation of diluted income per share</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(107,706)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">59,967 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(31,666)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">149,332 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="height:9pt;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="height:9pt;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="height:9pt;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted average number of common shares outstanding used in the computation of basic earnings per share</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">349,075,408 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">334,665,873 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">348,946,439</span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">317,940,749</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="padding-left:6.75pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Dilutive effect of warrants </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(i)</sup></div></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">19,287,262 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">21,239,056</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="padding-left:6.75pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Dilutive effect of stock options </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(i)</sup></div></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,992,464 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,291,914</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="padding-left:6.75pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Dilutive effect of restricted share units </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(i)</sup></div></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="padding-left:6.75pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Dilutive effect of Altria Warrant </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(i)</sup></div></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,100,465 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13,633,605</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="padding-left:6.75pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Dilutive effect of Top-up Rights – exercised and exercisable fixed price </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(i)</sup></div></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">630,531 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">766,769</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted average number of common shares for computation of diluted income (loss) per share</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">349,075,408 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">374,676,595 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">348,946.439 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">364,872,093 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Diluted earnings per share</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.31)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.16 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.09)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.41 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div><div style="text-indent:-27pt;padding-left:27pt;margin-bottom:3pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;vertical-align:top;">(i) </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;"> In computing diluted earnings per share, incremental common shares are not considered in periods in which a net loss is reported, as the inclusion of the common share equivalents would be anti-dilutive.</span></div><div style="margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following securities were not included in the computation of diluted shares outstanding because the effect would be anti-dilutive or because conditions for contingently issuable shares were not satisfied at the end of the reporting periods. </span></div><div style="margin-top:12pt;margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:40.222%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:11.194%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.466%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.194%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.466%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.194%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.466%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.198%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Three months ended June 30,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Six months ended June 30,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Ginkgo Equity Milestones</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14,674,904 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14,674,904 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14,674,904 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14,674,904 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Pre-emptive Rights</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12,006,740 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12,006,740 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12,006,740 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12,006,740 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Top-up Rights – fixed price</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">26,686,413 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">26,686,413 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Top-up Rights – market price</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,941,349 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">25,150,434 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,941,349 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">25,150,434 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Altria Warrant</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">77,752,533 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,076,553 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">77,752,533 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,076,553 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Stock options</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,495,235 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">51,830 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,547,256 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">51,830 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Warrants</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">17,536,558 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">17,521,903 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Restricted share units</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,012,249 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,012,249 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total anti-dilutive securities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">162,091,326 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">52,960,461 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">162,158,002 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">52,960,461 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div> <div style="margin-bottom:3pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Basic and diluted earnings (loss) per share are calculated using the following numerators and denominators:</span></div><div style="margin-bottom:3pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%;"><tr><td style="width:1.0%;"/><td style="width:41.254%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:10.934%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.468%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.934%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.468%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.934%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.468%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.940%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">For the three months ended June 30,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">For the six months ended June 30,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:2.25pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:2.25pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Basic earnings per share computation</span></td><td colspan="3" style="background-color:#cceeff;text-align:center;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="background-color:#cceeff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="background-color:#cceeff;text-align:center;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:center;vertical-align:middle;border-top:1pt solid #000000;padding-left:47.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:center;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net income (loss) attributable to common shareholders of Cronos Group</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(106,977)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">185,999 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(30,937)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">500,090 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted average number of common shares outstanding</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">349,075,408 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">334,665,873 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">348,946,439 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">317,940,749 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> Basic earnings per share </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.31)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.56 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.09)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.57 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;">Diluted earnings per share computation</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;vertical-align:top;">(i)</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:top;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:top;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net income (loss) used in the computation of basic earnings per share</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(106,977)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">185,999 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(30,937)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">500,090 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Adjustment for gain (loss) on revaluation of derivative liabilities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(729)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(126,032)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(729)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(350,758)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:12.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net income (loss) used in the computation of diluted income per share</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(107,706)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">59,967 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(31,666)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">149,332 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="height:9pt;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="height:9pt;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="height:9pt;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted average number of common shares outstanding used in the computation of basic earnings per share</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">349,075,408 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">334,665,873 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">348,946,439</span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">317,940,749</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="padding-left:6.75pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Dilutive effect of warrants </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(i)</sup></div></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">19,287,262 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">21,239,056</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="padding-left:6.75pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Dilutive effect of stock options </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(i)</sup></div></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,992,464 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,291,914</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="padding-left:6.75pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Dilutive effect of restricted share units </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(i)</sup></div></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="padding-left:6.75pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Dilutive effect of Altria Warrant </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(i)</sup></div></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,100,465 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13,633,605</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="padding-left:6.75pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Dilutive effect of Top-up Rights – exercised and exercisable fixed price </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(i)</sup></div></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">630,531 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">766,769</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted average number of common shares for computation of diluted income (loss) per share</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">349,075,408 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">374,676,595 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">348,946.439 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">364,872,093 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Diluted earnings per share</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.31)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.16 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.09)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.41 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div><div style="text-indent:-27pt;padding-left:27pt;margin-bottom:3pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;vertical-align:top;">(i) </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;"> In computing diluted earnings per share, incremental common shares are not considered in periods in which a net loss is reported, as the inclusion of the common share equivalents would be anti-dilutive.</span></div> -106977000 185999000 -30937000 500090000 349075408 334665873 348946439 317940749 -0.31 0.56 -0.09 1.57 -106977000 185999000 -30937000 500090000 -729000 -126032000 -729000 -350758000 -107706000 59967000 -31666000 149332000 349075408 334665873 348946439 317940749 0 19287262 0 21239056 0 10992464 0 11291914 0 0 0 0 0 9100465 0 13633605 0 630531 0 766769 349075408 374676595 348946439 364872093 -0.31 0.16 -0.09 0.41 <div style="margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following securities were not included in the computation of diluted shares outstanding because the effect would be anti-dilutive or because conditions for contingently issuable shares were not satisfied at the end of the reporting periods. </span></div><div style="margin-top:12pt;margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:40.222%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:11.194%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.466%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.194%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.466%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.194%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.466%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.198%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Three months ended June 30,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Six months ended June 30,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Ginkgo Equity Milestones</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14,674,904 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14,674,904 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14,674,904 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14,674,904 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Pre-emptive Rights</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12,006,740 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12,006,740 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12,006,740 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12,006,740 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Top-up Rights – fixed price</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">26,686,413 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">26,686,413 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Top-up Rights – market price</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,941,349 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">25,150,434 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,941,349 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">25,150,434 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Altria Warrant</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">77,752,533 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,076,553 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">77,752,533 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,076,553 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Stock options</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,495,235 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">51,830 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,547,256 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">51,830 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Warrants</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">17,536,558 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">17,521,903 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Restricted share units</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,012,249 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,012,249 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total anti-dilutive securities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">162,091,326 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">52,960,461 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">162,158,002 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">52,960,461 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div> 14674904 14674904 14674904 14674904 12006740 12006740 12006740 12006740 26686413 0 26686413 0 1941349 25150434 1941349 25150434 77752533 1076553 77752533 1076553 10495235 51830 10547256 51830 17536558 0 17521903 0 1012249 0 1012249 0 162091326 52960461 162158002 52960461 Related Party Transactions and Balances<div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">On March 8, 2019, in connection with the Altria Investment, Altria, through certain of its wholly owned subsidiaries, purchased a 45% equity interest in the Company. During the three and six months ended June 30, 2020, the Company incurred $281 and $953 respectively, for consulting services from Altria Pinnacle LLC, a subsidiary of Altria (“Altria Pinnacle”). As of June 30, 2020, the accrual for these consulting services was $281 (December 31, 2019 – $1,152). No consulting services were provided by Altria Pinnacle for the three and six months ended June 30, 2019.</span></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">During 2019, the Company purchased machinery and equipment amounting to $1,258 from a subsidiary of Altria. Refer to Note 19 for additional information. </span></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Refer to Note 11 for further information on the derivative liabilities related to the Altria Investment.</span></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">There were no other material related party transactions for the six months ended June 30, 2020 or June 30, 2019.</span></div> 0.45 281000 953000 281000 1152000 0 0 1258000 Segment Information<div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Segment reporting is prepared on the same basis that the Company’s chief operating decision makers (the “CODMs”) manage the business, make operating decisions and assess the Company’s performance. The Company determined that it has the following two reportable segments: United States and Rest of World. </span><span style="background-color:rgb(255,255,255, 0.0);color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The United States operating segment consists of the </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">manufacture and distribution of hemp-derived CBD infused products. </span><span style="background-color:rgb(255,255,255, 0.0);color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Rest of World operating segment is involved in </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets</span><span style="background-color:rgb(255,255,255, 0.0);color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">. </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">These two segments represent the geographic regions in which the Company operates and the different product offerings within each geographic region. The results of each segment are regularly reviewed by the CODMs to assess the performance of the segment and make decisions regarding the allocation of resources. The CODMs review operating income (loss) as the measure of segment profit or loss to evaluate performance of and allocate resources for its reportable segments. Operating income (loss) is defined as net revenue less cost of sales and operating expenses.</span></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Reporting by operating segments follows the same accounting policies as those used to prepare the consolidated financial statements. The operating segments are presented in accordance with the same criteria used for internal reporting prepared for the CODMs. Intersegment transactions are recorded at the stated values as agreed to by the segments.</span></div><div style="text-align:justify;margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Segment data was as follows for the three months ended June 30, 2020: </span></div><div style="text-align:justify;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:35.222%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.444%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.466%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.444%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.466%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.444%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.466%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.448%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="21" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Three months ended June 30, 2020</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">United States</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Rest of World</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Corporate</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Consolidated statements of net income (loss) and comprehensive income (loss)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net revenue</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cannabis flower</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,674 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,674 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cannabis extracts</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,174 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,917 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,091 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">118 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">118 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:12pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net revenue</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,174 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7,709 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,883 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Share of loss from investments in equity accounted investees</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">794 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">794 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest income</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,811 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,817 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest expense</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(83)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(83)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest income, net</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,728 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,734 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Impairment loss on goodwill and intangible assets</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">40,000 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">40,000 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Depreciation and amortization</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">36 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">654 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">684 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Income tax expense</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net income (loss)</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(47,762)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(52,899)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(7,042)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(107,703)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr></table></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Segment data was as follows for the six months ended June 30, 2020:</span></div><div style="margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:35.222%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.444%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.466%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.444%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.466%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.444%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.466%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.448%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="21" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Six months ended June 30, 2020</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">United States</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Rest of World</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Corporate</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Consolidated statements of net income (loss) and comprehensive income (loss)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net revenue</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cannabis flower</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8,415 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8,415 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cannabis extracts</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,350 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,317 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,667 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">233 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">233 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:18pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net revenue</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,350 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13,965 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18,315 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Share of loss from investments in equity accounted investees</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,966 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,966 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest income</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,562 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,575 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest expense</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(90)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(90)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest income, net</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,472 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,485 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Impairment loss on goodwill and intangible assets</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">40,000 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">40,000 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Depreciation and amortization</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">69 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,302 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,371 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Income tax expense</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net income (loss)</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(57,567)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">39,257 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(13,712)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(32,022)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Consolidated balance sheets</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total assets</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">250,470 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">348,569 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,311,248 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,910,287 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Investments in equity accounted investees</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">933 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">933 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Goodwill</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">178,414 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,322 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">179,736 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:6pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Purchase of property, plant and equipment, net</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">219 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13,125 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13,344 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div><div style="margin-top:12pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Sources of net revenue for the three and six months ended June 30, 2020 and 2019 were as follows:</span></div><div style="margin-bottom:12pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:50.777%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:8.972%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.911%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.972%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.911%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.972%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.911%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.974%;"/><td style="width:1.0%;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Three months ended June 30,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Six months ended June 30,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cannabis flower</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,674 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,096 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8,415 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7,921 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cannabis extracts</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,091 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,535 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,667 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,638 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">118 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">22 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">233 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">98 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:12pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net revenue</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,883 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7,653 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18,315 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,657 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr></table></div><div style="text-align:justify;margin-top:6pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Net revenue attributed to a geographic region based on the location of the customer were as follows:</span></div><div style="margin-top:6pt;margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:50.777%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:8.972%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.911%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.972%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.911%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.972%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.911%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.974%;"/><td style="width:1.0%;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Three months ended June 30,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Six months ended June 30,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Canada</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7,416 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7,340 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13,507 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,323 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">United States</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,174 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,350 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other countries</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">293 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">313 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">458 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">334 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,883 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-bottom:3pt double #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7,653 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18,315 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,657 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr></table></div><div style="text-align:justify;margin-top:12pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Property, plant and equipment assets were physically located in the following geographic regions: </span></div><div style="margin-top:12pt;margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:50.777%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:20.777%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.466%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:20.780%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">As of June 30, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">As of December 31, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Canada</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">140,357 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">141,021 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">United States</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,253 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,103 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other countries</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">21,680 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18,685 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">164,290 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">161,809 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div><div style="text-align:justify;margin-top:6pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company sells products through a limited number of major customers. Major customers are defined as customers that each individually accounted for greater than 10% of the Company’s revenues and greater than 10% of accounts receivable.</span></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">United States</span></div><div style="text-align:justify;margin-bottom:3pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">During the three and six months ended June 30, 2020, the U.S. segment had no major customers.</span></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As of June 30, 2020, $46 (December 31, 2019 – $12) in expected credit losses has been recognized on receivables from contracts with customers.</span></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Rest of World</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">During the three months ended, June 30, 2020, the Rest of World segment earned a total net revenue before excise taxes of $7,040 from four major customers, BC Liquor Distribution Branch, Alberta Gaming, Liquor and Cannabis Commission, Ontario Cannabis Retail Corporation, and Société Québécoise du Cannabis accounting for 26%, 19%, 16% and 12% of the Company’s total revenues, respectively (three months ended June 30, 2019 – $4,118 from one major customer accounting for 54% of the Company’s total revenues).</span></div><div style="text-align:justify;margin-top:6pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">During the six months ended, June 30, 2020, the Rest of World segment earned a total net revenue before excise taxes of $11,819 from the same four major customers as mentioned above, representing 19%, 22%, 13%, and 13% of the Company’s total revenues, respectively (six months ended June 30, 2019 – $5,800 from two major customers, together accounting for 54% of the Company’s total revenues). </span></div>As of June 30, 2020, $34 (December 31, 2019 – $124) in expected credit losses has been recognized on receivables from contracts with customers. 2 2 <div style="text-align:justify;margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Segment data was as follows for the three months ended June 30, 2020: </span></div><div style="text-align:justify;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:35.222%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.444%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.466%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.444%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.466%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.444%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.466%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.448%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="21" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Three months ended June 30, 2020</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">United States</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Rest of World</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Corporate</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Consolidated statements of net income (loss) and comprehensive income (loss)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net revenue</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cannabis flower</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,674 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,674 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cannabis extracts</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,174 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,917 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,091 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">118 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">118 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:12pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net revenue</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,174 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7,709 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,883 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Share of loss from investments in equity accounted investees</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">794 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">794 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest income</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,811 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,817 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest expense</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(83)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(83)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest income, net</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,728 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,734 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Impairment loss on goodwill and intangible assets</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">40,000 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">40,000 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Depreciation and amortization</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">36 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">654 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">684 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Income tax expense</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net income (loss)</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(47,762)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(52,899)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(7,042)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(107,703)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr></table></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Segment data was as follows for the six months ended June 30, 2020:</span></div><div style="margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:35.222%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.444%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.466%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.444%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.466%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.444%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.466%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.448%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="21" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Six months ended June 30, 2020</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">United States</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Rest of World</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Corporate</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Consolidated statements of net income (loss) and comprehensive income (loss)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net revenue</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cannabis flower</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8,415 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8,415 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cannabis extracts</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,350 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,317 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,667 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">233 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">233 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:18pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net revenue</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,350 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13,965 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18,315 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Share of loss from investments in equity accounted investees</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,966 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,966 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest income</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,562 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,575 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest expense</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(90)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(90)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest income, net</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,472 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,485 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Impairment loss on goodwill and intangible assets</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">40,000 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">40,000 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Depreciation and amortization</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">69 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,302 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,371 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Income tax expense</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net income (loss)</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(57,567)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">39,257 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(13,712)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(32,022)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Consolidated balance sheets</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total assets</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">250,470 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">348,569 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,311,248 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,910,287 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Investments in equity accounted investees</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">933 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">933 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Goodwill</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">178,414 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,322 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">179,736 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:6pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Purchase of property, plant and equipment, net</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">219 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13,125 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13,344 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div><div style="margin-top:12pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Sources of net revenue for the three and six months ended June 30, 2020 and 2019 were as follows:</span></div><div style="margin-bottom:12pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:50.777%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:8.972%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.911%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.972%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.911%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.972%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.911%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.974%;"/><td style="width:1.0%;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Three months ended June 30,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Six months ended June 30,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cannabis flower</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,674 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,096 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8,415 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7,921 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cannabis extracts</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,091 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,535 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,667 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,638 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">118 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">22 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">233 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">98 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:12pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net revenue</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,883 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7,653 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18,315 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,657 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr></table></div> 0 5674000 0 5674000 2174000 1917000 0 4091000 0 118000 0 118000 2174000 7709000 0 9883000 0 -794000 0 -794000 8000 3811000 -2000 3817000 0 83000 0 83000 8000 3728000 -2000 3734000 40000000 40000000 0 0 40000000 36000 654000 -6000 684000 0 0 0 0 -47762000 -52899000 -7042000 -107703000 0 8415000 0 8415000 4350000 5317000 0 9667000 0 233000 0 233000 4350000 13965000 0 18315000 0 -1966000 0 -1966000 13000 11562000 0 11575000 0 90000 0 90000 13000 11472000 0 11485000 40000000 40000000 0 0 40000000 69000 1302000 0 1371000 0 0 0 0 -57567000 39257000 -13712000 -32022000 250470000 348569000 1311248000 1910287000 0 933000 0 933000 178414000 1322000 0 179736000 219000 13125000 0 13344000 5674000 6096000 8415000 7921000 4091000 1535000 9667000 2638000 118000 22000 233000 98000 9883000 7653000 18315000 10657000 <div style="text-align:justify;margin-top:6pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Net revenue attributed to a geographic region based on the location of the customer were as follows:</span></div><div style="margin-top:6pt;margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:50.777%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:8.972%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.911%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.972%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.911%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.972%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.911%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.974%;"/><td style="width:1.0%;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Three months ended June 30,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Six months ended June 30,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Canada</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7,416 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7,340 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13,507 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,323 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">United States</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,174 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,350 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other countries</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">293 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">313 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">458 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">334 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,883 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-bottom:3pt double #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7,653 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18,315 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,657 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr></table></div> 7416000 7340000 13507000 10323000 2174000 0 4350000 0 293000 313000 458000 334000 9883000 7653000 18315000 10657000 <div style="text-align:justify;margin-top:12pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Property, plant and equipment assets were physically located in the following geographic regions: </span></div><div style="margin-top:12pt;margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:50.777%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:20.777%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.466%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:20.780%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">As of June 30, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">As of December 31, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Canada</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">140,357 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">141,021 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">United States</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,253 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,103 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other countries</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">21,680 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18,685 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">164,290 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">161,809 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div> 140357000 141021000 2253000 2103000 21680000 18685000 164290000 161809000 46000 12000 7040000 0.26 0.19 0.16 0.12 4118000 0.54 11819000 0.19 0.22 0.13 0.13 5800000 0.54 34000 124000 Commitments <div style="margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">(a)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt;">R&amp;D Commitments</span></div><div style="text-indent:-18pt;padding-left:45pt;text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(i) </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Ginkgo.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> On September 4, 2018, the Company announced an R&amp;D partnership with Ginkgo to develop scalable and consistent production of eight target cannabinoids, including THC, CBD and a variety of other lesser known and rarer cannabinoids. As part of this partnership, Cronos Group has agreed to issue up to 14,674,903 common shares of the Company (aggregate value of approximately $100,000 as of July 17, 2018 assuming all milestones are met) (collectively the “Ginkgo Equity Milestones”) in tranches and $22,000 in cash subject to Ginkgo’s achievement of certain milestones and to fund certain R&amp;D expenses, including foundry access fees. </span></div><div style="text-indent:-18pt;padding-left:45pt;text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(ii) </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Technion.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> On October 15, 2018, the Company entered into a sponsored research agreement with the Technion Research and Development Foundation of the Technion – Israel Institute of Technology (“Technion”). Research will be focused on the use of cannabinoids and their role in regulating skin health and skin disorders. The Company has committed to $1,784 of research funding over a period of three years. An additional $4,900 of cash payments will be paid to Technion upon the achievement of certain milestones.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"> </span></div><div style="margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">(b)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt;">Altria Consulting Services</span></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">On February 18, 2019, the Company entered into an agreement with a wholly owned subsidiary of Altria (which agreement was subsequently amended and restated to substitute Altria Pinnacle as a party thereto), to receive strategic advisory and project management services from Altria Pinnacle (the “Services Agreement”). Pursuant to the Services Agreement, the Company will pay Altria Pinnacle a monthly fee equal to the product of one hundred and five percent (105%) and the sum of: (i) all costs directly associated with the services incurred during the monthly period, and (ii) a reasonable and appropriate allocation of indirect costs incurred during the monthly period. The Company will also pay all third-party direct charges incurred during the monthly period in connection with the services, including any reasonable and documented costs, fees and expenses associated with obtaining any consent, license or permit. The Services Agreement will remain in effect until terminated by either party.</span></div><div style="margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">(c)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.91pt;">Use of Publicity Rights in Brand Development</span></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">On December 23, 2019, the Company issued 856,017 restricted common shares to an accredited investor in a private placement (“Private Placement – 2019”) in reliance on Section 4(a)(2) of the Securities Act of 1933 in connection with the use of certain publicity rights in brand development. One-third of such common shares vested on January 31, 2020 with the remaining shares vesting in two equal installments on June 23, 2021, and December 23, 2022. The issuance did not involve a public offering and was made without general solicitation or advertising. The total fair value of the consideration paid for the issuance of such common shares was approximately $6,000. The fair value of the shares was calculated using the ten-day volume weighted average price per share of the Company’s common shares on Nasdaq.</span></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Additional restricted common shares are issued when certain performance milestones are achieved:</span></div><div style="text-indent:-18pt;padding-left:45pt;text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(i) First Performance Issuance: if, prior to December 23, 2022, the product line generates at least $50,000 in net revenue, additional common shares with an aggregate value of $1,000 will be issued.</span></div><div style="text-indent:-18pt;padding-left:45pt;text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(ii) Second Performance Issuance: if, prior to December 23, 2022, the product line generates at least $100,000 in net revenue, additional common shares with an aggregate value of $1,000 will be issued (together with the First Performance Issuance noted above).</span></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The number of common shares that would be issued upon achieving the foregoing milestones will be determined based on the ten-day volume weighted average price per share of the Company’s common shares on Nasdaq as of the trading day immediately prior to the date of filing with the SEC of the Company’s audited year-end financial statements for the first fiscal year during which such milestones are achieved.</span></div><div style="margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">(d)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt;">Take or Pay Supply Agreement</span></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In January 2020, the Company entered into a take or pay supply agreement with a supplier of dried cannabis flower. The Company agreed to purchase a minimum of approximately C$1,734 ($1,290) of dried cannabis flower over 6 months from the date of the agreement and, subject to the supplier’s satisfaction of certain conditions and the availability of additional product, potentially up to a maximum of approximately C$4,284 ($3,188) over 6 months from the date of the agreement. As </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">a</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">t June 30, 2020, the Company is committed to purchase approximately C$1,230 ($906) of dried cannabis flower remaining under this agreement which, due to delays in deliveries from the supplier, are expected to be made during the remainder of 2020.</span></div> 8 14674903 100000000 22000000 1784000 P3Y 4900000 1.05 856017 6000000 10 50000000 1000000 100000000 1000000 10 1734000 1290000 P6M 4284000 3188000 P6M 1230000 906000 Contingencies <div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company is subject to various legal proceedings in the ordinary course of business and in connection with its marketing, distribution and sale of its products. Many of these legal proceedings are in the early stages of litigation and seek damages that are unspecified or not quantified. Although the outcome of these matters cannot be predicted with certainty, the Company does not believe these legal proceedings, individually or in the aggregate, will have a material adverse effect on the Company’s financial condition but could be material to the Company’s results of operations for a quarterly period depending, in part, on the results for that quarter.</span></div><div style="margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">(a)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt;">Class Action Complaints Relating to Restatements</span></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">On March 11 and 12, 2020, two alleged shareholders of the Company separately filed two putative class action complaints in the U.S. District Court for the Eastern District of New York against the Company and its Chief Executive Officer and Chief Financial Officer alleging violations of Section 10(b) of the Securities Exchange Act of 1934 (the “Exchange Act”) and Rule 10b-5 promulgated thereunder against all defendants, and Section 20(a) of the Exchange Act against the individual defendants. The complaints generally allege that certain of the Company’s prior public statements about revenues and internal controls were incorrect based on the Company’s March 2, 2020, disclosure that the Audit Committee of its Board of Directors was conducting a review of the appropriateness of revenue recognized in connection with certain bulk resin purchases and sales of products through the wholesale channel. The complaints do not quantify a damage request. Defendants have not yet responded to the complaints.</span></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">On June 3, 2020, an alleged shareholder filed a Statement of Claim in the Ontario Superior Court of Justice in Toronto, Ontario, Canada, seeking, among other things, an order certifying the action as a class action on behalf of a putative class of shareholders and damages of an unspecified amount. The Statement of Claim names the Company, its Chief Executive Officer, Chief Financial Officer, former Chief Financial Officer and Chief Commercial Officer, and current and former members of its Board of Directors as defendants and alleges breaches of the Ontario Securities Act, oppression under the Ontario Business Corporations Act and common law misrepresentation. The Statement of Claim generally alleges that certain of the Company’s prior public statements about revenues and internal controls were misrepresentations based on the Company’s March 2, 2020 disclosure that the Audit Committee of its Board of Directors was conducting a review of the appropriateness of revenue recognized in connection with certain bulk resin purchases and sales of products through the wholesale channel, and the Company’s subsequent restatements. The Statement of Claim does not quantify its damage request. The Company and the other named defendants have not yet filed a response to the Statement of Claim.</span></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">(b)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt;">Regulatory Reviews Relating to Restatements</span></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company has been responding to requests for information from various regulatory authorities relating to its previously disclosed restatement of its financial statements for the first three quarters of 2019. The Company is responding to all such requests for information and cooperating with all regulatory authorities. The Company cannot predict the outcome of any such regulatory review or investigation and it is possible that additional investigations or one or more formal proceedings may be commenced against the Company and its current and former officers and directors in connection with these regulatory reviews. </span></div><div style="margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">(c)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.91pt;">Litigation Relating to Marketing, Distribution and Sale of Products</span></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">On June 16, 2020, an alleged consumer filed a Statement of Claim on behalf of a class in the Court of Queen’s Bench of Alberta in Alberta, Canada, against the Company and other Canadian cannabis manufacturers and/or distributors. The Statement of Claim alleges claims related to the defendants’ advertised content of cannabinoids in cannabis products for medicinal use on or after June 16, 2010 and cannabis products for adult use on or after October 17, 2018. The Statement of Claim seeks a total of C$500 million for breach of contract, compensatory damages, and unjust enrichment or such other amount as may be proven in trial and C$5 million in punitive damages against each defendant, including the Company. The Statement of Claim also seeks interest and costs associated with the action. The Company has not responded to the Statement of the Claim. </span></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">A number of claims, including purported class actions, have been brought in the U.S. against companies engaged in the U.S. hemp business alleging, among other things, violations of state consumer protection, health and advertising laws. On April 8, 2020, a putative class action complaint was filed in the U.S. District Court for the Central District of California against Redwood, alleging violations of California’s Unfair Competition Law, False Advertising Law, Consumers Legal Remedies Act, and breaches of the California Commercial Code for breach of express warranties and implied warranty of merchantability with respect to Redwood’s marketing and sale of U.S. hemp products. The complaint does not quantify a damage request. On April 14, 2020, the class action complaint was dismissed for certain pleading deficiencies and the plaintiff was granted leave until April 24, 2020 to amend the complaint to establish federal subject matter jurisdiction. As of the date of this Quarterly Report, the plaintiff has not refiled the complaint and the complaint has been dismissed without prejudice</span></div>The Company expects litigation and regulatory proceedings relating to the marketing, distribution and sale of its products to increase. 2 2 500000000 5000000 Financial Instruments<div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company’s activities expose it to a variety of financial risks, including credit risk, liquidity risk, and market risk (including interest rate risk) and foreign currency risk.</span></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">(a)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt;">Credit Risk</span></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Credit risk is the risk of financial loss to the Company if a customer or counterparty to a financial instrument fails to meet its contractual obligations. The Company is exposed to credit risk from its operating activities, primarily accounts receivable and other receivables, and its investing activities, including cash held with banks and financial institutions, short-term investments, loan receivable, and advances to joint ventures. The Company’s maximum exposure to this risk is equal to the carrying amount of these financial assets, which amounted to $1,424,786 as of June 30, 2020 (December 31, 2019 – $1,586,978).</span></div><div style="text-indent:-18pt;padding-left:36pt;text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">(i)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:8.57pt;">Accounts receivable</span></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">An impairment analysis is performed at each reporting date using a provision matrix to measure expected credit losses. The provision rates are based on the days past due for groupings of various customer segments with similar loss patterns. The calculation reflects the probability-weighted outcome, the time value of money and reasonable and supportable information that is available at the reporting date about past events, current conditions and forecasts of future economic conditions. Accounts receivable are written off when there is no reasonable expectation of recovery. Indicators that there is no reasonable expectation of recovery include, among others, the failure of a debtor to engage in a repayment plan, and a failure to make contractual payments for a period of greater than 120 days past due. For the three months ended June 30, 2020, the Company recorded a current expected credit loss allowance of $80 (December 31, 2019 – $136). The Company has assessed that there is a concentration of credit risk, as 78% of the Company’s accounts receivable were due from four customers as of June 30, 2020 (December 31, 2019 – 56% due from two customers) with an established credit history with the Company.</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">(ii)</span><span style="background-color:rgb(255,255,255, 0.0);color:#002060;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%;padding-left:5.8pt;">C</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">ash and cash equivalents, short-term investments, and other receivables</span></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company held cash and cash equivalents of $1,109,700 as of June 30, 2020 (December 31, 2019 – $1,199,693). The short-term investments and related interest receivable of $213,614 as of June 30, 2020 (December 31, 2019 – $306,347) represents short-term investments with a maturity of less than a year and accrued interest as of period end. The cash and cash equivalents and short-term investments, including guaranteed investment certificates and bankers’ acceptances, are held with central banks and financial institutions that are highly rated. In addition to interest receivable, other receivables include sales taxes receivable from the government. As such, the Company has assessed an insignificant loss allowance on these financial instruments. </span></div><div style="text-indent:-18pt;padding-left:36pt;text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">(iii)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:3.03pt;">Advances to joint ventures</span></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company has assessed the credit risk of advances to joint ventures based on the financial position of the borrowers, and the regulatory and economic environment of the borrowers. Based on historical information, and adjusted for forward-looking expectations, the Company has assessed an expected credit loss allowance on these advances as of June 30, 2020 of $nil (December 31, 2019 – $nil).</span></div><div style="margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">(b)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt;"> Liquidity risk </span></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Liquidity risk is the risk that the Company will not be able to meet its financial obligations as they become due and arises principally from the Company’s accounts payable and other liabilities. The Company’s policy is to review liquidity resources and ensure that sufficient funds are available to meet financial obligations as they become due. Further, the Company’s management is responsible for ensuring funds exist and are readily accessible to support business opportunities as they arise. The Company’s funding is primarily provided in the form of capital raised through the issuance of common shares and warrants. As of June 30, 2020, 14% of the Company’s payables were due to one vendor (December 31, 2019 – 42% due to three vendors).</span></div><div style="text-indent:-36pt;padding-left:36pt;text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">(c)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.91pt;">Market risk</span></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Market risk is the risk that the fair value of, or future cash flows from, the Company’s financial instruments will significantly fluctuate due to changes in market prices. The value of financial instruments can be affected by changes in interest rates, market and economic conditions, and equity and commodity prices. The Company is exposed to market risk in divesting its investments, such that, unfavorable market conditions could result in dispositions of investments at less than their carrying values. Further, the revaluation of securities classified as fair value through net income, could result in significant write-downs of the Company’s investments, which would have an adverse impact on the Company’s financial position, unless these would flow through other comprehensive income.</span></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company manages market risk by having a portfolio of securities from multiple issuers so that the Company is not materially exposed to any one issuer.</span></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">(d) Interest rate risk </span></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Interest rate risk is the risk that the value or yield of fixed-income investments may decline if interest rates change. Fluctuations in interest rates may impact the level of income and expense recorded on the cash equivalents and short-term investments, and the market value of all interest-earning assets, other than those which possess a short-term to maturity. A 10% change in the interest rate in effect on June 30, 2020 and December 31, 2019, would not have a material effect on (i) fair value of the cash equivalents and short-term investments as the majority of the portfolio has a maturity date of three months or less, or (ii) interest income. Management continues to monitor external interest rates and revise the Company’s investment strategy as a result. </span></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">During the six months ended June 30, 2020, the Company had net interest income of $11,485 (June 30, 2019 – $11,528). During the three and six months ended June 30, 2020, the Company’s average variable interest rate fell 0.73% and 1.45%, respectively. Had the interest rates been consistent, net interest income would have increased by $2,090 and $7,292, respectively for the three and six months ended June 30, 2020.</span></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">(e) Currency rate risk </span></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Currency rate risk is the risk that the fair value of, or future cash flows from, the Company’s financial instruments will significantly fluctuate due to changes in foreign exchange rates. The Company is exposed to this risk on advances to joint ventures denominated in A$ and C$. The Company is further exposed to this risk through subsidiaries operating in Israel and the U.S. as the Company’s functional currency is in Canadian dollars. The Company does not currently use foreign exchange contracts to hedge its exposure to currency rate risk. As such, the Company’s financial position and financial results may be adversely affected by the unfavorable fluctuations in currency exchange rates. </span></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As of June 30, 2020, the Company had foreign currency gain (loss) on translation of $(61,821) (June 30, 2019 – $21,845). A 10% change in the exchange rates for the U.S. dollar would affect the carrying value of net assets by approximately $166,395 as of June 30, 2020 (December 31, 2019 – $174,902).</span></div> 1424786000 1586978000 P120D 80000 136000 0.78 0.56 1109700000 1199693000 213614000 306347000 0 0 0.14 0.42 11485000 11528000 -0.0073 -0.0145 2090000 7292000 -61821000 21845000 166395000 174902000 Fair Value Measurement <div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company complies with ASC 820, Fair Value Measurements, for its financial assets and liabilities that are re-measured and reported at fair value at each reporting period, and non-financial assets and liabilities that are re-measured and reported at fair value at least annually. In general, fair values are determined by:</span></div><div style="text-indent:-18pt;padding-left:36pt;text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">•</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Level 1 inputs utilize quoted prices (unadjusted) in active markets for identical assets or liabilities. </span></div><div style="text-indent:-18pt;padding-left:36pt;text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">•</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Level 2 inputs utilize data points that are observable such as quoted prices, interest rates and yield curves. </span></div><div style="text-indent:-18pt;padding-left:36pt;text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">•</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Level 3 inputs are unobservable data points for the asset or liability, and includes situations where there is little, if any, market activity for the asset or liability.</span></div><div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following tables present information about the Company’s assets that are measured at fair value on a recurring basis as of June 30, 2020 and December 31 2019, and indicates the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value. </span></div><div style="margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%;"><tr><td style="width:1.0%;"/><td style="width:35.134%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.881%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.912%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.881%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.912%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.881%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.912%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.887%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2020</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 1</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 2</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 3</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash and cash equivalents</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,109,700 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,109,700 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Short-term investments</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">213,614 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">213,614 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Derivative liabilities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">205,714 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">205,714 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:34.805%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.861%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.050%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.861%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.050%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.861%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.050%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.862%;"/><td style="width:1.0%;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31, 2019</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 1</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 2</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 3</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash and cash equivalents</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,199,693 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,199,693 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Short-term investments</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">306,347 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">306,347 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Derivative liabilities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">297,160 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">297,160 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/></tr></table></div><div style="margin-top:12pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">There were no transfers between categories during the periods presented.</span></div> <div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following tables present information about the Company’s assets that are measured at fair value on a recurring basis as of June 30, 2020 and December 31 2019, and indicates the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value. </span></div><div style="margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%;"><tr><td style="width:1.0%;"/><td style="width:35.134%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.881%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.912%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.881%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.912%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.881%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.912%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.887%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2020</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 1</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 2</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 3</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash and cash equivalents</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,109,700 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,109,700 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Short-term investments</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">213,614 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">213,614 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Derivative liabilities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">205,714 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">205,714 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:34.805%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.861%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.050%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.861%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.050%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.861%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.050%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.862%;"/><td style="width:1.0%;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31, 2019</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 1</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 2</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 3</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash and cash equivalents</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,199,693 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,199,693 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Short-term investments</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">306,347 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">306,347 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Derivative liabilities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">297,160 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">297,160 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/></tr></table></div> 1109700000 0 0 1109700000 213614000 0 0 213614000 0 0 205714000 205714000 1199693000 0 0 1199693000 306347000 0 0 306347000 0 0 297160000 297160000 Supplementary Cash Flow Information<div style="margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> The net changes in non-cash working capital items are as follows:</span></div><div style="margin-top:6pt;margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:66.055%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:13.138%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.466%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:13.141%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">For the six months ended June 30,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accounts receivable</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,161 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3,986)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other receivables</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2,336)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(7,681)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Prepaids and other assets</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,568 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2,564)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Inventory</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(23,913)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(15,105)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accounts payable and other liabilities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(6,985)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,877 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cumulative effect from foreign exchange</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(65)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2,132)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(30,570)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(21,591)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div> The net changes in non-cash working capital items are as follows:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:66.055%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:13.138%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.466%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:13.141%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">For the six months ended June 30,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accounts receivable</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,161 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3,986)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other receivables</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2,336)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(7,681)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Prepaids and other assets</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,568 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2,564)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Inventory</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(23,913)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(15,105)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accounts payable and other liabilities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(6,985)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,877 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cumulative effect from foreign exchange</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(65)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2,132)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(30,570)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(21,591)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table> -1161000 3986000 2336000 7681000 -1568000 2564000 23913000 15105000 -6985000 9877000 -65000 -2132000 30570000 21591000 Non-monetary Transactions <div style="text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">During the six months ended June 30, 2020, the Company had no non-monetary transactions.</span></div><div style="text-align:justify;margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">On March 28, 2019, the Company entered into two transactions to simultaneously purchase and sell inventory to a third party. The Company purchased cannabis resin from the third party and in turn sold cannabis dry flower to the third party. The transactions involved the exchange of work in progress inventory and were accounted for at the carrying value of inventory transferred by the Company, which equaled the value of the cannabis resin received. No revenue was recognized as a result of this transaction and no gain or loss was recognized in the condensed consolidated statements of operations and comprehensive income (loss).</span></div> 0 2 0 0 Subsequent Events <div style="text-align:justify;margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(a)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt;">On July 24, 2020, the Company entered into an amendment to the Series A Loan with Natuera to increase the principal amount of the Series A Loan by $6,350, to an aggregate principal amount of $15,500, of which the Company has committed to fund 50% and its joint venture partner has committed to fund the remaining 50%. Outstanding principal amounts continue to bear interest at a fixed annual rate of 5.67% and the maturity date of the Series A Loan has been extended to March 1, 2021. As of June 30, 2020, the Company has a loan receivable (net of credit allowance) of $2,984 from Natuera. Refer to Note 10 for details. </span></div><div style="text-align:justify;margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(b)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt;">On July 20, 2020, the Company entered into separation agreements with Robert Rosenheck and another Redwood employee pursuant to which they resigned from their employment with Redwood Wellness, LLC. In connection with such separation agreements, the 732,972 outstanding and unvested RSUs as of July 20, 2020 to which they were entitled were accelerated and vested as of July 20, 2020. A total of $6.2 million of share-based compensation costs will be recognized in the third quarter of 2020.</span></div> 6350000 15500000 0.50 0.50 0.0567 2984000 732972 6200000 Authorized for issuance as of June 30, 2020: unlimited (December 31, 2019 – unlimited). Shares issued as of June 30, 2020: 349,886,402 (as of December 31, 2019: 348,817,472) Net of current expected credit loss allowance of $80 as of June 30, 2020 (December 31, 2019 – $136) Refer to Note 19 and Note 20 in the notes to condensed consolidated financial statements. In computing diluted earnings per share, incremental common shares are not considered in periods in which a net loss is reported, as the inclusion of the common share equivalents would be anti-dilutive. XML 22 R1.htm IDEA: XBRL DOCUMENT v3.20.2
Cover Page - shares
6 Months Ended
Jun. 30, 2020
Aug. 05, 2020
Cover [Abstract]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Jun. 30, 2020  
Document Transition Report false  
Entity File Number 001-38403  
Entity Registrant Name CRONOS GROUP INC.  
Entity Incorporation, State or Country Code Z4  
Entity Address, Address Line One 111 Peter St. Suite 300  
Entity Address, City or Town Toronto  
Entity Address, State or Province ON  
Entity Address, Postal Zip Code M5V 2G9  
City Area Code 416  
Local Phone Number 504-0004  
Title of 12(b) Security Common Shares, no par value  
Trading Symbol CRON  
Security Exchange Name NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding (in shares)   349,886,402
Amendment Flag false  
Document Fiscal Year Focus 2020  
Document Fiscal Period Focus Q2  
Entity Central Index Key 0001656472  
Current Fiscal Year End Date --12-31